PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cahan, P; Li, Y; Izumi, M; Graubert, TA				Cahan, Patrick; Li, Yedda; Izumi, Masayo; Graubert, Timothy A.			The impact of copy number variation on local gene expression in mouse hematopoietic stem and progenitor cells	NATURE GENETICS			English	Article							HUMAN GENOME; DROSOPHILA-MELANOGASTER; DELETION POLYMORPHISM; LABORATORY MOUSE; ARRAY CGH; STRAINS; DISEASE; MICE; LOCUS; DUPLICATIONS	The extent to which differences in germline DNA copy number contribute to natural phenotypic variation is unknown. We analyzed the copy number content of the mouse genome to sub-10-kb resolution. We identified over 1,300 copy number variant regions (CNVRs), most of which are <10 kb in length, are found in more than one strain, and, in total, span 3.2% (85 Mb) of the genome. To assess the potential functional impact of copy number variation, we mapped expression profiles of purified hematopoietic stem and progenitor cells, adipose tissue and hypothalamus to CNVRs in cis. Of the more than 600 significant associations between CNVRs and expression profiles, most map to CNVRs outside of the transcribed regions of genes. In hematopoietic stem and progenitor cells, up to 28% of strain-dependent expression variation is associated with copy number variation, supporting the role of germline CNVs as key contributors to natural phenotypic variation in the laboratory mouse.	[Cahan, Patrick; Li, Yedda; Izumi, Masayo; Graubert, Timothy A.] Washington Univ, Dept Internal Med, Div Oncol, Stem Cell Biol Sect, St Louis, MO 63130 USA	Washington University (WUSTL)	Graubert, TA (corresponding author), Washington Univ, Dept Internal Med, Div Oncol, Stem Cell Biol Sect, St Louis, MO 63130 USA.	graubert@wustl.edu		Graubert, Timothy/0000-0002-7710-1171; Cahan, Patrick/0000-0003-3652-2540; Li, Yedda/0000-0001-7629-2757	US National Institutes of Health/National Cancer Institute [CA101937]; National Human Genome Research Institute [T32 HG000045]; Kauffman Fellowship; NCI Cancer Center [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, P01CA101937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015867] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082973] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Kauffman Fellowship; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by a grant from the US National Institutes of Health/National Cancer Institute (CA101937). P. C. was supported in part by the National Human Genome Research Institute (T32 HG000045) and a Kauffman Fellowship. Mice were provided through a collaboration with the Mouse Phenome Project (The Jackson Laboratory, Bar Harbor, Maine). Additional mice were provided by M. You (Washington University). We thank T. Ley, D. Link and M. Walter for helpful discussions. Cell sorting was done by the High Speed Cell Sorter Core in the Alvin J. Siteman Cancer Center at Washington University School of Medicine. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA91842).	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; BISHOP TR, 1986, P NATL ACAD SCI USA, V83, P5568, DOI 10.1073/pnas.83.15.5568; Bishop TR, 1998, GENOMICS, V48, P221, DOI 10.1006/geno.1997.5183; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; HOLM S, 1979, SCAND J STAT, V6, P65; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kaufman L, 1990, INTRO CLUSTER ANAL; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McClurg P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-61; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; Ohtsuka M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-178; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Szatkiewicz JP, 2008, MAMM GENOME, V19, P199, DOI 10.1007/s00335-008-9098-9; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070	47	101	102	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					430	437		10.1038/ng.350	http://dx.doi.org/10.1038/ng.350			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19270704	Green Accepted			2022-12-25	WOS:000264659000016
J	Hammad, H; Chieppa, M; Perros, F; Willart, MA; Germain, RN; Lambrecht, BN				Hammad, Hamida; Chieppa, Marcello; Perros, Frederic; Willart, Monique A.; Germain, Ronald N.; Lambrecht, Bart N.			House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells	NATURE MEDICINE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; DENDRITIC CELLS; EPITHELIAL-CELLS; ALVEOLAR MACROPHAGES; TH2 RESPONSES; INFLAMMATION; LIPOPOLYSACCHARIDE; ACTIVATION; INDUCTION; TOLL-LIKE-RECEPTOR-4	Barrier epithelial cells and airway dendritic cells (DCs) make up the first line of defense against inhaled substances such as house dust mite (HDM) allergen and endotoxin (lipopolysaccharide, LPS). We hypothesized that these cells need to communicate with each other to cause allergic disease. We show in irradiated chimeric mice that Toll-like receptor 4 (TLR4) expression on radioresistant lung structural cells, but not on DCs, is necessary and sufficient for DC activation in the lung and for priming of effector T helper responses to HDM. TLR4 triggering on structural cells caused production of the innate proallergic cytokines thymic stromal lymphopoietin, granulocyte-macrophage colony-stimulating factor, interleukin-25 and interleukin-33. The absence of TLR4 on structural cells, but not on hematopoietic cells, abolished HDM-driven allergic airway inflammation. Finally, inhalation of a TLR4 antagonist to target exposed epithelial cells suppressed the salient features of asthma, including bronchial hyperreactivity. Our data identify an innate immune function of airway epithelial cells that drives allergic inflammation via activation of mucosal DCs.	[Hammad, Hamida; Perros, Frederic; Willart, Monique A.; Lambrecht, Bart N.] Univ Ghent, Dept Resp Med, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium; [Chieppa, Marcello; Germain, Ronald N.] NIAID, Immunol Lab, Sect Lymphocyte Biol, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Lambrecht, Bart N.] Erasmus Univ, Med Ctr, Dept Pulm Med, Rotterdam, Netherlands	Ghent University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Univ Ghent, Dept Resp Med, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium.	bart.lambrecht@ugent.be	Germain, Ronald N./Z-1945-2019; Hammad, Hamida/J-9391-2015; Chieppa, Marcello/K-4846-2012; Chieppa, Marcello/AAG-9835-2019; Lambrecht, Bart N/K-2484-2014; Perros, Frédéric/N-6921-2017; Chieppa, Marcello/I-8447-2018; Germain, Ronald/ABE-7090-2020	Hammad, Hamida/0000-0003-3762-8603; Chieppa, Marcello/0000-0001-9819-0823; Lambrecht, Bart N/0000-0003-4376-6834; Perros, Frédéric/0000-0001-7730-2427; Chieppa, Marcello/0000-0001-9819-0823; 	Intramural NIH HHS [ZIA AI000545-21] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Berndt A, 2007, AM J PHYSIOL-LUNG C, V292, pL936, DOI 10.1152/ajplung.00394.2006; Beutler B, 2001, DRUG METAB DISPOS, V29, P474; BILYK N, 1993, J EXP MED, V177, P1773, DOI 10.1084/jem.177.6.1773; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fattouh R, 2005, AM J RESP CRIT CARE, V172, P314, DOI 10.1164/rccm.200502-198OC; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2007, ADV IMMUNOL, V93, P265, DOI 10.1016/S0065-2776(06)93007-7; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; IROMPETTE A, 2009, NATURE, V457, P585; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Lorenz E, 2001, AM J PHYSIOL-LUNG C, V281, pL1106, DOI 10.1152/ajplung.2001.281.5.L1106; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; NATHAN AI, 2009, J ALLERGY CLIN  0127, DOI DOI 10.1016/J.JACI.2008.12; Nolte MA, 2007, J EXP MED, V204, P1487, DOI 10.1084/jem.20070325; Noulin N, 2005, J IMMUNOL, V175, P6861, DOI 10.4049/jimmunol.175.10.6861; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; Saito T, 2005, CELL TISSUE RES, V321, P75, DOI 10.1007/s00441-005-1113-9; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Veres TZ, 2007, AM J RESP CELL MOL, V37, P553, DOI 10.1165/rcmb.2007-0087OC; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	45	814	844	3	103	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					410	416		10.1038/nm.1946	http://dx.doi.org/10.1038/nm.1946			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19330007	Green Accepted			2022-12-25	WOS:000264937200028
J	Hidalgo, A; Chang, JS; Jang, JE; Peired, AJ; Chiang, EY; Frenette, PS				Hidalgo, Andres; Chang, Jungshan; Jang, Jung-Eun; Peired, Anna J.; Chiang, Elaine Y.; Frenette, Paul S.			Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury	NATURE MEDICINE			English	Article							SICKLE-CELL-DISEASE; ACUTE LUNG INJURY; E-SELECTIN; P-SELECTIN; IN-VIVO; ADHESION MOLECULE-1; LEUKOCYTE ADHESION; MAC-1 CD11B/CD18; INTEGRIN; MICE	Selectins and their ligands mediate leukocyte rolling, allowing interactions with chemokines that lead to integrin activation and arrest. Here we show that E-selectin is crucial for generating a secondary wave of activating signals, transduced specifically by E-selectin ligand-1, that induces polarized, activated alpha(M)beta(2) integrin clusters at the leading edge of crawling neutrophils, allowing capture of circulating erythrocytes or platelets. In a humanized mouse model of sickle cell disease, the capture of erythrocytes by alpha(M)beta(2) microdomains leads to acute lethal vascular occlusions. In a model of transfusion-related acute lung injury, polarized neutrophils capture circulating platelets, resulting in the generation of oxidative species that produce vascular damage and lung injury. Inactivation of E-selectin or alpha(M)beta(2) prevents tissue injury in both inflammatory models, suggesting broad implications of this paradigm in thromboinflammatory diseases. These results indicate that endothelial selectins can influence neutrophil behavior beyond its canonical rolling step through delayed, organ-damaging, polarized activation.	[Hidalgo, Andres; Chang, Jungshan; Jang, Jung-Eun; Peired, Anna J.; Chiang, Elaine Y.; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Hidalgo, Andres; Chang, Jungshan; Jang, Jung-Eun; Peired, Anna J.; Chiang, Elaine Y.; Frenette, Paul S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA; [Frenette, Paul S.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Frenette, Paul S.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Frenette, Paul S.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	andres.hidalgo@mssm.edu; paul.frenette@mssm.edu	Hidalgo, Andrés/L-5643-2014; Frenette, Paul S/J-8272-2012; Peired, Anna Julie/J-9952-2019	Hidalgo, Andrés/0000-0001-5513-555X; Frenette, Paul S/0000-0003-0862-9922; Peired, Anna Julie/0000-0001-9732-1369	US National Institutes of Health [R01 HL69438, T32 HL07824]; American Heart Association [0735165N]; Spanish Ministry of Science and Innovation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824, R01HL069438] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. Jakubzick for help establishing the lung injury model and B. Wolitzky (Immune Tolerance Network) for the 9A9 antibody to E-selectin. This work was supported by US National Institutes of Health grants R01 HL69438 to P.S.F. and T32 HL07824 to J.C. and by a Scientist Development Grant from the American Heart Association to A.H.(0735165N). P.S.F. is supported by an Established Investigator Award from the American Heart Association. A.H. is the recipient of a Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation.	Abboud M, 1998, LANCET, V351, P959; Arimura Kosei, 2005, Haematologica, V90, pECR10; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Chang JS, 2008, BLOOD, V111, P915, DOI 10.1182/blood-2007-04-084061; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Dagia NM, 2006, NAT MED, V12, P1185, DOI 10.1038/nm1470; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Eppihimer MJ, 1996, CIRC RES, V79, P560, DOI 10.1161/01.RES.79.3.560; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Frenette PS, 2007, J CLIN INVEST, V117, P850, DOI 10.1172/JCI30920; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Goel MS, 2002, BLOOD, V100, P3797, DOI 10.1182/blood-2002-03-0712; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Holness L, 2004, TRANSFUS MED REV, V18, P184, DOI 10.1016/j.tmrv.2004.03.004; Husemann J, 2001, ARTERIOSCL THROM VAS, V21, P1301, DOI 10.1161/hq0801.095150; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LO SK, 1991, J EXP MED, V173, P1493, DOI 10.1084/jem.173.6.1493; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; LORANT DE, 1993, J CLIN INVEST, V92, P559, DOI 10.1172/JCI116623; LUTZ HU, 1987, P NATL ACAD SCI USA, V84, P7368, DOI 10.1073/pnas.84.21.7368; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032; SHAPPELL SB, 1990, J IMMUNOL, V144, P2702; Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Simon SI, 2000, J IMMUNOL, V164, P4348, DOI 10.4049/jimmunol.164.8.4348; SIMON SI, 1995, J IMMUNOL, V155, P1502; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Wakefield TW, 2008, ARTERIOSCL THROM VAS, V28, P387, DOI 10.1161/ATVBAHA.108.162289; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; WANG RH, 1993, J CLIN INVEST, V92, P1326, DOI 10.1172/JCI116706; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zennadi R, 2008, TRANSFUS CLIN BIOL, V15, P23, DOI 10.1016/j.tracli.2008.04.009	49	248	256	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					384	391		10.1038/nm.1939	http://dx.doi.org/10.1038/nm.1939			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19305412	Green Accepted			2022-12-25	WOS:000264937200025
J	Newton-Cheh, C; Eijgelsheim, M; Rice, KM; de Bakker, PIW; Yin, XY; Estrada, K; Bis, JC; Marciante, K; Rivadeneira, F; Noseworthy, PA; Sotoodehnia, N; Smith, NL; Rotter, JI; Kors, JA; Witteman, JCM; Hofman, A; Heckbert, SR; O'Donnell, CJ; Uitterlinden, AG; Psaty, BM; Lumley, T; Larson, MG; Stricker, BHC				Newton-Cheh, Christopher; Eijgelsheim, Mark; Rice, Kenneth M.; de Bakker, Paul I. W.; Yin, Xiaoyan; Estrada, Karol; Bis, Joshua C.; Marciante, Kristin; Rivadeneira, Fernando; Noseworthy, Peter A.; Sotoodehnia, Nona; Smith, Nicholas L.; Rotter, Jerome I.; Kors, Jan A.; Witteman, Jacqueline C. M.; Hofman, Albert; Heckbert, Susan R.; O'Donnell, Christopher J.; Uitterlinden, Andre G.; Psaty, Bruce M.; Lumley, Thomas; Larson, Martin G.; Stricker, Bruno H. Ch			Common variants at ten loci influence QT interval duration in the QTGEN Study	NATURE GENETICS			English	Article							NOS1 REGULATOR NOS1AP; SUDDEN CARDIAC DEATH; PHOSPHOLAMBAN GENE; HEART; ASSOCIATION; SCN5A; KCNH2; REPOLARIZATION; POLYMORPHISM; MUTATION	QT interval duration, reflecting myocardial repolarization on the electrocardiogram, is a heritable risk factor for sudden cardiac death and drug-induced arrhythmias. We conducted a meta-analysis of three genome-wide association studies in 13,685 individuals of European ancestry from the Framingham Heart Study, the Rotterdam Study and the Cardiovascular Health Study, as part of the QTGEN consortium. We observed associations at P < 5 x 10(-8) with variants in NOS1AP, KCNQ1, KCNE1, KCNH2 and SCN5A, known to be involved in myocardial repolarization and mendelian long-QT syndromes. Associations were found at five newly identified loci, including 16q21 near NDRG4 and GINS3, 6q22 near PLN, 1p36 near RNF207, 16p13 near LITAF and 17q12 near LIG3 and RFFL. Collectively, the 14 independent variants at these 10 loci explain 5.4-6.5% of the variation in QT interval. These results, together with an accompanying paper, offer insights into myocardial repolarization and suggest candidate genes that could predispose to sudden cardiac death and drug-induced arrhythmias.	[Newton-Cheh, Christopher; Noseworthy, Peter A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; de Bakker, Paul I. W.] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Newton-Cheh, Christopher; de Bakker, Paul I. W.] MIT, Cambridge, MA 02139 USA; [Newton-Cheh, Christopher; Yin, Xiaoyan; O'Donnell, Christopher J.; Larson, Martin G.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Eijgelsheim, Mark; Rivadeneira, Fernando; Witteman, Jacqueline C. M.; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rice, Kenneth M.; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Yin, Xiaoyan; Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bis, Joshua C.; Marciante, Kristin; Sotoodehnia, Nona; Smith, Nicholas L.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Sch Med, Div Cardiol, Seattle, WA 98195 USA; [Smith, Nicholas L.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Vet Adm Off Res & Dev, Seattle Epidemiol Res Ctr, Seattle, WA USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Kors, Jan A.; Stricker, Bruno H. Ch] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Witteman, Jacqueline C. M.; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Netherlands Genom Initiat Sponsored Netherlands C, NL-3000 CA Rotterdam, Netherlands; [Heckbert, Susan R.; Psaty, Bruce M.] Grp Hlth, Ctr Hlth Studies, Seattle, WA USA; [O'Donnell, Christopher J.] NHLBI, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Stricker, Bruno H. Ch] Inspectorate Hlth Care, The Hague, Netherlands	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Boston University; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle	Newton-Cheh, C (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA.	b.stricker@erasmusmc.nl	Rice, Kenneth M/A-4150-2013; Rivadeneira, Fernando/O-5385-2015; Rotter, Jerome/AAY-6598-2021; de Bakker, Paul IW/B-8730-2009	Rice, Kenneth M/0000-0001-5779-4495; Rivadeneira, Fernando/0000-0001-9435-9441; de Bakker, Paul IW/0000-0001-7735-7858; Larson, Martin/0000-0002-9631-1254	Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health; Boston University School of Medicine [N01-HC-25195]; Affymetrix [N02-HL-6-4278]; Doris Duke Charitable Foundation; Burroughs Wellcome Fund; Department of Medicine at Boston University School of Medicine; Boston Medical Center; Pfizer; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports, the European Commission (DG XII); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; CHS [N01-HC85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133]; National Institute of Neurological Disorders and Stroke [U01 HL080295, R01 HL087652]; National Center for Research Resources [M01RR00069]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology); US National Institutes of Health [K23-HL-080025]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Burroughs Wellcome Fund Career Award; Netherlands Heart Foundation [2007B221]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085083, N01HC085081, N01HC085086, N01HC085085, N01HC085079, N01HC025195, N01HC085080, N01HC085082, N01HC085084, N01HC055222, N01HC045133, N01HC015103, N01HC075150, N01HC035129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL064278, K23HL080025, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University School of Medicine; Affymetrix; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Department of Medicine at Boston University School of Medicine; Boston Medical Center; Pfizer(Pfizer); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports, the European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); CHS; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Netherlands Heart Foundation(Netherlands Heart Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Framingham Heart Study work was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine (contract #N01-HC-25195), its contract with Affymetrix for genotyping services (contract #N02-HL-6-4278), and the Doris Duke Charitable Foundation (C.N.-C.) and Burroughs Wellcome Fund (C.N.-C.). The Framingham analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The measurement of ECG intervals in Framingham Heart Study generation 1 and 2 samples was done by eResearch Technology and supported by an unrestricted grant from Pfizer. The measurement of ECG intervals in the Framingham Heart Study generation 3 sample was completed by A. Hirji and S. Kovvali using AMPS software provided through an unrestricted academic license by Analyzing Medical Parameters for Solutions (A.M.P.S., LLC). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (#175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project #050-060-810. The CHS research reported in this article was supported by contract numbers N01-HC85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00069 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The authors acknowledge the essential role of the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium in development and support of this manuscript. CHARGE members include the Netherland's Rotterdam Study, the NHLBI's Atherosclerosis Risk in Communities (ARIC) Study, Cardiovascular Health Study (CHS) and Framingham Heart Study (FHS), and the NIA's Iceland Age, Gene/Environment Susceptibility (AGES) Study. C. N.-C. is supported by US National Institutes of Health grant K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. M. E.; is funded by the Netherlands Heart Foundation (#2007221). J.I.R. is supported by the Cedars-Sinai Board of Governors' Chair in Medical Genetics. The authors wish to thank the following people: G. Crawford and C. Guiducci (Broad Institute of Harvard and Massachusetts Institute of Technology) who completed the Sequenom-based technical validation genotyping of the Framingham Heart Study samples; P. Arp and M. Jhamai (Erasmus Medical Center) for Illumina array genotyping and Taqman-based technical validation genotyping of the Rotterdam Study samples; and Dr. M. Moorhouse, M. Verkerk and S. Bervoets (Erasmus Medical Center) for database management in the Rotterdam Study; and the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The QTGEN consortium would like to thank the QTSCD consortium for the opportunity to exchange top results pre-publication.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; Burke A, 2005, CIRCULATION, V112, P798, DOI 10.1161/CIRCULATIONAHA.104.482760; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eijgelsheim M, 2009, HUM MOL GENET, V18, P347, DOI 10.1093/hmg/ddn341; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lehtinen AB, 2008, DIABETES, V57, P1108, DOI 10.2337/db07-1365; Li Y, 2006, AM J HUM GENET S, VS79, P2290; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Marjamaa A, 2009, J INTERN MED, V265, P448, DOI 10.1111/j.1365-2796.2008.02026.x; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Newton-Cheh C, 2007, CURR OPIN GENET DEV, V17, P213, DOI 10.1016/j.gde.2007.04.010; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pietila E, 2002, J AM COLL CARDIOL, V40, P511, DOI 10.1016/S0735-1097(02)01979-4; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; SALISBURY BA, 2006, HEART RHYTHM, V3, pS98, DOI DOI 10.1016/J.HRTHM.2006.02.297; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sotoodehnia N, 2005, CIRCULATION, V111, pE223; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Wei J, 1999, CIRCULATION, V100, P495	45	316	324	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					399	406		10.1038/ng.364	http://dx.doi.org/10.1038/ng.364			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19305408	Green Accepted			2022-12-25	WOS:000264659000012
J	Katsuno, M; Adachi, H; Sobue, G				Katsuno, Masahisa; Adachi, Hiroaki; Sobue, Gen			The case for cholesterol	NATURE MEDICINE			English	Editorial Material							HUNTINGTONS-DISEASE; BETA; MICE; PATHWAY		[Katsuno, Masahisa; Adachi, Hiroaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Katsuno, Masahisa] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Katsuno, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ka2no@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311				Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Huntington G., 1872, MED SURG REP, V26, P320; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Leoni V, 2008, BRAIN, V131, P2851, DOI 10.1093/brain/awn212; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Papassotiropoulos A, 2003, ARCH NEUROL-CHICAGO, V60, P29, DOI 10.1001/archneur.60.1.29; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Valenza M, 2007, HUM MOL GENET, V16, P2187, DOI 10.1093/hmg/ddm170	12	17	18	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					253	254		10.1038/nm0309-253	http://dx.doi.org/10.1038/nm0309-253			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19265827				2022-12-25	WOS:000263914000024
J	Santos, EB; Yeh, R; Lee, J; Nikhamin, Y; Punzalan, B; Punzalan, B; La Perle, K; Larson, SM; Sadelain, M; Brentjens, RJ				Santos, Elmer B.; Yeh, Raymond; Lee, James; Nikhamin, Yan; Punzalan, Blesida; Punzalan, Blesserene; La Perle, Krista; Larson, Steven M.; Sadelain, Michel; Brentjens, Renier J.			Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase	NATURE MEDICINE			English	Article							COLLAGEN-INDUCED ARTHRITIS; LYMPHOCYTE TRAFFICKING; ADOPTIVE IMMUNOTHERAPY; PROSTATE-CANCER; GENE-TRANSFER; EXPRESSION; BIOLUMINESCENCE; TUMORS; VISUALIZATION; REJECTION	We developed a new approach to bioluminescent T cell imaging using a membrane-anchored form of the Gaussia luciferase (GLuc) enzyme, termed extGLuc, which we could stably express in both mouse and human primary T cells. In vitro, extGLuc(+) cells emitted significantly higher bioluminescent signal when compared to cells expressing GLuc, Renilla luciferase (RLuc) or membrane-anchored RLuc (extRLuc). In vivo, mouse extGLuc(+) T cells showed higher bioluminescent signal when compared to GLuc(+) and RLuc(+) T cells. Application of this imaging approach to human T cells genetically modified to express tumor-specific chimeric antigen receptors (CARs) enabled us to show in vivo CAR-mediated T cell accumulation in tumor, T cell persistence over time and concomitant imaging of T cells and tumor cells modified to express firefly luciferase. This sensitive imaging technology has application to many in vivo cell-based studies in a wide array of mouse models.	[Yeh, Raymond; Lee, James; Nikhamin, Yan; Sadelain, Michel; Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Santos, Elmer B.; Punzalan, Blesida; Punzalan, Blesserene; Larson, Steven M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Santos, Elmer B.; Punzalan, Blesida; Punzalan, Blesserene; Larson, Steven M.; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Santos, Elmer B.; Larson, Steven M.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA; [La Perle, Krista] Mem Sloan Kettering Canc Ctr, Res Anim Resource Ctr, New York, NY 10021 USA; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Gene Transfer & Somat Cell Engn Lab, New York, NY 10021 USA; [Sadelain, Michel; Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Brentjens, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	brentjer@mskcc.org	La Perle, Krista Marie DuBray/B-3099-2015		US National Institutes of Health [CA95152, CA059350, CA08748, CA086438, CA096945, CA094060, CA083084]; Alliance for Cancer Gene Therapy; Damon Runyon Clinical Investigator Award; Canada Club of New York, Kate's Team; Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of MSKCC; Geoffrey Beene Cancer Foundation; Chronic Lymphocytic Leukemia Foundation; Ludwig Center for Cancer Immunotherapy; Bocina Cancer Research Fund; NATIONAL CANCER INSTITUTE [P01CA059350, P30CA008748, K08CA095152, P50CA086438, R25CA096945, P01CA094060] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Cancer Gene Therapy; Damon Runyon Clinical Investigator Award; Canada Club of New York, Kate's Team; Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of MSKCC; Geoffrey Beene Cancer Foundation; Chronic Lymphocytic Leukemia Foundation; Ludwig Center for Cancer Immunotherapy; Bocina Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes of Health grants CA95152, CA059350, CA08748, CA086438, CA096945, CA094060 and CA083084, The Alliance for Cancer Gene Therapy, the Damon Runyon Clinical Investigator Award (R.J.B.), The Annual Terry Fox Run for Cancer Research organized by the Canada Club of New York, Kate's Team, W. H. Goodwin and A. Goodwin and the Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of MSKCC, the Geoffrey Beene Cancer Foundation, the Chronic Lymphocytic Leukemia Foundation, the Ludwig Center for Cancer Immunotherapy and the Bocina Cancer Research Fund.	Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Billotey C, 2005, RADIOLOGY, V236, P579, DOI 10.1148/radiol.2362040603; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Cheng GF, 2007, MOL BIOCHEM PARASIT, V155, P167, DOI 10.1016/j.molbiopara.2007.06.013; Costa GL, 2001, J IMMUNOL, V167, P2379, DOI 10.4049/jimmunol.167.4.2379; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hinrichs CS, 2006, CURR OPIN IMMUNOL, V18, P363, DOI 10.1016/j.coi.2006.03.009; Hu DE, 2005, MAGN RESON MED, V54, P1473, DOI 10.1002/mrm.20717; Huang X, 2006, BLOOD, V107, P483, DOI 10.1182/blood-2005-05-2133; Kalikin LM, 2003, CANCER BIOL THER, V2, P656; Kim YJ, 2004, MOL IMAGING BIOL, V6, P331, DOI 10.1016/j.mibio.2004.06.009; Kircher MF, 2003, CANCER RES, V63, P6838; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Koehne G, 2003, NAT BIOTECHNOL, V21, P405, DOI 10.1038/nbt805; Latouche JB, 2000, NAT BIOTECHNOL, V18, P405, DOI 10.1038/74455; Nakajima A, 2001, J CLIN INVEST, V107, P1293, DOI 10.1172/JCI12037; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; Quintas-Cardama A, 2007, HUM GENE THER, V18, P1253, DOI 10.1089/hum.2007.088; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Scheffold C, 2002, CANCER RES, V62, P5785; Serrano LM, 2006, BLOOD, V107, P2643, DOI 10.1182/blood-2005-09-3904; Suzuki T, 2007, FEBS LETT, V581, P4551, DOI 10.1016/j.febslet.2007.08.036; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tarner IH, 2002, CLIN IMMUNOL, V105, P304, DOI 10.1006/clim.2002.5299; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Venisnik KM, 2007, MOL IMAGING BIOL, V9, P267, DOI 10.1007/s11307-007-0101-8; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329	36	100	114	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					338	344		10.1038/nm.1930	http://dx.doi.org/10.1038/nm.1930			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19219023	Green Accepted			2022-12-25	WOS:000263914000036
J	Meyre, D; Delplanque, J; Chevre, JC; Lecoeur, C; Lobbens, S; Gallina, S; Durand, E; Vatin, V; Degraeve, F; Proenca, C; Gaget, S; Korner, A; Kovacs, P; Kiess, W; Tichet, J; Marre, M; Hartikainen, AL; Horber, F; Potoczna, N; Hercberg, S; Levy-Marchal, C; Pattou, F; Heude, B; Tauber, M; McCarthy, MI; Blakemore, AIF; Montpetit, A; Polychronakos, C; Weill, J; Coin, LJM; Asher, J; Elliott, P; Jarvelin, MR; Visvikis-Siest, S; Balkau, B; Sladek, R; Balding, D; Walley, A; Dina, C; Froguel, P				Meyre, David; Delplanque, Jerome; Chevre, Jean-Claude; Lecoeur, Cecile; Lobbens, Stephane; Gallina, Sophie; Durand, Emmanuelle; Vatin, Vincent; Degraeve, Franck; Proenca, Christine; Gaget, Stefan; Koerner, Antje; Kovacs, Peter; Kiess, Wieland; Tichet, Jean; Marre, Michel; Hartikainen, Anna-Liisa; Horber, Fritz; Potoczna, Natascha; Hercberg, Serge; Levy-Marchal, Claire; Pattou, Francois; Heude, Barbara; Tauber, Maithe; McCarthy, Mark I.; Blakemore, Alexandra I. F.; Montpetit, Alexandre; Polychronakos, Constantin; Weill, Jacques; Coin, Lachlan J. M.; Asher, Julian; Elliott, Paul; Jarvelin, Marjo-Riitta; Visvikis-Siest, Sophie; Balkau, Beverley; Sladek, Rob; Balding, David; Walley, Andrew; Dina, Christian; Froguel, Philippe			Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations	NATURE GENETICS			English	Article							CHOLESTEROL TRAFFICKING; C-DISEASE; PROTEIN; EXPRESSION; MICE	We analyzed genome-wide association data from 1,380 Europeans with early-onset and morbid adult obesity and 1,416 age-matched normal-weight controls. Thirty-eight markers showing strong association were further evaluated in 14,186 European subjects. In addition to FTO and MC4R, we detected significant association of obesity with three new risk loci in NPC1 (endosomal/lysosomal Niemann-Pick C1 gene, P = 2.9 x 10(-7)), near MAF (encoding the transcription factor c-MAF, P 3.8 x 10(-13)) and near PTER (phosphotriesterase-related gene, P = 2.1 x 10(-7)).	[Meyre, David; Delplanque, Jerome; Chevre, Jean-Claude; Lecoeur, Cecile; Lobbens, Stephane; Gallina, Sophie; Durand, Emmanuelle; Vatin, Vincent; Degraeve, Franck; Proenca, Christine; Gaget, Stefan; Dina, Christian; Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS 8090, F-59000 Lille, France; [Koerner, Antje; Kiess, Wieland] Univ Leipzig, Univ Hosp Children & Adolescents, D-04103 Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany; [Tichet, Jean] Inst Inter Reg Sante, F-37521 La Riche, France; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol, F-75018 Paris, France; [Marre, Michel] Univ Paris 07, INSERM, U695, F-75007 Paris, France; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu 90014, Finland; [Horber, Fritz; Potoczna, Natascha] Univ Bern, CH-3012 Bern, Switzerland; [Horber, Fritz; Potoczna, Natascha] Klin Lindberg, CH-8400 Winterthur, Switzerland; [Hercberg, Serge] Univ Paris 13, Ctr Rech Nutr Humaine, UMR, U557,INSERM,U1125,INRA, F-93017 Bobigny, France; [Levy-Marchal, Claire] Univ Paris Diderot, FR-75205 Paris 13, France; [Levy-Marchal, Claire] INSERM, U690, FR-75019 Paris, France; [Pattou, Francois] Ctr Hosp Reg Univ Lille, INSERM, U859, F-59000 Lille, France; [Heude, Barbara; Balkau, Beverley] Univ Paris 11, F-91405 Orsay, France; [Heude, Barbara; Balkau, Beverley] INSERM, U780, F-94807 Villejuif, France; [Tauber, Maithe] CHU, INSERM, U563, Childrens Hosp, F-31000 Toulouse, France; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3, England; [McCarthy, Mark I.] Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3, England; [Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London W12 0HS, England; [Montpetit, Alexandre; Polychronakos, Constantin; Sladek, Rob] McGill Univ, Montreal, PQ H3A 1A, Canada; [Montpetit, Alexandre; Polychronakos, Constantin; Sladek, Rob] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A, Canada; [Weill, Jacques] Jeanne de Flandre Hosp, Pediat Endocrine Unit, F-59000 Lille, France; [Coin, Lachlan J. M.; Elliott, Paul; Jarvelin, Marjo-Riitta; Balding, David] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, Oulu 90014, Finland; [Visvikis-Siest, Sophie] INSERM, Cardiovasc Genet Team, Ctr Invest Clin, F-54000 Nancy, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Leipzig University; Leipzig University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oulu; University of Bern; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; McGill University; Universite de Lille - ISITE; CHU Lille; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; Institut National de la Sante et de la Recherche Medicale (Inserm)	Froguel, P (corresponding author), Inst Pasteur, Inst Biol, CNRS 8090, F-59000 Lille, France.	p.froguel@imperial.ac.uk	TAUBER, Maithe/K-7386-2014; Visvikis-Siest, Sophie/H-2324-2014; Heude, Barbara/G-3095-2016; Körner, Antje/B-3988-2015; Coin, Lachlan JM/A-9001-2014; Chèvre, Jean-Claude/C-3943-2015; Meyre, David/D-7315-2011; Pattou, Francois/O-6151-2017; Walley, Andrew J/D-2573-2009; Balding, David/G-9898-2011; Blakemore, Alexandra I F/D-2253-2009; Dina, Christian R/D-3535-2015; HERCBERG, Serge/B-4429-2008; FROGUEL, Philippe/O-6799-2017; Sladek, Robert/R-2391-2019; horber, Fritz/AAL-5419-2020; Heude, Barbara/GLU-9626-2022; Coin, Lachlan/O-4976-2019; Serge, Hercberg/F-3038-2017; McCarthy, Mark/M-3763-2015	Visvikis-Siest, Sophie/0000-0001-8104-8425; Heude, Barbara/0000-0002-1565-1629; Körner, Antje/0000-0001-6001-0356; Coin, Lachlan JM/0000-0002-4300-455X; Chèvre, Jean-Claude/0000-0002-5329-5231; Meyre, David/0000-0003-4850-7444; Pattou, Francois/0000-0001-8388-3766; Walley, Andrew J/0000-0001-7707-7549; Balding, David/0000-0002-1480-6115; Blakemore, Alexandra I F/0000-0003-0661-564X; Dina, Christian R/0000-0002-7722-7348; HERCBERG, Serge/0000-0002-3168-1350; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Heude, Barbara/0000-0002-1565-1629; Coin, Lachlan/0000-0002-4300-455X; Serge, Hercberg/0000-0002-3168-1350; Kovacs, Peter/0000-0002-0290-5423; Elliott, Paul/0000-0002-7511-5684; Gallina, Sophie/0000-0002-6194-3649; Marre, Michel/0000-0002-3071-1837; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; McCarthy, Mark/0000-0002-4393-0510; Polychronakos, Constantin/0000-0002-7624-6635	"Agence Nationale de la Recherche,"; "Conseil Regional Nord-Pas de Calais/Fonds europeen de developpement economique et regional,''; Genome Quebec/Genome Canada; Medical Research Council; German Research Council [KFO152]; European Commission [QLG1-CT-2000-01643]; Biocenter, University of Oulu; DNA [NFBC1986]; Medical Research Council [G0600331] Funding Source: researchfish; MRC [G0600331] Funding Source: UKRI	"Agence Nationale de la Recherche,"(French National Research Agency (ANR)); "Conseil Regional Nord-Pas de Calais/Fonds europeen de developpement economique et regional,''(Region Hauts-de-France); Genome Quebec/Genome Canada(Genome Canada); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Council(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Biocenter, University of Oulu; DNA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the subjects and families who participated in this study. This work was supported by grants from the "Agence Nationale de la Recherche," the "Conseil Regional Nord-Pas de Calais/Fonds europeen de developpement economique et regional," Genome Quebec/Genome Canada and the Medical Research Council. The German cohorts and projects were supported by grants from the German Research Council (KFO152 "Atherobesity"). We thank F. Allegaert, M. Deweirder, R. Tauscher and A. Berthold for their technical support in DNA extraction and distribution. We thank P. Bougneres and C. Le Stunff for providing DNA samples of the "Saint Vincent de Paul'' obese children cohort. Northern Finland Birth Cohort 1986 (NFBC1986) was supported by the European Commission; contract number QLG1-CT-2000-01643, Biocenter, University of Oulu, Finland and the Academy of Finland. We thank L. Peltonen for providing NFBC1986 DNA samples. We acknowledge the "Centre de Medecine Preventive (CMP) de Vandoeuvre les Nancy'' where the STANISLAS cohort was recruited.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Amigo L, 2002, HEPATOLOGY, V36, P819, DOI 10.1053/jhep.2002.35617; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Liu BH, 2002, BIOCHEM BIOPH RES CO, V293, P1396, DOI 10.1016/S0006-291X(02)00379-0; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Qi L, 2007, J CLIN ENDOCR METAB, V92, P3618, DOI 10.1210/jc.2007-0877; Serria MS, 2003, BIOCHEM BIOPH RES CO, V310, P318, DOI 10.1016/j.bbrc.2003.08.144; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tsuchiya M, 2006, PANCREAS, V32, P408, DOI 10.1097/01.mpa.0000220867.64787.99; Vance JE, 2006, FEBS LETT, V580, P5518, DOI 10.1016/j.febslet.2006.06.008; Xie CL, 1999, AM J PHYSIOL-ENDOC M, V276, pE336, DOI 10.1152/ajpendo.1999.276.2.E336	15	483	507	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					157	159		10.1038/ng.301	http://dx.doi.org/10.1038/ng.301			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19151714				2022-12-25	WOS:000263091300012
J	Van Gool, F; Galli, M; Gueydan, C; Kruys, V; Prevot, PP; Bedalov, A; Mostoslavsky, R; Alt, FW; De Smedt, T; Leo, O				Van Gool, Frederic; Galli, Mara; Gueydan, Cyril; Kruys, Veronique; Prevot, Pierre-Paul; Bedalov, Antonio; Mostoslavsky, Raul; Alt, Frederick W.; De Smedt, Thibaut; Leo, Oberdan			Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner	NATURE MEDICINE			English	Article							COLONY-ENHANCING FACTOR; NF-KAPPA-B; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; DEFICIENT MICE; INFLAMMATION; MOLECULE; INHIBITOR; APOPTOSIS; POLY(ADP-RIBOSE); LETHALITY	Tumor necrosis factor (TNF) synthesis is known to play a major part in numerous inflammatory disorders, and multiple transcriptional and post-transcriptional regulatory mechanisms have therefore evolved to dampen the production of this key proinflammatory cytokine(1,2). The high expression of nicotinamide phosphoribosyltransferase (Nampt), an enzyme involved in the nicotinamide-dependent NAD biosynthetic pathway, in cells of the immune system(3) has led us to examine the potential relationship between NAD metabolism and inflammation. We show here that intracellular NAD concentration promotes TNF synthesis by activated immune cells. Using a positive screen, we have identified Sirt6, a member of the sirtuin family(4), as the NAD-dependent enzyme able to regulate TNF production by acting at a post-transcriptional step. These studies reveal a previously undescribed relationship between metabolism and the inflammatory response and identify Sirt6 and the nicotinamide-dependent NAD biosynthetic pathway as novel candidates for immunointervention in an inflammatory setting.	[Van Gool, Frederic; Galli, Mara; Leo, Oberdan] Univ Libre Bruxelles, Inst Biol & Med Mol, Physiol Anim Lab, B-6041 Gosselies, Belgium; [Gueydan, Cyril; Kruys, Veronique] Univ Libre Bruxelles, Inst Biol & Med Mol, Chim Biol Lab, B-6041 Gosselies, Belgium; [Prevot, Pierre-Paul] Univ Libre Bruxelles, Inst Biol & Med Mol, Lab Mol Biol Ectoparasites, B-6041 Gosselies, Belgium; [Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Mostoslavsky, Raul; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Ctr Blood Res, Boston, MA 02115 USA; [Mostoslavsky, Raul; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [De Smedt, Thibaut] TopoTarget Switzerland SA, CH-1004 Lausanne, Switzerland	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Fred Hutchinson Cancer Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Leo, O (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Physiol Anim Lab, 12 Rue Prof Jeneer & Brachet, B-6041 Gosselies, Belgium.	oleo@ulb.ac.be	Kruys, Veronique I/N-6613-2018; Van Gool, Frederic/V-4638-2019	Kruys, Veronique/0000-0002-3144-5403; Gueydan, Cyril/0000-0003-3097-7667	The Belgian Program in Interuniversity Poles of Attraction initiated by the Belgian state, the Prime Minister's office; Research Concerted Action of the Communaute francaise de Belgique; Direction Generale des Technologies de la Recherche et de l'Energie, Region Wallonne ( Belgium); Fonds Jean Brachet and by TopoTarget Switzerland; Fonds national de la recherche scientifique (FRS-FNRS); French community of Belgium; NATIONAL CANCER INSTITUTE [R01CA129132] Funding Source: NIH RePORTER	The Belgian Program in Interuniversity Poles of Attraction initiated by the Belgian state, the Prime Minister's office; Research Concerted Action of the Communaute francaise de Belgique; Direction Generale des Technologies de la Recherche et de l'Energie, Region Wallonne ( Belgium); Fonds Jean Brachet and by TopoTarget Switzerland; Fonds national de la recherche scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); French community of Belgium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	APO866 was synthesized and kindly provided by Astellas Pharma. We wish to thank G. de Murcia ( formerly at the Ecole Superieure de Biotechnologie de Strasbourg, Illkirch Cedex) for providing the Parp1-knockout mouse strain and V. Sartorelli ( US National Institutes of Health) for providing the pHan-SIRT1 vector ( wild-type and mutant forms). This work was supported by The Belgian Program in Interuniversity Poles of Attraction initiated by the Belgian state, the Prime Minister's office, Science Policy Programming, by a Research Concerted Action of the Communaute francaise de Belgique, by grants from the Direction Generale des Technologies de la Recherche et de l'Energie, Region Wallonne ( Belgium), by a grant from the Fonds Jean Brachet and by TopoTarget Switzerland SA. F. V. G. and M. G. have been supported by research grants from the Fonds national de la recherche scientifique (FRS-FNRS), French community of Belgium. The scientific responsibility is assumed by the authors.	Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Cuzzocrea S, 2005, PHARMACOL RES, V52, P72, DOI 10.1016/j.phrs.2005.02.016; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Fukuzawa M, 1997, IMMUNOL LETT, V59, P7, DOI 10.1016/S0165-2478(97)00088-6; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kuhnle S, 1999, BIOCHEM BIOPH RES CO, V263, P433, DOI 10.1006/bbrc.1999.1393; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Szabo C, 2003, INTENS CARE MED, V29, P863, DOI 10.1007/s00134-003-1737-8; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	26	214	218	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					206	210		10.1038/nm.1906	http://dx.doi.org/10.1038/nm.1906			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19151729	Green Accepted			2022-12-25	WOS:000263119400024
J	Bouatia-Naji, N; Bonnefond, A; Cavalcanti-Proenca, C; Sparso, T; Holmkvist, J; Marchand, M; Delplanque, J; Lobbens, S; Rocheleau, G; Durand, E; De Graeve, F; Chevre, JC; Borch-Johnsen, K; Hartikainen, AL; Ruokonen, A; Tichet, J; Marre, M; Weill, J; Heude, B; Tauber, M; Lemaire, K; Schuit, F; Elliott, P; Jorgensen, T; Charpentier, G; Hadjadj, S; Cauchi, S; Vaxillaire, M; Sladek, R; Visvikis-Siest, S; Balkau, B; Levy-Marchal, C; Pattou, F; Meyre, D; Blakemore, AIF; Jarvelin, MR; Walley, AJ; Hansen, T; Dina, C; Pedersen, O; Froguel, P				Bouatia-Naji, Nabila; Bonnefond, Amelie; Cavalcanti-Proenca, Christine; Sparso, Thomas; Holmkvist, Johan; Marchand, Marion; Delplanque, Jerome; Lobbens, Stephane; Rocheleau, Ghislain; Durand, Emmanuelle; De Graeve, Franck; Chevre, Jean-Claude; Borch-Johnsen, Knut; Hartikainen, Anna-Liisa; Ruokonen, Aimo; Tichet, Jean; Marre, Michel; Weill, Jacques; Heude, Barbara; Tauber, Maithe; Lemaire, Katleen; Schuit, Frans; Elliott, Paul; Jorgensen, Torben; Charpentier, Guillaume; Hadjadj, Samy; Cauchi, Stephane; Vaxillaire, Martine; Sladek, Robert; Visvikis-Siest, Sophie; Balkau, Beverley; Levy-Marchal, Claire; Pattou, Francois; Meyre, David; Blakemore, Alexandra I. F.; Jarvelin, Marjo-Riita; Walley, Andrew J.; Hansen, Torben; Dina, Christian; Pedersen, Oluf; Froguel, Philippe			A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; GENE; MELATONIN; POLYMORPHISM; COHORT	In genome-wide association (GWA) data from 2,151 nondiabetic French subjects, we identified rs1387153, near MTNR1B (which encodes the melatonin receptor 2 (MT2)), as a modulator of fasting plasma glucose (FPG; P = 1.3 x 10(-7)). In European populations, the rs1387153 T allele is associated with increased FPG (beta = 0.06 mmol/l, P = 7.6 x 10(-29), N = 16,094), type 2 diabetes (T2D) risk (odds ratio (OR) = 1.15, 95% CI = 1.08-1.22, P = 6.3 x 10(-5), cases N = 6,332) and risk of developing hyperglycemia or diabetes over a 9-year period (hazard ratio (HR) = 1.20, 95% CI = 1.06-1.36, P = 0.005, incident cases N = 515). RT-PCR analyses confirm the presence of MT2 transcripts in neural tissues and show MT2 expression in human pancreatic islets and beta cells. Our data suggest a possible link between circadian rhythm regulation and glucose homeostasis through the melatonin signaling pathway.	[Bouatia-Naji, Nabila; Bonnefond, Amelie; Cavalcanti-Proenca, Christine; Marchand, Marion; Delplanque, Jerome; Lobbens, Stephane; Durand, Emmanuelle; De Graeve, Franck; Chevre, Jean-Claude; Cauchi, Stephane; Vaxillaire, Martine; Meyre, David; Dina, Christian; Froguel, Philippe] CNRS, Inst Biol, UMR 8090, F-59019 Lille, France; [Bouatia-Naji, Nabila; Bonnefond, Amelie; Cavalcanti-Proenca, Christine; Marchand, Marion; Delplanque, Jerome; Lobbens, Stephane; Durand, Emmanuelle; De Graeve, Franck; Chevre, Jean-Claude; Cauchi, Stephane; Vaxillaire, Martine; Meyre, David; Dina, Christian; Froguel, Philippe] Univ Lille 2, Inst Pasteur, F-59019 Lille, France; [Sparso, Thomas; Holmkvist, Johan; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rocheleau, Ghislain; Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Rocheleau, Ghislain; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Rocheleau, Ghislain] Prognomix, Montreal, PQ H1Y 3L1, Canada; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus C, Denmark; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Clin Sci Obstet & Gynecol, FIN-90014 Oulu, Finland; [Ruokonen, Aimo] Univ Oulu, Dept Clin Sci Clin Chem, FIN-90014 Oulu, Finland; [Tichet, Jean] Inst Inter Reg Sante IRSA, F-37521 La Riche, France; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, F-75018 Paris, France; [Marre, Michel] Univ Paris 07, INSERM, U695, F-75870 Paris, France; [Weill, Jacques] Jeanne Flandre Hosp, Pediatr Endocrine Unit, F-59800 Lille, France; [Heude, Barbara; Balkau, Beverley] INSERM, U780, F-94807 Villejuif, France; [Heude, Barbara; Balkau, Beverley] Univ Paris Sud, F-91405 Orsay, France; [Tauber, Maithe] Childrens Hosp, CHU, INSERM, U563, F-31059 Toulouse, France; [Lemaire, Katleen; Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium; [Elliott, Paul; Jarvelin, Marjo-Riita] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Jorgensen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, F-91108 Essonnes, France; [Hadjadj, Samy] Univ Poitiers, INSERM, UFR Med Pharm, Ctr Hosp Univ Poitiers,U927,CIC 0802, F-86034 Poitiers, France; [Visvikis-Siest, Sophie] INSERM, Cardiovasc Genet team, CIC 9501, F-54000 Nancy, France; [Levy-Marchal, Claire] Hop Robert Debre, INSERM, U690, F-75019 Paris, France; [Levy-Marchal, Claire] Paris Diderot Univ, F-75005 Paris, France; [Pattou, Francois] Univ Lille Nord France, CHRU Lille, INSERM, U859, F-59045 Lille, France; [Blakemore, Alexandra I. F.; Walley, Andrew J.; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England; [Jarvelin, Marjo-Riita] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riita] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, DK-5230 Odense, Denmark	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Steno Diabetes Center; McGill University; Aarhus University; University of Oulu; University of Oulu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; Imperial College London; University of Copenhagen; University of Copenhagen; Centre Hospitalier Sud Francilien; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Imperial College London; University of Oulu; University of Oulu; University of Southern Denmark	Froguel, P (corresponding author), CNRS, Inst Biol, UMR 8090, F-59019 Lille, France.	p.froguel@imperial.ac.uk	Heude, Barbara/G-3095-2016; FROGUEL, Philippe/O-6799-2017; Meyre, David/D-7315-2011; Pedersen, Oluf/Z-1731-2019; BOUATIA-NAJI, NABILA/D-5863-2013; Dina, Christian R/D-3535-2015; TAUBER, Maithe/K-7386-2014; Bouatia-Naji, Nabila/AGF-1400-2022; Heude, Barbara/GLU-9626-2022; Sladek, Robert/R-2391-2019; Pattou, Francois/O-6151-2017; Jansen, Heiko T./A-5770-2008; Visvikis-Siest, Sophie/H-2324-2014; Chèvre, Jean-Claude/C-3943-2015; Blakemore, Alexandra I F/D-2253-2009; Walley, Andrew J/D-2573-2009; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/AAG-8015-2020; Bonnefond, Amélie/O-2784-2017	Heude, Barbara/0000-0002-1565-1629; FROGUEL, Philippe/0000-0003-2972-0784; Meyre, David/0000-0003-4850-7444; Pedersen, Oluf/0000-0002-3321-3972; Dina, Christian R/0000-0002-7722-7348; Bouatia-Naji, Nabila/0000-0001-5424-2134; Heude, Barbara/0000-0002-1565-1629; Sladek, Robert/0000-0002-2730-1204; Pattou, Francois/0000-0001-8388-3766; Jansen, Heiko T./0000-0003-0178-396X; Visvikis-Siest, Sophie/0000-0001-8104-8425; Chèvre, Jean-Claude/0000-0002-5329-5231; Blakemore, Alexandra I F/0000-0003-0661-564X; Walley, Andrew J/0000-0001-7707-7549; Bonnefond, Amélie/0000-0001-9976-3005; Jorgensen, Torben/0000-0001-9453-2830; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Hansen, Torben/0000-0001-8748-3831; Marre, Michel/0000-0002-3071-1837; Elliott, Paul/0000-0002-7511-5684	MRC [G0600331] Funding Source: UKRI; Medical Research Council [G0600331] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Boden G, 1996, AM J PHYSIOL-ENDOC M, V271, pE246, DOI 10.1152/ajpendo.1996.271.2.E246; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hadjadj S, 2008, DIABETES CARE, V31, P1847, DOI 10.2337/dc07-2079; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jaquet D, 2004, HORM RES, V62, P92, DOI 10.1159/000079709; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Peschke E, 2006, J PINEAL RES, V40, P135, DOI 10.1111/j.1600-079X.2005.00287.x; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Van Cauter E, 1998, THERAPIE, V53, P467; Visvikis-Siest S, 2008, CLIN CHEM LAB MED, V46, P733, DOI 10.1515/CCLM.2008.178; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	28	438	448	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					89	94		10.1038/ng.277	http://dx.doi.org/10.1038/ng.277			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19060909	Green Published			2022-12-25	WOS:000262085300021
J	Sabatti, C; Service, SK; Hartikainen, AL; Pouta, A; Ripatti, S; Brodsky, J; Jones, CG; Zaitlen, NA; Varilo, T; Kaakinen, M; Sovio, U; Ruokonen, A; Laitinen, J; Jakkula, E; Coin, L; Hoggart, C; Collins, A; Turunen, H; Gabriel, S; Elliot, P; McCarthy, MI; Daly, MJ; Jarvelin, MR; Freimer, NB; Peltonen, L				Sabatti, Chiara; Service, Susan K.; Hartikainen, Anna-Liisa; Pouta, Anneli; Ripatti, Samuli; Brodsky, Jae; Jones, Chris G.; Zaitlen, Noah A.; Varilo, Teppo; Kaakinen, Marika; Sovio, Ulla; Ruokonen, Aimo; Laitinen, Jaana; Jakkula, Eveliina; Coin, Lachlan; Hoggart, Clive; Collins, Andrew; Turunen, Hannu; Gabriel, Stacey; Elliot, Paul; McCarthy, Mark I.; Daly, Mark J.; Jarvelin, Marjo-Riitta; Freimer, Nelson B.; Peltonen, Leena			Genome-wide association analysis of metabolic traits in a birth cohort from a founder population	NATURE GENETICS			English	Article							C-REACTIVE PROTEIN; NORTHERN FINLAND; BLOOD-PRESSURE; LINKAGE DISEQUILIBRIUM; CARDIOVASCULAR-DISEASE; LIPID CONCENTRATIONS; QUANTITATIVE TRAITS; PLASMA-GLUCOSE; RISK-FACTORS; COMMON	Genome-wide association studies (GWAS) of longitudinal birth cohorts enable joint investigation of environmental and genetic influences on complex traits. We report GWAS results for nine quantitative metabolic traits (triglycerides, high-density lipoprotein, low-density lipoprotein, glucose, insulin, C-reactive protein, body mass index, and systolic and diastolic blood pressure) in the Northern Finland Birth Cohort 1966 (NFBC1966), drawn from the most genetically isolated Finnish regions. We replicate most previously reported associations for these traits and identify nine new associations, several of which highlight genes with metabolic functions: high-density lipoprotein with NR1H3 (LXRA), low-density lipoprotein with AR and FADS1-FADS2, glucose with MTNR1B, and insulin with PANK1. Two of these new associations emerged after adjustment of results for body mass index. Gene-environment interaction analyses suggested additional associations, which will require validation in larger samples. The currently identified loci, together with quantified environmental exposures, explain little of the trait variation in NFBC1966. The association observed between low-density lipoprotein and an infrequent variant in AR suggests the potential of such a cohort for identifying associations with both common, low-impact and rarer, high-impact quantitative trait loci.	[Service, Susan K.; Jones, Chris G.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Sabatti, Chiara] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Sabatti, Chiara; Brodsky, Jae] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Obstet & Gynaecol, FIN-90220 Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, FIN-90101 Oulu, Finland; [Ripatti, Samuli; Jakkula, Eveliina; Turunen, Hannu; Peltonen, Leena] Univ Helsinki, Inst Mol Med FIMM, FIN-00014 Helsinki, Finland; [Jones, Chris G.; Zaitlen, Noah A.] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Varilo, Teppo] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Varilo, Teppo] Natl Publ Hlth Inst, Biomedicum Helsinki, Dept Mol Med, Helsinki 00290, Finland; [Kaakinen, Marika] Inst Hlth Sci, FIN-90220 Oulu, Finland; [Coin, Lachlan; Hoggart, Clive; Elliot, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, FIN-90220 Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, FIN-90220 Oulu, Finland; [Collins, Andrew] Univ Southampton, Southampton Gen Hosp, Human Genet Res Div, Southampton SO16 6YA, Hants, England; [Gabriel, Stacey; Daly, Mark J.; Peltonen, Leena] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.; Daly, Mark J.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Daly, Mark J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daly, Mark J.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FIN-90014 Oulu, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Freimer, Nelson B.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; University of California System; University of California Los Angeles; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Imperial College London; University of Oulu; Finnish Institute of Occupational Health; University of Southampton; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Oulu; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Wellcome Trust Sanger Institute	Freimer, NB (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	nfreimer@mednet.ucla.edu; leena@sanger.ac.uk	Coin, Lachlan/O-4976-2019; Collins, Andrew/A-6595-2010; Sovio, Ulla/H-8532-2019; Ripatti, Samuli/H-9446-2014; Coin, Lachlan JM/A-9001-2014; Collins, Andrew/S-2196-2019; Daly, Mark J/B-2453-2017; McCarthy, Mark/M-3763-2015	Coin, Lachlan/0000-0002-4300-455X; Collins, Andrew/0000-0001-7108-0771; Sovio, Ulla/0000-0002-0799-1105; Ripatti, Samuli/0000-0002-0504-1202; Coin, Lachlan JM/0000-0002-4300-455X; Collins, Andrew/0000-0001-7108-0771; Daly, Mark J/0000-0002-0949-8752; McCarthy, Mark/0000-0002-4393-0510; Varilo, Teppo/0000-0002-5839-8854; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Kaakinen, Marika/0000-0002-9228-0462	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NHGRI NIH HHS [T32 HG002536] Funding Source: Medline; NHLBI NIH HHS [R01 HL087679] Funding Source: Medline; NIGMS NIH HHS [R01 GM053275, GM053275-14] Funding Source: Medline; NIMH NIH HHS [MH083268, RL1 MH083268] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Donoho D, 2004, ANN STAT, V32, P962, DOI 10.1214/009053604000000265; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Hottenga JJ, 2006, TWIN RES HUM GENET, V9, P205, DOI 10.1375/twin.9.2.205; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; Kathiresan S, 2008, CURR OPIN LIPIDOL, V19, P122, DOI 10.1097/MOL.0b013e3282f70296; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Katoh S, 2005, J CLIN ENDOCR METAB, V90, P2642, DOI 10.1210/jc.2004-2471; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; KORKEILA M, 1991, INT J OBESITY, V15, P647; Laitinen J, 2004, EUR J CLIN NUTR, V58, P180, DOI 10.1038/sj.ejcn.1601765; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Morin-Papunen L, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.013; Pouta A, 2004, HYPERTENSION, V43, P825, DOI 10.1161/01.HYP.0000120122.39231.88; PROKOPENKO I, 2008, NAT GENET       1207, DOI DOI 10.1038/NG.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramaswamy G, 2004, J LIPID RES, V45, P17, DOI 10.1194/jlr.M300279-JLR200; Rantakallio P., 1969, ACTA PAEDIATR SC   S, V193, P43; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Saari KM, 2005, J CLIN PSYCHIAT, V66, P559, DOI 10.4088/JCP.v66n0503; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Souren NY, 2007, DIABETOLOGIA, V50, P2107, DOI 10.1007/s00125-007-0784-z; Taponen S, 2004, J CLIN ENDOCR METAB, V89, P2114, DOI 10.1210/jc.2003-031720; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Wessel J, 2007, J HYPERTENS, V25, P329, DOI 10.1097/HJH.0b013e328011753e; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013	50	564	578	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					35	46		10.1038/ng.271	http://dx.doi.org/10.1038/ng.271			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19060910	Green Accepted			2022-12-25	WOS:000262085300014
J	Tagore, DM; Nolte, WM; Neveu, JM; Rangel, R; Guzman-Rojas, L; Pasqualini, R; Arap, W; Lane, WS; Saghatelian, A				Tagore, Debarati M.; Nolte, Whitney M.; Neveu, John M.; Rangel, Roberto; Guzman-Rojas, Liliana; Pasqualini, Renata; Arap, Wadih; Lane, William S.; Saghatelian, Alan			Peptidase substrates via global peptide profiling	NATURE CHEMICAL BIOLOGY			English	Article							BRUSH-BORDER MEMBRANE; IV; IDENTIFICATION; METABOLISM; MICE	Peptide metabolism is a complex process that involves many proteins working in concert. Mass spectrometry-based global peptide profiling of mice lacking dipeptidyl peptidase 4 (DPP4) identified endogenous DPP4 substrates and revealed an unrecognized pathway during proline peptide catabolism that interlinks aminopeptidase and DPP4 activities. Together, these studies elucidate specific aspects of DPP4-regulated metabolism and, more generally, highlight the utility of global peptide profiling for studying peptide metabolism in vivo.	[Tagore, Debarati M.; Nolte, Whitney M.; Saghatelian, Alan] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Neveu, John M.; Lane, William S.] Harvard Univ, FAS Ctr Syst Biol, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA; [Rangel, Roberto; Guzman-Rojas, Liliana; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Harvard University; Harvard University; University of Texas System; UTMD Anderson Cancer Center	Saghatelian, A (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	saghatelian@chemistry.harvard.edu	Rangel, Roberto/AHE-6583-2022	Rangel, Roberto/0000-0002-9088-7957; Nolte, Whitney/0000-0002-0282-0833	US National Institutes of Health [1DP2OD002374]; Burroughs Wellcome Fund Career Award in the Biomedical Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002374] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health grant 1DP2OD002374 ( A. S.) and a Burroughs Wellcome Fund Career Award in the Biomedical Sciences ( A. S.). The authors thank B. F. Cravatt III, D. R. Liu, D. Kahne and other members of the research group for helpful discussions.	Che FY, 2005, J BIOL CHEM, V280, P4451, DOI 10.1074/jbc.M411178200; Deacon CF, 1996, AM J PHYSIOL-ENDOC M, V271, pE458, DOI 10.1152/ajpendo.1996.271.3.E458; ERICKSON RH, 1989, DIGEST DIS SCI, V34, P400, DOI 10.1007/BF01536262; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; MEDEIROS MD, 1994, ENDOCRINOLOGY, V134, P2088, DOI 10.1210/en.134.5.2088; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; TIRUPPATHI C, 1990, J BIOL CHEM, V265, P1476; Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; Weber AE, 2004, J MED CHEM, V47, P4135, DOI 10.1021/jm030628v; Yates NA, 2007, INT J MASS SPECTROM, V259, P174, DOI 10.1016/j.ijms.2006.09.020	15	55	56	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2009	5	1					23	25		10.1038/nchembio.126	http://dx.doi.org/10.1038/nchembio.126			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387EW	19011639	Green Accepted			2022-12-25	WOS:000261935500009
J	Di Bernardo, MC; Crowther-Swanepoel, D; Broderick, P; Webb, E; Sellick, G; Wild, R; Sullivan, K; Vijayakrishnan, J; Wang, YF; Pittman, AM; Sunter, NJ; Hall, AG; Dyer, MJS; Matutes, E; Dearden, C; Mainou-Fowler, T; Jackson, GH; Summerfield, G; Harris, RJ; Pettitt, AR; Hillmen, P; Allsup, DJ; Bailey, JR; Pratt, G; Pepper, C; Fegan, C; Allan, JM; Catovsky, D; Houlston, RS				Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Sunter, Nicola J.; Hall, Andrew G.; Dyer, Martin J. S.; Matutes, Estella; Dearden, Claire; Mainou-Fowler, Tryfonia; Jackson, Graham H.; Summerfield, Geoffrey; Harris, Robert J.; Pettitt, Andrew R.; Hillmen, Peter; Allsup, David J.; Bailey, James R.; Pratt, Guy; Pepper, Chris; Fegan, Chris; Allan, James M.; Catovsky, Daniel; Houlston, Richard S.			A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia	NATURE GENETICS			English	Article							CELL DEVELOPMENT; NUCLEAR-BODY; EXPRESSION; FAMILIES; RISK	We conducted a genome-wide association study of 299,983 tagging SNPs for chronic lymphocytic leukemia (CLL) and performed validation in two additional series totaling 1,529 cases and 3,115 controls. We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). These data provide the first evidence for the existence of common, low-penetrance susceptibility to a hematological malignancy and new insights into disease causation in CLL.	[Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Sunter, Nicola J.; Hall, Andrew G.; Allan, James M.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Matutes, Estella; Dearden, Claire; Catovsky, Daniel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; [Mainou-Fowler, Tryfonia] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Jackson, Graham H.] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Summerfield, Geoffrey] Queen Elizabeth Hosp, Dept Haematol, Newcastle Upon Tyne NE9 6SX, Tyne & Wear, England; [Harris, Robert J.; Pettitt, Andrew R.] Univ Liverpool, Sch Canc Studies, Div Haematol, Liverpool L69 3BX, Merseyside, England; [Hillmen, Peter] Gen Infirm, Dept Haematol, Leeds LS1 3EX, W Yorkshire, England; [Allsup, David J.] Hull Royal Infirm, Dept Haematol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bailey, James R.] Hull York Med Sch, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Bailey, James R.] Univ Hull, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Pratt, Guy] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9, W Midlands, England; [Pepper, Chris] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, S Glam, Wales; [Fegan, Chris] Cardiff & Vale NHS Trust, Cardiff CF14 4XW, S Glam, Wales	University of London; Institute of Cancer Research - UK; Newcastle University - UK; University of Leicester; University of London; Institute of Cancer Research - UK; Newcastle University - UK; Newcastle University - UK; University of Liverpool; Leeds General Infirmary; University of Hull; University of Hull; University of York - UK; University of Hull; Heart of England NHS Foundation Trust; Cardiff University; Cardiff University	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.houlston@icr.ac.uk	Pittman, Alan M/D-6231-2012; Allsup, David/H-2195-2017; Hall, Andy/AAD-8622-2020; Jackson, Graham/GMW-7638-2022; Hall, Andrew G/B-3485-2009; Pepper, Chris/B-4357-2009; Pittman, Alan/AAP-2534-2020; Allan, James/B-4448-2009; Dyer, Martin/F-2691-2014	Pittman, Alan M/0000-0002-8112-2987; Allsup, David/0000-0001-6159-6109; Jackson, Graham/0000-0003-0756-969X; Pittman, Alan/0000-0002-8112-2987; Broderick, Peter/0000-0002-8348-5829; Houlston, Richard/0000-0002-5268-0242; Allan, James/0000-0002-7580-5087; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Dyer, Martin/0000-0002-5033-2236; Pepper, Chris/0000-0003-3603-8839; Webb, Emily/0000-0002-4019-7456	Leukaemia Research Fund (LRF) [LRF05001 and 06002]; CLL Global Research Foundation, Cancer Research UK; Bobby Moore Fund [C1298/A8362]; European Union [CPRB LSHC-CT-2004-503465]; MRC [G0000934, MC_U132670597] Funding Source: UKRI; Medical Research Council [G0000934, MC_U132670597] Funding Source: researchfish	Leukaemia Research Fund (LRF); CLL Global Research Foundation, Cancer Research UK(Cancer Research UK); Bobby Moore Fund; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Leukaemia Research Fund (LRF) provided principal funding for the study (LRF05001 and 06002). Additional funding was provided by CLL Global Research Foundation, Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund), the Arbib fund and the European Union (CPRB LSHC-CT-2004-503465). D. C.-S. was in receipt of a PhD studentship from the Institute of Cancer Research. We are grateful to M. Yuille for input into our early work on familial CLL. This study made use of genotyping data on the 1958 Birth Cohort. Genotyping data on controls was generated and generously supplied to us by P. Deloukas of the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the data are available from http:// www. wtccc. org. uk. We are grateful to all investigators who contributed to the study of acute leukemia, from which phase 3 controls were drawn, to members of the ICLLLC (Supplementary Note online) and to investigators who contributed to NSCCG and GELCAPS, from which phase 1 and 2 controls were drawn. Finally, we are grateful to all the study subjects for their participation.	Allan JM, 2001, P NATL ACAD SCI USA, V98, P11592, DOI 10.1073/pnas.191211198; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kovalevska L. M., 2006, Experimental Oncology, V28, P225; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; Oliver PM, 2004, J EXP MED, V200, P1179, DOI 10.1084/jem.20041129; Petitti D, 1994, METAANALYSIS DECISIO; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Sayala HA, 2006, BLOOD, V108, p14A, DOI 10.1182/blood.V108.11.34.34; Sellick GS, 2007, BLOOD, V110, P3326, DOI 10.1182/blood-2007-05-091561; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Weiss N S, 1979, Natl Cancer Inst Monogr, P139	28	274	281	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1204	1210		10.1038/ng.219	http://dx.doi.org/10.1038/ng.219			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758461				2022-12-25	WOS:000259651000020
J	Geraldo, S; Khanzada, UK; Parsons, M; Chilton, JK; Gordon-Weeks, PR				Geraldo, Sara; Khanzada, Umme K.; Parsons, Maddy; Chilton, John K.; Gordon-Weeks, Phillip R.			Targeting of the F-actin-binding protein drebrin by the microtubule plus-tip protein EB3 is required for neuritogenesis	NATURE CELL BIOLOGY			English	Article							NEURONAL GROWTH CONES; FLUORESCENT PROTEIN; END; FILOPODIA; APC; FILAMENTS; RECRUITMENT; MECHANISMS; DYNAMICS; BUNDLES	Interactions between dynamic microtubules and actin filaments (F-actin) underlie a range of cellular processes including cell polarity and motility. In growth cones, dynamic microtubules are continually extending into selected filopodia, aligning alongside the proximal ends of the F-actin bundles. This interaction is essential for neuritogenesis and growth-cone pathfinding. However, the molecular components mediating the interaction between microtubules and filopodial F-actin have yet to be determined. Here we show that drebrin, an F-actin-associated protein, binds directly to the microtubule-binding protein EB3. In growth cones, this interaction occurs specifically when drebrin is located on F-actin in the proximal region of filopodia and when EB3 is located at the tips of microtubules invading filopodia. When this interaction is disrupted, the formation of growth cones and the extension of neurites are impaired. We conclude that drebrin targets EB3 to coordinate F-actin-microtubule interactions that underlie neuritogenesis.	[Geraldo, Sara; Khanzada, Umme K.; Chilton, John K.; Gordon-Weeks, Phillip R.] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London; University of London; King's College London	Gordon-Weeks, PR (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, New Hunts House,Guys Campus, London SE1 1UL, England.	phillip.gordon-weeks@kcl.ac.uk	Parsons, Maddy/B-2203-2013; Gordon-Weeks, Phillip R./C-5328-2009	Parsons, Maddy/0000-0002-2021-8379; Gordon-Weeks, Phillip R./0000-0002-4738-4246	Medical Research Council; Royal Society and the Wellcome Trust; Fundacao para a Ciencia e Tecnologia, Portugal; MRC [G9900989, G0100152] Funding Source: UKRI; Medical Research Council [G9900989, G0100152] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society and the Wellcome Trust; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Britta Eickholt and her laboratory and the P. R. G.-W. laboratory for helpful discussions. We are grateful to Brigitte Keon for the gift of human drebrin E cDNA, Ewan Morrison for EB1 cDNA, Roger Tsien for CherryRFP cDNA, Britta Eickholt for drebrin-RFP, and Niels Galjart for polyclonal antibodies against CLASP 1, CLASP 2 and CLIP-170 and EB3 cDNA, and Matthias Krause for help with kymography and comments on the manuscript. This work was supported by grants from the Medical Research Council, the Royal Society and the Wellcome Trust. Sara Geraldo's PhD studentship is funded by Fundacao para a Ciencia e Tecnologia, Portugal.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Bush MS, 1996, EUR J NEUROSCI, V8, P235, DOI 10.1111/j.1460-9568.1996.tb01208.x; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GORDONWEEKS PR, 1989, J NEUROCYTOL, V18, P451, DOI 10.1007/BF01474542; GORDONWEEKS PR, 1991, NEUROREPORT, V2, P573, DOI 10.1097/00001756-199110000-00005; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mizui T, 2005, MOL CELL NEUROSCI, V30, P630, DOI 10.1016/j.mcn.2005.06.013; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; PHELAN P, 1997, NEUROCHEMISTRY PRACT, P1; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHIRAO T, 1992, NEUROREPORT, V3, P109, DOI 10.1097/00001756-199201000-00029; SHIRAO T, 1995, J BIOCHEM-TOKYO, V117, P231, DOI 10.1093/jb/117.2.231; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Stepanova T, 2003, J NEUROSCI, V23, P2655; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	39	182	185	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1181	1189		10.1038/ncb1778	http://dx.doi.org/10.1038/ncb1778			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18806788				2022-12-25	WOS:000259682900012
J	Muller, T; Hess, MW; Schiefermeier, N; Pfaller, K; Ebner, HL; Heinz-Erian, P; Ponstingl, H; Partsch, J; Rollinghoff, B; Kohler, H; Berger, T; Lenhartz, H; Schlenck, B; Houwen, RJ; Taylor, CJ; Zoller, H; Lechner, S; Goulet, O; Utermann, G; Ruemmele, FM; Huber, LA; Janecke, AR				Mueller, Thomas; Hess, Michael W.; Schiefermeier, Natalia; Pfaller, Kristian; Ebner, Hannes L.; Heinz-Erian, Peter; Ponstingl, Hannes; Partsch, Joachim; Roellinghoff, Barbara; Koehler, Henrik; Berger, Thomas; Lenhartz, Henning; Schlenck, Barbara; Houwen, Roderick J.; Taylor, Christopher J.; Zoller, Heinz; Lechner, Silvia; Goulet, Olivier; Utermann, Gerd; Ruemmele, Frank M.; Huber, Lukas A.; Janecke, Andreas R.			MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity	NATURE GENETICS			English	Article							MEMBRANE-PROTEIN; APICAL MEMBRANE; PLASMA-MEMBRANE; MYOSIN-VB; ATROPHY; RAB8	Following homozygosity mapping in a single kindred, we identified nonsense and missense mutations in MYO5B, encoding type Vb myosin motor protein, in individuals with microvillus inclusion disease (MVID). MVID is characterized by lack of microvilli on the surface of enterocytes and occurrence of intracellular vacuolar structures containing microvilli. In addition, mislocalization of transferrin receptor in MVID enterocytes suggests that MYO5B deficiency causes defective trafficking of apical and basolateral proteins in MVID.	[Lechner, Silvia; Utermann, Gerd; Janecke, Andreas R.] Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria; [Mueller, Thomas; Heinz-Erian, Peter] Innsbruck Med Univ, Dept Pediat 2, A-6020 Innsbruck, Austria; [Hess, Michael W.; Pfaller, Kristian; Ebner, Hannes L.] Innsbruck Med Univ, Div Histol & Embryol, A-6020 Innsbruck, Austria; [Schiefermeier, Natalia; Huber, Lukas A.] Innsbruck Med Univ, Div Cell Biol, Bioctr, A-6020 Innsbruck, Austria; [Ponstingl, Hannes] Sanger Inst, Wellcome Trust, Sequencing Informat Div, Cambridge CB10 1SA, England; [Partsch, Joachim; Roellinghoff, Barbara] Childrens Hosp Esslingen, D-73730 Esslingen, Germany; [Koehler, Henrik] Univ Erlangen Nurnberg, Dept Pediat, D-91054 Erlangen, Germany; [Berger, Thomas] Univ Witten Herdecke, Dept Pediat, D-45711 Datteln, Germany; [Lenhartz, Henning] Childrens Hosp Wilhelmstift, D-22194 Hamburg, Germany; [Schlenck, Barbara] Innsbruck Med Univ, Div Pediat Urol, A-6020 Innsbruck, Austria; [Houwen, Roderick J.] Wilhelmina Childrens Hosp, NL-3508 AB Utrecht, Netherlands; [Taylor, Christopher J.] Univ Sheffield, Dept Child Hlth, Sheffield S10 2TH, S Yorkshire, England; [Zoller, Heinz] Innsbruck Med Univ, Clin Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria; [Lechner, Silvia] Univ Hlth Sci Med Informat & Technol, Inst Appl Syst Res & Dev, A-6060 Hall In Tirol, Austria; [Goulet, Olivier; Ruemmele, Frank M.] Univ Paris 05, AP HP, Inst Natl Sante Rech Med,INSERM U 793, Fac Necker,Dept Pediat,Serv Gastroenterol Pediat, F-75743 Paris, France	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Wellcome Trust Sanger Institute; University of Erlangen Nuremberg; Witten Herdecke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Innsbruck; Wilhelmina Kinderziekenhuis; University of Sheffield; Medical University of Innsbruck; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Janecke, AR (corresponding author), Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria.	Andreas.Janecke@i-med.ac.at	Huber, Lukas Alfons/AAM-3499-2021; Schiefermeier-Mach, Natalia/AAW-6428-2021; Zoller, Heinz/AAD-7225-2019; Janecke, Andreas/AAA-5227-2019; Hess, Michael/AAE-1985-2019; Berger, Thomas/AAY-8488-2020	Schiefermeier-Mach, Natalia/0000-0001-6638-5298; Hess, Michael/0000-0002-5154-3553; Janecke, Andreas/0000-0001-7155-0315; Huber, Lukas Alfons/0000-0003-1116-2120	Austrian Science Funds (FWF) [P18470, SFB021, P19486-B12]; Jubilaumsfonds [P-11050]; TILAK-Universitartskliniken	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); Jubilaumsfonds; TILAK-Universitartskliniken	We thank S. Steiner, V. Wild, K. Gutleben, A. Florl, T. Erdel and D. Hilber for technical assistance. The work was supported by the Austrian Science Funds (FWF), grants P18470 to A. R.J., SFB021 to L. A. H., P19486-B12 to M. W. H., Jubilaumsfonds grant P-11050 and support from TILAK-Universitartskliniken to M. W. H., a Dr.-Legerlotz-Stiftung grant to A. R. J. and a grant by Raiffeisen Landesbank-Tirol AG to T. M.	Ameen NA, 2000, TRAFFIC, V1, P76, DOI 10.1034/j.1600-0854.2000.010111.x; CARRUTHERS L, 1985, J PEDIATR GASTR NUTR, V4, P902, DOI 10.1097/00005176-198512000-00009; GILBERT T, 1991, J CELL SCI, V100, P451; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Reinshagen K, 2002, GUT, V51, P514, DOI 10.1136/gut.51.4.514; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Ruemmele FM, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-22; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sharma N, 2005, BIOCHEM J, V390, P437, DOI 10.1042/BJ20050256; Tako E, 2008, BRIT J NUTR, V99, P472, DOI 10.1017/S0007114507825128; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Wang EX, 2001, J CELL SCI, V114, P3309	15	239	249	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1163	1165		10.1038/ng.225	http://dx.doi.org/10.1038/ng.225			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18724368				2022-12-25	WOS:000259651000014
J	Najm, J; Horn, D; Wimplinger, I; Golden, JA; Chizhikov, VV; Sudi, J; Christian, SL; Ullmann, R; Kuechler, A; Haas, CA; Flubacher, A; Charnas, LR; Uyanik, G; Frank, U; Klopocki, E; Dobyns, WB; Kutsche, K				Najm, Juliane; Horn, Denise; Wimplinger, Isabella; Golden, Jeffrey A.; Chizhikov, Victor V.; Sudi, Jyotsna; Christian, Susan L.; Ullmann, Reinhard; Kuechler, Alma; Haas, Carola A.; Flubacher, Armin; Charnas, Lawrence R.; Uyanik, Goekhan; Frank, Ulrich; Klopocki, Eva; Dobyns, William B.; Kutsche, Kerstin			Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum	NATURE GENETICS			English	Article							SYNAPTIC FUNCTION; MOUSE; MUTANT; LETHAL	CASK is a multi-domain scaffolding protein that interacts with the transcription factor TBR1 and regulates expression of genes involved in cortical development such as RELN. Here we describe a previously unreported X-linked brain malformation syndrome caused by mutations of CASK. All five affected individuals with CASK mutations had congenital or postnatal microcephaly, disproportionate brainstem and cerebellar hypoplasia, and severe mental retardation.	[Najm, Juliane; Wimplinger, Isabella; Kutsche, Kerstin] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Horn, Denise; Klopocki, Eva] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Golden, Jeffrey A.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Golden, Jeffrey A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Sudi, Jyotsna; Christian, Susan L.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ullmann, Reinhard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Kuechler, Alma] Univ Klinikum Essen, Inst Human Genet, D-45122 Essen, Germany; [Haas, Carola A.; Flubacher, Armin] Univ Freiburg, Expt Epilepsy Res Grp, Neuroctr, D-79106 Freiburg, Germany; [Charnas, Lawrence R.] Univ Minnesota, Dept Pediat, Div Clin Neurosci, Minneapolis, MN 55455 USA; [Uyanik, Goekhan] Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany; [Frank, Ulrich] Sozialpadiatr Zentrum, Stadt Klinikum Braunschweig, D-38118 Braunschweig, Germany; [Dobyns, William B.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Dobyns, William B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Chicago; Max Planck Society; University of Duisburg Essen; University of Freiburg; University of Minnesota System; University of Minnesota Twin Cities; University of Regensburg; University of Chicago; University of Chicago	Kutsche, K (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany.	kkutsche@uke.de	Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020; Klopocki, Eva/B-6823-2017	Dobyns, William/0000-0002-7681-2844; Klopocki, Eva/0000-0003-1438-2081; Chizhikov, Victor/0000-0003-2338-1267; Golden, Jeffrey/0000-0001-9933-5502	Deutsche Forschungsgemeinschaft [KU 1240/3-2]; US National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01-NS050375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046616, R01NS050375] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the study participants and their parents. We thank I. Jantke, L. Schroedter and F. Trotier for skillful technical assistance, S. Fuchs and K. Ziegler for chromosome analysis, and A. Nowka for help with the in vitro splicing assay. We also thank T. Sudhof (Howard Hughes Medical Institute) for providing Cask knock-in mice. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (KU 1240/3-2 to K. K.), and a grant from the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01-NS050375 to W. B. D.).	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; Franco B, 2006, CURR OPIN GENET DEV, V16, P254, DOI 10.1016/j.gde.2006.04.012; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Laverty HG, 1998, GENOMICS, V53, P29, DOI 10.1006/geno.1998.5479; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009	15	198	209	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1065	1067		10.1038/ng.194	http://dx.doi.org/10.1038/ng.194			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165920				2022-12-25	WOS:000258761200018
J	Andrews, NL; Lidke, KA; Pfeiffer, JR; Burns, AR; Wilson, BS; Oliver, JM; Lidke, DS				Andrews, Nicholas L.; Lidke, Keith A.; Pfeiffer, Janet R.; Burns, Alan R.; Wilson, Bridget S.; Oliver, Janet M.; Lidke, Diane S.			Actin restricts Fc epsilon RI diffusion and facilitates antigen-induced receptor immobilization	NATURE CELL BIOLOGY			English	Article								The actin cytoskeleton has been implicated in restricting diffusion of plasma membrane components. Here, simultaneous observations of quantum dot-labelled Fc epsilon RI motion and GFP-tagged actin dynamics provide direct evidence that actin filament bundles define micron-sized domains that confine mobile receptors. Dynamic reorganization of actin structures occurs over seconds, making the location and dimensions of actin-defined domains time-dependent. Multiple Fc epsilon RI often maintain extended close proximity without detectable correlated motion, suggesting that they are co-confined within membrane domains. Fc epsilon RI signalling is activated by crosslinking with multivalent antigen. We show that receptors become immobilized within seconds of crosslinking. Disruption of the actin cytoskeleton results in delayed immobilization kinetics and increased diffusion of crosslinked clusters. These results implicate actin in membrane partitioning that not only restricts diffusion of membrane proteins, but also dynamically influences their long-range mobility, sequestration and response to ligand binding.	[Andrews, Nicholas L.; Pfeiffer, Janet R.; Wilson, Bridget S.; Oliver, Janet M.; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Andrews, Nicholas L.; Pfeiffer, Janet R.; Wilson, Bridget S.; Oliver, Janet M.; Lidke, Diane S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Lidke, Keith A.] Sandia Natl Labs, Albuquerque, NM 87185 USA	University of New Mexico; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories	Lidke, DS (corresponding author), Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA.	dlidke@salud.unm.edu			NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016918, P20RR011830, S10RR015734, S10RR014668, S10RR022493, S10RR019287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM067594, R01GM049814] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA118100] Funding Source: Medline; NCRR NIH HHS [S10 RR15734, S10 RR019287, S10 RR14668, S10 RR16918, S10 RR022493, P20 RR11830, RR022493, S10 RR19287] Funding Source: Medline; NIAID NIH HHS [R01 AO051575, R01 AI051575] Funding Source: Medline; NIGMS NIH HHS [P20 GM 67594, P20 GM067594-01, R01 GM49814, R01 GM049814, R01 GM049814-07, P20 GM067597, P20 GM067594] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDTJOVIN DJ, 2006, P SOC PHOTO-OPT INS, V6096, P1; Barisas BG, 2007, BIOPHYS CHEM, V126, P209, DOI 10.1016/j.bpc.2006.05.026; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DAHL SC, 1994, J CELL BIOL, V125, P1057, DOI 10.1083/jcb.125.5.1057; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Destainville N, 2006, BIOPHYS J, V90, pL17, DOI 10.1529/biophysj.105.075176; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Draber P, 2002, MOL IMMUNOL, V38, P1247, DOI 10.1016/S0161-5890(02)00071-8; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Frankel DJ, 2006, BIOPHYS J, V90, P2404, DOI 10.1529/biophysj.105.073692; Frigeri L, 1999, J IMMUNOL, V162, P2243; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; JACQUIER V, 2006, P NATL ACAD SCI US; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LIU FT, 1980, J IMMUNOL, V124, P2728; MAO SY, 1991, J IMMUNOL, V146, P958; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; MENON AK, 1986, J CELL BIOL, V102, P541, DOI 10.1083/jcb.102.2.541; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; ORTEGA E, 1988, EMBO J, V7, P4101, DOI 10.1002/j.1460-2075.1988.tb03304.x; PFEIFFER JR, 1994, J IMMUNOL, V152, P270; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHLESSINGER J, 1976, NATURE, V264, P550, DOI 10.1038/264550a0; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Tang Q, 2003, BIOPHYS J, V84, P400, DOI 10.1016/S0006-3495(03)74860-7; THOMAS JL, 1992, BIOPHYS J, V61, P1402, DOI 10.1016/S0006-3495(92)81946-X; Thyagarajan R, 2003, J IMMUNOL, V170, P6099, DOI 10.4049/jimmunol.170.12.6099; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014	46	227	229	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					955	963		10.1038/ncb1755	http://dx.doi.org/10.1038/ncb1755			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641640	Green Accepted			2022-12-25	WOS:000258147100013
J	Andriopoulos, B; Corradini, E; Xia, Y; Faasse, SA; Chen, SZ; Grgurevic, L; Knutson, MD; Pietrangelo, A; Vukicevic, S; Lin, HY; Babitt, JL				Andriopoulos, Billy, Jr.; Corradini, Elena; Xia, Yin; Faasse, Sarah A.; Chen, Shanzhuo; Grgurevic, Lovorka; Knutson, Mitchell D.; Pietrangelo, Antonello; Vukicevic, Slobodan; Lin, Herbert Y.; Babitt, Jodie L.			BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism	NATURE GENETICS			English	Article							ANTIMICROBIAL PEPTIDE HEPCIDIN; GUIDANCE MOLECULE RGMA; GENE-EXPRESSION; BONE; HEMOJUVELIN; ANEMIA; DRAGON; INFLAMMATION; FERROPORTIN; RECEPTORS	Juvenile hemochromatosis is an iron-overload disorder caused by mutations in the genes encoding the major iron regulatory hormone hepcidin ( HAMP) 1 and hemojuvelin (HFE2)(2). We have previously shown that hemojuvelin is a co-receptor for bone morphogenetic proteins (BMPs) and that BMP signals regulate hepcidin expression and iron metabolism(3,4). However, the endogenous BMP regulator(s) of hepcidin in vivo is unknown. Here we show that compared with soluble hemojuvelin (HJV.Fc), the homologous DRAGON.Fc is a more potent inhibitor of BMP2 or BMP4 but a less potent inhibitor of BMP6 in vitro. In vivo, HJV.Fc or a neutralizing antibody to BMP6 inhibits hepcidin expression and increases serum iron, whereas DRAGON.Fc has no effect. Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload. Finally, we demonstrate a physical interaction between HJV.Fc and BMP6, and we show that BMP6 increases hepcidin expression and reduces serum iron in mice. These data support a key role for BMP6 as a ligand for hemojuvelin and an endogenous regulator of hepcidin expression and iron metabolism in vivo.	[Andriopoulos, Billy, Jr.; Corradini, Elena; Xia, Yin; Faasse, Sarah A.; Chen, Shanzhuo; Lin, Herbert Y.; Babitt, Jodie L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Div Nephrol,Program Membrane Biol, Boston, MA 02115 USA; [Corradini, Elena; Pietrangelo, Antonello] Univ Hosp Modena & Reggio Emilia, Ctr Hemochromatosis, Modena, Italy; [Grgurevic, Lovorka; Vukicevic, Slobodan] Univ Zagreb, Sch Med, Lab Mineralized Tissues, Zagreb 41000, Croatia; [Knutson, Mitchell D.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Zagreb; State University System of Florida; University of Florida	Babitt, JL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Div Nephrol,Program Membrane Biol, Boston, MA 02115 USA.	babitt.jodie@mgh.harvard.edu	Corradini, Elena/O-4167-2016; Vukicevic, Slobodan/AEG-2646-2022; Xia, Yin/M-5440-2018; Pietrangelo, Antonello/K-1517-2016	Corradini, Elena/0000-0001-9477-2164; Vukicevic, Slobodan/0000-0003-4076-0285; Xia, Yin/0000-0003-0315-7532; Pietrangelo, Antonello/0000-0002-7411-935X	Associazione Modenese per le Malattie del Fegato; Croatian Ministry of Science, Education, and Sport; US National Institutes of Health [RO1 DK-69533, RO1 DK-071837]; National Institutes of Health [K08 DK-075846]; Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069533, R01DK071837, K08DK075846] Funding Source: NIH RePORTER	Associazione Modenese per le Malattie del Fegato; Croatian Ministry of Science, Education, and Sport(Ministry of Science, Education and Sports, Republic of Croatia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank V. Rosen for kindly providing BMP2 for our study. We thank L. M. Russo for assistance with animal work. E.C. was supported in part by the Associazione Modenese per le Malattie del Fegato. S.V. was supported in part by the Croatian Ministry of Science, Education, and Sport. H.Y.L. was supported in part by US National Institutes of Health grants RO1 DK-69533 and RO1 DK-071837. J.L.B. was supported in part by National Institutes of Health grant K08 DK-075846 and by a Claflin Distinguished Scholar Award from the Massachusetts General Hospital.	Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pietrangelo A, 2006, BBA-MOL CELL RES, V1763, P700, DOI 10.1016/j.bbamcr.2006.05.013; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simic P, 2006, J BIOL CHEM, V281, P25509, DOI 10.1074/jbc.M513276200; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	30	567	592	6	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					482	487		10.1038/ng.335	http://dx.doi.org/10.1038/ng.335			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19252486	Green Accepted			2022-12-25	WOS:000264659000025
J	Lin, HK; Wang, GC; Chen, ZB; Teruya-Feldstein, J; Liu, Y; Chan, CH; Yang, WL; Erdjument-Bromage, H; Nakayama, KI; Nimer, S; Tempst, P; Pandolfi, PP				Lin, Hui-Kuan; Wang, Guocan; Chen, Zhenbang; Teruya-Feldstein, Julie; Liu, Yan; Chan, Chia-Hsin; Yang, Wei-Lei; Erdjument-Bromage, Hediye; Nakayama, Keiichi I.; Nimer, Stephen; Tempst, Paul; Pandolfi, Pier Paolo			Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB	NATURE CELL BIOLOGY			English	Article							CDK INHIBITOR P27; BOX PROTEIN SKP2; TUBEROUS SCLEROSIS; CELL-CYCLE; S-PHASE; 3-KINASE/AKT PATHWAY; TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; TUMOR SUPPRESSION; E3 LIGASE	Skp2 is an F-box protein that forms the SCF complex with Skp1 and Cullin-1 to constitute an E3 ligase for ubiquitylation. Ubiquitylation and degradation of p27 are critical for Skp2-mediated entry to the cell cycle, and overexpression and cytosolic accumulation of Skp2 have been clearly associated with tumorigenesis, although the functional significance of the latter is still unknown. Here we show that Akt/protein kinase B (PKB) interacts with and directly phosphorylates Skp2. We find that Skp2 phosphorylation by Akt triggers SCF complex formation and E3 ligase activity. A phosphorylation-defective Skp2 mutant is drastically impaired in its ability to promote cell proliferation and tumorigenesis. Furthermore, we show that Akt-mediated phosphorylation triggers 14-3- 3 beta-dependent Skp2 relocalization to the cytosol, and we attribute a specific role to cytosolic Skp2 in the positive regulation of cell migration. Finally, we demonstrate that high levels of activation of Akt correlate with the cytosolic accumulation of Skp2 in human cancer specimens. Our results therefore define a novel proto-oncogenic Akt/PKB-dependent signalling pathway.	[Lin, Hui-Kuan; Wang, Guocan; Chen, Zhenbang; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, New York, NY 10021 USA; [Wang, Guocan; Chen, Zhenbang; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA; [Wang, Guocan; Chen, Zhenbang; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol & Med, Boston, MA 02215 USA; [Lin, Hui-Kuan; Chan, Chia-Hsin; Yang, Wei-Lei] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liu, Yan; Nimer, Stephen] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan	Memorial Sloan Kettering Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Kyushu University	Lin, HK (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	hklin@mdanderson.org; ppandolf@bidmc.harvard.edu	Wang, Guocan/F-1530-2011; Chan, Chia-Hsin/AAT-7782-2020; Yang, Wei-Lei/E-2598-2012; Chan, Chia-Hsin/F-2272-2011	Chan, Chia-Hsin/0000-0001-8506-7500; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	NIH [RO1 CA-71692, CA-74031, P30 CA-08748]; Anderson Cancer Center Trust; NATIONAL CANCER INSTITUTE [R01CA074031, P30CA008748, R01CA071692] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Cancer Center Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank D. Bohmann, P. Jackson, W. Wei, M. Pagano and M. H. Lee for reagents. We are also grateful to M. Asherov and I. Linkov in the Immunohistochemistry Pathology Core Laboratory, T. Matos for immunohistochemistry technical assistance, P. Bonner for data management, L. Lacomis for help with mass spectrometry, X. H. Zhu for technical advice, and S. Clohessy for flow cytometry analysis. We also thank M. C. Hung and L. Cantley for insightful comments and suggestions, and W. Wei for discussion and for sharing experimental results. Special thanks are extended to B. Carver and L. DiSantis for editing and critical reading of the manuscript, as well as to all the members of the Pandolfi laboratory for comments and discussion. This work was supported by NIH grants RO1 CA-71692 and CA-74031 to P.P.P. and by M.D. Anderson Cancer Center Trust Scholar funds to H.K.L. The Microchemistry & Proteomics Core is supported by NIH grant P30 CA-08748.	Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; Bilodeau M, 1999, FEBS LETT, V452, P247, DOI 10.1016/S0014-5793(99)00629-8; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Drobnjak M, 2003, CLIN CANCER RES, V9, P2613; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Li Q, 2004, J CUTAN PATHOL, V31, P633, DOI 10.1111/j.0303-6987.2004.00243.x; Lim MS, 2002, BLOOD, V100, P2950, DOI 10.1182/blood.V100.8.2950; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Shim EH, 2003, CANCER RES, V63, P1583; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	44	184	194	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					420	U144		10.1038/ncb1849	http://dx.doi.org/10.1038/ncb1849			34	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19270694	Green Accepted			2022-12-25	WOS:000265264900012
J	Watanabe, H; Chopra, N; Laver, D; Hwang, HS; Davies, SS; Roach, DE; Duff, HJ; Roden, DM; Wilde, AAM; Knollmann, BC				Watanabe, Hiroshi; Chopra, Nagesh; Laver, Derek; Hwang, Hyun Seok; Davies, Sean S.; Roach, Daniel E.; Duff, Henry J.; Roden, Dan M.; Wilde, Arthur A. M.; Knollmann, Bjoern C.			Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans	NATURE MEDICINE			English	Article							RYANODINE RECEPTOR; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; MUTATIONS; CASQ2; MECHANISMS; MYOCYTES; INCREASE; DEATH	Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal inherited arrhythmia syndrome in which drug therapy is often ineffective. We discovered that flecainide prevents arrhythmias in a mouse model of CPVT by inhibiting cardiac ryanodine receptor-mediated Ca2+ release and thereby directly targeting the underlying molecular defect. Flecainide completely prevented CPVT in two human subjects who had remained highly symptomatic on conventional drug therapy, indicating that this currently available drug is a promising mechanism-based therapy for CPVT.	[Watanabe, Hiroshi; Chopra, Nagesh; Hwang, Hyun Seok; Davies, Sean S.; Roden, Dan M.; Knollmann, Bjoern C.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Watanabe, Hiroshi; Chopra, Nagesh; Hwang, Hyun Seok; Davies, Sean S.; Roden, Dan M.; Knollmann, Bjoern C.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Laver, Derek] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia; [Laver, Derek] Hunter Med Res Inst, Callaghan, NSW, Australia; [Roach, Daniel E.; Duff, Henry J.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	Vanderbilt University; Vanderbilt University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Amsterdam; Academic Medical Center Amsterdam	Knollmann, BC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	bjorn.knollmann@vanderbilt.edu	Roden, Dan/ABD-5412-2021	Davies, Sean/0000-0001-9879-8062; Knollmann, Bjorn/0000-0003-4956-9735; Duff, Henry/0000-0001-9292-5411	US National Institutes of Health [HL88635, HL71670, HL49989]; American Heart Association Established Investigator Award [0840071N]; Australian Research Council [DP0557780]; New South Wales Health through Hunter Medical Research Institute; Leducq Foundation [05CVD01]; Alberta Heart and Stroke Foundation Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071670, R01HL049989, R01HL088635] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); Australian Research Council(Australian Research Council); New South Wales Health through Hunter Medical Research Institute; Leducq Foundation(Leducq Foundation); Alberta Heart and Stroke Foundation Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Huke and S. Kim for their assistance with the data analysis and the preparation of figures, P. Johnson for his assistance with the single-channel recording and N. Masalha and S.A. Clur for their assistance in patient care and management. This work was supported in part by the US National Institutes of Health grants HL88635 and HL71670 (to B.C.K.) and HL49989 (to D.M.R.), by the American Heart Association Established Investigator Award 0840071N (to B.C.K.), by the Australian Research Council grant DP0557780 (to D.R.L.), by an infrastructure grant from New South Wales Health through Hunter Medical Research Institute (to D.R.L.), by the Leducq Foundation grant 05CVD01 (to A.A.M.W. and D.M.R.) and by the Alberta Heart and Stroke Foundation Chair in Cardiovascular Medicine (to H.J.D.).	Cerrone M, 2007, CIRC RES, V101, P1039, DOI 10.1161/CIRCRESAHA.107.148064; De Rosa G, 2004, PEDIATR EMERG CARE, V20, P175, DOI 10.1097/01.pec.0000117927.65522.7a; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Gyorke S, 1997, J PHYSIOL-LONDON, V500, P297; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Mohamed U, 2006, HEART RHYTHM, V3, P1486, DOI 10.1016/j.hrthm.2006.08.018; PIZZAIE S, 2008, J CARDIOVASC ELECTR, V9, P1319; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Priori SG, 2001, CIRCULATION, V103, P196; ROBINSON M, 2007, HEART RHYTHM S, V4, pS100; ROSEN MR, 1980, CIRC RES, V46, P117, DOI 10.1161/01.RES.46.1.117; SHOSHANBARMATZ V, 1993, J MEMBRANE BIOL, V133, P171; Venetucci LA, 2006, CIRC RES, V98, P1299, DOI 10.1161/01.RES.0000222000.35500.65; Wilde AAM, 2008, NEW ENGL J MED, V358, P2024, DOI 10.1056/NEJMoa0708006	18	398	411	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					380	383		10.1038/nm.1942	http://dx.doi.org/10.1038/nm.1942			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19330009	Green Accepted			2022-12-25	WOS:000264937200024
J	Chen, BZ; Dodge, ME; Tang, W; Lu, JM; Ma, ZQ; Fan, CW; Wei, SG; Hao, WN; Kilgore, J; Williams, NS; Roth, MG; Amatruda, JF; Chen, C; Lum, L				Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Lu, Jianming; Ma, Zhiqiang; Fan, Chih-Wei; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Amatruda, James F.; Chen, Chuo; Lum, Lawrence			Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer	NATURE CHEMICAL BIOLOGY			English	Article							WNT/BETA-CATENIN; STEM-CELLS; BETA-CATENIN; PALMITOYLATION; ACYLTRANSFERASE; COMPARTMENTS; INTESTINE; PATHWAY; PROTEIN; LRP6	The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small molecules that target Wnt-mediated cellular responses. By screening a diverse synthetic chemical library, we have discovered two new classes of small molecules that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the production of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/beta-catenin pathway activity. With these small molecules, we establish a chemical genetic approach for studying Wnt pathway responses and stem cell function in adult tissue. We achieve transient, reversible suppression of Wnt/beta-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth. The signal transduction mechanisms shown here to be chemically tractable additionally contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chemical genetics and therapeutic goals.	[Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Fan, Chih-Wei; Lum, Lawrence] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lu, Jianming; Ma, Zhiqiang; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Biol Mol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lum, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lawrence.lum@utsouthwestern.edu		Chen, Chuo/0000-0002-3118-4901; Tang, Wei-Jen/0000-0002-8267-8995; Roth, Michael/0000-0002-9056-332X	US National Cancer Institute [PO1 CA095471]; US National Institute of General Medical Sciences [1R01GM076398-01]; American Cancer Society [RSG GMC-112251]; Welch Foundation [I-1665]; University of Texas Southwestern; NATIONAL CANCER INSTITUTE [R01CA095741, P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076398] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Welch Foundation(The Welch Foundation); University of Texas Southwestern; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Bienz ( Medical Research Council Laboratory of Molecular Biology), R. T. Moon ( University of Washington), P. T. Chuang (University of California, San Francisco), J. Laborda ( University of Castilla-La Mancha), G. Johnson ( University of Alabama at Birmingham), P. Beachy ( Stanford University), J. Minna, M. Brown and J. Goldstein ( University of Texas Southwestern Medical Center) for reagents, and D. Frantz, K. Lillard, the University of Texas Southwestern Pathology Core, S. McKnight and the High-Throughput Screening Core for support with the chemical screen. This work was supported by the US National Cancer Institute (PO1 CA095471; Z.M., J.K. and N.S.W.), the US National Institute of General Medical Sciences (1R01GM076398-01), the American Cancer Society (RSG GMC-112251), the Welch Foundation (I-1665), a High Risk/High Impact award from the University of Texas Southwestern and an endowment from Virginia Murchison Linthicum.	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; Orsulic S, 1999, J CELL SCI, V112, P1237; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	30	1076	1141	1	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					100	107		10.1038/nchembio.137	http://dx.doi.org/10.1038/nchembio.137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19125156	Green Accepted			2022-12-25	WOS:000263090700014
J	Helbig, I; Mefford, HC; Sharp, AJ; Guipponi, M; Fichera, M; Franke, A; Muhle, H; de Kovel, C; Baker, C; von Spiczak, S; Kron, KL; Steinich, I; Kleefuss-Lie, AA; Leu, C; Gaus, V; Schmitz, B; Klein, KM; Reif, PS; Rosenow, F; Weber, Y; Lerche, H; Zimprich, F; Urak, L; Fuchs, K; Feucht, M; Genton, P; Thomas, P; Visscher, F; de Haan, GJ; Moller, RS; Hjalgrim, H; Luciano, D; Wittig, M; Nothnagel, M; Elger, CE; Nurnberg, P; Romano, C; Malafosse, A; Koeleman, BPC; Lindhout, D; Stephani, U; Schreiber, S; Eichler, EE; Sander, T				Helbig, Ingo; Mefford, Heather C.; Sharp, Andrew J.; Guipponi, Michel; Fichera, Marco; Franke, Andre; Muhle, Hiltrud; de Kovel, Carolien; Baker, Carl; von Spiczak, Sarah; Kron, Katherine L.; Steinich, Ines; Kleefuss-Lie, Ailing A.; Leu, Costin; Gaus, Verena; Schmitz, Bettina; Klein, Karl M.; Reif, Philipp S.; Rosenow, Felix; Weber, Yvonne; Lerche, Holger; Zimprich, Fritz; Urak, Lydia; Fuchs, Karoline; Feucht, Martha; Genton, Pierre; Thomas, Pierre; Visscher, Frank; de Haan, Gerrit-Jan; Moller, Rikke S.; Hjalgrim, Helle; Luciano, Daniela; Wittig, Michael; Nothnagel, Michael; Elger, Christian E.; Nuernberg, Peter; Romano, Corrado; Malafosse, Alain; Koeleman, Bobby P. C.; Lindhout, Dick; Stephani, Ulrich; Schreiber, Stefan; Eichler, Evan E.; Sander, Thomas			15q13.3 microdeletions increase risk of idiopathic generalized epilepsy	NATURE GENETICS			English	Article							SCHIZOPHRENIA; SEIZURES	We identified 15q13.3 microdeletions encompassing the CHRNA7 gene in 12 of 1,223 individuals with idiopathic generalized epilepsy (IGE), which were not detected in 3,699 controls (joint P = 5.32 x 10(-8)). Most deletion carriers showed common IGE syndromes without other features previously associated with 15q13.3 microdeletions, such as intellectual disability, autism or schizophrenia. Our results indicate that 15q13.3 microdeletions constitute the most prevalent risk factor for common epilepsies identified to date.	[Mefford, Heather C.; Baker, Carl; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sharp, Andrew J.; Guipponi, Michel; Malafosse, Alain] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Sharp, Andrew J.; Guipponi, Michel; Malafosse, Alain] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Fichera, Marco; Luciano, Daniela; Romano, Corrado] IRCCS Associaz Oasi Maria Santissima, I-94018 Troina, Italy; [Genton, Pierre] Ctr St Paul Hop Henri Gastaut, F-13258 Marseille 09, France; [Thomas, Pierre] Hop Louis Pasteur, Unite Fonctionnelle EEG Epileptol, Serv Neurol, F-06002 Nice 01, France; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany	University of Washington; University of Washington Seattle; University of Geneva; University of Geneva; CHU Nice; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Bonn		sandert@uni-koeln.de	Nothnagel, Michael/H-6887-2012; Stephani, Ulrich/D-1004-2010; Muhle, Hiltrud/F-5715-2010; Fichera, Marco/K-9220-2016; Resource Center, NINDS Human Genetics/AGF-2474-2022; Zimprich, Fritz/W-1738-2017; Nothnagel, Michael/G-6545-2014; Lindhout, Dick/AAH-5765-2019; Sander-Effron, Samuel/AAX-2231-2020; Nothnagel, Michael/A-7759-2011; Helbig, Ingo/A-5544-2009; de Kovel, Carolien/AAI-3531-2021; Nothnagel, Michael/L-7187-2019; Romano, Corrado/B-9695-2008; Zimprich, Fritz/O-1406-2019; Helbig, Ingo/G-8467-2018; Franke, Andre/B-2151-2010; Helbig, Katherine/B-7454-2012	Fichera, Marco/0000-0002-8225-6880; Zimprich, Fritz/0000-0002-6998-5480; de Kovel, Carolien/0000-0002-7818-1396; Nothnagel, Michael/0000-0001-8305-7114; Romano, Corrado/0000-0003-1049-0683; Zimprich, Fritz/0000-0002-6998-5480; Helbig, Ingo/0000-0001-8486-0558; Franke, Andre/0000-0003-1530-5811; Helbig, Katherine/0000-0001-8249-0549; Leu, Costin/0000-0003-0598-3301; Moller, Rikke S./0000-0002-9664-1448; Klein, Karl Martin/0000-0002-6654-1665; Feucht, Martha/0000-0001-7691-8158; Lindhout, Dick/0000-0001-9580-624X; de Haan, Gerrit-Jan/0000-0003-2373-9863	German Research Foundation [SA434/4-1]; German Federal Ministry of Education and Research (National Genome Research Network [NGFN-2]; European Community; EPICURE [LSHM-CT-2006-037315, 219250]; PopGen biobank; University of Kiel; Danish National Research Foundation; NIH [HD043569]; National Epilepsy Funds (NEF) [04-08]; Netherlands Organization for Scientific Research (NOW) [917.66.315]; German Research Foundation/German Federal Ministry of Education and Research (DFG/BMBF); Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (National Genome Research Network(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); EPICURE; PopGen biobank; University of Kiel; Danish National Research Foundation(Danmarks Grundforskningsfond); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Epilepsy Funds (NEF); Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO)); German Research Foundation/German Federal Ministry of Education and Research (DFG/BMBF)(German Research Foundation (DFG)Federal Ministry of Education & Research (BMBF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank all the subjects and their families for participating in this study. We are also grateful to H. Bode for referral of subjects and A. Ackerhans and K. Moldenhauer for database management. This study used samples from the NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds), as well as clinical data. NINDS Repository sample numbers corresponding to the samples used are available upon request. This study was supported by grants from the German Research Foundation (SA434/4-1, T. S., P. N.), the German Federal Ministry of Education and Research (National Genome Research Network, NGFN-2: NeuroNet, NGFNplus: EMINet), the European Community (FP6 Integrated Project EPICURE, LSHM-CT-2006-037315; grant agreement 219250, A.J.S.), the PopGen biobank, the University of Kiel (I. H.), the Danish National Research Foundation (R. S. M.), in part by grants from the NIH (HD043569, E. E. E.), the National Epilepsy Funds (NEF, grant no. 04-08, B. P. C. K., D. Lindhout), the Netherlands Organization for Scientific Research (NOW, grant no. 917.66.315, B.P.C.K., C.d.K.) and the German Research Foundation/German Federal Ministry of Education and Research (DFG/BMBF) excellence cluster "Inflammation at Interfaces'' (A. F., M. W., S. S.). E. E. E. is an investigator of the Howard Hughes Medical Institute.	Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; Ottman R, 2005, EPILEPSIA, V46, P7, DOI 10.1111/j.1528-1167.2005.00350.x; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239	13	431	459	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2009	41	2					160	162		10.1038/ng.292	http://dx.doi.org/10.1038/ng.292			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19136953	Green Accepted, Green Submitted			2022-12-25	WOS:000263091300013
J	Kim, YC; Gerlitz, G; Furusawa, T; Catez, F; Nussenzweig, A; Oh, KS; Kraemer, KH; Shiloh, Y; Bustin, M				Kim, Yong-Chul; Gerlitz, Gabi; Furusawa, Takashi; Catez, Frederic; Nussenzweig, Andre; Oh, Kyu-Seon; Kraemer, Kenneth H.; Shiloh, Yosef; Bustin, Michael			Activation of ATM depends on chromatin interactions occurring before induction of DNA damage	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOMAL-PROTEIN HMGN1; HIGH-MOBILITY; CHECKPOINT; ACETYLATION; REPAIR; MDC1; AUTOPHOSPHORYLATION; PHOSPHORYLATION; MEDIATOR	Efficient and correct responses to double-stranded breaks (DSB) in chromosomal DNA are crucial for maintaining genomic stability and preventing chromosomal alterations that lead to cancer(1,2). The generation of DSB is associated with structural changes in chromatin and the activation of the protein kinase ataxia-telangiectasia mutated (ATM), a key regulator of the signalling network of the cellular response to DSB3,4. The interrelationship between DSB-induced changes in chromatin architecture and the activation of ATM is unclear(4). Here we show that the nucleosome-binding protein HMGN1 modulates the interaction of ATM with chromatin both before and after DSB formation, thereby optimizing its activation. Loss of HMGN1 or ablation of its ability to bind to chromatin reduces the levels of ionizing radiation (IR)-induced ATM autophosphorylation and the activation of several ATM targets. IR treatments lead to a global increase in the acetylation of Lys 14 of histone H3 (H3K14) in an HMGN1-dependent manner and treatment of cells with histone deacetylase inhibitors bypasses the HMGN1 requirement for efficient ATM activation. Thus, by regulating the levels of histone modifications, HMGN1 affects ATM activation. Our studies identify a new mediator of ATM activation and demonstrate a direct link between the steady-state intranuclear organization of ATM and the kinetics of its activation after DNA damage.	[Kim, Yong-Chul; Gerlitz, Gabi; Furusawa, Takashi; Catez, Frederic; Bustin, Michael] NCI, Lab Metab, CCR, NIH, Bethesda, MD 20892 USA; [Nussenzweig, Andre] NCI, Expt Immunol Branch, CCR, NIH, Bethesda, MD 20892 USA; [Oh, Kyu-Seon; Kraemer, Kenneth H.] NCI, Basic Res Lab, CCR, NIH, Bethesda, MD 20892 USA; [Shiloh, Yosef] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Bustin, M (corresponding author), NCI, Lab Metab, CCR, NIH, Bethesda, MD 20892 USA.	bustin@helix.nih.gov	CATEZ, Frédéric/AAM-4854-2020; Gabi, Gerlitz/L-9269-2019; Bustin, Michael/G-6155-2015; CATEZ, Frédéric/GQP-7328-2022	CATEZ, Frédéric/0000-0001-8255-9091; Gabi, Gerlitz/0000-0001-6422-8715; Bustin, Michael/0000-0002-5147-7242; Kraemer, Kenneth/0000-0002-2689-3316	NCI; A-T Medical Research Foundation; A-T Children's Project; The Israel Science Foundation; A-T Medical Research Trust; Israel-Germany Joint Program on Cancer Research; A-T Ease Foundation; NATIONAL CANCER INSTITUTE [ZIABC010959, ZIABC011154, ZIABC004496, ZIABC004517] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A-T Medical Research Foundation; A-T Children's Project; The Israel Science Foundation(Israel Science Foundation); A-T Medical Research Trust; Israel-Germany Joint Program on Cancer Research; A-T Ease Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Celeste (NCI) for advice and help, and S. Garfield (Confocal Core Facility of the LEC, NCI), for help with imaging. The research was supported by the intramural program of the NCI. Work in the laboratory of Y. S. is supported by the A-T Medical Research Foundation, the A-T Children's Project, The Israel Science Foundation, the A-T Medical Research Trust, the Israel-Germany Joint Program on Cancer Research, and the A-T Ease Foundation.	Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Catez F, 2003, BIOCHEM CELL BIOL, V81, P113, DOI 10.1139/o03-040; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Koundrioukoff S, 2004, DNA REPAIR, V3, P969, DOI 10.1016/j.dnarep.2004.03.010; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wurtele H, 2006, CURR OPIN CELL BIOL, V18, P137, DOI 10.1016/j.ceb.2006.02.008; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	32	103	104	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					92	U192		10.1038/ncb1817	http://dx.doi.org/10.1038/ncb1817			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079244	Green Accepted			2022-12-25	WOS:000262157000016
J	Koenen, RR; von Hundelshausen, P; Nesmelova, IV; Zernecke, A; Liehn, EA; Sarabi, A; Kramp, BK; Piccinini, AM; Paludan, SR; Kowalska, MA; Kungl, AJ; Hackeng, TM; Mayo, KH; Weber, C				Koenen, Rory R.; von Hundelshausen, Philipp; Nesmelova, Irina V.; Zernecke, Alma; Liehn, Elisa A.; Sarabi, Alisina; Kramp, Birgit K.; Piccinini, Anna M.; Paludan, Soren R.; Kowalska, M. Anna; Kungl, Andreas J.; Hackeng, Tilman M.; Mayo, Kevin H.; Weber, Christian			Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice	NATURE MEDICINE			English	Article							MONOCYTE ARREST; RANTES; PLATELET-FACTOR-4; DEFICIENT; CCR5; CXC; OLIGOMERIZATION; RECRUITMENT; DEPOSITION; RECEPTORS	Atherosclerosis is characterized by chronic inflammation of the arterial wall due to chemokine-driven mononuclear cell recruitment(1-4). Activated platelets can synergize with chemokines to exacerbate atherogenesis; for example, by deposition of the chemokines platelet factor-4 (PF4, also known as CXCL4) and RANTES (CCL5), triggering monocyte arrest on inflamed endothelium(5-9). Homo-oligomerization is required for the recruitment functions of CCL5, and chemokine heteromerization has more recently emerged as an additional regulatory mechanism, as evidenced by a mutual modulation of CXCL8 and CXCL4 activities and by enhanced monocyte arrest resulting from CCL5-CXCL4 interactions(10-13). The CCL5 antagonist Met-RANTES reduces diet-induced atherosclerosis(9,14); however, CCL5 antagonism may not be therapeutically feasible, as suggested by studies using Ccl5-deficient mice which imply that direct CCL5 blockade would severely compromise systemic immune responses, delay macrophage-mediated viral clearance and impair normal T cell functions(15,16). Here we determined structural features of CCL5-CXCL4 heteromers and designed stable peptide inhibitors that specifically disrupt proinflammatory CCL5-CXCL4 interactions, thereby attenuating monocyte recruitment and reducing atherosclerosis without the aforementioned side effects. These results establish the in vivo relevance of chemokine heteromers and show the potential of targeting heteromer formation to achieve therapeutic effects.	[Koenen, Rory R.; von Hundelshausen, Philipp; Zernecke, Alma; Liehn, Elisa A.; Sarabi, Alisina; Kramp, Birgit K.; Weber, Christian] Univ Aachen, Rhein Westfal TH Aachen, Fac Med, Inst Cardiovasc Mol Res, D-52074 Aachen, Germany; [Nesmelova, Irina V.; Mayo, Kevin H.] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Piccinini, Anna M.; Kungl, Andreas J.] Graz Univ, Dept Pharmaceut Chem, A-8010 Graz, Austria; [Paludan, Soren R.] Univ Aarhus, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark; [Kowalska, M. Anna] Childrens Hosp Philadelphia, Dept Hematol, Philadelphia, PA 19104 USA; [Hackeng, Tilman M.; Weber, Christian] Univ Maastricht, Cardiovasc Res Inst Maastricht, NL-6229 ER Maastricht, Netherlands	RWTH Aachen University; University of Minnesota System; University of Minnesota Twin Cities; University of Graz; Aarhus University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Maastricht University	Weber, C (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Fac Med, Inst Cardiovasc Mol Res, Pauwelsstr 30, D-52074 Aachen, Germany.	cweber@ukaachen.de	Koenen, Rory/H-4172-2012; Liehn, Elisa Anamaria/D-9623-2011; Nesmelova, Irina/D-6033-2015; Weber, Christian/AAW-2153-2020; von Hundelshausen, Philipp/F-7435-2014	Koenen, Rory/0000-0002-9955-9730; Liehn, Elisa Anamaria/0000-0002-1253-3272; Nesmelova, Irina/0000-0002-1835-1533; Weber, Christian/0000-0003-4610-8714; von Hundelshausen, Philipp/0000-0001-7474-9370; Hackeng, Tilman/0000-0003-0142-0843; Piccinini, Anna Maria/0000-0002-7588-0415; Kungl, Andreas/0000-0003-3362-797X	Deutsche Forschungsgemeinschaft [WE1913/5-2, WE1913/7-1, KO2948/1-1, HU1618/1-1, ZE827/1-1, FOR809]; Interdisciplinary Center for Clinical Research "Biomat'' within the Medical Faculty of RWTH Aachen University [TV-B112, TV-B113]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek [917.36.372]; US National Institutes of Health [HL07062]; US National Science Foundation [BIR-961477]; University of Minnesota Medical School and the Minnesota Medical Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research "Biomat'' within the Medical Faculty of RWTH Aachen University; Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); University of Minnesota Medical School and the Minnesota Medical Foundation	This study was supported by grants from the Deutsche Forschungsgemeinschaft (WE1913/5-2, WE1913/7-1 to C. W., KO2948/1-1 to R. R. K., HU1618/1-1 to P. v. H., ZE827/1-1 to A. Z. and FOR809 to R. R. K., P. v. H., A. Z. and C. W.), the Interdisciplinary Center for Clinical Research "Biomat'' within the Medical Faculty of RWTH Aachen University (TV-B112 and TV-B113 to R. R. K. and C. W.), Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI 917.36.372 to T. M. H.) and the US National Institutes of Health (National Research Service Award training grant HL07062 to I. V. N.). We thank S. Meiler, S. Winkler, J. Tupiec, S. Knarren, M. Garbe, S. Wilbertz, D. Suylen and W. Adriaens for technical assistance. Computer resources were provided by the Minnesota Supercomputing Institute ( University of Minnesota). NMR instrumentation was provided with funds from the US National Science Foundation (BIR-961477), the University of Minnesota Medical School and the Minnesota Medical Foundation. Met-RANTES was provided by P. Nelson ( University of Munich). NMR chemical-shift assignments for the CCL5 monomer state were provided by S. Grzesiek ( University of Basel).	Anders HJ, 2003, J IMMUNOL, V170, P5658, DOI 10.4049/jimmunol.170.11.5658; Baltus T, 2003, BLOOD, V102, P1985, DOI 10.1182/blood-2003-04-1175; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; ILYINA E, 1994, BIOCHEMISTRY-US, V33, P13436, DOI 10.1021/bi00249a032; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; MAYO KH, 1989, BIOCHEMISTRY-US, V28, P9469, DOI 10.1021/bi00450a034; Nesmelova IV, 2008, J BIOL CHEM, V283, P24155, DOI 10.1074/jbc.M803308200; Nesmelova IV, 2005, J BIOL CHEM, V280, P4948, DOI 10.1074/jbc.M405364200; Nesmelova IV, 2004, J MAGN RESON, V166, P129, DOI 10.1016/j.jmr.2003.09.004; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajagopal P, 1997, PROTEIN SCI, V6, P2624; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; Sorensen LN, 2004, SCAND J IMMUNOL, V59, P321, DOI 10.1111/j.0300-9475.2004.01399.x; Sticht H, 1999, BIOCHEMISTRY-US, V38, P5995, DOI 10.1021/bi990065i; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	42	336	350	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2009	15	1					97	103		10.1038/nm.1898	http://dx.doi.org/10.1038/nm.1898			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	394DF	19122657				2022-12-25	WOS:000262425100024
J	Romeo, S; Kozlitina, J; Xing, C; Pertsemlidis, A; Cox, D; Pennacchio, LA; Boerwinkle, E; Cohen, JC; Hobbs, HH				Romeo, Stefano; Kozlitina, Julia; Xing, Chao; Pertsemlidis, Alexander; Cox, David; Pennacchio, Len A.; Boerwinkle, Eric; Cohen, Jonathan C.; Hobbs, Helen H.			Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease	NATURE GENETICS			English	Article							LIPID ACYL HYDROLASE; HEPATIC STEATOSIS; UNITED-STATES; ETHNIC-DIFFERENCES; AFRICAN-AMERICANS; FAMILY-MEMBERS; POPULATION; PREVALENCE; PATATIN; EXPRESSION	Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown etiology that varies in prevalence among ancestry groups. To identify genetic variants contributing to differences in hepatic fat content, we carried out a genome-wide association scan of nonsynonymous sequence variations (n = 9,229) in a population comprising Hispanic, African American and European American individuals. An allele in PNPLA3 (rs738409[G], encoding I148M) was strongly associated with increased hepatic fat levels (P = 5.9 x 10(-10)) and with hepatic inflammation (P = 3.7 x 10(-4)). The allele was most common in Hispanics, the group most susceptible to NAFLD; hepatic fat content was more than twofold higher in PNPLA3 rs738409[G] homozygotes than in noncarriers. Resequencing revealed another allele of PNPLA3 (rs6006460[T], encoding S453I) that was associated with lower hepatic fat content in African Americans, the group at lowest risk of NAFLD. Thus, variation in PNPLA3 contributes to ancestry-related and inter-individual differences in hepatic fat content and susceptibility to NAFLD.	[Romeo, Stefano; Xing, Chao; Pertsemlidis, Alexander; Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Kozlitina, Julia; Xing, Chao] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kozlitina, Julia] So Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA; [Cox, David] Perlegen Sci, Mountain View, CA 94043 USA; [Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Pennacchio, Len A.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southern Methodist University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, 6000 Harry Hines Blvd Dallas, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu	Romeo, Stefano/L-6861-2015; Pertsemlidis, Alexander/Q-7899-2017; Adiels, Martin/C-9278-2011	Romeo, Stefano/0000-0001-9168-4898; Pertsemlidis, Alexander/0000-0003-1624-9372; Xing, Chao/0000-0002-1838-0502; Kozlitina, Julia/0000-0001-7720-2290; Pennacchio, Len/0000-0002-8748-3732	Donald W. Reynolds Foundation; US National Institutes of Health [RL1HL-092550, 1PL1DK081182, HL-20948]; US National Heart, Lung, and Blood Institute (NHLBI) Program for Genomic Applications [HL-066681]; US Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RL1HL092550, P01HL020948, U01HL066681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	Donald W. Reynolds Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Heart, Lung, and Blood Institute (NHLBI) Program for Genomic Applications(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Hyatt, J. Martin, W. Schackwitz, A. Ustaszewska, C. Wright and the team at Perlegen Sciences for technical assistance. We thank K. Lawson for the statistical analysis of the data from the ARIC study. We thank J. Horton and D. Hinds for helpful discussions. We are grateful to the staff and participants of the Dallas Heart Study and the Atherosclerosis Risk in Communities Study for their contributions. This work was supported by grants from the Donald W. Reynolds Foundation, the US National Institutes of Health (RL1HL-092550, 1PL1DK081182 and HL-20948), the US National Heart, Lung, and Blood Institute (NHLBI) Program for Genomic Applications (HL-066681) and the US Department of Energy (Contract DE-AC02-05CH11231).	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Browning JD, 2004, AM J GASTROENTEROL, V99, P292, DOI 10.1111/j.1572-0241.2004.04059.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Caldwell SH, 2002, AM J GASTROENTEROL, V97, P1496, DOI 10.1016/S0002-9270(02)04151-5; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Falush D, 2003, GENETICS, V164, P1567; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; National Heart Lung and Blood Institute, 1987, ATH RISK COMM ARIC S; Rietz S, 2004, PLANTA, V219, P743, DOI 10.1007/s00425-004-1275-9; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; STRICKLAND JA, 1995, PLANT PHYSIOL, V109, P667, DOI 10.1104/pp.109.2.667; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; YUAN X, AM J HUM GE IN PRESS; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	29	2060	2112	5	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1461	1465		10.1038/ng.257	http://dx.doi.org/10.1038/ng.257			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18820647	Green Accepted			2022-12-25	WOS:000261215900023
J	Chadt, A; Leicht, K; Deshmukh, A; Jiang, LQ; Scherneck, S; Bernhardt, U; Dreja, T; Vogel, H; Schmolz, K; Kluge, R; Zierath, JR; Hultschig, C; Hoeben, RC; Schurmann, A; Joost, HG; Al-Hasani, H				Chadt, Alexandra; Leicht, Katja; Deshmukh, Atul; Jiang, Lake Q.; Scherneck, Stephan; Bernhardt, Ulrike; Dreja, Tanja; Vogel, Heike; Schmolz, Katja; Kluge, Reinhart; Zierath, Juleen R.; Hultschig, Claus; Hoeben, Rob C.; Schuermann, Annette; Joost, Hans-Georg; Al-Hasani, Hadi			Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; SUSCEPTIBILITY LOCUS; CELL DESTRUCTION; MICE; HYPERCHOLESTEROLEMIA; CARBOHYDRATE; CONTRIBUTES; DOMAIN; GENES; RISK	We previously identified Nob1 as a quantitative trait locus for high-fat diet-induced obesity and diabetes in genome-wide scans of outcross populations of obese and lean mouse strains. Additional crossbreeding experiments indicated that Nob1 represents an obesity suppressor from the lean Swiss Jim Lambert (SJL) strain. Here we identify a SJL-specific mutation in the Tbc1d1 gene that results in a truncated protein lacking the TBC Rab-GTPase-activating protein domain. TBC1D1, which has been recently linked to human obesity, is related to the insulin signaling protein AS160 and is predominantly expressed in skeletal muscle. Knockdown of TBC1D1 in skeletal muscle cells increased fatty acid uptake and oxidation, whereas overexpression of TBC1D1 had the opposite effect. Recombinant congenic mice lacking TBC1D1 showed reduced body weight, decreased respiratory quotient, increased fatty acid oxidation and reduced glucose uptake in isolated skeletal muscle. Our data strongly suggest that mutation of Tbc1d1 suppresses high-fat diet-induced obesity by increasing lipid use in skeletal muscle.	[Chadt, Alexandra; Leicht, Katja; Scherneck, Stephan; Bernhardt, Ulrike; Dreja, Tanja; Vogel, Heike; Schmolz, Katja; Kluge, Reinhart; Schuermann, Annette; Joost, Hans-Georg; Al-Hasani, Hadi] German Inst Nutr, Dept Pharmacol, Potsdam Rehbruecke, D-14558 Nuthetal, Germany; [Deshmukh, Atul; Jiang, Lake Q.; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Hultschig, Claus] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Hoeben, Rob C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Karolinska Institutet; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Al-Hasani, H (corresponding author), German Inst Nutr, Dept Pharmacol, Potsdam Rehbruecke, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	al-hasani@dife.de	Deshmukh, Atul S/R-1967-2019; Hoeben, Rob C./A-5771-2008; Deshmukh, Atul s/K-9572-2015; Joost, Hans-Georg/J-4462-2013	Deshmukh, Atul S/0000-0002-2278-1843; Hoeben, Rob C./0000-0001-9443-8377; Deshmukh, Atul s/0000-0002-2278-1843; Joost, Hans-Georg/0000-0002-5860-606X; Scherneck, Stephan/0000-0002-2811-5040; Zierath, Juleen/0000-0001-6891-7497; Schurmann, Annette/0000-0002-4113-4377	German Bundesministerium fur Bildung und Forschung [NGFN2, 01GS0487, 01GR0472, 0313325]; Deutsche Forschungsgemeinschaft [FOR441, Jo-117/11-2, GRK-1208]; Swedish Research Council; European Union [EUGENE2, LSHM-CT-2004-512013, SysProt, LSHG-CT-2006-37457]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission)	We thank C. Borchert, P. Grossmann, A. Karasinsky, B. Rischke and T. Przewieslik for expert technical assistance; R. Herwig for the array analysis; and F. Russchendorf for the linkage analysis. This work was supported in part by the German Bundesministerium fur Bildung und Forschung (NGFN2, 01GS0487 and 01GR0472; PhysioSim, 0313325), the Deutsche Forschungsgemeinschaft (FOR441, Jo-117/11-2 and GRK-1208), the Swedish Research Council and the European Union (EUGENE2, LSHM-CT-2004-512013; SysProt, LSHG-CT-2006-37457).	Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; CROFFORD OB, 1965, METABOLIS, V14, P271, DOI 10.1016/0026-0495(65)90068-5; Giesen K, 2003, BIOCHEM BIOPH RES CO, V304, P812, DOI 10.1016/S0006-291X(03)00664-8; Herwig R, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e117; Jurgens HS, 2007, DIABETOLOGIA, V50, P1481, DOI 10.1007/s00125-007-0662-8; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kluge R, 2000, DIABETOLOGIA, V43, P1565, DOI 10.1007/s001250051570; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Leiter EH, 1998, DIABETES, V47, P1287, DOI 10.2337/diabetes.47.8.1287; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Ortlepp JR, 2000, EUR J CLIN INVEST, V30, P195; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Plum L, 2000, DIABETES, V49, P1590, DOI 10.2337/diabetes.49.9.1590; Plum L, 2002, DIABETOLOGIA, V45, P823, DOI 10.1007/s00125-002-0796-7; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wuschke S, 2007, INT J OBESITY, V31, P829, DOI 10.1038/sj.ijo.0803473; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	28	153	156	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1354	1359		10.1038/ng.244	http://dx.doi.org/10.1038/ng.244			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18931681				2022-12-25	WOS:000260501500030
J	Han, XJ; Feng, XL; Rattner, JB; Smith, H; Bose, P; Suzuki, K; Soliman, MA; Scott, MS; Burke, BE; Riabowol, K				Han, Xijing; Feng, Xiaolan; Rattner, Jerome B.; Smith, Heather; Bose, Pinaki; Suzuki, Keiko; Soliman, Mohamed A.; Scott, Michelle S.; Burke, Brian E.; Riabowol, Karl			Tethering by lamin A stabilizes and targets the ING1 tumour suppressor	NATURE CELL BIOLOGY			English	Article							A-TYPE LAMINS; GILFORD-PROGERIA-SYNDROME; PLANT HOMEODOMAIN FINGER; DEACETYLASE COMPLEX; NUCLEAR LAMINS; PROTEINS; BINDING; ACETYLATION; EXPRESSION; FAMILY	ING proteins interact with core histones through their plant homeodomains (PHDs)(1-4) and with histone acetyltransferase (HAT) and histone deacetylase (HDAC) complexes to alter chromatin structure(5-7). Here we identify a lamin interaction domain (LID) found only in ING proteins, through which they bind to and colocalize with lamin A. Lamin knockout (LMNA(-/-)) cells show reduced levels of ING1 that mislocalize. Ectopic lamin A expression increases ING1 levels and re-targets it to the nucleus to act as an epigenetic regulator(6,8). ING1 lacking the LID does not interact with lamin A or affect apoptosis. In LMNA-/- cells, apoptosis is not affected by ING1. Mutation of lamin A results in several laminopathies, including Hutchinson-Gilford progeria syndrome (HGPS), a severe premature ageing disorder(9). HGPS cells have reduced ING1 levels that mislocalize. Expression of LID peptides to block lamin A-ING1 interaction induces phenotypes reminiscent of laminopathies including HGPS(9,10). These data show that targeting of ING1 to the nucleus by lamin A maintains ING1 levels and biological function. Known roles for ING proteins in regulating apoptosis and chromatin structure indicate that loss of lamin A-ING interaction may be an effector of lamin A loss, contributing to the HGPS phenotype.	[Han, Xijing; Feng, Xiaolan; Rattner, Jerome B.; Smith, Heather; Bose, Pinaki; Suzuki, Keiko; Soliman, Mohamed A.; Riabowol, Karl] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Han, Xijing; Feng, Xiaolan; Rattner, Jerome B.; Smith, Heather; Bose, Pinaki; Suzuki, Keiko; Soliman, Mohamed A.; Riabowol, Karl] Univ Calgary, Fac Med, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Rattner, Jerome B.] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Soliman, Mohamed A.] Cairo Univ, Dept Biochem, Fac Pharm, Cairo, Egypt; [Burke, Brian E.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32606 USA	University of Calgary; University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Cairo University; State University System of Florida; University of Florida	Riabowol, K (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	karl@ucalgary.ca	Feng, Xiaolan/J-9997-2019; Scott, Michelle/C-7445-2013	Scott, Michelle/0000-0001-6231-7714; Feng, Xiaolan/0000-0002-7333-8198	CIHR; NSERC; NIH; AHFMR; Alberta Cancer Board (ACB); ACB	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHFMR(Alberta Heritage Foundation for Medical Research); Alberta Cancer Board (ACB); ACB	We thank E. White for lamin constructs, J. Quarrie and D. Rancourt for ES cells, the SACRI Microscopy Facility for cell imaging, D. Boland and S. Law of the SAS for ING antibodies, D. Schreimer for LC/MS/MS advice and L. Robertson for help with flow cytometry. This study was supported by grants from the CIHR to K. R., from the NSERC to J. B. R. and to B. B. from the NIH. K. R. is a Scientist of the AHFMR, M. A. S. holds studentships from AHFMR and the Alberta Cancer Board (ACB) and H. S. and P. B. hold an ACB studentship.	Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Broers JLV, 1999, J CELL SCI, V112, P3463; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Candelario J, 2008, AGING CELL, V7, P355, DOI 10.1111/j.1474-9726.2008.00393.x; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Garkavtsev I, 1997, MOL CELL BIOL, V17, P2014, DOI 10.1128/MCB.17.4.2014; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helsens K, 2007, PROTEOMICS, V7, P364, DOI 10.1002/pmic.200600682; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nouman GS, 2003, J CLIN PATHOL, V56, P507, DOI 10.1136/jcp.56.7.507; OZAKI T, 1994, ONCOGENE, V9, P2649; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Scott M, 2001, J CELL SCI, V114, P3455; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Vieyra D, 2002, CANCER RES, V62, P4445; Vieyra D, 2002, J BIOL CHEM, V277, P29832, DOI 10.1074/jbc.M200197200; Walzak AA, 2008, EXP CELL RES, V314, P273, DOI 10.1016/j.yexcr.2007.07.029; Wang J, 2006, CANCER RES, V66, P1906, DOI 10.1158/0008-5472.CAN-05-3444; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	35	76	77	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1333	U181		10.1038/ncb1792	http://dx.doi.org/10.1038/ncb1792			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836436				2022-12-25	WOS:000260586700016
J	Ambros, V				Ambros, Victor			The evolution of our thinking about microRNAs	NATURE MEDICINE			English	Editorial Material							HETEROCHRONIC GENE LIN-14; SMALL TEMPORAL RNAS; C-ELEGANS; CAENORHABDITIS-ELEGANS; REGULATORY RNA; INTERFERENCE; PROTEIN; EXPRESSION; ENCODES; SWITCH		Univ Massachusetts, Sch Med, Dept Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ambros, V (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Med, 373 Plantat St,B2-306, Worcester, MA 01605 USA.	victor.ambros@umassmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066826, R01GM034028] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM34028, GM066826] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen K, 2006, COLD SPRING HARB SYM, V71, P149, DOI 10.1101/sqb.2006.71.039; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; WICKENS M, 1994, NATURE, V367, P17, DOI 10.1038/367017a0; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813	31	142	154	2	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1036	1040		10.1038/nm1008-1036	http://dx.doi.org/10.1038/nm1008-1036			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18841144				2022-12-25	WOS:000259892300031
J	Chitalia, VC; Foy, RL; Bachschmid, MM; Zeng, L; Panchenko, MV; Zhou, MI; Bharti, A; Seldin, DC; Lecker, SH; Dominguez, I; Cohen, HT				Chitalia, Vipul C.; Foy, Rebecca L.; Bachschmid, Markus M.; Zeng, Liling; Panchenko, Maria V.; Zhou, Mina I.; Bharti, Ajit; Seldin, David C.; Lecker, Stewart H.; Dominguez, Isabel; Cohen, Herbert T.			Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL	NATURE CELL BIOLOGY			English	Article; Proceedings Paper	40th Annual Meeting of the American-Society-of-Nephrology/Annual Renal Week	OCT 31-NOV 05, 2007	San Francisco, CA	Amer Soc Nephrol			F-BOX PROTEIN; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; DEPENDENT PROTEOLYSIS; RENAL-CARCINOMA; TRANSGENIC MICE; XENOPUS EMBRYOS; DEGRADATION; PRODUCT; GENE	The von Hippel-Lindau protein pVHL suppresses renal tumorigenesis in part by promoting the degradation of hypoxia-inducible HIF-alpha transcription factors(1); additional mechanisms have been proposed(2). pVHL also stabilizes the plant homeodomain protein Jade-1, which is a candidate renal tumour suppressor that may correlate with renal cancer risk(3-5). Here we show that Jade-1 binds the oncoprotein beta-catenin in Wnt-responsive fashion. Moreover, Jade-1 destabilizes wildtype beta-catenin but not a cancer-causing form of beta-catenin. Whereas the well-established beta-catenin E3 ubiquitin ligase component beta-TrCP ubiquitylates only phosphorylated beta-catenin(6), Jade-1 ubiquitylates both phosphorylated and non-phosphorylated beta-catenin and therefore regulates canonical Wnt signalling in both Wnt-off and Wnt-on phases. Thus, the different characteristics of beta-TrCP and Jade-1 may ensure optimal Wnt pathway regulation. Furthermore, pVHL downregulates beta-catenin in a Jade-1-dependent manner and inhibits Wnt signalling, supporting a role for Jade-1 and Wnt signalling in renal tumorigenesis. The pVHL tumour suppressor and the Wnt tumorigenesis pathway are therefore directly linked through Jade-1.	[Chitalia, Vipul C.; Foy, Rebecca L.; Zeng, Liling; Panchenko, Maria V.; Zhou, Mina I.; Cohen, Herbert T.] Boston Univ, Sch Med, Renal Sect, Boston, MA 02118 USA; [Bharti, Ajit] Boston Univ, Sch Med, Mol Stress Response Unit, Boston, MA 02118 USA; [Bachschmid, Markus M.] Boston Univ, Sch Med, Vasc Biol Unit, Boston, MA 02118 USA; [Seldin, David C.; Dominguez, Isabel; Cohen, Herbert T.] Boston Univ, Sch Med, Hematol Oncol Sect, Dept Med, Boston, MA 02118 USA; [Lecker, Stewart H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Cohen, HT (corresponding author), Boston Univ, Sch Med, Renal Sect, Boston, MA 02118 USA.	htcohen@bu.edu		/0000-0001-9617-4141; Chitalia, Vipul/0000-0002-6663-6058; Bharti, Ajit/0000-0001-7972-6688; Seldin, David C/0000-0003-0168-2333; Bachschmid, Markus Michael/0000-0002-0748-5528; Panchenko, Maria/0000-0001-6247-6598; Cohen, Herbert/0000-0003-1900-8718	NATIONAL CANCER INSTITUTE [R01CA079830, R01CA071796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007053, R01DK067569] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA79830, R01 CA071796-11, R01 CA079830-08, R01 CA079830, R01 CA071796, R01 CA71796] Funding Source: Medline; NIDDK NIH HHS [R01 DK067569-05, R01 DK67569, T32 DK007053, T32 DK07053, T32 DK007053-32, R01 DK067569] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Battagli C, 2003, CANCER RES, V63, P8695; Belaidouni N, 2005, ONCOGENE, V24, P2271, DOI 10.1038/sj.onc.1208418; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Dominguez I, 2004, DEV BIOL, V274, P110, DOI 10.1016/j.ydbio.2004.06.021; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; NIEUWKOOP JM, 1967, NORMAL TABLE XENOPUS; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Panchenko MV, 2004, J BIOL CHEM, V279, P56032, DOI 10.1074/jbc.M410487200; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou MI, 2004, CANCER RES, V64, P1278, DOI 10.1158/0008-5472.CAN-03-0884; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200	32	139	144	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1208	1216		10.1038/ncb1781	http://dx.doi.org/10.1038/ncb1781			9	Cell Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18806787	Green Accepted			2022-12-25	WOS:000259682900015
J	Barkoulas, M; Hay, A; Kougioumoutzi, E; Tsiantis, M				Barkoulas, Michalis; Hay, Angela; Kougioumoutzi, Evagelia; Tsiantis, Miltos			A developmental framework for dissected leaf formation in the Arabidopsis relative Cardamine hirsuta	NATURE GENETICS			English	Article							POLAR AUXIN TRANSPORT; GENE-EXPRESSION; COMPOUND LEAVES; CLONAL ANALYSIS; EVOLUTION; SYSTEM; MORPHOGENESIS; PATTERNS; TOMATO; PLANTS	The developmental basis for the generation of divergent leaf forms is largely unknown. Here we investigate this problem by studying processes that distinguish development of two related species: Arabidopsis thaliana, which has simple leaves, and Cardamine hirsuta, which has dissected leaves with individual leaflets. Using genetics, expression studies and cell lineage tracing, we show that lateral leaflet formation in C. hirsuta requires the establishment of growth foci that form after leaf initiation. These growth foci are recruited at the leaf margin in response to activity maxima of auxin, a hormone that polarizes growth in diverse developmental contexts. Class I KNOTTED1-like homeobox (KNOX) proteins also promote leaflet initiation in C. hirsuta, and here we provide evidence that this action of KNOX proteins is contingent on the ability to organize auxin maxima via the PINFORMED1 (PIN1) auxin efflux transporter. Thus, differential deployment of a fundamental mechanism polarizing cellular growth contributed to the diversification of leaf form during evolution.	[Barkoulas, Michalis; Hay, Angela; Kougioumoutzi, Evagelia; Tsiantis, Miltos] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Tsiantis, M (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	miltos.tsiantis@plants.ox.ac.uk		Barkoulas, Michail/0000-0003-1974-7668	Biotechnology and Biological Sciences Research Council (BBSRC); EU NEST [120878]; EMBO Young Investigator Award; Royal Society Wolfson Merit award; Royal Society University Research Fellowship; Balliol College; Bodossakis foundation; Gatsby Charitable foundation	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU NEST(European Commission); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); Royal Society Wolfson Merit award(Royal Society of London); Royal Society University Research Fellowship(Royal Society of London); Balliol College; Bodossakis foundation; Gatsby Charitable foundation	We thank S. Hake ( Plant Gene Expression Center, University of California Berkeley), M. G. Heisler, E. M. Meyerowitz ( California Institute of Technology), R. Swarup, M. Bennett ( University of Nottingham), J. Friml ( Department of Plant Systems Biology, Flanders Institute for Biotechnology ( VIB), Ghent) and J. Jones ( John Innes Centre, Norwich) for seed stocks and reagents. We also thank A. Hudson and J. Langdale for comments on the manuscript, I. Moore for assistance with confocal microscopy, R. Mueller and R. Simon ( Heinrich- Heine University, Duesseldorf) for sharing sequences to design CLV3 primers, S. Langer for technical assistance and J. Baker for photography. This work was funded by the Biotechnology and Biological Sciences Research Council ( BBSRC) and EU NEST idea project NEST 120878. M. T. is a recipient of an EMBO Young Investigator Award and a Royal Society Wolfson Merit award, A. H. is a recipient of a Royal Society University Research Fellowship and a Junior Research Fellowship at Balliol College, and M. B. of a Bodossakis foundation award. We also acknowledge the support of the Gatsby Charitable foundation.	Arber A., 1950, NATURAL PHILOS PLANT; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; DeMason DA, 2004, PLANTA, V218, P435, DOI 10.1007/s00425-003-1100-x; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Felix MA, 2007, CURR BIOL, V17, P103, DOI 10.1016/j.cub.2006.12.024; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GLEISSBERG S, 2002, COMP DEV MOL GENETIC; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hofer J, 2001, PLANT MOL BIOL, V45, P387, DOI 10.1023/A:1010739812836; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Kim M, 2003, NATURE, V424, P438, DOI 10.1038/nature01820; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; LEVY AA, 1990, SCIENCE, V248, P1534, DOI 10.1126/science.2163107; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1987, AM J BOT, V74, P581, DOI 10.2307/2443838; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415	30	233	249	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1136	1141		10.1038/ng.189	http://dx.doi.org/10.1038/ng.189			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165928				2022-12-25	WOS:000258761200030
J	Ferreira, MAR; O'Donovan, MC; Meng, YA; Jones, IR; Ruderfer, DM; Jones, L; Fan, J; Kirov, G; Perlis, RH; Green, EK; Smoller, JW; Grozeva, D; Stone, J; Nikolov, I; Chambert, K; Hamshere, ML; Nimgaonkar, VL; Moskvina, V; Thase, ME; Caesar, S; Sachs, GS; Franklin, J; Gordon-Smith, K; Ardlie, KG; Gabriel, SB; Fraser, C; Blumenstiel, B; Defelice, M; Breen, G; Gill, M; Morris, DW; Elkin, A; Muir, WJ; McGhee, KA; Williamson, R; MacIntyre, DJ; MacLean, AW; Clair, DS; Robinson, M; Van Beck, M; Pereira, ACP; Kandaswamy, R; McQuillin, A; Collier, DA; Bass, NJ; Young, AH; Lawrence, J; Ferrier, IN; Anjorin, A; Farmer, A; Curtis, D; Scolnick, EM; McGuffin, P; Daly, MJ; Corvin, AP; Holmans, PA; Blackwood, DH; Gurling, HM; Owen, MJ; Purcell, SM; Sklar, P; Craddock, N				Ferreira, Manuel A. R.; O'Donovan, Michael C.; Meng, Yan A.; Jones, Ian R.; Ruderfer, Douglas M.; Jones, Lisa; Fan, Jinbo; Kirov, George; Perlis, Roy H.; Green, Elaine K.; Smoller, Jordan W.; Grozeva, Detelina; Stone, Jennifer; Nikolov, Ivan; Chambert, Kimberly; Hamshere, Marian L.; Nimgaonkar, Vishwajit L.; Moskvina, Valentina; Thase, Michael E.; Caesar, Sian; Sachs, Gary S.; Franklin, Jennifer; Gordon-Smith, Katherine; Ardlie, Kristin G.; Gabriel, Stacey B.; Fraser, Christine; Blumenstiel, Brendan; Defelice, Matthew; Breen, Gerome; Gill, Michael; Morris, Derek W.; Elkin, Amanda; Muir, Walter J.; McGhee, Kevin A.; Williamson, Richard; MacIntyre, Donald J.; MacLean, Alan W.; Clair, David St; Robinson, Michelle; Van Beck, Margaret; Pereira, Ana C. P.; Kandaswamy, Radhika; McQuillin, Andrew; Collier, David A.; Bass, Nicholas J.; Young, Allan H.; Lawrence, Jacob; Ferrier, I. Nicol; Anjorin, Adebayo; Farmer, Anne; Curtis, David; Scolnick, Edward M.; McGuffin, Peter; Daly, Mark J.; Corvin, Aiden P.; Holmans, Peter A.; Blackwood, Douglas H.; Gurling, Hugh M.; Owen, Michael J.; Purcell, Shaun M.; Sklar, Pamela; Craddock, Nick		Wellcome Trust Case Control Consor	Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder	NATURE GENETICS			English	Article							LOCI; DISEASES; RANVIER; GENES	To identify susceptibility loci for bipolar disorder, we tested 1.8 million variants in 4,387 cases and 6,209 controls and identified a region of strong association (rs10994336, P = 9.1 x 10(-9)) in ANK3 (ankyrin G). We also found further support for the previously reported CACNA1C (alpha 1C subunit of the L-type voltage-gated calcium channel; combined P = 7.0 x 10(-8), rs1006737). Our results suggest that ion channelopathies may be involved in the pathogenesis of bipolar disorder.	[Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Stone, Jennifer; Sachs, Gary S.; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Smoller, Jordan W.; Stone, Jennifer; Sachs, Gary S.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Stone, Jennifer; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Smoller, Jordan W.; Stone, Jennifer; Chambert, Kimberly; Ardlie, Kristin G.; Gabriel, Stacey B.; Blumenstiel, Brendan; Defelice, Matthew; Scolnick, Edward M.; Daly, Mark J.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02142 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Smoller, Jordan W.; Stone, Jennifer; Chambert, Kimberly; Ardlie, Kristin G.; Gabriel, Stacey B.; Blumenstiel, Brendan; Defelice, Matthew; Scolnick, Edward M.; Daly, Mark J.; Purcell, Shaun M.; Sklar, Pamela] MIT, Cambridge, MA 02142 USA; [Ferreira, Manuel A. R.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [O'Donovan, Michael C.; Jones, Ian R.; Kirov, George; Green, Elaine K.; Grozeva, Detelina; Nikolov, Ivan; Hamshere, Marian L.; Moskvina, Valentina; Fraser, Christine; Holmans, Peter A.; Owen, Michael J.; Craddock, Nick] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, England; [Jones, Lisa; Caesar, Sian; Gordon-Smith, Katherine] Univ Birmingham, Div Neurosci, Dept Psychiat, Birmingham B15 2QZ, England; [Nikolov, Ivan; Hamshere, Marian L.; Moskvina, Valentina; Holmans, Peter A.] Cardiff Univ, Sch Med, Biostat & Bioinformat Unit, Cardiff CF14 4XN, England; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; [Thase, Michael E.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Thase, Michael E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Breen, Gerome; Clair, David St] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Breen, Gerome; Elkin, Amanda; Williamson, Richard; Collier, David A.; McGuffin, Peter] Kings Coll London, Inst Psychiat, SGDP, London SE5 8AF, England; [Gill, Michael; Morris, Derek W.; Corvin, Aiden P.] St James Hosp, Trinity Coll, Trinity Ctr hlth Sci, Dublin 8, Ireland; [Muir, Walter J.; McGhee, Kevin A.; MacIntyre, Donald J.; MacLean, Alan W.; Van Beck, Margaret; Blackwood, Douglas H.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Robinson, Michelle; Pereira, Ana C. P.; Kandaswamy, Radhika; McQuillin, Andrew; Bass, Nicholas J.; Lawrence, Jacob; Anjorin, Adebayo; Curtis, David; Gurling, Hugh M.] UCL, Windeyer Inst Med Sci, Dept Mental Hlth Sci, Mol Psychiat Lab, London W1T 4JF, England; [Young, Allan H.; Ferrier, I. Nicol] Royal Victoria Infirm, Sch Neurol Neurolbiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Young, Allan H.] UBC, Inst Mental Hlth, Vancouver, BC V6T 2A1, Canada; [Scolnick, Edward M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); QIMR Berghofer Medical Research Institute; Cardiff University; University of Birmingham; Cardiff University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Aberdeen; University of London; King's College London; Trinity College Dublin; Royal Infirmary of Edinburgh; University of Edinburgh; University of London; University College London; Newcastle University - UK; University of British Columbia; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Sklar, P (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	sklar@chgr.mgh.harvard.edu; craddockn@Cardiff.ac.uk	Holmans, Peter/F-4518-2015; Curtis, David/HGB-3921-2022; Daly, Mark J/B-2453-2017; Breen, Gerome D/A-5540-2010; Jones, Ian R/B-4925-2009; blackwood, douglas/AIB-8874-2022; Morris, Derek/AAW-8343-2021; Ferreira, Manuel A R/D-3609-2013; Breen, Gerome/Y-2706-2019; McQuillin, Andrew/C-1623-2008; McGuffin, Peter/A-1565-2012; O'Donovan, Michael C/P-7005-2018; Gurling, Hugh M/A-5029-2010; Collier, David A/D-1649-2011; Ruderfer, Douglas M/M-5795-2016; anand, amit/A-7222-2009	Holmans, Peter/0000-0003-0870-9412; Curtis, David/0000-0002-4089-9183; Daly, Mark J/0000-0002-0949-8752; Breen, Gerome D/0000-0003-2053-1792; Jones, Ian R/0000-0001-5821-5889; Morris, Derek/0000-0002-3413-570X; Ferreira, Manuel A R/0000-0001-9059-1825; Breen, Gerome/0000-0003-2053-1792; McQuillin, Andrew/0000-0003-1567-2240; McGuffin, Peter/0000-0002-9888-2907; O'Donovan, Michael C/0000-0001-7073-2379; Collier, David A/0000-0003-4087-1559; Ruderfer, Douglas M/0000-0002-2365-386X; Escott-Price, Valentina/0000-0003-1784-5483; Corvin, Aiden/0000-0001-6717-4089; Gill, Michael/0000-0003-0206-5337; Kirov, George/0000-0002-3427-3950; MacIntyre, Donald J/0000-0001-6963-1335; Grozeva, Detelina/0000-0003-3239-8415; Gordon-Smith, Katherine/0000-0003-4083-1143; Walters, James/0000-0002-6980-4053; Jones, Lisa/0000-0002-5122-8334	US National Institute of Mental Health [MH062137, MH067288, MH063445, MH63420, N01MH80001]; Johnson & Johnson Pharmaceutical Research & Development, Sylvan C. Herman Foundation, Stanley Medical Research Institute, Dauten Family, Merck Genome Research Institute; National Health Medical Research Council; National Center for Research Resources [U54 RR020278]; MDF - The Bipolar Organization; Neuroscience Research Charitable Trust; central London NHS Blood Transfusion Service; Priory Hospitals; UK MRC [G9623693N, G0500791]; Health Research Board and Science Foundation Ireland; Trinity College Biobank; Wellcome Trust, London; Chief Scientist Office of the Scottish Executive; MRC, London; MRC [G9309834, G0500791, G0701003] Funding Source: UKRI; Medical Research Council [G9309834, G0701003, G0500791] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067288, R01MH063445, R01MH063420, R01MH062137, N01MH080001] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson Pharmaceutical Research & Development, Sylvan C. Herman Foundation, Stanley Medical Research Institute, Dauten Family, Merck Genome Research Institute(Johnson & JohnsonJohnson & Johnson USA); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MDF - The Bipolar Organization; Neuroscience Research Charitable Trust; central London NHS Blood Transfusion Service; Priory Hospitals; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Board and Science Foundation Ireland(Science Foundation Ireland); Trinity College Biobank; Wellcome Trust, London(Wellcome Trust); Chief Scientist Office of the Scottish Executive; MRC, London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Study supported by US National Institute of Mental Health (MH062137, MH067288, P. S.; MH063445, J. W. S.; MH63420, V. L. N.; N01MH80001, G. S. S., M. E. T. and M. S. Bauer), NARSAD (R. H. P., S. P., J. F., P. S.); Johnson & Johnson Pharmaceutical Research & Development, Sylvan C. Herman Foundation, Stanley Medical Research Institute, Dauten Family, Merck Genome Research Institute (E. M. S.); and National Health Medical Research Council (MRC), Australia (M. A. R. F.). Broad Institute Center for Genotyping and Analysis supported by U54 RR020278, National Center for Research Resources. UCL sample collection supported by MDF - The Bipolar Organization, Neuroscience Research Charitable Trust, central London NHS Blood Transfusion Service, Priory Hospitals and UK MRC (G9623693N, G0500791). Dublin sample collection supported by the Health Research Board and Science Foundation Ireland; controls supplied by J. McPartlin, Trinity College Biobank. Edinburgh cohort collection supported by the Wellcome Trust, London, Chief Scientist Office of the Scottish Executive and MRC, London. WTCCC genotype analyses were funded by the Wellcome Trust and undertaken within the context of the WTCCC. WTCCC members are listed in Supplementary Note.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Gargus JJ, 2006, BIOL PSYCHIAT, V60, P177, DOI 10.1016/j.biopsych.2005.12.008; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151	15	890	907	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1056	1058		10.1038/ng.209	http://dx.doi.org/10.1038/ng.209			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711365	Green Accepted			2022-12-25	WOS:000258761200015
J	Yamaji, M; Seki, Y; Kurimoto, K; Yabuta, Y; Yuasa, M; Shigeta, M; Yamanaka, K; Ohinata, Y; Saitou, M				Yamaji, Masashi; Seki, Yoshiyuki; Kurimoto, Kazuki; Yabuta, Yukihiro; Yuasa, Mihoko; Shigeta, Mayo; Yamanaka, Kaori; Ohinata, Yasuhide; Saitou, Mitinori			Critical function of Prdm14 for the establishment of the germ cell lineage in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; OLIGONUCLEOTIDE MICROARRAY ANALYSIS; CDNA AMPLIFICATION; BREAST CANCERS; MOUSE EMBRYO; SPECIFICATION; EXPRESSION; DYNAMICS; BLIMP1; SOX2	Specification of germ cell fate is fundamental in development and heredity. Recent evidence indicates that in mice, specification of primordial germ cells (PGCs), the common source of both oocytes and spermatozoa, occurs through the integration of three key events: repression of the somatic program(1), reacquisition of potential pluripotency(2,3) and ensuing genome-wide epigenetic reprogramming(4,5). Here we provide genetic evidence that Prdm14, a PR domain-containing transcriptional regulator with exclusive expression in the germ cell lineage and pluripotent cell lines, is critical in two of these events, the reacquisition of potential pluripotency and successful epigenetic reprogramming. In Prdm14 mutants, the failure of these two events manifests even in the presence of Prdm1 (also known as Blimp1), a key transcriptional regulator for PGC specification(6,7). Our combined evidence demonstrates that Prdm14 defines a previously unknown genetic pathway, initiating independently from Prdm1, for ensuring the launching of the mammalian germ cell lineage.	[Yamaji, Masashi; Seki, Yoshiyuki; Kurimoto, Kazuki; Yabuta, Yukihiro; Yuasa, Mihoko; Shigeta, Mayo; Yamanaka, Kaori; Ohinata, Yasuhide; Saitou, Mitinori] RIKEN, Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol,Chuo Ku, Kobe, Hyogo 6500047, Japan; [Saitou, Mitinori] Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Kyoto University	Saitou, M (corresponding author), RIKEN, Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol,Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	saitou@cdb.riken.jp	Yamaji, Masashi/ABA-5267-2020	Yamaji, Masashi/0000-0002-8215-2184				Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Bernstein A, 1990, CIBA F SYMP, V148, P166; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2005, CELL CYCLE, V4, P1736, DOI 10.4161/cc.4.12.2209; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	31	396	420	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1016	1022		10.1038/ng.186	http://dx.doi.org/10.1038/ng.186			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622394				2022-12-25	WOS:000258026900020
J	Pfeufer, A; Sanna, S; Arking, DE; Muller, M; Gateva, V; Fuchsberger, C; Ehret, GB; Orru, M; Pattaro, C; Kottgen, A; Perz, S; Usala, G; Barbalic, M; Li, M; Putz, B; Scuteri, A; Prineas, RJ; Sinner, MF; Gieger, C; Najjar, SS; Kao, WHL; Muhleisen, TW; Dei, M; Happle, C; Mohlenkamp, S; Crisponi, L; Erbel, R; Jockel, KH; Naitza, S; Steinbeck, G; Marroni, F; Hicks, AA; Lakatta, E; Muller-Myhsok, B; Pramstaller, PP; Wichmann, HE; Schlessinger, D; Boerwinkle, E; Meitinger, T; Uda, M; Coresh, J; Kaab, S; Abecasis, GR; Chakravarti, A				Pfeufer, Arne; Sanna, Serena; Arking, Dan E.; Mueller, Martina; Gateva, Vesela; Fuchsberger, Christian; Ehret, Georg B.; Orru, Marco; Pattaro, Cristian; Koettgen, Anna; Perz, Siegfried; Usala, Gianluca; Barbalic, Maja; Li, Man; Puetz, Benno; Scuteri, Angelo; Prineas, Ronald J.; Sinner, Moritz F.; Gieger, Christian; Najjar, Samer S.; Kao, W. H. Linda; Muehleisen, Thomas W.; Dei, Mariano; Happle, Christine; Moehlenkamp, Stefan; Crisponi, Laura; Erbel, Raimund; Joeckel, Karl-Heinz; Naitza, Silvia; Steinbeck, Gerhard; Marroni, Fabio; Hicks, Andrew A.; Lakatta, Edward; Mueller-Myhsok, Bertram; Pramstaller, Peter P.; Wichmann, H-Erich; Schlessinger, David; Boerwinkle, Eric; Meitinger, Thomas; Uda, Manuela; Coresh, Josef; Kaeaeb, Stefan; Abecasis, Goncalo R.; Chakravarti, Aravinda			Common variants at ten loci modulate the QT interval duration in the QTSCD Study	NATURE GENETICS			English	Article							NOS1 REGULATOR NOS1AP; CARDIAC REPOLARIZATION; GENETIC VARIANT; HEART-FAILURE; POPULATION; DISEASE; MUTATION; KCNH2; RISK; ASSOCIATION	The QT interval, a measure of cardiac repolarization, predisposes to ventricular arrhythmias and sudden cardiac death ( SCD) when prolonged or shortened. A common variant in NOS1AP is known to influence repolarization. We analyze genome-wide data from five population-based cohorts (ARIC, KORA, SardiNIA, GenNOVA and HNR) with a total of 15,842 individuals of European ancestry, to confirm the NOS1AP association and identify nine additional loci at P < 5 x 10(-8). Four loci map near the monogenic long-QT syndrome genes KCNQ1, KCNH2, SCN5A and KCNJ2. Two other loci include ATP1B1 and PLN, genes with established electrophysiological function, whereas three map to RNF207, near LITAF and within NDRG4-GINS3-SETD6-CNOT1, respectively, all of which have not previously been implicated in cardiac electrophysiology. These results, together with an accompanying paper from the QTGEN consortium, identify new candidate genes for ventricular arrhythmias and SCD.	[Arking, Dan E.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Pfeufer, Arne; Happle, Christine; Meitinger, Thomas] Helmholtz Ctr Munich, Inst Human Genet, Munich, Germany; [Pfeufer, Arne; Happle, Christine; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany; [Sanna, Serena; Orru, Marco; Usala, Gianluca; Crisponi, Laura; Naitza, Silvia; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy; [Mueller, Martina; Gieger, Christian; Wichmann, H-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Munich, Germany; [Mueller, Martina; Wichmann, H-Erich] Univ Munich, Inst Informat Biometry & Epidemiol, Munich, Germany; [Mueller, Martina; Sinner, Moritz F.; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-80804 Munich, Germany; [Gateva, Vesela; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Fuchsberger, Christian; Pattaro, Cristian; Marroni, Fabio; Hicks, Andrew A.; Pramstaller, Peter P.] EURAC European Acad, Inst Med Genet, Bolzano, Italy; [Koettgen, Anna; Li, Man; Kao, W. H. Linda; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Perz, Siegfried] Helmholtz Ctr Munich, Inst Med Informat, Munich, Germany; [Barbalic, Maja; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Genet Ctr, Houston, TX USA; [Puetz, Benno; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Scuteri, Angelo] Ist Ricovero & Cura Anziani, Unita Operat Geriatria, Rome, Italy; [Prineas, Ronald J.] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Najjar, Samer S.; Lakatta, Edward] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Muehleisen, Thomas W.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Muehleisen, Thomas W.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Moehlenkamp, Stefan; Erbel, Raimund] Univ Duisburg Essen, Univ Hosp Essen, W German Heart Ctr, Clin Cardiol, Duisburg, Germany; [Joeckel, Karl-Heinz] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Duisburg, Germany; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Coresh, Josef; Chakravarti, Aravinda] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Johns Hopkins University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Consiglio Nazionale delle Ricerche (CNR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Michigan System; University of Michigan; European Academy of Bozen-Bolzano; Johns Hopkins University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Texas System; University of Texas Health Science Center Houston; Max Planck Society; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bonn; University of Bonn; University of Duisburg Essen; University of Duisburg Essen; Krankenhaus Bozen; University of Lubeck; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	arne.pfeufer@helmholtz-muenchen.de; aravinda@jhmi.edu	Möhlenkamp, Stefan/AGG-1320-2022; Lakatta, Edward G/AAL-1447-2020; Crisponi, Laura/AAC-2642-2019; Fuchsberger, Christian/ABD-7127-2021; Meitinger, Thomas/O-1318-2015; Li, Man/AAX-3400-2020; Abecasis, Goncalo R/B-7840-2010; Pfeufer, Arne/B-6634-2013; Müller-Nurasyid, Martina/I-8735-2018; NAITZA, SILVIA/AAB-8775-2022; Uda, Manuela/AAC-2645-2019; Barbalić, Maja/E-2161-2017; Sinner, Moritz/AAW-5043-2020; Pütz, Benno/P-2630-2016; EHRET, Georg B/A-9532-2009; Hicks, Andrew Anthony/E-9518-2017; Dei, Mariano/AAY-3870-2020; Wichmann, Heinz Erich/AAA-5695-2022; sanna, serena/H-3009-2019; Pramstaller, Peter P/C-2357-2008; Marroni, Fabio/R-1819-2017; Kottgen, Anna/D-2920-2012; Fuchsberger, Christian/C-9646-2010; Müller-Myhsok, Bertram/A-3289-2013; Kaab, Stefan/H-3915-2012; Naitza, Silvia/D-5620-2017	Crisponi, Laura/0000-0001-9128-8537; Fuchsberger, Christian/0000-0002-5918-8947; Li, Man/0000-0002-3839-0281; Müller-Nurasyid, Martina/0000-0003-3793-5910; NAITZA, SILVIA/0000-0002-0108-757X; Uda, Manuela/0000-0002-4890-6456; Barbalić, Maja/0000-0001-8914-1691; Pütz, Benno/0000-0002-2208-209X; EHRET, Georg B/0000-0002-5730-0675; Hicks, Andrew Anthony/0000-0001-6320-0411; sanna, serena/0000-0002-3768-1749; Marroni, Fabio/0000-0002-1556-5907; Lakatta, Edward/0000-0002-4772-0035; Meitinger, Thomas/0000-0002-8838-8403; Dei, Mariano/0000-0002-7404-508X; Abecasis, Goncalo/0000-0003-1509-1825; Gieger, Christian/0000-0001-6986-9554; SCUTERI, ANGELO/0000-0003-4784-5441	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NHLBI [HL86694, HL054512]; Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University; German Research Foundation Fellowship; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFN); German National Competence network on atrial fibrillation (AFNET); Bioinformatics for the Functional Analysis of Mammalian Genomes [NGFN 01GS0499, 01GS0838, AF-Net01GI0204/N]; Fondation Leducq; State of Bavaria; National Institute on Aging [NO1-AG-1-2109]; National Institute on Aging to the University of Michigan [263-MA-410953]; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Ministry of Health of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; Heinz Nixdorf Foundation;  [NGFN 01GR0803];  [01EZ0874];  [NGFN 01GI0204];  [NGFN 01GR0103]; NATIONAL INSTITUTE ON AGING [ZIAAG000799, ZIAAG000675] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University(Johns Hopkins University); German Research Foundation Fellowship(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFN); German National Competence network on atrial fibrillation (AFNET); Bioinformatics for the Functional Analysis of Mammalian Genomes; Fondation Leducq(Leducq Foundation); State of Bavaria; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging to the University of Michigan(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Health of the Autonomous Province of Bolzano(Pronvincia Autonoma di Bolzano); South Tyrolean Sparkasse Foundation; Heinz Nixdorf Foundation; ; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge all participants in the community-based studies of ARIC, KORA, SardiNIA, GenNOVA and Heinz Nixdorf Recall Study, and all the members of our laboratories for helpful discussion of this study. We thank G. Fischer for help with genotype imputation and data management for the KORA samples, Y. Li for her help on statistical analysis, K. Tarasov for in silico promotor analysis, A. Cao for his valuable advice and support in the SardiNIA project and all ARIC, KORA, SardiNIA, GenNOVA and Heinz Nixdorf Recall Study investigators for study design and continued operation. We also thank C. Egger and Y. D'Elia for the valuable support in data management and data administration; S. Melville and M. Facheris for the important work of drug classification in the GenNOVA project; and the primary care practitioners R. Stocker, S. Waldner, T. Pizzecco, J. Plangger, U. Marcadent and the personnel of the Hospital of Silandro (Department of Laboratory Medicine) for their participation and collaboration in the GenNOVA project. ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. In addition, we acknowledge support from NHLBI grants HL86694 and HL054512, and the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University for genotyping and data analysis relevant to this study. A. K. is supported by a German Research Foundation Fellowship.; The KORA study was funded by grants by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN), the German National Competence network on atrial fibrillation (AFNET) and the Bioinformatics for the Functional Analysis of Mammalian Genomes program (BFAM) by grants to S. K. (NGFN 01GS0499, 01GS0838 and AF-Net01GI0204/N), A. P. (NGFN 01GR0803, 01EZ0874), H.-E. W. (NGFN 01GI0204) and to T. M. (NGFN 01GR0103). S. K. is also supported by a grant from the Fondation Leducq. The KORA platform is funded by the BMBF and by the State of Bavaria.; The SardiNIA team was supported by Contract NO1-AG-1-2109 from the National Institute on Aging and in part by the Intramural Research Program of the US National Institute on Aging, NIH. The efforts of G. R. A. were supported in part by contract 263-MA-410953 from the National Institute on Aging to the University of Michigan and by research grants from the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute (to G. R. A.). The GenNOVA study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Heinz Nixdorf Recall Study was funded by a grant of the Heinz Nixdorf Foundation (Chairman: G. Schmidt).	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Akyol M, 2007, EUR HEART J, V28, P305, DOI 10.1093/eurheartj/ehl460; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arking DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004333; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Friedlander Y, 2005, ANN HUM GENET, V69, P645, DOI 10.1046/j.1529-8817.2005.00182.x; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Liu Y, 2000, CYTOGENET CELL GENET, V90, P60, DOI 10.1159/000015662; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Vrtovec B, 2003, CIRCULATION, V107, P1764, DOI 10.1161/01.CIR.0000057980.84624.95; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	41	296	305	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					407	414		10.1038/ng.362	http://dx.doi.org/10.1038/ng.362			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19305409	Green Submitted, Green Accepted			2022-12-25	WOS:000264659000013
J	Ozaki, K; Sato, H; Inoue, K; Tsunoda, T; Sakata, Y; Mizuno, H; Lin, TH; Miyamoto, Y; Aoki, A; Onouchi, Y; Sheu, SH; Ikegawa, S; Odashiro, K; Nobuyoshi, M; Juo, SHH; Hori, M; Nakamura, Y; Tanaka, T				Ozaki, Kouichi; Sato, Hiroshi; Inoue, Katsumi; Tsunoda, Tatsuhiko; Sakata, Yasuhiko; Mizuno, Hiroya; Lin, Tsung-Hsien; Miyamoto, Yoshinari; Aoki, Asako; Onouchi, Yoshihiro; Sheu, Sheng-Hsiung; Ikegawa, Shiro; Odashiro, Keita; Nobuyoshi, Masakiyo; Juo, Suh-Hang H.; Hori, Masatsugu; Nakamura, Yusuke; Tanaka, Toshihiro			SNPs in BRAP associated with risk of myocardial infarction in Asian populations	NATURE GENETICS			English	Article							LYMPHOTOXIN-ALPHA GENE; SIGNAL-TRANSDUCTION; CONFERS RISK; POLYMORPHISMS; DISEASE; PROTEIN; SUSCEPTIBILITY; GENOME; FAMILY	Myocardial infarction is a common disease and among the leading causes of death in the world. We previously reported association of variants in LGALS2, encoding galectin-2, with myocardial infarction susceptibility in a case-control association study in a Japanese population(1). Here we identify BRAP (BRCA1-associated protein) as a galectin-2-binding protein. We report an association of SNPs in BRAP with myocardial infarction risk in a large Japanese cohort (P = 3.0 x 10(-18), OR = 1.48, 2,475 cases and 2,778 controls), with replication in additional Japanese and Taiwanese cohorts (P = 4.4 x 10(-6), 862 cases and 1,113 controls and P = 4.7 x 10(-3), 349 cases and 994 controls, respectively). BRAP expression was observed in smooth muscle cells (SMCs) and macrophages in human atherosclerotic lesions. BRAP knockdown by siRNA using cultured coronary endothelial cells suppressed activation of NF-kappa B, a central mediator of inflammation.	[Ozaki, Kouichi; Aoki, Asako; Onouchi, Yoshihiro; Tanaka, Toshihiro] RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Yokohama, Kanagawa 2300045, Japan; [Sato, Hiroshi; Sakata, Yasuhiko; Mizuno, Hiroya; Hori, Masatsugu] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Inoue, Katsumi; Odashiro, Keita; Nobuyoshi, Masakiyo] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka 8028555, Japan; [Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa 2300045, Japan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung 807, Taiwan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung 807, Taiwan; [Miyamoto, Yoshinari; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Juo, Suh-Hang H.] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan; [Juo, Suh-Hang H.] Kaohsiung Med Univ, Grad Inst Med Genet, Kaohsiung 807, Taiwan; [Juo, Suh-Hang H.] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	RIKEN; Osaka University; Kokura Memorial Hospital; RIKEN; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; RIKEN; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Tanaka, T (corresponding author), RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Yokohama, Kanagawa 2300045, Japan.	toshitan@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Juo, Suh-Hang/A-1765-2010; Sheu, Sheng-Hsiung/C-7445-2009; Juo, Suh-Hang/C-9545-2009; Tanaka, Toshihiro/J-9310-2014; SAKATA, YASUHIKO/G-6661-2019; Ikegawa, Shiro/N-6895-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tanaka, Toshihiro/0000-0001-6201-9784; Ikegawa, Shiro/0000-0003-0316-2147; Ozaki, Kouichi/0000-0003-0028-1570; Odashiro, Keita/0000-0003-0347-6330; Lin, Tsung-Hsien/0000-0002-7226-8730	Takeda Science Foundation; Uehara Science Foundation; Japanese Millennium Project; Ministry of Education, Science, Sports, Culture and Technology of Japan [NHRI-Ex96-9607PI]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Science Foundation(Uehara Memorial Foundation); Japanese Millennium Project; Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Takahashi, M. Yoshii, S. Abiko, W. Yamanobe, R. Ohishi, M. Watabe and T. Furusho for their assistance. We also thank all the other members of Center for Genomic Medicine, RIKEN and OACIS for their contribution to the completion of our study. We are also grateful to members of The Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was supported in part by grants from the Takeda Science Foundation, the Uehara Science Foundation, the Japanese Millennium Project and the Ministry of Education, Science, Sports, Culture and Technology of Japan and NHRI-Ex96-9607PI (Taiwan).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Asselbergs FW, 2007, CLIN SCI, V112, P291, DOI 10.1042/CS20060200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breslow JL, 1997, NAT MED, V3, P600, DOI 10.1038/nm0697-600; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Mangino M, 2007, ATHEROSCLEROSIS, V194, P112, DOI 10.1016/j.atherosclerosis.2006.10.004; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Mizuno H, 2006, ATHEROSCLEROSIS, V185, P400, DOI 10.1016/j.atherosclerosis.2005.06.020; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ory S, 2004, CURR BIOL, V14, pR277, DOI 10.1016/j.cub.2004.03.023; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Ozaki K, 2006, NAT GENET, V38, P921, DOI 10.1038/ng1846; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Watkins H, 2004, EUR J HUM GENET, V12, P770, DOI 10.1038/sj.ejhg.5201244	22	78	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					329	333		10.1038/ng.326	http://dx.doi.org/10.1038/ng.326			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198608				2022-12-25	WOS:000263640200014
J	Kon, N; Hirota, T; Kawamoto, T; Kato, Y; Tsubota, T; Fukada, Y				Kon, Naohiro; Hirota, Tsuyoshi; Kawamoto, Takeshi; Kato, Yukio; Tsubota, Tadashi; Fukada, Yoshitaka			Activation of TGF-beta/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; CHRONIC-FATIGUE-SYNDROME; GENE-EXPRESSION; LIGHT; PATHWAYS; SYSTEM; ENTRAINMENT; INHIBITOR; MAMMALS; RHYTHM	The circadian clock is reset by external time cues for synchronization to environmental changes(1). In mammals, the light-input signalling pathway mediated by Per gene induction has been extensively studied(2,3). On the other hand, little is known about resetting mechanisms that are independent of Per induction(4-6). Here we show that activation of activin receptor-like kinase (ALK), triggered by TGF-beta, activin or alkali signals, evoked resetting of the cellular clock independently of Per induction. The resetting was mediated by an immediate-early induction of Dec1, a gene whose physiological role in the function of the circadian clock has been unclear. Acute Dec1 induction was a prerequisite for ALK-mediated resetting and upregulation was dependent on SMAD3, which was phosphorylated for activation in response to the resetting stimuli. Intraperitoneal injection of TGF-beta into wild-type or Dec1-deficient mice demonstrated that Dec1 has an essential role in phase-shift of clock gene expression in the kidney and adrenal gland. These results indicate that ALK-SMAD3-Dec1 signalling provides an input pathway in the mammalian molecular clock.	[Kon, Naohiro; Hirota, Tsuyoshi; Tsubota, Tadashi; Fukada, Yoshitaka] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kawamoto, Takeshi; Kato, Yukio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent & Med Biochem, Hiroshima 7348553, Japan	University of Tokyo; Hiroshima University	Fukada, Y (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	Hirota, Tsuyoshi/D-8158-2015; 吉孝, 深田/G-5090-2014; , 河本健/D-7938-2015	Hirota, Tsuyoshi/0000-0003-4876-3608; , 河本健/0000-0003-3337-1775	Japanese Ministry of Education, Culture, Sports, Science and Technology; MEXT, Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Okano for valuable discussion; K. Sanada and H. Yoshitane for comments on the manuscripts; M. Akiyama for providing pGL3-Basic-Hyg reporter vector; K. Ui-Tei and Y. Naito for technical advice on RNA interference; M. Takekawa for technical advice for experiment with kinase inhibitors. This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology, by the 21st Century COE Program ( Promotion of basic biosciences for the understanding of organisms' uniqueness), and by Global COE Program ( Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan.	Akashi M, 2000, GENE DEV, V14, P645; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Bennett AL, 1997, J CLIN IMMUNOL, V17, P160, DOI 10.1023/A:1027330616073; Challet E, 2004, NEUROSCI LETT, V355, P131, DOI 10.1016/j.neulet.2003.10.041; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Foster CM, 2005, HUM REPROD, V20, P543, DOI 10.1093/humrep/deh607; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Hirano S, 2004, ARCH BIOCHEM BIOPHYS, V422, P81, DOI 10.1016/j.abb.2003.11.011; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue K, 1999, BRAIN RES, V846, P145, DOI 10.1016/S0006-8993(99)01966-6; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nakahata Y, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-5; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Tryon WW, 2004, PHYSIOL BEHAV, V82, P849, DOI 10.1016/j.physbeh.2004.07.005; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; YAMAMOTO F, 1992, EXP EYE RES, V54, P685, DOI 10.1016/0014-4835(92)90023-L; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yannielli P, 2004, PROG NEUROBIOL, V74, P59, DOI 10.1016/j.pneurobio.2004.06.001; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	36	97	99	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1463	U197		10.1038/ncb1806	http://dx.doi.org/10.1038/ncb1806			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19029909				2022-12-25	WOS:000261261800018
J	McKay, JD; Hung, RJ; Gaborieau, V; Boffetta, P; Chabrier, A; Byrnes, G; Zaridze, D; Mukeria, A; Szeszenia-Dabrowska, N; Lissowska, J; Rudnai, P; Fabianova, E; Mates, D; Bencko, V; Foretova, L; Janout, V; McLaughlin, J; Shepherd, F; Montpetit, A; Narod, S; Krokan, HE; Skorpen, F; Elvestad, MB; Vatten, L; Njolstad, I; Axelsson, T; Chen, C; Goodman, G; Barnett, M; Loomis, MM; Lubinski, J; Matyjasik, J; Lener, M; Oszutowska, D; Field, J; Liloglou, T; Xinarianos, G; Cassidy, A; Zelenika, D; Boland, A; Delepine, M; Foglio, M; Lechner, D; Matsuda, F; Blanche, H; Gut, I; Heath, S; Lathrop, M; Brennan, P				McKay, James D.; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Chabrier, Amelie; Byrnes, Graham; Zaridze, David; Mukeria, Anush; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Rudnai, Peter; Fabianova, Eleonora; Mates, Dana; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; McLaughlin, John; Shepherd, Frances; Montpetit, Alexandre; Narod, Steven; Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Vatten, Lars; Njolstad, Inger; Axelsson, Tomas; Chen, Chu; Goodman, Gary; Barnett, Matt; Loomis, Melissa M.; Lubinski, Jan; Matyjasik, Joanna; Lener, Marcin; Oszutowska, Dorota; Field, John; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian; Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Blanche, Helene; Gut, Ivo; Heath, Simon; Lathrop, Mark; Brennan, Paul		EPIC Study	Lung cancer susceptibility locus at 5p15.33	NATURE GENETICS			English	Article							HUMAN TELOMERASE; GENES; RNA	We carried out a genome-wide association study of lung cancer (3,259 cases and 4,159 controls), followed by replication in 2,899 cases and 5,573 controls. Two uncorrelated disease markers at 5p15.33, rs402710 and rs2736100 were detected by the genome-wide data (P - 2 x 10(-7) and P = 4 x 10(-6)) and replicated by the independent study series (P = 7 x 10(-5) and P = 0.016). The susceptibility region contains two genes, TERT and CLPTM1L, suggesting that one or both may have a role in lung cancer etiology.	[McKay, James D.; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Chabrier, Amelie; Byrnes, Graham; Brennan, Paul] Int Agcy Res Canc, F-69008 Lyon, France; [Hung, Rayjean J.; McLaughlin, John] Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Zaridze, David; Mukeria, Anush] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow 115478, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, PL-90950 Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, PL-02781 Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, PL-02781 Warsaw, Poland; [Rudnai, Peter] Natl Inst Environm Hlth, H-1097 Budapest, Hungary; [Fabianova, Eleonora] Specialized Inst Hyg & Epidemiol, Banska Bystrica 97556, Slovakia; [Mates, Dana] Inst Publ Hlth, Bucharest 050463, Romania; [Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague 12800 2, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno 65653, Czech Republic; [Janout, Vladimir] Palacky Univ, Olomouc 77515, Czech Republic; [McLaughlin, John] Canc Care Ontario, Toronto, ON M5G 2L7, Canada; [Shepherd, Frances] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Montpetit, Alexandre] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Narod, Steven] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Vatten, Lars] Norwegian Univ Sci & Technol, N-7489 Trondheim, Norway; [Njolstad, Inger] Univ Tromso, Inst Community Med, N-9037 Tromso, Norway; [Axelsson, Tomas] Uppsala Univ, Acad Hosp, Dept Med Sci, SNP Technol Platform, Uppsala 75185, Sweden; [Chen, Chu; Goodman, Gary; Barnett, Matt; Loomis, Melissa M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Lubinski, Jan; Matyjasik, Joanna; Lener, Marcin; Oszutowska, Dorota] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [Field, John; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Liverpool L3 9TA, Merseyside, England; [Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Gut, Ivo; Heath, Simon; Lathrop, Mark] CEA, Inst Genom, Ctr Natl Genotypage, F-91000 Evry, France; [Blanche, Helene; Lathrop, Mark] Fdn Jean Dausset CEPH, F-75010 Paris, France	World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Russian Academy of Medical Sciences; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Charles University Prague; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Uppsala University; Fred Hutchinson Cancer Center; Pomeranian Medical University; University of Liverpool; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH	Brennan, P (corresponding author), Int Agcy Res Canc, F-69008 Lyon, France.	brennan@iarc.fr	Narod, Steven A/AAA-6112-2022; Szeszenia-Dabrowska, Neonila/F-7190-2010; Bencko, Vladimir/H-8598-2017; Hung, Rayjean J/A-7439-2013; Gut, Ivo/ABF-3188-2020; Linseisen, Jakob/B-5353-2014; Trubicka, Joanna/R-1215-2018; Krogh, Vittorio/K-2628-2016; Janout, Vladimir/M-5133-2014; McLaughlin, John R/E-4577-2013; Oszutowska-Mazurek, Dorota/D-2000-2017; Njolstad, Inger/X-3784-2019; Zaridze, David/K-5605-2013; Boffetta, Paolo/AAI-7767-2021; Xinarianos, George/B-7534-2012; Heath, Simon C/J-4138-2012; Matsuda, Fumihiko/B-9893-2009; Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; Field, John K./AAD-5674-2020; Lissowska, Jolanta/AAH-3252-2020; Panico, Salvatore/K-6506-2016; Clavel-Chapelon, Francoise/G-6733-2014; Foglio, mary A./B-9149-2012	Bencko, Vladimir/0000-0003-1935-2228; Gut, Ivo/0000-0001-7219-632X; Linseisen, Jakob/0000-0002-9386-382X; Trubicka, Joanna/0000-0002-9848-3674; Krogh, Vittorio/0000-0003-0122-8624; Oszutowska-Mazurek, Dorota/0000-0001-6403-4160; Boffetta, Paolo/0000-0002-3811-2791; Heath, Simon C/0000-0002-9550-0897; Field, John K./0000-0003-3951-6365; Lissowska, Jolanta/0000-0003-2695-5799; Panico, Salvatore/0000-0002-5498-8312; Foglio, mary A./0000-0001-7715-4452; Skorpen, Frank/0000-0001-7093-8000; PALLI, Domenico/0000-0002-5558-2437; Byrnes, Graham/0000-0003-3893-7539; mates, dana/0000-0002-6219-9807; Riboli, Elio/0000-0001-6795-6080; tumino, rosario/0000-0003-2666-414X; Larranaga, Nerea/0000-0002-9993-9880; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; Navarro, Carmen/0000-0001-8896-7483; Xinarianos, George/0000-0001-9185-5554; Foretova, Lenka/0000-0003-0494-2620; Hung, Rayjean/0000-0002-4486-7496	Institut National du Cancer, France; European Community [LSHG-CT-2005-512113, MTKD-CT-2004-510114]; Norwegian Cancer Association; Research Council of Norway; Ontario Institute of Cancer Research; US National Cancer Institute [R01 CA092039]; NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER	Institut National du Cancer, France(Institut National du Cancer (INCA) France); European Community(European Commission); Norwegian Cancer Association; Research Council of Norway(Research Council of Norway); Ontario Institute of Cancer Research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P. Brennan and M. Lathrop designed the study. J.D.M., R.J.H., V.G., M.B.E., A. B. and H. Blanche coordinated the preparation and inclusion of all biological samples. J.D.M., S.H. and V.G. undertook the statistical analysis. Bioinformatics analysis was undertaken by F.M., M.F. and S.H. D. Z., D.L. and I.G. coordinated the genotyping of the central Europe samples. A.M. and R.J.H. coordinated the genotyping of the Toronto samples. J.D.M., D.Z., M.D., A.C., T.A. and H.E.K. coordinated the genotyping of the other studies. All other coauthors coordinated the initial recruitment and management of the studies. M. Lathrop obtained financial support for genotyping of the central Europe study; P. Brennan, R.J.H. and H.E.K. obtained financial support for genotyping of the other studies. P. Brennan and J.D.M. drafted the manuscript with substantial contributions from R.J.H. and M. Lathrop. All authors contributed to the final paper. The authors thank all of the participants who took part in this research and the funders and support and technical staff who made this study possible. Support for the central Europe, HUNT2/Tromso and CARET genome-wide studies and follow- up genotyping was provided by Institut National du Cancer, France. Support for the HUNT2/Tromso genome-wide study was also provided by the European Community (Integrated Project DNA repair, grant no. LSHG-CT-2005-512113), the Norwegian Cancer Association and the Functional Genomics Programme of Research Council of Norway. Funding for the Toronto genome-wide study was provided by the Ontario Institute of Cancer Research. Funding for the Szczecin/Poland replication study was provided by European Community program "Marie- Curie Host Fellowships for the Transfer of Knowledge,'' grant no. MTKD-CT-2004-510114. Additional funding for study coordination, genotyping of replication studies and statistical analysis was provided by the US National Cancer Institute (R01 CA092039).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; Lantuejoul S, 2007, INT J CANCER, V120, P1835, DOI 10.1002/ijc.22473; Mavrogiannou E, 2007, CLIN CHEM, V53, P53, DOI 10.1373/clinchem.2006.073015; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wu TC, 2003, LUNG CANCER-J IASLC, V41, P163, DOI 10.1016/S0169-5002(03)00195-8; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250	15	449	469	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1404	1406		10.1038/ng.254	http://dx.doi.org/10.1038/ng.254			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978790	Green Accepted			2022-12-25	WOS:000261215900014
J	Scott, RH; Douglas, J; Baskcomb, L; Huxter, N; Barker, K; Hanks, S; Craft, A; Gerrard, M; Kohler, JA; Levitt, GA; Picton, S; Pizer, B; Ronghe, MD; Williams, D; Cook, JA; Pujol, P; Maher, ER; Birch, JM; Stiller, CA; Pritchard-Jones, K; Rahman, N				Scott, Richard H.; Douglas, Jenny; Baskcomb, Linda; Huxter, Nikki; Barker, Karen; Hanks, Sandra; Craft, Alan; Gerrard, Mary; Kohler, Janice A.; Levitt, Gill A.; Picton, Sue; Pizer, Barry; Ronghe, Milind D.; Williams, Denise; Cook, Jackie A.; Pujol, Pascal; Maher, Eamonn R.; Birch, Jillian M.; Stiller, Charles A.; Pritchard-Jones, Kathy; Rahman, Nazneen		FACT Collaboration	Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; CHROMOSOME 11P15; H19; MICRODELETION; INDIVIDUALS; METHYLATION; DEFECTS; CANCER; REGION; IGF2	Constitutional abnormalities at the imprinted 11p15 growth regulatory region cause syndromes characterized by disordered growth, some of which include a risk of Wilms tumor(1-3). We explored their possible contribution to nonsyndromic Wilms tumor and identified constitutional 11p15 abnormalities in genomic lymphocyte DNA from 13 of 437 individuals (3%) with sporadic Wilms tumor without features of growth disorders, including 12% of bilateral cases (P = 0.001) and in one familial Wilms tumor pedigree. No abnormality was detected in 220 controls (P = 0.006). Abnormalities identified included H19 DMR epimutations, uniparental disomy 11p15 and H19 DMR imprinting center mutations (one microinsertion and one microdeletion), thus identifying microinsertion as a new class of imprinting center mutation. Our data identify constitutional 11p15 defects as one of the most common known causes of Wilms tumor, provide mechanistic insights into imprinting disruption and reveal clinically important epigenotype-phenotype associations. The impact on clinical management dictates that constitutional 11p15 analysis should be considered in all individuals with Wilms tumor.	[Scott, Richard H.; Douglas, Jenny; Baskcomb, Linda; Huxter, Nikki; Barker, Karen; Hanks, Sandra; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Scott, Richard H.; Douglas, Jenny; Baskcomb, Linda; Huxter, Nikki; Barker, Karen; Hanks, Sandra; Pritchard-Jones, Kathy; Rahman, Nazneen] Royal Marsden Hosp, Sutton SM2 5NG, Surrey, England; [Craft, Alan] Royal Victoria Infirm, Dept Paediat, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Gerrard, Mary] Sheffield Childrens Hosp, Dept Paediat Oncol, Sheffield S10 2TH, S Yorkshire, England; [Kohler, Janice A.] Southampton Gen Hosp, Dept Paediat Oncol, Southampton SO16 6YD, Hants, England; [Levitt, Gill A.] Great Ormond St Hosp Sick Children, Dept Haematol Oncol, London WC1N 3JH, England; [Picton, Sue] St James Univ Hosp, Reg Paediat Oncol Unit, Leeds LS9 7TF, W Yorkshire, England; [Pizer, Barry] Alder Hey Childrens Hosp, Dept Paediat Oncol, Liverpool L12 2AP, Merseyside, England; [Ronghe, Milind D.] Royal Hosp Sick Children, Schiehall Unit, Glasgow G3 8SJ, Lanark, Scotland; [Williams, Denise] Addenbrookes NHS Trust, Dept Paediat Oncol, Cambridge CB2 0QR, England; [Cook, Jackie A.] Sheffield Childrens Hosp, Dept Clin Genet, Sheffield S10 2TH, S Yorkshire, England; [Pujol, Pascal] Ctr Hosp Univ, Serv Genet Med, F-34000 Montpellier, France; [Maher, Eamonn R.] Univ Birmingham, Inst Biomed Res, Dept Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; [Birch, Jillian M.] Royal Manchester Childrens Hosp, Canc Res UK Paediat & Familial Canc Res Grp, Manchester M27 4HA, Lancs, England; [Stiller, Charles A.] Univ Oxford, Dept Paediat, Childhood Canc Res Grp, Oxford OX2 6HJ, England; [Pritchard-Jones, Kathy] Inst Canc Res, Sect Paediat Oncol, Sutton SM2 5NG, Surrey, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Newcastle University - UK; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Southampton; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Saint James's University Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Universite de Montpellier; CHU de Montpellier; University of Birmingham; Cancer Research UK; Royal Manchester Children's Hospital; University of Oxford; University of London; Institute of Cancer Research - UK	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Pharoah, Paul/V-6658-2019; Graf, Norbert/H-1328-2011; Pritchard-Jones, Kathy/F-4286-2014; MAHER, EAMONN R/A-9507-2008; Rahman, Nazneen/D-2802-2013	Pharoah, Paul/0000-0001-8494-732X; Graf, Norbert/0000-0002-2248-323X; Pritchard-Jones, Kathy/0000-0002-2384-9475; MAHER, EAMONN R/0000-0002-6226-6918; albright, lisa/0000-0003-2602-3668; Arbour, Laura/0000-0002-9589-0880; Rahman, Nazneen/0000-0003-4376-0440; Stiller, Charles/0000-0002-3006-7869	Michael and Betty Kadoorie Cancer Genetics Research Programme; Medical Research Council (UK); Cancer Research UK; Institute of Cancer Research (UK); Medical Research Council [G0400188] Funding Source: researchfish; MRC [G0400188] Funding Source: UKRI	Michael and Betty Kadoorie Cancer Genetics Research Programme; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Institute of Cancer Research (UK)(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the affected individuals and families involved in the research. We thank the many physicians and nurses who referred families and provided samples and clinical information. The following members of the FACT Collaboration provided familial Wilms tumor pedigrees analyzed in this study: L. Arbour, C. Bonaiti-Pellie, L. Cannon-Albright, A. Chompret, T. Cole, C. Dhooge, W. Dupuis, A. Foot, W. Foulkes, H. Galvin, A. Gnekow, N. Graf, D. King, J. Kingston, I. Lewis, A. O'Meara, F. Millot, H. Price, B. Royer-Pokora, V. Schumacher, C. Schwartz, R. Shannon, E. Sheridan, J. Skeen, P. Tonin and A. Weirich. We thank B. Messahel, R. Al-Saadi, M. Cohen, N. Coleman and M. Malone for providing Wilms tumor specimens. We thank M. Stratton and C. Turnbull for their comments on the manuscript. The research was carried out as part of the Investigation of Familial Wilms Tumour Genes and the Factors Associated with Childhood Tumours (FACT) study, which are UK Children's Cancer and Leukaemia Group (CCLG) studies. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health and the Scottish Ministers. R.H.S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme. This work was supported by grants from Medical Research Council (UK), Cancer Research UK and the Institute of Cancer Research (UK).	Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bliek J, 2004, J PEDIATR-US, V145, P796, DOI 10.1016/j.jpeds.2004.08.007; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Engel JR, 2000, J MED GENET, V37, P921, DOI 10.1136/jmg.37.12.921; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Little SE, 2004, J CLIN ONCOL, V22, P4140, DOI 10.1200/JCO.2004.02.136; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; Niemitz EL, 2004, AM J HUM GENET, V75, P844, DOI 10.1086/425343; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; Porteus MH, 2000, J CLIN ONCOL, V18, P2026, DOI 10.1200/JCO.2000.18.10.2026; Prawitt D, 2005, NAT GENET, V37, P785, DOI 10.1038/ng0805-785; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Scott RH, 2008, J MED GENET, V45, P106, DOI 10.1136/jmg.2007.053207; Scott RH, 2006, ARCH DIS CHILD, V91, P995, DOI 10.1136/adc.2006.101295; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sparago A, 2007, HUM MOL GENET, V16, P254, DOI 10.1093/hmg/ddl448; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989	30	105	108	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1329	1334		10.1038/ng.243	http://dx.doi.org/10.1038/ng.243			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836444				2022-12-25	WOS:000260501500026
J	Strauss, JF; De Paolo, LV				Strauss, Jerome F., III; De Paolo, Louis V.			Funding for the reproductive sciences in the US	NATURE MEDICINE			English	Editorial Material							ANIMAL REPRODUCTION; AGRICULTURE; TECHNOLOGY; PRIORITIES; BIOLOGY		[Strauss, Jerome F., III] Virginia Commonwealth Univ, Sch Med, Richmond, VA 23298 USA; [De Paolo, Louis V.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA	Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Sch Med, 1101 E Marshall St, Richmond, VA 23298 USA.	jfstrauss@vcu.edu						[Anonymous], 1996, CONTRACEPTIVE RES DE; Behrman RE, 2007, PRETERM BIRTH CAUSES; Clarke Adele, 1998, DISCIPLINING REPRODU; Ireland JJ, 2008, J ANIM SCI, V86, P2797, DOI 10.2527/jas.2008-1088; Longo LD, 2008, AM J OBSTET GYNECOL, V198, P489, DOI 10.1016/j.ajog.2008.02.032; Makinson C, 1999, INT J GYNECOL OBSTET, V67, pS101, DOI 10.1016/S0020-7292(99)00153-8; Mirando MA, 2007, J ANIM SCI, V85, pE11, DOI 10.2527/jas.2006-506; Mirando MA, 2006, BIOL REPROD, V74, P459, DOI 10.1095/biolreprod.105.048686; NASS S, 2004, NEW FRONTIERS CONTRA; Pion GA, 2006, BIOL REPROD, V74, P230, DOI 10.1095/biolreprod.105.045427; Population Reference Bureau, 2008, WORLD POP DAT SHEET; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Strauss JF, 2007, FERTIL STERIL, V87, P717, DOI 10.1016/j.fertnstert.2006.11.003; Strauss JF, 2004, NATURE, V432, P43, DOI 10.1038/432043a; Townsend J, 1992, STRENGTHENING RES AC	15	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11		S			1214	1217		10.1038/nm1108-1214	http://dx.doi.org/10.1038/nm1108-1214			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	397FU	18989308				2022-12-25	WOS:000262649100032
J	Banaszynski, LA; Sellmyer, MA; Contag, CH; Wandless, TJ; Thorne, SH				Banaszynski, Laura A.; Sellmyer, Mark A.; Contag, Christopher H.; Wandless, Thomas J.; Thorne, Steve H.			Chemical control of protein stability and function in living mice	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; MAMMALIAN PROTEIN; GENE-EXPRESSION; SMALL MOLECULES; STEM-CELLS; MUTATION; DEFECTS	Conditional control of protein function in vivo offers great potential for deconvoluting the roles of individual proteins in complicated systems. We recently developed a method in which a small protein domain, termed a destabilizing domain, confers instability to fusion protein partners in cultured cells. Instability is reversed when a cell-permeable small molecule binds this domain. Here we describe the use of this system to regulate protein function in living mammals. We show regulation of secreted proteins and their biological activity with conditional secretion of an immunomodulatory cytokine, resulting in tumor burden reduction in mouse models. Additionally, we use this approach to control the function of a specific protein after systemic delivery of the gene that encodes it to a tumor, suggesting uses for enhancing the specificity and efficacy of targeted gene-based therapies. This method represents a new strategy to regulate protein function in living organisms with a high level of control.	[Sellmyer, Mark A.; Contag, Christopher H.; Thorne, Steve H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Sellmyer, Mark A.; Contag, Christopher H.; Thorne, Steve H.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Sellmyer, Mark A.; Contag, Christopher H.; Thorne, Steve H.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Banaszynski, Laura A.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Sellmyer, Mark A.; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Contag, CH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	ccontag@stanford.edu; wandless@stanford.edu	Banaszynski, Laura/B-9612-2009	Contag, Christopher/0000-0002-1011-8278; Sellmyer, Mark/0000-0002-1407-1905	US National Institutes of Health; In vivo Cellular and Molecular Imaging Center [R24 CA92862, P50 CA114747, GM073046]; joint A. and Cynthia Fry Gunn Research Fund; US National Institutes of Health [pSC-65, VSC20]; NATIONAL CANCER INSTITUTE [P50CA114747, R24CA092862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); In vivo Cellular and Molecular Imaging Center; joint A. and Cynthia Fry Gunn Research Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was Supported by the US National Institutes of Health, through the Small Animal Imaging Resource Program, the In vivo Cellular and Molecular Imaging Center (grant numbers R24 CA92862 and P50 CA114747) and GM073046, and the joint A. and Cynthia Fry Gunn Research Fund. We thank T. Clackson for the Shield-1 formulation protocol and B. Moss (US National Institutes of Health) for pSC-65 and VSC20.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bockamp E, 2002, PHYSIOL GENOMICS, V11, P115, DOI 10.1152/physiolgenomics.00067.2002; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lode HN, 2000, IMMUNOL RES, V21, P279, DOI 10.1385/IR:21:2-3:279; Lucas R, 2005, CURR CANCER DRUG TAR, V5, P381, DOI 10.2174/1568009054863627; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thorne SH, 2007, J CLIN INVEST, V117, P3350, DOI 10.1172/JCI32727; Tisi LC, 2002, ANAL CHIM ACTA, V457, P115, DOI 10.1016/S0003-2670(01)01496-9; YAMADA G, 1995, DEVELOPMENT, V121, P2917	30	102	126	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1123	1127		10.1038/nm.1754	http://dx.doi.org/10.1038/nm.1754			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18836461	Green Accepted			2022-12-25	WOS:000259892300044
J	Hazra, A; Kraft, P; Selhub, J; Giovannucci, EL; Thomas, G; Hoover, RN; Chanock, SJ; Hunter, DJ				Hazra, Aditi; Kraft, Peter; Selhub, Jacob; Giovannucci, Edward L.; Thomas, Gilles; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.			Common variants of FUT2 are associated with plasma vitamin B-12 levels	NATURE GENETICS			English	Article							HELICOBACTER-PYLORI INFECTION; SECRETOR PHENOTYPE; HUMAN-POPULATIONS; GENE FUT2; MALABSORPTION; HOMOCYSTEINE; CANCER; RISK	We identified a strong association (P = 5.36 x 10(-17)) between rs492602 in FUT2 and plasma vitamin B-12 levels in a genome-wide scan (n = 1,658) and an independent replication sample (n = 1,059) from the Nurses' Health Study. Women homozygous for the rs492602[G] allele had higher B12 levels. This allele is in strong linkage disequilibrium with the FUT2 nonsecretor variant encoding W143X, suggesting a plausible mechanism for altered B12 absorption and plasma levels.	[Hazra, Aditi; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Hazra, Aditi; Giovannucci, Edward L.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Hazra, Aditi; Giovannucci, Edward L.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Selhub, Jacob] Tufts Univ, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Vitamin Metab & Aging Lab, Boston, MA 02111 USA; [Giovannucci, Edward L.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Thomas, Gilles; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Hunter, David J.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hunter, David J.] Harvard Univ, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tufts University; United States Department of Agriculture (USDA); Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Hunter, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	dhunter@hsph.harvard.edu			National Institutes of Health Research [U54 CA100971, P01 CA87969, P01 CA55075, U01 CA098233, R01 CA 065725, CA070817]; NIH [T-32 CA 09001-30]; NATIONAL CANCER INSTITUTE [U01CA098233, U54CA100971, P01CA087969, T32CA009001, P01CA055075, R01CA065725, R01CA070817] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Ranu, C. Chen and the staff at the Core Genotyping Facility at the National Cancer Institute for their expertise. This research is supported by the National Institutes of Health Research Grants U54 CA100971, P01 CA87969, P01 CA55075, U01 CA098233, R01 CA 065725 and CA070817. A. H. is supported in part by training grant NIH T-32 CA 09001-30.	Annibale B, 2002, DIGEST LIVER DIS, V34, pS72, DOI 10.1016/S1590-8658(02)80170-0; Azevedo M, 2008, J PATHOL, V215, P308, DOI 10.1002/path.2363; CARMEL R, 1987, J LAB CLIN MED, V109, P454; Dahlin AM, 2008, INT J CANCER, V122, P2057, DOI 10.1002/ijc.23299; Dholakia KR, 2005, WORLD J GASTROENTERO, V11, P7078, DOI 10.3748/wjg.v11.i45.7078; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kang JH, 2006, EPIDEMIOLOGY, V17, P650, DOI 10.1097/01.ede.0000239727.59575.da; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Koda Y, 2001, GENETICS, V158, P747; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Siva A, 2007, QJM-INT J MED, V100, P495, DOI 10.1093/qjmed/hcm054; Tamura A, 2002, AM J GASTROENTEROL, V97, P861, DOI 10.1111/j.1572-0241.2002.05601.x; Tanner SM, 2004, HUM MUTAT, V23, P327, DOI 10.1002/humu.20014; Van Oijen MGH, 2004, J NUTR SCI VITAMINOL, V50, P305, DOI 10.3177/jnsv.50.305; Watanabe F, 2007, EXP BIOL MED, V232, P1266, DOI 10.3181/0703-MR-67	15	108	117	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1160	1162		10.1038/ng.210	http://dx.doi.org/10.1038/ng.210			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776911	Green Accepted			2022-12-25	WOS:000259651000013
J	Rosenhouse-Dantsker, A; Sui, JL; Zhao, Q; Rusinova, R; Rodriguez-Menchaca, AA; Zhang, Z; Logothetis, DE				Rosenhouse-Dantsker, Avia; Sui, Jin L.; Zhao, Qi; Rusinova, Radda; Rodriguez-Menchaca, Aldo A.; Zhang, Zhe; Logothetis, Diomedes E.			A sodium-mediated structural switch that controls the sensitivity of Kir channels to PtdIns(4,5)P-2	NATURE CHEMICAL BIOLOGY			English	Article							RECTIFYING K+ CHANNELS; BETA-GAMMA-SUBUNITS; POTASSIUM CHANNELS; DEPENDENT ACTIVATION; ACH CHANNEL; G-PROTEINS; I-KACH; BINDING; EXPRESSION; GIRK1	Inwardly rectifying potassium (Kir) channels are gated by the membrane phospholipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2). Among them, Kir3 requires additional molecules, such as the beta gamma subunits of G proteins or intracellular sodium, for channel gating. Using an interactive computational-experimental approach, we show that sodium sensitivity of Kir channels involves the side chains of an aspartate and a histidine located across from each other in a crucial loop in the cytosolic domain, as well as the backbone carbonyls of two more residues and a water molecule. The location of the coordination site in the vicinity of a conserved arginine shown to affect channel-PtdIns(4,5)P-2 interactions suggests that sodium triggers a structural switch that frees the crucial arginine. Mutations of the aspartate and the histidine that affect sodium sensitivity also enhance the channel's sensitivity to PtdIns(4,5)P-2. Furthermore, on the basis of the molecular characteristics of the coordination site, we identify and confirm experimentally a sodium-sensitive phenotype in Kir5.1.	[Rosenhouse-Dantsker, Avia; Sui, Jin L.; Zhao, Qi; Rusinova, Radda; Logothetis, Diomedes E.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Rodriguez-Menchaca, Aldo A.; Zhang, Zhe] Virginia Commonwealth Univ, Med Coll Virginia Campus, Dept Physiol & Biophys, Richmond, VA 23298 USA	Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University	Logothetis, DE (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia Campus, Dept Physiol & Biophys, Sanger Hall 3-005,1101 E Marshall St, Richmond, VA 23298 USA.	delogothetis@vcu.edu	Rodríguez-Menchaca, Aldo A./AAD-4603-2019; Zhang, Zhe/C-2685-2011	Rodríguez-Menchaca, Aldo A./0000-0001-7501-8836; 	US National Institutes of Health [HL-59949]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Findeis, T. Borges, V. Petrou and H. Vaananen for oocyte preparation. This work was supported by a US National Institutes of Health grant (HL-59949) to D. E. L.	BEGLOV D, 1995, BIOPOLYMERS, V35, P171, DOI 10.1002/bip.360350205; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARPENTER GA, 1987, APPL OPTICS, V26, P4919, DOI 10.1364/AO.26.004919; Chan KW, 1997, J BIOL CHEM, V272, P6548, DOI 10.1074/jbc.272.10.6548; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann Donald W., 1995, P307; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Kapota C, 2005, PHYS CHEM CHEM PHYS, V7, P3744, DOI 10.1039/b508092d; KARPEN ME, 1993, BIOCHEMISTRY-US, V32, P412, DOI 10.1021/bi00053a005; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lamoureux G, 2006, J PHYS CHEM B, V110, P3308, DOI 10.1021/jp056043p; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Nerbonne JM, 2001, CIRC RES, V89, P944, DOI 10.1161/hh2301.100349; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pao Y.H., 1989, ADAPTIVE PATTERN REC; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; SCHREIBER H, 1992, BIOCHEMISTRY-US, V31, P5856, DOI 10.1021/bi00140a022; Stevens EB, 1997, J PHYSIOL-LONDON, V503, P547, DOI 10.1111/j.1469-7793.1997.547bg.x; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang P, 2007, J AM SOC MASS SPECTR, V18, P541, DOI 10.1016/j.jasms.2006.10.024; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Yu XM, 2006, MOL NEUROBIOL, V33, P63, DOI 10.1385/MN:33:1:063; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	47	33	34	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2008	4	10					624	631		10.1038/nchembio.112	http://dx.doi.org/10.1038/nchembio.112			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	349ZV	18794864	Green Accepted			2022-12-25	WOS:000259323100013
J	Satoh, D; Sato, D; Tsuyama, T; Saito, M; Ohkura, H; Rolls, MM; Ishikawa, F; Uemura, T				Satoh, Daisuke; Sato, Daichi; Tsuyama, Taiichi; Saito, Motoki; Ohkura, Hiroyuki; Rolls, Melissa M.; Ishikawa, Fuyuki; Uemura, Tadashi			Spatial control of branching within dendritic arbors by dynein-dependent transport of Rab5-endosomes	NATURE CELL BIOLOGY			English	Article							AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; DROSOPHILA; PROTEINS; RAB5; MORPHOGENESIS; MOTILITY; KINESIN	Dendrites allow neurons to integrate sensory or synaptic inputs, and the spatial disposition and local density of branches within the dendritic arbor limit the number and type of inputs(1,2). Drosophila melanogaster dendritic arborization (da) neurons provide a model system to study the genetic programs underlying such geometry in vivo. Here we report that mutations of motor-protein genes, including a dynein subunit gene (dlic) and kinesin heavy chain (khc), caused not only downsizing of the overall arbor, but also a marked shift of branching activity to the proximal area within the arbor. this phenotype was suppressed when dominant-negative Rab5 was expressed in the mutant neurons, which deposited early endosomes in the cell body. We also showed that 1) in dendritic branches of the wild-type neurons, Rab5-containing early endosomes were dynamically transported and 2) when Rab5 function alone was abrogated, terminal branches were almost totally deleted. these results reveal an important link between microtubule motors and endosomes in dendrite morphogenesis.	[Sato, Daichi; Tsuyama, Taiichi; Uemura, Tadashi] Kyoto Univ, Lab Cell Recognit & Pattern Format, Sakyo Ku, Kyoto 6068507, Japan; [Satoh, Daisuke] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068507, Japan; [Saito, Motoki; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Lab Cell Cycle Regulat, Sakyo Ku, Kyoto 6068507, Japan; [Ohkura, Hiroyuki] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Rolls, Melissa M.] Univ Oregon, Howard Hughes Med Inst, Inst Neurosci & Mol Biol, Eugene, OR 97403 USA	Kyoto University; Kyoto University; Kyoto University; University of Edinburgh; Howard Hughes Medical Institute; University of Oregon	Uemura, T (corresponding author), Kyoto Univ, Lab Cell Recognit & Pattern Format, Sakyo Ku, S Campus Res Bldg G,Yoshida Konoe Cho, Kyoto 6068507, Japan.	tauemura@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021; Rolls, Melissa/G-6402-2014	Ishikawa, Fuyuki/0000-0002-5580-2305; Rolls, Melissa/0000-0002-5021-4360; Ohkura, Hiroyuki/0000-0003-4059-431X; Satoh, Daisuke/0000-0002-4039-1670; Tsuyama, Taiichi/0000-0001-5860-6396; UEMURA, Tadashi/0000-0001-7204-3606	Wellcome Trust [081849] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bowman AB, 1999, J CELL BIOL, V146, P165; Brechbiel JL, 2008, CURR BIOL, V18, P745, DOI 10.1016/j.cub.2008.04.033; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	33	143	144	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1164	1171		10.1038/ncb1776	http://dx.doi.org/10.1038/ncb1776			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18758452				2022-12-25	WOS:000259682900010
J	Hawkins, KM; Smolke, CD				Hawkins, Kristy M.; Smolke, Christina D.			Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae	NATURE CHEMICAL BIOLOGY			English	Article							BERBERINE BRIDGE ENZYME; COPTIS-JAPONICA CELLS; BRANCH-POINT ENZYME; OPIUM POPPY; BIOSYNTHESIS; EXPRESSION; YEAST; RETICULINE; MORPHINE; BIOLOGY	The benzylisoquinoline alkaloids (BIAs) are a diverse class of metabolites that exhibit a broad range of pharmacological activities and are synthesized through plant biosynthetic pathways comprised of complex enzyme activities and regulatory strategies. We have engineered yeast to produce the key intermediate reticuline and downstream BIA metabolites from a commercially available substrate. An enzyme tuning strategy was implemented that identified activity differences between variants from different plants and determined optimal expression levels. By synthesizing both stereoisomer forms of reticuline and integrating enzyme activities from three plant sources and humans, we demonstrated the synthesis of metabolites in the sanguinarine/berberine and morphinan branches. We also demonstrated that a human P450 enzyme exhibits a novel activity in the conversion of (R)-reticuline to the morphinan alkaloid salutaridine. Our engineered microbial hosts offer access to a rich group of BIA molecules and associated activities that will be further expanded through synthetic chemistry and biology approaches.	[Hawkins, Kristy M.; Smolke, Christina D.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Smolke, CD (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	smolke@cheme.caltech.edu			Center for Biological Circuit Design at Caltech; US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077347] Funding Source: NIH RePORTER	Center for Biological Circuit Design at Caltech; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Facchini (University of Calgary), F. P. Guengerich (Vanderbilt University) and D. Pompon (Centre de Genetique Moleculaire, CNRS) for generously providing cDNAs and yeast strains used in this work. This work was supported by the Center for Biological Circuit Design at Caltech (fellowship to K. M. H.) and the US National Institutes of Health (grant to C. D. S.).	Allen RS, 2008, PLANT BIOTECHNOL J, V6, P22, DOI 10.1111/j.1467-7652.2007.00293.x; Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; Bentley KW, 2006, NAT PROD REP, V23, P444, DOI 10.1039/b509523a; Bird DA, 2001, PLANTA, V213, P888, DOI 10.1007/s004250100582; CASSELS BK, 1995, PHARMACOL RES, V31, P103, DOI 10.1016/1043-6618(95)80054-9; Chen JH, 2008, ELECTROPHORESIS, V29, P2135, DOI 10.1002/elps.200700797; Chulia S, 1997, BRIT J PHARMACOL, V122, P409, DOI 10.1038/sj.bjp.0701410; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Exley R, 2005, BRIT J PHARMACOL, V146, P15, DOI 10.1038/sj.bjp.0706307; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; GILLAM EMJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P540, DOI 10.1006/abbi.1995.1329; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Kashiwada Y, 2005, BIOORGAN MED CHEM, V13, P443, DOI 10.1016/j.bmc.2004.10.020; Kealey JT, 1998, P NATL ACAD SCI USA, V95, P505, DOI 10.1073/pnas.95.2.505; Kemeny-Beke A, 2006, CANCER LETT, V237, P67, DOI 10.1016/j.canlet.2005.05.037; KUTCHAN TM, 1995, J BIOL CHEM, V270, P24475, DOI 10.1074/jbc.270.41.24475; Kwan CY, 2002, ACTA PHARMACOL SIN, V23, P1057; Lai JH, 2002, ACTA PHARMACOL SIN, V23, P1093; Liscombe DK, 2008, CURR OPIN BIOTECH, V19, P173, DOI 10.1016/j.copbio.2008.02.012; MAPOLES J, 1993, EUR J BIOCHEM, V214, P735, DOI 10.1111/j.1432-1033.1993.tb17975.x; MARTIN ML, 1993, PLANTA MED, V59, P63, DOI 10.1055/s-2006-959606; McDaniel R, 2005, CURR OPIN BIOTECH, V16, P476, DOI 10.1016/j.copbio.2005.07.002; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Morais LCSL, 1998, J ETHNOPHARMACOL, V62, P57, DOI 10.1016/S0378-8741(98)00044-0; Nakaoji K, 1997, BIOL PHARM BULL, V20, P586, DOI 10.1248/bpb.20.586; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; Raith K, 2003, J AM SOC MASS SPECTR, V14, P1262, DOI 10.1016/S1044-0305(03)00539-7; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sambrook J., 2001, MOL CLONING; SATO F, 1994, EUR J BIOCHEM, V225, P125, DOI 10.1111/j.1432-1033.1994.00125.x; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; Sato F, 2007, CURR PHARM BIOTECHNO, V8, P211; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	44	244	283	5	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2008	4	9					564	573		10.1038/nchembio.105	http://dx.doi.org/10.1038/nchembio.105			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	339SN	18690217	Green Accepted			2022-12-25	WOS:000258597700015
J	Vandal, OH; Pierini, LM; Schnappinger, D; Nathan, CF; Ehrt, S				Vandal, Omar H.; Pierini, Lynda M.; Schnappinger, Dirk; Nathan, Carl F.; Ehrt, Sabine			A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; INTERFERON-GAMMA; PHAGOSOME MATURATION; CULTURED MACROPHAGES; MURINE MACROPHAGES; MOUSE MACROPHAGES; GENE-EXPRESSION; IDENTIFICATION; ACIDIFICATION; MUTANTS	Acidification of the phagosome is considered to be a major mechanism used by macrophages against bacteria, including Mycobacterium tuberculosis (Mtb). Mtb blocks phagosome acidification(1), but interferon-g (IFN-g) restores acidification and confers antimycobacterial activity2,3. Nonetheless, it remains unclear whether acid kills Mtb, whether the intrabacterial pH of any pathogen falls when it is in the phagosome and whether acid resistance is required for mycobacterial virulence. In vitro at pH 4.5, Mtb survived in a simple buffer and maintained intrabacterial pH. Therefore, Mtb resists phagolysosomal concentrations of acid. Mtb also maintained its intrabacterial pH and survived when phagocytosed by IFN-gamma-activated macrophages. We used transposon mutagenesis to identify genes responsible for Mtb's acid resistance. A strain disrupted in Rv3671c, a previously uncharacterized gene encoding a membrane-associated protein, was sensitive to acid and failed to maintain intrabacterial pH in acid in vitro and in activated macrophages. Growth of the mutant was also severely attenuated in mice. Thus, Mtb is able to resist acid, owing in large part to Rv3671c, and this resistance is essential for virulence. Disruption of Mtb's acid resistance and intrabacterial pH maintenance systems is an attractive target for chemotherapy.	[Vandal, Omar H.; Pierini, Lynda M.; Schnappinger, Dirk; Nathan, Carl F.; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Pierini, Lynda M.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University; Cornell University	Nathan, CF (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	cnathan@med.cornell.edu; sae2004@med.cornell.edu	Ehrt, Sabine/AAU-6449-2020		NIAID NIH HHS [P01 AI056293-04, P01 AI056293-05, P01 AI056293] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056293] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; DUBOS RJ, 1947, J EXP MED, V85, P9, DOI 10.1084/jem.85.1.9; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; KANAI K, 1979, JPN J MED SCI BIOL, V32, P135, DOI 10.7883/yoken1952.32.135; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Metchnikoff E., 1905, IMMUNITY INFECT DIS; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; NATHAN CF, 1986, NEW ENGL J MED, V315, P6, DOI 10.1056/NEJM198607033150102; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rose L, 2004, MICROBES INFECT, V6, P965, DOI 10.1016/j.micinf.2004.05.011; Schaible UE, 1998, J IMMUNOL, V160, P1290; SIBLEY LD, 1987, INFECT IMMUN, V55, P680, DOI 10.1128/IAI.55.3.680-685.1987; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vandal OH, 2006, INFECT IMMUN, V74, P1751, DOI 10.1128/IAI.74.3.1751-1756.2006; Via LE, 1998, J CELL SCI, V111, P897; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	40	230	236	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2008	14	8					849	854		10.1038/nm.1795	http://dx.doi.org/10.1038/nm.1795			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18641659	Green Accepted			2022-12-25	WOS:000258237500032
J	van Haaften, G; Dalgliesh, GL; Davies, H; Chen, L; Bignell, G; Greenman, C; Edkins, S; Hardy, C; O'Meara, S; Teague, J; Butler, A; Hinton, J; Latimer, C; Andrews, J; Barthorpe, S; Beare, D; Buck, G; Campbell, PJ; Cole, J; Forbes, S; Jia, MM; Jones, D; Kok, CY; Leroy, C; Lin, ML; McBride, DJ; Maddison, M; Maquire, S; Mclay, K; Menzies, A; Mironenko, T; Mulderrig, L; Mudie, L; Pleasance, E; Shepherd, R; Smith, R; Stebbings, L; Stephens, P; Tang, G; Tarpey, PS; Turner, R; Turrell, K; Varian, J; West, S; Widaa, S; Wray, P; Collins, VP; Ichimura, K; Law, S; Wong, J; Yuen, ST; Leung, SY; Tonon, G; DePinho, RA; Tai, YT; Anderson, KC; Kahnoski, RJ; Massie, A; Khoo, SK; Teh, BT; Stratton, MR; Futreal, PA				van Haaften, Gijs; Dalgliesh, Gillian L.; Davies, Helen; Chen, Lina; Bignell, Graham; Greenman, Chris; Edkins, Sarah; Hardy, Claire; O'Meara, Sarah; Teague, Jon; Butler, Adam; Hinton, Jonathan; Latimer, Calli; Andrews, Jenny; Barthorpe, Syd; Beare, Dave; Buck, Gemma; Campbell, Peter J.; Cole, Jennifer; Forbes, Simon; Jia, Mingming; Jones, David; Kok, Chai Yin; Leroy, Catherine; Lin, Meng-Lay; McBride, David J.; Maddison, Mark; Maquire, Simon; Mclay, Kirsten; Menzies, Andrew; Mironenko, Tatiana; Mulderrig, Lee; Mudie, Laura; Pleasance, Erin; Shepherd, Rebecca; Smith, Raffaella; Stebbings, Lucy; Stephens, Philip; Tang, Gurpreet; Tarpey, Patrick S.; Turner, Rachel; Turrell, Kelly; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Collins, V. Peter; Ichimura, Koichi; Law, Simon; Wong, John; Yuen, Siu Tsan; Leung, Suet Yi; Tonon, Giovanni; DePinho, Ronald A.; Tai, Yu-Tzu; Anderson, Kenneth C.; Kahnoski, Richard J.; Massie, Aaron; Khoo, Sok Kean; Teh, Bin Tean; Stratton, Michael R.; Futreal, P. Andrew			Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer	NATURE GENETICS			English	Article							MYELOMA CELL-LINE; TARGET GENES; METHYLTRANSFERASE; JMJD3; MICE	Somatically acquired epigenetic changes are present in many cancers. Epigenetic regulation is maintained via post-translational modifications of core histones. Here, we describe inactivating somatic mutations in the histone lysine demethylase gene UTX, pointing to histone H3 lysine methylation deregulation in multiple tumor types. UTX reintroduction into cancer cells with inactivating UTX mutations resulted in slowing of proliferation and marked transcriptional changes. These data identify UTX as a new human cancer gene.	[van Haaften, Gijs; Dalgliesh, Gillian L.; Davies, Helen; Chen, Lina; Bignell, Graham; Greenman, Chris; Edkins, Sarah; Hardy, Claire; O'Meara, Sarah; Teague, Jon; Butler, Adam; Hinton, Jonathan; Latimer, Calli; Andrews, Jenny; Barthorpe, Syd; Beare, Dave; Buck, Gemma; Campbell, Peter J.; Cole, Jennifer; Forbes, Simon; Jia, Mingming; Jones, David; Kok, Chai Yin; Leroy, Catherine; Lin, Meng-Lay; McBride, David J.; Maddison, Mark; Maquire, Simon; Mclay, Kirsten; Menzies, Andrew; Mironenko, Tatiana; Mulderrig, Lee; Mudie, Laura; Pleasance, Erin; Shepherd, Rebecca; Smith, Raffaella; Stebbings, Lucy; Stephens, Philip; Tang, Gurpreet; Tarpey, Patrick S.; Turner, Rachel; Turrell, Kelly; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Collins, V. Peter; Ichimura, Koichi] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Law, Simon; Wong, John] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Yuen, Siu Tsan; Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tonon, Giovanni; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Innovat Canc Sci,Dept Med Oncol,Ctr A, Boston, MA 02115 USA; [Tonon, Giovanni; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Innovat Canc Sci,Dept Med & Genet,Ctr, Boston, MA 02115 USA; [Tai, Yu-Tzu; Anderson, Kenneth C.] Dana Farber Canc Inst, Lebow Inst Myeloma Therapeut, Boston, MA 02115 USA; [Tai, Yu-Tzu; Anderson, Kenneth C.] Dana Farber Canc Inst, Lipper Myeloma Ctr, Boston, MA 02115 USA; [Kahnoski, Richard J.; Massie, Aaron] Spectrum Hlth Hosp, Dept Urol, Grand Rapids, MI USA; [Khoo, Sok Kean; Teh, Bin Tean] Van Andel Inst, Canc Genet Lab, Grand Rapids, MI USA; [Stratton, Michael R.] Inst Canc Res, Sutton, Surrey, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Hong Kong; University of Hong Kong; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Van Andel Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England.	mrs@sanger.ac.uk; paf@sanger.ac.uk	Yuen, Siu/K-6311-2014; Tonon, Giovanni/J-9804-2018; van Haaften, Gijs/G-7832-2012; Leung, Suet Yi/C-4340-2009; Law, Simon/C-4324-2009; Leung, Suet Yi/T-9620-2019; Dalgliesh, Gillian/B-7799-2008	Tonon, Giovanni/0000-0003-2973-5038; van Haaften, Gijs/0000-0003-3033-0329; Law, Simon/0000-0002-6518-5806; Leung, Suet Yi/0000-0001-8614-4619; Teh, Bin Tean/0000-0003-1514-1124; Dalgliesh, Gillian/0000-0001-8526-5064; DePinho, Ronald/0000-0002-5625-577X; Buck, Gemma/0000-0001-5289-1050	Wellcome Trus; EMBO fellowship; Kay Kendall Leukaemia Fund fellowship; Robert A. and Renee E. Belfer Foundation for Innovative Cancer Science; Leukemia and Lymphoma Society	Wellcome Trus(Wellcome Trust); EMBO fellowship(European Molecular Biology Organization (EMBO)); Kay Kendall Leukaemia Fund fellowship; Robert A. and Renee E. Belfer Foundation for Innovative Cancer Science; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	Funding was provided by the Wellcome Trust. G. v. H. is supported by an EMBO fellowship and P.J.C. by a Kay Kendall Leukaemia Fund fellowship. R. A. D. is supported by the Robert A. and Renee E. Belfer Foundation for Innovative Cancer Science. G. T. is supported by a fellowship from the Leukemia and Lymphoma Society. GlaxoSmithKline provided support for the SNP 6.0 microarray analyses. UTX antibodies were a kind gift from E. Canaani (Weizmann Institute of Science).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; KIRCHNER HH, 1981, BLUT, V43, P93, DOI 10.1007/BF00320467; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; PEGORARO L, 1989, BLOOD, V73, P1020; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950	15	583	596	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					521	523		10.1038/ng.349	http://dx.doi.org/10.1038/ng.349			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19330029	Green Accepted, Green Submitted			2022-12-25	WOS:000265575600011
J	La Spada, AR				La Spada, Albert R.			Silencing neurodegeneration	NATURE MEDICINE			English	Editorial Material							POLYGLUTAMINE-INDUCED NEURODEGENERATION; HUNTINGTONS-DISEASE; RNAI; THERAPY; MODEL		[La Spada, Albert R.] Univ Washington, UWMC, Dept Lab Med, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, UWMC, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, UWMC, Div Neurogenet, Dept Neurol, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, UWMC, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	La Spada, AR (corresponding author), Univ Washington, UWMC, Dept Lab Med, Room NW120,1959 NE Pacific St, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020					Bonini NM, 2005, NEURON, V48, P715, DOI 10.1016/j.neuron.2005.11.008; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	13	3	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2009	15	3					252	253		10.1038/nm0309-252	http://dx.doi.org/10.1038/nm0309-252			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19265826				2022-12-25	WOS:000263914000023
J	Nair, RP; Duffin, KC; Helms, C; Ding, J; Stuart, PE; Goldgar, D; Gudjonsson, JE; Li, Y; Tejasvi, T; Feng, BJ; Ruether, A; Schreiber, S; Weichenthal, M; Gladman, D; Rahman, P; Schrodi, SJ; Prahalad, S; Guthery, SL; Fischer, J; Liao, W; Kwok, PY; Menter, A; Lathrop, GM; Awise, C; Begovich, AB; Voorhees, JJ; Elder, JT; Krueger, GG; Bowcock, AM; Abecasis, GR				Nair, Rajan P.; Duffin, Kristina Callis; Helms, Cynthia; Ding, Jun; Stuart, Philip E.; Goldgar, David; Gudjonsson, Johann E.; Li, Yun; Tejasvi, Trilokraj; Feng, Bing-Jian; Ruether, Andreas; Schreiber, Stefan; Weichenthal, Michael; Gladman, Dafna; Rahman, Proton; Schrodi, Steven J.; Prahalad, Sampath; Guthery, Stephen L.; Fischer, Judith; Liao, Wilson; Kwok, Pui-Yan; Menter, Alan; Lathrop, G. Mark; Awise, Carol; Begovich, Ann B.; Voorhees, John J.; Elder, James T.; Krueger, Gerald G.; Bowcock, Anne M.; Abecasis, Goncalo R.		Collaborative Assoc Study Psoriasi	Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappa B pathways	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL; GENETIC-ASSOCIATION; VARIANTS; SUSCEPTIBILITY; IDENTIFICATION; MULTIPLE; DISEASE; RISK; PATHOGENESIS	Psoriasis is a common immune-mediated disorder that affects the skin, nails and joints. To identify psoriasis susceptibility loci, we genotyped 438,670 SNPs in 1,409 psoriasis cases and 1,436 controls of European ancestry. We followed up 21 promising SNPs in 5,048 psoriasis cases and 5,041 controls. Our results provide strong support for the association of at least seven genetic loci and psoriasis (each with combined P < 5 x 10(-8)). Loci with confirmed association include HLA-C, three genes involved in IL-23 signaling (IL23A, IL23R, IL12B), two genes that act downstream of TNF-alpha and regulate NF-kappa B signaling (TNIP1, TNFAIP3) and two genes involved in the modulation of Th2 immune responses (IL4, IL13). Although the proteins encoded in these loci are known to interact biologically, we found no evidence for epistasis between associated SNPs. Our results expand the catalog of genetic loci implicated in psoriasis susceptibility and suggest priority targets for study in other auto-immune disorders.	[Nair, Rajan P.; Stuart, Philip E.; Gudjonsson, Johann E.; Tejasvi, Trilokraj; Voorhees, John J.; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Duffin, Kristina Callis; Goldgar, David; Feng, Bing-Jian; Krueger, Gerald G.] Univ Utah, Dept Dermatol, Salt Lake City, UT 84131 USA; [Helms, Cynthia; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; [Ding, Jun; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Ruether, Andreas; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Weichenthal, Michael] Univ Kiel, Dept Dermatol, D-24105 Kiel, Germany; [Gladman, Dafna] Univ Toronto, Dept Rheumatol, Toronto, ON M5T 2S8, Canada; [Rahman, Proton] Mem Univ Newfoundland, Dept Med, St John, NF A1C 5B8, Canada; [Schrodi, Steven J.] Celera, Alameda, CA 94502 USA; [Prahalad, Sampath; Guthery, Stephen L.] Univ Utah, Dept Pediat, Salt Lake City, UT 84312 USA; [Prahalad, Sampath; Guthery, Stephen L.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Prahalad, Sampath; Guthery, Stephen L.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Fischer, Judith; Lathrop, G. Mark] Ctr Natl Genotypage, Inst Genom, F-91057 Evry, France; [Kwok, Pui-Yan] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94153 USA; [Menter, Alan] Baylor Univ, Med Ctr, Dept Dermatol, Dallas, TX 75246 USA; [Awise, Carol] Texas Scottish Rite Hosp Children, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Kiel; University of Kiel; University of Toronto; Memorial University Newfoundland; Utah System of Higher Education; University of Utah; Emory University; Emory University; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California San Francisco; Baylor University; Baylor University Medical Center; Texas Scottish Rite Hospital for Children	Elder, JT (corresponding author), Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA.	jelder@umich.edu; gerald.krueger@hsc.utah.edu; bowcock@wustl.edu; goncalo@umich.edu	Wu, Celia/H-5142-2013; Schrodi, Steven J./O-4288-2019; Feng, Bing-Jian/C-6974-2009; Weichenthal, Michael/A-5692-2009; Abecasis, Goncalo R/B-7840-2010; Franke, Andre/B-2151-2010; Kwok, Pui-Yan/F-7725-2014; Fischer, Judith/E-6327-2016; Voorhees, John/AAM-9966-2020; menter md, alan/A-8250-2009; Ding, Jun/G-3918-2011	Schrodi, Steven J./0000-0003-2304-8528; Franke, Andre/0000-0003-1530-5811; Kwok, Pui-Yan/0000-0002-5087-3059; Fischer, Judith/0000-0002-8580-8118; Voorhees, John/0000-0003-1856-785X; Abecasis, Goncalo/0000-0003-1509-1825; Wise, Carol/0000-0002-6790-2194; Bowcock, Anne/0000-0001-8691-9090	National Institutes of Health; Foundation for NIH's Genetic Association Information Network; National Psoriasis Foundation; German National Genome Research Network [BMFT 01GS 0171, BMBF NUW-S23T10]; POPGEN Biobank (BMBF) [01GR0468]; Canadian Institute of Health Research; Arthritis Society of Canada; Centre National de Genotypage; Association Francaise contre les Myopathies (AFM); Celera Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050511, R01AR042742, R01AR054966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for NIH's Genetic Association Information Network; National Psoriasis Foundation; German National Genome Research Network; POPGEN Biobank (BMBF)(Federal Ministry of Education & Research (BMBF)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Society of Canada; Centre National de Genotypage; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Celera Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We gratefully acknowledge funding from the National Institutes of Health, the Foundation for NIH's Genetic Association Information Network and the National Psoriasis Foundation. Analysis and genotyping of follow-up samples was also supported by the German National Genome Research Network (BMFT 01GS 0171/ BMBF NUW-S23T10) and POPGEN Biobank (BMBF 01GR0468), by the Canadian Institute of Health Research and the Arthritis Society of Canada, by the Centre National de Genotypage, Genethon and the Association Francaise contre les Myopathies (AFM), and by Celera Corporation.	Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chandran V, 2009, ANN RHEUM DIS, V68, P664, DOI 10.1136/ard.2008.089367; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Wang HL, 2008, J IMMUNOL, V180, P5520, DOI 10.4049/jimmunol.180.8.5520; YATES VM, 1982, BRIT J DERMATOL, V106, P323; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	30	1007	1050	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					199	204		10.1038/ng.311	http://dx.doi.org/10.1038/ng.311			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19169254	Green Accepted, Green Submitted			2022-12-25	WOS:000263091300020
J	Nishiyama, M; Oshikawa, K; Tsukada, Y; Nakagawa, T; Iemura, S; Natsume, T; Fan, Y; Kikuchi, A; Skoultchi, AI; Nakayama, KI				Nishiyama, Masaaki; Oshikawa, Kiyotaka; Tsukada, Yu-ichi; Nakagawa, Tadashi; Iemura, Shun-ichiro; Natsume, Tohru; Fan, Yuhong; Kikuchi, Akira; Skoultchi, Arthur I.; Nakayama, Keiichi I.			CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis	NATURE CELL BIOLOGY			English	Article							LINKER HISTONES; SACCHAROMYCES-CEREVISIAE; GENE-REGULATION; MICE LACKING; P53 PATHWAY; DNA-DAMAGE; IN-VITRO; CHROMATIN; TRANSCRIPTION; PROTEIN	The chromodomain helicase DNA-binding (CHD) family of enzymes is thought to regulate gene expression, but their role in the regulation of specific genes has been unclear. Here we show that CHD8 is expressed at a high level during early embryogenesis and prevents apoptosis mediated by the tumour suppressor protein p53. CHD8 was found to bind to p53 and to suppress its transactivation activity. CHD8 promoted the association of p53 and histone H1, forming a trimeric complex on chromatin that was required for inhibition of p53-dependent transactivation and apoptosis. Depletion of CHD8 or histone H1 resulted in p53 activation and apoptosis. Furthermore, Chd8(-/-) mice died early during embryogenesis, manifesting widespread apoptosis, whereas deletion of p53 ameliorated this developmental arrest. These observations reveal a mode of p53 regulation mediated by CHD8, which may set a threshold for induction of apoptosis during early embryogenesis by counteracting p53 function through recruitment of histone H1.	[Nishiyama, Masaaki; Oshikawa, Kiyotaka; Tsukada, Yu-ichi; Nakagawa, Tadashi; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Nishiyama, Masaaki; Oshikawa, Kiyotaka; Tsukada, Yu-ichi; Nakagawa, Tadashi; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Biol Informat Res Ctr JBIRC, Natl Inst Adv Ind Sci & Technol, Kohtoh Ku, Tokyo 1350064, Japan; [Fan, Yuhong; Skoultchi, Arthur I.] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Fan, Yuhong] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Fan, Yuhong] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Kikuchi, Akira] Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan	Kyushu University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Yeshiva University; Albert Einstein College of Medicine; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Hiroshima University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Nishiyama, Masaaki/GWU-5575-2022; Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Takeda Science Foundation; NIH [CA79057]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA079057, R56CA079057] Funding Source: NIH RePORTER	Takeda Science Foundation(Takeda Science Foundation (TSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Kitamura for pMX-puro; J.M. Cunningham and K. Hanada for the mCAT-1 plasmid; S. Miyake for the PG13-, p21-, and p21 mutant-Luc plasmids; T. Takemori for the NF-kappa B Luc plasmid; F. Ishikawa and R. Funayama for the N-fusion and C-fusion plasmids; M. Kitagawa for HCT116 and SaOS2 cells; M. Sato, Y. Yamada, T. Moroishi, Y. Katayama, N. Nishimura and K. Oyamada for technical assistance; M. Kimura and A. Ohta for help with preparation of the manuscript; and T. Ushijima, K. Hayashi and members of the authors' laboratories for discussion. K.I.N. was supported by Takeda Science Foundation. Y.F. and A.I.S. were supported by NIH grant CA79057. Y.F. is a GCC Cancer Scholar supported by Georgia Cancer Coalition.	Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Becker PB, 2005, NAT STRUCT MOL BIOL, V12, P732, DOI 10.1038/nsmb0905-732; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishiyama M, 2004, MOL CELL BIOL, V24, P8386, DOI 10.1128/MCB.24.19.8386-8394.2004; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; Rupp RAW, 2005, CELL, V123, P1178, DOI 10.1016/j.cell.2005.12.004; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMAS H, 1999, ENTREP REGION DEV, V11, P317; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zahir F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050823; Zhang L, 2005, EMBO J, V24, P2379, DOI 10.1038/sj.emboj.7600711; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	45	135	138	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					172	U139		10.1038/ncb1831	http://dx.doi.org/10.1038/ncb1831			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151705	Green Accepted			2022-12-25	WOS:000263285500015
J	Van Zeebroeck, G; Bonini, BM; Versele, M; Thevelein, JM				Van Zeebroeck, Griet; Bonini, Beatriz Monge; Versele, Matthias; Thevelein, Johan M.			Transport and signaling via the amino acid binding site of the yeast Gap1 amino acid transceptor	NATURE CHEMICAL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; CONSENSUS AMPHIPATHIC REGION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; A PATHWAY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; HOMOLOG SSY1P; PERMEASE; ACTIVATION	Transporter-related nutrient sensors, called transceptors, mediate nutrient activation of signaling pathways through the plasma membrane. The mechanism of action of transporting and nontransporting transceptors is unknown. We have screened 319 amino acid analogs to identify compounds that act on Gap1, a transporting amino acid transceptor in yeast that triggers activation of the protein kinase A pathway. We identified competitive and noncompetitive inhibitors of transport, either with or without agonist action for signaling, including nontransported agonists. Using substituted cysteine accessibility method ( SCAM) analysis, we identified Ser388 and Val389 as being exposed into the amino acid binding site, and we show that agonist action for signaling uses the same binding site as used for transport. Our results provide the first insight, to our knowledge, into the mechanism of action of transceptors. They indicate that signaling requires a ligand-induced specific conformational change that may be part of but does not require the complete transport cycle.	[Van Zeebroeck, Griet; Bonini, Beatriz Monge; Versele, Matthias; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Flanders, Belgium; [Van Zeebroeck, Griet; Bonini, Beatriz Monge; Versele, Matthias; Thevelein, Johan M.] Vlaams Inst Biotechnol, Dept Mol Microbiol, B-3001 Louvain, Flanders, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	Van Zeebroeck, G (corresponding author), Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Kasteelpk Arenberg 31, B-3001 Louvain, Flanders, Belgium.	johan.thevelein@bio.kuleuven.be	Thevelein, Johan M./A-7897-2013; Thevelein, Johan M./AAK-4203-2021	Thevelein, Johan M./0000-0002-2626-0180; 	Belgian Federal Science Policy Office; Fund for Scientific Research - Flanders, Interuniversity Attraction Poles Network [P5/30 and P6/14]; Research Fund of the Katholieke Universiteit Leuven	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Fund for Scientific Research - Flanders, Interuniversity Attraction Poles Network(Belgian Federal Science Policy OfficeFWO); Research Fund of the Katholieke Universiteit Leuven(KU Leuven)	We thank W. Verheyden and R. Wicik for technical help with the experiments, N. Vangoethem for help with preparation of the figures and B. Andre (Universite Libre de Bruxelles) for the kind gift of strains, plasmids and antibodies. This work was supported by a Return Grant from the Belgian Federal Science Policy Office to M. V. and by grants from the Fund for Scientific Research - Flanders, Interuniversity Attraction Poles Network P5/30 and P6/14 and the Research Fund of the Katholieke Universiteit Leuven (Concerted Research Actions).	Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605; APP H, 1989, J BIOL CHEM, V264, P17583; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; DURNEZ P, 1994, YEAST, V10, P1049, DOI 10.1002/yea.320100807; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; GRENSON M, 1983, EUR J BIOCHEM, V133, P135, DOI 10.1111/j.1432-1033.1983.tb07438.x; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Holyoake J, 2007, STRUCTURE, V15, P873, DOI 10.1016/j.str.2007.06.004; Hu LYA, 1998, BIOCHEM J, V330, P771; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Iraqui I, 1999, MOL CELL BIOL, V19, P989; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; King SC, 2003, BIOCHEM J, V376, P645, DOI 10.1042/BJ20030595; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Ma PS, 1999, MOL BIOL CELL, V10, P91, DOI 10.1091/mbc.10.1.91; MBONYI K, 1990, MOL CELL BIOL, V10, P4518, DOI 10.1128/MCB.10.9.4518; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Poulsen P, 2008, MOL MEMBR BIOL, V25, P164, DOI 10.1080/09687680701771917; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Schwoppe C, 2003, EUR J BIOCHEM, V270, P1450, DOI 10.1046/j.1432-1033.2003.03507.x; Schwoppe C, 2002, J BACTERIOL, V184, P2108, DOI 10.1128/JB.184.8.2108-2115.2002; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; Tamas MJ, 2000, FEBS LETT, V472, P159, DOI 10.1016/S0014-5793(00)01445-9; Thevelein JM, 2005, BIOCHEM SOC T, V33, P253, DOI 10.1042/BST0330253; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; UNO I, 1983, J BIOL CHEM, V258, P867; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	47	62	62	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2009	5	1					45	52		10.1038/nchembio.132	http://dx.doi.org/10.1038/nchembio.132			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387EW	19060912				2022-12-25	WOS:000261935500013
J	Bilguvar, K; Yasuno, K; Niemela, M; Ruigrok, YM; Fraunberg, MVZ; van Duijn, CM; van den Berg, LH; Mane, S; Mason, CE; Choi, M; Gaal, E; Bayri, Y; Kolb, L; Arlier, Z; Ravuri, S; Ronkainen, A; Tajima, A; Laakso, A; Hata, A; Kasuya, H; Koivisto, T; Rinne, J; Ohman, J; Breteler, MMB; Wijmenga, C; State, MW; Rinkel, GJE; Hernesniemi, J; Jaaskelainen, JE; Palotie, A; Inoue, I; Lifton, RP; Gunel, M				Bilguvar, Kaya; Yasuno, Katsuhito; Niemela, Mika; Ruigrok, Ynte M.; Fraunberg, Mikael von und zu; van Duijn, Cornelia M.; van den Berg, Leonard H.; Mane, Shrikant; Mason, Christopher E.; Choi, Murim; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; Ravuri, Sudhakar; Ronkainen, Antti; Tajima, Atsushi; Laakso, Aki; Hata, Akira; Kasuya, Hidetoshi; Koivisto, Timo; Rinne, Jaakko; Ohman, Juha; Breteler, Monique M. B.; Wijmenga, Cisca; State, Matthew W.; Rinkel, Gabriel J. E.; Hernesniemi, Juha; Jaaskelainen, Juha E.; Palotie, Aarno; Inoue, Ituro; Lifton, Richard P.; Guenel, Murat			Susceptibility loci for intracranial aneurysm in European and Japanese populations	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HEMATOPOIETIC STEM-CELLS; REDUNDANT ROLES; LARGE-SCALE; ANGIOGENESIS; REPLICATION; VARIANTS; LINKAGE; SOX17; CONTRIBUTE	Stroke is the world's third leading cause of death. One cause of stroke, intracranial aneurysm, affects similar to 2% of the population and accounts for 500,000 hemorrhagic strokes annually in mid-life (median age 50), most often resulting in death or severe neurological impairment(1). The pathogenesis of intracranial aneurysm is unknown, and because catastrophic hemorrhage is commonly the first sign of disease, early identification is essential. We carried out a multistage genome-wide association study (GWAS) of Finnish, Dutch and Japanese cohorts including over 2,100 intracranial aneurysm cases and 8,000 controls. Genome-wide genotyping of the European cohorts and replication studies in the Japanese cohort identified common SNPs on chromosomes 2q, 8q and 9p that show significant association with intracranial aneurysm with odds ratios 1.24-1.36. The loci on 2q and 8q are new, whereas the 9p locus was previously found to be associated with arterial diseases, including intracranial aneurysm(2-5). Associated SNPs on 8q likely act via SOX17, which is required for formation and maintenance of endothelial cells(6-8), suggesting a role in development and repair of the vasculature; CDKN2A at 9p may have a similar role(9). These findings have implications for the pathophysiology, diagnosis and therapy of intracranial aneurysm.	[Bilguvar, Kaya; Mason, Christopher E.; Choi, Murim; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; State, Matthew W.; Lifton, Richard P.; Guenel, Murat] Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Yale Program Neurogenet,Dept Genet, New Haven, CT 06510 USA; [Bilguvar, Kaya; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; Guenel, Murat] Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Dept Neurosurg, New Haven, CT 06510 USA; [Bilguvar, Kaya; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; Guenel, Murat] Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Dept Neurobiol, New Haven, CT 06510 USA; [Yasuno, Katsuhito; Tajima, Atsushi] Tokai Univ, Sch Med, Div Mol Life Sci, Kanagawa 2591193, Japan; [Niemela, Mika; Gaal, Emilia; Laakso, Aki; Hernesniemi, Juha] Univ Helsinki, Cent Hosp, Dept Neurosurg, FI-00029 Helsinki, Hus, Finland; [Ruigrok, Ynte M.; van den Berg, Leonard H.; Rinkel, Gabriel J. E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands; [Fraunberg, Mikael von und zu; Ronkainen, Antti; Koivisto, Timo; Rinne, Jaakko; Jaaskelainen, Juha E.] Kuopio Univ Hosp, Dept Neurosurg, FI-70211 Kuopio, Finland; [van Duijn, Cornelia M.; Breteler, Monique M. B.] Erasmus MC, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [van Duijn, Cornelia M.; Breteler, Monique M. B.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Mane, Shrikant; Ravuri, Sudhakar] Yale Univ, Keck Fdn Biotechnol Resource Lab, New Haven, CT 06510 USA; [Mason, Christopher E.; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Hata, Akira] Chiba Univ, Sch Med, Dept Publ Hlth, Chiba 2608670, Japan; [Kasuya, Hidetoshi] Tokyo Womens Univ, Med Ctr E, Dept Neurosurg, Tokyo 1168567, Japan; [Ohman, Juha] Tampere Univ Hosp, Dept Neurosurg, Tampere 33521, Finland; [Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RR Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, NL-9700 RR Groningen, Netherlands; [Palotie, Aarno] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Tokai University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Utrecht University; Utrecht University Medical Center; Kuopio University Hospital; University of Eastern Finland; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Yale University; Yale University; Chiba University; Tokyo Women's Medical University; Tampere University; Tampere University Hospital; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of Helsinki; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Yale Program Neurogenet,Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	richard.lifton@yale.edu; murat.gunel@yale.edu	Niemelä, Mika R/F-2539-2015; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Breteler, Monique M.B./J-5058-2014; Mason, Christopher/HCH-3977-2022; State, Matthew/W-2256-2019; Choi, Murim/AAP-9120-2021; Tajima, Atsushi/C-1053-2008; Yasuno, Katsuhito/E-1960-2012; Bayri, Yasar/B-1287-2017	Niemelä, Mika R/0000-0003-1526-0684; Wijmenga, Cisca/0000-0002-5635-1614; Breteler, Monique M.B./0000-0002-0626-9305; Tajima, Atsushi/0000-0001-6808-5491; Yasuno, Katsuhito/0000-0002-3606-532X; State, Matthew/0000-0003-1624-8302; Van Duijn, Cornelia/0000-0002-2374-9204; Laakso, Aki/0000-0002-5312-4926; Bayri, Yasar/0000-0003-1707-6055; Ohman, Juha/0000-0002-6592-1367; von und zu Fraunberg, Mikael/0000-0002-8457-4639	Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; US National Institutes of Health [R01NS057756, U24 NS051869]; Howard Hughes Medical Institute; Netherlands Heart Foundation [2005T014]; Core Research for Evolutional Science and Technology; Japan Science and Technology Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057756, U24NS051869] Funding Source: NIH RePORTER	Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Heart Foundation(Netherlands Heart Foundation); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the participants who made this study possible. We thank A. Chamberlain, O. Tornwall, M. Alalahti, K. Helin, S. Malin and J. Budzinack for their technical help. This study was supported by the Yale Center for Human Genetics and Genomics and the Yale Program on Neurogenetics, the US National Institutes of Health grants R01NS057756 (M.G.) and U24 NS051869 (S.M.) and the Howard Hughes Medical Institute (R.P.L.). C.E.M. and M.W.S. are supported by a gift from the Lawrence Family and Y.M.R. by the Dr E. Dekker program of The Netherlands Heart Foundation (2005T014). K.Y. and I.I. were supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bederson JB, 2000, STROKE, V31, P2742, DOI 10.1161/01.STR.31.11.2742; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Foroud T, 2008, STROKE, V39, P1434, DOI 10.1161/STROKEAHA.107.502930; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nahed BV, 2005, AM J HUM GENET, V76, P172, DOI 10.1086/426953; Ozturk AK, 2006, STROKE, V37, P1021, DOI 10.1161/01.STR.0000206153.92675.b9; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Ruigrok YM, 2008, STROKE, V39, P1096, DOI 10.1161/STROKEAHA.107.495168; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SCHIEVINK WI, 1995, J NEUROSURG, V83, P426, DOI 10.3171/jns.1995.83.3.0426; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	30	211	220	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1472	1477		10.1038/ng.240	http://dx.doi.org/10.1038/ng.240			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997786	Green Accepted			2022-12-25	WOS:000261215900025
J	Gadhoum, SZ; Sackstein, R				Gadhoum, Samah Zeineb; Sackstein, Robert			CD15 expression in human myeloid cell differentiation is regulated by sialidase activity	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN HEMATOPOIETIC PROGENITORS; ANTI-CD44 MONOCLONAL-ANTIBODIES; HUMAN T-CELLS; E-SELECTIN; ADHESION MOLECULES; LYMPHOCYTE MIGRATION; PLASMA-MEMBRANE; DENDRITIC CELLS; LEUKEMIA CELLS; BONE-MARROW	The glycan determinant CD15 (also known as Lewis x, or Le(x)) is a distinguishing marker for human myeloid cells and mediates neutrophil adhesion to dendritic cells. Despite broad interest in this structure, the mechanisms underlying CD15 expression remain relatively uncharacterized. Accordingly, we investigated the molecular basis of increasing CD15 expression associated with human myeloid cell differentiation. Flow cytometric analysis of differentiating cells together with biochemical studies using inhibitors of glycan synthesis and of sialidases showed that increased CD15 expression is not due to de novo biosynthesis of CD15, but results predominantly from induction of alpha(2- 3)-sialidase activity, which yields CD15 from cell-surface sialyl-CD15 (also known as sialyl-Lewis x, sLe(x) or CD15s). This differentiation-associated conversion of surface CD15s to CD15 occurs mainly on glycoproteins. Until now, modulation of post-translational glycan modifications has been attributed solely to dynamic variations in glycosyltransferase expression. Our results unveil a new paradigm by demonstrating a critical role for post-Golgi membrane glycosidase activity in the 'biosynthesis' of a key glycan determinant.	[Gadhoum, Samah Zeineb; Sackstein, Robert] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Gadhoum, Samah Zeineb; Sackstein, Robert] Harvard Univ, Sch Med, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Sackstein, Robert] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sackstein, Robert] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Sackstein, R (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	rsackstein@rics.bwh.harvard.edu			US National Heart, Lung, and Blood Institute [RO1 HL60528]; US National Institute of Diabetes and Digestive and Kidney Diseases [R21 DK075012]; Team Jobie Leukemia Research fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075012] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Team Jobie Leukemia Research fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to D. Floyd, S. Hamdan, C. Silvescu and C. Knoblauch for technical support, to J. Merzaban, N. Stamatos, C. Dimitroff and M. Burdick for helpful discussions of the manuscript, and to I. Galinsky, R. Stone, D. DeAngelo, M. Wadleigh and A. Sirulnik for assistance in procuring leukemia samples. This work was supported by US National Heart, Lung, and Blood Institute grant RO1 HL60528 (R.S.), US National Institute of Diabetes and Digestive and Kidney Diseases grant R21 DK075012 (R.S.) and the Team Jobie Leukemia Research fund (R.S.).	Aldape MJ, 2007, J INFECT DIS, V195, P1838, DOI 10.1086/518004; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Azuma Y, 2000, GLYCOCONJUGATE J, V17, P301, DOI 10.1023/A:1007165403771; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Charrad RS, 2002, BLOOD, V99, P290, DOI 10.1182/blood.V99.1.290; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; CYOPICK P, 1993, LEUKEMIA LYMPHOMA, V11, P79, DOI 10.3109/10428199309054733; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Dagia NM, 2006, NAT MED, V12, P1185, DOI 10.1038/nm1470; Datta AK, 1997, INDIAN J BIOCHEM BIO, V34, P157; Dimitroff CJ, 2003, BLOOD, V101, P602, DOI 10.1182/blood-2002-06-1736; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Fuhlbrigge RC, 2006, BLOOD, V107, P1421, DOI 10.1182/blood-2005-05-2112; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Gadhoum Z, 2004, LEUKEMIA LYMPHOMA, V45, P1501, DOI 10.1080/1042819042000206687; Gege C, 2002, CHEM-EUR J, V8, P2454, DOI 10.1002/1521-3765(20020603)8:11<2454::AID-CHEM2454>3.0.CO;2-U; GOOI HC, 1983, EUR J IMMUNOL, V13, P306, DOI 10.1002/eji.1830130407; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; Kannagi R, 2001, ADV EXP MED BIOL, V491, P267; KANSAS GS, 1990, BLOOD, V76, P2483; Kopitz J, 1997, EUR J CELL BIOL, V73, P1; Levesque JP, 1999, IMMUNITY, V11, P369, DOI 10.1016/S1074-7613(00)80112-0; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; LUNDJOHANSEN F, 1993, J LEUKOCYTE BIOL, V54, P47, DOI 10.1002/jlb.54.1.47; MAEMURA K, 1992, J BIOL CHEM, V267, P24379; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Nguyen DH, 2006, EXP HEMATOL, V34, P728, DOI 10.1016/j.exphem.2006.03.003; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Sackstein R, 2004, J INVEST DERMATOL, V122, P1061, DOI 10.1111/j.0022-202X.2004.09301.x; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; STROUD MR, 1995, BIOCHEM BIOPH RES CO, V209, P777, DOI 10.1006/bbrc.1995.1568; Tao W, 2004, STEM CELLS, V22, P1003, DOI 10.1634/stemcells.22-6-1003; TERSTAPPEN LWMM, 1992, LEUKEMIA, V6, P1001; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wang P, 2004, BIOCHEM J, V380, P425, DOI 10.1042/BJ20031896; WOODS JM, 1993, ANTIMICROB AGENTS CH, V37, P1473, DOI 10.1128/AAC.37.7.1473; ZANNETTINO ACW, 1995, BLOOD, V85, P3466, DOI 10.1182/blood.V85.12.3466.bloodjournal85123466	44	62	68	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2008	4	12					751	757		10.1038/nchembio.116	http://dx.doi.org/10.1038/nchembio.116			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	373FH	18953356	Green Accepted			2022-12-25	WOS:000260955900011
J	Cizkova, A; Stranecky, V; Mayr, JA; Tesarova, M; Havlickova, V; Paul, J; Ivanek, R; Kuss, AW; Hansikova, H; Kaplanova, V; Vrbacky, M; Hartmannova, H; Noskova, L; Honzik, T; Drahota, Z; Magner, M; Hejzlarova, K; Sperl, W; Zeman, J; Houstek, J; Kmoch, S				Cizkova, Alena; Stranecky, Viktor; Mayr, Johannes A.; Tesarova, Marketa; Havlickova, Vendula; Paul, Jan; Ivanek, Robert; Kuss, Andreas W.; Hansikova, Hana; Kaplanova, Vilma; Vrbacky, Marek; Hartmannova, Hana; Noskova, Lenka; Honzik, Tomas; Drahota, Zdenek; Magner, Martin; Hejzlarova, Katerina; Sperl, Wolfgang; Zeman, Jiri; Houstek, Josef; Kmoch, Stanislav			TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy	NATURE GENETICS			English	Article							ASSEMBLY FACTORS; DEFECTS; COMPLEX	We carried out whole-genome homozygosity mapping, gene expression analysis and DNA sequencing in individuals with isolated mitochondrial ATP synthase deficiency and identified disease-causing mutations in TMEM70. Complementation of the cell lines of these individuals with wild-type TMEM70 restored biogenesis and metabolic function of the enzyme complex. Our results show that TMEM70 is involved in mitochondrial ATP synthase biogenesis in higher eukaryotes.	[Cizkova, Alena; Havlickova, Vendula; Paul, Jan; Kaplanova, Vilma; Vrbacky, Marek; Drahota, Zdenek; Hejzlarova, Katerina; Houstek, Josef] Acad Sci Czech Republ, Inst Physiol, Dept Bioenerget, CR-14220 Prague, Czech Republic; [Cizkova, Alena; Stranecky, Viktor; Ivanek, Robert; Hartmannova, Hana; Noskova, Lenka; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12808, Czech Republic; [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Dept Pediat, A-5020 Salzburg, Austria; [Tesarova, Marketa; Hansikova, Hana; Honzik, Tomas; Magner, Martin; Zeman, Jiri] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague 12808, Czech Republic; [Kuss, Andreas W.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Paracelsus Private Medical University; Charles University Prague; Max Planck Society	Houstek, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Bioenerget, CR-14220 Prague, Czech Republic.	houstek@biomed.cas.cz; skmoch@lf1.cuni.cz	Stranecky, Viktor/I-8524-2017; Ivanek, Robert/A-8852-2008; Magner, Martin/J-3553-2017; Karbanova, Vendula/I-6851-2013; /F-8296-2014; Honzik, Tomas/N-7509-2017; Vrbacky, Marek/A-1044-2010; Kmoch, Stanislav/C-1575-2010; Kaplanova, Vilma/C-7960-2012; Houstek, Josef/C-5019-2012; Noskova, Lenka/F-6564-2017; Hansikova, Hana/E-9350-2017; Tauchmannova, Katerina/G-1023-2014; Hartmannova, Hana/H-4735-2017; Cizkova Vrbacka, Alena/F-4100-2011; Tesarova, Marketa/I-1531-2016; Zeman, Jiri/K-2691-2017	Stranecky, Viktor/0000-0002-2599-6479; Magner, Martin/0000-0002-5883-9509; /0000-0003-2117-6809; Honzik, Tomas/0000-0003-4300-2519; Vrbacky, Marek/0000-0001-7218-8370; Kmoch, Stanislav/0000-0002-6239-707X; Houstek, Josef/0000-0002-8413-4772; Noskova, Lenka/0000-0001-7011-4327; Hansikova, Hana/0000-0002-2734-225X; Tauchmannova, Katerina/0000-0002-3745-8790; Hartmannova, Hana/0000-0001-7787-832X; Cizkova Vrbacka, Alena/0000-0003-4640-1646; Tesarova, Marketa/0000-0002-5141-2289; Kuss, Andreas/0000-0002-9401-4627; Zeman, Jiri/0000-0002-2678-7919; Mayr, Johannes/0000-0001-6970-336X; Ivanek, Robert/0000-0002-8403-056X	Ministry of Education of Czech Republic [1M6837805002, AV0Z 50110509, MSM0021620806, 14/2006]; GACR [305/08/H037]; OeNB [12568]; Pad. Forschungsverein and PMU Salzburg [06/04/022]	Ministry of Education of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); GACR(Grant Agency of the Czech Republic); OeNB; Pad. Forschungsverein and PMU Salzburg	This study was supported by grants from Ministry of Education of Czech Republic (1M6837805002, AV0Z 50110509, MSM0021620806, Kontakt 14/2006), GACR (305/08/H037), OeNB 12568, Pad. Forschungsverein and PMU Salzburg (06/04/022). We thank R. Gallyova, S.. Rosipal, V. Smolka, A. Hlavata, P. Freisinger, M. Huemer and O. Bodamer, who provided samples from affected individuals for this study, and D. Seelow for bioinformatic support.	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Cizkova A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-38; Collinson IR, 1996, BIOCHEMISTRY-US, V35, P12640, DOI 10.1021/bi960969t; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Houstek J, 1999, HUM MOL GENET, V8, P1967; Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b; Pickova A, 2005, PROTEINS, V59, P393, DOI 10.1002/prot.20452; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	14	148	155	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1288	1290		10.1038/ng.246	http://dx.doi.org/10.1038/ng.246			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18953340				2022-12-25	WOS:000260501500019
J	Frokjaer-Jensen, C; Davis, MW; Hopkins, CE; Newman, BJ; Thummel, JM; Olesen, SP; Grunnet, M; Jorgensen, EM				Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Olesen, Soren-Peter; Grunnet, Morten; Jorgensen, Erik M.			Single-copy insertion of transgenes in Caenorhabditis elegans	NATURE GENETICS			English	Article							INDUCED GAP REPAIR; GENE CONVERSION; C-ELEGANS; DNA TRANSFORMATION; EXPRESSION; PROTEIN; GENOME; DROSOPHILA; TRANSPOSON; SEQUENCES	At present, transgenes in Caenorhabditis elegans are generated by injecting DNA into the germline. The DNA assembles into a semistable extrachromosomal array composed of many copies of injected DNA. These transgenes are typically overexpressed in somatic cells and silenced in the germline. We have developed a method that inserts a single copy of a transgene into a defined site. Mobilization of a Mos1 transposon generates a double-strand break in noncoding DNA. The break is repaired by copying DNA from an extrachromosomal template into the chromosomal site. Homozygous single-copy insertions can be obtained in less than 2 weeks by injecting approximately 20 worms. We have successfully inserted transgenes as long as 9 kb and verified that single copies are inserted at the targeted site. Single-copy transgenes are expressed at endogenous levels and can be expressed in the female and male germlines.	[Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Olesen, Soren-Peter; Grunnet, Morten] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-2200 Copenhagen N, Denmark; [Grunnet, Morten] NeuroSearch AS, DK-2750 Ballerup, Denmark	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Danmarks Grundforskningsfond; University of Copenhagen	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu	Frøkjær-Jensen, Christian/ABB-4637-2020; Olesen, Søren P/H-4206-2011; Olesen, Søren-Peter/B-9621-2012	Olesen, Søren P/0000-0002-4381-5192; Davis, Mikel/0000-0003-1867-1593; Hopkins, Chris/0000-0002-6981-6329; Frokjaer-Jensen, Christian/0000-0002-3178-0906	Fonden af 17.12.1981; Lundbeck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307] Funding Source: NIH RePORTER	Fonden af 17.12.1981; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Segalat and the NemaGENETAG consortium for generating and supplying Mos1 insertion alleles; L. Salkoff for twk-18 cDNA clones; G. Seydoux for promoter plasmids; J. Rand for UNC-18 antibodies; C. Thacker at the Utah worm core facility for generating biolistic transformants; G. Stanfield for help in confirming sperm expression; J.-L. Bessereau and V. Robert for sharing unpublished data; and M. Ailion, G. Hollopeter and the rest of the Jorgensen laboratory for scientific input. E. M. J. is an Investigator of the Howard Hughes Medical Institute. S.-P.O. is an Investigator of the Danish National Research Foundation. C.F.-J. was funded by fellowships from Fonden af 17.12.1981 and the Lundbeck Foundation.	Barrett PL, 2004, NAT GENET, V36, P1231, DOI 10.1038/ng1459; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Duverger Y, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1046; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kelly WG, 1997, GENETICS, V146, P227; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; MADURO M, 1995, GENETICS, V141, P977; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; PLASTERK RHA, 1992, EMBO J, V11, P287, DOI 10.1002/j.1460-2075.1992.tb05051.x; Praitis V, 2001, GENETICS, V157, P1217; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Robert VJ, 2008, GENETICS, V180, P673, DOI 10.1534/genetics.108.089698; Sha K, 2005, GENETICS, V170, P1633, DOI 10.1534/genetics.104.040303; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a	26	683	699	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1375	1383		10.1038/ng.248	http://dx.doi.org/10.1038/ng.248			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18953339	Green Accepted			2022-12-25	WOS:000260501500034
J	Weinberg, RA				Weinberg, Robert A.			Twisted epithelial-mesenchymal transition blocks senescence	NATURE CELL BIOLOGY			English	Editorial Material							CELLS; ACCUMULATION; PROGRESSION; RESISTANCE; EMBRYO	The epithelial-mesenchymal transition (EMT) is a cellular transdifferentiation program that enables epithelial cancer cells to acquire traits of high-grade malignancy, notably invasive and metastatic powers. A new study indicates that it may also function early in tumour progression by preventing oncogene-induced senescence.	MIT, Whitehead Inst Biomed Res, Ludwig Ctr Mol Oncol, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Ludwig Ctr Mol Oncol, Dept Biol, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu						Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104	13	64	71	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1021	1023		10.1038/ncb0908-1021	http://dx.doi.org/10.1038/ncb0908-1021			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	18758491				2022-12-25	WOS:000258910400006
J	Junutula, JR; Raab, H; Clark, S; Bhakta, S; Leipold, DD; Weir, S; Chen, Y; Simpson, M; Tsai, SP; Dennis, MS; Lu, YM; Meng, YG; Ng, C; Yang, JH; Lee, CC; Duenas, E; Gorrell, J; Katta, V; Kim, A; McDorman, K; Flagella, K; Venook, R; Ross, S; Spencer, SD; Wong, WL; Lowman, HB; Vandlen, R; Sliwkowski, MX; Scheller, RH; Polakis, P; Mallet, W				Junutula, Jagath R.; Raab, Helga; Clark, Suzanna; Bhakta, Sunil; Leipold, Douglas D.; Weir, Sylvia; Chen, Yvonne; Simpson, Michelle; Tsai, Siao Ping; Dennis, Mark S.; Lu, Yanmei; Meng, Y. Gloria; Ng, Carl; Yang, Jihong; Lee, Chien C.; Duenas, Eileen; Gorrell, Jeffrey; Katta, Viswanatham; Kim, Amy; McDorman, Kevin; Flagella, Kelly; Venook, Rayna; Ross, Sarajane; Spencer, Susan D.; Wong, Wai Lee; Lowman, Henry B.; Vandlen, Richard; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Mallet, William			Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index	NATURE BIOTECHNOLOGY			English	Article							AURISTATIN-E CONJUGATE; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; CYSTEINE RESIDUES; ARMING ANTIBODIES; MEMBRANE ANTIGEN; DISULFIDE BOND; CANCER-THERAPY; IN-VITRO; IMMUNOCONJUGATE	Antibody-drug conjugates enhance the antitumor effects of antibodies and reduce adverse systemic effects of potent cytotoxic drugs. However, conventional drug conjugation strategies yield heterogenous conjugates with relatively narrow therapeutic index (maximum tolerated dose/curative dose). Using leads from our previously described phage display-based method to predict suitable conjugation sites, we engineered cysteine substitutions at positions on light and heavy chains that provide reactive thiol groups and do not perturb immunoglobulin folding and assembly, or alter antigen binding. When conjugated to monomethyl auristatin E, an antibody against the ovarian cancer antigen MUC16 is as efficacious as a conventional conjugate in mouse xenograft models. Moreover, it is tolerated at higher doses in rats and cynomolgus monkeys than the same conjugate prepared by conventional approaches. The favorable in vivo properties of the near-homogenous composition of this conjugate suggest that our strategy offers a general approach to retaining the antitumor efficacy of antibody-drug conjugates, while minimizing their systemic toxicity.	[Junutula, Jagath R.; Raab, Helga; Clark, Suzanna; Bhakta, Sunil; Leipold, Douglas D.; Weir, Sylvia; Chen, Yvonne; Simpson, Michelle; Tsai, Siao Ping; Dennis, Mark S.; Lu, Yanmei; Meng, Y. Gloria; Ng, Carl; Yang, Jihong; Lee, Chien C.; Duenas, Eileen; Gorrell, Jeffrey; Katta, Viswanatham; Kim, Amy; McDorman, Kevin; Flagella, Kelly; Venook, Rayna; Ross, Sarajane; Spencer, Susan D.; Wong, Wai Lee; Lowman, Henry B.; Vandlen, Richard; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Mallet, William] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Junutula, JR (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	jagath@gene.com; wmallet@gene.com	Junutula, Jagath Reddy/ABD-4753-2020	Junutula, Jagath Reddy/0000-0002-5942-4428; BHAKTA, SUNIL/0000-0002-1554-7098				Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Baker M, 2005, NAT BIOTECHNOL, V23, P1065, DOI 10.1038/nbt0905-1065; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chen YJ, 2007, CANCER RES, V67, P4924, DOI 10.1158/0008-5472.CAN-06-4512; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dubowchik GM, 2002, BIOCONJUGATE CHEM, V13, P855, DOI 10.1021/bc025536j; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Henry MD, 2004, CANCER RES, V64, P7995, DOI 10.1158/0008-5472.CAN-04-1722; Junutula JR, 2008, J IMMUNOL METHODS, V332, P41, DOI 10.1016/j.jim.2007.12.011; Kovtun YV, 2006, CANCER RES, V66, P3214, DOI 10.1158/0008-5472.CAN-05-3973; Lambert JM, 2005, CURR OPIN PHARMACOL, V5, P543, DOI 10.1016/j.coph.2005.04.017; Liu C, 1997, Expert Opin Investig Drugs, V6, P169, DOI 10.1517/13543784.6.2.169; LYONS A, 1990, PROTEIN ENG, V3, P703, DOI 10.1093/protein/3.8.703; Ma DS, 2006, CLIN CANCER RES, V12, P2591, DOI 10.1158/1078-0432.CCR-05-2107; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; MICHAELSEN TE, 1994, P NATL ACAD SCI USA, V91, P9243, DOI 10.1073/pnas.91.20.9243; Mirsalis JC, 1999, CANCER CHEMOTH PHARM, V44, P395, DOI 10.1007/s002800050995; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; ROMANS DG, 1977, P NATL ACAD SCI USA, V74, P2531, DOI 10.1073/pnas.74.6.2531; Ross S, 2002, CANCER RES, V62, P2546; Sanderson RJ, 2005, CLIN CANCER RES, V11, P843; SEEGAN GW, 1979, P NATL ACAD SCI USA, V76, P907, DOI 10.1073/pnas.76.2.907; Stimmel JB, 2000, J BIOL CHEM, V275, P30445, DOI 10.1074/jbc.M001672200; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Tassone P, 2004, CANCER RES, V64, P4629, DOI 10.1158/0008-5472.CAN-04-0142; Tolcher AW, 2003, J CLIN ONCOL, V21, P211, DOI 10.1200/JCO.2003.05.137; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Wang LT, 2005, PROTEIN SCI, V14, P2436, DOI 10.1110/ps.051478705; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Xiang T, 2007, J CHROMATOGR B, V858, P254, DOI 10.1016/j.jchromb.2007.08.043; [No title captured]	33	875	1126	12	264	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2008	26	8					925	932		10.1038/nbt.1480	http://dx.doi.org/10.1038/nbt.1480			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	335WX	18641636				2022-12-25	WOS:000258325500027
J	Pulvirenti, T; Giannotta, M; Capestrano, M; Capitani, M; Pisanu, A; Polishchuk, RS; Pietro, ES; Beznoussenko, GV; Mironov, AA; Turacchio, G; Hsu, VW; Sallese, M; Luini, A				Pulvirenti, Teodoro; Giannotta, Monica; Capestrano, Mariagrazia; Capitani, Mirco; Pisanu, Antonio; Polishchuk, Roman S.; Pietro, Enrica San; Beznoussenko, Galina V.; Mironov, Alexander A.; Turacchio, Gabriele; Hsu, Victor W.; Sallese, Michele; Luini, Alberto			A traffic-activated Golgi-based signalling circuit coordinates the secretory pathway	NATURE CELL BIOLOGY			English	Article							LUMINAL ER PROTEINS; HUMAN KDEL RECEPTOR; SRC FAMILY KINASES; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; TYROSINE KINASE; MAMMALIAN-CELLS; PLASMA-MEMBRANE; COMPLEX; ENDOCYTOSIS	As with other complex cellular functions, intracellular membrane transport involves the coordinated engagement of a series of organelles and machineries; however, the molecular basis of this coordination is unknown. Here we describe a Golgi-based signalling system that is activated by traffic and is involved in monitoring and balancing trafficking rates into and out of the Golgi complex. We provide evidence that the traffic signal is due to protein chaperones that leave the endoplasmic reticulum and reach the Golgi complex where they bind to the KDEL receptor. This initiates a signalling reaction that includes the activation of a Golgi pool of Src kinases and a phosphorylation cascade that in turn activates intra-Golgi trafficking, thereby maintaining the dynamic equilibrium of the Golgi complex. The concepts emerging from this study should help to understand the control circuits that coordinate high-order cellular functions.	[Pulvirenti, Teodoro; Giannotta, Monica; Capestrano, Mariagrazia; Capitani, Mirco; Pisanu, Antonio; Polishchuk, Roman S.; Pietro, Enrica San; Beznoussenko, Galina V.; Mironov, Alexander A.; Turacchio, Gabriele; Sallese, Michele; Luini, Alberto] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Lab Membrane Traff, I-66030 Chieti, Italy; [Hsu, Victor W.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Luini, A (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Lab Membrane Traff, I-66030 Chieti, Italy.	sallese@negrisud.it; luini@negrisud.it	Pulvirenti, Teodoro/AAJ-7661-2020; Luini, Alberto/L-1372-2013; Sallese, Michele/J-5347-2016	Pulvirenti, Teodoro/0000-0001-9342-6614; Luini, Alberto/0000-0002-8729-2549; Sallese, Michele/0000-0002-2555-3571; Polishchuk, Roman/0000-0002-7698-1955	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Telethon [GGP04235] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon)		Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Austin CD, 1996, J CELL BIOL, V135, P1471, DOI 10.1083/jcb.135.6.1471; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bard F, 2002, EUR J CELL BIOL, V81, P26, DOI 10.1078/0171-9335-00217; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Cetkovic H, 2004, GENE, V342, P251, DOI 10.1016/j.gene.2004.07.044; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; DEMATTEIS MA, 1993, NATURE, V364, P818, DOI 10.1038/364818a0; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; GREEN H, 1965, P NATL ACAD SCI USA, V53, P1360, DOI 10.1073/pnas.53.6.1360; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Heinrich R, 2005, J CELL BIOL, V168, P271, DOI 10.1083/jcb.200409087; Hiyoshi M, 2008, BLOOD, V111, P243, DOI 10.1182/blood-2007-04-086017; HSU VW, 1992, CELL, V69, P625, DOI 10.1016/0092-8674(92)90226-3; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; KEUSCH GT, 1995, INFECT IMMUN, V63, P1138, DOI 10.1128/IAI.63.3.1138-1141.1995; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; Li M, 2008, MOL CELL BIOL, V28, P630, DOI 10.1128/MCB.00150-07; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; McGarrigle D., 2007, SCI STKE, V392, pp, DOI [10.1126/stke.3922007pe35, DOI 10.1126/STKE.3922007PE35]; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Mironov A, 1997, J CELL BIOL, V139, P1109, DOI 10.1083/jcb.139.5.1109; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PELHAM H R B, 1991, Current Opinion in Cell Biology, V3, P585, DOI 10.1016/0955-0674(91)90027-V; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sallese M, 2006, EMBO J, V25, P2663, DOI 10.1038/sj.emboj.7601172; Scheel AA, 1998, J BIOL CHEM, V273, P2467, DOI 10.1074/jbc.273.4.2467; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; SORKIN A, 2005, SCI STKE, pE1; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Webb RJ, 2005, AM J PHYSIOL-CELL PH, V289, pC748, DOI 10.1152/ajpcell.00019.2005; XIA ZP, 2005, SCI STKE, pE7; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200	60	145	146	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					912	922		10.1038/ncb1751	http://dx.doi.org/10.1038/ncb1751			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641641				2022-12-25	WOS:000258147100009
J	Hong, HS; Lee, J; Lee, E; Kwon, YS; Lee, E; Ahn, W; Jiang, MH; Kim, JC; Son, Y				Hong, Hyun Sook; Lee, Jungsun; Lee, EunAh; Kwon, Young Sam; Lee, Eunkyung; Ahn, Woosung; Jiang, Mei Hua; Kim, Jae Chan; Son, Youngsook			A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells	NATURE MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR RECEPTOR; BONE-MARROW STROMA; MYOCARDIAL-INFARCTION; PROTEIN-KINASE; WOUND REPAIR; DIFFERENTIATION; ACTIVATION; PROLIFERATION; EXPRESSION	Tissue injury may create a specific microenvironment for inducing the systemic participation of stromal-like cells in the repair process. Here we show that substance P is an injury-inducible factor that acts early in the wound healing process to induce CD29(+) stromal-like cell mobilization. Likewise, mobilization of such cells also occurs in uninjured mice, rats and rabbits if substance P is intravenously injected. Upon further characterization these substance P-mobilized CD29(+) cells were found to be similar to stromal cells from a number of connective tissues, including bone marrow (that is, bone marrow stromal cells, or BMSCs). Both substance P injection and transfusion of autologously derived substance P-mobilized CD29(+) cells from uninjured rabbits accelerated wound healing in an alkali burn model. Also, epithelial engraftment of the transfused cells into the injured tissue occurred during the wound healing. Finally, using human BMSCs as a test population, we show that substance P stimulates transmigration, cell proliferation, activation of the extracellular signal-related kinases (Erk) 1 and 2 and nuclear translocation of beta-catenin in vitro. This finding highlights a previously undescribed function of substance P as a systemically acting messenger of injury and a mobilizer of CD29(+) stromal-like cells to participate in wound healing.	[Kwon, Young Sam; Kim, Jae Chan] Chung Ang Univ, Coll Med, Dept Ophthalmol, Seoul 140757, South Korea; [Hong, Hyun Sook; Lee, EunAh; Lee, Eunkyung; Ahn, Woosung; Jiang, Mei Hua; Son, Youngsook] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 441706, South Korea; [Hong, Hyun Sook; Lee, EunAh; Lee, Eunkyung; Ahn, Woosung; Jiang, Mei Hua; Son, Youngsook] Kyung Hee Univ, Coll Life Sci, Dept Genet Engn, Yongin 441706, South Korea; [Hong, Hyun Sook; Lee, Jungsun] Seoul Natl Univ Technol, MCTT, Inst Res & Dev, Seoul 139743, South Korea	Chung Ang University; Chung Ang University Hospital; Kyung Hee University; Kyung Hee University	Kim, JC (corresponding author), Chung Ang Univ, Coll Med, Dept Ophthalmol, Hangangro 3,65-207, Seoul 140757, South Korea.	jck50ey@kornet.net; ysson@khu.ac.kr	Ahn, Woosung/GXG-2482-2022; HONG, HYUN SOOK/AAI-3017-2020	Ahn, Woosung/0000-0001-6933-4947; HONG, HYUN SOOK/0000-0003-3659-1386				Al-Sarraj A, 2002, NEUROSCI LETT, V332, P111, DOI 10.1016/S0304-3940(02)00939-4; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Castagliuolo I, 2000, J BIOL CHEM, V275, P26545, DOI 10.1074/jbc.M003990200; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; GALLAR J, 1990, INVEST OPHTH VIS SCI, V31, P1968; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Ho WZ, 1997, J IMMUNOL, V159, P5654; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Kidd BL, 2003, NEUROREPORT, V14, P2189, DOI 10.1097/00001756-200312020-00011; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Kuznetsov SA, 2007, STEM CELLS, V25, P1830, DOI 10.1634/stemcells.2007-0140; Lai XN, 1998, PEPTIDES, V19, P1209, DOI 10.1016/S0196-9781(98)00068-0; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lim Mira, 2003, Ocul Surf, V1, P53; LOTZ M, 1987, SCIENCE, V235, P893, DOI 10.1126/science.2433770; MILLER A, 1981, NEUROSCI LETT, V23, P243, DOI 10.1016/0304-3940(81)90005-7; Nakamura M, 2003, DIABETOLOGIA, V46, P839, DOI 10.1007/s00125-003-1105-9; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Opalenik SR, 2005, FASEB J, V19, P1561, DOI 10.1096/fj.04-2978fje; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; PAYAN DG, 1983, J IMMUNOL, V131, P1613; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; RAMESHWAR P, 1993, BLOOD, V81, P391; Rameshwar P, 2001, J NEUROIMMUNOL, V121, P22, DOI 10.1016/S0165-5728(01)00443-X; RAMESHWAR P, 1995, BLOOD, V86, P482, DOI 10.1182/blood.V86.2.482.bloodjournal862482; Rameshwar P, 2001, BLOOD, V97, P3025, DOI 10.1182/blood.V97.10.3025; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Watanabe M, 2002, JPN J OPHTHALMOL, V46, P616, DOI 10.1016/S0021-5155(02)00617-2; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yamada N, 2004, INVEST OPHTH VIS SCI, V45, P1125, DOI 10.1167/iovs.03-0626; Yang CM, 2002, CELL SIGNAL, V14, P913, DOI 10.1016/S0898-6568(02)00039-6; Ye J, 2004, EYE, V18, P839, DOI 10.1038/sj.eye.6701346; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zhong J, 2006, J CELL PHYSIOL, V207, P540, DOI 10.1002/jcp.20605	46	279	288	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					425	435		10.1038/nm.1909	http://dx.doi.org/10.1038/nm.1909			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19270709				2022-12-25	WOS:000264937200030
J	Maddika, S; Chen, JJ				Maddika, Subbareddy; Chen, Junjie			Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase	NATURE CELL BIOLOGY			English	Article							MICROTUBULE-SEVERING ACTIVITY; CUL4-DDB1 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE; C-ELEGANS; HYPERPLASTIC-DISCS; GLYCOGEN-SYNTHASE; FAMILY PROTEIN; S-PHASE; PHOSPHORYLATION	Protein kinases have central functions in various cellular signal transduction pathways through their substrate phosphorylation. Here we show that a protein kinase, DYRK2, has unexpected role as a scaffold for an E3 ubiquitin ligase complex. DYRK2 associates with an E3 ligase complex containing EDD, DDB1 and VPRBP proteins (EDVP complex). Strikingly, DYRK2 serves as a scaffold for the EDVP complex, because small-interfering-RNA-mediated depletion of DYRK2 disrupts the formation of the EDD DDB1-VPRBP complex. Although the kinase activity of DYRK2 is dispensable for its ability to mediate EDVP complex formation, it is required for the phosphorylation and subsequent degradation of its downstream substrate, katanin p60. Collectively, our results reveal a new type of E3-ubiquitin ligase complex in humans that depends on a protein kinase for complex formation as well as for the subsequent phosphorylation, ubiquitylation and degradation of their substrates.	[Maddika, Subbareddy; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	junjie.chen@yale.edu			National Institutes of Health; Department of Defense; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA113381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jamie Wood for critical reading of the manuscript and for providing valuable suggestions. We thank Amanda Russell for providing EDD expression vectors. This work was supported in part by grants from the National Institutes of Health (to J.C.). J.C. is a recipient of an Era of Hope Scholars award from the Department of Defense and is a member of Mayo Clinic Breast SPORE programme.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kinstrie R, 2006, BIOCHEM J, V398, P45, DOI 10.1042/BJ20060159; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lu CG, 2007, DEV BIOL, V302, P438, DOI 10.1016/j.ydbio.2006.09.053; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Miller CT, 2003, CANCER RES, V63, P4136; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985	33	132	138	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					409	U110		10.1038/ncb1848	http://dx.doi.org/10.1038/ncb1848			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19287380	Green Accepted			2022-12-25	WOS:000265264900011
J	Matsunaga, K; Saitoh, T; Tabata, K; Omori, H; Satoh, T; Kurotori, N; Maejima, I; Shirahama-Noda, K; Ichimura, T; Isobe, T; Akira, S; Noda, T; Yoshimori, T				Matsunaga, Kohichi; Saitoh, Tatsuya; Tabata, Keisuke; Omori, Hiroko; Satoh, Takashi; Kurotori, Naoki; Maejima, Ikuko; Shirahama-Noda, Kanae; Ichimura, Tohru; Isobe, Toshiaki; Akira, Shizuo; Noda, Takeshi; Yoshimori, Tamotsu			Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; SACCHAROMYCES-CEREVISIAE; TUMOR-SUPPRESSOR; CELL-DEATH; RETROGRADE TRANSPORT; NERVOUS-SYSTEM; MEMBRANE; YEAST; UVRAG; TUMORIGENESIS	Beclin 1, a protein essential for autophagy, binds to hVps34/Class III phosphatidylinositol-3-kinase and UVRAG. Here, we have identified two Beclin 1 associated proteins, Atg14L and Rubicon. Atg14L and UVRAG bind to Beclin 1 in a mutually exclusive manner, whereas Rubicon binds only to a subpopulation of UVRAG complexes; thus, three different Beclin 1 complexes exist. GFP- Atg14L localized to the isolation membrane and autophagosome, as well as to the ER and unknown puncta. Knockout of Atg14L in mouse ES cells caused a defect in autophagosome formation. GFP-Rubicon was localized at the endosome/lysosome. Knockdown of Rubicon caused enhancement of autophagy, especially at the maturation step, as well as enhancement of endocytic trafficking. These data suggest that the Beclin 1-hVps34 complex functions in two different steps of autophagy by altering the subunit composition.	[Matsunaga, Kohichi; Tabata, Keisuke; Omori, Hiroko; Kurotori, Naoki; Maejima, Ikuko; Shirahama-Noda, Kanae; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Matsunaga, Kohichi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4558540, Japan; [Saitoh, Tatsuya; Satoh, Takashi; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Satoh, Takashi; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; [Ichimura, Tohru; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Tokyo 1920397, Japan; [Yoshimori, Tamotsu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Graduate University for Advanced Studies - Japan; Osaka University; Osaka University; Tokyo Metropolitan University; Japan Science & Technology Agency (JST)	Yoshimori, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	tamyoshi@biken.osaka-u.ac.jp	Yoshimori, Tamotsu/K-9626-2014; Isobe, Toshiaki/Q-9279-2017; Noda, Takeshi/B-7240-2008; Akira, Shizuo/C-3134-2009	Yoshimori, Tamotsu/0000-0001-9787-3788; Noda, Takeshi/0000-0003-3581-7961; Tabata, Keisuke/0000-0001-6776-1689; MAEJIMA, Ikuko/0000-0002-0396-5890	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Beth Levine for Beclin 1 cDNA, Noboru Mizushima for anti-Atg16L antibody and Atg5 knockout mouse ES cells, Sumio Sugano and Yutaka Suzuki for UVRAG cDNA, Toshio Kitamura for PLAT-E cells and pMX-puro vector, Roger Y. Tesien for the plasmid encoding mStrawberry protein, Ryuichi Masaki for pEGFP-msALDH(35) vector, Yusuke Yamada for Beclin 1 deletion mutants cDNA construction, Asaya Nishi and Kunihiro Kawanishi for technical assistance. The work described in this report was supported in part by Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gniadek TJ, 2007, TRAFFIC, V8, P339, DOI 10.1111/j.1600-0854.2007.00538.x; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; James P, 1996, GENETICS, V144, P1425; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kikuno R, 2002, NUCLEIC ACIDS RES, V30, P166, DOI 10.1093/nar/30.1.166; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Masaki R, 2003, J BIOCHEM, V134, P415, DOI 10.1093/jb/mvg159; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	55	837	900	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					385	U69		10.1038/ncb1846	http://dx.doi.org/10.1038/ncb1846			39	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19270696				2022-12-25	WOS:000265264900009
J	Stamatoyannopoulos, JA; Adzhubei, I; Thurman, RE; Kryukov, GV; Mirkin, SM; Sunyaev, SR				Stamatoyannopoulos, John A.; Adzhubei, Ivan; Thurman, Robert E.; Kryukov, Gregory V.; Mirkin, Sergei M.; Sunyaev, Shamil R.			Human mutation rate associated with DNA replication timing	NATURE GENETICS			English	Article							HUMAN-CHROMOSOMES; GENOME; DISEASE; REGIONS	Eukaryotic DNA replication is highly stratified, with different genomic regions shown to replicate at characteristic times during S phase. Here we observe that mutation rate, as reflected in recent evolutionary divergence and human nucleotide diversity, is markedly increased in later-replicating regions of the human genome. All classes of substitutions are affected, suggesting a generalized mechanism involving replication time-dependent DNA damage. This correlation between mutation rate and regionally stratified replication timing may have substantial evolutionary implications.	[Stamatoyannopoulos, John A.; Thurman, Robert E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.; Thurman, Robert E.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Adzhubei, Ivan; Kryukov, Gregory V.; Sunyaev, Shamil R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Mirkin, Sergei M.] Tufts Univ, Dept Biol, Medford, MA 02155 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts University	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@u.washington.edu; ssunyaev@rics.bwh.harvard.edu	Mirkin, Sergei/AAR-7226-2020; Kryukov, Gregory V/A-9592-2008; Mirkin, Sergei/A-7310-2010	Mirkin, Sergei/0000-0003-4576-7582; Adzhubey, Ivan/0000-0002-1483-9259; Kryukov, Gregory/0000-0002-6131-9483	US National Institutes of Health [U54HG003042, R01GM071852];  [R01GM078598];  [R01MH084676];  [U54LM008748];  [R01GM60987]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003042, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060987, R01GM071923, R01GM071852, R01GM078598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank A. Kondrashov, M. Przeworski and J. Cameron for helpful discussions. This work was supported by US National Institutes of Health grants U54HG003042 and R01GM071852 to J.A.S.; R01GM078598, R01MH084676 and U54LM008748 to S. R. S. and R01GM60987 to S. M. M.	Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Tyekucheva S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r76; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	15	269	274	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					393	395		10.1038/ng.363	http://dx.doi.org/10.1038/ng.363			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287383	Green Accepted			2022-12-25	WOS:000264659000010
J	Yeh, JRJ; Munson, KM; Elagib, KE; Goldfarb, AN; Sweetser, DA; Peterson, RT				Yeh, Jing-Ruey J.; Munson, Kathleen M.; Elagib, Kamaleldin E.; Goldfarb, Adam N.; Sweetser, David A.; Peterson, Randall T.			Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation	NATURE CHEMICAL BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; GLYCOGEN-SYNTHASE KINASE-3; PROSTAGLANDIN E-2; VALPROIC ACID; INTESTINAL POLYPOSIS; PROGENITOR CELLS; GENE DISRUPTION; KNOCKOUT MICE; BETA-CATENIN; COLON-CANCER	It has been proposed that inhibitors of an oncogene's effects on multipotent hematopoietic progenitor cell differentiation may change the properties of the leukemic stem cells and complement the clinical use of cytotoxic drugs. Using zebrafish, we developed a robust in vivo hematopoietic differentiation assay that reflects the activity of the oncogene AML1-ETO. Screening for modifiers of AML1-ETO-mediated hematopoietic dysregulation uncovered unexpected roles of COX-2- and beta-catenin-dependent pathways in AML1-ETO function. This approach may open doors for developing therapeutics targeting oncogene function within leukemic stem cells.	[Yeh, Jing-Ruey J.; Munson, Kathleen M.; Peterson, Randall T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dev Biol Lab, Charlestown, MA 02129 USA; [Yeh, Jing-Ruey J.; Munson, Kathleen M.; Sweetser, David A.; Peterson, Randall T.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Yeh, Jing-Ruey J.; Munson, Kathleen M.; Peterson, Randall T.] MIT & Harvard, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Elagib, Kamaleldin E.; Goldfarb, Adam N.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Sweetser, David A.] Massachusetts Gen Hosp, Div Pediat Hematol Oncol, Dept Pediat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Virginia; Harvard University; Massachusetts General Hospital	Yeh, JRJ (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dev Biol Lab, 149 13th St, Charlestown, MA 02129 USA.	jyeh1@partners.org; peterson@cvrc.mgh.harvard.edu	Sweetser, David/ABB-9347-2021	Sweetser, David/0000-0002-1621-3284; Peterson, Randall/0000-0003-0727-3469; Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Munson, Kathleen/0000-0001-7158-9607	National Institute of Aging [AG031300]; National Cancer Institute [CA118498]; Mattina Proctor Foundation; Claflin Distinguished Scholar Award; NATIONAL CANCER INSTITUTE [R01CA118498, R01CA115772, R01CA140188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031300] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mattina Proctor Foundation; Claflin Distinguished Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. R. Plovie and M. N. Rivera (Massachusetts General Hospital) and H. Clevers (Hubrecht Institute) for providing reagents, and C. L. Tsai, C. Sachidanandan and the members of the Developmental Biology Laboratory for helpful discussion. J.- R.J.Y. is supported by a Career Development Award (AG031300) from the National Institute of Aging. The authors received financial support from the National Cancer Institute (CA118498 to R. T. P.), the Mattina Proctor Foundation (to D. A. S) and the Claflin Distinguished Scholar Award (to J.- R. J. Y.).	Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bug G, 2007, HAEMATOLOGICA, V92, P542, DOI 10.3324/haematol.10758; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Choi YJ, 2006, CANCER RES, V66, P2990, DOI 10.1158/0008-5472.CAN-05-2944; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Fenske TS, 2004, P NATL ACAD SCI USA, V101, P15184, DOI 10.1073/pnas.0400751101; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Gingerich JL, 2005, DEV BIOL, V286, P427, DOI 10.1016/j.ydbio.2005.07.031; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ishikawa T, 2007, BIOCHEM BIOPH RES CO, V352, P181, DOI 10.1016/j.bbrc.2006.11.007; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Liu SJ, 2007, J PHARMACOL EXP THER, V321, P953, DOI 10.1124/jpet.106.118406; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Nakamura H, 1997, LEUKEMIA, V11, P651, DOI 10.1038/sj.leu.2400618; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Patton EE, 2005, ZEBRAFISH, V1, P363, DOI 10.1089/zeb.2005.1.363; Redaelli A, 2004, CANCER TREAT REV, V30, P237, DOI 10.1016/j.ctrv.2003.11.002; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Terpstra W, 1996, BLOOD, V88, P1944, DOI 10.1182/blood.V88.6.1944.bloodjournal8861944; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; van de Water S, 2001, DEVELOPMENT, V128, P3877; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; YAMASAKI H, 1995, LEUKEMIA, V9, P1147; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	50	113	119	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2009	5	4					236	243		10.1038/nchembio.147	http://dx.doi.org/10.1038/nchembio.147			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	422KH	19172146	Green Accepted			2022-12-25	WOS:000264426100012
J	Gousset, K; Schiff, E; Langevin, C; Marijanovic, Z; Caputo, A; Browman, DT; Chenouard, N; de Chaumont, F; Martino, A; Enninga, J; Olivo-Marin, JC; Mannel, D; Zurzolo, C				Gousset, Karine; Schiff, Edwin; Langevin, Christelle; Marijanovic, Zrinka; Caputo, Anna; Browman, Duncan T.; Chenouard, Nicolas; de Chaumont, Fabrice; Martino, Angelo; Enninga, Jost; Olivo-Marin, Jean-Christophe; Maennel, Daniela; Zurzolo, Chiara			Prions hijack tunnelling nanotubes for intercellular spread	NATURE CELL BIOLOGY			English	Article							FOLLICULAR DENDRITIC CELLS; MEMBRANE NANOTUBES; IMMUNE CELLS; PEYERS-PATCHES; NEURONAL CELLS; IMAGINAL DISCS; CUTTING EDGE; T-CELLS; IN-VIVO; SCRAPIE	In variant Creutzfeldt-Jakob disease, prions (PrPSc) enter the body with contaminated foodstuffs and can spread from the intestinal entry site to the central nervous system (CNS) by intercellular transfer from the lymphoid system to the peripheral nervous system (PNS)(1). Although several means(2-4) and different cell types(5-7) have been proposed to have a role, the mechanism of cell-to-cell spreading remains elusive. Tunnelling nanotubes (TNTs) have been identified between cells(8-12), both in vitro and in vivo(10,11,13), and may represent a conserved means of cell-to-cell communication(14-16). Here we show that TNTs allow transfer of exogenous and endogenous PrPSc between infected and naive neuronal CAD cells(17). Significantly, transfer of endogenous PrPSc aggregates was detected exclusively when cells chronically infected with the 139A mouse prion strain were connected to mouse CAD cells by means of TNTs, identifying TNTs as an efficient route for PrPSc spreading in neuronal cells. In addition, we detected the transfer of labelled PrPSc from bone marrow-derived dendritic cells to primary neurons connected through TNTs. Because dendritic cells can interact with peripheral neurons in lymphoid organs, TNT-mediated intercellular transfer would allow neurons to transport prions retrogradely to the CNS1. We therefore propose that TNTs are involved in the spreading of PrPSc within neurons in the CNS and from the peripheral site of entry to the PNS by neuroimmune interactions with dendritic cells.	[Gousset, Karine; Schiff, Edwin; Langevin, Christelle; Marijanovic, Zrinka; Caputo, Anna; Browman, Duncan T.; Zurzolo, Chiara] Inst Pasteur, Unite Traf Membranaire & Pathogenese, F-75724 Paris 15, France; [Schiff, Edwin; Maennel, Daniela] Univ Regensburg, Dept Immunol, D-93042 Regensburg, Germany; [Caputo, Anna; Zurzolo, Chiara] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Chenouard, Nicolas; de Chaumont, Fabrice; Olivo-Marin, Jean-Christophe] Inst Pasteur, Unite Anal Images Quantitat, F-75724 Paris 15, France; [Martino, Angelo] Inst Pasteur, Unite Rech Genet Mycobacterienne, F-75724 Paris 15, France; [Enninga, Jost] Inst Pasteur, Grp Dynam Interact Hote Pathogene, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Regensburg; University of Naples Federico II; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zurzolo, C (corresponding author), Inst Pasteur, Unite Traf Membranaire & Pathogenese, 25 Rue Dr Roux, F-75724 Paris 15, France.	zurzolo@unina.it	Gousset, Karine/ADS-3249-2022; Zurzolo, Chiara/AAH-5225-2019; Olivo-Marin, Jean-Christophe/K-4428-2015	Gousset, Karine/0000-0002-0988-2332; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; ZURZOLO, Chiara/0000-0001-6048-6602; Langevin, Christelle/0000-0002-6013-4460; de Chaumont, Fabrice/0000-0001-7613-7204	Pasteur Foundation Fellowship Program; Bavarian Research Foundation; Fondation Canadienne Louis Pasteur; Ile-de-France; European Union [023183]; Telethon [GGP0414]	Pasteur Foundation Fellowship Program; Bavarian Research Foundation; Fondation Canadienne Louis Pasteur; Ile-de-France; European Union(European Commission); Telethon(Fondazione Telethon)	We thank P. Lazarow, G. Guizzunti and C. Bowler for critical reading of the manuscript. We thank S. Blanchard and D. Bohl- Delfaud for their help in preparing the GFP - PrPwt- retroviral vector, and P. Casanova and J. Vinatier for technical help. We thank H. Laude, A. F. Hill, P. Cossart and M. Way for their gifts ( cells, constructs and reagents). We are grateful for assistance with microscopes and image processing received from the Plate-Forme Imagerie Dynamique at the Pasteur Institut. K. G. is supported by the Pasteur Foundation Fellowship Program, E. S. received a fellowship (2004-07) from the Bavarian Research Foundation (BFS), D. B. received funding from the Fondation Canadienne Louis Pasteur, and Z. M. received funding from Ile-de-France. This work was supported by grants to C. Z. from the European Union ( Strainbarrier (FP6 Contract No 023183 ( Food)) and from Telethon GGP0414.	Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Brejot T, 2006, EXP NEUROL, V198, P167, DOI 10.1016/j.expneurol.2005.11.026; CHENOUARD N, 2008, IAPR INT C PATT REC, P8; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Defaweux V, 2005, MICROSC RES TECHNIQ, V66, P1, DOI 10.1002/jemt.20135; Demontis F, 2007, DEV DYNAM, V236, P3408, DOI 10.1002/dvdy.21324; Dorban G, 2007, HISTOCHEM CELL BIOL, V128, P243, DOI 10.1007/s00418-007-0303-9; DUFOUR A, 2008, P 42 AS C S IN PRESS; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Lambrecht BN, 2001, RESP RES, V2, P133, DOI 10.1186/rr49; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Marim MD, 2008, I S BIOMED IMAGING, P1003, DOI 10.1109/ISBI.2008.4541168; McBride PA, 1999, NEUROSCI LETT, V265, P135, DOI 10.1016/S0304-3940(99)00223-2; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Qi YP, 1997, J NEUROSCI, V17, P1217; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zhang B, 2007, APPL OPTICS, V46, P1819, DOI 10.1364/AO.46.001819	44	451	459	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					328	U232		10.1038/ncb1841	http://dx.doi.org/10.1038/ncb1841			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198598				2022-12-25	WOS:000263777900017
J	Medjkane, S; Perez-Sanchez, C; Gaggioli, C; Sahai, E; Treisman, R				Medjkane, Souhila; Perez-Sanchez, Cristina; Gaggioli, Cedric; Sahai, Erik; Treisman, Richard			Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis	NATURE CELL BIOLOGY			English	Article							SERUM RESPONSE FACTOR; BREAST-CANCER CELLS; GROWTH-FACTOR-RECEPTOR; NONMUSCLE MYOSIN-II; IN-VIVO; STROMAL FIBROBLASTS; ACTIN CYTOSKELETON; CARCINOMA-CELLS; MIGRATION; INVASION	Rho GTPases control cytoskeletal dynamics through cytoplasmic effectors and regulate transcriptional activation through myocardin-related transcription factors (MRTFs), which are co-activators for serum response factor (SRF). We used RNA interference to investigate the contribution of the MRTF-SRF pathway to cytoskeletal dynamics in MDA-MB-231 breast carcinoma and B16F2 melanoma cells, in which basal MRTF-SRF activity is Rho- dependent. Depletion of MRTFs or SRF reduced cell adhesion, spreading, invasion and motility in culture, without affecting proliferation or inducing apoptosis. MRTF-depleted tumour cell xenografts showed reduced cell motility but proliferated normally. Tumour cells depleted of MRTF or SRF failed to colonize the lung from the bloodstream, being unable to persist after their arrival in the lung. Only a few genes show MRTF-dependent expression in both cell lines. Two of these, MYH9 (NMHCIIa) and MYL9 (MLC2), are also required for invasion and lung colonization. Conversely, expression of activated MAL/MRTF-A increases lung colonization by poorly metastatic B16F0 cells. Actin-based cell behaviour and experimental metastasis thus require Rho-dependent nuclear signalling through the MRTF-SRF network.	[Medjkane, Souhila; Perez-Sanchez, Cristina; Treisman, Richard] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Transcript Lab, London WC2A 3PX, England; [Gaggioli, Cedric; Sahai, Erik] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Tumor Biol Lab, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Treisman, R (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Transcript Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Richard.Treisman@cancer.org.uk	Gaggioli, Cedric/F-3658-2011; gaggioli, cedric/L-5363-2019; Gaggioli, Cedric/Q-2642-2019	Gaggioli, Cedric/0000-0002-4710-1605; Gaggioli, Cedric/0000-0002-4710-1605; Medjkane, Souhila/0000-0001-7973-7707; Treisman, Richard/0000-0002-9658-0067; Sahai, Erik/0000-0002-3932-5086	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bouzahzah B, 2001, MOL MED, V7, P816, DOI 10.1007/BF03401974; Caceres M, 2005, EXP CELL RES, V309, P229, DOI 10.1016/j.yexcr.2005.05.020; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Dua P, 2008, EUR J CANCER, V44, P1587, DOI 10.1016/j.ejca.2008.04.009; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; GUETTLER S, 2007, MOL CELL BIOL; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kusama T, 2006, INT J ONCOL, V29, P217; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakajima M, 2003, CANCER CHEMOTH PHARM, V52, P319, DOI 10.1007/s00280-003-0641-9; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100	50	315	324	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					257	U85		10.1038/ncb1833	http://dx.doi.org/10.1038/ncb1833			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198601	Green Accepted			2022-12-25	WOS:000263777900009
J	Wang, Y; Roche, O; Yan, MS; Finak, G; Evans, AJ; Metcalf, JL; Hast, BE; Hanna, SC; Wondergem, B; Furge, KA; Irwin, MS; Kim, WY; Teh, BT; Grinstein, S; Park, M; Marsden, PA; Ohh, M				Wang, Yi; Roche, Olga; Yan, Mathew S.; Finak, Greg; Evans, Andrew J.; Metcalf, Julie L.; Hast, Bridgid E.; Hanna, Sara C.; Wondergem, Bill; Furge, Kyle A.; Irwin, Meredith S.; Kim, William Y.; Teh, Bin T.; Grinstein, Sergio; Park, Morag; Marsden, Philip A.; Ohh, Michael			Regulation of endocytosis via the oxygen-sensing pathway	NATURE MEDICINE			English	Article							VON-HIPPEL-LINDAU; HYPOXIA-INDUCIBLE FACTOR; SMALL GTPASE RAB5; MEMBRANE-FUSION; PROTEIN; RABAPTIN-5; EFFECTOR; BINDING; GROWTH; CANCER	Tumor hypoxia is associated with disease progression, resistance to conventional cancer therapies and poor prognosis(1,2). Hypoxia, by largely unknown mechanisms, leads to deregulated accumulation of and signaling via receptor tyrosine kinases (RTKs) that are critical for driving oncogenesis. Here, we show that hypoxia or loss of von Hippel-Lindau protein-the principal negative regulator of hypoxia-inducible factor (HIF)(3)-prolongs the activation of epidermal growth factor receptor that is attributable to lengthened receptor half-life and retention in the endocytic pathway. The deceleration in endocytosis is due to the attenuation of Rab5-mediated early endosome fusion via HIF-dependent downregulation of a critical Rab5 effector, rabaptin-5, at the level of transcription. Primary kidney and breast tumors with strong hypoxic signatures show significantly lower expression of rabaptin-5 RNA and protein. These findings reveal a general role of the oxygen-sensing pathway in endocytosis and support a model in which tumor hypoxia or oncogenic activation of HIF prolongs RTK-mediated signaling by delaying endocytosis-mediated deactivation of receptors.	[Wang, Yi; Evans, Andrew J.; Metcalf, Julie L.; Irwin, Meredith S.; Marsden, Philip A.; Ohh, Michael] Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Yan, Mathew S.; Marsden, Philip A.] Univ Toronto, St Michaels Hosp, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Yan, Mathew S.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5S 1A8, Canada; [Finak, Greg; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Evans, Andrew J.] Princess Margaret Hosp, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2M9, Canada; [Hast, Bridgid E.; Hanna, Sara C.; Kim, William Y.] Univ N Carolina, Dept Haematol Oncol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wondergem, Bill; Furge, Kyle A.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Irwin, Meredith S.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Grinstein, Sergio] Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada; [Grinstein, Sergio] Hosp Sick Children, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Grinstein, Sergio] Univ Toronto, Toronto, ON M5G 1X8, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of North Carolina; University of North Carolina Chapel Hill; Van Andel Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; McGill University	Ohh, M (corresponding author), Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.ohh@utoronto.ca	Roche, Olga/K-9342-2014; Marsden, Philip A/B-1441-2012; Roche, UCLM/F-5697-2019	Roche, UCLM/0000-0003-1884-8256; Teh, Bin Tean/0000-0003-1514-1124; Finak, Greg/0000-0003-4341-9090	Canadian Institutes of Health Research [MOP77718, MOP37778]; CIHR; Canada Research Chairs	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR MOP77718 to M.O., MOP37778 to P.A.M. and CIHR team grant to M. P.). Y.W. and O.R. are recipients of CIHR postdoctoral fellowships. M.S.I. and M.O. are Canada Research Chairs.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Koeman JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000176; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, GENE CHROMOSOME CANC, V34, P58, DOI 10.1002/gcc.10054; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Korobko EV, 2006, CELL CYCLE, V5, P1854, DOI 10.4161/cc.5.16.3092; Lippe R, 2001, METHOD ENZYMOL, V329, P132; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE145, DOI 10.1038/14097; Roberts AM, 2008, CURR OPIN ONCOL, V20, P83, DOI 10.1097/CCO.0b013e3282f310de; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Walmsley SR, 2006, BLOOD, V108, P3176, DOI 10.1182/blood-2006-04-018796; Woodman PG, 2000, TRAFFIC, V1, P695, DOI 10.1034/j.1600-0854.2000.010902.x; Zhong H, 1999, CANCER RES, V59, P5830	36	150	151	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					319	324		10.1038/nm.1922	http://dx.doi.org/10.1038/nm.1922			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19252501				2022-12-25	WOS:000263914000033
J	Yuan, JP; Zeng, WZ; Dorwart, MR; Choi, YJ; Worley, PF; Muallem, S				Yuan, Joseph P.; Zeng, Weizhong; Dorwart, Michael R.; Choi, Young-Jin; Worley, Paul F.; Muallem, Shmuel			SOAR and the polybasic STIM1 domains gate and regulate Orai channels	NATURE CELL BIOLOGY			English	Article							STORE-OPERATED CHANNELS; TRPC CHANNELS; CIRCULAR-DICHROISM; PLASMA-MEMBRANE; CA2+ INFLUX; CRAC; PROTEINS; STOICHIOMETRY; CONFORMATION; ACTIVATION	Influx of Ca2+ through store-operated Ca2+ channels (SOCs) is a central component of receptor-evoked Ca2+ signals(1). Orai channels are SOCs2-4 that are gated by STIM1, a Ca2+ sensor located in the ER5,6 but how it gates and regulates the Orai channels is unknown. Here, we report the molecular basis for gating of Orais by STIM1. All Orai channels are fully activated by the conserved STIM1 amino acid fragment 344-442, which we termed SOAR ( the STIM1 Orai activating region). SOAR acts in combination with STIM1 (450-485) to regulate the strength of interaction with Orai1. Activation of Orai1 by SOAR recapitulates all the kinetic properties of Orai1 activation by STIM1. However, mutations of STIM1 within SOAR prevent activation of Orai1 but not co-clustering of STIM1 and Orai1 in response to Ca2+ store depletion, indicating that STIM1-Orai1 co-clustering is not sufficient for Orai1 activation. An intact carboxy terminus alpha-helicial region of Orai is required for activation by SOAR. Deleting most of the Orai1 amino terminus impaired Orai1 activation by STIM1, but Orai(Delta 1-73) interacted with and was fully activated by SOAR. Accordingly, the characteristic inward rectification of Orai is mediated by an interaction between the polybasic STIM1 (672-685) and a Pro-rich region in the N terminus of Orai1. Hence, the essential properties of Orai1 function can be rationalized by interactions with discrete regions of STIM1.	[Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci & Neurol, Baltimore, MD 21205 USA; [Yuan, Joseph P.; Zeng, Weizhong; Dorwart, Michael R.; Choi, Young-Jin; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci & Neurol, Baltimore, MD 21205 USA.	pworley@jhmi.edu; Shmuel.muallem@utsouthwestern.edu			National Institutes of Health [DE12309, DK38938]; Ruth S. Harrell Professorship in Medical Research; National Institute on Drug Abuse [DA00266, DA10309]; National Institute of Mental Health [MH068830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013902, R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309, R37DA010309, P50DA000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth S. Harrell Professorship in Medical Research; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by a grant from the National Institutes of Health Grants DE12309 and DK38938 and the Ruth S. Harrell Professorship in Medical Research ( S. M.), and by the National Institute on Drug Abuse (NIDA; DA00266, DA10309) and the National Institute of Mental Health (NIMH; MH068830; P. F. W.).	CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	27	508	518	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					337	U246		10.1038/ncb1842	http://dx.doi.org/10.1038/ncb1842			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182790	Green Accepted			2022-12-25	WOS:000263777900018
J	Jaworski, K; Ahmadian, M; Duncan, RE; Sarkadi-Nagy, E; Varady, KA; Hellerstein, MK; Lee, HY; Samuel, VT; Shulman, GI; Kim, KH; de Val, S; Kang, C; Sul, HS				Jaworski, Kathy; Ahmadian, Maryam; Duncan, Robin E.; Sarkadi-Nagy, Eszter; Varady, Krista A.; Hellerstein, Marc K.; Lee, Hui-Young; Samuel, Varman T.; Shulman, Gerald I.; Kim, Kee-Hong; de Val, Sarah; Kang, Chulho; Sul, Hei Sook			AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency	NATURE MEDICINE			English	Article							INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; ARACHIDONIC-ACID; TRANSGENIC MICE; LIPID-METABOLISM; PROTEIN-KINASE; PPAR-GAMMA; EXPRESSION; RECEPTOR; CELLS	A main function of white adipose tissue is to release fatty acids from stored triacylglycerol for other tissues to use as an energy source. Whereas endocrine regulation of lipolysis has been extensively studied, autocrine and paracrine regulation is not well understood. Here we describe the role of the newly identified major adipocyte phospholipase A(2), AdPLA (encoded by Pla2g16, also called HREV107), in the regulation of lipolysis and adiposity. AdPLA-null mice have a markedly higher rate of lipolysis owing to increased cyclic AMP levels arising from the marked reduction in the amount of adipose prostaglandin E-2 that binds the Gai-coupled receptor, EP3. AdPLA-null mice have markedly reduced adipose tissue mass and triglyceride content but normal adipogenesis. They also have higher energy expenditure with increased fatty acid oxidation within adipocytes. AdPLA-deficient ob/ob mice remain hyperphagic but lean, with increased energy expenditure, yet have ectopic triglyceride storage and insulin resistance. AdPLA is a major regulator of adipocyte lipolysis and is crucial for the development of obesity.	[Jaworski, Kathy; Ahmadian, Maryam; Duncan, Robin E.; Sarkadi-Nagy, Eszter; Varady, Krista A.; Hellerstein, Marc K.; de Val, Sarah; Sul, Hei Sook] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Lee, Hui-Young; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Kim, Kee-Hong; Kang, Chulho] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Yale University; University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 220 Morgan Hall, Berkeley, CA 94720 USA.	hsul@nature.berkeley.edu	Shulman, Gerald I./P-7176-2019; Duncan, Robin/AAH-7465-2021; Han, Zaiqi/AAI-2233-2019	Shulman, Gerald I./0000-0003-1529-5668; Lee, Hui-Young/0000-0002-3464-6382; Jaworski, Kathy/0000-0001-6014-5066	US National Institutes of Health [DK75682]; Natural Sciences and Engineering Research Council of Canada [DK59635]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075682, U2CDK059635, R01DK040936, T32DK061918, U24DK059635, R01DK093928] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by DK75682 from the US National Institutes of Health to H. S. S. and DK59635 to G. I. S. R. E. D. and K. A. V. are recipients of postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada. R. E. D. is a recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research. The authors would like to thank O. Barauskas for technical help; D. Frasson for fatty acid oxidation measurement; Y. Wang for performing WR1339 injections; J. Lu, J. Chen, R. Mantara and N. Nag for assistance with animal maintenance; A. Birkenfled and D. Frederick for assistance with clamping studies; C. Lange and J. Chithalen for assistance with graphics; and Merck Frosst Canada for the kind gift of L826266.	Aubert J, 2000, MOL CELL ENDOCRINOL, V160, P149, DOI 10.1016/S0303-7207(99)00210-5; Bansode RR, 2008, J BIOL CHEM, V283, P231, DOI 10.1074/jbc.M707268200; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; COHENLURIA R, 1992, CELL SIGNAL, V4, P331, DOI 10.1016/0898-6568(92)90073-H; Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fain JN, 2000, J LIPID RES, V41, P1689; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; Girouard H, 1998, PROSTAG OTH LIPID M, V56, P43, DOI 10.1016/S0090-6980(98)00035-5; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Johansson SM, 2007, ACTA PHYSIOL, V190, P87, DOI 10.1111/j.1365-201X.2007.01692.x; KATHER H, 1979, J CLIN INVEST, V64, P609, DOI 10.1172/JCI109500; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Lucas S, 2003, J LIPID RES, V44, P154, DOI 10.1194/jlr.M200250-JLR200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; RICHELSEN B, 1992, PROSTAG LEUKOTR ESS, V47, P171, DOI 10.1016/0952-3278(92)90235-B; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; SCHALOSKE RH, 2006, BIOCH BIOPHYS ACTA; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; VANCE DE, 2008, BIOCH LIPIDS LIPOPRO, P277; VASSAUX G, 1992, J BIOL CHEM, V267, P11092; Viswanadha S, 2006, J LIPID RES, V47, P1859, DOI 10.1194/jlr.D600005-JLR200; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103	45	186	194	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					159	168		10.1038/nm.1904	http://dx.doi.org/10.1038/nm.1904			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19136964	Green Accepted			2022-12-25	WOS:000263119400018
J	Kobayashi, K; Luo, M; Zhang, Y; Wilkes, DC; Ge, GX; Grieskamp, T; Yamada, C; Liu, TC; Huang, G; Basson, CT; Kispert, A; Greenspan, DS; Sato, TN				Kobayashi, Koichi; Luo, Min; Zhang, Yue; Wilkes, David C.; Ge, Gaoxiang; Grieskamp, Thomas; Yamada, Chikaomi; Liu, Ting-Chun; Huang, Guorui; Basson, Craig T.; Kispert, Andreas; Greenspan, Daniel S.; Sato, Thomas N.			Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction	NATURE CELL BIOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN-1; XENOPUS EMBRYOS; WNT ANTAGONIST; TISSUE; GROWTH; CELLS; MICE; METALLOPROTEINASES; INHIBITORS; EXPRESSION	Secreted Frizzled-related proteins (sFRPs) have emerged as key regulators of a wide range of developmental and disease processes. Most of the known functions of mammalian sFRPs have been attributed to their ability to antagonize Wnt signalling. Recently however, Xenopus laevis and zebrafish sFRP, Sizzled, was shown to function as an antagonist of Chordin processing by Tolloid-like metalloproteinases. This has led to the proposal that sFRPs may function as evolutionarily conserved antagonists of chordinase activities of this class of proteinases. In contrast to this proposal, we show here that the mammalian sFRP, sFRP2, does not affect Chordin processing, but instead, can serve as a direct enhancer of procollagen C proteinase activity of Tolloid-like metalloproteinases. We also show that the level of fibrosis, in which procollagen processing by Tolloid-like proteinases has a rate-limiting role, is markedly reduced in Sfrp2-null mice subjected to myocardial infarction. Importantly, this reduced level of fibrosis is accompanied by significantly improved cardiac function. This study thus uncovers a function for sFRP2 and a potential therapeutic application for sFRP2 antagonism in controlling fibrosis in the infarcted heart.	[Zhang, Yue; Greenspan, Daniel S.] Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA; [Ge, Gaoxiang; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Ge, Gaoxiang; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Kobayashi, Koichi; Luo, Min; Wilkes, David C.; Yamada, Chikaomi; Liu, Ting-Chun; Basson, Craig T.; Sato, Thomas N.] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Wilkes, David C.; Basson, Craig T.] Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, New York, NY USA; [Wilkes, David C.; Basson, Craig T.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA; [Grieskamp, Thomas; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Cornell University; Cornell University; Cornell University; Hannover Medical School	Greenspan, DS (corresponding author), Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA.	dsgreens@wisc.edu; island1005@aol.com	Huang, Guorui/M-9641-2013; Kobayashi, Koichi/M-4911-2014	Greenspan, Daniel/0000-0001-8096-7446	German Research Foundation (DFG); European Union FP6 [LSHM-CT-2005-018630]; Snart Cardiovascular Fund; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071679] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union FP6(European Commission); Snart Cardiovascular Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Kuangfu Hsiao, Patricia Cobo and Guy Hoffman for technical assistance, and Tony Brown (Cornell) for providing information regarding qPCR primers for Wnt genes. K. K. and M. L. would like to acknowledge Rosemary Kraemer's teaching of technical procedures for the mouse myocardial infarction model. Work in the laboratory of A. K. is supported by funding from the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (from Regenerative Biology of Reconstructive Therapy), and by the European Union FP6 contract 'Heart Repair' (LSHM-CT-2005-018630). C. T. B. is an Established Investigator of the American Heart Association and is supported by the Snart Cardiovascular Fund. This work was supported in part by grants from the NIH (C.T.B,D.S.G,T.N.S).	Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; BERG RA, 1982, METHOD ENZYMOL, V82, P372; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dufourcq P, 2002, CIRCULATION, V106, P3097, DOI 10.1161/01.CIR.0000039342.85015.5C; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Garrigue-Antar L, 2004, J BIOL CHEM, V279, P49835, DOI 10.1074/jbc.M408134200; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Jugdutt Bodh I., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P1, DOI 10.2174/1568006033337276; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Lee CS, 2000, DEVELOPMENT, V127, P109; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; Mayr T, 1997, MECH DEVELOP, V63, P109, DOI 10.1016/S0925-4773(97)00035-X; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Salic AN, 1997, DEVELOPMENT, V124, P4739; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	53	179	187	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					46	U90		10.1038/ncb1811	http://dx.doi.org/10.1038/ncb1811			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079247	Green Accepted			2022-12-25	WOS:000262157000010
J	Miller, AL; Bement, WM				Miller, Ann L.; Bement, William M.			Regulation of cytokinesis by Rho GTPase flux	NATURE CELL BIOLOGY			English	Article							ACTIVATING-PROTEIN; CONTRACTILE RING; MITOTIC SPINDLE; AURORA-B; ACTIN-FILAMENTS; MGCRACGAP; COMPLEX; CDC42; PHOSPHORYLATION; MICROTUBULES	In animal cells, cytokinesis is powered by a contractile ring of actin filaments (F-actin) and myosin-2. Formation of the contractile ring is dependent on the small GTPase RhoA(1,2), which is activated in a precise zone at the cell equator(3). It has long been assumed that cytokinesis and other Rho-dependent processes are controlled in a sequential manner, whereby Rho activation by guanine nucleotide exchange factors (GEFs) initiates a particular event, and Rho inactivation by GTPase activating proteins (GAPs) terminates that event. MgcRacGAP is a conserved cytokinesis regulator thought to be required only at the end of cytokinesis(4,5). Here we show that GAP activity of MgcRacGAP is necessary early during cytokinesis for the formation and maintenance of the Rho activity zone. Disruption of GAP activity by point mutation results in poorly focused Rho activity zones, whereas complete removal of the GAP domain results in unfocused zones that show lateral instability and/or rapid side-to-side oscillations. We propose that the GAP domain of MgcRacGAP has two unexpected roles throughout cytokinesis: first, it transiently anchors active Rho, and second, it promotes local Rho inactivation, resulting in the constant flux of Rho through the GTPase cycle.	[Miller, Ann L.; Bement, William M.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Bement, William M.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miller, AL (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	almiller1@wisc.edu	Bement, William/AAA-5444-2021	Miller, Ann/0000-0002-7293-764X	American Cancer Society; Helen Hay Whitney Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052932] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank George von Dassow and Julie Canman for helpful discussions; Chloe Bulinski for the EMTB-3xGFP construct; Todd Stukenberg, Johne Liu and Aaron Straight for providing antibodies; John Wallingford and Esther Kieserman for advice on the midzone staining procedure; and members of the Bement Lab for advice and critical reading of the manuscript. A. L. M. is supported by postdoctoral fellowships from the American Cancer Society and the Helen Hay Whitney Foundation. W. M. B. is supported by an NIH grant.	Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; Danilchik MV, 2008, DEV DYNAM, V237, P565, DOI 10.1002/dvdy.21442; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Faire K, 1999, J CELL SCI, V112, P4243; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kieserman EK, 2008, CURR BIOL, V18, P116, DOI 10.1016/j.cub.2007.12.028; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Lee JS, 2004, EXP CELL RES, V293, P275, DOI 10.1016/j.yexcr.2003.10.015; Leonard DA, 1998, J BIOL CHEM, V273, P16210, DOI 10.1074/jbc.273.26.16210; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Toure A, 2008, FEBS LETT, V582, P1182, DOI 10.1016/j.febslet.2007.12.036; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	33	182	183	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					71	U137		10.1038/ncb1814	http://dx.doi.org/10.1038/ncb1814			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060892	Green Accepted			2022-12-25	WOS:000262157000013
J	Pannicke, U; Honig, M; Hess, I; Friesen, C; Holzmann, K; Rump, EM; Barth, TF; Rojewski, MT; Schulz, A; Boehm, T; Friedrich, W; Schwarz, K				Pannicke, Ulrich; Hoenig, Manfred; Hess, Isabell; Friesen, Claudia; Holzmann, Karlheinz; Rump, Eva-Maria; Barth, Thomas F.; Rojewski, Markus T.; Schulz, Ansgar; Boehm, Thomas; Friedrich, Wilhelm; Schwarz, Klaus			Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2	NATURE GENETICS			English	Article							CONGENITAL ALEUKOCYTOSIS; THYMIC ALYMPHOPLASIA; CELLS; IMMUNODEFICIENCY; ZEBRAFISH; DISEASES	Human severe combined immunodeficiencies (SCID) are phenotypically and genotypically heterogeneous diseases(1). Reticular dysgenesis is the most severe form of inborn SCID. It is characterized by absence of granulocytes and almost complete deficiency of lymphocytes in peripheral blood, hypoplasia of the thymus and secondary lymphoid organs, and lack of innate and adaptive humoral and cellular immune functions, leading to fatal septicemia within days after birth(2-8). In bone marrow of individuals with reticular dysgenesis, myeloid differentiation is blocked at the promyelocytic stage, whereas erythro- and megakaryocytic maturation is generally normal. These features exclude a defect in hematopoietic stem cells but point to a unique aberration of the myelo-lymphoid lineages. The dramatic clinical course of reticular dysgenesis and its unique hematological phenotype have spurred interest in the unknown genetic basis of this syndrome. Here we show that the gene encoding the mitochondrial energy metabolism enzyme adenylate kinase 2 (AK2) is mutated in individuals with reticular dysgenesis. Knockdown of zebrafish ak2 also leads to aberrant leukocyte development, stressing the evolutionarily conserved role of AK2. Our results provide in vivo evidence for AK2 selectivity in leukocyte differentiation. These observations suggest that reticular dysgenesis is the first example of a human immunodeficiency syndrome that is causally linked to energy metabolism and that can therefore be classified as a mitochondriopathy.	[Pannicke, Ulrich; Hoenig, Manfred; Rojewski, Markus T.; Schwarz, Klaus] Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany; [Hoenig, Manfred; Schulz, Ansgar; Friedrich, Wilhelm] Univ Childrens Hosp Ulm, D-89075 Ulm, Germany; [Hess, Isabell; Boehm, Thomas] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Friesen, Claudia] Univ Hosp, Inst Legal Med, D-89075 Ulm, Germany; [Holzmann, Karlheinz] Univ Hosp Ulm, Chip Facil ZKF, D-89069 Ulm, Germany; [Rump, Eva-Maria; Rojewski, Markus T.; Schwarz, Klaus] German Red Cross Blood Serv Baden Wuerttemberg He, Inst Clin Transfus Med & Immunogenet Ulm, D-89081 Ulm, Germany; [Barth, Thomas F.] Univ Hosp Ulm, Inst Pathol, D-89081 Ulm, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Ulm University; Ulm University	Schwarz, K (corresponding author), Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany.	klaus.schwarz@uni-ulm.de	Pannicke, Ulrich/D-7348-2014	Rojewski, Markus/0000-0003-4265-0442	Deutsche Forschungsgemeinschaft [SFB620]; Max-Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society)	We acknowledge the technical assistance of S. Braun, I. Janz, K. Heinrich, T. Kersten and S. Radecke. We are grateful to M. Schorpp for helpful advice. These studies were supported by the German Red Cross Blood Service Baden-Wuerttemberg-Hessen to K. S., the Deutsche Forschungsgemeinschaft (SFB620) and the Max-Planck Society to T. B.	ALONSO K, 1972, ARCH PATHOL, V94, P179; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; DEVAAL OM, 1959, LANCET, V2, P1123; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Emile JF, 1997, J PATHOL, V183, P70; ESPANOL T, 1979, CLIN EXP IMMUNOL, V38, P615; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Geha RS, 2007, J ALLERGY CLIN IMMUN, V120, P776, DOI 10.1016/j.jaci.2007.08.053; GITLIN D, 1964, PEDIATRICS, V33, P184; HAAS RJ, 1977, ACTA PAEDIATR SCAND, V66, P279, DOI 10.1111/j.1651-2227.1977.tb07894.x; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Muller A, 2007, BIOINFORMATICS, V23, P496, DOI 10.1093/bioinformatics/btl608; OWNBY DR, 1976, J PEDIATR-US, V89, P382, DOI 10.1016/S0022-3476(76)80532-X; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Schlauderer GJ, 1996, J MOL BIOL, V256, P223, DOI 10.1006/jmbi.1996.0080; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Small TN, 1999, J PEDIATR-US, V135, P387, DOI 10.1016/S0022-3476(99)70141-1; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393	20	137	143	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					101	105		10.1038/ng.265	http://dx.doi.org/10.1038/ng.265			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19043417				2022-12-25	WOS:000262085300023
J	Wang, J; Hevi, S; Kurash, JK; Lei, H; Gay, F; Bajko, J; Su, H; Sun, WT; Chang, H; Xu, GL; Gaudet, F; Li, E; Chen, T				Wang, Jing; Hevi, Sarah; Kurash, Julia K.; Lei, Hong; Gay, Frederique; Bajko, Jeffrey; Su, Hui; Sun, Weitao; Chang, Hua; Xu, Guoliang; Gaudet, Francois; Li, En; Chen, Taiping			The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation	NATURE GENETICS			English	Article							HISTONE H3 METHYLTRANSFERASE; EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; P53 ACTIVITY; IN-VIVO; PROTEIN; DNMT3A; REPRESSION; CANCER	Histone methylation and DNA methylation cooperatively regulate chromatin structure and gene activity. How these two systems coordinate with each other remains unclear. Here we study the biological function of lysine-specific demethylase 1 (LSD1, also known as KDM1 and AOF2), which has been shown to demethylate histone H3 on lysine 4 (H3K4) and lysine 9 (H3K9)(1,2). We show that LSD1 is required for gastrulation during mouse embryogenesis. Notably, targeted deletion of the gene encoding LSD1 (namely, Aof2) in embryonic stem (ES) cells induces progressive loss of DNA methylation. This loss correlates with a decrease in DNA methyltransferase 1 (Dnmt1) protein, as a result of reduced Dnmt1 stability. Dnmt1 protein is methylated in vivo, and its methylation is enhanced in the absence of LSD1. Furthermore, Dnmt1 can be methylated by Set7/9 (also known as KMT7) and demethylated by LSD1 in vitro. Our findings suggest that LSD1 demethylates and stabilizes Dnmt1, thus providing a previously unknown mechanistic link between the histone and DNA methylation systems.	[Wang, Jing; Hevi, Sarah; Kurash, Julia K.; Gay, Frederique; Bajko, Jeffrey; Su, Hui; Sun, Weitao; Gaudet, Francois; Li, En; Chen, Taiping] Novartis Inst Biomed Res, Epigenet Program, Cambridge, MA 02139 USA; [Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Novartis; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, T (corresponding author), Novartis Inst Biomed Res, Epigenet Program, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	en.li@novartis.com; taiping.chen@novartis.com						Agoston AT, 2005, J BIOL CHEM, V280, P18302, DOI 10.1074/jbc.M501675200; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ding F, 2002, P NATL ACAD SCI USA, V99, P14861, DOI 10.1073/pnas.232565599; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schmidt DMZ, 2007, BIOCHEMISTRY-US, V46, P4408, DOI 10.1021/bi0618621; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671	24	569	625	4	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					125	129		10.1038/ng.268	http://dx.doi.org/10.1038/ng.268			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19098913				2022-12-25	WOS:000262085300027
J	Ziegelbauer, JM; Sullivan, CS; Ganem, D				Ziegelbauer, Joseph M.; Sullivan, Christopher S.; Ganem, Don			Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs	NATURE GENETICS			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; GENE-EXPRESSION; PROTEIN; IDENTIFICATION; CLEAVAGE; MIR-155; LATENCY; MIRNA	MicroRNAs (miRNAs) are short noncoding RNAs of cellular(1) and viral origin(2-7) that post-transcriptionally regulate gene expression through imperfect base pairing to their mRNA targets. Because the recognition sequences of miRNAs for their targets are short and may be discontinuous, bioinformatic prediction of targets is difficult. Here we present an approach to the experimental identification of the mRNA targets of miRNAs encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV). KSHV encodes 17 miRNAs, derived from 12 pre-miRNAs expressed from a single locus during viral latency(2,5-10). We conducted multiple screens that examine small changes in transcript abundance under different conditions of miRNA expression or inhibition and then searched the identified transcripts for seed sequence matches. Using this strategy, we identified BCLAF1, encoding Bcl2-associated factor, as a target for miR-K5, and further analysis revealed that several other KSHV miRNAs also target this gene product. Our results support that this type of expression profiling provides a potentially general approach to the identification of miRNA targets.	[Ziegelbauer, Joseph M.; Ganem, Don] George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Ziegelbauer, Joseph M.; Ganem, Don] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ziegelbauer, Joseph M.; Ganem, Don] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Sullivan, Christopher S.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin	Ganem, D (corresponding author), George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu	Ziegelbauer, Joseph/L-2628-2013	Ziegelbauer, Joseph/0000-0001-6464-6941	US National Institutes of Health [P50 GM071508]; Damon Runyon Cancer Research Foundation [DRG-1793]; NATIONAL CANCER INSTITUTE [R01CA073506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Chandriani (University of California, San Francisco) for sharing the HUVEC expression data, expertise and advice. We thank A. Goga (UCSF) and P. Lengyel (UCSF) for sharing a custom gateway cloning vector. The recombinant KSHV virus was a gift from J. Vieira (University of Washington). The infected SLK cell line was generated by J. Myoung (UCSF). PUMAdb is supported by US National Institutes of Health grant P50 GM071508. J.M.Z. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-1793). D. G. is an investigator of the Howard Hughes Medical Institute.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Offermann MK, 2007, CURR TOP MICROBIOL, V312, P185; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	30	163	173	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					130	134		10.1038/ng.266	http://dx.doi.org/10.1038/ng.266			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19098914	Green Accepted			2022-12-25	WOS:000262085300028
J	Winkler, A; Lyskowski, A; Riedl, S; Puhl, M; Kutchan, TM; Macheroux, P; Gruber, K				Winkler, Andreas; Lyskowski, Andrzej; Riedl, Sabrina; Puhl, Martin; Kutchan, Toni M.; Macheroux, Peter; Gruber, Karl			A concerted mechanism for berberine bridge enzyme	NATURE CHEMICAL BIOLOGY			English	Article							COVALENTLY ATTACHED FAD; ALKALOID BIOSYNTHESIS; MONOAMINE-OXIDASE; AMINE OXIDATION; CANNABIS-SATIVA; ACID SYNTHASE; FLAVOENZYME	Berberine bridge enzyme catalyzes the conversion of (S)-reticuline to (S)-scoulerine by formation of a carbon-carbon bond between the N-methyl group and the phenolic ring. We elucidated the structure of berberine bridge enzyme from Eschscholzia californica and determined the kinetic rates for three active site protein variants. Here we propose a catalytic mechanism combining base-catalyzed proton abstraction with concerted carbon-carbon coupling accompanied by hydride transfer from the N-methyl group to the N5 atom of the FAD cofactor.	[Winkler, Andreas; Riedl, Sabrina; Puhl, Martin; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Lyskowski, Andrzej; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Graz University of Technology; University of Graz; Donald Danforth Plant Science Center	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-11, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Gruber, Karl/GPP-6706-2022; Kutchan, Toni/L-4625-2013; Macheroux, Peter/AAB-5157-2019	Gruber, Karl/0000-0002-3485-9740; Macheroux, Peter/0000-0002-0242-454X; Winkler, Andreas/0000-0001-6221-9671; Lyskowski, Andrzej/0000-0001-8625-4164	Austrian Science Fund [W901-B05]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We appreciate the support of staff scientists at the synchrotron beamlines at DESY/EMBL-Hamburg during diffraction data collection and of Hansjorg Weber (Institute of Organic Chemistry, Graz University of Technology) for recording the NMR spectra. Financial support was provided by the Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) through the Doktoratskolleg ''Molecular enzymology'' W901-B05 (to K.G. and P.M.).	Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; BJORKLUND JA, 1995, J AM CHEM SOC, V117, P1533, DOI 10.1021/ja00110a009; Edmondson DE, 2007, ARCH BIOCHEM BIOPHYS, V464, P269, DOI 10.1016/j.abb.2007.05.006; Fitzpatrick PF, 2004, BIOORG CHEM, V32, P125, DOI 10.1016/j.bioorg.2003.02.001; HARAYAMA T, 1987, J CHEM SOC PERK T 1, P75, DOI 10.1039/p19870000075; Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; IWATA M, 1980, J AM CHEM SOC, V102, P5036, DOI 10.1021/ja00535a035; KUTCHAN TM, 1995, J BIOL CHEM, V270, P24475, DOI 10.1074/jbc.270.41.24475; Malito E, 2004, J MOL BIOL, V341, P1237, DOI 10.1016/j.jmb.2004.06.083; Miller JR, 1999, BIOCHEMISTRY-US, V38, P13670, DOI 10.1021/bi990920y; Rand T, 2006, FEBS J, V273, P2693, DOI 10.1111/j.1742-4658.2006.05285.x; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; STEFFENS P, 1985, PHYTOCHEMISTRY, V24, P2577, DOI 10.1016/S0031-9422(00)80672-X; Taura F, 2007, FEBS LETT, V581, P2929, DOI 10.1016/j.febslet.2007.05.043; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200	19	92	97	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2008	4	12					739	741		10.1038/nchembio.123	http://dx.doi.org/10.1038/nchembio.123			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	373FH	18953357	Green Published			2022-12-25	WOS:000260955900009
J	Hansen, KH; Bracken, AP; Pasini, D; Dietrich, N; Gehani, SS; Monrad, A; Rappsilber, J; Lerdrup, M; Helin, K				Hansen, Klaus H.; Bracken, Adrian P.; Pasini, Diego; Dietrich, Nikolaj; Gehani, Simmi S.; Monrad, Astrid; Rappsilber, Juri; Lerdrup, Mads; Helin, Kristian			A model for transmission of the H3K27me3 epigenetic mark	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; CELL FATE; LYSINE 9; POLYCOMB; H3; PROTEINS; JMJD3; SUZ12; EZH2	Organization of chromatin by epigenetic mechanisms is essential for establishing and maintaining cellular identity in developing and adult organisms. A key question that remains unresolved about this process is how epigenetic marks are transmitted to the next cell generation during cell division. Here we provide a model to explain how trimethylated Lys 27 of histone 3 (H3K27me3), which is catalysed by the EZH2-containing Polycomb Repressive Complex 2 (PRC2), is maintained in proliferating cells. We show that the PRC2 complex binds to the H3K27me3 mark and colocalizes with this mark in G1 phase and with sites of ongoing DNA replication. Efficient binding requires an intact trimeric PRC2 complex containing EZH2, EED and SUZ12, but is independent of the catalytic SET domain of EZH2. Using a heterologous reporter system, we show that transient recruitment of the PRC2 complex to chromatin, upstream of the transcriptional start site, is sufficient to maintain repression through endogenous PRC2 during subsequent cell divisions. Thus, we suggest that once the H3K27me3 is established, it recruits the PRC2 complex to maintain the mark at sites of DNA replication, leading to methylation of H3K27 on the daughter strands during incorporation of newly synthesized histones. This mechanism ensures maintenance of the H3K27me3 epigenetic mark in proliferating cells, not only during DNA replication when histones synthesized de novo are incorporated, but also outside S phase, thereby preserving chromatin structure and transcriptional programs.	[Hansen, Klaus H.; Bracken, Adrian P.; Pasini, Diego; Dietrich, Nikolaj; Gehani, Simmi S.; Monrad, Astrid; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Rappsilber, Juri] Univ Edinburgh, Welcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Lerdrup, Mads] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Edinburgh; University of Copenhagen	Hansen, KH (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	klaus.hansen@bric.dk; kristian.helin@bric.dk	Rappsilber, Juri/ABF-3328-2020; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Pasini, Diego/J-9674-2012; Rappsilber, Juri/B-7265-2015	Helin, Kristian/0000-0003-1975-6097; Pasini, Diego/0000-0002-9879-6486; Rappsilber, Juri/0000-0001-5999-1310; Lerdrup, Mads/0000-0002-7730-8973; Hansen, Klaus/0000-0001-9657-8816; Bracken, Adrian/0000-0002-1547-9443	Novo Nordisk Foundation; Association for International Cancer Research; Danish Cancer Society; Danish Medical Research Council; Danish Natural Science Research Council; Danish National Research Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Association for International Cancer Research; Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank Danny Reinberg for providing the 5xGal4TKLucNeo reporter plasmid. We thank members of the Helin laboratory for technical advice and fruitful discussion. This work was supported by grants from the Novo Nordisk Foundation, Association for International Cancer Research, the Danish Cancer Society, the Danish Medical Research Council, the Danish Natural Science Research Council and the Danish National Research Foundation.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; DIETRICH N, 2007, EMBO J; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; McCall K, 1996, EMBO J, V15, P569, DOI 10.1002/j.1460-2075.1996.tb00389.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572	44	540	544	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1291	U89		10.1038/ncb1787	http://dx.doi.org/10.1038/ncb1787			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931660				2022-12-25	WOS:000260586700011
J	Jaks, V; Barker, N; Kasper, M; Van Es, JH; Snippert, HJ; Clevers, H; Toftgard, R				Jaks, Viljar; Barker, Nick; Kasper, Maria; Van Es, Johan H.; Snippert, Hugo J.; Clevers, Hans; Toftgard, Rune			Lgr5 marks cycling, yet long-lived, hair follicle stem cells	NATURE GENETICS			English	Article							LABEL-RETAINING CELLS; SONIC-HEDGEHOG; POPULATION; KERATINOCYTES; BULGE; IDENTIFICATION; PROLIFERATION; DISTINCT; RENEWAL; NICHE	In mouse hair follicles, a group of quiescent cells in the bulge is believed to have stem cell activity. Lgr5, a marker of intestinal stem cells, is expressed in actively cycling cells in the bulge and secondary germ of telogen hair follicles and in the lower outer root sheath of anagen hair follicles. Here we show that Lgr5(+) cells comprise an actively proliferating and multipotent stem cell population able to give rise to new hair follicles and maintain all cell lineages of the hair follicle over long periods of time. Lgr5(+) progeny repopulate other stem cell compartments in the hair follicle, supporting the existence of a stem or progenitor cell hierarchy. By marking Lgr5(+) cells during trafficking through the lower outer root sheath, we show that these cells retain stem cell properties and contribute to hair follicle growth during the next anagen. Expression analysis suggests involvement of autocrine Hedgehog signaling in maintaining the Lgr5(+) stem cell population.	[Jaks, Viljar; Kasper, Maria; Toftgard, Rune] Novum, Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden; [Jaks, Viljar] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Jaks, Viljar] Estonian Bioctr, EE-51010 Tartu, Estonia; [Barker, Nick; Van Es, Johan H.; Snippert, Hugo J.; Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Karolinska Institutet; University of Tartu; Estonian Biocentre; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Novum, Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.	h.clevers@niob.knaw.nl; rune.toftgard@ki.se	Barker, Nick/AAS-2774-2020; van+Es, Johan/ABD-5411-2021; Barker, Nick/AAE-9833-2021; Jaks, Viljar/H-2467-2012; Kasper, Maria/Q-6318-2016; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Jaks, Viljar/0000-0002-2221-6262; Kasper, Maria/0000-0002-6117-2717	Swedish Cancer Society; Swedish Research Council; National Institutes of Health [AR47898, U01CA105491]; Genmab BV; Koninklijke Nederlandse Akademie van Wetenschappen; Koningin Wilhelmina Fonds; Louis Jeantet Foundation; International Agency for Research on Cancer Research Training Fellowship; Marie-Curie Intra-European Fellowship; Wenner-Gren Foundation; NATIONAL CANCER INSTITUTE [U01CA105491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047898] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genmab BV(Genmab); Koninklijke Nederlandse Akademie van Wetenschappen; Koningin Wilhelmina Fonds; Louis Jeantet Foundation; International Agency for Research on Cancer Research Training Fellowship; Marie-Curie Intra-European Fellowship(European Commission); Wenner-Gren Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Roop and W. Buitrago for help with setting up the keratinocyte transplantation assay; A.-L. Dackland for help with cell sorting; A. Bergstrom and I. Sur for contributions during work with animals and preparation of samples; and M. van den Born, M. Cozijnsen and H. Begthel for help with histological procedures. This work was supported by the Swedish Cancer Society (to R. T.), the Swedish Research Council (to R. T.), the National Institutes of Health (AR47898 and U01CA105491 to R. T.), Genmab BV (to H. C.), Koninklijke Nederlandse Akademie van Wetenschappen (to H. C.), Koningin Wilhelmina Fonds (to H. C.), the Louis Jeantet Foundation (to H. C.), an International Agency for Research on Cancer Research Training Fellowship (to V. J.), a Marie-Curie Intra-European Fellowship (to V. J.) and a fellowship from the Wenner-Gren Foundation (M. K.).	Albert MR, 2001, J INVEST DERMATOL, V117, P943, DOI 10.1046/j.0022-202x.2001.01517.x; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; CHASE HB, 1951, PHYSIOL ZOOL, V24, P1; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; DRY FW, 1925, J GENET, V16, P278; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kopan R, 2002, DEV BIOL, V242, P44, DOI 10.1006/dbio.2001.0516; Lee J, 1997, DEVELOPMENT, V124, P2537; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2007, J INVEST DERMATOL, V127, P2904, DOI 10.1038/sj.jid.5700917; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wu WY, 2004, METH MOL B, V289, P79; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	704	739	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1291	1299		10.1038/ng.239	http://dx.doi.org/10.1038/ng.239			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849992				2022-12-25	WOS:000260501500020
J	Jinnin, M; Medici, D; Park, L; Limaye, N; Liu, YQ; Boscolo, E; Bischoff, J; Vikkula, M; Boye, E; Olsen, BR				Jinnin, Masatoshi; Medici, Damian; Park, Lucy; Limaye, Nisha; Liu, Yanqiu; Boscolo, Elisa; Bischoff, Joyce; Vikkula, Miikka; Boye, Eileen; Olsen, Bjorn R.			Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DOMAIN-CONTAINING RECEPTOR; FOCAL ADHESION KINASE; TYROSINE KINASE; TRANSCRIPTIONAL REGULATION; JUVENILE HEMANGIOMAS; CELL-ADHESION; ANTHRAX TOXIN; GENE; TRANSDUCTION	Infantile hemangiomas are localized and rapidly growing regions of disorganized angiogenesis. We show that expression of vascular endothelial growth factor receptor-1 (VEGFR1) in hemangioma endothelial cells (hemECs) and hemangioma tissue is markedly reduced compared to controls. Low VEGFR1 expression in hemECs results in VEGF-dependent activation of VEGFR2 and downstream signaling pathways. In hemECs, transcription of the gene encoding VEGFR1 (FLT1) is dependent on nuclear factor of activated T cells ( NFAT). Low VEGFR1 expression in hemECs is caused by reduced activity of a pathway involving beta 1 integrin, the integrin-like receptor tumor endothelial marker-8 (TEM8), VEGFR2 and NFAT. In a subset of individuals with hemangioma, we found missense mutations in the genes encoding VEGFR2 (KDR) and TEM8 (ANTXR1). These mutations result in increased interactions among VEGFR2, TEM8 and b1 integrin proteins and in inhibition of integrin activity. Normalization of the constitutive VEGFR2 signaling in hemECs with soluble VEGFR1 or antibodies that neutralize VEGF or stimulate b1 integrin suggests that local administration of these or similar agents may be effective in hemangioma treatment.	[Boscolo, Elisa; Bischoff, Joyce] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Jinnin, Masatoshi; Medici, Damian; Park, Lucy; Liu, Yanqiu; Boye, Eileen; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Limaye, Nisha; Vikkula, Miikka] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium	Harvard University; Boston Children's Hospital; Harvard University; Harvard School of Dental Medicine; Universite Catholique Louvain	Boye, E (corresponding author), Childrens Hosp, Dept Surg, Vasc Biol Program, 300 Longwood Ave, Boston, MA 02115 USA.	eileen_boye@hms.harvard.edu; bjorn_olsen@hms.harvard.edu	Boscolo, Elisa/F-9483-2019; BISCHOFF, JOYCE/K-3354-2019; Vikkula, Miikka/Q-1038-2018	Boscolo, Elisa/0000-0002-6996-0419; BISCHOFF, JOYCE/0000-0002-6367-1974; Vikkula, Miikka/0000-0002-6236-338X	NIAMS NIH HHS [P01 AR048564-01A1, AR36820, R01 AR036820, P01 AR048564-050004, P01 AR048564-01A10001, P01 AR048564-02, P01 AR048564-05, P01 AR048564-02S1, P01 AR048564-050003, P01 AR048564, AR48564, P01 AR048564-04, P01 AR048564-03] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036820, R01AR036820, P01AR048564] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Akuzawa N, 2000, ARTERIOSCL THROM VAS, V20, P377, DOI 10.1161/01.ATV.20.2.377; Aplin AE, 1998, PHARMACOL REV, V50, P197; Barnes CM, 2005, P NATL ACAD SCI USA, V102, P19097, DOI 10.1073/pnas.0509579102; Blei F, 1998, ARCH DERMATOL, V134, P718, DOI 10.1001/archderm.134.6.718; Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brouillard P, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024174; Chiller KG, 2002, ARCH DERMATOL, V138, P1567, DOI 10.1001/archderm.138.12.1567; Claesson-Welsh L, 2003, BIOCHEM SOC T, V31, P20, DOI 10.1042/bst0310020; Ferrara N, 2005, EXP SUPPL, V94, P209; Fragoso R, 2006, BLOOD, V107, P1608, DOI 10.1182/blood-2005-06-2530; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Haggstrom AN, 2007, J PEDIATR-US, V150, P291, DOI 10.1016/j.jpeds.2006.12.003; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Inoue T, 2000, FEBS LETT, V469, P14, DOI 10.1016/S0014-5793(00)01246-1; Ito N, 2001, CELL SIGNAL, V13, P849, DOI 10.1016/S0898-6568(01)00209-1; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Khan ZA, 2006, BLOOD, V108, P915, DOI 10.1182/blood-2006-03-006478; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuriyama M, 2004, BIOCHEM BIOPH RES CO, V325, P843, DOI 10.1016/j.bbrc.2004.10.102; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; Li Q, 2003, J PATHOL, V201, P296, DOI 10.1002/path.1443; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mulliken J B, 1993, Semin Vasc Surg, V6, P204; North PE, 2006, CARDIOVASC PATHOL, V15, P303, DOI 10.1016/j.carpath.2006.03.001; North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6; North PE, 2001, ARCH DERMATOL, V137, P559; Picard A, 2008, PEDIATR RES, V63, P263, DOI 10.1203/PDR.0b013e318163a243; Razon MJ, 1998, MICROCIRCULATION-LON, V5, P189, DOI 10.1038/sj.mn.7300009; Ritter MR, 2006, AM J PATHOL, V168, P621, DOI 10.2353/ajpath.2006.050618; Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X; Satonaka H, 2004, CIRC RES, V94, P693, DOI 10.1161/01.RES.0000118250.67032.5E; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; Shenoy PS, 2001, BIOCHEM CELL BIOL, V79, P399, DOI 10.1139/bcb-79-4-399; Shinkai A, 1998, J BIOL CHEM, V273, P31283, DOI 10.1074/jbc.273.47.31283; Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109; Sun YS, 2006, BLOOD, V107, P1476, DOI 10.1182/blood-2005-05-1912; TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Young AE, 1988, VASCULAR BIRTHMARKS, P24	48	247	267	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2008	14	11					1236	1246		10.1038/nm.1877	http://dx.doi.org/10.1038/nm.1877			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18931684	Green Accepted			2022-12-25	WOS:000260751200043
J	Ng, RK; Dean, W; Dawson, C; Lucifero, D; Madeja, Z; Reik, W; Hemberger, M				Ng, Ray Kit; Dean, Wendy; Dawson, Claire; Lucifero, Diana; Madeja, Zofia; Reik, Wolf; Hemberger, Myriam			Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; DNA METHYLATION; TRANSCRIPTION FACTOR; MOUSE EMBRYO; TROPHECTODERM; DIFFERENTIATION; EXPRESSION; MASS; UNDERMETHYLATION; EOMESODERMIN	Mouse ES cells can differentiate into all three germ layers of the embryo but are generally excluded from the trophoblast lineage. Here we show that ES cells deficient in DNA methylation can differentiate efficiently into trophoblast derivatives. In a genome-wide screen we identified the transcription factor Elf5 as methylated and repressed in ES cells, and hypomethylated and expressed in TS and methylation-deficient ES cells. Elf5 creates a positive-feedback loop with the TS cell determinants Cdx2 and Eomes that is restricted to the trophoblast lineage by epigenetic regulation of Elf5. Importantly, the late-acting function of Elf5 allows initial plasticity and regulation in the early blastocyst. Thus, Elf5 functions as a gatekeeper, downstream of initial lineage determination, to reinforce commitment to the trophoblast lineage or to abort this pathway in epiblast cells. This epigenetic restriction of cell lineage fate provides a molecular mechanism for Waddington's concept of canalization of developmental pathways.	[Ng, Ray Kit; Dean, Wendy; Dawson, Claire; Lucifero, Diana; Madeja, Zofia; Reik, Wolf; Hemberger, Myriam] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Ng, Ray Kit; Madeja, Zofia; Reik, Wolf; Hemberger, Myriam] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Hemberger, M (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	myriam.hemberger@bbsrc.ac.uk	Dean, Wendy/GSE-3948-2022; Reik, Wolf/I-6794-2012	Madeja, Zofia Eliza/0000-0001-9649-2422; Reik, Wolf/0000-0003-0216-9881; Hemberger, Myriam/0000-0003-3332-6958; Dean, Wendy/0000-0001-9441-5044	MRC Career Development Award; Croucher Foundation; BBSRC; MRC; EU NoE The Epigenome; CellCentric; DIUS; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C225, BBS/E/B/0000M100] Funding Source: researchfish; Medical Research Council [G120/824, G0300723, G0700098, G0400154] Funding Source: researchfish; BBSRC [BBS/E/B/0000C225] Funding Source: UKRI; MRC [G120/824, G0400154, G0700098, G0300723] Funding Source: UKRI	MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Croucher Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; CellCentric; DIUS; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Fatima Santos and Annabelle Lewis for expert help with confocal microscopy and qPCR design, respectively. We also thank En Li for Dnmt1<SUP>-</SUP> mice and ES cells, and Haruhiko Koseki, Nick Gilbert and David Skalnik for ES cell lines. This work was supported by an MRC Career Development Award to M. H., by the Croucher Foundation Fellowship to R. K. N., and by BBSRC, MRC, EU NoE The Epigenome, CellCentric, and DIUS.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRADLEY A, 1986, CURR TOP DEV BIOL, V20, P357, DOI 10.1016/S0070-2153(08)60675-4; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Choi YS, 2006, BIOCHEM J, V398, P497, DOI 10.1042/BJ20060375; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; DYCE J, 1987, DEVELOPMENT, V100, P685; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; GARDNER RL, 1985, PHILOS T R SOC B, V312, P163, DOI 10.1098/rstb.1985.0186; Haffner-Krausz R, 1999, MECH DEVELOP, V85, P167, DOI 10.1016/S0925-4773(99)00082-9; Hemberger M, 2004, DEV BIOL, V271, P362, DOI 10.1016/j.ydbio.2004.03.040; Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Lei H, 1996, DEVELOPMENT, V122, P3195; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Metzger DE, 2007, DEV DYNAM, V236, P1175, DOI 10.1002/dvdy.21133; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; ROSSANT J, 1980, DEV BIOL, V76, P475, DOI 10.1016/0012-1606(80)90395-4; ROSSANT J, 1986, DEV BIOL, V117, P567, DOI 10.1016/0012-1606(86)90325-8; ROSSANT J, 1979, DEV BIOL, V70, P255, DOI 10.1016/0012-1606(79)90022-8; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sambrook J, 2001, MOL CLONING LAB MANU; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Uy GD, 2002, DEVELOPMENT, V129, P3913; Waddington C.H., 1940, ORG GENES; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011	46	251	256	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1280	U68		10.1038/ncb1786	http://dx.doi.org/10.1038/ncb1786			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836439	Green Accepted			2022-12-25	WOS:000260586700010
J	German, MS				German, Michael S.			New beta-cells from old acini	NATURE BIOTECHNOLOGY			English	Editorial Material							INSULIN; PANCREAS; HORMONE		Univ Calif San Francisco, San Francisco Diabet Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	German, MS (corresponding author), Univ Calif San Francisco, San Francisco Diabet Ctr, 513 Parnassus Ave,HSW 1090,Box 0534, San Francisco, CA 94143 USA.	mgerman@diabetes.ucsf.edu			NIDDK NIH HHS [R01 DK021344] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Goldfine ID, 1997, NAT BIOTECHNOL, V15, P1378, DOI 10.1038/nbt1297-1378; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; ZHOU Q, 2008, NATURE          0827, DOI DOI 10.1038/NATURE07314	11	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1092	1093		10.1038/nbt1008-1092	http://dx.doi.org/10.1038/nbt1008-1092			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18846076				2022-12-25	WOS:000259926000018
J	Kwon, YK; Lu, WY; Melamud, E; Khanam, N; Bognar, A; Rabinowitz, JD				Kwon, Yun Kyung; Lu, Wenyun; Melamud, Eugene; Khanam, Nurussaba; Bognar, Andrew; Rabinowitz, Joshua D.			A domino effect in antifolate drug action in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							LIVER METHYLENETETRAHYDROFOLATE REDUCTASE; TANDEM MASS-SPECTROMETRY; ONE-CARBON METABOLISM; THYMIDYLATE SYNTHETASE; MATHEMATICAL-MODEL; FLUX ANALYSIS; FOLATE; ENZYME; FOLYLPOLYGLUTAMATES; DIHYDROFOLATE	Mass spectrometry technologies for measurement of cellular metabolism are opening new avenues to explore drug activity. Trimethoprim is an antibiotic that inhibits bacterial dihydrofolate reductase (DHFR). Kinetic flux profiling with N-15-labeled ammonia in Escherichia coli reveals that trimethoprim leads to blockade not only of DHFR but also of another critical enzyme of folate metabolism: folylpoly-gamma-glutamate synthetase (FP-gamma-GS). Inhibition of FP-gamma-GS is not directly due to trimethoprim. Instead, it arises from accumulation of DHFR's substrate dihydrofolate, which we show is a potent FP-gamma-GS inhibitor. Thus, owing to the inherent connectivity of the metabolic network, falling DHFR activity leads to falling FP-gamma-GS activity in a domino-like cascade. This cascade results in complex folate dynamics, and its incorporation in a computational model of folate metabolism recapitulates the dynamics observed experimentally. These results highlight the potential for quantitative analysis of cellular metabolism to reveal mechanisms of drug action.	[Kwon, Yun Kyung; Lu, Wenyun; Melamud, Eugene; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Carl Icahn Lab, Princeton, NJ 08544 USA; [Kwon, Yun Kyung; Lu, Wenyun; Melamud, Eugene; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA; [Khanam, Nurussaba; Bognar, Andrew] Univ Toronto, Dept Microbiol, Toronto, ON M5S 1A8, Canada	Princeton University; Princeton University; University of Toronto	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Carl Icahn Lab, Washington Rd, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Lunt, Sophia/0000-0003-4522-6065	US National Institutes of Health (NIH) [P50GM071508, AI078063]; Beckman Foundation; US National Science Foundation (NSF) [CNS-0540181]; American Heart Association [0635188N]; NSF Career Award [MCB-0643859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; US National Science Foundation (NSF)(National Science Foundation (NSF)); American Heart Association(American Heart Association); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health (NIH) Center for Quantitative Biology at Princeton University (P50GM071508). Additional support came from the Beckman Foundation, the US National Science Foundation (NSF) Dynamic Data Driven Applications Systems grant CNS-0540181, the American Heart Association grant 0635188N, NSF Career Award MCB-0643859 and the NIH grant AI078063 (to J. D. R.).	ALLEGRA CJ, 1985, P NATL ACAD SCI USA, V82, P4881, DOI 10.1073/pnas.82.15.4881; ALLEGRA CJ, 1987, J BIOL CHEM, V262, P13520; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; BOGNAR AL, 1985, J BIOL CHEM, V260, P5625; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; DANENBERG PV, 1977, BIOCHIM BIOPHYS ACTA, V473, P73, DOI 10.1016/0304-419X(77)90001-4; DOLNICK BJ, 1978, J BIOL CHEM, V253, P3563; FERONE R, 1986, J BIOL CHEM, V261, P6363; FERONE R, 1986, J BIOL CHEM, V261, P6356; FRIEDKIN M, 1973, ADV ENZYMOL RAMB, V38, P235; Gangjee A, 2007, ANTI-CANCER AGENT ME, V7, P524, DOI 10.2174/187152007781668724; Garratt LC, 2005, RAPID COMMUN MASS SP, V19, P2390, DOI 10.1002/rcm.2074; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hsieh Y, 2008, EXPERT OPIN DRUG MET, V4, P93, DOI 10.1517/17425255.4.1.93 ; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; KISLIUK RL, 1974, J BIOL CHEM, V249, P4100; KISLIUK RL, 1981, MOL CELL BIOCHEM, V39, P331, DOI 10.1007/BF00232583; LOWE KE, 1993, J BIOL CHEM, V268, P21665; Lu WY, 2007, J AM SOC MASS SPECTR, V18, P898, DOI 10.1016/j.jasms.2007.01.017; MASUREKAR M, 1975, BIOCHEMISTRY-US, V14, P2424, DOI 10.1021/bi00682a024; MATTHEWS RG, 1979, BIOCHEMISTRY-US, V18, P4845, DOI 10.1021/bi00589a012; MATTHEWS RG, 1980, BIOCHEMISTRY-US, V19, P2040, DOI 10.1021/bi00551a005; MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; Noh K, 2007, J BIOTECHNOL, V129, P249, DOI 10.1016/j.jbiotec.2006.11.015; POGOLOTTI AL, 1977, BIOORG CHEM, V1, P277; Quinlivan EP, 2000, FASEB J, V14, P2519, DOI 10.1096/fj.99-1037com; Quinlivan EP, 2006, ANAL BIOCHEM, V348, P163, DOI 10.1016/j.ab.2005.09.017; Reed MC, 2004, J THEOR BIOL, V226, P33, DOI 10.1016/j.jtbi.2003.08.001; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; REEVES DS, 1971, J CLIN PATHOL, V24, P430, DOI 10.1136/jcp.24.5.430; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; SANTI DV, 1984, FOLATES PTERINS, V1, P345; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Scott J. M., 1984, FOLATES PTERINS, P307; SHANE B, 1989, VITAM HORM, V45, P263; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; THEN RL, 1993, J CHEMOTHERAPY, V5, P361, DOI 10.1080/1120009X.1993.11741082; van der Werf MJ, 2007, ANAL BIOCHEM, V370, P17, DOI 10.1016/j.ab.2007.07.022; Voet D., 2004, BIOCHEMISTRY-US, P482; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816	45	73	73	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2008	4	10					602	608		10.1038/nchembio.108	http://dx.doi.org/10.1038/nchembio.108			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	349ZV	18724364	Green Accepted			2022-12-25	WOS:000259323100010
J	Ohn, T; Kedersha, N; Hickman, T; Tisdale, S; Anderson, P				Ohn, Takbum; Kedersha, Nancy; Hickman, Tyler; Tisdale, Sarah; Anderson, Paul			A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; P-BODIES; GLUCOSE DEPRIVATION; SITES; DECAY; DEGRADATION; CARDIOPROTECTION; ACCUMULATION; TRANSLATION; RECRUITMENT	Stress granules (SGs) and processing bodies (PBs) are microscopically visible ribonucleoprotein granules that cooperatively regulate the translation and decay of messenger RNA(1-3). Using an RNA-mediated interference-based screen, we identify 101 human genes required for SG assembly, 39 genes required for PB assembly, and 31 genes required for coordinate SG and PB assembly. Although 51 genes encode proteins involved in mRNA translation, splicing and transcription, most are not obviously associated with RNA metabolism. We find that several components of the hexosamine biosynthetic pathway, which reversibly modifies proteins with O-linked N-acetylglucosamine (O-GlcNAc) in response to stress, are required for SG and PB assembly. O-GlcNAc-modified proteins are prominent components of SGs but not PBs, and include RACK1 (receptor for activated C kinase 1), prohibitin-2, glyceraldehyde-3-phosphate dehydrogenase and numerous ribosomal proteins. Our results suggest that O-GlcNAc modification of the translational machinery is required for aggregation of untranslated messenger ribonucleoproteins into SGs. The lack of enzymes of the hexosamine biosynthetic pathway in budding yeast may contribute to differences between mammalian SGs and related yeast EGP (eIF4E, 4G and Pab1 containing) bodies.	[Ohn, Takbum; Kedersha, Nancy; Hickman, Tyler; Tisdale, Sarah; Anderson, Paul] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Anderson, P (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 1 Jimmy Fund Way, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu		Hickman, Tyler/0000-0003-2623-3251	NIH [AI065858, AI033600, AR0514732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI033600, R01AI033600, P01AI065858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051472] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank C. Shamu and colleagues in the ICCB-L RNAi screening facilities at Harvard Medical School for their assistance. We also thank N. Ramadan at the Drosophila RNAi Screening Centre at Harvard Medical School for assistance with the automated microscope. We thank Jens Lykke-Andersen for the DCP1a antibody, and Carlos Morales for the Myc-tagged sortilin plasmid. We thank Keith Blackwell, Pavel Ivanov and Dan Schoenberg for critical review of the manuscript. This work was supported by NIH grants AI065858, AI033600 and AR0514732.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; KEDERSHA N, METHODS ENZ IN PRESS; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Zachara NE, 2007, AM J PHYSIOL-HEART C, V293, pH1324, DOI 10.1152/ajpheart.00697.2007; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	36	281	292	5	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1224	1231		10.1038/ncb1783	http://dx.doi.org/10.1038/ncb1783			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18794846	Green Accepted			2022-12-25	WOS:000259682900017
J	Rothberg, JM; Leamon, JH				Rothberg, Jonathan M.; Leamon, John H.			The development and impact of 454 sequencing	NATURE BIOTECHNOLOGY			English	Article							SINGLE DNA-MOLECULES; DROSOPHILA-MELANOGASTER; COMPLETE GENOME; COMPLEX GENOME; BY-SYNTHESIS; ANCIENT DNA; TRANSCRIPTOME; PYROPHOSPHATE; AMPLIFICATION; NEANDERTHAL	The 454 Sequencer has dramatically increased the volume of sequencing conducted by the scientific community and expanded the range of problems that can be addressed by the direct readouts of DNA sequence. Key breakthroughs in the development of the 454 sequencing platform included higher throughput, simplified all in vitro sample preparation and the miniaturization of sequencing chemistries, enabling massively parallel sequencing reactions to be carried out at a scale and cost not previously possible. Together with other recently released next-generation technologies, the 454 platform has started to democratize sequencing, providing individual laboratories with access to capacities that rival those previously found only at a handful of large sequencing centers. Over the past 18 months, 454 sequencing has led to a better understanding of the structure of the human genome, allowed the first non-Sanger sequence of an individual human and opened up new approaches to identify small RNAs. To make next-generation technologies more widely accessible, they must become easier to use and less costly. In the longer term, the principles established by 454 sequencing might reduce cost further, potentially enabling personalized genomics.	[Rothberg, Jonathan M.] Rothberg Inst Childhood Dis, Guilford, CT 06437 USA; [Leamon, John H.] Ion Torrent Syst, Guilford, CT 06437 USA		Rothberg, JM (corresponding author), Rothberg Inst Childhood Dis, 530 Whitfield St, Guilford, CT 06437 USA.	jrothberg@childhooddiseases.org						Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; [Anonymous], 2008, NAT METHODS, V5, P15, DOI 10.1038/NMETH1155; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cantor C., 1999, GENOMICS SCI TECHNOL; CHEN YJ, 2007, Patent No. 7244567; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Christensen CM, 1997, INNOVATORS DILEMMA N; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; EFCAVITCH W, 2008, ADV GEN BIOL TECHN M; EGHOLM M, 2007, CAMBR HEALTHT I EXPL; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Ferguson JA, 2000, ANAL CHEM, V72, P5618, DOI 10.1021/ac0008284; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; GILBERT W, 1973, P NATL ACAD SCI USA, V70, P3581, DOI 10.1073/pnas.70.12.3581; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gowda Malali, 2006, Nucleic Acids Res, V34, pe126, DOI 10.1093/nar/gkl522; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; HANSMA HG, 1991, J VAC SCI TECHNOL B, V9, P1282, DOI 10.1116/1.585221; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HAYDEN E, 2007, NATURE NEWS, V250, P11; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; HYMAN ED, 1988, ANAL BIOCHEM, V174, P423, DOI 10.1016/0003-2697(88)90041-3; *ILL, 2008, ILL SEQ 1 AFR HUM GE; KAROW J, 2008, SEQUENCE, V2; KHRAPKO KR, 1989, FEBS LETT, V256, P118, DOI 10.1016/0014-5793(89)81730-2; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Koster H, 1996, NAT BIOTECHNOL, V14, P1123, DOI 10.1038/nbt0996-1123; Koster H., 1991, NUCL ACIDS S SER, V24, P318; Krause L, 2006, BIOINFORMATICS, V22, pE281, DOI 10.1093/bioinformatics/btl247; Leamon JH, 2003, ELECTROPHORESIS, V24, P3769, DOI 10.1002/elps.200305646; Leamon JH, 2007, CHEM REV, V107, P3367, DOI 10.1021/cr068297s; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Melamede RJ, 1985, U.S. Patent, Patent No. 4863849; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Moore G. E., 1965, ELECTRONICS, V38, P1, DOI DOI 10.1109/JPROC.1998.658762; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; NYREN P, 1993, ANAL BIOCHEM, V208, P171, DOI 10.1006/abio.1993.1024; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pantano P, 1996, CHEM MATER, V8, P2832, DOI 10.1021/cm9603314; Pennisi E, 2007, SCIENCE, V318, P1842, DOI 10.1126/science.318.5858.1842; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Raymond JA, 2007, FEMS MICROBIOL ECOL, V61, P214, DOI 10.1111/j.1574-6941.2007.00345.x; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Ronaghi Mostafa, 2003, Methods Mol Biol, V212, P189; SANGER F, 1975, PROC R SOC SER B-BIO, V191, P317, DOI 10.1098/rspb.1975.0131; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SPIERER P, 1983, J MOL BIOL, V168, P35, DOI 10.1016/S0022-2836(83)80321-0; Steemers FJ, 1999, MIKROCHIM ACTA, V131, P99, DOI 10.1007/s006040050014; Steemers FJ, 2000, NAT BIOTECHNOL, V18, P91, DOI 10.1038/72006; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; TURNER S, 2008, ADV GEN BIOL TECHN M; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; WOOLLEY AT, 1995, ANAL CHEM, V67, P3676, DOI 10.1021/ac00116a010	86	314	388	2	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1117	1124		10.1038/nbt1485	http://dx.doi.org/10.1038/nbt1485			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18846085				2022-12-25	WOS:000259926000026
J	Sadelain, M; Kwak, LW; Haining, N				Sadelain, Michel; Kwak, Larry W.; Haining, Nick			Turning T cells against tumors	NATURE MEDICINE			English	Editorial Material									[Sadelain, Michel] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Kwak, Larry W.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Haining, Nick] Dana Farber Canc Inst, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2008	14	10					1022	1022						1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18841138	Bronze			2022-12-25	WOS:000259892300026
J	Volgraf, M; Lumb, JP; Brastianos, HC; Carr, G; Chung, MKW; Munzel, M; Mauk, AG; Andersen, RJ; Trauner, D				Volgraf, Matthew; Lumb, Jean-Philip; Brastianos, Harry C.; Carr, Gavin; Chung, Marco K. W.; Muenzel, Martin; Mauk, A. Grant; Andersen, Raymond J.; Trauner, Dirk			Biomimetic synthesis of the IDO inhibitors exiguamine A and B	NATURE CHEMICAL BIOLOGY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; CANCER; ELECTROCYCLIZATIONS; EXPRESSION; CASCADE; ANALOGS; CELLS	Biomimetic synthesis is an attempt to assemble natural products along biosynthetic lines without recourse to the full enzymatic machinery of nature. We exemplify this with a total synthesis of exiguamine A and the newly isolated natural product exiguamine B. The most noteworthy feature of this work is an oxidative endgame drawing from the complex chemistry of catecholamines, which allows for ready access to a new class of nanomolar indoleamine-2,3-dioxygenase inhibitors.	[Brastianos, Harry C.; Carr, Gavin; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Brastianos, Harry C.; Carr, Gavin; Andersen, Raymond J.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z1, Canada; [Volgraf, Matthew; Lumb, Jean-Philip; Trauner, Dirk] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chung, Marco K. W.; Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Muenzel, Martin; Trauner, Dirk] Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany	University of British Columbia; University of British Columbia; University of California System; University of California Berkeley; University of British Columbia; University of Munich	Andersen, RJ (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	randersn@interchange.ubc.ca; trauner@berkeley.edu	Muenzel, Martin/B-3360-2011	Muenzel, Martin/0000-0002-4504-8281	University of California Berkeley; Novartis; Roche Pharmaceuticals; Wyeth Research; American Chemical Society; Medicinal Chemistry Division; Pfizer, Inc; ACS Organic Division; University of British Columbia; National Cancer Institute of Canada (NCIC); Canadian Cancer Society (CCS); National Science and Engineering Research Council of Canada (R.J.A.); Michael Smith Foundation for Health Research [INUFB074031]; Canada Research Chair	University of California Berkeley(University of California System); Novartis(Novartis); Roche Pharmaceuticals(Roche Holding); Wyeth Research(Wyeth); American Chemical Society(American Chemical Society); Medicinal Chemistry Division; Pfizer, Inc(Pfizer); ACS Organic Division; University of British Columbia; National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); National Science and Engineering Research Council of Canada (R.J.A.)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	Financial support at University of California Berkeley was provided by Novartis (D.T.), Roche Pharmaceuticals (D.T., M.V.), Wyeth Research (M.V.), the American Chemical Society (ACS) Medicinal Chemistry Division (M.V.), Pfizer, Inc. (J.-P.L.) and the ACS Organic Division (J.-P.L.) in the form of predoctoral fellowships and a Young Investigator Award. Financial support at University of British Columbia was provided by the National Cancer Institute of Canada (NCIC) and the Canadian Cancer Society (CCS) (R.J.A.), the National Science and Engineering Research Council of Canada (R.J.A.), NCIC and CCS (A.G.M.), the Michael Smith Foundation for Health Research (Grant INUFB074031) and a Canada Research Chair (A.G.M.).	Beaudry CM, 2005, CHEM REV, V105, P4757, DOI 10.1021/cr0406110; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Brastianos HC, 2006, J AM CHEM SOC, V128, P16046, DOI 10.1021/ja067211+; Carr G, 2008, J MED CHEM, V51, P2634, DOI 10.1021/jm800143h; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; Gravel E, 2008, EUR J ORG CHEM, V2008, P27, DOI 10.1002/ejoc.200700331; Han XJ, 1999, J AM CHEM SOC, V121, P7600, DOI 10.1021/ja991500z; JOHNSON WS, 1976, ANGEW CHEM INT EDIT, V15, P9, DOI 10.1002/anie.197600091; LIANG CD, 1986, TETRAHEDRON LETT, V27, P1971, DOI 10.1016/S0040-4039(00)84424-X; Liu H. W., 2004, MAR DRUGS, V2, P154; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Nicolaou KC, 2003, CHEM COMMUN, P551, DOI 10.1039/b209440c; NICOLAOU KC, 1982, J AM CHEM SOC, V104, P5555, DOI 10.1021/ja00384a077; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; PIERS E, 1962, CAN J CHEM, V40, P559, DOI 10.1139/v62-084; PIETTRE S, 1990, SCIENCE, V248, P1532, DOI 10.1126/science.248.4962.1532; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; SOBOTKA H, 1951, J AM CHEM SOC, V73, P3077, DOI 10.1021/ja01151a030	19	49	51	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2008	4	9					535	537		10.1038/nchembio.107	http://dx.doi.org/10.1038/nchembio.107			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	339SN	18677305				2022-12-25	WOS:000258597700011
J	Yang, SH; Andl, T; Grachtchouk, V; Wang, AQ; Liu, JH; Syu, LJ; Ferris, J; Wang, TS; Glick, AB; Millar, SE; Dlugosz, AA				Yang, Steven Hoseong; Andl, Thomas; Grachtchouk, Vladimir; Wang, Aiqin; Liu, Jianhong; Syu, Li-Jyun; Ferris, Jenny; Wang, Timothy S.; Glick, Adam B.; Millar, Sarah E.; Dlugosz, Andrzej A.			Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta-catenin signaling	NATURE GENETICS			English	Article							BASAL-CELL CARCINOMA; HAIR FOLLICLE MORPHOGENESIS; NUCLEAR BETA-CATENIN; SONIC-HEDGEHOG; MOUSE EPIDERMIS; WNT SIGNALS; CANCER; PROLIFERATION; EXPRESSION; INITIATION	Constitutive Hedgehog (Hh) signaling underlies several human tumors(1), including basal cell carcinoma (BCC) and basaloid follicular hamartoma in skin(2,3). Intriguingly, superficial BCCs arise as de novo epithelial buds resembling embryonic hair germs(4-6), collections of epidermal cells whose development is regulated by canonical Wnt/beta-catenin signaling(7,8). Similar to embryonic hair germs, human BCC buds showed increased levels of cytoplasmic and nuclear beta-catenin and expressed early hair follicle lineage markers. We also detected canonical Wnt/beta-catenin signaling in epithelial buds and hamartomas from mice expressing an oncogene, M2SMO(9), leading to constitutive Hh signaling in skin. Conditional overexpression of the Wnt pathway antagonist Dkk1 in M2SMO-expressing mice potently inhibited epithelial bud and hamartoma development without affecting Hh signaling. Our findings uncover a hitherto unknown requirement for ligand-driven, canonical Wnt/beta-catenin signaling for Hh pathway-driven tumorigenesis, identify a new pharmacological target for these neoplasms and establish the molecular basis for the well-known similarity between early superficial BCCs and embryonic hair germs.	[Yang, Steven Hoseong; Grachtchouk, Vladimir; Wang, Aiqin; Liu, Jianhong; Syu, Li-Jyun; Ferris, Jenny; Wang, Timothy S.; Dlugosz, Andrzej A.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; [Yang, Steven Hoseong; Grachtchouk, Vladimir; Wang, Aiqin; Liu, Jianhong; Syu, Li-Jyun; Ferris, Jenny; Wang, Timothy S.; Dlugosz, Andrzej A.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Yang, Steven Hoseong; Dlugosz, Andrzej A.] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Andl, Thomas; Millar, Sarah E.] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Andl, Thomas; Millar, Sarah E.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Glick, Adam B.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet Biomed Sci, University Pk, PA 16802 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dlugosz, AA (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	dlugosza@umich.edu		Andl, Thomas/0000-0002-5555-468X	NIH [R01-AR45973, R01-CA87837, T32-HD007505, T32-GM07863, R01-AR47709, R01-DE015342]; University of Michigan [P30-CA46592]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087837, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045973, R01AR047709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Pierre Coulombe for providing K17 rabbit polyclonal antibody and Henry Sun for providing AE13 and AE15 antibodies; Eric Fearon and Deb Gumucio for constructive comments on the manuscript; and members of the Dlugosz lab for valuable input on this project. This work was supported by NIH grants R01-AR45973 and R01-CA87837 (A.A.D.), T32-HD007505 and T32-GM07863 (S.H.Y.), and R01-AR47709 and R01-DE015342 (S.E.M.). For production of transgenic mice we acknowledge members of the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities, funded in part by P30-CA46592 (University of Michigan Cancer Center Core support).	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Caldwell Ira, 1935, RADIOLOGY, P8; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daya-Grosjean L, 2005, CANCER LETT, V225, P181, DOI 10.1016/j.canlet.2004.10.003; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; El-Bahrawy M, 2003, BRIT J DERMATOL, V148, P964, DOI 10.1046/j.1365-2133.2003.05240.x; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jih DM, 2003, AM J DERMATOPATH, V25, P130, DOI 10.1097/00000372-200304000-00006; LEVER WF, 1948, ARCH DERMATOL SYPH, V57, P709, DOI 10.1001/archderm.1948.01520170107011; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mullor JL, 2001, CURR BIOL, V11, P769, DOI 10.1016/S0960-9822(01)00229-9; Oseroff AR, 2005, ARCH DERMATOL, V141, P60, DOI 10.1001/archderm.141.1.60; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Sellheyer K, 2008, J AM ACAD DERMATOL, V58, P158, DOI 10.1016/j.jaad.2007.07.008; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yamazaki F, 2001, BRIT J DERMATOL, V145, P771, DOI 10.1046/j.1365-2133.2001.04468.x	30	158	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1130	1135		10.1038/ng.192	http://dx.doi.org/10.1038/ng.192			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165927	Green Accepted			2022-12-25	WOS:000258761200029
J	Yousefi, S; Gold, JA; Andina, N; Lee, JJ; Kelly, AM; Kozlowski, E; Schmid, I; Straumann, A; Reichenbach, J; Gleich, GJ; Simon, HU				Yousefi, Shida; Gold, Jeffrey A.; Andina, Nicola; Lee, James J.; Kelly, Ann M.; Kozlowski, Evelyne; Schmid, Ines; Straumann, Alex; Reichenbach, Janine; Gleich, Gerald J.; Simon, Hans-Uwe			Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense	NATURE MEDICINE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; CROHNS-DISEASE; T-CELLS; APOPTOSIS; INFLAMMATION; EXPRESSION; MECHANISMS; CYTOKINES; SURVIVIN; PROTEINS	Although eosinophils are considered useful in defense mechanisms against parasites, their exact function in innate immunity remains unclear. The aim of this study is to better understand the role of eosinophils within the gastrointestinal immune system. We show here that lipopolysaccharide from Gram-negative bacteria activates interleukin-5 (IL-5)- or interferon-gamma-primed eosinophils to release mitochondrial DNA in a reactive oxygen species - dependent manner, but independent of eosinophil death. Notably, the process of DNA release occurs rapidly in a catapult-like manner - in less than one second. In the extracellular space, the mitochondrial DNA and the granule proteins form extracellular structures able to bind and kill bacteria both in vitro and under inflammatory conditions in vivo. Moreover, after cecal ligation and puncture, II5-transgenic but not wild-type mice show intestinal eosinophil infiltration and extracellular DNA deposition in association with protection against microbial sepsis. These data suggest a previously undescribed mechanism of eosinophil-mediated innate immune responses that might be crucial for maintaining the intestinal barrier function after inflammation-associated epithelial cell damage, preventing the host from uncontrolled invasion of bacteria.	[Yousefi, Shida; Andina, Nicola; Kozlowski, Evelyne; Schmid, Ines; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland; [Gold, Jeffrey A.; Kelly, Ann M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care, Portland, OR 97239 USA; [Lee, James J.] Mayo Clin Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Straumann, Alex] Kantonsspital Olten, Dept Gastroenterol, CH-4600 Olten, Switzerland; [Reichenbach, Janine] Univ Childrens Hosp, CH-8032 Zurich, Switzerland; [Gleich, Gerald J.] Univ Utah, Dept Dermatol, Salt Lake City, UT 84132 USA	University of Bern; Oregon Health & Science University; Mayo Clinic; Mayo Clinic Phoenix; Kantonsspital Olten; University Children's Hospital Zurich; Utah System of Higher Education; University of Utah	Yousefi, S (corresponding author), Univ Bern, Inst Pharmacol, Friedbuhlstr 49, CH-3010 Bern, Switzerland.	shida.yousefi@pki.unibe.ch; hus@pki.unibe.ch	Simon, Hans-Uwe/AAU-7410-2020; Reichenbach, Janine/U-2171-2018; Yousefi, Shida/AAU-7986-2020; Yousefi, Shida/L-9689-2016; Simon, Hans-Uwe/AAU-5079-2020	Simon, Hans-Uwe/0000-0002-9404-7736; Reichenbach, Janine/0000-0002-9008-1312; Yousefi, Shida/0000-0002-9855-4305; Yousefi, Shida/0000-0002-9855-4305; gold, jeffrey/0000-0001-6683-9907	Swiss National Science Foundation [310000-112078, 310000-107526]; Stanley Thomas Johnson Foundation, Bern, Switzerland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067522] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stanley Thomas Johnson Foundation, Bern, Switzerland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Kohler for critical review of the confocal microscopy and imaging data. We also thank D. Simon for histological examination of the mouse tissue sections. This work was supported by the Swiss National Science Foundation (grants 310000-112078 and 310000-107526) and Stanley Thomas Johnson Foundation, Bern, Switzerland.	Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Davis MDP, 2003, J ALLERGY CLIN IMMUN, V112, P988, DOI 10.1016/j.jaci.2003.08.028; DUBUCQUOI S, 1995, GUT, V37, P242, DOI 10.1136/gut.37.2.242; Edwards J, 2005, NATURE, V435, P164, DOI 10.1038/435164a; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hankard GF, 1997, J PEDIATR GASTR NUTR, V24, P568, DOI 10.1097/00005176-199705000-00015; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238; Lee NA, 1997, J IMMUNOL, V158, P1332; MandicMulec I, 1997, INFECT IMMUN, V65, P110, DOI 10.1128/IAI.65.1.110-115.1997; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Melo RCN, 2008, J LEUKOCYTE BIOL, V83, P229, DOI 10.1189/jlb.0707503; Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; Simon D, 2007, J ALLERGY CLIN IMMUN, V119, P1291, DOI 10.1016/j.jaci.2007.02.010; Simon HU, 2000, J IMMUNOL, V165, P4069, DOI 10.4049/jimmunol.165.7.4069; Straumann A, 2004, ALLERGY, V59, P15, DOI 10.1046/j.1398-9995.2003.00382.x; Takedatsu H, 2004, EUR J IMMUNOL, V34, P1561, DOI 10.1002/eji.200324680; Vassina EM, 2006, EUR J IMMUNOL, V36, P1975, DOI 10.1002/eji.200635943; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407; YOUSEFI S, 1994, P NATL ACAD SCI USA, V91, P10868, DOI 10.1073/pnas.91.23.10868; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	31	652	674	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2008	14	9					949	953		10.1038/nm.1855	http://dx.doi.org/10.1038/nm.1855			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	345IB	18690244				2022-12-25	WOS:000258988600027
J	Burton, JB; Johnson, M; Sato, M; Koh, SBS; Mulholland, DJ; Stout, D; Chatziioannou, AF; Phelps, ME; Wu, H; Wu, L				Burton, Jeremy B.; Johnson, Mai; Sato, Makoto; Koh, Sok Boon S.; Mulholland, David J.; Stout, David; Chatziioannou, Arion F.; Phelps, Michael E.; Wu, Hong; Wu, Lily			Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer	NATURE MEDICINE			English	Article							RADICAL PROSTATECTOMY; PELVIC LYMPHADENECTOMY; IN-VIVO; VECTOR; PROGRESSION; SURVIVAL; CELLS; LEADS; MICE	The accurate assessment of nodal involvement in prostate cancer is crucial to planning treatment, yet there is a shortage of noninvasive imaging techniques capable of visualizing nodal lesions directly. This study demonstrates the feasibility of using recombinant human adenoviral vectors to detect nodal metastases in a human prostate cancer model. This was achieved by the prostate-restricted expression of optical and positron emission tomography (PET) imaging reporter genes by the viral vector coupled with the innate lymphotropic properties of adenovirus. We show that peritumoral administration of these vectors results in the direct detection of reporter gene expression in metastatic lesions within sentinel lymph nodes. Notably, this approach parallels the current lymphoscintigraphy method but enables the direct PET visualization of sentinel lymph node metastases, eliminating the need for invasive lymphadenectomy. These findings may lead to more effective diagnostic and therapeutic strategies for individuals with advanced-stage prostate cancer.	[Burton, Jeremy B.; Mulholland, David J.; Stout, David; Chatziioannou, Arion F.; Phelps, Michael E.; Wu, Hong; Wu, Lily] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Johnson, Mai; Sato, Makoto; Wu, Lily] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Urol, Los Angeles, CA 90095 USA; [Koh, Sok Boon S.; Wu, Lily] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Bioengn, Los Angeles, CA 90095 USA; [Koh, Sok Boon S.; Wu, Lily] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, L (corresponding author), Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	lwu@mednet.ucla.edu			NCI NIH HHS [2U24 CA092865, R01 CA101904-06, R01 CA101904, R21 CA122693, R01 CA101904-01, U24 CA092865, R21 CA122693-02, P50 CA092131, P50 CA092131-070003] Funding Source: Medline; NIGMS NIH HHS [T32 GM008652, T32-GM008652] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA092865, R01CA101904, R21CA122693, P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008652] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JY, 2002, NAT MED, V8, P891, DOI 10.1038/nm743; Bader P, 2003, J UROLOGY, V169, P849, DOI 10.1097/01.ju.0000049032.38743.c7; Brakenhielm E, 2007, INT J CANCER, V121, P2153, DOI 10.1002/ijc.22900; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Chow PL, 2006, PHYS MED BIOL, V51, P379, DOI 10.1088/0031-9155/51/2/013; Daneshmand S, 2004, J UROLOGY, V172, P2252, DOI 10.1097/01.ju.0000143448.04161.cc; Epstein JI, 2000, UROLOGY, V56, P283, DOI 10.1016/S0090-4295(00)00640-3; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Heidenreich A, 2007, EUR UROL, V52, P29, DOI 10.1016/j.eururo.2007.04.020; Ikomi F, 1999, LYMPHOLOGY, V32, P90; Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Johnson Mai, 2005, Mol Imaging, V4, P463; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Labow D, 2000, HUM GENE THER, V11, P759, DOI 10.1089/10430340050015653; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Link RE, 2001, UROL CLIN N AM, V28, P491, DOI 10.1016/S0094-0143(05)70157-9; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb; Rorvik J, 2001, Curr Opin Urol, V11, P181; Rosenfeld ME, 1995, CLIN CANCER RES, V1, P1571; Sadeghi H, 2005, CURR GENE THER, V5, P411, DOI 10.2174/1566523054546189; Szuba A, 2003, J NUCL MED, V44, P43; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; TILNEY NL, 1970, IMMUNOLOGY, V19, P181; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; WOLF JS, 1995, J UROLOGY, V153, P993, DOI 10.1016/S0022-5347(01)67620-1; Wu L, 2001, GENE THER, V8, P1416, DOI 10.1038/sj.gt.3301549	32	71	76	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2008	14	8					882	888		10.1038/nm.1727	http://dx.doi.org/10.1038/nm.1727			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18622403	Green Accepted			2022-12-25	WOS:000258237500037
J	Pielberg, GR; Golovko, A; Sundstrom, E; Curik, I; Lennartsson, J; Seltenhammer, MH; Druml, T; Binns, M; Fitzsimmons, C; Lindgren, G; Sandberg, K; Baumung, R; Vetterlein, M; Stromberg, S; Grabherr, M; Wade, C; Lindblad-Toh, K; Ponten, F; Heldin, CH; Solkner, J; Andersson, L				Pielberg, Gerli Rosengren; Golovko, Anna; Sundstrom, Elisabeth; Curik, Ino; Lennartsson, Johan; Seltenhammer, Monika H.; Druml, Thomas; Binns, Matthew; Fitzsimmons, Carolyn; Lindgren, Gabriella; Sandberg, Kaj; Baumung, Roswitha; Vetterlein, Monika; Stromberg, Sara; Grabherr, Manfred; Wade, Claire; Lindblad-Toh, Kerstin; Ponten, Fredrik; Heldin, Carl-Henrik; Soelkner, Johann; Andersson, Leif			A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse	NATURE GENETICS			English	Article							STIMULATING-HORMONE-RECEPTOR; STEM-CELL MAINTENANCE; COAT COLOR GENE; EQUUS-CABALLUS; MC1R; MECHANISMS; LINKAGE; GENOME	In horses, graying with age is an autosomal dominant trait associated with a high incidence of melanoma and vitiligo-like depigmentation. Here we show that the Gray phenotype is caused by a 4.6-kb duplication in intron 6 of STX17 (syntaxin-17) that constitutes a cis-acting regulatory mutation. Both STX17 and the neighboring NR4A3 gene are overexpressed in melanomas from Gray horses. Gray horses carrying a loss-of-function mutation in ASIP ( agouti signaling protein) had a higher incidence of melanoma, implying that increased melanocortin-1 receptor signaling promotes melanoma development in Gray horses. The Gray horse provides a notable example of how humans have cherry-picked mutations with favorable phenotypic effects in domestic animals.	[Pielberg, Gerli Rosengren; Golovko, Anna; Fitzsimmons, Carolyn; Lindblad-Toh, Kerstin; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Sundstrom, Elisabeth; Lindgren, Gabriella; Sandberg, Kaj; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Curik, Ino] Univ Zagreb, Dept Anim Sci, Fac Agr, HR-10000 Zagreb, Croatia; [Lennartsson, Johan; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Seltenhammer, Monika H.] Univ Vet Med, Dept Clin Surg & Ophthalmol, A-1200 Vienna, Austria; [Druml, Thomas; Baumung, Roswitha; Soelkner, Johann] Univ Nat Resources & Appl Life Sci, Dept Sustainable Agr Syst, A-1180 Vienna, Austria; [Binns, Matthew] Univ London Royal Vet Coll, London NW1 0TU, England; [Vetterlein, Monika] Med Univ Vienna, Dept Cell Biol & Ultrastruct Res, Ctr Anat & Cell Biol, A-1080 Vienna, Austria; [Stromberg, Sara; Ponten, Fredrik] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Grabherr, Manfred; Wade, Claire; Lindblad-Toh, Kerstin] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wade, Claire] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Uppsala University; Swedish University of Agricultural Sciences; University of Zagreb; Ludwig Institute for Cancer Research; Uppsala University; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of London; University of London Royal Veterinary College; Medical University of Vienna; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 597, SE-75124 Uppsala, Sweden.	leif.andersson@imbim.uu.se		Solkner, Johann/0000-0002-1517-5829; Lindgren, Gabriella/0000-0001-6046-9669; Wade, Claire/0000-0003-3413-4771; Grabherr, Manfred/0000-0001-8792-6508				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; COMFORT A, 1958, NATURE, V182, P1531, DOI 10.1038/1821531a0; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DESSER H, 1980, ZBL VET MED A, V27, P45; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Fleury C, 2000, PIGM CELL RES, V13, P47, DOI 10.1034/j.1600-0749.2000.130109.x; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Henner J, 2002, MAMM GENOME, V13, P535, DOI 10.1007/s00335-002-2174-7; Locke MM, 2002, ANIM GENET, V33, P329, DOI 10.1046/j.1365-2052.2002.00885.x; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Pielberg G, 2005, ANIM GENET, V36, P390, DOI 10.1111/j.1365-2052.2005.01334.x; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Seltenhammer MH, 2004, PIGM CELL RES, V17, P674, DOI 10.1111/j.1600-0749.2004.00192.x; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; SPONENBERG DP, 2003, EQUINE COAT COLOR GE, P215; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Steingrimsson E, 2005, CELL, V121, P9, DOI 10.1016/j.cell.2005.03.021; SUTTON RH, 1997, MELANOMA GRAYING HOR, P1; Swinburne JE, 2002, ANIM GENET, V33, P338, DOI 10.1046/j.1365-2052.2002.00895.x; Van Neste D, 2004, MICRON, V35, P193, DOI 10.1016/j.micron.2003.11.006; VANDORSSEN J, 1903, GENESE MELANOME HAUT; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	28	209	226	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1004	1009		10.1038/ng.185	http://dx.doi.org/10.1038/ng.185			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18641652	Green Published			2022-12-25	WOS:000258026900018
J	Wang, JH; Lozier, J; Johnson, G; Kirshner, S; Verthelyi, D; Pariser, A; Shores, E; Rosenberg, A				Wang, Jinhai; Lozier, Jay; Johnson, Gibbes; Kirshner, Susan; Verthelyi, Daniela; Pariser, Anne; Shores, Elizabeth; Rosenberg, Amy			Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment	NATURE BIOTECHNOLOGY			English	Article							ACID ALPHA-GLUCOSIDASE; T-CELL TOLERANCE; FACTOR-VIII INHIBITORS; LONG-TERM ACCEPTANCE; HUMAN GROWTH-HORMONE; SEVERE HEMOPHILIA-A; DISEASE TYPE-II; REPLACEMENT THERAPY; IMMUNE TOLERANCE; FABRY-DISEASE	Lysosomal storage diseases are characterized by deficiencies in lysosomal enzymes, allowing accumulation of target substrate in cells and eventually causing cell death. Enzyme replacement therapy is the principal treatment for most of these diseases. However, these therapies are often complicated by immune responses to the enzymes, blocking efficacy and causing severe adverse outcomes by neutralizing product activity. It is thus crucial to understand the relationships between genetic mutations, endogenous residual enzyme proteins (cross-reactive immunologic material), development of neutralizing antibodies and their impact on clinical outcomes of lysosomal storage diseases. For patients in whom neutralizing antibodies may cause severe adverse clinical outcomes, it is paramount to develop tolerance inducing protocols to preclude, where predictable, or treat such life-threatening responses.	[Wang, Jinhai; Johnson, Gibbes; Kirshner, Susan; Verthelyi, Daniela; Shores, Elizabeth; Rosenberg, Amy] US FDA, Ctr Drug Evaluat & Res, Div Therapeut Proteins, Off Biotechnol Prod, Bethesda, MD 20892 USA; [Lozier, Jay] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Pariser, Anne] US FDA, Ctr Drug Evaluat & Res, Div Gastroenterol Prod, Off New Drugs, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); US Food & Drug Administration (FDA)	Rosenberg, A (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Therapeut Proteins, Off Biotechnol Prod, NIH Bldg 29B,8800 Rockville Pike, Bethesda, MD 20892 USA.	amy.rosenberg@fda.hhs.gov			Intramural NIH HHS [Z01 SC003811-33] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC003811] Funding Source: NIH RePORTER; CLINICAL CENTER [Z01CL080015] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER		ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Ahangari G, 2004, INT J IMMUNOPATH PH, V17, P33, DOI 10.1177/039463200401700105; Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Anandacoomarasamy A, 2006, INTERN MED J, V36, P474, DOI 10.1111/j.1445-5994.2006.01113.x; ANTONARAKIS SE, 1995, BLOOD, V86, P2206, DOI 10.1182/blood.V86.6.2206.bloodjournal8662206; Bearden CM, 2005, AM J TRANSPLANT, V5, P50, DOI 10.1111/j.1600-6143.2003.00646.x; Bennett CL, 2005, BLOOD, V106, P3343, DOI 10.1182/blood-2005-02-0508; Berntorp Erik, 2000, Haematologica, V85, P48; Brackmann HH, 1996, VOX SANG, V70, P30, DOI 10.1111/j.1423-0410.1996.tb01346.x; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; CARDOSO AI, 1993, ACTA ENDOCRINOL-COP, V129, P20, DOI 10.1530/acta.0.1290020; Casadevall N, 2005, J AM SOC NEPHROL, V16, pS67, DOI 10.1681/ASN.2004110959; Chemnitz J, 2002, AM J HEMATOL, V71, P105, DOI 10.1002/ajh.10204; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; Cobbold SP, 2006, IMMUNOL REV, V213, P239, DOI 10.1111/j.1600-065X.2006.00428.x; Cornall RJ, 1998, CIBA F SYMP, V215, P21; Daley SR, 2007, J IMMUNOL, V179, P3648, DOI 10.4049/jimmunol.179.6.3648; Darabi K, 2006, AM J CLIN PATHOL, V125, P592, DOI 10.1309/RLNM-J01W-BJRN-LH03; Desai DD, 2007, J IMMUNOL, V178, P6217, DOI 10.4049/jimmunol.178.10.6217; Ewenstein BM, 1997, BLOOD, V89, P1115, DOI 10.1182/blood.V89.3.1115; FABBRO D, 1987, AM J HUM GENET, V40, P15; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Garman RD, 2004, CLIN EXP IMMUNOL, V137, P496, DOI 10.1111/j.1365-2249.2004.02567.x; Garman SC, 2002, MOL GENET METAB, V77, P3, DOI 10.1016/S1096-7192(02)00151-8; Germain DP, 2001, MUTAT RES-FUND MOL M, V483, P89, DOI 10.1016/S0027-5107(01)00232-9; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Goodeve A, 2003, BLOOD COAGUL FIBRIN, V14, pS17, DOI 10.1097/00001721-200306001-00005; Goodeve AC, 2000, THROMB HAEMOSTASIS, V83, P844; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; HARADA H, 1993, BLOOD, V81, P2658; Haribhai D, 2003, J IMMUNOL, V170, P3007, DOI 10.4049/jimmunol.170.6.3007; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Haznedaroglu IC, 2002, CLIN APPL THROMB-HEM, V8, P193, DOI 10.1177/107602960200800301; Hermans MMP, 2004, HUM MUTAT, V23, P47, DOI 10.1002/humu.10286; Herndon RM, 2005, MULT SCLER, V11, P409, DOI 10.1191/1352458505ms1209oa; Herve M, 2007, J EXP MED, V204, P1583, DOI 10.1084/jem.20062287; Herzog RW, 2002, HUM GENE THER, V13, P1281, DOI 10.1089/104303402760128513; Horn J, 2007, CLIN IMMUNOL, V122, P156, DOI 10.1016/j.clim.2006.10.002; Huang WH, 2003, TRANSPLANTATION, V75, P368, DOI 10.1097/01.TP.0000044360.20396.AB; Hunley TE, 2004, PEDIATRICS, V114, pE532, DOI 10.1542/peds.2003-0988-L; Joseph A, 2008, CLIN EXP IMMUNOL, V152, P138, DOI 10.1111/j.1365-2249.2008.03602.x; Kakavanos R, 2003, LANCET, V361, P1608, DOI 10.1016/S0140-6736(03)13311-9; Kakkis E, 2004, P NATL ACAD SCI USA, V101, P829, DOI 10.1073/pnas.0305480101; Kang HK, 2005, J IMMUNOL, V174, P3247, DOI 10.4049/jimmunol.174.6.3247; Keystone E, 2007, ARTHRITIS RHEUM-US, V56, P3896, DOI 10.1002/art.23059; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Knobe KE, 2002, ACTA PAEDIATR, V91, P910, DOI 10.1080/080352502760148621; Koren E., 2002, Current Pharmaceutical Biotechnology, V3, P349, DOI 10.2174/1389201023378175; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lacroix-Desmazes S, 2002, NEW ENGL J MED, V346, P662, DOI 10.1056/NEJMoa011979; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Lozier JN, 2002, P NATL ACAD SCI USA, V99, P12991, DOI 10.1073/pnas.192219599; MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; MONGINI PKA, 1984, J IMMUNOL, V132, P1647; Ohashi PS, 2002, CURR OPIN IMMUNOL, V14, P744, DOI 10.1016/S0952-7915(02)00406-5; Oldenburg J, 2006, HAEMOPHILIA, V12, P15, DOI 10.1111/j.1365-2516.2006.01361.x; PIRCHER H, 1993, EUR J IMMUNOL, V23, P669, DOI 10.1002/eji.1830230315; Reipert BM, 2007, BRIT J HAEMATOL, V136, P12, DOI 10.1111/j.1365-2141.2006.06359.x; Romball CG, 1999, J INTERF CYTOK RES, V19, P671, DOI 10.1089/107999099313820; Rosenberg M, 1999, BLOOD, V93, P2081, DOI 10.1182/blood.V93.6.2081.406k07_2081_2088; Salooja N, 2002, BRIT J HAEMATOL, V118, P839, DOI 10.1046/j.1365-2141.2002.03666.x; Shankar G, 2006, TRENDS BIOTECHNOL, V24, P274, DOI 10.1016/j.tibtech.2006.04.001; Shimada E, 2002, TRANSFUSION, V42, P766, DOI 10.1046/j.1537-2995.2002.00117.x; Siemionow M, 2002, J HAND SURG-AM, V27A, P1095, DOI 10.1053/jhsu.2002.36524; St Clair EW, 2007, ANNU REV MED, V58, P329, DOI 10.1146/annurev.med.58.061705.145449; Sun B, 2007, AM J HUM GENET, V81, P1042, DOI 10.1086/522236; Thorland EC, 1999, HAEMOPHILIA, V5, P101, DOI 10.1046/j.1365-2516.1999.00303.x; Tivol EA, 1997, J IMMUNOL, V158, P5091; Vedder AC, 2006, MOL GENET METAB, V89, P239, DOI 10.1016/j.ymgme.2006.04.013; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x; Warrier I, 1997, J PEDIAT HEMATOL ONC, V19, P23, DOI 10.1097/00043426-199701000-00003; WEIGLE WO, 1987, CRC CR REV IMMUNOL, V7, P285; Whitmer KJ, 1997, J IMMUNOL, V159, P644; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Winsor-Hines D, 2004, J IMMUNOL, V173, P4715, DOI 10.4049/jimmunol.173.7.4715; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; Withers DR, 2007, BLOOD, V109, P4856, DOI 10.1182/blood-2006-08-043414; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zhang MF, 2003, J IMMUNOL, V170, P3954, DOI 10.4049/jimmunol.170.8.3954; Zinkernagel RM, 2000, SEMIN IMMUNOL, V12, P163, DOI 10.1006/smim.2000.0253	88	124	140	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2008	26	8					901	908		10.1038/nbt.1484	http://dx.doi.org/10.1038/nbt.1484			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	335WX	18688246	Green Accepted			2022-12-25	WOS:000258325500024
J	Zhou, CC; Zhang, YJ; Irani, RA; Zhang, H; Mi, TJ; Popek, EJ; Hicks, MJ; Ramin, SM; Kellems, RE; Xia, Y				Zhou, Cissy C.; Zhang, Yujin; Irani, Roxanna A.; Zhang, Hong; Mi, Tiejuan; Popek, Edwina J.; Hicks, M. John; Ramin, Susan M.; Kellems, Rodney E.; Xia, Yang			Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice	NATURE MEDICINE			English	Article							REDUCED UTERINE PERFUSION; MATERNAL AUTOANTIBODIES; SOLUBLE ENDOGLIN; HYPERTENSION; RENIN; CELLS; PATHOPHYSIOLOGY; PATHOGENESIS; ENDOTHELIN; ANTIBODIES	Pre-eclampsia affects approximately 5% of pregnancies and remains a leading cause of maternal and neonatal mortality and morbidity in the United States and the world(1,2). The clinical hallmarks of this maternal disorder include hypertension, proteinuria, endothelial dysfunction and placental defects. Advanced-stage clinical symptoms include cerebral hemorrhage, renal failure and the HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. An effective treatment of pre-eclampsia is unavailable owing to the poor understanding of the pathogenesis of the disease. Numerous recent studies(3-5) have shown that women with pre-eclampsia possess autoantibodies, termed AT(1)-AAs, that bind and activate the angiotensin II receptor type 1a (AT(1) receptor). We show here that key features of pre-eclampsia, including hypertension, proteinuria, glomerular endotheliosis (a classical renal lesion of pre-eclampsia), placental abnormalities and small fetus size appeared in pregnant mice after injection with either total IgG or affinity-purified AT(1)-AAs from women with pre-eclampsia. These features were prevented by co-injection with losartan, an AT(1) receptor antagonist, or by an antibody neutralizing seven-amino-acid epitope peptide. Thus, our studies indicate that pre-eclampsia may be a pregnancy-induced autoimmune disease in which key features of the disease result from autoantibody-induced angiotensin receptor activation. This hypothesis has obvious implications regarding pre-eclampsia screening, diagnosis and therapy.	[Zhou, Cissy C.; Zhang, Yujin; Irani, Roxanna A.; Mi, Tiejuan; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Sch Med, Dept Biochem, Houston, TX 77030 USA; [Zhou, Cissy C.; Zhang, Yujin; Irani, Roxanna A.; Mi, Tiejuan; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Sch Med, Dept Mol Biol, Houston, TX 77030 USA; [Zhang, Hong] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Popek, Edwina J.; Hicks, M. John] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Ramin, Susan M.] Univ Texas Houston, Sch Med, Dept Obstet Gynecol & Reprod Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Xia, Y (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem, 6431 Fannin, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034130] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD034130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076558] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL076558, HL076558] Funding Source: Medline; NICHD NIH HHS [HD34130, R56 HD034130, R01 HD034130-11A2, R01 HD034130] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexander BT, 2001, HYPERTENSION, V37, P485, DOI 10.1161/01.HYP.37.2.485; Alexander BT, 2001, HYPERTENSION, V37, P1191, DOI 10.1161/01.HYP.37.4.1191; Barron LA, 2001, HYPERTENSION, V38, P730, DOI 10.1161/01.HYP.38.3.730; Bobst SM, 2005, AM J HYPERTENS, V18, P330, DOI 10.1016/j.amjhyper.2004.10.002; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; CAMPBELL DM, 1985, BRIT J OBSTET GYNAEC, V92, P131, DOI 10.1111/j.1471-0528.1985.tb01064.x; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Dechend R, 2005, HYPERTENSION, V45, P742, DOI 10.1161/01.HYP.0000154785.50570.63; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; DECHEND R, 2006, HYPERTENS PREGNANCY, V25; DEJONG CLD, 1991, CLIN PERINATOL, V18, P683, DOI 10.1016/S0095-5108(18)30491-3; ESKENAZI B, 1993, AM J OBSTET GYNECOL, V169, P1112, DOI 10.1016/0002-9378(93)90265-K; Gilbert JS, 2007, HYPERTENSION, V50, P1142, DOI 10.1161/HYPERTENSIONAHA.107.096594; Granger JP, 2002, MICROCIRCULATION, V9, P147, DOI 10.1038/sj.mn.7800137; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Herse F, 2007, HYPERTENSION, V49, P604, DOI 10.1161/01.HYP.0000257797.49289.71; LaMarca BBD, 2005, HYPERTENSION, V46, P1022, DOI 10.1161/01.HYP.0000175476.26719.36; LaMarca BBD, 2005, HYPERTENSION, V46, P82, DOI 10.1161/01.HYP.0000169152.59854.36; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Llinas M, 2005, HYPERTENSION, V46, P884; Luft FC, 2000, J MOL MED-JMM, V78, P63, DOI 10.1007/s001090000087; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Roberts L, 2006, HYPERTENSION, V47, P615, DOI 10.1161/01.HYP.0000197950.42301.dd; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Thway TM, 2004, CIRCULATION, V110, P1612, DOI 10.1161/01.CIR.0000142855.68398.3A; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Wallukat G, 2003, CAN J PHYSIOL PHARM, V81, P79, DOI 10.1139/Y02-160; Walther T, 2005, HYPERTENSION, V46, P1275, DOI 10.1161/01.HYP.0000190040.66563.04; Xia Y, 2003, J SOC GYNECOL INVEST, V10, P82, DOI 10.1016/S1071-5576(02)00259-9; Xia Y, 2007, J IMMUNOL, V179, P3391, DOI 10.4049/jimmunol.179.6.3391; Xia Y, 2007, HYPERTENSION, V50, P269, DOI 10.1161/HYPERTENSIONAHA.107.091322; Zhou CCY, 2008, HYPERTENSION, V51, P1010, DOI 10.1161/HYPERTENSIONAHA.107.097790; Zhou CC, 2007, CIRC RES, V100, P88, DOI 10.1161/01.RES.0000254703.11154.18	40	331	353	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2008	14	8					855	862		10.1038/nm.1856	http://dx.doi.org/10.1038/nm.1856			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18660815	Green Accepted			2022-12-25	WOS:000258237500033
J	Blum, B; Bar-Nur, O; Golan-Lev, T; Benvenisty, N				Blum, Barak; Bar-Nur, Ori; Golan-Lev, Tamar; Benvenisty, Nissim			The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							CANCER; DIFFERENTIATION; EXPRESSION; TUMORS; INHIBITION; CHECKPOINT; THERAPY; GROWTH; MUTANT; LINES	Teratomas derived from human embryonic stem (hES) cells are unique among oncogenic phenomena as they are polyclonal and develop from apparently normal cells(1,2). A deeper understanding of this process should aid in the development of safer cell therapies and may help elucidate the basic principles of tumor initiation. We find that transplantation of diploid hES cells from four independent cell lines generates benign teratomas with no sign of malignancy or persisting embryonal carcinoma-like cells. In contrast, mouse embryonic stem (mES) cells from four cell lines consistently generate malignant teratocarcinomas. Global gene expression analysis shows that survivin (BIRC5), an anti-apoptotic oncofetal gene, is highly expressed in hES cells and teratomas but not in embryoid bodies. Genetic and pharmacological ablation of survivin induces apoptosis in hES cells and in teratomas both in vitro and in vivo. We suggest that continued expression of survivin upon differentiation in vivo may contribute to teratoma formation by hES cells.	[Blum, Barak; Bar-Nur, Ori; Golan-Lev, Tamar; Benvenisty, Nissim] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Bar-Nur, Ori/GWQ-5917-2022	Blum, Barak/0000-0002-5308-4194	Bereshit Consortium; The Israeli Ministry of Trade and Industry [37675]; European Community [018739]; Legacy Heritage Fund	Bereshit Consortium; The Israeli Ministry of Trade and Industry; European Community(European Commission); Legacy Heritage Fund	We thank Douglas Grossman (University of Utah) and Dario C. Altieri (University of Massachusetts) for survivin-GFP expression vectors; Austin Smith (University of Cambridge, UK) for Nanog antibody; Yehudit Bergman (Hebrew University of Jerusalem) for Oct4 antibody; Eran Meshorer (Hebrew University of Jerusalem) for J1, R1 and E14 mES cells; Amir Eden (Hebrew University of Jerusalem) for the P53<SUP>-/-</SUP> Ras and E1A transformed MEFs; Yoav Sherman and Victoria Doviner for assistance with tumor histology; Yehuda Tzfati and Noa Lam for help with telomerase activity assays; Micha Drukker for help with establishing the teratoma production protocol; Yoav Mayshar and Ofra Yanuka for assistance with DNA microarray analysis; Marjorie Pick for help with flow cytometry experiments; and Nadav Sharon for help with statistical analyses. This research was partially supported by funds from Bereshit Consortium, The Israeli Ministry of Trade and Industry (Grant number 37675), the European Community (ESTOOLS, Grant number 018739) and by the Legacy Heritage Fund.	Adida C, 1998, AM J PATHOL, V152, P43; Albanell J, 1999, J NATL CANCER I, V91, P1321, DOI 10.1093/jnci/91.15.1321; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2007, STEM CELLS, V25, P1924, DOI 10.1634/stemcells.2007-0073; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; DAMJANOV I, 1983, CANCER RES, V43, P2190; Damjanov I, 2007, NAT BIOTECHNOL, V25, P1212, DOI 10.1038/nbt1107-1212a; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Grossman D, 2001, P NATL ACAD SCI USA, V98, P635, DOI 10.1073/pnas.230450097; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kameda T, 2005, STEM CELLS, V23, P1535, DOI 10.1634/stemcells.2005-0054; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Looijenga LHJ, 2003, CANCER RES, V63, P2244; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Ma XY, 2006, J BIOTECHNOL, V123, P367, DOI 10.1016/j.jbiotec.2005.11.018; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI12983; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; WALT H, 1993, INT J ANDROL, V16, P267, DOI 10.1111/j.1365-2605.1993.tb01190.x; Yang D, 2004, P NATL ACAD SCI USA, V101, P15100, DOI 10.1073/pnas.0406665101	35	133	142	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2009	27	3					281	287		10.1038/nbt.1527	http://dx.doi.org/10.1038/nbt.1527			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	416UJ	19252483				2022-12-25	WOS:000264030700022
J	Gudbjartsson, DF; Bjornsdottir, US; Halapi, E; Helgadottir, A; Sulem, P; Jonsdottir, GM; Thorleifsson, G; Helgadottir, H; Steinthorsdottir, V; Stefansson, H; Williams, C; Hui, J; Beilby, J; Warrington, NM; James, A; Palmer, LJ; Koppelman, GH; Heinzmann, A; Krueger, M; Boezen, HM; Wheatley, A; Altmuller, J; Shin, HD; Uh, ST; Cheong, HS; Jonsdottir, B; Gislason, D; Park, CS; Rasmussen, LM; Porsbjerg, C; Hansen, JW; Backer, V; Werge, T; Janson, C; Jonsson, UB; Ng, MCY; Chan, J; So, WY; Ma, R; Shah, SH; Granger, CB; Quyyumi, AA; Levey, AI; Vaccarino, V; Reilly, MP; Rader, DJ; Williams, MJA; van Rij, AM; Jones, GT; Trabetti, E; Malerba, G; Pignatti, PF; Boner, A; Pescollderungg, L; Girelli, D; Olivieri, O; Martinelli, N; Ludviksson, BR; Ludviksdottir, D; Eyjolfsson, GI; Arnar, D; Thorgeirsson, G; Deichmann, K; Thompson, PJ; Wjst, M; Hall, IP; Postma, DS; Gislason, T; Gulcher, J; Kong, A; Jonsdottir, I; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Bjornsdottir, Unnur S.; Halapi, Eva; Helgadottir, Anna; Sulem, Patrick; Jonsdottir, Gudrun M.; Thorleifsson, Gudmar; Helgadottir, Hafdis; Steinthorsdottir, Valgerdur; Stefansson, Hreinn; Williams, Carolyn; Hui, Jennie; Beilby, John; Warrington, Nicole M.; James, Alan; Palmer, Lyle J.; Koppelman, Gerard H.; Heinzmann, Andrea; Krueger, Marcus; Boezen, H. Marike; Wheatley, Amanda; Altmuller, Janine; Shin, Hyoung Doo; Uh, Soo-Taek; Cheong, Hyun Sub; Jonsdottir, Brynja; Gislason, David; Park, Choon-Sik; Rasmussen, Linda M.; Porsbjerg, Celeste; Hansen, Jakob W.; Backer, Vibeke; Werge, Thomas; Janson, Christer; Joensson, Ulla-Britt; Ng, Maggie C. Y.; Chan, Juliana; So, Wing Yee; Ma, Ronald; Shah, Svati H.; Granger, Christopher B.; Quyyumi, Arshed A.; Levey, Allan I.; Vaccarino, Viola; Reilly, Muredach P.; Rader, Daniel J.; Williams, Michael J. A.; van Rij, Andre M.; Jones, Gregory T.; Trabetti, Elisabetta; Malerba, Giovanni; Pignatti, Pier Franco; Boner, Attilio; Pescollderungg, Lydia; Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola; Ludviksson, Bjorn R.; Ludviksdottir, Dora; Eyjolfsson, Gudmundur I.; Arnar, David; Thorgeirsson, Gudmundur; Deichmann, Klaus; Thompson, Philip J.; Wjst, Matthias; Hall, Ian P.; Postma, Dirkje S.; Gislason, Thorarinn; Gulcher, Jeffrey; Kong, Augustine; Jonsdottir, Ingileif; Thorsteinsdottir, Unnur; Stefansson, Kari			Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction	NATURE GENETICS			English	Article							THYMIC STROMAL LYMPHOPOIETIN; DISEASE; GENE; CYTOKINE; EXPRESSION; RECEPTOR; GENOME; IL-33; MICE; ST2	Eosinophils are pleiotropic multifunctional leukocytes involved in initiation and propagation of inflammatory responses and thus have important roles in the pathogenesis of inflammatory diseases. Here we describe a genome-wide association scan for sequence variants affecting eosinophil counts in blood of 9,392 Icelanders. The most significant SNPs were studied further in 12,118 Europeans and 5,212 East Asians. SNPs at 2q12 (rs1420101), 2q13 (rs12619285), 3q21 (rs4857855), 5q31 (rs4143832) and 12q24 (rs3184504) reached genome-wide significance (P = 5.3 x 10(-14), 5.4 x 10(-10), 8.6 x 10(-17), 1.2 x 10(-10) and 6.5 x 10(-19), respectively). A SNP at IL1RL1 associated with asthma (P = 5.5 x 10(-12)) in a collection of ten different populations (7,996 cases and 44,890 controls). SNPs at WDR36, IL33 and MYB that showed suggestive association with eosinophil counts were also associated with atopic asthma (P = 4.2 x 10(-6), 2.2 x 10(-5) and 2.4 x 10(-4), respectively). We also found that a nonsynonymous SNP at 12q24, in SH2B3, associated significantly (P = 8.6 x 10(-8)) with myocardial infarction in six different populations (6,650 cases and 40,621 controls).	[Gudbjartsson, Daniel F.; Bjornsdottir, Unnur S.; Halapi, Eva; Helgadottir, Anna; Sulem, Patrick; Jonsdottir, Gudrun M.; Thorleifsson, Gudmar; Helgadottir, Hafdis; Steinthorsdottir, Valgerdur; Stefansson, Hreinn; Gulcher, Jeffrey; Kong, Augustine; Jonsdottir, Ingileif; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Bjornsdottir, Unnur S.; Ludviksson, Bjorn R.; Arnar, David; Thorgeirsson, Gudmundur; Gislason, Thorarinn] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Williams, Carolyn; Thompson, Philip J.] Lung Inst Western Australia, Nedlands, WA 6006, Australia; [Williams, Carolyn; Thompson, Philip J.] Western Australian Inst Med Res, Perth, WA 6000, Australia; [Williams, Carolyn; Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Hui, Jennie; Beilby, John] QEII Med Ctr, PathWest Lab Med Western Australia, Dept Mol Genet, Nedlands, WA 6009, Australia; [Hui, Jennie] Univ Western Australia, QEII Med Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; [Beilby, John] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia; [Warrington, Nicole M.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Nedlands, WA 6009, Australia; [James, Alan] Sir Charles Gairdner Hosp, Dept Pulm Physiol, W Australian Sleep Disorders Res Inst, Nedlands, WA 6009, Australia; [James, Alan] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Koppelman, Gerard H.] Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, NL-9700 RB Groningen, Netherlands; [Heinzmann, Andrea; Krueger, Marcus; Deichmann, Klaus] Univ Freiburg, Ctr Pediat & Adolescent Med, D-79085 Freiburg, Germany; [Boezen, H. Marike] Univ Groningen, Univ Med Ctr, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Wheatley, Amanda] Univ Nottingham Hosp, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, England; [Altmuller, Janine; Hall, Ian P.] Univ Cologne, Cologne Ctr Genom, D-50923 Cologne, Germany; [Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Lab Genom Divers, Seoul 121742, South Korea; [Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul 153803, South Korea; [Uh, Soo-Taek; Cheong, Hyun Sub] Soonchunhyang Univ, Seoul Hosp, Div Allergy & Resp Med, Seoul 140210, South Korea; [Jonsdottir, Brynja; Gislason, David; Arnar, David; Thorgeirsson, Gudmundur; Gislason, Thorarinn; Jonsdottir, Ingileif] Landspitali Univ Hosp, IS-101 Reykjavik, Iceland; [Park, Choon-Sik] Soonchunhyang Univ, Div Allergy & Resp Med, Bucheon Hosp, Puchon 420031, South Korea; [Rasmussen, Linda M.; Porsbjerg, Celeste; Hansen, Jakob W.; Backer, Vibeke] Copenhagen Univ Hosp, Bispebjerg Hosp, Dept Resp Med, DK-2400 Copenhagen, Denmark; [Werge, Thomas] Sct Hans Hosp Boserupve, Res Inst Biol Psychiat, DK-4000 Roskilde, Denmark; [Janson, Christer; Joensson, Ulla-Britt] Uppsala Univ, Dept Med Sci Inflammat, S-75105 Uppsala, Sweden; [Ng, Maggie C. Y.; Chan, Juliana; So, Wing Yee; Ma, Ronald] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Shah, Svati H.; Granger, Christopher B.] Duke Univ, Sch Med, Durham, NC 27710 USA; [Quyyumi, Arshed A.; Levey, Allan I.; Vaccarino, Viola] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Reilly, Muredach P.; Rader, Daniel J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Williams, Michael J. A.; van Rij, Andre M.; Jones, Gregory T.] Univ Otago Sch Med, Vasc Res Grp, Dunedin 9054, New Zealand; [Trabetti, Elisabetta; Malerba, Giovanni; Pignatti, Pier Franco] Univ Verona, Dept Mother & Child, Sect Biol & Genet, I-37129 Verona, Italy; [Boner, Attilio] Univ Verona, Dept Mother & Child, Sect Pediat, I-37129 Verona, Italy; [Pescollderungg, Lydia] Bolzano Hosp, Dept Pediat, I-39100 Bolzano, Italy; [Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola] Univ Verona, Sect Internal Med, Dept Clin & Expt Med, I-37129 Verona, Italy; [Eyjolfsson, Gudmundur I.] RAM, Lab Mjodd, IS-109 Reykjavik, Iceland; [Wjst, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Wjst, Matthias] EURAC Res, Inst Med Genet, D-39100 Bozen, Germany; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr, Dept Pulmonol, NL-9700 RB Groningen, Netherlands	University of Iceland; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Groningen; University of Freiburg; University of Groningen; University of Nottingham; University of Cologne; Sogang University; SNP Genetics; Soonchunhyang University; Landspitali National University Hospital; Soonchunhyang University; University of Copenhagen; Bispebjerg Hospital; Uppsala University; Chinese University of Hong Kong; Prince of Wales Hospital; Duke University; Emory University; University of Pennsylvania; University of Otago; University of Verona; University of Verona; Krankenhaus Bozen; University of Verona; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Groningen	Gudbjartsson, DF (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Granger, Christopher B/D-3458-2014; Palmer, Lyle John/N-1948-2019; Ma, Ronald/C-2788-2009; Palmer, Lyle John/K-3196-2014; Koppelman, Gerard/AAG-9187-2020; Lúðvíksson, Björn Rúnar/AFQ-7993-2022; Malerba, Giovanni/T-3278-2019; Chan, Juliana/B-7918-2016; , Viola/AAW-5600-2020; Hui, Jennie/A-9543-2013; Levey, Allan/F-2104-2011; Michael, Williams J A/C-1759-2008; Olivieri, Oliviero/A-9126-2008; Martinelli, Nicola/J-5622-2016; Backer, Vibeke/I-9573-2014; Stefansson, Kari/AAE-7187-2019; Halapi, Eva/AAL-7666-2020; Warrington, Nicole/P-4868-2014; Girelli, Domenico/B-1183-2008; Backer, Vibeke/AAQ-9379-2021; Werge, Thomas/G-7263-2012	Granger, Christopher B/0000-0002-0045-3291; Palmer, Lyle John/0000-0002-1628-3055; Ma, Ronald/0000-0002-1227-803X; Palmer, Lyle John/0000-0002-1628-3055; Chan, Juliana/0000-0003-1325-1194; Hui, Jennie/0000-0002-1653-2496; Levey, Allan/0000-0002-3153-502X; Michael, Williams J A/0000-0003-4822-4962; Olivieri, Oliviero/0000-0001-8209-9056; Martinelli, Nicola/0000-0001-6465-5119; Backer, Vibeke/0000-0002-7806-7219; Halapi, Eva/0000-0003-2025-7148; Warrington, Nicole/0000-0003-4195-775X; Girelli, Domenico/0000-0001-9684-1899; Gudbjartsson, Daniel/0000-0002-5222-9857; Jones, Gregory T/0000-0002-6950-4210; Beilby, John/0000-0002-4915-2254; Helgadottir, Hafdis/0000-0003-4352-152X; Hall, Ian/0000-0001-9933-3216; Stefansson, Hreinn/0000-0002-9331-6666; Hansen, Jakob Werner/0000-0002-7315-3775; Kong, Augustine/0000-0001-8193-5438; Altmuller, Janine/0000-0003-4372-1521; Koppelman, Gerard/0000-0001-8567-3252; Porsbjerg, Celeste/0000-0003-4825-9436; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Malerba, Giovanni/0000-0001-8705-8560; Henry, Amanda/0000-0001-6299-7676; Ludviksson, Bjorn/0000-0002-6445-148X; Reilly, Muredach/0000-0002-3035-9386	US National Heart, Lung, and Blood Institute [SR01HL089650-01]; Health Research Council of New Zealand; Korean Health 21 RD project; Ministry of Health & Welfare, Republic of Korea [A010249]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL077506, R01HL089650] Funding Source: NIH RePORTER; Asthma UK [08/016] Funding Source: researchfish	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Health Research Council of New Zealand(Health Research Council of New Zealand); Korean Health 21 RD project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Asthma UK	The genotyping of some of the myocardial infarction sample sets was funded in part through a grant from the US National Heart, Lung, and Blood Institute (SR01HL089650-01). The New Zealand cohort study was supported by a programme grant from the Health Research Council of New Zealand. The Korean study was supported by a grant from the Korean Health 21 R&D project, Ministry of Health & Welfare, Republic of Korea (A010249).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Mao M, 2004, GENOMICS, V83, P989, DOI 10.1016/j.ygeno.2003.12.019; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Reijmerink NE, 2008, J ALLERGY CLIN IMMUN, V122, P651, DOI 10.1016/j.jaci.2008.06.030; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhu GH, 2008, EUR J HUM GENET, V16, P1083, DOI 10.1038/ejhg.2008.67	28	564	587	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					342	347		10.1038/ng.323	http://dx.doi.org/10.1038/ng.323			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198610				2022-12-25	WOS:000263640200016
J	Liesz, A; Suri-Payer, E; Veltkamp, C; Doerr, H; Sommer, C; Rivest, S; Giese, T; Veltkamp, R				Liesz, Arthur; Suri-Payer, Elisabeth; Veltkamp, Claudia; Doerr, Henrike; Sommer, Clemens; Rivest, Serge; Giese, Thomas; Veltkamp, Roland			Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; INTERFERON-GAMMA; BRAIN; INFLAMMATION; INJURY; ACTIVATION; INTERLEUKIN-10; LYMPHOCYTES; MECHANISMS	Systemic and local inflammatory processes have a key, mainly detrimental role in the pathophysiology of ischemic stroke. Currently, little is known about endogenous counterregulatory immune mechanisms. We examined the role of the key immunomodulators CD4(+)CD25(+) forkhead box P3 (Foxp3)(+) regulatory T lymphocytes (T-reg cells), after experimental brain ischemia. Depletion of T-reg cells profoundly increased delayed brain damage and deteriorated functional outcome. Absence of T-reg cells augmented postischemic activation of resident and invading inflammatory cells including microglia and T cells, the main sources of deleterious cerebral tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), respectively. Early antagonization of TNF-alpha and delayed neutralization of IFN-gamma prevented infarct growth in T-reg cell-depleted mice. Intracerebral interleukin-10 (IL-10) substitution abrogated the cytokine overexpression after T-reg cell depletion and prevented secondary infarct growth, whereas transfer of IL-10 deficient T-reg cells in an adoptive transfer model was ineffective. In conclusion, T-reg cells are major cerebroprotective modulators of postischemic inflammatory brain damage targeting multiple inflammatory pathways. IL-10 signaling is essential for their immunomodulatory effect.	[Liesz, Arthur; Veltkamp, Roland] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Suri-Payer, Elisabeth] German Canc Res Ctr, Dept Immunogenet, D-69120 Heidelberg, Germany; [Veltkamp, Claudia] German Canc Res Ctr, Dept Internal Med 4, D-69120 Heidelberg, Germany; [Doerr, Henrike; Sommer, Clemens] Johannes Gutenberg Univ Mainz, Dept Neuropathol, D-55131 Mainz, Germany; [Rivest, Serge] Univ Laval, Res Ctr, CHU Laval, Mol Endocrinol Lab, Quebec City, PQ G1V 4G2, Canada; [Giese, Thomas] Heidelberg Univ, Dept Immunol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz; Laval University; Ruprecht Karls University Heidelberg	Veltkamp, R (corresponding author), Heidelberg Univ, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	Roland.Veltkamp@med.uni-heidelberg.de	Suri-Payer, Elisabeth/ABC-2448-2021; Liesz, Arthur/AAT-7147-2021	Liesz, Arthur/0000-0002-9069-2594; Rivest, Serge/0000-0002-6082-770X	Else-Krorner Fresenius Stiftung; Ministerium fur Wissenschaftund Kultur Baden-Wurttemberg	Else-Krorner Fresenius Stiftung; Ministerium fur Wissenschaftund Kultur Baden-Wurttemberg	This study was supported by grants from the Else-Krorner Fresenius Stiftung and the Ministerium fur Wissenschaftund Kultur Baden-Wurttemberg to R. V. We would like to thank H. Burgers and D. Stefan for excellent technical assistance and I. Galani ( German Cancer Research Center, Heidelberg) for providing the Rag2<SUP>-/-</SUP> mice.	Arumugam TV, 2005, NEUROMOL MED, V7, P229, DOI 10.1385/NMM:7:3:229; Baird AE, 2006, CIRCULATION, V113, P2035, DOI 10.1161/CIRCULATIONAHA.105.620732; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Blais V, 2004, J IMMUNOL, V172, P7043, DOI 10.4049/jimmunol.172.11.7043; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; del Zoppo GJ, 2001, ARCH NEUROL-CHICAGO, V58, P669, DOI 10.1001/archneur.58.4.669; Dirnagl U, 2004, E SCHERING RES FDN W, V47, P87; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Frenkel D, 2005, J NEUROL SCI, V233, P125, DOI 10.1016/j.jns.2005.03.022; Gee JM, 2008, STROKE, V39, P1575, DOI 10.1161/STROKEAHA.107.501486; Gee JM, 2007, STROKE, V38, P783, DOI 10.1161/01.STR.0000248425.59176.7b; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Lambertsen KL, 2005, J CEREBR BLOOD F MET, V25, P119, DOI 10.1038/sj.jcbfm.9600014; Lambertsen KL, 2004, J NEUROPATH EXP NEUR, V63, P942, DOI 10.1093/jnen/63.9.942; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; McNeill A, 2007, SCAND J IMMUNOL, V65, P63, DOI 10.1111/j.1365-3083.2006.01870.x; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Perera MN, 2006, J CLIN NEUROSCI, V13, P1, DOI 10.1016/j.jocn.2005.07.005; Planas AM, 2006, BIOCHEM SOC T, V34, P1267, DOI 10.1042/BST0341267; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Steiner GE, 2000, J IMMUNOL METHODS, V237, P39, DOI 10.1016/S0022-1759(99)00240-9; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Suri-Payer E, 2006, SPRINGER SEMIN IMMUN, V28, P3, DOI 10.1007/s00281-006-0021-8; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vogel J, 1999, STROKE, V30, P1134, DOI 10.1161/01.STR.30.5.1134; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	50	735	776	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					192	199		10.1038/nm.1927	http://dx.doi.org/10.1038/nm.1927			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19169263				2022-12-25	WOS:000263119400022
J	Liu, QH; Busby, JC; Molkentin, JD				Liu, Qinghang; Busby, Jennifer Caldwell; Molkentin, Jeffery D.			Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point	NATURE CELL BIOLOGY			English	Article							TAK1 MAPKKK; CALCINEURIN; PROTEIN; PHOSPHORYLATION; KINASE; FAMILY; IDENTIFICATION; PHOSPHATASE-1; ACTIVATOR; RECEPTOR	The calcium-activated protein phosphatase calcineurin is controlled by regulator of calcineurin (RCAN) in organisms ranging from yeast to mammals. Here we performed a yeast two-hybrid screen with RCAN1 as bait, identifying TAK1 binding protein 2 (TAB2) as an interacting partner. TAB2 interacted directly with RCAN1 in vitro and in vivo, recruiting TAK1, TAB1 and calcineurin, forming a macromolecular signalling complex. Overexpression of TAK1 and TAB1, or active TAK1(Delta N), promoted direct phosphorylation of RCAN1 in vitro and in vivo. TAK1 phosphorylated RCAN1 at Ser 94 and Ser 136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signalling, and enhancing NFATc1 nuclear translocation, NFAT transcriptional activation and the hypertrophic growth of cultured cardiomyocytes. The TAK1-TAB1-TAB2 and the calcineurin-NFAT signalling modules did not interact in Rcan1/2-or Tab2-deficient mouse embryonic fibroblast (MEF) cultures. Calcineurin activation also dephosphorylated and inhibited TAK1 and TAB1, an effect that was absent in Rcan1/2 deficient MEFs. Functionally, TAK1 was indispensable for the cardiomyocyte growth response induced by pro-hypertrophic stimuli through calcineurin. These results describe a signalling relationship between two central regulatory pathways in which TAK1-TAB1-TAB2 selectively induces calcineurin-NFAT signalling through direct phosphorylation of RCAN1, while calcineurin activation diminishes TAK1 signalling by dephosphorylation of TAK1 and TAB1.	[Liu, Qinghang; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Liu, Qinghang; Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Cincinnati, OH 45229 USA; [Busby, Jennifer Caldwell] Scripps Res Inst, Jupiter, FL 33458 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; Scripps Research Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org		Liu, Qinghang/0000-0003-0638-6509; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health; Fondation Leducq; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL060562, R01HL081104, R01HL060562, P50HL077101, P01HL069779, R01HL062927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are very grateful to Yang Xia for the generous gift of the S108/112A mutant RCAN1 plasmid, and Jun Tsuji for providing the Tak1<SUP>-/-</SUP> MEFs originated from Akira's laboratory. This work was supported by grants from the National Institutes of Health (J.D.M), the Fondation Leducq (Heart failure network grant to J.D.M), and the Howard Hughes Medical Institute.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Cohen PTW, 2002, J CELL SCI, V115, P241; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Godeny MD, 2007, CELL SIGNAL, V19, P600, DOI 10.1016/j.cellsig.2006.08.010; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hilioti Z, 2003, BIOCHEM BIOPH RES CO, V311, P1089, DOI 10.1016/S0006-291X(03)01515-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	30	98	102	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					154	U93		10.1038/ncb1823	http://dx.doi.org/10.1038/ncb1823			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136967	Green Accepted			2022-12-25	WOS:000263285500013
J	Subach, FV; Subach, OM; Gundorov, IS; Morozova, KS; Piatkevich, KD; Cuervo, AM; Verkhusha, VV				Subach, Fedor V.; Subach, Oksana M.; Gundorov, Illia S.; Morozova, Kateryna S.; Piatkevich, Kiryl D.; Cuervo, Ana Maria; Verkhusha, Vladislav V.			Monomeric fluorescent timers that change color from blue to red report on cellular trafficking	NATURE CHEMICAL BIOLOGY			English	Article							LYSOSOMAL MEMBRANE GLYCOPROTEIN; CHROMOPHORE FORMATION; PROTEIN; VARIANTS; PATHWAYS; GALACTOSYLTRANSFERASE; BIOCHEMISTRY; MUTAGENESIS; EXPRESSION; MATURATION	Based on the mechanism for chromophore formation in red fluorescent proteins, we developed three mCherry-derived monomeric variants, called fluorescent timers (FTs), that change their fluorescence from the blue to red over time. These variants exhibit distinctive fast, medium and slow blue-to-red chromophore maturation rates that depend on the temperature. At 37 degrees C, the maxima of the blue fluorescence are observed at 0.25, 1.2 and 9.8 h for the purified fast-FT, medium-FT and slow-FT, respectively. The half-maxima of the red fluorescence are reached at 7.1, 3.9 and 28 h, respectively. The FTs show similar timing behavior in bacteria, insect and mammalian cells. Medium-FT allowed for tracking of the intracellular dynamics of the lysosome-associated membrane protein type 2A (LAMP-2A) and determination of its age in the targeted compartments. The results indicate that LAMP-2A transport through the plasma membrane and early or recycling endosomes to lysosomes is a major pathway for LAMP-2A trafficking.	[Subach, Fedor V.; Subach, Oksana M.; Gundorov, Illia S.; Morozova, Kateryna S.; Piatkevich, Kiryl D.; Cuervo, Ana Maria; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Subach, Fedor V.; Subach, Oksana M.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Verkhusha, VV (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	vverkhus@aecom.yu.edu	Subach, Fedor/AAA-5320-2021; Subach, Oksana (Gritsenko)/K-7086-2014; Verkhusha, Vladislav/AAU-7784-2020; Subach, Fedor/K-7080-2014	Subach, Fedor/0000-0003-2720-7821; Verkhusha, Vladislav/0000-0002-2083-8121; Cuervo, Ana Maria/0000-0002-0771-700X; Piatkevich, Kiryl/0000-0002-7777-9468	US National Institutes of Health [GM070358, GM073913, AG021904]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913, R01GM070358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021904, R37AG021904] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Zhang (Albert Einstein College of Medicine) for assistance with flow cytometry. We are grateful to R. Tsien ( University of California at San Diego) for the complementary DNA of mCherry and D. Reeves ( Albert Einstein College of Medicine) for the pcDNA-3.1-LAMP-2A-TSapphire-GFP vector. This work was supported by grants from the US National Institutes of Health (GM070358 and GM073913 to V.V.V. and AG021904 to A.M.C.).	AKASAKI K, 1995, EXP CELL RES, V220, P464, DOI 10.1006/excr.1995.1338; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CARLSSON SR, 1992, ARCH BIOCHEM BIOPHYS, V296, P630, DOI 10.1016/0003-9861(92)90619-8; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gough NR, 1997, J CELL BIOL, V137, P1161, DOI 10.1083/jcb.137.5.1161; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; MATHEWS PM, 1992, J CELL BIOL, V118, P1027, DOI 10.1083/jcb.118.5.1027; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Mirabella R, 2004, PLANT PHYSIOL, V135, P1879, DOI 10.1104/pp.103.038539; Miyawaki A, 2007, NAT CHEM BIOL, V3, P598, DOI 10.1038/nchembio1007-598; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Storrie Brian, 1996, Bioessays, V18, P895, DOI 10.1002/bies.950181108; Strongin DE, 2007, PROTEIN ENG DES SEL, V20, P525, DOI 10.1093/protein/gzm046; STROUS GJ, 1986, CRC CR REV BIOCH MOL, V21, P119, DOI 10.3109/10409238609113610; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	39	117	121	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					118	126		10.1038/nchembio.138	http://dx.doi.org/10.1038/nchembio.138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19136976	Green Accepted			2022-12-25	WOS:000263090700016
J	Lagresle-Peyrou, C; Six, EM; Picard, C; Rieux-Laucat, F; Michel, V; Ditadi, A; Demerens-de Chappedelaine, C; Morillon, E; Valensi, F; Simon-Stoos, KL; Mullikin, JC; Noroski, LM; Besse, C; Wulffraat, NM; Ferster, A; Abecasis, MM; Calvo, F; Petit, C; Candotti, F; Abel, L; Fischer, A; Cavazzana-Calvo, M				Lagresle-Peyrou, Chantal; Six, Emmanuelle M.; Picard, Capucine; Rieux-Laucat, Frederic; Michel, Vincent; Ditadi, Andrea; Demerens-de Chappedelaine, Corinne; Morillon, Estelle; Valensi, Francoise; Simon-Stoos, Karen L.; Mullikin, James C.; Noroski, Lenora M.; Besse, Celine; Wulffraat, Nicolas M.; Ferster, Alina; Abecasis, Manuel M.; Calvo, Fabien; Petit, Christine; Candotti, Fabio; Abel, Laurent; Fischer, Alain; Cavazzana-Calvo, Marina			Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness	NATURE GENETICS			English	Article							MITOCHONDRIAL-INTERMEMBRANE SPACE; BONE-MARROW-TRANSPLANTATION; RETICULAR DYSGENESIS; CYTOCHROME-C; APOPTOTIC PATHWAY; EXPRESSION; KOSTMANN; SURVIVAL; CELLS; DNA	Reticular dysgenesis is an autosomal recessive form of human severe combined immunodeficiency characterized by an early differentiation arrest in the myeloid lineage and impaired lymphoid maturation. In addition, affected newborns have bilateral sensorineural deafness. Here we identify biallelic mutations in AK2 (adenylate kinase 2) in seven individuals affected with reticular dysgenesis. These mutations result in absent or strongly decreased protein expression. We then demonstrate that restoration of AK2 expression in the bone marrow cells of individuals with reticular dysgenesis overcomes the neutrophil differentiation arrest, underlining its specific requirement in the development of a restricted set of hematopoietic lineages. Last, we establish that AK2 is specifically expressed in the stria vascularis region of the inner ear, which provides an explanation of the sensorineural deafness in these individuals. These results identify a previously unknown mechanism involved in regulation of hematopoietic cell differentiation and in one of the most severe human immunodeficiency syndromes.	[Lagresle-Peyrou, Chantal; Six, Emmanuelle M.; Picard, Capucine; Rieux-Laucat, Frederic; Ditadi, Andrea; Demerens-de Chappedelaine, Corinne; Morillon, Estelle; Valensi, Francoise; Fischer, Alain; Cavazzana-Calvo, Marina] INSERM, U768, Res Lab Normal & Pathol Dev Immune Syst, F-75015 Paris, France; [Lagresle-Peyrou, Chantal; Six, Emmanuelle M.; Picard, Capucine; Rieux-Laucat, Frederic; Ditadi, Andrea; Demerens-de Chappedelaine, Corinne; Morillon, Estelle; Abel, Laurent; Fischer, Alain; Cavazzana-Calvo, Marina] Univ Paris 05, Fac Med, IFR94, F-75015 Paris, France; [Lagresle-Peyrou, Chantal] Ecole Prat Hautes Etud, Lab Immunol Cellulaire & Immunopathol, F-75015 Paris, France; [Lagresle-Peyrou, Chantal] Univ Paris 07, CNRS, UMR 7151, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; [Picard, Capucine; Abel, Laurent] INSERM, U550, Lab Human Genet Infect Dis, F-75015 Paris, France; [Michel, Vincent; Petit, Christine] Univ Paris 06, Inst Pasteur, INSERM, Unite Genet & Physiol Audit,UMRS587, F-75015 Paris, France; [Simon-Stoos, Karen L.] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; Candotti, Fabio] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Noroski, Lenora M.] Baylor Coll Med, Dept Pediat, Div Allergy & Immunol, Houston, TX 77030 USA; [Besse, Celine] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, F-91000 Evry, France; [Wulffraat, Nicolas M.] Wilhelmina Childrens Hosp, Utrecht Med Ctr, Dept Immunol BMT, NL-3584 CX Utrecht, Netherlands; [Ferster, Alina] Childrens Univ Hosp Reine Fabiola, Pediat Hematooncol Unit, B-1020 Brussels, Belgium; [Abecasis, Manuel M.] Portuguese Inst Oncol Francisco Gentil, Bone Marrow Transplantat Unit, P-1099023 Lisbon, Portugal; [Calvo, Fabien] Univ Paris 07, Hop St Louis, AP HP, INSERM,U716,Clin Invest Ctr, F-75015 Paris, France; [Petit, Christine] Coll France, F-75015 Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, AP HP, Serv Immunol & Hematol Pediat, F-75015 Paris, France; [Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, AP HP, Dept Biotherapie, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cavazzana-Calvo, M (corresponding author), INSERM, U768, Res Lab Normal & Pathol Dev Immune Syst, F-75015 Paris, France.	m.cavazzana@nck.aphp.fr	Six, Emmanuelle/H-7891-2017; Ditadi, Andrea/K-3461-2016; Abel, Laurent/H-8888-2017; Peyrou, Chantal Lagresle/H-2911-2017; Wulffraat, Nico M/AAE-8929-2020; Peyrou, Chantal Lagresle/AAK-9689-2020; Picard, Capucine/H-3914-2017; Rieux-Laucat, Frédéric/A-7916-2017; Demerens de Chappedelaine, Corinne/H-1648-2017	Six, Emmanuelle/0000-0001-7806-0968; Ditadi, Andrea/0000-0003-3283-8943; Abel, Laurent/0000-0001-7016-6493; Peyrou, Chantal Lagresle/0000-0002-2216-6453; Wulffraat, Nico M/0000-0001-9548-5562; Peyrou, Chantal Lagresle/0000-0002-2216-6453; Picard, Capucine/0000-0001-8788-5056; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Vincent, Michel/0000-0002-7025-4343; Petit, Christine/0000-0002-9069-002X; Cavazzana, Marina/0000-0002-0264-0891; calvo, fabien/0000-0002-0298-7633; Demerens de Chappedelaine, Corinne/0000-0003-3651-0646; Candotti, Fabio/0000-0001-6399-6042	Intramural NIH HHS [Z01 HG000122-10, Z99 HG999999] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330, ZIAHG000122] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; BUJAN W, 1993, BLOOD, V82, P1684, DOI 10.1182/blood.V82.5.1684.bloodjournal8251684a; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; DEVAAL OM, 1959, LANCET, V2, P1123; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Heine P, 1999, EUR J BIOCHEM, V262, P102, DOI 10.1046/j.1432-1327.1999.00347.x; Heltzer ML, 2007, J ALLERGY CLIN IMMUN, V120, P950, DOI 10.1016/j.jaci.2007.07.026; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kohler C, 1999, FEBS LETT, V447, P10, DOI 10.1016/S0014-5793(99)00251-3; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; LEVINSKY RJ, 1983, LANCET, V1, P671; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Peters UR, 1999, CANCER RES, V59, P4233; Reubsaet LL, 2007, BONE MARROW TRANSPL, V39, P307, DOI 10.1038/sj.bmt.1705577; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Solary E, 2008, NAT GENET, V40, P379, DOI 10.1038/ng0408-379; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888	26	138	148	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					106	111		10.1038/ng.278	http://dx.doi.org/10.1038/ng.278			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19043416	Green Accepted			2022-12-25	WOS:000262085300024
J	Dogan, T; Harms, GS; Hekman, M; Karreman, C; Oberoi, TK; Alnemri, ES; Rapp, UR; Rajalingam, K				Dogan, Taner; Harms, Gregory S.; Hekman, Mirko; Karreman, Christiaan; Oberoi, Tripat Kaur; Alnemri, Emad S.; Rapp, Ulf R.; Rajalingam, Krishnaraj			X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility	NATURE CELL BIOLOGY			English	Article							APOPTOSIS PROTEINS; SIGNALING PATHWAYS; XIAP; INHIBITOR; CHAPERONE; DESTABILIZATION	Inhibitor of apoptosis proteins (IAP) are evolutionarily conserved anti-apoptotic regulators(1,2). C-RAF protein kinase is a direct RAS effector protein, which initiates the classical mitogen-activated protein kinase ( MAPK) cascade. This signalling cascade mediates diverse biological functions, such as cell growth, proliferation, migration, differentiation and survival(3,4). Here we demonstrate that XIAP and c-IAPs bind directly to C-RAF kinase and that siRNA-mediated silencing of XIAP and c-IAPs leads to stabilization of C-RAF in human cells. XIAP binds strongly to C-RAF and promotes the ubiquitylation of C-RAF in vivo through the Hsp90-mediated quality control system, independently of its E3 ligase activity. In addition, XIAP or c-IAP-1/2 knockdown cells showed enhanced cell migration in a C-RAF-dependent manner. XIAP promotes binding of CHIP ( carboxy terminal Hsc70-interacting protein), a chaperone-associated ubiquitin ligase, to the C-RAF-Hsp90 complex in vivo. Interfering with CHIP expression resulted in stabilization of C-RAF and enhanced cell migration, as observed in XIAP knockdown cells. Our data show an unexpected role of XIAP and c-IAPs in the turnover of C-RAF protein, thereby modulating the MAPK signalling pathway and cell migration.	[Dogan, Taner; Oberoi, Tripat Kaur; Rajalingam, Krishnaraj] Goethe Univ Frankfurt, Emmy Noether Grp, DFG, Med Sch,Inst Biochem 2, Frankfurt, Germany; [Hekman, Mirko; Karreman, Christiaan; Rapp, Ulf R.] Univ Wurzburg, Bayer Krebsforschungszentrum, MZS, D-97070 Wurzburg, Germany; [Harms, Gregory S.] Univ Wurzburg, Dept Mol Microscopy, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Ctr Apoptosis Res, Kimmel Canc Inst, Philadelphia, PA 19107 USA	German Research Foundation (DFG); Goethe University Frankfurt; University of Wurzburg; University of Wurzburg; Jefferson University	Rajalingam, K (corresponding author), Goethe Univ Frankfurt, Emmy Noether Grp, DFG, Med Sch,Inst Biochem 2, Frankfurt, Germany.	krishna@biochem2.de	Rajalingam, krishnaraj/D-3081-2011; Alnemri, Emad S/B-4526-2010	Oberoi, Tripat Kaur/0000-0001-9299-9496	DFG [RA1739/1-1, SFB487, SFB581]; NIH [GMO76167]	DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Pascal Meier, Richard Marais, Len Neckers, Yuri Lazebnik and H. Wayant for valuable reagents; Brigitte Ruester and Reinhard Henschler for assistance with cell sorting; Renate Metz for help with the purification of proteins; Andreas Fischer for Biacore analysis; Juliane Mooz and Barbara Bauer for technical assistance. This work is supported by an Emmy Noether programme grant (RA1739/1-1) to K. R. from the DFG and various grants to U. R. R. from DFG, including Immunomodulation and German-French Graduate Schools, SFB487, SFB581, and grants from the Scheel Stiftung. E. S. A. is supported by grants from the NIH (GMO76167). We thank Antoine Galmiche for sharing unpublished observations, Ralf Schreck and Ritva Tikkanen for critically reading the manuscript.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp UR, 2004, BBA-MOL CELL RES, V1644, P149, DOI 10.1016/j.bbamcr.2003.10.015; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tian S, 2006, INT J ONCOL, V29, P861; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vucic D, 2008, CURR CANCER DRUG TAR, V8, P110, DOI 10.2174/156800908783769373; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	31	82	82	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1447	1455		10.1038/ncb1804	http://dx.doi.org/10.1038/ncb1804			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011619				2022-12-25	WOS:000261261800015
J	Yu, PB; Deng, DY; Lai, CS; Hong, CC; Cuny, GD; Bouxsein, ML; Hong, DW; McManus, PM; Katagiri, T; Sachidanandan, C; Kamiya, N; Fukuda, T; Mishina, Y; Peterson, RT; Bloch, KD				Yu, Paul B.; Deng, Donna Y.; Lai, Carol S.; Hong, Charles C.; Cuny, Gregory D.; Bouxsein, Mary L.; Hong, Deborah W.; McManus, Patrick M.; Katagiri, Takenobu; Sachidanandan, Chetana; Kamiya, Nobuhiro; Fukuda, Tomokazu; Mishina, Yuji; Peterson, Randall T.; Bloch, Kenneth D.			BMP type I receptor inhibition reduces heterotopic ossification	NATURE MEDICINE			English	Article							BONE-FORMATION; SMAD PROTEINS; PROGRESSIVA; DIFFERENTIATION; IDENTIFICATION; ELEMENTS; ARREST; CELLS; ACVR1	Fibrodysplasia ossificans progressiva (FOP) is a congenital disorder of progressive and widespread postnatal ossification of soft tissues(1-4) and is without known effective treatments. Affected individuals harbor conserved mutations in the ACVR1 gene that are thought to cause constitutive activation of the bone morphogenetic protein (BMP) type I receptor, activin receptor-like kinase-2 (ALK2)(5). Here we show that intramuscular expression in the mouse of an inducible transgene encoding constitutively active ALK2 (caALK2), resulting from a glutamine to aspartic acid change at amino acid position 207, leads to ectopic endochondral bone formation, joint fusion and functional impairment, thus phenocopying key aspects of human FOP. A selective inhibitor of BMP type I receptor kinases, LDN-193189 (ref. 6), inhibits activation of the BMP signaling effectors SMAD1, SMAD5 and SMAD8 in tissues expressing caALK2 induced by adenovirus specifying Cre (Ad. Cre). This treatment resulted in a reduction in ectopic ossification and functional impairment. In contrast to localized induction of caALK2 by Ad. Cre (which entails inflammation), global postnatal expression of caALK2 (induced without the use of Ad. Cre and thus without inflammation) does not lead to ectopic ossification. However, if in this context an inflammatory stimulus was provided with a control adenovirus, ectopic bone formation was induced. Like LDN-193189, corticosteroid treatment inhibits ossification in Ad.Cre-injected mutant mice, suggesting caALK2 expression and an inflammatory milieu are both required for the development of ectopic ossification in this model. These results support the role of dysregulated ALK2 kinase activity in the pathogenesis of FOP and suggest that small molecule inhibition of BMP type I receptor activity may be useful in treating FOP and heterotopic ossification syndromes associated with excessive BMP signaling.	[Yu, Paul B.; Deng, Donna Y.; Lai, Carol S.; Hong, Deborah W.; McManus, Patrick M.; Sachidanandan, Chetana; Peterson, Randall T.; Bloch, Kenneth D.] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Boston, MA 02114 USA; [Yu, Paul B.; Bloch, Kenneth D.] Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA; [Yu, Paul B.; Bloch, Kenneth D.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37232 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Cuny, Gregory D.] Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Harvard NeuroDiscovery Ctr, Cambridge, MA 02139 USA; [Cuny, Gregory D.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA; [Bouxsein, Mary L.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Katagiri, Takenobu] Saitama Med Univ, Div Pathophysiol, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Kamiya, Nobuhiro; Fukuda, Tomokazu; Mishina, Yuji] NIEHS, Mol Dev Biol Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Saitama Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Yu, PB (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Dept Med, Thier 505,50 Blossom St, Boston, MA 02114 USA.	pbyu@partners.org	Hong, Charles/C-9989-2010; Yu, Paul B./J-7540-2019; Fukuda, Tomokazu/O-1257-2018	Yu, Paul B./0000-0003-2145-4944; Fukuda, Tomokazu/0000-0001-8456-0483; Peterson, Randall/0000-0003-0727-3469; Cuny, Gregory/0000-0002-3188-4748	US National Institutes of Health [HL079943, HL074352]; US National Institute of Environmental Health Sciences Intramural Research Program [ES071003-10]; Howard Hughes Medical Institute Early Career Award; GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease; Center for Research in Fibrodysplasia Ossificans Progressiva and Related Disorders at the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, K08HL081535, R01HL074352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067497] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Environmental Health Sciences Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Howard Hughes Medical Institute Early Career Award(Howard Hughes Medical Institute); GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease(GlaxoSmithKline); Center for Research in Fibrodysplasia Ossificans Progressiva and Related Disorders at the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. ten Dijke (Leiden University Medical Center) for providing BRE-Luc and CAGA-Luc and K. Miyazono (University of Tokyo) for providing caALK2, caALK3, caALK4, caALK5, caALK6 and caALK7. We are grateful to H. Beppu, E. Schipani, H. Kronenberg, A. Wagers, J. Groppe, W. Zapol and F. Kaplan for insightful discussions and technical expertise, A. Graveline and D. Panus for technical assistance and E. Buys for technical expertise. This work was supported by US National Institutes of Health grants HL079943 (P.B.Y.) and HL074352 (K. D. B.), the US National Institute of Environmental Health Sciences Intramural Research Program grant ES071003-10 (Y.M.) and Partners Healthcare. This work was also supported by a Howard Hughes Medical Institute Early Career Award (P.B.Y.), a Pulmonary Hypertension Association Mentored Clinical Scientist Award (P.B.Y.), a grant from the GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease (P.B.Y.) and a Developmental Grant from the Center for Research in Fibrodysplasia Ossificans Progressiva and Related Disorders at the University of Pennsylvania (C. C. H.).	Billings PC, 2008, J BONE MINER RES, V23, P305, DOI 10.1359/JBMR.071030; BUYSE G, 1995, EUR J PEDIATR, V154, P694, DOI 10.1007/BF02276711; Corriere MA, 2008, J SURG RES, V145, P142, DOI 10.1016/j.jss.2007.03.077; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Groppe JC, 2007, CLIN ORTHOP RELAT R, P87, DOI 10.1097/BLO.0b013e318126c049; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hegyi L, 2003, J PATHOL, V201, P141, DOI 10.1002/path.1413; Kaplan FS, 2008, BEST PRACT RES CL RH, V22, P191, DOI 10.1016/j.berh.2007.11.007; Kaplan FS, 2007, EXPERT OPIN BIOL TH, V7, P705, DOI 10.1517/14712598.7.5.705; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Koefoed M, 2005, MOL THER, V12, P212, DOI 10.1016/j.ymthe.2005.02.026; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Pignolo RJ, 2005, CLIN REV BONE MINER, V3, P195, DOI 10.1385/BMM:3:3-4:195; Scarlett RF, 2004, CLIN ORTHOP RELAT R, P275, DOI 10.1097/01.blo.0000129557.38803.26; Shimizu A, 1998, GENES CELLS, V3, P125, DOI 10.1046/j.1365-2443.1998.00174.x; Shore EM, 2006, J BONE MINER RES, V21, pS75; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; TSUCHIDA K, 1993, P NATL ACAD SCI USA, V90, P11242, DOI 10.1073/pnas.90.23.11242; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Waheed I, 2005, HUM GENE THER, V16, P489, DOI 10.1089/hum.2005.16.489; Yu PB, 2008, J BIOL CHEM, V283, P3877, DOI 10.1074/jbc.M706797200; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	33	487	535	3	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1363	1369		10.1038/nm.1888	http://dx.doi.org/10.1038/nm.1888			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029982	Green Accepted			2022-12-25	WOS:000261393600021
J	Chaouat, G				Chaouat, Gerard			Funding for research in reproduction in the European union	NATURE MEDICINE			English	Editorial Material									Univ Paris Sud Orsay & Assistance Publ, INSERM, U782, Equipe Implantat & Dialogue Cytokin Mere Conceptu, F-92141 Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Chaouat, G (corresponding author), Univ Paris Sud Orsay & Assistance Publ, INSERM, U782, Equipe Implantat & Dialogue Cytokin Mere Conceptu, 3 Rue Carnets, F-92141 Clamart, France.	gerard_chaouat@wanadoo.fr						Bischof P, 2006, GYNECOL OBSTET INVES, V62, P206, DOI 10.1159/000094005; MARIOMON R, 2004, EVALUATION EFFECTIVE; REDMAN CWE, 1992, PREECLAMPSIA FACTS H; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; Zondervan K, 2000, BEST PRACT RES CL OB, V14, P403, DOI 10.1053/beog.1999.0083; 2007, J REPROD IMMUNOL, V76, P1	6	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11		S			1218	1220		10.1038/nm1108-1218	http://dx.doi.org/10.1038/nm1108-1218			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	397FU	18989309				2022-12-25	WOS:000262649100033
J	Zamir, E; Bastiaens, PIH				Zamir, Eli; Bastiaens, Philippe I. H.			Reverse engineering intracellular biochemical networks	NATURE CHEMICAL BIOLOGY			English	Editorial Material							SIGNALING NETWORKS; SPATIAL REGULATION; GENE-EXPRESSION; PROTEIN-KINASE; LIVING CELLS; SINGLE-CELL; DYNAMICS; REPORTERS; PATHWAYS; STRATEGY	Although much is known about the molecular components of cellular signaling pathways, very little is known about how these multicomponent biochemical machineries process complex extracellular signals to generate a consolidated cellular response. A newly developed theoretical approach for reverse engineering network structure analyzing how perturbations propagate in a network-can be combined with chemical perturbations and quantitative detection approaches to reveal the causal connections within protein networks in cells. This information indicates the dynamic capabilities of a network and thereby its potential function.	[Zamir, Eli; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	Max Planck Society	Zamir, E (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de		Zamir, Eli/0000-0001-8226-5480				Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gregan J, 2007, NAT PROTOC, V2, P2996, DOI 10.1038/nprot.2007.447; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	25	30	31	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2008	4	11					643	647		10.1038/nchembio1108-643	http://dx.doi.org/10.1038/nchembio1108-643			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364CY	18936743				2022-12-25	WOS:000260315000004
J	Chen, VC; Stull, R; Joo, D; Cheng, X; Keller, G				Chen, Vincent C.; Stull, Robert; Joo, Daniel; Cheng, Xin; Keller, Gordon			Notch signaling respecifies the hemangioblast to a cardiac fate	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC-STEM-CELL; CARDIOVASCULAR PROGENITOR CELLS; SMOOTH-MUSCLE; INTRACELLULAR DOMAIN; DIFFERENTIATION; EXPRESSION; MESODERM; INDUCTION; HEART; COMMITMENT	To efficiently generate cardiomyocytes from embryonic stem (ES) cells in culture it is essential to identify key regulators of the cardiac lineage and to develop methods to control them. Using a tet-inducible mouse ES cell line to enforce expression of a constitutively activated form of the Notch 4 receptor, we show that signaling through the Notch pathway can efficiently respecify hemangioblasts to a cardiac fate, resulting in the generation of populations consisting of 460% cardiomyocytes. Microarray analyses reveal that this respecification is mediated in part through the coordinated regulation of the BMP and Wnt pathways by Notch signaling. Together, these findings have uncovered a potential role for the Notch pathway in cardiac development and provide an approach for generating large numbers of cardiac progenitors from ES cells.	[Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Chen, Vincent C.; Cheng, Xin] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Gene & Cell Med, New York, NY 10029 USA; [Stull, Robert; Joo, Daniel] VistaGen Therapeut Inc, San Francisco, CA 94080 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Icahn School of Medicine at Mount Sinai	Keller, G (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada.	gkeller@uhnresearch.ca		Keller, Gordon/0000-0001-9309-9297	National Institutes of Health [R01 HL71800, R01 HL 48834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048834, R01HL071800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank members of the Keller laboratory for discussions and critical reading of the manuscript, Stefan Irion (McEwen Center for Regenerative Medicine) for providing the Bry-GFP/Ainv ES cell line, Kitajewski for providing the activated form of Notch4 cDNA (int- 3) 27 tagged with hemagglutinin (HA) sequence, M. Kyba (Lillehei Heart Institute, University of Minnesota) for the tet- on inducible ES cell line, Ainv18 and Zuniga-Pflucker (University of Toronto, Sunnybrook Research Institute) for the OP9-DL1 cell line. This work was supported by National Institutes of Health grants R01 HL71800, R01 HL 48834.	Alexandrovich A, 2006, MECH DEVELOP, V123, P297, DOI 10.1016/j.mod.2006.02.002; Andree B, 1998, MECH DEVELOP, V70, P119, DOI 10.1016/S0925-4773(97)00186-X; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Choi K, 1998, DEVELOPMENT, V125, P725; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; Dudley AT, 1997, DEV DYNAM, V208, P349; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kim RY, 2001, DEV BIOL, V235, P449, DOI 10.1006/dbio.2001.0284; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Loomes KM, 2002, AM J MED GENET, V112, P181, DOI 10.1002/ajmg.10592; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Rones MS, 2000, DEVELOPMENT, V127, P3865; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shirayoshi Y, 1997, GENES CELLS, V2, P213, DOI 10.1046/j.1365-2443.1997.d01-310.x; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wang H, 2007, J BIOL CHEM, V282, P782, DOI 10.1074/jbc.M606610200; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang HB, 1996, DEVELOPMENT, V122, P2977	49	65	72	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1169	1178		10.1038/nbt.1497	http://dx.doi.org/10.1038/nbt.1497			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18820686	Green Accepted			2022-12-25	WOS:000259926000032
J	Sorrentino, A; Thakur, N; Grimsby, S; Marcusson, A; von Bulow, V; Schuster, N; Zhang, S; Heldin, CH; Landstrom, M				Sorrentino, Alessandro; Thakur, Noopur; Grimsby, Susanne; Marcusson, Anders; von Bulow, Verena; Schuster, Norbert; Zhang, Shouting; Heldin, Carl-Henrik; Landstroem, Marene			The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; CELL-MEMBRANE; PATHWAY; BINDING; UBIQUITINATION; IDENTIFICATION; SUFFICIENT; MECHANISMS; APOPTOSIS; REQUIRES	Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that regulates embryonic development and tissue homeostasis; however, aberrations of its activity occur in cancer(1,2). TGF-beta signals through its Type II and Type I receptors (T beta RII and T beta RI) causing phosphorylation of Smad proteins(3,4). TGF-beta-associated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, was originally identified as an effector of TGF-beta-induced p38 activation(5). However, the molecular mechanisms for its activation are unknown. Here we report that the ubiquitin ligase (E3) TRAF6 interacts with a consensus motif present in T beta RI. The T beta RI-TRAF6 interaction is required for TGF-beta-induced autoubiquitylation of TRAF6 and subsequent activation of the TAK1-p38/JNK pathway, which leads to apoptosis. T beta RI kinase activity is required for activation of the canonical Smad pathway, whereas E3 activity of TRAF6 regulates the activation of TAK1 in a receptor kinase-independent manner. Intriguingly, TGF-beta-induced TRAF6-mediated Lys 63-linked polyubiquitylation of TAK1 Lys 34 correlates with TAK1 activation. Our data show that TGF-beta specifically activates TAK1 through interaction of T beta RI with TRAF6, whereas activation of Smad2 is not dependent on TRAF6.	[Sorrentino, Alessandro; Thakur, Noopur; Grimsby, Susanne; Marcusson, Anders; von Bulow, Verena; Schuster, Norbert; Zhang, Shouting; Heldin, Carl-Henrik; Landstroem, Marene] Uppsala Univ, Rudbeck Lab, Ludwig Inst Canc Res, SE-75185 Uppsala, Sweden; [Thakur, Noopur; Marcusson, Anders; Landstroem, Marene] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Landstrom, M (corresponding author), Uppsala Univ, Rudbeck Lab, Ludwig Inst Canc Res, SE-75185 Uppsala, Sweden.	Marene.Landstrom@genpat.uu.se	高, 雨莉/HGU-8187-2022; Thakur, Noopur/AAD-5145-2019	Landstrom, Marene/0000-0001-6737-7230; Thakur, Noopur/0000-0002-5531-7182				Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Takatsu Y, 2000, MOL CELL BIOL, V20, P3015, DOI 10.1128/MCB.20.9.3015-3026.2000; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang ST, 2006, CELL CYCLE, V5, P2787, DOI 10.4161/cc.5.23.3523	27	412	429	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1199	1207		10.1038/ncb1780	http://dx.doi.org/10.1038/ncb1780			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18758450				2022-12-25	WOS:000259682900014
J	Shaye, DD; Casanova, J; Llimargas, M				Shaye, Daniel D.; Casanova, Jordi; Llimargas, Marta			Modulation of intracellular trafficking regulates cell intercalation in the Drosophila trachea	NATURE CELL BIOLOGY			English	Article							MORPHOGENESIS; PROTEIN; RAB11; ENDOCYTOSIS; MOVEMENTS; MIGRATION; TRANSPORT; HOMOLOG; SYSTEM	Through intercalation, a fundamental mechanism underlying elongation during morphogenesis, epithelial cells exchange places in a spatially oriented manner(1). epithelial cells are tightly coupled through distinct intercellular junctions, including adherens junctions. Whether trafficking-mediated regulation of adhesion through adherens junctions modulates intercalation in vivo remains controversial(1,2). In Drosophila melanogaster, cells in most branches intercalate during tracheal development. However, Wingless (Wg)-promoted expression of the transcription factor spalt (sal) in the dorsal trunk inhibits intercalation(3) by an unknown mechanism. Here we have examined the role of trafficking in tracheal intercalation and show that it requires endocytosis, whereas it is opposed by Rab11-mediated recycling in the dorsal trunk. subapical Rab11 accumulation is enhanced by sal and elevated Rab11-mediated recycling occurs in the dorsal trunk, suggesting that upregulation of Rab11 is one way in which sal inhibits intercalation. We found that dRip11, which regulates Rab11 localization and function(4), is regulated by sal and can modulate intercalation. Finally, we provide evidence that levels of E-cadherin (DE-cad), an adherens junction component(5) and Rab11-compartment cargo(6-8), are dynamically regulated by trafficking during tracheal development, and that such regulation modulates intercalation. Our work suggests a mechanism by which trafficking of adhesion molecules regulates intercalation, and shows how this mechanism can be modulated in vivo to influence cell behaviour.	[Shaye, Daniel D.; Casanova, Jordi; Llimargas, Marta] CSIC, Inst Mol Biol, E-08028 Barcelona, Spain; [Shaye, Daniel D.; Casanova, Jordi] Inst Recerca Biomed Barcelona, Barcelona 08028, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Llimargas, M (corresponding author), CSIC, Inst Mol Biol, C Baldiri Reixac 10, E-08028 Barcelona, Spain.	jcrbmc@cid.csic.es; mlcbmc@cid.csic.es	Casanova, Jordi/L-5181-2014; Shaye, Daniel/AAY-5351-2020	Casanova, Jordi/0000-0001-6121-8589; Shaye, Daniel/0000-0002-3962-6903				Beloussov LV, 2000, DEV GENES EVOL, V210, P92, DOI 10.1007/s004270050015; Cela C, 2006, DEVELOPMENT, V133, P3115, DOI 10.1242/dev.02482; Chen CK, 1998, DEVELOPMENT, V125, P4959; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dollar G, 2002, DEVELOPMENT, V129, P517; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Jarrett O, 2002, INT J DEV BIOL, V46, P467; Jung AC, 2006, CURR BIOL, V16, P1224, DOI 10.1016/j.cub.2006.04.048; Kleeff J, 2002, DIS ESOPHAGUS, V15, P10, DOI 10.1046/j.1442-2050.2002.00211.x; Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Moline MM, 1999, DEVELOPMENT, V126, P4375; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Rodman JS, 2000, J CELL SCI, V113, P183; SCHONBAUM CP, 1992, DEV BIOL, V151, P431, DOI 10.1016/0012-1606(92)90183-H; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0	30	89	90	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					964	970		10.1038/ncb1756	http://dx.doi.org/10.1038/ncb1756			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641639				2022-12-25	WOS:000258147100014
J	Oh, DC; Poulsen, M; Currie, CR; Clardy, J				Oh, Dong-Chan; Poulsen, Michael; Currie, Cameron R.; Clardy, Jon			Dentigerumycin: a bacterial mediator of an ant-fungus symbiosis	NATURE CHEMICAL BIOLOGY			English	Article							ABSOLUTE-CONFIGURATION; MICROBE SYMBIOSIS; GROWING ANTS; AMINO-ACIDS; STREPTOMYCES; DERIVATIVES; PEPTIDE	Fungus-growing ants engage in mutualistic associations with both the fungus they cultivate for food and actinobacteria (Pseudonocardia spp.) that produce selective antibiotics to defend that fungus from specialized fungal parasites. We have analyzed one such system at the molecular level and found that the bacterium associated with the ant Apterostigma dentigerum produces dentigerumycin, a cyclic depsipeptide with highly modified amino acids, to selectively inhibit the associated parasitic fungus (Escovopsis sp.).	[Poulsen, Michael; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Oh, Dong-Chan; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School	Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	currie@bact.wisc.edu; jon_clardy@hms.harvard.edu	Poulsen, Michael/C-6276-2012	Poulsen, Michael/0000-0002-2839-1715	Lundbeck and Carlsberg Foundations; US National Science Foundation [MCB07020255]; US National Institutes of Health [CA24487]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086258] Funding Source: NIH RePORTER	Lundbeck and Carlsberg Foundations(Carlsberg Foundation); US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Smithsonian Tropical Research Institute for providing facilities in which to work in Panama, the Autoridad Nacional del Ambiente y el Mar for sampling and export permits, J. Heemstra and C. Walsh (Harvard Medical School) for providing synthetic piperazic acids, and A. Adams, S. Marsh, A. Pinto-Tomas and G. Suen (University of Wisconsin-Madison) for comments on a manuscript draft. This work was supported by funding from the Lundbeck and Carlsberg Foundations to M. P., from the US National Science Foundation (MCB07020255) to C. R. C. and from the US National Institutes of Health (CA24487) to J. C.	Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Fujii K, 2002, TETRAHEDRON, V58, P6873, DOI 10.1016/S0040-4020(02)00748-2; Fujii K, 1997, ANAL CHEM, V69, P5146, DOI 10.1021/ac970289b; GRAFE U, 1995, J ANTIBIOT, V48, P119; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; Miller ED, 2007, J ORG CHEM, V72, P323, DOI 10.1021/jo061064g; Oh DC, 2009, ORG LETT, V11, P633, DOI 10.1021/ol802709x; PENNINGS MLM, 1983, J ORG CHEM, V48, P486, DOI 10.1021/jo00152a015; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Schultz AW, 2008, J AM CHEM SOC, V130, P4507, DOI 10.1021/ja711188x; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Seco JM, 2001, TETRAHEDRON-ASYMMETR, V12, P2915, DOI 10.1016/S0957-4166(01)00508-0; SNATZKE G, 1981, TETRAHEDRON, V37, P349, DOI 10.1016/S0040-4020(01)92021-6; Umezawa K, 1999, J ORG CHEM, V64, P3034, DOI 10.1021/jo981512n	20	291	309	6	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					391	393		10.1038/nchembio.159	http://dx.doi.org/10.1038/nchembio.159			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19330011	Green Accepted			2022-12-25	WOS:000266383800010
J	Binder, NB; Niederreiter, B; Hoffmann, O; Stange, R; Pap, T; Stulnig, TM; Mack, M; Erben, RG; Smolen, JS; Redlich, K				Binder, Nikolaus B.; Niederreiter, Birgit; Hoffmann, Oskar; Stange, Richard; Pap, Thomas; Stulnig, Thomas M.; Mack, Matthias; Erben, Reinhold G.; Smolen, Josef S.; Redlich, Kurt			Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis	NATURE MEDICINE			English	Article							KAPPA-B LIGAND; BONE LOSS; RECEPTOR ACTIVATOR; NECROSIS-FACTOR; EXPRESSION; CELLS; CYTOKINE; HORMONE; MCP-1; DIFFERENTIATION	Understanding the mechanisms of osteoclastogenesis is crucial for developing new drugs to treat diseases associated with bone loss, such as osteoporosis. Here we report that the C-C chemokine receptor-2 (CCR2) is crucially involved in balancing bone mass. CCR2-knockout mice have high bone mass owing to a decrease in number, size and function of osteoclasts. In normal mice, activation of CCR2 in osteoclast progenitor cells results in both nuclear factor-kappa B (NF-kappa B) and extracellular signal-related kinase 1 and 2 (ERK1/2) signaling but not that of p38 mitogen-activated protein kinase or c-Jun N-terminal kinase. The induction of NF-kappa B and ERK1/2 signaling in turn leads to increased surface expression of receptor activator of NF-kappa B (RANK, encoded by Tnfrsf11a), making the progenitor cells more susceptible to RANK ligand-induced osteoclastogenesis. In ovariectomized mice, a model of postmenopausal osteoporosis, CCR2 is upregulated on wild-type preosteoclasts, thus increasing the surface expression of RANK on these cells and their osteoclastogenic potential, whereas CCR2-knockout mice are resistant to ovariectomy-induced bone loss. These data reveal a previously undescribed pathway by which RANK, osteoclasts and bone homeostasis are regulated in health and disease.	[Binder, Nikolaus B.; Niederreiter, Birgit; Smolen, Josef S.; Redlich, Kurt] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Hoffmann, Oskar] Univ Vienna, Inst Pharmacol & Toxicol, Vienna, Austria; [Stange, Richard; Pap, Thomas] Univ Munster, Inst Expt Musculoskeletal Med, Munster, Germany; [Stange, Richard] Univ Munster, Dept Trauma Hand & Reconstruct Surg, Munster, Germany; [Stulnig, Thomas M.] Med Univ Vienna, Div Endocrinol & Metab, Vienna, Austria; [Mack, Matthias] Univ Regensburg, Div Nephrol, Regensburg, Germany; [Erben, Reinhold G.] Univ Vet Med Vienna, Inst Pathophysiol, Vienna, Austria	Medical University of Vienna; University of Vienna; University of Munster; University of Munster; Medical University of Vienna; University of Regensburg; University of Veterinary Medicine Vienna	Redlich, K (corresponding author), Med Univ Vienna, Div Rheumatol, Vienna, Austria.	kurt.redlich@meduniwien.ac.at	Erben, Reinhold/AAG-8007-2020	Erben, Reinhold/0000-0003-0801-6958; Stange, Richard/0000-0003-0807-3151; Stulnig, Thomas/0000-0003-3300-6161				Arici A, 1999, BIOL REPROD, V61, P85, DOI 10.1095/biolreprod61.1.85; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Breitkreutz I, 2007, BRIT J HAEMATOL, V139, P55, DOI 10.1111/j.1365-2141.2007.06747.x; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Choi SJ, 2000, BLOOD, V96, P671; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Hayer S, 2005, J EXP MED, V201, P903, DOI 10.1084/jem.20040852; Herault O, 1999, BRIT J HAEMATOL, V104, P530, DOI 10.1046/j.1365-2141.1999.01203.x; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Janis K, 2004, AM J REPROD IMMUNOL, V51, P22, DOI 10.1046/j.8755-8920.2003.00117.x; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kim MS, 2006, J BIOL CHEM, V281, P1274, DOI 10.1074/jbc.M510156200; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Koh KK, 2001, INT J CARDIOL, V81, P43, DOI 10.1016/S0167-5273(01)00527-7; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KRUSE K, 1986, EUR J PEDIATR, V145, P27, DOI 10.1007/BF00441848; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lean JM, 2002, J CELL BIOCHEM, V87, P386, DOI 10.1002/jcb.10319; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; MANOLAGAS SC, 1992, CALCIFIED TISSUE INT, V50, P199, DOI 10.1007/BF00296282; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Owen JL, 2005, CELL IMMUNOL, V235, P122, DOI 10.1016/j.cellimm.2005.08.032; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; RUSSELL RGG, 1981, METAB BONE DIS RELAT, V3, P255, DOI 10.1016/0221-8747(81)90041-2; Stepan J J, 2003, Endocr Regul, V37, P225; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; TURNER RT, 1988, ENDOCRINOLOGY, V122, P1146, DOI 10.1210/endo-122-3-1146; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Yamada Y, 2002, GENOMICS, V80, P8, DOI 10.1006/geno.2002.6793; Zallone A, 2006, ANN NY ACAD SCI, V1068, P173, DOI 10.1196/annals.1346.019	44	136	144	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					417	424		10.1038/nm.1945	http://dx.doi.org/10.1038/nm.1945			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19330010				2022-12-25	WOS:000264937200029
J	Kilpivaara, O; Mukherjee, S; Schram, AM; Wadleigh, M; Mullally, A; Ebert, BL; Bass, A; Marubayashi, S; Heguy, A; Garcia-Manero, G; Kantarjian, H; Offit, K; Stone, RM; Gilliland, DG; Klein, RJ; Levine, RL				Kilpivaara, Outi; Mukherjee, Semanti; Schram, Alison M.; Wadleigh, Martha; Mullally, Ann; Ebert, Benjamin L.; Bass, Adam; Marubayashi, Sachie; Heguy, Adriana; Garcia-Manero, Guillermo; Kantarjian, Hagop; Offit, Kenneth; Stone, Richard M.; Gilliland, D. Gary; Klein, Robert J.; Levine, Ross L.			A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; SUSCEPTIBILITY LOCI; ACTIVATING MUTATION; FAMILIAL RISKS; DISORDERS; CLONALITY; DISEASE	Polycythemia vera, essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms (MPN) characterized by multilineage clonal hematopoiesis(1-5). Given that the identical somatic activating mutation in the JAK2 tyrosine kinase gene (JAK2(V617F)) is observed in most individuals with polycythemia vera, essential thrombocythemia and primary myelofibrosis(6-10), there likely are additional genetic events that contribute to the pathogenesis of these phenotypically distinct disorders. Moreover, family members of individuals with MPN are at higher risk for the development of MPN, consistent with the existence of MPN predisposition loci(11). We hypothesized that germline variation contributes to MPN predisposition and phenotypic pleiotropy. Genome-wide analysis identified an allele in the JAK2 locus (rs10974944) that predisposes to the development of JAK2(V617F)-positive MPN, as well as three previously unknown MPN modifier loci. We found that JAK2(V617F) is preferentially acquired in cis with the predisposition allele. These data suggest that germline variation is an important contributor to MPN phenotype and predisposition.	[Mukherjee, Semanti; Klein, Robert J.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Kilpivaara, Outi; Schram, Alison M.; Marubayashi, Sachie; Heguy, Adriana; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Mukherjee, Semanti] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Wadleigh, Martha; Mullally, Ann; Bass, Adam; Stone, Richard M.; Gilliland, D. Gary] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Mullally, Ann; Ebert, Benjamin L.; Gilliland, D. Gary] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Ebert, Benjamin L.; Bass, Adam; Gilliland, D. Gary] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Ebert, Benjamin L.; Bass, Adam; Gilliland, D. Gary] MIT, Cambridge, MA 02139 USA; [Garcia-Manero, Guillermo; Kantarjian, Hagop] Univ Texas Houston, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Gilliland, D. Gary] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Memorial Sloan Kettering Cancer Center	Klein, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	kleinr@mskcc.org; leviner@mskcc.org	levine, ross/AAE-7658-2019; Heguy, Adriana/GPP-3907-2022; Klein, Robert/K-1888-2013	Klein, Robert/0000-0003-3539-5391; Schram, Alison/0000-0002-6070-2413	Wellcome Trust [076113]; National Institutes of Health; Starr Cancer Consortium; Myeloproliferative Disorders Foundation; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; Kristen Amico Sesselman Leukemia Research Fund; Academy of Finland; US National Institutes of Health [P30 CA008748]; Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA008748, K08CA134931] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Myeloproliferative Disorders Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Kristen Amico Sesselman Leukemia Research Fund; Academy of Finland(Academy of Finland); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to acknowledge the subjects who have contributed to our understanding of these disorders. We thank S. Thomas, I. Dolgalev and T. Landers for assistance with high-throughput resequencing, A. Viale for assistance with JAK2 expression analysis, and T. Kirchhoff for advice and suggestions. This study makes use of data generated by the Wellcome Trust Case-Control Consortium; a full list of the investigators who contributed to the generation of the data are available from http://www.wtccc.org.uk and funding was provided by the Wellcome Trust under award 076113. This work was supported by grants from the National Institutes of Health, the Starr Cancer Consortium, the Myeloproliferative Disorders Foundation, the Howard Hughes Medical Institute, the Doris Duke Charitable Foundation and the Kristen Amico Sesselman Leukemia Research Fund. O.K. is supported by a grant from the Academy of Finland. D.G.G. is an Investigator of the Howard Hughes Medical Institute and is a Doris Duke Charitable Foundation Distinguished Clinical Scientist. Work in the laboratory of R.J.K. is supported by Memorial Sloan Kettering Cancer Center through US National Institutes of Health grant P30 CA008748. R. L. L. is an Early Career Award recipient of the Howard Hughes Medical Institute and a Clinical Scientist Development Award recipient of the Doris Duke Charitable Foundation and is the Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center.	ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; El Kassar Nahed, 1995, British Journal of Haematology, V90, P131; GILLILAND DG, 1991, P NATL ACAD SCI USA, V88, P6848, DOI 10.1073/pnas.88.15.6848; Hemminki K, 2008, INT J CANCER, V123, P1726, DOI 10.1002/ijc.23702; Hemminki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002504; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; TSUKAMOTO N, 1994, BRIT J HAEMATOL, V86, P253, DOI 10.1111/j.1365-2141.1994.tb04723.x; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	28	266	272	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2009	41	4					455	459		10.1038/ng.342	http://dx.doi.org/10.1038/ng.342			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287384	Green Accepted			2022-12-25	WOS:000264659000020
J	Lefkimmiatis, K; Srikanthan, M; Maiellaro, I; Moyer, MP; Curci, S; Hofer, AM				Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Moyer, Mary Pat; Curci, Silvana; Hofer, Aldebaran M.			Store-operated cyclic AMP signalling mediated by STIM1	NATURE CELL BIOLOGY			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CA2+ STORE; FLUORESCENT PROTEIN; INTRACELLULAR CA2+; CAPACITATIVE CA2+; CRAC CHANNEL; I-CRAC; CAMP; CALCIUM	Depletion of Ca2+ from the endoplasmic reticulum ( ER) results in activation of plasma membrane Ca2+ entry channels. This 'store-operated' process requires translocation of a transmembrane ER Ca2+ sensor protein, stromal interaction molecule 1 (STIM1), to sites closely apposed to Ca2+ channels at the cell surface. However, it is not known whether a reduction in Ca2+ stores is coupled to other signalling pathways by this mechanism. We found that lowering the concentration of free Ca2+ in the ER, independently of the cytosolic Ca2+ concentration, also led to recruitment of adenylyl cyclases. This resulted in enhanced cAMP accumulation and PKA activation, measured using FRET-based cAMP indicators. Translocation of STIM1 was required for efficient coupling of ER Ca2+ depletion to adenylyl cyclase activity. We propose the existence of a pathway (store-operated cAMP signalling or SOcAMPS) in which the content of internal Ca2+ stores is directly connected to cAMP signalling through a process that involves STIM1.	[Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Curci, Silvana; Hofer, Aldebaran M.] Brigham & Womens Hosp, VA Boston Healthcare Syst, W Roxbury, MA 02132 USA; [Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Curci, Silvana; Hofer, Aldebaran M.] Brigham & Womens Hosp, Dept Surg, W Roxbury, MA 02132 USA; [Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Curci, Silvana; Hofer, Aldebaran M.] Harvard Univ, Sch Med, W Roxbury, MA 02132 USA; [Moyer, Mary Pat] INCELL Corp LLC, San Antonio, TX 78249 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University	Hofer, AM (corresponding author), Brigham & Womens Hosp, VA Boston Healthcare Syst, 1400 VFW Pkwy, W Roxbury, MA 02132 USA.	ahofer@rics.bwh.harvard.edu	Lefkimmiatis, Konstantinos/AAL-1647-2021; Lefkimmiatis, Konstantinos/I-1239-2016	Lefkimmiatis, Konstantinos/0000-0001-7137-7866; Lefkimmiatis, Konstantinos/0000-0001-7137-7866; Maiellaro, Isabella/0000-0001-5595-8011	Department of Veteran's Affairs; Harvard Digestive Diseases Center; American Heart Association	Department of Veteran's Affairs(US Department of Veterans Affairs); Harvard Digestive Diseases Center; American Heart Association(American Heart Association)	We are grateful to the following individuals for their kind gifts of plasmids: Kees Jalink for the Epac sensor, Roger Tsien for mCherry, Jin Zhang for AKAR3, Marie Dziadek and Lorna Johnstone for STIM1 and STIM2, Masaru Okabe for pCX-EGFP, and Tobias Meyer for YFP-STIM1, YFP-STIM1D76A, and YFP-STIM2 constructs. We thank Jessica Roy for technical assistance and Drs. Dheeraj Pelluru, Eberhard Fromter and Raj K. Goyal for helpful comments. This study was supported by a Merit Review award from the Department of Veteran's Affairs (A.M.H.) and by an NIH Center grant from the Harvard Digestive Diseases Center (to A.M. H.). K.L. is the recipient of an American Heart Association Postdoctoral Fellowship award..	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Baragli A, 2008, CELL SIGNAL, V20, P480, DOI 10.1016/j.cellsig.2007.10.033; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; CHENG KT, 2008, J BIOL CHEM; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Lau BW, 2005, GASTROENTEROLOGY, V128, P695, DOI 10.1053/j.gastro.2004.12.046; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Maloney JA, 1999, AM J PHYSIOL-CELL PH, V276, pC221, DOI 10.1152/ajpcell.1999.276.1.C221; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; PEINELT C, 2008, J PHYSL; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SARGEANT P, 1994, EXP PHYSIOL, V79, P269, DOI 10.1113/expphysiol.1994.sp003762; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Strayer DS, 1999, BIOCHEM J, V344, P39, DOI 10.1042/0264-6021:3440039; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Urushidani T, 1997, J MEMBRANE BIOL, V159, P99, DOI 10.1007/s002329900274; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	53	119	122	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					433	U164		10.1038/ncb1850	http://dx.doi.org/10.1038/ncb1850			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19287379				2022-12-25	WOS:000265264900013
J	Song, R; Ro, S; Michaels, JD; Park, C; McCarrey, JR; Yan, W				Song, Rui; Ro, Seungil; Michaels, Jason D.; Park, Chanjae; McCarrey, John R.; Yan, Wei			Many X-linked microRNAs escape meiotic sex chromosome inactivation	NATURE GENETICS			English	Article							SPERMATOGENIC CELLS; GERM-CELLS; SMALL RNAS; EXPRESSION; GENES; MOUSE; CLONING; TESTIS; BIOGENESIS; CHROMATIN	Meiotic sex chromosome inactivation (MSCI) during spermatogenesis is characterized by transcriptional silencing of genes on both the X and Y chromosomes in mid-to-late pachytene spermatocytes(1). MSCI is believed to result from meiotic silencing of unpaired DNA because the X and Y chromosomes remain largely unpaired throughout first meiotic prophase(2). However, unlike X-chromosome inactivation in female embryonic cells, where 25-30% of X-linked structural genes have been reported to escape inactivation(3), previous microarray(4)- and RT-PCR5-based studies of expression of > 364 X-linked mRNA-encoding genes during spermatogenesis have failed to reveal any X-linked gene that escapes the silencing effects of MSCI in primary spermatocytes. Here we show that many X-linked miRNAs are transcribed and processed in pachytene spermatocytes. This unprecedented escape from MSCI by these X-linked miRNAs suggests that they may participate in a critical function at this stage of spermatogenesis, including the possibility that they contribute to the process of MSCI itself, or that they may be essential for post-transcriptional regulation of autosomal mRNAs during the late meiotic and early postmeiotic stages of spermatogenesis.	[Song, Rui; Ro, Seungil; Michaels, Jason D.; Park, Chanjae; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Texas System; University of Texas at San Antonio (UTSA)	Yan, W (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA.	wyan@unr.edu	Yan, Wei/G-1618-2011; Yan, Wei/AAH-7943-2019	Ro, Seungil/0000-0003-0861-8334	National Institutes of Health [HD048855, HD050281, HD046637]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048855, R01HD050281, R01HD046637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank D. Page for critically reading the manuscript and providing helpful suggestions. This study was supported by grants from the National Institutes of Health (HD048855 and HD050281 to W. Y., and HD046637 to J. R. M.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koslowski M, 2006, HUM MOL GENET, V15, P2392, DOI 10.1093/hmg/ddl163; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Reinke V, 2004, NAT GENET, V36, P548, DOI 10.1038/ng0604-548; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101	30	150	160	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					488	493		10.1038/ng.338	http://dx.doi.org/10.1038/ng.338			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19305411	Green Accepted			2022-12-25	WOS:000264659000026
J	Goraczniak, R; Behlke, MA; Gunderson, SI				Goraczniak, Rafal; Behlke, Mark A.; Gunderson, Samuel I.			Gene silencing by synthetic U1 Adaptors	NATURE BIOTECHNOLOGY			English	Article							PRE-MESSENGER-RNA; LOCKED NUCLEIC-ACIDS; ANTISENSE OLIGONUCLEOTIDES; MAMMALIAN-CELLS; POLY(A) POLYMERASE; MODIFIED SIRNAS; RAF KINASE; IN-VIVO; EXPRESSION; POLYADENYLATION	We describe a gene silencing method that employs a mechanism of action distinct from those of antisense and RNA interference. U1 Adaptors are bifunctional oligonucleotides with a 'target domain' complementary to a site in the target gene's terminal exon and a 'U1 domain' that binds to the U1 small nuclear RNA component of the U1 small nuclear ribonucleoprotein (U1 snRNP) splicing factor. Tethering of U1 snRNP to the target pre-mRNA inhibits poly(A)-tail addition, causing degradation of that RNA species in the nucleus. U1 Adaptors can inhibit both endogenous and reporter genes in a sequence-specific manner. Comparison of U1 Adaptors with small interfering RNA (siRNA) using a genome-wide microarray analysis indicates that U1 Adaptors have limited off-target effects and no detectable adverse effects on splicing. Further, targeting the same gene either with multiple U1 Adaptors or with a U1 Adaptor and siRNA strongly enhances gene silencing.	[Goraczniak, Rafal; Gunderson, Samuel I.] Rutgers State Univ, Piscataway, NJ 08854 USA; [Behlke, Mark A.] Integrated DNA Technol, Coralville, IA 52241 USA	Rutgers State University New Brunswick	Gunderson, SI (corresponding author), Rutgers State Univ, 604 Allison Rd, Piscataway, NJ 08854 USA.	gunderson@biology.rutgers.edu		Behlke, Mark/0000-0002-4218-857X	National Institutes of Health [GM057286, CA119934, R43GM085863]; Gunderson lab; Rutgers University/University of Medicine and Dentistry New Jersey RNA community; IDT corporation; NATIONAL CANCER INSTITUTE [R21CA119934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM085863, R01GM057286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gunderson lab; Rutgers University/University of Medicine and Dentistry New Jersey RNA community; IDT corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM057286 and to S.I.G. and R43GM085863 to M.A.B. We thank members of the Gunderson lab, the Rutgers University/University of Medicine and Dentistry New Jersey RNA community and IDT corporation for advice and comments during the course of this work. We also thank Chris Jakubowski and Nick Zaphiros for helping to perform experiments shown in Supplementary Figs. 7, 8 and 11, and we thank Kim Lennox for help in editing the manuscript.	Abad X, 2008, NUCLEIC ACIDS RES, V36, P2338, DOI 10.1093/nar/gkn068; Baserga S., 1993, RNA WORLD, P359; Beckley SA, 2001, MOL CELL BIOL, V21, P2815, DOI 10.1128/MCB.21.8.2815-2825.2001; Crooke ST, 2004, CURR MOL MED, V4, P465, DOI 10.2174/1566524043360375; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; FURTH PA, 1994, MOL CELL BIOL, V14, P5278, DOI 10.1128/MCB.14.8.5278; GILES RV, 1995, NUCLEIC ACIDS RES, V23, P954, DOI 10.1093/nar/23.6.954; Goraczniak R, 2008, J BIOL CHEM, V283, P2286, DOI 10.1074/jbc.M708789200; Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409; Guan F, 2007, RNA, V13, P2129, DOI 10.1261/rna.756707; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hemmings-Mieszczak M, 2003, NUCLEIC ACIDS RES, V31, P2117, DOI 10.1093/nar/gkg322; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kauppinen Sakari, 2005, Drug Discov Today Technol, V2, P287, DOI 10.1016/j.ddtec.2005.08.012; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Ko B, 2002, J MOL BIOL, V318, P1189, DOI 10.1016/S0022-2836(02)00240-1; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lau QC, 1998, ONCOGENE, V16, P1899, DOI 10.1038/sj.onc.1201709; Lennox KA, 2006, OLIGONUCLEOTIDES, V16, P26, DOI 10.1089/oli.2006.16.26; Liu P, 2004, NUCLEIC ACIDS RES, V32, P1512, DOI 10.1093/nar/gkh316; Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007; McQuisten KA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-184; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Monia BP, 1996, NAT MED, V2, P668, DOI 10.1038/nm0696-668; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Sridhar SS, 2005, MOL CANCER THER, V4, P677, DOI 10.1158/1535-7163.MCT-04-0297; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	37	45	51	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2009	27	3					257	263		10.1038/nbt.1525	http://dx.doi.org/10.1038/nbt.1525			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	416UJ	19219028				2022-12-25	WOS:000264030700019
J	Ishii, K; Fumoto, T; Iwai, K; Takeshita, S; Ito, M; Shimohata, N; Aburatani, H; Taketani, S; Lelliott, CJ; Vidal-Puig, A; Ikeda, K				Ishii, Kiyo-aki; Fumoto, Toshio; Iwai, Kazuhiro; Takeshita, Sunao; Ito, Masako; Shimohata, Nobuyuki; Aburatani, Hiroyuki; Taketani, Shigeru; Lelliott, Christopher J.; Vidal-Puig, Antonio; Ikeda, Kyoji			Coordination of PGC-1 beta and iron uptake in mitochondrial biogenesis and osteoclast activation	NATURE MEDICINE			English	Article							RESPONSIVE ELEMENT; BONE-RESORPTION; CRUCIAL ROLE; TRANSCRIPTION; OSTEOPOROSIS; COACTIVATOR; INSIGHTS; RANKL; PATHOPHYSIOLOGY; DIFFERENTIATION	Osteoclasts are acid-secreting polykaryons that have high energy demands and contain abundant mitochondria. How mitochondrial biogenesis is integrated with osteoclast differentiation is unknown. We found that the transcription of Ppargc1b, which encodes peroxisome proliferator-activated receptor-gamma coactivator 1 beta (PGC-1 beta), was induced during osteoclast differentiation by cAMP response element-binding protein (CREB) as a result of reactive oxygen species. Knockdown of Ppargc1b in vitro inhibited osteoclast differentiation and mitochondria biogenesis, whereas deletion of the Ppargc1b gene in mice resulted in increased bone mass due to impaired osteoclast function. We also observed defects in PGC-1 beta-deficient osteoblasts. Owing to the heightened iron demand in osteoclast development, transferrin receptor 1 (TfR1) expression was induced post-transcriptionally via iron regulatory protein 2. TfR1-mediated iron uptake promoted osteoclast differentiation and bone-resorbing activity, associated with the induction of mitochondrial respiration, production of reactive oxygen species and accelerated Ppargc1b transcription. Iron chelation inhibited osteoclastic bone resorption and protected against bone loss following estrogen deficiency resulting from ovariectomy. These data establish mitochondrial biogenesis orchestrated by PGC-1 beta, coupled with iron uptake through TfR1 and iron supply to mitochondrial respiratory proteins, as a fundamental pathway linked to osteoclast activation and bone metabolism.	[Ishii, Kiyo-aki; Fumoto, Toshio; Takeshita, Sunao; Ikeda, Kyoji] NCGG, Dept Bone & Joint Dis, Aichi 4748522, Japan; [Iwai, Kazuhiro] Osaka Univ, Dept Biochem & Biophys, Grad Sch Med, Suita, Osaka 5650871, Japan; [Iwai, Kazuhiro] Osaka Univ, Cell Biol & Metab Grp, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Iwai, Kazuhiro; Shimohata, Nobuyuki] Osaka City Univ, Dept Mol Cell Biol, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan; [Iwai, Kazuhiro] Japan Sci Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; [Ito, Masako] Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 8528501, Japan; [Aburatani, Hiroyuki] Univ Tokyo, RCAST, Genomesci Div, Meguro Ku, Tokyo 1538904, Japan; [Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Sakyo Ku, Kyoto 6068585, Japan; [Lelliott, Christopher J.] AstraZeneca R&D, Dept Biosci, SE-43183 Molndal, Sweden; [Vidal-Puig, Antonio] Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 0QQ, England	Osaka University; Osaka University; Osaka Metropolitan University; Japan Science & Technology Agency (JST); Nagasaki University; University of Tokyo; Kyoto Institute of Technology; AstraZeneca; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ikeda, K (corresponding author), NCGG, Dept Bone & Joint Dis, 36-3 Gengo, Aichi 4748522, Japan.	kikeda@nils.go.jp	Lelliott, Christopher J/G-4620-2011; fumoto, toshio/F-6345-2015; IWAI, KAZUHIRO/GSN-7385-2022	Lelliott, Christopher J/0000-0001-8087-4530; fumoto, toshio/0000-0002-9273-8939; Iwai, Kazuhiro/0000-0001-5620-5951; Ishii, Kiyo-aki/0000-0001-9846-5575; Vidal-Puig, Antonio/0000-0003-4220-9577	British Heart Foundation Funding Source: Medline; Medical Research Council [G0600717, G0802051] Funding Source: Medline; MRC [G0600717, G0802051] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Ashizuka M, 2002, MOL CELL BIOL, V22, P6375, DOI 10.1128/MCB.22.18.6375-6383.2002; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Borgna-Pignatti C, 2006, HAEMATOLOGICA, V91, P1159; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown D, 1996, J EXP BIOL, V199, P2345; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Ito M, 2005, J BONE MINER RES, V20, P1828, DOI 10.1359/JBMR.050610; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Morabito N, 2004, J BONE MINER RES, V19, P722, DOI 10.1359/JBMR.040113; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; SASSA S, 1977, J BIOL CHEM, V252, P2428; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; STEINBECK MJ, 1994, J CELL BIOL, V126, P765, DOI 10.1083/jcb.126.3.765; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Voskaridou E, 2004, BRIT J HAEMATOL, V127, P127, DOI 10.1111/j.1365-2141.2004.05143.x; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	39	241	260	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					259	266		10.1038/nm.1910	http://dx.doi.org/10.1038/nm.1910			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19252502				2022-12-25	WOS:000263914000025
J	Jagannath, C; Lindsey, DR; Dhandayuthapani, S; Xu, Y; Hunter, RL; Eissa, NT				Jagannath, Chinnaswamy; Lindsey, Devin R.; Dhandayuthapani, Subramanian; Xu, Yi; Hunter, Robert L., Jr.; Eissa, N. Tony			Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells	NATURE MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS H37RV; CLASS-II MOLECULES; ANTIGEN PRESENTATION; PHAGOSOME MATURATION; PROTEIN-DEGRADATION; ADAPTIVE IMMUNITY; HUMAN MACROPHAGES; INNATE IMMUNITY; EXPRESSION; INFECTION	The variable efficacy of Bacille Calmette Guerin ( BCG) vaccination against tuberculosis has prompted efforts to improve the vaccine. In this study, we used autophagy to enhance vaccine efficacy against tuberculosis in a mouse model. We examined the effect of autophagy on the processing of the immunodominant mycobacterial antigen Ag85B by antigen presenting cells (APCs), macrophages and dendritic cells (DCs). We found that rapamycin-induced autophagy enhanced Ag85B presentation by APCs infected with wild-type Mycobacterium tuberculosis H37Rv, H37Rv-derived Delta fbpA attenuated candidate vaccine or BCG. Furthermore, rapamycin enhanced localization of mycobacteria with autophagosomes and lysosomes. Rapamycin-enhanced antigen presentation was attenuated when autophagy was suppressed by 3-methyladenine or by small interfering RNA against beclin-1. Notably, mice immunized with rapamycin-treated DCs infected with either DfbpA or BCG showed enhanced T helper type 1-mediated protection when challenged with virulent Mycobacterium tuberculosis. Finally, overexpression of Ag85B in BCG induced autophagy in APCs and enhanced immunogenicity in mice, suggesting that vaccine efficacy can be enhanced by augmenting autophagy-mediated antigen presentation.	[Jagannath, Chinnaswamy; Lindsey, Devin R.; Hunter, Robert L., Jr.] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX 78541 USA; [Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, Edinburg, TX 78541 USA; [Xu, Yi; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine	Jagannath, C (corresponding author), Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, 6431 Fannin, Houston, TX 77030 USA.	Chinnaswamy.Jagannath@uth.tmc.edu			US National Institutes of Health National Institute of Allergy and Infectious Diseases [AI49534]; National Heart, Lung, and Blood Institute [HL080205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R01AI049534] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by US National Institutes of Health National Institute of Allergy and Infectious Diseases grant AI49534 (C.J.) and National Heart, Lung, and Blood Institute grant HL080205 (N.T.E.). We are grateful to L.Y. Armitige (University of Texas Health Sciences Center-Houston) for the fbpA and fbpB mutant strains, K. Rock (University of Massachusetts-Worcester) for the BMA.A3 cell line and C. Harding and H. Boom (Case Western Reserve University) for BB7 T cells. Recombinant ESAT-6 was kindly provided by A. Arora (Central Drug Research Institute, India), and TD17 mAb was a gift from K. Huygen (Pasteur Institute). Mycobacterial vector pMV206 was kindly provided by W. Jacobs (Albert Einstein Medical College).	AM AO, 2005, AUTOPHAGY, V1, P53; Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Copenhaver RH, 2004, INFECT IMMUN, V72, P7084, DOI 10.1128/IAI.72.12.7084-7095.2004; DEAN RT, 1977, ACTA BIOL MED GER, V36, P1815; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GRIFFIN JP, 1994, INFECT IMMUN, V62, P1683, DOI 10.1128/IAI.62.5.1683-1690.1994; Gupta UD, 2007, VACCINE, V25, P3742, DOI 10.1016/j.vaccine.2007.01.112; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harth G, 1996, INFECT IMMUN, V64, P3038, DOI 10.1128/IAI.64.8.3038-3047.1996; Hmama Z, 1998, J IMMUNOL, V161, P4882; Horwitz MA, 2006, VACCINE, V24, P1593, DOI 10.1016/j.vaccine.2005.10.002; Katti MK, 2008, CELL MICROBIOL, V10, P1286, DOI 10.1111/j.1462-5822.2008.01126.x; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; LEVINE TP, 1991, CRIT REV BIOCHEM MOL, V26, P439, DOI 10.3109/10409239109086790; Mazzaccaro RJ, 1998, ADV EXP MED BIOL, V452, P85; Medd PG, 2000, SEMIN CELL DEV BIOL, V11, P203, DOI 10.1006/scdb.2000.0162; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Moulton RA, 2007, J LEUKOCYTE BIOL, V82, P956, DOI 10.1189/jlb.0206119; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Noss EH, 2000, CELL IMMUNOL, V201, P63, DOI 10.1006/cimm.2000.1633; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, AUTOPHAGY, V3, P133, DOI 10.4161/auto.3591; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Soualhine H, 2007, J IMMUNOL, V179, P5137, DOI 10.4049/jimmunol.179.8.5137; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Ullrich HJ, 2000, J IMMUNOL, V165, P6073, DOI 10.4049/jimmunol.165.11.6073; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	36	362	385	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2009	15	3					267	276		10.1038/nm.1928	http://dx.doi.org/10.1038/nm.1928			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19252503				2022-12-25	WOS:000263914000026
J	Stefansson, H; Steinberg, S; Petursson, H; Gustafsson, O; Gudjonsdottir, IH; Jonsdottir, GA; Palsson, ST; Jonsson, T; Saemundsdottir, J; Bjornsdottir, G; Bottcher, Y; Thorlacius, T; Haubenberger, D; Zimprich, A; Auff, E; Hotzy, C; Testa, CM; Miyatake, LA; Rosen, AR; Kristleifsson, K; Rye, D; Asmus, F; Schols, L; Dichgans, M; Jakobsson, F; Benedikz, J; Thorsteinsdottir, U; Gulcher, J; Kong, A; Stefansson, K				Stefansson, Hreinn; Steinberg, Stacy; Petursson, Hjorvar; Gustafsson, Omar; Gudjonsdottir, Iris H.; Jonsdottir, Gudrun A.; Palsson, Stefan T.; Jonsson, Thorlakur; Saemundsdottir, Jona; Bjornsdottir, Gyda; Boettcher, Yvonne; Thorlacius, Theodora; Haubenberger, Dietrich; Zimprich, Alexander; Auff, Eduard; Hotzy, Christoph; Testa, Claudia M.; Miyatake, Lisa A.; Rosen, Ami R.; Kristleifsson, Kristleifur; Rye, David; Asmus, Friedrich; Schoels, Ludger; Dichgans, Martin; Jakobsson, Finnbogi; Benedikz, John; Thorsteinsdottir, Unnur; Gulcher, Jeffrey; Kong, Augustine; Stefansson, Kari			Variant in the sequence of the LINGO1 gene confers risk of essential tremor	NATURE GENETICS			English	Article							DISORDERS; MOUSE	We identified a marker in LINGO1 showing genome-wide significant association (P = 1.2 x 10(-9), odds ratio = 1.55) with essential tremor. LINGO1 has potent, negative regulatory influences on neuronal survival and is also important in regulating both central-nervous-system axon regeneration and oligodendrocyte maturation. An increase in the number of fusiform swellings of Purkinje cell axons in LINGO1 knockout models highlights the potential role of LINGO1 in essential tremor pathophysiology.	[Stefansson, Hreinn; Steinberg, Stacy; Petursson, Hjorvar; Gustafsson, Omar; Gudjonsdottir, Iris H.; Jonsdottir, Gudrun A.; Palsson, Stefan T.; Jonsson, Thorlakur; Saemundsdottir, Jona; Bjornsdottir, Gyda; Boettcher, Yvonne; Thorlacius, Theodora; Kristleifsson, Kristleifur; Thorsteinsdottir, Unnur; Gulcher, Jeffrey; Kong, Augustine; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Haubenberger, Dietrich; Zimprich, Alexander; Auff, Eduard; Hotzy, Christoph] Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; [Testa, Claudia M.] Emory Dept Neurol, Atlanta, GA 30322 USA; [Testa, Claudia M.] Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Miyatake, Lisa A.; Rosen, Ami R.; Rye, David] Wesley Woods Hlth Ctr, Emory Dept Neurol, Atlanta, GA 30329 USA; [Asmus, Friedrich] Univ Tubingen, Ctr Neurol, Dystonia Genet Unit, Inst Clin Brain Res, Tubingen, Germany; [Schoels, Ludger] Univ Tubingen, Ctr Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Dichgans, Martin] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Jakobsson, Finnbogi] Landspitalinn Univ Hosp, Dept Neurol, IS-108 Reykjavik, Iceland; [Benedikz, John] Landspitalinn Univ Hosp, Dept Neurol, IS-101 Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland	Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland	Stefansson, K (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Schöls, Ludger/ABB-2482-2021; Dichgans, Martin/HCH-3247-2022; Stefansson, Kari/AAE-7187-2019; Zimprich, Alexander/A-5232-2017	Schöls, Ludger/0000-0001-7774-5025; Dichgans, Martin/0000-0002-0654-387X; Zimprich, Alexander/0000-0002-1668-5177; Stefansson, Hreinn/0000-0002-9331-6666; Haubenberger, Dietrich/0000-0002-6233-8168; Gudjonsdottir, Iris Hronn/0000-0001-6013-9520; Kong, Augustine/0000-0001-8193-5438; Bjornsdottir, Gyda/0000-0002-8100-0306	Emory General Clinical Research Center [NIH/NCRR M01 RR00039]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	Emory General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals taking part in this study whose contribution made this work possible. We also thank the Nurses at Krokhals (deCODE's recruitment center) and the personnel at the deCODE core facilities. The US sample was recruited through support from Emory General Clinical Research Center NIH/NCRR M01 RR00039 (CRIN Infra-structure support).	BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Deuschl G, 2000, BRAIN, V123, P1568, DOI 10.1093/brain/123.8.1568; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Laursen LS, 2007, NEURON GLIA BIOL, V3, P367, DOI 10.1017/S1740925X08000161; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Louis ED, 2005, LANCET NEUROL, V4, P100, DOI 10.1016/S1474-4422(05)00991-9; Louis ED, 2007, BRAIN, V130, P3297, DOI 10.1093/brain/awm266; Louis ED, 2007, NEUROEPIDEMIOLOGY, V29, P208, DOI 10.1159/000111584; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mi S, 2008, INT J BIOCHEM CELL B, V40, P1971, DOI 10.1016/j.biocel.2008.03.018; MOGHAL S, 1994, NEUROEPIDEMIOLOGY, V13, P175, DOI 10.1159/000110376; Oliver PL, 2005, CLIN SCI, V108, P385, DOI 10.1042/CS20050041; Shill HA, 2008, NEUROLOGY, V70, P1452, DOI 10.1212/01.wnl.0000310425.76205.02; Zhao XH, 2008, CELL MOL NEUROBIOL, V28, P727, DOI 10.1007/s10571-007-9258-6	15	148	156	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					277	279		10.1038/ng.299	http://dx.doi.org/10.1038/ng.299			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19182806	Green Accepted			2022-12-25	WOS:000263640200005
J	Zheng, W; Long, JR; Gao, YT; Li, C; Zheng, Y; Xiang, YB; Wen, WQ; Levy, S; Deming, SL; Haines, JL; Gu, K; Fair, AM; Cai, QY; Lu, W; Shu, XO				Zheng, Wei; Long, Jirong; Gao, Yu-Tang; Li, Chun; Zheng, Ying; Xiang, Yong-Bin; Wen, Wanqing; Levy, Shawn; Deming, Sandra L.; Haines, Jonathan L.; Gu, Kai; Fair, Alecia Malin; Cai, Qiuyin; Lu, Wei; Shu, Xiao-Ou			Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1	NATURE GENETICS			English	Article							RECEPTOR-ALPHA GENE; RISK; CHROMOSOME; VARIANTS; ALLELES; BRCA2	We carried out a genome-wide association study among Chinese women to identify risk variants for breast cancer. After analyzing 607,728 SNPs in 1,505 cases and 1,522 controls, we selected 29 SNPs for a fast-track replication in an independent set of 1,554 cases and 1,576 controls. We further investigated four replicated loci in a third set of samples comprising 3,472 cases and 900 controls. SNP rs2046210 at 6q25.1, located upstream of the gene encoding estrogen receptor alpha (ESR1), showed strong and consistent association with breast cancer across all three stages. Adjusted odds ratio (95% CI) were 1.36 (1.24-1.49) and 1.59 (1.40-1.82), respectively, for genotypes A/G and A/A versus G/G (P for trend 2.0 x 10(-15)) in the pooled analysis of samples from all three stages. We also found a similar, albeit weaker, association in an independent study comprising 1,591 cases and 1,466 controls of European ancestry (P-trend = 0.01). These results strongly implicate 6q25.1 as a susceptibility locus for breast cancer.	[Zheng, Wei; Long, Jirong; Wen, Wanqing; Deming, Sandra L.; Cai, Qiuyin; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37232 USA; [Gao, Yu-Tang; Xiang, Yong-Bin] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China; [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Li, Chun; Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37232 USA; [Zheng, Ying; Gu, Kai; Lu, Wei] Shanghai Inst Prevent Med, Shanghai Ctr Dis Prevent & Control, Shanghai 200336, Peoples R China; [Levy, Shawn] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Fair, Alecia Malin] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA	Vanderbilt University; Shanghai Jiao Tong University; Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention; Vanderbilt University; Meharry Medical College	Zheng, W (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37232 USA.	wei.zheng@vanderbilt.edu	Li, Chun/R-1095-2019; Lu, Wei/AAE-2921-2022; zhang, weihua/GXV-1334-2022; Li, Chun/B-8388-2012; Gao, Yu/HGE-1937-2022; Zheng, Wei/O-3351-2013; Haines, Jonathan/C-3374-2012	Li, Chun/0000-0002-8819-2443; Lu, Wei/0000-0002-4150-8674; Zheng, Wei/0000-0003-1226-070X; Haines, Jonathan/0000-0002-4351-4728; Long, Jirong/0000-0002-7433-9766; Levy, Shawn/0000-0002-1369-5740	US National Institutes of Health [R01CA124558, R01CA64277, R01CA70867, R01CA90899, R01CA100374]; Ingram professorship funds [R01 CA118229, R01CA92585]; Department of Defense (DOD) Idea Award [BC011118, R01CA122756, BC050791]; Vanderbilt-Ingram Cancer Center [P30 CA68485]; NATIONAL CANCER INSTITUTE [Z01BC011118, R01CA070867, R01CA100374, R01CA122756, R01CA118229, P30CA068485, R01CA090899, R01CA124558, R01CA064277, R01CA092585] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ingram professorship funds; Department of Defense (DOD) Idea Award(United States Department of Defense); Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by US National Institutes of Health grants R01CA124558, R01CA64277, R01CA70867, R01CA90899 and R01CA100374, as well as Ingram professorship funds and research award funds to W. Z., R01 CA118229, R01CA92585 and Department of Defense (DOD) Idea Award BC011118 to X.-O. S., and R01CA122756 and DOD Idea Award BC050791 to Q. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The authors wish to thank study participants and research staff for their contributions and commitment to this project, R. Courtney and Q. Wang for DNA preparation, and B. Venuti for clerical support in the preparation of this manuscript. Sample preparation and stage 1 genotyping were conducted at the Survey and Biospecimen and Microarray Shared Resources that are supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA68485). Stage 2 and 3 genotyping was carried out at the Proactive Genomics.	Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cai QY, 2003, CANCER RES, V63, P5727; Cai QY, 2003, CANCER EPIDEM BIOMAR, V12, P853; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frank B, 2008, J NATL CANCER I, V100, P437, DOI 10.1093/jnci/djn037; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Houlston RS, 2004, ONCOGENE, V23, P6471, DOI 10.1038/sj.onc.1207951; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitrunen K, 2003, MUTAT RES-REV MUTAT, V544, P9, DOI 10.1016/S1383-5742(03)00016-4; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Zheng SL, 2003, CANCER RES, V63, P7624	27	429	444	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					324	328		10.1038/ng.318	http://dx.doi.org/10.1038/ng.318			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19219042	Green Accepted			2022-12-25	WOS:000263640200013
J	Rutsch, F; Gailus, S; Miousse, IR; Suormala, T; Sagne, C; Toliat, MR; Nurnberg, G; Wittkampf, T; Buers, I; Sharifi, A; Stucki, M; Becker, C; Baumgartner, M; Robenek, H; Marquardt, T; Hohne, W; Gasnier, B; Rosenblatt, DS; Fowler, B; Nurnberg, P				Rutsch, Frank; Gailus, Susann; Miousse, Isabelle R.; Suormala, Terttu; Sagne, Corinne; Toliat, Mohammad Reza; Nuernberg, Gudrun; Wittkampf, Tanja; Buers, Insa; Sharifi, Azita; Stucki, Martin; Becker, Christian; Baumgartner, Matthias; Robenek, Horst; Marquardt, Thorsten; Hoehne, Wolfgang; Gasnier, Bruno; Rosenblatt, David S.; Fowler, Brian; Nuernberg, Peter			Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B-12 metabolism	NATURE GENETICS			English	Article							INBORN ERROR; CELLULAR INTERNALIZATION; GENE; COMPLEMENTATION; MUTATIONS; PROTEIN; LIPOCALIN-1; EXPRESSION; TOOL; DNA	Vitamin B-12 (cobalamin) is essential in animals for metabolism of branched chain amino acids and odd chain fatty acids, and for remethylation of homocysteine to methionine(1). In the cblF inborn error of vitamin B-12 metabolism, free vitamin accumulates in lysosomes, thus hindering its conversion to cofactors(2,3). Using homozygosity mapping in 12 unrelated cblF individuals and microcell-mediated chromosome transfer, we identified a candidate gene on chromosome 6q13, LMBRD1, encoding LMBD1, a lysosomal membrane protein with homology to lipocalin membrane receptor LIMR. We identified five different frameshift mutations in LMBRD1 resulting in loss of LMBD1 function, with 18 of the 24 disease chromosomes carrying the same mutation embedded in a common 1.34-Mb haplotype. Transfection of fibroblasts of individuals with cblF with wild-type LMBD1 rescued cobalamin coenzyme synthesis and function. This work identifies LMBRD1 as the gene underlying the cblF defect of cobalamin metabolism and suggests that LMBD1 is a lysosomal membrane exporter for cobalamin.	[Rutsch, Frank; Gailus, Susann; Wittkampf, Tanja; Marquardt, Thorsten] Munster Univ Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Hoehne, Wolfgang] Charite, Inst Biochem, D-10117 Berlin, Germany; [Miousse, Isabelle R.; Rosenblatt, David S.] McGill Univ, Ctr Hlth, Dept Human Genet, Div Med Genet, Montreal, PQ H3A 1B1, Canada; [Suormala, Terttu; Fowler, Brian] Univ Childrens Hosp, Metab Unit, CH-4058 Basel, Switzerland; [Stucki, Martin] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland; [Stucki, Martin; Baumgartner, Matthias] Univ Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland; [Buers, Insa; Robenek, Horst] Univ Munster, Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Toliat, Mohammad Reza; Nuernberg, Gudrun; Becker, Christian; Nuernberg, Peter] Cologne Ctr Genom, D-50674 Cologne, Germany; [Toliat, Mohammad Reza; Nuernberg, Gudrun; Becker, Christian; Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Sagne, Corinne; Sharifi, Azita; Gasnier, Bruno] Univ Paris 05, Inst Biol Physicochim, CNRS, UPR 1929, F-75005 Paris, France	University of Munster; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University Children's Hospital Zurich; University of Munster; University of Cologne; University of Cologne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Rutsch, F (corresponding author), Munster Univ Childrens Hosp, Dept Gen Pediat, Albert Schweitzer Str 33, D-48149 Munster, Germany.	rutschf@mednet.uni-muenster.de	Gasnier, Bruno/AAD-9124-2022; Sagné, Corinne/AAY-1819-2021; Baumgartner, Matthias R/Q-2855-2017; Miousse, Isabelle R./K-3512-2013; Sagne, Corinne/K-7601-2017	Gasnier, Bruno/0000-0003-4458-6296; Sagné, Corinne/0000-0001-5971-4831; Baumgartner, Matthias R/0000-0002-9270-0826; Miousse, Isabelle R./0000-0001-6543-3219; 	University of Munster Medical School; Centre National de la Recherche Scientifique; Institut national de la sante et de la recherche medicale; Agence Nationale de la Recherche; Fonds de la Recherche en Sante du Quebec; Canadian Institutes of Health Research; Swiss National Foundation; German Federal Ministry of Education and Research through the National Genome Research Network	University of Munster Medical School; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German Federal Ministry of Education and Research through the National Genome Research Network	We thank the following individuals who provided subject samples and/or clinical information: D. Applegarth, J. Bever, S. Cederbaum, G. Davidson, B. S. Dowton, G. Hoganson, R. Laframboise, U. Lichter, M. Lindner, M. Seashore, V. Shih, G. P. A. Smit, J. Vockley and H. E. Wiltse. We thank E. Kirst, C. Kluck and U. Botschen for expert technical assistance. F. R. and S. G. were supported by the fund "Innovative Medical Research'' of University of Munster Medical School. B. G. and C. S. were supported by the Centre National de la Recherche Scientifique, the Institut national de la sante et de la recherche medicale and the Agence Nationale de la Recherche - Programme Pluriannuel de Recherche sur les Maladies Rares. I. R. M. was supported by a studentship from the Fonds de la Recherche en Sante du Quebec. D. S. R. and I. R. M. were supported by funds from the Canadian Institutes of Health Research and the Hess B. and Diane Finestone Laboratory in memory of Jacob and Jenny Finestone. Financial support was further given by the Swiss National Foundation and the German Federal Ministry of Education and Research through the National Genome Research Network.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; CHANARIN I, 1985, BLOOD, V66, P479; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Crisponi L, 2007, AM J HUM GENET, V80, P971, DOI 10.1086/516843; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; DUFOUR E, 1990, FEBS LETT, V277, P223, DOI 10.1016/0014-5793(90)80850-I; Flower DR, 1996, BIOCHEM J, V318, P1; Fluckinger M, 2008, BBA-BIOMEMBRANES, V1778, P342, DOI 10.1016/j.bbamem.2007.10.010; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; LITZKAS P, 1984, MOL CELL BIOL, V4, P2549, DOI 10.1128/MCB.4.11.2549; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Robenek H, 2008, BIOL PROCED ONLINE, V10, P9, DOI 10.1251/bpo138; Robenek H, 2009, J CELL MOL MED, V13, P1381, DOI 10.1111/j.1582-4934.2008.00407.x; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; SCHUH S, 1984, NEW ENGL J MED, V310, P686, DOI 10.1056/NEJM198403153101104; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; VASSILIADIS A, 1991, EXP CELL RES, V195, P295, DOI 10.1016/0014-4827(91)90376-6; Wang YH, 2005, J VIROL, V79, P8113, DOI 10.1128/JVI.79.13.8113-8120.2005; Watkins D, 2000, J MED GENET, V37, P510, DOI 10.1136/jmg.37.7.510; Wojnar P, 2003, J BIOL CHEM, V278, P16209, DOI 10.1074/jbc.M210922200; Wojnar P, 2001, J BIOL CHEM, V276, P20206, DOI 10.1074/jbc.M101762200	30	122	128	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					234	239		10.1038/ng.294	http://dx.doi.org/10.1038/ng.294			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19136951				2022-12-25	WOS:000263091300026
J	Cai, CX; Masumiya, H; Weisleder, N; Matsuda, N; Nishi, M; Hwang, M; Ko, JK; Lin, PH; Thornton, A; Zhao, XL; Pan, Z; Komazaki, S; Brotto, M; Takeshima, H; Ma, JJ				Cai, Chuanxi; Masumiya, Haruko; Weisleder, Noah; Matsuda, Noriyuki; Nishi, Miyuki; Hwang, Moonsun; Ko, Jae-Kyun; Lin, Peihui; Thornton, Angela; Zhao, Xiaoli; Pan, Zui; Komazaki, Shinji; Brotto, Marco; Takeshima, Hiroshi; Ma, Jianjie			MG53 nucleates assembly of cell membrane repair machinery	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; PLASMA-MEMBRANE; CA2+ RELEASE; DYSFERLIN; DISRUPTIONS; MECHANISM; CHANNELS; SARCOLEMMA; CALCIUM	Dynamic membrane repair and remodelling is an elemental process that maintains cell integrity and mediates efficient cellular function. Here we report that MG53, a muscle-specific tripartite motif family protein (TRIM72), is a component of the sarcolemmal membrane-repair machinery. MG53 interacts with phosphatidylserine to associate with intracellular vesicles that traffic to and fuse with sarcolemmal membranes. Mice null for MG53 show progressive myopathy and reduced exercise capability, associated with defective membrane-repair capacity. Injury of the sarcolemmal membrane leads to entry of the extracellular oxidative environment and MG53 oligomerization, resulting in recruitment of MG53-containing vesicles to the injury site. After vesicle translocation, entry of extracellular Ca2+ facilitates vesicle fusion to reseal the membrane. Our data indicate that intracellular vesicle translocation and Ca2+-dependent membrane fusion are distinct steps involved in the repair of membrane damage and that MG53 may initiate the assembly of the membrane repair machinery in an oxidation-dependent manner.	[Masumiya, Haruko; Nishi, Miyuki; Takeshima, Hiroshi] Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 980, Japan; [Cai, Chuanxi; Weisleder, Noah; Hwang, Moonsun; Ko, Jae-Kyun; Lin, Peihui; Thornton, Angela; Zhao, Xiaoli; Pan, Zui; Brotto, Marco; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Ctr Lab Frontier Sci, Tokyo, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Saitama 3500495, Japan	Tohoku University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tokyo Metropolitan Institute of Medical Science; Kyoto University; Saitama Medical University	Takeshima, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 980, Japan.	takeshim@pharm.kyoto-u.ac.jp; maj2@umdnj.edu	Lin, Pei-Hui/I-3011-2015; Weisleder, Noah L/A-7098-2013; Matsuda, Noriyuki/AAI-3156-2020; Cai, Chuanxi/AAW-1488-2020	Lin, Pei-Hui/0000-0002-3894-5099; Weisleder, Noah L/0000-0002-2619-8022; Matsuda, Noriyuki/0000-0001-8199-952X; Weisleder, Noah/0000-0003-2710-3088; Pan, Zui/0000-0003-4105-901X; Takeshima, Hiroshi/0000-0003-4525-3725	NIH; Ministry of Education, Science, Sports and Culture of Japan; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Michael Reid, Jerome Parness, and Heping Cheng for helpful suggestions to this work. Yi Chu provided assistance in data processing and graphic conversions. We also thank the Cancer Institute of New Jersey Tissue Analytic Services Shared Resource and the UMDNJ-Cell Imaging Core facility, which is supported by NCRR from NIH, for providing assistance with imaging. This work was supported by grants from NIH (J.M.), Ministry of Education, Science, Sports and Culture of Japan ( H. T.) and the American Heart Association (C.C.,N.W.,M.B.).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saito A, 2002, ACTA NEUROPATHOL, V104, P615, DOI 10.1007/s00401-002-0593-x; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; Weiler T, 1999, HUM MOL GENET, V8, P871, DOI 10.1093/hmg/8.5.871; Weisleder N, 2008, CELL CALCIUM, V43, P1, DOI 10.1016/j.ceca.2007.10.006; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Yang DM, 2001, J BIOL CHEM, V276, P40210, DOI 10.1074/jbc.M106944200; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928	37	314	339	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					56	U108		10.1038/ncb1812	http://dx.doi.org/10.1038/ncb1812			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19043407	Green Accepted			2022-12-25	WOS:000262157000011
J	Calzado, MA; de la Vega, L; Moller, A; Bowtell, DDL; Schmitz, ML				Calzado, Marco A.; de la Vega, Laureano; Moeller, Andreas; Bowtell, David D. L.; Schmitz, M. Lienhard			An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response	NATURE CELL BIOLOGY			English	Article							INTERACTING PROTEIN KINASE-2; P53; PHOSPHORYLATION; DEGRADATION; APOPTOSIS; STABILITY	Oxygen deprivation (hypoxia) results in reprogrammed gene expression patterns that induce multifaceted cellular responses. Here we identify a regulated interaction between the serine/threonine kinase HIPK2 and the ubiquitin E3 ligase Siah2 as a mechanism controlling the hypoxic response. Under normoxic conditions, several mechanisms ensure HIPK2 stability: only a fraction of HIPK2 is found in association with Siah2, whereas HIPK2-mediated phosphorylation of this E3 ligase at positions 26, 28 and 68 weakens mutual binding and destabilizes its phosphorylated interaction partner. Hypoxic conditions allow a markedly increased HIPK2/Siah2 interaction and result in efficient polyubiquitylation and proteasomal degradation of the kinase. Accordingly, hypoxia-induced HIPK2 elimination is markedly reduced in Siah2-deficient cells. As HIPK2 has an important role as a negative regulator of gene expression, its elimination from promoter-associated repressor complexes allows the induction of a substantial fraction of hypoxia-induced genes.	[Calzado, Marco A.; de la Vega, Laureano; Schmitz, M. Lienhard] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Moeller, Andreas; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Dept Res, Canc Genom & Biochem Lab, Melbourne, Vic 3002, Australia; [Moeller, Andreas; Bowtell, David D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Justus Liebig University Giessen; Peter Maccallum Cancer Center; University of Melbourne	Schmitz, ML (corresponding author), Univ Giessen, Fac Med, Inst Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	lienhard.schmitz@biochemie.med.uni-giessen.de	Calzado, Marco A./S-2295-2019; Schmitz, M. Lienhard/D-9328-2017; Calzado, Marco/E-9046-2016; de la Vega, Laureano/AAE-5456-2020; Möller, Andreas/O-1063-2015; Bowtell, David/H-1007-2016	Calzado, Marco A./0000-0002-5338-535X; Schmitz, M. Lienhard/0000-0002-6984-7192; Calzado, Marco/0000-0002-5338-535X; de la Vega, Laureano/0000-0003-2707-7414; Möller, Andreas/0000-0002-8618-6998; Bowtell, David/0000-0001-9089-7525	Deutsche Forschungsgemeinschaft [SCHM 1417/4-1, SCHM 1417/5-1, SFB 547]; ECCPS-Excellence Cluster Cardio-Pulmonary System; ISCIII-RETIC [RD06/006]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ECCPS-Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); ISCIII-RETIC(Instituto de Salud Carlos III)	We are grateful to Stephanie Wack for excellent technical assistance, Michael Kracht for inspiring discussions and Elena Puccetti (Frankfurt) for help with microarrays. Our work is supported by grants from the Deutsche Forschungsgemeinschaft projects SCHM 1417/4-1, SCHM 1417/5-1, SFB 547 and the ECCPS-Excellence Cluster Cardio-Pulmonary System. M. A. C has been partially co-funded by the ISCIII-RETIC RD06/006 (RIS).	Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; KANEIISHII C, 2008, J BIOL CHEM; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; Lieser SA, 2005, BBA-PROTEINS PROTEOM, V1754, P191, DOI 10.1016/j.bbapap.2005.07.024; MOLLER A, 2008, ONCOGENE; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; QI J, 2008, P NATL ACAD SCI US; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; SHIMA Y, 2008, MOL CELL BIOL; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743	25	105	107	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					85	U180		10.1038/ncb1816	http://dx.doi.org/10.1038/ncb1816			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19043406				2022-12-25	WOS:000262157000015
J	Jenkins, ZA; van Kogelenberg, M; Morgan, T; Jeffs, A; Fukuzawa, R; Pearl, E; Thaller, C; Hing, AV; Porteous, ME; Garcia-Minaur, S; Bohring, A; Lacombe, D; Stewart, F; Fiskerstrand, T; Bindoff, L; Berland, S; Ades, LC; Tchan, M; David, A; Wilson, LC; Hennekam, RCM; Donnai, D; Mansour, S; Cormier-Daire, V; Robertson, SP				Jenkins, Zandra A.; van Kogelenberg, Margriet; Morgan, Tim; Jeffs, Aaron; Fukuzawa, Ryuji; Pearl, Esther; Thaller, Christina; Hing, Anne V.; Porteous, Mary E.; Garcia-Minaur, Sixto; Bohring, Axel; Lacombe, Didier; Stewart, Fiona; Fiskerstrand, Torunn; Bindoff, Laurence; Berland, Siren; Ades, Lesley C.; Tchan, Michel; David, Albert; Wilson, Louise C.; Hennekam, Raoul C. M.; Donnai, Dian; Mansour, Sahar; Cormier-Daire, Valerie; Robertson, Stephen P.			Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis	NATURE GENETICS			English	Article							FOCAL DERMAL HYPOPLASIA; TIME QUANTITATIVE PCR; HIGH-BONE-MASS; GENE-EXPRESSION; BETA-CATENIN; WILMS-TUMOR; WNT; DIFFERENTIATION; OSTEOBLAST; REGULATOR	Abnormalities in WNT signaling are implicated in a broad range of developmental anomalies and also in tumorigenesis(1). Here we demonstrate that germline mutations in WTX (FAM123B), a gene that encodes a repressor of canonical WNT signaling(2), cause an X-linked sclerosing bone dysplasia, osteopathia striata congenita with cranial sclerosis (OSCS; MIM300373)(3). This condition is typically characterized by increased bone density and craniofacial malformations in females and lethality in males. The mouse homolog of WTX is expressed in the fetal skeleton, and alternative splicing implicates plasma membrane localization of WTX as a factor associated with survival in males with OSCS. WTX has also been shown to be somatically inactivated in 11-29% of cases of Wilms tumor(4-6). Despite being germline for such mutations, individuals with OSCS are not predisposed to tumor development. The observed phenotypic discordance dependent upon whether a mutation is germline or occurs somatically suggests the existence of temporal or spatial constraints on the action of WTX during tumorigenesis.	[Jenkins, Zandra A.; van Kogelenberg, Margriet; Morgan, Tim; Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Paediat, Dunedin 9054, New Zealand; [Jeffs, Aaron] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9054, New Zealand; [Fukuzawa, Ryuji] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin 9054, New Zealand; [Pearl, Esther] Univ Otago, Dept Zool, Dunedin 9054, New Zealand; [Thaller, Christina] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hing, Anne V.] Univ Washington, Sch Med, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Porteous, Mary E.; Garcia-Minaur, Sixto] Western Gen Hosp, S E Scotland Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Bohring, Axel] Univ Munster, Inst Humangenet, D-48149 Munster, Germany; [Lacombe, Didier] Univ Bordeaux, CHU Bordeaux, F-33800 Bordeaux, France; [Stewart, Fiona] Belfast City Hosp, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland; [Fiskerstrand, Torunn; Berland, Siren] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Bindoff, Laurence] Univ Bergen, Inst Clin Med, N-5021 Bergen, Norway; [Bindoff, Laurence] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Ades, Lesley C.; Tchan, Michel] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2101, Australia; [Ades, Lesley C.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2101, Australia; [David, Albert] Nantes Univ Hosp, Dept Clin Genet, F-44093 Nantes, France; [Wilson, Louise C.; Hennekam, Raoul C. M.] Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 3JH, England; [Donnai, Dian] St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; [Mansour, Sahar] St George Hosp, S W Thames Reg Genet Unit, London SW17 0RE, England; [Cormier-Daire, Valerie] Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France	University of Otago; University of Otago; University of Otago; University of Otago; Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Edinburgh; University of Munster; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Belfast City Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Sydney; University of Sydney; Nantes Universite; CHU de Nantes; University of London; University College London; University of Manchester; St Georges University London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Robertson, SP (corresponding author), Univ Otago, Dunedin Sch Med, Dept Paediat, Dunedin 9054, New Zealand.	stephen.robertson@otago.ac.nz	lacombe, didier/K-7967-2014; Jeffs, Aaron/B-4324-2008; cormier-daire, valerie/H-6520-2017	cormier-daire, valerie/0000-0002-2839-9856; Berland, Siren/0000-0002-8048-6682; Pearl, Esther/0000-0001-6510-0959; Lacombe, Didier/0000-0002-8956-2207; garcia, sixto/0000-0003-3406-3424; Bindoff, Laurence/0000-0003-0988-276X; Robertson, Stephen/0000-0002-5181-7809				Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Behninger C, 2000, GENET COUNSEL, V11, P157; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; HURT RL, 1953, J BONE JOINT SURG BR, V35, P89, DOI 10.1302/0301-620X.35B1.89; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; RUTESHOUSER EC, 2008, CANCER, V47, P461; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	30	136	174	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					95	100		10.1038/ng.270	http://dx.doi.org/10.1038/ng.270			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079258				2022-12-25	WOS:000262085300022
J	Hillmer, AM; Brockschmidt, FF; Hanneken, S; Eigelshoven, S; Steffens, M; Flaquer, A; Herms, S; Becker, T; Kortum, AK; Nyholt, DR; Zhao, ZZ; Montgomery, GW; Martin, NG; Muhleisen, TW; Alblas, MA; Moebus, S; Jockel, KH; Brocker-Preuss, M; Erbel, R; Reinartz, R; Betz, RC; Cichon, S; Propping, P; Baur, MP; Wienker, TF; Kruse, R; Nothen, MM				Hillmer, Axel M.; Brockschmidt, Felix F.; Hanneken, Sandra; Eigelshoven, Sibylle; Steffens, Michael; Flaquer, Antonia; Herms, Stefan; Becker, Tim; Kortuem, Anne-Katrin; Nyholt, Dale R.; Zhao, Zhen Zhen; Montgomery, Grant W.; Martin, Nicholas G.; Muehleisen, Thomas W.; Alblas, Margrieta A.; Moebus, Susanne; Joeckel, Karl-Heinz; Broecker-Preuss, Martina; Erbel, Raimund; Reinartz, Roman; Betz, Regina C.; Cichon, Sven; Propping, Peter; Baur, Max P.; Wienker, Thomas F.; Kruse, Roland; Noethen, Markus M.			Susceptibility variants for male-pattern baldness on chromosome 20p11	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; ALOPECIA; POLYMORPHISM	We carried out a genome-wide association study in 296 individuals with male-pattern baldness (androgenetic alopecia) and 347 controls. We then investigated the 30 best SNPs in an independent replication sample and found highly significant association for five SNPs on chromosome 20p11 (rs2180439 combined P = 2.7 x 10(-15)). No interaction was detected with the X-chromosomal androgen receptor locus, suggesting that the 20p11 locus has a role in a yet-to-be-identified androgen-independent pathway.	[Hillmer, Axel M.; Brockschmidt, Felix F.; Herms, Stefan; Muehleisen, Thomas W.; Alblas, Margrieta A.; Reinartz, Roman; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Hanneken, Sandra; Eigelshoven, Sibylle; Kortuem, Anne-Katrin; Kruse, Roland] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; [Steffens, Michael; Flaquer, Antonia; Becker, Tim; Baur, Max P.; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany; [Nyholt, Dale R.; Zhao, Zhen Zhen; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Moebus, Susanne; Joeckel, Karl-Heinz] Univ Duisburg Essen, Inst Med Bioinformat Biometry & Epidemiol, D-45122 Essen, Germany; [Broecker-Preuss, Martina] Univ Duisburg Essen, Univ Hosp Essen, Cent Lab Unit Res & Educ, Clin Endocrinol, D-45122 Essen, Germany; [Erbel, Raimund] Univ Duisburg Essen, W German Heart Ctr Essen, Clin Cardiol, D-45122 Essen, Germany; [Betz, Regina C.; Cichon, Sven; Propping, Peter; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany	University of Bonn; Heinrich Heine University Dusseldorf; University of Bonn; QIMR Berghofer Medical Research Institute; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Bonn	Hillmer, AM (corresponding author), Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany.	axel.hillmer@uni-bonn.de	Nöthen, Markus/B-2027-2009; Hillmer, Axel M/B-7485-2015; Nyholt, Dale Robert/J-3174-2017; Montgomery, Grant W/B-7148-2008; Hillmer, Axel M/N-2927-2014; Cichon, Sven/B-9618-2014; Herms, Stefan/J-1949-2014; Betz, Regina C/E-8591-2011; Cichon, Sven/H-8803-2013	Nöthen, Markus/0000-0002-8770-2464; Hillmer, Axel M/0000-0002-3381-7266; Nyholt, Dale Robert/0000-0001-7159-3040; Montgomery, Grant W/0000-0002-4140-8139; Hillmer, Axel M/0000-0002-3381-7266; Cichon, Sven/0000-0002-9475-086X; Herms, Stefan/0000-0002-2786-8200; Betz, Regina C/0000-0001-5024-3623; Cichon, Sven/0000-0002-9475-086X; Reinartz, Roman/0000-0002-6417-9156; Martin, Nicholas/0000-0003-4069-8020; Steffens, Michael/0000-0002-6445-8593; Moebus, Susanne/0000-0002-0072-5410	Deutsche Forschungsgemeinschaft; Alfried Krupp von Bohlen; Halbach-Stiftung; Heinz Nixdorf Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfried Krupp von Bohlen; Halbach-Stiftung; Heinz Nixdorf Foundation	We thank all probands for participating in the study and providing blood samples. This study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and Emmy Noether) and the Alfried Krupp von Bohlen und Halbach-Stiftung. The Heinz Nixdorf Recall cohort was established with the support of the Heinz Nixdorf Foundation (G. Schmidt, Chairman).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Ellis JA, 2007, HUM GENET, V121, P451, DOI 10.1007/s00439-006-0317-8; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Lotufo PA, 2000, ARCH INTERN MED, V160, P165, DOI 10.1001/archinte.160.2.165; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Paik JH, 2001, BRIT J DERMATOL, V145, P95, DOI 10.1046/j.1365-2133.2001.04289.x; RISCH N, 1996, SCIENCE, V273, P1517	15	88	92	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1279	1281		10.1038/ng.228	http://dx.doi.org/10.1038/ng.228			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849994				2022-12-25	WOS:000260501500016
J	Caldwell, JH; Howell, KE				Caldwell, John H.; Howell, Kathryn E.			Pores galore for the Golgi	NATURE CELL BIOLOGY			English	Editorial Material							SECRETORY PATHWAY; ANION CHANNEL; COMPLEX; PH; DETERMINANTS	Strict control of cisternal pH in the Golgi is required for posttranslational modification and trafficking of proteins and lipids. a chloride channel to neutralize the charge of the proton pump and to keep the Golgi membrane potential near zero has finally been discovered.	[Caldwell, John H.; Howell, Kathryn E.] Univ Colorado Denver, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Caldwell, JH (corresponding author), Univ Colorado Denver, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA.	kathryn.howell@uchsc.edu						Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nordeen MH, 2000, BIOPHYS J, V78, P2918, DOI 10.1016/S0006-3495(00)76832-9; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Thompson RJ, 2006, AM J PHYSIOL-CELL PH, V290, pC499, DOI 10.1152/ajpcell.00585.2004; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200	16	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1125	1127		10.1038/ncb1008-1125	http://dx.doi.org/10.1038/ncb1008-1125			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18830217				2022-12-25	WOS:000259682900003
J	Diks, SH; da Silva, MAS; Hillebrands, JL; Bink, RJ; Versteeg, HH; van Rooijen, C; Brouwers, A; Chitnis, AB; Peppelenbosch, MP; Zivkovic, D				Diks, Sander H.; da Silva, Maria A. Sartori; Hillebrands, Jan-Luuk; Bink, Robert J.; Versteeg, Henri H.; van Rooijen, Carina; Brouwers, Anke; Chitnis, Ajay B.; Peppelenbosch, Maikel P.; Zivkovic, Danica			d-Asb11 is an essential mediator of canonical Delta-Notch signalling	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; CELL FATE; MIND BOMB; ZEBRAFISH; DROSOPHILA; ENDOCYTOSIS; PATHWAY; PROTEIN; GENE; NRARP	In canonical Delta-Notch signalling, expression of Delta activates Notch in neighbouring cells, leading to of Delta in these cells(1). This process of lateral inhibition results in selection of either Delta-signalling cells or Notch-signalling cells. Here we show that d-Asb11 is an important mediator of this lateral inhibition. In zebrafish embryos, morpholino oligonucleotide (MO)-mediated knockdown of d-Asb11 caused repression of specific Delta-Notch elements and their transcriptional targets, whereas these were induced when d-Asb11 was misexpressed. d-Asb11 also activated legitimate Notch reporters cell-non-autonomously in vitro and in vivo when co-expressed with a Notch reporter. However, it repressed Notch reporters when expressed in Delta-expressing cells. Consistent with these results, d-Asb11 was able to specifically ubiquitylate and degrade DeltaA both in vitro and in vivo. We conclude that d-Asb11 is a component in the regulation of Delta-Notch signalling, important in fine-tuning the lateral inhibition gradients between DeltaA and Notch through a cell non-autonomous mechanism.	[Diks, Sander H.; da Silva, Maria A. Sartori; Hillebrands, Jan-Luuk; Versteeg, Henri H.; Peppelenbosch, Maikel P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [da Silva, Maria A. Sartori; Bink, Robert J.; van Rooijen, Carina; Brouwers, Anke; Zivkovic, Danica] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Chitnis, Ajay B.] NICHD, Sect Neural Dev Dynam, Mol Genet Lab, NIH, Bethesda, MD 20892 USA	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Peppelenbosch, MP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	M.P.Peppelenbosch@med.umcg.nl	Versteeg, Henri/G-1783-2018; Sartori, Maria A/R-9317-2016	Versteeg, Henri/0000-0003-4294-175X; Sartori, Maria A/0000-0002-6474-280X; Peppelenbosch, Maikel/0000-0001-9112-6028; Hillebrands, Jan-Luuk/0000-0003-3135-3274				Appel B, 1998, DEVELOPMENT, V125, P371; Baron M, 2002, MOL MEMBR BIOL, V19, P27, DOI 10.1080/09687680110112929; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Crowe R, 1998, DEVELOPMENT, V125, P767; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Diks SH, 2006, J CELL BIOL, V174, P581, DOI 10.1083/jcb.200601081; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Holley SA, 2002, DEVELOPMENT, V129, P1175; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JOORE J, 1994, MECH DEVELOP, V46, P137, DOI 10.1016/0925-4773(94)90082-5; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Latimer AJ, 2002, DEVELOPMENT, V129, P2555; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Westerfield M, 1994, ZEBRAFISH BOOK; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	34	19	19	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1190	1198		10.1038/ncb1779	http://dx.doi.org/10.1038/ncb1779			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18776899				2022-12-25	WOS:000259682900013
J	Munger, J; Bennett, BD; Parikh, A; Feng, XJ; McArdle, J; Rabitz, HA; Shenk, T; Rabinowitz, JD				Munger, Joshua; Bennett, Bryson D.; Parikh, Anuraag; Feng, Xiao-Jiang; McArdle, Jessica; Rabitz, Herschel A.; Shenk, Thomas; Rabinowitz, Joshua D.			Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy	NATURE BIOTECHNOLOGY			English	Article							HUMAN CYTOMEGALOVIRUS GENOME; ESCHERICHIA-COLI; MASS ISOTOPOMER; QUANTITATION; FIBROBLASTS; INFECTION; PROTEINS; REPLICATION; INHIBITORS; PARTICLES	Viruses rely on the metabolic network of their cellular hosts to provide energy and building blocks for viral replication. We developed a flux measurement approach based on liquid chromatography -tandem mass spectrometry to quantify changes in metabolic activity induced by human cytomegalovirus (HCMV). This approach reliably elucidated fluxes in cultured mammalian cells by monitoring metabolome labeling kinetics after feeding cells C-13-labeled forms of glucose and glutamine. Infection with HCMV markedly upregulated flux through much of the central carbon metabolism, including glycolysis. Particularly notable increases occurred in flux through the tricarboxylic acid cycle and its efflux to the fatty acid biosynthesis pathway. Pharmacological inhibition of fatty acid biosynthesis suppressed the replication of both HCMV and influenza A, another enveloped virus. These results show that fatty acid synthesis is essential for the replication of two divergent enveloped viruses and that systems-level metabolic flux profiling can identify metabolic targets for antiviral therapy.	[Bennett, Bryson D.; Parikh, Anuraag; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Bennett, Bryson D.; Parikh, Anuraag; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA; [Munger, Joshua; Shenk, Thomas] Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; [Munger, Joshua; McArdle, Jessica] Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA; [Feng, Xiao-Jiang; Rabitz, Herschel A.] Princeton Univ, Dept Chem, Frick Lab, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; University of Rochester; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu	Munger, Joshua/ABA-6395-2020; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Munger, Joshua/0000-0001-5379-9440	National Institutes of Health (NIH) Metabolomics Roadmap initiative [AI068678]; NIH [CA82396, CA85786]; NIH Center for Systems Biology at Princeton University [5 P50 GM071508]; National Science Foundation Faculty Early Career Development award program [MCB-0643859]; Beckman Foundation; American Heart Association [0635188N]; National Science Foundation Dynamic Data-Driven Applications Systems program [CNS-0549181]; NATIONAL CANCER INSTITUTE [R01CA085786, R01CA082396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Metabolomics Roadmap initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Systems Biology at Princeton University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Faculty Early Career Development award program(National Science Foundation (NSF)); Beckman Foundation; American Heart Association(American Heart Association); National Science Foundation Dynamic Data-Driven Applications Systems program(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Metabolomics Roadmap initiative (AI068678), NIH grants CA82396 and CA85786, and the NIH Center for Systems Biology at Princeton University (5 P50 GM071508). Development of the fluxomic technology was supported by the National Science Foundation Faculty Early Career Development award program (MCB-0643859), the Beckman Foundation, the American Heart Association (0635188N) and the National Science Foundation Dynamic Data-Driven Applications Systems program (CNS-0549181). J. Munger was supported by a postdoctoral fellowship from the American Cancer Society.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Andrei G, 2008, CURR OPIN INVEST DR, V9, P132; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Boros LG, 2003, CURR CANCER DRUG TAR, V3, P445, DOI 10.2174/1568009033481769; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Bruggeman Cathrien A, 2000, Herpes, V7, P51; Burny Wivine, 2004, Expert Rev Anti Infect Ther, V2, P881, DOI 10.1586/14789072.2.6.881; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; CHANCE EM, 1983, J BIOL CHEM, V258, P3785; CHATHAM JC, 1995, J BIOL CHEM, V270, P7999, DOI 10.1074/jbc.270.14.7999; CONTI G, 1995, RES VIROLOGY, V146, P141, DOI 10.1016/0923-2516(96)81083-1; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Feng XJ, 2004, BIOPHYS J, V86, P1270, DOI 10.1016/S0006-3495(04)74201-0; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fishman JA, 2000, TRANSPLANTATION, V69, P389, DOI 10.1097/00007890-200002150-00014; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; FURUKAWA T, 1973, J VIROL, V11, P991, DOI 10.1128/JVI.11.6.991-997.1973; Gerna G, 2004, HUM IMMUNOL, V65, P381, DOI 10.1016/j.humimm.2004.02.009; Gibson J P, 1981, Fundam Appl Toxicol, V1, P19; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; KARIYA T, 1978, BIOCHEM BIOPH RES CO, V80, P1022, DOI 10.1016/0006-291X(78)91347-5; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; LANDINI MP, 1984, J GEN VIROL, V65, P1229, DOI 10.1099/0022-1317-65-7-1229; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Munger J, 2006, J VIROL, V80, P3541, DOI 10.1128/JVI.80.7.3541-3548.2006; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; MYERSON D, 1984, HUM PATHOL, V15, P430, DOI 10.1016/S0046-8177(84)80076-3; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Pizer ES, 1996, CANCER RES, V56, P2745; Pizer ES, 1998, CANCER RES, V58, P4611; Reinhardt B, 2006, J GEN VIROL, V87, P2849, DOI 10.1099/vir.0.81955-0; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; SCHMIDT MFG, 1984, EMBO J, V3, P2295, DOI 10.1002/j.1460-2075.1984.tb02129.x; Silva MC, 2003, J VIROL, V77, P10594, DOI 10.1128/JVI.77.19.10594-10605.2003; SZYPERSKI T, 1995, EUR J BIOCHEM, V232, P433, DOI 10.1111/j.1432-1033.1995.433zz.x; TANAKA S, 1975, J VIROL, V15, P297, DOI 10.1128/JVI.15.2.297-304.1975; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; van Winden WA, 2005, FEMS YEAST RES, V5, P559, DOI 10.1016/j.femsyr.2004.10.007; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wikoff WR, 2008, J CLIN INVEST, V118, P2661, DOI 10.1172/JCI34138; Wikoff WR, 2007, CLIN CHEM, V53, P2169, DOI 10.1373/clinchem.2007.089011; Yu D, 2002, J VIROL, V76, P2316, DOI 10.1128/JVI.76.5.2316-2328.2002; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816; Zhao J, 2004, APPL MICROBIOL BIOT, V64, P91, DOI 10.1007/s00253-003-1458-5; Zupke C, 1995, APPL MICROBIOL BIOT, V44, P27	58	471	523	3	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1179	1186		10.1038/nbt.1500	http://dx.doi.org/10.1038/nbt.1500			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18820684	Green Accepted			2022-12-25	WOS:000259926000033
J	Mackay, DJG; Callaway, JLA; Marks, SM; White, HE; Acerini, CL; Boonen, SE; Dayanikli, P; Firth, HV; Goodship, JA; Haemers, AP; Hahnemann, JMD; Kordonouri, O; Masoud, AF; Oestergaard, E; Storr, J; Ellard, S; Hattersley, AT; Robinson, DO; Temple, IK				Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Marks, Sophie M.; White, Helen E.; Acerini, Carlo L.; Boonen, Susanne E.; Dayanikli, Pinar; Firth, Helen V.; Goodship, Judith A.; Haemers, Andreas P.; Hahnemann, Johanne M. D.; Kordonouri, Olga; Masoud, Ahmed F.; Oestergaard, Elsebet; Storr, John; Ellard, Sian; Hattersley, Andrew T.; Robinson, David O.; Temple, I. Karen			Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57	NATURE GENETICS			English	Article							STEM-CELLS; MELLITUS; IDENTIFICATION; REGION; ZFP-57	We have previously described individuals presenting with transient neonatal diabetes and showing a variable pattern of DNA hypomethylation at imprinted loci throughout the genome. We now report mutations in ZFP57, which encodes a zinc-finger transcription factor expressed in early development, in seven pedigrees with a shared pattern of mosaic hypomethylation and a conserved range of clinical features. This is the first description of a heritable global imprinting disorder that is compatible with life.	[Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Robinson, David O.; Temple, I. Karen] Univ Southampton, Div Human Genet, Southampton SO16 6YD, England; [Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Marks, Sophie M.; Robinson, David O.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, England; [White, Helen E.] Natl Genet Reference Lab Wessex, Salisbury SP2 8BJ, England; [Acerini, Carlo L.] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England; [Boonen, Susanne E.] Kennedy Ctr, Genet Counselling Clin, DK-2600 Glostrup, Denmark; [Dayanikli, Pinar] Amer Hosp, TR-80200 Istanbul, Turkey; [Firth, Helen V.] Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 0QQ, England; [Goodship, Judith A.] Univ Newcastle, Inst Human Genet, Newcastle upon Tyne NE1 3BZ, Tyne & Wear, England; [Hahnemann, Johanne M. D.] Kennedy Ctr, Med Genet Lab, DK-2600 Glostrup, Denmark; [Kordonouri, Olga] Kinderkrankenhaus Bult, D-30173 Hannover, Germany; [Masoud, Ahmed F.] Northwick Pk Hosp & Clin Res Ctr, Childrens Serv, Harrow HA1 3UJ, Middx, England; [Oestergaard, Elsebet] Natl Univ Hosp Rigshospitalet, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Storr, John] Cumberland Infirm, Dept Paediat, Carlisle CA2 7HY, Cumbria, England; [Ellard, Sian; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Temple, I. Karen] Southampton Univ Hosp, Acad Unit Genet Med, Wessex Clin Genet Serv, Southampton SO16 5YA, England	University of Southampton; Salisbury District Hospital; University of Cambridge; Amerikan Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK; Imperial College London; Rigshospitalet; University of Copenhagen; University of Exeter; University of Southampton	Mackay, DJG (corresponding author), Univ Southampton, Div Human Genet, Southampton SO16 6YD, England.	djgm@soton.ac.uk	temple, isabel K/K-2391-2015; Mackay, Deborah JG/B-2879-2015	Mackay, Deborah JG/0000-0003-3088-4401; Hattersley, Andrew/0000-0001-5620-473X; Acerini, Carlo/0000-0003-2121-5871; Boonen, Susanne Eriksen/0000-0002-7824-2080; Temple, Isabel Karen/0000-0002-6045-1781; Ellard, Sian/0000-0002-7620-5526				Akagi T, 2005, BIOCHEM BIOPH RES CO, V331, P23, DOI 10.1016/j.bbrc.2005.03.118; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Alonso MBD, 2004, J BIOL CHEM, V279, P25653, DOI 10.1074/jbc.M400415200; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Boonen SE, 2008, EUR J HUM GENET, V16, P453, DOI 10.1038/sj.ejhg.5201993; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Mackay DJG, 2005, HUM GENET, V116, P255, DOI 10.1007/s00439-004-1236-1; OKAZAKI S, 1994, J BIOL CHEM, V269, P6900; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rossignol S, 2006, J MED GENET, V43, P902, DOI 10.1136/jmg.2006.042135; Temple IK, 2002, J MED GENET, V39, P872, DOI 10.1136/jmg.39.12.872; Valerio G, 2001, J PEDIATR ENDOCR MET, V14, P897; Wood AJ, 2007, NUCLEIC ACIDS RES, V35, P7031, DOI 10.1093/nar/gkm742	15	373	385	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					949	951		10.1038/ng.187	http://dx.doi.org/10.1038/ng.187			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622393				2022-12-25	WOS:000258026900009
J	Down, TA; Rakyan, VK; Turner, DJ; Flicek, P; Li, H; Kulesha, E; Graf, S; Johnson, N; Herrero, J; Tomazou, EM; Thorne, NP; Backdahl, L; Herberth, M; Howe, KL; Jackson, DK; Miretti, MM; Marioni, JC; Birney, E; Hubbard, TJP; Durbin, R; Tavare, S; Beck, S				Down, Thomas A.; Rakyan, Vardhman K.; Turner, Daniel J.; Flicek, Paul; Li, Heng; Kulesha, Eugene; Graf, Stefan; Johnson, Nathan; Herrero, Javier; Tomazou, Eleni M.; Thorne, Natalie P.; Backdahl, Liselotte; Herberth, Marlis; Howe, Kevin L.; Jackson, David K.; Miretti, Marcos M.; Marioni, John C.; Birney, Ewan; Hubbard, Tim J. P.; Durbin, Richard; Tavare, Simon; Beck, Stephan			A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE; METHYLATION PATTERNS; CANCER-CELLS; MICROARRAY; EPIGENOME; REVEALS; TARGETS; GENES; SITES; ARABIDOPSIS	DNA methylation is an indispensible epigenetic modification required for regulating the expression of mammalian genomes. Immunoprecipitation-based methods for DNA methylome analysis are rapidly shifting the bottleneck in this field from data generation to data analysis, necessitating the development of better analytical tools. In particular, an inability to estimate absolute methylation levels remains a major analytical difficulty associated with immunoprecipitation-based DNA methylation profiling. To address this issue, we developed a cross-platform algorithm - Bayesian tool for methylation analysis ( Batman) - for analyzing methylated DNA immunoprecipitation (MeDIP) profiles generated using oligonucleotide arrays (MeDIP-chip) or next-generation sequencing (MeDIP-seq). We developed the latter approach to provide a high-resolution whole-genome DNA methylation profile ( DNA methylome) of a mammalian genome. Strong correlation of our data, obtained using mature human spermatozoa, with those obtained using bisulfite sequencing suggest that combining MeDIP-seq or MeDIP-chip with Batman provides a robust, quantitative and cost-effective functional genomic strategy for elucidating the function of DNA methylation.	[Rakyan, Vardhman K.] Barts & London, Inst Cell & Mol Sci, London E1 2AT, England; [Down, Thomas A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; [Down, Thomas A.] Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; [Turner, Daniel J.; Li, Heng; Tomazou, Eleni M.; Jackson, David K.; Miretti, Marcos M.; Hubbard, Tim J. P.; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Flicek, Paul; Kulesha, Eugene; Graf, Stefan; Johnson, Nathan; Herrero, Javier; Birney, Ewan] Wellcome Trust Genome Campus Hinxton, European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England; [Thorne, Natalie P.; Howe, Kevin L.; Marioni, John C.; Tavare, Simon] Univ Cambridge, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England; [Backdahl, Liselotte; Beck, Stephan] UCL, Inst Canc, London WC1E 6BT, England; [Herberth, Marlis] Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England	University of London; Queen Mary University London; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; University of Cambridge	Rakyan, VK (corresponding author), Barts & London, Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	thomas.down@gurdon.cam.ac.uk; v.rakyan@qmul.ac.uk; s.beck@ucl.ac.uk	Li, Heng/D-9344-2011; Herrero, Javier/H-6971-2019; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Miretti, Marcos M./AAY-5895-2020; Durbin, Richard/AAE-7178-2019; Tomazou, Eleni M/J-1475-2014; Huebner, Marlis/A-2984-2009	Li, Heng/0000-0003-4874-2874; Herrero, Javier/0000-0001-7313-717X; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Miretti, Marcos M./0000-0001-8179-1606; Durbin, Richard/0000-0002-9130-1006; Marioni, John/0000-0001-9092-0852; Kulesha, Eugene/0000-0002-4285-6232; Birney, Ewan/0000-0001-8314-8497; Howe, Kevin/0000-0002-1751-9226; Tomazou, Eleni Marina/0000-0002-7497-4567; Johnson, Nathan/0000-0002-2783-9047; Flicek, Paul/0000-0002-3897-7955	Cancer Research UK [C14303/A8646] Funding Source: Medline; Wellcome Trust [077198, 083563, 084071] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Adorjan P, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.5.e21; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BESTOR TH, 1999, NOVART FDN SYMP, V214, P187; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Reinders J, 2008, GENOME RES, V18, P469, DOI 10.1101/gr.7073008; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Sandovici I, 2005, HUM MOL GENET, V14, P2135, DOI 10.1093/hmg/ddi218; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	44	450	482	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2008	26	7					779	785		10.1038/nbt1414	http://dx.doi.org/10.1038/nbt1414			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	324BC	18612301	Green Accepted			2022-12-25	WOS:000257491600022
J	Ahmed, S; Thomas, G; Ghoussaini, M; Healey, CS; Humphreys, MK; Platte, R; Morrison, J; Maranian, M; Pooley, KA; Luben, R; Eccles, D; Evans, DG; Fletcher, O; Johnson, N; Silva, ID; Peto, J; Stratton, MR; Rahman, N; Jacobs, K; Prentice, R; Anderson, GL; Rajkovic, A; Curb, JD; Ziegler, RG; Berg, CD; Buys, SS; McCarty, CA; Feigelson, HS; Calle, EE; Thun, MJ; Diver, WR; Bojesen, S; Nordestgaard, BG; Flyger, H; Dork, T; Schurmann, P; Hillemanns, P; Karstens, JH; Bogdanova, NV; Antonenkova, NN; Zalutsky, IV; Bermisheva, M; Fedorova, S; Khusnutdinova, E; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Devilee, P; van Asperen, CJ; Tollenaar, RAEM; Seynaeve, C; Garcia-Closas, M; Lissowska, J; Brinton, L; Peplonska, B; Nevanlinna, H; Heikkinen, T; Aittomaki, K; Blomqvist, C; Hopper, JL; Southey, MC; Smith, L; Spurdle, AB; Schmidt, MK; Broeks, A; van Hien, RR; Cornelissen, S; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Schmutzler, RK; Burwinkel, B; Bartram, CR; Meindl, A; Brauch, H; Justenhoven, C; Hamann, U; Chang-Claude, J; Hein, R; Wang-Gohrke, S; Lindblom, A; Margolin, S; Mannermaa, A; Kosma, VM; Kataja, V; Olson, JE; Wang, XS; Fredericksen, Z; Giles, GG; Severi, G; Baglietto, L; English, DR; Hankinson, SE; Cox, DG; Kraft, P; Vatten, LJ; Hveem, K; Kumle, M; Sigurdson, A; Doody, M; Bhatti, P; Alexander, BH; Hooning, MJ; van den Ouweland, AMW; Oldenburg, RA; Schutte, M; Hall, P; Czene, K; Liu, JJ; Li, YQ; Cox, A; Elliott, G; Brock, I; Reed, MWR; Shen, CY; Yu, JC; Hsu, GC; Chen, ST; Anton-Culver, H; Ziogas, A; Andrulis, IL; Knight, JA; Beesley, J; Goode, EL; Couch, F; Chenevix-Trench, G; Hoover, RN; Ponder, BAJ; Hunter, DJ; Pharoah, PDP; Dunning, AM; Chanock, SJ; Easton, DF				Ahmed, Shahana; Thomas, Gilles; Ghoussaini, Maya; Healey, Catherine S.; Humphreys, Manjeet K.; Platte, Radka; Morrison, Jonathan; Maranian, Melanie; Pooley, Karen A.; Luben, Robert; Eccles, Diana; Evans, D. Gareth; Fletcher, Olivia; Johnson, Nichola; Silva, Isabel dos Santos; Peto, Julian; Stratton, Michael R.; Rahman, Nazneen; Jacobs, Kevin; Prentice, Ross; Anderson, Garnet L.; Rajkovic, Aleksandar; Curb, J. David; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S.; McCarty, Catherine A.; Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, W. Ryan; Bojesen, Stig; Nordestgaard, Borge G.; Flyger, Henrik; Doerk, Thilo; Schuermann, Peter; Hillemanns, Peter; Karstens, Johann H.; Bogdanova, Natalia V.; Antonenkova, Natalia N.; Zalutsky, Iosif V.; Bermisheva, Marina; Fedorova, Sardana; Khusnutdinova, Elza; Kang, Daehee; Yoo, Keun-Young; Noh, Dong Young; Ahn, Sei-Hyun; Devilee, Peter; van Asperen, Christi J.; Tollenaar, R. A. E. M.; Seynaeve, Caroline; Garcia-Closas, Montserrat; Lissowska, Jolanta; Brinton, Louise; Peplonska, Beata; Nevanlinna, Heli; Heikkinen, Tuomas; Aittomaki, Kristiina; Blomqvist, Carl; Hopper, John L.; Southey, Melissa C.; Smith, Letitia; Spurdle, Amanda B.; Schmidt, Marjanka K.; Broeks, Annegien; van Hien, Richard R.; Cornelissen, Sten; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Schmutzler, Rita K.; Burwinkel, Barbara; Bartram, Claus R.; Meindl, Alfons; Brauch, Hiltrud; Justenhoven, Christina; Hamann, Ute; Chang-Claude, Jenny; Hein, Rebecca; Wang-Gohrke, Shan; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kosma, Veli-Matti; Kataja, Vesa; Olson, Janet E.; Wang, Xianshu; Fredericksen, Zachary; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; English, Dallas R.; Hankinson, Susan E.; Cox, David G.; Kraft, Peter; Vatten, Lars J.; Hveem, Kristian; Kumle, Merethe; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Alexander, Bruce H.; Hooning, Maartje J.; van den Ouweland, Ans M. W.; Oldenburg, Rogier A.; Schutte, Mieke; Hall, Per; Czene, Kamila; Liu, Jianjun; Li, Yuqing; Cox, Angela; Elliott, Graeme; Brock, Ian; Reed, Malcolm W. R.; Shen, Chen-Yang; Yu, Jyh-Cherng; Hsu, Giu-Cheng; Chen, Shou-Tung; Anton-Culver, Hoda; Ziogas, Argyrios; Andrulis, Irene L.; Knight, Julia A.; Beesley, Jonathan; Goode, Ellen L.; Couch, Fergus; Chenevix-Trench, Georgia; Hoover, Robert N.; Ponder, Bruce A. J.; Hunter, David J.; Pharoah, Paul D. P.; Dunning, Alison M.; Chanock, Stephen J.; Easton, Douglas F.		SEARCH; GENICA Consortium; KConFab; Australian Ovarian Cancer Study	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; COMMON VARIANTS	Genome-wide association studies (GWAS) have identified seven breast cancer susceptibility loci, but these explain only a small fraction of the familial risk of the disease. Five of these loci were identified through a two-stage GWAS involving 390 familial cases and 364 controls in the first stage, and 3,990 cases and 3,916 controls in the second stage(1). To identify additional loci, we tested over 800 promising associations from this GWAS in a further two stages involving 37,012 cases and 40,069 controls from 33 studies in the CGEMS collaboration and Breast Cancer Association Consortium. We found strong evidence for additional susceptibility loci on 3p (rs4973768: per-allele OR 1.11, 95% CI = 1.08-1.13, P = 4.1 x 10(-23)) and 17q (rs6504950: per-allele OR 0.95, 95% CI = 0.92-0.97, P = 1.4 x 10(-8)). Potential causative genes include SLC4A7 and NEK10 on 3p and COX11 on 17q.	[Humphreys, Manjeet K.; Morrison, Jonathan; Pooley, Karen A.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge, England; [Ahmed, Shahana; Ghoussaini, Maya; Healey, Catherine S.; Platte, Radka; Maranian, Melanie; Ponder, Bruce A. J.; Dunning, Alison M.; SEARCH] Univ Cambridge, Dept Oncol, Cambridge, England; [Thomas, Gilles; Jacobs, Kevin; Ziegler, Regina G.; Garcia-Closas, Montserrat; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Hoover, Robert N.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD USA; [Luben, Robert] Univ Cambridge, EPIC, Dept Publ Hlth & Primary Care, Cambridge, England; [Eccles, Diana] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Evans, D. Gareth] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; [Fletcher, Olivia; Johnson, Nichola] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Fletcher, Olivia; Silva, Isabel dos Santos; Peto, Julian] London Sch Hyg & Trop Med, London WC1, England; [Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Jacobs, Kevin] Bioinformed Consulting Serv, Gaithersburg, MD USA; [Jacobs, Kevin] NCI, Core Genotyping Facil, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Prentice, Ross; Anderson, Garnet L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Rajkovic, Aleksandar] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Curb, J. David] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Pacific Hlth Res Inst, Honolulu, HI 96822 USA; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Buys, Saundra S.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, W. Ryan] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Bojesen, Stig; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Dept Breast Surg, Herlev, Denmark; [Doerk, Thilo; Schuermann, Peter; Hillemanns, Peter; Bogdanova, Natalia V.; Bermisheva, Marina] Hannover Med Sch, Dept Obstet & Gynaecol, D-3000 Hannover, Germany; [Karstens, Johann H.] Hannover Med Sch, Dept Radiat Oncol, D-3000 Hannover, Germany; [Bogdanova, Natalia V.; Antonenkova, Natalia N.; Zalutsky, Iosif V.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Bermisheva, Marina; Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Fedorova, Sardana] Russian Acad Med Sci, Yakut Res Ctr, Dept Med Genet, Yakutsk, Russia; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong Young; Ahn, Sei-Hyun] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Tollenaar, R. A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Daniel Hoed Canc Ctr, Rotterdam Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Dept Epidemiol & Canc Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Brinton, Louise] NCI, Hormonal & Reprod Epidemiol Branch, Rockville, MD USA; [Peplonska, Beata] Nofer Inst Occupat Med, Dept Occupat & Environm Epidemiol, Lodz, Poland; [Nevanlinna, Heli; Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Hopper, John L.; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Smith, Letitia; Spurdle, Amanda B.; Beesley, Jonathan; Chenevix-Trench, Georgia] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Schmidt, Marjanka K.; Broeks, Annegien; Cornelissen, Sten] Netherlands Canc Inst, Amsterdam, Netherlands; [Milne, Roger L.] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Ribas, Gloria; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain; [Gonzalez-Neira, Anna; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Natl Genotyping Ctr CEGEN, Human Canc Genet Program, Madrid, Spain; [Schmutzler, Rita K.] Spanish Natl Canc Res Ctr CNIO, Natl Genotyping Ctr CEGEN, Human Canc Genet Program, Madrid, Spain; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, D-6900 Heidelberg, Germany; [Burwinkel, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Bartram, Claus R.] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Meindl, Alfons] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Brauch, Hiltrud; Justenhoven, Christina; GENICA Consortium] Univ Tubingen, Tubingen, Germany; [Hamann, Ute] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Chang-Claude, Jenny; Hein, Rebecca] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Wang-Gohrke, Shan] Womens Hosp Univ Ulm, Ulm, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Pathol & Oncol, S-17176 Stockholm, Sweden; [Mannermaa, Arto; Kosma, Veli-Matti] Univ Kuopio, Pathol & Forens Med & Bioctr Kuopio, Inst Clin Med, FIN-70211 Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Dept Oncol, SF-70210 Kuopio, Finland; [Kataja, Vesa] Vaasa Cent Hosp, Dept Oncol, Vaasa, Finland; [Olson, Janet E.; Wang, Xianshu; Fredericksen, Zachary; Couch, Fergus] Mayo Clin, Coll Med, Rochester, MN USA; [Giles, Graham G.; Severi, Gianluca; English, Dallas R.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Hankinson, Susan E.; Cox, David G.; Hunter, David J.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Hankinson, Susan E.; Cox, David G.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Vatten, Lars J.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Kumle, Merethe] Univ Tromso, Inst Community Med, Tromso, Norway; [Alexander, Bruce H.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Serv, Minneapolis, MN USA; [Hooning, Maartje J.; Schutte, Mieke] Erasmus Univ, Med Ctr, Rotterdam Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [van den Ouweland, Ans M. W.; Oldenburg, Rogier A.] Erasmus Univ, Med Ctr, Rotterdam Family Canc Clin, Dept Clin Genet, Rotterdam, Netherlands; [Hall, Per; Czene, Kamila] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Jianjun; Li, Yuqing] Genome Inst Singapore, Singapore, Singapore; [Elliott, Graeme] Univ Sheffield, Sch Med & Biomed Sci, Inst Canc Studies, Sheffield, S Yorkshire, England; [Reed, Malcolm W. R.] Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Surg Oncol, Sheffield, S Yorkshire, England; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Grad Inst Environm Sci, Taichong, Taiwan; [Yu, Jyh-Cherng; Hsu, Giu-Cheng] Tri Serv Gen Hosp, Taipei, Taiwan; [Chen, Shou-Tung] Changhua Christian Hosp, Changhua, Taiwan; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Andrulis, Irene L.; Knight, Julia A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Ontario Familial Breast Canc Registry, Toronto, ON, Canada; [KConFab; Australian Ovarian Cancer Study] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Ponder, Bruce A. J.] Canc Res UK Cambridge Canc Res Inst, Cambridge, England; [Chanock, Stephen J.] NCI, Adv Technol Ctr, Gaithersburg, MD USA; [Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Surrey, England	University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Fred Hutchinson Cancer Center; Baylor College of Medicine; Pacific Health Research & Education Institute; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; American Cancer Society; University of Copenhagen; University of Copenhagen; University of Copenhagen; Hannover Medical School; Hannover Medical School; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Russian Academy of Medical Sciences; Seoul National University (SNU); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nofer Institute of Occupational Medicine; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; Netherlands Cancer Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Vaasa Central Hospital; Mayo Clinic; Cancer Council Victoria; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University of Minnesota System; University of Minnesota Twin Cities; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Sheffield; University of Sheffield; Academia Sinica - Taiwan; China Medical University Taiwan; Tri-Service General Hospital; Changhua Christian Hospital; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Peter Maccallum Cancer Center; Cancer Research UK; CRUK Cambridge Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Institute of Cancer Research - UK	Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge, England.	douglas@srl.cam.ac.uk	Vatten, Lars/AFK-2073-2022; Hveem, Kristian/AFV-4683-2022; van Asperen, Christi J/D-3970-2012; Andrulis, Irene L./E-7267-2013; Noh, Dong-Young/G-5531-2011; Knight, Julia/A-6843-2012; Chenevix-Trench, Georgia/AAV-2014-2020; Bogdanova, Natalia V./Y-2205-2019; Fedorova, Sardana/K-5445-2017; Dörk, Thilo/J-8620-2012; Spurdle, Amanda B/A-4978-2011; Reed, Malcolm Walter/AAG-9219-2020; Knight, Julia/R-5617-2019; Kang, Dae Hee/E-8631-2012; Schmidt, Marjanka K/G-9058-2011; DEVILEE, PETER/ABR-2140-2022; Lissowska, Jolanta/AAH-3252-2020; Peplonska, Beata/F-6004-2010; Evans, D Gareth/AAB-4308-2022; Baglietto, Laura/AAB-9051-2019; Diver, Ryan/AAG-3469-2019; Severi, Gianluca/H-3774-2018; Nordestgaard, Borge Gronne/ABF-1310-2020; Luben, Robert N/H-5519-2015; Severi, Gianluca/Q-1824-2019; Eccles, Diana/K-6327-2019; Ribas-Despuig, Gloria/M-6190-2017; Garcia-Closas, Montserrat/F-3871-2015; English, Dallas/AAH-5005-2019; Brinton, Louise A/G-7486-2015; Bowtell, David/H-1007-2016; Gonzalez-Neira, Anna/C-5791-2015; Margolin, Sara/AAX-9034-2020; Devilee, Peter/GXV-8005-2022; Khusnutdinova, Elza Kamilevna/A-4810-2013; Rahman, Nazneen/B-8890-2012; Peplonska, Beata/AAO-1265-2020; Flyger, Henrik/AAM-6494-2021; Shen, CY/F-6271-2010; Cox, David G/A-2023-2009; Pharoah, Paul/V-6658-2019; Yoo, Keun-Young/J-5548-2012; Garcia-Closas, Montserrat/AAZ-6930-2021; Smith, Letitia/J-9035-2014; Cox, David/ABA-7454-2020; Vatten, Lars/AAF-9380-2022; Rahman, Nazneen/D-2802-2013; Ribas, Gloria/K-3379-2013	van Asperen, Christi J/0000-0002-1436-7650; Chenevix-Trench, Georgia/0000-0002-1878-2587; Dörk, Thilo/0000-0002-9458-0282; Spurdle, Amanda B/0000-0003-1337-7897; Reed, Malcolm Walter/0000-0001-7442-2132; Knight, Julia/0000-0002-7610-7635; Schmidt, Marjanka K/0000-0002-2228-429X; Lissowska, Jolanta/0000-0003-2695-5799; Evans, D Gareth/0000-0002-8482-5784; Diver, Ryan/0000-0002-5418-9000; Severi, Gianluca/0000-0001-7157-419X; Luben, Robert N/0000-0002-5088-6343; Severi, Gianluca/0000-0001-7157-419X; Eccles, Diana/0000-0002-9935-3169; Garcia-Closas, Montserrat/0000-0003-1033-2650; English, Dallas/0000-0001-7828-8188; Brinton, Louise A/0000-0003-3853-8562; Bowtell, David/0000-0001-9089-7525; Gonzalez-Neira, Anna/0000-0002-5421-2020; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Peplonska, Beata/0000-0003-3915-2872; Cox, David G/0000-0002-2152-9259; Pharoah, Paul/0000-0001-8494-732X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Margolin, Sara/0000-0002-5526-5570; Cox, Angela/0000-0002-5138-1099; Nevanlinna, Heli/0000-0002-0916-2976; Czene, Kamila/0000-0002-3233-5695; Baglietto, Laura/0000-0002-8193-7529; Fletcher, Olivia/0000-0001-9387-7116; Roth, Rebecca/0000-0002-2841-4921; Dunning, Alison Margaret/0000-0001-6651-7166; Brauch, Hiltrud/0000-0001-7531-2736; Rahman, Nazneen/0000-0003-4376-0440; Ribas, Gloria/0000-0001-6883-4130; McCarty, Catherine/0000-0003-1089-0142; Beesley, Jonathan/0000-0003-1942-325X; dos Santos Silva, Isabel/0000-0002-6596-8798; Cox, David/0000-0003-2047-4687; Heikkinen, Tuomas/0000-0003-1154-6204; Thorne, Heather/0000-0003-3610-2511; Southey, Melissa/0000-0002-6313-9005; Fedorova, Sardana/0000-0002-6952-3868; Kang, Daehee/0000-0003-4031-5878; Liu, Jianjun/0000-0002-3255-3019; Giles, Graham/0000-0003-4946-9099; Bowcock, Anne/0000-0001-8691-9090; Kataja, Vesa/0000-0003-4846-4843; Blomqvist, Carl/0000-0003-3041-1938; Bhatti, Parveen/0000-0003-1709-1781	NATIONAL CANCER INSTITUTE [P01CA087969, R01CA067262, R01CA050385, U01CA069446, R01CA122340, R01CA102740, U01CA069398, K07CA092044, U01CA049449, U01CA098233, U01CA069638, R01CA049449, U01CA069417, R01CA104021, K22CA095011, U01CA069631, R01CA058860, U01CA058860, P50CA116201, R01CA065725, P30CA062203, U01CA069467, U01CA098710, U01CA067262] Funding Source: NIH RePORTER; The Francis Crick Institute [10124] Funding Source: researchfish; Cancer Research UK [C490/A11021, C1287/A10118, A10123, 10118, C1287/A7497, 11022, 10124, 11021, C1287/A5260] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01 CA102740-01A2, R01 CA102740, U01 CA069417, R01 CA050385, U01 CA069638, 5UO1CA098233, U01 CA069631, U01 CA69398, R01 CA058860, U01 CA069467, U01 CA098233, U01 CA69638, R01 CA067262, U01 CA058860, U01 CA69417, CA-92044, CA-06-503, U01 CA69446, U01 CA69631, CA-58860, R01 CA104021-04, CA50385, P30 CA062203, UO1 CA098710, U01 CA049449, R01 CA049449, R01 CA122340, CA-95-011, U01 CA098710, U01 CA69467, U01 CA069446, P50 CA116201, P01 CA087969, CA67262, CA87969, U01 CA069398, K07 CA092044, CA65725, CA49449, U01 CA067262, R01 CA065725, UO1 CA69467] Funding Source: Medline; Breast Cancer Now [2004NOV49] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Francis Crick Institute; Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Now		Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	11	376	386	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					585	590		10.1038/ng.354	http://dx.doi.org/10.1038/ng.354			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19330027	Green Accepted			2022-12-25	WOS:000265575600020
J	Dhandapany, PS; Sadayappan, S; Xue, YL; Powell, GT; Rani, DS; Nallari, P; Rai, TS; Khullar, M; Soares, P; Bahl, A; Tharkan, JM; Vaideeswar, P; Rathinavel, A; Narasimhan, C; Ayapati, DR; Ayub, Q; Mehdi, SQ; Oppenheimer, S; Richards, MB; Price, AL; Patterson, N; Reich, D; Singh, L; Tyler-Smith, C; Thangaraj, K				Dhandapany, Perundurai S.; Sadayappan, Sakthivel; Xue, Yali; Powell, Gareth T.; Rani, Deepa Selvi; Nallari, Prathiba; Rai, Taranjit Singh; Khullar, Madhu; Soares, Pedro; Bahl, Ajay; Tharkan, Jagan Mohan; Vaideeswar, Pradeep; Rathinavel, Andiappan; Narasimhan, Calambur; Ayapati, Dharma Rakshak; Ayub, Qasim; Mehdi, S. Qasim; Oppenheimer, Stephen; Richards, Martin B.; Price, Alkes L.; Patterson, Nick; Reich, David; Singh, Lalji; Tyler-Smith, Chris; Thangaraj, Kumarasamy			A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SPLICE DONOR SITE; GENE; MUTATIONS; IDENTIFICATION; INDIA; PHOSPHORYLATION; IMPAIRMENT; MUTANTS; DOMAIN	Heart failure is a leading cause of mortality in South Asians. However, its genetic etiology remains largely unknown(1). Cardiomyopathies due to sarcomeric mutations are a major monogenic cause for heart failure (MIM600958). Here, we describe a deletion of 25 bp in the gene encoding cardiac myosin binding protein C (MYBPC3) that is associated with heritable cardiomyopathies and an increased risk of heart failure in Indian populations (initial study OR 5.3 (95% CI = 2.3-13), P = 2 x 10(-6); replication study OR = 8.59 (3.19-25.05), P = 2 x 10(-8); combined OR = 6.99 (3.68-13.57), P = 4 x 10(-11)) and that disrupts cardiomyocyte structure in vitro. Its prevalence was found to be high (similar to 4%) in populations of Indian subcontinental ancestry. The finding of a common risk factor implicated in South Asian subjects with cardiomyopathy will help in identifying and counseling individuals predisposed to cardiac diseases in this region.	[Rani, Deepa Selvi; Singh, Lalji; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Dhandapany, Perundurai S.] Madurai Kamaraj Univ, Dept Biochem, Madurai 625021, Tamil Nadu, India; [Sadayappan, Sakthivel] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Xue, Yali; Powell, Gareth T.; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Nallari, Prathiba] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Rai, Taranjit Singh; Khullar, Madhu; Bahl, Ajay] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Soares, Pedro; Richards, Martin B.] Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; [Tharkan, Jagan Mohan] Sri Chitra Tirunal Inst Med Sci & Technol, Dept Cardiol, Thiruvananthapuram 695011, Kerala, India; [Vaideeswar, Pradeep] Seth GS Med Coll, Dept Pathol, Cardiovasc & Thorac Div, Bombay 400012, Maharashtra, India; [Rathinavel, Andiappan] Rajaji Govt Hosp, Dept Cardiothorac Surg, Madurai 625020, Tamil Nadu, India; [Vaideeswar, Pradeep] King Edward Mem Hosp, Bombay 400012, Maharashtra, India; [Rathinavel, Andiappan] Madurai Med Coll, Madurai 625020, Tamil Nadu, India; [Narasimhan, Calambur] CARE Hosp, Cardiol Unit, Hyderabad 500001, Andhra Pradesh, India; [Ayapati, Dharma Rakshak] Nizams Inst Med Sci, Dept Cardiac Surg, Hyderabad 500082, Andhra Pradesh, India; [Ayub, Qasim; Mehdi, S. Qasim] Univ Karachi, Inst Biotechnol & Genet Engn KIBGE, Karachi 75270, Pakistan; [Oppenheimer, Stephen] Univ Oxford, Dept Anthropol, Oxford OX1 2JD, England; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Patterson, Nick; Reich, David] Broad Inst Harvard, Cambridge, MA 02142 USA; [Patterson, Nick; Reich, David] MIT, Cambridge, MA 02142 USA; [Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Madurai Kamaraj University; Cincinnati Children's Hospital Medical Center; Wellcome Trust Sanger Institute; Osmania University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Leeds; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Madurai Medical College; Nizam's Institute of Medical Sciences; University of Karachi; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	thangs@ccmb.res.in	Singh, Taranjit/ABE-8233-2020; Thangaraj, Kumarasamy/G-5596-2010; Soares, Pedro A/G-9422-2011; Rai, Taranjit Singh/A-3659-2012; Mehdi, Syed Qasim/L-2385-2015	Singh, Taranjit/0000-0002-7276-7492; Soares, Pedro A/0000-0002-2807-690X; Rai, Taranjit Singh/0000-0002-7276-7492; Powell, Gareth/0000-0003-4125-2290; Ayub, Qasim/0000-0003-3291-0917; Thangaraj, Kumarasamy/0000-0002-0075-0106; Perundurai, Dhandapany/0000-0001-7831-9570; Sadayappan, Sakthivel/0000-0003-2006-7678; Khullar, Madhu/0000-0003-4461-2466; RICHARDS, MARTIN/0000-0003-3118-0967	Council of Scientific and Industrial Research-Senior Research Fellowship (CSIR-SRF); Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR) Raman Research; Senior Research Fellowship (SRF) from Indian Council of Medical Research (ICMR); Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh; American Heart Association, Ohio Valley Affiliate, USA; Burroughs Wellcome Career Development; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research-Senior Research Fellowship (CSIR-SRF)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) Raman Research(Council of Scientific & Industrial Research (CSIR) - India); Senior Research Fellowship (SRF) from Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh; American Heart Association, Ohio Valley Affiliate, USA(American Heart Association); Burroughs Wellcome Career Development(Burroughs Wellcome Fund); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all participants for making this study possible. We acknowledge the help of G. S. Selvam, C. Rajamanickam, R. Srinivasan, V. Madhavan, S. Madhavan, A. G. Reddy, A. Vanniarajan, P. Govindaraj, B. D. Gelb and Q. Long. P. S. D. was supported by Council of Scientific and Industrial Research-Senior Research Fellowship (CSIR-SRF) and P. N. by Department of Biotechnology (DBT). K. T. was supported by Council of Scientific and Industrial Research (CSIR) Raman Research Fellowship and Y.X., G. T. P., Q. A., S. Q. M. and C.T.-S. were supported by The Wellcome Trust. T. S. R. received an Senior Research Fellowship (SRF) from Indian Council of Medical Research (ICMR), M. K. and A. B. were supported by Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. S. S. received a post-doctoral training grant from the American Heart Association, Ohio Valley Affiliate, USA. D. R. is supported by a Burroughs Wellcome Career Development Award in the Biomedical Sciences.	Berul CI, 2001, CIRCULATION, V104, P2734, DOI 10.1161/hc4701.099582; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Flavigny J, 2003, CARDIOVASC RES, V60, P388, DOI 10.1016/j.cardiores.2003.07.001; Flavigny J, 1999, J MOL BIOL, V294, P443, DOI 10.1006/jmbi.1999.3276; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Gupta R, 2006, INT J CARDIOL, V108, P291, DOI 10.1016/j.ijcard.2005.05.044; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Kubo T, 2005, J AM COLL CARDIOL, V46, P1737, DOI 10.1016/j.jacc.2005.05.087; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; Moolman JA, 2000, CIRCULATION, V101, P1396, DOI 10.1161/01.CIR.101.12.1396; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Rottbauer W, 1997, J CLIN INVEST, V100, P475, DOI 10.1172/JCI119555; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sarikas A, 2005, CARDIOVASC RES, V66, P33, DOI 10.1016/j.cardiores.2005.01.004; Sato N, 2003, MOL BIOL CELL, V14, P3180, DOI 10.1091/mbc.E02-10-0685; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Van Driest SL, 2005, MAYO CLIN PROC, V80, P463, DOI 10.4065/80.4.463; Vignier N, 2001, CIRCULATION, V104, P1; Waldmuller S, 2003, J MOL CELL CARDIOL, V35, P623, DOI 10.1016/S0022-2828(03)00050-6; Yang QL, 2001, J MOL CELL CARDIOL, V33, P1649, DOI 10.1006/jmcc.2001.1417	28	194	197	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					187	191		10.1038/ng.309	http://dx.doi.org/10.1038/ng.309			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19151713	Green Accepted			2022-12-25	WOS:000263091300018
J	Haselhorst, T; Fleming, FE; Dyason, JC; Hartnell, RD; Yu, X; Holloway, G; Santegoets, K; Kiefel, MJ; Blanchard, H; Coulson, BS; von Itzstein, M				Haselhorst, Thomas; Fleming, Fiona E.; Dyason, Jeffrey C.; Hartnell, Regan D.; Yu, Xing; Holloway, Gavan; Santegoets, Kim; Kiefel, Milton J.; Blanchard, Helen; Coulson, Barbara S.; von Itzstein, Mark			Sialic acid dependence in rotavirus host cell invasion	NATURE CHEMICAL BIOLOGY			English	Article							VP4; BINDING; SURFACE; INFECTION; RECEPTOR; STRAINS	We used NMR spectroscopy, molecular modeling and infectivity competition assays to investigate the key interactions between the spike protein (VP8*) from 'sialidase-insensitive' human Wa and 'sialidase-sensitive' porcine CRW-8 rotaviruses and the glycans of gangliosides G(M1) and G(D1a). Our data provide strong evidence that N-acetylneuraminic acid is a key determinant for binding of these rotaviruses. This is in contrast to the widely accepted paradigm that sialic acids are irrelevant in host cell recognition by sialidase-insensitive rotaviruses.	[Haselhorst, Thomas; Dyason, Jeffrey C.; Hartnell, Regan D.; Yu, Xing; Kiefel, Milton J.; Blanchard, Helen; von Itzstein, Mark] Griffith Univ, Inst Glycom, Southport, Qld 4222, Australia; [Fleming, Fiona E.; Holloway, Gavan; Santegoets, Kim; Coulson, Barbara S.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Griffith University; University of Melbourne	von Itzstein, M (corresponding author), Griffith Univ, Inst Glycom, Gold Coast Campus,Parklands Dr, Southport, Qld 4222, Australia.	m.vonitzstein@griffith.edu.au	Kiefel, Milton/O-4740-2019; Dyason, Jeffrey C/L-5534-2014; Santegoets, Kim/S-4267-2017; Kiefel, Milton/A-6509-2015; von Itzstein, Mark/E-4823-2010; Haselhorst, Thomas/A-5066-2015; Blanchard, Helen/A-4681-2009; Yu, Xing/G-7624-2015	Kiefel, Milton/0000-0003-1030-1440; Haselhorst, Thomas/0000-0002-3373-8680; Blanchard, Helen/0000-0003-3372-5027; Coulson, Barbara/0000-0002-2110-8147	Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC)	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	We thank K. Hidari (University of Shizuoka) for the gift of G<INF>D1a</INF>, A. Bugarcic (Griffith University) and M. Kraschnefski (Griffith University) for preparation of Wa VP8* protein, and A. Szyczew (Griffith University) for production of Neu5Ac alpha 2Me. B.S.C., M.J.K., H.B. and M.v.I. gratefully acknowledge the financial support of the Australian Research Council (ARC). B.S.C. thanks the National Health and Medical Research Council of Australia (NHMRC) for the award of a Senior Research Fellowship. M.v.I. thanks the ARC for the award of an Australian Federation Fellowship and the NHMRC for financial support.	Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; Ballotti S, 2007, J PEDIATR GASTR NUTR, V45, P147, DOI 10.1097/MPG.0b013e31805fc256; Blanchard H, 2007, J MOL BIOL, V367, P1215, DOI 10.1016/j.jmb.2007.01.028; Ciarlet M, 2002, J VIROL, V76, P4087, DOI 10.1128/JVI.76.8.4087-4095.2002; Ciarlet M, 1999, J GEN VIROL, V80, P943, DOI 10.1099/0022-1317-80-4-943; FIORE L, 1991, VIROLOGY, V181, P553, DOI 10.1016/0042-6822(91)90888-I; Graham KL, 2008, J VIROL, V82, P6139, DOI 10.1128/JVI.00597-08; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; Guo CT, 1999, J BIOCHEM-TOKYO, V126, P683, DOI 10.1093/oxfordjournals.jbchem.a022503; Haselhorst T, 2007, GLYCOBIOLOGY, V17, P68, DOI 10.1093/glycob/cwl051; Haselhorst T, 2008, ANGEW CHEM INT EDIT, V47, P1910, DOI 10.1002/anie.200704872; Isa P, 2006, GLYCOCONJUGATE J, V23, P27, DOI 10.1007/s10719-006-5435-y; Kuhlenschmidt TB, 1999, ADV EXP MED BIOL, V473, P309; Ludert JE, 1996, J VIROL, V70, P487, DOI 10.1128/JVI.70.1.487-493.1996; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mendez E, 1999, VIROLOGY, V263, P450, DOI 10.1006/viro.1999.9976; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Rolsma MD, 1998, J VIROL, V72, P9079, DOI 10.1128/JVI.72.11.9079-9091.1998	18	119	129	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					91	93		10.1038/nchembio.134	http://dx.doi.org/10.1038/nchembio.134			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19109595				2022-12-25	WOS:000263090700011
J	Shapiro, PJ; Hsu, HH; Jung, H; Robbins, ES; Ryoo, HD				Shapiro, Peter J.; Hsu, Hans H.; Jung, Heekyung; Robbins, Edith S.; Ryoo, Hyung Don			Regulation of the Drosophila apoptosome through feedback inhibition	NATURE CELL BIOLOGY			English	Article							DEVELOPMENTAL CELL-DEATH; CASPASE DRONC; DIAP1; GENE; PROTEIN; REAPER; APAF-1; HOMOLOG; SYSTEM; FORM	Apoptosis is induced by caspases, which are members of the cysteine protease family(1). Caspases are synthesized as inactive zymogens and initiator caspases first gain activity by associating with an oligomeric complex of their adaptor proteins, such as the apoptosome(2,3). Activated initiator caspases subsequently cleave and activate effector caspases. Although such a proteolytic cascade would predict that a small number of active caspases could irreversibly amplify caspase activity and trigger apoptosis, many cells can maintain moderate levels of caspase activity to perform non-apoptotic roles in cellular differentiation, shape change and migration(4). Here we show that the Drosophila melanogaster apoptosome engages in a feedback inhibitory loop, which moderates its activation level in vivo. Specifically, the adaptor protein Apaf-1 lowers the level of its associated initiator caspase Dronc, without triggering apoptosis. Conversely, Dronc lowers Apaf-1 protein levels. This mutual suppression depends on the catalytic site of Dronc and a caspase cleavage site within Apaf-1. Moreover, the Drosophila inhibitor of apoptosis protein 1 (Diap1) is required for this process. We speculate that this feedback inhibition allows cells to regulate the degree of caspase activation for apoptotic and non-apoptotic purposes.	[Shapiro, Peter J.; Hsu, Hans H.; Jung, Heekyung; Robbins, Edith S.; Ryoo, Hyung Don] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University	Ryoo, HD (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	hyungdon.ryoo@nyumc.org		Robbins, Edith S/0000-0003-1035-0621	NIH [5T32GM007239-32, 1RO1GM079425]; Leukemia-Lymphoma Society; Dimes Foundation; Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia-Lymphoma Society(Leukemia and Lymphoma Society); Dimes Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank John Abrams, Andreas Bergmann, George Jackson, Pascal Meier for fly stocks; David Sabatini for making available the scanning electron microscope; Milton Adesnik, Ramanuj Dasgupta, Zehra Ordulu, David Sabatini, Greg Suh and Jessica Treisman for advice and comments on the manuscript. P. J. S. is supported by an NIH predoctoral training grant 5T32GM007239-32. H. D. R. is a Special Fellow of the Leukemia-Lymphoma Society, a Basil O'Conner Scholar of the March of Dimes Foundation and an Ellison Medical Foundation New Scholar. This work was supported by a grant to H. D. R. from the National Institutes of Health (1RO1GM079425)	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Herman-Bachinsky Y, 2007, CELL DEATH DIFFER, V14, P861, DOI 10.1038/sj.cdd.4402079; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Lisi S, 2000, GENETICS, V154, P669; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	35	47	48	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1440	U134		10.1038/ncb1803	http://dx.doi.org/10.1038/ncb1803			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011620	Green Accepted			2022-12-25	WOS:000261261800014
J	Skog, J; Wurdinger, T; van Rijn, S; Meijer, DH; Gainche, L; Sena-Esteves, M; Curry, WT; Carter, BS; Krichevsky, AM; Breakefield, XO				Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Curry, William T., Jr.; Carter, Bob S.; Krichevsky, Anna M.; Breakefield, Xandra O.			Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; MESSENGER-RNA; CELLS; EXOSOMES; CANCER; ANGIOGENESIS; RECEPTOR; MEMBRANE; DETERMINANTS; SUPPRESSION	Glioblastoma tumour cells release microvesicles (exosomes) containing mRNA, miRNA and angiogenic proteins. These microvesicles are taken up by normal host cells, such as brain microvascular endothelial cells. By incorporating an mRNA for a reporter protein into these microvesicles, we demonstrate that messages delivered by microvesicles are translated by recipient cells. These microvesicles are also enriched in angiogenic proteins and stimulate tubule formation by endothelial cells. Tumour-derived microvesicles therefore serve as a means of delivering genetic information and proteins to recipient cells in the tumour environment. Glioblastoma microvesicles also stimulated proliferation of a human glioma cell line, indicating a self-promoting aspect. Messenger RNA mutant/variants and miRNAs characteristic of gliomas could be detected in serum microvesicles of glioblastoma patients. The tumour-specific EGFRvIII was detected in serum microvesicles from 7 out of 25 glioblastoma patients. Thus, tumour-derived microvesicles may provide diagnostic information and aid in therapeutic decisions for cancer patients through a blood test.	[Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Breakefield, Xandra O.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Charlestown, MA 02129 USA; [Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Breakefield, Xandra O.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Charlestown, MA 02129 USA; [Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Breakefield, Xandra O.] Harvard Univ, Sch Med, Neurosci Program, Charlestown, MA 02129 USA; [Wuerdinger, Tom] VU Med Ctr, Dept Neurosurg, Neurooncol Res Grp, Canc Ctr Amsterdam, NL-1007 MB Amsterdam, Netherlands; [Curry, William T., Jr.; Carter, Bob S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA; [Krichevsky, Anna M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Breakefield, XO (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, 149 13th St, Charlestown, MA 02129 USA.	breakefield@hms.harvard.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324; Krichevsky, Anna/0000-0002-5080-5507; Skog, Johan/0000-0002-0926-1691	Wenner-Gren Foundation [NCI CA86355, NCI CA69246]; Goldhirs Foundation; Brain Tumor Society; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [P01CA069246, P50CA086355] Funding Source: NIH RePORTER	Wenner-Gren Foundation; Goldhirs Foundation; Brain Tumor Society; American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to express our gratitude to B. Tannous for supplying the Gluc lentivirus construct, C. Maguire, M. Broekman, K. Miranda, L. Russo and O. Saydam for fruitful discussions. We also would like to thank Applied Biosystems for supplying the miRNA qRT-PCR primers and S. Idema (Neuro-oncology Research Group, Cancer Center Amsterdam) for supplying some of the serum/biopsy samples. This work was supported by the Wenner-Gren Foundation (J.S.) Stiftelsen Olle Engkvist Byggmastare (J.S.), NCI CA86355 (X. O. B. and M. S. E.), NCI CA69246 (X. O. B., M. S. E. and B. S. C.), The Goldhirs Foundation (B. S. C.) the Brain Tumor Society (A. M. K.) and the American Brain Tumor Association (T. W.).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chaput N, 2005, EXPERT OPIN BIOL TH, V5, P737, DOI 10.1517/14712598.5.6.737; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Delves GH, 2007, SEMIN THROMB HEMOST, V33, P75, DOI 10.1055/s-2006-958465; Eberle K, 2000, ANTICANCER RES, V20, P1679; Gabrilovich DI, 2007, CURR CANCER DRUG TAR, V7, P1, DOI 10.2174/156800907780006850; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pelloski CE, 2007, J CLIN ONCOL, V25, P2288, DOI 10.1200/JCO.2006.08.0705; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rolhion C, 2001, J NEUROSURG, V94, P97, DOI 10.3171/jns.2001.94.1.0097; Singer CF, 2008, BREAST CANCER RES TR, V110, P273, DOI 10.1007/s10549-007-9725-2; Sonabend Adam M, 2007, Expert Rev Anticancer Ther, V7, pS45, DOI 10.1586/14737140.7.12s.S45; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Taraboletti G, 2006, NEOPLASIA, V8, P96, DOI 10.1593/neo.05583; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wieckowski E, 2006, IMMUNOL RES, V36, P247, DOI 10.1385/IR:36:1:247; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x	37	3453	3669	21	599	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1470	U209		10.1038/ncb1800	http://dx.doi.org/10.1038/ncb1800			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011622	Green Accepted			2022-12-25	WOS:000261261800019
J	Lloyd-Evans, E; Morgan, AJ; He, XX; Smith, DA; Elliot-Smith, E; Sillence, DJ; Churchill, GC; Schuchman, EH; Galione, A; Platt, FM				Lloyd-Evans, Emyr; Morgan, Anthony J.; He, Xingxuan; Smith, David A.; Elliot-Smith, Elena; Sillence, Daniel J.; Churchill, Grant C.; Schuchman, Edward H.; Galione, Antony; Platt, Frances M.			Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium	NATURE MEDICINE			English	Article							INTRACELLULAR CA2+; NPC1 PROTEIN; CHOLESTEROL; BINDING; METABOLISM; STORES; CELLS; CERAMIDE; MODEL; MICE	Niemann-Pick type C1 (NPC1) disease is a neurodegenerative lysosomal storage disorder caused by mutations in the acidic compartment (which we define as the late endosome and the lysosome) protein, NPC1. The function of NPC1 is unknown, but when it is dysfunctional, sphingosine, glycosphingolipids, sphingomyelin and cholesterol accumulate. We have found that NPC1-mutant cells have a large reduction in the acidic compartment calcium store compared to wild-type cells. Chelating luminal endocytic calcium in normal cells with high-affinity Rhod-dextran induced an NPC disease cellular phenotype. In a drug-induced NPC disease cellular model, sphingosine storage in the acidic compartment led to calcium depletion in these organelles, which then resulted in cholesterol, sphingomyelin and glycosphingolipid storage in these compartments. Sphingosine storage is therefore an initiating factor in NPC1 disease pathogenesis that causes altered calcium homeostasis, leading to the secondary storage of sphingolipids and cholesterol. This unique calcium phenotype represents a new target for therapeutic intervention, as elevation of cytosolic calcium with curcumin normalized NPC1 disease cellular phenotypes and prolonged survival of the NPC1 mouse.	[Lloyd-Evans, Emyr; Morgan, Anthony J.; Smith, David A.; Elliot-Smith, Elena; Churchill, Grant C.; Galione, Antony; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [He, Xingxuan; Schuchman, Edward H.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	University of Oxford; Icahn School of Medicine at Mount Sinai	Lloyd-Evans, E (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	emyr.lloyd-evans@pharm.ox.ac.uk; frances.platt@pharm.ox.ac.uk	Galione, Antony/E-5884-2011; Platt, Frances/G-1004-2010; Sillence, Dan J/J-9513-2019	Sillence, Dan J/0000-0003-4747-5655; Platt, Frances/0000-0001-7614-0403; Galione, Antony/0000-0002-4132-7646	BBSRC [BB/D012694/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054830, R56DK054830] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D012694/1] Funding Source: Medline; NIDDK NIH HHS [NIHR01 DK54830] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayala-Sanmartin J, 2001, BBA-BIOMEMBRANES, V1510, P18, DOI 10.1016/S0005-2736(00)00262-5; Babalola JO, 2007, BIOL CHEM, V388, P617, DOI 10.1515/BC.2007.063; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Biwersi J, 1996, P NATL ACAD SCI USA, V93, P12484, DOI 10.1073/pnas.93.22.12484; BUTLER JD, 1993, BIOCHEM BIOPH RES CO, V196, P154, DOI 10.1006/bbrc.1993.2228; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Deisz RA, 2005, NEUROSCIENCE, V130, P867, DOI 10.1016/j.neuroscience.2004.09.065; Elliot-Smith E, 2008, MOL GENET METAB, V94, P204, DOI 10.1016/j.ymgme.2008.02.005; Erickson RP, 2000, J INHERIT METAB DIS, V23, P54, DOI 10.1023/A:1005650930330; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; Ginzburg L, 2004, SEMIN CELL DEV BIOL, V15, P417, DOI 10.1016/j.semcdb.2004.03.003; He XX, 2005, ANAL BIOCHEM, V340, P113, DOI 10.1016/j.ab.2005.01.058; Houben E, 2006, J LIPID RES, V47, P1063, DOI 10.1194/jlr.M600001-JLR200; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Lachmann RH, 2004, NEUROBIOL DIS, V16, P654, DOI 10.1016/j.nbd.2004.05.002; LEMONS RM, 1991, J BIOL CHEM, V266, P14378; Liscum L, 2000, TRAFFIC, V1, P218, DOI 10.1034/j.1600-0854.2000.010304.x; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; MASSON M, 1992, J NEUROSCI RES, V31, P84, DOI 10.1002/jnr.490310112; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Ozbay T, 2006, ENDOCRINOLOGY, V147, P1427, DOI 10.1210/en.2005-1091; PANDOL SJ, 1994, BBA-BIOMEMBRANES, V1195, P45, DOI 10.1016/0005-2736(94)90007-8; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; PATTERSON MC, 1993, NEUROLOGY, V43, P61, DOI 10.1212/WNL.43.1_Part_1.61; Pelled D, 1999, J NEUROCHEM, V72, P1139, DOI 10.1046/j.1471-4159.1999.0721139.x; Piper RC, 2004, TRENDS CELL BIOL, V14, P471, DOI 10.1016/j.tcb.2004.07.010; Rakovic S, 1999, J BIOL CHEM, V274, P17820, DOI 10.1074/jbc.274.25.17820; Somers KL, 2001, J INHERIT METAB DIS, V24, P427, DOI 10.1023/A:1010588112003; Srinivas SP, 2002, INVEST OPHTH VIS SCI, V43, P2341; Sun XF, 2001, AM J HUM GENET, V68, P1361, DOI 10.1086/320599; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vruchte DT, 2004, J BIOL CHEM, V279, P26167, DOI 10.1074/jbc.M311591200; Walter M, 2009, BIOL CELL, V101, P141, DOI 10.1042/BC20070171; Wu YP, 2008, HUM MOL GENET, V17, P2257, DOI 10.1093/hmg/ddn126; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707	50	581	597	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11					1247	1255		10.1038/nm.1876	http://dx.doi.org/10.1038/nm.1876			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18953351				2022-12-25	WOS:000260751200044
J	Loo, YM; Gale, M				Loo, Yueh-Ming; Gale, Michael, Jr.			Unveiling viral enablers	NATURE BIOTECHNOLOGY			English	Editorial Material							VIRUS-REPLICATION; HIV-INFECTION; SCREEN; IDENTIFICATION; COFACTORS		[Loo, Yueh-Ming; Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Loo, YM (corresponding author), Univ Washington, Sch Med, Dept Immunol, 1959 NE Pacific St, Seattle, WA 98195 USA.	mgale@u.washington.edu		Gale, Michael/0000-0002-6332-7436; Loo, Yueh-Ming/0000-0001-6294-7273	NIAID NIH HHS [R01 AI060389] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060389] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Ng TI, 2007, HEPATOLOGY, V45, P1413, DOI 10.1002/hep.21608; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104	7	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1093	1094		10.1038/nbt1008-1093	http://dx.doi.org/10.1038/nbt1008-1093			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18846077				2022-12-25	WOS:000259926000019
J	Zheng, Y; Wildonger, J; Ye, B; Zhang, Y; Kita, A; Younger, SH; Zimmerman, S; Jan, LY; Jan, YN				Zheng, Yi; Wildonger, Jill; Ye, Bing; Zhang, Ye; Kita, Angela; Younger, Susan H.; Zimmerman, Sabina; Jan, Lily Yeh; Jan, Yuh Nung			Dynein is required for polarized dendritic transport and uniform microtubule orientation in axons	NATURE CELL BIOLOGY			English	Article							RECYCLING ENDOSOMES; SECRETORY PATHWAY; DROSOPHILA; NEURONS; PROTEIN; GOLGI; MORPHOGENESIS; TRAFFICKING; PLASTICITY; COMPLEX	Axons and dendrites differ in both microtubule organization and in the organelles and proteins they contain. Here we show that the microtubule motor dynein has a crucial role in polarized transport and in controlling the orientation of axonal microtubules in Drosophila melanogaster dendritic arborization (da) neurons. Changes in organelle distribution within the dendritic arbors of dynein mutant neurons correlate with a proximal shift in dendritic branch position. Dynein is also necessary for the dendrite-specific localization of Golgi outposts and the ion channel Pickpocket. Axonal microtubules are normally oriented uniformly plus-end-distal; however, without dynein, axons contain both plus-and minus-end distal microtubules. These data suggest that dynein is required for the distinguishing properties of the axon and dendrites: without dynein, dendritic organelles and proteins enter the axon and the axonal microtubules are no longer uniform in polarity.	[Zheng, Yi; Wildonger, Jill; Ye, Bing; Zhang, Ye; Kita, Angela; Younger, Susan H.; Zimmerman, Sabina; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Zheng, Yi; Wildonger, Jill; Ye, Bing; Zhang, Ye; Kita, Angela; Younger, Susan H.; Zimmerman, Sabina; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	Ye, Bing/V-1306-2018; Zhang, Ye/D-1664-2010	Ye, Bing/0000-0002-8828-4065; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Kirschstein NRSA [F32-MH75223, F32-HD53199]; NIH Pathway to Independence [K99MH080599]; Sandler Family Supporting Foundation; NIH [R01NS40929, R01NS47200]; Investigators of the Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD053199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH080599, F32MH075223, R01MH084234, K99MH080599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929, R37NS040929, R01NS047200] Funding Source: NIH RePORTER	Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pathway to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigators of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank T. Uemura, F. B. Gao, L. Luo, R. Warrior, T. Hays and the Bloomington Stock Center for fly stocks; W. Song, C. Han, S. Zhu, P. Soba, J. Parrish, J. Kardon and S. Reck-Peterson for helpful suggestions and comments on the manuscript, and members of the Jan Lab for stimulating discussions. We thank T. Uemura for communicating results before publication. This work was supported by Kirschstein NRSA fellowships F32-MH75223 (Y. Zheng.), F32-HD53199 (J. W.), an NIH Pathway to Independence Award K99MH080599 (B. Y.), a graduate fellowship from Genentech and the Sandler Family Supporting Foundation (Y. Zhang) and NIH grants R01NS40929 and R01NS47200 (Y.N.J.). Y.N.J. and L. Y. J. are Investigators of the Howard Hughes Medical Institute.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Baas PW, 2006, TRAFFIC, V7, P490, DOI 10.1111/j.1600-0854.2006.00392.x; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Clark IE, 1997, DEVELOPMENT, V124, P461; Cui W, 2005, MOL BIOL CELL, V16, P5400, DOI 10.1091/mbc.E05-06-0582; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; GINIGER E, 1993, ROUX ARCH DEV BIOL, V202, P112, DOI 10.1007/BF00636536; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026; Sharp DJ, 1997, J CELL BIOL, V138, P833, DOI 10.1083/jcb.138.4.833; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000	30	212	215	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1172	1180		10.1038/ncb1777	http://dx.doi.org/10.1038/ncb1777			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18758451	Green Accepted			2022-12-25	WOS:000259682900011
J	Dankort, D; Curley, DP; Cartlidge, RA; Nelson, B; Karnezis, AN; Damsky, WE; You, MJ; DePinho, RA; McMahon, M; Bosenberg, M				Dankort, David; Curley, David P.; Cartlidge, Robert A.; Nelson, Betsy; Karnezis, Anthony N.; Damsky, William E., Jr.; You, Mingjian J.; DePinho, Ronald A.; McMahon, Martin; Bosenberg, Marcus			Braf(V600E) cooperates with Pten loss to induce metastatic melanoma	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; MALIGNANT-MELANOMA; BRAF MUTATIONS; B-RAF; SENESCENCE; GENETICS; PROTEIN; MODELS; KINASE; POTENT	Mutational activation of BRAF is the earliest and most common genetic alteration in human melanoma. To build a model of human melanoma, we generated mice with conditional melanocyte-specific expression of BRaf(V600E). Upon induction of BRaf(V600E) expression, mice developed benign melanocytic hyperplasias that failed to progress to melanoma over 15-20 months. By contrast, expression of BRaf(V600E) combined with Pten tumor suppressor gene silencing elicited development of melanoma with 100% penetrance, short latency and with metastases observed in lymph nodes and lungs. Melanoma was prevented by inhibitors of mTorc1 (rapamycin) or MEK1/2 (PD325901) but, upon cessation of drug administration, mice developed melanoma, indicating the presence of long-lived melanoma-initiating cells in this system. Notably, combined treatment with rapamycin and PD325901 led to shrinkage of established melanomas. These mice, engineered with a common genetic profile to human melanoma, provide a system to study melanoma's cardinal feature of metastasis and for preclinical evaluation of agents designed to prevent or treat metastatic disease.	[Dankort, David; Cartlidge, Robert A.; Karnezis, Anthony N.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA; [Curley, David P.; Nelson, Betsy; Damsky, William E., Jr.; Bosenberg, Marcus] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Dankort, David; Cartlidge, Robert A.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Cell & Mol Pharmacol, San Francisco, CA 94143 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Pathol, San Francisco, CA 94143 USA; [You, Mingjian J.; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [You, Mingjian J.; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med, Boston, MA 02115 USA; [You, Mingjian J.; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Genet, Boston, MA 02115 USA; [You, Mingjian J.; DePinho, Ronald A.] Harvard Univ, Sch Med, Boston, MA USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Vermont; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	McMahon, M (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA.	mcmahon@cc.ucsf.edu; marcus.bosenberg@yale.edu	McMahon, Martin/L-3303-2013	McMahon, Martin/0000-0003-2812-1042; DePinho, Ronald/0000-0002-5625-577X; Dankort, David/0000-0002-5862-6829	University of California San Francisco Helen Diller Family Comprehensive Cancer Center Mouse Pathology and Pre-Clinical Therapeutics cores; Melanoma Research Foundation; U.C. Discovery Award; US National Institutes of Health [CA 108972, CA 84313, CA 89124, CA 112054]; NATIONAL CANCER INSTITUTE [R01CA112054, U01CA084313, R01CA108972, K08CA089124] Funding Source: NIH RePORTER	University of California San Francisco Helen Diller Family Comprehensive Cancer Center Mouse Pathology and Pre-Clinical Therapeutics cores(University of California System); Melanoma Research Foundation; U.C. Discovery Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the McMahon and Bosenberg laboratories as well as B. Bastian, L. Chin, E. Filenova, B. Hann, M. Herlyn, L. Johnson, G. Merlino, P. P. Pandolfi, V. Hearing, M. Held, G. Kay and D. Matzen for the provision of mouse strains, reagents, advice and support. M. M. thanks A. Ricart and J. Sebolt-Leopold (Pfizer) for provision of PD325901 and acknowledges the support of the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Mouse Pathology and Pre-Clinical Therapeutics cores. R. A. D. is supported as an American Cancer Society Research Professor. This work was supported by grants from the Melanoma Research Foundation, U.C. Discovery Award and from the US National Institutes of Health (CA 108972 to M. M., CA 84313 to R. A. D. and CA 89124 and CA 112054 to M. B., respectively).	Bardeesy N, 2000, ADV CANCER RES, V79, P123, DOI 10.1016/S0065-230X(00)79004-X; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Inoue-Narita T, 2008, CANCER RES, V68, P5760, DOI 10.1158/0008-5472.CAN-08-0889; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Sosman JA, 2006, CLIN CANCER RES, V12, p2376S, DOI 10.1158/1078-0432.CCR-05-2558; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Tietze MK, 2000, MOL MED TODAY, V6, P408, DOI 10.1016/S1357-4310(00)01781-0; Tonks ID, 2003, GENESIS, V37, P131, DOI 10.1002/gene.10242; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2000, CANCER RES, V60, P1800; Walker GJ, 2002, J INVEST DERMATOL, V119, P783, DOI 10.1046/j.1523-1747.2002.00217.x; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Willmore-Payne C, 2006, HUM PATHOL, V37, P520, DOI 10.1016/j.humpath.2006.01.003; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	50	798	835	6	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					544	552		10.1038/ng.356	http://dx.doi.org/10.1038/ng.356			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19282848	Green Accepted, Green Published			2022-12-25	WOS:000265575600015
J	Yang, X; Deignan, JL; Qi, HX; Zhu, J; Qian, S; Zhong, J; Torosyan, G; Majid, S; Falkard, B; Kleinhanz, RR; Karlsson, J; Castellani, LW; Mumick, S; Wang, K; Xie, T; Coon, M; Zhang, C; Estrada-Smith, D; Farber, CR; Wang, SS; Van Nas, A; Ghazalpour, A; Zhang, B; MacNeil, DJ; Lamb, JR; Dipple, KM; Reitman, ML; Mehrabian, M; Lum, PY; Schadt, EE; Lusis, AJ; Drake, TA				Yang, Xia; Deignan, Joshua L.; Qi, Hongxiu; Zhu, Jun; Qian, Su; Zhong, Judy; Torosyan, Gevork; Majid, Sana; Falkard, Brie; Kleinhanz, Robert R.; Karlsson, Jenny; Castellani, Lawrence W.; Mumick, Sheena; Wang, Kai; Xie, Tao; Coon, Michael; Zhang, Chunsheng; Estrada-Smith, Daria; Farber, Charles R.; Wang, Susanna S.; Van Nas, Atila; Ghazalpour, Anatole; Zhang, Bin; MacNeil, Douglas J.; Lamb, John R.; Dipple, Katrina M.; Reitman, Marc L.; Mehrabian, Margarete; Lum, Pek Y.; Schadt, Eric E.; Lusis, Aldons J.; Drake, Thomas A.			Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GLUTATHIONE PEROXIDASES; GLYCEROL KINASE-DEFICIENCY; INSULIN-RESISTANCE; EXPRESSION; MICE; DISEASE; LOCI; GENETICS; PROTEIN	A principal task in dissecting the genetics of complex traits is to identify causal genes for disease phenotypes. We previously developed a method to infer causal relationships among genes through the integration of DNA variation, gene transcription and phenotypic information. Here we have validated our method through the characterization of transgenic and knockout mouse models of genes predicted to be causal for abdominal obesity. Perturbation of eight out of the nine genes, with Gas7, Me1 and Gpx3 being newly confirmed, resulted in significant changes in obesity-related traits. Liver expression signatures revealed alterations in common metabolic pathways and networks contributing to abdominal obesity and overlapped with a macrophage-enriched metabolic network module that is highly associated with metabolic traits in mice and humans. Integration of gene expression in the design and analysis of traditional F-2 intercross studies allows high-confidence prediction of causal genes and identification of pathways and networks involved.	[Karlsson, Jenny; Drake, Thomas A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Yang, Xia; Deignan, Joshua L.; Qi, Hongxiu; Castellani, Lawrence W.; Farber, Charles R.; Mehrabian, Margarete; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Zhu, Jun; Zhong, Judy; Kleinhanz, Robert R.; Wang, Kai; Xie, Tao; Coon, Michael; Zhang, Chunsheng; Zhang, Bin; Lamb, John R.; Lum, Pek Y.; Schadt, Eric E.] Rosetta Inphamat LLC, Seattle, WA USA; [Qian, Su; Mumick, Sheena; MacNeil, Douglas J.] Merck & Co Inc, Dept Metab Disorders, Rahway, NJ 07065 USA; [Torosyan, Gevork; Majid, Sana; Falkard, Brie; Estrada-Smith, Daria; Wang, Susanna S.; Van Nas, Atila; Ghazalpour, Anatole; Dipple, Katrina M.; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Reitman, Marc L.] Merck & Co Inc, Dept Clin Pharmacol, Rahway, NJ 07065 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Merck & Company; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Merck & Company	Drake, TA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	tdrake@mednet.ucla.edu	zhong, Judy/ABE-8314-2020; Majid, Sana/GRK-0013-2022; Reitman, Marc/B-4448-2013; Longo, Kenneth A/A-5631-2010; Pillay, Nischalan/F-9536-2012	Reitman, Marc/0000-0002-0426-9475; Wang, Kai/0000-0003-0567-3004; Farber, Charles/0000-0002-6748-4711; MacNeil, Doug/0000-0001-7089-0668; Zhong, Judy/0000-0002-2163-8447	US National Institutes of Health [DK072206, HL28481, HL30568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072206] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank R. Davis, P. Wen, M. Rosales, X. Wu, K. Ranola and X. Xia for helping with the tissue collection. We would also like to thank L. Ingram-Drake and S. Charugundla for technical support and O. Mirochnitchenko and I. Goldberg for providing mouse models. The study was funded by US National Institutes of Health grants DK072206, HL28481 and HL30568.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Francis K, 2003, FASEB J, V17, P2266, DOI 10.1096/fj.02-1103fje; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Huq AHMM, 1997, HUM MOL GENET, V6, P1803, DOI 10.1093/hmg/6.11.1803; Ishibashi N, 2002, METHOD ENZYMOL, V353, P460; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Merkel M, 2002, J BIOL CHEM, V277, P7405, DOI 10.1074/jbc.M107914200; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; MIROCHNITCHENKO O, 1995, P NATL ACAD SCI USA, V92, P8120, DOI 10.1073/pnas.92.18.8120; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Moorthy PP, 2005, STEM CELLS DEV, V14, P664, DOI 10.1089/scd.2005.14.664; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; Qian S, 2008, BASIC CLIN PHARMACOL, V103, P36, DOI 10.1111/j.1742-7843.2008.00228.x; Rahib L, 2007, EUR J HUM GENET, V15, P646, DOI 10.1038/sj.ejhg.5201801; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van Schothorst EM, 2006, OBESITY, V14, P974, DOI 10.1038/oby.2006.111; Vidal O, 2006, ANIM GENET, V37, P28, DOI 10.1111/j.1365-2052.2005.01366.x; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	49	205	210	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					415	423		10.1038/ng.325	http://dx.doi.org/10.1038/ng.325			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19270708	Green Accepted, Green Submitted			2022-12-25	WOS:000264659000014
J	Ferre, S; Baler, R; Bouvier, M; Caron, MG; Devi, LA; Durroux, T; Fuxe, K; George, SR; Javitch, JA; Lohse, MJ; Mackie, K; Milligan, G; Pfleger, KDG; Pin, JP; Volkow, ND; Waldhoer, M; Woods, AS; Franco, R				Ferre, Sergi; Baler, Ruben; Bouvier, Michel; Caron, Marc G.; Devi, Lakshmi A.; Durroux, Thierry; Fuxe, Kjell; George, Susan R.; Javitch, Jonathan A.; Lohse, Martin J.; Mackie, Ken; Milligan, Graeme; Pfleger, Kevin D. G.; Pin, Jean-Philippe; Volkow, Nora D.; Waldhoer, Maria; Woods, Amina S.; Franco, Rafael			Building a new conceptual framework for receptor heteromers	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; INTERNATIONAL UNION; PHARMACOLOGY; RELEVANCE; HETERODIMERIZATION; CLASSIFICATION; IDENTIFICATION; NOMENCLATURE; MODULATION; STRIATUM	Receptor heteromers constitute a new area of research that is reshaping our thinking about biochemistry, cell biology, pharmacology and drug discovery. In this commentary, we recommend clear definitions that should facilitate both information exchange and research on this growing class of transmembrane signal transduction units and their complex properties. We also consider research questions underlying the proposed nomenclature, with recommendations for receptor heteromer identification in native tissues and their use as targets for drug development.	[Ferre, Sergi] NIH, Natl Inst Drug Abuse, IRP, DHHS, Baltimore, MD 21224 USA; [Baler, Ruben] NIH, Natl Inst Drug Abuse, DHHS, Bethesda, MD 20892 USA; [Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Devi, Lakshmi A.] Mt Sinai Sch Med, New York, NY 10029 USA; [Durroux, Thierry] Univ Montpellier, INSERM, CNRS, Inst Genom Fonct, F-34000 Montpellier, France; [Fuxe, Kjell] Karolinska Inst, S-17177 Stockholm, Sweden; [George, Susan R.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A8, Canada; [Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, Coll Phys & Surg, New York, NY 10032 USA; [Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany; [Mackie, Ken] Indiana Univ, Bloomington, IN 47405 USA; [Milligan, Graeme] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Pfleger, Kevin D. G.] Univ Western Australia, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; [Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Pin, Jean-Philippe] Univ Montpellier, INSERM, CNRS, Inst Genom Fonct, F-34000 Montpellier, France; [Volkow, Nora D.] NIH, Natl Inst Drug Abuse, DHHS, Bethesda, MD 20892 USA; [Waldhoer, Maria] Med Univ Graz, A-8010 Graz, Austria; [Woods, Amina S.] NIH, Natl Inst Drug Abuse, IRP, DHHS, Baltimore, MD 21224 USA; [Franco, Rafael] Univ Barcelona, IDIBAPS Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08028, Spain; [Franco, Rafael] Univ Navarra, CIMA, Pamplona 31008, Spain	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Universite de Montreal; Duke University; Icahn School of Medicine at Mount Sinai; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Karolinska Institutet; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Columbia University; University of Wurzburg; Indiana University System; Indiana University Bloomington; University of Glasgow; University of Western Australia; University of Western Australia; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Medical University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra	Ferre, S (corresponding author), NIH, Natl Inst Drug Abuse, IRP, DHHS, 251 Bayview Blvd, Baltimore, MD 21224 USA.	sferre@intra.nida.nih.gov	Ferre, Sergi/K-6115-2014; Lohse, Martin J/A-7160-2012; Bouvier, Michel/H-2758-2014; Milligan, Graeme/F-9426-2011; Pin, Jean-Philippe/Y-6668-2019; Devi P, Lakshmi/GXM-5982-2022; George, Susan/W-7494-2019; Pfleger, Kevin/H-5629-2014; Franco, Rafael/C-3694-2015; George, Susan R/P-9669-2018; Mackie, Ken/E-3715-2013; Mackie, Kenneth P/B-7358-2011; Waldhoer, Maria/HDO-0619-2022	Ferre, Sergi/0000-0002-1747-1779; Lohse, Martin J/0000-0002-0599-3510; Bouvier, Michel/0000-0003-1128-0100; Milligan, Graeme/0000-0002-6946-3519; Pin, Jean-Philippe/0000-0002-1423-345X; Devi P, Lakshmi/0000-0001-9274-4776; Franco, Rafael/0000-0003-2549-4919; Mackie, Ken/0000-0001-8501-6199; Fuxe, Kjell/0000-0001-8491-4288; Pfleger, Kevin/0000-0001-8261-9189; Durroux, Thierry/0000-0003-1091-6066; Waldhoer, Maria/0000-0003-3534-1959; Javitch, Jonathan/0000-0001-7395-2967	Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; Medical Research Council [G9811527] Funding Source: Medline; NIDA NIH HHS [R01 DA007223, K05 DA022413] Funding Source: Medline; NIMH NIH HHS [R01 MH054137] Funding Source: Medline; MRC [G9811527] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550, ZIAAA000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007223, ZIADA000493, K05DA022413] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Franco R, 2005, TRENDS BIOCHEM SCI, V30, P360, DOI 10.1016/j.tibs.2005.05.010; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Humphrey PPA, 1998, PHARMACOL REV, V50, P271; Levoye A, 2006, EMBO REP, V7, P1094, DOI 10.1038/sj.embor.7400838; Marcellino D, 2008, J BIOL CHEM, V283, P26016, DOI 10.1074/jbc.M710349200; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; ROZENFELD R, 2006, DRUG DISCOV TODAY TH, V3, P437; Salter MW, 2003, TRENDS NEUROSCI, V26, P235, DOI 10.1016/S0166-2236(03)00081-X; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wager-Miller J, 2002, CHEM PHYS LIPIDS, V121, P83, DOI 10.1016/S0009-3084(02)00151-2; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	30	297	304	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2009	5	3					131	134		10.1038/nchembio0309-131	http://dx.doi.org/10.1038/nchembio0309-131			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410DG	19219011	Green Accepted			2022-12-25	WOS:000263556100004
J	Halperin, E; Stephan, DA				Halperin, Eran; Stephan, Dietrich A.			Maximizing power in association studies	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM	Only a subset of genetic variants can be examined in genome-wide surveys for genetic risk factors. How can a fixed set of markers account for the entire genome by acting as proxies for neighboring associations?	[Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Halperin, Eran] Tel Aviv Univ, Dept Comp Sci, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Tel Aviv Univ, Dept Biotechnol, IL-69978 Tel Aviv, Israel; [Stephan, Dietrich A.] Navigenics, Div Genom Res, Foster City, CA 94404 USA	Tel Aviv University; Tel Aviv University	Halperin, E (corresponding author), Int Comp Sci Inst, Berkeley, CA 94704 USA.	dietrich@navigenics.com						Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109	9	7	7	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2009	27	3					255	256		10.1038/nbt0309-255	http://dx.doi.org/10.1038/nbt0309-255			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	416UJ	19270676				2022-12-25	WOS:000264030700018
J	Nagahara, AH; Merrill, DA; Coppola, G; Tsukada, S; Schroeder, BE; Shaked, GM; Wang, L; Blesch, A; Kim, A; Conner, JM; Rockenstein, E; Chao, MV; Koo, EH; Geschwind, D; Masliah, E; Chiba, AA; Tuszynski, MH				Nagahara, Alan H.; Merrill, David A.; Coppola, Giovanni; Tsukada, Shingo; Schroeder, Brock E.; Shaked, Gideon M.; Wang, Ling; Blesch, Armin; Kim, Albert; Conner, James M.; Rockenstein, Edward; Chao, Moses V.; Koo, Edward H.; Geschwind, Daniel; Masliah, Eliezer; Chiba, Andrea A.; Tuszynski, Mark H.			Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease	NATURE MEDICINE			English	Article							ENTORHINAL CORTEX NEURONS; PHASE-I TRIAL; PARKINSONS-DISEASE; LAYER-II; COGNITIVE IMPAIRMENT; GENE-EXPRESSION; TRANSGENIC MICE; NERVOUS-SYSTEM; OPEN-LABEL; AGED RATS	Profound neuronal dysfunction in the entorhinal cortex contributes to early loss of short-term memory in Alzheimer's disease(1-3). Here we show broad neuroprotective effects of entorhinal brain-derived neurotrophic factor (BDNF) administration in several animal models of Alzheimer's disease, with extension of therapeutic benefits into the degenerating hippocampus. In amyloid-transgenic mice, BDNF gene delivery, when administered after disease onset, reverses synapse loss, partially normalizes aberrant gene expression, improves cell signaling and restores learning and memory. These outcomes occur independently of effects on amyloid plaque load. In aged rats, BDNF infusion reverses cognitive decline, improves age-related perturbations in gene expression and restores cell signaling. In adult rats and primates, BDNF prevents lesion-induced death of entorhinal cortical neurons. In aged primates, BDNF reverses neuronal atrophy and ameliorates age-related cognitive impairment. Collectively, these findings indicate that BDNF exerts substantial protective effects on crucial neuronal circuitry involved in Alzheimer's disease, acting through amyloid-independent mechanisms. BDNF therapeutic delivery merits exploration as a potential therapy for Alzheimer's disease.	[Nagahara, Alan H.; Merrill, David A.; Tsukada, Shingo; Schroeder, Brock E.; Shaked, Gideon M.; Wang, Ling; Blesch, Armin; Conner, James M.; Rockenstein, Edward; Koo, Edward H.; Masliah, Eliezer; Chiba, Andrea A.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci 0626, La Jolla, CA 92093 USA; [Coppola, Giovanni; Geschwind, Daniel] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Kim, Albert; Chao, Moses V.] NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; [Chiba, Andrea A.] Univ Calif San Diego, Dept Cognit Sci 0515, La Jolla, CA 92093 USA; [Tuszynski, Mark H.] Vet Affairs Med Ctr, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; New York University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci 0626, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu	Kim, Albert H./HGF-0057-2022	Merrill, David/0000-0003-2181-3839; Chao, Moses/0000-0002-6969-3744; Blesch, Armin/0000-0003-1133-1174	US National Institutes of Health [AG10435]; California Regional Primate Research Center Base Grant; Veterans Administration; Alzheimer's Association; State of California [04-35530]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Shiley Family Foundation; NATIONAL INSTITUTE ON AGING [P01AG010435, R37AG018440, P01AG022074] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Regional Primate Research Center Base Grant; Veterans Administration(US Department of Veterans Affairs); Alzheimer's Association(Alzheimer's Association); State of California; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Shiley Family Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Glabe (University of California, Irvine) for A beta 1-42 peptide. We thank D. Amaral and P. Lavenex for assistance with the primate perforant path model, K. Loew, T. Mead, R. Torres and M. Mateling for technical support, and F. Gao for data analysis. This work was supported by the US National Institutes of Health (AG10435), the California Regional Primate Research Center Base Grant, the Veterans Administration, the Alzheimer's Association, the State of California (04-35530), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and The Shiley Family Foundation.	Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gazzaley AH, 1997, NEUROBIOL AGING, V18, P549, DOI 10.1016/S0197-4580(97)00112-7; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gould RL, 2003, NEUROIMAGE, V20, P1006, DOI 10.1016/S1053-8119(03)00365-3; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOLTZMAN DM, 1995, J NEUROSCI, V15, P1567; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Merrill DA, 2000, J COMP NEUROL, V422, P396, DOI 10.1002/1096-9861(20000703)422:3<396::AID-CNE6>3.0.CO;2-R; Merrill DA, 2001, J COMP NEUROL, V438, P445, DOI 10.1002/cne.1327; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; OWEN AM, 1991, NEUROPSYCHOLOGIA, V29, P993, DOI 10.1016/0028-3932(91)90063-E; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; PETERSON DA, 1994, J NEUROSCI, V14, P6872; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140; Rohn TT, 2002, DRUG NEWS PERSPECT, V15, P549, DOI 10.1358/dnp.2002.15.9.740233; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SQUIRE LR, 2000, MEMORY, pCH5; Stoop R, 1996, PROG BRAIN RES, V109, P359; Taffe MA, 2004, BEHAV BRAIN RES, V149, P123, DOI 10.1016/S0166-4328(03)00214-6; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Winkler C, 1996, J NEUROSCI, V16, P7206; Yan Q, 1997, J COMP NEUROL, V378, P135	39	708	755	4	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					331	337		10.1038/nm.1912	http://dx.doi.org/10.1038/nm.1912			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19198615	Green Accepted			2022-12-25	WOS:000263914000035
J	Bell, RD; Deane, R; Chow, NW; Long, XC; Sagare, A; Singh, I; Streb, JW; Guo, H; Rubio, A; Van Nostrand, W; Miano, JM; Zlokovic, BV				Bell, Robert D.; Deane, Rashid; Chow, Nienwen; Long, Xiaochun; Sagare, Abhay; Singh, Itender; Streb, Jeffrey W.; Guo, Huang; Rubio, Anna; Van Nostrand, William; Miano, Joseph M.; Zlokovic, Berislav V.			SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells	NATURE CELL BIOLOGY			English	Article							SERUM RESPONSE FACTOR; ELEMENT-BINDING PROTEIN-2; ALZHEIMER-DISEASE; NEUROVASCULAR DYSFUNCTION; APOLIPOPROTEIN-E; IN-VITRO; PEPTIDE; SMOOTH; GENE; EXPRESSION	Amyloid beta-peptide (A beta) deposition in cerebral vessels contributes to cerebral amyloid angiopathy (CAA) in Alzheimer's disease (AD). Here, we report that in AD patients and two mouse models of AD, overexpression of serum response factor (SRF) and myocardin (MYOCD) in cerebral vascular smooth muscle cells (VSMCs) generates an A beta non-clearing VSMC phenotype through transactivation of sterol regulatory element binding protein-2, which downregulates low density lipoprotein receptor-related protein-1, a key A beta clearance receptor. Hypoxia stimulated SRF/MYOCD expression in human cerebral VSMCs and in animal models of AD. We suggest that SRF and MYOCD function as a transcriptional switch, controlling A beta cerebrovascular clearance and progression of AD.	[Bell, Robert D.; Deane, Rashid; Sagare, Abhay; Singh, Itender; Guo, Huang; Zlokovic, Berislav V.] Univ Rochester, Sch Med & Dent, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Chow, Nienwen; Guo, Huang; Rubio, Anna] Univ Rochester, Sch Med & Dent, Socratech Res Labs, Rochester, NY 14642 USA; [Long, Xiaochun; Streb, Jeffrey W.; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Van Nostrand, William] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	University of Rochester; University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zlokovic, BV (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Neurodegenerat & Vasc Brain Disorders, Arthur Kornberg Med Res Bldg,601 Elmwood Ave, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu	Sagare, Abhay/Y-3273-2019; Miano, Joseph/L-5634-2018	Sagare, Abhay/0000-0002-8178-3785; Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	Socratech LLC;  [R37AG023084];  [R37NS34467];  [1R43 AG02400];  [HL62572];  [R42AG026950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, R42AG026950] Funding Source: NIH RePORTER	Socratech LLC; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ms. Theresa Barrett for assisting with some immunostaining studies. This study was supported by R37AG023084, R37NS34467 and Socratech LLC to BVZ, 1R43 AG02400 to NC and HL62572 and R42AG026950 to JMM. JMM and BVZ are co-senior authors.	Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Davis J, 2003, J BIOL CHEM, V278, P19054, DOI 10.1074/jbc.M301398200; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Herring A, 2008, BRAIN PATHOL, V18, P32, DOI 10.1111/j.1750-3639.2007.00094.x; Herz J, 2003, CELL, V112, P289, DOI 10.1016/S0092-8674(03)00073-4; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 2007, ALZHEIMERS DIS ADV G, P179; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Moir Robert D., 2005, Current Alzheimer Research, V2, P269, DOI 10.2174/1567205053585918; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Pettersen JA, 2008, ARCH NEUROL-CHICAGO, V65, P790, DOI 10.1001/archneur.65.6.790; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Ribault S, 2001, CIRC RES, V88, P468, DOI 10.1161/01.RES.88.5.468; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; SATO R, 1994, J BIOL CHEM, V269, P17267; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Urmoneit B, 1997, LAB INVEST, V77, P157; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhu PC, 2006, INT J EXP PATHOL, V87, P463, DOI 10.1111/j.1365-2613.2006.00503.x; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	61	205	208	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					143	U83		10.1038/ncb1819	http://dx.doi.org/10.1038/ncb1819			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098903	Green Accepted			2022-12-25	WOS:000263285500012
J	Kuroiwa, Y; Kasinathan, P; Sathiyaseelan, T; Jiao, JA; Matsushita, H; Sathiyaseelan, J; Wu, H; Mellquist, J; Hammitt, M; Koster, J; Kamoda, S; Tachibana, K; Ishida, I; Robl, JM				Kuroiwa, Yoshimi; Kasinathan, Poothappillai; Sathiyaseelan, Thillainayagen; Jiao, Jin-an; Matsushita, Hiroaki; Sathiyaseelan, Janaki; Wu, Hua; Mellquist, Jenny; Hammitt, Melissa; Koster, Julie; Kamoda, Satoru; Tachibana, Katsumi; Ishida, Isao; Robl, James M.			Antigen-specific human polyclonal antibodies from hyperimmunized cattle	NATURE BIOTECHNOLOGY			English	Article							IMMUNOGLOBULIN-MU; HEAVY-CHAINS; IG HEAVY; B-CELL; GENE; REPERTOIRE; DIVERSIFICATION; CLONING; SHEEP; MICE	Antigen-specific human polyclonal antibodies (hpAbs), produced by hyperimmunization, could be useful for treating many human diseases. However, yields from available transgenic mice and transchromosomic (Tc) cattle carrying human immunoglobulin loci are too low for therapeutic applications. We report a Tc bovine system that produces large yields of hpAbs. Tc cattle were generated by transferring a human artificial chromosome vector carrying the entire unrearranged, human immunoglobulin heavy (hIGH) and kappa-light (hIGK) chain loci to bovine fibroblasts in which two endogenous bovine IgH chain loci were inactivated. Plasma from the oldest animal contained > 2g/I of hIgG, paired with either human kappa-light chain (up to similar to 650 mu g/ml, fully human) or with bovine kappa- or lambda-light chain (chimeric), with a normal hIgG subclass distribution. Hyperimmunization with anthrax protective antigen triggered a hIgG-mediated humoral immune response comprising a high proportion of antigen-specific hIgG. Purified, fully human and chimeric hIgGs were highly active in an in vitro toxin neutralization assay and protective in an in vivo mouse challenge assay.	[Kuroiwa, Yoshimi; Kasinathan, Poothappillai; Sathiyaseelan, Thillainayagen; Jiao, Jin-an; Matsushita, Hiroaki; Sathiyaseelan, Janaki; Wu, Hua; Mellquist, Jenny; Hammitt, Melissa; Koster, Julie; Robl, James M.] Hematech Inc, Sioux Falls, SD 57106 USA; [Kuroiwa, Yoshimi; Kamoda, Satoru; Tachibana, Katsumi; Ishida, Isao] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo 1008185, Japan	Kyowa Kirin Ltd	Kuroiwa, Y (corresponding author), Hematech Inc, 4401 S Technol Dr, Sioux Falls, SD 57106 USA.	ykuroiwa@hematech.com						Aitken R, 1999, VET IMMUNOL IMMUNOP, V72, P21, DOI 10.1016/S0165-2427(99)00113-0; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Brey RN, 2005, ADV DRUG DELIVER REV, V57, P1266, DOI 10.1016/j.addr.2005.01.028; Butler JE, 1998, REV SCI TECH OIE, V17, P43, DOI 10.20506/rst.17.1.1096; Chowdhary BP, 1996, MAMM GENOME, V7, P297, DOI 10.1007/s003359900086; GU F, 1992, HEREDITAS, V117, P237, DOI 10.1111/j.1601-5223.1992.tb00020.x; HAYES HC, 1993, MAMM GENOME, V4, P207, DOI 10.1007/BF00417564; Hering D, 2004, BIOLOGICALS, V32, P17, DOI 10.1016/j.biologicals.2003.09.003; HOOD L, 1967, COLD SPRING HARB SYM, V32, P133, DOI 10.1101/SQB.1967.032.01.021; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; Jenne CN, 2003, J IMMUNOL, V170, P3739, DOI 10.4049/jimmunol.170.7.3739; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Kamoda S, 2006, J CHROMATOGR A, V1133, P332, DOI 10.1016/j.chroma.2006.08.028; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KNIGHT KL, 1995, J IMMUNOL, V155, P684; Kubota C, 2004, NAT BIOTECHNOL, V22, P693, DOI 10.1038/nbt975; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Lemieux W, 2005, MOL IMMUNOL, V42, P839, DOI 10.1016/j.molimm.2004.07.046; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Lucier MR, 1998, J IMMUNOL, V161, P5438; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Meyer A, 1997, Int Rev Immunol, V15, P165, DOI 10.3109/08830189709068175; Newcombe C, 2007, J CHROMATOGR B, V848, P2, DOI 10.1016/j.jchromb.2006.07.004; NOLANWILLARD M, 1992, P NATL ACAD SCI USA, V89, P1234, DOI 10.1073/pnas.89.4.1234; Pittman PR, 2002, VACCINE, V20, P1412, DOI 10.1016/S0264-410X(01)00462-5; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Semenova VA, 2004, CLIN DIAGN LAB IMMUN, V11, P919, DOI 10.1128/CDLI.11.5.919-923.2004; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; TOBINJANZEN TC, 1992, IMMUNOGENETICS, V36, P157, DOI 10.1007/BF00661092; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Waltz E, 2006, NAT BIOTECHNOL, V24, P1181, DOI 10.1038/nbt1006-1181; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200	38	79	93	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2009	27	2					173	181		10.1038/nbt.1521	http://dx.doi.org/10.1038/nbt.1521			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	405FT	19151699	Bronze			2022-12-25	WOS:000263209000024
J	Lee, JY; Huerta, PT; Zhang, J; Kowal, C; Bertini, E; Volpe, BT; Diamond, B				Lee, Ji Y.; Huerta, Patricio T.; Zhang, Jie; Kowal, Czeslawa; Bertini, Eva; Volpe, Bruce T.; Diamond, Betty			Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus	NATURE MEDICINE			English	Article							NMDA RECEPTORS; GLUTAMATE-RECEPTOR; NEURONAL MIGRATION; ERYTHEMATOSUS; ANTIBODIES; MECHANISMS; CHILDREN; INJURY; CORTEX; IDENTIFICATION	Systemic lupus erythematosus (SLE) is an autoimmune disease mediated by autoantibodies and preferentially affecting women of childbearing age. Because the offspring of mothers with SLE show a high frequency of learning disorders(1-5), we hypothesized that maternally transferred autoantibodies that bind DNA and the N-methyl-D-aspartate receptor (NMDAR)(6-12) could have a pathogenic role during fetal brain development. Here we describe a maternal SLE mouse model wherein pregnant dams harbored DNA-specific, NMDAR-specific autoantibodies throughout gestation. High titers of these autoantibodies in maternal circulation led to histological abnormalities in fetal brain and subsequent cognitive impairments in adult offspring. These data support a paradigm in which in utero exposure to neurotoxic autoantibodies causes abnormal brain development with long-term consequences. This paradigm may apply to multiple congenital neuropsychiatric disorders.	[Lee, Ji Y.; Kowal, Czeslawa; Diamond, Betty] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Huerta, Patricio T.; Volpe, Bruce T.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Burke Cornell Med Res Inst, White Plains, NY 10605 USA; [Zhang, Jie; Kowal, Czeslawa; Bertini, Eva; Diamond, Betty] Autoimmune & Musculoskeletal Dis Ctr, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Bertini, Eva] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy	Yeshiva University; Albert Einstein College of Medicine; Cornell University; Northwell Health; University of Genoa	Diamond, B (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	bdiamond@nshs.edu	Bertini, Enrico/ABG-1278-2020; volpe, b/U-8409-2019	Huerta, Patricio/0000-0003-0270-2308; Volpe, Bruce/0000-0002-1098-1848	US National Institutes of Health; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049126] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by grants from the US National Institutes of Health ( B. D., P. T. H. and B. T. V.) and the Alliance for Lupus Research ( B. T. V.). We are grateful to L. DeGiorgio, S. Loncar, T. Huerta and R. Berlin for technical assistance; M. Scharff, E. Chang and T. Faust for suggestions on the manuscript; and S. Jones for help in preparing the manuscript.	Barker GRI, 2006, J NEUROSCI, V26, P3561, DOI 10.1523/JNEUROSCI.3154-05.2006; Buyon JP, 2003, CURR OPIN RHEUMATOL, V15, P535, DOI 10.1097/00002281-200309000-00003; Dalton P, 2003, ANN NEUROL, V53, P533, DOI 10.1002/ana.10557; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Fragoso-Loyo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003347; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Goodrich-Hunsaker NJ, 2005, BEHAV NEUROSCI, V119, P1307, DOI 10.1037/0735-7044.119.5.1307; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanly John G, 2007, Curr Rheumatol Rep, V9, P116, DOI 10.1007/s11926-007-0005-2; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; Husebye ES, 2005, ANN RHEUM DIS, V64, P1210, DOI 10.1136/ard.2004.029280; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; LAHITA RG, 1988, PSYCHONEUROENDOCRINO, V13, P385, DOI 10.1016/0306-4530(88)90045-5; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Manent JB, 2005, J NEUROSCI, V25, P4755, DOI 10.1523/JNEUROSCI.0553-05.2005; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; McAllister D L, 1997, J Int Neuropsychol Soc, V3, P370; MORPHIS LG, 1970, NATURE, V228, P573, DOI 10.1038/228573a0; Neri F, 2004, LUPUS, V13, P805, DOI 10.1191/0961203304lu2018oa; Newman J, 2003, J IMMUNOL METHODS, V272, P177, DOI 10.1016/S0022-1759(02)00499-4; Omdal R, 2005, EUR J NEUROL, V12, P392, DOI 10.1111/j.1468-1331.2004.00976.x; Putterman C, 1998, J EXP MED, V188, P29, DOI 10.1084/jem.188.1.29; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Ritter LM, 2001, DEV BRAIN RES, V127, P123, DOI 10.1016/S0165-3806(01)00126-2; Ross G, 2003, ARCH PEDIAT ADOL MED, V157, P397, DOI 10.1001/archpedi.157.4.397; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Steup-Beekman GM, 2007, LUPUS, V16, P329, DOI 10.1177/0961203307078224; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Tincani A, 2006, LUPUS, V15, P801, DOI 10.1177/0961203306071005; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547; Zhang J, 2008, J IMMUNOL METHODS, V338, P79, DOI 10.1016/j.jim.2008.07.015	40	119	121	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2009	15	1					91	96		10.1038/nm.1892	http://dx.doi.org/10.1038/nm.1892			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	394DF	19079257	Green Accepted			2022-12-25	WOS:000262425100023
J	Prokopenko, I; Langenberg, C; Florez, JC; Saxena, R; Soranzo, N; Thorleifsson, G; Loos, RJF; Manning, AK; Jackson, AU; Aulchenko, Y; Potter, SC; Erdos, MR; Sanna, S; Hottenga, JJ; Wheeler, E; Kaakinen, M; Lyssenko, V; Chen, WM; Ahmadi, K; Beckmann, JS; Bergman, RN; Bochud, M; Bonnycastle, LL; Buchanan, TA; Cao, A; Cervino, A; Coin, L; Collins, FS; Crisponi, L; De Geus, EJC; Dehghan, A; Deloukas, P; Doney, ASF; Elliott, P; Freimer, N; Gateva, V; Herder, C; Hofman, A; Hughes, TE; Hunt, S; Illig, T; Inouye, M; Isomaa, B; Johnson, T; Kong, A; Krestyaninova, M; Kuusisto, J; Laakso, M; Lim, N; Lindblad, U; Lindgren, CM; McCann, OT; Mohlke, KL; Morris, AD; Naitza, S; Orru, M; Palmer, CNA; Pouta, A; Randall, J; Rathmann, W; Saramies, J; Scheet, P; Scott, LJ; Scuteri, A; Sharp, S; Sijbrands, E; Smit, JH; Song, K; Steinthorsdottir, V; Stringham, HM; Tuomi, T; Tuomilehto, J; Uitterlinden, AG; Voight, BF; Waterworth, D; Wichmann, HE; Willemsen, G; Witteman, JCM; Yuan, X; Zhao, JH; Zeggini, E; Schlessinger, D; Sandhu, M; Boomsma, DI; Uda, M; Spector, TD; Penninx, BWJH; Altshuler, D; Vollenweider, P; Jarvelin, MR; Lakatta, E; Waeber, G; Fox, CS; Peltonen, L; Groop, LC; Mooser, V; Cupples, LA; Thorsteinsdottir, U; Boehnke, M; Barroso, IS; Van Duijn, C; Dupuis, J; Watanabe, RM; Stefansson, K; McCarthy, MI; Wareham, NJ; Meigs, JB; Abecasis, GR				Prokopenko, Inga; Langenberg, Claudia; Florez, Jose C.; Saxena, Richa; Soranzo, Nicole; Thorleifsson, Gudmar; Loos, Ruth J. F.; Manning, Alisa K.; Jackson, Anne U.; Aulchenko, Yurii; Potter, Simon C.; Erdos, Michael R.; Sanna, Serena; Hottenga, Jouke-Jan; Wheeler, Eleanor; Kaakinen, Marika; Lyssenko, Valeriya; Chen, Wei-Min; Ahmadi, Kourosh; Beckmann, Jacques S.; Bergman, Richard N.; Bochud, Murielle; Bonnycastle, Lori L.; Buchanan, Thomas A.; Cao, Antonio; Cervino, Alessandra; Coin, Lachlan; Collins, Francis S.; Crisponi, Laura; De Geus, Eco J. C.; Dehghan, Abbas; Deloukas, Panos; Doney, Alex S. F.; Elliott, Paul; Freimer, Nelson; Gateva, Vesela; Herder, Christian; Hofman, Albert; Hughes, Thomas E.; Hunt, Sarah; Illig, Thomas; Inouye, Michael; Isomaa, Bo; Johnson, Toby; Kong, Augustine; Krestyaninova, Maria; Kuusisto, Johanna; Laakso, Markku; Lim, Noha; Lindblad, Ulf; Lindgren, Cecilia M.; McCann, Owen T.; Mohlke, Karen L.; Morris, Andrew D.; Naitza, Silvia; Orru, Marco; Palmer, Colin N. A.; Pouta, Anneli; Randall, Joshua; Rathmann, Wolfgang; Saramies, Jouko; Scheet, Paul; Scott, Laura J.; Scuteri, Angelo; Sharp, Stephen; Sijbrands, Eric; Smit, Jan H.; Song, Kijoung; Steinthorsdottir, Valgerdur; Stringham, Heather M.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Uitterlinden, Andre G.; Voight, Benjamin F.; Waterworth, Dawn; Wichmann, H-Erich; Willemsen, Gonneke; Witteman, Jacqueline C. M.; Yuan, Xin; Zhao, Jing Hua; Zeggini, Eleftheria; Schlessinger, David; Sandhu, Manjinder; Boomsma, Dorret I.; Uda, Manuela; Spector, Tim D.; Penninx, Brenda W. J. H.; Altshuler, David; Vollenweider, Peter; Jarvelin, Marjo Riitta; Lakatta, Edward; Waeber, Gerard; Fox, Caroline S.; Peltonen, Leena; Groop, Leif C.; Mooser, Vincent; Cupples, L. Adrienne; Thorsteinsdottir, Unnur; Boehnke, Michael; Barroso, Ines; Van Duijn, Cornelia; Dupuis, Josee; Watanabe, Richard M.; Stefansson, Kari; McCarthy, Mark I.; Wareham, Nicholas J.; Meigs, James B.; Abecasis, Goncalo R.			Variants in MTNR1B influence fasting glucose levels	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL FUNCTION; GENE-EXPRESSION; PLASMA-GLUCOSE; RISK LOCI; MELATONIN; TRIGLYCERIDE; REPLICATION; HAPLOTYPE; IMPACT	To identify previously unknown genetic loci associated with fasting glucose concentrations, we examined the leading association signals in ten genome-wide association scans involving a total of 36,610 individuals of European descent. Variants in the gene encoding melatonin receptor 1B (MTNR1B) were consistently associated with fasting glucose across all ten studies. The strongest signal was observed at rs10830963, where each G allele (frequency 0.30 in HapMap CEU) was associated with an increase of 0.07 (95% CI = 0.06-0.08) mmol/l in fasting glucose levels (P = 3.2 x 10(-50)) and reduced beta-cell function as measured by homeostasis model assessment (HOMA-B, P = 1.1 x 10(-15)). The same allele was associated with an increased risk of type 2 diabetes (odds ratio = 1.09 (1.05-1.12), per G allele P = 3.3 x 10(-7)) in a meta-analysis of 13 case-control studies totaling 18,236 cases and 64,453 controls. Our analyses also confirm previous associations of fasting glucose with variants at the G6PC2 (rs560887, P = 1.1 x 10(-57)) and GCK (rs4607517, P = 1.0 x 10(-25)) loci.	[Jackson, Anne U.; Gateva, Vesela; Scheet, Paul; Scott, Laura J.; Stringham, Heather M.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Prokopenko, Inga; Lindgren, Cecilia M.; Randall, Joshua; Zeggini, Eleftheria; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Langenberg, Claudia; Loos, Ruth J. F.; Sharp, Stephen; Waterworth, Dawn; Zhao, Jing Hua; Sandhu, Manjinder; Wareham, Nicholas J.] Addenbrookes Hosp, Epidemiol Unit, MRC, Cambridge CB2 0QQ, England; [Florez, Jose C.; Saxena, Richa; Voight, Benjamin F.; Altshuler, David] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Florez, Jose C.; Altshuler, David; Meigs, James B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Florez, Jose C.; Waterworth, Dawn; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Florez, Jose C.; Waterworth, Dawn; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Diabet Unit, Boston, MA 02114 USA; [Saxena, Richa; Voight, Benjamin F.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA; [Soranzo, Nicole; Potter, Simon C.; Wheeler, Eleanor; Deloukas, Panos; Hunt, Sarah; Inouye, Michael; McCann, Owen T.; Peltonen, Leena; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Soranzo, Nicole; Ahmadi, Kourosh; Cervino, Alessandra; Spector, Tim D.] Kings Coll London, Twin Res & Genet Epidemiol Dept, London SE1 7EH, England; [Thorleifsson, Gudmar; Kong, Augustine; Steinthorsdottir, Valgerdur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Manning, Alisa K.; Cupples, L. Adrienne; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Aulchenko, Yurii; Dehghan, Abbas; Hofman, Albert; Witteman, Jacqueline C. M.; Van Duijn, Cornelia] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Erdos, Michael R.; Bonnycastle, Lori L.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Sanna, Serena; Cao, Antonio; Crisponi, Laura; Naitza, Silvia; Orru, Marco; Uda, Manuela] Cittadella Univ Monserrato, CNR, INN, I-09042 Cagliari, Italy; [Hottenga, Jouke-Jan; De Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Kaakinen, Marika; Jarvelin, Marjo Riitta] Univ Oulu, Inst Hlth Sci & Biocenter Oulu, Oulu 90014, Finland; [Lyssenko, Valeriya; Groop, Leif C.] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Chen, Wei-Min] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA 22908 USA; [Chen, Wei-Min] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Beckmann, Jacques S.; Johnson, Toby] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Bergman, Richard N.; Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Bochud, Murielle] CHU Vaudois, Univ Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol, Dept Med, Los Angeles, CA 90033 USA; [Coin, Lachlan; Elliott, Paul; Jarvelin, Marjo Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Doney, Alex S. F.; Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland; [Freimer, Nelson] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Herder, Christian; Johnson, Toby] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Hughes, Thomas E.] Novartis Inst BioMed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA; [Illig, Thomas; Wichmann, H-Erich] Helmholtz Zentrum Muenchen, Natl Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Isomaa, Bo] Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; [Krestyaninova, Maria; Yuan, Xin] European Bioinformat Inst, EMBL, Hinxton, England; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Lim, Noha; Song, Kijoung; Mooser, Vincent] Glaxo SmithKline, Med Genet Clin Pharmacol & Discovery Med, King Of Prussia, PA 19406 USA; [Lindblad, Ulf] Skaraborg Inst, Skovde, Sweden; [Lindblad, Ulf] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Populat Pharmacogenet Grp, Dundee DD1 9SY, Scotland; [Pouta, Anneli] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Jarvelin, Marjo Riitta] Natl Publ Hlth Inst KLT, Dept Child & Adolescent Hlth, Oulu 90101, Finland; [Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Saramies, Jouko] Savitaipale Hlth Ctr, Savitaipale 54800, Finland; [Scuteri, Angelo] Ist Patol Endocrina & Metabol, Unita Operat Geriatria, Rome, Italy; [Sijbrands, Eric; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Smit, Jan H.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 GZ Groningen, Netherlands; [Tuomi, Tiinamaija] Univ Helsinki, Helsinki Univ Hosp, Dept Med, FIN-00014 Helsinki, Finland; [Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Senajoki 60220, Finland; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Schlessinger, David; Lakatta, Edward] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Sandhu, Manjinder; Penninx, Brenda W. J. H.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2300 RC Leiden, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, Inst Neurosci, EMGO Inst, Dept Psychiat, NL-1081 AL Amsterdam, Netherlands; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Fox, Caroline S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Peltonen, Leena] Inst Mol Med, Biomedicum, Helsinki 00290, Finland; [Peltonen, Leena] MIT, Broad Inst, Cambridge, MA 02141 USA; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA	University of Michigan System; University of Michigan; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute; University of London; King's College London; Boston University; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; Vrije Universiteit Amsterdam; University of Oulu; Lund University; Skane University Hospital; University of Virginia; University of Virginia; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Southern California; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Southern California; Imperial College London; University of Dundee; University of California System; University of California Los Angeles; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Novartis; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Molecular Biology Laboratory (EMBL); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; GlaxoSmithKline; Lund University; Skane University Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Dundee; University of Oulu; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iceland; University of Southern California; Harvard University; Massachusetts General Hospital	Abecasis, GR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	mark.mccarthy@drl.ox.ac.uk; nick.wareham@mrc-epid.cam.ac.uk; jmeigs@partners.org; goncalo@umich.edu	Dehghan, Abbas/ABE-7377-2020; Voight, Benjamin/F-1775-2011; Uda, Manuela/AAC-2645-2019; Lim, Noha/ABA-2509-2020; Aulchenko, Yurii/M-8270-2013; Morris, Andrew D/C-2837-2009; Coin, Lachlan JM/A-9001-2014; Chen, Wei-Min/A-8469-2009; Penninx, Brenda WJH/S-7627-2017; Prokopenko, Inga/AAU-9895-2020; Study, GoDARTS/K-9448-2016; Prokopenko, Inga/H-3241-2014; Wichmann, Heinz Erich/AAA-5695-2022; sanna, serena/H-3009-2019; Lakatta, Edward G/AAL-1447-2020; Manning, Alisa Knodle/ABC-7711-2021; Loos, Ruth J F/Q-2862-2016; Deloukas, Panos/B-2922-2013; NAITZA, SILVIA/AAB-8775-2022; Coin, Lachlan/O-4976-2019; Abecasis, Goncalo R/B-7840-2010; Sijbrands, Eric/A-1065-2009; Colaus, PsyColaus/K-6607-2013; Bochud, Murielle/A-3981-2010; Saxena, Richa/AAG-7279-2020; Loos, Ruth/GON-5877-2022; Beckmann, Jacques S/A-9772-2008; Altshuler, David M/A-4476-2009; Spector, Tim D/F-6533-2012; Palmer, Colin NA/C-7053-2008; Langenberg, Claudia/ABG-9067-2021; Crisponi, Laura/AAC-2642-2019; Meigs, James/P-3927-2019; Stefansson, Kari/AAE-7187-2019; Doney, Alexander SF/P-7437-2017; de Geus, Eco J.C./M-9318-2015; Naitza, Silvia/D-5620-2017; Boomsma, Dorret I/AAX-4470-2020; Dehghan, Abbas/B-9896-2008; McCarthy, Mark/M-3763-2015	Uda, Manuela/0000-0002-4890-6456; Aulchenko, Yurii/0000-0002-7899-1575; Coin, Lachlan JM/0000-0002-4300-455X; Penninx, Brenda WJH/0000-0001-7779-9672; Prokopenko, Inga/0000-0003-1624-7457; sanna, serena/0000-0002-3768-1749; Loos, Ruth J F/0000-0002-8532-5087; Deloukas, Panos/0000-0001-9251-070X; NAITZA, SILVIA/0000-0002-0108-757X; Coin, Lachlan/0000-0002-4300-455X; Sijbrands, Eric/0000-0001-8857-7389; Bochud, Murielle/0000-0002-5727-0218; Beckmann, Jacques S/0000-0002-9741-1900; Altshuler, David M/0000-0002-7250-4107; Palmer, Colin NA/0000-0002-6415-6560; Langenberg, Claudia/0000-0002-5017-7344; Crisponi, Laura/0000-0001-9128-8537; Meigs, James/0000-0002-2439-2657; Doney, Alexander SF/0000-0002-6210-5620; de Geus, Eco J.C./0000-0001-6022-2666; Saxena, Richa/0000-0003-2233-1065; Abecasis, Goncalo/0000-0003-1509-1825; Johnson, Toby/0000-0002-5998-3270; Barroso, Ines/0000-0001-5800-4520; Dupuis, Josee/0000-0003-2871-3603; Krestyaninova, Maria/0000-0002-8705-8111; Randall, Joshua/0000-0003-1540-203X; SCUTERI, ANGELO/0000-0003-4784-5441; Inouye, Michael/0000-0001-9413-6520; Kong, Augustine/0000-0001-8193-5438; Kaakinen, Marika/0000-0002-9228-0462; Tuomi, Tiinamaija/0000-0002-8306-6202; Van Duijn, Cornelia/0000-0002-2374-9204; Zeggini, Eleftheria/0000-0003-4238-659X; Elliott, Paul/0000-0002-7511-5684; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Lindgren, Cecilia/0000-0002-4903-9374; Dehghan, Abbas/0000-0001-6403-016X; Waeber, Gerard/0000-0003-4193-788X; Lakatta, Edward/0000-0002-4772-0035; Willemsen, Gonneke/0000-0003-3755-0236; McCarthy, Mark/0000-0002-4393-0510; Hunt, Sarah/0000-0002-8350-1235; Wheeler, Eleanor/0000-0002-8616-6444; Voight, Benjamin/0000-0002-6205-9994; Soranzo, Nicole/0000-0003-1095-3852; Cupples, L. Adrienne/0000-0003-0273-7965	Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [G0601261, G0000649, G016121, G0701863, G0500539, MC_U106179471, MC_U106188470] Funding Source: Medline; NCRR NIH HHS [RR-163736] Funding Source: Medline; NHGRI NIH HHS [HG-02651, R01 HG002651-05, R01 HG002651] Funding Source: Medline; NHLBI NIH HHS [N02-HL-6-4278, R01 HL087679-02, N01 HC025195, HL-084729, HC-25195, N01HC25195, R01 HL087679, U01 HL084729-03, HL-087679, U01 HL084729] Funding Source: Medline; NIDA NIH HHS [U54 DA021519-04, DA-021519, U54 DA021519] Funding Source: Medline; NIDDK NIH HHS [U01 DK062370, U01 DK078616, R01 DK072193-04, R01 DK069922-02, K24 DK080140, DK069922, DK-080140, DK-065978, R56 DK062370, R01 DK062370-05, K23 DK065978-05, R01 DK069922, K23 DK065978, R01 DK062370, DK-078616, R01 DK078616, K24 DK080140-01, R01 DK072193, DK-072193, DK-062370, R01 DK078616-01A1, K24 DK080140-02, R01 DK029867] Funding Source: Medline; NIMH NIH HHS [R01 MH059160-04, MH059160] Funding Source: Medline; Wellcome Trust [076113, GR069224, 077011, 089061, 079557, 077016, GR072960, 090532, 083948] Funding Source: Medline; MRC [G0601261, MC_U106188470, G0701863] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, R01HL064278, U01HL084729, R01HL087679] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, Z01HG000024, R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069922, K23DK065978, R01DK078616, U01DK078616, R01DK062370, R01DK029867, K24DK080140, R01DK072193, R56DK062370, U01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Boden G, 1996, AM J PHYSIOL-ENDOC M, V271, pE246, DOI 10.1152/ajpendo.1996.271.2.E246; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Herder C, 2008, HORM METAB RES, V40, P722, DOI 10.1055/s-2008-1078730; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Mason CC, 2007, DIABETES, V56, P2054, DOI 10.2337/db07-0053; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Peschke E, 2007, J PINEAL RES, V42, P350, DOI 10.1111/j.1600-079X.2007.00426.x; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stumpf I, 2008, J PINEAL RES, V45, P318, DOI 10.1111/j.1600-079X.2008.00593.x; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Watanabe RM, 1999, HUM HERED, V49, P159, DOI 10.1159/000022865; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Xiang AH, 2006, DIABETES, V55, P1074, DOI 10.2337/diabetes.55.04.06.db05-1109; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	557	568	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2009	41	1					77	81		10.1038/ng.290	http://dx.doi.org/10.1038/ng.290			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19060907	Green Published, Green Accepted			2022-12-25	WOS:000262085300019
J	Thorleifsson, G; Walters, GB; Gudbjartsson, DF; Steinthorsdottir, V; Sulem, P; Helgadottir, A; Styrkarsdottir, U; Gretarsdottir, S; Thorlacius, S; Jonsdottir, I; Jonsdottir, T; Olafsdottir, EJ; Olafsdottir, GH; Jonsson, T; Jonsson, F; Borch-Johnsen, K; Hansen, T; Andersen, G; Jorgensen, T; Lauritzen, T; Aben, KK; Verbeek, ALM; Roeleveld, N; Kampman, E; Yanek, LR; Becker, LC; Tryggvadottir, L; Rafnar, T; Becker, DM; Gulcher, J; Kiemeney, LA; Pedersen, O; Kong, A; Thorsteinsdottir, U; Stefansson, K				Thorleifsson, Gudmar; Walters, G. Bragi; Gudbjartsson, Daniel F.; Steinthorsdottir, Valgerdur; Sulem, Patrick; Helgadottir, Anna; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Thorlacius, Steinunn; Jonsdottir, Ingileif; Jonsdottir, Thorbjorg; Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.; Jonsson, Thorvaldur; Jonsson, Frosti; Borch-Johnsen, Knut; Hansen, Torben; Andersen, Gitte; Jorgensen, Torben; Lauritzen, Torsten; Aben, Katja K.; Verbeek, Andre L. M.; Roeleveld, Nel; Kampman, Ellen; Yanek, Lisa R.; Becker, Lewis C.; Tryggvadottir, Laufey; Rafnar, Thorunn; Becker, Diane M.; Gulcher, Jeffrey; Kiemeney, Lambertus A.; Pedersen, Oluf; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity	NATURE GENETICS			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; NEURITE OUTGROWTH; GENETIC-VARIATION; ALPHA GENE; PROTEIN; WEIGHT; POLYMORPHISM; METAANALYSIS; OVERWEIGHT	Obesity results from the interaction of genetic and environmental factors. To search for sequence variants that affect variation in two common measures of obesity, weight and body mass index (BMI), both of which are highly heritable, we performed a genome-wide association (GWA) study with 305,846 SNPs typed in 25,344 Icelandic, 2,998 Dutch, 1,890 European Americans and 1,160 African American subjects and combined the results with previously published results from the Diabetes Genetics Initiative (DGI) on 3,024 Scandinavians. We selected 43 variants in 19 regions for follow-up in 5,586 Danish individuals and compared the results to a genome-wide study on obesity-related traits from the GIANT consortium. In total, 29 variants, some correlated, in 11 chromosomal regions reached a genome-wide significance threshold of P < 1.6 x 10(-7). This includes previously identified variants close to or in the FTO, MC4R, BDNF and SH2B1 genes, in addition to variants at seven loci not previously connected with obesity.	[Thorleifsson, Gudmar; Walters, G. Bragi; Gudbjartsson, Daniel F.; Steinthorsdottir, Valgerdur; Sulem, Patrick; Helgadottir, Anna; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Thorlacius, Steinunn; Jonsdottir, Ingileif; Jonsdottir, Thorbjorg; Jonsson, Frosti; Rafnar, Thorunn; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Jonsdottir, Ingileif; Jonsson, Thorvaldur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.] Iceland Canc Registry, IS-105 Reykjavik, Iceland; [Jonsson, Thorvaldur] Univ Hosp, Dept Surg, IS-101 Reykjavik, Iceland; [Borch-Johnsen, Knut; Hansen, Torben; Andersen, Gitte; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Hansen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Lauritzen, Torsten] Univ Aarhus, Dept Gen Med Practice, DK-8000 Aarhus, Denmark; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, NL-6500 HB Nijmegen, Netherlands; [Verbeek, Andre L. M.; Roeleveld, Nel; Kampman, Ellen; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Yanek, Lisa R.; Becker, Lewis C.; Tryggvadottir, Laufey; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Johns Hopkins Sibling & Family Heart Study, Baltimore, MD 21287 USA; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6500 HB Nijmegen, Netherlands	University of Iceland; Landspitali National University Hospital; Steno Diabetes Center; Aarhus University; University of Copenhagen; University of Copenhagen; Aarhus University; Radboud University Nijmegen; Johns Hopkins University; Radboud University Nijmegen	Thorleifsson, G (corresponding author), deCODE Genet, IS-101 Reykjavik, Iceland.	thorleif@decode.is; kstefans@decode.is	Jørgensen, Torben/Z-1335-2018; Kampman, E./H-8057-2014; Kiemeney, Lambertus A./D-3357-2009; Aben, Katja KH/G-9686-2016; Pedersen, Oluf/AAG-8015-2020; Verbeek, A.L.M./H-8103-2014; Stefansson, Kari/AAE-7187-2019; Pedersen, Oluf/Z-1731-2019; Walters, G. Bragi/L-4215-2013; Roeleveld, Nel/B-4242-2008	Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Verbeek, A.L.M./0000-0002-2319-5002; Pedersen, Oluf/0000-0002-3321-3972; Walters, G. Bragi/0000-0002-5415-6487; Roeleveld, Nel/0000-0002-3390-4466; Gudbjartsson, Daniel/0000-0002-5222-9857; Tryggvadottir, Laufey/0000-0001-8067-9030; Jorgensen, Torben/0000-0001-9453-2830; Kong, Augustine/0000-0001-8193-5438; Styrkarsdottir, Unnur/0000-0001-8146-8278; Steinthorsdottir, Valgerdur/0000-0003-1846-6274	NCRR NIH HHS [M01-RR000052] Funding Source: Medline; NHLBI NIH HHS [HL072518, HL087698] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072518, R01HL087698] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chouchane L, 2001, INT J OBESITY, V25, P462, DOI 10.1038/sj.ijo.0801545; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Ding XF, 2008, DNA CELL BIOL, V27, P257, DOI 10.1089/dna.2007.0662; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Gullicksen PS, 2003, APOPTOSIS, V8, P327, DOI 10.1023/A:1024112716024; Gunstad J, 2006, NEUROPSYCHOBIOLOGY, V53, P153, DOI 10.1159/000093341; Hamid YH, 2005, DIABETOLOGIA, V48, P445, DOI 10.1007/s00125-004-1659-1; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jamshidi Y, 2007, OBESITY, V15, P5, DOI 10.1038/oby.2007.637; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Jurvansuu J, 2008, CANCER RES, V68, P4614, DOI 10.1158/0008-5472.CAN-07-5291; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Parikh NI, 2007, AM J MED, V120, P242, DOI 10.1016/j.amjmed.2006.06.004; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schafer M, 2005, MOL CELL NEUROSCI, V29, P580, DOI 10.1016/j.mcn.2005.04.010; Sookoian SC, 2005, OBES RES, V13, P2122, DOI 10.1038/oby.2005.263; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	35	1011	1055	1	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					18	24		10.1038/ng.274	http://dx.doi.org/10.1038/ng.274			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079260				2022-12-25	WOS:000262085300012
J	Villani, AC; Lemire, M; Fortin, G; Louis, E; Silverberg, MS; Collette, C; Baba, N; Libioulle, C; Belaiche, J; Bitton, A; Gaudet, D; Cohen, A; Langelier, D; Fortin, PR; Wither, JE; Sarfati, M; Rutgeerts, P; Rioux, JD; Vermeire, S; Hudson, TJ; Franchimont, D				Villani, Alexandra-Chloe; Lemire, Mathieu; Fortin, Genevieve; Louis, Edouard; Silverberg, Mark S.; Collette, Catherine; Baba, Nobuyasu; Libioulle, Cecile; Belaiche, Jacques; Bitton, Alain; Gaudet, Daniel; Cohen, Albert; Langelier, Diane; Fortin, Paul R.; Wither, Joan E.; Sarfati, Marika; Rutgeerts, Paul; Rioux, John D.; Vermeire, Severine; Hudson, Thomas J.; Franchimont, Denis			Common variants in the NLRP3 region contribute to Crohn's disease susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; GENE; EXPRESSION; LOCI; ANTAGONIST; DIPEPTIDE; AUTOPHAGY; DISTINCT; MAPS	We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease. The associations were consistently replicated in four sample sets from individuals of European descent. In the combined analysis of all samples (710 father-mother-child trios, 239 cases and 107 controls), these SNPs were strongly associated with risk of Crohn's disease (P-combined = 3.49 x 10(-9), odds ratio 1.78, confidence interval = 1.47-2.16 for rs10733113), reaching a level consistent with the stringent significance thresholds imposed by whole-genome association studies. In addition, we observed significant associations between SNPs in the associated regions and NLRP3 expression and IL-1b production. Mutations in NLRP3 are known to be responsible for three rare autoinflammatory disorders(1,2). These results suggest that the NLRP3 region is also implicated in the susceptibility of more common inflammatory diseases such as Crohn's disease.	[Villani, Alexandra-Chloe] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Villani, Alexandra-Chloe] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Lemire, Mathieu; Hudson, Thomas J.] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Louis, Edouard; Libioulle, Cecile; Belaiche, Jacques] Univ Liege, CHU, Div Gastroenterol, B-4000 Liege, Belgium; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; [Baba, Nobuyasu; Sarfati, Marika] Univ Montreal, CHUM Res Ctr, Immunoregulat Lab, Montreal, PQ H2L 4M1, Canada; [Bitton, Alain] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3A 1A1, Canada; [Gaudet, Daniel] Univ Montreal, Hop Univ Chicoutimi, Ctr Med Genique Communautaire, Chicoutimi, PQ G7H 2B1, Canada; [Cohen, Albert] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Langelier, Diane] CHU Sherbrooke, Hotel Dieu, Sherbrooke, PQ J1G 2E8, Canada; [Fortin, Paul R.; Wither, Joan E.] Toronto Western Hosp, Res Inst, Arthritis Ctr Excellence, Toronto, ON M5T 2S8, Canada; [Fortin, Paul R.; Vermeire, Severine] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Franchimont, Denis] ULB, Erasme Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium	McGill University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Liege; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Universite de Montreal; McGill University; Royal Victoria Hospital; Universite de Montreal; McGill University; Laval University; University of Sherbrooke; University of Toronto; University Toronto Affiliates; University Health Network Toronto; KU Leuven; University Hospital Leuven; Universite de Montreal; Universite de Montreal; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Villani, AC (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Gastroenterol, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	alexandra-chloe.villani@mail.mcgill.ca; Denis.Franchimont@erasme.ulb.ac.be	Baba, Nobuyasu/AAF-8593-2019; Silverberg, Mark/B-4183-2008; Rioux, John D/A-9599-2015	Baba, Nobuyasu/0000-0001-9945-080X; Rioux, John D/0000-0001-7560-8326; Fortin, Paul R./0000-0002-7278-2596; Vermeire, Severine/0000-0001-9942-3019; Wither, Joan/0000-0001-5961-9228	Canada Foundation for Innovation; Canada Research Chair program; McGill University Health Centre; Crohn's & Colitis Foundation of Canada (CCFC); National Institute of Diabetes and Digestive and Kidney Diseases [DK624230]; National Institutes of Allergy and Infectious Diseases [AI065687, AI067152, DK064869, DK062432]; Crohn's and Colitis Foundation of America [SRA512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065687, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062423, R01DK064869, U01DK062432] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs); McGill University Health Centre; Crohn's & Colitis Foundation of Canada (CCFC); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the study participants and their families for their collaboration; A. Montpetit and the genotyping and sequencing platforms of the McGill University and Genome Quebec Innovation Centre for their technical assistance; T. McKenzie, G. Bonventi and C. Landolt-Maticorena for their help with acquisition and preparation of the PBCs; F. Martinon and J. Tschopp for their technical assistance in designing the functional studies; and T. Kwan for helpful discussion. This research was supported by grants to D. F. from the Canada Foundation for Innovation, the Canada Research Chair program, the Research Institute of the McGill University Health Centre and the Crohn's & Colitis Foundation of Canada (CCFC). A.- C. V. is supported by a PhD training award from the Fonds de la recherche en sante du Quebec. M. S. S. is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (DK624230), the CCFC and the Mount Sinai Hospital Gale and Graham Wright Research Chair in Digestive Diseases. J. D. R. is funded by grants from the National Institutes of Allergy and Infectious Diseases (AI065687 and AI067152), the National Institute of Diabetes and Digestive and Kidney Diseases (DK064869 and DK062432) and the Crohn's and Colitis Foundation of America (SRA512). E. L. is a senior research associate at the Belgium Foundation for Scientific Research (FNRS). S. V. is a clinical investigator for the Funds for Scientific Research of Flanders. T. J. H. is the recipient of an Investigator Award from the Ontario Institute for Cancer Research through funding from the Government of Ontario's Ministry of Research and Innovation. D. F. is a senior clinical scientist at the Belgium FNRS. None of the funding agencies had any role in the design and conduct of the study; in the collection, analysis and interpretation of the data; or in the preparation, review or approval of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bell PA, 2002, BIOTECHNIQUES, P70; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van den Boom Dirk, 2007, Methods Mol Biol, V366, P287; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8	30	394	400	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					71	76		10.1038/ng.285	http://dx.doi.org/10.1038/ng.285			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19098911	Green Submitted, Green Accepted			2022-12-25	WOS:000262085300018
J	Hashimoto, K; Aida, T				Hashimoto, Kazunori; Aida, Tomomi			Antibody patenting without antibodies: a global trend	NATURE BIOTECHNOLOGY			English	Editorial Material							GENES		[Hashimoto, Kazunori] Tokyo Med & Dent Univ, Sch Biomed Sci, Intellectual Property Div, Bunkyo Ku, Tokyo 1138510, Japan; [Aida, Tomomi] Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Mol Neurosci, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Hashimoto, K (corresponding author), Tokyo Med & Dent Univ, Sch Biomed Sci, Intellectual Property Div, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	hashimoto.tlo@tmd.ac.jp						Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; ASANO T, 2004, IIP B, V13, P78; Doll JJ, 1998, SCIENCE, V280, P689, DOI 10.1126/science.280.5364.689; Gaeta BA, 2007, BIOINFORMATICS, V23, P1580, DOI 10.1093/bioinformatics/btm147; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a; NISHI T, 2004, IIP B, V13, P154; Reichert J, 2004, NAT REV DRUG DISCOV, V3, P383, DOI 10.1038/nrd1386	10	1	1	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1341	1344		10.1038/nbt1208-1341	http://dx.doi.org/10.1038/nbt1208-1341			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19060868				2022-12-25	WOS:000261591300015
J	Jansson, M; Durant, ST; Cho, EC; Sheahan, S; Edelmann, M; Kessler, B; La Thangue, NB				Jansson, Martin; Durant, Stephen T.; Cho, Er-Chieh; Sheahan, Sharon; Edelmann, Mariola; Kessler, Benedikt; La Thangue, Nicholas B.			Arginine methylation regulates the p53 response	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; GENE-EXPRESSION; LI-FRAUMENI; COFACTOR; PATHWAY; TETRAMERIZATION; MUTATIONS; APOPTOSIS; MEDIATOR; TARGETS	Activation of the p53 tumour suppressor protein in response to DNA damage leads to apoptosis or cell-cycle arrest. Enzymatic modifications are widely believed to affect and regulate p53 activity. We describe here a level of post-translational control that has an important functional consequence on the p53 response. We show that the protein arginine methyltransferase (PRMT) 5, as a co-factor in a DNA damage responsive co-activator complex that interacts with p53, is responsible for methylating p53. Arginine methylation is regulated during the p53 response and affects the target gene specificity of p53. Furthermore, PRMT5 depletion triggers p53-dependent apoptosis. Thus, methylation on arginine residues is an underlying mechanism of control during the p53 response.	[Jansson, Martin; Durant, Stephen T.; Cho, Er-Chieh; Sheahan, Sharon; La Thangue, Nicholas B.] Univ Oxford, Canc Biol Lab, Dept Clin Pharmacol, Div Med Sci, Oxford OX3 7DQ, England; [Edelmann, Mariola; Kessler, Benedikt] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England	University of Oxford; University of Oxford	La Thangue, NB (corresponding author), Univ Oxford, Canc Biol Lab, Dept Clin Pharmacol, Div Med Sci, Old Rd Campus Res Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7DQ, England.	nick.lathangue@ndcls.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Jansson, Martin/0000-0002-6946-145X; Edelmann, Mariola/0000-0003-0459-7716	MRC; Cancer Research UK; EU; LRF; AICR; MRC [G0501068, G9400953, G0500905] Funding Source: UKRI; Medical Research Council [G9400953, G0500905, G0501068] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); EU(European Commission); LRF; AICR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the MRC, Cancer Research UK, EU, LRF and AICR for supporting this work, and Rosemary Williams for assistance in preparing the manuscript.	Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Coutts AS, 2005, BIOCHEM BIOPH RES CO, V331, P778, DOI 10.1016/j.bbrc.2005.03.150; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; Demonacos C, 2001, MOL CELL, V8, P71, DOI 10.1016/S1097-2765(01)00277-5; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; NISHI K, 1994, J BIOL CHEM, V269, P6320; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Zhao RB, 2000, GENE DEV, V14, P981	30	327	355	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1431	U122		10.1038/ncb1802	http://dx.doi.org/10.1038/ncb1802			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011621				2022-12-25	WOS:000261261800013
J	Vaughn, AE; Deshmukh, M				Vaughn, Allyson E.; Deshmukh, Mohanish			Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c	NATURE CELL BIOLOGY			English	Article							CASPASE ACTIVATION; DEATH; STATE; OXYGEN; SYSTEM; GLUTATHIONE; MECHANISM; RELEASE	Neurons and cancer cells use glucose extensively, yet the precise advantage of this adaptation remains unclear. These two seemingly disparate cell types also show an increased regulation of the apoptotic pathway, which allows for their long-term survival(1). Here we show that both neurons and cancer cells strictly inhibit cytochrome c-mediated apoptosis by a mechanism dependent on glucose metabolism. We report that the pro-apoptotic activity of cytochrome c is influenced by its redox state and that increases in reactive oxygen species (ROS) following an apoptotic insult lead to the oxidation and activation of cytochrome c. In healthy neurons and cancer cells, however, cytochrome c is reduced and held inactive by intracellular glutathione (GSH), generated as a result of glucose metabolism by the pentose phosphate pathway. These results uncover a striking similarity in apoptosis regulation between neurons and cancer cells and provide insight into an adaptive advantage offered by the Warburg effect for cancer cell evasion of apoptosis and for long-term neuronal survival.	[Vaughn, Allyson E.; Deshmukh, Mohanish] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Deshmukh, Mohanish] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Deshmukh, M (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Box 7250,115 Mason Farm Rd, Chapel Hill, NC 27599 USA.	mohanish@med.unc.edu			NIH [NS42197, GM078366, NS055486]; UNC Cancer Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042197, F31NS055486] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Cancer Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jeffery Rathmell, Gary Pielak, Eugene Johnson and members of the Deshmukh Lab for helpful discussions and critical review of this manuscript. This work was supported by NIH grants NS42197 and GM078366 ( to M. D.), NS055486 ( to A. E. V.) and by the UNC Cancer Research Fund.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Borutaite V, 2007, J BIOL CHEM, V282, P31124, DOI 10.1074/jbc.M700322200; Cai JY, 1999, J BIOENERG BIOMEMBR, V31, P327, DOI 10.1023/A:1005423818280; CARNEY JM, 1994, ANN NY ACAD SCI, V738, P44; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Doyle DF, 1996, BIOCHEMISTRY-US, V35, P7403, DOI 10.1021/bi960409u; Esposti MD, 2002, APOPTOSIS, V7, P433, DOI 10.1023/A:1020035124855; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Hampton MB, 1998, BIOCHEM J, V329, P95; Hancock JT, 2001, FREE RADICAL BIO MED, V31, P697, DOI 10.1016/S0891-5849(01)00646-3; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Kirkland RA, 2001, J NEUROSCI, V21, P1949, DOI 10.1523/JNEUROSCI.21-06-01949.2001; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kuo WY, 2000, INT J CANCER, V85, P857, DOI 10.1002/(SICI)1097-0215(20000315)85:6<857::AID-IJC20>3.3.CO;2-L; Li M, 2008, PROTEIN PEPTIDE LETT, V15, P200; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pan ZH, 1999, CELL DEATH DIFFER, V6, P683, DOI 10.1038/sj.cdd.4400544; Patel CN, 2001, PROTEIN EXPRES PURIF, V22, P220, DOI 10.1006/prep.2001.1438; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Suto D, 2005, BIOCHEM J, V392, P399, DOI 10.1042/BJ20050580; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084; Verhagen AM, 2002, APOPTOSIS, V7, P163, DOI 10.1023/A:1014318615955; Wang XD, 2001, GENE DEV, V15, P2922; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; YANG J, 1997, SCIENCE, V275, P1132; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	33	286	292	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1477	U228		10.1038/ncb1807	http://dx.doi.org/10.1038/ncb1807			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19029908	Green Submitted, Green Accepted			2022-12-25	WOS:000261261800020
J	Abd El-Aziz, MM; Barragan, I; O'Driscoll, CA; Goodstadt, L; Prigmore, E; Borrego, S; Mena, M; Pieras, JI; El-Ashry, MF; Abu Safieh, L; Shah, A; Cheetham, ME; Carter, NP; Chakarova, C; Ponting, CP; Bhattacharya, SS; Antinolo, G				Abd El-Aziz, Mai M.; Barragan, Isabel; O'Driscoll, Ciara A.; Goodstadt, Leo; Prigmore, Elena; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; El-Ashry, Mohamed F.; Abu Safieh, Leen; Shah, Amna; Cheetham, Michael E.; Carter, Nigel P.; Chakarova, Christina; Ponting, Chris P.; Bhattacharya, Shomi S.; Antinolo, Guillermo			EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa	NATURE GENETICS			English	Article							LOCUS; REFINEMENT; PHYLOGENY; EYES; 6Q	Using a positional cloning approach supported by comparative genomics, we have identified a previously unreported gene, EYS, at the RP25 locus on chromosome 6q12 commonly mutated in autosomal recessive retinitis pigmentosa. Spanning over 2 Mb, this is the largest eye-specific gene identified so far. EYS is independently disrupted in four other mammalian lineages, including that of rodents, but is well conserved from Drosophila to man and is likely to have a role in the modeling of retinal architecture.	[Abd El-Aziz, Mai M.; O'Driscoll, Ciara A.; El-Ashry, Mohamed F.; Abu Safieh, Leen; Shah, Amna; Chakarova, Christina; Bhattacharya, Shomi S.] Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; [Barragan, Isabel; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; Antinolo, Guillermo] Hosp Univ Virgen Rocio, Unidad Gest Clin Genet Reprod & Med Fetal, Seville 41013, Spain; [Barragan, Isabel; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; Antinolo, Guillermo] CIBERER, Seville, Spain; [Goodstadt, Leo; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3QX, England; [Prigmore, Elena; Carter, Nigel P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cheetham, Michael E.] Inst Ophthalmol, Div Mol & Cellular Neurosci, London EC1V 9EL, England; [Bhattacharya, Shomi S.] Univ Paris 06, INSERM U592, Inst Vis, UMR 592, Paris, France	University of London; University College London; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Oxford; Wellcome Trust Sanger Institute; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Bhattacharya, SS (corresponding author), Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England.	smbcssb@ucl.ac.uk; guillermo.antinolo.sspa@juntadeandalucia.es	Borrego, Salud/M-6314-2015; IBIS, GENETICA/P-3384-2015; IBIS, REPRODUCCION/P-3399-2015; Shah, Amna/C-4471-2013; Barragan, Isabel/AAJ-6532-2020; Chakarova, Christina/C-9479-2013; Ponting, Chris/AAV-2621-2021; Cheetham, Michael/B-4672-2011; Bhattacharya, Shom/N-2926-2016	Barragan, Isabel/0000-0002-8586-6502; Bhattacharya, Shom/0000-0002-1601-6344; Antinolo Gil, Guillermo/0000-0002-2113-074X; Mena, Marcela Daniela/0000-0002-8734-9031; Cheetham, Michael/0000-0001-6429-654X; Ponting, Chris/0000-0003-0202-7816	Fondo de Investigacion Sanitaria, Spain [PI050857]; Consejeria de Salud [PI-0334/2007]; Junta de Andalucia, Spain; British Retinitis Pigmentosa Society [GR556]; Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology; Special Trustees of Moorfields Eye Hospital London; UK Medical Research Council; EU-Neurotrain [MEST-CT-2005020235]; EU-GENORET [LSHG-CT-2005-512036]; Wellcome Trust; MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: researchfish	Fondo de Investigacion Sanitaria, Spain(Instituto de Salud Carlos III); Consejeria de Salud; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); British Retinitis Pigmentosa Society; Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology(National Institute for Health Research (NIHR)); Special Trustees of Moorfields Eye Hospital London; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU-Neurotrain; EU-GENORET; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the families who participated in the study. This study was funded by Fondo de Investigacion Sanitaria (PI050857), Spain; Consejeria de Salud (PI-0334/2007), Junta de Andalucia, Spain; British Retinitis Pigmentosa Society (grant ref. GR556); Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology, The Special Trustees of Moorfields Eye Hospital London; the UK Medical Research Council and EU-Neurotrain (grant ref. MEST-CT-2005020235); EU-GENORET (grant ref. LSHG-CT-2005-512036). The El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the Instituto de Salud Carlos III. N.P.C. and E. P. were supported by the Wellcome Trust. We would like also to thank R. Molday (University of British Columbia, Vancouver) for the gift of 1D4 antibody and G. Jeffery for his advice with immunohistochemistry.	Barragan I, 2008, ANN HUM GENET, V72, P454, DOI 10.1111/j.1469-1809.2008.00448.x; Barragan I, 2005, OPHTHALMIC RES, V37, P89, DOI 10.1159/000084250; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; El-Aziz MMA, 2008, ANN HUM GENET, V72, P463, DOI 10.1111/j.1469-1809.2008.00455.x; El-Aziz MMA, 2007, ANN HUM GENET, V71, P281, DOI 10.1111/j.1469-1809.2006.00333.x; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Khaliq S, 1999, AM J HUM GENET, V65, P571, DOI 10.1086/302493; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ruiz A, 1998, AM J HUM GENET, V62, P1452, DOI 10.1086/301866; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	13	140	143	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1285	1287		10.1038/ng.241	http://dx.doi.org/10.1038/ng.241			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836446	Green Accepted			2022-12-25	WOS:000260501500018
J	Li, HB; Guo, FL; Rubinstein, B; Li, R				Li, Hongbin; Guo, Fengli; Rubinstein, Boris; Li, Rong			Actin-driven chromosomal motility leads to symmetry breaking in mammalian meiotic oocytes	NATURE CELL BIOLOGY			English	Article							MOUSE OOCYTES; MECHANISM; SPINDLE; CYTOSKELETON; NETWORK; CELL; MICROTUBULES; MATURATION; FORMIN-2; COMPLEX	Movement of meiosis I (MI) chromosomes from the oocyte centre to a subcortical location is the first step in the establishment of cortical polarity. this is required for two consecutive rounds of asymmetric meiotic cell divisions, which generate a mature egg and two polar bodies(1). Here we use live-cell imaging and genetic and pharmacological manipulations to determine the force-generating mechanism underlying this chromosome movement. Chromosomes were observed to move toward the cortex in a pulsatile manner along a meandering path. this movement is not propelled by myosin-II-driven cortical flow but is associated with a cloud of dynamic actin filaments trailing behind the chromosomes/spindle. Formation of these filaments depends on the actin nucleation activity of Fmn2, a formin-family protein that concentrates around chromosomes through its amino-terminal region. symmetry breaking of the actin cloud relative to chromosomes, and net chromosome translocation toward the cortex require actin turnover.	[Li, Hongbin; Guo, Fengli; Rubinstein, Boris; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers-institute.org			Stowers Institute for Medical Research	Stowers Institute for Medical Research	We thank Roland Wedlich-Soldner (Max Plank Institute, Munich) for providing F-Lifeact peptide; Philip Leder (Harvard Medical School, Boston)) for Fmn2<SUP>-/-</SUP> mice and full-length Fmn2 cDNA; Marie-Helene Verlhac (Universite Paris VI, Paris) for pBluescript RN3 vector; Eric Jessen (Stowers Institute, Kansa City, applying to all persons mentioned hereafter) for help in site-directed mutagenesis; Rhonda Allen for electron microscopy; Xiaoxue Fan for help with actin preparation; Praveen Suraneni and Manqi Deng for help with the mouse work; Heather Marshall and Michael Durnin for training in oocyte dissection and microinjection; and Stowers Imaging Center for assistance with live imaging; Stacie Hughes for comments on the manuscript. This work was supported by funds to R. L. from the Stowers Institute for Medical Research.	Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Boggio EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000604; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; CAPCO DG, 1993, CELL MOTIL CYTOSKEL, V24, P85, DOI 10.1002/cm.970240202; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Fehrenbacher KL, 2003, TRENDS CELL BIOL, V13, P472, DOI 10.1016/S0962-8924(03)00174-0; Gobert GN, 2000, J ELECTRON MICROSC, V49, P539, DOI 10.1093/oxfordjournals.jmicro.a023841; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; LONGO E, 1985, J THEOR BIOL, V112, P783, DOI 10.1016/S0022-5193(85)80061-8; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Miyazaki A, 2005, DEV BIOL, V280, P237, DOI 10.1016/j.ydbio.2005.01.026; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Simerly C, 1998, MOL BIOL CELL, V9, P2509, DOI 10.1091/mbc.9.9.2509; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Verlhac MH, 2008, MOL CELL ENDOCRINOL, V282, P12, DOI 10.1016/j.mce.2007.11.018; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Yang HY, 2005, J CELL BIOL, V169, P447, DOI 10.1083/jcb.200411132	30	119	121	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1301	U101		10.1038/ncb1788	http://dx.doi.org/10.1038/ncb1788			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836438				2022-12-25	WOS:000260586700012
J	Chen, ST; Dou, JH; Temple, R; Agarwal, R; Wu, KM; Walker, S				Chen, Shaw T.; Dou, Jinhui; Temple, Robert; Agarwal, Rajiv; Wu, Kuei-Meng; Walker, Susan			New therapies from old medicines	NATURE BIOTECHNOLOGY			English	Editorial Material							ST-JOHNS-WORT; RANDOMIZED CONTROLLED TRIAL; MAJOR DEPRESSION; DOUBLE-BLIND; TEA; EFFICACY; PLACEBO; EXTRACT		[Agarwal, Rajiv; Wu, Kuei-Meng; Walker, Susan] US FDA, Ctr Drug Evaluat & Res, Div Dermatol & Dent Prod, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)		shaw.chen@fda.hhs.gov						Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807; Gloro R, 2005, EUR J GASTROEN HEPAT, V17, P1135, DOI 10.1097/00042737-200510000-00021; JIANG X, 1977, ENCY CHINESE MAT MED; Kasper S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-14; Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b; Lindenmuth GF, 2000, J ALTERN COMPLEM MED, V6, P327, DOI 10.1089/10755530050120691; MURAYAMA M, 1991, J ETHNOPHARMACOL, V35, P159, DOI 10.1016/0378-8741(91)90068-O; Nakachi K, 2003, AGEING RES REV, V2, P1, DOI 10.1016/S1568-1637(02)00047-8; Shelton RC, 2001, JAMA-J AM MED ASSOC, V285, P1978, DOI 10.1001/jama.285.15.1978; Stevens T, 2005, ANN INTERN MED, V142, P477, DOI 10.7326/0003-4819-142-6-200503150-00026; Turner RB, 2005, NEW ENGL J MED, V353, P341, DOI 10.1056/NEJMoa044441; *US FDA CTR DRUG E, 2004, GUID IND BOT DRUG PR; Wu KM, 2000, TOXICOL LETT, V111, P199, DOI 10.1016/S0378-4274(99)00152-6; Wu Kuei-Meng, 2004, Am J Ther, V11, P213, DOI 10.1097/00045391-200405000-00010	14	70	77	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1077	1083		10.1038/nbt1008-1077	http://dx.doi.org/10.1038/nbt1008-1077			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18846070	Green Published			2022-12-25	WOS:000259926000014
J	Le Goff, C; Morice-Picard, F; Dagoneau, N; Wang, LW; Perrot, C; Crow, YJ; Bauer, F; Flori, E; Prost-Squarcioni, C; Krakow, D; Ge, GX; Greenspan, DS; Bonnet, D; Le Merrer, M; Munnich, A; Apte, SS; Cormier-Daire, V				Le Goff, Carine; Morice-Picard, Fanny; Dagoneau, Nathalie; Wang, Lauren W.; Perrot, Claire; Crow, Yanick J.; Bauer, Florence; Flori, Elisabeth; Prost-Squarcioni, Catherine; Krakow, Deborah; Ge, Gaoxiang; Greenspan, Daniel S.; Bonnet, Damien; Le Merrer, Martine; Munnich, Arnold; Apte, Suneel S.; Cormier-Daire, Valerie			ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation	NATURE GENETICS			English	Article							GLYCOPROTEIN; ACTIVATION	Geleophysic dysplasia is an autosomal recessive disorder characterized by short stature, brachydactyly, thick skin and cardiac valvular anomalies often responsible for an early death. Studying six geleophysic dysplasia families, we first mapped the underlying gene to chromosome 9q34.2 and identified five distinct nonsense and missense mutations in ADAMTSL2 (a disintegrin and metalloproteinase with thrombospondin repeats-like 2), which encodes a secreted glycoprotein of unknown function. Functional studies in HEK293 cells showed that ADAMTSL2 mutations lead to reduced secretion of the mutated proteins, possibly owing to the misfolding of ADAMTSL2. A yeast two-hybrid screen showed that ADAMTSL2 interacts with latent TGF-beta-binding protein 1. In addition, we observed a significant increase in total and active TGF-beta in the culture medium as well as nuclear localization of phosphorylated SMAD2 in fibroblasts from individuals with geleophysic dysplasia. These data suggest that ADAMTSL2 mutations may lead to a dysregulation of TGF-beta signaling and may be the underlying mechanism of geleophysic dysplasia.	[Le Goff, Carine; Morice-Picard, Fanny; Dagoneau, Nathalie; Perrot, Claire; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, Dept Genet, Unite INSERM U781, Hop Necker Enfants Malad,AP HP, F-75015 Paris, France; [Wang, Lauren W.; Apte, Suneel S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Crow, Yanick J.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England; [Bauer, Florence] Clin Paofai, Papeete, Tahiti, France; [Flori, Elisabeth] Hop Hautepierre, Dept Genet, F-67000 Strasbourg, France; [Prost-Squarcioni, Catherine] Hop Avicennes, Fac Med, CNRS, UPRES 3410, F-93000 Bobigny, France; [Krakow, Deborah] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Ge, Gaoxiang; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Bonnet, Damien] Hop Necker Enfants Malad, Serv Cardiol Pediat, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Saint James's University Hospital; University of Leeds; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Cedars Sinai Medical Center; University of Wisconsin System; University of Wisconsin Madison; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, Dept Genet, Unite INSERM U781, Hop Necker Enfants Malad,AP HP, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Le Goff, Carine/N-9940-2017; MORICE-PICARD, Fanny/M-5125-2014; Crow, Yanick J/N-6120-2014; Krakow, Deborah/B-5778-2009; LE GOFF, Carine/AAG-2390-2020; cormier-daire, valerie/H-6520-2017	Crow, Yanick J/0000-0001-7211-7564; Krakow, Deborah/0000-0001-9906-4968; LE GOFF, Carine/0000-0002-7788-708X; Apte, Suneel/0000-0001-8441-1226; cormier-daire, valerie/0000-0002-2839-9856; Greenspan, Daniel/0000-0001-8096-7446	French National Research Agency (ANR) [R06215KS]; Medical Research Foundation; US National Institutes of Health; NIH [GM71679, HD22657]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071679] Funding Source: NIH RePORTER	French National Research Agency (ANR)(French National Research Agency (ANR)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Kazusa DNA Research Institute for providing the KIAA0605 cDNA. We thank J. Martinovic for her help. We also thank T. Arai and M. Papouin. The work presented here was supported by French National Research Agency (ANR) award R06215KS (to V.C.-D.), the Medical Research Foundation (FRM, to C.L.G.), US National Institutes of Health (NIH) award AR53890 (to S.S.A.), NIH award GM71679 (to D.S.G.) and NIH award HD22657 (to D.K.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Collod-Beroud G, 2002, EUR J HUM GENET, V10, P673, DOI 10.1038/sj.ejhg.5200876; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jones KB, 2005, SPINE, V30, P291, DOI 10.1097/01.brs.0000152166.88174.1c; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pontz BF, 1996, AM J MED GENET, V63, P50, DOI 10.1002/(SICI)1096-8628(19960503)63:1<50::AID-AJMG11>3.0.CO;2-T; SHOHAT M, 1990, J PEDIATR-US, V117, P227, DOI 10.1016/S0022-3476(05)80534-7; Sinha S, 1998, MATRIX BIOL, V17, P529, DOI 10.1016/S0945-053X(98)90106-8; SPRANGER JW, 1971, LANCET, V2, P97; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200	20	159	162	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1119	1123		10.1038/ng.199	http://dx.doi.org/10.1038/ng.199			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18677313	Green Accepted			2022-12-25	WOS:000258761200027
J	Wang, Z; Gu, C; Colby, T; Shindo, T; Balamurugan, R; Waldmann, H; Kaiser, M; van der Hoorn, RAL				Wang, Zheming; Gu, Christian; Colby, Tom; Shindo, Takayuki; Balamurugan, Rengarajan; Waldmann, Herbert; Kaiser, Markus; van der Hoorn, Renier A. L.			beta-Lactone probes identify a papain-like peptide ligase in Arabidopsis thaliana	NATURE CHEMICAL BIOLOGY			English	Article							CYSTEINE PROTEASE; SERINE; PROTEINASE; INHIBITORS; DISCOVERY; EFFECTOR; REVEALS; FAMILY; CELLS; GENE	New activity-based probes are essential for expanding studies on the hundreds of serine and cysteine proteases encoded by the genome of Arabidopsis thaliana. To monitor protease activities in plant extracts, we generated biotinylated peptides containing a beta-lactone reactive group. These probes cause strong labeling in leaf proteomes. Unexpectedly, labeling was detected at the N terminus of PsbP, nonproteolytic protein of photosystem II. Inhibitor studies and reverse genetics led to the discovery that this unusual modification is mediated by a single plant-specific, papain-like protease called RD21. In cellular extracts, RD21 accepts both beta-lactone probes and peptides as donor molecules and ligates them, probably through a thioester intermediate, to unmodified N termini of acceptor proteins.	[Wang, Zheming; Gu, Christian; Shindo, Takayuki; van der Hoorn, Renier A. L.] Max Planck Inst Plant Breeding Res, Plant Chemet Lab, D-50829 Cologne, Germany; [Wang, Zheming; Kaiser, Markus; van der Hoorn, Renier A. L.] Chem Genom Ctr, Max Planck Soc, D-44227 Dortmund, Germany; [Colby, Tom] Max Planck Inst Plant Breeding Res, Prote Serv Ctr, D-50829 Cologne, Germany; [Balamurugan, Rengarajan; Waldmann, Herbert] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Balamurugan, Rengarajan] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; University of Hyderabad	van der Hoorn, RAL (corresponding author), Max Planck Inst Plant Breeding Res, Plant Chemet Lab, Carl von Linne Weg 10, D-50829 Cologne, Germany.	hoorn@mpiz-koeln.mpg.de	van der Hoorn, Renier/E-5346-2011; Balamurugan, Rengarajan/X-9584-2018; Waldmann, Herbert/B-7406-2017; van der Hoorn, Renier/AAU-1005-2020	Balamurugan, Rengarajan/0000-0002-8373-5736; Waldmann, Herbert/0000-0002-9606-7247; van der Hoorn, Renier/0000-0002-3692-7487	International Max Planck Research School; Deutsche Forschungsgemeinschaft; Alexander von Humboldt Foundation; Max Planck Society	International Max Planck Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank C. MacKintosh (University of Dundee) for providing the antibodies to RD21 and C. Koncz (Max Planck Institute for Plant Breeding Research) for providing the rd21B knockout. This work was supported by the International Max Planck Research School (to C. G. and T. S.), the Arabidopsis Functional Genomics Netwerk of the Deutsche Forschungsgemeinschaft (to T. C.), the Alexander von Humboldt Foundation (to R. B.) and the Max Planck Society (to Z. W., R. B., H. W., M. K. and R. A. L. v. d. H.).	Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; CHANG TK, 1994, P NATL ACAD SCI USA, V91, P12544, DOI 10.1073/pnas.91.26.12544; Clemens S, 2006, J PLANT PHYSIOL, V163, P319, DOI 10.1016/j.jplph.2005.11.010; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dick LR, 1997, J BIOL CHEM, V272, P182; Drahl C, 2005, ANGEW CHEM INT EDIT, V44, P5788, DOI 10.1002/anie.200500900; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fonovic M, 2007, CURR PHARM DESIGN, V13, P253, DOI 10.2174/138161207779313623; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Lall MS, 1999, ORG LETT, V1, P803, DOI 10.1021/ol990148r; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lombard C, 2005, PROTEIN PEPTIDE LETT, V12, P621, DOI 10.2174/0929866054696118; Mahrus S, 2005, CHEM BIOL, V12, P567, DOI 10.1016/j.chembiol.2005.03.006; Pan ZY, 2006, BIOORG MED CHEM LETT, V16, P2882, DOI 10.1016/j.bmcl.2006.03.012; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; TABAEIZADEH Z, 1995, PROTOPLASMA, V186, P208, DOI 10.1007/BF01281331; Tan XH, 2008, CHEMBIOCHEM, V9, P1052, DOI 10.1002/cbic.200700740; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200	38	62	68	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2008	4	9					557	563		10.1038/nchembio.104	http://dx.doi.org/10.1038/nchembio.104			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	339SN	18660805				2022-12-25	WOS:000258597700014
J	Swarup, K; Benkova, E; Swarup, R; Casimiro, I; Peret, B; Yang, Y; Parry, G; Nielsen, E; De Smet, I; Vanneste, S; Levesque, MP; Carrier, D; James, N; Calvo, V; Ljung, K; Kramer, E; Roberts, R; Graham, N; Marillonnet, S; Patel, K; Jones, JDG; Taylor, CG; Schachtman, DP; May, S; Sandberg, G; Benfey, P; Friml, J; Kerr, I; Beeckman, T; Laplaze, L; Bennett, MJ				Swarup, Kamal; Benkova, Eva; Swarup, Ranjan; Casimiro, Ilda; Peret, Benjamin; Yang, Yaodong; Parry, Geraint; Nielsen, Erik; De Smet, Ive; Vanneste, Steffen; Levesque, Mitch P.; Carrier, David; James, Nicholas; Calvo, Vanessa; Ljung, Karin; Kramer, Eric; Roberts, Rebecca; Graham, Neil; Marillonnet, Sylvestre; Patel, Kanu; Jones, Jonathan D. G.; Taylor, Christopher G.; Schachtman, Daniel P.; May, Sean; Sandberg, Goran; Benfey, Philip; Friml, Jiri; Kerr, Ian; Beeckman, Tom; Laplaze, Laurent; Bennett, Malcolm J.			The auxin influx carrier LAX3 promotes lateral root emergence	NATURE CELL BIOLOGY			English	Article							CULTURED TOBACCO CELLS; ARABIDOPSIS-THALIANA; GENE; TRANSPORT; INITIATION; ORGANIZATION; EXPRESSION; MUTATIONS	Lateral roots originate deep within the parental root from a small number of founder cells at the periphery of vascular tissues and must emerge through intervening layers of tissues. We describe how the hormone auxin, which originates from the developing lateral root, acts as a local inductive signal which re-programmes adjacent cells. Auxin induces the expression of a previously uncharacterized auxin influx carrier LAX3 in cortical and epidermal cells directly overlaying new primordia. Increased LAX3 activity reinforces the auxin-dependent induction of a selection of cell-wall-remodelling enzymes, which are likely to promote cell separation in advance of developing lateral root primordia.	[Swarup, Kamal; Swarup, Ranjan; Parry, Geraint; Carrier, David; James, Nicholas; Roberts, Rebecca; Graham, Neil; May, Sean; Bennett, Malcolm J.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; [Benkova, Eva; Friml, Jiri] Univ Tubingen, ZMBP, D-72074 Tubingen, Germany; [Casimiro, Ilda; Calvo, Vanessa] Univ Extremadura, Fac Ciencias, Badajoz, Spain; [Peret, Benjamin; Laplaze, Laurent] INRA, IRD, UMR DiA PC, Agro M,UM2, F-34394 Montpellier 5, France; [Yang, Yaodong; Nielsen, Erik; Taylor, Christopher G.; Schachtman, Daniel P.] Donald Danforth Plant Sci Ctr, St Louis, MO 63122 USA; [Benkova, Eva; De Smet, Ive; Vanneste, Steffen; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Levesque, Mitch P.; Benfey, Philip] Duke Univ, Dept Biol, Durham, NC USA; [Levesque, Mitch P.; Benfey, Philip] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Carrier, David; Kerr, Ian] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England; [Ljung, Karin] SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; [Kramer, Eric] Simons Rock Coll, Dept Phys, Great Barrington, MA 01201 USA; [Marillonnet, Sylvestre; Patel, Kanu; Jones, Jonathan D. G.] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England; [Sandberg, Goran] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; [Parry, Geraint] Indiana Univ, Dept Biol, Bloomington, IN USA; [De Smet, Ive] Univ Tubingen, ZMBP Entwicklungsgenet, D-72074 Tubingen, Germany; [Levesque, Mitch P.] Max Planck Inst Dev Biol, Tubingen, Germany	University of Nottingham; Eberhard Karls University of Tubingen; Universidad de Extremadura; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Donald Danforth Plant Science Center; Flanders Institute for Biotechnology (VIB); Ghent University; Duke University; Duke University; University of Nottingham; Swedish University of Agricultural Sciences; Umea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Umea University; Indiana University System; Indiana University Bloomington; Eberhard Karls University of Tubingen; Max Planck Society	Bennett, MJ (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.	malcolm.bennett@nottingham.ac.uk	Friml, Jiri/D-9511-2012; Vanneste, Steffen/K-8353-2013; Benkova, Eva/E-2910-2012; may, sean t/B-6838-2012; Graham, Neil/C-5489-2008; Kerr, Ian D/B-3803-2015; Jones, Jonathan DG/J-5129-2012; Laplaze, Laurent/I-5435-2016; Kramer, Eric M/B-9752-2008; Yang, Yaodong/L-8445-2019; Beeckman, Tom/ABA-1164-2020; Nielsen, Erik/G-5843-2013; Ljung, Karin/AAE-8691-2019; Beeckman, Tom/ABI-1703-2020; Casimiro, Ilda/R-3506-2019; Taylor, Christopher/E-4508-2012; De Smet, Ive/A-6583-2011; De Smet, Ive/E-6086-2011; Bennett, Malcolm/G-4004-2010	Friml, Jiri/0000-0002-8302-7596; Vanneste, Steffen/0000-0002-9948-9672; may, sean t/0000-0001-5282-3250; Graham, Neil/0000-0001-9080-8967; Kerr, Ian D/0000-0002-7544-8454; Jones, Jonathan DG/0000-0002-4953-261X; Laplaze, Laurent/0000-0002-6568-6504; Yang, Yaodong/0000-0002-6599-5665; Ljung, Karin/0000-0003-2901-189X; Beeckman, Tom/0000-0001-8656-2060; De Smet, Ive/0000-0003-4607-8893; De Smet, Ive/0000-0003-4607-8893; swarup, Ranjan/0000-0002-6438-9188; Schachtman, Daniel/0000-0003-1807-4369; Bennett, Malcolm/0000-0003-0475-390X; Kramer, Eric/0000-0002-1424-2356; PERET, Benjamin/0000-0003-1336-0796	Biotechnology and Biological Sciences Research Council [BB/C514958/1, BB/D019613/1, REI20541, BB/E022758/1, G17764, BB/E01772X/1, G18881, BBS/B/1356X] Funding Source: Medline; BBSRC [BB/E022758/1, BB/D019613/1, BB/E01772X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Beeckman T., 1994, Plant Molecular Biology Reporter, V12, P37, DOI 10.1007/BF02668662; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dharmasiri S, 2006, SCIENCE, V312, P1218, DOI 10.1126/science.1122847; DOLAN L, 1993, DEVELOPMENT, V119, P71; Dubrovsky J.G., 2003, ENCY APPL PLANT SCI, P1101; Dubrovsky JG, 2001, PLANTA, V214, P30, DOI 10.1007/s004250100598; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hochholdinger F, 2004, TRENDS PLANT SCI, V9, P42, DOI 10.1016/j.tplants.2003.11.003; Imhoff V, 2000, PLANTA, V210, P580, DOI 10.1007/s004250050047; Ivanchenko MG, 2006, PLANT J, V46, P436, DOI 10.1111/j.1365-313X.2006.02702.x; KARLINNEUMANN GA, 1991, PLANT CELL, V3, P573, DOI 10.1105/tpc.3.6.573; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Laskowski M, 2006, PLANT CELL PHYSIOL, V47, P788, DOI 10.1093/pcp/pcj043; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; LLORET PG, 2002, LATERAL ROOT INITIAT; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; Marin-Rodriguez MC, 2002, J EXP BOT, V53, P2115, DOI 10.1093/jxb/erf089; Neuteboom LW, 1999, PLANT MOL BIOL, V39, P273, DOI 10.1023/A:1006104205959; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Tian Q, 1999, DEVELOPMENT, V126, P711; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vissenberg K, 2005, J EXP BOT, V56, P673, DOI 10.1093/jxb/eri048; Wen F, 2006, ANN PLANT REV, V25, P91; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029	40	542	566	6	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					946	954		10.1038/ncb1754	http://dx.doi.org/10.1038/ncb1754			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18622388				2022-12-25	WOS:000258147100012
J	Lutz, B; Monory, K				Lutz, Beat; Monory, Krisztina			Soothing the seizures of children	NATURE MEDICINE			English	Editorial Material							ENDOCANNABINOID SYSTEM; FEBRILE SEIZURES; PLASTICITY; HIPPOCAMPUS		[Lutz, Beat; Monory, Krisztina] Johannes Gutenberg Univ Mainz, Dept Phys Chem, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Lutz, B (corresponding author), Johannes Gutenberg Univ Mainz, Dept Phys Chem, Duesbergweg 6, D-55099 Mainz, Germany.	blutz@uni-mainz.de	Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022					Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006	7	9	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					721	722		10.1038/nm0708-721	http://dx.doi.org/10.1038/nm0708-721			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18607372				2022-12-25	WOS:000257452700018
J	Deng, J; Shoemaker, R; Xie, B; Gore, A; LeProust, EM; Antosiewicz-Bourget, J; Egli, D; Maherali, N; Park, IH; Yu, JY; Daley, GQ; Eggan, K; Hochedlinger, K; Thomson, J; Wang, W; Gao, Y; Zhang, K				Deng, Jie; Shoemaker, Robert; Xie, Bin; Gore, Athurva; LeProust, Emily M.; Antosiewicz-Bourget, Jessica; Egli, Dieter; Maherali, Nimet; Park, In-Hyun; Yu, Junying; Daley, George Q.; Eggan, Kevin; Hochedlinger, Konrad; Thomson, James; Wang, Wei; Gao, Yuan; Zhang, Kun			Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming	NATURE BIOTECHNOLOGY			English	Article							SOMATIC-CELLS; PLURIPOTENT; EPIGENOME; MAPS	Current DNA methylation assays are limited in the flexibility and efficiency of characterizing a large number of genomic targets. We report a method to specifically capture an arbitrary subset of genomic targets for single-molecule bisulfite sequencing for digital quantification of DNA methylation at single-nucleotide resolution. A set of similar to 30,000 padlock probes was designed to assess methylation of similar to 66,000 CpG sites within 2,020 CpG islands on human chromosome 12, chromosome 20, and 34 selected regions. To investigate epigenetic differences associated with dedifferentiation, we compared methylation in three human fibroblast lines and eight human pluripotent stem cell lines. Chromosome-wide methylation patterns were similar among all lines studied, but cytosine methylation was slightly more prevalent in the pluripotent cells than in the fibroblasts. Induced pluripotent stem (iPS) cells appeared to display more methylation than embryonic stem cells. We found 288 regions methylated differently in fibroblasts and pluripotent cells. This targeted approach should be particularly useful for analyzing DNA methylation in large genomes.	[Deng, Jie; Gore, Athurva; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Shoemaker, Robert; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Xie, Bin; Gao, Yuan] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Gao, Yuan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA; [LeProust, Emily M.] Agilent Technol, Genom Solut Unit, Santa Clara, CA USA; [Antosiewicz-Bourget, Jessica; Yu, Junying; Thomson, James] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Egli, Dieter; Eggan, Kevin] Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Egli, Dieter; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Maherali, Nimet; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Maherali, Nimet; Hochedlinger, Konrad] Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA USA; [Park, In-Hyun; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Virginia Commonwealth University; Virginia Commonwealth University; Agilent Technologies; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Stowers Institute for Medical Research; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Zhang, K (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	ygao@vcu.edu; kzhang@bioeng.ucsd.edu	Gao, Yuan/E-1706-2011; Eggan, Kevin/P-7119-2018; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224	NIDA NIH HHS [R01-DA025779, R01 DA025779, R01 DA025779-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	31	370	451	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					353	360		10.1038/nbt.1530	http://dx.doi.org/10.1038/nbt.1530			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19330000	Green Accepted, Green Submitted			2022-12-25	WOS:000264971800021
J	Ho, CH; Magtanong, L; Barker, SL; Gresham, D; Nishimura, S; Natarajan, P; Koh, JLY; Porter, J; Gray, CA; Andersen, RJ; Giaever, G; Nislow, C; Andrews, B; Botstein, D; Graham, TR; Yoshida, M; Boone, C				Ho, Cheuk Hei; Magtanong, Leslie; Barker, Sarah L.; Gresham, David; Nishimura, Shinichi; Natarajan, Paramasivam; Koh, Judice L. Y.; Porter, Justin; Gray, Christopher A.; Andersen, Raymond J.; Giaever, Guri; Nislow, Corey; Andrews, Brenda; Botstein, David; Graham, Todd R.; Yoshida, Minoru; Boone, Charles			A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; SPONGE THEONELLA SP; ELONGATION-FACTOR 2; DELETION MUTANTS; 1,3-BETA-D-GLUCAN SYNTHASE; CYCLOHEXIMIDE RESISTANCE; OVEREXPRESSION STRAINS; MAMMALIAN PROTEIN; ORDERED ARRAYS; GENE-DELETION	We present a yeast chemical-genomics approach designed to identify genes that when mutated confer drug resistance, thereby providing insight about the modes of action of compounds. We developed a molecular barcoded yeast open reading frame (MoBY-ORF) library in which each gene, controlled by its native promoter and terminator, is cloned into a centromere-based vector along with two unique oligonucleotide barcodes. The MoBY-ORF resource has numerous genetic and chemical-genetic applications, but here we focus on cloning wild-type versions of mutant drug-resistance genes using a complementation strategy and on simultaneously assaying the fitness of all transformants with barcode microarrays. The complementation cloning was validated by mutation detection using whole-genome yeast tiling microarrays, which identified unique polymorphisms associated with a drug-resistant mutant. We used the MoBY-ORF library to identify the genetic basis of several drug-resistant mutants and in this analysis discovered a new class of sterol-binding compounds.	[Ho, Cheuk Hei; Magtanong, Leslie; Barker, Sarah L.; Koh, Judice L. Y.; Giaever, Guri; Nislow, Corey; Andrews, Brenda; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ho, Cheuk Hei; Magtanong, Leslie; Barker, Sarah L.; Koh, Judice L. Y.; Giaever, Guri; Nislow, Corey; Andrews, Brenda; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Gresham, David; Botstein, David] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Nishimura, Shinichi; Yoshida, Minoru; Boone, Charles] RIKEN, Chem Genet Lab, Chem Genom Res Grp, Adv Sci Inst, Saitama, Japan; [Nishimura, Shinichi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Natarajan, Paramasivam; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Porter, Justin; Gray, Christopher A.; Andersen, Raymond J.] Univ British Columbia, Dept Chem Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; Princeton University; RIKEN; Kyoto University; Vanderbilt University; University of British Columbia; University of Toronto	Boone, C (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	yoshidam@riken.jp; charlie.boone@utoronto.ca	Nishimura, Shinichi/AGE-1316-2022; Yoshida, Minoru/C-8049-2014; Giaever, Guri/D-3930-2009	Nishimura, Shinichi/0000-0002-5998-3780; Yoshida, Minoru/0000-0002-4376-5674; Nislow, Corey/0000-0002-4016-8874	NSERC; NHGRI [MOP-84305, MOP-81340]; NIGMS Center for Quantitative Biology [GM071508, R01 (GM046406)]; National Institutes of Health [GM62637]; Energy and Industrial Technology Development Organization (NEDO); Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health [MOP-57830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM046406, R37GM046406] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS Center for Quantitative Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ontario Genomics Institute; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Smith and L. Heisler for advice on the data analysis of barcode microarray and A. Ward for technical assistance with the YTM experiments. We thank B. Sheikh for primer design, diagnostic digest predictions and sequencing scripts. We thank K. Toufighi for data analysis of liposome leakage experiments. Theonellamide was a kind gift from S. Matsunaga (Graduate School of Agricultural and Life Sciences, The University of Tokyo). L. M. was supported by a Canadian Institutes of Health Research Doctoral Research Award. R. J. A. was supported by a research grant from NSERC. C. N. was supported by NHGRI (MOP-84305). G. G. was supported by NHGRI (MOP-81340). D. B. was supported by NIGMS Center for Quantitative Biology (GM071508) and R01 (GM046406). T. R. G. was supported by National Institutes of Health (GM62637). M. Y. and S. N. were supported by an Energy and Industrial Technology Development Organization (NEDO) project on development of basic technology to control biological systems using chemical compounds. C. B. was supported by Genome Canada through the Ontario Genomics Institute as per research agreement 2004-OGI-3-01 and Canadian Institutes of Health Research agreement number MOP-57830.	ARNESON PA, 1968, PLANT PHYSIOL, V43, P683, DOI 10.1104/pp.43.5.683; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; BEWLEY CA, 1994, J ORG CHEM, V59, P4849, DOI 10.1021/jo00096a028; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Butcher RA, 2006, NAT CHEM BIOL, V2, P103, DOI 10.1038/nchembio762; Butcher RA, 2006, NAT PROTOC, V1, P569, DOI 10.1038/nprot.2006.80; Capa L, 1998, ANTIMICROB AGENTS CH, V42, P2694, DOI 10.1128/AAC.42.10.2694; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; COVAL SJ, 1995, J ANTIBIOT, V48, P1171, DOI 10.7164/antibiotics.48.1171; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; DOUGLAS CM, 1994, J BACTERIOL, V176, P5686, DOI 10.1128/JB.176.18.5686-5696.1994; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; FRIED HM, 1982, NUCLEIC ACIDS RES, V10, P3133, DOI 10.1093/nar/10.10.3133; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; HAUSER D, 1971, HELV CHIM ACTA, V54, P1178, DOI 10.1002/hlca.19710540427; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Jorgensen P, 2002, GENETICS, V162, P1091; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; KANIKENNULAT C, 1995, GENETICS, V140, P933; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; KEUKENS EAJ, 1992, BIOCHIM BIOPHYS ACTA, V1110, P127, DOI 10.1016/0005-2736(92)90349-Q; KITAGAWA I, 1981, CHEM PHARM BULL, V29, P2387; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; LIU YX, 1994, CANCER RES, V54, P2943; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; MATSUNAGA S, 1995, J ORG CHEM, V60, P1177, DOI 10.1021/jo00110a020; MATSUNAGA S, 1989, J AM CHEM SOC, V111, P2582, DOI 10.1021/ja00189a035; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Ott RG, 2005, BBA-MOL CELL BIOL L, V1735, P111, DOI 10.1016/j.bbalip.2005.05.003; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simons V, 2006, ANTIMICROB AGENTS CH, V50, P2732, DOI 10.1128/AAC.00289-06; SMITH V, 1995, P NATL ACAD SCI USA, V92, P6479, DOI 10.1073/pnas.92.14.6479; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Wiesen KM, 2007, CANCER LETT, V257, P227, DOI 10.1016/j.canlet.2007.07.022; Williams DE, 2005, J NAT PROD, V68, P327, DOI 10.1021/np049711r; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yan Z, 2008, NAT METHODS, V5, P719, DOI 10.1038/nmeth.1231	60	186	188	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					369	377		10.1038/nbt.1534	http://dx.doi.org/10.1038/nbt.1534			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19349972	Green Accepted			2022-12-25	WOS:000264971800023
J	Northcott, PA; Nakahara, Y; Wu, XC; Feuk, L; Ellison, DW; Croul, S; Mack, S; Kongkham, PN; Peacock, J; Dubuc, A; Ra, YS; Zilberberg, K; Mcleod, J; Scherer, SW; Rao, JS; Eberhart, CG; Grajkowska, W; Gillespie, Y; Lach, B; Grundy, R; Pollack, IF; Hamilton, RL; Van Meter, T; Carlotti, CG; Boop, F; Bigner, D; Gilbertson, RJ; Rutka, JT; Taylor, MD				Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Feuk, Lars; Ellison, David W.; Croul, Sid; Mack, Stephen; Kongkham, Paul N.; Peacock, John; Dubuc, Adrian; Ra, Young-Shin; Zilberberg, Karen; Mcleod, Jessica; Scherer, Stephen W.; Rao, J. Sunil; Eberhart, Charles G.; Grajkowska, Wiesia; Gillespie, Yancey; Lach, Boleslaw; Grundy, Richard; Pollack, Ian F.; Hamilton, Ronald L.; Van Meter, Timothy; Carlotti, Carlos G.; Boop, Frederick; Bigner, Darrell; Gilbertson, Richard J.; Rutka, James T.; Taylor, Michael D.			Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SMALL-MOLECULE INHIBITOR; CEREBELLAR DEVELOPMENT; COMPLEX; CELLS; DIFFERENTIATION; ABNORMALITIES; TRANSCRIPTION; LEUKEMIA; PROTEIN	We used high-resolution SNP genotyping to identify regions of genomic gain and loss in the genomes of 212 medulloblastomas, malignant pediatric brain tumors. We found focal amplifications of 15 known oncogenes and focal deletions of 20 known tumor suppressor genes (TSG), most not previously implicated in medulloblastoma. Notably, we identified previously unknown amplifications and homozygous deletions, including recurrent, mutually exclusive, highly focal genetic events in genes targeting histone lysine methylation, particularly that of histone 3, lysine 9 (H3K9). Post-translational modification of histone proteins is critical for regulation of gene expression, can participate in determination of stem cell fates and has been implicated in carcinogenesis. Consistent with our genetic data, restoration of expression of genes controlling H3K9 methylation greatly diminishes proliferation of medulloblastoma in vitro. Copy number aberrations of genes with critical roles in writing, reading, removing and blocking the state of histone lysine methylation, particularly at H3K9, suggest that defective control of the histone code contributes to the pathogenesis of medulloblastoma.	[Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Mack, Stephen; Kongkham, Paul N.; Peacock, John; Dubuc, Adrian; Ra, Young-Shin; Zilberberg, Karen; Mcleod, Jessica; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Mack, Stephen; Peacock, John; Dubuc, Adrian; Zilberberg, Karen; Mcleod, Jessica; Taylor, Michael D.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Northcott, Paul A.; Mack, Stephen; Kongkham, Paul N.; Dubuc, Adrian; Zilberberg, Karen; Rutka, James T.; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Feuk, Lars; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Feuk, Lars; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ellison, David W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Croul, Sid] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada; [Rao, J. Sunil] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Grajkowska, Wiesia] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Gillespie, Yancey] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Lach, Boleslaw] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Grundy, Richard] Univ Nottingham, Nottingham NG7 2RD, England; [Pollack, Ian F.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Van Meter, Timothy] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; [Carlotti, Carlos G.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg, Div Neurosurg, Sao Paulo, Brazil; [Boop, Frederick] St Jude Childrens Hosp, Div Pediat Neurosurg, Memphis, TN 38105 USA; [Bigner, Darrell] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Case Western Reserve University; Johns Hopkins University; Children's Memorial Health Institute; University of Alabama System; University of Alabama Birmingham; McMaster University; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Virginia Commonwealth University; Universidade de Sao Paulo; St Jude Children's Research Hospital; Duke University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mdtaylor@sickkids.ca	Northcott, Paul A/N-4022-2018; Gilbertson, Richard James/ABE-1346-2021; Carlotti, Carlos G/C-1608-2012; Scherer, Stephen W./B-3785-2013; Ellison, David/N-4806-2018	Northcott, Paul A/0000-0002-1220-5252; Gilbertson, Richard James/0000-0001-7539-9472; Carlotti, Carlos G/0000-0002-7055-0564; Scherer, Stephen W./0000-0002-8326-1999; Grajkowska, Wieslawa/0000-0001-8318-5781; Kongkham, Paul/0000-0002-1047-9305; Taylor, Michael/0000-0001-7009-3466; Croul, Sidney/0000-0002-2224-5485; Gillespie, George/0000-0001-6436-9542; Mack, Stephen C./0000-0001-9620-4742	Hospital for Sick Children Foundation; Neurosurgery Research and Education Foundation; BRAINCHILD; Laurie Berman fund in Brain Tumor Research; American Brain Tumor Association; Canadian Institutes of Health Research; Hospital for Sick Children; NATIONAL CANCER INSTITUTE [R01CA129541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089] Funding Source: NIH RePORTER	Hospital for Sick Children Foundation; Neurosurgery Research and Education Foundation; BRAINCHILD; Laurie Berman fund in Brain Tumor Research; American Brain Tumor Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children(University of Toronto); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals and families who agreed to take part in these studies. We thank S. Egan, J. Ellis and R. Bremner for critical review of the manuscript. We thank R. Wechsler- Reya (Duke), A. M. Kenney (Memorial- Sloan Kettering) and D. Rowitch (University of California San Francisco) for reagents and helpful discussions. We are grateful to K. Helin (University of Copenhagen) for providing JMJD2C expression constructs. We thank P. Paroutis for artwork and S. Archer for editing. We are grateful to C. Marshall and J. Wei for assistance with copy number analysis. This work was supported by the Canadian Cancer Society and the Pediatric Brain Tumor Foundation. M. D. T. is supported by a Sontag Foundation Distinguished Scholar award. Additional research support was obtained from the Hospital for Sick Children Foundation, The Neurosurgery Research and Education Foundation, BRAINCHILD, the 407 Express Toll Route, and the Walker family. M. D. T. was supported by the Laurie Berman fund in Brain Tumor Research, the American Brain Tumor Association and a ClinicianScientist award from the Canadian Institutes of Health Research. P. A. N. was supported by a Restracomp salary award from the Hospital for Sick Children.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Marino S, 2000, GENE DEV, V14, P994; Marino S, 2003, DEVELOPMENT, V130, P3359, DOI 10.1242/dev.00553; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Olson MV, 2007, CANCER RES, V67, P4005, DOI 10.1158/0008-5472.CAN-06-2973; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Reardon DA, 1997, CANCER RES, V57, P4042; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06	30	321	328	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					465	472		10.1038/ng.336	http://dx.doi.org/10.1038/ng.336			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19270706	Green Accepted			2022-12-25	WOS:000264659000022
J	Moser, M; Bauer, M; Schmid, S; Ruppert, R; Schmidt, S; Sixt, M; Wang, HV; Sperandio, M; Fassler, R				Moser, Markus; Bauer, Martina; Schmid, Stephan; Ruppert, Raphael; Schmidt, Sarah; Sixt, Michael; Wang, Hao-Ven; Sperandio, Markus; Faessler, Reinhard			Kindlin-3 is required for beta(2) integrin-mediated leukocyte adhesion to endothelial cells	NATURE MEDICINE			English	Article							GDP-FUCOSE TRANSPORTER; LAD-III; DEFICIENCY; NEUTROPHILS; ACTIVATION; MOUSE; MICE; INFLAMMATION; EXPRESSION; SYSTEM	Integrin activation is essential for the function of all blood cells, including platelets and leukocytes(1). The blood cell-specific FERM domain protein Kindlin-3 is required for the activation of the beta(1) and beta(3) integrins on platelets(2). Impaired activation of beta(1), beta(2) and beta(3) integrins on platelets and leukocytes is the hallmark of a rare autosomal recessive leukocyte adhesion deficiency syndrome in humans called LAD-III, characterized by severe bleeding and impaired adhesion of leukocytes to inflamed endothelia(3). Here we show that Kindlin-3 also binds the beta(2) integrin cytoplasmic domain and is essential for neutrophil binding and spreading on beta(2) integrin-dependent ligands such as intercellular adhesion molecule-1 and the complement C3 activation product iC3b. Moreover, loss of Kindlin-3 expression abolished firm adhesion and arrest of neutrophils on activated endothelial cells in vitro and in vivo, whereas selectin-mediated rolling was unaffected. Thus, Kindlin-3 is essential to activate the beta(1), beta(2) and beta(3) integrin classes, and loss of Kindlin-3 function is sufficient to cause a LAD-III-like phenotype in mice.	[Moser, Markus; Bauer, Martina; Ruppert, Raphael; Schmidt, Sarah; Sixt, Michael; Wang, Hao-Ven; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Schmid, Stephan; Sperandio, Markus] Univ Munich, Walter Brendel Ctr Expt Med, D-81377 Munich, Germany	Max Planck Society; University of Munich	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de	Sixt, Michael/F-3925-2010	Wang, Hao-Ven/0000-0001-7523-087X; Sixt, Michael/0000-0002-6620-9179; Sperandio, Markus/0000-0002-7689-3613	Deutsche Forschungsgemeinschaft; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank the members of the Fassler lab for discussions, R. Zent for careful reading of the manuscript, K. Kessenbrock for help with the oxidative burst experiment, T. Lammermann for help with the skin inflammation assay and S. Dietzel for help with generating the movie clips. The work was funded by the Deutsche Forschungsgemeinschaft and the Max Planck Society.	Alon R, 2003, TRENDS IMMUNOL, V24, P561, DOI 10.1016/j.it.2003.08.001; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Frommhold D, 2008, J EXP MED, V205, P1435, DOI 10.1084/jem.20070846; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Karsan A, 1998, J CLIN INVEST, V101, P2438, DOI 10.1172/JCI905; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kuijpers TW, 2007, BLOOD, V109, P3529, DOI 10.1182/blood-2006-05-021402; Kuijpers TW, 1997, J CLIN INVEST, V100, P1725, DOI 10.1172/JCI119697; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Long DS, 2004, P NATL ACAD SCI USA, V101, P10060, DOI 10.1073/pnas.0402937101; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; PRIES AR, 1988, INT J MICROCIRC, V7, P327; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Smith ML, 2004, J LEUKOCYTE BIOL, V76, P985, DOI 10.1189/jlb.1003483; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Sperandio M, 2006, METHOD ENZYMOL, V416, P346, DOI 10.1016/S0076-6879(06)16023-1; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030	30	279	287	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2009	15	3					300	305		10.1038/nm.1921	http://dx.doi.org/10.1038/nm.1921			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19234461				2022-12-25	WOS:000263914000030
J	Chang, DJ; Cimprich, KA				Chang, Debbie J.; Cimprich, Karlene A.			DNA damage tolerance: when it's OK to make mistakes	NATURE CHEMICAL BIOLOGY			English	Article							CELL NUCLEAR ANTIGEN; STALLED REPLICATION FORKS; DOUBLE-STRAND BREAK; UBIQUITIN-CONJUGATING ENZYMES; POSTREPLICATION REPAIR; TRANSLESION SYNTHESIS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; POLYMERASE-ETA; ERROR-FREE	Mutations can be beneficial under conditions in which genetic diversity is advantageous, such as somatic hypermutation and antibody generation, but they can also be lethal when they disrupt basic cellular processes or cause uncontrolled proliferation and cancer. Mutations arise from inaccurate processing of lesions generated by endogenous and exogenous DNA damaging agents, and the genome is particularly vulnerable to such damage during S phase. In this phase of the cell cycle, many lesions in the DNA template block replication. Such lesions must be bypassed in order to preserve fork stability and to ensure completion of DNA replication. Lesion bypass is carried out by a set of error-prone and error-free processes collectively referred to as DNA damage tolerance mechanisms. Here, we discuss how two types of DNA damage tolerance, translesion synthesis and template switching, are regulated at stalled replication forks by ubiquitination of PCNA, and the conditions under which they occur.	[Chang, Debbie J.; Cimprich, Karlene A.] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Clark Ctr, Stanford, CA 94305 USA	Stanford University	Chang, DJ (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Clark Ctr, 318 Campus Dr,W350B, Stanford, CA 94305 USA.	cimprich@stanford.edu	高, 雨莉/HGU-8187-2022		NIEHS NIH HHS [R01 ES016486-07, R01 ES016486] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016486] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chang DJ, 2006, J BIOL CHEM, V281, P32081, DOI 10.1074/jbc.M606799200; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Fujii S, 2004, EMBO J, V23, P4342, DOI 10.1038/sj.emboj.7600438; Fujii S, 2007, J MOL BIOL, V372, P883, DOI 10.1016/j.jmb.2007.07.036; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Gohler T, 2008, DNA REPAIR, V7, P775, DOI 10.1016/j.dnarep.2008.02.001; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hirano Y, 2006, CURR BIOL, V16, P586, DOI 10.1016/j.cub.2006.01.063; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; LAWRENCE CW, 1976, GENETICS, V82, P207; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; LEHMANN AR, 1972, J MOL BIOL, V66, P319, DOI 10.1016/0022-2836(72)90418-4; LEMONTT JF, 1971, GENETICS, V68, P21; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Masuda Y, 2006, J BIOL CHEM, V281, P24314, DOI 10.1074/jbc.M602967200; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pages V, 2008, GENETICS, V180, P73, DOI 10.1534/genetics.108.091066; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Peng J, 2008, TRENDS BIOCHEM SCI, V33, P191, DOI 10.1016/j.tibs.2008.02.003; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Tsuji Y, 2008, GENES CELLS, V13, P343, DOI 10.1111/j.1365-2443.2008.01176.x; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xiao W, 2000, GENETICS, V155, P1633; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zou L, 2007, GENE DEV, V21, P879, DOI 10.1101/gad.1550307	87	145	148	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					82	90		10.1038/nchembio.139	http://dx.doi.org/10.1038/nchembio.139			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19148176	Green Accepted			2022-12-25	WOS:000263090700010
J	Gill, WP; Harik, NS; Whiddon, MR; Liao, RP; Mittler, JE; Sherman, DR				Gill, Wendy P.; Harik, Nada S.; Whiddon, Molly R.; Liao, Reiling P.; Mittler, John E.; Sherman, David R.			A replication clock for Mycobacterium tuberculosis	NATURE MEDICINE			English	Article							HOST-PARASITE EQUILIBRIUM; STATIONARY-PHASE; HYPOXIC RESPONSE; INFECTED MICE; GRANULOMAS; CHEMOTHERAPY; ZEBRAFISH; IMMUNITY; MURINE	Few tools exist to assess replication of chronic pathogens during infection. This has been a considerable barrier to understanding latent tuberculosis, and efforts to develop new therapies generally assume that the bacteria are very slowly replicating or nonreplicating during latency(1-3). To monitor Mycobacterium tuberculosis replication within hosts, we exploit an unstable plasmid that is lost at a steady, quantifiable rate from dividing cells in the absence of antibiotic selection. By applying a mathematical model, we calculate bacterial growth and death rates during infection of mice. We show that during chronic infection, the cumulative bacterial burden enumerating total live, dead and removed organisms encountered by the mouse lung-is substantially higher than estimates from colony-forming units. Our data show that M. tuberculosis replicates throughout the course of chronic infection of mice and is restrained by the host immune system. This approach may also shed light on the replication dynamics of other chronic pathogens.	[Whiddon, Molly R.; Liao, Reiling P.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Gill, Wendy P.] Univ Washington, Med Ctr, Div Allerg & Infect Dis, Seattle, WA 98195 USA; [Harik, Nada S.] Univ Arkansas Med Sci, Div Pediat Infect Dis, Little Rock, AR 72202 USA; [Whiddon, Molly R.; Sherman, David R.] Univ Washington, Dept Global Hlth, Interdisciplinary Program Pathobiol, Seattle, WA 98195 USA; [Mittler, John E.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Arkansas System; University of Arkansas Medical Sciences; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sherman, DR (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N,Suite 500, Seattle, WA 98109 USA.	david.sherman@sbri.org		Harik, Nada/0000-0003-0445-8652	US National Institutes of Health; Paul G. Allen Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047744] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank L. Ramakrishnan, J. Chang, K. Guinn, T. Walker and members of the Sherman lab for review of and contributions to this work, C. DeMille for expert help with manuscript preparation and K. G. Papavinasasundaram ( University of Massachusetts Medical School) for providing pBP10. This research was supported by grants from the US National Institutes of Health and the Paul G. Allen Family Foundation.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Bachrach G, 2000, MICROBIOL-UK, V146, P297, DOI 10.1099/00221287-146-2-297; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DAVISON AC, 1997, BOOTSTRAP METHODS TH, pCH2; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; KANAI K, 1966, JPN J MED SCI BIOL, V19, P181, DOI 10.7883/yoken1952.19.181; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nuermberger E, 2005, AM J RESP CRIT CARE, V172, P1452, DOI 10.1164/rccm.200507-1047OC; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; REES RJ, 1961, BRIT J EXP PATHOL, V42, P83; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rivas-Santiago B, 2006, J INFECT DIS, V194, P697, DOI 10.1086/506454; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	32	218	222	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					211	214		10.1038/nm.1915	http://dx.doi.org/10.1038/nm.1915			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19182798	Green Accepted			2022-12-25	WOS:000263119400025
J	Goldman, B; DeFrancesco, L				Goldman, Bruce; DeFrancesco, Laura			The cancer vaccine roller coaster	NATURE BIOTECHNOLOGY			English	Article							VITESPEN; THERAPY	The cancer vaccine field is littered with promising products that failed to show clinical efficacy. Could it finally be on the verge of a first US approval?										Allison M, 2008, NAT BIOTECHNOL, V26, P967, DOI 10.1038/nbt0908-967; Choudhury A, 2006, ADV CANCER RES, V95, P147, DOI 10.1016/S0065-230X(06)95005-2; Small EJ, 2000, J CLIN ONCOL, V18, P3894, DOI 10.1200/JCO.2000.18.23.3894; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Valone FH, 2001, CANCER J, V7, pS53; Wood C, 2008, LANCET, V372, P145, DOI 10.1016/S0140-6736(08)60697-2	6	129	143	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2009	27	2					129	139		10.1038/nbt0209-129	http://dx.doi.org/10.1038/nbt0209-129			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	405FT	19204689				2022-12-25	WOS:000263209000015
J	Prakash, S; Inobe, T; Hatch, AJ; Matouschek, A				Prakash, Sumit; Inobe, Tomonao; Hatch, Ace Joseph; Matouschek, Andreas			Substrate selection by the proteasome during degradation of protein complexes	NATURE CHEMICAL BIOLOGY			English	Article							N-END RULE; 26S PROTEASOME; MEDIATED DEGRADATION; DESTRUCTION; SIGNAL; SUBUNIT; PATHWAY; RECOGNITION; RAD23; UBIQUITINATION	The proteasome controls the turnover of many cellular proteins. Two structural features are typically required for proteins to be degraded: covalently attached ubiquitin polypeptides that allow binding to the proteasome and an unstructured region in the targeted protein that initiates proteolysis. Here, we have tested the degradation of model proteins to further explore how the proteasome selects its substrates. Using purified yeast proteasome and mammalian proteasome in cell lysate, we have demonstrated that the two structural features can act in trans when separated onto different proteins in a multisubunit complex. In such complexes, the location of the unstructured initiation site and its chemical properties determine which subunit is degraded. Thus, our findings reveal the molecular basis of subunit specificity in the degradation of protein complexes. In addition, our data provide a plausible explanation for how adaptor proteins can bind to otherwise stable proteins and target them for degradation.	[Matouschek, Andreas] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Matouschek, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	matouschek@northwestern.edu	Matouschek, Andreas/L-9379-2013; Prakash, Sumit/B-2679-2009	Matouschek, Andreas/0000-0001-6016-2341; Prakash, Sumit/0000-0002-0608-3420; Inobe, Tomonao/0000-0002-5864-6889	US National Institutes of Health [R01GM64003]; Leukemia and Lymphoma Society; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; Japan Society for the Promotion of Science Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Robert H. Lurie Comprehensive Cancer Center at Northwestern University; Japan Society for the Promotion of Science Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. W. Carthew, A. C. Rosenzweig, J. Widom and members of the Matouschek lab (Northwestern University), as well as R.J. Deshaies (Caltech), for advice and comments, and we thank G. Leigh for editing the manuscript. The work was supported by grant R01GM64003 from the US National Institutes of Health, by the Leukemia and Lymphoma Society and by the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. T. I. gratefully acknowledges a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad.	BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Berezutskaya E, 1997, J BIOL CHEM, V272, P30135, DOI 10.1074/jbc.272.48.30135; Bienkiewicz EA, 2002, BIOCHEMISTRY-US, V41, P752, DOI 10.1021/bi015763t; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOEBL MG, 1994, MOL CELL BIOL, V14, P3022, DOI 10.1128/MCB.14.5.3022; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; HARTLEY RW, 1993, BIOCHEMISTRY-US, V32, P5978, DOI 10.1021/bi00074a008; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Nishiyama A, 2000, GENE DEV, V14, P2344, DOI 10.1101/gad.823200; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Pratt MR, 2007, P NATL ACAD SCI USA, V104, P11209, DOI 10.1073/pnas.0700816104; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Sharon M, 2006, J BIOL CHEM, V281, P9569, DOI 10.1074/jbc.M511951200; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Stankunas K, 2007, P NATL ACAD SCI USA, V104, P11511, DOI 10.1073/pnas.0704762104; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Verhoef LGGC, 2009, FASEB J, V23, P123, DOI 10.1096/fj.08-115055; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Whitby FG, 2007, STRUCTURE, V15, P137, DOI 10.1016/j.str.2007.01.009; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	50	95	98	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2009	5	1					29	36		10.1038/nchembio.130	http://dx.doi.org/10.1038/nchembio.130			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387EW	19029916	Green Accepted			2022-12-25	WOS:000261935500011
J	Hiratsuka, S; Watanabe, A; Sakurai, Y; Akashi-Takamura, S; Ishibashi, S; Miyake, K; Shibuya, M; Akira, S; Aburatani, H; Maru, Y				Hiratsuka, Sachie; Watanabe, Akira; Sakurai, Yoshiko; Akashi-Takamura, Sachiko; Ishibashi, Sachie; Miyake, Kensuke; Shibuya, Masabumi; Akira, Shizuo; Aburatani, Hiroyuki; Maru, Yoshiro			The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase	NATURE CELL BIOLOGY			English	Article							TOLL-LIKE RECEPTORS; CELL ACTIVATION; LUNG; A3; LIPOPOLYSACCHARIDE; INFLAMMATION; INDUCTION; SECRETION; MOLECULE; AFFINITY	A large number of macrophages and haematopoietic progenitor cells accumulate in pre-metastatic lungs(1,2) in which chemoattractants, such as S100A8 and S100A9, are produced by distant primary tumours serving as metastatic soil(3). The exact mechanism by which these chemoattractants elicit cell accumulation is not known. Here, we show that serum amyloid A (SAA) 3, which is induced in pre-metastatic lungs by S100A8 and S100A9, has a role in the accumulation of myeloid cells and acts as a positive-feedback regulator for chemoattractant secretion. We also show that in lung endothelial cells and macrophages, Toll-like receptor (TLR) 4 acts as a functional receptor for SAA3 in the pre-metastatic phase. In our study, SAA3 stimulated NF-kappa B signalling in a TLR4-dependent manner and facilitated metastasis. This inflammation-like state accelerated the migration of primary tumour cells to lung tissues, but this was suppressed by the inhibition of either TLR4 or SAA3. Thus, blocking SAA3-TLR4 function in the pre-metastatic phase could prove to be an effective strategy for the prevention of pulmonary metastasis.	[Hiratsuka, Sachie; Sakurai, Yoshiko; Ishibashi, Sachie; Maru, Yoshiro] Tokyo Womens Med Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan; [Watanabe, Akira; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Infect Genet,Minato Ku, Tokyo 1088639, Japan; [Shibuya, Masabumi] Univ Tokyo, Inst Med Sci, Div Genet, Minato Ku, Tokyo 1088639, Japan; [Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka 5651871, Japan	Tokyo Women's Medical University; University of Tokyo; University of Tokyo; University of Tokyo; Osaka University	Maru, Y (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ymaru@research.twmu.ac.jp	Eckhardt, Erik/G-1567-2010; Akira, Shizuo/C-3134-2009		Ministry of Education, Culture, Sports, Science and Technology [12147210, 16101006]; NIBIO program; New Energy and Industrial Technology Development Organization; Uehara foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIBIO program(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Uehara foundation(Uehara Memorial Foundation)	We thank P. E. Scherer for providing the anti-mouse SAA3 antibody and pGEX-SAA3 vector, and T. Noda for preparation of the VEGFR1TK<SUP>-/-</SUP> mouse. We are grateful to B. Panda for checking the manuscript and also O. N. Witte for critical reading of manuscript and providing comments. This study was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, 12147210 (Y.M.) and 16101006 (H. A.) the NIBIO program and NFAT project of New Energy and Industrial Technology Development Organization (H. A.) and Uehara foundation (S. H.)	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2002, CURR OPIN HEMATOL, V9, P2, DOI 10.1097/00062752-200201000-00002; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; MEEK RL, 1989, P NATL ACAD SCI USA, V86, P1890, DOI 10.1073/pnas.86.6.1890; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Ogawa T, 2002, INT IMMUNOL, V14, P1325, DOI 10.1093/intimm/dxf097; PAGET S, 1989, CANCER METAST REV, V8, P98; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; VERGHESE MW, 1982, J IMMUNOL, V128, P608; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang H, 2001, AMYLOID, V8, P250, DOI 10.3109/13506120108993821	30	485	500	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1349	U229		10.1038/ncb1794	http://dx.doi.org/10.1038/ncb1794			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18820689				2022-12-25	WOS:000260586700018
J	Niwa, S; Tanaka, Y; Hirokawa, N				Niwa, Shinsuke; Tanaka, Yosuke; Hirokawa, Nobutaka			KIF1B beta- and KIF1A-mediated axonal transport of presynaptic regulator Rab3 occurs in a GTP-dependent manner through DENN/MADD	NATURE CELL BIOLOGY			English	Article							GDP/GTP EXCHANGE PROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; SYNAPTIC VESICLE; PLASMA-MEMBRANE; DEATH DOMAIN; MYOSIN-VA; CAENORHABDITIS-ELEGANS; BINDING PROTEIN; KINESIN MOTOR; C-ELEGANS	Synaptic proteins are synthesized in the cell body and transported down the axon by microtubule-dependent motors. We previously reported that KIF1B beta and KIF1A motors are essential for transporting synaptic vesicle precursors; however the mechanisms that regulate transport, as well as cargo recognition and control of cargo loading and unloading remain largely unknown. Here, we show that DENN/MADD (Rab3-GEP) is an essential part of the regulation mechanism through direct interaction with the stalk domain of KIF1B beta and KIF1A. We also show that DENN/MADD binds preferentially to GTP-Rab3 and acts as a Rab3 effector. These molecular interactions are fundamental as sequential genetic perturbations revealed that KIF1B beta and KIF1A are essential for the transport of DENN/MADD and Rab3, whereas DENN/ MADD is essential for the transport of Rab3. GTP-Rab3 was more effectively transported than GDP-Rab3, suggesting that the nucleotide state of Rab3 regulates axonal transport of Rab3-carrying vesicles through preferential interaction with DENN/ MADD.	[Niwa, Shinsuke; Tanaka, Yosuke; Hirokawa, Nobutaka] Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp		NIWA, SHINSUKE/0000-0002-8367-9228; Tanaka, Yosuke/0000-0001-5376-5726	Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ministry of Education, Culture, Sports, Science and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank H. Fukuda, H. Sato, T. Aizawa and others from the Hirokawa laboratory for discussions and technical assistance. We are also grateful to the Kazusa DNA Institute (Chiba, Japan) for providing KIAA clones. This study was supported by a Grant-in-Aid for Specially Promoted Research to N. H. and Global COE programme to University of Tokyo from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; FISCHER V, 1991, NATURE, V349, P79; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Iwasaki K, 2000, EMBO J, V19, P4806, DOI 10.1093/emboj/19.17.4806; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kommers GD, 2002, VET PATHOL, V39, P353, DOI 10.1354/vp.39-3-353; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; LI JY, 1995, EUR J CELL BIOL, V67, P297; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NGSEE JK, 1993, MOL BIOL CELL, V7, P747; Oishi H, 1998, J BIOL CHEM, V273, P34580, DOI 10.1074/jbc.273.51.34580; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Roa M, 1997, J IMMUNOL, V159, P2815; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; STETTLER O, 1994, NEUROSCIENCE, V62, P587, DOI 10.1016/0306-4522(94)90391-3; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yamaguchi K, 2002, P NATL ACAD SCI USA, V99, P14536, DOI 10.1073/pnas.212511399; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	50	129	135	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1269	U52		10.1038/ncb1785	http://dx.doi.org/10.1038/ncb1785			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849981				2022-12-25	WOS:000260586700009
J	Pan, YP; Weng, J; Kabaleeswaran, V; Li, HG; Cao, Y; Bhosle, RC; Zhou, M				Pan, Yaping; Weng, Jun; Kabaleeswaran, Venkataraman; Li, Huiguang; Cao, Yu; Bhosle, Rahul C.; Zhou, Ming			Cortisone dissociates the Shaker family K+ channels from their beta subunits	NATURE CHEMICAL BIOLOGY			English	Article							POTASSIUM CHANNELS; INACTIVATION GATE; ALPHA-SUBUNITS; PROTEIN MODELS; RAT-BRAIN; EXPRESSION; KV-BETA-1; CRYSTALLOGRAPHY; ASSOCIATION; COMPLEXES	The Shaker family voltage-dependent potassium channels (Kv1) are expressed in a wide variety of cells and are essential for cellular excitability. In humans, loss-of-function mutations of Kv1 channels lead to hyperexcitability and are directly linked to episodic ataxia and atrial fibrillation. All Kv1 channels assemble with beta subunits (Kv beta s), and certain Kv beta s, for example Kv beta 1, have an N-terminal segment that closes the channel by the N-type inactivation mechanism. In principle, dissociation of Kv beta 1, although never reported, should eliminate inactivation and thus potentiate Kv1 current. We found that cortisone increases rat Kv1 channel activity by binding to Kv beta 1. A crystal structure of the Kv beta-cortisone complex was solved to 1.82-angstrom resolution and revealed novel cortisone binding sites. Further studies demonstrated that cortisone promotes dissociation of Kv beta. The new mode of channel modulation may be explored by native or synthetic ligands to fine-tune cellular excitability.	[Pan, Yaping; Weng, Jun; Kabaleeswaran, Venkataraman; Li, Huiguang; Cao, Yu; Bhosle, Rahul C.; Zhou, Ming] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Zhou, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Cao, Yu/GNP-6653-2022	Cao, Yu/0000-0003-1409-2068	American Heart Association [0630148N, 0826067D]; US National Institutes of Health [HL086392]; March of Dimes Birth Defects Foundation [5-FY06-20]; Pew Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); Pew Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank R. MacKinnon (Rockefeller University) for advice and generous help throughout the project. We thank C. Deutsch (University of Pennsylvania) and C. Miller (Brandeis University) for critical comments on the manuscript. Data for this study were measured at beamlines X4A, X4C and X29 of the National Synchrotron Light Source. We thank J. Schwanof, R. Abramowitz, S. Myers, N. Whalen and R. Jackimowicz for technical support during data collection. This work was supported by the American Heart Association (0630148N to M. Z. and 0826067D to Y.P.), the US National Institutes of Health (HL086392 to M.Z.), the March of Dimes Birth Defects Foundation (research grant #5-FY06-20 to M.Z.) and a grant from the Pew Scholars Program (to M.Z.).	Accili EA, 1998, J PHYSIOL-LONDON, V512, P325, DOI 10.1111/j.1469-7793.1998.325be.x; Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; HEINEMANN S, 1994, J PHYSIOL-PARIS, V88, P173, DOI 10.1016/0928-4257(94)90003-5; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YP, 2008, J BIOL CHEM, V283, P8634, DOI 10.1074/jbc.M709304200; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Rhodes KJ, 1996, J NEUROSCI, V16, P4846; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Sokolova O, 2003, P NATL ACAD SCI USA, V100, P12607, DOI 10.1073/pnas.2235650100; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Weng J, 2006, J BIOL CHEM, V281, P15194, DOI 10.1074/jbc.M513809200; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	31	19	20	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2008	4	11					708	714		10.1038/nchembio.114	http://dx.doi.org/10.1038/nchembio.114			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364CY	18806782	Green Accepted			2022-12-25	WOS:000260315000016
J	Simon, GM; Cravatt, BF				Simon, Gabriel M.; Cravatt, Benjamin F.			Challenges for the 'chemical-systems' biologist	NATURE CHEMICAL BIOLOGY			English	Editorial Material							SMALL-MOLECULE; PROTEOME; IDENTIFICATION; INHIBITORS; PROTEINS; INACTIVATION; CHEMISTRY; DISCOVERY; APOPTOSIS; GENETICS	As the field of chemical biology matures, its practitioners are tackling ever more sophisticated biological problems. Chemical approaches, both synthetic and analytical, provide researchers with powerful new technologies to perturb, dissect and even reconstruct complex biological systems. Here we discuss the special challenges and opportunities confronted at the burgeoning interface of chemical and systems biology.	[Simon, Gabriel M.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Simon, GM (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu						Ahn K, 2007, BIOCHEMISTRY-US, V46, P13019, DOI 10.1021/bi701378g; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Dalhoff C, 2006, NAT CHEM BIOL, V2, P31, DOI 10.1038/nchembio754; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Lee JY, 2008, MOL BIOSYST, V4, P59, DOI 10.1039/b712307h; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101	25	17	18	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2008	4	11					639	642		10.1038/nchembio1108-639	http://dx.doi.org/10.1038/nchembio1108-639			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364CY	18936742				2022-12-25	WOS:000260315000003
J	McCarroll, SA; Huett, A; Kuballa, P; Chilewski, SD; Landry, A; Goyette, P; Zody, MC; Hall, JL; Brant, SR; Cho, JH; Duerr, RH; Silverberg, MS; Taylor, KD; Rioux, JD; Altshuler, D; Daly, MJ; Xavier, RJ				McCarroll, Steven A.; Huett, Alan; Kuballa, Petric; Chilewski, Shannon D.; Landry, Aimee; Goyette, Philippe; Zody, Michael C.; Hall, Jennifer L.; Brant, Steven R.; Cho, Judy H.; Duerr, Richard H.; Silverberg, Mark S.; Taylor, Kent D.; Rioux, John D.; Altshuler, David; Daly, Mark J.; Xavier, Ramnik J.			Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION; AUTOPHAGY; GENE; SUSCEPTIBILITY; ENHANCER; RETROPOSON; SELECTION; LOCI; SNPS	Following recent success in genome-wide association studies, a critical focus of human genetics is to understand how genetic variation at implicated loci influences cellular and disease processes. Crohn's disease (CD) is associated with SNPs around IRGM(1,2), but coding-sequence variation has been excluded as a source of this association(2). We identified a common, 20-kb deletion polymorphism, immediately upstream of IRGM and in perfect linkage disequilibrium (r(2) = 1.0) with the most strongly CD-associated SNP, that causes IRGM to segregate in the population with two distinct upstream sequences. The deletion (CD risk) and reference (CD protective) haplotypes of IRGM showed distinct expression patterns. Manipulation of IRGM expression levels modulated cellular autophagy of internalized bacteria, a process implicated in CD. These results suggest that the CD association at IRGM arises from an alteration in IRGM regulation that affects the efficacy of autophagy and identify a common deletion polymorphism as a likely causal variant.	[McCarroll, Steven A.; Altshuler, David; Daly, Mark J.] Harvard Univ, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [McCarroll, Steven A.; Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [McCarroll, Steven A.; Chilewski, Shannon D.; Zody, Michael C.; Rioux, John D.; Altshuler, David; Daly, Mark J.] MIT, Broad Inst, Cambridge, MA 02142 USA; [McCarroll, Steven A.; Chilewski, Shannon D.; Zody, Michael C.; Rioux, John D.; Altshuler, David; Daly, Mark J.] Harvard Univ, Cambridge, MA 02142 USA; [Huett, Alan; Kuballa, Petric; Landry, Aimee; Xavier, Ramnik J.] Harvard Univ, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Huett, Alan; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Goyette, Philippe] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Goyette, Philippe] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Zody, Michael C.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Hall, Jennifer L.] Univ Minnesota, Sch Med, Div Cardiol, Dept Med, Minneapolis, MN 55455 USA; [Brant, Steven R.] Johns Hopkins Univ, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21231 USA; [Cho, Judy H.] Yale Univ, Div Gastroenterol, Dept Med, Ctr Inflammatory Bowel Dis, New Haven, CT 06519 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Med,Med Ctr, Pittsburgh, PA 15213 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; [Taylor, Kent D.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Taylor, Kent D.] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universite de Montreal; Universite de Montreal; Uppsala University; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Daly, MJ (corresponding author), Harvard Univ, Sch Med, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; xavier@molbio.mgh.harvard.edu	Rioux, John D/A-9599-2015; McCarroll, Steven A/A-8433-2009; Huett, Alan/AAI-7998-2020; Daly, Mark J/B-2453-2017; Silverberg, Mark/B-4183-2008; Duerr, Richard H/B-4188-2009; Altshuler, David M/A-4476-2009	Rioux, John D/0000-0001-7560-8326; Huett, Alan/0000-0001-7385-5585; Daly, Mark J/0000-0002-0949-8752; Duerr, Richard H/0000-0001-6586-3905; Altshuler, David M/0000-0002-7250-4107	US National Institute of Allergy and Infection Diseases [AI062773, HL088297, DK43351]; CCIB developmental funds; Lilly Life Sciences Research Fellowship; Burroughs Wellcome Foundation; Crohn's and Colitis Foundation of America; NIDDK [DK064869];  [DK62431];  [DK62422];  [DK62420];  [DK62432];  [DK62423];  [DK62413];  [DK62429]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062413, U01DK062429, U01DK062432, U01DK062423, R01DK083756, U01DK062420, U01DK062431, R01DK064869, P30DK063491, U01DK062422, P30DK043351, P30DK040561] Funding Source: NIH RePORTER	US National Institute of Allergy and Infection Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CCIB developmental funds; Lilly Life Sciences Research Fellowship; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The current work was funded by a US National Institute of Allergy and Infection Diseases grant, AI062773, HL088297, DK43351, and CCIB developmental funds to R.J.X. and by a Lilly Life Sciences Research Fellowship to S. A. M. The National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) IBD Genetics Consortium is funded by the following grants: DK62431 (S. R. B.), DK62422 (J.H.C.), DK62420 (R.H.D.), DK62432 and DK064869 (J.D.R.), DK62423 (M.S.S.), DK62413 (K.D.T.), and DK62429 (J.H.C.). Additional support was provided by the Burroughs Wellcome Foundation (J.H.C.), the Crohn's and Colitis Foundation of America (S.R.B., J.H.C., J.D.R.), and the NIDDK, DK064869 (J.D.R.). M. Garber and C. Bekpen provided helpful discussion; C. Patil and J. Korn provided thoughtful comments on the manuscript. LC3-GFP lentiviral vector was a gift from C. Munz (The Rockefeller University).	Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2008, GENOME RES, V18, P555, DOI 10.1101/gr.068692.107; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hosokawa N, 2007, FEBS LETT, V581, P2623, DOI 10.1016/j.febslet.2006.04.008; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Macville M, 1999, CANCER RES, V59, P141; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ruda VM, 2004, VIRUS RES, V104, P11, DOI 10.1016/j.virusres.2004.02.036; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634	28	502	518	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1107	1112		10.1038/ng.215	http://dx.doi.org/10.1038/ng.215			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165925	Green Accepted			2022-12-25	WOS:000258761200025
J	Shlomi, T; Cabili, MN; Herrgard, MJ; Palsson, BO; Ruppin, E				Shlomi, Tomer; Cabili, Moran N.; Herrgard, Markus J.; Palsson, Bernhard O.; Ruppin, Eytan			Network-based prediction of human tissue-specific metabolism	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION DATA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; GENOME; DATABASE; FLUX; RECONSTRUCTION; PROFILES; ENZYME; INTEGRATION	Direct in vivo investigation of mammalian metabolism is complicated by the distinct metabolic functions of different tissues. We present a computational method that successfully describes the tissue specificity of human metabolism on a large scale. By integrating tissue-specific gene- and protein-expression data with an existing comprehensive reconstruction of the global human metabolic network, we predict tissue-specific metabolic activity in ten human tissues. This reveals a central role for post- transcriptional regulation in shaping tissue-specific metabolic activity profiles. The predicted tissue specificity of genes responsible for metabolic diseases and tissue-specific differences in metabolite exchange with biofluids extend markedly beyond tissue-specific differences manifest in enzyme-expression data, and are validated by large-scale mining of tissue-specificity data. Our results establish a computational basis for the genome-wide study of normal and abnormal human metabolism in a tissue-specific manner.	[Shlomi, Tomer; Cabili, Moran N.; Ruppin, Eytan] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Herrgard, Markus J.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ruppin, Eytan] Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; University of California System; University of California San Diego; Tel Aviv University	Shlomi, T (corresponding author), Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.	shlomito@post.tau.ac.il; ruppin@post.tau.ac.il	Ruppin, Eytan/R-9698-2017; Califano, Andrea/F-7239-2012	Ruppin, Eytan/0000-0002-7862-3940; Palsson, Bernhard/0000-0003-2357-6785	National Institutes of Health [GM071808]; Israeli Science Foundation; German-Israeli Foundation; Tauber fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Tauber fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Shiri Freilich and Ben Sandbank for helpful comments and suggestions. We wish to thank the reviewers for their constructive remarks that helped improve this manuscript considerably. T. S. is supported by an Eshkol Fellowship from the Israeli Ministry of Science. M. C. is a fellow of the Edmond J. Safra Program in Tel-Aviv University. M. J. H. was supported by National Institutes of Health grant no. GM071808. This research was supported by grants from the Israeli Science Foundation, the German-Israeli Foundation and the Tauber fund to E. R.	Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bilu Y, 2006, PLOS COMPUT BIOL, V2, P932, DOI 10.1371/journal.pcbi.0020106; BOHM M, 1995, J AM COLL CARDIOL, V25, P146, DOI 10.1016/0735-1097(94)00353-R; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Chatziioannou A, 2003, METAB ENG, V5, P201, DOI 10.1016/S1096-7176(03)00029-6; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Domach MM, 2000, BIOTECHNOL BIOENG, V67, P827, DOI 10.1002/(SICI)1097-0290(20000320)67:6<827::AID-BIT18>3.0.CO;2-N; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; FELL D, 1996, UNDERSTANDING CONTRO; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; GREENE HL, 1988, HEPATOLOGY, V8, P302, DOI 10.1002/hep.1840080219; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kell DB, 2007, EXPERT REV MOL DIAGN, V7, P329, DOI 10.1586/14737159.7.4.329; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Levine DM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r93; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Romero P, 2005, GENOME BIOL, V6; Rossell S, 2006, P NATL ACAD SCI USA, V103, P2166, DOI 10.1073/pnas.0509831103; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuster S, 2002, BIOPROC BIOSYST ENG, V24, P363, DOI 10.1007/s004490100253; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tay SKH, 2004, NEUROMUSCULAR DISORD, V14, P253, DOI 10.1016/j.nmd.2003.12.006; Vo TD, 2004, J BIOL CHEM, V279, P39532, DOI 10.1074/jbc.M403782200; Wiback SJ, 2002, BIOPHYS J, V83, P808, DOI 10.1016/S0006-3495(02)75210-7; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Yan Q, 2000, AAPS PHARMSCI, V2, part. no.; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	53	450	458	1	59	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2008	26	9					1003	1010		10.1038/nbt.1487	http://dx.doi.org/10.1038/nbt.1487			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	346NG	18711341				2022-12-25	WOS:000259074700022
J	Holt, KE; Parkhill, J; Mazzoni, CJ; Roumagnac, P; Weill, FX; Goodhead, I; Rance, R; Baker, S; Maskell, DJ; Wain, J; Dolecek, C; Achtman, M; Dougan, G				Holt, Kathryn E.; Parkhill, Julian; Mazzoni, Camila J.; Roumagnac, Philippe; Weill, Francois-Xavier; Goodhead, Ian; Rance, Richard; Baker, Stephen; Maskell, Duncan J.; Wain, John; Dolecek, Christiane; Achtman, Mark; Dougan, Gordon			High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi	NATURE GENETICS			English	Article							ENTERICA SEROVAR TYPHI; PATHOGENICITY ISLAND; VI EXOPOLYSACCHARIDE; STRAINS; RECOMBINATION; ACQUISITION; RESISTANCE; DIVERSITY; SANTIAGO; CARRIERS	Isolates of Salmonella enterica serovar Typhi (Typhi), a human-restricted bacterial pathogen that causes typhoid, show limited genetic variation. We generated whole-genome sequences for 19 Typhi isolates using 454 (Roche) and Solexa (Illumina) technologies. Isolates, including the previously sequenced CT18 and Ty2 isolates, were selected to represent major nodes in the phylogenetic tree. Comparative analysis showed little evidence of purifying selection, antigenic variation or recombination between isolates. Rather, evolution in the Typhi population seems to be characterized by ongoing loss of gene function, consistent with a small effective population size. The lack of evidence for antigenic variation driven by immune selection is in contrast to strong adaptive selection for mutations conferring antibiotic resistance in Typhi. The observed patterns of genetic isolation and drift are consistent with the proposed key role of asymptomatic carriers of Typhi as the main reservoir of this pathogen, highlighting the need for identification and treatment of carriers.	[Holt, Kathryn E.; Parkhill, Julian; Goodhead, Ian; Rance, Richard; Baker, Stephen; Wain, John; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Mazzoni, Camila J.; Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Mazzoni, Camila J.; Roumagnac, Philippe; Achtman, Mark] Max Planck Inst Infektionsbiol, Dept Mol Biol, D-10117 Berlin, Germany; [Roumagnac, Philippe] Aix Marseille Univ, Univ Mixte Rech Ctr Natl Rech Sci 6191, Commissariat Energie Atom, F-13108 St Paul Les Durance, France; [Weill, Francois-Xavier] Inst Pasteur, Lab Bacteries Pathogenes Enter, F-75724 Paris 15, France; [Baker, Stephen; Dolecek, Christiane] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Maskell, Duncan J.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Wellcome Trust Sanger Institute; University College Cork; Max Planck Society; CEA; UDICE-French Research Universities; Aix-Marseille Universite; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford; University of Cambridge	Holt, KE (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	kh2@sanger.ac.uk	Mazzoni, Camila J/L-3441-2014; Mazzoni, Camila/AAJ-9702-2020; Goodhead, Ian/ABC-9200-2020; Holt, Kathryn E/A-8108-2012; Wain, John/B-3446-2013; Parkhill, Julian/G-4703-2011	Mazzoni, Camila/0000-0001-6758-5427; Holt, Kathryn E/0000-0003-3949-2471; Wain, John/0000-0002-1257-1148; Parkhill, Julian/0000-0002-7069-5958; Weill, Francois-Xavier/0000-0001-9941-5799; Roumagnac, Philippe/0000-0001-5002-6039; Goodhead, Ian/0000-0002-3110-9442; Baker, Stephen/0000-0003-1308-5755; Achtman, Mark/0000-0001-6815-0070	Wellcome Trust [067321] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; Boyd EF, 2003, J CLIN MICROBIOL, V41, P3823, DOI 10.1128/JCM.41.8.3823-3828.2003; Bueno SM, 2004, J BACTERIOL, V186, P3202, DOI 10.1128/JB.186.10.3202-3213.2004; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Cho JC, 1999, FEMS MICROBIOL LETT, V170, P257, DOI 10.1111/j.1574-6968.1999.tb13382.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Falush D, 2006, TRENDS MICROBIOL, V14, P353, DOI 10.1016/j.tim.2006.06.003; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Lewis MD, 2005, CLIN INFECT DIS, V40, P554, DOI 10.1086/427503; Nair S, 2004, J BACTERIOL, V186, P3214, DOI 10.1128/JB.186.10.3214-3223.2004; Octavia S, 2007, J CLIN MICROBIOL, V45, P3795, DOI 10.1128/JCM.00720-07; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; SEARS SD, 1984, J INFECT DIS, V149, P640, DOI 10.1093/infdis/149.4.640; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050	41	389	405	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					987	993		10.1038/ng.195	http://dx.doi.org/10.1038/ng.195			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18660809	Green Accepted			2022-12-25	WOS:000258026900015
J	Kuznetsov, SG; Liu, PT; Sharan, SK				Kuznetsov, Sergey G.; Liu, Pentao; Sharan, Shyam K.			Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2	NATURE MEDICINE			English	Article							UNKNOWN CLINICAL-SIGNIFICANCE; SEQUENCE VARIANTS; HOMOLOGOUS RECOMBINATION; CANCER-RISK; CROSS-LINKS; MICE; HYPERSENSITIVITY; RADIATION; REPAIR; CHROMOSOME	Individuals with mutations in breast cancer susceptibility genes BRCA1 and BRCA2 have up to an 80% risk of developing breast cancer by the age of 70. Sequencing-based genetic tests are now available to identify mutation carriers in an effort to reduce mortality through prevention and early diagnosis. However, lack of a suitable functional assay hinders the risk assessment of more than 1,900 BRCA1 and BRCA2 variants in the Breast Cancer Information Core database that do not clearly disrupt the gene product. We have established a simple, versatile and reliable assay to test for the functional significance of mutations in BRCA2 using mouse embryonic stem cells (ES cells) and bacterial artificial chromosomes and have used it to classify 17 sequence variants. The assay is based on the ability of human BRCA2 to complement the loss of endogenous Brca2 in mouse ES cells. This technique may also serve as a paradigm for functional analysis of mutations found in other genes linked to human diseases.	[Kuznetsov, Sergey G.; Liu, Pentao; Sharan, Shyam K.] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sharan, SK (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, 1050 Boyles St, Frederick, MD 21702 USA.	sharans@mail.nih.gov		Kuznetsov, Sergey/0000-0002-5662-9700	Intramural NIH HHS [Z01 BC010387-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010387, ZIABC011181] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atanassov BS, 2005, GENE CHROMOSOME CANC, V44, P429, DOI 10.1002/gcc.20255; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Deffenbaugh AM, 2002, GENET TEST, V6, P119, DOI 10.1089/10906570260199375; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Fackenthal JD, 2002, AM J HUM GENET, V71, P625, DOI 10.1086/342192; Freedman ML, 2004, HUM MOL GENET, V13, P2431, DOI 10.1093/hmg/ddh270; Godthelp BC, 2006, MUTAT RES-FUND MOL M, V601, P191, DOI 10.1016/j.mrfmmm.2006.07.003; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Marple T, 2006, MUTAT RES-FUND MOL M, V602, P110, DOI 10.1016/j.mrfmmm.2006.08.005; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Morimatsu M, 1998, CANCER RES, V58, P3441; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sharan SK, 2004, DEVELOPMENT, V131, P131, DOI 10.1242/dev.00888; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; Wu KJ, 2005, CANCER RES, V65, P417; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang YP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng080; Yang YP, 2003, HUM MOL GENET, V12, P2121, DOI 10.1093/hmg/ddg222; Yuan SSF, 1999, CANCER RES, V59, P3547	29	93	97	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2008	14	8					875	881		10.1038/nm.1719	http://dx.doi.org/10.1038/nm.1719			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18607349	Green Accepted			2022-12-25	WOS:000258237500036
J	Lu, KF; Yin, XS; Weng, TJ; Xi, SL; Li, L; Xing, GC; Cheng, X; Yang, X; Zhang, LQ; He, FC				Lu, Kefeng; Yin, Xiushan; Weng, Tujun; Xi, Shenli; Li, Li; Xing, Guichun; Cheng, Xuan; Yang, Xiao; Zhang, Lingqiang; He, Fuchu			Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1	NATURE CELL BIOLOGY			English	Article							CONTAINING PROTEIN CKIP-1; FUNCTIONAL DIVERSITY; BONE HOMEOSTASIS; NEDD4 FAMILY; DEGRADATION; OSTEOBLAST; POLARITY; RHOA	E3 ubiquitin ligases are final effectors of the enzyme cascade controlling ubiquitylation(1). A central issue in understanding their regulation is to decipher mechanisms of their assembly and activity(2). In contrast with RING-type E3s, fewer mechanisms are known for regulation of HECT-type E3s(2-4). Smad ubiquitylation regulatory factor 1 (Smurf1), a C2-WW-HECT-domain E3, is crucial for bone homeostasis, in which it suppresses osteoblast activity(5,6). However, whether and how its activity is regulated remains unclear. Here we show that Smurf1, but not Smurf2, interacts with casein kinase-2 interacting protein-1 (CKIP-1), resulting in an increase in its E3 ligase activity. Surprisingly, CKIP-1 targets specifically the linker region between the WW domains of Smurf1, thereby augmenting its affinity for and promoting ubiquitylation of the substrate. Moreover, CKIP-1-deficient mice undergo an age-dependent increase in bone mass as a result of accelerated osteogenesis and decreased Smurf1 activity. These findings provide evidence that the WW domains linker is important in complex assembly and in regulating activity of HECT-type E3s and that CKIP-1 functions as the first auxiliary factor to enhance the activation of Smurf1.	[Lu, Kefeng; Yin, Xiushan; Xi, Shenli; Li, Li; Xing, Guichun; Zhang, Lingqiang; He, Fuchu] Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Weng, Tujun; Cheng, Xuan; Yang, Xiao] Beijing Inst Biotechnol, Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Academy of Military Medical Sciences - China; Fudan University	He, FC (corresponding author), Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; hefc@nic.bmi.ac.cn	sitong, bao/GXH-5258-2022; yin, xiushan/G-9679-2016; XIAO, YANG/GPW-5529-2022	Yang, Xiao/0000-0002-0298-9831; Lu, Kefeng/0000-0001-8200-9380; Li, Li/0000-0003-2342-3658; Zhang, Lingqiang/0000-0002-9795-2141				Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	30	140	151	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					994	1002		10.1038/ncb1760	http://dx.doi.org/10.1038/ncb1760			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641638				2022-12-25	WOS:000258147100018
J	Schormair, B; Kemlink, D; Roeske, D; Eckstein, G; Xiong, L; Lichtner, P; Ripke, S; Trenkwalder, C; Zimprich, A; Stiasny-Kolster, K; Oertel, W; Bachmann, CG; Paulus, W; Hogl, B; Frauscher, B; Gschliesser, V; Poewe, W; Peglau, I; Vodicka, P; Vavrova, J; Sonka, K; Nevsimalova, S; Montplaisir, J; Turecki, G; Rouleau, G; Gieger, C; Illig, T; Wichmann, HE; Holsboer, F; Mueller-Myhsok, B; Meitinger, T; Winkelmann, J				Schormair, Barbara; Kemlink, David; Roeske, Darina; Eckstein, Gertrud; Xiong, Lan; Lichtner, Peter; Ripke, Stephan; Trenkwalder, Claudia; Zimprich, Alexander; Stiasny-Kolster, Karin; Oertel, Wolfgang; Bachmann, Cornelius G.; Paulus, Walter; Hoegl, Birgit; Frauscher, Birgit; Gschliesser, Viola; Poewe, Werner; Peglau, Ines; Vodicka, Pavel; Vavrova, Jana; Sonka, Karel; Nevsimalova, Sona; Montplaisir, Jacques; Turecki, Gustavo; Rouleau, Guy; Gieger, Christian; Illig, Thomas; Wichmann, H-Erich; Holsboer, Florian; Mueller-Myhsok, Bertram; Meitinger, Thomas; Winkelmann, Juliane			PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome	NATURE GENETICS			English	Article							PERIODIC LIMB MOVEMENTS; GENETIC RISK-FACTOR; CHROMOSOME 9P; LINKAGE; LOCUS; CANCER; FAMILY; SLEEP	We identified association of restless legs syndrome (RLS) with PTPRD at 9p23-24 in 2,458 affected individuals and 4,749 controls from Germany, Austria, Czechia and Canada. Two independent SNPs in the 5' UTR of splice variants expressed predominantly in the central nervous system showed highly significant P values (rs4626664, P(nominal/lambda corrected) = 5.91 x 10(-10), odds ratio (OR) = 1.44; rs1975197, P(nominal/lambda corrected) = 5.81 x 10(-9), OR 1.31). This work identifies PTPRD as the fourth genome-wide significant locus for RLS.	[Schormair, Barbara; Kemlink, David; Eckstein, Gertrud; Lichtner, Peter; Meitinger, Thomas; Winkelmann, Juliane] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Schormair, Barbara; Lichtner, Peter; Meitinger, Thomas; Winkelmann, Juliane] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kemlink, David; Eckstein, Gertrud; Sonka, Karel; Nevsimalova, Sona] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague 12000, Czech Republic; [Roeske, Darina; Ripke, Stephan; Holsboer, Florian; Mueller-Myhsok, Bertram; Winkelmann, Juliane] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Xiong, Lan] Univ Montreal, Hop Notre Dame de Bon Secours, Ctr Excellence Neurom, Montreal, PQ H2L 4M1, Canada; [Trenkwalder, Claudia] Paracelsus Elena Hosp, D-34128 Kassel, Germany; [Zimprich, Alexander] Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; [Stiasny-Kolster, Karin; Oertel, Wolfgang] Philipps Univ, Dept Neurol, Ctr Nervous Dis, D-35039 Marburg, Germany; [Bachmann, Cornelius G.; Paulus, Walter] Univ Gottingen, Dept Clin Neurophysiol, D-37070 Gottingen, Germany; [Hoegl, Birgit; Frauscher, Birgit; Gschliesser, Viola; Poewe, Werner] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Peglau, Ines] Neurol Praxis, D-10969 Berlin, Germany; [Vodicka, Pavel] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic; [Montplaisir, Jacques] Hop Sacre Coeur, Ctr Etude Sommeil, Montreal, PQ H4J 1C5, Canada; [Montplaisir, Jacques] Univ Montreal, Ctr Rech Sci Neurol, Montreal, PQ H4J 1C5, Canada; [Turecki, Gustavo] McGill Univ, Douglas Hosp, Dept Psychiat, Verdun, PQ H4H 1R3, Canada; McGill Univ, Douglas Hosp, Dept Human Genet, Verdun, PQ H4H 1R3, Canada; [Illig, Thomas; Wichmann, H-Erich] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol, D-85764 Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Neurol Klin & Poliklin, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Charles University Prague; Max Planck Society; Universite de Montreal; Medical University of Vienna; Philipps University Marburg; University of Gottingen; Medical University of Innsbruck; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Winkelmann, J (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.	meitinger@helmholtz-muenchen.de; winkelmann@lrz.tu-muenchen.de	Turecki, Gustavo/K-5100-2015; Vodicka, Pavel/H-3370-2014; Zimprich, Alexander/A-5232-2017; Ripke, Stephan/AAK-5486-2021; Wichmann, Heinz Erich/AAA-5695-2022; Trenkwalder, Claudia/AHD-1232-2022; Nevšímalová, Soňa/H-3533-2017; Paulus, Walter/A-3544-2009; Šonka, Karel/G-1801-2017; Kemlink, David/Q-3019-2019; Kemlink, David/F-9567-2017; Meitinger, Thomas/O-1318-2015; Trenkwalder, Claudia/ABD-6559-2021	Zimprich, Alexander/0000-0002-1668-5177; Trenkwalder, Claudia/0000-0001-6407-1199; Nevšímalová, Soňa/0000-0003-0083-3742; Paulus, Walter/0000-0001-5549-8377; Šonka, Karel/0000-0001-5773-9656; Kemlink, David/0000-0003-1398-5796; Vodicka, Pavel/0000-0003-2376-1243; Hogl, Birgit/0000-0003-1894-7641; ripke, stephan/0000-0003-3622-835X; Meitinger, Thomas/0000-0002-8838-8403; Gieger, Christian/0000-0001-6986-9554; Winkelmann, Juliane/0000-0003-2667-9691; Turecki, Gustavo/0000-0003-4075-2736				Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Bonnen PE, 2002, GENOME RES, V12, P1846, DOI 10.1101/gr.483802; Chen SH, 2004, AM J HUM GENET, V74, P876, DOI 10.1086/420772; Kemlink D, 2007, MOVEMENT DISORD, V22, P207, DOI 10.1002/mds.21254; Liebetanz KM, 2006, NEUROLOGY, V67, P320, DOI 10.1212/01.wnl.0000224886.65213.b5; Lohmann-Hedrich K, 2008, NEUROLOGY, V70, P686, DOI 10.1212/01.wnl.0000282760.07650.ba; Nair P, 2008, GENE CHROMOSOME CANC, V47, P197, DOI 10.1002/gcc.20521; PULIDO R, 1995, J BIOL CHEM, V270, P6722, DOI 10.1074/jbc.270.12.6722; Ray A, 2005, AM J HUM GENET, V76, P705, DOI 10.1086/429392; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Vilarino-Guell C, 2008, NEW ENGL J MED, V358, P425, DOI 10.1056/NEJMc072518; Winkelmann J, 2007, MOVEMENT DISORD, V22, pS449, DOI 10.1002/mds.21587; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099	15	190	195	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					946	948		10.1038/ng.190	http://dx.doi.org/10.1038/ng.190			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18660810				2022-12-25	WOS:000258026900008
J	Palavalli, LH; Prickett, TD; Wunderlich, JR; Wei, XM; Burrell, AS; Porter-Gill, P; Davis, S; Wang, CW; Cronin, JC; Agrawal, NS; Lin, JC; Westbroek, W; Hoogstraten-Miller, S; Molinolo, AA; Fetsch, P; Filie, AC; O'Connell, MP; Banister, CE; Howard, JD; Buckhaults, P; Weeraratna, AT; Brody, LC; Rosenberg, SA; Samuels, Y				Palavalli, Lavanya H.; Prickett, Todd D.; Wunderlich, John R.; Wei, Xiaomu; Burrell, Allison S.; Porter-Gill, Patricia; Davis, Sean; Wang, Chenwei; Cronin, Julia C.; Agrawal, Neena S.; Lin, Jimmy C.; Westbroek, Wendy; Hoogstraten-Miller, Shelley; Molinolo, Alfredo A.; Fetsch, Patricia; Filie, Armando C.; O'Connell, Michael P.; Banister, Carolyn E.; Howard, Jason D.; Buckhaults, Phillip; Weeraratna, Ashani T.; Brody, Lawrence C.; Rosenberg, Steven A.; Samuels, Yardena			Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma	NATURE GENETICS			English	Article							HUMAN BREAST; CANCER; PROGRESSION; METASTASIS	A mutational analysis of the matrix metalloproteinase (MMP) gene family in human melanoma identified somatic mutations in 23% of melanomas. Five mutations in one of the most commonly mutated genes, MMP8, reduced MMP enzyme activity. Expression of wild-type but not mutant MMP8 in human melanoma cells inhibited growth on soft agar in vitro and tumor formation in vivo, suggesting that wild-type MMP-8 has the ability to inhibit melanoma progression.	[Palavalli, Lavanya H.; Prickett, Todd D.; Wei, Xiaomu; Burrell, Allison S.; Porter-Gill, Patricia; Wang, Chenwei; Cronin, Julia C.; Agrawal, Neena S.; Westbroek, Wendy; Hoogstraten-Miller, Shelley; Brody, Lawrence C.; Samuels, Yardena] NHGRI, NIH, Bethesda, MD 20892 USA; [Wunderlich, John R.; Davis, Sean; Fetsch, Patricia; Filie, Armando C.; Rosenberg, Steven A.] NCI, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Molinolo, Alfredo A.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [O'Connell, Michael P.; Weeraratna, Ashani T.] NIA, Immunol Lab, NIH, Baltimore, MD 21224 USA; [Banister, Carolyn E.; Buckhaults, Phillip] Univ S Carolina, Sch Med, Columbia, SC USA; [Howard, Jason D.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Johns Hopkins University; Johns Hopkins Medicine	Samuels, Y (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	samuelsy@mail.nih.gov	O'Connell, Michael/F-9236-2017; Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Samuels, Yardena/0000-0002-3349-7266; O'Connell, Michael/0000-0002-8615-7660	National Human Genome Research Institute; National Institute on Aging; NATIONAL CANCER INSTITUTE [ZIABC010984, ZICBC011052, ZICBC010905] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200337, ZIAHG000120, ZIGHG200356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000442] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Xu, J. Polite, I. Cardenas-Navia, D. Leja and I. Ginty for technical assistance. We thank R. Weinberg (Massachusetts Institute of Technology) for the Mel-STR cells, and W. Gahl (National Institutes of Health) and R. Alani (Johns Hopkins University) for normal melanocyte RNA. We also thank L. Matrisian, P. Meltzer, T. Waldman, G. Merlino, T. Hornyak and T. Bugge for their comments on the manuscript. Funded by the National Human Genome Research Institute and National Institute on Aging.	Acuff HB, 2006, CANCER RES, V66, P7968, DOI 10.1158/0008-5472.CAN-05-4279; *AM JOINT COMM CAN, 2004, CANC STAG HDB, P469; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Freije JMP, 2003, ADV EXP MED BIOL, V532, P91; Gorrin-Rivas MJ, 2000, CLIN CANCER RES, V6, P1647; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427	15	111	113	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					518	520		10.1038/ng.340	http://dx.doi.org/10.1038/ng.340			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19330028	Green Accepted			2022-12-25	WOS:000265575600010
J	Ball, MP; Li, JB; Gao, Y; Lee, JH; LeProust, EM; Park, IH; Xie, B; Daley, GQ; Church, GM				Ball, Madeleine P.; Li, Jin Billy; Gao, Yuan; Lee, Je-Hyuk; LeProust, Emily M.; Park, In-Hyun; Xie, Bin; Daley, George Q.; Church, George M.			Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells	NATURE BIOTECHNOLOGY			English	Article							DNA METHYLATION; ARABIDOPSIS; GENERATION; RESOLUTION; TRANSCRIPTION; PLURIPOTENT; EPIGENETICS; METHYLOME; PROBES; MAPS	Studies of epigenetic modifications would benefit from improved methods for high-throughput methylation profiling. We introduce two complementary approaches that use next-generation sequencing technology to detect cytosine methylation. In the first method, we designed similar to 10,000 bisulfite padlock probes to profile similar to 7,000 CpG locations distributed over the ENCODE pilot project regions and applied them to human B-lymphocytes, fibroblasts and induced pluripotent stem cells. This unbiased choice of targets takes advantage of existing expression and chromatin immunoprecipitation data and enabled us to observe a pattern of low promoter methylation and high gene-body methylation in highly expressed genes. The second method, methyl-sensitive cut counting, generated nontargeted genome-scale data for similar to 1.4 million HpaII sites in the DNA of B-lymphocytes and confirmed that gene-body methylation in highly expressed genes is a consistent phenomenon throughout the human genome. Our observations highlight the usefulness of techniques that are not inherently or intentionally biased towards particular subsets like CpG islands or promoter regions.	[Ball, Madeleine P.; Li, Jin Billy; Lee, Je-Hyuk; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02138 USA; [Ball, Madeleine P.; Li, Jin Billy; Lee, Je-Hyuk; Church, George M.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Gao, Yuan; Xie, Bin] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [LeProust, Emily M.] Agilent Technol, Genom Solut Unit, Santa Clara, CA USA; [Park, In-Hyun; Daley, George Q.] Childrens Hosp, Dept Med, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun; Daley, George Q.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Virginia Commonwealth University; Agilent Technologies; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02138 USA.	jli@genetics.med.harvard.edu; gmc@harvard.edu	Gao, Yuan/E-1706-2011	church, george/0000-0001-6232-9969; Ball, Mad/0000-0003-0544-5925	NHGRI-Centers of Excellence in Genomic Science; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	NHGRI-Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Kun Zhang for discussion throughout this work; Wei Lin for help with computational design; Andrew Chess and Ravid Straussman for discussion and critical reading of the manuscript; Harvard Biopolymers Facility for Solexa sequencing; and Harvard Partners Center for Genetics and Genomics for gene expression profiling. This work was supported by the NHGRI-Centers of Excellence in Genomic Science (to G. M. C.).	Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; BIRD AP, 1978, J MOL BIOL, V118, P27, DOI 10.1016/0022-2836(78)90242-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shann YJ, 2008, GENOME RES, V18, P791, DOI 10.1101/gr.070961.107; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	41	751	814	1	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					361	368		10.1038/nbt.1533	http://dx.doi.org/10.1038/nbt.1533			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19329998	Green Submitted, Green Accepted			2022-12-25	WOS:000264971800022
J	Ayroles, JF; Carbone, MA; Stone, EA; Jordan, KW; Lyman, RF; Magwire, MM; Rollmann, SM; Duncan, LH; Lawrence, F; Anholt, RRH; Mackay, TFC				Ayroles, Julien F.; Carbone, Mary Anna; Stone, Eric A.; Jordan, Katherine W.; Lyman, Richard F.; Magwire, Michael M.; Rollmann, Stephanie M.; Duncan, Laura H.; Lawrence, Faye; Anholt, Robert R. H.; Mackay, Trudy F. C.			Systems genetics of complex traits in Drosophila melanogaster	NATURE GENETICS			English	Article							EXPRESSION; SEX; EVOLUTION; NETWORKS; FITNESS; SELECTION; PROTEINS; GENOMICS; BEHAVIOR; GENES	Determining the genetic architecture of complex traits is challenging because phenotypic variation arises from interactions between multiple, environmentally sensitive alleles. We quantified genome-wide transcript abundance and phenotypes for six ecologically relevant traits in D. melanogaster wild-derived inbred lines. We observed 10,096 genetically variable transcripts and high heritabilities for all organismal phenotypes. The transcriptome is highly genetically intercorrelated, forming 241 transcriptional modules. Modules are enriched for transcripts in common pathways, gene ontology categories, tissue-specific expression and transcription factor binding sites. The high degree of transcriptional connectivity allows us to infer genetic networks and the function of predicted genes from annotations of other genes in the network. Regressions of organismal phenotypes on transcript abundance implicate several hundred candidate genes that form modules of biologically meaningful correlated transcripts affecting each phenotype. Overlapping transcripts in modules associated with different traits provide insight into the molecular basis of pleiotropy between complex traits.	[Ayroles, Julien F.; Carbone, Mary Anna; Jordan, Katherine W.; Lyman, Richard F.; Magwire, Michael M.; Rollmann, Stephanie M.; Duncan, Laura H.; Lawrence, Faye; Anholt, Robert R. H.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Ayroles, Julien F.; Carbone, Mary Anna; Jordan, Katherine W.; Lyman, Richard F.; Magwire, Michael M.; Rollmann, Stephanie M.; Duncan, Laura H.; Lawrence, Faye; Anholt, Robert R. H.; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Stone, Eric A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu	Anholt, Robert/S-5977-2019; Stone, Eric/Q-7840-2016	Stone, Eric/0000-0002-2725-4209	NIAAA NIH HHS [R01 AA016560] Funding Source: Medline; NIGMS NIH HHS [R01 GM076083, R01 GM059469, R01 GM 59469, R01 GM045146, R01 GM 076083, R01 GM 45146, R01 GM059469-12A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059469, R01GM076083, R01GM045146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016560] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Date-Ito A, 2002, J MOL EVOL, V54, P665, DOI 10.1007/s00239-001-0062-5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeZazzo J, 2000, NEURON, V27, P145, DOI 10.1016/S0896-6273(00)00016-7; *DROS 12 GEN CONS, 2007, NATURE, V45, P203; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Falconer D. S, 1996, INTRO QUANTITATIVE G; Foronda D, 2006, DEVELOPMENT, V133, P117, DOI 10.1242/dev.02173; HARTL DL, 1979, EVOLUTION, V33, P371, DOI 10.1111/j.1558-5646.1979.tb04690.x; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KNIGHT GR, 1957, GENETICS, V42, P524; Lemos B, 2008, P NATL ACAD SCI USA, V105, P14471, DOI 10.1073/pnas.0805160105; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morozova TV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r231; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Robertson A., 1967, Heritage from Mendel., P265; Robertson LK, 2004, DEVELOPMENT, V131, P2781, DOI 10.1242/dev.01159; Rollmann SM, 2006, NAT GENET, V38, P824, DOI 10.1038/ng1823; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; *WELLC TRUST CAS C, 2007, NATURE, V44, P66; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wolfner M.F., 2007, P183; Wong A, 2008, MOL BIOL EVOL, V25, P497, DOI 10.1093/molbev/msm270; Yamamoto A, 2008, P NATL ACAD SCI USA, V105, P12393, DOI 10.1073/pnas.0804889105; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	48	396	401	1	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					299	307		10.1038/ng.332	http://dx.doi.org/10.1038/ng.332			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19234471	Green Accepted			2022-12-25	WOS:000263640200010
J	Shakya, A; Cooksey, R; Cox, JE; Wang, V; McClain, DA; Tantin, D				Shakya, Arvind; Cooksey, Robert; Cox, James E.; Wang, Victoria; McClain, Donald A.; Tantin, Dean			Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity	NATURE CELL BIOLOGY			English	Article							HISTONE H2B; POU DOMAIN; TRANSCRIPTION; IMMUNOGLOBULIN; PROMOTER; CANCER; BINDING; ENHANCER; ACTIVATION; EXPRESSION	Cancer cells frequently undergo a shift from oxidative to glycolytic metabolism(1). Although there is interest in targeting metabolism as a form of cancer therapy, this area still remains in its infancy. Using cells, embryos and adult animals, we show here that loss of the widely expressed transcription factor Oct1 induces a coordinated metabolic shift: mitochondrial activity and amino acid oxidation are increased, while glucose metabolism is reduced. Altered expression of direct Oct1 targets encoding metabolic regulators provides a mechanistic underpinning to these results. We show that these metabolic changes directly oppose tumorigenicity. Collectively, our findings show that Oct1, the genes it regulates and the pathways these genes affect could be used as targets for new modes of cancer therapy.	[Shakya, Arvind; Tantin, Dean] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Cooksey, Robert; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA; [Cox, James E.] Univ Utah, Sch Med, Hlth Sci Ctr, Core Res Facil, Salt Lake City, UT 84112 USA; [Wang, Victoria] Harvard Radiat Oncol Program, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School	Tantin, D (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA.	dean.tantin@path.utah.edu		McClain, Don/0000-0002-3310-2359; Shakya, Arvind/0000-0001-7993-6159	Centers of Excellence Grant in Molecular Haematology; National Institutes of Health; American Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043526] Funding Source: NIH RePORTER	Centers of Excellence Grant in Molecular Haematology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to J. Kaplan for helpful suggestions during the formative stages of this work. We thank D. Ayer and J. Rutter for critical reading of the manuscript. C. Cheng provided the H - RasV12 retroviral construct and T. Jacks provided p53 -/ - mice. We thank D. Abel and J. Soto for use of laboratory equipment and N. Chandler and the EM core facility for TEM. We thank P. Sharp and members of his laboratory for invaluable assistance. We also thank D. Stillman, J. Rutter, S. Lessnick and J. Shaw for helpful advice and reagents. This work was supported by a Centers of Excellence Grant in Molecular Haematology from the National Institutes of Health and a grant from the American Cancer Society to D. T.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Debidda M, 2006, J BIOL CHEM, V281, P38519, DOI 10.1074/jbc.M604607200; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Glahn F, 2008, ARCH TOXICOL, V82, P513, DOI 10.1007/s00204-008-0331-9; GUNDERSON SI, 1988, J BIOL CHEM, V263, P17603; Hafstad AD, 2006, AM J PHYSIOL-HEART C, V290, pH1763, DOI 10.1152/ajpheart.01063.2005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; HICKS GG, 1991, MOL CELL BIOL, V11, P1344, DOI 10.1128/MCB.11.3.1344; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; Melgar S, 2007, AM J PHYSIOL-GASTR L, V292, pG165, DOI 10.1152/ajpgi.00152.2006; QIN XF, 1994, EMBO J, V13, P5967, DOI 10.1002/j.1460-2075.1994.tb06942.x; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SAKAI K, 1988, BIOCHIM BIOPHYS ACTA, V952, P297, DOI 10.1016/0167-4838(88)90130-6; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; Stryer L., 2006, BIOCHEMISTRY; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Wang VEH, 2004, P NATL ACAD SCI USA, V101, P2005, DOI 10.1073/pnas.0307304101; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	36	77	79	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					320	U204		10.1038/ncb1840	http://dx.doi.org/10.1038/ncb1840			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19219035				2022-12-25	WOS:000263777900016
J	Tiranti, V; Viscomi, C; Hildebrandt, T; Di Meo, I; Mineri, R; Tiveron, C; Levitt, MD; Prelle, A; Fagiolari, G; Rimoldi, M; Zeviani, M				Tiranti, Valeria; Viscomi, Carlo; Hildebrandt, Tatjana; Di Meo, Ivano; Mineri, Rossana; Tiveron, Cecilia; Levitt, Michael D.; Prelle, Alessandro; Fagiolari, Gigliola; Rimoldi, Marco; Zeviani, Massimo			Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy	NATURE MEDICINE			English	Article							HYDROGEN-SULFIDE; OXIDASE DEFICIENCY; ACIDURIA; PROTEIN; MUTATIONS; GENE; IDENTIFICATION; THIOSULFATE; OXIDATION; OXIDOREDUCTASE	Ethylmalonic encephalopathy is an autosomal recessive, invariably fatal disorder characterized by early-onset encephalopathy, microangiopathy, chronic diarrhea, defective cytochrome c oxidase (COX) in muscle and brain, high concentrations of C4 and C5 acylcarnitines in blood and high excretion of ethylmalonic acid in urine. ETHE1, a gene encoding a beta-lactamase-like, iron-coordinating metalloprotein, is mutated in ethylmalonic encephalopathy. In bacteria, ETHE1-like sequences are in the same operon of, or fused with, orthologs of TST, the gene encoding rhodanese, a sulfurtransferase. In eukaryotes, both ETHE1 and rhodanese are located within the mitochondrial matrix. We created a Ethe1(-/-) mouse that showed the cardinal features of ethylmalonic encephalopathy. We found that thiosulfate was excreted in massive amounts in urine of both Ethe1(-/-) mice and humans with ethylmalonic encephalopathy. High thiosulfate and sulfide concentrations were present in Ethe1(-/-) mouse tissues. Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients. Sulfide is detoxified by a mitochondrial pathway that includes a sulfur dioxygenase. Sulfur dioxygenase activity was absent in Ethe1(-/-) mice, whereas it was markedly increased by ETHE1 overexpression in HeLa cells and Escherichia coli. Therefore, ETHE1 is a mitochondrial sulfur dioxygenase involved in catabolism of sulfide that accumulates to toxic levels in ethylmalonic encephalopathy.	[Tiranti, Valeria; Viscomi, Carlo; Di Meo, Ivano; Mineri, Rossana; Zeviani, Massimo] IRCCS Fdn, Inst Neurol Carlo Besta, Pierfranco & Luisa Mariani Ctr Res Childrens Mito, Unit Mol Neurogenet, I-20126 Milan, Italy; [Hildebrandt, Tatjana] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Tiveron, Cecilia] Fdn European Brain Res Inst EBRI Rita Levi Montal, Dis Modelling Facil, I-00143 Rome, Italy; [Levitt, Michael D.] Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA; [Prelle, Alessandro; Fagiolari, Gigliola] Mangiagalli & Regina Elena IRCCS Fdn, Osped Maggiore Policlin, Div Neurol, Dino Ferrari Ctr, I-20122 Milan, Italy; [Rimoldi, Marco] Inst Neurol Carlo Besta IRCCS Fdn, Unit Biochem & Genet, I-20133 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Heinrich Heine University Dusseldorf; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta	Tiranti, V (corresponding author), IRCCS Fdn, Inst Neurol Carlo Besta, Pierfranco & Luisa Mariani Ctr Res Childrens Mito, Unit Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.	tiranti@istituto-besta.it; zeviani@istituto-besta.it	Di Meo, Ivano/A-4668-2009; Zeviani, Massimo/K-2891-2014; Di Meo, Ivano/H-7840-2014; Zeviani, Massimo/AAU-2632-2021; viscomi, Carlo/R-1940-2016; Tiranti, Valeria/AFN-5783-2022; Tiranti, Valeria/J-8233-2016	Di Meo, Ivano/0000-0002-4616-5623; Zeviani, Massimo/0000-0002-9067-5508; Tiranti, Valeria/0000-0002-3584-7338; Tiranti, Valeria/0000-0002-3584-7338; prelle, alessandro/0000-0002-7019-5291; Hildebrandt, Tatjana/0000-0002-3562-5241; Viscomi, Carlo/0000-0001-6050-0566	Pierfranco and Luisa Mariani Foundation Italy, Fondazione Telethon-Italy [GGP07019]; Italian Ministry of University and Research [RBLA038RMA]; European Union; Deutsche Forschungsgemeinschaft [GR 456/22-1]	Pierfranco and Luisa Mariani Foundation Italy, Fondazione Telethon-Italy(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Bradley ( The Wellcome Trust Sanger Institute) for AB1 mouse embryonic stem cells. We are grateful to M. Bada for skillful technical assistance; to B. Garavaglia, E. Lamantea, F. Forlani and M. K. Grieshaber for valuable discussion; to the Chemical Analysis Laboratory, University of Georgia, for metal analysis; and to Primm for MALDI TOF mass spectometry analysis. This work was supported by the Pierfranco and Luisa Mariani Foundation Italy, Fondazione Telethon-Italy grant number GGP07019, the Italian Ministry of University and Research (FIRB 2003-project RBLA038RMA), MITOCIRCLE and EUMITOCOMBAT network grants from the European Union framework program 6 and by the Deutsche Forschungsgemeinschaft (GR 456/22-1).	BELLA DL, 1995, AM J PHYSIOL-ENDOC M, V269, pE910, DOI 10.1152/ajpendo.1995.269.5.E910; BENNETT MJ, 1984, J INHERIT METAB DIS, V7, P57, DOI 10.1007/BF01805802; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; BURLINA AB, 1991, LANCET, V338, P1522, DOI 10.1016/0140-6736(91)92338-3; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; DIDONATO S, 1986, NEUROLOGY, V36, P957; Dorman DC, 2002, TOXICOL SCI, V65, P18, DOI 10.1093/toxsci/65.1.18; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GARCIASILVA MT, 1994, J PEDIATR-US, V125, P843, DOI 10.1016/S0022-3476(06)80197-6; GarciaSilva MT, 1997, PEDIATR NEUROL, V17, P165, DOI 10.1016/S0887-8994(97)00048-9; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Gregersen N, 1998, HUM MOL GENET, V7, P619, DOI 10.1093/hmg/7.4.619; Higashitsuji H, 2002, CANCER CELL, V2, P335, DOI 10.1016/S1535-6108(02)00152-6; Higashitsuji H, 2007, J BIOL CHEM, V282, P13716, DOI 10.1074/jbc.M609751200; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Koeberl DD, 2003, PEDIATR RES, V54, P219, DOI 10.1203/01.PDR.0000074972.36356.89; Leschelle X, 2005, BBA-GEN SUBJECTS, V1725, P201, DOI 10.1016/j.bbagen.2005.06.002; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271; Moroni I, 2000, NEUROL SCI, V21, P103, DOI 10.1007/s100720070104; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; Sass JO, 2008, MOL GENET METAB, V93, P30, DOI 10.1016/j.ymgme.2007.09.002; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; SHIH VE, 1979, CLIN CHIM ACTA, V95, P143, DOI 10.1016/0009-8981(79)90348-6; SORBO B, 1987, METHOD ENZYMOL, V143, P3; SORBO BH, 1955, METHOD ENZYMOL, V2, P334, DOI 10.1016/S0076-6879(55)02207-6; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Theissen U, 2008, FEBS J, V275, P1131, DOI 10.1111/j.1742-4658.2008.06273.x; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Vockley J, 2006, AM J MED GENET C, V142C, P95, DOI 10.1002/ajmg.c.30089	39	264	277	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2009	15	2					200	205		10.1038/nm.1907	http://dx.doi.org/10.1038/nm.1907			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19136963	Green Published			2022-12-25	WOS:000263119400023
J	Bakhoum, SF; Thompson, SL; Manning, AL; Compton, DA				Bakhoum, Samuel F.; Thompson, Sarah L.; Manning, Amity L.; Compton, Duane A.			Genome stability is ensured by temporal control of kinetochore-microtubule dynamics	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; MAMMALIAN TISSUE-CELLS; AURORA-B; CHROMOSOME INSTABILITY; COLORECTAL CANCERS; MITOTIC CENTROMERE; CLONAL EVOLUTION; ERROR-CORRECTION; REGULATES MCAK; MITOSIS	Most solid tumours are aneuploid and many frequently mis-segregate chromosomes. This chromosomal instability is commonly caused by persistent mal-oriented attachment of chromosomes to spindle microtubules. Chromosome segregation requires stable microtubule attachment at kinetochores, yet those attachments must be sufficiently dynamic to permit correction of mal-orientations. How this balance is achieved is unknown, and the permissible boundaries of attachment stability versus dynamics essential for genome stability remain poorly understood. Here we show that two microtubule-depolymerizing kinesins, Kif2b and MCAK, stimulate kinetochore-microtubule dynamics during distinct phases of mitosis to correct mal-orientations. Few-fold reductions in kinetochore-microtubule turnover, particularly in early mitosis, induce severe chromosome segregation defects. In addition, we show that stimulation of microtubule dynamics at kinetochores restores stability to chromosomally unstable tumour cell lines, establishing a causal relationship between deregulation of kinetochore-microtubule dynamics and chromosomal instability. Thus, temporal control of microtubule attachment to chromosomes during mitosis is central to genome stability in human cells.	[Bakhoum, Samuel F.; Thompson, Sarah L.; Manning, Amity L.; Compton, Duane A.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Bakhoum, Samuel F.; Thompson, Sarah L.; Manning, Amity L.; Compton, Duane A.] Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	Dartmouth College; Norris Cotton Cancer Center	Compton, DA (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	duane.a.compton@dartmouth.edu	Manning, Amity/AAC-8205-2019	Manning, Amity/0000-0003-1332-9086; Compton, Duane/0000-0002-4445-9118; Bakhoum, Samuel/0000-0002-4779-8422	National Institutes of Health [GM51542, GM008704]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051542, T32GM008704, R01GM051542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Linda Wordeman (University of Washington) for providing plasmids encoding GFP-tagged proteins, Tarun Kapoor for providing Hesperadin, and Kevin Sullivan for providing the CenpB-GFP U2OS cells. This work was supported by National Institutes of Health grants GM51542 to D. A. C. and GM008704 to S. L. T.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 1999, MUTAGENESIS, V14, P563, DOI 10.1093/mutage/14.6.563; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HOULSTON R, 2008, GUT, DOI DOI 10.1136/GUT.2007.135004; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RAJAGOPALAN H, 2001, NATURE, V409, P355; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	39	310	316	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					27	U51		10.1038/ncb1809	http://dx.doi.org/10.1038/ncb1809			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060894	Green Accepted			2022-12-25	WOS:000262157000008
J	Foudi, A; Hochedlinger, K; Van Buren, D; Schindler, JW; Jaenisch, R; Carey, V; Hock, H				Foudi, Adlen; Hochedlinger, Konrad; Van Buren, Denille; Schindler, Jeffrey W.; Jaenisch, Rudolf; Carey, Vincent; Hock, Hanno			Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells	NATURE BIOTECHNOLOGY			English	Article							SELF-RENEWAL; PROLIFERATION; QUIESCENCE; NICHE; IDENTIFICATION; RECONSTITUTION; EXPRESSION; GFI-1; MICE	Hematopoietic stem cells (HSCs) are thought to divide infrequently based on their resistance to cytotoxic injury targeted at rapidly cycling cells(1,2) and have been presumed to retain labels such as the thymidine analog 5-bromodeoxyuridine (BrdU). However, BrdU retention is neither a sensitive nor specific marker for HSCs3. Here we show that transient, transgenic expression of a histone 2B (H2B)-green fluorescent protein (GFP) fusion protein in mice has several advantages for label-retention studies over BrdU, including rapid induction of H2B-GFP in virtually all HSCs, higher labeling intensity and the ability to prospectively study label-retaining cells, which together permit a more precise analysis of division history. Mathematical modeling of H2B-GFP dilution in HSCs, identified with a stringent marker combination (L-K(+)S(+)CD48(-)CD150(+))(4), revealed unexpected heterogeneity in their proliferation rates and showed that similar to 20% of HSCs divide at an extremely low rate (<= 0.8-1.8% per day). (C) 2009 Nature America, Inc. All rights reserved.	[Foudi, Adlen; Hochedlinger, Konrad; Van Buren, Denille; Schindler, Jeffrey W.; Hock, Hanno] Ctr Canc, Boston, MA 02114 USA; [Foudi, Adlen; Hochedlinger, Konrad; Van Buren, Denille; Schindler, Jeffrey W.; Hock, Hanno] Ctr Regenerat Med, Boston, MA 02114 USA; [Foudi, Adlen; Hochedlinger, Konrad; Van Buren, Denille; Schindler, Jeffrey W.; Hock, Hanno] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Foudi, Adlen; Hochedlinger, Konrad; Carey, Vincent; Hock, Hanno] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hochedlinger, Konrad; Hock, Hanno] Harvard Stem Cell Inst, Boston, MA 02114 USA; [Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Cambridge, MA 02142 USA; [Carey, Vincent] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital	Hock, H (corresponding author), Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	Hock.Hanno@mgh.harvard.edu	Foudi, Adlen/L-7251-2018	Foudi, Adlen/0000-0001-5002-5490	Ellison Foundation; Harvard Stem Cell Institute; NIH; Kimmel Foundation; V Foundation;  [RO1CA122726]; NATIONAL CANCER INSTITUTE [R01CA122726] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Foundation; V Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Laura Prickett and Kat Folz-Donahue from the HSCI Flow-core at Massachusetts General Hospital (MGH) for their expert assistance, Geoffrey Wahl for providing the H2B-GFP cDNA, and Matthias Stadtfeld, Wenjun Guo and Ben Wittner for valuable input. We thank Linheng Li for the kind gift of biotinylated MNCD-2. We thank Mark Kiel and Sean Morrison for sharing unpublished results and for the gift of excised bone marrow of conditional N-cadherin mutant mice. We thank Glenn Radice for permission to use bone marrow from conditional N-cadherin mutant mice. This work was supported by a contribution from the Ellison Foundation to MGH startup funds for H. H., a seed grant by Harvard Stem Cell Institute to H. H. and by RO1CA122726. H. H. is the recipient of an ASH Scholar Award. K. H. was supported by the NIH Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation. A. F. was the recipient of an MGH ECOR Fund for Medical Discovery Award.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bradford GB, 1997, EXP HEMATOL, V25, P445; Chen CZ, 2003, IMMUNITY, V19, P525, DOI 10.1016/S1074-7613(03)00265-6; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; JOHNSON NL, 1994, CONTINUOUS UNIFORM D; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LERNER C, 1990, EXP HEMATOL, V18, P114; Miller R. G., 1981, SURVIVAL ANAL; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	37	406	411	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2009	27	1					84	90		10.1038/nbt.1517	http://dx.doi.org/10.1038/nbt.1517			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	394TP	19060879	Green Accepted			2022-12-25	WOS:000262471200027
J	Brunetti-Pierri, N; Berg, JS; Scaglia, F; Belmont, J; Bacino, CA; Sahoo, T; Lalani, SR; Graham, B; Lee, B; Shinawi, M; Shen, J; Kang, SHL; Pursley, A; Lotze, T; Kennedy, G; Lansky-Shafer, S; Weaver, C; Roeder, ER; Grebe, TA; Arnold, GL; Hutchison, T; Reimschisel, T; Amato, S; Geragthy, MT; Innis, JW; Obersztyn, E; Nowakowska, B; Rosengren, SS; Bader, PI; Grange, DK; Naqvi, S; Garnica, AD; Bernes, SM; Fong, CT; Summers, A; Walters, WD; Lupski, JR; Stankiewicz, P; Cheung, SW; Patel, A				Brunetti-Pierri, Nicola; Berg, Jonathan S.; Scaglia, Fernando; Belmont, John; Bacino, Carlos A.; Sahoo, Trilochan; Lalani, Seema R.; Graham, Brett; Lee, Brendan; Shinawi, Marwan; Shen, Joseph; Kang, Sung-Hae L.; Pursley, Amber; Lotze, Timothy; Kennedy, Gail; Lansky-Shafer, Susan; Weaver, Christine; Roeder, Elizabeth R.; Grebe, Theresa A.; Arnold, Georgianne L.; Hutchison, Terry; Reimschisel, Tyler; Amato, Stephen; Geragthy, Michael T.; Innis, Jeffrey W.; Obersztyn, Ewa; Nowakowska, Beata; Rosengren, Sally S.; Bader, Patricia I.; Grange, Dorothy K.; Naqvi, Sayed; Garnica, Adolfo D.; Bernes, Saunder M.; Fong, Chin-To; Summers, Anne; Walters, W. David; Lupski, James R.; Stankiewicz, Pawel; Cheung, Sau Wai; Patel, Ankita			Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; CHROMOSOME 1Q21.1; HUMAN GENOME; BRAIN SIZE; LONG ARM; SCHIZOPHRENIA; HYDIN; ASPM; GENE; MICRODELETION	Chromosome region 1q21.1 contains extensive and complex low-copy repeats, and copy number variants (CNVs) in this region have recently been reported in association with congenital heart defects(1), developmental delay(2,3), schizophrenia and related psychoses(4,5). We describe 21 probands with the 1q21.1 microdeletion and 15 probands with the 1q21.1 microduplication. These CNVs were inherited in most of the cases in which parental studies were available. Consistent and statistically significant features of microcephaly and macrocephaly were found in individuals with microdeletion and microduplication, respectively. Notably, a paralog of the HYDIN gene located on 16q22.2 and implicated in autosomal recessive hydrocephalus(6) was inserted into the 1q21.1 region during the evolution of Homo sapiens(7); we found this locus to be deleted or duplicated in the individuals we studied, making it a probable candidate for the head size abnormalities observed. We propose that recurrent reciprocal microdeletions and microduplications within 1q21.1 represent previously unknown genomic disorders characterized by abnormal head size along with a spectrum of developmental delay, neuropsychiatric abnormalities, dysmorphic features and congenital anomalies. These phenotypes are subject to incomplete penetrance and variable expressivity.	[Brunetti-Pierri, Nicola; Berg, Jonathan S.; Scaglia, Fernando; Belmont, John; Bacino, Carlos A.; Sahoo, Trilochan; Lalani, Seema R.; Graham, Brett; Lee, Brendan; Shinawi, Marwan; Shen, Joseph; Kang, Sung-Hae L.; Pursley, Amber; Lupski, James R.; Stankiewicz, Pawel; Cheung, Sau Wai; Patel, Ankita] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Lotze, Timothy] Texas Childrens Hosp, Dept Pediat, Neurol Sect, Houston, TX 77030 USA; [Kennedy, Gail; Lansky-Shafer, Susan; Weaver, Christine] Carle Clin Assoc, Urbana, IL 61821 USA; [Kennedy, Gail; Lansky-Shafer, Susan; Weaver, Christine] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Roeder, Elizabeth R.] Univ Texas Hlth Sci Ctr San Antonio, Div Genet & Metab Disorders, Dept Pediat, San Antonio, TX 78207 USA; [Grebe, Theresa A.] St Josephs Hosp, CHC Phoenix Genet Program, Phoenix, AZ 85013 USA; [Arnold, Georgianne L.; Fong, Chin-To] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hutchison, Terry] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Reimschisel, Tyler; Grange, Dorothy K.] Washington Univ, Sch Med, Div Genet & Genom Med, St Louis, MO 63110 USA; [Amato, Stephen] Eastern Maine Med Ctr, Dept Med Genet, Bangor, ME 04401 USA; [Geragthy, Michael T.] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Innis, Jeffrey W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Innis, Jeffrey W.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Obersztyn, Ewa; Nowakowska, Beata] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Rosengren, Sally S.] Univ Connecticut, Sch Med, Div Human Genet, Farmington, CT 06030 USA; [Bader, Patricia I.] Parkview Hosp, Dept Cytogenet, Ft Wayne, IN 46805 USA; [Naqvi, Sayed] Miami Childrens Hosp, Dept Neurol, Miami, FL 33155 USA; [Garnica, Adolfo D.] Oklahoma State Univ, Dept Pediat, Tulsa, OK 74127 USA; [Bernes, Saunder M.] Phoenix Childrens Hosp, Dept Neurol, Phoenix, AZ 85016 USA; [Summers, Anne] N York Gen Hosp, Toronto, ON P1B 4E7, Canada; [Walters, W. David] Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72202 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Health San Antonio; St. Joseph's Hospital and Medical Center; University of Rochester; University of California System; University of California San Francisco; Washington University (WUSTL); Eastern Maine Medical Center; University of Ottawa; Children's Hospital of Eastern Ontario; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Connecticut; Phoenix Children's Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; Arkansas Children's Hospital	Patel, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	ankitap@bcm.edu	Belmont, John W/AAI-2494-2019; Stankiewicz, Paweł/AAP-7906-2021; Lalani, Seema/AAI-5090-2020; Shen, Joseph/AAY-5083-2020; Brunetti-Pierri, Nicola/K-8465-2016; Patel, Ankita/D-3247-2013; Belmont, John/AAH-6084-2021; Graham, Brett/R-8685-2018	Belmont, John W/0000-0001-7409-3578; Stankiewicz, Paweł/0000-0002-6456-7490; Shen, Joseph/0000-0002-5604-7639; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Graham, Brett/0000-0001-8451-8154; Berg, Jonathan/0000-0003-2360-2664; shinawi, Marwan/0000-0003-1329-4100; Obersztyn, Ewa/0000-0002-3044-9517	NHLBI NIH HHS [R01 HL091771, R01 HL091771-01, R01 HL091771-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091771] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; CALLEN DF, 1993, J MED GENET, V30, P828, DOI 10.1136/jmg.30.10.828; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Doggett NA, 2006, GENOMICS, V88, P762, DOI 10.1016/j.ygeno.2006.07.012; FUJIWARA M, 1992, AM J MED GENET, V43, P561, DOI 10.1002/ajmg.1320430311; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Kelly BD, 2005, ACTA PSYCHIAT SCAND, V111, P202, DOI 10.1111/j.1600-0447.2004.00473.x; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; MCNEIL TF, 1993, BRIT J PSYCHIAT, V162, P517, DOI 10.1192/bjp.162.4.517; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; NATT E, 1989, CYTOGENET CELL GENET, V50, P145, DOI 10.1159/000132745; Ponting CP, 2006, BIOINFORMATICS, V22, P1031, DOI 10.1093/bioinformatics/btl022; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Ward KE, 1996, SCHIZOPHR RES, V22, P197, DOI 10.1016/S0920-9964(96)00076-X; WILSON DI, 1992, LANCET, V340, P573, DOI 10.1016/0140-6736(92)92107-Q; Zankl A, 2003, AM J MED GENET A, V121A, P146, DOI 10.1002/ajmg.a.20185	25	429	441	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1466	1471		10.1038/ng.279	http://dx.doi.org/10.1038/ng.279			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19029900	Green Accepted			2022-12-25	WOS:000261215900024
J	Fabene, PF; Mora, GN; Martinello, M; Rossi, B; Merigo, F; Ottoboni, L; Bach, S; Angiari, S; Benati, D; Chakir, A; Zanetti, L; Schio, F; Osculati, A; Marzola, P; Nicolato, E; Homeister, JW; Xia, LJ; Lowe, JB; McEver, RP; Osculati, F; Sbarbati, A; Butcher, EC; Constantin, G				Fabene, Paolo F.; Mora, Graciela Navarro; Martinello, Marianna; Rossi, Barbara; Merigo, Flavia; Ottoboni, Linda; Bach, Simona; Angiari, Stefano; Benati, Donatella; Chakir, Asmaa; Zanetti, Lara; Schio, Federica; Osculati, Antonio; Marzola, Pasquina; Nicolato, Elena; Homeister, Jonathon W.; Xia, Lijun; Lowe, John B.; McEver, Rodger P.; Osculati, Francesco; Sbarbati, Andrea; Butcher, Eugene C.; Constantin, Gabriela			A role for leukocyte-endothelial adhesion mechanisms in epilepsy	NATURE MEDICINE			English	Article							BLOOD-BRAIN-BARRIER; SELECTIN GLYCOPROTEIN LIGAND-1; INDUCED NEURONAL INJURY; TEMPORAL-LOBE EPILEPSY; MULTIPLE-SCLEROSIS; INFLAMMATION; PILOCARPINE; RECRUITMENT; SEIZURE; MICE	The mechanisms involved in the pathogenesis of epilepsy, a chronic neurological disorder that affects approximately one percent of the world population, are not well understood(1-3). Using a mouse model of epilepsy, we show that seizures induce elevated expression of vascular cell adhesion molecules and enhanced leukocyte rolling and arrest in brain vessels mediated by the leukocyte mucin P-selectin glycoprotein ligand-1 (PSGL-1, encoded by Selplg) and leukocyte integrins alpha(4)beta(1) and alpha(L)beta(2). Inhibition of leukocyte-vascular interactions, either with blocking antibodies or by genetically interfering with PSGL-1 function in mice, markedly reduced seizures. Treatment with blocking antibodies after acute seizures prevented the development of epilepsy. Neutrophil depletion also inhibited acute seizure induction and chronic spontaneous recurrent seizures. Blood-brain barrier (BBB) leakage, which is known to enhance neuronal excitability, was induced by acute seizure activity but was prevented by blockade of leukocyte-vascular adhesion, suggesting a pathogenetic link between leukocyte-vascular interactions, BBB damage and seizure generation. Consistent with the potential leukocyte involvement in epilepsy in humans, leukocytes were more abundant in brains of individuals with epilepsy than in controls. Our results suggest leukocyte-endothelial interaction as a potential target for the prevention and treatment of epilepsy.	[Fabene, Paolo F.; Mora, Graciela Navarro; Merigo, Flavia; Benati, Donatella; Chakir, Asmaa; Zanetti, Lara; Schio, Federica; Nicolato, Elena; Osculati, Francesco; Sbarbati, Andrea] Univ Verona, Dept Morphol Biomed Sci, Sect Anat, I-37134 Verona, Italy; [Martinello, Marianna; Rossi, Barbara; Ottoboni, Linda; Bach, Simona; Angiari, Stefano; Constantin, Gabriela] Univ Verona, Dept Pathol, Sect Gen Pathol, I-37134 Verona, Italy; [Osculati, Antonio] Univ Insubria, Sect Forens Med, Dept Med & Publ Hlth, I-21100 Varese, Italy; [Marzola, Pasquina] Univ Verona, Fac Med, Expt Magnet Resonance Imaging Ctr, I-37134 Verona, Italy; [Homeister, Jonathon W.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Xia, Lijun; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Lowe, John B.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Osculati, Francesco] Carattere Sci Ctr Neurol Bonino Pulejo, Ist Ricovero & Cura, I-98124 Messina, Italy; [Butcher, Eugene C.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Butcher, Eugene C.] Palo Alto VA Hlth Care Syst, Stanford, CA 94305 USA	University of Verona; University of Verona; University of Insubria; University of Verona; University of North Carolina; University of North Carolina Chapel Hill; Oklahoma Medical Research Foundation; Case Western Reserve University; IRCCS Bonino Pulejo; Stanford University	Fabene, PF (corresponding author), Univ Verona, Dept Morphol Biomed Sci, Sect Anat, I-37134 Verona, Italy.	paolo.fabene@univr.it; gabriela.constantin@univr.it	Ottoboni, Linda/AAC-4508-2022; Martinello, Marianna/AAE-3863-2021	Ottoboni, Linda/0000-0001-5412-7785; Martinello, Marianna/0000-0001-9811-6308; Fabene, Paolo/0000-0002-9644-4399; Constantin, Gabriela/0000-0001-8978-3539; Angiari, Stefano/0000-0003-4434-2224; ROSSI, Barbara/0000-0003-4711-1528; MARZOLA, Pasquina/0000-0001-6936-8901	Fondazione Cariverona, Ministero dell'Universita e della Ricerca (MIUR)-Progetti di ricerca di interese nazionale; US National Multiple Sclerosis Society, Fondo Incentivazione Ricerca di Base; Italian Ministry of Health; Fondazione Italiana Sclerosi Multipla; University of Verona ex 60% MIUR; European Community Research [LSH-CT-2006-037315]; US National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607, R01HL090823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072618] Funding Source: NIH RePORTER	Fondazione Cariverona, Ministero dell'Universita e della Ricerca (MIUR)-Progetti di ricerca di interese nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); US National Multiple Sclerosis Society, Fondo Incentivazione Ricerca di Base(National Multiple Sclerosis Society); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); University of Verona ex 60% MIUR(Ministry of Education, Universities and Research (MIUR)); European Community Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Antibody to PSGL-1 (4RA10) was kindly provided by D. Vestweber, Max Plank Institute. We wish to thank C. Laudanna for critically discussing the manuscript. This work was supported in part by grants from the Fondazione Cariverona, Ministero dell'Universita e della Ricerca (MIUR)-Progetti di ricerca di interese nazionale, the US National Multiple Sclerosis Society, Fondo Incentivazione Ricerca di Base, the Italian Ministry of Health; Fondazione Italiana Sclerosi Multipla, the University of Verona ex 60% MIUR (to G. C.); the European Community Research Grants LSH-CT-2006-037315 (EPICURE, thematic priority LIFESCIHEALTH; University of Verona ex 60% MIUR (to P. F. F.); and by US National Institutes of Health grants (to E. C. B., L. X., R. P. M. and J.B.L.). L.O. was supported in part by a fellowship from Fondazione Italiana Sclerosi Multipla. The authors are grateful to S. Fiorini, I. Cwojdzinski, P. Bernardi, M. Pellitteri, S. Becchi, L. Andrello and A. Calbi for their invaluable help in the experimental procedures.	Battistini L, 2003, BLOOD, V101, P4775, DOI 10.1182/blood-2002-10-3309; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Duncan JS, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.9_suppl_5.S15; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; Glien M, 2001, EPILEPSY RES, V46, P111, DOI 10.1016/S0920-1211(01)00272-8; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Holmes GL, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.9_suppl_5.S3; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; RUNGE V M, 1985, Magnetic Resonance Imaging, V3, P43, DOI 10.1016/0730-725X(85)90008-6; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Strzelczyk A, 2008, PHARMACOECONOMICS, V26, P463, DOI 10.2165/00019053-200826060-00002; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani Annamaria, 2005, Epilepsy Curr, V5, P1, DOI 10.1111/j.1535-7597.2005.05101.x; Xia LJ, 2002, J CLIN INVEST, V109, P939	30	363	377	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2008	14	12					1377	1383		10.1038/nm.1878	http://dx.doi.org/10.1038/nm.1878			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029985	Green Submitted, Green Accepted			2022-12-25	WOS:000261393600024
J	Houghton, AM; Mouded, M; Shapiro, SD				Houghton, A. McGarry; Mouded, Majd; Shapiro, Steven D.			Common origins of lung cancer and COPD	NATURE MEDICINE			English	Editorial Material							RISK; EMPHYSEMA; CELLS		[Houghton, A. McGarry; Mouded, Majd; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Houghton, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.	sds33@pitt.edu						Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Shapiro SD, 2005, NEW ENGL J MED, V352, P2016, DOI 10.1056/NEJMe058044; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; WILSON DO, AM J RESP CRIT CARE	9	122	128	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1023	1024		10.1038/nm1008-1023	http://dx.doi.org/10.1038/nm1008-1023			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18841139				2022-12-25	WOS:000259892300027
J	Williamson, JR				Williamson, James R.			Cooperativity in macromolecular assembly	NATURE CHEMICAL BIOLOGY			English	Article							MAMMALIAN 20S PROTEASOMES; TRANSCRIPTION COMPLEXES; RIBOSOMAL-SUBUNIT; PROTEIN; CHAPERONES; REPRESSOR; KINETICS; BINDING; DOMAIN	The thermodynamic principle of cooperativity is used to drive the formation of specific macromolecular complexes during the assembly of a macromolecular machine. Understanding cooperativity provides insight into the mechanisms that govern assembly and disassembly of multicomponent complexes. Our understanding of assembly mechanisms is lagging considerably behind our understanding of the structure and function of these complexes. A significant challenge remains in tackling the thermodynamics and kinetics of the intermolecular interactions required for all cellular functions.	[Williamson, James R.] Scripps Res Inst, Dept Mol Biol & Chem, La Jolla, CA 92037 USA; [Williamson, James R.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Williamson, JR (corresponding author), Scripps Res Inst, Dept Mol Biol & Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrwill@scripps.edu	Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053757, R01GM053757] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-53757] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; DE SB, 1999, NATURE, V398, P518; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; DILL KA, 1995, PROTEIN SCI, V4, P561; Gracias DH, 2000, SCIENCE, V289, P1170, DOI 10.1126/science.289.5482.1170; HELD WA, 1974, J BIOL CHEM, V249, P3103; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Kranz JK, 1999, J MOL BIOL, V285, P215, DOI 10.1006/jmbi.1998.2296; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Olson AJ, 2007, P NATL ACAD SCI USA, V104, P20731, DOI 10.1073/pnas.0709489104; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Recht MI, 2004, J MOL BIOL, V344, P395, DOI 10.1016/j.jmb.2004.09.009; Recht MI, 2001, J MOL BIOL, V313, P35, DOI 10.1006/jmbi.2001.5018; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P218, DOI 10.1038/nsmb0308-218; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Torres FE, 2004, P NATL ACAD SCI USA, V101, P9517, DOI 10.1073/pnas.0403573101; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	33	92	92	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2008	4	8					458	465		10.1038/nchembio.102	http://dx.doi.org/10.1038/nchembio.102			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329FO	18641626				2022-12-25	WOS:000257852500011
J	[Anonymous]				[Anonymous]			Capturing cancer stem cells	NATURE MEDICINE			English	Editorial Material																		Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401	1	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2008	14	8					814	814		10.1038/nm0808-814	http://dx.doi.org/10.1038/nm0808-814			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18685595				2022-12-25	WOS:000258237500018
J	Chen, S; Borowiak, M; Fox, JL; Maehr, R; Osafune, K; Davidow, L; Lam, K; Peng, LF; Schreiber, SL; Rubin, LL; Melton, D				Chen, Shuibing; Borowiak, Malgorzata; Fox, Julia L.; Maehr, Rene; Osafune, Kenji; Davidow, Lance; Lam, Kelvin; Peng, Lee F.; Schreiber, Stuart L.; Rubin, Lee L.; Melton, Douglas			A small molecule that directs differentiation of human ESCs into the pancreatic lineage	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE-C; EMBRYONIC STEM-CELLS; TRANS-RETINOIC ACID; DEFINITIVE ENDODERM; EXPRESSION; MOUSE; HEDGEHOG; (-)-INDOLACTAM-V; SPECIFICATION; INHIBITION	Stepwise differentiation from embryonic stem cells (ESCs) to functional insulin-secreting beta cells will identify key steps in beta-cell development and may yet prove useful for transplantation therapy for diabetics. An essential step in this schema is the generation of pancreatic progenitors-cells that express Pdx1 and produce all the cell types of the pancreas. High-content chemical screening identified a small molecule, (-)-indolactam V, that induces differentiation of a substantial number of Pdx1-expressing cells from human ESCs. The Pdx1-expressing cells express other pancreatic markers and contribute to endocrine, exocrine and duct cells, in vitro and in vivo. Further analyses showed that (-)-indolactam V works specifically at one stage of pancreatic development, inducing pancreatic progenitors from definitive endoderm. This study describes a chemical screening platform to investigate human ESC differentiation and demonstrates the generation of a cell population that is a key milepost on the path to making beta cells.	[Chen, Shuibing; Borowiak, Malgorzata; Fox, Julia L.; Maehr, Rene; Osafune, Kenji; Davidow, Lance; Lam, Kelvin; Rubin, Lee L.; Melton, Douglas] Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Peng, Lee F.; Schreiber, Stuart L.] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Melton, D (corresponding author), Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Borowiak, Malgorzata/0000-0002-5829-1213; Rubin, Lee/0000-0002-8658-841X	Howard Hughes Medical Institute; Juvenile Diabetes Research Foundation; American Gastroenterological Association; National Pancreas Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Gastroenterological Association; National Pancreas Foundation	D. M. and S. L. S. are investigators of the Howard Hughes Medical Institute. S. C. is supported by the Howard Hughes Medical Institute and Juvenile Diabetes Research Foundation. R. M. is supported by the Howard Hughes Medical Institute. L. F. P. is supported by the American Gastroenterological Association and the National Pancreas Foundation. The authors thank D. Huangfu for thoughtful discussion, H. Ngo for assistance with the high-content screen, S. Huang for help with NMR analysis and the Beta Cell Biology Consortium for providing antibodies.	BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; BENDAYAN M, 1979, J HISTOCHEM CYTOCHEM, V27, P1029, DOI 10.1177/27.6.110872; Bhushan A, 2001, DEVELOPMENT, V128, P5109; BOUZINBASEGARD H, 1994, BIOCHEM BIOPH RES CO, V204, P112, DOI 10.1006/bbrc.1994.2433; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; diIorio PJ, 2002, DEV BIOL, V244, P75, DOI 10.1006/dbio.2002.0573; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; DZIADEK MA, 1983, EMBO J, V2, P549, DOI 10.1002/j.1460-2075.1983.tb01461.x; Frandsen U, 2007, BIOCHEM BIOPH RES CO, V362, P568, DOI 10.1016/j.bbrc.2007.07.200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; HEIKKILA J, 1989, BIOCHEM BIOPH RES CO, V162, P1207, DOI 10.1016/0006-291X(89)90802-4; HIROTA M, 1987, JPN J CANCER RES, V78, P577; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; KORSGREN O, 1991, DIABETOLOGIA, V34, P379, DOI 10.1007/BF00403174; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Ku HT, 2004, STEM CELLS, V22, P1205, DOI 10.1634/stemcells.2004-0027; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; MAILHOS C, 1994, BRAIN RES, V644, P7, DOI 10.1016/0006-8993(94)90339-5; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Movassat J, 2002, J CLIN ENDOCR METAB, V87, P4775, DOI 10.1210/jc.2002-020137; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Offield MF, 1996, DEVELOPMENT, V122, P983; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Radominska-Pandya A, 2000, J BIOL CHEM, V275, P22324, DOI 10.1074/jbc.M907722199; Rajagopal J, 2003, SCIENCE, V299, P363; Rosewicz S, 1996, ENDOCRINOLOGY, V137, P3340, DOI 10.1210/en.137.8.3340; Roy S, 2001, CURR BIOL, V11, P1358, DOI 10.1016/S0960-9822(01)00402-X; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Soria B, 2001, DIFFERENTIATION, V68, P205, DOI 10.1046/j.1432-0436.2001.680408.x; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tiso N, 2002, MECH DEVELOP, V118, P29, DOI 10.1016/S0925-4773(02)00252-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; 2006, REGENERATIVE MED	49	372	427	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2009	5	4					258	265		10.1038/nchembio.154	http://dx.doi.org/10.1038/nchembio.154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	422KH	19287398				2022-12-25	WOS:000264426100015
J	Morris, ES; MacDonald, KPA; Kuns, RD; Morris, HM; Banovic, T; Don, ALJ; Rowe, V; Wilson, YA; Raffelt, NC; Engwerda, CR; Burman, AC; Markey, KA; Godfrey, DI; Smyth, MJ; Hill, GR				Morris, Edward S.; MacDonald, Kelli P. A.; Kuns, Rachel D.; Morris, Helen M.; Banovic, Tatjana; Don, Alistair L. J.; Rowe, Vanessa; Wilson, Yana A.; Raffelt, Neil C.; Engwerda, Christian R.; Burman, Angela C.; Markey, Kate A.; Godfrey, Dale I.; Smyth, Mark J.; Hill, Geoffrey R.			Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation	NATURE MEDICINE			English	Article							VERSUS-HOST-DISEASE; G-CSF ANALOGS; NKT CELLS; GASTROINTESTINAL-TRACT; GVHD; DEPLETION; MOBILIZATION; TOLERANCE; GVL	Granulocyte colony-stimulating factor (G-CSF) is often used to hasten neutrophil recovery after allogeneic bone marrow transplantation (BMT), but the clinical and immunological consequences evoked remain unclear(1). We examined the effect of G-CSF administration after transplantation in mouse models and found that exposure to either standard G-CSF or pegylated-G-CSF soon after BMT substantially increased graft-versus-host disease (GVHD). This effect was dependent on total body irradiation (TBI) rendering host dendritic cells (DCs) responsive to G-CSF by upregulating their expression of the G-CSF receptor. Stimulation of host DCs by G-CSF subsequently unleashed a cascade of events characterized by donor natural killer T cell (NKT cell) activation, interferon-gamma secretion and CD40-dependent amplification of donor cytotoxic T lymphocyte function during the effector phase of GVHD. Crucially, the detrimental effects of G-CSF were only present when it was administered after TBI conditioning and at a time when residual host antigen presenting cells were still present, perhaps explaining the conflicting and somewhat controversial clinical studies from the large European and North American BMT registries(2,3). These data have major implications for the use of G-CSF in disease states where NKT cell activation may have effects on outcome.	[Smyth, Mark J.] Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, St Andrews Pl, Australia; [Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Morris, Edward S.; MacDonald, Kelli P. A.; Kuns, Rachel D.; Morris, Helen M.; Banovic, Tatjana; Don, Alistair L. J.; Rowe, Vanessa; Wilson, Yana A.; Raffelt, Neil C.; Engwerda, Christian R.; Burman, Angela C.; Markey, Kate A.; Hill, Geoffrey R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute	Hill, GR (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, St Andrews Pl, Australia.	geoff.hill@qimr.edu.au	MacDonald, Kelli/AAV-5365-2020; Hill, Geoffrey/O-2630-2016; Smyth, Mark J/H-8709-2014; MacDonald, Kelli PA/O-2722-2016; Engwerda, Christian/I-3072-2015; Markey, Kate/A-5385-2016	Hill, Geoffrey/0000-0003-2994-0429; Smyth, Mark J/0000-0001-7098-7240; MacDonald, Kelli PA/0000-0003-3451-4221; Godfrey, Dale/0000-0002-3009-5472; Engwerda, Christian/0000-0003-2813-4804; Wilson, Yana/0000-0002-6878-1806; Markey, Kate/0000-0002-7064-2362				Banovic T, 2005, BLOOD, V106, P2206, DOI 10.1182/blood-2005-01-0062; Burman AC, 2007, BLOOD, V110, P1064, DOI 10.1182/blood-2006-12-063982; Cooke KR, 2000, TRANSPLANTATION, V70, P272, DOI 10.1097/00007890-200007270-00006; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Hashimoto D, 2005, J IMMUNOL, V174, P551, DOI 10.4049/jimmunol.174.1.551; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Khoury HJ, 2006, BLOOD, V107, P1712, DOI 10.1182/blood-2005-07-2661; KLUMPP TR, 1995, J CLIN ONCOL, V13, P1323, DOI 10.1200/JCO.1995.13.6.1323; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; MacDonald KPA, 2003, BLOOD, V101, P2033, DOI 10.1182/blood-2002-05-1529; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; McQuaker IG, 1997, J CLIN ONCOL, V15, P451, DOI 10.1200/JCO.1997.15.2.451; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Morecki S, 2004, EXP HEMATOL, V32, P630, DOI 10.1016/j.exphem.2004.04.005; Morris ES, 2006, BLOOD, V107, P3430, DOI 10.1182/blood-2005-10-4299; Morris ES, 2005, J CLIN INVEST, V115, P3093, DOI 10.1172/JCI25249; Morris ES, 2004, BLOOD, V103, P3573, DOI 10.1182/blood-2003-08-2864; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Pagliuca A, 2003, BRIT J HAEMATOL, V123, P22, DOI 10.1046/j.1365-2141.2003.04546.x; Patterson S, 2008, J IMMUNOL, V181, P3268, DOI 10.4049/jimmunol.181.5.3268; Pillai AB, 2007, J IMMUNOL, V178, P6242, DOI 10.4049/jimmunol.178.10.6242; Ringden O, 2004, J CLIN ONCOL, V22, P416, DOI 10.1200/JCO.2004.06.102; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Westerhof GR, 2000, CANCER RES, V60, P5470; Zeng DF, 1999, J EXP MED, V189, P1073, DOI 10.1084/jem.189.7.1073	30	53	58	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					436	441		10.1038/nm.1948	http://dx.doi.org/10.1038/nm.1948			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19330008				2022-12-25	WOS:000264937200031
J	Lorenz, K; Schmitt, JP; Schmitteckert, EM; Lohse, MJ				Lorenz, Kristina; Schmitt, Joachim P.; Schmitteckert, Eva M.; Lohse, Martin J.			A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; BETA-GAMMA-SUBUNITS; SIGNAL-REGULATED KINASES-1/2; CHRONIC PRESSURE-OVERLOAD; HEART-FAILURE; MYOCARDIAL HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; NUCLEAR TRANSLOCATION; MAP KINASES; IN-VIVO	The extracellular-regulated kinases ERK1 and ERK2 (commonly referred to as ERK1/2) have a crucial role in cardiac hypertrophy. ERK1/2 is activated by mitogen-activated protein kinase kinase-1 (MEK1) and MEK2 (commonly referred to as MEK1/2)-dependent phosphorylation in the TEY motif of the activation loop, but how ERK1/2 is targeted toward specific substrates is not well understood. Here we show that autophosphorylation of ERK1/2 on Thr188 directs ERK1/2 to phosphorylate nuclear targets known to cause cardiac hypertrophy. Thr188 autophosphorylation requires the activation and assembly of the entire Raf-MEK-ERK kinase cascade, phosphorylation of the TEY motif, dimerization of ERK1/2 and binding to G protein beta gamma subunits released from activated G(q). Thr188 phosphorylation of ERK1/2 was observed in isolated cardiomyocytes induced to undergo hypertrophic growth, in mice upon stimulation of G(q)-coupled receptors or after aortic banding and in failing human hearts. Experiments using transgenic mouse models carrying mutations at the Thr188 phosphorylation site of ERK2 suggested a causal relationship to cardiac hypertrophy. We propose that specific phosphorylation events on ERK1/2 integrate differing upstream signals (Raf1-MEK1/2 or G protein-coupled receptor-G(q)) to induce cardiac hypertrophy.	[Lorenz, Kristina; Schmitt, Joachim P.; Schmitteckert, Eva M.; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Schmitteckert, Eva M.; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97078 Wurzburg, Germany	University of Wurzburg; German Research Foundation (DFG); University of Wurzburg	Lorenz, K (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	lorenz@toxi.uni-wuerzburg.de	Schmitt, Joachim/GQP-7068-2022; Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Lorenz, Kristina/0000-0002-5747-2207	Deutsche Forschungsgemeinschaft; Leducq Foundation and the Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leducq Foundation and the Fonds der Chemischen Industrie	We wish to thank U. Quitterer for stimulating discussions during the early phase of this work; M. Maier-Peuschel, M. Vidal, K. Dei ,D. Calebiro, K. Hadameck, M. Frank, K. von Hayn and A. Zurn for their help; M. Fischer, M. Babl, M. Hoffmann, N. Ziegler and C. Dees for excellent technical assistance; S. Jacobs for help with the immunohistochemistry; and U. Zabel and R. Schreck for helpful discussion. This work was supported by the Deutsche Forschungsgemeinschaft, the Leducq Foundation and the Fonds der Chemischen Industrie.	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Baliga RR, 1999, AM J PHYSIOL-HEART C, V277, pH2026, DOI 10.1152/ajpheart.1999.277.5.H2026; Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; Brown JH, 1997, LIFE SCI, V60, P1077; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; FAURE M, 1994, J BIOL CHEM, V269, P7851; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; Haq S, 2001, CIRCULATION, V103, P670; Hartkamp J, 1999, CANCER RES, V59, P2195; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Li Z, 2003, GENE THER, V10, P1354, DOI 10.1038/sj.gt.3301995; Lips DJ, 2003, EUR HEART J, V24, P883, DOI 10.1016/S0195-668X(02)00829-1; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Markou T, 2004, J MOL CELL CARDIOL, V37, P1001, DOI 10.1016/j.yjmcc.2004.08.002; MULLER S, 1993, P NATL ACAD SCI USA, V90, P10439, DOI 10.1073/pnas.90.22.10439; Muslin AJ, 2005, TRENDS CARDIOVAS MED, V15, P225, DOI 10.1016/j.tcm.2005.06.008; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; ROSSOMANDO AJ, 1992, P NATL ACAD SCI USA, V89, P5779, DOI 10.1073/pnas.89.13.5779; Sakata Y, 1998, CIRCULATION, V97, P1488; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Schmitt JP, 2003, CIRCULATION, V108, P1133, DOI 10.1161/01.CIR.0000086469.85750.48; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Slupsky JR, 1999, CURR BIOL, V9, P971, DOI 10.1016/S0960-9822(99)80426-6; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tachibana H, 2005, CIRCULATION, V111, P591, DOI 10.1161/01.CIR.0000142291.70954.DF; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; Umemori H, 1997, SCIENCE, V276, P1878, DOI 10.1126/science.276.5320.1878; Valks DM, 2002, J MOL CELL CARDIOL, V34, P749, DOI 10.1006/jmcc.2002.2014; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252	47	163	173	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2009	15	1					75	83		10.1038/nm.1893	http://dx.doi.org/10.1038/nm.1893			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	394DF	19060905				2022-12-25	WOS:000262425100021
J	Styrkarsdottir, U; Halldorsson, BV; Gretarsdottir, S; Gudbjartsson, DF; Walters, GB; Ingvarsson, T; Jonsdottir, T; Saemundsdottir, J; Snorradottir, S; Center, JR; Nguyen, TV; Alexandersen, P; Gulcher, JR; Eisman, JA; Christiansen, C; Sigurdsson, G; Kong, A; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gretarsdottir, Solveig; Gudbjartsson, Daniel F.; Walters, G. Bragi; Ingvarsson, Thorvaldur; Jonsdottir, Thorbjorg; Saemundsdottir, Jona; Snorradottir, Steinunn; Center, Jacqueline R.; Nguyen, Tuan V.; Alexandersen, Peter; Gulcher, Jeffrey R.; Eisman, John A.; Christiansen, Claus; Sigurdsson, Gunnar; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			New sequence variants associated with bone mineral density	NATURE GENETICS			English	Article							OSTEOPOROTIC FRACTURES; BUCHEM-DISEASE; SOST GENE; BMD; SCLEROSTEOSIS; PROTEIN; LRP5; HIP	In an extended genome-wide association study of bone mineral density among 6,865 Icelanders and a follow-up in 8,510 subjects of European descent, we identified four new genome-wide significant loci. These are near the SOST gene at 17q21, the MARK3 gene at 14q32, the SP7 gene at 12q13 and the TNFRSF11A (RANK) gene at 18q21. Furthermore, nonsynonymous SNPs in the C17orf53, LRP4, ADAM19 and IBSP genes were suggestively associated with bone density.	[Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gretarsdottir, Solveig; Gudbjartsson, Daniel F.; Walters, G. Bragi; Jonsdottir, Thorbjorg; Saemundsdottir, Jona; Snorradottir, Steinunn; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Styrkarsdottir, Unnur] Reykjavik Univ, IS-103 Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, FSA Univ Hosp, IS-600 Akureyri, Iceland; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Univ New S Wales, Sydney, NSW 2010, Australia; [Alexandersen, Peter] Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark; [Christiansen, Claus] Nordic Biosci AS, DK-2730 Herlev, Denmark; [Sigurdsson, Gunnar] Univ Iceland, Landspitali Univ Hosp, Div Endocrinol & Metab, IS-108 Reykjavik, Iceland	Reykjavik University; University of Akureyri; Garvan Institute of Medical Research; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Center Clinical & Basic Research; Landspitali National University Hospital; University of Iceland	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.styrkarsdottir@decode.is; kari.stefansson@decode.is	Eisman, John A/C-2886-2014; Nguyen, Tuan V./AAD-9503-2020; Walters, G. Bragi/L-4215-2013; Center, Jacqueline/AAY-8712-2021; Stefansson, Kari/AAE-7187-2019; Nguyen, Tuan V/B-6147-2008	Nguyen, Tuan V./0000-0002-3246-6281; Walters, G. Bragi/0000-0002-5415-6487; Center, Jacqueline/0000-0002-5278-4527; Nguyen, Tuan V/0000-0002-3246-6281; Halldorsson, Bjarni/0000-0003-0756-0767; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Styrkarsdottir, Unnur/0000-0001-8146-8278				Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sigurdsson G, 2008, J BONE MINER RES, V23, P1584, DOI 10.1359/JBMR.080507; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277	15	270	291	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					15	17		10.1038/ng.284	http://dx.doi.org/10.1038/ng.284			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079262				2022-12-25	WOS:000262085300011
J	Werbowetski-Ogilvie, TE; Bosse, M; Stewart, M; Schnerch, A; Ramos-Mejia, V; Rouleau, A; Wynder, T; Smith, MJ; Dingwall, S; Carter, T; Williams, C; Harris, C; Dolling, J; Wynder, C; Boreham, D; Bhatia, M				Werbowetski-Ogilvie, Tamra E.; Bosse, Marc; Stewart, Morag; Schnerch, Angelique; Ramos-Mejia, Veronica; Rouleau, Anne; Wynder, Tracy; Smith, Mary-Jo; Dingwall, Steve; Carter, Tim; Williams, Christopher; Harris, Charles; Dolling, Joanna; Wynder, Christopher; Boreham, Doug; Bhatia, Mickie			Characterization of human embryonic stem cells with features of neoplastic progression	NATURE BIOTECHNOLOGY			English	Article							CHROMOSOMAL-ABNORMALITIES; DEVELOPMENTAL REGULATORS; CULTURE; DIFFERENTIATION; EXPRESSION; LINES; DERIVATION; INTEGRITY; POLYCOMB; REVEALS	Cultured human embryonic stem (hES) cells can acquire genetic and epigenetic changes that make them vulnerable to transformation. As hES cells with cancer-cell characteristics share properties with normal hES cells, such as self-renewal, teratoma formation and the expression of pluripotency markers, they may be misconstrued as superior hES cells with enhanced 'stemness'. We characterize two variant hES cell lines (v-hESC-1 and v-hESC-2) that express pluripotency markers at high levels and do not harbor chromosomal abnormalities by standard cytogenetic measures. We show that the two lines possess some features of neoplastic progression, including a high proliferative capacity, growth-factor independence, a 9- to 20-fold increase in frequency of tumor-initiating cells, niche independence and aberrant lineage specification, although they are not malignant. Array comparative genomic hybridization reveals an amplification at 20q11.1-11.2 in v-hESC-1 and a deletion at 5q34a-5q34b; 5q3 and a mosaic gain of chromosome 12 in v-hESC-2. These results emphasize the need for functional characterization to distinguish partially transformed and normal hES cells. (C) 2009 Nature America, Inc. All rights reserved.	[Werbowetski-Ogilvie, Tamra E.; Bosse, Marc; Stewart, Morag; Schnerch, Angelique; Ramos-Mejia, Veronica; Rouleau, Anne; Wynder, Tracy; Wynder, Christopher; Bhatia, Mickie] McMaster Univ, Michael G DeGroote Sch Med, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Smith, Mary-Jo] McMaster Univ, Ctr Gene Therapeut, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Dingwall, Steve; Carter, Tim; Boreham, Doug] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4M1, Canada; [Williams, Christopher; Harris, Charles] PerkinElmer Life & Analyt Sci, Waltham, MA 02451 USA; [Dolling, Joanna] Credit Valley Hosp, Dept Pathol & Mol Med, Mississauga, ON L5M 2N1, Canada	McMaster University; McMaster University; McMaster University; University of Toronto; Trillium Health Partners; Credit Valley Hospital	Bhatia, M (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, Stem Cell & Canc Res Inst, MDCL 5029,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Ramos-Mejia, Veronica/C-4338-2017; Bosse, Marc/AAM-8593-2021	Ramos-Mejia, Veronica/0000-0002-8013-4273; Werbowetski-Ogilvie, Tamra/0000-0002-5469-0559; DINGWALL, Steve/0000-0003-4557-9768	Canadian Institute of Health Research; National Cancer Institute of Canada (NCIC); Ontario Institute of Cancer Research (OICR); Canadian Cancer Society (CCS); NCIC; Canada Research Chair Program	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); Ontario Institute of Cancer Research (OICR); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canada Research Chair Program(Canada Research Chairs)	This work was funded by the Canadian Institute of Health Research, the National Cancer Institute of Canada (NCIC), Ontario Institute of Cancer Research (OICR) and the Canadian Cancer Society (CCS). A fellowship from the NCIC supports T. E. W.-O. and support to M. B. from the Canada Research Chair Program. In addition, thanks to Jiabi Yang for technical support in scoring teratoma formation assays and members of the Stem Cell and Cancer Research Institute for helpful insights during the writing of the manuscript.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Caisander G, 2006, CHROMOSOME RES, V14, P131, DOI 10.1007/s10577-006-1019-8; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Damjanov I, 2007, NAT BIOTECHNOL, V25, P1212, DOI 10.1038/nbt1107-1212a; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; HOOK EB, 1977, AM J HUM GENET, V29, P94; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Lodish H., 1995, MOL CELL BIOL; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574	33	190	204	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2009	27	1					91	97		10.1038/nbt.1516	http://dx.doi.org/10.1038/nbt.1516			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	394TP	19122652				2022-12-25	WOS:000262471200028
J	Willer, CJ; Speliotes, EK; Loos, RJF; Li, SX; Lindgren, CM; Heid, IM; Berndt, SI; Elliott, AL; Jackson, AU; Lamina, C; Lettre, G; Lim, N; Lyon, HN; McCarroll, SA; Papadakis, K; Qi, L; Randall, JC; Roccasecca, RM; Sanna, S; Scheet, P; Weedon, MN; Wheeler, E; Zhao, JH; Jacobs, LC; Prokopenko, I; Soranzo, N; Tanaka, T; Timpson, NJ; Almgren, P; Bennett, A; Bergman, RN; Bingham, SA; Bonnycastle, LL; Brown, M; Burtt, NLP; Chines, P; Coin, L; Collins, FS; Connell, JM; Cooper, C; Smith, GD; Dennison, EM; Deodhar, P; Elliott, P; Erdos, MR; Estrada, K; Evans, DM; Gianniny, L; Gieger, C; Gillson, CJ; Guiducci, C; Hackett, R; Hadley, D; Hall, AS; Havulinna, AS; Hebebrand, J; Hofman, A; Isomaa, B; Jacobs, KB; Johnson, T; Jousilahti, P; Jovanovic, Z; Khaw, KT; Kraft, P; Kuokkanen, M; Kuusisto, J; Laitinen, J; Lakatta, EG; Luan, J; Luben, RN; Mangino, M; McArdle, WL; Meitinger, T; Mulas, A; Munroe, PB; Narisu, N; Ness, AR; Northstone, K; O'Rahilly, S; Purmann, C; Rees, MG; Ridderstraale, M; Ring, SM; Rivadeneira, F; Ruokonen, A; Sandhu, MS; Saramies, J; Scott, LJ; Scuteri, A; Silander, K; Sims, MA; Song, K; Stephens, J; Stevens, S; Stringham, HM; Tung, YCL; Valle, TT; Van Duijn, CM; Vimaleswaran, KS; Vollenweider, P; Waeber, G; Wallace, C; Watanabe, RM; Waterworth, DM; Watkins, N; Witteman, JCM; Zeggini, E; Zhai, GJ; Zillikens, MC; Altshuler, D; Caulfield, MJ; Chanock, SJ; Farooqi, IS; Ferrucci, L; Guralnik, JM; Hattersley, AT; Hu, FB; Jarvelin, MR; Laakso, M; Mooser, V; Ong, KK; Ouwehand, WH; Salomaa, V; Samani, NJ; Spector, TD; Tuomi, T; Tuomilehto, J; Uda, M; Uitterlinden, AG; Wareham, NJ; Deloukas, P; Frayling, TM; Groop, LC; Hayes, RB; Hunter, DJ; Mohlke, KL; Peltonen, L; Schlessinger, D; Strachan, DP; Wichmann, HE; McCarthy, MI; Boehnke, M; Barroso, I; Abecasis, GR; Hirschhorn, JN				Willer, Cristen J.; Speliotes, Elizabeth K.; Loos, Ruth J. F.; Li, Shengxu; Lindgren, Cecilia M.; Heid, Iris M.; Berndt, Sonja I.; Elliott, Amanda L.; Jackson, Anne U.; Lamina, Claudia; Lettre, Guillaume; Lim, Noha; Lyon, Helen N.; McCarroll, Steven A.; Papadakis, Konstantinos; Qi, Lu; Randall, Joshua C.; Roccasecca, Rosa Maria; Sanna, Serena; Scheet, Paul; Weedon, Michael N.; Wheeler, Eleanor; Zhao, Jing Hua; Jacobs, Leonie C.; Prokopenko, Inga; Soranzo, Nicole; Tanaka, Toshiko; Timpson, Nicholas J.; Almgren, Peter; Bennett, Amanda; Bergman, Richard N.; Bingham, Sheila A.; Bonnycastle, Lori L.; Brown, Morris; Burtt, Noel L. P.; Chines, Peter; Coin, Lachlan; Collins, Francis S.; Connell, John M.; Cooper, Cyrus; Smith, George Davey; Dennison, Elaine M.; Deodhar, Parimal; Elliott, Paul; Erdos, Michael R.; Estrada, Karol; Evans, David M.; Gianniny, Lauren; Gieger, Christian; Gillson, Christopher J.; Guiducci, Candace; Hackett, Rachel; Hadley, David; Hall, Alistair S.; Havulinna, Aki S.; Hebebrand, Johannes; Hofman, Albert; Isomaa, Bo; Jacobs, Kevin B.; Johnson, Toby; Jousilahti, Pekka; Jovanovic, Zorica; Khaw, Kay-Tee; Kraft, Peter; Kuokkanen, Mikko; Kuusisto, Johanna; Laitinen, Jaana; Lakatta, Edward G.; Luan, Jian'an; Luben, Robert N.; Mangino, Massimo; McArdle, Wendy L.; Meitinger, Thomas; Mulas, Antonella; Munroe, Patricia B.; Narisu, Narisu; Ness, Andrew R.; Northstone, Kate; O'Rahilly, Stephen; Purmann, Carolin; Rees, Matthew G.; Ridderstrale, Martin; Ring, Susan M.; Rivadeneira, Fernando; Ruokonen, Aimo; Sandhu, Manjinder S.; Saramies, Jouko; Scott, Laura J.; Scuteri, Angelo; Silander, Kaisa; Sims, Matthew A.; Song, Kijoung; Stephens, Jonathan; Stevens, Suzanne; Stringham, Heather M.; Tung, Y. C. Loraine; Valle, Timo T.; Van Duijn, Cornelia M.; Vimaleswaran, Karani S.; Vollenweider, Peter; Waeber, Gerard; Wallace, Chris; Watanabe, Richard M.; Waterworth, Dawn M.; Watkins, Nicholas; Witteman, Jacqueline C. M.; Zeggini, Eleftheria; Zhai, Guangju; Zillikens, M. Carola; Altshuler, David; Caulfield, Mark J.; Chanock, Stephen J.; Farooqi, I. Sadaf; Ferrucci, Luigi; Guralnik, Jack M.; Hattersley, Andrew T.; Hu, Frank B.; Jarvelin, Marjo-Riitta; Laakso, Markku; Mooser, Vincent; Ong, Ken K.; Ouwehand, Willem H.; Salomaa, Veikko; Samani, Nilesh J.; Spector, Timothy D.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Uda, Manuela; Uitterlinden, Andre G.; Wareham, Nicholas J.; Deloukas, Panagiotis; Frayling, Timothy M.; Groop, Leif C.; Hayes, Richard B.; Hunter, David J.; Mohlke, Karen L.; Peltonen, Leena; Schlessinger, David; Strachan, David P.; Wichmann, H-Erich; McCarthy, Mark I.; Boehnke, Michael; Barroso, Ines; Abecasis, Goncalo R.; Hirschhorn, Joel N.		Wellcome Trust Case Control; Giant Consortium	Six new loci associated with body mass index highlight a neuronal influence on body weight regulation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; FTO GENE; ALCOHOL DEPENDENCE; COMMON VARIANTS; NEURITE OUTGROWTH; CHILDHOOD OBESITY; ADULT OBESITY; EXPRESSION; MICE	Common variants at only two loci, FTO and MC4R, have been reproducibly associated with body mass index (BMI) in humans. To identify additional loci, we conducted meta-analysis of 15 genome-wide association studies for BMI (n > 32,000) and followed up top signals in 14 additional cohorts (n > 59,000). We strongly confirm FTO and MC4R and identify six additional loci (P < 5 x 10(-8)): TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2 and NEGR1 (where a 45-kb deletion polymorphism is a candidate causal variant). Several of the likely causal genes are highly expressed or known to act in the central nervous system (CNS), emphasizing, as in rare monogenic forms of obesity, the role of the CNS in predisposition to obesity.	[Speliotes, Elizabeth K.; Lyon, Helen N.; Hirschhorn, Joel N.] Harvard & Massachusetts Inst Technol, Broad Inst, Metabol Initiat, Cambridge, MA 02142 USA; [Speliotes, Elizabeth K.; Lyon, Helen N.; Hirschhorn, Joel N.] Harvard & Massachusetts Inst Technol, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Speliotes, Elizabeth K.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Willer, Cristen J.; Jackson, Anne U.; Scott, Laura J.; Stringham, Heather M.; Boehnke, Michael] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Loos, Ruth J. F.; Li, Shengxu; Zhao, Jing Hua; Gillson, Christopher J.; Luan, Jian'an; Sandhu, Manjinder S.; Sims, Matthew A.; Vimaleswaran, Karani S.; Wareham, Nicholas J.] Addenbrookes Hosp, MRC, Epidemiol Unit, Cambridge CB2 0QQ, England; [Loos, Ruth J. F.; Li, Shengxu; Zhao, Jing Hua; Gillson, Christopher J.; Jovanovic, Zorica; Luan, Jian'an; Purmann, Carolin; Sims, Matthew A.; Farooqi, I. Sadaf; Ong, Ken K.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England; [Lindgren, Cecilia M.; Randall, Joshua C.; Prokopenko, Inga; Zeggini, Eleftheria; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Heid, Iris M.; Gieger, Christian; Wichmann, H-Erich] Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Berndt, Sonja I.; Chanock, Stephen J.; Hayes, Richard B.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Lettre, Guillaume; McCarroll, Steven A.; Bennett, Amanda; Burtt, Noel L. P.; Kuokkanen, Mikko; Hunter, David J.; Peltonen, Leena] MIT & Harvard, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Elliott, Amanda L.; McCarroll, Steven A.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lettre, Guillaume; Lyon, Helen N.; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Lettre, Guillaume; Lyon, Helen N.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Lettre, Guillaume; Lyon, Helen N.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Papadakis, Konstantinos; Hadley, David; Strachan, David P.] Univ London, Div Commun Hlth Sci, London SW17 0RE, England; [Qi, Lu; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [Roccasecca, Rosa Maria; Wheeler, Eleanor; Ouwehand, Willem H.; Deloukas, Panagiotis; Peltonen, Leena; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Sanna, Serena; Uda, Manuela] CNR, Inst Neurogenet & Neurofarmacol, I-09042 Cagaliai, Italy; [Scheet, Paul; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Weedon, Michael N.; Frayling, Timothy M.] Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Jacobs, Leonie C.; Zillikens, M. Carola; Uitterlinden, Andre G.] Eramus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Soranzo, Nicole; Zhai, Guangju; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, Longitudinal Studies Sect, Baltimore, MD 21225 USA; [Timpson, Nicholas J.; Smith, George Davey; Evans, David M.] Univ Bristol, Dept Social Med, Ctr Causal Analyses Translat Epidemiol, MRC, Bristol BS8 2PR, Avon, England; [Almgren, Peter; Groop, Leif C.] Lund Univ, Dept Clin Sci, Ctr Diabet, Malmo 20502, Sweden; [Bennett, Amanda] Churchill Hosp, OCDEM, DRL, Oxford OX3 7LJ, England; [Bergman, Richard N.] Univ So Calif, Sch Med, Los Angeles, CA 90033 USA; [Bingham, Sheila A.] MRC, Dunn Human Nutr Unit, Cambridge CB2 0XY, England; [Bingham, Sheila A.] MRC, Ctr Nutr Epidemiol Canc Prevent & Survival, Cambridge CB1 8RN, England; [Bonnycastle, Lori L.; Chines, Peter; Collins, Francis S.; Deodhar, Parimal; Erdos, Michael R.; Rees, Matthew G.] NHGRI, Bethesda, MD 20892 USA; [Brown, Morris] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 0QQ, England; [Coin, Lachlan; Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Connell, John M.] Univ Glasgow, Fac Med, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Glasgow G12 8TA, Lanark, Scotland; [Cooper, Cyrus; Dennison, Elaine M.] Univ Southampton, Southampton Gen Hosp, Epidemiol Resource Ctr, MRC, Southampton SO16 6YD, Hants, England; [Hall, Alistair S.] Leeds Gen Infirm, Yorkshire Heart Ctr, Leeds LS1 3EX, W Yorkshire, England; [Havulinna, Aki S.; Jousilahti, Pekka; Salomaa, Veikko] Natl Publ Hlth Inst, KTL, FI-00300 Helsinki, Finland; [Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; [Hofman, Albert; Van Duijn, Cornelia M.; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Isomaa, Bo] Malmska Municipal Hlth Ctr & Hosp, Folkhalsan Res Ctr, FIN-00014 Helsinki, Finland; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; [Johnson, Toby] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Johnson, Toby] CHU Vaudois, Univ Inst Social & Preventat Med, CH-1005 Lausanne, Switzerland; [Johnson, Toby] Swiss Inst Bioinformat, CH-1005 Lausanne, Switzerland; [Jovanovic, Zorica; O'Rahilly, Stephen; Purmann, Carolin; Tung, Y. C. Loraine] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Cambridge CB2 0QQ, England; [Khaw, Kay-Tee; Luben, Robert N.; Sandhu, Manjinder S.; Farooqi, I. Sadaf] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Silander, Kaisa] Natl Publ Hlth Inst, Dept Mol Med, FIN-00300 Helsinki, Finland; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, FIN-90220 Oulu, Finland; [Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Mangino, Massimo; Stevens, Suzanne; Samani, Nilesh J.] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [McArdle, Wendy L.; Northstone, Kate; Ring, Susan M.] Univ Bristol, Dept Social Med, ALSPAC, Bristol BS8 1TQ, Avon, England; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81765 Munich, Germany; [Munroe, Patricia B.; Wallace, Chris; Caulfield, Mark J.; McCarthy, Mark I.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Ness, Andrew R.] Univ Bristol, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England; [Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, FIN-90220 Oulu, Finland; [Saramies, Jouko] Savitaipale Hlth Ctr, FIN-54800 Savitaipale, Finland; [Scuteri, Angelo] Ist Nazl Ricovero & Cura Anziani, Unita Operat Geriatria, I-00189 Rome, Italy; [Stephens, Jonathan; Watkins, Nicholas] Univ Cambridge, Dept Haematol, NHS Blood & Transplant, Cambridge CB2 2PR, England; [Valle, Timo T.] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; [Vollenweider, Peter] BH 10 Ctr Hosp Univ Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Div Biostat, Dept Prevent Med, Los Angeles, CA 90089 USA; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Gerontol Res Ctr, Bethesda, MD 20892 USA; [Hattersley, Andrew T.] Peninsula Med Sch, Exeter EX5 2DW, Devon, England; [Groop, Leif C.] Univ Helsinki, Cent Hosp, Dept Med, FIN-00290 Helsinki, Finland; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Peltonen, Leena] Univ Helsinki, Inst Mol Med, FIN-00014 Helsinki, Finland; [Schlessinger, David] NIA, US Natl Inst Hlth Biomed Res Ctr, Genet Lab, Baltimore, MD 21224 USA; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Proc Biometry & Epidemiol, D-81377 Munich, Germany; [McCarthy, Mark I.] Univ Oxford, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX3 7LJ, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Wellcome Trust Sanger Institute; Consiglio Nazionale delle Ricerche (CNR); University of Michigan System; University of Michigan; University of Exeter; University of Oxford; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bristol; Lund University; University of Oxford; University of Southern California; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; University of Glasgow; University of Southampton; Leeds General Infirmary; University of Leeds; Finland National Institute for Health & Welfare; University of Duisburg Essen; Erasmus University Rotterdam; Erasmus MC; Folkhalsan Research Center; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; Finland National Institute for Health & Welfare; University of Eastern Finland; Finnish Institute of Occupational Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Bristol; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of London; Queen Mary University London; University of Bristol; University of Oulu; University of Cambridge; Finland National Institute for Health & Welfare; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Exeter; University of Helsinki; Helsinki University Central Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Munich; University of Oxford; Harvard University; Harvard Medical School	Hirschhorn, JN (corresponding author), Harvard & Massachusetts Inst Technol, Broad Inst, Metabol Initiat, Cambridge, MA 02142 USA.	mark.mccarthy@drl.ox.ac.uk; boehnke@umich.edu; ib1@sanger.ac.uk; goncalo@umich.edu; joelh@broad.mit.edu	Evans, David M/H-6325-2013; Timpson, Nicholas John/O-7548-2015; Uda, Manuela/AAC-2645-2019; Abecasis, Goncalo R/B-7840-2010; Mulas, Antonella/B-4231-2015; Northstone, Kate/A-8165-2011; Mangino, Massimo/F-5134-2011; Hall, Alistair/K-1953-2019; Deloukas, Panos/B-2922-2013; Prokopenko, Inga/AAU-9895-2020; Colaus, PsyColaus/K-6607-2013; Berndt, Sonja I/J-8423-2016; Spector, Tim D/F-6533-2012; Hadley, David/I-6902-2012; Khaw, Kay-Tee/AAZ-3209-2021; Meitinger, Thomas/O-1318-2015; Lamina, Claudia/F-7608-2010; Loos, Ruth J F/Q-2862-2016; Altshuler, David M/A-4476-2009; Loos, Ruth/GON-5877-2022; Prokopenko, Inga/H-3241-2014; sanna, serena/H-3009-2019; Davey Smith, George/A-7407-2013; Rivadeneira, Fernando/O-5385-2015; Wichmann, Heinz Erich/AAA-5695-2022; Attrill, Lauren/V-1688-2018; Narisu, Narisu/T-6908-2019; Fox, Laura J/C-6249-2016; Coin, Lachlan/O-4976-2019; Luben, Robert N/H-5519-2015; Brown, Matthew A/E-5749-2010; Lakatta, Edward G/AAL-1447-2020; Havulinna, Aki/AAM-4769-2021; Ridderstråle, Martin/F-7678-2012; Lim, Noha/ABA-2509-2020; O'Rahilly, Stephen/ABF-6509-2020; Kuokkanen, Mikko/M-8247-2016; McCarroll, Steven A/A-8433-2009; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Ness, Andy R/M-7612-2013; Li, Shengxu/D-8915-2012; Coin, Lachlan JM/A-9001-2014; Elliott, Amanda/G-5120-2012; McCarthy, Mark/M-3763-2015	Evans, David M/0000-0003-0663-4621; Timpson, Nicholas John/0000-0002-7141-9189; Uda, Manuela/0000-0002-4890-6456; Northstone, Kate/0000-0002-0602-1983; Mangino, Massimo/0000-0002-2167-7470; Deloukas, Panos/0000-0001-9251-070X; Lamina, Claudia/0000-0002-5398-5806; Loos, Ruth J F/0000-0002-8532-5087; Altshuler, David M/0000-0002-7250-4107; Prokopenko, Inga/0000-0003-1624-7457; sanna, serena/0000-0002-3768-1749; Davey Smith, George/0000-0002-1407-8314; Rivadeneira, Fernando/0000-0001-9435-9441; Coin, Lachlan/0000-0002-4300-455X; Luben, Robert N/0000-0002-5088-6343; Brown, Matthew A/0000-0003-0538-8211; O'Rahilly, Stephen/0000-0003-2199-4449; Kuokkanen, Mikko/0000-0003-4375-9327; Ness, Andy R/0000-0003-3548-9523; Coin, Lachlan JM/0000-0002-4300-455X; Caulfield, Mark/0000-0001-9295-3594; Munroe, Patricia/0000-0002-4176-2947; Lindgren, Cecilia/0000-0002-4903-9374; Dennison, Elaine/0000-0002-3048-4961; Johnson, Toby/0000-0002-5998-3270; Abecasis, Goncalo/0000-0003-1509-1825; Waeber, Gerard/0000-0003-4193-788X; Weedon, Michael/0000-0002-6174-6135; Karani, Vimal/0000-0002-8485-8930; Elliott, Paul/0000-0002-7511-5684; Willer, Cristen/0000-0001-5645-4966; SCUTERI, ANGELO/0000-0003-4784-5441; Jacobs, Kevin/0000-0002-4657-6473; Hayes, Richard/0000-0002-0918-661X; Mulas, Antonella/0000-0002-6856-1483; Hattersley, Andrew/0000-0001-5620-473X; bennett, amanda/0000-0003-2140-8710; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Hall, Alistair/0000-0003-0306-7887; Gieger, Christian/0000-0001-6986-9554; Barroso, Ines/0000-0001-5800-4520; Wallace, Chris/0000-0001-9755-1703; Zeggini, Eleftheria/0000-0003-4238-659X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; McCarthy, Mark/0000-0002-4393-0510; Tuomi, Tiinamaija/0000-0002-8306-6202; Van Duijn, Cornelia/0000-0002-2374-9204; Lakatta, Edward/0000-0002-4772-0035; Wheeler, Eleanor/0000-0002-8616-6444; Bergman, Richard/0000-0003-1539-4471; Cooper, Cyrus/0000-0003-3510-0709; s, hema/0000-0002-3440-9475; Soranzo, Nicole/0000-0003-1095-3852; Meitinger, Thomas/0000-0002-8838-8403; Farooqi, Sadaf/0000-0001-7609-3504	MRC [G0800582, G0701863, MC_U106188470, G9824984, G0400874, MC_U147585819, G0400491, MC_U106179472, G0600705, MC_U147585827, MC_U105630924, G0000934, G9521010, G0601261] Funding Source: UKRI; Medical Research Council [U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA098233, R01CA049449, U01CA067262, P01CA087969, R01CA067262, R01CA065725, U01CA049449, R01CA050385] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679, U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, ZIAHG000024, N01HG065403, R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062370, R01DK029867, T32DK007191, R01DK062370, R56DK062370, R01DK075787, K23DK067288, F32DK079466, R01DK072193, K23DK080145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, ZIAAG001050, ZIAAG000799] Funding Source: NIH RePORTER; British Heart Foundation [FS/05/061/19501] Funding Source: Medline; Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [MC_U106179471, G0400874, MC_U105630924, G0401527, G0600705, MC_U147585819, MC_U106188470, MC_U147585824, MC_UP_A620_1014, MC_U147585827, U.1475.00.003.00010.02 (85819), G0601261, G0400491, G9815508, G0800582, G0000934, G0000649, MC_U106179472, G9521010, G9824984, G0701863] Funding Source: Medline; NCI NIH HHS [U01 CA098233, R01 CA067262, CA50385, CA49449, CA65725, P01 CA087969, CA67262, R01 CA065725, U01 CA067262, R01 CA049449, 5UO1CA098233, CA87969, R01 CA050385, U01 CA049449] Funding Source: Medline; NHGRI NIH HHS [1Z01 HG000024, 01-HG-65403, N01HG65403, R01 HG002651, HG02651] Funding Source: Medline; NHLBI NIH HHS [HL084729, R01 HL087679, HL087679, U01 HL084729] Funding Source: Medline; NIA NIH HHS [N01-AG-1-2109] Funding Source: Medline; NIDDK NIH HHS [U01 DK062370, F32 DK079466, K23 DK080145-01, R56 DK062370, T32DK07191, DK075787, R01 DK075787, K23 DK080145, R01 DK029867, F32 DK079466-01, R01 DK062370, K23 DK067288, DK072193, R01 DK072193, DK062370, T32 DK007191] Funding Source: Medline; NIMH NIH HHS [1RL1MH083268, RL1 MH083268] Funding Source: Medline; Wellcome Trust [082390, 077011, 076113, 089061, 076467/Z/05/Z, 077016, 068545/Z/02, 079557, 090532] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Covault J, 2004, AM J MED GENET B, V129B, P104, DOI 10.1002/ajmg.b.30091; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Farooqi I Sadaf, 2006, Pediatr Endocrinol Rev, V3 Suppl 4, P528; Fehr C, 2006, PSYCHIAT GENET, V16, P9, DOI 10.1097/01.ypg.0000185027.89816.d9; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schafer M, 2005, MOL CELL NEUROSCI, V29, P580, DOI 10.1016/j.mcn.2005.04.010; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	49	1309	1351	4	221	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					25	34		10.1038/ng.287	http://dx.doi.org/10.1038/ng.287			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079261	Green Accepted, Green Published			2022-12-25	WOS:000262085300013
J	Chung, WH; Hung, SI; Yang, JY; Su, SC; Huang, SP; Wei, CY; Chin, SW; Chiou, CC; Chu, SC; Ho, HC; Yang, CH; Lu, CF; Wu, JY; Liao, YD; Chen, YT				Chung, Wen-Hung; Hung, Shuen-Iu; Yang, Jui-Yung; Su, Shih-Chi; Huang, Shien-Ping; Wei, Chun-Yu; Chin, See-Wen; Chiou, Chien-Chun; Chu, Sung-Chao; Ho, Hsin-Chun; Yang, Chih-Hsun; Lu, Chi-Fang; Wu, Jer-Yuarn; Liao, You-Di; Chen, Yuan-Tsong			Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis	NATURE MEDICINE			English	Article							SOLUBLE FAS LIGAND; CYTOTOXIC T-CELLS; CYTOLYTIC MOLECULE; INDUCED APOPTOSIS; MARKER; MECHANISM; SERUM	Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening adverse drug reactions characterized by massive epidermal necrosis, in which the specific danger signals involved remain unclear. Here we show that blister cells from skin lesions of SJS-TEN primarily consist of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, and both blister fluids and cells were cytotoxic. Gene expression profiling identified granulysin as the most highly expressed cytotoxic molecule, confirmed by quantitative PCR and immunohistochemistry. Granulysin concentrations in the blister fluids were two to four orders of magnitude higher than perforin, granzyme B or soluble Fas ligand concentrations, and depleting granulysin reduced the cytotoxicity. Granulysin in the blister fluids was a 15-kDa secretory form, and injection of it into mouse skin resulted in features mimicking SJS-TEN. Our findings demonstrate that secretory granulysin is a key molecule responsible for the disseminated keratinocyte death in SJS-TEN and highlight a mechanism for CTL- or NK cell-mediated cytotoxicity that does not require direct cellular contact.	[Chung, Wen-Hung; Hung, Shuen-Iu; Su, Shih-Chi; Huang, Shien-Ping; Wei, Chun-Yu; Wu, Jer-Yuarn; Liao, You-Di; Chen, Yuan-Tsong] Acad Sinica, Taiwan Int Grad Program, Program Mol Med, Inst Biomed Sci, Taipei 115, Taiwan; [Chung, Wen-Hung; Chiou, Chien-Chun; Ho, Hsin-Chun; Yang, Chih-Hsun] Chang Gung Univ, Dept Dermatol, Chang Gung Mem Hosp, Coll Med, Taipei 105, Taiwan; [Chung, Wen-Hung] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan; [Hung, Shuen-Iu; Chin, See-Wen] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Yang, Jui-Yung] Chang Gung Univ, Linkou Burn Ctr, Taipei 105, Taiwan; [Yang, Jui-Yung] Chang Gung Univ, Dept Plast Surg, Chang Gung Mem Hosp, Coll Med, Taipei 105, Taiwan; [Chu, Sung-Chao] Buddhist Tzu Chi Gen Hosp, Div Hematol & Oncol, Hualien 971, Taiwan; [Lu, Chi-Fang] Chung Shan Hosp, Dept Dermatol, Taipei 105, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Duke University	Chen, YT (corresponding author), Acad Sinica, Taiwan Int Grad Program, Program Mol Med, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	chen0010@ibms.sinica.edu.tw	Liao, You-Di/S-7018-2018; Wu, Jer-Yuarn/S-7010-2018; Hung, Shuen-Iu/HHS-9012-2022; Hung, Shuen-Iu/ABB-2139-2021	Liao, You-Di/0000-0001-5527-4736; Hung, Shuen-Iu/0000-0001-6531-5538	National Science Council, Taiwan [NSC95-2314-B-182A-048, 95-2314-B-010-096, 96-2320-B-010-021-MY2, 96-2628-B-182A-065-MY2]; Chang-Gung Memorial Hospital, Taiwan Ministry of Education (Aim for the Top University Plan, National Yang-Ming University); National Research Program for Genomic Medicine, Taiwan [NSC-95-3112-B-001-010, NSC-95-3112-B-001-011]; Genomics and Proteomics Program, Academia Sinica	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang-Gung Memorial Hospital, Taiwan Ministry of Education (Aim for the Top University Plan, National Yang-Ming University)(Ministry of Education, Taiwan); National Research Program for Genomic Medicine, Taiwan(Ministry of Science and Technology, Taiwan); Genomics and Proteomics Program, Academia Sinica(Academia Sinica - Taiwan)	DH4 monoclonal antibody was a gift from A. M. Krensky (Stanford University). We thank H.-J. Lin, S.-J. Li, K.-H. Chen, L.-H. Lu of the Institute of Biomedical Sciences, Academia Sinica and members of the National Microarray & Gene Expression Analysis Core Facility, National Yang-Ming University, Taiwan, for excellent technical assistance. This work was supported by grants from the National Science Council, Taiwan (NSC95-2314-B-182A-048, 95-2314-B-010-096, 96-2320-B-010-021-MY2 and 96-2628-B-182A-065-MY2), Chang-Gung Memorial Hospital, Taiwan Ministry of Education (Aim for the Top University Plan, National Yang-Ming University), National Research Program for Genomic Medicine, Taiwan (National Clinical Core, NSC-95-3112-B-001-010 and National Genotyping Core, NSC-95-3112-B-001-011) and the Genomics and Proteomics Program, Academia Sinica.	Abe R, 2003, AM J PATHOL, V162, P1515, DOI 10.1016/S0002-9440(10)64284-8; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Bronnimann M, 2005, CURR OPIN ALLERGY CL, V5, P317; Chave TA, 2005, BRIT J DERMATOL, V153, P241, DOI 10.1111/j.1365-2133.2005.06721.x; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Correia O, 2001, DERMATOLOGY, V203, P212, DOI 10.1159/000051751; Deng AM, 2005, J IMMUNOL, V174, P5243, DOI 10.4049/jimmunol.174.9.5243; Gamen S, 1998, J IMMUNOL, V161, P1758; Gomes ER, 2005, CURR OPIN ALLERGY CL, V5, P309, DOI 10.1097/01.all.0000173785.81024.33; Hanson DA, 1999, MOL IMMUNOL, V36, P413, DOI 10.1016/S0161-5890(99)00063-2; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Krensky AM, 2005, AM J TRANSPLANT, V5, P1789, DOI 10.1111/j.1600-6143.2005.00970.x; Nagasawa M, 2006, AM J HEMATOL, V81, P340, DOI 10.1002/ajh.20570; Nassif A, 2004, J ALLERGY CLIN IMMUN, V114, P1209, DOI 10.1016/j.jaci.2004.07.047; Nassif A, 2002, J INVEST DERMATOL, V118, P728, DOI 10.1046/j.1523-1747.2002.01622.x; Ogawa K, 2003, EUR J IMMUNOL, V33, P1925, DOI 10.1002/eji.200323977; Pardo J, 2001, J IMMUNOL, V167, P1222, DOI 10.4049/jimmunol.167.3.1222; Paul C, 1996, BRIT J DERMATOL, V134, P710, DOI 10.1111/j.1365-2133.1996.tb06976.x; Pena SV, 1997, J IMMUNOL, V158, P2680; Pereira FA, 2007, J AM ACAD DERMATOL, V56, P181, DOI 10.1016/j.jaad.2006.04.048; Quinn AM, 2005, ARCH DERMATOL, V141, P683, DOI 10.1001/archderm.141.6.683; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1994, J INVEST DERMATOL, V102, P28; Roujeau Jean-Claude, 2006, Allergol Int, V55, P27, DOI 10.2332/allergolint.55.27; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stur K, 2007, J INVEST DERMATOL, V127, P802, DOI 10.1038/sj.jid.5700648; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490	28	477	520	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1343	1350		10.1038/nm.1884	http://dx.doi.org/10.1038/nm.1884			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029983				2022-12-25	WOS:000261393600018
J	Kharchenko, PV; Tolstorukov, MY; Park, PJ				Kharchenko, Peter V.; Tolstorukov, Michael Y.; Park, Peter J.			Design and analysis of ChIP-seq experiments for DNA-binding proteins	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ANALYSIS; PROFILES; SITES; STAT1	Recent progress in massively parallel sequencing platforms has enabled genome-wide characterization of DNA-associated proteins using the combination of chromatin immunoprecipitation and sequencing (ChIP-seq). Although a variety of methods exist for analysis of the established alternative ChIP microarray (ChIP-chip), few approaches have been described for processing ChIP-seq data. To fill this gap, we propose an analysis pipeline specifically designed to detect protein-binding positions with high accuracy. Using previously reported data sets for three transcription factors, we illustrate methods for improving tag alignment and correcting for background signals. We compare the sensitivity and spatial precision of three peak detection algorithms with published methods, demonstrating gains in spatial precision when an asymmetric distribution of tags on positive and negative strands is considered. We also analyze the relationship between the depth of sequencing and characteristics of the detected binding positions, and provide a method for estimating the sequencing depth necessary for a desired coverage of protein binding sites.	[Kharchenko, Peter V.; Tolstorukov, Michael Y.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kharchenko, Peter V.; Tolstorukov, Michael Y.; Park, Peter J.] Brigham & Womens Hosp, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Harvard MIT Hlth Sci & Technol Informat Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA.	peter_park@harvard.edu		Park, Peter/0000-0001-9378-960X	National Institutes of Health [U01HG004258, R01GM082798, UL1RR024920]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024920] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Dustin Schones and Keji Zhao for providing raw data and detailed descriptions for the CTCF data set, and Ali Mortazavi and Barbara Wold for providing sequence tag data for NRSF binding. This work was supported by grants from the National Institutes of Health to P.J.P. (U01HG004258, R01GM082798, UL1RR024920).	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Peng SY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-219; Price RM, 2000, COMPUT STAT DATA AN, V34, P345, DOI 10.1016/S0167-9473(99)00100-0; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128	19	593	613	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1351	1359		10.1038/nbt.1508	http://dx.doi.org/10.1038/nbt.1508			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19029915	Green Accepted			2022-12-25	WOS:000261591300019
J	Lawrence, PA; Struhl, G; Casal, J				Lawrence, Peter A.; Struhl, Gary; Casal, Jose			Do the protocadherins Fat and Dachsous link up to determine both planar cell polarity and the dimensions of organs?	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR GENE; WING GROWTH; DROSOPHILA; PROLIFERATION; INSIGHTS; GRADIENT; HEDGEHOG; SIZE; ACTS	Most, perhaps all cells in epithelial sheets are polarized in the plane of the sheet. This type of polarity, referred to as planar cell polarity (PCP), can be expressed in the orientation of cilia and stereocilia, in oriented outgrowths such as hairs, in the plane of cell division, in directed cell movement and possibly in the orientation of axon extension(1,2). Another popular area in current research is growth: there is an attempt to find systems that fix the shape and size of organs. Although both polarity and growth are subject to overall control by morphogen gradients(3), the mechanisms of this control are almost completely unknown. Here we discuss recent evidence for a 'steepness hypothesis' that links these two apparently disconnected features of animal development.	[Lawrence, Peter A.; Casal, Jose] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Lawrence, Peter A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Struhl, Gary] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	University of Cambridge; MRC Laboratory Molecular Biology; Columbia University; Howard Hughes Medical Institute	Lawrence, PA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	pal@mrc-lmb.cam.ac.uk		Lawrence, Peter/0000-0002-9554-8268; Casal, Jose/0000-0002-5149-1335	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U105184283] Funding Source: Medline; Wellcome Trust [078889] Funding Source: Medline; MRC [MC_U105184283] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Day SJ, 2000, DEVELOPMENT, V127, P2977; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Huxley J., 1932, PROBLEMS RELATIVE GR; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Lawrence P. A., 1970, Adv. Insect Physiol., V7, P197, DOI 10.1016/S0065-2806(08)60242-8; LAWRENCE PA, 1966, J EXP BIOL, V44, P607; Lawrence PA, 2004, NATURE, V429, P247, DOI 10.1038/429247a; LAWRENCE PA, 1972, J CELL SCI, V11, P815; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; MA D, 2003, NATURE; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; MATAKATSU H, 2006, DEVELOPMENT; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Struhl G, 1997, DEVELOPMENT, V124, P2155; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Thompson D.W, 1917, GROWTH FORM; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Willecke M, 2008, P NATL ACAD SCI USA, V105, P14897, DOI 10.1073/pnas.0805201105; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zecca M, 2007, DEVELOPMENT, V134, P3011, DOI 10.1242/dev.006445; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	37	53	53	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1379	1382		10.1038/ncb1208-1379	http://dx.doi.org/10.1038/ncb1208-1379			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19043429	Green Accepted, Green Submitted			2022-12-25	WOS:000261261800004
J	Soares, MM; King, SW; Thorpe, PE				Soares, M. Melina; King, Steven W.; Thorpe, Philip E.			Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases	NATURE MEDICINE			English	Article							MEMBRANE PHOSPHOLIPID ASYMMETRY; CHRONIC HEPATITIS-C; LIPID RAFTS; MONOCLONAL-ANTIBODY; PLASMA-MEMBRANE; ANIONIC PHOSPHOLIPIDS; INFLUENZA-VIRUSES; DENDRITIC CELLS; ACTINOMYCIN-D; ANNEXIN-V	There is a pressing need for antiviral agents that are effective against multiple classes of viruses. Broad specificity might be achieved by targeting phospholipids that are widely expressed on infected host cells or viral envelopes. We reasoned that events occurring during virus replication (for example, cell activation or preapoptotic changes) would trigger the exposure of normally intracellular anionic phospholipids on the outer surface of virus-infected cells. A chimeric antibody, bavituximab, was used to identify and target the exposed anionic phospholipids. Infection of cells with Pichinde virus (a model for Lassa fever virus, a potential bioterrorism agent) led to the exposure of anionic phospholipids. Bavituximab treatment cured overt disease in guinea pigs lethally infected with Pichinde virus. Direct clearance of infectious virus from the blood and antibody-dependent cellular cytotoxicity of virus-infected cells seemed to be the major antiviral mechanisms. Combination therapy with bavituximab and ribavirin was more effective than either drug alone. Bavituximab also bound to cells infected with multiple other viruses and rescued mice with lethal mouse cytomegalovirus infections. Targeting exposed anionic phospholipids with bavituximab seems to be safe and effective. Our study demonstrates that anionic phospholipids on infected host cells and virions may provide a new target for the generation of antiviral agents.	[Soares, M. Melina; Thorpe, Philip E.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [King, Steven W.] Peregrine Pharmaceut Inc, Tustin, CA 92780 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Thorpe, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Philip.Thorpe@UTSouthwestern.edu			US National Institutes of Health [5 U01 AI1056412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056412] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Rabbit Pichinde-specific antiserum was a gift from J. Aronson, University of Texas Medical Branch, Galveston. This work was supported by a US National Institutes of Health grant (5 U01 AI1056412) and a sponsored research agreement with Peregrine Pharmaceuticals. We thank G. Barbero, S. Mims, H. Arizpe, L. Ingram, S. Syed, L. Watkins, S. Li and J. Iglehart for technical assistance. We also thank W. Bresnahan, S. Ran, O. Ramilo, H. Jafri, S. Fussey, M. Roth and J. Albanesi for discussions and comments on the manuscript.	Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Banki K, 1998, J BIOL CHEM, V273, P11944, DOI 10.1074/jbc.273.19.11944; Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500; Briggs JAG, 2003, J GEN VIROL, V84, P757, DOI 10.1099/vir.0.18779-0; Brown G, 2002, J GEN VIROL, V83, P1841, DOI 10.1099/0022-1317-83-8-1841; Callahan MK, 2003, J IMMUNOL, V170, P4840, DOI 10.4049/jimmunol.170.9.4840; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Choe W, 2002, J VIROL, V76, P5274, DOI 10.1128/JVI.76.10.5274-5277.2002; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Gautier I, 2003, EXP CELL RES, V289, P174, DOI 10.1016/S0014-4827(03)00258-1; Godofsky EW, 2006, HEPATOLOGY, V44, p236A; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huang RTC, 1996, FEBS LETT, V392, P59, DOI 10.1016/0014-5793(96)00783-1; JAHRLING PB, 1981, INFECT IMMUN, V32, P872, DOI 10.1128/IAI.32.2.872-880.1981; Lawitz EJ, 2007, HEPATOLOGY, V46, p257A; LUKASHEVICH IS, 1984, VOP VIRUSOL+, P569; Luster TA, 2006, J BIOL CHEM, V281, P29863, DOI 10.1074/jbc.M605252200; MARCONESCU A, BIOCH BIOPHYS ACTA, V1778, P2217; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; PRYZDIAL ELG, 1994, BLOOD, V84, P3749, DOI 10.1182/blood.V84.11.3749.bloodjournal84113749; Ran S, 2005, CLIN CANCER RES, V11, P1551, DOI 10.1158/1078-0432.CCR-04-1645; RAWLS WE, 1976, J GEN VIROL, V33, P421, DOI 10.1099/0022-1317-33-3-421; Sanchez V, 2002, SCIENCE, V297, P778, DOI 10.1126/science.1075102; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Sutherland MR, 1997, P NATL ACAD SCI USA, V94, P13510, DOI 10.1073/pnas.94.25.13510; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	40	144	155	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1357	1362		10.1038/nm.1885	http://dx.doi.org/10.1038/nm.1885			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029986	Green Accepted			2022-12-25	WOS:000261393600020
J	Broady, R; Levings, MK				Broady, Raewyn; Levings, Megan K.			Graft-versus-host disease: suppression by statins	NATURE MEDICINE			English	Editorial Material							COA REDUCTASE INHIBITION; LEUKEMIA; THERAPY; CELLS		[Broady, Raewyn] Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada; [Levings, Megan K.] Univ British Columbia, Dept Surg, Vancouver, BC V6H 3Z6, Canada; [Levings, Megan K.] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Broady, R (corresponding author), Univ British Columbia, Dept Med, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	mlevings@interchange.ubc.ca		Levings, Megan/0000-0002-0305-5790				Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Chen X, 2007, BLOOD, V110, P3804, DOI 10.1182/blood-2007-05-091074; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Hamadani M, 2008, BLOOD, V111, P3901, DOI 10.1182/blood-2008-01-132050; Hori A, 2005, TRANSPLANTATION, V79, P372, DOI 10.1097/01.TP.0000151001.64189.1D; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Mason RP, 2005, AM J CARDIOL, V96, p11F, DOI 10.1016/j.amjcard.2005.06.008; Mausner-Fainberg K, 2008, ATHEROSCLEROSIS, V197, P829, DOI 10.1016/j.atherosclerosis.2007.07.031; Mira E, 2008, J IMMUNOL, V181, P3524, DOI 10.4049/jimmunol.181.5.3524; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Zeiser R, 2007, BLOOD, V110, P4588, DOI 10.1182/blood-2007-08-106005; Zhang X, 2008, J IMMUNOL, V180, P6988, DOI 10.4049/jimmunol.180.10.6988	12	39	44	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11					1155	1156		10.1038/nm1108-1155	http://dx.doi.org/10.1038/nm1108-1155			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18989280				2022-12-25	WOS:000260751200015
J	Kattah, MG; Coller, J; Cheung, RK; Oshidary, N; Utz, PJ				Kattah, Michael G.; Coller, John; Cheung, Regina K.; Oshidary, Neekaan; Utz, Paul J.			HIT: a versatile proteomics platform for multianalyte phenotyping of cytokines, intracellular proteins and surface molecules	NATURE MEDICINE			English	Article							ROLLING-CIRCLE AMPLIFICATION; T-CELLS; AUTOIMMUNE-DISEASES; PROXIMITY LIGATION; MICROARRAYS; ANTIBODIES; ANTIGEN; ACTIVATION; 2-COLOR; SERUM	We have developed a multianalyte fluid-phase protein array technology termed high-throughput immunophenotyping using transcription (HIT). This method employs a panel of monoclonal antibodies, each tagged with a unique oligonucleotide sequence that serves as a molecular bar code. After staining a sample, T7 polymerase amplifies the tags, which are then hybridized to a DNA microarray for indirect measurement of each analyte. Although there are many potential applications for this technology, here we report its suitability for profiling cytokines, intracellular molecules and cell surface markers. Using HIT, we profiled 90 surface markers on human naive T helper cells activated in vitro. The markers identified in this screen are consistent with previously described activation markers and were validated by flow cytometry. Additionally, a HIT screen of surface markers expressed on T helper cells activated in the presence of transforming growth factor-beta identified downregulation of CD26 in these cells. HIT arrays are an ideal platform for rapidly identifying markers for further characterization and therapeutic intervention.	[Kattah, Michael G.; Cheung, Regina K.; Oshidary, Neekaan; Utz, Paul J.] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Coller, John] Stanford Univ, Sch Med, Stanford Funct Genom Facil, Stanford, CA 94305 USA	Stanford University; Stanford University	Utz, PJ (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.	pjutz@stanford.edu		Kattah, Michael/0000-0002-6067-6585	Stanford Program in Immunology [5 T32 AI07290]; US National Institutes of Health [DK61934, AI50854, AI50865, AR49328]; National Heart, Lung, and Blood Institute Proteomics [N01-HV-28183]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR049328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061934] Funding Source: NIH RePORTER	Stanford Program in Immunology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute Proteomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Chan, D. Thibault, J. Mollick, P. Teo, A. Venteicher, S. Wrenn, R. Tibshirani, M. Schaner, J. Chi and other members of our laboratory for helpful discussion and technical assistance. We thank A. Ting (Massachusetts Institute of Technology) for kindly providing mSA plasmids. We also thank the Stanford University Human Immune Monitoring Center for assistance with Luminex cytokine data acquisition. M. G. K. was funded by the Stanford Medical Scientist Training Program and the Floren Family Trust. N. O. was funded by the Center for Clinical Immunology at Stanford Summer Research Program and the Northern California Chapter of the Arthritis Foundation. R. K. C. was funded by the Stanford Program in Immunology training grant 5 T32 AI07290. P. J. U. is the recipient of a Donald E. and Delia B. Baxter Foundation Career Development Award and was supported by the Dana Foundation, the Floren Family Trust, the Northern California Chapter of the Arthritis Foundation, US National Institutes of Health Grants DK61934, AI50854, AI50865 and AR49328 and National Heart, Lung, and Blood Institute Proteomics Contract N01-HV-28183.	Balboni I, 2006, ANNU REV IMMUNOL, V24, P391, DOI 10.1146/annurev.immunol.24.021605.090709; Belov L, 2006, BRIT J HAEMATOL, V135, P184, DOI 10.1111/j.1365-2141.2006.06266.x; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brown JK, 2004, J HISTOCHEM CYTOCHEM, V52, P1219, DOI 10.1369/jhc.3A6200.2004; Chan SM, 2005, ANN NY ACAD SCI, V1062, P61, DOI 10.1196/annals.1358.009; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; HENDRICKSON ER, 1995, NUCLEIC ACIDS RES, V23, P522, DOI 10.1093/nar/23.3.522; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Kattah MG, 2006, NAT METHODS, V3, P745, DOI 10.1038/nmeth910; Kozlov IA, 2004, BIOPOLYMERS, V73, P621, DOI 10.1002/bip.20009; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Niemeyer CM, 2005, TRENDS BIOTECHNOL, V23, P208, DOI 10.1016/j.tibtech.2005.02.006; Reinhold D, 1998, J NEUROIMMUNOL, V87, P203, DOI 10.1016/S0165-5728(98)00100-3; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; TWEEDDALE ME, 1987, BLOOD, V69, P1307; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Zhang HT, 2001, P NATL ACAD SCI USA, V98, P5497, DOI 10.1073/pnas.101124598; Zhang HT, 2006, NAT MED, V12, P473, DOI 10.1038/nm1378; Zhou HP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r28	32	26	26	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2008	14	11					1284	1289		10.1038/nm.1755	http://dx.doi.org/10.1038/nm.1755			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18849997	Green Accepted			2022-12-25	WOS:000260751200049
J	Pule, MA; Savoldo, B; Myers, GD; Rossig, C; Russell, HV; Dotti, G; Huls, MH; Liu, EL; Gee, AP; Mei, Z; Yvon, E; Weiss, HL; Liu, H; Rooney, CM; Heslop, HE; Brenner, MK				Pule, Martin A.; Savoldo, Barbara; Myers, G. Doug; Rossig, Claudia; Russell, Heidi V.; Dotti, Gianpietro; Huls, M. Helen; Liu, Enli; Gee, Adrian P.; Mei, Zhuyong; Yvon, Eric; Weiss, Heidi L.; Liu, Hao; Rooney, Cliona M.; Heslop, Helen E.; Brenner, Malcolm K.			Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma	NATURE MEDICINE			English	Article							EPSTEIN-BARR-VIRUS; ADOPTIVE TRANSFER; TRANSPLANT RECIPIENTS; METASTATIC MELANOMA; CANCER-THERAPY; LYMPHOCYTES; IMMUNOTHERAPY; IMMUNOSURVEILLANCE; EXPRESSION; STRATEGIES	Cytotoxic T lymphocytes (CTLs) directed to nonviral tumor-associated antigens do not survive long term and have limited antitumor activity in vivo, in part because such tumor cells typically lack the appropriate costimulatory molecules. We therefore engineered Epstein-Barr virus (EBV)-specific CTLs to express a chimeric antigen receptor directed to the diasialoganglioside GD2, a nonviral tumor-associated antigen expressed by human neuroblastoma cells. We reasoned that these genetically engineered lymphocytes would receive optimal costimulation after engagement of their native receptors, enhancing survival and antitumor activity mediated through their chimeric receptors. Here we show in individuals with neuroblastoma that EBV-specific CTLs expressing a chimeric GD2-specific receptor indeed survive longer than T cells activated by the CD3-specific antibody OKT3 and expressing the same chimeric receptor but lacking virus specificity. Infusion of these genetically modified cells seemed safe and was associated with tumor regression or necrosis in half of the subjects tested. Hence, virus-specific CTLs can be modified to function as tumor-directed effector cells.	[Pule, Martin A.; Savoldo, Barbara; Myers, G. Doug; Rossig, Claudia; Russell, Heidi V.; Dotti, Gianpietro; Huls, M. Helen; Liu, Enli; Gee, Adrian P.; Mei, Zhuyong; Yvon, Eric; Rooney, Cliona M.; Heslop, Helen E.; Brenner, Malcolm K.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Pule, Martin A.; Savoldo, Barbara; Myers, G. Doug; Rossig, Claudia; Russell, Heidi V.; Dotti, Gianpietro; Huls, M. Helen; Liu, Enli; Gee, Adrian P.; Mei, Zhuyong; Yvon, Eric; Rooney, Cliona M.; Heslop, Helen E.; Brenner, Malcolm K.] Methodist Hosp, Houston, TX 77030 USA; [Pule, Martin A.; Savoldo, Barbara; Myers, G. Doug; Rossig, Claudia; Russell, Heidi V.; Dotti, Gianpietro; Huls, M. Helen; Liu, Enli; Gee, Adrian P.; Mei, Zhuyong; Yvon, Eric; Rooney, Cliona M.; Heslop, Helen E.; Brenner, Malcolm K.] Texas Childrens Hosp, Houston, TX 77030 USA; [Myers, G. Doug; Russell, Heidi V.; Rooney, Cliona M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Dotti, Gianpietro; Gee, Adrian P.; Heslop, Helen E.; Brenner, Malcolm K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Weiss, Heidi L.; Liu, Hao] Baylor Coll Med, Biostat Core Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Rooney, Cliona M.] Baylor Coll Med, Dept Virol, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Brenner, MK (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, 6621 Fannin St, Houston, TX 77030 USA.	mbrenner@bcm.edu	Brenner, Malcolm/Y-2509-2019; Wilson, Matthew H/K-3193-2013; Heslop, Helen/AAC-9500-2020; Rooney, Cliona/ABD-5475-2021	Pule, Martin/0000-0002-8347-9867	US National Institutes of Health [PO1 CA94237]; General Clinical Research Centers at Baylor College of Medicine [RR00188]; NATIONAL CANCER INSTITUTE [P01CA094237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000188, M01RR000188] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers at Baylor College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Maloney murine leukemia virus-based vector was generously provided by R. C. Mulligan (Harvard Stem Cell Institute). This work was supported by grant PO1 CA94237 from the US National Institutes of Health, the General Clinical Research Centers at Baylor College of Medicine (RR00188) and a Doris Duke Distinguished Clinical Scientist Award to H. E. H.	Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Bollard CM, 2007, BLOOD, V110, P2838, DOI 10.1182/blood-2007-05-091280; Bollard CM, 2004, J EXP MED, V200, P1623, DOI 10.1084/jem.20040890; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Cooper LJN, 2005, BLOOD, V105, P1622, DOI 10.1182/blood-2004-03-1208; FISHER B, 1989, J CLIN ONCOL, V7, P250, DOI 10.1200/JCO.1989.7.2.250; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jaffe CC, 2006, J CLIN ONCOL, V24, P3245, DOI 10.1200/JCO.2006.06.5599; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Khanna R, 2005, NAT CLIN PRACT ONCOL, V2, P138, DOI 10.1038/ncponc0107; Krance RA, 2003, BIOL BLOOD MARROW TR, V9, P273, DOI 10.1053/bbmt.2003.50024; Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527; Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; O'Reilly RJ, 2007, IMMUNOL RES, V38, P237, DOI 10.1007/s12026-007-0059-2; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; Rossig C, 2006, J IMMUNOTHER, V29, P21, DOI 10.1097/01.cji.0000175492.28723.d6; Rossig C, 2002, BLOOD, V99, P2009, DOI 10.1182/blood.V99.6.2009; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Savoldo B, 2007, BLOOD, V110, P2620, DOI 10.1182/blood-2006-11-059139; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Stauss HJ, 2007, MOL THER, V15, P1744, DOI 10.1038/sj.mt.6300216; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Straathof KCM, 2005, BLOOD, V105, P1898, DOI 10.1182/blood-2004-07-2975; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	39	881	994	3	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2008	14	11					1264	1270		10.1038/nm.1882	http://dx.doi.org/10.1038/nm.1882			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18978797	Green Submitted, Green Accepted			2022-12-25	WOS:000260751200046
J	van den Berg, MA; Albang, R; Albermann, K; Badger, JH; Daran, JM; Driessen, AJM; Garcia-Estrada, C; Fedorova, ND; Harris, DM; Heijne, WHM; Joardar, V; Kiel, JAKW; Kovalchuk, A; Martin, JF; Nierman, WC; Nijland, JG; Pronk, JT; Roubos, JA; van der Klei, IJ; van Peij, NNME; Veenhuis, M; von Dohren, H; Wagner, C; Wortman, J; Bovenberg, RAL				van den Berg, Marco A.; Albang, Richard; Albermann, Kaj; Badger, Jonathan H.; Daran, Jean-Marc; Driessen, Arnold J. M.; Garcia-Estrada, Carlos; Fedorova, Natalie D.; Harris, Diana M.; Heijne, Wilbert H. M.; Joardar, Vinita; Kiel, Jan A. K. W.; Kovalchuk, Andriy; Martin, Juan F.; Nierman, William C.; Nijland, Jeroen G.; Pronk, Jack T.; Roubos, Johannes A.; van der Klei, Ida J.; van Peij, Noel N. M. E.; Veenhuis, Marten; von Doehren, Hans; Wagner, Christian; Wortman, Jennifer; Bovenberg, Roel A. L.			Genome sequencing and analysis of the filamentous fungus Penicillium chrysogenum	NATURE BIOTECHNOLOGY			English	Article							RICE BLAST FUNGUS; COA LIGASE GENE; ISOPENICILLIN-N; STREPTOMYCES-CLAVULIGERUS; ASPERGILLUS-NIDULANS; SECONDARY METABOLISM; BIOSYNTHESIS GENES; MAGNAPORTHE-ORYZAE; TANDEM REPEATS; EXPRESSION	Industrial penicillin production with the filamentous fungus Penicillium chrysogenum is based on an unprecedented effort in microbial strain improvement. To gain more insight into penicillin synthesis, we sequenced the 32.19 Mb genome of P. chrysogenum Wisconsin54-1255 and identified numerous genes responsible for key steps in penicillin production. DNA microarrays were used to compare the transcriptomes of the sequenced strain and a penicillinG high-producing strain, grown in the presence and absence of the side-chain precursor phenylacetic acid. Transcription of genes involved in biosynthesis of valine, cysteine and alpha-aminoadipic acid -precursors for penicillin biosynthesis-as well as of genes encoding microbody proteins, was increased in the high-producing strain. Some gene products were shown to be directly controlling beta-lactam output. Many key cellular transport processes involving penicillins and intermediates remain to be characterized at the molecular level. Genes predicted to encode transporters were strongly overrepresented among the genes transcriptionally upregulated under conditions that stimulate penicillinG production, illustrating potential for future genomics-driven metabolic engineering.	[van den Berg, Marco A.; Bovenberg, Roel A. L.] DSM Anti Infect, NL-2600 AK Delft, Netherlands; [Albang, Richard; Albermann, Kaj; Wagner, Christian] Biomax Informat AG, D-82152 Martinsried, Germany; [Badger, Jonathan H.; Fedorova, Natalie D.; Joardar, Vinita; Nierman, William C.; Wortman, Jennifer] J Craig Venter Inst Genom Res, Rockville, MD 20850 USA; [Daran, Jean-Marc; Driessen, Arnold J. M.; Harris, Diana M.; van der Klei, Ida J.] Kluyver Ctr Genom Ind Fermentat, NL-2628 BC Delft, Netherlands; [Daran, Jean-Marc; Harris, Diana M.; Pronk, Jack T.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Driessen, Arnold J. M.; Kiel, Jan A. K. W.; Kovalchuk, Andriy; Nijland, Jeroen G.; van der Klei, Ida J.; Veenhuis, Marten] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands; [Garcia-Estrada, Carlos; Martin, Juan F.] Inst Biotecnol Leon, Leon 24006, Spain; [Heijne, Wilbert H. M.; Roubos, Johannes A.; van Peij, Noel N. M. E.] DSM Food Specialties, NL-2600 MA Delft, Netherlands; [Martin, Juan F.] Univ Leon, Fac CC Biol & Ambientales, Area Microbiol, Dept Biol Mol, E-24071 Leon, Spain; [Nierman, William C.] George Washington Univ, Dept Biochem & Mol Biol, Sch Med, Washington, DC 20037 USA; [von Doehren, Hans] Univ Berlin, Inst Chem, Sekretariat OE2, D-10623 Berlin, Germany	DSM NV; Biomax Informatics; J. Craig Venter Institute; Delft University of Technology; University of Groningen; DSM NV; Universidad de Leon; George Washington University	van den Berg, MA (corresponding author), DSM Anti Infect, POB 425, NL-2600 AK Delft, Netherlands.	Marco.Berg-van-den@DSM.com	van der Klei, Ida J/D-1919-2012; Garcia-Estrada, Carlos/F-7932-2014; Abrams, Natalie/F-4845-2011; Daran, Jean-Marc/X-8787-2019; Driessen, Arnold J.M./D-1876-2012; Abrams, Natalie/AAM-5468-2021	Garcia-Estrada, Carlos/0000-0001-5617-9669; Abrams, Natalie/0000-0001-9698-2819; Abrams, Natalie/0000-0001-9698-2819; Joardar, Vinita/0000-0001-9018-3151; Wortman, Jennifer/0000-0002-8713-1227; Van der Klei, Ida J./0000-0001-7165-9679; Pronk, Jack/0000-0002-5617-4611; Kovalchuk, Andriy/0000-0001-8704-4644; Driessen, Arnold J.M./0000-0001-9258-9104; Daran, Jean-Marc/0000-0003-3136-8193				Andrade AC, 2000, MOL GEN GENET, V263, P966, DOI 10.1007/PL00008697; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey JE, 2002, BIOTECHNOL BIOENG, V79, P568, DOI 10.1002/bit.10441; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; CANTWELL CA, 1990, CURR GENET, V17, P213, DOI 10.1007/BF00312612; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; DIEZ B, 1990, J BIOL CHEM, V265, P16358; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elander R.P., 1983, ANTIBIOTICS CONTAINI, P97; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; FIERRO F, 1995, P NATL ACAD SCI USA, V92, P6200, DOI 10.1073/pnas.92.13.6200; Fierro F, 2006, FUNGAL GENET BIOL, V43, P618, DOI 10.1016/j.fgb.2006.03.001; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Forster Jochen, 2003, OMICS A Journal of Integrative Biology, V7, P193, DOI 10.1089/153623103322246584; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gidijala L, 2007, FEMS YEAST RES, V7, P1160, DOI 10.1111/j.1567-1364.2007.00228.x; GORDON M, 1953, SCIENCE, V118, P43, DOI 10.1126/science.118.3054.43; Gutierrez S, 1999, ANTON LEEUW INT J G, V75, P81, DOI 10.1023/A:1001861025070; Harris DM, 2006, METAB ENG, V8, P91, DOI 10.1016/j.ymben.2005.09.004; HERSBACH GJM, 1984, DRUGS PHARM SCI, V22, P45; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; KIM KW, 1993, BIOSCI BIOTECH BIOCH, V57, P787, DOI 10.1271/bbb.57.787; Kosalkova K, 2000, J BIOL CHEM, V275, P2423, DOI 10.1074/jbc.275.4.2423; KOVACEVIC S, 1990, J BACTERIOL, V172, P3952, DOI 10.1128/jb.172.7.3952-3958.1990; KUNAU WH, 2006, BIOCH BIOPHYS ACTA, V1763; Lamas-Maceiras M, 2006, BIOCHEM J, V395, P147, DOI 10.1042/BJ20051599; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; MALLOCH D, 1985, PENICILLIUM ASPERGIL, P365; Martin JF, 2000, J BACTERIOL, V182, P2355, DOI 10.1128/JB.182.9.2355-2362.2000; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; POLONSKY J, 1977, ANN NUTR ALIMENT, V31, P693; Raper KB, 1944, J BACTERIOL, V48, P639, DOI 10.1128/JB.48.6.639-659.1944; Rehmeyer C, 2006, NUCLEIC ACIDS RES, V34, P4685, DOI 10.1093/nar/gkl588; Rodriguez-Saiz M, 2001, J BACTERIOL, V183, P5465, DOI 10.1128/JB.183.19.5465-5471.2001; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Thon MR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r16; Ullan RV, 2007, CHEM BIOL, V14, P329, DOI 10.1016/j.chembiol.2007.01.012; Ullan RV, 2002, J BIOL CHEM, V277, P46216, DOI 10.1074/jbc.M207482200; van den Berg MA, 2007, FUNGAL GENET BIOL, V44, P830, DOI 10.1016/j.fgb.2007.03.008; VANDENBERG MA, 2001, Patent No. 200132904; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VERWEIJ PE, 1995, J MED VET MYCOL, V33, P185, DOI 10.1080/02681219580000381; Wang FQ, 2007, BIOCHEM BIOPH RES CO, V360, P453, DOI 10.1016/j.bbrc.2007.06.074; Xu ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni037	50	366	540	3	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1161	1168		10.1038/nbt.1498	http://dx.doi.org/10.1038/nbt.1498			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18820685	hybrid, Green Published			2022-12-25	WOS:000259926000031
J	Mujtaba, S; Manzur, KL; Gurnon, JR; Kang, M; Van Etten, JL; Zhou, MM				Mujtaba, Shiraz; Manzur, Karishma L.; Gurnon, James R.; Kang, Ming; Van Etten, James L.; Zhou, Ming-Ming			Epigenetic transcriptional repression of cellular genes by a viral SET protein	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; POLYCOMB GROUP PROTEINS; EMBRYONIC STEM-CELLS; CHROMATIN-STRUCTURE; H3K27 DEMETHYLASES; CHLORELLA VIRUSES; PCAF BROMODOMAIN; STRUCTURAL BASIS; BREAST-CANCER	Viruses recruit host proteins to secure viral genome maintenance and replication. However, whether they modify host histones directly to interfere with chromatin-based transcription is unknown. Here we report that Paramecium bursaria chlorella virus 1 (PBCV-1) encodes a functional SET domain histone Lys methyltransferase (HKMTase) termed vSET, which is linked to rapid inhibition of host transcription after viral infection. We show that vSET is packaged in the PBCV-1 virion, and that it contains a nuclear localization signal and probably represses host transcription by methylating histone H3 at Lys 27 (H3K27), a modification known to trigger gene silencing in eukaryotes. We also show that vSET induces cell accumulation at the G2/M phase by recruiting the Polycomb repressive complex CBX8 to the methylated H3K27 site in a heterologous system. vSET-like proteins that have H3K27 methylation activity are conserved in chlorella viruses. Our findings suggest a viral mechanism to repress gene transcription by direct modification of chromatin by PBCV-1 vSET.	[Gurnon, James R.; Kang, Ming; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Gurnon, James R.; Kang, Ming; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Mujtaba, Shiraz; Manzur, Karishma L.; Zhou, Ming-Ming] NYU, Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Icahn School of Medicine at Mount Sinai; New York University	Van Etten, JL (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	jvanetten@unlnotes.unl.edu; ming-ming.zhou@mssm.edu			NIH-NCI; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. W. Enquist for the Us9-GFP construct, M. Ptashne for the Gal4-DBD construct, P. Traber for the firefly luciferase construct, R. Slany for the HOX7A luciferase construct, I. V. Agarkova for the results used in Fig. 1a, and M. Walsh for helpful discussions. Fluorescence microscopy imaging was performed at the Mount Sinai Microscopy Shared Resource Facility supported in part with funding from NIH-NCI shared resources grant. This work was supported by grants from the National Institutes of Health (M.-M.Z. and J.L.V.E.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alvarez-Venegas R, 2007, MOL BIOL EVOL, V24, P482, DOI 10.1093/molbev/msl184; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Kang M, 2004, VIROLOGY, V326, P150, DOI 10.1016/j.virol.2004.05.023; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Manzur KL, 2005, FEBS LETT, V579, P3859, DOI 10.1016/j.febslet.2005.05.026; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SCHUSTER AM, 1986, VIROLOGY, V150, P170, DOI 10.1016/0042-6822(86)90276-X; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Svingen T, 2003, CANCER BIOL THER, V2, P518, DOI 10.4161/cbt.2.5.441; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yap KL, 2006, RES PRO CEL, V41, P1, DOI 10.1007/010; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7	35	48	49	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1114	1122		10.1038/ncb1772	http://dx.doi.org/10.1038/ncb1772			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160493	Green Accepted, Green Published			2022-12-25	WOS:000258910400018
J	Jones, AV; Chase, A; Silver, RT; Oscier, D; Zoi, K; Wang, YL; Cario, H; Pahl, HL; Collins, A; Reiter, A; Grand, F; Cross, NCP				Jones, Amy V.; Chase, Andrew; Silver, Richard T.; Oscier, David; Zoi, Katerina; Wang, Y. Lynn; Cario, Holger; Pahl, Heike L.; Collins, Andrew; Reiter, Andreas; Grand, Francis; Cross, Nicholas C. P.			JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; SUSCEPTIBILITY LOCI; ESSENTIAL THROMBOCYTHEMIA; CANCER SUSCEPTIBILITY; ACTIVATING MUTATION; MYELOID METAPLASIA; DISORDERS; MYELOFIBROSIS	Chronic myeloproliferative neoplasms (MPNs) are a group of related conditions characterized by the overproduction of cells from one or more myeloid lineages. More than 95% of cases of polycythemia vera, and roughly half of essential thrombocythemia and primary myelofibrosis acquire a unique somatic 1849G> T JAK2 mutation (encoding V617F) that is believed to be a critical driver of excess proliferation(1-4). We report here that JAK2(V617F)-associated disease is strongly associated with a specific constitutional JAK2 haplotype, designated 46/1, in all three disease entities compared to healthy controls ( polycythemia vera, n = 192, P = 2.9 x 10(-16); essential thrombocythemia, n 78, P = 8.2 x 10(-9) and myelofibrosis, n = 41, P = 8.0 x 10(-5)). Furthermore, JAK2(V617F) specifically arises on the 46/1 allele in most cases. The 46/1 JAK2 haplotype thus predisposes to the development of JAK2(V617F)-associated MPNs (OR 3.7; 95% CI = 3.1-4.3) and provides a model whereby a constitutional genetic factor is associated with an increased risk of acquiring a specific somatic mutation.	[Jones, Amy V.; Chase, Andrew; Grand, Francis; Cross, Nicholas C. P.] Wessex Reg Genet Lab, Salisbury, Wilts, England; [Jones, Amy V.; Chase, Andrew; Collins, Andrew; Grand, Francis; Cross, Nicholas C. P.] Univ Southampton, Div Human Genet, Southampton SO9 5NH, Hants, England; [Silver, Richard T.; Wang, Y. Lynn] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Oscier, David] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England; [Zoi, Katerina] Acad Athens, Biomed Res Fdn, Haematol Res Lab, Athens, Greece; [Cario, Holger] Univ Hosp Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Pahl, Heike L.] Univ Hosp Freiburg, Dept Expt Anaesthesiol, Freiburg, Germany; [Reiter, Andreas] Univ Heidelberg, Fak Klin Med Mannheim, Med Univ Klin 3, D-6900 Heidelberg, Germany	University of Southampton; Cornell University; Academy of Athens; Ulm University; University of Freiburg; Ruprecht Karls University Heidelberg	Cross, NCP (corresponding author), Wessex Reg Genet Lab, Salisbury, Wilts, England.	ncpc@soton.ac.uk	Collins, Andrew/A-6595-2010; Pahl, Heike/AGM-5260-2022; Cross, Nicholas/B-4817-2009; Cario, Holger/AAH-6713-2019; Wang, Y. Lynn/GRF-6667-2022; Silver MD, Richard T/GRE-5925-2022; Collins, Andrew/S-2196-2019	Collins, Andrew/0000-0001-7108-0771; Cross, Nicholas/0000-0001-5481-2555; Wang, Y. Lynn/0000-0003-0773-1212; Collins, Andrew/0000-0001-7108-0771; Jones, Amy Victoria/0000-0003-3467-6765; Cario, Holger/0000-0002-6923-488X	Leukaemia Research (UK) Specialist Programme [0280]; Wellcome Trust [076113]; Deutsche Jose Carreras Leukarmie-Stiftung e. V. [DJCLS R06/02]; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER	Leukaemia Research (UK) Specialist Programme; Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Jose Carreras Leukarmie-Stiftung e. V.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Leukaemia Research (UK) Specialist Programme Grant 0280 and makes use (in part) of data generated by the WTCCC. A full list of the investigators who contributed to the generation of the WTCCC data are available from www.wtccc.org.uk, funding for which was provided by the Wellcome Trust under award 076113. We are grateful to P. Strike (Salisbury Research and Development Support Unit) for statistical advice. A. R. was supported by the 'Deutsche Jose Carreras Leukarmie-Stiftung e. V. - DJCLS R06/02, Germany.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2006, BLOOD, V107, P3339, DOI 10.1182/blood-2005-09-3917; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P264; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Rumi E, 2008, BLOOD, V112, P2587, DOI 10.1182/blood-2008-05-160739; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378	21	296	305	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					446	449		10.1038/ng.334	http://dx.doi.org/10.1038/ng.334			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287382	Green Accepted			2022-12-25	WOS:000264659000018
J	Nguyen, UTT; Guo, Z; Delon, C; Wu, YW; Deraeve, C; Fraenzel, B; Bon, RS; Blankenfeldt, W; Goody, RS; Waldmann, H; Wolters, D; Alexandrov, K				Nguyen, Uyen T. T.; Guo, Zhong; Delon, Christine; Wu, Yaowen; Deraeve, Celine; Fraenzel, Benjamin; Bon, Robin S.; Blankenfeldt, Wulf; Goody, Roger S.; Waldmann, Herbert; Wolters, Dirk; Alexandrov, Kirill			Analysis of the eukaryotic prenylome by isoprenoid affinity tagging	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN PRENYLATION; POSTTRANSLATIONAL MODIFICATIONS; FARNESYLTRANSFERASE INHIBITORS; RAB GERANYLGERANYLTRANSFERASE; FARNESYL TRANSFERASE; PROVIDE INSIGHTS; TOOLS; CELLS; PRENYLTRANSFERASES; IDENTIFICATION	Protein prenylation is a widespread phenomenon in eukaryotic cells that affects many important signaling molecules. We describe the structure-guided design of engineered protein prenyltransferases and their universal synthetic substrate, biotin-geranylpyrophosphate. These new tools allowed us to detect femtomolar amounts of prenylatable proteins in cells and organs and to identify their cognate protein prenyltransferases. Using this approach, we analyzed the in vivo effects of protein prenyltransferase inhibitors. Whereas some of the inhibitors displayed the expected activities, others lacked in vivo activity or targeted a broader spectrum of prenyltransferases than previously believed. To quantitate the in vivo effect of the prenylation inhibitors, we profiled biotin-geranyl-tagged RabGTPases across the proteome by mass spectrometry. We also demonstrate that sites of active vesicular transport carry most of the RabGTPases. This approach enables a quantitative proteome-wide analysis of the regulation of protein prenylation and its modulation by therapeutic agents.	[Nguyen, Uyen T. T.; Guo, Zhong; Delon, Christine; Wu, Yaowen; Deraeve, Celine; Bon, Robin S.; Blankenfeldt, Wulf; Goody, Roger S.; Waldmann, Herbert; Alexandrov, Kirill] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany; [Fraenzel, Benjamin; Wolters, Dirk] Ruhr Univ Bochum, Biomol Massenspektrometrie Prot Ctr, Bochum, Germany; [Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Alexandrov, Kirill] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	Max Planck Society; Ruhr University Bochum; University of Queensland; University of Queensland	Alexandrov, K (corresponding author), Max Planck Inst Mol Physiol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	k.alexandrov@imb.uq.edu.au	Blankenfeldt, Wulf/F-8877-2010; Goody, Roger S/J-8845-2014; Deraeve, Celine/R-2544-2017; Alexandrov, Kirill/A-5830-2013; Wu, Yaowen/N-9802-2015; GUO, Zhong/J-8723-2014; Waldmann, Herbert/B-7406-2017; GUO, Zhong/J-8723-2014	Blankenfeldt, Wulf/0000-0001-9886-9668; Goody, Roger S/0000-0002-0772-0444; Deraeve, Celine/0000-0001-6435-5765; Alexandrov, Kirill/0000-0002-0957-6511; Wu, Yaowen/0000-0002-2573-8736; GUO, Zhong/0000-0003-0285-5021; Waldmann, Herbert/0000-0002-9606-7247; Bon, Robin/0000-0003-1733-3680; GUO, Zhong/0000-0002-2277-0087; Delon, Christine/0000-0001-5163-1716	Deutsche Forschungsgemeinschaft [AL 484/7-2]; Sonderforschungsbereich [642]; Fonds der chemischen Industrie; Alexander von Humboldt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Alexander von Humboldt(Alexander von Humboldt Foundation)	This work was supported in part by grant Deutsche Forschungsgemeinschaft AL 484/7-2 to K. A. and grant Sonderforschungsbereich 642 to K. A., D. W., R. S. G. and H.W.U.T.T.N. was supported by the predoctoral fellowship of Fonds der chemischen Industrie. R. S. B. and C. Deraeve thank the Alexander von Humboldt Stiftung for a scholarship. We thank R. Heuann (Ruhr-Universitat Bochum) for supplying mouse brains. The authors gratefully acknowledge M. Terbeck, A. Sander, T. Rogowsky, S. Thuns and N. Lupilova for excellent technical assistance. The authors are very grateful to T. Bergbrede and the Dortmund Protein Facility at the Max Planck Institute. The use of beamlines at the Swiss Light Source (Paul Scherrrer Institute) and the help of the X-ray communities at the Max Planck Institute of Molecular Physiology and the Max Planck Insitute of Medical Research with data collection is gratefully acknowledged. We thank A. Barnekow (University of Munster) for the generous gift of Rab6A antibody.	ARMSTRONG SA, 1995, METHOD ENZYMOL, V257, P30; Baron R, 2000, P NATL ACAD SCI USA, V97, P11626, DOI 10.1073/pnas.97.21.11626; Benetka Wolfgang, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-6; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CASSIDY PB, 1995, METHOD ENZYMOL, V250, P30; Chen BC, 2001, TETRAHEDRON LETT, V42, P1245, DOI 10.1016/S0040-4039(00)02257-7; COX AD, 1994, J BIOL CHEM, V269, P19203; Delahunty CM, 2007, BIOTECHNIQUES, V43, P563; Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gelb MH, 1997, SCIENCE, V275, P1750, DOI 10.1126/science.275.5307.1750; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P60; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Krzysiak AJ, 2007, ACS CHEM BIOL, V2, P385, DOI 10.1021/cb700062b; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; LUTCKE A, 1993, J CELL BIOL, V121, P553, DOI 10.1083/jcb.121.3.553; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGuire TF, 1996, J BIOL CHEM, V271, P27402, DOI 10.1074/jbc.271.44.27402; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Meri S, 2001, BIOMOL ENG, V18, P213, DOI 10.1016/S1389-0344(01)00106-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen UTT, 2007, CHEMBIOCHEM, V8, P408, DOI 10.1002/cbic.200600440; PETER M, 1992, J CELL SCI, V102, P857; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Reigard SA, 2005, BIOCHEMISTRY-US, V44, P11214, DOI 10.1021/bi050725l; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Troutman JM, 2005, BIOCONJUGATE CHEM, V16, P1209, DOI 10.1021/bc050068+; Turek-Etienne TC, 2003, BIOCHEMISTRY-US, V42, P3716, DOI 10.1021/bi0266838; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	40	138	145	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2009	5	4					227	235		10.1038/nchembio.149	http://dx.doi.org/10.1038/nchembio.149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	422KH	19219049				2022-12-25	WOS:000264426100011
J	Reynolds, AR; Hart, IR; Watson, AR; Welti, JC; Silva, RG; Robinson, SD; Da Violante, G; Gourlaouen, M; Salih, M; Jones, MC; Jones, DT; Saunders, G; Kostourou, V; Perron-Sierra, F; Norman, JC; Tucker, GC; Hodivala-Dilke, KM				Reynolds, Andrew R.; Hart, Ian R.; Watson, Alan R.; Welti, Jonathan C.; Silva, Rita G.; Robinson, Stephen D.; Da Violante, Georges; Gourlaouen, Morgane; Salih, Mishal; Jones, Matt C.; Jones, Dylan T.; Saunders, Garry; Kostourou, Vassiliki; Perron-Sierra, Francoise; Norman, Jim C.; Tucker, Gordon C.; Hodivala-Dilke, Kairbaan M.			Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors	NATURE MEDICINE			English	Article							ADVANCED SOLID TUMORS; ENDOTHELIAL-CELLS; IN-VIVO; PATHOLOGICAL ANGIOGENESIS; ALPHA-V-BETA-3 INTEGRIN; CILENGITIDE EMD-121974; MALIGNANT GLIOMA; BREAST-CANCER; PHASE-I; ALPHA	Inhibitors of alpha(v)beta(3) and alpha(v)beta(5) integrin have entered clinical trials as antiangiogenic agents for cancer treatment but generally have been unsuccessful. Here we present in vivo evidence that low (nanomolar) concentrations of RGD-mimetic alpha(v)beta(3) and alpha(v)beta(5) inhibitors can paradoxically stimulate tumor growth and tumor angiogenesis. We show that low concentrations of these inhibitors promote VEGF-mediated angiogenesis by altering alpha(v)beta(3) integrin and vascular endothelial growth factor receptor-2 trafficking, thereby promoting endothelial cell migration to VEGF. The proangiogenic effects of low concentrations of RGD-mimetic integrin inhibitors could compromise their efficacy as anticancer agents and have major implications for the use of RGD-mimetic compounds in humans.	[Reynolds, Andrew R.; Watson, Alan R.; Silva, Rita G.; Robinson, Stephen D.; Salih, Mishal; Jones, Dylan T.; Kostourou, Vassiliki; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc,John Vane Sci Ctr, Adhes & Angiogenesis Lab, London, England; [Hart, Ian R.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc,John Vane Sci Ctr, Tumor Biol Ctr, London, England; [Reynolds, Andrew R.; Welti, Jonathan C.; Gourlaouen, Morgane] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Tumour Angiogenesis Grp, London SW3 6JB, England; [Da Violante, Georges] Technol Servier, Orleans, France; [Jones, Matt C.; Norman, Jim C.] Beatson Inst Canc Res, Integrin Cell Biol Lab, Glasgow G61 1BD, Lanark, Scotland; [Saunders, Garry] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms, Herts, England; [Tucker, Gordon C.] Inst Rech Servier, Canc Res & Drug Discovery Div, Croissy Sur Seine, France	University of London; Queen Mary University London; University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Servier; Beatson Institute; Cancer Research UK; Servier; Institut de Recherches Internationales Servier	Hodivala-Dilke, KM (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc,John Vane Sci Ctr, Adhes & Angiogenesis Lab, London, England.	andrew.reynolds@icr.ac.uk; Kairbaan.Hodivala-Dilke@cancer.org.uk	Silva, Rita/AAC-8021-2020	Welti, Jonathan/0000-0002-9433-8138; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; NORMAN, Jim/0000-0002-0098-3014; Jones, Matthew/0000-0003-4723-3277; Kostourou, Vassiliki/0000-0001-7053-6247; Robinson, Stephen/0000-0002-6606-7588	Cancer Research UK Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Breast Cancer Now		Bailly M, 2000, MOL BIOL CELL, V11, P3873, DOI 10.1091/mbc.11.11.3873; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Buerkle MA, 2002, BRIT J CANCER, V86, P788, DOI 10.1038/sj.bjc.6600141; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chatterjee S, 2000, J NEURO-ONCOL, V46, P135, DOI 10.1023/A:1006444300504; Chen XY, 2004, CANCER RES, V64, P8009, DOI 10.1158/0008-5472.CAN-04-1956; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Dormond O, 2004, THROMB HAEMOSTASIS, V92, P151, DOI 10.1160/th03-11-0728; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eskens FALM, 2003, EUR J CANCER, V39, P917, DOI 10.1016/S0959-8049(03)00057-1; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Friess H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-285; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Hariharan S, 2007, ANN ONCOL, V18, P1400, DOI 10.1093/annonc/mdm140; Haubner R, 2001, CANCER RES, V61, P1781; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Legler DF, 2001, J CELL SCI, V114, P1545; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Mitjans F, 2000, INT J CANCER, V87, P716, DOI 10.1002/1097-0215(20000901)87:5<716::AID-IJC14>3.3.CO;2-I; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Perron-Sierra F, 2002, BIOORG MED CHEM LETT, V12, P3291, DOI 10.1016/S0960-894X(02)00696-0; Prewett M, 1999, CANCER RES, V59, P5209; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Taga T, 2002, INT J CANCER, V98, P690, DOI 10.1002/ijc.10265; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Tucker Gordon C, 2003, Curr Opin Investig Drugs, V4, P722; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3	53	366	383	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2009	15	4					392	400		10.1038/nm.1941	http://dx.doi.org/10.1038/nm.1941			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19305413				2022-12-25	WOS:000264937200026
J	Keng, VW; Villanueva, A; Chiang, DY; Dupuy, AJ; Ryan, BJ; Matise, I; Silverstein, KAT; Sarver, A; Starr, TK; Akagi, K; Tessarollo, L; Collier, LS; Powers, S; Lowe, SW; Jenkins, NA; Copeland, NG; Llovet, JM; Largaespada, DA				Keng, Vincent W.; Villanueva, Augusto; Chiang, Derek Y.; Dupuy, Adam J.; Ryan, Barbara J.; Matise, Ilze; Silverstein, Kevin A. T.; Sarver, Aaron; Starr, Timothy K.; Akagi, Keiko; Tessarollo, Lino; Collier, Lara S.; Powers, Scott; Lowe, Scott W.; Jenkins, Nancy A.; Copeland, Neal G.; Llovet, Josep M.; Largaespada, David A.			A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma	NATURE BIOTECHNOLOGY			English	Article							GROWTH-FACTOR-RECEPTOR; NF-KAPPA-B; SLEEPING-BEAUTY; IN-VITRO; LIVER-CANCER; EXPRESSION; KINASE; TUMOR; ACTIVATION; PATHWAY	We describe a system that permits conditional mobilization of a Sleeping Beauty (SB) transposase allele by Cre recombinase to induce cancer specifically in a tissue of interest. To demonstrate its potential for developing tissue-specific models of cancer in mice, we limit SB transposition to the liver by placing Cre expression under the control of an albumin enhancer/promoter sequence and screen for hepatocellular carcinoma (HCC)-associated genes. From 8,060 nonredundant insertions cloned from 68 tumor nodules and comparative analysis with data from human HCC samples, we identify 19 loci strongly implicated in causing HCC. These encode genes, such as EGFR and MET, previously associated with HCC and others, such as UBE2H, that are potential new targets for treating this neoplasm. Our system, which could be modified to drive transposon-based insertional mutagenesis wherever tissue-specific Cre expression is possible, promises to enhance understanding of cancer genomes and identify new targets for therapeutic development.	[Keng, Vincent W.; Ryan, Barbara J.; Matise, Ilze; Silverstein, Kevin A. T.; Sarver, Aaron; Starr, Timothy K.; Largaespada, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Keng, Vincent W.; Ryan, Barbara J.; Starr, Timothy K.; Largaespada, David A.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Villanueva, Augusto; Llovet, Josep M.] Hosp Clin Barcelona, CIBERehd, IDIBAPS, HCC Translat Res Lab,BCLC Grp Liver Unit, E-08036 Barcelona, Spain; [Chiang, Derek Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chiang, Derek Y.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Chiang, Derek Y.] Broad Inst Harvard, Canc Program, Cambridge, MA 02142 USA; [Chiang, Derek Y.] MIT, Cambridge, MA 02142 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Akagi, Keiko; Tessarollo, Lino] NCI, Frederick, MD 21702 USA; [Collier, Lara S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Powers, Scott; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Jenkins, Nancy A.; Copeland, Neal G.] Inst Mol & Cellular Biol, Singapore 138673, Singapore; [Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, New York, NY 10029 USA; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison; Cold Spring Harbor Laboratory; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Icahn School of Medicine at Mount Sinai; ICREA	Largaespada, DA (corresponding author), Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA.	larga002@umn.edu	Starr, Tim/AAX-9342-2021; Llovet, Josep M/D-4340-2014; Largaespada, David/C-9832-2014; Chiang, Derek/L-6452-2019; Augusto, Villanueva/F-9378-2012; Llovet, Josep M/ABB-6264-2021	Llovet, Josep M/0000-0003-0547-2667; Augusto, Villanueva/0000-0003-3585-3727; Llovet, Josep M/0000-0003-0547-2667; Keng, Vincent/0000-0003-3473-0653; Powers, Scott/0000-0003-2769-1932; Chiang, Derek/0000-0002-1131-6065; Starr, Timothy/0000-0002-6308-3451; Dupuy, Adam/0000-0002-8561-4911	European Association for the Study of the Liver; National Cancer Institute [1K01CA122183-01, U01 CA84221, R01 CA113636]; Department of Health and Human Services; National Institutes of Health; US National Institute of Diabetes; Digestive and Kidney Diseases [1R01DK076986-01]; Spanish National Institute of Health [SAF-200761898]; Samuel Waxman Cancer Research Foundation; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [K01CA122183, P30CA008748, ZICBC011198, R01CA113636, U01CA084221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076986] Funding Source: NIH RePORTER	European Association for the Study of the Liver; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Diabetes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Spanish National Institute of Health; Samuel Waxman Cancer Research Foundation; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank Christine E. Nelson, Stefanie S. Breitbarth, Michelle K. Gleason and Geoff Hart for their excellent technical support; Jason B. Bell for performing the hydrodynamic injections; and Heidi Gruelich, Dana Farber Cancer Institute, for her kind gift pBabe-Puro-LTR-EGFR. We are also grateful to the Minnesota Supercomputing Institute for providing extensive computational resources (hardware and systems administration support) used to carry out the sequence analysis. A.V. is supported by a Sheila Sherlock fellowship from the European Association for the Study of the Liver. L.S.C. is supported by a 1K01CA122183-01 grant from the National Cancer Institute. N.G.C., N.A.J. and L.T. are supported by the Department of Health and Human Services, National Institutes of Health and the National Cancer Institute. J.M.L. is supported by the US National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK076986-01), Spanish National Institute of Health (SAF-200761898) and Samuel Waxman Cancer Research Foundation. D.A.L. is supported by U01 CA84221 and R01 CA113636 grants from the National Cancer Institute.	Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Bekaii-Saab T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-278; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Boerner JL, 2003, EXP CELL RES, V284, P111, DOI 10.1016/S0014-4827(02)00096-4; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Buckley AF, 2008, AM J CLIN PATHOL, V129, P245, DOI 10.1309/WF10QAAED3PP93BH; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Calvisi DF, 2001, CANCER RES, V61, P2085; CHANG CM, 1995, J VIROL, V69, P1172, DOI 10.1128/JVI.69.2.1172-1180.1995; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Frederick L, 2000, CANCER RES, V60, P1383; Hirota K, 2001, J BIOL CHEM, V276, P25953, DOI 10.1074/jbc.M011021200; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Iizuka N, 2003, ONCOGENE, V22, P3007, DOI 10.1038/sj.onc.1206401; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Lee TK, 2006, CLIN CANCER RES, V12, P6910, DOI 10.1158/1078-0432.CCR-06-0489; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lopes LF, 2007, MODERN PATHOL, V20, P990, DOI 10.1038/modpathol.3800932; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moinzadeh P, 2005, BRIT J CANCER, V92, P935, DOI 10.1038/sj.bjc.6602448; Nakayama K, 2006, CANCER BIOL THER, V5, P630, DOI 10.4161/cbt.5.6.2675; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Philip PA, 2005, J CLIN ONCOL, V23, P6657, DOI 10.1200/JCO.2005.14.696; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; RAJKUMAR T, 1994, BREAST CANCER RES TR, V29, P3, DOI 10.1007/BF00666177; Rohde F, 2007, INT J CANCER, V121, P1717, DOI 10.1002/ijc.22868; Salvi A, 2007, INT J ONCOL, V31, P451; Sasaoka T, 1996, J BIOL CHEM, V271, P8338, DOI 10.1074/jbc.271.14.8338; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Su Gloria H, 2002, Hum Mutat, V19, P81, DOI 10.1002/humu.9002; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; VANLUENEN HGAM, 1994, CELL, V79, P293, DOI 10.1016/0092-8674(94)90198-8; VILLANUEVA A, 2008, GASTROENTEROLOGY; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Vos JC, 1996, GENE DEV, V10, P755, DOI 10.1101/gad.10.6.755; Wangensteen KJ, 2008, HEPATOLOGY, V47, P1714, DOI 10.1002/hep.22195; Wilber A, 2007, MOL THER, V15, P1280, DOI 10.1038/sj.mt.6300160; Xin W, 2004, CLIN CANCER RES, V10, P8516, DOI 10.1158/1078-0432.CCR-04-0885; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zimmermann U, 1997, HEPATOLOGY, V26, P1492	52	162	172	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2009	27	3					264	274		10.1038/nbt.1526	http://dx.doi.org/10.1038/nbt.1526			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	416UJ	19234449	Green Accepted			2022-12-25	WOS:000264030700020
J	Simons, M; Gault, WJ; Gotthardt, D; Rohatgi, R; Klein, TJ; Shao, YM; Lee, HJ; Wu, AL; Fang, YM; Satlin, LM; Dow, JT; Chen, J; Zheng, J; Boutros, M; Mlodzik, M				Simons, Matias; Gault, William J.; Gotthardt, Daniel; Rohatgi, Rajeev; Klein, Thomas J.; Shao, Youming; Lee, Ho-Jin; Wu, Ai-Luen; Fang, Yimin; Satlin, Lisa M.; Dow, Julian T.; Chen, Jie; Zheng, Jie; Boutros, Michael; Mlodzik, Marek			Electrochemical cues regulate assembly of the Frizzled/Dishevelled complex at the plasma membrane during planar epithelial polarization	NATURE CELL BIOLOGY			English	Article							NA+/H+ EXCHANGER; CELL POLARITY; PHOSPHATIDIC-ACID; DROSOPHILA; BINDING; PROTEIN; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; MOTILITY	Dishevelled (Dsh) is a cytoplasmic multidomain protein that is required for all known branches of the Wnt signalling pathway(1-3). The Frizzled/planar cell polarity (Fz/PCP) signalling branch requires an asymmetric cortical localization of Dsh, but this process remains poorly understood. Using a genome-wide RNA interference (RNAi) screen in Drosophila melanogaster cells, we show that Dsh membrane localization is dependent on the Na+/H+ exchange activity of the plasma membrane exchanger Nhe2. Manipulating Nhe2 expression levels in the eye causes PCP defects, and Nhe2 interacts genetically with Fz. Our data show that the binding and surface recruitment of Dsh by Fz is pH- and charge-dependent. We identify a polybasic stretch within the Dsh DEP domain that binds to negatively charged phospholipids and appears to be mechanistically important. Dsh recruitment by Fz can be abolished by converting these basic amino-acid residues into acidic ones, as in the mutant, DshKR/E. In vivo, the DshKR/E(2x) mutant with two substituted residues fails to associate with the membrane during active PCP signalling but rescues canonical Wnt signalling defects in a dsh-background. These results suggest that direct interaction between Fz and Dsh is stabilized by a pH and charge-dependent interaction of the DEP domain with phospholipids. This stabilization is particularly important for the PCP signalling branch and, thus, promotes specific pathway selection in Wnt signalling.	[Simons, Matias; Gault, William J.; Klein, Thomas J.; Mlodzik, Marek] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Gotthardt, Daniel] Univ Heidelberg Hosp, Dept Med, Div Gastroenterol, D-69120 Heidelberg, Germany; [Rohatgi, Rajeev; Satlin, Lisa M.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Shao, Youming; Lee, Ho-Jin; Zheng, Jie] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wu, Ai-Luen; Fang, Yimin; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Dow, Julian T.] Univ Glasgow, Inst Biomed & Life Sci, Div Mol Genet, Glasgow, Lanark, Scotland; [Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany	Icahn School of Medicine at Mount Sinai; Ruprecht Karls University Heidelberg; Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Glasgow; Helmholtz Association; German Cancer Research Center (DKFZ)	Mlodzik, M (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	marek.mlodzik@mssm.edu	Boutros, Michael/C-3566-2008; Dow, Julian/M-2371-2019; Simons, Matias/I-2038-2017; Lee, Ho-Jin/O-9944-2014	Boutros, Michael/0000-0002-9458-817X; Dow, Julian/0000-0002-9595-5146; Simons, Matias/0000-0003-3959-6350; Lee, Ho-Jin/0000-0002-3251-4984; Gault, William/0000-0002-4470-8428; Chen, Jie/0000-0002-7887-3747; Zheng, Jie/0000-0001-6524-6800	NIH [RO1 GM62917]; EMBO; DFG; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492, R01GM062917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bloomington Stock Center for fly strains, S. Grinstein, J. Orlowski, T. Kirchhausen and R. Bizzarri for cDNA constructs. We are grateful to A. Jenny and Y. Wang for the cloning of cDNA constructs, and U. Weber for analysis of the embryonic/ early larval lethal phenotype. We thank C. Iomini, R. Krauss, S. Sokol and D. del Alamo for reading the manuscript, members of the Mlodzik laboratory for discussions and S. Okello, G. Garcia and M. Stricker for technical support. The work has been supported by NIH grant to M. M. RO1 GM62917. M. S. was a recipient of EMBO and DFG long-term fellowships.	Axelrod JD, 2001, GENE DEV, V15, P1182; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Giannakou ME, 2001, J EXP BIOL, V204, P3703; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; MUSTONEN P, 1993, BIOCHEMISTRY-US, V32, P5373, DOI 10.1021/bi00071a012; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Penton A, 2002, GENETICS, V161, P747; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	29	139	141	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					286	U142		10.1038/ncb1836	http://dx.doi.org/10.1038/ncb1836			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19234454	Green Accepted			2022-12-25	WOS:000263777900012
J	van den Bogaart, G; Meinema, AC; Krasnikov, V; Veenhoff, LM; Poolman, B				van den Bogaart, Geert; Meinema, Anne C.; Krasnikov, Victor; Veenhoff, Liesbeth M.; Poolman, Bert			Nuclear transport factor directs localization of protein synthesis during mitosis	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA TRANSLATION; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEINS; LIVING CELLS; YEAST; EXPORT; REQUIREMENT; MOBILITY; IMPORT; NAB2P	Export of messenger RNA from the transcription site in the nucleus and mRNA targeting to the translation site in the cytoplasm are key regulatory processes in protein synthesis. In yeast, the mRNA-binding proteins Nab2p and Nab4p/Hrp1p accompany transcripts to their translation site, where the karyopherin Kap104p mediates both their dissociation from the mRNA and their transport back into the nucleus. We found that Kap104p localized to the distal bud tip and the bud neck during cell division, resulting in a localized release of translation-competent mRNA and increased protein synthesis in the emerging daughter cell. Temporally and spatially coordinated localization of Kap104p is a new mechanism for the asymmetric distribution of protein synthesis in dividing cells.	[van den Bogaart, Geert; Meinema, Anne C.; Veenhoff, Liesbeth M.; Poolman, Bert] Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands; [van den Bogaart, Geert; Krasnikov, Victor; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Veenhoff, LM (corresponding author), Univ Groningen, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	l.m.veenhoff@rug.nl; b.poolman@rug.nl	van den Bogaart, Geert/GLV-3283-2022; Poolman, Bert/D-1882-2012; van den Bogaart, Geert/A-1089-2014; Institute, Zernike/W-7033-2019	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; Veenhoff, Liesbeth/0000-0002-0158-4728	Netherlands Science Foundation NWO [814.02.002]; VENI fellowship; Netherlands Proteomics Centre; Zernike Institute for Advanced Materials	Netherlands Science Foundation NWO(Netherlands Organization for Scientific Research (NWO)); VENI fellowship; Netherlands Proteomics Centre; Zernike Institute for Advanced Materials	We thank M. P. Rout, B. L. Timney, C. Strambio- de- Castillia, J. J. Schuringa, J. D. Aitchison and P. Orlean for strains, plasmids and valuable comments. Financial support was provided by the Netherlands Science Foundation NWO ( ALW grant number 814.02.002; VENI fellowship to L. M. V.; TopSubsidy to B. P.), the Netherlands Proteomics Centre and the Zernike Institute for Advanced Materials.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Apponi LH, 2007, MOL CELL BIOL, V27, P6569, DOI 10.1128/MCB.00881-07; Asakawa K, 2002, GENETICS, V162, P1545; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Muller M, 2007, CELL MOL LIFE SCI, V64, P171, DOI 10.1007/s00018-006-6286-1; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Stewart M, 2007, MOL CELL, V25, P327, DOI 10.1016/j.molcel.2007.01.016; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; van den Bogaart G, 2007, BIOPHYS J, V92, P1598, DOI 10.1529/biophysj.106.096461; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004	30	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					350	U269		10.1038/ncb1844	http://dx.doi.org/10.1038/ncb1844			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198597	Green Published			2022-12-25	WOS:000263777900020
J	de Cid, R; Riveira-Munoz, E; Zeeuwen, PLJM; Robarge, J; Liao, W; Dannhauser, EN; Giardina, E; Stuart, PE; Nair, R; Helms, C; Escaramis, G; Ballana, E; Martin-Ezquerra, G; den Heijer, M; Kamsteeg, M; Joosten, I; Eichler, EE; Lazaro, C; Pujol, RM; Armengol, L; Abecasis, G; Elder, JT; Novelli, G; Armour, JAL; Kwok, PY; Bowcock, A; Schalkwijk, J; Estivill, X				de Cid, Rafael; Riveira-Munoz, Eva; Zeeuwen, Patrick L. J. M.; Robarge, Jason; Liao, Wilson; Dannhauser, Emma N.; Giardina, Emiliano; Stuart, Philip E.; Nair, Rajan; Helms, Cynthia; Escaramis, Georgia; Ballana, Ester; Martin-Ezquerra, Gemma; den Heijer, Martin; Kamsteeg, Marijke; Joosten, Irma; Eichler, Evan E.; Lazaro, Conxi; Pujol, Ramon M.; Armengol, Lluis; Abecasis, Goncalo; Elder, James T.; Novelli, Giuseppe; Armour, John A. L.; Kwok, Pui-Yan; Bowcock, Anne; Schalkwijk, Joost; Estivill, Xavier			Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis	NATURE GENETICS			English	Article							COPY NUMBER; STRUCTURAL VARIATION; HUMAN GENOME; ASSOCIATION; PATHOGENESIS; GENETICS; PSORS1; LOCUS; IL12B; IL23R	Psoriasis is a common inflammatory skin disease with a prevalence of 2-3% in individuals of European ancestry(1). In a genome-wide search for copy number variants (CNV) using a sample pooling approach, we have identified a deletion comprising LCE3B and LCE3C, members of the late cornified envelope (LCE) gene cluster(2). The absence of LCE3B and LCE3C (LCE3C_LCE3B-del) is significantly associated (P = 1.38E-08) with risk of psoriasis in 2,831 samples from Spain, The Netherlands, Italy and the United States, and in a family-based study (P = 5.4E-04). LCE3C_LCE3B-del is tagged by rs4112788 (r(2) = 0.93), which is also strongly associated with psoriasis (P < 6.6E-09). LCE3C_LCE3B-del shows epistatic effects with the HLA-Cw6 allele on the development of psoriasis in Dutch samples and multiplicative effects in the other samples. LCE expression can be induced in normal epidermis by skin barrier disruption and is strongly expressed in psoriatic lesions, suggesting that compromised skin barrier function has a role in psoriasis susceptibility.	[de Cid, Rafael; Riveira-Munoz, Eva; Escaramis, Georgia; Ballana, Ester; Armengol, Lluis; Estivill, Xavier] Ctr Gene Regulat, Genes & Dis Programme, Barcelona 08003, Spain; [de Cid, Rafael; Riveira-Munoz, Eva; Escaramis, Georgia; Ballana, Ester; Armengol, Lluis; Estivill, Xavier] Publ Hlth & Epidemiol Network Biomed Res Ctr CIBE, Barcelona 08003, Spain; [Zeeuwen, Patrick L. J. M.; Kamsteeg, Marijke; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 Nijmegen, Netherlands; [Zeeuwen, Patrick L. J. M.; Kamsteeg, Marijke; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 Nijmegen, Netherlands; [Robarge, Jason; Helms, Cynthia; Bowcock, Anne] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Liao, Wilson; Kwok, Pui-Yan] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Dannhauser, Emma N.; Armour, John A. L.] Univ Nottingham, Inst Genet, Queens Med Ctr, Nottingham NG7 2RD, England; [Dannhauser, Emma N.; Armour, John A. L.] Univ Nottingham, Sch Biol, Queens Med Ctr, Nottingham NG7 2RD, England; [Giardina, Emiliano; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol, I-00133 Rome, Italy; [Stuart, Philip E.; Nair, Rajan; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Martin-Ezquerra, Gemma; Pujol, Ramon M.] Hosp del Mar, Dermatol Serv, IMAS, Barcelona 08003, Spain; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6525 Nijmegen, Netherlands; [Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 Nijmegen, Netherlands; [Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Lazaro, Conxi] Hosp Llobregat, Catalan Inst Canc, Barcelona 08907, Spain; [Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Estivill, Xavier] Pompeu Fabra Univ UPF, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Radboud University Nijmegen; Radboud University Nijmegen; Washington University (WUSTL); University of California System; University of California San Francisco; University of Nottingham; University of Nottingham; University of Rome Tor Vergata; University of Michigan System; University of Michigan; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Washington; University of Washington Seattle; University of Barcelona; University of Michigan System; University of Michigan; Pompeu Fabra University	Estivill, X (corresponding author), Ctr Gene Regulat, Genes & Dis Programme, Barcelona 08003, Spain.	xavier.estivill@crg.es	Escaramis, Georgia/AAR-5586-2020; Novelli, Giuseppe/A-5195-2013; Estivill, Xavier/E-2957-2012; Kamsteeg, M./L-4422-2015; Kwok, Pui-Yan/F-7725-2014; Abecasis, Goncalo R/B-7840-2010; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022; Schalkwijk, Joost/N-1774-2013; Joosten, Irma/N-4418-2013; Guix, Ester Ballana/R-4117-2018; de Cid, Rafael/I-4220-2015; Estivill, Xavier/A-3125-2013; Martin-Ezquerra, Gemma/AAF-2276-2021; Giardina, Emiliano/J-1965-2012; GARCIA, CONXI LAZARO/Q-2410-2016; Schalkwijk, Joost/R-7509-2019; Zeeuwen, Patrick/N-1779-2013; Escaramis, Georgia/B-2997-2015; de cid, rafael/Q-2952-2016; den Heijer, Martin/J-8036-2015	Novelli, Giuseppe/0000-0002-7781-602X; Kwok, Pui-Yan/0000-0002-5087-3059; Novelli, Giuseppe/0000-0002-7781-602X; Joosten, Irma/0000-0003-2950-4977; Estivill, Xavier/0000-0002-0723-2256; Martin-Ezquerra, Gemma/0000-0002-5106-7526; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Schalkwijk, Joost/0000-0002-1308-1319; Zeeuwen, Patrick/0000-0002-6878-2438; Escaramis, Georgia/0000-0002-5416-3177; de cid, rafael/0000-0003-3579-6777; PUJOL, RAMON M/0000-0002-5622-6055; Abecasis, Goncalo/0000-0003-1509-1825; den Heijer, Martin/0000-0003-3620-5617; Robarge, Jason/0000-0001-8941-1153; Armour, John/0000-0002-8558-8506; Ballana, Ester/0000-0002-5215-7363; Riveira Munoz, Eva/0000-0002-6396-1162; giardina, emiliano/0000-0002-2741-5009; Bowcock, Anne/0000-0001-8691-9090	Spanish Ministry of Science and Innovation; European Commission ENGAGE Project; ADIPSO; National Institutes for Arthritis; Musculoskeletal and Skin Diseases; CIBERESP (Carlos III Health Institute); Ann Arbor Veterans Affairs Hospital; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042742, R01AR054966, R01AR050511] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission ENGAGE Project(European CommissionEuropean Commission Joint Research Centre); ADIPSO; National Institutes for Arthritis; Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CIBERESP (Carlos III Health Institute)(Instituto de Salud Carlos III); Ann Arbor Veterans Affairs Hospital; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We gratefully acknowledge the participants in the genetic studies whose contributions made this work possible and personnel at the CeGen genotyping core facility (Barcelona node). We thank T. Henseler, S. Jenisch, M. Weichenthal and E. Christophers from the University of Kiel for making samples from Kiel, Germany available for analysis. We thank A. Poon for technical assistance, the University of California San Francisco Psoriasis Center Staff for help with subject recruitment and J. Gartlon for proofreading the manuscript. This work was supported in part by funds from the "Generalitat de Catalunya,'' the Spanish Ministry of Science and Innovation and the European Commission ENGAGE Project (X. E., R. d. C., L. A., E. R.-M., G. E. and E. B.), ADIPSO (G.N.) and National Institutes for Arthritis, Musculoskeletal and Skin Diseases (A. B., J.T.E., R.N. and P. E. S.). E. R.-M. is supported by CIBERESP (Carlos III Health Institute). J. T. E. is supported by the Ann Arbor Veterans Affairs Hospital. W. L. is supported by a grant from the Dermatology Foundation.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; ALKEMADE JAC, 1994, J CELL SCI, V107, P2335; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Capon F, 1999, J INVEST DERMATOL, V112, P32, DOI 10.1046/j.1523-1747.1999.00471.x; Capon F, 1999, AM J HUM GENET, V65, P1798, DOI 10.1086/302653; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen HJ, 2009, J INVEST DERMATOL, V129, P606, DOI 10.1038/jid.2008.273; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Elder JT, 2006, J INVEST DERMATOL, V126, P1205, DOI 10.1038/sj.jid.5700357; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Gonzalez JR, 2008, GENET EPIDEMIOL, V32, P246, DOI 10.1002/gepi.20299; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RUSSELL TJ, 1972, NEW ENGL J MED, V287, P738, DOI 10.1056/NEJM197210122871503; Zhao XP, 1997, GENOMICS, V45, P250, DOI 10.1006/geno.1997.4952	26	375	391	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					211	215		10.1038/ng.313	http://dx.doi.org/10.1038/ng.313			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19169253	Green Accepted			2022-12-25	WOS:000263091300022
J	Maetzel, D; Denzel, S; Mack, B; Canis, M; Went, P; Benk, M; Kieu, C; Papior, P; Baeuerle, PA; Munz, M; Gires, O				Maetzel, Dorothea; Denzel, Sabine; Mack, Brigitte; Canis, Martin; Went, Philip; Benk, Michael; Kieu, Cuong; Papior, Peer; Baeuerle, Patrick A.; Munz, Markus; Gires, Olivier			Nuclear signalling by tumour-associated antigen EpCAM	NATURE CELL BIOLOGY			English	Article							DEPENDENT GAMMA-SECRETASE; EP-CAM; BREAST-CANCER; BETA-CATENIN; CELL-PROLIFERATION; ADHESION MOLECULE; COLORECTAL-CANCER; STEM-CELLS; C-MYC; TARGET	EpCAM was found to be overexpressed on epithelial progenitors, carcinomas and cancer-initiating cells. The role of EpCAM in proliferation, and its association with cancer is poorly explained by proposed cell adhesion functions. Here we show that regulated intramembrane proteolysis activates EpCAM as a mitogenic signal transducer in vitro and in vivo. This involves shedding of its ectodomain EpEX and nuclear translocation of its intracellular domain EpICD. Cleavage of EpCAM is sequentially catalysed by TACE and presenilin-2. Pharmacological inhibition or genetic silencing of either protease impairs growth-promoting signalling by EpCAM, which is compensated for by EpICD. Released EpICD associates with FHL2, beta-catenin and Lef-1 to form a nuclear complex that contacts DNA at Lef-1 consensus sites, induces gene transcription and is oncogenic in immunodeficient mice. In patients, EpICD was found in nuclei of colon carcinoma but not of normal tissue. Nuclear signalling of EpCAM explains how EpCAM functions in cell proliferation.	[Maetzel, Dorothea; Denzel, Sabine; Benk, Michael; Munz, Markus; Gires, Olivier] Univ Munich, Helmholtz Zentrum Munchen, Clin Cooperat Grp Mol Oncol, German Res Ctr Environm Hlth, D-81377 Munich, Germany; [Maetzel, Dorothea; Denzel, Sabine; Benk, Michael; Munz, Markus; Gires, Olivier] Univ Munich, Head & Neck Res Dept, Munich, Germany; [Mack, Brigitte; Canis, Martin; Kieu, Cuong; Gires, Olivier] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, D-81377 Munich, Germany; [Went, Philip] Univ Zurich, Inst Pathol, CH-8063 Zurich, Switzerland; [Baeuerle, Patrick A.; Munz, Markus] Micromet Inc, Bethesda, MD 20817 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; University of Zurich	Gires, O (corresponding author), Univ Munich, Helmholtz Zentrum Munchen, Clin Cooperat Grp Mol Oncol, German Res Ctr Environm Hlth, D-81377 Munich, Germany.	olivier.gires@med.uni-muenchen.de	Went, Philip/C-8203-2009; Gires, Olivier/V-2689-2017	Gires, Olivier/0000-0002-2292-7064	Deutsche Krebshilfe; Mildred-Scheel-Stiftung; Ralf Schulz	Deutsche Krebshilfe(Deutsche Krebshilfe); Mildred-Scheel-Stiftung(Deutsche Krebshilfe); Ralf Schulz	Work was supported by funding from the Deutsche Krebshilfe, Mildred-Scheel-Stiftung to M. M. and O.G. We are indebted to Jurgen Haas for technical help. We thank Wenlong Bai for FHL-2-GST constructs. We thank Ralf Schulz for support with in vivo fluorescence imaging. Animal experiments were conducted at the Walter Brendel Center (Director, U. Pohl).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Birchmeier W, 2005, EMBO REP, V6, P413, DOI 10.1038/sj.embor.7400408; BOHM C, 2006, J BIOL CHEM; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; CANAULT M, 2006, J CELL PHYSL; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conacci -Sorrell M, 2005, CANCER RES, V65, P11605, DOI 10.1158/0008-5472.CAN-05-2647; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gires O, 2006, BIOCHEM BIOPH RES CO, V343, P252, DOI 10.1016/j.bbrc.2006.02.139; Gires O, 2008, ATLAS GENET CYTOGENE; Hampe W, 2000, J CELL SCI, V113, P4475; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kenny PA, 2007, DIFFERENTIATION, V75, P800, DOI 10.1111/j.1432-0436.2007.00198.x; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Merchant NB, 2008, CLIN CANCER RES, V14, P1182, DOI 10.1158/1078-0432.CCR-07-1216; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; RUF P, 2007, BR J CANC; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmelzer E., 2006, STEM CELLS; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; TRZPIS M, 2008, J PATHOL; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908	49	512	536	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					162	U117		10.1038/ncb1824	http://dx.doi.org/10.1038/ncb1824			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136966				2022-12-25	WOS:000263285500014
J	Rustighi, A; Tiberi, L; Soldano, A; Napoli, M; Nuciforo, P; Rosato, A; Kaplan, F; Capobianco, A; Pece, S; Di Fiore, PP; Del Sal, G				Rustighi, Alessandra; Tiberi, Luca; Soldano, Alessia; Napoli, Marco; Nuciforo, Paolo; Rosato, Antonio; Kaplan, Fred; Capobianco, Anthony; Pece, Salvatore; Di Fiore, Pier Paolo; Del Sal, Giannino			The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer	NATURE CELL BIOLOGY			English	Article							MEDIATED PROTEOLYSIS; BREAST-CANCER; CELL-CYCLE; PHOSPHORYLATION; RECEPTOR; ISOMERIZATION; LOCALIZATION; APOPTOSIS; REVEALS; PATHWAY	Signalling through Notch receptors requires ligand-induced cleavage to release the intracellular domain, which acts as a transcriptional activator in the nucleus. Deregulated Notch1 signalling has been implicated in mammary tumorigenesis; however the mechanisms underlying Notch activation in breast cancer remain unclear. Here, we demonstrate that the prolyl-isomerase Pin1 interacts with Notch1 and affects Notch1 activation. Pin1 potentiates Notch1 cleavage by gamma-secretase, leading to an increased release of the active intracellular domain and ultimately enhancing Notch1 transcriptional and tumorigenic activity. We found that Notch1 directly induces transcription of Pin1, thereby generating a positive loop. In human breast cancers, we observed a strong correlation between Pin1 overexpression and high levels of activated Notch1. Thus, the molecular circuitry established by Notch1 and Pin1 may have a key role in cancer.	[Rustighi, Alessandra; Tiberi, Luca; Soldano, Alessia; Napoli, Marco; Del Sal, Giannino] Lab Nazl CIB LNCIB, I-34012 Trieste, Italy; [Rustighi, Alessandra; Tiberi, Luca; Soldano, Alessia; Napoli, Marco; Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34128 Trieste, Italy; [Nuciforo, Paolo; Pece, Salvatore; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy; [Rosato, Antonio] Univ Padua, Dipartimento Sci Oncol & Chirurg, I-35128 Padua, Italy; [Rosato, Antonio] IOV, I-35128 Padua, Italy; [Kaplan, Fred; Capobianco, Anthony] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Pece, Salvatore; Di Fiore, Pier Paolo] Ist Europeo Oncol, I-20141 Milan, Italy; [Di Fiore, Pier Paolo] Inst Mol Oncol Fdn, FIRC, IFOM, I-20139 Milan, Italy	University of Trieste; University of Milan; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); The Wistar Institute; IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology	Del Sal, G (corresponding author), Lab Nazl CIB LNCIB, Area Sci Pk,Padriciano 99, I-34012 Trieste, Italy.	delsal@lncib.it	Pece, Salvatore/B-9609-2013; Di Fiore, Pier Paolo/K-2130-2012; Rosato, Antonio/E-8626-2010; Nuciforo, Paolo/Q-2885-2019; Tiberi, Luca/AAQ-4253-2021	Pece, Salvatore/0000-0003-1764-3929; Di Fiore, Pier Paolo/0000-0002-2252-0950; Rosato, Antonio/0000-0002-5263-8386; Napoli, Marco/0000-0001-7192-5252; Tiberi, Luca/0000-0002-5983-3782; Soldano, Alessia/0000-0002-3120-9929; Nuciforo, Paolo/0000-0003-1380-0990; DEL SAL, GIANNINO/0000-0003-2185-6003	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian University and Research Ministerium (Cofin MIUR); Friuli-Venezia-Giulia; Association for International Cancer Research (AICR, UK); Fondazione Giancarla Vollaro; Fondazione Monzino; FIRC fellow (Fondazione Italiana per la Ricerca sul Cancro);  [R01 CA-83736-07]; NATIONAL CANCER INSTITUTE [R01CA083736] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian University and Research Ministerium (Cofin MIUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Friuli-Venezia-Giulia(Regione Friuli Venezia Giulia); Association for International Cancer Research (AICR, UK); Fondazione Giancarla Vollaro(Fondazione CarifeFondazione Caritro); Fondazione Monzino; FIRC fellow (Fondazione Italiana per la Ricerca sul Cancro); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank LNCIB colleagues, F. Mantovani, L. Collavin and S. Piccolo for critical reading of the manuscript; R. Poddighe for technical support, and M. Stebel and C. Degrassi of the C.S.P.A., University of Trieste. We are grateful to M. Donzelli for generation of the pcDNA3<SUP>N1 Delta E</SUP>-Flag construct, to T. Sudo for the anti-HES-1 antibody, A. Israel for pGL2-HES-1/LUC, T. Uchida for providing Pin1 knockout mice and to ICGEB for access to their facilities. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), from Italian University and Research Ministerium (Cofin MIUR), from Friuli-Venezia-Giulia (regional grant), from Association for International Cancer Research (AICR, UK) to G.D.S., and from R01 CA-83736-07 to A.C, AIRC and Fondazione Giancarla Vollaro to S.P. and to Fondazione Monzino and AIRC to P.P.D.F.; M.N. is a FIRC fellow (Fondazione Italiana per la Ricerca sul Cancro). This paper is dedicated to the memory of Stefano Ferrari.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; [Anonymous], 1989, CANC METASTASIS REV, V8, P82; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1997, J BIOL CHEM, V272, P11336; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; DE SB, 1999, NATURE, V398, P518; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; Hopfer O, 2005, BRIT J CANCER, V93, P709, DOI 10.1038/sj.bjc.6602719; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Ito T, 2000, DEVELOPMENT, V127, P3913; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lacroix M, 2009, CANCER CHEMOTH PHARM, V63, P567, DOI 10.1007/s00280-008-0776-9; Laws AM, 2004, EUR J IMMUNOL, V34, P726, DOI 10.1002/eji.200324772; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; OSIPO C, 2008, ONCOGENE; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ramdya P, 2003, J NEUROCHEM, V87, P843, DOI 10.1046/j.1471-4159.2003.02030.x; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ronchini C, 2000, ONCOGENE, V19, P3914, DOI 10.1038/sj.onc.1203719; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Takahashi K, 2007, ONCOGENE, V26, P3835, DOI 10.1038/sj.onc.1210153; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	55	140	143	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					133	U62		10.1038/ncb1822	http://dx.doi.org/10.1038/ncb1822			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151708	Green Published			2022-12-25	WOS:000263285500011
J	Ji, L; Lim, J; Danuser, G				Ji, Lin; Lim, James; Danuser, Gaudenz			Fluctuations of intracellular forces during cell protrusion	NATURE CELL BIOLOGY			English	Article							FLUORESCENT SPECKLE MICROSCOPY; ACTIN NETWORKS; ENDOTHELIAL-CELLS; F-ACTIN; TRACKING MICRORHEOLOGY; MIGRATING FIBROBLASTS; FOCAL ADHESIONS; LIVING CELLS; GENERATION; MECHANICS	We present a model to estimate intracellular force variations from live-cell images of actin filament (F-actin) flow during protrusion-retraction cycles of epithelial cells in a wound healing response. To establish a mechanistic relationship between force development and cytoskelal dynamics, force fluctuations were correlated with fluctuations in F-actin turnover, flow and F-actin-vinculin coupling. Our analyses suggest that force transmission at focal adhesions requires binding of vinculin to F-actin and integrin ( indirectly), which is modulated at the vinculin-integrin but not the vinculin-F-actin interface. Force transmission at focal adhesions is colocalized in space and synchronized in time with transient increases in the boundary force at the cell edge. Surprisingly, the maxima in adhesion and boundary forces lag behind maximal edge advancement by about 40 s. Maximal F-actin assembly was observed about 20 s after maximal edge advancement. On the basis of these findings, we propose that protrusion events are limited by membrane tension and that the characteristic duration of a protrusion cycle is determined by the efficiency in reinforcing F-actin assembly and adhesion formation as tension increases.	[Ji, Lin; Lim, James; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Danuser, G (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gdanuser@scripps.edu		Danuser, Gaudenz/0000-0001-8583-2014	NIH [R01 GM71868]; NIGMS [U54 GM064346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071868, U54GM064346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Clare Waterman and Ke Hu for continued discussion of and encouragement for this study. We gratefully acknowledge funding from NIH R01 GM71868 and the Cell Migration Consortium, Grant No U54 GM064346 from NIGMS.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Almqvist N, 2004, BIOPHYS J, V86, P1753, DOI 10.1016/S0006-3495(04)74243-5; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Boal D. H., 2002, MECH CELL; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Diez S, 2005, P NATL ACAD SCI USA, V102, P7601, DOI 10.1073/pnas.0408546102; Engl H. W., 1996, REGULARIZATION INVER, V375; ENGL HW, 1994, NUMER MATH, V69, P25, DOI 10.1007/s002110050078; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; HOWARD J, 2001, J MECH MOTOR PROTEIN; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Kole TP, 2004, MOL BIOL CELL, V15, P3475, DOI 10.1091/mbc.E04-03-0218; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Marion S, 2005, EUR BIOPHYS J BIOPHY, V34, P262, DOI 10.1007/s00249-004-0449-5; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Prigozhina NL, 2006, J CELL SCI, V119, P3571, DOI 10.1242/jcs.03066; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; Sterba RE, 1998, METHOD CELL BIOL, V55, P29; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Van Citters KM, 2006, BIOPHYS J, V91, P3946, DOI 10.1529/biophysj.106.091264; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Wang N, 1998, HYPERTENSION, V32, P162, DOI 10.1161/01.HYP.32.1.162; Wang Q, 2001, BLOOD, V97, P660, DOI 10.1182/blood.V97.3.660; Waterman-Storer C, 2002, CURR PROTOC CELL BIO; Weisswange I, 2005, J CELL SCI, V118, P4375, DOI 10.1242/jcs.02551; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Yanai M, 2004, AM J PHYSIOL-CELL PH, V287, pC603, DOI 10.1152/ajpcell.00347.2003	62	137	137	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1393	U38		10.1038/ncb1797	http://dx.doi.org/10.1038/ncb1797			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011623	Green Accepted			2022-12-25	WOS:000261261800009
J	Marsh, V; Winton, DJ; Williams, GT; Dubois, N; Trumpp, A; Sansom, OJ; Clarke, AR				Marsh, Victoria; Winton, Douglas J.; Williams, Geraint T.; Dubois, Nicole; Trumpp, Andreas; Sansom, Owen J.; Clarke, Alan R.			Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation	NATURE GENETICS			English	Article							GENE-EXPRESSION; DEFICIENCY; CRE; NEOPLASIA; DELETION; LEADS; RECOMBINATION; PROSTATE; DEFECTS; CANCER	PTEN acts as a tumor suppressor in a range of tissue types and has been implicated in the regulation of intestinal stem cells. To study Pten function in the intestine, we used various conditional transgenic strategies to specifically delete Pten from the mouse intestinal epithelium. We show that Pten loss specifically within the adult or embryonic epithelial cell population does not affect the normal architecture or homeostasis of the epithelium. However, loss of Pten in the context of Apc deficiency accelerates tumorigenesis through increased activation of Akt, leading to rapid development of adenocarcinoma. We conclude that Pten is redundant in otherwise normal intestinal epithelium and epithelial stem cells but, in the context of activated Wnt signaling, suppresses progression to adenocarcinoma through modulation of activated Akt levels.	[Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Marsh, Victoria; Clarke, Alan R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Winton, Douglas J.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Williams, Geraint T.] Cardiff Univ, Wales Coll Med, Cardiff CF14 4XN, S Glam, Wales; [Dubois, Nicole; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1066 Epalinges, Switzerland	Beatson Institute; Cardiff University; CRUK Cambridge Institute; University of Cambridge; Cardiff University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Parry, Lee/A-9623-2011; Clarke, Alan R/A-6256-2008; Trumpp, Andreas/Z-2141-2019; clarke, alan r/P-2820-2014	Parry, Lee/0000-0002-4467-9196; Trumpp, Andreas/0000-0002-6212-3466; Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X	Cancer Research UK; Wales Gene Park; Swiss National Science Foundation; Swiss Cancer League; EU; Medical Research Council [G0301154] Funding Source: researchfish; MRC [G0301154] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Wales Gene Park; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Bishop, L. Pietzka and D. Scarborough for technical assistance and R. Kemp for assistance with the epithelial extraction protocol. Villin-CreER<SUP>T2</SUP> mice were provided by S. Robine (Center National de la Recherche Scientifique/ Institut Curie). This work was supported by Cancer Research UK and the Wales Gene Park and by grants to A.T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU FP6 INTACT program and the EU FP7 program 'Eurosystem'.	Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; Bjerknes M, 2005, NAT GENET, V37, P1016, DOI 10.1038/ng1005-1016; CARLSON GJ, 1984, AM J SURG PATHOL, V8, P763, DOI 10.1097/00000478-198410000-00005; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jansen M, 2006, GUT, V55, P1, DOI 10.1136/gut.2005.069062; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Li DM, 1997, CANCER RES, V57, P2124; Li G, 2002, DEVELOPMENT, V129, P4159; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Merg A, 2004, AM J MED GENET C, V129C, P44, DOI 10.1002/ajmg.c.30020; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2003, ONCOGENE, V22, P7130, DOI 10.1038/sj.onc.1206850; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	39	82	85	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1436	1444		10.1038/ng.256	http://dx.doi.org/10.1038/ng.256			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19011632				2022-12-25	WOS:000261215900020
J	Higuchi, M; Onishi, K; Kikuchi, C; Gotoh, Y				Higuchi, Maiko; Onishi, Keisuke; Kikuchi, Chikako; Gotoh, Yukiko			Scaffolding function of PAK in the PDK1-Akt pathway	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-B; P21-ACTIVATED KINASE; CELL-MIGRATION; CDC42; AKT; ACTIVATION; PHOSPHORYLATION; MOTILITY; BINDING; RAC	Many extracellular signals stimulate phosphatidylinositol-3- kinase, which in turn activates the Rac1 GTPase, the protein kinase Akt and the Akt Thr 308 upstream kinase PDK1. Active Rac1 stimulates a number of events, including substrate phosphorylation by a subgroup of the PAK family of kinases. The combined effects of Rac1, PDK1 and Akt are crucial for cell migration, growth, survival, metabolism and tumorigenesis. Here we show that Rac1 stimulates a second, kinase-independent function of PAK1. The PAK1 kinase domain serves as a scaffold to facilitate Akt stimulation by PDK1 and to aid recruitment of Akt to the membrane. PAK differentially activates subpopulations of Akt. These findings reveal scaffolding functions of PAK that regulate the efficiency, localization and specificity of the PDK1-Akt pathway.	[Higuchi, Maiko; Onishi, Keisuke; Kikuchi, Chikako; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Gotoh, Yukiko] Japan Sci & Technol Corp, SORST Res Project, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	ygotoh@iam.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; SORST of the Japan Science and Technology Corporation; MEXT; Mitsubishi Foundation; Uehara Foundation; Princess Takamatsu Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SORST of the Japan Science and Technology Corporation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Uehara Foundation(Uehara Memorial Foundation); Princess Takamatsu Foundation	We thank Jonathan A. Cooper, Michael E. Greenberg and members of the Gotoh Laboratory for critical reading of the manuscript, encouragement and helpful discussion. We also thank Michael E. Greenberg and Steve M. Shamah for phosphorylated Bad antibody and phosphorylated PAK1 antibody, and Masaki Inagaki for PAK construct. This work was supported in part by Grants-Aid from the Ministry of Education, Science, Sports and Culture of Japan, SORST of the Japan Science and Technology Corporation, Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, the Mitsubishi Foundation, the Uehara Foundation and the Princess Takamatsu Foundation.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gorlach A, 2005, THROMB HAEMOSTASIS, V93, P1168, DOI 10.1160/TH05-01-0006; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jakobi R, 2002, BIOTECHNIQUES, V33, P1218, DOI 10.2144/02336bm07; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Reeder MK, 2001, J BIOL CHEM, V276, P40606, DOI 10.1074/jbc.M103925200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	30	149	150	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1356	U257		10.1038/ncb1795	http://dx.doi.org/10.1038/ncb1795			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931661				2022-12-25	WOS:000260586700019
J	Wilensky, RL; Shi, Y; Mohler, ER; Hamamdzic, D; Burgert, ME; Li, J; Postle, A; Fenning, RS; Bollinger, JG; Hoffman, BE; Pelchovitz, DJ; Yang, JS; Mirabile, RC; Webb, CL; Zhang, LF; Zhang, P; Gelb, MH; Walker, MC; Zalewski, A; Macphee, CH				Wilensky, Robert L.; Shi, Yi; Mohler, Emile R., III; Hamamdzic, Damir; Burgert, Mark E.; Li, Jun; Postle, Anthony; Fenning, Robert S.; Bollinger, James G.; Hoffman, Bryan E.; Pelchovitz, Daniel J.; Yang, Jisheng; Mirabile, Rosanna C.; Webb, Christine L.; Zhang, LeFeng; Zhang, Ping; Gelb, Michael H.; Walker, Max C.; Zalewski, Andrew; Macphee, Colin H.			Inhibition of lipoprotein-associated phospholipase A(2) reduces complex coronary atherosclerotic plaque development	NATURE MEDICINE			English	Article							PLATELET-ACTIVATING-FACTOR; LOW-DENSITY-LIPOPROTEIN; FACTOR ACETYLHYDROLASE; CARDIOVASCULAR-DISEASE; OXIDIZED PHOSPHOLIPIDS; OXIDATION HYPOTHESIS; COMPLETE SET; RISK-FACTOR; ATHEROGENESIS; MECHANISMS	Increased lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity is associated with increased risk of cardiac events, but it is not known whether Lp-PLA(2) is a causative agent. Here we show that selective inhibition of Lp-PLA(2) with darapladib reduced development of advanced coronary atherosclerosis in diabetic and hypercholesterolemic swine. Darapladib markedly inhibited plasma and lesion Lp-PLA(2) activity and reduced lesion lysophosphatidylcholine content. Analysis of coronary gene expression showed that darapladib exerted a general anti-inflammatory action, substantially reducing the expression of 24 genes associated with macrophage and T lymphocyte functioning. Darapladib treatment resulted in a considerable decrease in plaque area and, notably, a markedly reduced necrotic core area and reduced medial destruction, resulting in fewer lesions with an unstable phenotype. These data show that selective inhibition of Lp-PLA(2) inhibits progression to advanced coronary atherosclerotic lesions and confirms a crucial role of vascular inflammation independent from hypercholesterolemia in the development of lesions implicated in the pathogenesis of myocardial infarction and stroke.	[Wilensky, Robert L.; Mohler, Emile R., III; Hamamdzic, Damir; Fenning, Robert S.; Pelchovitz, Daniel J.; Yang, Jisheng] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Shi, Yi; Zhang, LeFeng; Zhang, Ping; Zalewski, Andrew] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Li, Jun; Hoffman, Bryan E.; Mirabile, Rosanna C.; Webb, Christine L.; Walker, Max C.; Zalewski, Andrew; Macphee, Colin H.] GlaxoSmithKline Inc, King Of Prussia, PA 19406 USA; [Postle, Anthony] Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; [Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Pennsylvania; Pennsylvania Medicine; Jefferson University; GlaxoSmithKline; University of Southampton; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wilensky, RL (corresponding author), Hosp Univ Penn, 3400 Spruce St,9 Gates, Philadelphia, PA 19104 USA.	robert.wilensky@uphs.upenn.edu		Postle, Anthony/0000-0001-7361-0756; gelb, michael/0000-0001-7000-5219	GlaxoSmithKline air industry-academic alliance; US National Institutes of Health [R37HL036235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER	GlaxoSmithKline air industry-academic alliance(GlaxoSmithKline); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The superb animal husbandry of H. Profka is gratefully acknowledged. We greatly appreciate the input by M. Hurle into the design and confirmation of the Taqman probes and the advice and support related to immunofluorescence procedures of R Crino. These studies were supported by funding from GlaxoSmithKline air industry-academic alliance via the Alternative Drug Discovery Initiative with tire University of Pennsylvania School of Medicine. M.H.G. is funded by US National Institutes of Health grain R37HL036235.	Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Blackie JA, 2003, BIOORG MED CHEM LETT, V13, P1067, DOI 10.1016/S0960-894X(03)00058-1; Burke AP, 2004, ARTERIOSCL THROM VAS, V24, P1266, DOI 10.1161/01.ATV.0000131783.74034.97; Carpenter KLH, 2003, FEBS LETT, V553, P145, DOI 10.1016/S0014-5793(03)01007-X; Caslake MJ, 2000, ATHEROSCLEROSIS, V150, P413, DOI 10.1016/S0021-9150(99)00406-2; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Collins R, 2003, LANCET, V361, P2005; Davis B, 2008, J BIOL CHEM, V283, P6428, DOI 10.1074/jbc.M709970200; Gardner AA, 2008, J BIOL CHEM, V283, P17099, DOI 10.1074/jbc.M802394200; Garza CA, 2007, MAYO CLIN PROC, V82, P159; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Jo H, 2006, ANTIOXID REDOX SIGN, V8, P1609, DOI 10.1089/ars.2006.8.1609; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; Macintyre Sally, 2005, Int J Behav Nutr Phys Act, V2, P16, DOI 10.1186/1479-5868-2-16; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; McIntyre TM, 1999, J BIOL CHEM, V274, P25189, DOI 10.1074/jbc.274.36.25189; Mohler ER, 2008, ARTERIOSCL THROM VAS, V28, P850, DOI 10.1161/ATVBAHA.107.154534; Moreno PR, 2000, CIRCULATION, V102, P2180; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Pennathur S, 2007, ANTIOXID REDOX SIGN, V9, P955, DOI 10.1089/ars.2007.1595; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sangvanich P, 2003, BIOCHEM BIOPH RES CO, V300, P501, DOI 10.1016/S0006-291X(02)02849-8; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Shah PK, 2007, CURR OPIN LIPIDOL, V18, P492, DOI 10.1097/MOL.0b013e3282efa326; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Smart BP, 2004, BIOORGAN MED CHEM, V12, P1737, DOI 10.1016/j.bmc.2004.01.022; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; Steinberg D, 2006, J LIPID RES, V47, P1339, DOI 10.1194/jlr.R600009-JLR200; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tsimikas S, 2007, ARTERIOSCL THROM VAS, V27, P2094, DOI 10.1161/01.atv.0000280571.28102.d4; VanEck M, 1997, ARTERIOSCL THROM VAS, V17, P3117, DOI 10.1161/01.ATV.17.11.3117; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7	46	300	320	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2008	14	10					1059	1066		10.1038/nm.1870	http://dx.doi.org/10.1038/nm.1870			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18806801	Green Accepted			2022-12-25	WOS:000259892300036
J	Yang, JS; Gad, H; Lee, SY; Mironov, A; Zhang, LL; Beznoussenko, GV; Valente, C; Turacchio, G; Bonsra, AN; Du, GW; Baldanzi, G; Graziani, A; Bourgoin, S; Frohman, MA; Luini, A; Hsu, VW				Yang, Jia-Shu; Gad, Helge; Lee, Stella Y.; Mironov, Alexander; Zhang, Leiliang; Beznoussenko, Galina V.; Valente, Carmen; Turacchio, Gabriele; Bonsra, Akua N.; Du, Guangwei; Baldanzi, Gianluca; Graziani, Andrea; Bourgoin, Sylvain; Frohman, Michael A.; Luini, Alberto; Hsu, Victor W.			A role for phosphatidic acid in COPI vesicle fission yields insights into Golgi maintenance	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR; BREFELDIN-A; MEMBRANE CURVATURE; COATED VESICLES; PHOSPHOLIPASE-D; GUANINE-NUCLEOTIDE; MAMMALIAN-CELLS; PROTEIN COMPLEX; ARF PROTEINS; TRANSPORT	Proteins essential for vesicle formation by the Coat Protein I (COPI) complex are being identified, but less is known about the role of specific lipids. Brefeldin-A ADP-ribosylated substrate (BARS) functions in the fission step of COPI vesicle formation. Here, we show that BARS induces membrane curvature in cooperation with phosphatidic acid. This finding has allowed us to further delineate COPI vesicle fission into two sub-stages: 1) an earlier stage of bud-neck constriction, in which BARS and other COPI components are required, and 2) a later stage of bud-neck scission, in which phosphatidic acid generated by phospholipase D2 (PLD2) is also required. Moreover, in contrast to the disruption of the Golgi seen on perturbing the core COPI components (such as coatomer), inhibition of PLD2 causes milder disruptions, suggesting that such COPI components have additional roles in maintaining Golgi structure other than through COPI vesicle formation.	[Yang, Jia-Shu; Lee, Stella Y.; Zhang, Leiliang; Hsu, Victor W.] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Yang, Jia-Shu; Lee, Stella Y.; Zhang, Leiliang; Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gad, Helge; Mironov, Alexander; Beznoussenko, Galina V.; Valente, Carmen; Turacchio, Gabriele; Luini, Alberto] Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; [Bonsra, Akua N.; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Bonsra, Akua N.; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Baldanzi, Gianluca; Graziani, Andrea] Univ Piemonte Orientale, Dept Clin & Expt Med, I-28100 Novara, Italy; [Bourgoin, Sylvain] Ctr Hosp Univ Quebec, Pavillon CHUL, Quebec City, PQ G1V 4G2, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Consorzio Mario Negri Sud; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Eastern Piedmont Amedeo Avogadro; Laval University	Hsu, VW (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Brigham & Womens Hosp, Boston, MA 02115 USA.	vhsu@rics.bwh.harvard.edu	Valente, Carmen/AAH-5261-2019; graziani, andrea/B-2554-2009; Baldanzi, Gianluca/AAO-7673-2021; Graziani, Andrea/AAB-6301-2022; Gad, Helge/J-2238-2014	Valente, Carmen/0000-0002-6244-9108; graziani, andrea/0000-0002-6302-2317; Baldanzi, Gianluca/0000-0002-1370-9903; Graziani, Andrea/0000-0002-6302-2317; Du, Guangwei/0000-0003-4193-6975; Bourgoin, Sylvain/0000-0001-9779-0368; Gad, Helge/0000-0001-6530-1443	NIH [GM058615, GM071520, GM071475]; Telethon (Italy); AIRC (Italy); Canadian Institutes of Health Research; Marie Curie Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071475, R01GM071520, R01GM058615, R37GM058615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon (Italy)(Fondazione Telethon); AIRC (Italy)(Fondazione AIRC per la ricerca sul cancro); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jian Li and Ming Bai for advice and discussions, and Richard Premont for technical assistance. This work was funded by grants from the NIH to V. W. H. (GM058615), M. A. F. (GM071520) and G. D. (GM071475), from Telethon (Italy), AIRC (Italy) to A. L. and A. M., and from the Canadian Institutes of Health Research (S. B.). H. G. was supported by a Marie Curie Fellowship.	Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HIMPENS B, 1994, FASEB J, V8, P879, DOI 10.1096/fasebj.8.11.8070638; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; Kweon HS, 2004, MOL BIOL CELL, V15, P4710, DOI 10.1091/mbc.E03-12-0881; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; ORCI L, 1991, CELL, V64, P1183; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stamnes M, 1998, P NATL ACAD SCI USA, V95, P13676, DOI 10.1073/pnas.95.23.13676; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	45	120	123	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1146	1153		10.1038/ncb1774	http://dx.doi.org/10.1038/ncb1774			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18776900	Green Accepted			2022-12-25	WOS:000259682900008
J	Li, M; Shin, YH; Hou, LF; Huang, XX; Wei, ZB; Klann, E; Zhang, PM				Li, Min; Shin, Yong-Hyun; Hou, Lingfei; Huang, Xingxu; Wei, Zhubo; Klann, Eric; Zhang, Pumin			The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; DEPENDENT DEGRADATION; CONTEXTUAL FEAR; AURORA-B; S-PHASE; EXPRESSION; PHOSPHORYLATION; SENESCENCE; MUTATIONS; MITOSIS	The anaphase promoting complex (APC) or cyclosome is a multi-subunit E3 ubiquitin ligase. Cdc20 (fizzy (fzy)) or p55CDC, and Cdh1 (Hct1, srw1 or fizzy-related 1 (fzr1)) encode two adaptor proteins that bring substrates to the APC. Both APC-Cdc20 and APC-Cdh1 have been implicated in the control of mitosis through mediating ubiquitination of mitotic regulators, such as cyclin B1 and securin. However, the importance of Cdh1 function in vivo and whether its function is redundant with that of Cdc20 are unclear. Here we have analysed mice lacking Cdh1. We show that Cdh1 is essential for placental development and that its deficiency causes early lethality. Cdh1-deficient mouse embryonic fibroblasts (MEFs) entered replicative senescence prematurely because of stabilization of Ets2 and subsequent activation of p16(Ink4a) expression. These results have uncovered an unexpected role of the APC in maintaining replicative lifespan of MEFs. Further, Cdh1 heterozygous mice show defects in late-phase long-term potentiation (L-LTP) in the hippocampus and are deficient in contextual fear-conditioning, suggesting that Cdh1 has a role in learning and memory.	[Li, Min; Shin, Yong-Hyun; Huang, Xingxu; Wei, Zhubo; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Zhang, Pumin] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hou, Lingfei] NYU, Ctr Neural Sci, New York, NY 10003 USA	Baylor College of Medicine; Baylor College of Medicine; New York University	Zhang, PM (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	pzhang@bcm.tmc.edu	Holt, Janet E/B-2415-2013	huang, xingxu/0000-0001-8934-1247	NATIONAL CANCER INSTITUTE [R01CA122623, R01CA116097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384, R37NS034007, R01NS034007, R29NS034007] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA122623, CA116097, R01 CA116097, R01 CA116097-02] Funding Source: Medline; NINDS NIH HHS [R01 NS034007, NS047384, NS034007, R01 NS047384, R29 NS034007, R37 NS034007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yang BS, 1996, MOL CELL BIOL, V16, P538	25	114	119	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1083	1089		10.1038/ncb1768	http://dx.doi.org/10.1038/ncb1768			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160489	Green Accepted			2022-12-25	WOS:000258910400014
J	Shomura, A; Izawa, T; Ebana, K; Ebitani, T; Kanegae, H; Konishi, S; Yano, M				Shomura, Ayahiko; Izawa, Takeshi; Ebana, Kaworu; Ebitani, Takeshi; Kanegae, Hiromi; Konishi, Saeko; Yano, Masahiro			Deletion in a gene associated with grain size increased yields during rice domestication	NATURE GENETICS			English	Article							SELECTION; MUTATION; ORIGIN; WHEAT	The domestication of crops involves a complex process of selection in plant evolution and is associated with changes in the DNA regulating agronomically important traits. Here we report the cloning of a newly identified QTL, qSW5 (QTL for seed width on chromosome 5), involved in the determination of grain width in rice. Through fine mapping, complementation testing and association analysis, we found that a deletion in qSW5 resulted in a significant increase in sink size owing to an increase in cell number in the outer glume of the rice flower; this trait might have been selected by ancient humans to increase yield of rice grains. In addition, we mapped two other defective functional nucleotide polymorphisms of rice domestication-related genes with genome-wide RFLP polymorphisms of various rice landraces. These analyses show that the qSW5 deletion had an important historical role in artificial selection, propagation of cultivation and natural crossings in rice domestication, and shed light on how the rice genome was domesticated.	[Izawa, Takeshi; Konishi, Saeko] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Shomura, Ayahiko] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; [Ebana, Kaworu; Kanegae, Hiromi; Yano, Masahiro] Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Ebitani, Takeshi] Toyama Agr Res Ctr, Toyama 9398153, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Izawa, T (corresponding author), Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	tizawa@nias.affrc.go.jp	Kajiya-Kanegae, Hiromi/AAA-2951-2020; Yano, Masahiro/AAC-5441-2019; Kanegae, Hiromi/AFS-0023-2022	Kanegae, Hiromi/0000-0002-5719-7559; Yano, Masahiro/0000-0003-1510-4622; Izawa, Takeshi/0000-0001-5109-0024				Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; DARWIN C, 1857, VARIATIONS ANIMALS P; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Hong SK, 1996, DEVELOPMENT, V122, P2051; Isshiki M, 1998, PLANT J, V15, P133, DOI 10.1046/j.1365-313X.1998.00189.x; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Olsen KM, 2002, GENETICS, V162, P941; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Sang T, 2007, J INTEGR PLANT BIOL, V49, P760, DOI 10.1111/j.1744-7909.2007.00510.x; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	23	636	776	13	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					1023	1028		10.1038/ng.169	http://dx.doi.org/10.1038/ng.169			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18604208				2022-12-25	WOS:000258026900021
J	Yen, CLE; Cheong, ML; Grueter, C; Zhou, P; Moriwaki, J; Wong, JS; Hubbard, B; Marmor, S; Farese, RV				Yen, Chi-Liang Eric; Cheong, Mei-Leng; Grueter, Carrie; Zhou, Ping; Moriwaki, Junya; Wong, Jinny S.; Hubbard, Brian; Marmor, Stephen; Farese, Robert V., Jr.			Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding	NATURE MEDICINE			English	Article							MONOACYLGLYCEROL ACYLTRANSFERASE; COENZYME-A; ABSORPTION; IDENTIFICATION; CLONING; GENE; COA	Animals are remarkably efficient in absorbing dietary fat and assimilating this energy-dense nutrient into the white adipose tissue (WAT) for storage. Although this metabolic efficiency may confer an advantage in times of calorie deprivation, it contributes to obesity and associated metabolic disorders when dietary fat is abundant(1,2). Here we show that the intestinal lipid synthesis enzyme acyl CoA: monoacylglycerol acyltransferase-2 (MGAT2) has a crucial role in the assimilation of dietary fat and the accretion of body fat in mice. Mice lacking MGAT2 have a normal phenotype on a low-fat diet. However, on a high-fat diet, MGAT2-deficient mice are protected against developing obesity, glucose intolerance, hypercholesterolemia and fatty livers. Caloric intake is normal in MGAT2-deficient mice, and dietary fat is absorbed fully. However, entry of dietary fat into the circulation occurs at a reduced rate. This altered kinetics of fat absorption apparently results in more partitioning of dietary fat toward energy dissipation rather than toward storage in the WAT. Thus, our studies identify MGAT2 as a key determinant of energy metabolism in response to dietary fat and suggest that the inhibition of this enzyme may prove to be a useful strategy for treating obesity and other metabolic diseases associated with excessive fat intake.	[Yen, Chi-Liang Eric; Cheong, Mei-Leng; Grueter, Carrie; Zhou, Ping; Moriwaki, Junya; Wong, Jinny S.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Yen, Chi-Liang Eric; Grueter, Carrie; Farese, Robert V., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Hubbard, Brian; Marmor, Stephen] Novartis Inst Biomed Res, Cambridge, MA USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Novartis; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Farese, RV (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	bfarese@gladstone.ucsf.edu		Grueter, Carrie/0000-0002-1913-2527	NCRR NIH HHS [C06 RR018928] Funding Source: Medline; NIDDK NIH HHS [R01 DK056084-01A1, DK-056084, R56 DK056084, R01 DK056084] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056084, R56DK056084] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; HAMILTON RL, 1980, J LIPID RES, V21, P981; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MATTSON FH, 1964, J BIOL CHEM, V239, P2772; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; NEEL JV, 1962, AM J HUM GENET, V14, P353; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; SENIOR JR, 1962, J BIOL CHEM, V237, P1454; SNYDER F, 1959, BIOCHIM BIOPHYS ACTA, V34, P244; *UN FAO, 2008, FOOD CONS DIET EN PR; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	23	123	139	0	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					442	446		10.1038/nm.1937	http://dx.doi.org/10.1038/nm.1937			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19287392	Green Accepted			2022-12-25	WOS:000264937200032
J	Ma, L; Tsai, MY; Wang, SS; Lu, BW; Chen, R; Yates, JR; Zhu, XL; Zheng, YX				Ma, Li; Tsai, Ming-Ying; Wang, Shusheng; Lu, Bingwen; Chen, Rong; Yates, John R., III; Zhu, Xueliang; Zheng, Yixian			Requirement for Nudel and dynein for assembly of the lamin B spindle matrix	NATURE CELL BIOLOGY			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; CYTOPLASMIC DYNEIN; PROTEIN DATABASE; YEAST PROTEOME; AURORA-A; ORGANIZATION; MIGRATION; KINETOCHORES; ARCHITECTURE; ASSOCIATION	The small guanosine triphosphatase Ran loaded with GTP ( RanGTP) can stimulate assembly of the type V intermediate filament protein lamin B into a membranous lamin B spindle matrix, which is required for proper microtubule organization during spindle assembly. Microtubules in turn enhance assembly of the matrix. Here we report that the isolated matrix contains known spindle assembly factors such as dynein and Nudel. Using spindle assembly assays in Xenopus egg extracts, we show that Nudel regulates microtubule organization during spindle assembly independently of its function at kinetochores. Importantly, Nudel interacts directly with lamin B to facilitate the accumulation and assembly of lamin-B-containing matrix on microtubules in a dynein-dependent manner. Perturbing either Nudel or dynein inhibited the assembly of lamin B matrix. However, depleting lamin B still allowed the formation of matrices containing dynein and Nudel. Therefore, dynein and Nudel regulate assembly of the lamin B matrix. Interestingly, we found that whereas depleting lamin B resulted in disorganized spindle and spindle poles, disrupting the function of Nudel or dynein caused a complete lack of spindle pole focusing. We suggest that Nudel regulates microtubule organization in part by facilitating assembly of the lamin B spindle matrix in a dynein-dependent manner.	[Ma, Li; Zhu, Xueliang; Zheng, Yixian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China; [Ma, Li; Zhu, Xueliang; Zheng, Yixian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Ctr Cell Signaling, Shanghai, Peoples R China; [Ma, Li; Tsai, Ming-Ying; Wang, Shusheng; Chen, Rong; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Ma, Li; Tsai, Ming-Ying; Wang, Shusheng; Chen, Rong; Zheng, Yixian] Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Tsai, Ming-Ying] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Lu, Bingwen; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Carnegie Institution for Science; Howard Hughes Medical Institute; University of Nebraska System; University of Nebraska Medical Center; Scripps Research Institute	Zhu, XL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China.	xlzhu@sibs.ac.cn; zheng@ciwemb.edu			National Institutes of Health [GM56312, MH067880, P41 RR011823]; Chinese Academy of Sciences [CXTD-S2005-3]; Ministry of Science and Technology of China [2007CB914501, 2005CB522703]; National Science Foundation of China [30721065, 30623003, 30830060]; Cystic Fibrosis Foundation Therapeutics, Inc [BALCH05X5]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cystic Fibrosis Foundation Therapeutics, Inc; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr Reimer Stick for LB3 monoclonal antibody, Dr Robert Goldman for the full- length LB3 construct, Ms Shufang He and Ms Xiaoyan Wang for help with the Biacore experiments, Mr Dan Ducat and Mr Ben Goodman for help with egg extracts, Ms Ona Martin for technical support, and Dr Max Guo and the members of the Zheng laboratory for critical comments. The work was supported by the National Institutes of Health (GM56312 to Y. Z.; MH067880 and P41 RR011823 to J.R.Y.), the Chinese Academy of Sciences (CXTD-S2005-3 to X. Z.), the Ministry of Science and Technology of China (2007CB914501 and 2005CB522703 to X. Z.), the National Science Foundation of China ( 30721065, 30623003 and 30830060 to X. Z.) and a Cystic Fibrosis Foundation Therapeutics, inc. computational fellowship (BALCH05X5 to B. L.). Y. Z. is an investigator of the Howard Hughes Medical Institute.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Cao K, 2004, CELL CYCLE, V3, P422; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Lourim D, 1996, J CELL SCI, V109, P1775; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Merdes A, 1997, J CELL BIOL, V138, P953, DOI 10.1083/jcb.138.5.953; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010; Yamamoto A, 2003, J CELL SCI, V116, P4501, DOI 10.1242/jcs.00835; Zheng YX, 2006, CELL CYCLE, V5, P2345, DOI 10.4161/cc.5.20.3365	36	80	80	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					246	U58		10.1038/ncb1832	http://dx.doi.org/10.1038/ncb1832			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198602	Green Accepted			2022-12-25	WOS:000263777900008
J	Runguphan, W; O'Connor, SE				Runguphan, Weerawat; O'Connor, Sarah E.			Metabolic reprogramming of periwinkle plant culture	NATURE CHEMICAL BIOLOGY			English	Article							ALKALOID BIOSYNTHESIS; BENZYLISOQUINOLINE ALKALOIDS; STRICTOSIDINE SYNTHASE; CATHARANTHUS-ROSEUS; PATHWAY; ENZYME	We transformed an alkaloid biosynthetic gene with reengineered substrate specificity into Catharanthus roseus. The resulting transgenic plant cell culture produced a variety of unnatural alkaloid compounds when cocultured with simple, achiral, commercially available precursors that the reengineered enzyme was designed to accept. This work demonstrates the power of genetic engineering to retailor the structures of complex alkaloid natural products in plant culture.	[Runguphan, Weerawat; O'Connor, Sarah E.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	O'Connor, SE (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave 18-592, Cambridge, MA 02139 USA.	soc@mit.edu	O'Connor, Sarah Ellen/X-2893-2019; Runguphan, Weerawat/GSM-9179-2022; O'Connor, Sarah/O-5850-2016	Runguphan, Weerawat/0000-0001-5707-3516; O'Connor, Sarah/0000-0003-0356-6213	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074820] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074820-01A2, R01 GM074820] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernhardt P, 2007, CHEM BIOL, V14, P888, DOI 10.1016/j.chembiol.2007.07.008; Chen S, 2006, CHEM BIOL, V13, P1137, DOI 10.1016/j.chembiol.2006.10.009; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hughes EH, 2002, BIOTECHNOL PROGR, V18, P1183, DOI 10.1021/bp025603o; Katsuyama Y, 2007, CHEM BIOL, V14, P613, DOI 10.1016/j.chembiol.2007.05.004; Loris EA, 2007, CHEM BIOL, V14, P979, DOI 10.1016/j.chembiol.2007.08.009; Ma XY, 2006, PLANT CELL, V18, P907, DOI 10.1105/tpc.105.038018; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; TOIVONEN L, 1989, PLANT CELL TISS ORG, V18, P79, DOI 10.1007/BF00033467; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; YUN DJ, 1992, P NATL ACAD SCI USA, V89, P11799, DOI 10.1073/pnas.89.24.11799	15	75	77	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2009	5	3					151	153		10.1038/nchembio.141	http://dx.doi.org/10.1038/nchembio.141			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410DG	19151732	Green Accepted			2022-12-25	WOS:000263556100011
J	Tregouet, DA; Konig, IR; Erdmann, J; Munteanu, A; Braund, PS; Hall, AS; Grosshennig, A; Linsel-Nitschke, P; Perret, C; DeSuremain, M; Meitinger, T; Wright, BJ; Preuss, M; Balmforth, AJ; Ball, SG; Meisinger, C; Germain, C; Evans, A; Arveiler, D; Luc, G; Ruidavets, JB; Morrison, C; van der Harst, P; Schreiber, S; Neureuther, K; Schafer, A; Bugert, P; El Mokhtari, NE; Schrezenmeir, J; Stark, K; Rubin, D; Wichmann, HE; Hengstenberg, C; Ouwehand, W; Ziegler, A; Tiret, L; Thompson, JR; Cambien, F; Schunkert, H; Samani, NJ				Tregouet, David-Alexandre; Koenig, Inke R.; Erdmann, Jeanette; Munteanu, Alexandru; Braund, Peter S.; Hall, Alistair S.; Grosshennig, Anika; Linsel-Nitschke, Patrick; Perret, Claire; DeSuremain, Maylis; Meitinger, Thomas; Wright, Ben J.; Preuss, Michael; Balmforth, Anthony J.; Ball, Stephen G.; Meisinger, Christa; Germain, Cecile; Evans, Alun; Arveiler, Dominique; Luc, Gerald; Ruidavets, Jean-Bernard; Morrison, Caroline; van der Harst, Pim; Schreiber, Stefan; Neureuther, Katharina; Schaefer, Arne; Bugert, Peter; El Mokhtari, Nour E.; Schrezenmeir, Juergen; Stark, Klaus; Rubin, Diana; Wichmann, H-Erich; Hengstenberg, Christian; Ouwehand, Willem; Ziegler, Andreas; Tiret, Laurence; Thompson, John R.; Cambien, Francois; Schunkert, Heribert; Samani, Nilesh J.		Wellcome Trust Case Control Consor; Cardiogenics Consortium	Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease	NATURE GENETICS			English	Article							APOLIPOPROTEIN(A) GENE; MYOCARDIAL-INFARCTION; LIPOPROTEIN(A) LEVELS; HEART-DISEASE; POLYMORPHISMS; ECTIM	We identify the SLC22A3-LPAL2-LPA gene cluster as a strong susceptibility locus for coronary artery disease (CAD) through a genome-wide haplotype association (GWHA) study. This locus was not identified from previous genome-wide association (GWA) studies focused on univariate analyses of SNPs. The proposed approach may have wide utility for analyzing GWA data for other complex traits.	[Tregouet, David-Alexandre; Munteanu, Alexandru; Perret, Claire; DeSuremain, Maylis; Tiret, Laurence; Cambien, Francois] Univ Paris 06, INSERM, UMR S 525, F-75013 Paris, France; [Koenig, Inke R.; Grosshennig, Anika; Preuss, Michael; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Erdmann, Jeanette; Grosshennig, Anika; Linsel-Nitschke, Patrick; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Braund, Peter S.; van der Harst, Pim; Samani, Nilesh J.] Univ Leicester, Clin Sci Wing, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Hall, Alistair S.; Balmforth, Anthony J.; Ball, Stephen G.] Univ Leeds, LIGHT, Leeds LS1 3EX, W Yorkshire, England; [Meitinger, Thomas; Meisinger, Christa; Wichmann, H-Erich] Deutsch Forschungszentrum Umwelt & Gesundheit, Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Wright, Ben J.; Thompson, John R.] Univ Leicester, Dept Hlth Sci & Genet, Leicester LE1 7RH, Leics, England; [Germain, Cecile] Univ Paris 11, CNRS, UMR S 8623, Rech Informat Lab, F-91403 Orsay, France; [Evans, Alun] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; [Arveiler, Dominique] Multinat MONItoring Trends & Determinants CArdiov, Fac Med, Lab Epidemiol & Sante Publ EA1801, F-67085 Strasbourg, France; [Luc, Gerald] Univ Lille 2, Pasteur Inst Lille, INSERM, U545, F-59019 Lille, France; [Ruidavets, Jean-Bernard] MONICA Toulouse, Fac Med, INSERM, U518, F-31073 Toulouse, France; [Morrison, Caroline] Glasgow Royal Infirm, MONICA Project, Glasgow G4 0SF, Lanark, Scotland; [Schreiber, Stefan; Schaefer, Arne; El Mokhtari, Nour E.] Univ Kiel, Inst Klin Mol Biol, D-24105 Kiel, Germany; [Neureuther, Katharina; Stark, Klaus; Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93042 Regensburg, Germany; [Bugert, Peter] Univ Heidelberg, Med Fac Mannheim, Inst Transfus Med & Immunol, Mol Biol Lab, D-69117 Heidelberg, Germany; [Schrezenmeir, Juergen; Rubin, Diana] Inst Physiol & Biochem Ernahrung, Bundesforsch Sanstalt Ernahrung & Lebensmittel, D-24121 Kiel, Germany; [Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leeds; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Leicester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Glasgow; University of Kiel; University of Regensburg; Ruprecht Karls University Heidelberg; University of Cambridge	Tregouet, DA (corresponding author), Univ Paris 06, INSERM, UMR S 525, F-75013 Paris, France.	david.tregouet@upmc.fr	Trégouët, David-Alexandre/P-9210-2019; Tregouet, David-Alexandre/E-3961-2016; Hall, Alistair/K-1953-2019; Stark, Klaus/L-7367-2013; Meitinger, Thomas/O-1318-2015; Hengstenberg, Christian/U-5485-2019; Cambien, Francois/AAP-9751-2020; König, Inke R/A-4544-2009; Stark, Klaus/D-3813-2009; Erdmann, Jeanette/A-4417-2009; Meisinger, Christine/B-5358-2014; Wichmann, Heinz Erich/AAA-5695-2022; Erdmann, Jeanette/P-7513-2014; Ziegler, Andreas/G-4246-2012	Trégouët, David-Alexandre/0000-0001-9084-7800; Stark, Klaus/0000-0002-7832-1942; König, Inke R/0000-0003-0504-6465; Stark, Klaus/0000-0002-7832-1942; Erdmann, Jeanette/0000-0002-4486-6231; Schaefer, Arne/0000-0001-5816-6765; Meisinger, Christa/0000-0002-9026-6544; Ziegler, Andreas/0000-0002-8386-5397; Hall, Alistair/0000-0003-0306-7887; Preuss, Michael/0000-0001-5266-8465; Meitinger, Thomas/0000-0002-8838-8403	Wellcome Trust; Deutsche Forschungsgemeinschaft; German National Genome Research Network; German Federal Ministry of Education and Research; State of Bavaria; European Union [INFSO-RI-031688]; BHF; Cardiogenics [LSHM-CT-2006-037593]; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Genome Research Network; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; European Union(European Commission); BHF(British Heart Foundation); Cardiogenics(European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The WTCCC Study was funded by the Wellcome Trust. Recruitment of cases for the WTCCC Study was carried out by the British Heart Foundation (BHF) Family Heart Study Research Group and supported by the BHF and the UK Medical Research Council. We also acknowledge support of the Wellcome Trust Functional Genomics Initiative in Cardiovascular Genetics. The German Study was supported by the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF-National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and of the State of Bavaria. This work has also been partially supported by the EGEEII project funded by the European Union INFSO-RI-031688. N. J. S. is supported by a Chair funded by the BHF. The main sponsor of the current analysis is the EU funded integrated project 'Cardiogenics' (LSHM-CT-2006-037593).	BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Brazier L, 1999, ATHEROSCLEROSIS, V144, P323, DOI 10.1016/S0021-9150(98)00333-5; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Gagliardi F, 2005, PHILOS T R SOC A, V363, P1729, DOI 10.1098/rsta.2005.1603; Holmer SR, 2003, CIRCULATION, V107, P696, DOI 10.1161/01.CIR.0000048125.79640.77; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Li Y, 2006, AM J HUM GENET S, VS79, P2290; PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701, DOI 10.1161/01.ATV.12.6.701; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226	13	341	349	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2009	41	3					283	285		10.1038/ng.314	http://dx.doi.org/10.1038/ng.314			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198611	Green Published			2022-12-25	WOS:000263640200007
J	Kleaveland, B; Zheng, XJ; Liu, JJ; Blum, Y; Tung, JJ; Zou, ZY; Chen, M; Guo, LL; Lu, MM; Zhou, D; Kitajewski, J; Affolter, M; Ginsberg, MH; Kahn, ML				Kleaveland, Benjamin; Zheng, Xiangjian; Liu, Jian J.; Blum, Yannick; Tung, Jennifer J.; Zou, Zhiying; Chen, Mei; Guo, Lili; Lu, Min-min; Zhou, Diane; Kitajewski, Jan; Affolter, Markus; Ginsberg, Mark H.; Kahn, Mark L.			Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway	NATURE MEDICINE			English	Article							VASCULAR DEVELOPMENT; CONCENTRIC GROWTH; GENE; MUTATIONS; KRIT1; CCM1; MORPHOGENESIS; PATHOGENESIS	Cerebral cavernous malformations (CCMs) are human vascular malformations caused by mutations in three genes of unknown function: KRIT1, CCM2 and PDCD10. Here we show that the heart of glass (HEG1) receptor, which in zebrafish has been linked to ccm gene function, is selectively expressed in endothelial cells. Heg1(-/-) mice showed defective integrity of the heart, blood vessels and lymphatic vessels. Heg1(-/-); Ccm2(lacZ/+) and Ccm2(lacZ/lacZ) mice had more severe cardiovascular defects and died early in development owing to a failure of nascent endothelial cells to associate into patent vessels. This endothelial cell phenotype was shared by zebrafish embryos deficient in heg, krit1 or ccm2 and reproduced in CCM2-deficient human endothelial cells in vitro. Defects in the hearts of zebrafish lacking heg or ccm2, in the aortas of early mouse embryos lacking CCM2 and in the lymphatic vessels of neonatal mice lacking HEG1 were associated with abnormal endothelial cell junctions like those observed in human CCMs. Biochemical and cellular imaging analyses identified a cell-autonomous pathway in which the HEG1 receptor couples to KRIT1 at these cell junctions. This study identifies HEG1-CCM protein signaling as a crucial regulator of heart and vessel formation and integrity.	[Kleaveland, Benjamin; Zheng, Xiangjian; Zou, Zhiying; Chen, Mei; Guo, Lili; Lu, Min-min; Zhou, Diane; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Kleaveland, Benjamin; Zheng, Xiangjian; Zou, Zhiying; Chen, Mei; Guo, Lili; Lu, Min-min; Zhou, Diane; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Liu, Jian J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Blum, Yannick; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Kitajewski, Jan] Columbia Univ, Med Ctr, Inst Canc Genet & Herbert Irving, Dept Pathol, New York, NY 10032 USA; [Kitajewski, Jan] Columbia Univ, Med Ctr, Inst Canc Genet & Herbert Irving, Dept Obstet & Gynaecol, New York, NY 10032 USA	University of Pennsylvania; University of Pennsylvania; University of California System; University of California San Diego; University of Basel; Columbia University; Columbia University	Kahn, ML (corresponding author), Univ Penn, Dept Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.	markkahn@mail.med.upenn.edu	Liu, Jay/D-4711-2011	Affolter, Markus/0000-0002-5171-0016; Zheng, Xiangjian/0000-0001-6277-5168	Swiss National Science Foundation,; European Community; US National Institutes of Health [T32 HL07439, T32 HL07971, HL078784, AR27214, HL62454, HL075380, HL095326]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078784, T32HL007439, R01HL094326, T32HL007971, R01HL062454, R01HL102138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER	Swiss National Science Foundation,(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank C. Bertozzi, C. Chen, A. Granger, J. Lee, D. Li, P. Mericko, A. Schmaier, E. Sebzda, N. Shanbhag, S. Sweeney and K. Whitehead for valuable insights; M. Pack and J. He for assistance with zebrafish studies; R. Meade for preparation of the electron microscopy samples; and T. Branson for animal husbandry. This work was supported by the Swiss National Science Foundation, a Network of Excellence grant from the European Community ( M. A.) and the US National Institutes of Health grants T32 HL07439 ( to B. K.), T32 HL07971 ( to X. Z.), HL078784 and AR27214 ( to M. G.), HL62454 ( to J. K.) and HL075380 and HL095326 ( to M. L. K.).	Amsterdam A, 2004, METHOD CELL BIOL, V77, P3; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Hogan BM, 2008, HUM MOL GENET, V17, P2424, DOI 10.1093/hmg/ddn142; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Mably JD, 2006, DEVELOPMENT, V133, P3139, DOI 10.1242/dev.02469; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Plummer NW, 2006, MAMM GENOME, V17, P119, DOI 10.1007/s00335-005-0098-8; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Tu J, 2005, J NEUROSURG, V103, P903, DOI 10.3171/jns.2005.103.5.0903; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wong JH, 2000, NEUROSURGERY, V46, P1454, DOI 10.1097/00006123-200006000-00027; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83	31	172	180	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					169	176		10.1038/nm.1918	http://dx.doi.org/10.1038/nm.1918			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19151727	Green Accepted			2022-12-25	WOS:000263119400019
J	Teotonio, H; Chelo, IM; Bradic, M; Rose, MR; Long, AD				Teotonio, Henrique; Chelo, Ivo M.; Bradic, Martina; Rose, Michael R.; Long, Anthony D.			Experimental evolution reveals natural selection on standing genetic variation	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; ADAPTATION; POLYMORPHISMS; FIXATION; LOCUS	Evolution depends on genetic variation generated by mutation or recombination from standing genetic variation. In sexual organisms, little is known about the molecular population genetics of adaptation and reverse evolution(1-11). We carry out 50 generations of experimental reverse evolution in populations of Drosophila melanogaster, previously differentiated by forward evolution, and follow changes in the frequency of SNPs in both arms of the third chromosome. We characterize the effects of sampling finite population sizes and natural selection at the genotype level. We demonstrate that selection has occurred at several loci and further that there is no general loss or gain of allele diversity. We also observe that despite the complete convergence to ancestral levels of adaptation, allele frequencies only show partial return.	[Teotonio, Henrique; Chelo, Ivo M.] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal; [Bradic, Martina] NYU, Dept Biol, New York, NY 10003 USA; [Rose, Michael R.; Long, Anthony D.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	Instituto Gulbenkian de Ciencia; New York University; University of California System; University of California Irvine	Teotonio, H (corresponding author), Inst Gulbenkian Ciencias, Apartado 14, P-2781901 Oeiras, Portugal.	teotonio@igc.gulbenkian.pt	Chelo, Ivo M/I-3080-2012	Chelo, Ivo M/0000-0002-5414-6625; Long, Tony/0000-0002-5007-8514; Teotonio, Henrique/0000-0003-1057-6882; Bradic, Martina/0000-0001-6078-5311	The National Science Foundation [DEB-0614429]; Fundacao para a Ciencia e a Tecnologia [FCT/FEDER POCTI/BSE/48228/2002]; Fundacao Calouste Gulbenkian	The National Science Foundation(National Science Foundation (NSF)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission)	We thank T. Aires, D. Brites, J. Costa and I. Marques for support with SNP discovery and genotyping, and G. McVean for support with LDhat. We thank R. Azevedo, S. Carvalho, A. Coutinho, S. Estes, L. Mueller, P. Phillips, S. Proulx, M. Che Soares and E. Sucena for comments on the project and manuscript. Financial support was provided by The National Science Foundation to A. D. L. (DEB-0614429), and Fundacao para a Ciencia e a Tecnologia (FCT/FEDER POCTI/BSE/48228/2002) and Fundacao Calouste Gulbenkian to H. T.	Balakirev ES, 2006, J MOL EVOL, V62, P496, DOI 10.1007/s00239-005-0140-1; BULL JJ, 1985, EVOLUTION, V39, P1149, DOI 10.2307/2408742; CHURCHILL GA, 1994, GENETICS, V138, P963; COHAN FM, 1984, EVOLUTION, V38, P495, DOI 10.1111/j.1558-5646.1984.tb00315.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Crill WD, 2000, GENETICS, V154, P27; DeckertCruz DJ, 1997, EVOLUTION, V51, P865, DOI [10.2307/2411161, 10.1111/j.1558-5646.1997.tb03668.x]; Goldringer I, 2004, GENETICS, V168, P563, DOI 10.1534/genetics.103.025908; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hartl D., 1989, PRINCIPLES POPULATIO; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hudson RR, 1997, P NATL ACAD SCI USA, V94, P7725, DOI 10.1073/pnas.94.15.7725; Macdonald SJ, 2005, GENETICS, V171, P1741, DOI 10.1534/genetics.105.045344; McVean G, 2002, GENETICS, V160, P1231; NEI M, 1986, EVOLUTION, V40, P643, DOI 10.1111/j.1558-5646.1986.tb00516.x; NEI M, 1981, GENETICS, V98, P625; Porter ML, 2003, TRENDS ECOL EVOL, V18, P541, DOI 10.1016/S0169-5347(03)00244-1; R Development Core Team, 2006, R LANG ENV STAT COMP; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Teotonio H, 2000, NATURE, V408, P463, DOI 10.1038/35044070; Teotonio H, 2004, J GENET, V83, P265, DOI 10.1007/BF02717896; Teotonio H, 2002, J EVOLUTION BIOL, V15, P608, DOI 10.1046/j.1420-9101.2002.00424.x; Teotonio H, 2001, EVOLUTION, V55, P653, DOI 10.1554/0014-3820(2001)055[0653:PRE]2.0.CO;2; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Verrelli BC, 2001, GENETICS, V157, P1649; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Whitlock MC, 2002, EVOLUTION, V56, P1968	29	112	112	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					251	257		10.1038/ng.289	http://dx.doi.org/10.1038/ng.289			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19136954				2022-12-25	WOS:000263091300029
J	Spits, C; Mateizel, I; Geens, M; Mertzanidou, A; Staessen, C; Vandeskelde, Y; Van der Elst, J; Liebaers, I; Sermon, K				Spits, Claudia; Mateizel, Ileana; Geens, Mieke; Mertzanidou, Afroditi; Staessen, Catherine; Vandeskelde, Yves; Van der Elst, Josiane; Liebaers, Inge; Sermon, Karen			Recurrent chromosomal abnormalities in human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CANCER; GENES	Cultured human embryonic stem (hES) cells have a known predisposition to aneuploidy of chromosomes 12, 17 and X. We studied 17 hES cell lines by array-based comparative genomic hybridization (aCGH) and found that the cells accumulate other recurrent chromosomal abnormalities, including amplification at 20q11.21 and a derivative chromosome 18. These genomic changes have a variable impact at the transcriptional level.	[Spits, Claudia; Mateizel, Ileana; Geens, Mieke; Mertzanidou, Afroditi; Van der Elst, Josiane; Liebaers, Inge; Sermon, Karen] Vrije Univ Brussels, Dept Embryol & Genet, B-1090 Brussels, Belgium; [Staessen, Catherine; Vandeskelde, Yves; Liebaers, Inge] Vrije Univ Brussels, UZ Brussel, Ctr Med Genet, B-1090 Brussels, Belgium; [Van der Elst, Josiane] Vrije Univ Brussels, Ctr Reprod Med, UZ Brussel, B-1090 Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	Spits, C (corresponding author), Vrije Univ Brussels, Dept Embryol & Genet, Laarbeeklaan 101, B-1090 Brussels, Belgium.	claudia.spits@uzbrussel.be	Spits, Claudia/J-1964-2014; Geens, Mieke/N-5576-2015	Spits, Claudia/0000-0002-0187-5138; Geens, Mieke/0000-0003-2849-1406; Sermon, Karen/0000-0002-2311-9034	Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen); STEM-HD	Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen)(FWO); STEM-HD	This work has been supported by grants from the Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen) and by the STEM-HD (STREP EU FP6 program). C. S. is a postdoctoral fellow at the FWO Vlaanderen. M. G. is a PhD student at the FWO Vlaanderen. A. M. is a PhD student at the Instituut voor de aanmoediging van innovatie door Wetenschap en Technologie in Vlaanderen (IWT-Vlaanderen).	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Guled M, 2008, MODERN PATHOL, V21, P770, DOI 10.1038/modpathol.2008.57; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Josephson R, 2007, EXPERT REV MOL DIAGN, V7, P395, DOI 10.1586/14737159.7.4.395; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Yin ZN, 2001, ONCOGENE, V20, P2273, DOI 10.1038/sj.onc.1204310	13	174	183	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1361	1363		10.1038/nbt.1510	http://dx.doi.org/10.1038/nbt.1510			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19029912				2022-12-25	WOS:000261591300020
J	Devenport, D; Fuchs, E				Devenport, Danelle; Fuchs, Elaine			Planar polarization in embryonic epidermis orchestrates global asymmetric morphogenesis of hair follicles	NATURE CELL BIOLOGY			English	Article							NEURAL-TUBE DEFECTS; CELL POLARITY; CONVERGENT EXTENSION; SONIC HEDGEHOG; VAN-GOGH; LOCALIZATION; NOTCH; EXPRESSION; FLAMINGO; PATTERNS	Mammalian body hairs align along the anterior-posterior (A-P) axis and offer a striking but poorly understood example of global cell polarization, a phenomenon known as planar cell polarity (PCP). We have discovered that during embryogenesis, marked changes in cell shape and cytoskeletal polarization occur as nascent hair follicles become anteriorly angled, morphologically polarized and molecularly compartmentalized along the A-P axis. Hair follicle initiation coincides with asymmetric redistribution of Vangl2, Celsr1 and Fzd6 within the embryonic epidermal basal layer. Moreover, loss-of-function mutations in Vangl2 and Celsr1 show that they have an essential role in hair follicle polarization and orientation, which develop in part through non-autonomous mechanisms. Vangl2 and Celsr1 are both required for their planar localization in vivo, and physically associate in a complex in vitro. Finally, we provide in vitro evidence that homotypic intracellular interactions of Celsr1 are required to recruit Vangl2 and Fzd6 to sites of cell-cell contact.	[Devenport, Danelle; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Devenport, Danelle/0000-0002-5464-259X	National Institutes of Health [R01 AR27883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053019, R01AR027883, R01AR031737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Murdoch, K. Anderson, M. Kelley, R. Rachel, B. Lake and C. Tabin, for mice and embryos; M. Montcouquiol, S. Sokol and M. Takeiechi for antibodies and reagents; L. Polak, N. Stokes and LARC staff for care and breeding of mice; J. Zallen, S. Sokol and A. vandenBerg for helpful discussions; Alison North and Rockefeller's Bioimaging Resource Centre for assistance with image acquisition and analysis; J. Racelis and A. Firland-Schill for experimental assistance; B. Short, V. Horsley and J. Nowak for advice and critical reading of the manuscript. D. D. is a Ruth L. Kirschstein NRSA postdoctoral fellow. This work was supported by a grant from the National Institutes of Health (R01 AR27883). E. F. is an Investigator of the Howard Hughes Medical Institute.	Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Chen CWJ, 1997, DEV BIOL, V188, P181, DOI 10.1006/dbio.1997.8643; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hardy MH, 1996, ACTA ANAT, V157, P169; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Muller-Rover S, 1998, J HISTOCHEM CYTOCHEM, V46, P1401; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tada M, 2000, DEVELOPMENT, V127, P2227; Taylor J, 1998, GENETICS, V150, P199; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	50	239	243	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1257	U12		10.1038/ncb1784	http://dx.doi.org/10.1038/ncb1784			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849982	Green Accepted			2022-12-25	WOS:000260586700008
J	Franke, A; Balschun, T; Karlsen, TH; Sventoraityte, J; Nikolaus, S; Mayr, G; Domingues, FS; Albrecht, M; Nothnagel, M; Ellinghaus, D; Sina, C; Onnie, CM; Weersma, RK; Stokkers, PCF; Wijmenga, C; Gazouli, M; Strachan, D; McArdle, WL; Vermeire, S; Rutgeerts, P; Rosenstiel, P; Krawczak, M; Vatn, MH; Mathew, CG; Schreiber, S				Franke, Andre; Balschun, Tobias; Karlsen, Tom H.; Sventoraityte, Jurgita; Nikolaus, Susanna; Mayr, Gabriele; Domingues, Francisco S.; Albrecht, Mario; Nothnagel, Michael; Ellinghaus, David; Sina, Christian; Onnie, Clive M.; Weersma, Rinse K.; Stokkers, Pieter C. F.; Wijmenga, Cisca; Gazouli, Maria; Strachan, David; McArdle, Wendy L.; Vermeire, Severine; Rutgeerts, Paul; Rosenstiel, Philip; Krawczak, Michael; Vatn, Morten H.; Mathew, Christopher G.; Schreiber, Stefan		IBSEN Study Grp	Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CYTOKINE GENE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; IL-10 GENE; TNF-ALPHA; INTERLEUKIN-10; METAANALYSIS; PHENOTYPE; IBD	Inflammatory bowel disease (IBD) typically manifests as either ulcerative colitis (UC) or Crohn's disease (CD). Systematic identification of susceptibility genes for IBD has thus far focused mainly on CD, and little is known about the genetic architecture of UC. Here we report a genome-wide association study with 440,794 SNPs genotyped in 1,167 individuals with UC and 777 healthy controls. Twenty of the most significantly associated SNPs were tested for replication in three independent European case-control panels comprising a total of 1,855 individuals with UC and 3,091 controls. Among the four consistently replicated markers, SNP rs3024505 immediately flanking the IL10 (interleukin 10) gene on chromosome 1q32.1 showed the most significant association in the combined verification samples (P = 1.35 x 10(-12); OR = 1.46 (1.31-1.62)). The other markers were located in ARPC2 and in the HLA-BTNL2 region. Association between rs3024505 and CD (1,848 cases, 1,804 controls) was weak (P = 0.013; OR = 1.17 (1.01-1.34)). IL10 is an immunosuppressive cytokine that has long been proposed to influence IBD pathophysiology. Our findings strongly suggest that defective IL10 function is central to the pathogenesis of the UC subtype of IBD.	[Franke, Andre; Balschun, Tobias; Sventoraityte, Jurgita; Ellinghaus, David; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Karlsen, Tom H.; Vatn, Morten H.] Rikshosp Univ Hosp, Dept Med, N-0027 Oslo, Norway; [Nikolaus, Susanna; Sina, Christian] Univ Kiel, Poppgen Biobank, D-24105 Kiel, Germany; [Nikolaus, Susanna; Sina, Christian; Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Mayr, Gabriele; Domingues, Francisco S.; Albrecht, Mario] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Nothnagel, Michael; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany; [Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Weersma, Rinse K.] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [Weersma, Rinse K.; Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Stokkers, Pieter C. F.] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Gazouli, Maria] Univ Athens, Sch Med, Dept Biol, GR-11527 Athens, Greece; [Strachan, David] St Georgess Univ, Div Community Hlth Sci, London SW17 0RE, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, ALSPAC, Bristol BS8 1TQ, Avon, England; [Vermeire, Severine; Rutgeerts, Paul] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium; [Vatn, Morten H.] Akershus Univ Hosp, Fac Med, N-1474 Oslo, Norway	University of Kiel; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; University of Kiel; University of London; King's College London; University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Athens Medical School; National & Kapodistrian University of Athens; St Georges University London; University of Bristol; KU Leuven; University Hospital Leuven; University of Oslo	Schreiber, S (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Balschun, Tobias/B-2356-2010; Nothnagel, Michael/H-6887-2012; Weersma, Rinse/ABE-3807-2021; Wijmenga, Cisca/D-2173-2009; Ellinghaus, David/G-4467-2012; Rosenstiel, Philip/A-5137-2009; Gazouli, Maria/I-2572-2018; Nothnagel, Michael/A-7759-2011; Franke, Andre/B-2151-2010; Ellinghaus, David/ABC-3610-2020; Albrecht, Mario/B-6694-2008; Krawczak, Michael/A-8964-2010; Mathew, Christopher G/G-3434-2015; Wijmenga, Cisca/AAE-7719-2019; Gazouli, Maria/W-6245-2019; Nothnagel, Michael/G-6545-2014; Sina, Christian/D-5348-2014; Nothnagel, Michael/L-7187-2019	Rosenstiel, Philip/0000-0002-9692-8828; Gazouli, Maria/0000-0002-3295-6811; Franke, Andre/0000-0003-1530-5811; Ellinghaus, David/0000-0002-4332-6110; Albrecht, Mario/0000-0002-3103-9624; Krawczak, Michael/0000-0003-2603-1502; Mathew, Christopher G/0000-0003-4178-1838; Wijmenga, Cisca/0000-0002-5635-1614; Gazouli, Maria/0000-0002-3295-6811; Nothnagel, Michael/0000-0001-8305-7114; Domingues, Francisco/0000-0003-4567-4562; Vermeire, Severine/0000-0001-9942-3019	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); popgen biobank; DFG; British Birth Cohort collection; UK MRC [G0000934]; Wellcome Trust [068545/Z/02]; CORE (UK); MRC [G0000934, MC_qA137934] Funding Source: UKRI; Medical Research Council [MC_qA137934, G0000934] Funding Source: researchfish	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); popgen biobank; DFG(German Research Foundation (DFG)); British Birth Cohort collection; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); CORE (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank all individuals with IBD, families and physicians for their cooperation. We gratefully acknowledge the cooperation of the German Crohn and Colitis Foundation (Deutsche Morbus Crohn und Colitis Vereinigung e. V.), the BMBF competence network "IBD'' and of the contributing gastroenterologists. Finally, we wish to thank T. Wesse, T. Henke, A. Dietsch, R. Vogler, C.v.d. Lancken and M. Friskovec for expert technical help. We thank T. Wienker and M. Steffens (IMBIE, University of Bonn) for performing the quality control of the GWAS datasets. We thank B. A. Lie and the Norwegian Bone Marrow Donor Registry at Rikshospitalet University Hospital, Oslo, for contributing the healthy Norwegian control population. This study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the popgen biobank and the SFB617 "Molecular Mechanisms of Epithelial Defense.'' The project received infrastructure support through the DFG excellence cluster "Inflammation at Interfaces.'' We acknowledge use of DNA from the 1958 British Birth Cohort collection (R. Jones, S. Ring, W. McArdle and M. Pembrey), funded by the UK MRC (grant G0000934) and The Wellcome Trust (grant 068545/Z/02). C. G. M. and C.M.O. were supported by The Wellcome Trust and CORE (UK).	Aithal GP, 2001, DIGEST DIS SCI, V46, P1520, DOI 10.1023/A:1010604307776; Balding J, 2004, MEDIAT INFLAMM, V13, P181, DOI 10.1080/09511920410001713529; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cantor MJ, 2005, AM J GASTROENTEROL, V100, P1134, DOI 10.1111/j.1572-0241.2005.40979.x; Castro-Santos P, 2006, AM J GASTROENTEROL, V101, P1039, DOI 10.1111/j.1572-0241.2006.00501.x; Celik Y, 2006, SCAND J GASTROENTERO, V41, P559, DOI 10.1080/00365520500349523; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fernandez L, 2005, INFLAMM BOWEL DIS, V11, P739, DOI 10.1097/01.MIB.0000173457.64868.20; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Kim Tae Ho, 2003, Korean J Gastroenterol, V42, P377; Klein W, 2000, ELECTROPHORESIS, V21, P3578, DOI 10.1002/1522-2683(200011)21:17<3578::AID-ELPS3578>3.3.CO;2-Q; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875; Parkes M, 1998, CLIN EXP IMMUNOL, V113, P28, DOI 10.1046/j.1365-2249.1998.00625.x; Schreiber S, 1998, GASTROENTEROLOGY, V114, pA1080; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Tagore A, 1999, TISSUE ANTIGENS, V54, P386, DOI 10.1034/j.1399-0039.1999.540408.x; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; van der Linde K, 2005, DIGEST LIVER DIS, V37, P330, DOI 10.1016/j.dld.2004.12.009; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; WEBB MC, 1993, TRANSPLANTATION, V56, P1585	30	446	461	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1319	1323		10.1038/ng.221	http://dx.doi.org/10.1038/ng.221			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836448				2022-12-25	WOS:000260501500024
J	Jin, J; Huang, W; Gao, JP; Yang, J; Shi, M; Zhu, MZ; Luo, D; Lin, HX				Jin, Jian; Huang, Wei; Gao, Ji-Ping; Yang, Jun; Shi, Min; Zhu, Mei-Zhen; Luo, Da; Lin, Hong-Xuan			Genetic control of rice plant architecture under domestication	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; ZINC-FINGER PROTEINS; TOMATO FRUIT; EVOLUTION; ORIGIN; MAIZE; ARABIDOPSIS; ENCODES; SIZE; DNA	The closely related wild rice species Oryza rufipogon is considered the progenitor of cultivated rice (Oryza sativa)(1-5). The transition from the characteristic plant architecture of wild rice to that of cultivated rice was one of the most important events in rice domestication; however, the molecular basis of this key domestication transition has not been elucidated. Here we show that the PROG1 gene controls aspects of wild-rice plant architecture, including tiller angle and number of tillers. The gene encodes a newly identified zinc-finger nuclear transcription factor with transcriptional activity and is mapped on chromosome 7. PROG1 is predominantly expressed in the axillary meristems, the site of tiller bud formation. Rice transformation experiments demonstrate that artificial selection of an amino acid substitution in the PROG1 protein during domestication led to the transition from the plant architecture of wild rice to that of domesticated rice.	[Jin, Jian; Huang, Wei; Gao, Ji-Ping; Yang, Jun; Shi, Min; Zhu, Mei-Zhen; Luo, Da; Lin, Hong-Xuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	hxlin@sibs.ac.cn	Lin, Hong-Xuan/AEQ-6607-2022	Lin, Hong-Xuan/0000-0002-2818-023X; Gao, Ji-Ping/0000-0002-8968-4423	Ministry of Science and Technology of China; National Natural Science Foundation of China; Chinese Academy of Sciences; Shanghai Science and Technology Development Fund	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Science and Technology Development Fund	We thank Z.-Z. Piao and X.-M. Li for technical assistance. We thank S. Luan for critically reading the manuscript. This work was supported by grants from the Ministry of Science and Technology of China, the National Natural Science Foundation of China, the Chinese Academy of Sciences and the Shanghai Science and Technology Development Fund to H.-X.L.	CHANT S, 1995, GENDER PLACE CULT, V2, P147; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Hao Wei, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P354; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Oka H. I., 1988, Origin of cultivated rice.; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sharma SD, 2000, RICE BREEDING AND GENETICS, P349; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x	30	283	354	13	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1365	1369		10.1038/ng.247	http://dx.doi.org/10.1038/ng.247			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820696				2022-12-25	WOS:000260501500032
J	Rahimov, F; Marazita, ML; Visel, A; Cooper, ME; Hitchler, MJ; Rubini, M; Domann, FE; Govil, M; Christensen, K; Bille, C; Melbye, M; Jugessur, A; Lie, RT; Wilcox, AJ; Fitzpatrick, DR; Green, ED; Mossey, PA; Little, J; Steegers-Theunissen, RP; Pennacchio, LA; Schutte, BC; Murray, JC				Rahimov, Fedik; Marazita, Mary L.; Visel, Axel; Cooper, Margaret E.; Hitchler, Michael J.; Rubini, Michele; Domann, Frederick E.; Govil, Manika; Christensen, Kaare; Bille, Camille; Melbye, Mads; Jugessur, Astanand; Lie, Rolv T.; Wilcox, Allen J.; Fitzpatrick, David R.; Green, Eric D.; Mossey, Peter A.; Little, Julian; Steegers-Theunissen, Regine P.; Pennacchio, Len A.; Schutte, Brian C.; Murray, Jeffrey C.		NISC Comparative Sequencing Pr	Disruption of an AP-2 alpha binding site in an IRF6 enhancer is associated with cleft lip	NATURE GENETICS			English	Article							OROFACIAL CLEFTS; ORAL CLEFTS; PALATE; GENE; POPULATION; SEQUENCES; POLYMORPHISMS; CONTRIBUTES; EXPRESSION; MUTATIONS	Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P)(1) is strongly associated with SNPs in IRF6 (interferon regulatory factor 6)(2). Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G>A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P = 1 x 10(-11)) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.	[Rahimov, Fedik; Schutte, Brian C.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Marazita, Mary L.; Cooper, Margaret E.; Govil, Manika] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA; [Visel, Axel; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genome Div, Berkeley, CA 94720 USA; [Hitchler, Michael J.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Rubini, Michele] Univ Ferrara, Med Genet Unit, Dept Expt Diagnost Med, I-44100 Ferrara, Italy; [Christensen, Kaare; Bille, Camille] Univ So Denmark, Inst Publ Hlth, Ctr Prevent Congenital Malinformat, DK-5000 Odense C, Denmark; [Melbye, Mads] Danish Epidemiol Sci Ctr, State Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jugessur, Astanand; Lie, Rolv T.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5018 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Fitzpatrick, David R.] Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, US Natl Inst Hlth Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Dundee DD1 4HR, Scotland; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Steegers-Theunissen, Regine P.] Univ Med Ctr, NL-3015 GD Rotterdam, Netherlands	University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Iowa; University of Ferrara; University of Southern Denmark; Aarhus University; Statens Serum Institut; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Dundee; University of Ottawa	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, 2182 ML,S Grand Ave, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu	Visel, Axel/A-9398-2009; Christensen, Kaare/C-2360-2009; Little, Julian/AAR-6117-2020; Rahimov, Fedik/H-2685-2013; Rubini, Michele/AFF-8477-2022; FitzPatrick, David R/C-7301-2013; Wilcox, Allen J/C-7723-2019	Visel, Axel/0000-0002-4130-7784; Christensen, Kaare/0000-0002-5429-5292; Little, Julian/0000-0001-5026-5531; Rubini, Michele/0000-0003-1448-9516; Wilcox, Allen J/0000-0002-3376-1311; Pennacchio, Len/0000-0002-8748-3732; FitzPatrick, David R./0000-0003-4861-969X; Mossey, Peter/0000-0002-9914-6901; melbye, mads/0000-0001-8264-6785; Rahimov, Fedik/0000-0001-6519-7404; Domann, Frederick/0000-0002-0489-2179	National Institutes of Health (NIH) [P50 DE16215, P30 ES05605, R37 DE08559, R01-DE13513, 1 UL1 RR024979-01, R01-CA73612, R01-HG003988]; Intramural Research Program of the National Human Genome Research Institute; Intramural Research Program of the NIH; National Institute of Environmental Health Sciences; European Commission FP5; EUROCRAN [QLG1-CT-2000-01019]; American Heart Association;  [DE-AC02-05CH11231];  [T32 CA078586]; NATIONAL CANCER INSTITUTE [R01CA073612, T32CA078586] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988, ZIAHG000060, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148, R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, P50DE009170, R01DE013513, P50DE016215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, R01ES010876, ZIAES049027] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561093] Funding Source: researchfish; MRC [MC_U127561093] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Commission FP5(European CommissionEuropean Commission Joint Research Centre); EUROCRAN; American Heart Association(American Heart Association); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Kinoshita, K. Frees, A. Mansilla, J. L'Heureux, M. Johnson, H. Morrison, G. Wehby, N. Rorick, K. Bedell and L. Powers for technical assistance and S. McConnell, D. Benton and M. DeVore for their administrative assistance. We would also like to thank A. Klingelhutz (University of Iowa) for kindly providing us with HFK cell line. This work was supported by grants from the National Institutes of Health (NIH): P50 DE16215 (J.C.M., M.L.M., B.C.S.), P30 ES05605 (J.C.M.), R37 DE08559 (J.C.M., M.L.M.), R01-DE13513 (B.C.S.), 1 UL1 RR024979-01 (J.C.M., B.C.S.), R01-CA73612 (F.E.D.), R01-HG003988 administered under Department of Energy Contract DE-AC02-05CH11231 (L.A.P.) as well as by the Intramural Research Program of the National Human Genome Research Institute (E.D.G.), in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (A.J.W.), and European Commission FP5: EUROCRAN Project (contract no. QLG1-CT-2000-01019) (M.R., P.A.M., J.L., R.P.S.-T.). A.V. was supported by the American Heart Association. M.J.H. received salary support from T32 CA078586.	Bille C, 2007, EUR J EPIDEMIOL, V22, P173, DOI 10.1007/s10654-006-9099-5; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Harville EW, 2005, AM J EPIDEMIOL, V162, P448, DOI 10.1093/aje/kwi214; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Mitchell LE, 2002, CLEFT PALATE-CRAN J, V39, P93, DOI 10.1597/1545-1569(2002)039<0093:GFTDAA>2.0.CO;2; Mossey P, 2007, ORTHOD CRANIOFAC RES, V10, P114, DOI 10.1111/j.1601-6343.2007.00398.x; Nguyen RHN, 2007, ANN EPIDEMIOL, V17, P763, DOI 10.1016/j.annepidem.2007.04.008; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Provenzano MJ, 2007, EXP MOL PATHOL, V83, P277, DOI 10.1016/j.yexmp.2007.06.001; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	30	314	331	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1341	1347		10.1038/ng.242	http://dx.doi.org/10.1038/ng.242			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836445	Green Accepted			2022-12-25	WOS:000260501500028
J	Fu, DX; Tanhehco, Y; Chen, JM; Foss, CA; Fox, JJ; Chong, JM; Hobbs, RF; Fukayama, M; Sgouros, G; Kowalski, J; Pomper, MG; Ambinder, RF				Fu, De-Xue; Tanhehco, Yvette; Chen, Jianmeng; Foss, Catherine A.; Fox, James J.; Chong, Ja-Mun; Hobbs, Robert F.; Fukayama, Masashi; Sgouros, George; Kowalski, Jeanne; Pomper, Martin G.; Ambinder, Richard F.			Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors	NATURE MEDICINE			English	Article							EPSTEIN-BARR-VIRUS; NON-HODGKINS-LYMPHOMA; THYMIDINE KINASE; IN-VIVO; CELLS; GENE; EXPRESSION; INDUCTION; FIAU; GANCICLOVIR	We investigated the possibility of using a pharmacologic agent to modulate viral gene expression to target radiotherapy to tumor tissue. In a mouse xenograft model, we had previously shown targeting of [[I-125]2'-fluoro-2'-deoxy-beta-D-5-iodouracil-arabinofuranoside ([I-125]FIAU) to tumors engineered to express the Epstein-Barr virus thymidine kinase (EBV-TK). Here we extend those results to targeting of a therapeutic radiopharmaceutical [I-131]FIAU to slow or stop tumor growth or to achieve tumor regression. These outcomes were achieved in xenografts with tumors that constitutively expressed the EBV-TK. With naturally infected EBV tumor cell lines (Burkitt's lymphoma and gastric carcinoma), activation of viral gene expression by pretreatment with bortezomib was required. Marked changes in tumor growth could also be achieved in naturally infected Kaposi's sarcoma herpesvirus tumors after pretreatment with bortezomib. Bortezomib-induced enzyme-targeted radiation therapy illustrates the possibility of pharmacologically modulating tumor gene expression to result in targeted radiotherapy.	[Fu, De-Xue; Tanhehco, Yvette; Chen, Jianmeng; Chong, Ja-Mun; Kowalski, Jeanne; Pomper, Martin G.; Ambinder, Richard F.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Foss, Catherine A.; Fox, James J.; Hobbs, Robert F.; Sgouros, George; Pomper, Martin G.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD 21287 USA; [Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Human Pathol, Bunkyo Ku, Tokyo 1130033, Japan	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Tokyo	Ambinder, RF (corresponding author), Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21287 USA.	ambinri@jhmi.edu	Tanhehco, Yvette/AAA-6906-2019	Kowalski, Jeanne/0000-0003-3458-3024	US National Institutes of Health [NIH/NCI P50 CA96888, P01 CA113239, U24 CA92871]; NATIONAL CANCER INSTITUTE [P01CA113239, P50CA096888, P01CA069266, P01CA081400, U24CA092871] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S.D. Hayward (Johns Hopkins School of Medicine) for Burkitt's lymphoma cell lines and G. Hayward (Johns Hopkins School of Medicine) for primary effusion lymphoma cell lines. We think R. Wahl, S.D. Hayward, W.-S. Hsieh and M. Shamay for suggestions; S. Bonekamp, K.F. Kwok and J. Yu for reconstruction of imaging data; S. Wang for assistance in the syntheses of [<SUP>125</SUP>I]FIAU anti [<SUP>131</SUP>I]FIAU; G, Green for assistance with mouse imaging and therapy and S. Nimmagadda for assistance with mouse experiments. This work was supported by grants from the US National Institutes of Health (NIH/NCI P50 CA96888, P01 CA113239 and U24 CA92871).	Blasberg RG, 1999, Q J NUCL MED, V43, P163; Chong JM, 2002, J VIROL, V76, P6825, DOI 10.1128/JVI.76.13.6825-6831.2002; CUI LX, 1995, J CLIN INVEST, V95, P555, DOI 10.1172/JCI117698; Diaz LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001007; Dixon KL, 2003, NUCL MED COMMUN, V24, P951, DOI 10.1097/00006231-200309000-00002; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; Fu DX, 2007, CLIN CANCER RES, V13, P1453, DOI 10.1158/1078-0432.CCR-06-2295; Gentry BG, 2005, GENE THER, V12, P1033, DOI 10.1038/sj.gt.3302487; Haubner R, 2000, EUR J NUCL MED, V27, P283, DOI 10.1007/s002590050035; Jacobs A, 2001, J NUCL MED, V42, P467; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; JUWEID M, 1992, CANCER RES, V52, P5144; Kaminski MS, 2005, NEW ENGL J MED, V352, P441, DOI 10.1056/NEJMoa041511; Lewis W, 1996, P NATL ACAD SCI USA, V93, P3592, DOI 10.1073/pnas.93.8.3592; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Moore SM, 2001, ANTIMICROB AGENTS CH, V45, P2082, DOI 10.1128/AAC.45.7.2082-2091.2001; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perrine SR, 2007, BLOOD, V109, P2571, DOI 10.1182/blood-2006-01-024703; Robe PA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-32; Rodriguez A, 2001, J VIROL, V75, P4482, DOI 10.1128/JVI.75.10.4482-4489.2001; Schipper ML, 2007, MOL IMAGING BIOL, V9, P110, DOI 10.1007/s11307-007-0078-3; Sgouros G, 2003, J NUCL MED, V44, P260; Song H, 2007, J NUCL MED, V48, P150; Takada K, 2000, J CLIN PATHOL-MOL PA, V53, P255, DOI 10.1136/mp.53.5.255; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Ushiku T, 2007, INT J CANCER, V120, P60, DOI 10.1002/ijc.22275; Wang XZ, 2003, GLOBAL CHANGE BIOL, V9, P612, DOI 10.1046/j.1365-2486.2003.00615.x; Westphal EM, 2000, CANCER RES, V60, P5781; Witzig TE, 2007, CANCER, V109, P1804, DOI 10.1002/cncr.22617; Wu FY, 2003, J VIROL, V77, P1481, DOI 10.1128/JVI.77.2.1481-1500.2003	30	71	74	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1118	1122		10.1038/nm.1864	http://dx.doi.org/10.1038/nm.1864			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18776891	Green Accepted			2022-12-25	WOS:000259892300043
J	Hofmann, S; Franke, A; Fischer, A; Jacobs, G; Nothnagel, M; Gaede, KI; Schurmann, M; Muller-Quernheim, J; Krawczak, M; Rosenstiel, P; Schreiber, S				Hofmann, Sylvia; Franke, Andre; Fischer, Annegret; Jacobs, Gunnar; Nothnagel, Michael; Gaede, Karoline I.; Schuermann, Manfred; Mueller-Quernheim, Joachim; Krawczak, Michael; Rosenstiel, Philip; Schreiber, Stefan			Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis	NATURE GENETICS			English	Article							AFRICAN-AMERICANS; ANNEXIN-XI; BTNL2 GENE; APOPTOSIS; ALG-2; IL-15; EXPRESSION; PROTEIN; SEARCH; DOMAIN	Sarcoidosis is a complex chronic inflammatory disorder with predominant manifestation in the lung. In the first genome-wide association study (4440,000 SNPs) of this disease, comprising 499 German individuals with sarcoidosis and 490 controls, we detected a series of genetic associations. The strongest association signal maps to the ANXA11 (annexin A11) gene on chromosome 10q22.3. Validation in an independent sample (1,649 cases, 1,832 controls) confirmed the association (SNP rs2789679: P = 3.0 x 10(-13), rs7091565: P = 1.0 x 10(-5), allele-based test). Extensive fine mapping located the association signal to a region between exon 5 and exon 14 of ANXA11. A common nonsynonymous SNP (rs1049550, T > C, R230C) was found to be strongly associated with sarcoidosis. The GWAS lead SNP and additional risk variants in the region (rs1953600, rs2573346, rs2784773) were in strong linkage disequilibrium with rs1049550. Annexin A11 has complex and essential functions in several biological pathways, including apoptosis and proliferation.	[Hofmann, Sylvia; Franke, Andre; Fischer, Annegret; Jacobs, Gunnar; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Nothnagel, Michael; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany; [Gaede, Karoline I.] Res Ctr Borstel, D-23845 Borstel, Germany; [Schuermann, Manfred] Med Univ Lubeck, Inst Human Genet, D-23538 Lubeck, Germany; [Mueller-Quernheim, Joachim] Univ Freiburg, Dept Pneumol, D-79106 Freiburg, Germany; [Schreiber, Stefan] Univ Kiel, Dept Internal Med, D-24105 Kiel, Germany	University of Kiel; University of Kiel; Forschungszentrum Borstel; University of Lubeck; University of Freiburg; University of Kiel	Schreiber, S (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Franke, Andre/B-2151-2010; Rosenstiel, Philip/A-5137-2009; Fischer, Annegret/D-4084-2011; Nothnagel, Michael/A-7759-2011; Nothnagel, Michael/G-6545-2014; Hofmann, Sylvia/AAO-4802-2021; Hofmann, Sylvia/E-4214-2010; Jacobs, Gunnar/A-4969-2009; Nothnagel, Michael/H-6887-2012; Nothnagel, Michael/L-7187-2019; Müller-Quernheim, Joachim/H-1983-2011; Krawczak, Michael/A-8964-2010	Franke, Andre/0000-0003-1530-5811; Rosenstiel, Philip/0000-0002-9692-8828; Nothnagel, Michael/0000-0001-8305-7114; Krawczak, Michael/0000-0003-2603-1502; Hofmann, Dr. S./0000-0003-0621-9049	German National Genome Research Network [NGFN-2]	German National Genome Research Network	The authors wish to thank all individuals with sarcoidosis, families and physicians for their cooperation. The efforts of the German Sarcoidosis Patients Organization (Deutsche Sarkoidose-Vereinigung) and the contribution of pulmonary specialist physicians are gratefully acknowledged. The authors wish to thank T. Wienker, M. Steffens, M. Albrecht, T. Wesse and C. von der Lanken for expert technical help, R. Kleindorp and G. Richter for logistic help, and R. Vogler for database and computer support. This study was funded by the German National Genome Research Network (NGFN-2).	Agostini C, 1996, J IMMUNOL, V157, P910; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; BulfonePaus S, 1997, NAT MED, V3, P1124, DOI 10.1038/nm1097-1124; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gray-McGuire C, 2006, HUM GENET, V120, P420, DOI 10.1007/s00439-006-0201-6; Hayes M. J., 2007, V45, P1; Iannuzzi MC, 2005, GENES IMMUN, V6, P509, DOI 10.1038/sj.gene.6364235; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Joo JH, 2008, J CELL BIOCHEM, V103, P1183, DOI 10.1002/jcb.21496; Jorgensen CS, 2000, LUPUS, V9, P515; Jullien D, 1997, J IMMUNOL, V158, P800; Lacana E, 1997, J IMMUNOL, V158, P5129; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Li Y, 2006, THORAX, V61, P273, DOI 10.1136/thx.2005.056564; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Rybicki BA, 2005, AM J HUM GENET, V77, P491, DOI 10.1086/444435; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; TOKUMITSU H, 1993, ARCH BIOCHEM BIOPHYS, V303, P302, DOI 10.1006/abbi.1993.1287; Tomas A, 2003, J BIOL CHEM, V278, P20210, DOI 10.1074/jbc.M212669200; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521	26	169	170	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1103	1106		10.1038/ng.198	http://dx.doi.org/10.1038/ng.198			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165924				2022-12-25	WOS:000258761200024
J	Musone, SL; Taylor, KE; Lu, TT; Nititham, J; Ferreira, RC; Ortmann, W; Shifrin, N; Petri, MA; Kamboh, MI; Manzi, S; Seldin, MF; Gregersen, PK; Behrens, TW; Ma, A; Kwok, PY; Criswell, LA				Musone, Stacy L.; Taylor, Kimberly E.; Lu, Timothy T.; Nititham, Joanne; Ferreira, Ricardo C.; Ortmann, Ward; Shifrin, Nataliya; Petri, Michelle A.; Kamboh, M. Ilyas; Manzi, Susan; Seldin, Michael F.; Gregersen, Peter K.; Behrens, Timothy W.; Ma, Averil; Kwok, Pui-Yan; Criswell, Lindsey A.			Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; ENZYME A20; RESPONSES; 6Q23	The TNFAIP3 (tumor necrosis factor alpha-induced protein 3) gene encodes a ubiquitin editing enzyme, A20, that restricts NF-kappa B-dependent signaling and prevents inflammation. We show that three independent SNPs in the TNFAIP3 region (rs13192841, rs2230926 and rs6922466) are associated with systemic lupus erythematosus (SLE) among individuals of European ancestry. These findings provide critical links between A20 and the etiology of SLE.	[Taylor, Kimberly E.; Nititham, Joanne; Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Musone, Stacy L.; Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Lu, Timothy T.; Shifrin, Nataliya; Ma, Averil] Univ Calif San Francisco, Colitis & Crohns Dis Ctr, Dept Med, San Francisco, CA 94143 USA; [Ferreira, Ricardo C.; Ortmann, Ward; Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 20205 USA; [Kamboh, M. Ilyas; Manzi, Susan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15261 USA; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Mol Med & Human Genet, Davis, CA 95616 USA; [Gregersen, Peter K.] Feinstein Inst Med Res, N Shore Long Isl Jewish Hlth Syst, Manhasset, NY 11030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; Northwell Health	Criswell, LA (corresponding author), Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA.	lindsey.criswell@ucsf.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Kamboh, M. Ilyas/0000-0002-3453-1438; Ferreira, Ricardo C./0000-0001-5733-3285	ABCoN contract [NO1-AR-1-2256]; Mary Kirkland Center for Lupus Research; Rainin Foundation; National Center for Research Resources [5 M01 RR-00079]; US Public Health Service;  [R01 AR44804];  [K24 AR02175];  [AI95386];  [AR050267];  [T32 DK07007];  [U19 AI063603];  [2R01 AR4658805];  [K24 AR02213];  [R01 HL 54900];  [R01 HL 74165]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074165, R01HL054900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095386, U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002175, R01AR044804, K24AR002213, R01AR050267, N01AR012256, R01AR046588, P60AR053308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007007] Funding Source: NIH RePORTER	ABCoN contract; Mary Kirkland Center for Lupus Research; Rainin Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 AR44804 (L. A. C.), K24 AR02175 (L. A. C.), N01 AI95386 (P. K. G.), ABCoN contract NO1-AR-1-2256 (P. K. G.), AR050267 (M. F. S.), the Mary Kirkland Center for Lupus Research (L. A. C.), the Rainin Foundation (A. M.), T32 DK07007 (T. T. L.), U19 AI063603 (P.-Y. K.), 2R01 AR4658805 (S. M.), K24 AR02213 (S. M.), R01 HL 54900 (M. I. K.) and R01 HL 74165 (M. I. K.). These studies were performed in part in the General Clinical Research Center, Moffitt Hospital, University of California, San Francisco, with funds provided by the National Center for Research Resources, 5 M01 RR-00079, US Public Health Service. We also thank the individuals and physicians who contributed DNA samples and clinical data for this study.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Crow MK, 2008, NEW ENGL J MED, V358, P956, DOI 10.1056/NEJMe0800096; GRAHAM RR, 2008, NAT GENET       0801; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	10	348	360	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1062	1064		10.1038/ng.202	http://dx.doi.org/10.1038/ng.202			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165919	Green Accepted			2022-12-25	WOS:000258761200017
J	Gao, DM; Inuzuka, H; Tseng, A; Chin, RY; Toker, A; Wei, WY				Gao, Daming; Inuzuka, Hiroyuki; Tseng, Alan; Chin, Rebecca Y.; Toker, Alex; Wei, Wenyi			Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdh1-mediated Skp2 destruction	NATURE CELL BIOLOGY			English	Article							LIGASE SUBUNIT SKP2; UBIQUITIN LIGASE; BREAST-CANCER; TRANSCRIPTION FACTOR; INHIBITOR P27(KIP1); PROSTATE-CANCER; NUCLEAR IMPORT; KINASE-B; EXPRESSION; CELLS	Deregulated Skp2 function promotes cell transformation, and this is consistent with observations of Skp2 overexpression in many human cancers. However, the mechanisms underlying elevated Skp2 expression are still unknown. Here we show that the serine/threonine protein kinase Akt1, but not Akt2, directly controls Skp2 stability by a mechanism that involves degradation by the APC-Cdh1 ubiquitin ligase complex. We show further that Akt1 phosphorylates Skp2 at Ser 72, which is required to disrupt the interaction between Cdh1 and Skp2. In addition, we show that Ser 72 is localized within a putative nuclear localization sequence and that phosphorylation of Ser 72 by Akt leads to cytoplasmic translocation of Skp2. This finding expands our knowledge of how specific signalling kinase cascades influence proteolysis governed by APC-Cdh1 complexes, and provides evidence that elevated Akt activity and cytoplasmic Skp2 expression may be causative for cancer progression.	[Gao, Daming; Inuzuka, Hiroyuki; Tseng, Alan; Chin, Rebecca Y.; Toker, Alex; Wei, Wenyi] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wei, WY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Holt, Janet E/B-2415-2013	Gao, Daming/0000-0003-4374-1055; CHIN, Yuet Ming Rebecca/0000-0001-8976-3466	Harvard Medical School Milton Fund; Emerald Foundation; National Institutes of Health [CA076120, CA122099]; Susan G. Komen Breast Cancer Foundation [0706963]; NATIONAL CANCER INSTITUTE [R01CA122099, R01CA076120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089763] Funding Source: NIH RePORTER	Harvard Medical School Milton Fund; Emerald Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank William Kaelin Jr, Lewis Cantley, Roya Khosravi-Far and Susan Glueck for critical reading of the manuscript; James DeCaprio, Christoph Geisen, Ronald DePinho, Laura Benjamin, Suzanne Conzen, John Blenis and Peter Jackson for providing reagents; Ross Tomaino for his kind assistance on the mass spectrum analysis; Isaac Robinovitz for his technical support on the fluorescence microscopy; Pier Paolo Pandolfi for sharing unpublished data; and members of the Wei and Toker laboratories for useful discussions. W. W. is a Leukemia and Lymphoma Society Special Fellow, Kimmel Scholar and V Scholar. This work was supported in part by the Harvard Medical School Milton Fund (W.W.) and the Emerald Foundation, and by grants from the National Institutes of Health (W.G.K., CA076120; A.T., CA122099) and the Susan G. Komen Breast Cancer Foundation (R.Y.C., 0706963).	Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dowen SE, 2003, INT J CANCER, V105, P326, DOI 10.1002/ijc.11066; Drobnjak M, 2003, CLIN CANCER RES, V9, P2613; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ji P, 2006, J BIOL CHEM, V281, P24058, DOI 10.1074/jbc.M603105200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Reichert M, 2007, CANCER RES, V67, P4149, DOI 10.1158/0008-5472.CAN-06-4484; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Shapira M, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1533; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; van Duijn PW, 2006, PROSTATE, V66, P749, DOI 10.1002/pros.20398; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yam CH, 1999, MOL CELL BIOL, V19, P635; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	48	189	198	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					397	U92		10.1038/ncb1847	http://dx.doi.org/10.1038/ncb1847			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19270695	Green Accepted			2022-12-25	WOS:000265264900010
J	Erdmann, J; Grosshennig, A; Braund, PS; Konig, IR; Hengstenberg, C; Hall, AS; Linsel-Nitschke, P; Kathiresan, S; Wright, B; Tregouet, DA; Cambien, F; Bruse, P; Aherrahrou, Z; Wagner, AK; Stark, K; Schwartz, SM; Salomaa, V; Elosua, R; Melander, O; Voight, BF; O'Donnell, CJ; Peltonen, L; Siscovick, DS; Altshuler, D; Merlini, PA; Peyvandi, F; Bernardinelli, L; Ardissino, D; Schillert, A; Blankenberg, S; Zeller, T; Wild, P; Schwarz, DF; Tiret, L; Perret, C; Schreiber, S; El Mokhtari, NE; Schafer, A; Marz, W; Renner, W; Bugert, P; Kluter, H; Schrezenmeir, J; Rubin, D; Ball, SG; Balmforth, AJ; Wichmann, HE; Meitinger, T; Fischer, M; Meisinger, C; Baumert, J; Peters, A; Ouwehand, WH; Deloukas, P; Thompson, JR; Ziegler, A; Samani, NJ; Schunkert, H				Erdmann, Jeanette; Grosshennig, Anika; Braund, Peter S.; Koenig, Inke R.; Hengstenberg, Christian; Hall, Alistair S.; Linsel-Nitschke, Patrick; Kathiresan, Sekar; Wright, Ben; Tregouet, David-Alexandre; Cambien, Francois; Bruse, Petra; Aherrahrou, Zouhair; Wagner, Arnika K.; Stark, Klaus; Schwartz, Stephen M.; Salomaa, Veikko; Elosua, Roberto; Melander, Olle; Voight, Benjamin F.; O'Donnell, Christopher J.; Peltonen, Leena; Siscovick, David S.; Altshuler, David; Merlini, Piera Angelica; Peyvandi, Flora; Bernardinelli, Luisa; Ardissino, Diego; Schillert, Arne; Blankenberg, Stefan; Zeller, Tanja; Wild, Philipp; Schwarz, Daniel F.; Tiret, Laurence; Perret, Claire; Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne; Maerz, Winfried; Renner, Wilfried; Bugert, Peter; Klueter, Harald; Schrezenmeir, Juergen; Rubin, Diana; Ball, Stephen G.; Balmforth, Anthony J.; Wichmann, H-Erich; Meitinger, Thomas; Fischer, Marcus; Meisinger, Christa; Baumert, Jens; Peters, Annette; Ouwehand, Willem H.; Deloukas, Panos; Thompson, John R.; Ziegler, Andreas; Samani, Nilesh J.; Schunkert, Heribert		Italian Atherosclerosis Thrombosis; Myocardial Infarction Genetics Con; Wellcome Trust Case Control Consor; Cardiogenics Consortium	New susceptibility locus for coronary artery disease on chromosome 3q22.3	NATURE GENETICS			English	Article							ASSOCIATION; GENOME	We present a three-stage analysis of genome-wide SNP data in 1,222 German individuals with myocardial infarction and 1,298 controls, in silico replication in three additional genome-wide datasets of coronary artery disease (CAD) and subsequent replication in similar to 25,000 subjects. We identified one new CAD risk locus on 3q22.3 in MRAS (P = 7.44 x 10(-13); OR = 1.15, 95% CI = 1.11-1.19), and suggestive association with a locus on 12q24.31 near HNF1A-C12orf43 (P = 4.81 x 10(-7); OR = 1.08, 95% CI = 1.05-1.11).	[Erdmann, Jeanette; Grosshennig, Anika; Linsel-Nitschke, Patrick; Bruse, Petra; Aherrahrou, Zouhair; Wagner, Arnika K.; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Grosshennig, Anika; Koenig, Inke R.; Schillert, Arne; Schwarz, Daniel F.; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Ctr, Glenfield Hosp, Leicester LE3 9QP, Leics, England; [Hengstenberg, Christian; Stark, Klaus; Fischer, Marcus] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Hall, Alistair S.; Ball, Stephen G.; Balmforth, Anthony J.] Univ Leeds, LIGHT, Leeds LS1 3EX, W Yorkshire, England; [Kathiresan, Sekar] Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Ctr Human Genet Res, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wright, Ben; Thompson, John R.] Univ Leicester, Dept Hlth Sci & Genet, Leicester LE1 7RH, Leics, England; [Tregouet, David-Alexandre; Cambien, Francois; Tiret, Laurence; Perret, Claire] Univ Paris 06, INSERM, UMR S 525, Paris, France; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98109 USA; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Gen Med, Seattle, WA 98109 USA; [Salomaa, Veikko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Chron Dis Epidemiol Unit, FI-00271 Helsinki, Finland; [Elosua, Roberto] Inst Municipal Invest Med, Cardiovasc Epidemiol & Genet Grp, Barcelona 08036, Spain; [Elosua, Roberto] Ciber Epidemiol & Salud Publ, CIBERESP, Barcelona, Spain; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, SE-20502 Malmo, Sweden; [Voight, Benjamin F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [O'Donnell, Christopher J.] NHLBI, NIH, Bethesda, MD 20824 USA; [Peltonen, Leena; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02115 USA; [Altshuler, David] Harvard Univ, Sch Med, Ctr Human Genet Res, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Merlini, Piera Angelica] Azienda Osped Niguarda Ca Granda, Div Cardiol, I-20162 Milan, Italy; [Peyvandi, Flora] Univ Milan, Osped Maggiore Mangiagalli & Regina Elena, Fdn Ist Ricovera & Cura Carattere Sci, Dept Internal Med & Med Special, I-20162 Milan, Italy; [Bernardinelli, Luisa] Univ Pavia, Dept Appl Hlth Sci, I-27100 Pavia, Italy; [Bernardinelli, Luisa] MRC, Biostat Unit, Cambridge CB2 0SR, England; [Ardissino, Diego] Univ Parma, Azienda Osped, Div Cardiol, I-43100 Parma, Italy; [Blankenberg, Stefan; Zeller, Tanja; Wild, Philipp] Johannes Gutenberg Univ Mainz, Dept Med 2, D-55099 Mainz, Germany; [Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne] Univ Kiel, Inst Klin Mol Biol, D-24118 Kiel, Germany; [Maerz, Winfried] Synlab Ctr Lab Diagnost Heidelberg, D-69037 Heidelberg, Germany; [Renner, Wilfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Maerz, Winfried] Univ Heidelberg, Dept Publ Hlth Social & Prevent Med, D-69117 Heidelberg, Germany; [Bugert, Peter; Klueter, Harald] Univ Heidelberg, Inst Transfus Med & Immunol, D-69117 Heidelberg, Germany; [Bugert, Peter; Klueter, Harald] Med Fac Mannheim, D-68131 Mannheim, Germany; [Schrezenmeir, Juergen; Rubin, Diana] Inst Physiol & Biochem Ernahrung, Bundesforsch Sanstalt Ernahrung & Lebensmittel, D-24118 Kiel, Germany; [Wichmann, H-Erich; Meisinger, Christa; Baumert, Jens; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Wichmann, H-Erich] LMU, Inst Med Informat Sci Biometry & Epidemiol, D-80539 Munich, Germany; [Meitinger, Thomas] Deutsch Forschungszentrum Umwelt & Gesundheit, Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Humangenet, D-80333 Munich, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Lubeck; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Regensburg; University of Leeds; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Finland National Institute for Health & Welfare; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Lund University; Skane University Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wellcome Trust Sanger Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Milan; University of Pavia; MRC Biostatistics Unit; University of Parma; University Hospital of Parma; Johannes Gutenberg University of Mainz; University of Kiel; SYNLAB Group; Medical University of Graz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Cambridge	Erdmann, J (corresponding author), Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany.	j.erdmann@cardiogenics.eu	Stark, Klaus/L-7367-2013; Stark, Klaus/D-3813-2009; Voight, Benjamin/F-1775-2011; Cambien, Francois/AAP-9751-2020; Erdmann, Jeanette/P-7513-2014; Meitinger, Thomas/O-1318-2015; Peters, Annette/A-6117-2011; Tregouet, David-Alexandre/E-3961-2016; Altshuler, David M/A-4476-2009; Peyvandi, Flora/AAK-7437-2020; König, Inke R/A-4544-2009; Wang, Weili/D-1546-2011; Ardissino, Diego/AAC-4041-2022; Hall, Alistair/K-1953-2019; Bernardinelli, Luisa/AAL-5750-2021; Wild, Philipp S./M-2106-2019; Trégouët, David-Alexandre/P-9210-2019; Meisinger, Christine/B-5358-2014; Hengstenberg, Christian/U-5485-2019; Erdmann, Jeanette/A-4417-2009; Wichmann, Heinz Erich/AAA-5695-2022; Deloukas, Panos/B-2922-2013; Ziegler, Andreas/G-4246-2012	Stark, Klaus/0000-0002-7832-1942; Stark, Klaus/0000-0002-7832-1942; Erdmann, Jeanette/0000-0002-4486-6231; Peters, Annette/0000-0001-6645-0985; Altshuler, David M/0000-0002-7250-4107; Peyvandi, Flora/0000-0001-7423-9864; König, Inke R/0000-0003-0504-6465; Trégouët, David-Alexandre/0000-0001-9084-7800; Deloukas, Panos/0000-0001-9251-070X; Meisinger, Christa/0000-0002-9026-6544; Voight, Benjamin/0000-0002-6205-9994; Wagner, Arnika/0000-0002-0339-8259; Zeller, Tanja/0000-0003-3379-2641; solinas, emilia/0000-0003-3532-1317; Schaefer, Arne/0000-0001-5816-6765; Meitinger, Thomas/0000-0002-8838-8403; Wild, Philipp/0000-0003-4413-9752; Ziegler, Andreas/0000-0002-8386-5397; Melander, Olle/0000-0002-2581-484X; Hall, Alistair/0000-0003-0306-7887; Aherrahrou, Zouhair/0000-0002-1241-8733	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676, R01HL056931] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Medical Research Council Funding Source: Medline; NCRR NIH HHS [U54 RR020278, U54RR020278] Funding Source: Medline; NHLBI NIH HHS [R01 HL056931-02, R01HL087676, R01 HL056931-03, R01 HL087676, R01 HL056931-04] Funding Source: Medline; Wellcome Trust [077011, 089061, 076113] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome Trust)		*ARTH THROMB VASC, 2003, CIRCULATION, V107, P111; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Yoshikawa Y, 2007, MOL BIOL CELL, V18, P2949, DOI 10.1091/mbc.E07-03-0250	14	366	379	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2009	41	3					280	282		10.1038/ng.307	http://dx.doi.org/10.1038/ng.307			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198612	Green Accepted			2022-12-25	WOS:000263640200006
J	Jiao, YL; Tausta, SL; Gandotra, N; Sun, N; Liu, T; Clay, NK; Ceserani, T; Chen, MQ; Ma, LG; Holford, M; Zhang, HY; Zhao, HY; Deng, XW; Nelson, T				Jiao, Yuling; Tausta, S. Lori; Gandotra, Neeru; Sun, Ning; Liu, Tie; Clay, Nicole K.; Ceserani, Teresa; Chen, Meiqin; Ma, Ligeng; Holford, Matthew; Zhang, Hui-yong; Zhao, Hongyu; Deng, Xing-Wang; Nelson, Timothy			A transcriptome atlas of rice cell types uncovers cellular, functional and developmental hierarchies	NATURE GENETICS			English	Article							ABSCISIC-ACID RECEPTOR; EXPRESSION PATTERNS; MICROARRAY ANALYSIS; GENE-EXPRESSION; GENOME-WIDE; ARABIDOPSIS; IDENTIFICATION; GIBBERELLIN; DOMAINS; COMPLEX	The functions of the plant body rely on interactions among distinct and nonequivalent cell types. The comparison of transcriptomes from different cell types should expose the transcriptional networks that underlie cellular attributes and contributions. Using laser microdissection and microarray profiling, we have produced a cell type transcriptome atlas that includes 40 cell types from rice (Oryza sativa) shoot, root and germinating seed at several developmental stages, providing patterns of cell specificity for individual genes and gene classes. Cell type comparisons uncovered previously unrecognized properties, including cell-specific promoter motifs and coexpressed cognate binding factor candidates, interaction partner candidates and hormone response centers. We inferred developmental regulatory hierarchies of gene expression in specific cell types by comparison of several stages within root, shoot and embryo.	[Jiao, Yuling; Tausta, S. Lori; Gandotra, Neeru; Liu, Tie; Clay, Nicole K.; Ceserani, Teresa; Chen, Meiqin; Ma, Ligeng; Zhang, Hui-yong; Deng, Xing-Wang; Nelson, Timothy] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Jiao, Yuling; Tausta, S. Lori; Gandotra, Neeru; Liu, Tie; Clay, Nicole K.; Ceserani, Teresa; Chen, Meiqin; Ma, Ligeng; Zhang, Hui-yong; Deng, Xing-Wang; Nelson, Timothy] Peking Univ, Coll Life Sci, Peking Yale Joint Res Ctr Plant Mol Genet & Agrob, Beijing 100871, Peoples R China; [Sun, Ning; Holford, Matthew; Zhao, Hongyu] Yale Univ, Ctr Stat Genom & Proteom, New Haven, CT 06520 USA	Yale University; Peking University; Yale University	Nelson, T (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	timothy.nelson@yale.edu	Liu, Tie/AAT-6012-2020; Deng, Xing Wang/ABF-4107-2020; Tausta, Lori/GXH-7773-2022; Jiao, Yuling/A-5489-2011	Liu, Tie/0000-0003-0159-8270; Jiao, Yuling/0000-0002-1189-1676; Tausta, Lori/0000-0003-0720-1182	US National Science Foundation Plant Genome Program [DBI-0325821]; Peking-Yale Monsanto Fellowships	US National Science Foundation Plant Genome Program(National Science Foundation (NSF)); Peking-Yale Monsanto Fellowships	We thank N. Li for valuable database advice and assistance and P. Wu (Zhejiang University) for the rice root micrograph in Figure 3. This work was supported by US National Science Foundation Plant Genome Program grant DBI-0325821 to T. N., X.-W. D. and H. Z. T. L. and M. C. were supported in part by Peking-Yale Monsanto Fellowships.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Carland FM, 2004, PLANT CELL, V16, P1263, DOI 10.1105/tpc.021030; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Coustry F, 1998, BIOCHEM J, V331, P291, DOI 10.1042/bj3310291; Du LM, 2007, GENOMICS, V89, P697, DOI 10.1016/j.ygeno.2007.02.001; Edwards D, 1998, PLANT PHYSIOL, V117, P1015, DOI 10.1104/pp.117.3.1015; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Ishiwatari Y, 1998, PLANTA, V205, P12, DOI 10.1007/s004250050291; Ito Y, 2006, GENE, V382, P57, DOI 10.1016/j.gene.2006.06.020; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; KULLDORFF M, 1998, SATSCAN V2 1 SOFTWAR; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Ma LG, 2005, GENOME RES, V15, P1274, DOI 10.1101/gr.3657405; Nelson T, 2008, CURR OPIN PLANT BIOL, V11, P567, DOI 10.1016/j.pbi.2008.06.006; Nelson T, 2006, ANNU REV PLANT BIOL, V57, P181, DOI 10.1146/annurev.arplant.56.032604.144138; Petricka JJ, 2007, PLANT PHYSIOL, V144, P173, DOI 10.1104/pp.106.093575; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Yang GX, 2004, MOL GENET GENOMICS, V271, P468, DOI 10.1007/s00438-004-0998-4; Yazaki J, 2004, PHYSIOL GENOMICS, V17, P87, DOI 10.1152/physiolgenomics.00201.2003; Yu HY, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r55; Zhan S, 2006, PLANT J, V45, P347, DOI 10.1111/j.1365-313X.2005.02619.x	30	182	188	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					258	263		10.1038/ng.282	http://dx.doi.org/10.1038/ng.282			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19122662				2022-12-25	WOS:000263091300030
J	Markoulaki, S; Hanna, J; Beard, C; Carey, BW; Cheng, AW; Lengner, CJ; Dausman, JA; Fu, DD; Gao, Q; Wu, S; Cassady, JP; Jaenisch, R				Markoulaki, Styliani; Hanna, Jacob; Beard, Caroline; Carey, Bryce W.; Cheng, Albert W.; Lengner, Christopher J.; Dausman, Jessica A.; Fu, Dongdong; Gao, Qing; Wu, Su; Cassady, John P.; Jaenisch, Rudolf			Transgenic mice with defined combinations of drug-inducible reprogramming factors	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; MOUSE; INDUCTION; OCT4; MYC	Proviruses carrying drug-inducible Oct4, Sox2, Klf4 and c-Myc used to derive 'primary' induced pluripotent stem (iPS) cells were segregated through germline transmission, generating mice and cells carrying subsets of the reprogramming factors. Drug treatment produced 'secondary' iPS cells only when the missing factor was introduced. This approach creates a defined system for studying reprogramming mechanisms and allows screening of genetically homogeneous cells for compounds that can replace any transcription factor required for iPS cell derivation.	[Markoulaki, Styliani; Hanna, Jacob; Beard, Caroline; Carey, Bryce W.; Cheng, Albert W.; Lengner, Christopher J.; Dausman, Jessica A.; Fu, Dongdong; Gao, Qing; Wu, Su; Cassady, John P.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Carey, Bryce W.; Cheng, Albert W.; Cassady, John P.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Lengner, Christopher/0000-0002-0574-5189; Cheng, Albert/0000-0003-2653-5743; Wu, Su/0000-0002-7317-3389	National Institutes of Health [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869]; Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Bell, R. Flannery and members of the Jaenisch lab for assistance and comments. R. J. is supported by grants from the National Institutes of Health: 5-RO1-HDO45022, 5-R37-CA084198 and 5-RO1-CA087869. J. H. is a Novartis Fellow by the Helen Hay Whitney Foundation.	Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944	12	80	87	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2009	27	2					169	171		10.1038/nbt.1520	http://dx.doi.org/10.1038/nbt.1520			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	405FT	19151700	Green Accepted			2022-12-25	WOS:000263209000023
J	Scott, SA; Selvy, PE; Buck, JR; Cho, HP; Criswell, TL; Thomas, AL; Armstrong, MD; Arteaga, CL; Lindsley, CW; Brown, HA				Scott, Sarah A.; Selvy, Paige E.; Buck, Jason R.; Cho, Hyekyung P.; Criswell, Tracy L.; Thomas, Ashley L.; Armstrong, Michelle D.; Arteaga, Carlos L.; Lindsley, Craig W.; Brown, H. Alex			Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness	NATURE CHEMICAL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR; HUMAN BREAST-CANCER; PROTEIN-KINASE-C; STIMULATED HUMAN NEUTROPHILS; PHOSPHATIDIC-ACID; MATRIX-METALLOPROTEINASE-9 SECRETION; FIBROSARCOMA CELLS; CATALYTIC-ACTIVITY; D ACTIVATION; IN-VITRO	Phospholipase D (PLD) is an essential enzyme responsible for the production of the lipid second messenger phosphatidic acid. Phosphatidic acid participates in both G protein-coupled receptor and receptor tyrosine kinase signal transduction networks. The lack of potent and isoform-selective inhibitors has limited progress in defining the cellular roles of PLD. We used a diversity-oriented synthetic approach and developed a library of PLD inhibitors with considerable pharmacological characterization. Here we report the rigorous evaluation of that library, which contains highly potent inhibitors, including the first isoform-selective PLD inhibitors. Specific members of this series inhibit isoforms with > 100-fold selectivity both in vitro and in cells. A subset of inhibitors was shown to block invasiveness in metastatic breast cancer models. These findings demonstrate the power of diversity-oriented synthesis combined with biochemical assays and mass spectrometric lipid profiling of cellular responses to develop the first isoform-selective PLD inhibitors-a new class of antimetastatic agents.	[Scott, Sarah A.; Selvy, Paige E.; Buck, Jason R.; Cho, Hyekyung P.; Thomas, Ashley L.; Armstrong, Michelle D.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Dept Pharmacol,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Criswell, Tracy L.; Arteaga, Carlos L.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Dept Canc Biol,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Arteaga, Carlos L.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Dept Med,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Dept Chem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brown, HA (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Dept Pharmacol,Vanderbilt Inst Chem Biol, 2220 Pierce Ave S, Nashville, TN 37232 USA.	alex.brown@vanderbilt.edu			A.B. Hancock Jr. Memorial Laboratory for Cancer Research; Vanderbilt Institute for Chemical Biology; US National Research Service [T32 GM007628]; US National Cancer Institute [CA09592]; Breast Cancer Specialized Program of Research Excellence [P50-CA98131]; NATIONAL CANCER INSTITUTE [T32CA009592, P50CA098131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER	A.B. Hancock Jr. Memorial Laboratory for Cancer Research; Vanderbilt Institute for Chemical Biology; US National Research Service; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Specialized Program of Research Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge outstanding support from A. Goodman ( mass spectrometry) and D. Myers ( data analysis and statistics) as well as R. Bruntz ( Vanderbilt University) for assisting with the generation of the HEK293-gfpPLD2 stable cell line. We thank C. Rouzer for helpful discussions. We gratefully acknowledge partial support for this project from the A.B. Hancock Jr. Memorial Laboratory for Cancer Research and the Vanderbilt Institute for Chemical Biology ( to H.A.B. and C.W.L.). P.E.S. was supported in part by a US National Research Service Award Training Fellowship (T32 GM007628). T. L. C. was partially supported by the US National Cancer Institute T32 grant CA09592 and the Breast Cancer Specialized Program of Research Excellence (P50-CA98131 to C.L.A.).	Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BOCCKINO SB, 1987, FEBS LETT, V225, P201, DOI 10.1016/0014-5793(87)81157-2; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Eisen SF, 2002, MOL PHARMACOL, V62, P911, DOI 10.1124/mol.62.4.911; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Ghiso JAA, 1997, INT J CANCER, V71, P881, DOI 10.1002/(SICI)1097-0215(19970529)71:5<881::AID-IJC29>3.0.CO;2-9; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hancock JF, 2007, NAT CELL BIOL, V9, P615, DOI 10.1038/ncb0607-615; Henage LG, 2006, J BIOL CHEM, V281, P3408, DOI 10.1074/jbc.M508800200; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; Levy BD, 2005, BRIT J PHARMACOL, V146, P344, DOI 10.1038/sj.bjp.0706338; McDonald LA, 2004, J NAT PROD, V67, P1565, DOI 10.1021/np049924g; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Noh DY, 2000, CANCER LETT, V161, P207, DOI 10.1016/S0304-3835(00)00612-1; PAI JK, 1994, ANTI-CANCER DRUG DES, V9, P363; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; Ponting CP, 1996, PROTEIN SCI, V5, P914; Puar MS, 2000, J ANTIBIOT, V53, P837, DOI 10.7164/antibiotics.53.837; REICH R, 1995, CLIN EXP METASTAS, V13, P134, DOI 10.1007/BF00133618; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Shen YJ, 2002, BIOCHEM BIOPH RES CO, V293, P201, DOI 10.1016/S0006-291X(02)00204-8; Tou JS, 2008, STEROIDS, V73, P216, DOI 10.1016/j.steroids.2007.10.002; Tou JS, 2001, CELL SIGNAL, V13, P191, DOI 10.1016/S0898-6568(01)00137-1; Uchida H, 1999, ANTICANCER RES, V19, P671; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Williger BT, 1999, J BIOL CHEM, V274, P735, DOI 10.1074/jbc.274.2.735; WILLIGER BT, 1995, J BIOL CHEM, V270, P29656; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xie Z, 1998, J BIOL CHEM, V273, P34679, DOI 10.1074/jbc.273.52.34679; Yamada Y, 2003, J MOL MED, V81, P126, DOI 10.1007/s00109-002-0411-x; Yang HY, 2003, PROTEIN SCI, V12, P2087, DOI 10.1110/ps.03192503; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	47	227	236	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					108	117		10.1038/nchembio.140	http://dx.doi.org/10.1038/nchembio.140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19136975	Green Accepted			2022-12-25	WOS:000263090700015
J	Kass, DA				Kass, David A.			Rescuing a failing heart: putting on the squeeze	NATURE MEDICINE			English	Editorial Material							FAILURE; THERAPY		Johns Hopkins Univ, Inst Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Kass, DA (corresponding author), Johns Hopkins Univ, Inst Med, Dept Med, Ross 858,720 Rutland Ave, Baltimore, MD 21205 USA.	dkass@jhmi.edu						CHAKIR K, CIRCULATION IN PRESS; Endoh M, 2006, EXPERT OPIN PHARMACO, V7, P2179, DOI 10.1517/14656566.7.16.2179; Kawase Y, 2008, NAT CLIN PRACT CARD, V5, P554, DOI 10.1038/ncpcardio1301; Landmesser Ulf, 2007, Curr Treat Options Cardiovasc Med, V9, P443, DOI 10.1007/s11936-007-0039-9; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Paolocci N, 2007, PHARMACOL THERAPEUT, V113, P442, DOI 10.1016/j.pharmthera.2006.11.002; Phan HM, 2007, TRENDS CARDIOVAS MED, V17, P215, DOI 10.1016/j.tcm.2007.07.001; Pleger ST, 2007, J CARD FAIL, V13, P401, DOI 10.1016/j.cardfail.2007.01.003; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Spragg DD, 2006, PROG CARDIOVASC DIS, V49, P26, DOI 10.1016/j.pcad.2006.05.001; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038	12	9	10	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2009	15	1					24	25		10.1038/nm0109-24	http://dx.doi.org/10.1038/nm0109-24			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	394DF	19129779				2022-12-25	WOS:000262425100013
J	Marumoto, T; Tashiro, A; Friedmann-Morvinski, D; Scadeng, M; Soda, Y; Gage, FH; Verma, IM				Marumoto, Tomotoshi; Tashiro, Ayumu; Friedmann-Morvinski, Dinorah; Scadeng, Miriam; Soda, Yasushi; Gage, Fred H.; Verma, Inder M.			Development of a novel mouse glioma model using lentiviral vectors	NATURE MEDICINE			English	Article							HUMAN-BRAIN; GLIOBLASTOMA-MULTIFORME; GENETIC ALTERATIONS; TRANSGENIC MICE; EGF RECEPTOR; EXPRESSION; CELLS; IDENTIFICATION; PROLIFERATION; ASTROCYTES	We report the development of a new method to induce glioblastoma multiforme in adult immunocompetent mice by injecting Cre-loxP-controlled lentiviral vectors expressing oncogenes. Cell type- or region-specific expression of activated forms of the oncoproteins Harvey-Ras and AKT in fewer than 60 glial fibrillary acidic protein-positive cells in the hippocampus, subventricular zone or cortex of mice heterozygous for the gene encoding the tumor suppressor Tp53 were tested. Mice developed glioblastoma multiforme when transduced either in the subventricular zone or the hippocampus. However, tumors were rarely detected when the mice were transduced in the cortex. Transplantation of brain tumor cells into naive recipient mouse brain resulted in the formation of glioblastoma multiforme-like tumors, which contained CD133(+) cells, formed tumorspheres and could differentiate into neurons and astrocytes. We suggest that the use of Cre-loxP-controlled lentiviral vectors is a novel way to generate a mouse glioblastoma multiforme model in a region- and cell type-specific manner in adult mice.	[Marumoto, Tomotoshi; Friedmann-Morvinski, Dinorah; Soda, Yasushi; Gage, Fred H.; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Marumoto, Tomotoshi] Kobe Med Ctr Natl Hosp Org, Dept Neurosurg, Suma Ku, Kobe, Hyogo 6540155, Japan; [Tashiro, Ayumu] Memory Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Med Tech Res Ctr, NO-7489 Trondheim, Norway; [Tashiro, Ayumu] Memory Norwegian Univ Sci & Technol, Ctr Biol, Med Tech Res Ctr, NO-7489 Trondheim, Norway; [Scadeng, Miriam] Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA	Salk Institute; Kobe City Medical Center General Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of California System; University of California San Diego	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu	Tashiro, Ayumu/Z-2900-2019; Tashiro, Ayumu/A-2675-2008	Tashiro, Ayumu/0000-0001-7967-7409; Tashiro, Ayumu/0000-0001-7967-7409; Scadeng, Miriam/0000-0002-9593-2956; Friedmann-Morvinski, Dinorah/0000-0002-6394-9876	American Brain Tumor Association; US National Institutes of Health; H. N. and Frances C. Berger Foundation; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER	American Brain Tumor Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); H. N. and Frances C. Berger Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Shaw for discussions and critical reading of the manuscript; N. Varki and H. Powell for pathological analyses; S. Yla-Herttuala, K. Suzuki, N. Tanaka, G. Pao, A. Parker and H. Suh for useful discussions; T. Sawai, G. Estepa and M. Lawrence for technical assistance; M. Schmitt and B. Coyne for administrative assistance; and S. Withoff (St. Jude Hospital), V. Tergaonkar (Bioprocessing Technology Institute), O. Singer (Salk Institute) and G. Wahl (Salk Institute) for providing pSETB mRFP1, pGEM H-RasV12, p156RRLsin PPTCMVIRESPRE myr-AKT vectors and Tp53<SUP>-/-</SUP> mice, respectively. T. M. is supported by the American Brain Tumor Association. I. M. V. is an American Cancer Society Professor of Molecular Biology and is supported in part by grants from the US National Institutes of Health and the H. N. and Frances C. Berger Foundation. The project described was supported in part by the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; FINKELSTEIN SD, 1994, NEUROSURGERY, V34, P136; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; Hesselager G, 2003, NEUROSURGERY, V53, P685, DOI 10.1227/01.NEU.0000081304.57547.B5; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; HOUCHENS DP, 1983, EUR J CANCER CLIN ON, V19, P799, DOI 10.1016/0277-5379(83)90012-3; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LANTOS PL, 1976, EXPERIENTIA, V32, P1467, DOI 10.1007/BF01937439; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Uhrbom L, 1998, CANCER RES, V58, P5275; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	35	224	232	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2009	15	1					110	116		10.1038/nm.1863	http://dx.doi.org/10.1038/nm.1863			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	394DF	19122659	Green Accepted			2022-12-25	WOS:000262425100026
J	Wong, CH; Chan, H; Ho, CY; Lai, SK; Chan, KS; Koh, CG; Li, HY				Wong, Chi-Hang; Chan, Hei; Ho, Chin-Yee; Lai, Soak-Kuan; Chan, Kheng-Sze; Koh, Cheng-Gee; Li, Hoi-Yeung			Apoptotic histone modification inhibits nuclear transport by regulating RCC1	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; GUANINE-NUCLEOTIDE EXCHANGE; CHROMOSOME CONDENSATION; STERILE-20 KINASE; CELL-NUCLEUS; LIVING CELLS; RAN; CHROMATIN; IMPORT; PHOSPHORYLATION	A number of signalling pathways have been identified that regulate apoptosis, but the mechanism that initiates apoptosis remains incompletely understood. We have found that the nuclear RanGTP level is diminished during the early stages of apoptosis, which correlates with immobilization of RCC1 on the chromosomes. Furthermore, the expression of phosphomimetic histone H2B or caspase-activated Mst1 immobilizes RCC1 and causes reduction of nuclear RanGTP levels, which leads to inactivation of the nuclear transport machinery. As a consequence, nuclear localization signal (NLS)-containing proteins, including NF-kappa B-p65, remain bound to importins alpha and beta in the cytoplasm. Knocking down Mst1 allows resumption of nuclear transport and the nuclear entry of NF-kappa B-p65, which have important roles in rescuing cells from apoptosis. Therefore, we propose that RCC1 reads the histone code created by caspase-activated Mst1 to initiate apoptosis by reducing the level of RanGTP in the nucleus.	[Wong, Chi-Hang; Chan, Hei; Ho, Chin-Yee; Lai, Soak-Kuan; Chan, Kheng-Sze; Koh, Cheng-Gee; Li, Hoi-Yeung] Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Cell & Mol Biol, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Koh, CG (corresponding author), Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Cell & Mol Biol, Singapore 637551, Singapore.	cgkoh@ntu.edu.sg; hyli@ntu.edu.sg	Wong, Chi Hang/C-6909-2015; Li Hoi Yeung, ./A-2218-2011; Wong, Chi Hang/ABE-8673-2021; Koh, Cheng Gee/A-2215-2011	Wong, Chi Hang/0000-0003-4157-6287; Wong, Chi Hang/0000-0003-4157-6287; Koh, Cheng Gee/0000-0003-1905-8010; Li, Hoi Yeung/0000-0002-8603-1953; Chan, Anna/0000-0003-2176-5734	Academic Research Fund; Ministry of Education, Singapore [ARC 7/06]; Biomedical Research Council, A*STAR, Singapore [05/1/22/19/388]	Academic Research Fund(Ministry of Education, Singapore); Ministry of Education, Singapore(Ministry of Education, Singapore); Biomedical Research Council, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Academic Research Fund, Ministry of Education, Singapore (ARC 7/06) and Biomedical Research Council, A*STAR, Singapore (05/1/22/19/388).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, METHOD ENZYMOL, V257, P135; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cushman I, 2004, MOL BIOL CELL, V15, P245, DOI 10.1091/mbc.e03-06-0409; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; FERRANDOMAY E, 2005, CELL DEATH DIFFER; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kihlmark M, 2004, EXP CELL RES, V293, P346, DOI 10.1016/j.yexcr.2003.10.019; Kihlmark M, 2001, J CELL SCI, V114, P3643; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Komeili A, 2001, ANNU REV GENET, V35, P341, DOI 10.1146/annurev.genet.35.102401.090720; Li HN, 2003, J CELL BIOL, V160, P635, DOI 10.1083/jcb.200211004; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Nomura M, 1999, CANCER RES, V59, P5542; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; TACHIBANA T, 1994, J BIOL CHEM, V269, P24542; UCHIDA S, 1990, MOL CELL BIOL, V10, P577, DOI 10.1128/MCB.10.2.577; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Wang CW, 2004, J ASSIST REPROD GEN, V21, P163, DOI 10.1023/B:JARG.0000031249.37862.3a	36	49	51	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					36	U65		10.1038/ncb1810	http://dx.doi.org/10.1038/ncb1810			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060893				2022-12-25	WOS:000262157000009
J	Eirew, P; Stingl, J; Raouf, A; Turashvili, G; Aparicio, S; Emerman, JT; Eaves, CJ				Eirew, Peter; Stingl, John; Raouf, Afshin; Turashvili, Gulisa; Aparicio, Samuel; Emerman, Joanne T.; Eaves, Connie J.			A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability	NATURE MEDICINE			English	Article							BREAST; GLAND; PURIFICATION; VITRO	Previous studies have demonstrated that normal mouse mammary tissue contains a rare subset of mammary stem cells. We now describe a method for detecting an analogous subpopulation in normal human mammary tissue. Dissociated cells are suspended with fibroblasts in collagen gels, which are then implanted under the kidney capsule of hormone-treated immunodeficient mice. After 2-8 weeks, the gels contain bilayered mammary epithelial structures, including luminal and myoepithelial cells, their in vitro clonogenic progenitors and cells that produce similar structures in secondary transplants. The regenerated clonogenic progenitors provide an objective indicator of input mammary stem cell activity and allow the frequency and phenotype of these human mammary stem cells to be determined by limiting-dilution analysis. This new assay procedure sets the stage for investigations of mechanisms regulating normal human mammary stem cells (and possibly stem cells in other tissues) and their relationship to human cancer stem cell populations.	[Eirew, Peter; Stingl, John; Raouf, Afshin; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Turashvili, Gulisa; Aparicio, Samuel] British Columbia Canc Agcy, Mol Oncol & Breast Canc Program, Vancouver, BC V5Z 1L3, Canada; [Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Emerman, Joanne T.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca	Turashvili, Gulisa/A-6056-2008	Turashvili, Gulisa/0000-0001-6125-5865; Aparicio, Samuel/0000-0002-0487-9599	Terry Fox Laboratory; Centre for Translational and Applied Genomics; Genome British Columbia and Genome Canada; Canadian Stem Cell Network; Canadian Breast Cancer Foundation British Columbia and Yukon Division; Canada Research Chair in Molecular Oncology; Medical Research Council [G0300723, G0300723B] Funding Source: researchfish; MRC [G0300723] Funding Source: UKRI	Terry Fox Laboratory; Centre for Translational and Applied Genomics; Genome British Columbia and Genome Canada; Canadian Stem Cell Network; Canadian Breast Cancer Foundation British Columbia and Yukon Division; Canada Research Chair in Molecular Oncology(Canada Research Chairs); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	C3H 10T<SUP>1/2</SUP> mouse embryonic fibroblasts were a kind gift from G. Cunha, University of California, San Francisco. The authors acknowledge the excellent technical contributions of D. Wilkinson, G. Edin, the staff of the Flow Cytometry Facility of the Terry Fox Laboratory and the Centre for Translational and Applied Genomics. Mammoplasty tissue was obtained with the assistance of J. Sproul, P. Lennox, N. Van Laeken and R. Warren. This project was funded by grants from Genome British Columbia and Genome Canada, the Canadian Stem Cell Network and the Canadian Breast Cancer Foundation British Columbia and Yukon Division. P. E. was a recipient of a US Department of Defense Breast Cancer Research Program Studentship, a Terry Fox Foundation Research Studentship from the National Cancer Institute of Canada, a Canadian Imperial Bank of Commerce interdisciplinary award and a Canadian Stem Cell Network Studentship. J. S. held a Canadian Breast Cancer Foundation British Columbia and Yukon Division Fellowship and a Canadian National Science and Engineering Research Council Industrial Fellowship. A. R. held a Canadian Breast Cancer Foundation British Columbia and Yukon Division Fellowship and a Canadian Institutes of Health Research Fellowship. G. T. holds a Canadian Institutes of Health Research Pathology Training Fellowship. S. A. is supported by a Canada Research Chair in Molecular Oncology. The Centre for Translational and Applied Genomics laboratory is supported by a Canadian Institutes for Health Research Resource award.	Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; EAVES CJ, 1991, SEMIN HEMATOL, V28, P126; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Kordon EC, 1998, DEVELOPMENT, V125, P1921; KOUKOULIS GK, 1991, AM J PATHOL, V139, P787; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; LAIDLAW IJ, 1995, ENDOCRINOLOGY, V136, P164, DOI 10.1210/en.136.1.164; LATZA U, 1990, J CLIN PATHOL, V43, P213, DOI 10.1136/jcp.43.3.213; MILLER CL, 2002, METHODS MOL MED HEMA, P123; OHARE MJ, 1991, DIFFERENTIATION, V46, P209, DOI 10.1111/j.1432-0436.1991.tb00883.x; Parmar H, 2002, ENDOCRINOLOGY, V143, P4886, DOI 10.1210/en.2002-220570; PLOEMACHER RE, 1989, BLOOD, V74, P2755; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; RICHARDS J, 1983, METHODS CELL SCI, V8, P31; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; STINGL J, 2005, METHODS MOL BIOL BAS, P249; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Tsai YC, 1996, CANCER RES, V56, P402; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114	24	238	245	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1384	1389		10.1038/nm.1791	http://dx.doi.org/10.1038/nm.1791			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029987				2022-12-25	WOS:000261393600025
J	Garcin, ED; Arvai, AS; Rosenfeld, RJ; Kroeger, MD; Crane, BR; Andersson, G; Andrews, G; Hamley, PJ; Mallinder, PR; Nicholls, DJ; St-Gallay, SA; Tinker, AC; Gensmantel, NP; Mete, A; Cheshire, DR; Connolly, S; Stuehr, DJ; Aberg, A; Wallace, AV; Tainer, JA; Getzoff, ED				Garcin, Elsa D.; Arvai, Andrew S.; Rosenfeld, Robin J.; Kroeger, Matt D.; Crane, Brian R.; Andersson, Gunilla; Andrews, Glen; Hamley, Peter J.; Mallinder, Philip R.; Nicholls, David J.; St-Gallay, Stephen A.; Tinker, Alan C.; Gensmantel, Nigel P.; Mete, Antonio; Cheshire, David R.; Connolly, Stephen; Stuehr, Dennis J.; Aberg, Anders; Wallace, Alan V.; Tainer, John A.; Getzoff, Elizabeth D.			Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; OXYGENASE DOMAIN; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ACTIVE-SITE; BINDING; 2-AMINOPYRIDINES; SPECIFICITY; MODELS; PTERIN	Nitric oxide synthase ( NOS) enzymes synthesize nitric oxide, a signal for vasodilatation and neurotransmission at low concentrations and a defensive cytotoxin at higher concentrations. The high active site conservation among all three NOS isozymes hinders the design of selective NOS inhibitors to treat inflammation, arthritis, stroke, septic shock and cancer. Our crystal structures and mutagenesis results identified an isozyme-specific induced-fit binding mode linking a cascade of conformational changes to a new specificity pocket. Plasticity of an isozyme-specific triad of distant second-and third-shell residues modulates conformational changes of invariant first-shell residues to determine inhibitor selectivity. To design potent and selective NOS inhibitors, we developed the anchored plasticity approach: anchor an inhibitor core in a conserved binding pocket, then extend rigid bulky substituents toward remote specificity pockets, which become accessible upon conformational changes of flexible residues. This approach exemplifies general principles for the design of selective enzyme inhibitors that overcome strong active site conservation.	[Garcin, Elsa D.; Arvai, Andrew S.; Rosenfeld, Robin J.; Kroeger, Matt D.; Crane, Brian R.; Tainer, John A.; Getzoff, Elizabeth D.] Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Andersson, Gunilla; Aberg, Anders] AstraZeneca R&D, AstraZeneca Struct Chem Lab, S-43183 Molndal, Sweden; [Andrews, Glen; Hamley, Peter J.; Mallinder, Philip R.; Nicholls, David J.; St-Gallay, Stephen A.; Tinker, Alan C.; Gensmantel, Nigel P.; Mete, Antonio; Cheshire, David R.; Connolly, Stephen; Wallace, Alan V.] AstraZeneca R&D Charnwood, Loughborough LE11 5RH, Leics, England; [Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Garcin, Elsa D.; Arvai, Andrew S.; Rosenfeld, Robin J.; Kroeger, Matt D.; Crane, Brian R.; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; AstraZeneca; AstraZeneca; Cleveland Clinic Foundation; Scripps Research Institute	Garcin, ED (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	egarcin@umbc.edu; edg@scripps.edu	Tainer, John/GWQ-4878-2022; Garcin, Elsa D/C-1556-2013	Tainer, John/0000-0003-1659-2429; Garcin, Elsa D/0000-0003-0501-8421; Hamley, Peter/0000-0002-1565-7342	US National Institutes of Health; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Panda (Cleveland Clinic) and S. Ghosh (Cleveland Clinic) for preparation of the mouse iNOSox and bovine eNOSox proteins used in this study. Part of this work is based on research conducted at CHESS, SSRL, ESRF and MAX-LAB (Lund University). This work was supported in part by US National Institutes of Health grants (E.D.Getzoff and D.J.S.), and by the Skaggs Institute for Chemical Biology (E.D.Garcin).	ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bian K, 2003, FRONT BIOSCI-LANDMRK, V8, pD264, DOI 10.2741/997; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHESHIRE D, 2000, Patent No. 2000064904; Connolly S, 2004, J MED CHEM, V47, P3320, DOI 10.1021/jm031035n; CONNOLLY S, 2000, Patent No. 2000021934; Crane BR, 2000, BIOCHEMISTRY-US, V39, P4608, DOI 10.1021/bi992409a; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Duncan Andrew J., 2005, Molecular Aspects of Medicine, V26, P67, DOI 10.1016/j.mam.2004.09.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov R, 2003, J BIOL CHEM, V278, P45818, DOI 10.1074/jbc.M306030200; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Flinspach M, 2004, BIOCHEMISTRY-US, V43, P5181, DOI 10.1021/bi0361867; Flinspach ML, 2004, NAT STRUCT MOL BIOL, V11, P54, DOI 10.1038/nsmb704; Gachhui R, 1997, BIOCHEMISTRY-US, V36, P5097, DOI 10.1021/bi970331x; Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Hagmann WH, 2000, BIOORG MED CHEM LETT, V10, P1975, DOI 10.1016/S0960-894X(00)00389-9; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Ji HT, 2008, J AM CHEM SOC, V130, P3900, DOI 10.1021/ja0772041; Ji HT, 2003, J MED CHEM, V46, P5700, DOI 10.1021/jm030301u; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Li HY, 2005, BIOCHEMISTRY-US, V44, P15222, DOI 10.1021/bi0513610; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nathan Carl, 2004, Sci STKE, V2004, ppe52; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rosenfeld RJ, 2002, BIOCHEMISTRY-US, V41, P13915, DOI 10.1021/bi026313j; Sandstrom P, 2005, PANCREAS, V30, pE10; SHERMAN PA, 1993, BIOCHEMISTRY-US, V32, P11600, DOI 10.1021/bi00094a017; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; Strub A, 2006, MOL PHARMACOL, V69, P328, DOI 10.1124/mol.105.017087; Tafi A, 2006, CURR MED CHEM, V13, P1929, DOI 10.2174/092986706777585031; Thippeswamy T, 2006, HISTOL HISTOPATHOL, V21, P445, DOI 10.14670/HH-21.445; Tinker AC, 2006, CURR TOP MED CHEM, V6, P77, DOI 10.2174/156802606775270297; Tinker AC, 2003, J MED CHEM, V46, P913, DOI 10.1021/jm0255926; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; Zhu YQ, 2005, J AM CHEM SOC, V127, P858, DOI 10.1021/ja0445645	54	168	171	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2008	4	11					700	707		10.1038/nchembio.115	http://dx.doi.org/10.1038/nchembio.115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364CY	18849972	Green Accepted			2022-12-25	WOS:000260315000015
J	Gold, B; Deng, H; Bryk, R; Vargas, D; Eliezer, D; Roberts, J; Jiang, X; Nathan, C				Gold, Ben; Deng, Haiteng; Bryk, Ruslana; Vargas, Diana; Eliezer, David; Roberts, Julia; Jiang, Xiuju; Nathan, Carl			Identification of a copper-binding metallothionein in pathogenic mycobacteria	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE; PROKARYOTIC METALLOTHIONEIN; ESCHERICHIA-COLI; IRON ACQUISITION; TUBERCULOSIS; ZINC; GENE; MACROPHAGES; LOCUS; CONSTRUCTION	A screen of a genomic library from Mycobacterium tuberculosis (Mtb) identified a small, unannotated open reading frame (MT0196) that encodes a 4.9-kDa, cysteine-rich protein. Despite extensive nucleotide divergence, the amino acid sequence is highly conserved among mycobacteria that are pathogenic in vertebrate hosts. We synthesized the protein and found that it preferentially binds up to six Cu(I) ions in a solvent-shielded core. Copper, cadmium and compounds that generate nitric oxide or superoxide induced the gene's expression in Mtb up to 1,000-fold above normal expression. The native protein bound copper within Mtb and partially protected Mtb from copper toxicity. We propose that the product of the MT0196 gene be named mycobacterial metallothionein (MymT). To our knowledge, MymT is the first metallothionein of a Gram-positive bacterium with a demonstrated function.	[Gold, Ben; Bryk, Ruslana; Roberts, Julia; Jiang, Xiuju; Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Deng, Haiteng] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Vargas, Diana] Publ Hlth Res Inst, Dept Mol Genet, Newark, NJ 07103 USA; [Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10065 USA	Cornell University; Rockefeller University; Cornell University; Cornell University; Cornell University	Nathan, C (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	cnathan@med.cornell.edu		Deng, Haiteng/0000-0001-9496-1280	US National Institutes of Health [AI 62559]; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG019391, R01AG019391, R01AG025440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Domaille and C. Chang (University of California, Berkeley); H. Erdjument-Bromage and P. Tempst (Protein Center, Sloan-Kettering Institute); P. Wille, A. Morrishow and S. Gross (Weill Medical College); T. Kapoor and J. Cherian (Rockefeller University); and M. Gurney, J. Singh and R. Samy (deCODE Chemistry) for help with experiments not included here. We thank J. Cox (University of California, San Francisco) and V. Rao and M. Glickman (Sloan Kettering Institute) for phages; N. Chandramouli (Rockefeller University) for synthesis of MymT; S. Ehrt, A. Ding and K. Rhee for critical review of the manuscript; and N. Brot, S. Marras, S. Walters, M. Monteleone and members of the labs of C. Nathan, S. Ehrt and A. Ding for advice. We thank the anonymous reviewers for important guidance. This work was supported by US National Institutes of Health grant AI 62559. The Department of Microbiology and Immunology of Weill Cornell Medical College is supported by the William Randolph Hearst Foundation.	Agranoff D, 1999, J EXP MED, V190, P717, DOI 10.1084/jem.190.5.717; Arthur JW, 2004, J PROTEOME RES, V3, P393, DOI 10.1021/pr034056e; BELTRAMINI M, 1981, FEBS LETT, V127, P201, DOI 10.1016/0014-5793(81)80204-9; Beltramini M, 1987, Experientia Suppl, V52, P237; Binet MRB, 2002, FEMS MICROBIOL LETT, V213, P121, DOI 10.1016/S0378-1097(02)00803-0; Blindauer CA, 2002, MOL MICROBIOL, V45, P1421, DOI 10.1046/j.1365-2958.2002.03109.x; Blindauer CA, 2001, P NATL ACAD SCI USA, V98, P9593, DOI 10.1073/pnas.171120098; Blindauer CA, 2007, J BIOL INORG CHEM, V12, P393, DOI 10.1007/s00775-006-0196-4; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ehrt S, 1997, J EXP MED, V186, P1885, DOI 10.1084/jem.186.11.1885; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; HAMER DH, 1985, SCIENCE, V228, P685, DOI 10.1126/science.3887570; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jacob C, 1998, BIOCHEM BIOPH RES CO, V248, P569, DOI 10.1006/bbrc.1998.9026; Jungblut PR, 2001, INFECT IMMUN, V69, P5905, DOI 10.1128/IAI.69.9.5905-5907.2001; KLAASSEN CD, 1994, ENVIRON HEALTH PERSP, V102, P141, DOI 10.2307/3431778; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; MORBY AP, 1993, NUCLEIC ACIDS RES, V21, P921, DOI 10.1093/nar/21.4.921; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Robinson NJ, 2001, ADV MICROB PHYSIOL, V44, P183, DOI 10.1016/S0065-2911(01)44014-8; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Ruan J, 1999, INFECT IMMUN, V67, P3276, DOI 10.1128/IAI.67.7.3276-3283.1999; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Schapiro JM, 2003, P NATL ACAD SCI USA, V100, P8496, DOI 10.1073/pnas.1033133100; Schmidt F, 2004, MOL CELL PROTEOMICS, V3, P24, DOI 10.1074/mcp.M300074-MCP200; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; TURNER JS, 1995, J IND MICROBIOL, V14, P259, DOI 10.1007/BF01569937; TURNER JS, 1993, J BIOL CHEM, V268, P4494; TURNER JS, 1995, J IND MICROBIOL, V14, P119, DOI 10.1007/BF01569893; Wagner D, 2005, MICROBIOL-SGM, V151, P323, DOI 10.1099/mic.0.27213-0; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Wu CHH, 1998, FEBS LETT, V439, P192, DOI 10.1016/S0014-5793(98)01373-8	46	149	154	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2008	4	10					609	616		10.1038/nchembio.109	http://dx.doi.org/10.1038/nchembio.109			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	349ZV	18724363	Green Accepted			2022-12-25	WOS:000259323100011
J	To, MD; Wong, CE; Karnezis, AN; Del Rosario, R; Di Lauro, R; Balmain, A				To, Minh D.; Wong, Christine E.; Karnezis, Anthony N.; Del Rosario, Reyno; Di Lauro, Roberto; Balmain, Allan			Kras regulatory elements and exon 4A determine mutation specificity in lung cancer	NATURE GENETICS			English	Article							K-RAS 4A; MOUSE SKIN CARCINOGENESIS; TUMOR SUSCEPTIBILITY; HA-RAS; N-RAS; MICE; GENE; PROGRESSION; ACTIVATION; EXPRESSION	Kras is the most frequently mutated ras family member in lung carcinomas(1,2), whereas Hras mutations are common in tumors from stratified epithelia such as the skin. Using a Hras knock-in mouse model(3), we demonstrate that specificity for Kras mutations in lung and Hras mutations in skin tumors is determined by local regulatory elements in the target ras genes. Although the Kras 4A isoform is dispensable for mouse development(4,5), it is the most important isoform for lung carcinogenesis in vivo and for the inhibitory effect of wild-type (WT) Kras on the mutant allele(6,7). Kras 4A expression is detected in a subpopulation of normal lung epithelial cells, but at very low levels in lung tumors, suggesting that it may not be required for tumor progression. The two Kras isoforms undergo different post-translational modifications(8); therefore, these findings can have implications for the design of therapeutic strategies for inhibiting oncogenic Kras activity in human cancers.	[To, Minh D.; Wong, Christine E.; Karnezis, Anthony N.; Del Rosario, Reyno; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94115 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA; [Di Lauro, Roberto] Staz Zool Anton Dohrn, I-80121 Naples, Italy; [Di Lauro, Roberto] Inst Genet Res Gaetano Salvatore IRGS, I-83031 Ariano Irpino, Italy	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Stazione Zoologica Anton Dohrn di Napoli	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94115 USA.	abalmain@cc.ucsf.edu	Di Lauro, Roberto/A-2746-2012	Di Lauro, Roberto/0000-0001-9493-3036	Sandler Foundation Postdoctoral Research Fellowship [CA111834, CA084244]; Swiss National Science Foundation (SNSF); Associazione Italiana per la ricerca sul cancro (AIRC); Bruce and Davina Isackson Foundation; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA111834] Funding Source: NIH RePORTER	Sandler Foundation Postdoctoral Research Fellowship; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Associazione Italiana per la ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Bruce and Davina Isackson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA111834 and CA084244 (A. B.). M. D. T. was supported in part by a Sandler Foundation Postdoctoral Research Fellowship. C. E. W. was supported by the Swiss National Science Foundation (SNSF). R. D. L. was supported by a grant of Associazione Italiana per la ricerca sul cancro (AIRC). A. B. acknowledges support from the Bruce and Davina Isackson Foundation and from the Barbara Bass Bakar Chair of Cancer Genetics. Phospho-Akt was provided by D. Stokoe (University of California San Francisco), and primary antibodies against CCA/CC10 were a gift from A. Mukherjee (National Institute of Child Health and Human Development, US National Institutes of Health).	BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BOS JL, 1989, CANCER RES, V49, P4682; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Diaz R, 2005, INT J CANCER, V113, P241, DOI 10.1002/ijc.20563; GUERRERO I, 1985, P NATL ACAD SCI USA, V82, P7810, DOI 10.1073/pnas.82.23.7810; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Li J, 2003, ONCOGENE, V22, P1243, DOI 10.1038/sj.onc.1206192; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Nagase H, 2003, CANCER RES, V63, P4849; NELSON MA, 1992, P NATL ACAD SCI USA, V89, P6398, DOI 10.1073/pnas.89.14.6398; Patek CE, 2008, EXP CELL RES, V314, P1105, DOI 10.1016/j.yexcr.2007.11.004; Pells S, 1997, ONCOGENE, V15, P1781, DOI 10.1038/sj.onc.1201354; Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; To MD, 2006, NAT GENET, V38, P926, DOI 10.1038/ng1836; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wang M, 2005, EXP LUNG RES, V31, P165, DOI 10.1080/01902140490495543; Wang Y, 2001, EXP LUNG RES, V27, P255, DOI 10.1080/019021401300054028; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	30	95	96	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1240	1244		10.1038/ng.211	http://dx.doi.org/10.1038/ng.211			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758463	Green Accepted			2022-12-25	WOS:000259651000026
J	Namy, O; Galopier, A; Martini, C; Matsufuji, S; Fabret, C; Rousset, JP				Namy, Olivier; Galopier, Aurelie; Martini, Cyrielle; Matsufuji, Senya; Fabret, Celine; Rousset, Jean-Pierre			Epigenetic control of polyamines by the prion [PSI(+)]	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; ORNITHINE DECARBOXYLASE; TRANSLATION TERMINATION; STOP CODON; GENETIC-VARIATION; ANTIZYME; YEAST; CONSERVATION; READTHROUGH; METABOLISM	Prion proteins are found in mammals and yeast, and can transmit diseases and encode heritable phenotypic traits(1). In Saccharomyces cerevisiae, eRF3, Rnq1, Ure2 and Swi1 are functional proteins with a soluble conformation that can switch to a non-functional, amyloid conformation denoted as [PSI(+)], [PIN(+)], [URE3] and [SWI(+)], respectively(2,3). The prion [PSI+] corresponds to an aggregated conformation of the translational release factor eRF3, which suppresses nonsense codons(2). [PSI(+)] modifies cellular fitness and induces several phenotypes according to the genetic background(4,5). An elegant series of studies has demonstrated that several [PSI(+)]-induced phenotypes occur as a consequence of decreased translational termination efficiency(6,7). However, the genes whose expression levels are controlled by [PSI(+)] remain largely unknown. Here, we show that [PSI(+)] enhances expression of antizyme, a negative regulator of cellular polyamines, by modulating the +1 frameshifting required for its expression(8). Our study also demonstrates that [PSI(+)] greatly affects cellular polyamines in yeast. We show that modification of the cellular content of polyamines by the prion accounts for half of the [PSI(+)]-induced phenotypes. Antizyme is the first protein to be described for which expression of its functional form is stimulated by [PSI(+)].	[Namy, Olivier; Galopier, Aurelie; Martini, Cyrielle; Fabret, Celine; Rousset, Jean-Pierre] IGM, CNRS, UMR 8621, F-91405 Orsay, France; [Namy, Olivier; Galopier, Aurelie; Martini, Cyrielle; Fabret, Celine; Rousset, Jean-Pierre] Univ Paris 11, F-91405 Orsay, France; [Matsufuji, Senya] Jikei Univ, Sch Med, Dept Mol Biol, Minato Ku, Tokyo 1058461, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Jikei University	Namy, O (corresponding author), IGM, CNRS, UMR 8621, F-91405 Orsay, France.	olivier.namy@igmors.u-psud.fr	Namy, olivier/B-8906-2008; Namy, Olivier/ABD-4379-2020	Namy, Olivier/0000-0002-1143-5961	Agence Nationale pour la Recherche [ANR-06-BLAN-0391-01]; Association Pour la Recherche sur le Cancer [3849]; Ministry of Education, Sports, Culture, Science and Technology of Japan; ARC; French Ministry of Education and Research (MENESR)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association Pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministry of Education, Sports, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ARC(Australian Research Council); French Ministry of Education and Research (MENESR)	We thank Hiroko Takizawa for technical assistance. English usage was corrected by Alex Edelman & Associates. This work was supported by grants from the Agence Nationale pour la Recherche to J.P.R. (ANR-06-BLAN-0391-01), the Association Pour la Recherche sur le Cancer to J.P.R. (Contract 3849) and by grants-in-aid to S. M. from the Ministry of Education, Sports, Culture, Science and Technology of Japan. O.N. was funded by a fellowship from the ARC for part of this study. A. G. is funded by a fellowship from the French Ministry of Education and Research (MENESR).	Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Karamysheva ZN, 2003, NUCLEIC ACIDS RES, V31, P5949, DOI 10.1093/nar/gkg789; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Morgan DML, 1999, MOL BIOTECHNOL, V11, P229, DOI 10.1007/BF02788682; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURAKAMI Y, 1989, EUR J BIOCHEM, V180, P181, DOI 10.1111/j.1432-1033.1989.tb14630.x; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Namy O, 2002, GENETICS, V161, P585; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Walters D, 1998, MICROBIOL RES, V153, P179, DOI 10.1016/S0944-5013(98)80038-4; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wilson MA, 2005, P NATL ACAD SCI USA, V102, P10244, DOI 10.1073/pnas.0504557102; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	32	87	87	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1069	1075		10.1038/ncb1766	http://dx.doi.org/10.1038/ncb1766			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160487				2022-12-25	WOS:000258910400012
J	Do, CB; Batzoglou, S				Do, Chuong B.; Batzoglou, Serafim			What is the expectation maximization algorithm?	NATURE BIOTECHNOLOGY			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; FREQUENCIES		[Do, Chuong B.; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University	Do, CB (corresponding author), Stanford Univ, Dept Comp Sci, 318 Campus Dr, Stanford, CA 94305 USA.	chuong@cs.stanford.edu						BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DEPIERRO AR, 1995, IEEE T MED IMAGING, V14, P132, DOI 10.1109/42.370409; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55	13	302	325	12	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2008	26	8					897	899		10.1038/nbt1406	http://dx.doi.org/10.1038/nbt1406			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	335WX	18688245				2022-12-25	WOS:000258325500023
J	McGowan, KA; Li, JZ; Park, CY; Beaudry, V; Tabor, HK; Sabnis, AJ; Zhang, W; Fuchs, H; de Angelis, MH; Myers, RM; Attardi, LD; Barsh, GS				McGowan, Kelly A.; Li, Jun Z.; Park, Christopher Y.; Beaudry, Veronica; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Fuchs, Helmut; de Angelis, Martin Hrabe; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.			Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects	NATURE GENETICS			English	Article							DIAMOND-BLACKFAN ANEMIA; PROTEIN S19; P53-DEPENDENT CHECKPOINT; DROSOPHILA-MELANOGASTER; CRE RECOMBINASE; MOUSE; MICE; GENE; PROLIFERATION; P53	Mutations in genes encoding ribosomal proteins cause the Minute phenotype in Drosophila and mice, and Diamond-Blackfan syndrome in humans. Here we report two mouse dark skin (Dsk) loci caused by mutations in Rps19 (ribosomal protein S19) and Rps20 (ribosomal protein S20). We identify a common pathophysiologic program in which p53 stabilization stimulates Kit ligand expression, and, consequently, epidermal melanocytosis via a paracrine mechanism. Accumulation of p53 also causes reduced body size and erythrocyte count. These results provide a mechanistic explanation for the diverse collection of phenotypes that accompany reduced dosage of genes encoding ribosomal proteins, and have implications for understanding normal human variation and human disease.	[McGowan, Kelly A.; Li, Jun Z.; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.] Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA; [Li, Jun Z.; Tabor, Holly K.; Myers, Richard M.] Stanford Univ, Stanford Human Genome Ctr, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Park, Christopher Y.] Stanford Univ, Dept Pathol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Beaudry, Veronica; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University	Barsh, GS (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014	de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Sabnis, Amit/0000-0002-2061-5139; Li, Jun/0000-0001-6727-0812	NIGMS NIH HHS [R01 GM068882] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068882] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alizadeh A, 2008, PIGM CELL MELANOMA R, V21, P63, DOI 10.1111/j.1755-148X.2007.00425.x; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Angelini M, 2007, HUM MOL GENET, V16, P1720, DOI 10.1093/hmg/ddm120; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; Chan EL, 2007, MOL CARCINOGEN, V46, P49, DOI 10.1002/mc.20192; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Flygare J, 2007, BLOOD, V109, P3152, DOI 10.1182/blood-2006-09-001222; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2006, BLOOD CELL MOL DIS, V36, P259, DOI 10.1016/j.bcmd.2005.12.002; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; MCCULLOC.EA, 1965, BLOOD-J HEMATOL, V26, P399, DOI 10.1182/blood.V26.4.399.399; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schultz J, 1929, GENETICS, V14, P366; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147	50	269	275	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					963	970		10.1038/ng.188	http://dx.doi.org/10.1038/ng.188			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18641651	Green Accepted			2022-12-25	WOS:000258026900012
J	Tsukiji, S; Miyagawa, M; Takaoka, Y; Tamura, T; Hamachi, I				Tsukiji, Shinya; Miyagawa, Masayoshi; Takaoka, Yousuke; Tamura, Tomonori; Hamachi, Itaru			Ligand-directed tosyl chemistry for protein labeling in vivo	NATURE CHEMICAL BIOLOGY			English	Article							CARBONIC-ANHYDRASE INHIBITORS; UNNATURAL AMINO-ACIDS; ISOZYME-IX; REACTIVITY; SURFACE; PROBES; DESIGN; CELLS; F-19	Here we describe a method for the site-selective attachment of synthetic molecules into specific 'endogenous' proteins in vivo using ligand-directed tosyl (LDT) chemistry. This approach was applied not only for chemically labeling proteins in living cells, tissues and mice but also for constructing a biosensor directly inside cells without genetic engineering. These data establish LDT chemistry as a new tool for the study and manipulation of biological systems.	[Tsukiji, Shinya; Miyagawa, Masayoshi; Takaoka, Yousuke; Tamura, Tomonori; Hamachi, Itaru] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto, Japan; [Hamachi, Itaru] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Hamachi, I (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto, Japan.	ihamachi@sbchem.kyoto-u.ac.jp	Takaoka, Yousuke/GQR-1838-2022	Yousuke, Takaoka/0000-0003-1559-4924				Adam GC, 2002, NAT BIOTECHNOL, V20, P805, DOI 10.1038/nbt714; Adam GC, 2001, CHEM BIOL, V8, P81, DOI 10.1016/S1074-5521(00)90060-7; Casey JR, 2004, J MED CHEM, V47, P2337, DOI 10.1021/jm031079w; Chen G, 2003, J AM CHEM SOC, V125, P8130, DOI 10.1021/ja034287m; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Danielson MA, 1996, ANNU REV BIOPH BIOM, V25, P163, DOI 10.1146/annurev.bb.25.060196.001115; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Hamachi I, 2000, J AM CHEM SOC, V122, P12065, DOI 10.1021/ja002044d; Harvey JH, 2008, CHEMBIOCHEM, V9, P191, DOI 10.1002/cbic.200700570; Koshi Y, 2008, J AM CHEM SOC, V130, P245, DOI 10.1021/ja075684q; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Marks KM, 2006, NAT METHODS, V3, P591, DOI 10.1038/NMETH906; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Srivastava DK, 2007, J AM CHEM SOC, V129, P5528, DOI 10.1021/ja068359w; Takaoka Y, 2006, J AM CHEM SOC, V128, P3273, DOI 10.1021/ja057926x; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Winum JY, 2005, J MED CHEM, V48, P2121, DOI 10.1021/jm0494826; Wold F, 1977, Methods Enzymol, V46, P3; Yu JX, 2005, CURR MED CHEM, V12, P819, DOI 10.2174/0929867053507342	25	253	255	6	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2009	5	5					341	343		10.1038/nchembio.157	http://dx.doi.org/10.1038/nchembio.157			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	436PT	19330012				2022-12-25	WOS:000265427000015
J	Field, Y; Fondufe-Mittendorf, Y; Moore, IK; Mieczkowski, P; Kaplan, N; Lubling, Y; Lieb, JD; Widom, J; Segal, E				Field, Yair; Fondufe-Mittendorf, Yvonne; Moore, Irene K.; Mieczkowski, Piotr; Kaplan, Noam; Lubling, Yaniv; Lieb, Jason D.; Widom, Jonathan; Segal, Eran			Gene expression divergence in yeast is coupled to evolution of DNA-encoded nucleosome organization	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; COMPARATIVE GENOMICS; TRANSCRIPTION; POSITIONS; PROMOTERS; SEQUENCE; HISTONE; MODULES; NETWORK; MODEL	Eukaryotic transcription occurs within a chromatin environment, whose organization has an important regulatory function and is partly encoded in cis by the DNA sequence itself. Here, we examine whether evolutionary changes in gene expression are linked to changes in the DNA-encoded nucleosome organization of promoters. We find that in aerobic yeast species, where cellular respiration genes are active under typical growth conditions, the promoter sequences of these genes encode a relatively open (nucleosome-depleted) chromatin organization. This nucleosome-depleted organization requires only DNA sequence information, is independent of any cofactors and of transcription, and is a general property of growth-related genes. In contrast, in anaerobic yeast species, where cellular respiration genes are relatively inactive under typical growth conditions, respiration gene promoters encode relatively closed (nucleosome-occupied) chromatin organizations. Our results suggest a previously unidentified genetic mechanism underlying phenotypic diversity, consisting of DNA sequence changes that directly alter the DNA-encoded nucleosome organization of promoters.	[Field, Yair; Kaplan, Noam; Lubling, Yaniv; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Fondufe-Mittendorf, Yvonne; Moore, Irene K.; Widom, Jonathan] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Mieczkowski, Piotr; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Dept Biol, Chapel Hill, NC 27599 USA; [Mieczkowski, Piotr; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Northwestern University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Weizmann Institute of Science	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	j-widom@northwestern.edu; eran@weizmann.ac.il	Kaplan, Noam/K-4383-2019; Kaplan, Noam/A-3544-2011; Segal, Eran/AAF-4855-2019	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987; Mieczkowski, Piotr/0000-0003-2418-0096; Segal, Eran/0000-0002-6859-1164; Lubling, Yaniv/0000-0003-3461-9621; Lieb, Jason/0000-0001-7601-8061	University of Minnesota; University of North Carolina; US National Institutes of Health; European Research Council (ERC); NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518, R01GM058617, R01GM054692] Funding Source: NIH RePORTER	University of Minnesota(University of Minnesota System); University of North Carolina; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge with gratitude the gift of strains, protocols and advice from J. Berman (University of Minnesota), and thank H. Kelkar (University of North Carolina) for help with the Illumina sequencing data and the members of our respective laboratories for discussions and comments on the manuscript. This work was supported by grants from the US National Institutes of Health to J. D. L., from the NIH to J. W., and from the European Research Council (ERC) and NIH to E. S. N. K. is a Clore scholar. E. S. is the incumbent of the Soretta and Henry Shapiro career development chair.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; KAPLAN N, 2008, NATURE          1217, DOI DOI 10.1038/NATURE07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; MAGER WH, 1991, MOL CELL BIOCHEM, V104, P181; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]	28	111	114	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					438	445		10.1038/ng.324	http://dx.doi.org/10.1038/ng.324			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19252487	Green Submitted, Green Accepted			2022-12-25	WOS:000264659000017
J	van der Voet, M; Berends, CWH; Perreault, A; Nguyen-Ngoc, T; Gonczy, P; Vidal, M; Boxem, M; van den Heuvel, S				van der Voet, Monique; Berends, Christian W. H.; Perreault, Audrey; Nguyen-Ngoc, Tu; Goenczy, Pierre; Vidal, Marc; Boxem, Mike; van den Heuvel, Sander			NuMA-related LIN-5, ASPM-1, calmodulin and dynein promote meiotic spindle rotation independently of cortical LIN-5/GPR/G alpha	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; GENETIC INTERFERENCE; INTERACTOME NETWORK; PLANAR DIVISIONS; CLEAVAGE PLANE; OOCYTE CORTEX; PROTEIN; EMBRYOS; ORGANIZATION	The spindle apparatus dictates the plane of cell cleavage, which is critical in the choice between symmetric or asymmetric division. spindle positioning is controlled by an evolutionarily conserved pathway, which involves LIN-5/GPr-1/2/G alpha in Caenorhabditis elegans, Mud/Pins/Ga in Drosophila and NuMA/IGN/G alpha in humans(1). GPr-1/2 and G alpha localize LIN-5 to the cell cortex, which engages dynein and controls the cleavage plane during early mitotic divisions in C. elegans(2-6). Here we identify AsPM-1 (abnormal spindle-like, microcephaly-associated) as a novel LIN-5 binding partner. AsPM-1, together with calmodulin (CMD-1), promotes meiotic spindle organization and the accumulation of LIN-5 at meiotic and mitotic spindle poles. spindle rotation during maternal meiosis is independent of GPR-1/2 and G alpha, yet requires LIN-5, AsPM-1, CMD-1 and dynein. Our data support the existence of two distinct LIN-5 complexes that determine localized dynein function: LIN-5/GPR-1/2/G alpha at the cortex, and LIN-5/AsPM-1/CMD-1 at spindle poles. these functional interactions may be conserved in mammals, with implications for primary microcephaly.	[van der Voet, Monique; Berends, Christian W. H.; Boxem, Mike; van den Heuvel, Sander] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Perreault, Audrey] MGH Canc Ctr, Charlestown, MA 02129 USA; [Nguyen-Ngoc, Tu; Goenczy, Pierre] Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1066 Lausanne, Switzerland; [Vidal, Marc; Boxem, Mike] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Vidal, Marc; Boxem, Mike] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Vidal, Marc; Boxem, Mike] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Utrecht University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	van den Heuvel, S (corresponding author), Univ Utrecht, Dept Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	s.j.l.vandenheuvel@uu.nl	van den Heuvel, Sander J.L./B-8892-2011; Boxem, Mike/B-8857-2011; van der Voet, Monique/F-5772-2012	van den Heuvel, Sander J.L./0000-0001-9015-7463; van der Voet, Monique/0000-0002-8829-1767; Nguyen-Ngoc, Tu/0000-0001-7574-2947; Gonczy, Pierre/0000-0002-6305-6883	National Institutes of Health [GM57990]; Swiss National Science Foundation [3100A0-102087]; Marie Curie International Reintegration [MIRG-CT-2007-046458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie International Reintegration(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Steve Gygi and Ross Tomaino ( Taplin Biological Mass Spectrometry, Harvard Medical School) for analysis of peptides by mass spectrometry ( HMS), to Sean O'Rourke and Bruce Bowerman for the GFP - DHC- 1 strain EU1561, to Inge The for assistance with ASPM- 1 antibody production, Kristiaan de Vries for scoring embryonic lethality, and the Caenorhabditis Genetics Center ( National Institutes of Health, National Center for Research Resources) for providing strains. We thank Adri Thomas and Marjolein Wildwater for critically reading the manuscript. This work was supported in part by National Institutes of Health grant GM57990 to S. v. d. H, Swiss National Science Foundation grant 3100A0-102087 to P. G., and Marie Curie International Reintegration grant MIRG-CT-2007-046458 to M. B.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Galli M, 2008, ANNU REV GENET, V42, P389, DOI 10.1146/annurev.genet.40.110405.090523; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; GONZALEZ C, 1990, J CELL SCI, V96, P605; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Green RF, 2004, MOL GENET GENOMICS, V271, P532, DOI 10.1007/s00438-004-1012-x; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HULEN D, 1991, CELL MOTIL CYTOSKEL, V18, P113, DOI 10.1002/cm.970180206; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kleijn M, 1995, J CELL BIOCHEM, V59, P443, DOI 10.1002/jcb.240590405; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; MAINS PE, 1990, GENETICS, V126, P593; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Park DH, 2008, DEV BIOL, V315, P42, DOI 10.1016/j.ydbio.2007.11.037; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Yang HY, 2003, DEV BIOL, V260, P245, DOI 10.1016/S0012-1606(03)00216-1; Yang HY, 2005, J CELL BIOL, V169, P447, DOI 10.1083/jcb.200411132	41	92	102	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					269	U101		10.1038/ncb1834	http://dx.doi.org/10.1038/ncb1834			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19219036				2022-12-25	WOS:000263777900010
J	Fu, J; Keurentjes, JJB; Bouwmeester, H; America, T; Verstappen, FWA; Ward, JL; Beale, MH; de Vos, RCH; Dijkstra, M; Scheltema, RA; Johannes, F; Koornneef, M; Vreugdenhil, D; Breitling, R; Jansen, RC				Fu, Jingyuan; Keurentjes, Joost J. B.; Bouwmeester, Harro; America, Twan; Verstappen, Francel W. A.; Ward, Jane L.; Beale, Michael H.; de Vos, Ric C. H.; Dijkstra, Martijn; Scheltema, Richard A.; Johannes, Frank; Koornneef, Maarten; Vreugdenhil, Dick; Breitling, Rainer; Jansen, Ritsert C.			System-wide molecular evidence for phenotypic buffering in Arabidopsis	NATURE GENETICS			English	Article							GENETIC GENOMICS; EXPRESSION	We profiled 162 lines of Arabidopsis for variation in transcript, protein and metabolite abundance using mRNA microarrays, two-dimensional polyacrylamide gel electrophoresis, gas chromatography time-of-flight mass spectrometry, liquid chromatography quadrupole time-of-flight mass spectrometry, and proton nuclear magnetic resonance. We added all publicly available phenotypic data from the same lines and mapped quantitative trait loci (QTL) for 40,580 molecular and 139 phenotypic traits. We found six QTL hot spots with major, system-wide effects, suggesting there are six breakpoints in a system otherwise buffered against many of the 500,000 SNPs.	[Fu, Jingyuan; Dijkstra, Martijn; Scheltema, Richard A.; Johannes, Frank; Breitling, Rainer; Jansen, Ritsert C.] Univ Groningen, Groningen Bioinformat Ctr, NL-9751 NN Haren, Netherlands; [Fu, Jingyuan; Jansen, Ritsert C.] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Keurentjes, Joost J. B.; Koornneef, Maarten] Wageningen Univ, Genet Lab, NL-6703 BD Wageningen, Netherlands; [Keurentjes, Joost J. B.; Bouwmeester, Harro; Verstappen, Francel W. A.; Vreugdenhil, Dick] Wageningen Univ, Lab Plant Physiol, NL-6703 BD Wageningen, Netherlands; [Keurentjes, Joost J. B.; Bouwmeester, Harro; America, Twan; Verstappen, Francel W. A.; de Vos, Ric C. H.] Ctr Biosyst Genom, NL-6708 PB Wageningen, Netherlands; [Bouwmeester, Harro; America, Twan; Verstappen, Francel W. A.; de Vos, Ric C. H.] Plant Res Int, NL-6708 PB Wageningen, Netherlands; [Ward, Jane L.; Beale, Michael H.] Natl Ctr Plant & Microbial Metab, Harpenden AL5 2JQ, Herts, England; [Koornneef, Maarten] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	University of Groningen; University of Groningen; Wageningen University & Research; Wageningen University & Research; Centre for BioSystems Genomics; Max Planck Society	Jansen, RC (corresponding author), Univ Groningen, Groningen Bioinformat Ctr, NL-9751 NN Haren, Netherlands.	r.c.jansen@rug.nl	Fu, Jingyuan/ABE-6868-2020; Fu, Jingyuan/E-8980-2012; De Vos, Ric/F-5012-2017; Scheltema, Richard A/I-3856-2016; Bouwmeester, Harro J/C-1414-2008; Jansen, Ritsert C/C-1160-2013; Fu, JY/GRR-6179-2022	Fu, Jingyuan/0000-0001-5578-1236; Scheltema, Richard A/0000-0002-1668-0253; Jansen, Ritsert C/0000-0003-2977-9110; Koornneef, Maarten/0000-0002-7759-4869; Breitling, Rainer/0000-0001-7173-0922; Keurentjes, Joost/0000-0001-8918-0711; Bouwmeester, Harro/0000-0003-0907-2732; America, Antoine/0000-0002-0167-1194	Netherlands Organization for Scientific Research (NWO); Netherlands Genomics Initiative (NGI); UK Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/C/00004976, MET20482] Funding Source: researchfish; BBSRC [BBS/E/C/00004976] Funding Source: UKRI	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Netherlands Organization for Scientific Research (NWO), the Netherlands Genomics Initiative (NGI) and the UK Biotechnology and Biological Sciences Research Council (BBSRC).	[Anonymous], 2007, NAT GENET, V39, P423; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gjuvsland AB, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-57; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; YANG L, 2008, TRENDS GENET, V24, P518	15	187	193	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					166	167		10.1038/ng.308	http://dx.doi.org/10.1038/ng.308			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19169256	Green Published, Green Submitted			2022-12-25	WOS:000263091300015
J	Gnirke, A; Melnikov, A; Maguire, J; Rogov, P; LeProust, EM; Brockman, W; Fennell, T; Giannoukos, G; Fisher, S; Russ, C; Gabriel, S; Jaffe, DB; Lander, ES; Nusbaum, C				Gnirke, Andreas; Melnikov, Alexandre; Maguire, Jared; Rogov, Peter; LeProust, Emily M.; Brockman, William; Fennell, Timothy; Giannoukos, Georgia; Fisher, Sheila; Russ, Carsten; Gabriel, Stacey; Jaffe, David B.; Lander, Eric S.; Nusbaum, Chad			Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing	NATURE BIOTECHNOLOGY			English	Article							MULTIPLEX AMPLIFICATION; GENOMIC SELECTION; DNA FRAGMENTS; LARGE SETS; PROBES; GENES	Targeting genomic loci by massively parallel sequencing requires new methods to enrich templates to be sequenced. We developed a capture method that uses biotinylated RNA 'baits' to fish targets out of a 'pond' of DNA fragments. The RNA is transcribed from PCR-amplified oligodeoxynucleotides originally synthesized on a microarray, generating sufficient bait for multiple captures at concentrations high enough to drive the hybridization. We tested this method with 170-mer baits that target > 15,000 coding exons (2.5 Mb) and four regions (1.7 Mb total) using Illumina sequencing as read-out. About 90% of uniquely aligning bases fell on or near bait sequence; up to 50% lay on exons proper. The uniformity was such that similar to 60% of target bases in the exonic 'catch', and similar to 80% in the regional catch, had at least half the mean coverage. One lane of Illumina sequence was sufficient to call high-confidence genotypes for 89% of the targeted exon space.	[Gnirke, Andreas; Melnikov, Alexandre; Maguire, Jared; Rogov, Peter; Brockman, William; Fennell, Timothy; Giannoukos, Georgia; Fisher, Sheila; Russ, Carsten; Gabriel, Stacey; Jaffe, David B.; Lander, Eric S.; Nusbaum, Chad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [LeProust, Emily M.] Agilent Technol, Santa Clara, CA 95051 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agilent Technologies; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Gnirke, A (corresponding author), Broad Inst MIT & Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	gnirke@broad.mit.edu			National Human Genome Research Institute [HG03067-05]; funds of the Broad Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); funds of the Broad Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the staff of the Broad Institute Genome Sequencing Platform and Genetic Analysis Platform for generating sequencing and genotyping data. This work was supported by National Human Genome Research Institute grant HG03067-05 (to E. S. L.) and funds of the Broad Institute.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; Dahl F, 2007, P NATL ACAD SCI USA, V104, P9387, DOI 10.1073/pnas.0702165104; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fredriksson S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm078; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	25	974	1115	0	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2009	27	2					182	189		10.1038/nbt.1523	http://dx.doi.org/10.1038/nbt.1523			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	405FT	19182786	Green Accepted			2022-12-25	WOS:000263209000025
J	Rosen, CJ				Rosen, Clifford J.			Breaking into bone biology Serotonin's secrets	NATURE MEDICINE			English	Editorial Material							TRANSPORTER INHIBITION EVIDENCE; DENSITY		Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA	Maine Medical Center	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	rosenc@mmc.org						Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Clowes JA, 2002, BONE, V30, P886, DOI 10.1016/S8756-3282(02)00728-7; Diem SJ, 2007, ARCH INTERN MED, V167, P1240, DOI 10.1001/archinte.167.12.1240; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Haney E. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P133; Haney EM, 2007, ARCH INTERN MED, V167, P1246, DOI 10.1001/archinte.167.12.1246; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Warden S. J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P121; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	12	16	17	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					145	146		10.1038/nm0209-145	http://dx.doi.org/10.1038/nm0209-145			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19197289				2022-12-25	WOS:000263119400016
J	Skokowa, J; Lan, D; Thakur, BK; Wang, F; Gupta, K; Cario, G; Brechlin, AM; Schambach, A; Hinrichsen, L; Meyer, G; Gaestel, M; Stanulla, M; Tong, Q; Welte, K				Skokowa, Julia; Lan, Dan; Thakur, Basant Kumar; Wang, Fei; Gupta, Kshama; Cario, Gunnar; Brechlin, Annette Mueller; Schambach, Axel; Hinrichsen, Lars; Meyer, Gustav; Gaestel, Matthias; Stanulla, Martin; Tong, Qiang; Welte, Karl			NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway	NATURE MEDICINE			English	Article							COLONY-ENHANCING FACTOR; SEVERE CONGENITAL NEUTROPENIA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; AXONAL DEGENERATION; NAD BIOSYNTHESIS; CYCLIC NEUTROPENIA; STIMULATING FACTOR; GENE-EXPRESSION; C/EBP-BETA; SIRT1	We identified nicotinamide phosphoribosyltransferase (NAMPT), also known as pre-B cell colony enhancing factor (PBEF), as an essential enzyme mediating granulocyte colony-stimulating factor (G-CSF)-triggered granulopoiesis in healthy individuals and in individuals with severe congenital neutropenia. Intracellular NAMPT and NAD+ amounts in myeloid cells, as well as plasma NAMPT and NAD+ levels, were increased by G-CSF treatment of both healthy volunteers and individuals with congenital neutropenia. NAMPT administered both extracellularly and intracellularly induced granulocytic differentiation of CD34(+) hematopoietic progenitor cells and of the promyelocytic leukemia cell line HL-60. Treatment of healthy individuals with high doses of vitamin B3 ( nicotinamide), a substrate of NAMPT, induced neutrophilic granulocyte differentiation. The molecular events triggered by NAMPT include NAD(+)-dependent sirtuin-1 activation, subsequent induction of CCAAT/enhancer binding protein-alpha and CCAAT/enhancer binding protein-beta, and, ultimately, upregulation of G-CSF synthesis and G-CSF receptor expression. G-CSF, in turn, further increases NAMPT levels. These results reveal a decisive role of the NAD+ metabolic pathway in G-CSF-triggered myelopoiesis.	[Skokowa, Julia; Lan, Dan; Thakur, Basant Kumar; Gupta, Kshama; Brechlin, Annette Mueller; Hinrichsen, Lars; Stanulla, Martin; Welte, Karl] Hannover Med Sch, Dept Mol Hematopoiesis, D-30625 Hannover, Germany; [Wang, Fei; Tong, Qiang] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Cario, Gunnar; Stanulla, Martin] Univ Hosp Schleswig Holstein, Dept Pediat, D-24105 Kiel, Germany; [Meyer, Gustav; Gaestel, Matthias] Hannover Med Sch, Dept Biochem, D-30625 Hannover, Germany; [Schambach, Axel] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany	Hannover Medical School; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Kiel; Schleswig Holstein University Hospital; Hannover Medical School; Hannover Medical School	Skokowa, J (corresponding author), Hannover Med Sch, Dept Mol Hematopoiesis, Carl Neuberg Str 1, D-30625 Hannover, Germany.	skokowa.julia@mh-hannover.de; Welte.Karl.H@mh-hannover.de	Wang, Fei/F-8015-2010; Gupta, Kshama/GRS-8778-2022; Stanulla, Martin/D-2528-2010; Skokowa, Julia/AAU-3622-2021; Stanulla, Martin/N-4674-2017; Cario, Gunnar/D-2535-2010; Schambach, Axel/C-5491-2011; Gaestel, Matthias/A-6560-2013	Skokowa, Julia/0000-0002-4399-2324; Stanulla, Martin/0000-0002-3834-0727; Gaestel, Matthias/0000-0002-4944-4652; Thakur, Barun Kumar/0000-0002-1713-9186	Elternverein Krebskranker Kinder Hannover e. V.; MadeleineSchickedanz- Kinderkrebsstiftung; Deutsche Jose Carreras Leukamia Stiftung e. V; REBIRTH Excellence Cluster; Else Kroner Foundation; American Federation for Aging Research senior postdoctoral fellowship; US Department of Agriculture; National Institutes of Health	Elternverein Krebskranker Kinder Hannover e. V.; MadeleineSchickedanz- Kinderkrebsstiftung; Deutsche Jose Carreras Leukamia Stiftung e. V; REBIRTH Excellence Cluster; Else Kroner Foundation; American Federation for Aging Research senior postdoctoral fellowship; US Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Uenalan for helpful discussion, M. Morgan for critically reading the manuscript and M. Ballmaier and C. Reimer for assistance in cell sorting. We also thank C. Zeidler and the physicians within the Severe Chronic Neutropenia International Registry for providing subject material ( bone marrow cells, peripheral blood neutrophils and plasma). Special thanks to study subjects and colleagues, especially M. Schatz, for their great cooperation. This work was supported by Elternverein Krebskranker Kinder Hannover e. V., MadeleineSchickedanz- Kinderkrebsstiftung, Deutsche Jose Carreras Leukamia Stiftung e. V., REBIRTH Excellence Cluster ( A. S.), Else Kroner Foundation ( A. S.), an American Federation for Aging Research senior postdoctoral fellowship ( F. W.) and the US Department of Agriculture and National Institutes of Health ( Q. T.).	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hasmann M, 2003, CANCER RES, V63, P7436; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kaneko S, 2006, J NEUROSCI, V26, P9794, DOI 10.1523/JNEUROSCI.2116-06.2006; KASPER B, 1997, LEUKOCYTE TYPING, V4, P1072; Kendal CE, 2007, PLACENTA, V28, P305, DOI 10.1016/j.placenta.2006.03.011; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; KYAS U, 1992, BLOOD, V79, P1144; Lenny N, 1997, MOL BIOL REP, V24, P157, DOI 10.1023/A:1006859700409; Libert S, 2008, NAT CELL BIOL, V10, P373, DOI 10.1038/ncb0408-373; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2007, CURR OPIN HEMATOL, V14, P22; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Tanaka T, 2007, CELL METAB, V6, P341, DOI 10.1016/j.cmet.2007.10.004; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	42	165	179	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2009	15	2					151	158		10.1038/nm.1913	http://dx.doi.org/10.1038/nm.1913			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19182797				2022-12-25	WOS:000263119400017
J	Taylor, IW; Linding, R; Warde-Farley, D; Liu, YM; Pesquita, C; Faria, D; Bull, S; Pawson, T; Morris, Q; Wrana, JL				Taylor, Ian W.; Linding, Rune; Warde-Farley, David; Liu, Yongmei; Pesquita, Catia; Faria, Daniel; Bull, Shelley; Pawson, Tony; Morris, Quaid; Wrana, Jeffrey L.			Dynamic modularity in protein interaction networks predicts breast cancer outcome	NATURE BIOTECHNOLOGY			English	Article							INTERACTION DATABASE; DATA SETS; EXPRESSION; SIGNATURE; BIOLOGY; GENES; CELLS; TOOL	Changes in the biochemical wiring of oncogenic cells drives phenotypic transformations that directly affect disease outcome. Here we examine the dynamic structure of the human protein interaction network (interactome) to determine whether changes in the organization of the interactome can be used to predict patient outcome. An analysis of hub proteins identified intermodular hub proteins that are co-expressed with their interacting partners in a tissue-restricted manner and intramodular hub proteins that are co-expressed with their interacting partners in all or most tissues. Substantial differences in biochemical structure were observed between the two types of hubs. Signaling domains were found more often in intermodular hub proteins, which were also more frequently associated with oncogenesis. Analysis of two breast cancer patient cohorts revealed that altered modularity of the human interactome may be useful as an indicator of breast cancer prognosis.	[Taylor, Ian W.; Linding, Rune; Liu, Yongmei; Bull, Shelley; Pawson, Tony; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Taylor, Ian W.; Pawson, Tony; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Linding, Rune] Inst Canc Res, Sect Cell, Mol & Syst Sect, Cellular & Mol Log Team, London SW3 6JB, England; [Warde-Farley, David; Morris, Quaid] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Warde-Farley, David; Morris, Quaid] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Pesquita, Catia; Faria, Daniel] Univ Lisbon, Fac Sci, P-1749016 Lisbon, Portugal; [Bull, Shelley] Univ Toronto, Sch Publ Hlth, Toronto, ON M5T 3M7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Toronto; University of Toronto; Universidade de Lisboa; University of Toronto	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Pesquita, Catia LSC/O-8883-2015; Bull, Shelley B/A-1920-2013; Wrana, Jeffrey/F-8857-2013; Pawson, Tony J/E-4578-2013; Morris, Quaid/ABE-8343-2020	Pesquita, Catia LSC/0000-0002-1847-9393; Morris, Quaid/0000-0002-2760-6999; Faria, Daniel/0000-0003-1511-277X; Linding, Rune/0000-0003-0420-4839				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BERTIN N, 2007, PLOS BIOL E, V153; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Roukos DH, 2007, NEW ENGL J MED, V357, P1555; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soderlund K, 2007, INT J RADIAT ONCOL, V68, P50, DOI 10.1016/j.ijrobp.2006.12.005; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tengowski MW, 2007, BIOL REPROD, V76, P149, DOI 10.1095/biolreprod.106.053173; Thomas MK, 1999, MOL CELL BIOL, V19, P8492; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Yip KY, 2006, BIOINFORMATICS, V22, P2968, DOI 10.1093/bioinformatics/btl488; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008	35	534	552	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2009	27	2					199	204		10.1038/nbt.1522	http://dx.doi.org/10.1038/nbt.1522			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	405FT	19182785				2022-12-25	WOS:000263209000027
J	Price, WN; Chen, Y; Handelman, SK; Neely, H; Manor, P; Karlin, R; Nair, R; Liu, JF; Baran, M; Everett, J; Tong, SCN; Forouhar, F; Swaminathan, SS; Acton, T; Xiao, R; Luft, JR; Lauricella, A; DeTitta, GT; Rost, B; Montelione, GT; Hunt, JF				Price, W. Nicholson, II; Chen, Yang; Handelman, Samuel K.; Neely, Helen; Manor, Philip; Karlin, Richard; Nair, Rajesh; Liu, Jinfeng; Baran, Michael; Everett, John; Tong, Saichiu N.; Forouhar, Farhad; Swaminathan, Swarup S.; Acton, Thomas; Xiao, Rong; Luft, Joseph R.; Lauricella, Angela; DeTitta, George T.; Rost, Burkhard; Montelione, Gaetano T.; Hunt, John F.			Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data	NATURE BIOTECHNOLOGY			English	Article							RNA-POLYMERASE-II; STRUCTURAL GENOMICS; ANGSTROM RESOLUTION; ENTROPY; PROTEOMICS; SERVER; TRANSCRIPTION; MUTATIONS; DISCOVERY; DISORDER	Crystallization is the most serious bottleneck in high-throughput protein-structure determination by diffraction methods. We have used data mining of the large-scale experimental results of the Northeast Structural Genomics Consortium and experimental folding studies to characterize the biophysical properties that control protein crystallization. This analysis leads to the conclusion that crystallization propensity depends primarily on the prevalence of well-ordered surface epitopes capable of mediating interprotein interactions and is not strongly influenced by overall thermodynamic stability. We identify specific sequence features that correlate with crystallization propensity and that can be used to estimate the crystallization probability of a given construct. Analyses of entire predicted proteomes demonstrate substantial differences in the amino acid-sequence properties of human versus eubacterial proteins, which likely reflect differences in biophysical properties, including crystallization propensity. Our thermodynamic measurements do not generally support previous claims regarding correlations between sequence properties and protein stability.	[Price, W. Nicholson, II; Chen, Yang; Handelman, Samuel K.; Neely, Helen; Manor, Philip; Karlin, Richard; Nair, Rajesh; Liu, Jinfeng; Baran, Michael; Everett, John; Tong, Saichiu N.; Forouhar, Farhad; Swaminathan, Swarup S.; Acton, Thomas; Xiao, Rong; Luft, Joseph R.; Lauricella, Angela; DeTitta, George T.; Rost, Burkhard; Montelione, Gaetano T.; Hunt, John F.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Price, W. Nicholson, II; Chen, Yang; Handelman, Samuel K.; Neely, Helen; Manor, Philip; Karlin, Richard; Forouhar, Farhad; Swaminathan, Swarup S.; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Nair, Rajesh; Liu, Jinfeng; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Baran, Michael; Everett, John; Tong, Saichiu N.; Acton, Thomas; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Luft, Joseph R.; Lauricella, Angela; DeTitta, George T.] Hauptman Woodward Inst, Buffalo, NY 14203 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Columbia University; Columbia University; Columbia University; Rutgers State University New Brunswick; Hauptman Woodward Medical Research Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hunt, JF (corresponding author), Columbia Univ, NE Struct Genom Consortium, 702A Fairchild Ctr,MC2434, New York, NY 10027 USA.	jfhunt@biology.columbia.edu	Rost, Burkhard/A-1908-2016	Rost, Burkhard/0000-0003-0179-8424; Price, Nicholson/0000-0003-0729-290X; Handelman, Samuel/0000-0001-6970-2172; Montelione, Gaetano/0000-0002-9440-3059; Liu, Jinfeng/0000-0002-0343-8222	National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, U54GM074899, U54GM074958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Protein Structure Initiative grants from the National Institutes of Health (NIH) to the Northeast Structural Genomics Consortium and the Center for High- Throughput Structural Biology. The full staffs of these consortia contributed to the experimental data analyzed in this paper. W. N. P. II was supported in part by an NIH training grant to the Department of Biological Sciences at Columbia, and S. K. H. was supported in part by a National Science Foundation grant to J. F. H. The authors thank Wayne Hendrickson and Liang Tong for support and advice and John Schwanoff and the New York Structural Biology Center for maintenance of the X4 beamlines at Brookhaven National Laboratory.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Canaves JM, 2004, J MOL BIOL, V344, P977, DOI 10.1016/j.jmb.2004.09.076; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Creamer TP, 2000, PROTEINS, V40, P443, DOI 10.1002/1097-0134(20000815)40:3<443::AID-PROT100>3.3.CO;2-C; Cumbaa CA, 2003, ACTA CRYSTALLOGR D, V59, P1619, DOI 10.1107/S0907444903015130; Dasgupta S, 1997, PROTEINS, V28, P494, DOI 10.1002/(SICI)1097-0134(199708)28:4<494::AID-PROT4>3.0.CO;2-A; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; Goh CS, 2003, NUCLEIC ACIDS RES, V31, P2833, DOI 10.1093/nar/gkg397; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; KENDREW JC, 1959, FED PROC, V18, P740; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Mateja A, 2002, ACTA CRYSTALLOGR D, V58, P1983, DOI 10.1107/S090744490201394X; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oldfield CJ, 2005, PROTEINS, V59, P444, DOI 10.1002/prot.20446; Overton IM, 2006, FEBS LETT, V580, P4005, DOI 10.1016/j.febslet.2006.06.015; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rost B., 2005, PROTEOMICS PROTOCOLS, P875, DOI DOI 10.1385/1-59259-890-0:875; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vekilov PG, 2003, METHOD ENZYMOL, V368, P84, DOI 10.1016/S0076-6879(03)68006-7; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WUKOVITZ SW, 1995, NAT STRUCT BIOL, V2, P1062, DOI 10.1038/nsb1295-1062	37	106	113	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2009	27	1					51	57		10.1038/nbt.1514	http://dx.doi.org/10.1038/nbt.1514			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	394TP	19079241	Green Submitted, Green Accepted			2022-12-25	WOS:000262471200023
J	Traore, DAK; El Ghazouani, A; Jacquamet, L; Borel, F; Ferrer, JL; Lascoux, D; Ravanat, JL; Jaquinod, M; Blondin, G; Caux-Thang, C; Duarte, V; Latour, JM				Traore, Daouda A. K.; El Ghazouani, Abdelnasser; Jacquamet, Lilian; Borel, Franck; Ferrer, Jean-Luc; Lascoux, David; Ravanat, Jean-Luc; Jaquinod, Michel; Blondin, Genevieve; Caux-Thang, Christelle; Duarte, Victor; Latour, Jean-Marc			Structural and functional characterization of 2-oxo-histidine in oxidized PerR protein	NATURE CHEMICAL BIOLOGY			English	Article							METAL-CATALYZED OXIDATION; TRANSCRIPTION FACTOR; PEROXIDE; HISTIDINE; SWITCH; H2O2; ACTIVATION; MECHANISMS; BEAMLINE; REGULON	In Bacillus subtilis, PerR is a metal-dependent sensor of hydrogen peroxide. PerR is a dimeric zinc protein with a regulatory site that coordinates either Fe2+ (PerR-Zn-Fe) or Mn2+ (PerR-Zn-Mn). Though most of the peroxide sensors use cysteines to detect H2O2, it has been shown that reaction of PerR-Zn-Fe with H2O2 leads to the oxidation of one histidine residue. Oxidation of PerR leads to the incorporation of one oxygen atom into His37 or His91. This study presents the crystal structure of the oxidized PerR protein (PerR-Zn-ox), which clearly shows a 2-oxo-histidine residue in position 37. Formation of 2-oxo-histidine is demonstrated and quantified by HPLC-MS/MS. EPR experiments indicate that PerR-Zn-H37ox retains a significant affinity for the regulatory metal, whereas PerR-Zn-H91ox shows a considerably reduced affinity for the metal ion. In spite of these major differences in terms of metal binding affinity, oxidation of His37 and/or His91 in PerR prevents DNA binding.	[Traore, Daouda A. K.; El Ghazouani, Abdelnasser; Blondin, Genevieve; Caux-Thang, Christelle; Duarte, Victor; Latour, Jean-Marc] CEA, Lab Chim & Biol Metaux, Inst Rech Technol & Sci Vivant, Commissariat Energie Atom Inst, F-38054 Grenoble 9, France; [Traore, Daouda A. K.; El Ghazouani, Abdelnasser; Blondin, Genevieve; Caux-Thang, Christelle; Duarte, Victor; Latour, Jean-Marc] Univ Grenoble 1, CEA Grenoble, CNRS, Unite Mixte Rech 5249, F-38054 Grenoble 9, France; [Traore, Daouda A. K.; Jacquamet, Lilian; Borel, Franck; Ferrer, Jean-Luc] CEA, Inst Biol Struct, Cristallog & Cristallogenese Prot Lab, Groupe Synchrotron, F-38054 Grenoble 9, France; [Traore, Daouda A. K.; Jacquamet, Lilian; Borel, Franck; Ferrer, Jean-Luc; Lascoux, David] Univ Grenoble 1, CNRS, CEA, Unite Mixte Rech 5075, F-38027 Grenoble 1, France; [Lascoux, David] CEA, Inst Biol Struct, Lab Spectrometrie Masse Prot, F-38027 Grenoble 1, France; [Ravanat, Jean-Luc] CEA, Inst Nanosci & Cryogenie, Serv Chim Inorgan & Biol, F-38054 Grenoble 9, France; [Ravanat, Jean-Luc] Univ Grenoble 1, CEA E3, Unite Mixte Rech, Lab Chim Inorgan & Biol, F-38054 Grenoble 9, France; [Jaquinod, Michel] Univ Grenoble 1, Inst Rech Technol & Sci Vivant, Lab Etud Dynam Prot, F-38054 Grenoble 9, France; [Jaquinod, Michel] CEA, Lab Etud Dynam Prot, INSERM, U880, F-38054 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Duarte, V (corresponding author), CEA, Lab Chim & Biol Metaux, Inst Rech Technol & Sci Vivant, Commissariat Energie Atom Inst, 17 Ave Martyrs, F-38054 Grenoble 9, France.	victor.duarte@cea.fr; jean-luc.ferrer@ibs.fr	Traore, Daouda/B-5242-2013; Ravanat, Jean-Luc/E-3452-2018	Traore, Daouda/0000-0003-1001-4716; Ravanat, Jean-Luc/0000-0002-7123-6358				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farquhar ER, 2005, BIOCHEM BIOPH RES CO, V338, P230, DOI 10.1016/j.bbrc.2005.08.191; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Hillmann F, 2008, MOL MICROBIOL, V68, P848, DOI 10.1111/j.1365-2958.2008.06192.x; Hovorka SW, 2002, PHARMACEUT RES, V19, P530, DOI 10.1023/A:1015164200431; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; LEWISCH SA, 1995, ANAL BIOCHEM, V231, P440, DOI 10.1006/abio.1995.9974; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mongkolsuk S, 2002, MOL MICROBIOL, V45, P9, DOI 10.1046/j.1365-2958.2002.03015.x; Ohana J, 2004, J APPL CRYSTALLOGR, V37, P72, DOI 10.1107/S0021889803025482; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Piraud M, 2005, RAPID COMMUN MASS SP, V19, P1587, DOI 10.1002/rcm.1957; REED GH, 1970, J BIOL CHEM, V245, P662; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schoneich C, 2002, CHEM RES TOXICOL, V15, P717, DOI 10.1021/tx025504k; Schoneich C, 2000, J PHARMACEUT BIOMED, V21, P1093, DOI 10.1016/S0731-7085(99)00182-X; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5; Winter GEM, 1996, BIOCHEMISTRY-US, V35, P11805, DOI 10.1021/bi960381m; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	32	91	93	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2009	5	1					53	59		10.1038/nchembio.133	http://dx.doi.org/10.1038/nchembio.133			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387EW	19079268				2022-12-25	WOS:000261935500014
J	Chatterjee, A; Li, Y; Zhang, Y; Grove, TL; Lee, M; Krebs, C; Booker, SJ; Begley, TP; Ealick, SE				Chatterjee, Abhishek; Li, Yue; Zhang, Yang; Grove, Tyler L.; Lee, Michael; Krebs, Carsten; Booker, Squire J.; Begley, Tadhg P.; Ealick, Steven E.			Reconstitution of ThiC in thiamine pyrimidine biosynthesis expands the radical SAM superfamily	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; S-ADENOSYLMETHIONINE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; STRUCTURAL INSIGHTS; MOLECULAR-GRAPHICS; THIAZOLE SYNTHASE; CLUSTER PROTEIN; ENZYME	4-Amino-5-hydroxymethyl-2-methylpyrimidine phosphate (HMP-P) synthase catalyzes a complex rearrangement of 5-aminoimidazole ribonucleotide (AIR) to form HMP-P, the pyrimidine moiety of thiamine phosphate. We determined the three-dimensional structures of HMP-P synthase and its complexes with the product HMP-P and a substrate analog imidazole ribotide. The structure of HMP-P synthase reveals a homodimer in which each protomer comprises three domains: an N-terminal domain with a novel fold, a central (beta alpha)(8) barrel and a disordered C-terminal domain that contains a conserved CX2CX4C motif, which is suggestive of a [4Fe-4S] cluster. Biochemical studies have confirmed that HMP-P synthase is iron sulfur cluster-dependent, that it is a new member of the radical SAM superfamily and that HMP-P and 5'-deoxyadenosine are products of the reaction. Mossbauer and EPR spectroscopy confirm the presence of one [4Fe-4S] cluster. Structural comparisons reveal that HMP-P synthase is homologous to a group of adenosylcobalamin radical enzymes. This similarity supports an evolutionary relationship between these two superfamilies.	[Chatterjee, Abhishek; Li, Yue; Zhang, Yang; Begley, Tadhg P.; Ealick, Steven E.] Cornell Univ, Baker Lab 120, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; [Grove, Tyler L.; Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Lee, Michael; Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Begley, TP (corresponding author), Cornell Univ, Baker Lab 120, Dept Chem & Biol Chem, Ithaca, NY 14853 USA.	tpb2@cornell.edu; see3@cornell.edu	Krebs, Carsten/D-4773-2009; chatterjee, abhishek/N-9443-2019; Begley, Tadhg/B-5801-2015	Krebs, Carsten/0000-0002-3302-7053; chatterjee, abhishek/0000-0002-6231-5302; 	US National Institutes of Health [RR15301, DK44083, GM63847, DK67081]; Beckman Foundation; Dreyfus Foundation; W. M. Keck Foundation; Lucille P. Markey Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067081, R37DK044083, R01DK044083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063847] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Dreyfus Foundation; W. M. Keck Foundation(W.M. Keck Foundation); Lucille P. Markey Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NE-CAT beamline 24-ID-C, supported by US National Institutes of Health grant RR15301, for the use of beam time. We thank C. Kinsland (Cornell University Protein Facility) for the preparation of the HMP-P synthase overexpression plasmid and L. Kinsland for assistance in the preparation of this manuscript. This work was supported by US National Institutes of Health grants DK44083 (T.P.B.), GM63847 (S.J.B.) and DK67081 (S.E.E.), the Beckman Foundation (Young Investigator Award to C.K.) and the Dreyfus Foundation (Camille Dreyfus Teacher Scholar Award to C.K.). S.E.E. is indebted to the W. M. Keck Foundation and the Lucille P. Markey Charitable Trust.	Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chatterjee A, 2007, J AM CHEM SOC, V129, P2914, DOI 10.1021/ja067606t; Chatterjee A, 2006, J AM CHEM SOC, V128, P7158, DOI 10.1021/ja061413o; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dougherty MJ, 2006, MICROBIOL-SGM, V152, P2345, DOI 10.1099/mic.0.28926-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurgenson CT, 2006, BIOCHEMISTRY-US, V45, P11061, DOI 10.1021/bi061025z; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lawhorn BG, 2004, ORG BIOMOL CHEM, V2, P2538, DOI 10.1039/b405429f; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Leslie A. G. W., 1991, CCP4 STUDY WEEKEND, P80; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Munck E., 2000, PHYS METHODS BIOINOR, P287; NEWELL PC, 1968, BIOCHEM J, V106, P279, DOI 10.1042/bj1060279; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2004, J BACTERIOL, V186, P1571, DOI 10.1128/JB.186.5.1571-1573.2004; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Raschke M, 2007, P NATL ACAD SCI USA, V104, P19637, DOI 10.1073/pnas.0709597104; Reddick JJ, 2001, BIOCHEMISTRY-US, V40, P10095, DOI 10.1021/bi010267q; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Svetlitchnaia T, 2006, P NATL ACAD SCI USA, V103, P14331, DOI 10.1073/pnas.0601420103; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vallazza M, 2004, ACTA CRYSTALLOGR D, V60, P1, DOI 10.1107/S0907444903027690; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Zeidler J, 2003, J AM CHEM SOC, V125, P13094, DOI 10.1021/ja030261j	47	113	117	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2008	4	12					758	765		10.1038/nchembio.121	http://dx.doi.org/10.1038/nchembio.121			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	373FH	18953358	Green Accepted			2022-12-25	WOS:000260955900012
J	Poeck, H; Besch, R; Maihoefer, C; Renn, M; Tormo, D; Morskaya, SS; Kirschnek, S; Gaffal, E; Landsberg, J; Hellmuth, J; Schmidt, A; Anz, D; Bscheider, M; Schwerd, T; Berking, C; Bourquin, C; Kalinke, U; Kremmer, E; Kato, H; Akira, S; Meyers, R; Hacker, G; Neuenhahn, M; Busch, D; Ruland, J; Rothenfusser, S; Prinz, M; Hornung, V; Endres, S; Tuting, T; Hartmann, G				Poeck, Hendrik; Besch, Robert; Maihoefer, Cornelius; Renn, Marcel; Tormo, Damia; Morskaya, Svetlana Shulga; Kirschnek, Susanne; Gaffal, Evelyn; Landsberg, Jennifer; Hellmuth, Johannes; Schmidt, Andreas; Anz, David; Bscheider, Michael; Schwerd, Tobias; Berking, Carola; Bourquin, Carole; Kalinke, Ulrich; Kremmer, Elisabeth; Kato, Hiroki; Akira, Shizuo; Meyers, Rachel; Haecker, Georg; Neuenhahn, Michael; Busch, Dirk; Ruland, Juergen; Rothenfusser, Simon; Prinz, Marco; Hornung, Veit; Endres, Stefan; Tueting, Thomas; Hartmann, Gunther			5 '-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma	NATURE MEDICINE			English	Article							INTERFERON INDUCTION; ANTIVIRAL RESPONSES; DENDRITIC CELLS; RNA; CANCER; DEFENSE; SIRNA; STIMULATION; RECOGNITION; DISEASE	Genetic and epigenetic plasticity allows tumors to evade single-targeted treatments. Here we direct Bcl2-specific short interfering RNA ( siRNA) with 5'-triphosphate ends (3p-siRNA) against melanoma. Recognition of 5'-triphosphate by the cytosolic antiviral helicase retinoic acid - induced protein I ( Rig-I, encoded by Ddx58) activated innate immune cells such as dendritic cells and directly induced expression of interferons (IFNs) and apoptosis in tumor cells. These Rig-I- mediated activities synergized with siRNA-mediated Bcl2 silencing to provoke massive apoptosis of tumor cells in lung metastases in vivo. The therapeutic activity required natural killer cells and IFN, as well as silencing of Bcl2, as evidenced by rescue with a mutated Bcl2 target, by site-specific cleavage of Bcl2 messenger RNA in lung metastases and downregulation of Bcl-2 protein in tumor cells in vivo. Together, 3p-siRNA represents a single molecule - based approach in which Rig-I activation on both the immune- and tumor cell level corrects immune ignorance and in which gene silencing corrects key molecular events that govern tumor cell survival.	[Renn, Marcel; Tormo, Damia; Gaffal, Evelyn; Landsberg, Jennifer; Tueting, Thomas] Univ Bonn, Dept Dermatol & Allergol, Lab Expt Dermatol, D-53105 Bonn, Germany; [Poeck, Hendrik; Hellmuth, Johannes; Hornung, Veit; Hartmann, Gunther] Univ Bonn, Univ Hosp, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany; [Maihoefer, Cornelius; Schmidt, Andreas; Anz, David; Bscheider, Michael; Schwerd, Tobias; Bourquin, Carole; Rothenfusser, Simon; Endres, Stefan] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80336 Munich, Germany; [Poeck, Hendrik; Maihoefer, Cornelius; Bscheider, Michael; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; [Besch, Robert; Berking, Carola] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany; [Morskaya, Svetlana Shulga; Meyers, Rachel] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Kirschnek, Susanne; Haecker, Georg; Neuenhahn, Michael; Busch, Dirk] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany; [Kremmer, Elisabeth] Univ Munich, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Kato, Hiroki; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; [Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany	University of Bonn; University of Bonn; University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Osaka University; University of Freiburg	Tuting, T (corresponding author), Univ Bonn, Dept Dermatol & Allergol, Lab Expt Dermatol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	thomas.tueting@ukb.uni-bonn.de; gunther.hartmann@ukb.uni-bonn.de	Bourquin, Carole/AAU-1418-2020; Landsberg, Jennifer/AAF-5113-2019; Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022; Hartmann, Gunther/P-7492-2017; Hornung, Veit/C-3565-2012; Ruland, Jurgen/Q-6680-2018	Bourquin, Carole/0000-0003-3862-4583; Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Maihofer, Cornelius/0000-0002-0506-4519; Hartmann, Gunther/0000-0003-1021-2018; Hellmuth, Johannes C./0000-0001-8409-3037; Hornung, Veit/0000-0002-4150-194X; Ruland, Jurgen/0000-0002-8381-3597; Kalinke, Ulrich/0000-0003-0503-9564; Renn, Marcel/0000-0002-0120-4035				Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Stetson DB, 2006, J EXP MED, V203, P1837, DOI 10.1084/jem.20061377; Tormo D, 2006, CANCER RES, V66, P5427, DOI 10.1158/0008-5472.CAN-06-0399; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	31	293	312	4	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2008	14	11					1256	1263		10.1038/nm.1887	http://dx.doi.org/10.1038/nm.1887			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18978796				2022-12-25	WOS:000260751200045
J	Du, H; Guo, L; Fang, F; Chen, D; Sosunov, AA; McKhann, GM; Yan, YL; Wang, CY; Zhang, H; Molkentin, JD; Gunn-Moore, FJ; Vonsattel, JP; Arancio, O; Chen, JX; Du Yan, S				Du, Heng; Guo, Lan; Fang, Fang; Chen, Doris; Sosunov, Alexander A.; McKhann, Guy M.; Yan, Yilin; Wang, Chunyu; Zhang, Hong; Molkentin, Jeffery D.; Gunn-Moore, Frank J.; Vonsattel, Jean Paul; Arancio, Ottavio; Chen, John Xi; Du Yan, Shi			Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease	NATURE MEDICINE			English	Article							PERMEABILITY TRANSITION PORE; AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; MANGANESE SUPEROXIDE-DISMUTASE; ADENINE-NUCLEOTIDE TRANSLOCASE; SURFACE-PLASMON RESONANCE; FOCAL CEREBRAL-ISCHEMIA; FREE-RADICAL GENERATION; CYTOCHROME-C-OXIDASE; A-BETA	Cyclophilin D (CypD, encoded by Ppif) is an integral part of the mitochondrial permeability transition pore, whose opening leads to cell death. Here we show that interaction of CypD with mitochondrial amyloid-beta protein (A beta) potentiates mitochondrial, neuronal and synaptic stress. The CypD-deficient cortical mitochondria are resistant to A beta- and Ca2+-induced mitochondrial swelling and permeability transition. Additionally, they have an increased calcium buffering capacity and generate fewer mitochondrial reactive oxygen species. Furthermore, the absence of CypD protects neurons from A beta- and oxidative stress-induced cell death. Notably, CypD deficiency substantially improves learning and memory and synaptic function in an Alzheimer's disease mouse model and alleviates A beta-mediated reduction of long-term potentiation. Thus, the CypD-mediated mitochondrial permeability transition pore is directly linked to the cellular and synaptic perturbations observed in the pathogenesis of Alzheimer's disease. Blockade of CypD may be a therapeutic strategy in Alzheimer's disease.	[Yan, Yilin; Wang, Chunyu] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Du, Heng; Guo, Lan; Fang, Fang; Chen, Doris; Du Yan, Shi] Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; [Du, Heng; Guo, Lan; Fang, Fang; Chen, Doris; Du Yan, Shi] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA; [Zhang, Hong; Vonsattel, Jean Paul; Arancio, Ottavio; Du Yan, Shi] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Zhang, Hong; Arancio, Ottavio; Du Yan, Shi] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Molkentin, Jeffery D.] Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Gunn-Moore, Frank J.] Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland; [Chen, John Xi] Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA	Rensselaer Polytechnic Institute; Columbia University; Columbia University; Columbia University; Columbia University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of St Andrews; Cornell University; Memorial Sloan Kettering Cancer Center	Du Yan, S (corresponding author), Columbia Univ Coll Phys & Surg, Dept Surg, 630 W 168th St, New York, NY 10032 USA.	sdyl@columbia.edu	Yan, Yi/GSO-3046-2022; arancio, ottavio/AAB-7959-2019; Wang, Chunyu/AAH-5952-2019	Wang, Chunyu/0000-0001-5165-7959; arancio, ottavio/0000-0001-6335-164X; Molkentin, Jeffery/0000-0002-3558-6529	US Public Health Service Commissioned Corps [1101 AG17490, 11050 AG08702]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [P01AG017490, P50AG008702] Funding Source: NIH RePORTER	US Public Health Service Commissioned Corps(United States Department of Health & Human ServicesUnited States Public Health Service); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US Public Health Service Commissioned Corps (1101 AG17490, 11050 AG08702) and the Alzheimer's Association. We thank S. Katz for assistance with performing the behavioral experiments.	Aguilar MI, 2005, NEUROTOX RES, V7, P17, DOI 10.1007/BF03033773; Andreeva L, 1999, INT J EXP PATHOL, V80, P305, DOI 10.1046/j.1365-2613.1999.00128.x; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bergersen LH, 2008, NAT PROTOC, V3, P144, DOI 10.1038/nprot.2007.525; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Blass JP, 2000, ANN NY ACAD SCI, V924, P170; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Cardoso SM, 2002, BRAIN RES, V931, P117, DOI 10.1016/S0006-8993(02)02256-4; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; CHEN X, 2007, NEUROBIOLOGY ALZHEIM, P227; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Fernandez-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hou FF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351296; Kamsler A, 2003, J NEUROSCI, V23, P10359; Klann E, 1998, J BIOL CHEM, V273, P4516, DOI 10.1074/jbc.273.8.4516; Lin MT, 2006, NAT MED, V12, P1241, DOI 10.1038/nm1106-1241; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Maragos WF, 2000, BRAIN RES, V878, P218, DOI 10.1016/S0006-8993(00)02707-4; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282; Murakami K, 1998, J NEUROSCI, V18, P205; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Sheehan JP, 1997, J NEUROSCI, V17, P4612; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang JD, 2006, FEBS LETT, V580, P4392, DOI 10.1016/j.febslet.2006.07.002; Xie CW, 2004, NEUROMOL MED, V6, P53, DOI 10.1385/NMM:6:1:053; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	56	711	738	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1097	1105		10.1038/nm.1868	http://dx.doi.org/10.1038/nm.1868			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18806802	Green Accepted			2022-12-25	WOS:000259892300040
J	Mandl, JN; Barry, AP; Vanderford, TH; Kozyr, N; Chavan, R; Mucking, S; Barrat, FJ; Coffman, RL; Staprans, SI; Feinberg, MB				Mandl, Judith N.; Barry, Ashley P.; Vanderford, Thomas H.; Kozyr, Natalia; Chavan, Rahul; Mucking, Sara; Barrat, Franck J.; Coffman, Robert L.; Staprans, Silvija I.; Feinberg, Mark B.			Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PLASMACYTOID DENDRITIC CELLS; CD4(+) T-CELLS; TOLL-LIKE RECEPTORS; SOOTY MANGABEYS; NATURAL-KILLER; HIV-INFECTION; TRANSCRIPTION FACTORS; IMMUNE ACTIVATION; INNATE IMMUNITY	Pathogenic HIV infections of humans and simian immunodeficiency virus (SIV) infections of rhesus macaques are characterized by generalized immune activation and progressive CD4(+) T cell depletion. In contrast, natural reservoir hosts for SIV, such as sooty mangabeys, do not progress to AIDS and show a lack of aberrant immune activation and preserved CD4(+) T cell populations, despite high levels of SIV replication. Here we show that sooty mangabeys have substantially reduced levels of innate immune system activation in vivo during acute and chronic SIV infection and that sooty mangabey plasmacytoid dendritic cells (pDCs) produce markedly less interferon-a in response to SIV and other Toll-like receptor 7 and 9 ligands ex vivo. We propose that chronic stimulation of pDCs by SIV and HIV in non-natural hosts may drive the unrelenting immune system activation and dysfunction underlying AIDS progression. Such a vicious cycle of continuous virus replication and immunopathology is absent in natural sooty mangabey hosts.	[Mandl, Judith N.; Barry, Ashley P.; Vanderford, Thomas H.; Kozyr, Natalia; Chavan, Rahul; Mucking, Sara; Staprans, Silvija I.; Feinberg, Mark B.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Mandl, Judith N.] Emory Univ, Grad Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA; [Barrat, Franck J.; Coffman, Robert L.] Dynavax Technol, Berkeley, CA 94710 USA; [Staprans, Silvija I.; Feinberg, Mark B.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30329 USA; [Staprans, Silvija I.; Feinberg, Mark B.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30329 USA; [Mandl, Judith N.; Barry, Ashley P.; Vanderford, Thomas H.; Kozyr, Natalia; Chavan, Rahul; Mucking, Sara; Staprans, Silvija I.; Feinberg, Mark B.] Emory Vaccine Ctr, Atlanta, GA 30329 USA	Emory University; Emory University; Emory University; Emory University	Feinberg, MB (corresponding author), Merck & Co Inc, Merck Vaccines & Infect Dis, WP97-A337,770 Sumneytown Pike,POB 4, West Point, PA 19486 USA.	mark_feinberg@merck.com			US National Institutes of Health [R01 HL075766, R01 AI049155]; Yerkes National primate Research Center [RR000165]; Emory Center for AIDS Research [P30-AI-50409]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI049155] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes National primate Research Center; Emory Center for AIDS Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank B. Weaver, J. Skvarich, B. O'Hara and M. Mulligan for their help coordinating blood draws from HIV-infected humans, S. Ehnert and E. Strobert lot their care of the study animals, B. Lawson and 1). Lee for performing the SIVsm and SIVmac239 viral load assays, J. Ingersoll tot performing, the HIV viral load assays, A. McCrary for assistance with cloning and sequencing, K. Dalbey for help with running ELISAs, H.Yi for help with electron microscopy, J. Bess and J. Lifson at the US National Cancer Institute for providing the aldrithiol-2-inactivated SIV and HIV strains and microvesicle controls, 3M Pharmaceuticals lot providing the R-848 and anonymous human volunteers for providing blood samples for these studies. We would also like to thank G. Silvestri for his input. We gratefully acknowledge the support of the US National Institutes of Health grants R01 HL075766 and R01 AI049155, the Yerkes National primate Research Center Grant RR000165 and the Emory Center for AIDS Research Grant P30-AI-50409. The authors apologize for not citing all relevant publications due to Space limitations.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Barry AP, 2007, J IMMUNOL, V178, P8002, DOI 10.4049/jimmunol.178.12.8002; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bochud PY, 2007, LANCET INFECT DIS, V7, P531, DOI 10.1016/S1473-3099(07)70185-8; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Coates PTH, 2003, BLOOD, V102, P2513, DOI 10.1182/blood-2002-09-2929; Decalf J, 2007, J EXP MED, V204, P2423, DOI 10.1084/jem.20070814; Dunham R, 2006, BLOOD, V108, P209, DOI 10.1182/blood-2005-12-4897; Ferlazzo G, 2005, IMMUNOL LETT, V101, P12, DOI 10.1016/j.imlet.2005.04.015; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kottilil S, 2007, JAIDS-J ACQ IMM DEF, V46, P151, DOI 10.1097/QAI.0b013e3180dc9909; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Stewart TA, 2003, CYTOKINE GROWTH F R, V14, P139, DOI 10.1016/S1359-6101(02)00088-6; Sumpter B, 2007, J IMMUNOL, V178, P1680, DOI 10.4049/jimmunol.178.3.1680; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	60	294	314	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2008	14	10					1077	1087		10.1038/nm.1871	http://dx.doi.org/10.1038/nm.1871			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18806803				2022-12-25	WOS:000259892300038
J	McCarroll, SA; Kuruvilla, FG; Korn, JM; Cawley, S; Nemesh, J; Wysoker, A; Shapero, MH; de Bakker, PIW; Maller, JB; Kirby, A; Elliott, AL; Parkin, M; Hubbell, E; Webster, T; Mei, R; Veitch, J; Collins, PJ; Handsaker, R; Lincoln, S; Nizzari, M; Blume, J; Jones, KW; Rava, R; Daly, MJ; Gabriel, SB; Altshuler, D				McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Cawley, Simon; Nemesh, James; Wysoker, Alec; Shapero, Michael H.; de Bakker, Paul I. W.; Maller, Julian B.; Kirby, Andrew; Elliott, Amanda L.; Parkin, Melissa; Hubbell, Earl; Webster, Teresa; Mei, Rui; Veitch, James; Collins, Patrick J.; Handsaker, Robert; Lincoln, Steve; Nizzari, Marcia; Blume, John; Jones, Keith W.; Rava, Rich; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David			Integrated detection and population-genetic analysis of SNPs and copy number variation	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; POLYMORPHISMS; HAPLOTYPE; VARIANTS	Dissecting the genetic basis of disease risk requires measuring all forms of genetic variation, including SNPs and copy number variants (CNVs), and is enabled by accurate maps of their locations, frequencies and population-genetic properties. We designed a hybrid genotyping array (Affymetrix SNP 6.0) to simultaneously measure 906,600 SNPs and copy number at 1.8 million genomic locations. By characterizing 270 HapMap samples, we developed a map of human CNV (at 2-kb breakpoint resolution) informed by integer genotypes for 1,320 copy number polymorphisms (CNPs) that segregate at an allele frequency >1%. More than 80% of the sequence in previously reported CNV regions fell outside our estimated CNV boundaries, indicating that large (>100 kb) CNVs affect much less of the genome than initially reported. Approximately 80% of observed copy number differences between pairs of individuals were due to common CNPs with an allele frequency >5%, and more than 99% derived from inheritance rather than new mutation. Most common, diallelic CNPs were in strong linkage disequilibrium with SNPs, and most low-frequency CNVs segregated on specific SNP haplotypes.	[McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Nemesh, James; Wysoker, Alec; de Bakker, Paul I. W.; Elliott, Amanda L.; Parkin, Melissa; Handsaker, Robert; Nizzari, Marcia; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David] MIT, Broad Inst, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Nemesh, James; Wysoker, Alec; de Bakker, Paul I. W.; Elliott, Amanda L.; Parkin, Melissa; Handsaker, Robert; Nizzari, Marcia; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David] Harvard Univ, Cambridge, MA 02142 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Maller, Julian B.; Kirby, Andrew; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; de Bakker, Paul I. W.; Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Korn, Joshua M.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Cawley, Simon; Shapero, Michael H.; Hubbell, Earl; Webster, Teresa; Mei, Rui; Veitch, James; Collins, Patrick J.; Lincoln, Steve; Blume, John; Jones, Keith W.; Rava, Rich] Affymetrix Inc, Santa Clara, CA 95051 USA; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Partners HealthCare Syst Ctr Genet & Genom, Boston, MA 02115 USA; [Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Affymetrix; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts General Hospital	McCarroll, SA (corresponding author), MIT, Broad Inst, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA.	smccarro@broad.mit.edu; altshuler@molbio.mgh.harvard.edu	McCarroll, Steven A/A-8433-2009; Daly, Mark J/B-2453-2017; Elliott, Amanda/G-5120-2012; Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009; maller, julian B/A-9323-2009; Handsaker, Bob/AAX-9095-2021	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Handsaker, Bob/0000-0002-3128-3547; Blume, John/0000-0003-3026-953X; Maller, Julian/0000-0002-1565-9559; Hubbell, Earl/0000-0001-7301-3759; McCarroll, Steven/0000-0002-6954-8184				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antipova AA, 2002, GENOME BIOL, V3; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shen F, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-27; Smemo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000287; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	29	692	725	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1166	1174		10.1038/ng.238	http://dx.doi.org/10.1038/ng.238			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776908				2022-12-25	WOS:000259651000015
J	Graham, RR; Cotsapas, C; Davies, L; Hackett, R; Lessard, CJ; Leon, JM; Burtt, NP; Guiducci, C; Parkin, M; Gates, C; Plenge, RM; Behrens, TW; Wither, JE; Rioux, JD; Fortin, PR; Graham, DC; Wong, AK; Vyse, TJ; Daly, MJ; Altshuler, D; Moser, KL; Gaffney, PM				Graham, Robert R.; Cotsapas, Chris; Davies, Leela; Hackett, Rachel; Lessard, Christopher J.; Leon, Joanlise M.; Burtt, Noel P.; Guiducci, Candace; Parkin, Melissa; Gates, Casey; Plenge, Robert M.; Behrens, Timothy W.; Wither, Joan E.; Rioux, John D.; Fortin, Paul R.; Graham, Deborah Cunninghame; Wong, Andrew K.; Vyse, Timothy J.; Daly, Mark J.; Altshuler, David; Moser, Kathy L.; Gaffney, Patrick M.			Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							RHEUMATOID-ARTHRITIS; UNITED-STATES; A20; ITGAM; RISK	Systemic lupus erythematosus (SLE) is an autoimmune disease influenced by genetic and environmental factors. We carried out a genome-wide association scan and replication study and found an association between SLE and a variant in TNFAIP3 (rs5029939, meta-analysis P = 2.89 x 10-(12), OR = 2.29). We also found evidence of two independent signals near TNFAIP3 associated with SLE, including one previously associated with rheumatoid arthritis ( RA). These results establish that variants near TNFAIP3 contribute to differential risk of SLE and RA.	[Lessard, Christopher J.; Moser, Kathy L.; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthritis & Immunol Res Program, Oklahoma City, OK 73104 USA; [Graham, Robert R.; Cotsapas, Chris; Davies, Leela; Hackett, Rachel; Burtt, Noel P.; Guiducci, Candace; Parkin, Melissa; Gates, Casey; Plenge, Robert M.; Daly, Mark J.; Altshuler, David] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Cotsapas, Chris; Daly, Mark J.] Harvard Univ, Sch Med, Mass Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cotsapas, Chris; Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Lessard, Christopher J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Leon, Joanlise M.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Wither, Joan E.] Arthritis Ctr Excellence, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Toronto Western Hosp, Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Wither, Joan E.; Fortin, Paul R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rioux, John D.] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Fortin, Paul R.] Univ Hlth Network, Univ Toronto Lupus Clin, Ctr Prognosis Studies Rheumat Dis, Toronto Western Hosp, Toronto, ON, Canada; [Graham, Deborah Cunninghame; Wong, Andrew K.; Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Mol Genet & Rheumatol Sect, London, England	Oklahoma Medical Research Foundation; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; Genentech; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Imperial College London	Gaffney, PM (corresponding author), Oklahoma Med Res Fdn, Arthritis & Immunol Res Program, Oklahoma City, OK 73104 USA.	gaffneyp@lupus.omrf.org	Daly, Mark J/B-2453-2017; Wong, Andrew/M-8899-2016; Rioux, John D/A-9599-2015; Wong, Andrew/AAE-6995-2019; Altshuler, David M/A-4476-2009	Daly, Mark J/0000-0002-0949-8752; Wong, Andrew/0000-0003-2079-4779; Rioux, John D/0000-0001-7560-8326; Wong, Andrew/0000-0003-2079-4779; Altshuler, David M/0000-0002-7250-4107; Wither, Joan/0000-0001-5961-9228; Fortin, Paul R./0000-0002-7278-2596; Lessard, Christopher J./0000-0003-2440-3843; Gaffney, Patrick/0000-0002-1580-869X; Cotsapas, Chris/0000-0002-7772-5910	US National Institutes of Health [AI063274, AR052125, AR043247]; NIH NSRA award [5F32AR50927-RRG]; Lupus Foundation of Minnesota; Arthritis Foundation; Wellcome Trust [076113]; ENH/Northwestern University [MH059571]; Emory University School of Medicine [MH59587]; Louisiana State University Health Sciences Center, New Orleans, Louisiana [MH067257]; University of California-Irvine [MH60870]; Washington University, St. Louis [U01, MH060879]; University of Iowa, Iowa [MH59566]; University of Colorado [MH059565]; University of Pennsylvania [MH061675]; University of Queensland [MH059588]; Mt. Sinai School of Medicine [MH59586]; Massachusetts General Hospital [63420]; Canadian Institute of Health Research [CIHR 62840]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063274, R01AI063274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR050927, R01AR052125, R01AR056768, P30AR053483, K08AR002105, R01AR043274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061675, R01MH059566, R01MH060870, R01MH067257, R01MH059588, R01MH059587, R01MH059586, R01MH060879, R01MH059565, R01MH063420, R01MH059571] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NSRA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Foundation of Minnesota; Arthritis Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); ENH/Northwestern University; Emory University School of Medicine; Louisiana State University Health Sciences Center, New Orleans, Louisiana; University of California-Irvine(University of California System); Washington University, St. Louis; University of Iowa, Iowa; University of Colorado; University of Pennsylvania; University of Queensland(University of Queensland); Mt. Sinai School of Medicine; Massachusetts General Hospital(General Electric); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work was obtained from the US National Institutes of Health (grants AI063274 (P. M. G.), AR052125 (P. M. G.) and AR043247 (K. L. M.)), NIH NSRA award (5F32AR50927-RRG), Lupus Foundation of Minnesota (P. M. G., K. L. M.) and the Arthritis Foundation (K. L. M.).; This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. Permission for use of these data was obtained from the oversight committees of the respective cohorts. Control subjects from the National Institute of Mental Health Schizophrenia Genetics Initiative (NIMH-GI), data and biomaterials are being collected by the "Molecular Genetics of Schizophrenia II'' (MGS-2) collaboration. The investigators and co-investigators are as follows: ENH/Northwestern University, MH059571, P. V. Gejman (Collaboration Coordinator; PI), A. R. Sanders; Emory University School of Medicine, MH59587, F. Amin (PI); Louisiana State University Health Sciences Center, New Orleans, Louisiana, MH067257, N. Buccola (PI); University of California-Irvine, MH60870, W. Byerley (PI); Washington University, St. Louis, U01, MH060879, C. R. Cloninger (PI); University of Iowa, Iowa, MH59566, R. Crowe (PI), D. Black; University of Colorado, MH059565, R. Freedman (PI); University of Pennsylvania, MH061675, D. Levinson (PI); University of Queensland, MH059588, B. Mowry (PI); Mt. Sinai School of Medicine, MH59586, J. Silverman (PI). The samples were collected by V. L. Nimgaonkar's group at the University of Pittsburgh, as part of a multi-institutional collaborative research project with J. Smoller and P. Sklar (Massachusetts General Hospital) (grant MH 63420). We thank T. Hudson for helpful discussions, T. McKenzie for coordinating the GenES study, J.O. Claudio for ensuring ethics approval of DNA sample sharing, J. Su for assistance with management of the GenES database and all the CaNIOS investigators that have contributed to GenES. GenES is funded by the Canadian Institute of Health Research (CIHR# 62840).; We thank S. Gabriel and the entire Affymetrix genotyping team at the Broad Institute of Harvard and MIT. We thank F. Kuruvilla, J. Korn and S. McCarroll for assistance with the Birdseed genotype-calling algorithm.; We would also like to acknowledge the research assistants and coordinators that recruited the individuals in the study. Most importantly, we thank the individuals who have participated in and contributed to these studies.	Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; KASLOW RA, 1978, ARTHRITIS RHEUM-US, V21, P473, DOI 10.1002/art.1780210412; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	12	441	452	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1059	1061		10.1038/ng.200	http://dx.doi.org/10.1038/ng.200			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165918	Green Accepted			2022-12-25	WOS:000258761200016
J	Kahn, ML				Kahn, Mark L.			Counteracting clotting in sepsis	NATURE MEDICINE			English	Editorial Material							ACTIVATED PROTEIN-C; COAGULATION; RECEPTOR-1		Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Kahn, ML (corresponding author), Univ Penn, 925 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	markkahn@med.upenn.edu						Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Camerer E, 2006, BLOOD, V107, P3912, DOI 10.1182/blood-2005-08-3130; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; MANASSE P, 1982, VIRCHOWS ARCH, V130, P217; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zheng X, 2007, J THROMB HAEMOST, V5, P1394, DOI 10.1111/j.1538-7836.2007.02592.x	13	6	7	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2008	14	9					918	919		10.1038/nm0908-918	http://dx.doi.org/10.1038/nm0908-918			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	345IB	18776884				2022-12-25	WOS:000258988600015
J	Kong, A; Masson, G; Frigge, ML; Gylfason, A; Zusmanovich, P; Thorleifsson, G; Olason, PI; Ingason, A; Steinberg, S; Rafnar, T; Sulem, P; Mouy, M; Jonsson, F; Thorsteinsdottir, U; Gudbjartsson, DF; Stefansson, H; Stefansson, K				Kong, Augustine; Masson, Gisli; Frigge, Michael L.; Gylfason, Arnaldur; Zusmanovich, Pasha; Thorleifsson, Gudmar; Olason, Pall I.; Ingason, Andres; Steinberg, Stacy; Rafnar, Thorunn; Sulem, Patrick; Mouy, Magali; Jonsson, Frosti; Thorsteinsdottir, Unnur; Gudbjartsson, Daniel F.; Stefansson, Hreinn; Stefansson, Kari			Detection of sharing by descent, long-range phasing and haplotype imputation	NATURE GENETICS			English	Article							POPULATION GENOTYPE DATA; GENOME-WIDE ASSOCIATION; BREAST-CANCER FAMILIES; LUNG-CANCER; SUSCEPTIBILITY LOCUS; RECOMBINATION RATES; NICOTINE DEPENDENCE; GENES; RECONSTRUCTION; HUMANS	Uncertainty about the phase of strings of SNPs creates complications in genetic analysis, although methods have been developed for phasing population-based samples. However, these methods can only phase a small number of SNPs effectively and become unreliable when applied to SNPs spanning many linkage disequilibrium (LD) blocks. Here we show how to phase more than SNPs simultaneously for a large fraction of the 35,528 Icelanders genotyped by Illumina chips. Moreover, haplotypes that are identical by descent (IBD) between close and distant relatives, for example, those separated by ten meioses or more, can often be reliably detected. This method is particularly powerful in studies of the inheritance of recurrent mutations and fine-scale recombinations in large sample sets. A further extension of the method allows us to impute long haplotypes for individuals who are not genotyped.	[Kong, Augustine; Stefansson, Kari] deCODE genet, Reykjavik, Iceland		Kong, A (corresponding author), deCODE genet, Strulugata 8, Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Stefansson, Kari/AAE-7187-2019; Ingason, Andres/G-6817-2012	Kong, Augustine/0000-0001-8193-5438; Stefansson, Hreinn/0000-0002-9331-6666; Gudbjartsson, Daniel/0000-0002-5222-9857	NIDA NIH HHS [R01 DA017932] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; GOFFMAN C, 1969, AM MATH MON, V76, P791, DOI 10.2307/2317868; Gudmundsson J, 1996, AM J HUM GENET, V58, P749; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; STEFANSSON H, 2008, NATURE          0730; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	23	303	310	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1068	1075		10.1038/ng.216	http://dx.doi.org/10.1038/ng.216			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165921	Green Accepted			2022-12-25	WOS:000258761200019
J	Krishnamoorthy, L; Bess, JW; Preston, AB; Nagashima, K; Mahal, LK				Krishnamoorthy, Lakshmi; Bess, Julian W., Jr.; Preston, Alex B.; Nagashima, Kunio; Mahal, Lara K.			HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin	NATURE CHEMICAL BIOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNOAFFINITY DEPLETION; LECTIN MICROARRAY; BINDING-PROTEINS; PLASMA-MEMBRANE; INFECTIVITY; GLYCANS; MACROPHAGES; RECOGNITION; GALECTIN-1	HIV-1 is a master at deceiving the immune system and usurping host biosynthetic machinery. Although HIV-1 is coated with host-derived glycoproteins, only glycosylation of viral gp120 has been described. Here we use lectin microarray technology to analyze the glycome of intact HIV-1 virions. We show that the glycan coat of human T cell line-derived HIV-1 matches that of native immunomodulatory microvesicles. The carbohydrate composition of both virus and microvesicles is cell-line dependent, which suggests a mechanism to rapidly camouflage the virus within the host. In addition, binding of both virus and microvesicles to antiviral lectins is enriched over the host cell, raising concern about targeting these glycans for therapeutics. This work also sheds light on the binding of HIV-1 to galectin-1, an important human immune lectin. Overall, our work strongly supports the theory that HIV-1 co-opts the exocytic pathway of microvesicles, thus potentially explaining why eliciting a protective antiviral immune response is difficult.	[Krishnamoorthy, Lakshmi; Preston, Alex B.; Mahal, Lara K.] Univ Texas Austin, Dept Chem & Biochem, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Krishnamoorthy, Lakshmi; Preston, Alex B.; Mahal, Lara K.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Bess, Julian W., Jr.] NCI, AIDS Vaccine Program, Frederick, MD USA; [Nagashima, Kunio] NCI, SAIC Frederick Inc, Image Anal Lab, Frederick, MD USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Mahal, LK (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	lmahal@cm.utexas.edu	Mahal, Lara/GRY-7287-2022	Krishnamoorthy, Lakshmi/0000-0002-3469-8166; Krishnamoorthy, Lakshmi/0000-0002-4083-526X; Mahal, Lara/0000-0003-4791-8524	Consortium for Functional Glycomics [GM62116]; US National Science Foundation; National Cancer Institute, National Institutes of Health [N01-CO-12400]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Consortium for Functional Glycomics; US National Science Foundation(National Science Foundation (NSF)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Bohn, J. Miller and B. Imming (AIDS Vaccine Program, NCI-Frederick) for help with virus and microvesicle purification; E. Chertova and D. Roser (AIDS Vaccine Program, NCI-Frederick) for biochemical analysis of the samples; D. Graham (University of Texas, Austin) for generous use of his ultracentrifuge; L. Baum (UCLA Medical School) for the generous gift of galectin-1; B. O'Keefe (NCI-Frederick) for the generous gift of cyanovirin, scytovirin and griffithsin; E. Thoyakulathu for help in the lectin analysis; University of Texas at Austin Microarray Core Facility; and J. Lifson (NCI- Frederick) for insightful reading of the manuscript. We thank Q. Sattentau (University of Oxford) for the Jurkat-Tat-CCR5 cells. In addition, we wish to acknowledge the Consortium for Functional Glycomics (grant number GM62116) for publicly available glycan array data from their database used in this work. Funding was provided by the Arnold and Mabel Beckman Foundation (L. K. M.) and the US National Science Foundation (CAREER CHE-0644530, L. K. M.), and by federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400 (J. W. B.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bess JW, 1997, VIROLOGY, V230, P134, DOI 10.1006/viro.1997.8499; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Chertova E, 2003, CURR MOL MED, V3, P265, DOI 10.2174/1566524033479889; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Coren LV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-64; Esser MT, 2001, J VIROL, V75, P6173, DOI 10.1128/JVI.75.13.6173-6182.2001; Gaskill PJ, 2008, J VIROL, V82, P1615, DOI 10.1128/JVI.01757-07; Gluschankof P, 1997, VIROLOGY, V230, P125, DOI 10.1006/viro.1997.8453; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; HOXIE JA, 1987, HUM IMMUNOL, V18, P39, DOI 10.1016/0198-8859(87)90111-X; Hsu KL, 2006, NAT PROTOC, V1, P543, DOI 10.1038/nprot.2006.76; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; LABRANCHE CC, 1994, J VIROL, V68, P5509, DOI 10.1128/JVI.68.9.5509-5522.1994; Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; OTT DE, 1995, J VIROL, V69, P2443, DOI 10.1128/JVI.69.4.2443-2450.1995; Ouellet M, 2005, J IMMUNOL, V174, P4120, DOI 10.4049/jimmunol.174.7.4120; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Swaminathan GJ, 1999, BIOCHEMISTRY-US, V38, P13837, DOI 10.1021/bi990756e; Tejler J, 2007, CARBOHYD RES, V342, P1869, DOI 10.1016/j.carres.2007.03.012; Trubey CM, 2003, J VIROL, V77, P12699, DOI 10.1128/JVI.77.23.12699-12709.2003; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003	43	123	127	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2009	5	4					244	250		10.1038/nchembio.151	http://dx.doi.org/10.1038/nchembio.151			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	422KH	19234452	Green Accepted			2022-12-25	WOS:000264426100013
J	Oh, YM; Kwon, YE; Kim, JM; Bae, SJ; Lee, BK; Yoo, SJ; Chung, CH; Deshaies, RJ; Seol, JH				Oh, Young Mi; Kwon, Young Eun; Kim, Joo Mi; Bae, Sung Jun; Lee, Bo Keun; Yoo, Soon Ji; Chung, Chin Ha; Deshaies, Raymond J.; Seol, Jae Hong			Chfr is linked to tumour metastasis through the downregulation of HDAC1	NATURE CELL BIOLOGY			English	Article							MITOTIC CHECKPOINT PROTEIN; HISTONE DEACETYLASE-1; SUPPRESSOR GENE; E-CADHERIN; CANCER; DOMAIN; HYPERMETHYLATION; DEGRADATION; EXPRESSION; PROMOTER	Chfr is a ubiquitin ligase that functions in the mitotic checkpoint by delaying entry into metaphase in response to mitotic stress(1,2). It has been suggested that Chfr is a tumour suppressor as Chfr is frequently silenced in human cancers(3). To better understand how Chfr activity relates to cell-cycle progression and tumorigenesis, we sought to identify Chfr-interacting proteins using affinity purification combined with mass spectrometry. Histone deacetylase 1 (HDAC1), which represses transcription by deacetylating histones, was newly isolated as a Chfr-interacting protein. Chfr binds and downregulates HDAC1 by inducing its polyubiquitylation, both in vitro and in vivo. Ectopic expression of Chfr in cancer cells that normally do not express it results in downregulation of HDAC1, leading to upregulation of the Cdk inhibitor p21(CIP1/WAF1) and the metastasis suppressors KAI1 and E-cadherin. Coincident with these changes, cells arrest in the G1 phase of the cell cycle and become less invasive. Collectively, our data suggest that Chfr functions as a tumour suppressor by regulating HDAC1.	[Oh, Young Mi; Kwon, Young Eun; Kim, Joo Mi; Bae, Sung Jun; Lee, Bo Keun; Chung, Chin Ha; Seol, Jae Hong] Seoul Natl Univ, Sch Biol Sci, Res Ctr Funct Cellul, Seoul 151742, South Korea; [Yoo, Soon Ji] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Yoo, Soon Ji] Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea; [Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Seoul National University (SNU); Kyung Hee University; Kyung Hee University; California Institute of Technology	Seol, JH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Res Ctr Funct Cellul, Seoul 151742, South Korea.	jhseol@snu.ac.kr	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	Korea Science and Engineering Foundation [M10533010001-07N3301-00110]; SRC program [R11-2005-009-02002-0]; Korea Research Foundation [KRF2002-015-CS0069]; Seoul Science Fellowship	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); SRC program; Korea Research Foundation(National Research Foundation of Korea); Seoul Science Fellowship	We thank S. H. Baek ( SNU) for reagents. This work was supported by grants from the Korea Science and Engineering Foundation (M10533010001-07N3301-00110), the SRC program (R11-2005-009-02002-0), the Korea Research Foundation (KRF2002-015-CS0069) and the BK21 program. Y. E. K. was supported by the Seoul Science Fellowship.	Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chaturvedi P, 2002, CANCER RES, V62, P1797; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Li H, 2004, BIOCHEM BIOPH RES CO, V324, P860, DOI 10.1016/j.bbrc.2004.09.130; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj.onc.1205402; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Oh YM, 2007, BIOCHEM BIOPH RES CO, V357, P615, DOI 10.1016/j.bbrc.2007.03.193; Privette LM, 2007, CANCER RES, V67, P6064, DOI 10.1158/0008-5472.CAN-06-4109; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Tsai MD, 2002, STRUCTURE, V10, P887, DOI 10.1016/S0969-2126(02)00795-5; Wang AG, 2005, BIOL PHARM BULL, V28, P1966, DOI 10.1248/bpb.28.1966; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	25	64	70	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					295	U158		10.1038/ncb1837	http://dx.doi.org/10.1038/ncb1837			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182791				2022-12-25	WOS:000263777900013
J	Vicens, Q; Cech, TR				Vicens, Quentin; Cech, Thomas R.			A natural ribozyme with 3 ',5 ' RNA ligase activity	NATURE CHEMICAL BIOLOGY			English	Article							GROUP-I INTRONS; INTERVENING SEQUENCE; EVOLUTION; CIRCLES; ORIGIN; VITRO	Using electrophoresis, sequencing and enzymatic digestion, we show that the group I intron from the cyanobacterium Anabaena sp. PCC 7120 catalyzes phosphodiester bond formation using a triphosphate on the 5'-terminal nucleotide, much like protein polymerases and engineered ribozymes. In the process, this ribozyme forms a unique circular RNA that incorporates the exogenous guanosine cofactor added during self-splicing. This finding may have relevance to a prebiotic RNA world and to modern biology.	[Vicens, Quentin; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Vicens, Q (corresponding author), Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, UCB 215, Boulder, CO 80309 USA.	quentin.vicens@colorado.edu	Vicens, Quentin/N-6139-2019; Vicens, Quentin/A-8319-2009	Vicens, Quentin/0000-0003-3751-530X; Vicens, Quentin/0000-0003-3751-530X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Beckert B, 2008, EMBO J, V27, P667, DOI 10.1038/emboj.2008.4; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; CECH TR, 1993, RNA WORLD, P239; FERRIS JP, 1988, BIOCHEMISTRY-US, P1120; Golden BL, 1996, BIOCHEMISTRY-US, V35, P3754, DOI 10.1021/bi952599z; GRABOWSKI PJ, 1981, CELL, V23, P467, DOI 10.1016/0092-8674(81)90142-2; Hammann C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-210; Jaeger L, 1999, P NATL ACAD SCI USA, V96, P14712, DOI 10.1073/pnas.96.26.14712; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; KJEMS J, 1998, LAB TECHNIQUES BIOCH, P181; LOHRMANN R, 1978, TETRAHEDRON, V34, P853, DOI 10.1016/0040-4020(78)88129-0; MORL M, 1992, CELL, V70, P803, DOI 10.1016/0092-8674(92)90313-2; Murray HL, 2001, MOL CELL, V8, P201, DOI 10.1016/S1097-2765(01)00300-8; Nielsen H, 2003, RNA, V9, P1464, DOI 10.1261/rna.5290903; Orgel LE, 1998, TRENDS BIOCHEM SCI, V23, P491, DOI 10.1016/S0968-0004(98)01300-0; Vicens Q, 2008, RNA, V14, P2013, DOI 10.1261/rna.1027208; XU MQ, 1990, SCIENCE, V250, P1566, DOI 10.1126/science.2125747; Yoshioka W, 2004, RNA, V10, P1900, DOI 10.1261/rna.7170304; ZAUG AJ, 1993, BIOCHEMISTRY-US, V32, P7946, DOI 10.1021/bi00082a016; ZAUG AJ, 1983, NATURE, V301, P578, DOI 10.1038/301578a0	21	23	24	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					97	99		10.1038/nchembio.136	http://dx.doi.org/10.1038/nchembio.136			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19125157	Green Accepted			2022-12-25	WOS:000263090700013
J	Whitehead, KJ; Chan, AC; Navankasattusas, S; Koh, W; London, NR; Ling, J; Mayo, AH; Drakos, SG; Marchuk, DA; Davis, GE; Li, DY				Whitehead, Kevin J.; Chan, Aubrey C.; Navankasattusas, Sutip; Koh, Wonshill; London, Nyall R.; Ling, Jing; Mayo, Anne H.; Drakos, Stavros G.; Marchuk, Douglas A.; Davis, George E.; Li, Dean Y.			The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases	NATURE MEDICINE			English	Article							TRUNCATING MUTATIONS; ENCODING KRIT1; GENE; PROTEIN; EXPRESSION; KINASE; CCM1; ACTIVATION; HEMORRHAGE; STRESS	Cerebral cavernous malformation (CCM) is a common vascular dysplasia that affects both systemic and central nervous system blood vessels. Loss of function mutations in the CCM2 gene cause CCM. Here we show that targeted disruption of Ccm2 in mice results in failed lumen formation and early embryonic death through an endothelial cell autonomous mechanism. We show that CCM2 regulates endothelial cytoskeletal architecture, cell-to-cell interactions and lumen formation. Heterozygosity at Ccm2, a genotype equivalent to that in human CCM, results in impaired endothelial barrier function. On the basis of our biochemical studies indicating that loss of CCM2 results in activation of RHOA GTPase, we rescued the cellular phenotype and barrier function in heterozygous mice with simvastatin, a drug known to inhibit Rho GTPases. These data offer the prospect for pharmacological treatment of a human vascular dysplasia with a widely available and safe drug.	[Whitehead, Kevin J.; Li, Dean Y.] Univ Utah, Dept Med, Div Cardiol, Salt Lake City, UT 84132 USA; [Whitehead, Kevin J.; Chan, Aubrey C.; Navankasattusas, Sutip; London, Nyall R.; Ling, Jing; Drakos, Stavros G.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84132 USA; [Koh, Wonshill; Mayo, Anne H.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Marchuk, Douglas A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Missouri System; University of Missouri Columbia; Duke University	Whitehead, KJ (corresponding author), Univ Utah, Dept Med, Div Cardiol, 30 North 1900 East,Room 4A100, Salt Lake City, UT 84132 USA.	kevin.whitehead@hsc.utah.edu; dean.li@hmbg.utah.edu		Chan, Aubrey/0000-0002-9191-2173; Marchuk, Douglas/0000-0002-3110-6671	US National Institutes of Health [T32-GM007464]; Ruth L. Kirschstein National Research Service award; American Heart Association; Edna Benning Foundation; Juvenile Diabetes Research Foundation, the Burroughs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065648, R01HL077671, R01HL084516, R01HL068873, K02HL069774, K08HL079095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Edna Benning Foundation; Juvenile Diabetes Research Foundation, the Burroughs(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Colvin, C. Jones, W. Zhu and A. Frias for technical assistance; M. Sanguinetti, S. Odelberg and I. Benjamin for critical comments; M. Kahn, K. Thomas, M. Ginsberg and R. Stockton for helpful scientific discussions; and A. Hall ( Memorial Sloan- Kettering Cancer Center) for GTPase complementary DNA constructs. This work was funded by the US National Institutes of Health ( K. J. W., D. A. M., G. E. D. and D. Y. L.), including training grant T32-GM007464 ( A. C. C.) and a Ruth L. Kirschstein National Research Service award ( N. R. L.), the American Heart Association ( K. J. W. and D. Y. L.), the H. A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the Burroughs	Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; CHAPPELL PM, 1992, RADIOLOGY, V183, P719, DOI 10.1148/radiology.183.3.1584926; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Collisson EA, 2002, J INVEST DERMATOL, V119, P1172, DOI 10.1046/j.1523-1747.2002.19519.x; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Hasegawa T, 2002, NEUROSURGERY, V50, P1190, DOI 10.1097/00006123-200206000-00003; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Jung KH, 2003, ARCH NEUROL-CHICAGO, V60, P1613, DOI 10.1001/archneur.60.11.1613; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kranenburg O, 1997, J CELL SCI, V110, P2417; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Larson JJ, 1998, J NEUROSURG, V88, P51, DOI 10.3171/jns.1998.88.1.0051; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; MOHR C, 1992, FEBS LETT, V297, P95, DOI 10.1016/0014-5793(92)80335-E; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C; Petit N, 2006, GENE EXPR PATTERNS, V6, P495, DOI 10.1016/j.modgep.2005.11.001; Plummer NW, 2006, MAMM GENOME, V17, P119, DOI 10.1007/s00335-005-0098-8; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Sclafani AM, 2006, GENESIS, V44, P336, DOI 10.1002/dvg.20220; Seker A, 2006, STROKE, V37, P518, DOI 10.1161/01.STR.0000198835.49387.25; Shi C, 2007, J NEUROSURG, V107, P1023, DOI 10.3171/JNS-07/11/1023; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Toldo I, 2009, SURG NEUROL, V71, P167, DOI 10.1016/j.surneu.2007.07.067; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	41	259	266	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					177	184		10.1038/nm.1911	http://dx.doi.org/10.1038/nm.1911			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19151728	Green Accepted			2022-12-25	WOS:000263119400020
J	Hanafusa, H; Matsumoto, K; Nishida, E				Hanafusa, Hiroshi; Matsumoto, Kunihiro; Nishida, Eisuke			Regulation of ERK activity duration by Sprouty contributes to dorsoventral patterning	NATURE CELL BIOLOGY			English	Article							SIGNAL; SPECIFICITY; PROTEINS; EMBRYOS	Distinct modes of ERK activation, sustained or transient, are essential for cell fate decision in cultured cells. Here we show that Xenopus laevis Sprouty2 (XSpry2) controls the duration of ERK activity and thereby contributes to the establishment of dorsoventral patterning during mesoderm formation. furthermore, Xenopus Fos (XFos) can function as a molecular sensor of the ERK signalling duration in Xenopus embryos. this work provides the first evidence that regulating the duration of ERK activity contributes to cell fate decisions in the context of the whole organism.	[Hanafusa, Hiroshi; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hanafusa, Hiroshi; Matsumoto, Kunihiro] JST, SORST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Nagoya University; Japan Science & Technology Agency (JST); Kyoto University	Matsumoto, K (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44177a@nucc.cc.nagoya-u.ac.jp; L50174@sakura.kudpc.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Sasai, H. Kuroda, S. Kusakabe, M. Itoh and T. Ishitani for helpful discussion and suggestions. This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. M., H. H. and E. N.).	Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Christen B, 1999, DEVELOPMENT, V126, P119; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4	11	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					106	U222		10.1038/ncb1820	http://dx.doi.org/10.1038/ncb1820			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19122596				2022-12-25	WOS:000262157000018
J	Yamanaka, K; Maruyama, C; Takagi, H; Hamano, Y				Yamanaka, Kazuya; Maruyama, Chitose; Takagi, Hiroshi; Hamano, Yoshimitsu			epsilon-Poly-L-lysine dispersity is controlled by a highly unusual nonribosomal peptide synthetase	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-ALBULUS; BIOSYNTHESIS; DOMAINS; SYSTEM	epsilon-Poly-L-lysine (epsilon-PL) consists of 25-35 L-lysine residues in isopeptide linkages and is one of only two amino acid homopolymers known in nature. Elucidating the biosynthetic mechanism of epsilon-PL should open new avenues for creating novel classes of biopolymers. Here we report the purification of an epsilon-PL synthetase (Pls; 130 kDa) and the cloning of its gene from an epsilon-PL-producing strain of Streptomyces albulus. Pls was found to be a membrane protein with adenylation and thiolation domains characteristic of the nonribosomal peptide synthetases (NRPSs). It had no traditional condensation or thioesterase domain; instead, it had six transmembrane domains surrounding three tandem soluble domains. These tandem domains iteratively catalyzed L-lysine polymerization using free L-lysine polymer (or monomer in the initial reaction) as acceptor and Pls-bound L-lysine as donor, directly yielding chains of diverse length. Thus, Pls is a new single-module NRPS having an amino acid ligase-like catalytic activity for peptide bond formation.	[Maruyama, Chitose; Takagi, Hiroshi; Hamano, Yoshimitsu] Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui 9101195, Japan; [Yamanaka, Kazuya] Chisso Corp, Yokohama Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 2368605, Japan	Fukui Prefectural University; Chisso Corporation	Hamano, Y (corresponding author), Fukui Prefectural Univ, Dept Biosci, 4-1-1 Matsuoka Kenjojima, Eiheiji, Fukui 9101195, Japan.	hamano@fpu.ac.jp	Yamanaka, Kazuya/AFQ-2728-2022	Yamanaka, Kazuya/0000-0002-6141-697X; Maruyama, Chitose/0000-0001-7354-9342				Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Hamano Y, 2006, APPL MICROBIOL BIOT, V72, P173, DOI 10.1007/s00253-006-0396-4; Hamano Y, 2005, J BIOSCI BIOENG, V99, P636, DOI 10.1263/jbb.99.636; Hamano Y., 2006, ACTINOMYCETOLOGICA, V20, P35; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Kawai T, 2003, BIOCHEM BIOPH RES CO, V311, P635, DOI 10.1016/j.bbrc.2003.10.033; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; KELLER U, 1987, J BIOL CHEM, V262, P5852; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Nishikawa M, 2002, APPL ENVIRON MICROB, V68, P3575, DOI 10.1128/AEM.68.7.3575-3581.2002; Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0; Saimura M, 2008, BIOTECHNOL LETT, V30, P377, DOI 10.1007/s10529-007-9563-7; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; SHIMA S, 1984, J ANTIBIOT, V37, P1449, DOI 10.7164/antibiotics.37.1449; Walsh C., 2003, ANTIBIOTICS ACTION O	19	120	142	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2008	4	12					766	772		10.1038/nchembio.125	http://dx.doi.org/10.1038/nchembio.125			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	373FH	18997795				2022-12-25	WOS:000260955900013
J	O'Maille, PE; Malone, A; Dellas, N; Hess, BA; Smentek, L; Sheehan, I; Greenhagen, BT; Chappell, J; Manning, G; Noel, JP				O'Maille, Paul E.; Malone, Arthur; Dellas, Nikki; Hess, B. Andes, Jr.; Smentek, Lidia; Sheehan, Iseult; Greenhagen, Bryan T.; Chappell, Joe; Manning, Gerard; Noel, Joseph P.			Quantitative exploration of the catalytic landscape separating divergent plant sesquiterpene synthases	NATURE CHEMICAL BIOLOGY			English	Article							MONOTERPENE SYNTHASE; EVOLUTION; PROTEIN; ENZYME; BIOSYNTHESIS; PHYTOALEXINS; EXPRESSION; PRODUCTS; CYCLASE; GENES	Throughout molecular evolution, organisms create assorted chemicals in response to varying ecological niches. Catalytic landscapes underlie metabolic evolution, wherein mutational steps alter the biosynthetic properties of enzymes. Here we report the first systematic quantitative characterization of the catalytic landscape underlying the evolution of sesquiterpene chemical diversity. On the basis of our previous discovery of a set of nine naturally occurring amino acid substitutions that functionally interconverted orthologous sesquiterpene synthases from Nicotiana tabacum and Hyoscyamus muticus, we created a library of all possible residue combinations (2(9) = 512) in the N. tabacum enzyme. The product spectra of 418 active enzymes revealed a rugged landscape where several minimal combinations of the nine mutations encode convergent solutions to the interconversions of parental activities. Quantitative comparisons indicated context dependence for mutational effects-epistasis-in product specificity and promiscuity. These results provide a measure of the mutational accessibility of phenotypic variability in a diverging lineage of terpene synthases.	[O'Maille, Paul E.; Malone, Arthur; Dellas, Nikki; Sheehan, Iseult; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Dellas, Nikki] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Hess, B. Andes, Jr.; Smentek, Lidia] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Smentek, Lidia] Nicholas Copernicus Univ, Inst Phys, PL-87100 Torun, Poland; [Greenhagen, Bryan T.; Chappell, Joe] Univ Kentucky, Dept Plant & Soil Sci, Plant Biol Program, Lexington, KY 40546 USA; [Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; Vanderbilt University; Nicolaus Copernicus University; University of Kentucky; Salk Institute	Noel, JP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noel@salk.edu	Manning, Gerard/C-8308-2009; Noel, Joseph P/A-9459-2009; Dellas, Nikki/E-7814-2013	Dellas, Nikki/0000-0002-4528-1729; Manning, Gerard/0000-0002-5087-9151	National Institutes of Health [GM54029]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Austin and J. Melnick for critical review of the manuscript, Y. Zhai for computational support and J. Gullberg and A. Nordstom for insightful discussions. This work was supported by National Institutes of Health grant GM54029 to J. C. and J. P. N. J. P. N. is supported by the Howard Hughes Medical Institute.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Back KW, 1998, PLANT CELL PHYSIOL, V39, P899, DOI 10.1093/oxfordjournals.pcp.a029452; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; FEENY P, 1992, HERBIVORES THEIR INT; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Grayer RJ, 2001, PHYTOCHEMISTRY, V56, P253, DOI 10.1016/S0031-9422(00)00450-7; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Harborne JB, 1999, BIOCHEM SYST ECOL, V27, P335, DOI 10.1016/S0305-1978(98)00095-7; Hyatt DC, 2005, ARCH BIOCHEM BIOPHYS, V439, P222, DOI 10.1016/j.abb.2005.05.017; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Mumm R, 2005, CHEM SENSES, V30, P337, DOI 10.1093/chemse/bji028; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Maille PE, 2006, ARCH BIOCHEM BIOPHYS, V448, P73, DOI 10.1016/j.abb.2005.10.028; O'Maille PE, 2004, ANAL BIOCHEM, V335, P210, DOI 10.1016/j.ab.2004.09.011; O'Maille PE, 2004, METHOD ENZYMOL, V388, P75; O'Maille PE, 2002, J MOL BIOL, V321, P677, DOI 10.1016/S0022-2836(02)00675-7; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pedras MSC, 2000, PHYTOCHEMISTRY, V53, P161, DOI 10.1016/S0031-9422(99)00494-X; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	34	139	147	3	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2008	4	10					617	623		10.1038/nchembio.113	http://dx.doi.org/10.1038/nchembio.113			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	349ZV	18776889	Green Accepted			2022-12-25	WOS:000259323100012
J	Sapieha, P; Sirinyan, M; Hamel, D; Zaniolol, K; Joyal, JS; Cho, JH; Honore, JC; Kermorvant-Duchemin, E; Varma, DR; Tremblay, S; Leduc, M; Rihakova, L; Hardy, P; Klein, WH; Mu, XQ; Mamer, O; Lachapelle, P; Di Polo, A; Beausiour, C; Andelfinger, G; Mitchell, G; Sennlaub, F; Chemtob, S				Sapieha, Przemyslaw; Sirinyan, Mirna; Hamel, David; Zaniolol, Karine; Joyal, Jean-Sebastien; Cho, Jang-Hyeon; Honore, Jean-Claude; Kermorvant-Duchemin, Elsa; Varma, Daya R.; Tremblay, Sophie; Leduc, Martin; Rihakova, Lenka; Hardy, Pierre; Klein, William H.; Mu, Xiuqian; Mamer, Orval; Lachapelle, Pierre; Di Polo, Adriana; Beausiour, Christian; Andelfinger, Gregor; Mitchell, Grant; Sennlaub, Florian; Chemtob, Sylvain			The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GANGLION-CELLS; ACID CYCLE; ALPHA-KETOGLUTARATE; MOUSE MODEL; HYPOXIA; EXPRESSION; VEGF; MECHANISMS; ISCHEMIA	Vascularization is essential for tissue development and in restoration of tissue integrity after an ischemic injury. in studies of vascularization, the focus has largely been placed on vascular endothelial growth factor (VEGF), yet other factors may also orchestrate this process. Here we show that succinate accumulates in the hypoxic retina of rodents and, via its cognate receptor G protein-coupled receptor-91 (GPR91), is a potent mediator of vessel growth in the settings of both normal retinal development and proliferative ischemic retinopathy. The effects of GPR91 are mediated by retinal ganglion neurons (RGCs), which, in response to increased succinate levels, regulate the production of numerous angiogenic factors including VEGF. Accordingly, succinate did not have proangiogenic effects in RGC-deficient rats. Our observations show a pathway of metabolite signaling where succinate, acting through GPR91, governs retinal angiogenesis and show the propensity of RGCs to act as sensors of ischemic stress. These findings provide a new therapeutic target for modulating revascularization.	[Sapieha, Przemyslaw; Sirinyan, Mirna; Joyal, Jean-Sebastien; Varma, Daya R.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Cho, Jang-Hyeon; Klein, William H.; Mu, Xiuqian] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kermorvant-Duchemin, Elsa; Sennlaub, Florian] Ctr Rech Cordeliers, Unite Mixte Rech Sci S 872, Inst Natl Sante & Rech Med, F-75006 Paris, France; [Mamer, Orval] McGill Univ Montreal, Dept Med, Mass Spectrometry Facil, Quebec City, PQ H3A 1A4, Canada; [Lachapelle, Pierre] McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Ophthalmol, Montreal, PQ H3H 1P3, Canada; [Lachapelle, Pierre] McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Neurol Neurosurg, Montreal, PQ H3H 1P3, Canada; [Sapieha, Przemyslaw; Sirinyan, Mirna; Hamel, David; Zaniolol, Karine; Joyal, Jean-Sebastien; Honore, Jean-Claude; Tremblay, Sophie; Leduc, Martin; Rihakova, Lenka; Hardy, Pierre; Beausiour, Christian; Andelfinger, Gregor; Mitchell, Grant; Chemtob, Sylvain] Univ Montreal, Ctr Hosp Univ St Justine, Res Ctr, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Sapieha, Przemyslaw; Sirinyan, Mirna; Hamel, David; Zaniolol, Karine; Joyal, Jean-Sebastien; Honore, Jean-Claude; Tremblay, Sophie; Leduc, Martin; Rihakova, Lenka; Hardy, Pierre; Beausiour, Christian; Andelfinger, Gregor; Mitchell, Grant; Chemtob, Sylvain] Univ Montreal, Ctr Hosp Univ St Justine, Res Ctr, Dept Pharmacol, Montreal, PQ H3T 1C5, Canada; [Di Polo, Adriana] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Sennlaub, Florian] Univ Paris 06, Unite Mixte Rech Sci S 872, F-75006 Paris, France; [Sennlaub, Florian] Univ Paris 05, Unite Mixte Rech Sci 872, F-75006 Paris, France	McGill University; University of Texas System; UTMD Anderson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Chemtob, S (corresponding author), Univ Montreal, Ctr Hosp Univ St Justine, Res Ctr, Dept Pediat, Montreal, PQ H3T 1C5, Canada.	sylvain.chemtob@umontreal.ca	Mu, Xiuqian/I-9146-2014; Sennlaub, Florian/F-2756-2017	Mu, Xiuqian/0000-0002-8003-7529; Sennlaub, Florian/0000-0003-4412-1341; Lachapelle, Pierre/0000-0002-7792-1102	Canadian Institutes of Health Research; March of Dimes Birth Defects Foundation; Heart and Stroke Foundation of Quebec; Fonds de la Recherche en Sante du Quebec; Heart and Stroke Foundation of Canada; Foundation Fighting Blindness Postdoctoral Fellowship Award; US National Eye Institute [EY011930]; Robert A. Welch Foundation [G-0010]; NATIONAL EYE INSTITUTE [R01EY011930] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); March of Dimes Birth Defects Foundation(March of Dimes); Heart and Stroke Foundation of Quebec; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Foundation Fighting Blindness Postdoctoral Fellowship Award; US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the Canadian Institutes of Health Research, the March of Dimes Birth Defects Foundation, the Heart and Stroke Foundation of Quebec and the Fonds de la Recherche en Sante du Quebec. P.S. and M.S. hold a Research Fellowship Award and a studentship from the Heart and Stroke Foundation of Canada, respectively. K.Z. is a recipient of The Foundation Fighting Blindness Postdoctoral Fellowship Award. F.S. and S.C are recipients of a fellowship and scientist awards, respectively, from the Canadian Institutes of Health Research. S.C. also holds a Canada Research Chair (perinatology). Generation of brn3b<SUP>Z-dtaf+</SUP>; six3-cre mice and J.-H.C's salart were supported by a US National Eye Institute grant EY011930 to W.H.K. and by the Robert A. Welch Foundation (G-0010), respectively. We wish to thank H. Fernandez and S. Leclere for valuable technical assistance	ADAIR TH, 1990, AM J PHYSIOL, V259, pR393, DOI 10.1152/ajpregu.1990.259.3.R393; Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Burns P. A., 2003, Angiogenesis, V6, P73, DOI 10.1023/A:1025862731653; Cai WY, 2000, INVEST OPHTH VIS SCI, V41, P1885; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; Cringle SJ, 2006, INVEST OPHTH VIS SCI, V47, P4072, DOI 10.1167/iovs.05-1638; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; DREHER B, 1988, BRAIN BEHAV EVOLUT, V31, P369, DOI 10.1159/000116602; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; FOLBERGR.J, 1974, BRAIN RES, V80, P265, DOI 10.1016/0006-8993(74)90690-8; FRANCOIS J, 1974, EYE, V5, P1; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; GUTMAN M, 1980, BIOCHIM BIOPHYS ACTA, V591, P400, DOI 10.1016/0005-2728(80)90171-1; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; HEMS DA, 1970, BIOCHEM J, V120, P105, DOI 10.1042/bj1200105; Higgins RD, 1999, CURR EYE RES, V18, P20, DOI 10.1076/ceyr.18.1.20.5390; HOYER S, 1986, NEUROBIOL AGING, V7, P23, DOI 10.1016/0197-4580(86)90022-9; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; HUXLIN KR, 1995, GLIA, V15, P105, DOI 10.1002/glia.440150203; Ikeda M, 2000, J PATHOL, V191, P426; Iriyama A, 2007, BRIT J OPHTHALMOL, V91, P1230, DOI 10.1136/bjo.2007.117309; JOHNSON FM, 1968, BIOCHEM GENET, V2, P1, DOI 10.1007/BF01458447; JOHNSON RN, 1975, BIOCHEM J, V146, P527, DOI 10.1042/bj1460527; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kushnir MM, 2001, CLIN CHEM, V47, P1993; Lee MS, 2001, CANCER RES, V61, P3290; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; MATTHEWS PM, 1994, CLIN NEUROPATHOL, V13, P139; McColm J, 2004, MOL VIS, V10, P512; MEIXNERMONORI B, 1985, J BACTERIOL, V161, P265, DOI 10.1128/JB.161.1.265-271.1985; MICHAELSON IC, 1954, RETINAL CIRCULATION, pCH1; Mu XQ, 2005, CURR BIOL, V15, P525, DOI 10.1016/j.cub.2005.01.043; Murray Brenda, 2001, Angiogenesis, V4, P71, DOI 10.1023/A:1016792319207; NEUMAN RE, 1958, P SOC EXP BIOL MED, V98, P303, DOI 10.3181/00379727-98-24025; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; PENN JS, 1994, PEDIATR RES, V36, P724, DOI 10.1203/00006450-199412000-00007; Piao YS, 2006, NEUROPATHOLOGY, V26, P218, DOI 10.1111/j.1440-1789.2006.00686.x; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1997, SCIENCE, V276, P1706, DOI 10.1126/science.276.5319.1706; Stowe AM, 2007, J CEREBR BLOOD F MET, V27, P76, DOI 10.1038/sj.jcbfm.9600320; Usui T, 2004, INVEST OPHTH VIS SCI, V45, P368, DOI 10.1167/iovs.03-0106; Van Adel BA, 2003, HUM GENE THER, V14, P103, DOI 10.1089/104303403321070801; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Wittenberger T, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-17; Zhu T, 2006, ARTERIOSCL THROM VAS, V26, P744, DOI 10.1161/01.ATV.0000205591.88522.d4	59	260	274	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1067	1076		10.1038/nm.1873	http://dx.doi.org/10.1038/nm.1873			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18836459				2022-12-25	WOS:000259892300037
J	Steiger, D; Furrer, M; Schwinkendorf, D; Gallant, P				Steiger, Dominik; Furrer, Michael; Schwinkendorf, Daniela; Gallant, Peter			Max-independent functions of Myc in Drosophila melanogaster	NATURE GENETICS			English	Article							POLYMERASE-III TRANSCRIPTION; C-MYC; CELL-GROWTH; FACTOR NETWORK; RIBOSOMAL DNA; DMYC; APOPTOSIS; PROTEIN; TRANSFORMATION; PROLIFERATION	Myc proteins are powerful proto-oncoproteins and important promoters of growth and proliferation during normal development. They are thought to exercise their effects upon binding to their partner protein Max, and their activities are largely antagonized by complexes of Max with Mnt or an Mxd family protein. Although the biological functions of Myc, Mxd and Mnt have been intensively studied, comparatively little is known about the in vivo role of Max. Here we generate Max loss-of-function and reduction-of-function mutations in Drosophila melanogaster to address the contribution of Max to Myc-dependent growth control. We find that many biological activities of Myc do not, or only partly, require the association with Max - for example, the control of endoreplication and cell competition - and that a Myc mutant that does not interact with Max retains substantial biological activity. We further show that Myc can control RNA polymerase III independently of Max, which explains some of Myc's observed biological activities. These studies show the ability of Myc to function independently of Max in vivo and thus change the current model of Max network function.	[Steiger, Dominik; Furrer, Michael; Schwinkendorf, Daniela; Gallant, Peter] Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Zurich	Gallant, P (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gallant@zool.uzh.ch	Steiger, Dominik/F-1092-2010	Steiger, Dominik/0000-0003-2191-8091	Schweizerische Nationalfonds (SNF)	Schweizerische Nationalfonds (SNF)(Swiss National Science Foundation (SNSF))	We thank S. Pierce and R. Eisenman (Fred Hutchinson Cancer Research Center) for providing us with a dm Mnt recombinant chromosome before publication; K. Basler, J. Bischof (University of Zurich), E. Hafen, H. Stocker (ETH Zurich), S. Takada (MD Anderson) and D. Stein (University of Texas, Austin) for flies and antibodies; H. Stocker and C. Hugentobler for advice; N. Muller, R. Perez and other members of the lab for technical help and support; O. Carreno, L. Damerius, N. Arnold, N. Meier and S. Peterhans for help with fly work; and K. Basler and R. Eisenman for critical comments on the manuscript. This work was financially supported by a grant from the Schweizerische Nationalfonds (SNF).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bellosta P, 2005, P NATL ACAD SCI USA, V102, P11799, DOI 10.1073/pnas.0408945102; Benassayag C, 2005, MOL CELL BIOL, V25, P9897, DOI 10.1128/MCB.25.22.9897-9909.2005; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hong SL, 2000, GENE DEV, V14, P17; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Hurlin PJ, 2003, EMBO J, V22, P4584, DOI 10.1093/emboj/cdg442; Isogai Y, 2007, EMBO J, V26, P76, DOI 10.1038/sj.emboj.7601448; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; LAROCCA SA, 1994, ONCOGENE, V9, P3499; Loo LWM, 2005, MOL CELL BIOL, V25, P7078, DOI 10.1128/MCB.25.16.7078-7091.2005; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nilsson JA, 2004, MOL CELL BIOL, V24, P1560, DOI 10.1128/MCB.24.4.1560-1569.2004; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pierce SB, 2008, DEV BIOL, V315, P303, DOI 10.1016/j.ydbio.2007.12.026; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Prober DA, 2001, CURR OPIN GENET DEV, V11, P19, DOI 10.1016/S0959-437X(00)00151-9; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wert M, 2001, ONCOGENE, V20, P3746, DOI 10.1038/sj.onc.1204466	50	78	81	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1084	1091		10.1038/ng.178	http://dx.doi.org/10.1038/ng.178			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165923				2022-12-25	WOS:000258761200021
J	Zhan, YP; Du, XP; Chen, HZ; Liu, JJ; Zhao, BX; Huang, DH; Li, GD; Xu, QY; Zhang, MQ; Weimer, BC; Chen, D; Cheng, Z; Zhang, LR; Li, QX; Li, SW; Zheng, ZH; Song, SY; Huang, YJ; Ye, ZY; Su, WJ; Lin, SC; Shen, YM; Wu, Q				Zhan, Yanyan; Du, Xiping; Chen, Hangzi; Liu, Jingjing; Zhao, Bixing; Huang, Danhong; Li, Guideng; Xu, Qingyan; Zhang, Mingqing; Weimer, Bart C.; Chen, Dong; Cheng, Zhe; Zhang, Lianru; Li, Qinxi; Li, Shaowei; Zheng, Zhonghui; Song, Siyang; Huang, Yaojian; Ye, Zhiyun; Su, Wenjin; Lin, Sheng-Cai; Shen, Yuemao; Wu, Qiao			Cytosporone B is an agonist for nuclear orphan receptor Nur77	NATURE CHEMICAL BIOLOGY			English	Article							GASTRIC-CANCER CELLS; RETINOID-X-RECEPTOR; NGFI-B; COACTIVATOR RECRUITMENT; GLUCOSE-METABOLISM; LIGAND-BINDING; APOPTOSIS; GAMMA; TR3; TRANSACTIVATION	Nuclear orphan receptor Nur77 has important roles in many biological processes. However, a physiological ligand for Nur77 has not been identified. Here, we report that the octaketide cytosporone B (Csn-B) is a naturally occurring agonist for Nur77. Csn-B specifically binds to the ligand-binding domain of Nur77 and stimulates Nur77-dependent transactivational activity towards target genes including Nr4a1 (Nur77) itself, which contains multiple consensus response elements allowing positive autoregulation in a Csn-B-dependent manner. Csn-B also elevates blood glucose levels in fasting C57 mice, an effect that is accompanied by induction of multiple genes involved in gluconeogenesis. These biological effects were not observed in Nur77-null (Nr4a1(-/-)) mice, which indicates that Csn-B regulates gluconeogenesis through Nur77. Moreover, Csn-B induced apoptosis and retarded xenograft tumor growth by inducing Nur77 expression, translocating Nur77 to mitochondria to cause cytochrome c release. Thus, Csn-B may represent a promising therapeutic drug for cancers and hypoglycemia, and it may also be useful as a reagent to increase understanding of Nur77 biological function.	[Zhan, Yanyan; Du, Xiping; Chen, Hangzi; Liu, Jingjing; Zhao, Bixing; Huang, Danhong; Li, Guideng; Xu, Qingyan; Zhang, Mingqing; Cheng, Zhe; Zhang, Lianru; Li, Qinxi; Li, Shaowei; Zheng, Zhonghui; Song, Siyang; Huang, Yaojian; Ye, Zhiyun; Su, Wenjin; Lin, Sheng-Cai; Shen, Yuemao; Wu, Qiao] Xiamen Univ, Sch Life Sci, Minist Educ Cell Biol & Tumor Cell Engn, Key Lab, Xiamen 361005, Peoples R China; [Weimer, Bart C.; Chen, Dong] Utah State Univ, Ctr Integrated Biosyst, Logan, UT 84322 USA	Xiamen University; Utah System of Higher Education; Utah State University	Lin, SC (corresponding author), Xiamen Univ, Sch Life Sci, Minist Educ Cell Biol & Tumor Cell Engn, Key Lab, 422 S Siming Rd, Xiamen 361005, Peoples R China.	linsc@xmu.edu.cn; yshen@xmu.edu.cn; qiaow@xmu.edu.cn	Huang, YJ/G-4624-2010; Lin, SC/G-4666-2010; Zheng, ZH/G-4657-2010; Weimer, Bart/AAK-8501-2021; Li, QX/G-4669-2010; Wu, Q/G-4646-2010; Weimer, Bart C/G-6928-2012; Shen, YM/G-4681-2010; LI, Guideng/A-7183-2012	Weimer, Bart/0000-0002-7471-1978; Weimer, Bart C/0000-0002-7471-1978; Shen, Yuemao/0000-0002-3881-0135; Cheng, Zhe/0000-0003-4764-0163	National Natural Science Fund of China [30630070, 30425014, 30325044]; Ministry of Science and Technology [2006CB503905, 2004CB518800, 2007CB914402]; Ministry of Education [706036, 306010, 705030]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education	We are grateful to S. Safe (Institute of Biosciences and Technology, Texas A&M University Health Science Center) for the vectors of GAL4-Nur77 and GAL4-LBD. We also thank F. Chen (Cancer Research Center, Xiamen University) for help with mouse experiments. This work was supported by grants from the National Natural Science Fund of China (30630070 and 30425014 to Q. W., 30325044 to Y.S.), grants from the "973'' Project of the Ministry of Science and Technology (2006CB503905 to S.-C. L., 2004CB518800 and 2007CB914402 to Q. W.) and grants from the Ministry of Education (706036 to Q. W., 306010 to Y.S. and 705030 to S.-C. L.). Q. W., Y.S. and S.-C. L. are recipients of the National Science Fund for Distinguished Young Scholars. S.-C.L. is a Cheung Kong Scholar.	Agostini M, 2004, ENDOCRINOLOGY, V145, P1527, DOI 10.1210/en.2003-1271; Auwerx J, 1999, CELL, V97, P161; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Brady SF, 2000, ORG LETT, V2, P4043, DOI 10.1021/ol006680s; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; CHEN ZP, 1994, J BIOL CHEM, V269, P25770; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Cheskis BJ, 1997, J BIOL CHEM, V272, P11384; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; Kagaya S, 2005, INT ARCH ALLERGY IMM, V137, P35, DOI 10.1159/000085430; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin XF, 2004, J CELL SCI, V117, P5609, DOI 10.1242/jcs.01474; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Najarian T, 2000, J APPL PHYSIOL, V89, P777, DOI 10.1152/jappl.2000.89.2.777; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Ray DW, 1999, MOL ENDOCRINOL, V13, P1855, DOI 10.1210/me.13.11.1855; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Wu Q, 1997, MOL CELL BIOL, V17, P6598, DOI 10.1128/MCB.17.11.6598	42	244	252	6	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2008	4	9					548	556		10.1038/nchembio.106	http://dx.doi.org/10.1038/nchembio.106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	339SN	18690216				2022-12-25	WOS:000258597700013
J	Bachovchin, DA; Brown, SJ; Rosen, H; Cravatt, BF				Bachovchin, Daniel A.; Brown, Steven J.; Rosen, Hugh; Cravatt, Benjamin F.			Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes	NATURE BIOTECHNOLOGY			English	Article							PROTEOMIC ANALYSIS; STRUCTURAL BASIS; CHEMICAL PROBES; OMEGA CLASS; PROTEIN; EMETINE; TARGETS; RESISTANCE; SUBSTRATE; PLATFORM	High-throughput screening to discover small-molecule modulators of enzymes typically relies on highly tailored substrate assays, which are not available for poorly characterized enzymes. Here we report a general, substrate-free method for identifying inhibitors of uncharacterized enzymes. The assay measures changes in the kinetics of covalent active-site labeling with broad-spectrum, fluorescent probes in the presence of inhibitors by monitoring the fluorescence polarization signal. We show that this technology is applicable to enzymes from at least two mechanistic classes, regardless of their degree of functional annotation, and can be coupled with secondary proteomic assays that use competitive activity-based profiling to rapidly determine the specificity of screening hits. Using this method, we identify the bioactive alkaloid emetine as a selective inhibitor of the uncharacterized cancer-associated hydrolase RBBP9. Furthermore, we show that the detoxification enzyme GSTO1, also implicated in cancer, is inhibited by several electrophilic compounds found in public libraries, some of which display high selectivity for this protein.	[Bachovchin, Daniel A.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Bachovchin, Daniel A.; Brown, Steven J.; Rosen, Hugh; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Brown, Steven J.; Rosen, Hugh] Scripps Res Inst, Scripps Res Inst Mol Screening Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu			National Institutes of Health [CA132630, MH084512]; National Science Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA163930, R01CA132630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404, U54MH084512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the Cravatt laboratory for helpful discussions. We are grateful to S. Schurer and P. Baillargeon for help purchasing emetine analogs, to S. Tully for assistance with the synthesis of 4NPG and to J. Garfunkle for assembly of the Boger chemical library. Full- length cDNA encoding human RBBP9 was a gift of the Cheresh laboratory (UCSD). This work was supported by the National Institutes of Health (CA132630, MH084512), a National Science Foundation Predoctoral Fellowship (D. A. B.), and the Skaggs Institute for Chemical Biology.	Adam GC, 2002, MOL CELL PROTEOMICS, V1, P828, DOI 10.1074/mcp.T200007-MCP200; Adam GC, 2002, NAT BIOTECHNOL, V20, P805, DOI 10.1038/nbt714; Ahn K, 2007, BIOCHEMISTRY-US, V46, P13019, DOI 10.1021/bi701378g; Antczak C, 2008, J BIOMOL SCREEN, V13, P285, DOI 10.1177/1087057108315877; Barglow KT, 2006, ANGEW CHEM INT EDIT, V45, P7408, DOI 10.1002/anie.200603187; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; GUPTA RS, 1977, CELL, V10, P61, DOI 10.1016/0092-8674(77)90140-4; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Owicki JC, 2000, J BIOMOL SCREEN, V5, P297, DOI 10.1177/108705710000500501; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Saario SM, 2005, CHEM BIOL, V12, P649, DOI 10.1016/j.chembiol.2005.04.013; Semba S, 2006, J BIOL CHEM, V281, P28244, DOI 10.1074/jbc.M603590200; Shelat AA, 2007, NAT CHEM BIOL, V3, P442, DOI 10.1038/nchembio0807-442; Torta F, 2008, PROTEOMICS, V8, P4484, DOI 10.1002/pmic.200800089; Vila A, 2008, CHEM RES TOXICOL, V21, P432, DOI 10.1021/tx700347w; Vorobiev SM, 2009, PROTEINS, V74, P526, DOI 10.1002/prot.22278; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Woitach JT, 1998, NAT GENET, V19, P371, DOI 10.1038/1258; Yan XD, 2007, J PROTEOME RES, V6, P772, DOI 10.1021/pr060402r; Zhang K, 1997, BIOCHEM J, V325, P417, DOI 10.1042/bj3250417	50	169	196	4	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					387	394		10.1038/nbt.1531	http://dx.doi.org/10.1038/nbt.1531			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19329999	Green Accepted			2022-12-25	WOS:000264971800025
J	Choi, JK; Kim, YJ				Choi, Jung Kyoon; Kim, Young-Joon			Intrinsic variability of gene expression encoded in nucleosome positioning sequences	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; EPIGENETIC REGULATION; SINGLE-CELL; GENOME; IDENTIFICATION; MECHANISMS; PROMOTER; REVEALS; NOISE	Variation in gene expression is an essential material for biological diversity among single cells(1-3), individuals(4-6) and populations or species(7-9). Here we show that expression variability is an intrinsic property that persists at those different levels. Each promoter seems to have a unique capacity to respond to external signals that can be environmental, genetic or even stochastic. Our investigation into nucleosome organization of variably responding promoters revealed a commonly positioned nucleosome at a critical regulatory region where most transcription start sites and TATA elements are located, a deviation from typical nucleosome-free status. The nucleotide sequences in this region of variable promoters showed a high propensity for DNA bending and a periodic distribution of particular dinucleotides, encoding preferences for DNA-nucleosome interaction. Variable expression is likely to occur during removal of this nucleosome for gene activation. This is a unique example of how promoter sequences intrinsically encode regulatory flexibility, which is vital for biological processes such as adaptation, development and evolution.	[Choi, Jung Kyoon; Kim, Young-Joon] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Yonsei University	Choi, JK (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Choi, Jung Kyoon/C-2070-2011		Korean Ministry of Science and Technology	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by grants from the Korean Ministry of Science and Technology to Y.-J.K. (Epigenomic Research of Human Disease and Global Research Lab).	Ahmad K, 2002, CELL, V111, P281, DOI 10.1016/S0092-8674(02)01081-4; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	29	103	105	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					498	503		10.1038/ng.319	http://dx.doi.org/10.1038/ng.319			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19252489				2022-12-25	WOS:000264659000028
J	Huang, XZ; Qian, Q; Liu, ZB; Sun, HY; He, SY; Luo, D; Xia, GM; Chu, CC; Li, JY; Fu, XD				Huang, Xianzhong; Qian, Qian; Liu, Zhengbin; Sun, Hongying; He, Shuyuan; Luo, Da; Xia, Guangmin; Chu, Chengcai; Li, Jiayang; Fu, Xiangdong			Natural variation at the DEP1 locus enhances grain yield in rice	NATURE GENETICS			English	Article							MAJOR QTL; PANICLE; AGROBACTERIUM; ENCODES; WEIGHT; WIDTH; GENE	Grain yield is controlled by quantitative trait loci (QTLs) derived from natural variations in many crop plants. Here we report the molecular characterization of a major rice grain yield QTL that acts through the determination of panicle architecture. The dominant allele at the DEP1 locus is a gain-of-function mutation causing truncation of a phosphatidylethanolamine-binding protein-like domain protein. The effect of this allele is to enhance meristematic activity, resulting in a reduced length of the inflorescence internode, an increased number of grains per panicle and a consequent increase in grain yield. This allele is common to many Chinese high-yielding rice varieties and likely represents a relatively recent introduction into the cultivated rice gene pool. We also show that a functionally equivalent allele is present in the temperate cereals and seems to have arisen before the divergence of the wheat and barley lineages. (C) 2009 Nature America, Inc. All rights reserved.	[Huang, Xianzhong; Liu, Zhengbin; Sun, Hongying; He, Shuyuan; Fu, Xiangdong] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Qian, Qian] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Luo, Da] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Xia, Guangmin] Shandong Univ, Coll Life Sci, Jinan 250100, Peoples R China; [Chu, Chengcai; Li, Jiayang] Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shandong University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Fu, XD (corresponding author), Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China.	xdfu@genetics.ac.cn	Ding, Cheng-Qiang/B-6287-2011; qian, qian/AAH-8708-2021; Chu, Chengcai/AAF-6083-2019; Li, Jiayang/AAG-4377-2020	Chu, Chengcai/0000-0001-8097-6115; Liu, Zhengbin/0000-0001-6638-2708	Ministry of Science and Technology of China [2009CB941501, 2007AA10Z190, 2006AA10A101]; Chinese Academy of Sciences [KSCX2-YW-N-050]; National Natural Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank N. Harberd and Y. Xue for their critical comments. This research was supported by grants from the Ministry of Science and Technology of China ( 2009CB941501, 2007AA10Z190 and 2006AA10A101), Chinese Academy of Sciences ( KSCX2-YW-N-050) and National Natural Science Foundation of China.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Chen WF, 2001, ACTA AGRONOMICA SINI, V27, P665; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fu XD, 2001, PLANT CELL, V13, P1791, DOI 10.1105/tpc.13.8.1791; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kellogg EA, 2007, CURR OPIN PLANT BIOL, V10, P26, DOI 10.1016/j.pbi.2006.11.009; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Kong FN, 2007, MOL BREEDING, V19, P297, DOI 10.1007/s11032-006-9062-x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Nakagawa M, 2002, PLANT J, V29, P743, DOI 10.1046/j.1365-313X.2002.01255.x; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Xu Z., 1995, J SHENYANG AGR U, V26, P1; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan CJ, 2007, THEOR APPL GENET, V115, P1093, DOI 10.1007/s00122-007-0635-9; YANG S, 1984, ACTA AGRON SIN, V17, P6; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhao TJ, 2006, PLANT CELL REP, V25, P1199, DOI 10.1007/s00299-006-0184-8	25	640	814	24	402	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					494	497		10.1038/ng.352	http://dx.doi.org/10.1038/ng.352			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19305410				2022-12-25	WOS:000264659000027
J	Fox, JL				Fox, Jeffrey L.			Biotech under Barack	NATURE BIOTECHNOLOGY			English	Article								The Obama administration looks to be a welcome shot in the arm for the scientific endeavor, but the current economic crisis is likely to keep several issues of key interest to biotech firmly on the back burner.											0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2009	27	3					237	244		10.1038/nbt0309-237	http://dx.doi.org/10.1038/nbt0309-237			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	416UJ	19270669				2022-12-25	WOS:000264030700013
J	Gillette, JM; Larochelle, A; Dunbar, CE; Lippincott-Schwartz, J				Gillette, Jennifer M.; Larochelle, Andre; Dunbar, Cynthia E.; Lippincott-Schwartz, Jennifer			Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC-STEM-CELL; PROGENITOR CELLS; SURFACE PROTEINS; STROMAL CELLS; INTERNALIZATION; OSTEOBLASTS; MIGRATION; MEMBRANE; PATHWAYS; ADHESION	Haematopoietic stem-progenitor cells (HSPCs) reside in the bone marrow niche, where interactions with osteoblasts provide essential cues for their proliferation and survival. Here, we use live-cell imaging to characterize both the site of contact between osteoblasts and haematopoietic progenitor cells (HPCs) and events at this site that result in downstream signalling responses important for niche maintenance. HPCs made prolonged contact with the osteoblast surface through a specialized membrane domain enriched in prominin 1, CD63 and rhodamine PE. At the contact site, portions of the specialized domain containing these molecules were taken up by the osteoblast and internalized into SARA-positive signalling endosomes. This caused osteoblasts to downregulate Smad signalling and increase production of stromal-derived factor-1 (SDF-1), a chemokine responsible for HSPC homing to bone marrow. These findings identify a mechanism involving intercellular transfer to signalling endosomes for targeted regulation of signalling and remodelling events within an ex vivo osteoblastic niche.	[Gillette, Jennifer M.; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Larochelle, Andre; Dunbar, Cynthia E.] NHLBI, Mol Hematopoiesis Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lippincott-Schwartz, J (corresponding author), NICHHD, Cell Biol & Metab Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov	Larochelle, Andre/P-1342-2016	Larochelle, Andre/0000-0003-0685-2186; Dunbar, Cynthia/0000-0002-7645-838X	Intramural Research Program of the US National Institute of Child Health and Human Development; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006063, ZIAHL002339] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Victoria Cogger ( University of Sydney, ANZAC Research Institute, Australia) for assistance with scanning electron microscopy. We would also like to thank Denis Corbeil ( University of Dresden, Germany) for providing the prominin 1 - GFP construct, and Suliana Manley and George Patterson ( NIH) for critical reading of the manuscript. This project was supported by the Intramural Research Program of the US National Institute of Child Health and Human Development, National Institutes of Health.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; BAUER N, 2007, CELLS TISSUES OR DEC; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CORVERA S, 2000, SCI STKE, pPE1; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feigelson SW, 2003, J BIOL CHEM, V278, P51203, DOI 10.1074/jbc.M303601200; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Jung Y, 2005, CYTOKINE, V32, P155, DOI 10.1016/j.cyto.2005.09.001; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wagner W, 2005, STEM CELLS, V23, P1180, DOI 10.1634/stemcells.2004-0361; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	32	72	75	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					303	U168		10.1038/ncb1838	http://dx.doi.org/10.1038/ncb1838			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198600	Green Accepted			2022-12-25	WOS:000263777900014
J	Johnsson, K				Johnsson, Kai			Visualizing biochemical activities in living cells	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; IMPROVED FLUORESCENCE; FUSION PROTEINS; COPPER-FREE; FRET; CHEMISTRY	Autofluorescent proteins have become indispensable in our quest to visualize molecular events in living cells. Further progress in the visualization and quantification of all biochemical activities of the cell will require the introduction of additional and complementary methods for sensing and probing biomolecules. Here I highlight some of the areas where the development of new probes and labeling methods is eagerly awaited and where chemical biologists could make important contributions.	Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Johnsson, K (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch	johnsson, kai/P-4222-2014	johnsson, kai/0000-0002-8002-1981				ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gronemeyer T, 2005, CURR OPIN BIOTECH, V16, P453, DOI 10.1016/j.copbio.2005.06.001; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; TAYLOR DL, 1978, P NATL ACAD SCI USA, V75, P857, DOI 10.1073/pnas.75.2.857; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	25	36	39	5	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					63	65		10.1038/nchembio0209-63	http://dx.doi.org/10.1038/nchembio0209-63			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19148167				2022-12-25	WOS:000263090700002
J	Ren, PH; Lauckner, JE; Kachirskaia, I; Heuser, JE; Melki, R; Kopito, RR				Ren, Pei-Hsien; Lauckner, Jane E.; Kachirskaia, Ioulia; Heuser, John E.; Melki, Ronald; Kopito, Ron R.			Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates	NATURE CELL BIOLOGY			English	Article							PROTEIN MISFOLDING DISEASES; YEAST PRION; IN-VITRO; HUNTINGTIN; TOXICITY; PROPAGATION; MECHANISM; PEPTIDES; FIBRILS	Sequence-specific nucleated protein aggregation is closely linked to the pathogenesis of most neurodegenerative diseases and constitutes the molecular basis of prion formation(1). Here we report that fibrillar polyglutamine peptide aggregates can be internalized by mammalian cells in culture where they gain access to the cytosolic compartment and become co-sequestered in aggresomes together with components of the ubiquitin-proteasome system and cytoplasmic chaperones. Remarkably, these internalized fibrillar aggregates are able to selectively recruit soluble cytoplasmic proteins with which they share homologous but not heterologous amyloidogenic sequences, and to confer a heritable phenotype on cells expressing the homologous amyloidogenic protein from a chromosomal locus.	[Ren, Pei-Hsien; Lauckner, Jane E.; Kachirskaia, Ioulia; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94035 USA; [Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Heuser, John E.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL)	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94035 USA.	kopito@stanford.edu	Heuser, John/H-5940-2012		NINDS; Stanford Graduate Fellowship; CNRS; ANR [ANR-06-BLAN-0266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanford Graduate Fellowship(Stanford University); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Perrino and J. Mulholland for help with electron and confocal microscopy; K. Kirkegaard for comments on the manuscript and G. Chang and T. Hastie for statistical analysis. This research was supported in part by a grant from the NINDS and a Stanford Graduate Fellowship to P.-H.R.; R.M. is supported by the CNRS and the ANR contract no. ANR-06-BLAN-0266.	Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Porat Y, 2003, BIOCHEMISTRY-US, V42, P10971, DOI 10.1021/bi034889i; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sousa MM, 2001, AM J PATHOL, V159, P1993; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905	27	320	324	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					219	U232		10.1038/ncb1830	http://dx.doi.org/10.1038/ncb1830			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151706	Green Accepted			2022-12-25	WOS:000263285500021
J	Tian, B; Yang, QA; Mao, ZX				Tian, Bo; Yang, Qian; Mao, Zixu			Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; INDUCED CELL-DEATH; ATAXIA-TELANGIECTASIA; NERVOUS-SYSTEM; ACTIVATION; APOPTOSIS; TRANSCRIPTION; AUTOPHOSPHORYLATION; P53; REQUIREMENT	The phosphatidylinositol-3-kinase-like kinase ATM (ataxia-telangiectasia mutated) has a central role in coordinating DNA damage responses, including cell-cycle checkpoint control, DNA repair and apoptosis. Mutations of ATM cause a spectrum of defects ranging from neurodegeneration to cancer predisposition. However, the mechanism by which DNA damage activates ATM is poorly understood. Here we show that Cdk5 (cyclin-dependent kinase 5), activated by DNA damage, directly phosphorylates ATM at Ser 794 in post-mitotic neurons. Phosphorylation at Ser 794 precedes, and is required for, ATM autophosphorylation at Ser 1981, and activates ATM kinase activity. The Cdk5-ATM signal regulates phosphorylation and function of the ATM targets p53 and H2AX. Interruption of the Cdk5-ATM pathway attenuates DNA-damage-induced neuronal cell cycle re-entry and expression of the p53 targets PUMA and Bax, protecting neurons from death. Thus, activation of Cdk5 by DNA damage serves as a critical signal to initiate the ATM response and regulate ATM dependent cellular processes.	[Tian, Bo; Yang, Qian; Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Tian, Bo; Yang, Qian; Mao, Zixu] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Tian, Bo; Yang, Qian; Mao, Zixu] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 615 Michael St, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	TIAN, BO/G-2354-2011	TIAN, BO/0000-0002-8318-3046	NIH [R01 NS048254, R01 AG023695]; Robert W. Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert W. Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Bert Vogelstein, Richard Gatti, Michael Kastan, Martin Lavin and Shuki Mizutani for p53 reporter constructs, purified ATM protein, ATM mammalian expression constructs, GST-ATM expression constructs, and A-T cell lines, respectively. This work was partially supported by NIH grants R01 NS048254 (Z.M.) and R01 AG023695 (Z.M.) and The Robert W. Woodruff Health Sciences Center Fund (Z.M.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; EL DW, 1993, CELL, V75, P817; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Li BS, 2000, J NEUROSCI, V20, P6055, DOI 10.1523/JNEUROSCI.20-16-06055.2000; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100	37	129	135	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					211	U221		10.1038/ncb1829	http://dx.doi.org/10.1038/ncb1829			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151707	Green Accepted			2022-12-25	WOS:000263285500020
J	Hennies, HC; Kornak, U; Zhang, HK; Egerer, J; Zhang, X; Seifert, W; Kuhnisch, J; Budde, B; Natebus, M; Brancati, F; Wilcox, WR; Muller, D; Kaplan, PB; Rajab, A; Zampino, G; Fodale, V; Dallapiccola, B; Newman, W; Metcalfe, K; Clayton-Smith, J; Tassabehji, M; Steinmann, B; Barr, FA; Nurnberg, P; Wieacker, P; Mundlos, S				Hennies, Hans Christian; Kornak, Uwe; Zhang, Haikuo; Egerer, Johannes; Zhang, Xin; Seifert, Wenke; Kuehnisch, Jirko; Budde, Birgit; Naetebus, Marc; Brancati, Francesco; Wilcox, William R.; Mueller, Dietmar; Kaplan, Paige B.; Rajab, Anna; Zampino, Giuseppe; Fodale, Valentina; Dallapiccola, Bruno; Newman, William; Metcalfe, Kay; Clayton-Smith, Jill; Tassabehji, May; Steinmann, Beat; Barr, Francis A.; Nuernberg, Peter; Wieacker, Peter; Mundlos, Stefan			Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin	NATURE GENETICS			English	Article							SPINOCEREBELLAR NEURODEGENERATION; RECESSIVE FORM; GENE; TRANSPORT; APPARATUS	Gerodermia osteodysplastica is an autosomal recessive disorder characterized by wrinkly skin and osteoporosis. Here we demonstrate that gerodermia osteodysplastica is caused by loss-of-function mutations in SCYL1BP1, which is highly expressed in skin and osteoblasts. The protein localizes to the Golgi apparatus and interacts with Rab6, identifying SCYL1BP1 as a golgin. These results associate abnormalities of the secretory pathway with age-related changes in connective tissues.	[Kornak, Uwe; Zhang, Haikuo; Zhang, Xin; Seifert, Wenke; Kuehnisch, Jirko; Mundlos, Stefan] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Hennies, Hans Christian; Seifert, Wenke; Budde, Birgit; Naetebus, Marc; Nuernberg, Peter] Univ Cologne, CCG, D-50674 Cologne, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Kornak, Uwe; Zhang, Haikuo; Egerer, Johannes; Zhang, Xin; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Egerer, Johannes; Barr, Francis A.] Max Planck Inst Biochem, D-82152 Munich, Germany; [Brancati, Francesco; Dallapiccola, Bruno] San Giovanni Rotondo & CSS Mendel Inst, IRCCS CSS, I-00198 Rome, Italy; [Brancati, Francesco; Dallapiccola, Bruno] CeSI G Annunzio Univ Fdn, Dept Biomed Sci, Chieti, Italy; [Brancati, Francesco; Dallapiccola, Bruno] CeSI G Annunzio Univ Fdn, Aging Res Ctr, Chieti, Italy; [Wilcox, William R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Mueller, Dietmar] Klinikum Chemnitz, Inst Med Genet, D-09116 Chemnitz, Germany; [Kaplan, Paige B.] Univ Penn, Childrens Hosp Philadelphia, Sect Metab Dis, Philadelphia, PA 19104 USA; [Rajab, Anna] Minist Hlth, Directorate Gen Hlth Affairs, Genet Unit, Muscat 113, Oman; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-00168 Rome, Italy; [Fodale, Valentina] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Newman, William; Metcalfe, Kay; Clayton-Smith, Jill; Tassabehji, May] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Steinmann, Beat] Univ Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland; [Barr, Francis A.] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Wieacker, Peter] Univ Munster, Inst Humangenet, D-48149 Munster, Germany; [Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Cologne; Max Planck Society; Max Planck Society; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Cedars Sinai Medical Center; Chemnitz Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS); University of Manchester; University Children's Hospital Zurich; University of Liverpool; University of Cologne; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mundlos, S (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Hennies, Hans C/G-9424-2014; Seifert, Wenke/B-8772-2011; Kühnisch, Jirko/M-3744-2019; Mundlos, Stefan/ABH-9585-2020; Kühnisch, Jirko/L-7761-2013; Zampino, Giuseppe/AAC-2152-2019; Brancati, Francesco/AAC-3778-2022; Dallapiccola, Bruno/K-8692-2016	Hennies, Hans C/0000-0001-7210-2389; Kühnisch, Jirko/0000-0003-4744-5421; Brancati, Francesco/0000-0003-3624-2354; Newman, William/0000-0002-6382-4678; Dallapiccola, Bruno/0000-0002-5031-1013; Barr, Francis/0000-0001-7518-253X; Seifert, Wenke/0000-0003-1432-9862; Mundlos, Stefan/0000-0002-9788-3166; Budde, Birgit/0000-0001-9385-4168	German Federal Ministry of Education and Research; Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen; Deutsche Forschungsgemeinschaft; Italian Telethon; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to all participants in this study. We thank J. Evans, B.N. Chodirker and K. Wrogemann for their support. We wish to thank F. Andre, B. Fischer, S. Kolberg and N. Wittstruck for technical assistance. This work was funded by grants from the German Federal Ministry of Education and Research and the Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen to H.C.H. and by funds from the Deutsche Forschungsgemeinschaft (collaborative research centre 577) to U. K. The sample IG was obtained from the "Cell line and DNA Bank from patients affected by Genetic Diseases'' collection (http://www.gaslini.org/labdppm.htm) supported by Italian Telethon grants. We thank H. Zentgraf for the generation of monoclonal antibodies.	Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Di YJ, 2003, J HUM GENET, V48, P315, DOI 10.1007/s10038-003-0031-5; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; HUNTER AGW, 1988, J MED GENET, V25, P854, DOI 10.1136/jmg.25.12.854; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Rajab A, 2008, AM J MED GENET A, V146A, P965, DOI 10.1002/ajmg.a.32143; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	15	119	126	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1410	1412		10.1038/ng.252	http://dx.doi.org/10.1038/ng.252			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997784	Green Accepted			2022-12-25	WOS:000261215900016
J	Shibata, S; Nagase, M; Yoshida, S; Kawarazaki, W; Kurihara, H; Tanaka, H; Miyoshi, J; Takai, Y; Fujita, T				Shibata, Shigeru; Nagase, Miki; Yoshida, Shigetaka; Kawarazaki, Wakako; Kurihara, Hidetake; Tanaka, Hirotoshi; Miyoshi, Jun; Takai, Yoshimi; Fujita, Toshiro			Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease	NATURE MEDICINE			English	Article							ESTROGEN-RECEPTOR; HYPERTENSIVE-RATS; OXIDATIVE STRESS; PODOCYTE INJURY; RHO-GDI; ACTIVATION; ALDOSTERONE; KINASE; MODULATION; CELLS	Blockade of mineralocorticoid receptor has been shown to improve the clinical outcomes of proteinuric kidney diseases(1,2). However, little is known about the regulation of mineralocorticoid receptor-dependent transcriptional activity in renal disease. Here we identify a new role for Rac1, a member of the Rho family GTPases, as a potent activator of mineralocorticoid receptor signal transduction both in vitro and in vivo. Transient transfection assays in HEK 293 cells revealed that constitutively active Rac1 (CA-Rac1) enhanced mineralocorticoid receptor-dependent reporter activity, which was accompanied by increased nuclear translocation of mineralocorticoid receptor. CA-Rac1 facilitated mineralocorticoid receptor nuclear accumulation also in podocytes via p21-activated kinase phosphorylation. In mice lacking Rho GDP-dissociation inhibitor-alpha (Arhgdia(-/-) mice)(3), renal abnormalities, including heavy albuminuria and podocyte damage, were associated with increased Rac1 (but not RhoA) and mineralocorticoid receptor signaling in the kidney, without alteration in systemic aldosterone status. Pharmacological intervention with a Rac-specific small-molecule inhibitor(4,5) diminished mineralocorticoid receptor overactivity and renal damage in this model. Furthermore, albuminuria and histological changes in Arhgdia(-/-) mice were suppressed by mineralocorticoid receptor blockade, confirming the pathological role of Rac1-mineralocorticoid receptor interaction. Our results provide evidence that signaling cross-talk between Rac1 and mineralocorticoid receptor modulates mineralocorticoid receptor activity and identify Rac1 as a therapeutic target for chronic kidney disease.	[Shibata, Shigeru; Nagase, Miki; Yoshida, Shigetaka; Kawarazaki, Wakako; Fujita, Toshiro] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anat, Bunkyo Ku, Tokyo 1138421, Japan; [Tanaka, Hirotoshi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan; [Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Higashinari Ku, Osaka 5378511, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan	University of Tokyo; Juntendo University; University of Tokyo; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kobe University	Fujita, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	fujita-dis@h.u-tokyo.ac.jp		Kawarazaki, Wakako/0000-0002-1332-8537; Shibata, Shigeru/0000-0002-6868-0626; Fujita, Toshiro/0000-0001-9141-7060				Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Chrysostomou A, 2001, NEW ENGL J MED, V345, P925, DOI 10.1056/NEJM200109203451215; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Eto N, 2007, KIDNEY INT, V72, P455, DOI 10.1038/sj.ki.5002311; Funder JW, 2004, TRENDS ENDOCRIN MET, V15, P139, DOI 10.1016/j.tem.2004.03.006; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Iida T, 2000, KIDNEY INT, V58, P1450, DOI 10.1046/j.1523-1755.2000.00307.x; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kino T, 2006, J BIOL CHEM, V281, P9118, DOI 10.1074/jbc.M509339200; Komuro R, 1996, GENES CELLS, V1, P943, DOI 10.1046/j.1365-2443.1996.760276.x; Le Menuet D, 2001, J BIOL CHEM, V276, P38911, DOI 10.1074/jbc.M103984200; Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329; Massaad C, 1999, MOL ENDOCRINOL, V13, P57, DOI 10.1210/me.13.1.57; Nagase M, 2007, HYPERTENSION, V50, P877, DOI 10.1161/HYPERTENSIONAHA.107.091058; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pitt B, 2005, J MOL CELL CARDIOL, V39, P415, DOI 10.1016/j.yjmcc.2005.05.005; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Shibata S, 2006, J AM SOC NEPHROL, V17, P754, DOI 10.1681/ASN.2005050571; Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAKENAKA T, 1992, CIRC RES, V71, P471, DOI 10.1161/01.RES.71.2.471; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Tronche F, 2004, GENE DEV, V18, P492, DOI 10.1101/gad.284704; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Williams GH, 2004, AM J CARDIOL, V93, P990, DOI 10.1016/j.amjcard.2004.01.007; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	34	308	329	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1370	1376		10.1038/nm.1879	http://dx.doi.org/10.1038/nm.1879			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029984				2022-12-25	WOS:000261393600023
J	Stubbs, JL; Oishi, I; Belmonte, JCI; Kintner, C				Stubbs, Jennifer L.; Oishi, Isao; Izpisua Belmonte, Juan Carlos; Kintner, Chris			The forkhead protein Foxj1 specifies node-like cilia in Xenopus and zebrafish embryos	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; TRANSCRIPTION FACTOR HFH-4; KUPFFERS VESICLE; MALE-INFERTILITY; GENE-EXPRESSION; MICE DEFICIENT; LEFTWARD FLOW; CILIOGENESIS; CELLS; FLUID	It has been proposed that ciliated cells that produce a leftward fluid flow mediate left-right patterning in many vertebrate embryos. The cilia on these cells combine features of primary sensory and motile cilia, but how this cilia subtype is specified is unknown. We address this issue by analyzing the Xenopus and zebrafish homologs of Foxj1, a forkhead transcription factor necessary for ciliogenesis in multiciliated cells of the mouse. We show that the cilia that underlie left-right patterning on the Xenopus gastrocoel roof plate (GRP) and zebrafish Kupffer's vesicle are severely shortened or fail to form in Foxj1 morphants. We also show that misexpressing Foxj1 is sufficient to induce ectopic GRP-like cilia formation in frog embryos. Microarray analysis indicates that Xenopus Foxj1 induces the formation of cilia by upregulating the expression of motile cilia genes. These results indicate that Foxj1 is a critical determinant in the specification of cilia used in left-right patterning.	[Stubbs, Jennifer L.; Oishi, Isao; Izpisua Belmonte, Juan Carlos; Kintner, Chris] Salk Inst Biol Studies, San Diego, CA 92186 USA; [Oishi, Isao; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Kintner, C (corresponding author), Salk Inst Biol Studies, POB 85800, San Diego, CA 92186 USA.	kintner@salk.edu	Oishi, Isao/L-8639-2018	Oishi, Isao/0000-0003-3682-5349	Kanae Foundation; G. Harold and Leila Y. Mathers and Cellex MEC foundations; US National Institutes of Health; US NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076507] Funding Source: NIH RePORTER	Kanae Foundation; G. Harold and Leila Y. Mathers and Cellex MEC foundations; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of the Kintner laboratory for comments on the manuscript, M. Wood for technical assistance with the TEM and B. Mitchell for assistance with high-speed photography in collaboration with C. Yu, P. Taborek and F. Huisman in the Department of Physics at University of California, Irvine. The work was supported by grants from the Kanae Foundation to I.O., from the G. Harold and Leila Y. Mathers and Cellex MEC foundations and US National Institutes of Health to J.C.I.B. and from the US NIH to C. K.	Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Davidson LA, 2002, DEV BIOL, V242, P109, DOI 10.1006/dbio.2002.0537; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Feistel K, 2006, DEV DYNAM, V235, P3348, DOI 10.1002/dvdy.20986; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pelletier GJ, 1998, AM J PHYSIOL-LUNG C, V274, pL351, DOI 10.1152/ajplung.1998.274.3.L351; Pohl BS, 2004, DEV GENES EVOL, V214, P200, DOI 10.1007/s00427-004-0391-7; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Sive HL, 1998, EARLY DEV XENOPUS LA; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stubbs JL, 2006, DEVELOPMENT, V133, P2507, DOI 10.1242/dev.02417; Supp DM, 2000, TRENDS CELL BIOL, V10, P41, DOI 10.1016/S0962-8924(99)01701-8; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tanaka H, 2004, MOL CELL BIOL, V24, P7958, DOI 10.1128/MCB.24.18.7958-7964.2004; THISSE C, 1993, DEVELOPMENT, V119, P1203; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Whitsett JA, 1999, AM J RESP CELL MOL, V21, P153, DOI 10.1165/ajrcmb.21.2.f159; WILSON PA, 1989, DEVELOPMENT, V105, P155; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zapala MA, 2002, GENOME BIOL, V3; Zhang M, 2004, BIOCHEM BIOPH RES CO, V324, P1413, DOI 10.1016/j.bbrc.2004.09.207	44	208	214	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1454	1460		10.1038/ng.267	http://dx.doi.org/10.1038/ng.267			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19011629	Green Accepted			2022-12-25	WOS:000261215900022
J	Wagner, TFJ; Loch, S; Lambert, S; Straub, I; Mannebach, S; Mathar, I; Dufer, M; Lis, A; Flockerzi, V; Philipp, SE; Oberwinkler, J				Wagner, Thomas F. J.; Loch, Sabine; Lambert, Sachar; Straub, Isabelle; Mannebach, Stefanie; Mathar, Ilka; Duefer, Martina; Lis, Annette; Flockerzi, Veit; Philipp, Stephan E.; Oberwinkler, Johannes			Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells	NATURE CELL BIOLOGY			English	Article							D-ASPARTATE RECEPTOR; PREGNENOLONE SULFATE; NEUROACTIVE STEROIDS; TRP CHANNELS; ADRENAL-HYPERPLASIA; INSULIN-SECRETION; ACTIVATION; NEUROSTEROIDS; PLASMA; RAT	Transient receptor potential (TRP) cation channels are renowned for their ability to sense diverse chemical stimuli. Still, for many members of this large and heterogeneous protein family it is unclear how their activity is regulated and whether they are influenced by endogenous substances. On the other hand, steroidal compounds are increasingly recognized to have rapid effects on membrane surface receptors that often have not been identified at the molecular level. We show here that TRPM3, a divalent-permeable cation channel, is rapidly and reversibly activated by extracellular pregnenolone sulphate, a neuroactive steroid. We show that pregnenolone sulphate activates endogenous TRPM3 channels in insulin-producing beta cells. Application of pregnenolone sulphate led to a rapid calcium influx and enhanced insulin secretion from pancreatic islets. Our results establish that TRPM3 is an essential component of an ionotropic steroid receptor enabling unanticipated crosstalk between steroidal and insulin-signalling endocrine systems.	[Wagner, Thomas F. J.; Loch, Sabine; Lambert, Sachar; Straub, Isabelle; Oberwinkler, Johannes] Univ Saarland, Emmy Noether Res Grp, D-66421 Homburg, Germany; [Duefer, Martina] Pharmakol & Toxikol Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Saarland University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Oberwinkler, J (corresponding author), Univ Saarland, Emmy Noether Res Grp, D-66421 Homburg, Germany.	johannes.oberwinkler@uniklinikum-saarland.de	Philipp, Stephan/AAR-7519-2020	Oberwinkler, Johannes/0000-0002-8541-3626; Philipp, Stephan/0000-0003-1959-9167	DFG [SFB530]; HOMFOR	DFG(German Research Foundation (DFG)); HOMFOR	We thank S. Plant, M. Portz, H. Lohr, K. Kraushaar, U. Soltek and M. Simon-Thomas for technical support; U. Wissenbach for TRPV6 and TRPM8 expressing cells; V. Chubanov for the TRPM7 expression vector; A. Luckhoff and F.J.P. Kuhn for the TRPM2 expression vector; M. Menger and P. Weissgerber for initial help with isolating pancreatic islets. We also thank A. Beck, D. Beech, B. Fakler, M. Flick, M. Freichel, B. Niemeyer and F. Zufall for discussions and for reading an earlier version of the manuscript. Financial support was provided by DFG (Emmy Noether program, J.O., and SFB530, S. E. P. and V. F.) and HOMFOR.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bicikova M, 2002, STEROIDS, V67, P399, DOI 10.1016/S0039-128X(01)00196-9; Bicikova M, 2000, NEUROCHEM RES, V25, P1623, DOI 10.1023/A:1026622704704; BILLIAR RB, 1974, J CLIN ENDOCR METAB, V39, P27, DOI 10.1210/jcem-39-1-27; Bodding M, 2002, J BIOL CHEM, V277, P36656, DOI 10.1074/jbc.M202822200; Charmandari E, 2002, J CLIN ENDOCR METAB, V87, P2114, DOI 10.1210/jc.87.5.2114; CHATTORAJ SC, 1970, STEROIDS, V16, P523, DOI 10.1016/S0039-128X(70)80134-9; Chen SC, 2004, BRAIN RES, V1027, P196, DOI 10.1016/j.brainres.2004.08.053; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; DEPERETTI E, 1986, ACTA ENDOCRINOL-COP, V113, P259; DEPERETTI E, 1983, J CLIN ENDOCR METAB, V57, P550, DOI 10.1210/jcem-57-3-550; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; GILLIS KD, 1992, PFLUG ARCH EUR J PHY, V420, P121, DOI 10.1007/BF00378654; Grimm C, 2005, MOL PHARMACOL, V67, P798, DOI 10.1124/mol.104.006734; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Havlikova H, 2002, J CLIN ENDOCR METAB, V87, P2225, DOI 10.1210/jc.87.5.2225; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hige T, 2006, EUR J NEUROSCI, V24, P1955, DOI 10.1111/j.1460-9568.2006.05080.x; Hill M, 2002, J STEROID BIOCHEM, V82, P241, DOI 10.1016/S0960-0760(02)00188-7; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jacobson D. A., 2007, V179, P409; Jang MK, 2004, P NATL ACAD SCI USA, V101, P8198, DOI 10.1073/pnas.0401838101; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; Mameli M, 2005, J NEUROSCI, V25, P2285, DOI 10.1523/JNEUROSCI.3877-04.2005; MATHUR RS, 1980, J CLIN ENDOCR METAB, V51, P1235, DOI 10.1210/jcem-51-6-1235; MAYO W, 1993, BRAIN RES, V607, P324, DOI 10.1016/0006-8993(93)91524-V; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mennerick S, 2008, BIOPHYS J, V95, P176, DOI 10.1529/biophysj.107.124768; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; SCOMMEGNA A, 1971, J CLIN ENDOCR METAB, V33, P787, DOI 10.1210/jcem-33-5-787; SCOMMEGNA A, 1970, AM J OBSTET GYNECOL, V108, P1023, DOI 10.1016/0002-9378(70)90447-3; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P227, DOI 10.1007/s10863-005-6632-2; SPEISER PW, 1992, J CLIN ENDOCR METAB, V75, P1421, DOI 10.1210/jc.75.6.1421; Tagawa N, 2000, CLIN CHEM, V46, P523; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; Vriens J, 2008, CURR NEUROPHARMACOL, V6, P79, DOI 10.2174/157015908783769644; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; WU FS, 1991, MOL PHARMACOL, V40, P333	61	271	275	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1421	U103		10.1038/ncb1801	http://dx.doi.org/10.1038/ncb1801			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18978782				2022-12-25	WOS:000261261800012
J	Bonci, D; Coppola, V; Musumeci, M; Addario, A; Giuffrida, R; Memeo, L; D'Urso, L; Pagliuca, A; Biffoni, M; Labbaye, C; Bartucci, M; Muto, G; Peschle, C; De Maria, R				Bonci, Desiree; Coppola, Valeria; Musumeci, Maria; Addario, Antonio; Giuffrida, Raffaella; Memeo, Lorenzo; D'Urso, Leonardo; Pagliuca, Alfredo; Biffoni, Mauro; Labbaye, Catherine; Bartucci, Monica; Muto, Giovanni; Peschle, Cesare; De Maria, Ruggero			The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities	NATURE MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL-LINES; MICRORNA TARGETS; IN-VIVO; GENE; 13Q14; APOPTOSIS; VECTORS; REGIONS	MicroRNAs (miRNAs) are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs. miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2. These miRNAs form a cluster at the chromosomal region 13q14, which is frequently deleted in cancer. Here, we report that the miR-15a and miR-16-1 cluster targets CCND1 (encoding cyclin D1) and WNT3A, which promotes several tumorigenic features such as survival, proliferation and invasion. In cancer cells of advanced prostate tumors, the miR-15a and miR-16 level is significantly decreased, whereas the expression of BCL2, CCND1 and WNT3A is inversely upregulated. Delivery of antagomirs specific for miR-15a and miR-16 to normal mouse prostate results in marked hyperplasia, and knockdown of miR-15a and miR-16 promotes survival, proliferation and invasiveness of untransformed prostate cells, which become tumorigenic in immunodeficient NOD-SCID mice. Conversely, reconstitution of miR-15a and miR-16-1 expression results in growth arrest, apoptosis and marked regression of prostate tumor xenografts. Altogether, we propose that miR-15a and miR-16 act as tumor suppressor genes in prostate cancer through the control of cell survival, proliferation and invasion. These findings have therapeutic implications and may be exploited for future treatment of prostate cancer.	[Bonci, Desiree; Coppola, Valeria; Musumeci, Maria; Addario, Antonio; Pagliuca, Alfredo; Biffoni, Mauro; Labbaye, Catherine; Bartucci, Monica; Peschle, Cesare; De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Giuffrida, Raffaella; Memeo, Lorenzo; De Maria, Ruggero] Mediterranean Inst Oncol, Dept Expt Oncol, I-95029 Catania, Italy; [D'Urso, Leonardo; Muto, Giovanni] San Giovanni Bosco Hosp, Dept Urol, I-10154 Turin, Italy; [Peschle, Cesare] Ist Ricovero & Cura Carattere Sci, I-20138 Milan, Italy	Istituto Superiore di Sanita (ISS); Mediterranean Institute of Oncology; IRCCS Ca Granda Ospedale Maggiore Policlinico	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	demaria@iss.it	De Maria, Ruggero/S-6385-2019; Labbaye, Catherine/J-9930-2016; Bonci, Desiree/K-6488-2016; Addario, Antonio/AAC-4707-2022; Jackson, Benjamin L/C-4297-2012; pagliuca, alfredo/J-3107-2012; Biffoni, Mauro/J-8318-2016; Coppola, Valeria/K-5120-2016; Pagliuca, Alfredo/AAI-3689-2020	De Maria, Ruggero/0000-0003-2255-0583; Bonci, Desiree/0000-0002-2472-5140; Addario, Antonio/0000-0001-8527-8738; pagliuca, alfredo/0000-0002-8703-2077; Biffoni, Mauro/0000-0002-1304-9060; Coppola, Valeria/0000-0002-5745-2572; Labbaye, Catherine/0000-0003-1255-4396; Muto, Giovanni/0000-0003-3593-6450; Memeo, Lorenzo/0000-0003-4251-7203; Musumeci, Maria/0000-0001-6680-8158	Italian Health Ministry, the Italian Ministry of University and Research [RBIP06ZJ78]; Italian Association for Cancer Research	Italian Health Ministry, the Italian Ministry of University and Research(Ministry of Health, Italy); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	We thank G. Loreto, A. Di Virgilio and M. Blasi for technical assistance and E. Palio and M. Gulisano for valuable discussion and suggestions. This work was supported by the Italian Health Ministry, the Italian Ministry of University and Research (project number RBIP06ZJ78), and the Italian Association for Cancer Research. M. Bartucci is a recipient of a fellowship from the Italian Association for Cancer Research.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dong JT, 2001, PROSTATE, V49, P166, DOI 10.1002/pros.1131; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Hyytinen ER, 1999, GENE CHROMOSOME CANC, V25, P108, DOI 10.1002/(SICI)1098-2264(199906)25:2<108::AID-GCC6>3.0.CO;2-Y; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loberg RD, 2005, J CLIN ONCOL, V23, P8232, DOI 10.1200/JCO.2005.03.0841; Navone NM, 2004, METH MOLEC MED, V88, P121; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Nupponen NN, 1998, CANCER GENET CYTOGEN, V101, P53, DOI 10.1016/S0165-4608(97)00060-5; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tolcher AW, 2005, CLIN CANCER RES, V11, P3854, DOI 10.1158/1078-0432.CCR-04-2145; Yin ZN, 1999, ONCOGENE, V18, P7576, DOI 10.1038/sj.onc.1203203; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	33	777	851	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11					1271	1277		10.1038/nm.1880	http://dx.doi.org/10.1038/nm.1880			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18931683				2022-12-25	WOS:000260751200047
J	Tan, LB; Li, XR; Liu, FX; Sun, XY; Li, CG; Zhu, ZF; Fu, YC; Cai, HW; Wang, XK; Xie, DX; Sun, CQ				Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Xie, Daoxin; Sun, Chuanqing			Control of a key transition from prostrate to erect growth in rice domestication	NATURE GENETICS			English	Article							ORYZA-RUFIPOGON; PLANT; GENE; GRAVITROPISM; EVOLUTION; PROTEIN; ORIGIN; MAIZE; LAZY1	The transition from the prostrate growth of ancestral wild rice (O. rufipogon Griff.) to the erect growth of Oryza sativa cultivars was one of the most critical events in rice domestication. This evolutionary step importantly improved plant architecture and increased grain yield. Here we find that prostrate growth of wild rice from Yuanjiang County in China is controlled by a semi-dominant gene, PROG1 (PROSTRATE GROWTH 1), on chromosome 7 that encodes a single Cys(2)-His(2) zinc-finger protein. prog1 variants identified in O. sativa disrupt the prog1 function and inactivate prog1 expression, leading to erect growth, greater grain number and higher grain yield in cultivated rice. Sequence comparison shows that 182 varieties of cultivated rice, including 87 indica and 95 japonica cultivars from 17 countries, carry identical mutations in the prog1 coding region that may have become fixed during rice domestication.	[Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Sun, Chuanqing] China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xie, Daoxin] Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	China Agricultural University; Tsinghua University	Sun, CQ (corresponding author), China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	daoxin@tsinghua.edu.cn; suncq@cau.edu.cn	Li, Xianran/I-5651-2012; xie, daoxin d/C-8646-2017; Li, Xianran/AAH-1070-2019; Tan, Lubin/H-9270-2017	Li, Xianran/0000-0002-4252-6911; Tan, Lubin/0000-0003-3775-7720	National Natural Science Foundation; Ministry of Agriculture; Ministry of Science and Technology of China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank N. Harberd for comments on the manuscript, Y. Wang for assisting in cross sections, and the International Rice Research Institute, Chinese Rice Research Institute, Institute of Crop Sciences of Chinese Academy of Agricultural Sciences, Guangxi Academy of Agricultural Sciences and Guangdong Academy of Agricultural Sciences for providing the wild rice and cultivated rice samples. This research was supported by the National Natural Science Foundation, the Ministry of Agriculture and the Ministry of Science and Technology of China.	Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XR, 2008, BIOTECHNOL LETT, V30, P555, DOI 10.1007/s10529-007-9558-4; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tan LB, 2007, J INTEGR PLANT BIOL, V49, P871, DOI 10.1111/j.1744-7909.2007.00497.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WAISEL Y, 1987, OECOLOGIA, V73, P630, DOI 10.1007/BF00379428; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yuan QP, 2003, NUCLEIC ACIDS RES, V31, P229, DOI 10.1093/nar/gkg059	21	303	365	15	228	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1360	1364		10.1038/ng.197	http://dx.doi.org/10.1038/ng.197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820699				2022-12-25	WOS:000260501500031
J	Nathans, R; Cao, H; Sharova, N; Ali, A; Sharkey, M; Stranska, R; Stevenson, M; Rana, TM				Nathans, Robin; Cao, Hong; Sharova, Natalia; Ali, Akbar; Sharkey, Mark; Stranska, Ruzena; Stevenson, Mario; Rana, Tariq M.			Small-molecule inhibition of HIV-1 Vif	NATURE BIOTECHNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEAMINASE APOBEC3G; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; SOCS-BOX; DEGRADATION; PROTEASOME; COMPLEX; PROTEIN; DNA	The HIV-1 protein Vif, essential for in vivo viral replication(1-4), targets the human DNA-editing enzyme, APOBEC3G (A3G)(5), which inhibits replication of retroviruses and hepatitis B virus(6,7). As Vif has no known cellular homologs, it is an attractive, yet unrealized, target for antiviral intervention. Although zinc chelation inhibits Vif and enhances viral sensitivity to A3G(8), this effect is unrelated to the interaction of Vif with A3G. We identify a small molecule, RN-18, that antagonizes Vif function and inhibits HIV-1 replication only in the presence of A3G. RN-18 increases cellular A3G levels in a Vif-dependent manner and increases A3G incorporation into virions without inhibiting general proteasome-mediated protein degradation. RN-18 enhances Vif degradation only in the presence of A3G, reduces viral infectivity by increasing A3G incorporation into virions and enhances cytidine deamination of the viral genome. These results demonstrate that the HIV-1 Vif-A3G axis is a valid target for developing small molecule based new therapies for HIV infection or for enhancing innate immunity against viruses.	[Sharova, Natalia; Sharkey, Mark; Stranska, Ruzena; Stevenson, Mario] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Nathans, Robin; Cao, Hong; Ali, Akbar; Rana, Tariq M.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Chem Biol Program, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stevenson, M (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	Mario.stevenson@umassmed.edu; trana@burnham.org			NIH; UMASS CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, R33AI088595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH081836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMASS CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The HIV-1 subgenomic proviral vector pNL-A1 harboring HXB2 strain Vif, and the corresponding pNL-A1Dvif were generous gifts of Klaus Strebel. HIV-1 luciferase reporter constructs pNL4-3LucR-E-and pNL4-3DVif LucR-E-were provided by Nathaniel Landau through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH. The plasmid APOBEC3F-HA was a gift from Michael Malim, and plasmids APOBEC3B-HA and APOBEC3CHA were generous gifts from Bryan Cullen. We also thank Rana laboratory members for helpful discussions and support and the University of Massachusetts Center for AIDS Research (CFAR) for virology support. This work was supported in part by an NIH grant to T. M. R. and M. S. and by a Developmental award from the UMASS CFAR.	Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Madani N, 2000, J VIROL, V74, P5982, DOI 10.1128/JVI.74.13.5982-5987.2000; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zavrski I, 2005, ANTI-CANCER DRUG, V16, P475, DOI 10.1097/00001813-200506000-00002; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	25	155	172	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1187	1192		10.1038/nbt.1496	http://dx.doi.org/10.1038/nbt.1496			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18806783	Green Accepted			2022-12-25	WOS:000259926000034
J	Ebisuya, M; Yamamoto, T; Nakajima, M; Nishida, E				Ebisuya, Miki; Yamamoto, Takuya; Nakajima, May; Nishida, Eisuke			Ripples from neighbouring transcription	NATURE CELL BIOLOGY			English	Article							FACTOR-BINDING SITES; HUMAN GENOME; GENE-EXPRESSION; CELL-CYCLE; IDENTIFICATION; PROMOTERS; SEQUENCES; DATABASE; RNA; MAP	Transcriptional initiation of each gene is assumed to be independently controlled in mammals. On the other hand, recent large-scale transcriptome analyses have shown that the genome is pervasively transcribed, such that the most of its DNA gives rise to RNAs1-4. This raises the question of whether it is possible to pinpoint and activate a particular locus without perturbing numerous neighbouring transcripts. Here we show that intensive transcription at one locus frequently spills over into its physical neighbouring loci. Rapid induction of immediate-early genes (IEGs) in response to growth factor stimulation(5) is accompanied by co-upregulation of their neighbouring genes. Profiling the primary transcripts in the nucleus with whole-genome tiling arrays delineated simultaneous activation of transcription centred on IEGs. Even in surrounding intergenic regions, transcriptional activation took place at the same time. Acetylation levels of histone H3 and H4 are elevated along with the IEG induction and neighbouring co-upregulation. Inhibition of the mitogen-activated protein kinase (MAPK) pathway or the transcription factor SRF suppresses all transcriptional upregulation. These results suggest that transcriptional activation has a ripple effect, which may be advantageous for coordinated expression.	[Ebisuya, Miki; Yamamoto, Takuya; Nakajima, May; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	150174@sakura.kudpc.kyoto-u.ac.jp	Ebisuya, Miki/N-5388-2015; Yamamoto, Takuya/H-2792-2017	Ebisuya, Miki/0000-0003-1854-7496; Yamamoto, Takuya/0000-0002-0022-3947	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank I. Smith for helpful discussion and M. McMahon for Delta B-Raf-ER cells. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E.N.).	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	30	190	196	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1106	1113		10.1038/ncb1771	http://dx.doi.org/10.1038/ncb1771			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160492				2022-12-25	WOS:000258910400017
J	Wei, A; Jackson, SP				Wei, Andrew; Jackson, Shaun P.			Boosting platelet production	NATURE MEDICINE			English	Editorial Material							IMMUNE THROMBOCYTOPENIC PURPURA; THROMBOPOIETIN; ELTROMBOPAG; ITP		[Wei, Andrew; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Monash University	Wei, A (corresponding author), Monash Univ, Australian Ctr Blood Dis, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	Shaun.Jackson@med.monash.edu.au	Jackson, Shaun P/E-9633-2011; Wei, Andrew H/F-3707-2012	Jackson, Shaun/0000-0002-4750-1991; Wei, Andrew/0000-0002-7514-3298				BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Bussel JB, 2006, NEW ENGL J MED, V355, P1672, DOI 10.1056/NEJMoa054626; Chang M, 2003, BLOOD, V102, P887, DOI 10.1182/blood-2002-05-1475; Feudjo-Tepie MA, 2008, J THROMB HAEMOST, V6, P711, DOI 10.1111/j.1538-7836.2008.02911.x; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; HARRINGTON WJ, 1951, J LAB CLIN MED, V38, P1; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; PISCIOTTA AV, 1953, BLOOD, V8, P703, DOI 10.1182/blood.V8.8.703.703	13	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2008	14	9					917	918		10.1038/nm0908-917	http://dx.doi.org/10.1038/nm0908-917			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	345IB	18776883				2022-12-25	WOS:000258988600014
J	Lam, BJ; Joyce, GF				Lam, Bianca J.; Joyce, Gerald F.			Autocatalytic aptazymes enable ligand-dependent exponential amplification of RNA	NATURE BIOTECHNOLOGY			English	Article							IN-VITRO SELECTION; GENE-EXPRESSION; ALLOSTERIC RIBOZYMES; REAL-TIME; DNA; APTAMERS; LIGATION; PROTEINS; DESIGN; ARRAYS	RNA enzymes have been developed that undergo self-sustained replication at a constant temperature in the absence of proteins(1). These RNA molecules amplify exponentially through a cross-replicative process, whereby two enzymes catalyze each other's synthesis by joining component oligonucleotides. Other RNA enzymes have been made to operate in a ligand-dependent manner by combining a catalytic domain with a ligand-binding domain (aptamer) to produce an 'aptazyme'(2,3). The principle of ligand-dependent RNA catalysis has now been extended to the cross-replicating RNA enzymes so that exponential amplification occurs in the presence, but not the absence, of the cognate ligand. The exponential growth rate of the RNA depends on the concentration of the ligand, allowing one to determine the concentration of ligand in a sample. This process is analogous to quantitative PCR (qPCR) but can be generalized to a wide variety of targets, including proteins and small molecules that are relevant to medical diagnostics and environmental monitoring.	[Lam, Bianca J.; Joyce, Gerald F.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Lam, Bianca J.; Joyce, Gerald F.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Lam, Bianca J.; Joyce, Gerald F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu			National Institutes of Health (NIH) [R01GM065130]; Skaggs Institute for Chemical Biology at The Scripps Research Institute; NIH Ruth L. Kirschstein National Research Service [5F32GM078691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065130, F32GM078691] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology at The Scripps Research Institute; NIH Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R01GM065130 from the National Institutes of Health (NIH) and by The Skaggs Institute for Chemical Biology at The Scripps Research Institute. B.J.L. was supported by NIH Ruth L. Kirschstein National Research Service Award 5F32GM078691. We thank William McAllister, State University of New York, Brooklyn, for kindly providing plasmid pBH161 encoding histidine-tagged T7 RNA polymerase.	Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Bock C, 2004, PROTEOMICS, V4, P609, DOI 10.1002/pmic.200300631; BURGSTALLER P, 1994, ANGEW CHEM INT EDIT, V33, P1084, DOI 10.1002/anie.199410841; Ciesiolka J, 1996, METHOD ENZYMOL, V267, P315; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Hartig JS, 2002, NAT BIOTECHNOL, V20, P717, DOI 10.1038/nbt0702-717; Hesselberth JR, 2003, ANAL BIOCHEM, V312, P106, DOI 10.1016/S0003-2697(02)00441-4; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kirby R, 2004, ANAL CHEM, V76, P4066, DOI 10.1021/ac049858n; LIN Y, 1994, NUCLEIC ACIDS RES, V22, P5229, DOI 10.1093/nar/22.24.5229; LINCOLN TA, 2009, SCIENCE         0108, DOI DOI 10.1126/SCIENCE.1167856; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; PLUTHERO FG, 1993, NUCLEIC ACIDS RES, V21, P4850, DOI 10.1093/nar/21.20.4850; Robertson MP, 2000, NUCLEIC ACIDS RES, V28, P1751, DOI 10.1093/nar/28.8.1751; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Stojanovic MN, 2004, J AM CHEM SOC, V126, P9266, DOI 10.1021/ja032013t; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Vaish NK, 2002, NAT BIOTECHNOL, V20, P810, DOI 10.1038/nbt719; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; WU DY, 1989, GENOMICS, V4, P560, DOI 10.1016/0888-7543(89)90280-2; Yoshida W, 2007, CHEM COMMUN, P195, DOI 10.1039/b613201d	30	45	46	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2009	27	3					288	292		10.1038/nbt.1528	http://dx.doi.org/10.1038/nbt.1528			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	416UJ	19234448	Green Accepted, Green Submitted			2022-12-25	WOS:000264030700023
J	Newton-Cheh, C; Larson, MG; Vasan, RS; Levy, D; Bloch, KD; Surti, A; Guiducci, C; Kathiresan, S; Benjamin, EJ; Struck, J; Morgenthaler, NG; Bergmann, A; Blankenberg, S; Kee, F; Nilsson, P; Yin, XY; Peltonen, L; Vartiainen, E; Salomaa, V; Hirschhorn, JN; Melander, O; Wang, TJ				Newton-Cheh, Christopher; Larson, Martin G.; Vasan, Ramachandran S.; Levy, Daniel; Bloch, Kenneth D.; Surti, Aarti; Guiducci, Candace; Kathiresan, Sekar; Benjamin, Emelia J.; Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas; Blankenberg, Stefan; Kee, Frank; Nilsson, Peter; Yin, Xiaoyan; Peltonen, Leena; Vartiainen, Erkki; Salomaa, Veikko; Hirschhorn, Joel N.; Melander, Olle; Wang, Thomas J.			Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure	NATURE GENETICS			English	Article							CARDIOVASCULAR-DISEASE; RISK; IMPACT; HYPERTENSION; CONTRIBUTE; MUTATIONS; MORTALITY; FINLAND; PROJECT; LINKAGE	We examined the association of common variants at the NPPA-NPPB locus with circulating concentrations of the natriuretic peptides, which have blood pressure-lowering properties. We genotyped SNPs at the NPPA-NPPB locus in 14,743 individuals of European ancestry, and identified associations of plasma atrial natriuretic peptide with rs5068 (P = 8 x 10(-70)), rs198358 (P = 8 x 10(-30)) and rs632793 (P = 2 x 10(-10)), and of plasma B-type natriuretic peptide with rs5068 (P = 3 x 10(-12)), rs198358 (P = 1 x 10(-25)) and rs632793 (P = 2 x 10(-68)). In 29,717 individuals, the alleles of rs5068 and rs198358 that showed association with increased circulating natriuretic peptide concentrations were also found to be associated with lower systolic (P = 2 x 10(-6) and 6 x 10(-5), respectively) and diastolic blood pressure (P = 1 x 10(-6) and 5 x 10(-5)), as well as reduced odds of hypertension (OR = 0.85, 95% CI = 0.79-0.92, P = 4 x 10(-5); OR = 0.90, 95% CI = 0.85-0.95, P = 2 x 10(-4), respectively). Common genetic variants at the NPPA-NPPB locus found to be associated with circulating natriuretic peptide concentrations contribute to interindividual variation in blood pressure and hypertension.	[Newton-Cheh, Christopher; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Bloch, Kenneth D.; Kathiresan, Sekar; Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Surti, Aarti; Guiducci, Candace; Kathiresan, Sekar; Hirschhorn, Joel N.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Newton-Cheh, Christopher; Larson, Martin G.; Vasan, Ramachandran S.; Levy, Daniel; Kathiresan, Sekar; Benjamin, Emelia J.; Yin, Xiaoyan; Wang, Thomas J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Larson, Martin G.] Boston Univ, Sch Med, Dept Math, Boston, MA 02215 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA; [Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas] BRAHMS AG, Dept Res, D-16761 Hennigsdorf, Germany; [Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Dept Med 2, D-55131 Mainz, Germany; [Kee, Frank] Royal Victoria Hosp, Ctr Excellence Publ Hlth NI, A UKCRC, Belfast BT12 6BJ, Antrim, North Ireland; [Nilsson, Peter; Melander, Olle] Malmo Univ Hosp, CRC, SE-20502 Malmo, Sweden; [Peltonen, Leena; Vartiainen, Erkki; Salomaa, Veikko] KTL Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FI-00300 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Peltonen, Leena] Inst Mol Med Finland FIMM, Biomedicum Helsinki, FI-00290 Helsinki, Finland; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; Thermo Fisher Scientific; Brahms AG; Johannes Gutenberg University of Mainz; Lund University; Skane University Hospital; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Newton-Cheh, C (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 55 Fruit St, Boston, MA 02114 USA.	cnewtoncheh@chgr.mgh.harvard.edu; tjwang@partners.org	Levy, Daniel/ABF-6873-2021; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Larson, Martin/0000-0002-9631-1254; Wang, Thomas/0000-0003-4063-6508; Benjamin, Emelia/0000-0003-4076-2336; Melander, Olle/0000-0002-2581-484X	ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL083197, R01HL093328, R01HL070896, K23HL080025, ZIAHL006001, R01HL086875, U01HL066582, K23HL074077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572] Funding Source: NIH RePORTER	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conen D, 2007, HYPERTENSION, V50, P1114, DOI 10.1161/HYPERTENSIONAHA.107.097634; Cupples LA, 1987, SOME RISK FACTORS RE; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kastarinen MJ, 1998, J HYPERTENS, V16, P1379, DOI 10.1097/00004872-199816090-00019; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lynch AI, 2008, JAMA-J AM MED ASSOC, V299, P296, DOI 10.1001/jama.299.3.296; Nilsson PM, 2007, DIABETIC MED, V24, P464, DOI 10.1111/j.1464-5491.2007.02142.x; Numata Y, 1998, CLIN CHEM, V44, P1008; Schillinger KJ, 2005, P NATL ACAD SCI USA, V102, P13789, DOI 10.1073/pnas.0506807102; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wang TJ, 2003, CIRCULATION, V108, P13, DOI 10.1161/01.CIR.0000081657.83724.A7; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5	30	306	321	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					348	353		10.1038/ng.328	http://dx.doi.org/10.1038/ng.328			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19219041	Green Accepted			2022-12-25	WOS:000263640200017
J	Smith, E; Dejsuphong, D; Balestrini, A; Hampel, M; Lenz, C; Takeda, S; Vindigni, A; Costanzo, V				Smith, Eloise; Dejsuphong, Donniphat; Balestrini, Alessia; Hampel, Martin; Lenz, Christof; Takeda, Shunichi; Vindigni, Alessandro; Costanzo, Vincenzo			An ATM- and ATR-dependent checkpoint inactivates spindle assembly by targeting CEP63	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; MITOTIC SPINDLE; CELL-CYCLE; CENTROSOME AMPLIFICATION; PROTEIN-PHOSPHORYLATION; SELF-ORGANIZATION; VERTEBRATE CELLS; IDENTIFICATION	Activation of the protein kinases ATM and ATR following chromosomal breakage prevents initiation of DNA replication and entry into mitosis. However, the effects of ATM and ATR activation in cells already progressing through mitosis are poorly understood. Here we report that ATM and ATR activation induced by DNA double-strand breaks (DSBs) inhibits centrosome-driven spindle assembly in Xenopus laevis mitotic egg extract and somatic cells, delaying mitotic progression. Using a cDNA expression library to screen for ATM and ATR substrates, we identified centrosomal protein CEP63 as an ATM and ATR target required for normal spindle assembly. ATM and ATR phosphorylate Xenopus CEP63 (XCEP63) on Ser 560 and promote its delocalization from the centrosome. Suppression of ATM and ATR activity or mutation of XCEP63 Ser 560 to Ala prevented spindle assembly defects. Consistently, inactivation of the CEP63 gene in avian DT40 cells impaired spindle assembly and prevented ATM- and ATR-dependent effects on mitosis. These data indicate that ATM and ATR control mitotic events in vertebrate cells by targeting CEP63 and centrosome dependent spindle assembly.	[Smith, Eloise; Dejsuphong, Donniphat; Balestrini, Alessia; Costanzo, Vincenzo] Clare Hall Labs, London Res Inst, Genome Stabil Unit, S Mimms EN6 3LD, Herts, England; [Dejsuphong, Donniphat; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan; [Hampel, Martin; Vindigni, Alessandro] ICGEB, Trieste, Italy; [Lenz, Christof] Appl Biosyst Inc, D-64293 Frankfurt Darmstadt, Germany	Kyoto University; International Center for Genetic Engineering & Biotechnology (ICGEB); Thermo Fisher Scientific; Applied Biosystems	Costanzo, V (corresponding author), Clare Hall Labs, London Res Inst, Genome Stabil Unit, S Mimms EN6 3LD, Herts, England.	Vincenzo.Costanzo@cancer.org.uk		Costanzo, Vincenzo/0000-0002-2920-9508; Dejsuphong, Donniphat/0000-0001-8367-9415; Takeda, Shunichi/0000-0002-7924-7991	Cancer Research UK; Lister Institute of Preventive Medicine; European Research Council ( ERC); EMBO Young Investigator Program (YIP).; AIRC	Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; European Research Council ( ERC)(European Research Council (ERC)European Commission); EMBO Young Investigator Program (YIP).(European Molecular Biology Organization (EMBO)); AIRC(Fondazione AIRC per la ricerca sul cancro)	We thank Tim Hunt, members of Clare Hall Laboratories and of the Genome Stability Unit for their comments. We thank H Mahbubani and J Kirk for technical support with Xenopus laevis. This work was funded by Cancer Research UK. V. Costanzo is also supported by the Lister Institute of Preventive Medicine, the European Research Council ( ERC) start up grant and the EMBO Young Investigator Program (YIP). A. Vindigni thanks AIRC for its support.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Buim ME, 2005, ONCOLOGY-BASEL, V69, P445, DOI 10.1159/000090984; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Cox David M, 2005, J Biomol Tech, V16, P83; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Liu JJ, 2005, ONCOGENE, V24, P238, DOI 10.1038/sj.onc.1208220; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Maller JL, 2002, MOL CELL ENDOCRINOL, V187, P173, DOI 10.1016/S0303-7207(01)00695-5; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Morrison C, 2004, DNA REPAIR, V3, P1133, DOI 10.1016/j.dnarep.2004.03.005; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	36	52	58	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					278	U125		10.1038/ncb1835	http://dx.doi.org/10.1038/ncb1835			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182792	Green Submitted, Green Published			2022-12-25	WOS:000263777900011
J	Du, JY; Bernasconi, P; Clauser, KR; Mani, DR; Finn, SP; Beroukhim, R; Burns, M; Julian, B; Peng, XP; Hieronymus, H; Maglathlin, RL; Lewis, TA; Liau, LM; Nghiemphu, P; Mellinghoff, IK; Louis, DN; Loda, M; Carr, SA; Kung, AL; Golub, TR				Du, Jinyan; Bernasconi, Paula; Clauser, Karl R.; Mani, D. R.; Finn, Stephen P.; Beroukhim, Rameen; Burns, Melissa; Julian, Bina; Peng, Xiao P.; Hieronymus, Haley; Maglathlin, Rebecca L.; Lewis, Timothy A.; Liau, Linda M.; Nghiemphu, Phioanh; Mellinghoff, Ingo K.; Louis, David N.; Loda, Massimo; Carr, Steven A.; Kung, Andrew L.; Golub, Todd R.			Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy	NATURE BIOTECHNOLOGY			English	Article							BRAIN-TUMORS; STEM-CELLS; AMPLIFICATION; GROWTH; CANCER; GENE; RESISTANCE; INHIBITOR; GLIOMA; MET	The aberrant activation of tyrosine kinases represents an important oncogenic mechanism, and yet the majority of such events remain undiscovered. Here we describe a bead-based method for detecting phosphorylation of both wild-type and mutant tyrosine kinases in a multiplexed, high-throughput and low-cost manner. With the aim of establishing a tyrosine kinase-activation catalog, we used this method to profile 130 human cancer lines. Follow-up experiments on the finding that SRC is frequently phosphorylated in glioblastoma cell lines showed that SRC is also activated in primary glioblastoma patient samples and that the SRC inhibitor dasatinib (Sprycel) inhibits viability and cell migration in vitro and tumor growth in vivo. Testing of dasatinib-resistant tyrosine kinase alleles confirmed that SRC is indeed the relevant target of dasatinib, which inhibits many tyrosine kinases. These studies establish the feasibility of tyrosine kinome-wide phosphorylation profiling and point to SRC as a possible therapeutic target in glioblastoma. (C) 2009 Nature America, Inc. All rights reserved.	[Du, Jinyan; Bernasconi, Paula; Clauser, Karl R.; Mani, D. R.; Beroukhim, Rameen; Burns, Melissa; Julian, Bina; Peng, Xiao P.; Hieronymus, Haley; Maglathlin, Rebecca L.; Lewis, Timothy A.; Carr, Steven A.; Golub, Todd R.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Du, Jinyan; Bernasconi, Paula; Clauser, Karl R.; Mani, D. R.; Beroukhim, Rameen; Burns, Melissa; Julian, Bina; Peng, Xiao P.; Hieronymus, Haley; Maglathlin, Rebecca L.; Lewis, Timothy A.; Carr, Steven A.; Golub, Todd R.] MIT, Cambridge, MA 02142 USA; [Du, Jinyan; Bernasconi, Paula; Burns, Melissa; Hieronymus, Haley; Kung, Andrew L.; Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Finn, Stephen P.; Beroukhim, Rameen; Loda, Massimo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Finn, Stephen P.; Beroukhim, Rameen; Loda, Massimo] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Julian, Bina; Peng, Xiao P.; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Liau, Linda M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Nghiemphu, Phioanh] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Louis, David N.] Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02114 USA; [Louis, David N.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Louis, David N.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Golub, TR (corresponding author), Harvard Univ, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	golub@broad.mit.edu	Finn, Stephen/V-3236-2019; Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020; Carr, Steven A./AAH-8366-2019	Finn, Stephen/0000-0002-8628-5814; Kung, Andrew L/0000-0002-9091-488X; Lewis, Timothy/0000-0001-9748-9575; Liau, Linda/0000-0002-4053-0052; Clauser, Karl/0000-0002-1052-9456; Mani, D. R./0000-0003-3914-133X; Burns, Melissa/0000-0002-0953-766X	Leukemia and Lymphoma Society; Irving Family; Brain Tumor Funders' Collaborative; National Cancer Institute's (NCI) Initiative for Chemical Genetics, National Institutes of Health [N01-CO-12400]; NATIONAL CANCER INSTITUTE [K08CA122833, U54CA112962] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Irving Family; Brain Tumor Funders' Collaborative; National Cancer Institute's (NCI) Initiative for Chemical Genetics, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Levi Garraway and Johnathan Fletcher for cell lines. We thank Julie Dang for her technical support on the pY419SRC IHC experiment. J.D. is supported by a fellowship from the Leukemia and Lymphoma Society and The Irving Family. I. K. M. is funded by the Brain Tumor Funders' Collaborative. The project has been funded in part with funds from the National Cancer Institute's (NCI) Initiative for Chemical Genetics, National Institutes of Health, under contract no. N01-CO-12400, and through the NCI's Integrative Cancer Biology Program.	Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Desbois-Mouthon C, 2002, HEPATOLOGY, V36, P1528, DOI 10.1053/jhep.2002.37192; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Feinstein A, 2002, PRINCIPLES MED STAT; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; KITA YA, 1994, FEBS LETT, V349, P139, DOI 10.1016/0014-5793(94)00644-X; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lund CV, 2006, J NEURO-ONCOL, V78, P19, DOI 10.1007/s11060-005-9068-y; Nakamura Y, 2008, CANCER SCI, V99, P14, DOI 10.1111/j.1349-7006.2007.00640.x; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Phuong LK, 2003, CANCER RES, V63, P2462; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Ueda T, 1999, CANCER RES, V59, P6080; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889	28	188	195	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2009	27	1					77	83		10.1038/nbt.1513	http://dx.doi.org/10.1038/nbt.1513			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	394TP	19098899	Green Accepted			2022-12-25	WOS:000262471200026
J	Lyssenko, V; Nagorny, CLF; Erdos, MR; Wierup, N; Jonsson, A; Spegel, P; Bugliani, M; Saxena, R; Fex, M; Pulizzi, N; Isomaa, B; Tuomi, T; Nilsson, P; Kuusisto, J; Tuomilehto, J; Boehnke, M; Altshuler, D; Sundler, F; Eriksson, JG; Jackson, AU; Laakso, M; Marchetti, P; Watanabe, RM; Mulder, H; Groop, L				Lyssenko, Valeriya; Nagorny, Cecilia L. F.; Erdos, Michael R.; Wierup, Nils; Jonsson, Anna; Spegel, Peter; Bugliani, Marco; Saxena, Richa; Fex, Malin; Pulizzi, Nicolo; Isomaa, Bo; Tuomi, Tiinamaija; Nilsson, Peter; Kuusisto, Johanna; Tuomilehto, Jaakko; Boehnke, Michael; Altshuler, David; Sundler, Frank; Eriksson, Johan G.; Jackson, Anne U.; Laakso, Markku; Marchetti, Piero; Watanabe, Richard M.; Mulder, Hindrik; Groop, Leif			Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MELATONIN RECEPTORS; SENSITIVITY; EXPRESSION; PANCREAS; LOCI; REPLICATION; INDEXES; ISLET	Genome-wide association studies have shown that variation in MTNR1B (melatonin receptor 1B) is associated with insulin and glucose concentrations. Here we show that the risk genotype of this SNP predicts future type 2 diabetes (T2D) in two large prospective studies. Specifically, the risk genotype was associated with impairment of early insulin response to both oral and intravenous glucose and with faster deterioration of insulin secretion over time. We also show that the MTNR1B mRNA is expressed in human islets, and immunocytochemistry confirms that it is primarily localized in beta cells in islets. Nondiabetic individuals carrying the risk allele and individuals with T2D showed increased expression of the receptor in islets. Insulin release from clonal beta cells in response to glucose was inhibited in the presence of melatonin. These data suggest that the circulating hormone melatonin, which is predominantly released from the pineal gland in the brain, is involved in the pathogenesis of T2D. Given the increased expression of MTNR1B in individuals at risk of T2D, the pathogenic effects are likely exerted via a direct inhibitory effect on beta cells. In view of these results, blocking the melatonin ligand-receptor system could be a therapeutic avenue in T2D.	[Lyssenko, Valeriya; Jonsson, Anna; Groop, Leif] Lund Univ, Univ Hosp, Dept Clin Sci Malmoe, Unit Diabet & Endocrinol,Diabet Ctr, S-20520 Malmo, Sweden; [Nagorny, Cecilia L. F.; Spegel, Peter; Mulder, Hindrik] Lund Univ, Ctr Diabet, Dept Clin Sci Malmoe, Unit Mol Metab, S-20502 Malmo, Sweden; [Erdos, Michael R.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Wierup, Nils; Sundler, Frank] Lund Univ, Dept Expt Med Sci, Unit Neuroendocrine Cell Biol, S-22184 Lund, Sweden; [Bugliani, Marco; Pulizzi, Nicolo; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56124 Pisa, Italy; [Saxena, Richa; Altshuler, David] Harvard & Massachusetts Inst Technol, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02142 USA; [Saxena, Richa; Altshuler, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Fex, Malin] Lund Univ, Ctr Diabet, Dept Clin Sci Malmoe, Unit Diabet & Celiac Dis, S-20502 Malmo, Sweden; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki 00251, Finland; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Cent Hosp, Dept Med, Helsinki 00140, Finland; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Res Program Mol Med, Helsinki 00140, Finland; [Nilsson, Peter] Lund Univ, Dept Clin Sci, S-20502 Malmo, Sweden; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Senajoki 60220, Finland; [Boehnke, Michael; Jackson, Anne U.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	Lund University; Skane University Hospital; Lund University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Lund University; University of Pisa; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Lund University; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Lund University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Helsinki; University of Michigan System; University of Michigan; University of Helsinki; University of Southern California; University of Southern California	Groop, L (corresponding author), Lund Univ, Univ Hosp, Dept Clin Sci Malmoe, Unit Diabet & Endocrinol,Diabet Ctr, S-20520 Malmo, Sweden.	Leif.Groop@med.lu.se	Marchetti, Piero/J-7439-2013; Jansen, Heiko T./A-5770-2008; Mulder, Hindrik/E-1045-2012; Spégel, Peter/G-9947-2018; Bugliani, Marco/I-3168-2019; Altshuler, David M/A-4476-2009; Saxena, Richa/AAG-7279-2020	Marchetti, Piero/0000-0003-4907-0635; Jansen, Heiko T./0000-0003-0178-396X; Spégel, Peter/0000-0002-6092-2387; Bugliani, Marco/0000-0002-1744-1561; Altshuler, David M/0000-0002-7250-4107; Saxena, Richa/0000-0003-2233-1065; Fex, Malin/0000-0003-0675-7576; Tuomi, Tiinamaija/0000-0002-8306-6202; Mulder, Hindrik/0000-0002-6593-8417; Eriksson, Johan/0000-0002-2516-2060; Jonsson, Anna/0000-0003-1252-8673; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Novartis; Swedish Research Council [31475113580]; Lund University; Pahlsson Foundation; Heart and Lung Foundation; Wallenberg Foundation; Swedish Diabetes Research Society; Crafoord Foundation; Swedish Medical Society; Swedish Royal Physiographic Society; Nordic Centre of Excellence Grant in Disease Genetics; Finnish Diabetes Research Society; Sigrid Juselius Foundation; Folkhalsan Research Foundation; Novo Nordisk Foundation; European Network of Genomic and Genetic Epidemiology (ENGAGE); Italian Ministry of University and Research [PRIN 2007-2008]; European Community [LSHM-CT-2006-518153]; NIH [DK062370]; American Diabetes Association [1-05-RA-140, DK072193]; Academy of Finland [124243]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193, U01DK062370, R56DK062370, R01DK062370] Funding Source: NIH RePORTER	Novartis(Novartis); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University; Pahlsson Foundation; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Wallenberg Foundation(European Commission); Swedish Diabetes Research Society; Crafoord Foundation; Swedish Medical Society; Swedish Royal Physiographic Society; Nordic Centre of Excellence Grant in Disease Genetics; Finnish Diabetes Research Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Network of Genomic and Genetic Epidemiology (ENGAGE); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Academy of Finland(Academy of Finland); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The DGI study was supported by a grant from Novartis. Studies in Malmoe were supported by grants from the Swedish Research Council, including a Linne grant (No. 31475113580), the Diabetes Programme at Lund University, the Pahlsson Foundation, the Heart and Lung Foundation, the Wallenberg Foundation, the Swedish Diabetes Research Society, the Crafoord Foundation, Swedish Medical Society, Swedish Royal Physiographic Society, a Nordic Centre of Excellence Grant in Disease Genetics, the Finnish Diabetes Research Society, the Sigrid Juselius Foundation, Folkhalsan Research Foundation, Novo Nordisk Foundation, the European Network of Genomic and Genetic Epidemiology (ENGAGE), the Wallenberg Foundation, the European Foundation for the Study of Diabetes (EFSD) and the Human Tissue facility at the Lund University Diabetes Center. Studies in human islets were supported in part by the Italian Ministry of University and Research (PRIN 2007-2008) and the European Community (LSHM-CT-2006-518153). Pancreatic islets at US National Institutes of Health were obtained through the ICR Basic Science Islet Distribution Program (City of Hope Hospital, Joslin Diabetes Center, Northwestern University, Southern California Islet Consortium, University of Alabama Birmingham, University of Illinois, University of Miami, University of Minnesota, University of Pennsylvania, University of Wisconsin and Washington University), the Juvenile Diabetes Research Foundation Islet Resources (Washington University) and the National Disease Resource Interchange (NDRI). The FUSION study would like to thank the many research volunteers who generously participated in the various studies represented in FUSION. We also thank A. J. Swift, M. Morken, P. S. Chines and N. Narisu for genotying and informatics support. Support for FUSION was provided by the following: NIH grant DK062370 (M. Boehnke), American Diabetes Association research grant 1-05-RA-140 ( R. M. W.), DK072193 ( K. L. Mohlke) and National Human Genome Research Institute intramural project number 1 Z01 HG000024 ( F. S. Collins). The METSIM study was supported by Academy of Finland grant 124243 ( M. L.).	Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Boden G, 1996, AM J PHYSIOL-ENDOC M, V271, pE246, DOI 10.1152/ajpendo.1996.271.2.E246; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Kvetnoy IM, 1999, HISTOCHEM J, V31, P1, DOI 10.1023/A:1003431122334; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muhlbauer E, 2007, J PINEAL RES, V42, P105, DOI 10.1111/j.1600-079X.2006.00399.x; Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001; Peschke E, 2006, J PINEAL RES, V40, P184, DOI 10.1111/j.1600-079X.2005.00297.x; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Peschke E, 2007, J PINEAL RES, V42, P350, DOI 10.1111/j.1600-079X.2007.00426.x; PROKOPENKO I, 2008, NAT GENET       1207, DOI DOI 10.1038/NG.290; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; STEIL GM, 1993, DIABETES, V42, P250, DOI 10.2337/diabetes.42.2.250; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; YANG YJ, 1987, AM J PHYSIOL, V253, pE595, DOI 10.1152/ajpendo.1987.253.6.E595; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	534	546	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					82	88		10.1038/ng.288	http://dx.doi.org/10.1038/ng.288			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19060908	Green Accepted			2022-12-25	WOS:000262085300020
J	Wang, Y; Baskerville, S; Shenoy, A; Babiarz, JE; Baehner, L; Blelloch, R				Wang, Yangming; Baskerville, Scott; Shenoy, Archana; Babiarz, Joshua E.; Baehner, Lauren; Blelloch, Robert			Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation	NATURE GENETICS			English	Article							DNA METHYLATION; DIFFERENTIATION; CYCLE; TARGETS; BIOGENESIS; DIVISION; PATHWAY; GENES	Dgcr8 knockout embryonic stem (ES) cells lack microprocessor activity and hence all canonical microRNAs (miRNAs). These cells proliferate slowly and accumulate in G1 phase of the cell cycle(1). Here, by screening a comprehensive library of individual miRNAs in the background of the Dgcr8 knockout ES cells, we report that multiple ES cell-specific miRNAs, members of the miR-290 family, rescue the ES cell proliferation defect. Furthermore, rescued cells no longer accumulate in the G1 phase of the cell cycle. These miRNAs function by suppressing several key regulators of the G1-S transition. These results show that post-transcriptional regulation by miRNAs promotes the G1-S transition of the ES cell cycle, enabling rapid proliferation of these cells. Our screening strategy provides an alternative and powerful approach for uncovering the role of individual miRNAs in biological processes, as it overcomes the common problem of redundancy and saturation in the miRNA system.	[Wang, Yangming; Shenoy, Archana; Babiarz, Joshua E.; Baehner, Lauren; Blelloch, Robert] Univ Calif San Francisco, Inst Regenerat Med, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Baskerville, Scott] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Baskerville, Scott] Dharmacon Technol, Thermo Fisher Sci, Lafayette, CO 80026 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thermo Fisher Scientific	Blelloch, R (corresponding author), Univ Calif San Francisco, Inst Regenerat Med, Ctr Reprod Sci, San Francisco, CA 94143 USA.	BlellochR@stemcell.ucsf.edu	Wang, Yangming/J-8939-2015	Wang, Yangming/0000-0001-6974-6060	US National Institutes of Health [K08 NS48118, R01 NS057221]; Stem Cell Research Foundation; Pew Charitable Trust; California Institute of Regenerative Medicine Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057221, K08NS048118] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stem Cell Research Foundation; Pew Charitable Trust; California Institute of Regenerative Medicine Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank A. D. Sharma and K. Okamura for their technical assistance with the immunoblot assay; M. Grskovic and C. Chaivorapol for their technical assistance with the luciferase reporter assay; M. Sachs for help in developing the overexpression construct; and M. Conti, M. Ramalho-Santos, J. Reiter and members of the Blelloch laboratory for critical reading of the manuscript. This work was supported by funds to R. B. from the US National Institutes of Health (K08 NS48118 and R01 NS057221), the Stem Cell Research Foundation and the Pew Charitable Trust. Y. W. is supported by a California Institute of Regenerative Medicine Training Grant.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kato Jun-ya, 1999, Frontiers in Bioscience, V4, pd787, DOI 10.2741/Kato; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Savatier P, 1996, ONCOGENE, V12, P309; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Sorrentino E, 2007, GENE EXPR PATTERNS, V7, P714, DOI 10.1016/j.modgep.2007.02.002; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131	28	501	531	3	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1478	1483		10.1038/ng.250	http://dx.doi.org/10.1038/ng.250			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978791	Green Accepted			2022-12-25	WOS:000261215900026
J	Chaouat, G				Chaouat, Gerard			Funding for research in reproduction in the European Union	NATURE MEDICINE			English	Editorial Material									Univ Paris Sud Orsay & Assistance Publ, INSERM, Equipe Implantat & Dialogue Cytokin Mere Conceptu, U782, F-92141 Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Chaouat, G (corresponding author), Univ Paris Sud Orsay & Assistance Publ, INSERM, Equipe Implantat & Dialogue Cytokin Mere Conceptu, U782, 3E Rue Carnets, F-92141 Clamart, France.	gerard_chaouat@wanadoo.fr						Bischof P, 2006, GYNECOL OBSTET INVES, V62, P206, DOI 10.1159/000094005; MARIOMON R, 2004, EVALUATION EFFECTIVE, V6; REDMAN CWE, 1992, PREECLAMPSIA FACTS H; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; Zondervan K, 2000, BEST PRACT RES CL OB, V14, P403, DOI 10.1053/beog.1999.0083; 2007, J REPROD IMMUNOL, V76, P1	6	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11					1218	1220		10.1038/nm1108-1218	http://dx.doi.org/10.1038/nm1108-1218			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18989309				2022-12-25	WOS:000260751200040
J	Kelly, EJ; Hadac, EM; Greiner, S; Russell, SJ				Kelly, Elizabeth J.; Hadac, Elizabeth M.; Greiner, Suzanne; Russell, Stephen J.			Engineering microRNA responsiveness to decrease virus pathogenicity	NATURE MEDICINE			English	Article							ONCOLYTIC VIROTHERAPY; TRANSGENE EXPRESSION; ENDOGENOUS MICRORNA; COXSACKIEVIRUS A21; TUMORS; COMBINATION; ADENOVIRUS; EFFICACY; THERAPY; TISSUE	The cellular tropisms of eukaryotic viruses are shaped by their need for entry receptors and intracellular transcription factors. Here we show that viral tropisms can also be regulated by tissue-specific microRNAs ( miRNAs). Target sequences complementary to muscle-specific miRNAs were inserted into the 3' untranslated region (UTR) of an oncolytic picornavirus that causes lethal myositis in tumor-bearing mice. The recombinant virus still propagated in subcutaneous tumors, causing total regression and sustained viremia, but could not replicate in cells expressing complementary miRNAs and therefore did not cause myositis. This altered tropism was not due to insertional attenuation, as a control virus containing a 3' UTR insert with a disrupted miRNA target sequence fully retained its lethal myotropism. Tissue-specific destabilization of viral genomes by miRNA target insertion provides a potentially versatile new mechanism for controlling the tropism of replicating viruses for therapy and may serve as a new modality for attenuating viruses for vaccine purposes.	[Kelly, Elizabeth J.; Hadac, Elizabeth M.; Greiner, Suzanne; Russell, Stephen J.] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Russell, SJ (corresponding author), Mayo Clin, Coll Med, Dept Mol Med, 200 1st St SW, Rochester, MN 55905 USA.	sjr@mayo.edu						Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Alonso MM, 2007, CANCER GENE THER, V14, P756, DOI 10.1038/sj.cgt.7701067; Au GG, 2005, INT J ONCOL, V26, P1471; Barber GN, 2004, VIRAL IMMUNOL, V17, P516, DOI 10.1089/vim.2004.17.516; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Dekel B, 2002, ACTA PAEDIATR, V91, P357, DOI 10.1080/08035250252834067; Domingo E, 1997, REV MED VIROL, V7, P87, DOI 10.1002/(SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0; Dufresne AT, 2004, P NATL ACAD SCI USA, V101, P13636, DOI 10.1073/pnas.0403998101; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Grimm D, 2007, MOL THER, V15, P878, DOI 10.1038/sj.mt.6300116; Heise CC, 1999, CANCER RES, V59, P2623; Hingorani M, 2007, CURR CANCER DRUG TAR, V7, P389, DOI 10.2174/156800907780809787; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Knipe D. M., 2007, FIELDS VIROLOGY; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Qiao J, 2008, NAT MED, V14, P37, DOI 10.1038/nm1681; Qiao J, 2008, CLIN CANCER RES, V14, P259, DOI 10.1158/1078-0432.CCR-07-1510; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Roberts L, 2007, SCIENCE, V317, P1842, DOI 10.1126/science.317.5846.1842; ROHLL JB, 1995, J VIROL, V69, P7835, DOI 10.1128/JVI.69.12.7835-7844.1995; Schiff GM, 2000, J INFECT DIS, V181, P20, DOI 10.1086/315176; Skelding KA, 2009, BREAST CANCER RES TR, V113, P21, DOI 10.1007/s10549-008-9899-2; Thorne SH, 2005, SEMIN ONCOL, V32, P537, DOI 10.1053/j.seminoncol.2005.09.007; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao CM, 2007, ADV INTEL SYS RES, V2, P317	31	177	200	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11					1278	1283		10.1038/nm.1776	http://dx.doi.org/10.1038/nm.1776			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18953352	Bronze			2022-12-25	WOS:000260751200048
J	Miyagawa, T; Kawashima, M; Nishida, N; Ohashi, J; Kimura, R; Fujimoto, A; Shimada, M; Morishita, S; Shigeta, T; Lin, L; Hong, SC; Faraco, J; Shin, YK; Jeong, JH; Okazaki, Y; Tsuji, S; Honda, M; Honda, Y; Mignot, E; Tokunaga, K				Miyagawa, Taku; Kawashima, Minae; Nishida, Nao; Ohashi, Jun; Kimura, Ryosuke; Fujimoto, Akihiro; Shimada, Mihoko; Morishita, Shinichi; Shigeta, Takashi; Lin, Ling; Hong, Seung-Chul; Faraco, Juliette; Shin, Yoon-Kyung; Jeong, Jong-Hyun; Okazaki, Yuji; Tsuji, Shoji; Honda, Makoto; Honda, Yutaka; Mignot, Emmanuel; Tokunaga, Katsushi			Variant between CPT1B and CHKB associated with susceptibility to narcolepsy	NATURE GENETICS			English	Article							OREXIN NEURONS; DEFICIENCY; MICE; HYPOCRETIN/OREXIN; POLYMORPHISMS; OXIDATION; MUTATION	Narcolepsy (hypocretin deficiency), a sleep disorder characterized by sleepiness, cataplexy and rapid eye movement (REM) sleep abnormalities, is tightly associated with HLA-DRB1*1501 (M17378) and HLA-DQB1*0602 (M20432). Susceptibility genes other than those in the HLA region are also likely involved. We conducted a genome-wide association study using 500K SNP microarrays in 222 Japanese individuals with narcolepsy and 389 Japanese controls, with replication of top hits in 159 Japanese individuals with narcolepsy and 190 Japanese controls, followed by the testing of 424 Koreans, 785 individuals of European descent and 184 African Americans. rs5770917, a SNP located between CPT1B and CHKB, was associated with narcolepsy in Japanese (rs5770917[C], odds ratio (OR) = 1.79, combined P = 4.4 x 10(-7)) and other ancestry groups (OR = 1.40, P = 0.02). Real-time quantitative PCR assays in white blood cells indicated decreased CPT1B and CHKB expression in subjects with the C allele, suggesting that a genetic variant regulating CPT1B or CHKB expression is associated with narcolepsy. Either of these genes is a plausible candidate, as CPT1B regulates beta-oxidation, a pathway involved in regulating theta frequency during REM sleep, and CHKB is an enzyme involved in the metabolism of choline, a precursor of the REM- and wake-regulating neurotransmitter acetylcholine.	[Miyagawa, Taku; Kawashima, Minae; Nishida, Nao; Ohashi, Jun; Kimura, Ryosuke; Fujimoto, Akihiro; Shimada, Mihoko; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Kawashima, Minae] Univ Tokyo, Grad Sch Med, Dept Sleep Disorder Res, Tokyo 1130033, Japan; [Kimura, Ryosuke] Tokai Univ, Sch Med, Dept Forens Med, Isehara 259100, Japan; [Morishita, Shinichi; Shigeta, Takashi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2770000, Japan; [Lin, Ling; Faraco, Juliette; Mignot, Emmanuel] Stanford Univ, Sch Med, Ctr Narcolepsy, Stanford, CA 94305 USA; [Hong, Seung-Chul; Shin, Yoon-Kyung; Jeong, Jong-Hyun] Catholic Univ Korea, St Vincents Hosp, Dept Neuropsychiat, Suwon 442723, South Korea; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Tokyo 1560057, Japan; [Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1130033, Japan; [Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Ctr Integrated Brain Med Sci, 21st Century COE Program, Tokyo 1130033, Japan; [Honda, Makoto] Tokyo Inst Psychiat, Dept Sleep Disorders Res, Tokyo 1568585, Japan; [Honda, Makoto; Honda, Yutaka] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo 1510053, Japan; [Mignot, Emmanuel] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Tokyo; University of Tokyo; Tokai University; University of Tokyo; Stanford University; Catholic University of Korea; University of Tokyo; University of Tokyo; Tokyo Institute of Psychiatry; Howard Hughes Medical Institute; Stanford University	Tokunaga, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan.	tokunaga@m.u-tokyo.ac.jp	Kimura, Ryosuke/B-3354-2015; OHASHI, JUN/G-5907-2015	Jeong, Jong-Hyun/0000-0003-3570-7607; Morishita, Shinichi/0000-0002-6201-8885	Ministry of Education, Culture, Sports, Science and Technology of Japan,; JSPS; US National Institutes of Health [NS 23724]	Ministry of Education, Culture, Sports, Science and Technology of Japan,(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to express our sincere thanks to the study participants. This study was supported by Grants-in-Aid for Scientific Research on Priority Areas "Comprehensive Genomics'' and "Applied Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for JSPS fellows, and US National Institutes of Health grant NS 23724 to E. Mignot, a Howard Hughes Investigator.	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Fioravanti M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000269.pub3; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Gencik M, 2001, NEUROLOGY, V56, P115, DOI 10.1212/WNL.56.1.115; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hungs M, 2001, NEUROLOGY, V57, P1893, DOI 10.1212/WNL.57.10.1893; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Kuwajima M, 2007, ENDOCR J, V54, P911, DOI 10.1507/endocrj.K07-044; LANGDON N, 1984, LANCET, V2, P1178; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mignot E, 2005, SLEEP, V28, P754, DOI 10.1093/sleep/28.6.754; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Nishino S, 1997, PROG NEUROBIOL, V52, P27, DOI 10.1016/S0301-0082(96)00070-6; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Olafsdottir BR, 2001, NEUROLOGY, V57, P1896, DOI 10.1212/WNL.57.10.1896; Overeem S, 2001, J CLIN NEUROPHYSIOL, V18, P78, DOI 10.1097/00004691-200103000-00002; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Rao KVR, 1997, CAN J PHYSIOL PHARM, V75, P423, DOI 10.1139/cjpp-75-5-423; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yoshida G, 2006, NEUROSCI RES, V55, P78, DOI 10.1016/j.neures.2006.02.003; Zweigner J, 2004, J EXP MED, V200, P99, DOI 10.1084/jem.20032100	30	111	113	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1324	1328		10.1038/ng.231	http://dx.doi.org/10.1038/ng.231			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820697				2022-12-25	WOS:000260501500025
J	Kain, R; Exner, M; Brandes, R; Ziebermayr, R; Cunningham, D; Alderson, CA; Davidovits, A; Raab, I; Jahn, R; Ashour, O; Spitzauer, S; Sunder-Plassmann, G; Fukuda, M; Klemm, P; Rees, AJ; Kerjaschki, D				Kain, Renate; Exner, Markus; Brandes, Ricarda; Ziebermayr, Reinhard; Cunningham, Dawn; Alderson, Carol A.; Davidovits, Agnes; Raab, Ingrid; Jahn, Renate; Ashour, Oliver; Spitzauer, Susanne; Sunder-Plassmann, Gere; Fukuda, Minoru; Klemm, Per; Rees, Andrew J.; Kerjaschki, Dontscho			Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis	NATURE MEDICINE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; LYSOSOMAL MEMBRANE GLYCOPROTEIN; CHAPERONE-MEDIATED AUTOPHAGY; CLASS-II PRESENTATION; CRESCENTIC GLOMERULONEPHRITIS; WEGENERS-GRANULOMATOSIS; FIMH-ADHESIN; BACTERIAL LIPOPOLYSACCHARIDE; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI	Pauci-immune focal necrotizing glomerulonephritis (FNGN) is a severe inflammatory disease associated with autoantibodies to neutrophil cytoplasmic antigens (ANCA). Here we characterize autoantibodies to lysosomal membrane protein-2 (LAMP-2) and show that they are a new ANCA subtype present in almost all individuals with FNGN. Consequently, its prevalence is nearly twice that of the classical ANCAs that recognize myeloperoxidase or proteinase-3. Furthermore, antibodies to LAMP-2 cause pauci-immune FNGN when injected into rats, and a monoclonal antibody to human LAMP-2 (H4B4) induces apoptosis of human microvascular endothelium in vitro. The autoantibodies in individuals with pauci-immune FNGN commonly recognize a human LAMP-2 epitope (designated P41-49) with 100% homology to the bacterial adhesin FimH, with which they cross-react. Rats immunized with Ill develop pauci-immune FNGN and also develop antibodies to rat and human LAMP-2. Finally, we show that infections with fimbriated pathogens are common before the onset of FNGN. Thus, FimH-triggered autoimmunity to LAMP-2 provides a previously undescribed clinically relevant molecular mechanism for the development of pauci-immune FNGN.	[Kain, Renate; Brandes, Ricarda; Ziebermayr, Reinhard; Davidovits, Agnes; Raab, Ingrid; Jahn, Renate; Ashour, Oliver; Rees, Andrew J.; Kerjaschki, Dontscho] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Exner, Markus; Spitzauer, Susanne] Med Univ Vienna, Inst Med & Chem Lab Diagnost, A-1090 Vienna, Austria; [Cunningham, Dawn; Alderson, Carol A.; Rees, Andrew J.] Univ Aberdeen, Sch Med, Immunol Programme, Aberdeen AB25 2ZD, Scotland; [Cunningham, Dawn; Alderson, Carol A.; Rees, Andrew J.] Univ Aberdeen, Sch Med Sci, Immunol Programme, Aberdeen AB25 2ZD, Scotland; [Sunder-Plassmann, Gere] Med Univ Vienna, Dept Nephrol, A-1090 Vienna, Austria; [Fukuda, Minoru] Burnham Inst, La Jolla, CA 92037 USA; [Klemm, Per] Tech Univ Denmark, Bioctr, DK-2800 Lyngby, Denmark	Medical University of Vienna; Medical University of Vienna; University of Aberdeen; University of Aberdeen; Medical University of Vienna; Sanford Burnham Prebys Medical Discovery Institute; Technical University of Denmark	Kain, R (corresponding author), Med Univ Vienna, Dept Pathol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	renate.kain@meduniwien.ac.at	Kain, Renate/ACR-4709-2022	Kain, Renate/0000-0002-2428-543X; Sunder-Plassmann, Gere/0000-0002-9253-9921	R.K.'s Senior Research Fellowship [KRUK SF3/2000-2005]; University of Aberdeen and Scottish Hospitals Endowment Research Trust [RG15/02]; EU Marie Curie Excellence Chair [MEXC-CT-2006-042742]; Austrian Federal Ministry of Science and Research;  [RO1CA48737]; NATIONAL CANCER INSTITUTE [R01CA048737] Funding Source: NIH RePORTER	R.K.'s Senior Research Fellowship; University of Aberdeen and Scottish Hospitals Endowment Research Trust; EU Marie Curie Excellence Chair(European Commission); Austrian Federal Ministry of Science and Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This paper is dedicated to the memory of Fokko van der Woude. We thank A. Jungbauer (University of Agriculture and Forestry, Vienna) for synthetic peptides. We thank Kidney Research UK, who generously funded R.K.'s Senior Research Fellowship (KRUK SF3/2000-2005) at the University of Aberdeen and Scottish Hospitals Endowment Research Trust (RG15/02) for supporting parts of this project. A.R. is funded by an EU Marie Curie Excellence Chair (MEXC-CT-2006-042742). Parts of this work were funded by the Austrian Federal Ministry of Science and Research. M.F.'s research is supported by grant RO1CA48737. We are indebted to H. Schachner tor technical assistance and to A. Jager for his help in preparing the figures. We also would like to thank the many physicians who provided sera and subject details.	CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; Connell I, 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827; DAVIES DJ, 1982, BMJ-BRIT MED J, V285, P606, DOI 10.1136/bmj.285.6342.606; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Fourneau JM, 2004, MOL IMMUNOL, V40, P1095, DOI 10.1016/j.molimm.2003.11.011; Franssen CFM, 1999, J AM SOC NEPHROL, V10, P1506; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gough NR, 1997, J CELL BIOL, V137, P1161, DOI 10.1083/jcb.137.5.1161; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; HASLETT C, 1985, AM J PATHOL, V119, P101; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Huugen D, 2005, AM J PATHOL, V167, P47, DOI 10.1016/S0002-9440(10)62952-5; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Jennette JC, 2006, J AM SOC NEPHROL, V17, P1235, DOI 10.1681/ASN.2005101048; KAIN R, 1995, J EXP MED, V181, P585, DOI 10.1084/jem.181.2.585; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kerjaschki D, 1996, J EXP MED, V183, P2007, DOI 10.1084/jem.183.5.2007; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Levin MC, 2002, NAT MED, V8, P509, DOI 10.1038/nm0502-509; Little MA, 2005, BLOOD, V106, P2050, DOI 10.1182/blood-2005-03-0921; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Morgan MD, 2006, J AM SOC NEPHROL, V17, P1224, DOI 10.1681/ASN.2005080882; Neumann I, 2005, NEPHROL DIAL TRANSPL, V20, P96, DOI 10.1093/ndt/gfh563; Pendergraft WF, 2004, NAT MED, V10, P72, DOI 10.1038/nm968; Pfister H, 2004, BLOOD, V104, P1411, DOI 10.1182/blood-2004-01-0267; PINCHING AJ, 1980, BRIT MED J, V281, P836, DOI 10.1136/bmj.281.6244.836; Ruth AJ, 2006, J AM SOC NEPHROL, V17, P1940, DOI 10.1681/ASN.2006020108; Savige J, 2002, Clin Exp Rheumatol, V20, P783; Savige J, 2003, AM J CLIN PATHOL, V120, P312, DOI 10.1309/WAEPADW0K4LPUHFN; SAWADA R, 1993, J BIOL CHEM, V268, P12675; Schembri MA, 2000, FEMS MICROBIOL LETT, V188, P147, DOI 10.1111/j.1574-6968.2000.tb09186.x; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Tse WY, 2005, KIDNEY INT, V67, P130, DOI 10.1111/j.1523-1755.2005.00063.x; van der Geld YM, 2007, ANN RHEUM DIS, V66, P1679, DOI 10.1136/ard.2006.064626; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Wegener F, 1936, VERHANDLUNGEN DTSCH, V29, P202; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	50	297	337	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2008	14	10					1088	1096		10.1038/nm.1874	http://dx.doi.org/10.1038/nm.1874			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18836458	Green Accepted			2022-12-25	WOS:000259892300039
J	Maeda, Y; Ide, T; Koike, M; Uchiyama, Y; Kinoshita, T				Maeda, Yusuke; Ide, Toru; Koike, Masato; Uchiyama, Yasuo; Kinoshita, Taroh			GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus	NATURE CELL BIOLOGY			English	Article							GREEN FLUORESCENT PROTEINS; VACUOLAR H+-ATPASE; CELL-SURFACE; LIVING CELLS; ENDOSOMAL ACIDIFICATION; ENDOPLASMIC-RETICULUM; COLORECTAL-CANCER; SECRETORY PATHWAY; ION CHANNELS; PH	The organelles within secretory and endocytotic pathways in mammalian cells have acidified lumens, and regulation of their acidic pH is critical for the trafficking, processing and glycosylation of cargo proteins and lipids, as well as the morphological integrity of the organelles. How organelle lumen acidification is regulated, and how luminal pH elevation disturbs these fundamental cellular processes, is largely unknown. Here, we describe a novel molecule involved in Golgi acidification. First, mutant cells defective in Golgi acidification were established that exhibited delayed protein transport, impaired glycosylation and Golgi disorganization. Using expression cloning, a novel Golgi-resident multi-transmembrane protein, named Golgi pH regulator (GPHR), was identified as being responsible for the mutant cells. After reconstitution in planar lipid bilayers, GPHR exhibited a voltage-dependent anion-channel activity that may function in counterion conductance. Thus, GPHR modulates Golgi functions through regulation of acidification.	[Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Maeda, Yusuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ide, Toru] Osaka Univ, Grad Sch Frontier Biosci, Labs Nanobiol, Suita, Osaka 5650871, Japan; [Ide, Toru] RIKEN, Mol Informat Life Sci Res Grp, Wako, Saitama 3510198, Japan; [Koike, Masato; Uchiyama, Yasuo] Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; [Kinoshita, Taroh] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; RIKEN; Osaka University; Japan Science & Technology Agency (JST)	Maeda, Y (corresponding author), Osaka Univ, Res Inst Microbial Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ymaeda@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009; Ide, Toru/L-7110-2015; Koike, Masato/F-9584-2010	Koike, Masato/0000-0002-3174-5684				ANDRESSON T, 1995, J BIOL CHEM, V270, P6830, DOI 10.1074/jbc.270.12.6830; Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; GLICKMAN J, 1983, J CELL BIOL, V97, P1303, DOI 10.1083/jcb.97.4.1303; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Ide T, 1999, BIOCHEM BIOPH RES CO, V265, P595, DOI 10.1006/bbrc.1999.1720; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kellokumpu S, 2002, FEBS LETT, V516, P217, DOI 10.1016/S0014-5793(02)02535-8; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Laver DR, 1997, PROG BIOPHYS MOL BIO, V67, P99, DOI 10.1016/S0079-6107(97)00008-4; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MORIYAMA Y, 1989, J BIOL CHEM, V264, P18445; Nagasawa M, 2001, J BIOL CHEM, V276, P20413, DOI 10.1074/jbc.M100366200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nordeen MH, 2000, BIOPHYS J, V78, P2918, DOI 10.1016/S0006-3495(00)76832-9; PALOKANGAS H, 1994, J BIOL CHEM, V269, P17577; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Puri S, 2002, TRAFFIC, V3, P641, DOI 10.1034/j.1600-0854.2002.30906.x; Pusch M, 2006, EXP PHYSIOL, V91, P149, DOI 10.1113/expphysiol.2005.031799; REAVES B, 1994, FEBS LETT, V345, P61, DOI 10.1016/0014-5793(94)00437-4; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; TARTAKOFF A, 1978, J CELL BIOL, V79, P694, DOI 10.1083/jcb.79.3.694; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; Weisz OA, 2003, INT REV CYTOL, V226, P259, DOI 10.1016/S0074-7696(03)01005-2; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; XIE XS, 1983, J BIOL CHEM, V258, P4834; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723	44	119	127	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1135	1145		10.1038/ncb1773	http://dx.doi.org/10.1038/ncb1773			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18794847				2022-12-25	WOS:000259682900007
J	Schilling, S; Zeitschel, U; Hoffmann, T; Heiser, U; Francke, M; Kehlen, A; Holzer, M; Hutter-Paier, B; Prokesch, M; Windisch, M; Jagla, W; Schlenzig, D; Lindner, C; Rudolph, T; Reuter, G; Cynis, H; Montag, D; Demuth, HU; Rossner, S				Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen			Glutaminyl cyclase inhibition attenuates pyroglutamate A beta and Alzheimer's disease-like pathology	NATURE MEDICINE			English	Article							PEPTIDES IN-VITRO; MOUSE MODEL; SENILE PLAQUES; DEPOSITION; PROTEIN; A-BETA-42(43); COMPONENT; DEMENTIA; BRAIN	Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified A beta peptides have been suggested as being important in the initiation of pathological cascades resulting in the development of Alzheimer's disease(1-6). We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo. Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified A beta. Oral application of a glutaminyl cyclase inhibitor resulted in reduced A beta(3(pE)-42) burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model. Treatment of mice was accompanied by reductions in A beta(x-40/42), diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests. These observations are consistent with the hypothesis that A beta(3(pE)-42) acts as a seed for A beta aggregation by self-aggregation and co-aggregation with A beta(1-40/42). Therefore, A beta(3(pE)-40/42) peptides seem to represent A beta forms with exceptional potency for disturbing neuronal function. The reduction of brain pE-A beta by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.	[Schilling, Stephan; Hoffmann, Torsten; Heiser, Ulrich; Kehlen, Astrid; Schlenzig, Dagmar; Cynis, Holger; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Germany; [Zeitschel, Ulrike; Francke, Mike; Holzer, Max; Rossner, Steffen] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred] JSW CNS Res GmbH, A-8074 Grambach Graz, Austria; [Jagla, Wolfgang; Demuth, Hans-Ulrich] Ingenim Pharmaceut GmbH, D-82152 Munich, Germany; [Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter] Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06120 Halle, Germany; [Montag, Dirk] Leibniz Inst Neurobiol, Res Grp Neurogenet, D-39118 Magdeburg, Germany	Vivoryon Therapeutics; Leipzig University; Martin Luther University Halle Wittenberg; Leibniz Institut fur Neurobiologie (LIN)	Demuth, HU (corresponding author), Probiodrug AG, Weinbergweg 22, D-06120 Halle, Germany.	hans-ulrich.demuth@probiodrug.de	Montag, Dirk/D-3925-2014; Zeitschel, Ulrike/A-8930-2017; Francke, Mike/A-7505-2017; Rossner, Steffen/A-5184-2017; Holzer, Max/A-1729-2008	Montag, Dirk/0000-0002-4964-1330; Holzer, Max/0000-0003-1754-9932; Cynis, Holger/0000-0001-6655-7539	German Federal Department of Education, Science and Technology BMBF [3013185]	German Federal Department of Education, Science and Technology BMBF(Federal Ministry of Education & Research (BMBF))	We thank K. Sowa, R. Jendrek, K. Schulz, M, Bornack, E. Scheel and NI. Buchholz for technical assistance. The authors would like to express their gratitude to K. Hsiao (University of Minnesota) for kindly providing Tg2576 mice and E. Masliah (University of California, San Diego) for providing the TASD-41 mice. Thanks are due to T.C. Saido (Riken Brain Science Institute) for the gift of the APP-NLE vector. S. Winter maintained and analyzed organotypic brain slice cultures from Tg2576 mice. We are also grateful to J. Heins for statistical analysis and to M.T. Stubbs, K. Glund and M. Hartlage-Rubsamen for helpful discussion. This work was supported by, German Federal Department of Education, Science and Technology BMBF grant #3013185 to H.-U.D.	Buchholz M, 2006, J MED CHEM, V49, P664, DOI 10.1021/jm050756e; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; Ghiso J, 2001, AMYLOID, V8, P277, DOI 10.3109/13506120108993826; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Shirotani K, 2002, NEUROSCI LETT, V327, P25, DOI 10.1016/S0304-3940(02)00351-8; Sykes PA, 1999, FEBS LETT, V455, P159, DOI 10.1016/S0014-5793(99)00872-8; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Vanderstichele H, 2005, CLIN CHEM, V51, P1650, DOI 10.1373/clinchem.2005.051201; Yu L, 2006, J PHARMACEUT BIOMED, V42, P455, DOI 10.1016/j.jpba.2006.05.008	30	283	295	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2008	14	10					1106	1111		10.1038/nm.1872	http://dx.doi.org/10.1038/nm.1872			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18836460				2022-12-25	WOS:000259892300041
J	Fallon, PG; Sasaki, T; Sandilands, A; Campbell, LE; Saunders, SP; Mangan, NE; Callanan, JJ; Kawasaki, H; Shiohama, A; Kubo, A; Sundberg, JP; Presland, RB; Fleckman, P; Shimizu, N; Kudoh, J; Irvine, AD; Amagai, M; McLean, WHI				Fallon, Padraic G.; Sasaki, Takashi; Sandilands, Aileen; Campbell, Linda E.; Saunders, Sean P.; Mangan, Niamh E.; Callanan, John J.; Kawasaki, Hiroshi; Shiohama, Aiko; Kubo, Akiharu; Sundberg, John P.; Presland, Richard B.; Fleckman, Philip; Shimizu, Nobuyoshi; Kudoh, Jun; Irvine, Alan D.; Amagai, Masayuki; McLean, W. H. Irwin			A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming	NATURE GENETICS			English	Article							OF-FUNCTION MUTATIONS; ATOPIC-DERMATITIS; ICHTHYOSIS VULGARIS; FILAGGRIN MUTATIONS; HUMAN PROFILAGGRIN; MICE; EXPRESSION; DISEASE; ASTHMA; ECZEMA	Loss-of-function mutations in the FLG (filaggrin) gene cause the semidominant keratinizing disorder ichthyosis vulgaris(1) and convey major genetic risk for atopic dermatitis (eczema)(2-4), eczema-associated asthma(2,3) and other allergic phenotypes(5). Several low-frequency FLG null alleles occur in Europeans and Asians, with a cumulative frequency of similar to 9% in Europe(4). Here we report a 1-bp deletion mutation, 5303delA, analogous to common human FLG mutations, within the murine Flg gene in the spontaneous mouse mutant flaky tail (ft). We demonstrate that topical application of allergen to mice homozygous for this mutation results in cutaneous inflammatory infiltrates and enhanced cutaneous allergen priming with development of allergen-specific antibody responses. These data validate flaky tail as a useful model of filaggrin deficiency and provide experimental evidence for the hypothesis that antigen transfer through a defective epidermal barrier is a key mechanism underlying elevated IgE sensitization and initiation of cutaneous inflammation in humans with filaggrin-related atopic disease.	[Sandilands, Aileen; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland; [Sandilands, Aileen; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland; [Fallon, Padraic G.; Saunders, Sean P.; Mangan, Niamh E.; Irvine, Alan D.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Sasaki, Takashi; Shiohama, Aiko; Kudoh, Jun] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Sasaki, Takashi; Shiohama, Aiko; Shimizu, Nobuyoshi; Kudoh, Jun] Keio Univ, Adv Res Ctr Genome Super Power, Ibaraki, Japan; [Callanan, John J.] Univ Coll Dublin, Coll Life Sci, Conway Inst Biomol & Biomed Res, Vet Sci Ctr, Dublin 2, Ireland; [Kawasaki, Hiroshi; Kubo, Akiharu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Presland, Richard B.] Univ Washington, Sch Dent, Dept Oral Biol, Seattle, WA 98195 USA; [Presland, Richard B.; Fleckman, Philip] Univ Washington, Dept Med, Div Dermatol, Seattle, WA USA; [Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Paediat Dermatol, Dublin, Ireland	University of Dundee; University of Dundee; Trinity College Dublin; Keio University; Keio University; University College Dublin; Keio University; Jackson Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	McLean, WHI (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland.	w.h.i.mclean@dundee.ac.uk	McLean, William HI/C-6352-2009; Kubo, Akiharu/I-2711-2014; Amagai, Masayuki/K-5325-2013; Irvine, Alan D/A-3982-2008; Fallon, Padraic/Y-2711-2019; Sasaki, Takashi/AAD-1461-2019	Kubo, Akiharu/0000-0003-0902-3586; Amagai, Masayuki/0000-0003-3314-7052; Irvine, Alan D/0000-0002-9048-2044; Fallon, Padraic/0000-0002-8401-7293; Mangan, Niamh/0000-0003-3844-0709; McLean, William Henry Irwin/0000-0001-5539-5757; Presland, Richard/0000-0003-1440-7402; Callanan, John/0000-0003-4356-1783; Sasaki, Takashi/0000-0002-6275-046X; Saunders, Sean/0000-0003-1689-3598	Ministry of Health, Labour, and Welfare of Japan; National Institute of Health [P01 AM21557, R01 AR49183]; Odland Endowed Research Fund; Science Foundation Ireland; Children's Medical and Research Foundation, OLCHC; British Skin Foundation; National Eczema Society; Medical Research Council [G0700314]; MRC [G0700314] Funding Source: UKRI; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM021557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049183] Funding Source: NIH RePORTER	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Odland Endowed Research Fund; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation, OLCHC; British Skin Foundation; National Eczema Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. Mistry, A. Smyth, T. Adachi and M. Furuhashi for their technical assistance and T. Yoshida for his cooperation. We are grateful for the assistance of B. Cloak with photomicrography and S. Worrell with histopathology. This work was supported by the Labour Sciences Research Grants for Research on Allergic Disease and Immunology from the Ministry of Health, Labour, and Welfare of Japan (M. A.), National Institute of Health grants P01 AM21557 (P. F.), R01 AR49183 (R. B. P.) and the Odland Endowed Research Fund (P. F.). P. G. F. was supported by Science Foundation Ireland. A. D. I. is supported by the Children's Medical and Research Foundation, OLCHC. Filaggrin research in the McLean laboratory is supported by grants from The British Skin Foundation, The National Eczema Society, The Medical Research Council (Reference number G0700314) and donations from anonymous families affected by eczema in the Tayside Region of Scotland.	Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Chen L, 2008, CLIN EXP ALLERGY, V38, P1367, DOI 10.1111/j.1365-2222.2008.02987.x; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; PRESLAND RB, 1995, J INVEST DERMATOL, V104, P218, DOI 10.1111/1523-1747.ep12612770; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; ROTHNAGEL JA, 1987, J BIOL CHEM, V262, P15643; ROTHNAGEL JA, 1990, J BIOL CHEM, V265, P1862; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sasaki T, 2008, J DERMATOL SCI, V51, P113, DOI 10.1016/j.jdermsci.2008.02.009; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Sundberg JP., 1984, HDB MOUSE MUTATIONS, V2, P269; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Zhang D, 2002, J INVEST DERMATOL, V119, P905, DOI 10.1046/j.1523-1747.2002.00133.x	30	338	348	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					602	608		10.1038/ng.358	http://dx.doi.org/10.1038/ng.358			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19349982	Green Accepted			2022-12-25	WOS:000265575600023
J	Hu, HZ; Bandell, M; Petrus, MJ; Zhu, MX; Patapoutian, A				Hu, Hongzhen; Bandell, Michael; Petrus, Matt J.; Zhu, Michael X.; Patapoutian, Ardem			Zinc activates damage-sensing TRPA1 ion channels	NATURE CHEMICAL BIOLOGY			English	Article							SPINAL-CORD; COVALENT MODIFICATION; COLD; RECEPTOR; NEURONS; PAIN; INFLAMMATION; HYPERALGESIA; SENSATION; MENTHOL	Zinc is an essential biological trace element. It is required for the structure or function of over 300 proteins, and it is increasingly recognized for its role in cell signaling. However, high concentrations of zinc have cytotoxic effects, and overexposure to zinc can cause pain and inflammation through unknown mechanisms. Here we show that zinc excites nociceptive somatosensory neurons and causes nociception in mice through TRPA1, a cation channel previously shown to mediate the pungency of wasabi and cinnamon through cysteine modification. Zinc activates TRPA1 through a unique mechanism that requires zinc influx through TRPA1 channels and subsequent activation via specific intracellular cysteine and histidine residues. TRPA1 is highly sensitive to intracellular zinc, as low nanomolar concentrations activate TRPA1 and modulate its sensitivity. These findings identify TRPA1 as an important target for the sensory effects of zinc and support an emerging role for zinc as a signaling molecule that can modulate sensory transmission.	[Hu, Hongzhen; Bandell, Michael; Petrus, Matt J.; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; University System of Ohio; Ohio State University; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	apatapou@gnf.org		Hu, Hongzhen/0000-0002-8967-7522	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758, R21NS056942, R01NS046303] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE016927, R01 DE016927-03, R01 DE016927-01A1, R01 DE016927-02] Funding Source: Medline; NINDS NIH HHS [R01 NS046303-06, R01 NS046303-04, R21 NS056942, R01 NS046303, P30 NS045758, R01 NS046303-05, P30 NS045758-05S19003, R21 NS056942-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamson IYR, 2000, TOXICOL APPL PHARM, V166, P111, DOI 10.1006/taap.2000.8955; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P279, DOI 10.1081/CLT-100102426; BARNHART S, 1984, CHEST, V86, P789, DOI 10.1378/chest.86.5.789; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BLANC PD, 1993, AM REV RESPIR DIS, V147, P134, DOI 10.1164/ajrccm/147.1.134; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jo SM, 2008, BIOMETALS, V21, P151, DOI 10.1007/s10534-007-9103-x; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Kosugi M, 2007, J NEUROSCI, V27, P4443, DOI 10.1523/JNEUROSCI.0557-07.2007; Krezel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P188, DOI 10.1016/j.abb.2007.02.017; Kuschner WG, 1997, ENVIRON RES, V75, P7, DOI 10.1006/enrs.1997.3765; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Larson AA, 1997, J PHARMACOL EXP THER, V282, P1319; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Nordberg G, 1999, REGUL TOXICOL PHARM, V30, pS57, DOI 10.1006/rtph.1999.1327; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Ozaktay AC, 2006, EUR SPINE J, V15, P1529, DOI 10.1007/s00586-005-0058-8; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Patel K, 2007, BBA-PROTEINS PROTEOM, V1774, P1247, DOI 10.1016/j.bbapap.2007.07.010; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Qian WJ, 2000, ANAL CHEM, V72, P711, DOI 10.1021/ac991085t; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; SafiehGarabedian B, 1996, NEUROPHARMACOLOGY, V35, P599, DOI 10.1016/0028-3908(96)84630-2; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Velazquez RA, 1999, J NEUROSCI, V19, P2288; Wang GY, 2007, J BIOL CHEM, V282, P13637, DOI 10.1074/jbc.M609182200; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081	50	166	173	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2009	5	3					183	190		10.1038/nchembio.146	http://dx.doi.org/10.1038/nchembio.146			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410DG	19202543	Green Accepted			2022-12-25	WOS:000263556100016
J	Bi, WM; Sapir, T; Shchelochkov, OA; Zhang, F; Withers, MA; Hunter, JV; Levy, T; Shinder, V; Peiffer, DA; Gunderson, KL; Nezarati, MM; Shotts, VA; Amato, SS; Savage, SK; Harris, DJ; Day-Salvatore, DL; Horner, M; Lu, XY; Sahoo, T; Yanagawa, Y; Beaudet, AL; Cheung, SW; Martinez, S; Lupski, JR; Reiner, O				Bi, Weimin; Sapir, Tamar; Shchelochkov, Oleg A.; Zhang, Feng; Withers, Marjorie A.; Hunter, Jill V.; Levy, Talia; Shinder, Vera; Peiffer, Daniel A.; Gunderson, Kevin L.; Nezarati, Marjan M.; Shotts, Vern Ann; Amato, Stephen S.; Savage, Sarah K.; Harris, David J.; Day-Salvatore, Debra-Lynn; Horner, Michele; Lu, Xin-Yan; Sahoo, Trilochan; Yanagawa, Yuchio; Beaudet, Arthur L.; Cheung, Sau Wai; Martinez, Salvador; Lupski, James R.; Reiner, Orly			Increased LIS1 expression affects human and mouse brain development	NATURE GENETICS			English	Article							NEURONAL MIGRATION; REARRANGEMENTS; DYNEIN; GENE; MICRODELETIONS; SCHIZOPHRENIA; ASSOCIATION; ACTIVATION; MICROARRAY; MUTATIONS	Deletions of the PAFAH1B1 gene (encoding LIS1) in 17p13.3 result in isolated lissencephaly sequence, and extended deletions including the YWHAE gene (encoding 14-3-3 epsilon) cause Miller-Dieker syndrome. We identified seven unrelated individuals with submicroscopic duplication in 17p13.3 involving the PAFAH1B1 and/or YWHAE genes, and using a 'reverse genomics' approach, characterized the clinical consequences of these duplications. Increased PAFAH1B1 dosage causes mild brain structural abnormalities, moderate to severe developmental delay and failure to thrive. Duplication of YWHAE and surrounding genes increases the risk for macrosomia, mild developmental delay and pervasive developmental disorder, and results in shared facial dysmorphologies. Transgenic mice conditionally overexpressing LIS1 in the developing brain showed a decrease in brain size, an increase in apoptotic cells and a distorted cellular organization in the ventricular zone, including reduced cellular polarity but preserved cortical cell layer identity. Collectively, our results show that an increase in LIS1 expression in the developing brain results in brain abnormalities in mice and humans.	[Bi, Weimin; Shchelochkov, Oleg A.; Zhang, Feng; Withers, Marjorie A.; Lu, Xin-Yan; Sahoo, Trilochan; Beaudet, Arthur L.; Cheung, Sau Wai; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bi, Weimin; Lu, Xin-Yan; Sahoo, Trilochan; Cheung, Sau Wai; Lupski, James R.] Baylor Coll Med, Med Genet Labs, Houston, TX 77030 USA; [Sapir, Tamar; Reiner, Orly] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Shchelochkov, Oleg A.; Hunter, Jill V.; Beaudet, Arthur L.; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Shinder, Vera] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Peiffer, Daniel A.; Gunderson, Kevin L.] Illumina Inc, San Diego, CA 92024 USA; [Nezarati, Marjan M.] N York Gen Hosp, Toronto, ON M2K 1E1, Canada; [Shotts, Vern Ann] Arkansas Childrens Hosp, Little Rock, AR 72202 USA; [Amato, Stephen S.; Savage, Sarah K.] Eastern Maine Med Ctr, Bangor, ME 04401 USA; [Harris, David J.] Childrens Hosp, Boston, MA 02115 USA; [Day-Salvatore, Debra-Lynn; Horner, Michele] St Peters Univ Hosp, Inst Med Genet, New Brunswick, NJ 08901 USA; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 3718511, Japan; [Beaudet, Arthur L.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Martinez, Salvador] UMH CSIC, Inst Neurociencias, Alicante 03550, Spain	Baylor College of Medicine; Baylor College of Medicine; Weizmann Institute of Science; Baylor College of Medicine; Weizmann Institute of Science; Illumina; University of Toronto; University Toronto Affiliates; North York General Hospital; Arkansas Children's Hospital; Eastern Maine Medical Center; Harvard University; Boston Children's Hospital; Saint Peter's University Hospital; Gunma University; Baylor College of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu; orly.reiner@weizmann.ac.il	Zhang, Feng/C-7735-2009; Mratinez, Salvador/L-4896-2014; Reiner, Orly/E-9455-2010	Zhang, Feng/0000-0003-4556-8276; Mratinez, Salvador/0000-0002-9320-4103; Reiner, Orly/0000-0001-7560-9599; Martinez, Salvador/0000-0002-2910-8926	Israeli Science Foundation [270/04]; Foundation Jerome Lejeune; Minerva Foundation; Federal German Ministry for Education and Research; German-Israeli [Gr-1905]; March of Dimes [6-FY07-388]; BSF [2007081]; Paul Godfrey Research Foundation in Children's Diseases; Benoziyo Center for Neurological Diseases; Kekst Center; Forcheimer Center; Weizmann-Pasteur collaborative; Michigan Women of Wisdom Fund; Maurice Janin; Jewish Communal Fund; Albert Einstein College of Medicine of Yeshiva University; David and Fela Shapell Family Center; Genetic Disorders Research; DIGESIC-MEC [BFU2005-09085]; Ingenio 2010 MEC-CONSOLIDER [CSD2007-00023]; EU [LSHG-CT-2004-512003]; Baylor Medical Genetics Laboratories; Mental Retardation Developmental Disabilities Research Center [HD024064]; National Institute of Child Health and Human Development [P01 HD39420]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420] Funding Source: NIH RePORTER	Israeli Science Foundation(Israel Science Foundation); Foundation Jerome Lejeune; Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German-Israeli(German-Israeli Foundation for Scientific Research and Development); March of Dimes(March of Dimes); BSF(US-Israel Binational Science Foundation); Paul Godfrey Research Foundation in Children's Diseases; Benoziyo Center for Neurological Diseases; Kekst Center; Forcheimer Center; Weizmann-Pasteur collaborative; Michigan Women of Wisdom Fund; Maurice Janin; Jewish Communal Fund; Albert Einstein College of Medicine of Yeshiva University; David and Fela Shapell Family Center; Genetic Disorders Research; DIGESIC-MEC; Ingenio 2010 MEC-CONSOLIDER; EU(European Commission); Baylor Medical Genetics Laboratories; Mental Retardation Developmental Disabilities Research Center; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the participating families for their cooperation in the study, the members of the Chromosomal Microarray Analysis and Cytogenetic/FISH laboratories for technical assistance, G. Eichele for help with the in situ hybridization experiments, E. Arama and S. Haiderleu for useful comments and advice, S. McConnell for the Foxg1(Cre) mice and M. O'Gorman (Children's Memorial Hospital, Chicago) for assistance with specimen collection. The work was supported in part by the Israeli Science Foundation (grant no. 270/04 to O.R. and an equipment grant), the Foundation Jerome Lejeune, the Minerva Foundation with funding from the Federal German Ministry for Education and Research, German-Israeli collaboration grant Gr-1905, March of Dimes grant 6-FY07-388, collaborative BSF grant 2007081 (to O.R. and J.R.L.), a grant from the Paul Godfrey Research Foundation in Children's Diseases, the Benoziyo Center for Neurological Diseases, the Kekst Center, the Forcheimer Center, a Weizmann-Pasteur collaborative grant, a research grant from the Michigan Women of Wisdom Fund to support Weizmann Women scientists, support from Maurice Janin, the Jewish Communal Fund, Albert Einstein College of Medicine of Yeshiva University, the David and Fela Shapell Family Center research grant for Genetic Disorders Research, grants DIGESIC-MEC BFU2005-09085 and Ingenio 2010 MEC-CONSOLIDER CSD2007-00023 (to S. M.), support from EU grant LSHG-CT-2004-512003, the Baylor Medical Genetics Laboratories, the Mental Retardation Developmental Disabilities Research Center (HD024064) and a Program Project grant (P01 HD39420) from the National Institute of Child Health and Human Development (to J.R.L.). O.R. is an Incumbent of the Bernstein-Mason professorial chair of Neurochemistry.	Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Chen KL, 2004, J CELL SCI, V117, P4527, DOI 10.1242/jcs.01320; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Harding B, 1996, DYSPLASIAS OF CEREBRAL CORTEX AND EPILEPSY, P81; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mikhail FM, 2006, AM J MED GENET A, V140A, P1647, DOI 10.1002/ajmg.a.31330; Morelli SH, 1999, CLIN GENET, V55, P372, DOI 10.1034/j.1399-0004.1999.550513.x; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiner O, 2006, NEUROMOL MED, V8, P547, DOI 10.1385/NMM:8:4:547; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026	50	173	180	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					168	177		10.1038/ng.302	http://dx.doi.org/10.1038/ng.302			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19136950	Green Accepted			2022-12-25	WOS:000263091300016
J	Chandrasekharan, S; Kumar, S; Valley, CM; Rai, A				Chandrasekharan, Subhashini; Kumar, Sapna; Valley, Cory M.; Rai, Arti			Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins	NATURE BIOTECHNOLOGY			English	Editorial Material							ACADEMIC BIOMEDICAL-RESEARCH; INTELLECTUAL PROPERTY; TRANSCRIPTION FACTORS; NUCLEASES; CONSTRUCTION; REPAIR; CELLS	A closer look at the large patent estate now covering both the engineering and use of zinc-finger proteins.	[Chandrasekharan, Subhashini; Rai, Arti] Duke Univ, Ctr Publ Gen, Ctr Genome Eth Law & Policy, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Rai, Arti] Duke Univ, Sch Law, Durham, NC 27708 USA; [Kumar, Sapna] US Court Appeals Seventh Circuit, Chicago, IL 60604 USA; [Valley, Cory M.] Univ Maryland, Sch Law, Baltimore, MD 21201 USA	Duke University; Duke University; University System of Maryland; University of Maryland Baltimore	Chandrasekharan, S (corresponding author), Duke Univ, Ctr Publ Gen, Ctr Genome Eth Law & Policy, Inst Genome Sci & Policy, Durham, NC 27708 USA.	rai@law.duke.edu			NHGRI NIH HHS [P50 HG003391, P50 HG003391-050002] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Acs Zoltan J., 1990, INNOVATION SMALL FIR; AUDRESTSCH D, 1995, INNOVATION IND EVOLU; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; BESSEN J, 2008, PATENT FAILURE; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Burk Dan L., 2002, BERKELEY TECH LJ, V17, P1155, DOI [DOI 10.2139/ssrn.349761, 10.2139/ssrn.349761, DOI 10.2139/SSRN.349761]; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cohen WM, 2007, INNOV POLICY ECON, V8, P1; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eisenberg RS, 2002, ACAD MED, V77, P1392, DOI 10.1097/00001888-200212001-00011; Farrell J., 2003, HARVARD J LAW TECHNO, V17, P86, DOI [10.2139/ssrn.452220, DOI 10.2139/SSRN.452220]; Fore Joe Jr, 2006, J Biomed Discov Collab, V1, P7, DOI 10.1186/1747-5333-1-7; Fox JL, 1999, NAT BIOTECHNOL, V17, P325, DOI 10.1038/7876; Hager J, 2006, METHOD ENZYMOL, V410, P135, DOI 10.1016/S0076-6879(06)10007-5; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Holman Christopher M., 2007, ALB LJ SCI TECH, V17, P1; Kaiser J, 2005, SCIENCE, V310, P1894, DOI 10.1126/science.310.5756.1894; KAISER J, 2008, SCIENCENOW DAIL 0724; KITCH EW, 1977, J LAW ECON, V20, P265, DOI 10.1086/466903; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mann RJ, 2007, RES POLICY, V36, P193, DOI 10.1016/j.respol.2006.10.002; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; MERGES RP, 1990, COLUMBIA LAW REV, V90, P839, DOI 10.2307/1122920; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Pearson H, 2008, NATURE, V455, P160, DOI [10.1038/455160a, 10.1038/453150a]; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; Rai A, 2007, PLOS BIOL, V5, P389, DOI 10.1371/journal.pbio.0050058; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Rouse R, 2003, PHARMACOGENOMICS, V4, P623, DOI 10.1517/phgs.4.5.623.23792; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Scott CT, 2005, NAT BIOTECHNOL, V23, P915, DOI 10.1038/nbt0805-915; Segal DJ, 2003, BIOCHEMISTRY-US, V42, P2137, DOI 10.1021/bi026806o; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Walsh JP, 2007, RES POLICY, V36, P1184, DOI 10.1016/j.respol.2007.04.006; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; 2007, SANGAMO BIOSCIENCES; 2004, SANGAMO BIOSCIENCES; 2008, SANGAMO BIOSCIENCES	44	30	38	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2009	27	2					140	144		10.1038/nbt0209-140	http://dx.doi.org/10.1038/nbt0209-140			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	405FT	19204690	Green Accepted			2022-12-25	WOS:000263209000016
J	Choi, YW; Walsh, MC; Arron, JR				Choi, Yongwon; Walsh, Matthew C.; Arron, Joseph R.			Breaking into bone biology Target practice	NATURE MEDICINE			English	Editorial Material							OSTEOIMMUNOLOGY; MECHANISMS; IMMUNE; MASS		[Choi, Yongwon; Walsh, Matthew C.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Arron, Joseph R.] Genentech Inc, Immunol Tissue Growth & Repair Biomarker Grp, San Francisco, CA 94080 USA	University of Pennsylvania; Roche Holding; Genentech	Choi, YW (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu		Arron, Joseph/0000-0001-7677-9979	NIAMS NIH HHS [R01 AR053843, R01 AR053843-03] Funding Source: Medline; NIDCR NIH HHS [R01 DE019381-01, R01 DE019381] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019381] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/JBMR.0809010, 10.1359/jbmr.080901]; Iwasaki R, 2008, BIOCHEM BIOPH RES CO, V377, P899, DOI 10.1016/j.bbrc.2008.10.076; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; RAISZ LG, 2002, WILLIAMS TXB ENDOCRI, V10, P1373; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; U.S. Public Health Service, 2004, BON HLTH OST REP SUR; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646	10	2	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2009	15	2					144	145		10.1038/nm0209-144	http://dx.doi.org/10.1038/nm0209-144			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19197288	Green Accepted			2022-12-25	WOS:000263119400015
J	Wu, D; Vu, Q; Nguyen, A; Stone, JR; Stubbs, H; Kuhlmann, G; Sholl, LM; Iafrate, AJ				Wu, David; Vu, Quynh; Nguyen, Anhthu; Stone, James R.; Stubbs, Hannah; Kuhlmann, Georgiana; Sholl, Lynette M.; Iafrate, A. John			In situ genetic analysis of cellular chimerism	NATURE MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN GENOME; STEM-CELLS; EPITHELIAL-CELLS; POLYMORPHISMS; TRANSPLANTATION; ENGRAFTMENT; HEART	Copy number variants are a recently discovered source of large-scale genomic diversity present in all individuals. We capitalize on these inherent genomic differences, focusing on deletion polymorphisms, to develop informative fluorescence in situ hybridization probes with the ability to unequivocally distinguish between donor and recipient cells in situ. These probes are accurate, specific, highly polymorphic and, notably, can be used to assign genetic identity in situ in a completely gender-independent fashion. We anticipate that these polymorphic deletion probes will be useful in further understanding the dynamics of cellular chimerism after transplantation, including the details of chronic organ rejection, post-transplant lymphoproliferative disorder and graft-versus-host disease, and in optimizing future tissue engineering and pluripotent stem cell therapies.	[Wu, David; Vu, Quynh; Nguyen, Anhthu; Stone, James R.; Stubbs, Hannah; Kuhlmann, Georgiana; Sholl, Lynette M.; Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wu, David; Sholl, Lynette M.] Harvard Univ, Sch Mol Genet Pathol Fellowship, Boston, MA 02115 USA; [Wu, David; Stone, James R.; Sholl, Lynette M.; Iafrate, A. John] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School	Iafrate, AJ (corresponding author), Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St, Boston, MA 02114 USA.	aiafrate@partners.org			Department of Pathology, Massachusetts General Hospital	Department of Pathology, Massachusetts General Hospital	We thank M. Han, J. Miller-Batten and J. Reid for excellent technical assistance. We thank C. Lee (Brigham and Women's Hospital) and S. Kantarci (Beth Israel Deaconess Medical Center) for helpful discussions and reagents. We thank S. Ogino for helpful discussions. This work was supported in part by intramural funding from the Department of Pathology, Massachusetts General Hospital to A.J.I.	Braak H, 2008, NAT MED, V14, P483, DOI 10.1038/nm0508-483; BUCKLE VJ, 1994, CURR OPIN GENET DEV, V4, P374, DOI 10.1016/0959-437X(94)90024-8; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hochberg EP, 2003, BLOOD, V101, P363, DOI 10.1182/blood-2002-05-1365; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeffreys AJ, 2005, NAT MED, V11, P1035, DOI 10.1038/nm1005-1035; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; LITT M, 1989, AM J HUM GENET, V44, P397; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Mullally A, 2007, BLOOD, V109, P1355, DOI 10.1182/blood-2006-06-030858; Oliver DH, 2000, J MOL DIAGN, V2, P202, DOI 10.1016/S1525-1578(10)60638-1; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; WEBER JL, 1989, AM J HUM GENET, V44, P388	24	11	13	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					215	219		10.1038/nm.1862	http://dx.doi.org/10.1038/nm.1862			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19151730				2022-12-25	WOS:000263119400026
J	Foust, KD; Nurre, E; Montgomery, CL; Hernandez, A; Chan, CM; Kaspar, BK				Foust, Kevin D.; Nurre, Emily; Montgomery, Chrystal L.; Hernandez, Anna; Chan, Curtis M.; Kaspar, Brian K.			Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes	NATURE BIOTECHNOLOGY			English	Article							ADENOASSOCIATED VIRUS SEROTYPE-8; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSDUCTION IN-VIVO; MOUSE ALS MODEL; DISEASE PROGRESSION; GENE-TRANSFER; PARKINSONS-DISEASE; PROLONGS SURVIVAL; RNA INTERFERENCE; EXTENDS SURVIVAL	Delivery of genes to the brain and spinal cord across the blood-brain barrier (BBB) has not yet been achieved. Here we show that adeno-associated virus (AAV) 9 injected intravenously bypasses the BBB and efficiently targets cells of the central nervous system (CNS). Injection of AAV9-GFP into neonatal mice through the facial vein results in extensive transduction of dorsal root ganglia and motor neurons throughout the spinal cord and widespread transduction of neurons throughout the brain, including the neocortex, hippocampus and cerebellum. In adult mice, tail vein injection of AAV9-GFP leads to robust transduction of astrocytes throughout the entire CNS, with limited neuronal transduction. This approach may enable the development of gene therapies for a range of neurodegenerative diseases, such as spinal muscular atrophy, through targeting of motor neurons, and amyotrophic lateral sclerosis, through targeting of astrocytes. It may also be useful for rapid postnatal genetic manipulations in basic neuroscience studies.	[Foust, Kevin D.; Nurre, Emily; Montgomery, Chrystal L.; Kaspar, Brian K.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA; [Nurre, Emily; Kaspar, Brian K.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA; [Hernandez, Anna; Chan, Curtis M.] Preclin Serv Nevada, Special Pathol Serv, Reno, NV 89511 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Kaspar, BK (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, 700 Childrens Dr, Columbus, OH 43205 USA.	brian.kaspar@nationwidechildrens.org	Kaspar, Brian/E-6490-2010; Kaspar, Brian/E-3349-2011		(NIH)/National Eye Institute [R21EY018491]; NIH/ National Institute of Neurological Disorders and Stroke (NINDS) [R21NS064328]; NATIONAL EYE INSTITUTE [R21EY018491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064328, R01NS064492] Funding Source: NIH RePORTER	(NIH)/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/ National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH)/National Eye Institute (NEI) R21EY018491, NIH/ National Institute of Neurological Disorders and Stroke (NINDS) R21NS064328, Project A. L. S. and The Muscular Dystrophy Association. We kindly thank Jeff Rothstein (Johns Hopkins University) for the EAAT2 antibody, Terri Shaffer (Nationwide Children's Hospital) for expertise in mouse tail vein injections, Michele Basso (Ohio State University) and Megan Detloff (Ohio State University) for stereology usage and advice and Phillip Popovich (Ohio State University) and Kristina Kigerl (Ohio State University) for expertise in microglial detection.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Baughan T, 2006, MOL THER, V14, P54, DOI 10.1016/j.ymthe.2006.01.012; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Dodge JC, 2008, MOL THER, V16, P1056, DOI 10.1038/mt.2008.60; Foust KD, 2008, HUM GENE THER, V19, P61, DOI 10.1089/hum.2007.093; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hollis ER, 2008, MOL THER, V16, P296, DOI 10.1038/sj.mt.6300367; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Koerber JT, 2008, MOL THER, V16, P1703, DOI 10.1038/mt.2008.167; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Pardridge WM, 2002, NAT REV DRUG DISCOV, V1, P131, DOI 10.1038/nrd725; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Siegel RM, 2004, PLOS BIOL, V2, P2029, DOI 10.1371/journal.pbio.0020419; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	37	894	985	7	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2009	27	1					59	65		10.1038/nbt.1515	http://dx.doi.org/10.1038/nbt.1515			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	394TP	19098898	Green Accepted			2022-12-25	WOS:000262471200024
J	Lee, TH; Tun-Kyi, A; Shi, R; Lim, J; Soohoo, C; Finn, G; Balastik, M; Pastorino, L; Wulf, G; Zhou, XZ; Lu, KP				Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping			Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance	NATURE CELL BIOLOGY			English	Article							PROLYL ISOMERASE PIN1; PROTEIN PIN2/TRF1; MOUSE CELLS; LENGTH; DISEASE; MITOSIS; BETA; RNA	Telomeres are essential for maintaining cellular proliferative capacity and their loss has been implicated in ageing. A key regulator in telomere maintenance is the telomeric protein TRF1, which was also identified as Pin2 in a screen for Pin1. Pin1 is a unique prolyl isomerase that regulates protein conformation and function after phosphorylation. However, little is known about the role of Pin1 in telomere regulation or the modulation of TRF1 by upstream signals. Here we identify TRF1 as a major conserved substrate for Pin1 during telomere maintenance and ageing. Pin1 inhibition renders TRF1 resistant to protein degradation, enhances TRF1 binding to telomeres, and leads to gradual telomere loss in human cells and in mice. Pin1-deficient mice also show widespread premature ageing phenotypes within just one generation, similar to those in telomerase-deficient mice after 4-5 consecutive generations. Thus, Pin1 is an essential regulator of TRF1 stability, telomere maintenance and ageing.	[Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Dept Med, Boston, MA 02215 USA; [Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Biol Aging Program,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zhou, XZ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Dept Med, 330 Brookline Ave,CLS 0408, Boston, MA 02215 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	Lim, Jormay/A-7257-2011; Balastik, Martin/C-4410-2014; Wulf, Gerburg/AAS-6713-2021; Lee, Tae Ho/AAT-1721-2020	Lim, Jormay/0000-0001-7191-545X; Balastik, Martin/0000-0001-5833-9996; 	Human Frontiers Science Program Fellow; DOD Breast Cancer Research Program; NIH [K01, R01CA122434, R01GM058556, AG017870]; NATIONAL CANCER INSTITUTE [R01CA122434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017870] Funding Source: NIH RePORTER	Human Frontiers Science Program Fellow(Human Frontier Science Program); DOD Breast Cancer Research Program(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J. Frangioni and R. Bronson for assistance in determining bonerelated and ageing phenotypes in Pin1 knockout mice, and W. Hahn for TERT and TER expression vectors. J. L. is a Human Frontiers Science Program Fellow, C. Y. S. is a Predoctoral Fellow of the DOD Breast Cancer Research Program and L. P. is a recipient of a Mentored Research Scientist Development Award from the NIH (K01). The work was supported by NIH grants to X. Z. Z. (R01CA122434) and K. P. L. (R01GM058556 and AG017870).	Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Milyavsky M, 2003, CANCER RES, V63, P7147; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2003, J CELL BIOCHEM, V89, P19, DOI 10.1002/jcb.10496; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	40	87	89	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					97	U212		10.1038/ncb1818	http://dx.doi.org/10.1038/ncb1818			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060891	Green Accepted			2022-12-25	WOS:000262157000017
J	Ligtenberg, MJL; Kuiper, RP; Chan, TL; Goossens, M; Hebeda, KM; Voorendt, M; Lee, TYH; Bodmer, D; Hoenselaar, E; Hendriks-Cornelissen, SJB; Tsui, WY; Kong, CK; Brunner, HG; van Kessel, AG; Yuen, ST; van Krieken, JHJM; Leung, SY; Hoogerbrugge, N				Ligtenberg, Marjolijn J. L.; Kuiper, Roland P.; Chan, Tsun Leung; Goossens, Monique; Hebeda, Konnie M.; Voorendt, Marsha; Lee, Tracy Y. H.; Bodmer, Danielle; Hoenselaar, Eveline; Hendriks-Cornelissen, Sandra J. B.; Tsui, Wai Yin; Kong, Chi Kwan; Brunner, Han G.; van Kessel, Ad Geurts; Yuen, Siu Tsan; van Krieken, J. Han J. M.; Leung, Suet Yi; Hoogerbrugge, Nicoline			Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1	NATURE GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MLH1 GERMLINE EPIMUTATIONS; REPAIR GENE HMSH2; PROMOTER HYPERMETHYLATION; ANTISENSE RNA; TUMOR; TRANSCRIPTION; CARCINOMA; HNPCC; HMLH1	Lynch syndrome patients are susceptible to colorectal and endometrial cancers owing to inactivating germline mutations in mismatch repair genes, including MSH2 (ref. 1). Here we describe patients from Dutch and Chinese families with MSH2-deficient tumors carrying heterozygous germline deletions of the last exons of TACSTD1, a gene directly upstream of MSH2 encoding Ep-CAM. Due to these deletions, transcription of TACSTD1 extends into MSH2. The MSH2 promoter in cis with the deletion is methylated in Ep-CAM positive but not in Ep-CAM negative normal tissues, thus revealing a correlation between activity of the mutated TACSTD1 allele and epigenetic inactivation of the corresponding MSH2 allele. Gene silencing by transcriptional read-through of a neighboring gene in either sense, as demonstrated here, or antisense direction(2), could represent a general mutational mechanism. Depending on the expression pattern of the neighboring gene that lacks its normal polyadenylation signal, this may cause either generalized or mosaic patterns of epigenetic inactivation.	[Ligtenberg, Marjolijn J. L.; Kuiper, Roland P.; Voorendt, Marsha; Bodmer, Danielle; Hoenselaar, Eveline; Brunner, Han G.; van Kessel, Ad Geurts; Hoogerbrugge, Nicoline] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 849, NL-6500 HB Nijmegen, Netherlands; [Ligtenberg, Marjolijn J. L.; Goossens, Monique; Hebeda, Konnie M.; Hendriks-Cornelissen, Sandra J. B.; van Krieken, J. Han J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Chan, Tsun Leung; Lee, Tracy Y. H.; Tsui, Wai Yin; Yuen, Siu Tsan; Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hereditary Gastrointestinal Canc Genet Diag Lab, Pokfulam, Hong Kong, Peoples R China; [Chan, Tsun Leung; Yuen, Siu Tsan; Leung, Suet Yi] St Pauls Hosp, Dept Pathol, Hereditary Gastrointestinal Canc Registry, Hong Kong, Hong Kong, Peoples R China; [Kong, Chi Kwan] Yan Chai Hosp, Dept Surg, Tsuen Wan, Hong Kong, Peoples R China	Radboud University Nijmegen; Radboud University Nijmegen; University of Hong Kong; Hong Kong St. Paul's Hospital	Ligtenberg, MJL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 849, POB 9101, NL-6500 HB Nijmegen, Netherlands.	m.ligtenberg@antrg.umcn.nl; suetyi@hkucc.hku.hk	Yuen, Siu/K-6311-2014; Kuiper, Roland/A-9646-2014; Ligtenberg, Marjolijn/N-9666-2013; Hebeda, K./L-4354-2015; Brunner, Han/C-9928-2013; Bodmer, D./L-4207-2015; van Krieken, Joannes H J M/D-4138-2009; van Kessel, Ad Geurts/A-2810-2010; Hoogerbrugge, Nicoline/O-1016-2013; Leung, Suet Yi/C-4340-2009; Leung, Suet Yi/T-9620-2019	Ligtenberg, Marjolijn/0000-0003-1290-1474; Hebeda, K./0000-0002-4181-3302; van Krieken, Joannes H J M/0000-0001-6544-1040; Hoogerbrugge, Nicoline/0000-0003-2393-8141; Leung, Suet Yi/0000-0001-8614-4619	Dutch Cancer Society; Research Grants Council of the Hong Kong Special Administrative Region [GRF HKU 7614/08M, HKU 7622/05M]; Hong Kong Cancer Fund; Michael and Betty Kadoorie Cancer Genetics Research Programme	Dutch Cancer Society(KWF Kankerbestrijding); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Hong Kong Cancer Fund; Michael and Betty Kadoorie Cancer Genetics Research Programme	We thank S. Wezenberg, M. Schliekelmann, E. Kamping, M. Steehouwer, R. Willems, A. S. Y. Chan, A. K. W. Chan, J. K. Y. Lau and C. Li for technical assistance, Diederik de Bruijn for advice and support, and clinicians in Hong Kong Hospital Authority for clinical care. This work was supported by research grants from the Dutch Cancer Society, the Research Grants Council of the Hong Kong Special Administrative Region (GRF HKU 7614/08M and HKU 7622/05M), the Hong Kong Cancer Fund and the Michael and Betty Kadoorie Cancer Genetics Research Programme.	Barbour VM, 2000, BLOOD, V96, P800, DOI 10.1182/blood.V96.3.800.015k11a_800_807; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Gazzoli I, 2002, CANCER RES, V62, P3925; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Iwahashi Y, 1998, GENE, V213, P141, DOI 10.1016/S0378-1119(98)00187-5; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kane MF, 1997, CANCER RES, V57, P808; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Morak M, 2008, EUR J HUM GENET, V16, P804, DOI 10.1038/ejhg.2008.25; Overbeek LIH, 2007, BRIT J CANCER, V96, P1605, DOI 10.1038/sj.bjc.6603754; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Scherer SJ, 1996, HUM GENET, V97, P114; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Valle L, 2007, CLIN GENET, V71, P232, DOI 10.1111/j.1399-0004.2007.00751.x; van der Klift H, 2005, GENE CHROMOSOME CANC, V44, P123, DOI 10.1002/gcc.20219; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	24	516	528	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2009	41	1					112	117		10.1038/ng.283	http://dx.doi.org/10.1038/ng.283			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19098912				2022-12-25	WOS:000262085300025
J	Castle, JC; Zhang, CL; Shah, JK; Kulkarni, AV; Kalsotra, A; Cooper, TA; Johnson, JM				Castle, John C.; Zhang, Chaolin; Shah, Jyoti K.; Kulkarni, Amit V.; Kalsotra, Auinash; Cooper, Thomas A.; Johnson, Jason M.			Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines	NATURE GENETICS			English	Article							BIVATUZUMAB MERTANSINE; RNA; IDENTIFICATION; FOX-1; ENHANCERS; SEQUENCES; ELEMENTS; PROTEIN; HOMOLOGS	Alternative pre-messenger RNA splicing influences development, physiology and disease, but its regulation in humans is not well understood, partially because of the limited scale at which the expression of specific splicing events has been measured. We generated the first genome-scale expression compendium of human alternative splicing events using custom whole-transcript microarrays monitoring expression of 24,426 alternative splicing events in 48 diverse human samples. Over 11,700 genes and 9,500 splicing events were differentially expressed, providing a rich resource for studying splicing regulation. An unbiased, systematic screen of 21,760 4-mer to 7-mer words for cis-regulatory motifs identified 143 RNA 'words' enriched near regulated cassette exons, including six clusters of motifs represented by UCUCU, UGCAUG, UGCU, UGUGU, UUUU and AGGG, which map to trans-acting regulators PTB, Fox, Muscleblind, CELF/CUG-BP, TIA-1 and hnRNP F/H, respectively. Each cluster showed a distinct pattern of genomic location and tissue specificity. For example, UCUCU occurs 110 to 35 nucleotides preceding cassette exons upregulated in brain and striated muscle but depleted in other tissues. UCUCU and UGCAUG seem to have similar function but independent action, occurring 5' and 3', respectively, of 33% of the cassette exons upregulated in skeletal muscle but co-occurring for only 2%.	[Castle, John C.; Shah, Jyoti K.; Kulkarni, Amit V.; Johnson, Jason M.] Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Zhang, Chaolin] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kalsotra, Auinash; Cooper, Thomas A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Merck & Company; Cold Spring Harbor Laboratory; Baylor College of Medicine; Baylor College of Medicine	Castle, JC (corresponding author), Rosetta Inpharmat LLC, Seattle, WA 98109 USA.	john_castle@merck.com; jason_johnson@merck.com		Kalsotra, Auinash/0000-0002-1011-0006	 [R01GM076493]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076493, R01GM074688] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Armour, C. Raymond, D. Haynor, V. Emilsson, P. Garrett-Engele, F. Roth, P. Loerch, R. Chen, C. Rohl, M. Tompa, E. Schadt and L. Lim for input, Rosetta's Gene Expression Laboratory microarray hybridization facility for microarray data, and S. Carlson for project management. Funding for T.A.C. provided by R01GM076493.	Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66; CHAN RC, 1995, MOL CELL BIOL, V15, P6377; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Fehlbaum P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni047; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gooding C, 1998, RNA, V4, P85; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Griffith M, 2008, NAT METHODS, V5, P118, DOI 10.1038/nmeth0208-118; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KAN Z, 2004, PAC S BIOCOMPUT, V9, P42; Kuroyanagi H, 2007, MOL CELL BIOL, V27, P8612, DOI 10.1128/MCB.01508-07; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Minovitsky S, 2005, NUCLEIC ACIDS RES, V33, P714, DOI 10.1093/nar/gki210; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Perez I, 1997, RNA, V3, P764; Riechelmann H, 2008, ORAL ONCOL, V44, P823, DOI 10.1016/j.oraloncology.2007.10.009; Rupp U, 2007, ANTI-CANCER DRUG, V18, P477, DOI 10.1097/CAD.0b013e32801403f4; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; TAYLOR JR, 1982, INTRO ERROR ANAL, V270; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	49	231	235	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1416	1425		10.1038/ng.264	http://dx.doi.org/10.1038/ng.264			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978788	Green Accepted			2022-12-25	WOS:000261215900018
J	Engelman, JA; Chen, L; Tan, XH; Crosby, K; Guimaraes, AR; Upadhyay, R; Maira, M; McNamara, K; Perera, SA; Song, YC; Chirieac, LR; Kaur, R; Lightbown, A; Simendinger, J; Li, T; Padera, RF; Garcia-Echeverria, C; Weissleder, R; Mahmood, U; Cantley, LC; Wong, KK				Engelman, Jeffrey A.; Chen, Liang; Tan, Xiaohong; Crosby, Katherine; Guimaraes, Alexander R.; Upadhyay, Rabi; Maira, Michel; McNamara, Kate; Perera, Samanthi A.; Song, Youngchul; Chirieac, Lucian R.; Kaur, Ramneet; Lightbown, Angela; Simendinger, Jessica; Li, Timothy; Padera, Robert F.; Garcia-Echeverria, Carlos; Weissleder, Ralph; Mahmood, Umar; Cantley, Lewis C.; Wong, Kwok-Kin			Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers	NATURE MEDICINE			English	Article							CATALYTIC SUBUNIT; RAS; MUTATIONS; TUMORIGENESIS; SENSITIVITY; EXPRESSION; P110-ALPHA; ABSENCE; POTENT; GENE	Somatic mutations that activate phosphoinositide 3-kinase (PI3K) have been identified in the p110-alpha catalytic subunit (encoded by PIK3CA)(1). They are most frequently observed in two hotspots: the helical domain (E545K and E542K) and the kinase domain (H1047R). Although the p110-alpha mutants are transforming in vitro, their oncogenic potential has not been assessed in genetically engineered mouse models. Furthermore, clinical trials with PI3K inhibitors have recently been initiated, and it is unknown if their efficacy will be restricted to specific, genetically defined malignancies. In this study, we engineered a mouse model of lung adenocarcinomas initiated and maintained by expression of p110-alpha H1047R. Treatment of these tumors with NVP-BEZ235, a dual pan-PI3K and mammalian target of rapamycin (mTOR) inhibitor in clinical development, led to marked tumor regression as shown by positron emission tomography-computed tomography, magnetic resonance imaging and microscopic examination. In contrast, mouse lung cancers driven by mutant Kras did not substantially respond to single-agent NVP-BEZ235. However, when NVP-BEZ235 was combined with a mitogen-activated protein kinase kinase (MEK) inhibitor, ARRY-142886, there was marked synergy in shrinking these Kras-mutant cancers. These in vivo studies suggest that inhibitors of the PI3K-mTOR pathway may be active in cancers with PIK3CA mutations and, when combined with MEK inhibitors, may effectively treat KRAS mutated lung cancers.	Beth Israel Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Engelman, Jeffrey A.; Song, Youngchul; Kaur, Ramneet] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Engelman, Jeffrey A.; Kaur, Ramneet; Cantley, Lewis C.; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chen, Liang; Tan, Xiaohong; McNamara, Kate; Perera, Samanthi A.; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chen, Liang; Tan, Xiaohong; McNamara, Kate; Perera, Samanthi A.; Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA; [Crosby, Katherine; Lightbown, Angela; Simendinger, Jessica] Cell Signaling Technol, Danvers, MA 01923 USA; [Guimaraes, Alexander R.; Upadhyay, Rabi; Weissleder, Ralph; Mahmood, Umar] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA; [Guimaraes, Alexander R.; Upadhyay, Rabi; Weissleder, Ralph; Mahmood, Umar] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Maira, Michel; Garcia-Echeverria, Carlos] Novartis Inst Biomed Res, Oncol Dis Area, CH-4057 Basel, Switzerland; [Chirieac, Lucian R.; Padera, Robert F.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Weissleder, Ralph; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Novartis; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Cantley, LC (corresponding author), Beth Israel Hosp, Beth Israel Deaconess Med Ctr, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	lewis_cantley@hms.harvard.edu; KWONG1@PARTNERS.ORG	Cantley, Lewis C/D-1800-2014; Chirieac, Lucian R./AAD-2030-2019	Cantley, Lewis C/0000-0002-1298-7653; wong, kwok kin/0000-0001-6323-235X; /0000-0003-0828-4143; Upadhyay, Rabi/0000-0002-2154-0132; Chen, Liang/0000-0001-7300-6604; Mahmood, Umar/0000-0001-7414-6123	US National Institutes of Health (NIH) [CA120060-01]; American Association for Cancer Research; International Association for the Study of Lung Cancer; NIH [CA089021, P01 CA117969, R01 GM41890, K08 AG024004, R01 CA122794, R01 AG2400401]; Dana-Farber-Harvard Cancer Center Lung Cancer Specialized Program of Research Excellence (SPORE) [P50 CA090578]; Dana-Farber-Harvard Cancer Center Gastrointestinal Cancer SPORE [P50 CA127003, U24-CA092782]; Joan Scarangello Foundation to Conquer Lung Cancer; Cecily and Robert Harris Foundation; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [P01CA089021, P50CA090578, P50CA127003, U24CA092782, R01CA137008, K08CA120060, P01CA117969, R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, R01GM036624, R01GM041890, R37GM041890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG024004] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; International Association for the Study of Lung Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber-Harvard Cancer Center Lung Cancer Specialized Program of Research Excellence (SPORE); Dana-Farber-Harvard Cancer Center Gastrointestinal Cancer SPORE; Joan Scarangello Foundation to Conquer Lung Cancer; Cecily and Robert Harris Foundation; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CCSP-rtTA mice were generously provided by J. Whitsett at the University of Cincinnati. Tet-op-Kras mice were generously provided by H. Varmus (Memorial Sloan-Kettering Cancer Center). LSL-Kras G12D mice were kindly provided by T. Jacks (Massachusetts Institute of Technology). This work was supported by US National Institutes of Health (NIH) K08 grant CA120060-01 (J. A. E.), the American Association for Cancer Research (J. A. E.), the International Association for the Study of Lung Cancer (J. A. E.), NIH prostate cancer grant P01 CA089021 (L. C. C.), NIH pancreatic cancer grant P01 CA117969 (L. C. C.), NIH grant R01 GM41890 (L. C. C.), a Dana-Farber-Harvard Cancer Center Lung Cancer Specialized Program of Research Excellence (SPORE) grant P50 CA090578 (J. A. E. and K.-K.W.) and Dana-Farber-Harvard Cancer Center Gastrointestinal Cancer SPORE grants P50 CA127003 (J. A. E., R. W., U. M. and L. C. C.) and U24-CA092782 (R. W., U. M., A. R. G.). K.-K.W. was supported by NIH grants K08 AG024004, R01 CA122794 and R01 AG2400401; the Joan Scarangello Foundation to Conquer Lung Cancer; the Cecily and Robert Harris Foundation; and the Flight Attendant Medical Research Institute.	Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Engelman JA, 2007, CLIN CANCER RES, V13, p4637S, DOI 10.1158/1078-0432.CCR-07-0653; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Luo J, 2005, P NATL ACAD SCI USA, V102, P10238, DOI 10.1073/pnas.0504378102; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	21	1077	1139	4	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1351	1356		10.1038/nm.1890	http://dx.doi.org/10.1038/nm.1890			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029981	Green Accepted			2022-12-25	WOS:000261393600019
J	Nilsson, J; Yekezare, M; Minshull, J; Pines, J				Nilsson, Jakob; Yekezare, Mona; Minshull, Jeremy; Pines, Jonathon			The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; CYCLIN-A; CHROMOSOME ALIGNMENT; MITOTIC CHECKPOINT; PROTEIN BUBR1; KINETOCHORES; BINDING; MAD2; MITOSIS; CELLS	The spindle assembly checkpoint (SAC) is required to block sister chromatid separation until all chromosomes are properly attached to the mitotic apparatus. The SAC prevents cells from entering anaphase by inhibiting the ubiquitylation of cyclin B1 and securin by the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase. The target of the SAC is the essential APC/C activator Cdc20. It is unclear how the SAC inactivates Cdc20 but most current models suggest that Cdc20 forms a stable complex with the Mad2 checkpoint protein. Here we show that most Cdc20 is not in a complex with Mad2; instead Mad2 is required for Cdc20 to form a complex with another checkpoint protein, BubR1. We further show that during the SAC, the APC/C ubiquitylates Cdc20 to target it for degradation. Thus, ubiquitylation of human Cdc20 is not required to release it from the checkpoint complex, but to degrade it to maintain mitotic arrest.	[Nilsson, Jakob; Yekezare, Mona; Pines, Jonathon] Wellcome CR UK Gurdon Inst, Cambridge CB2 1QN, England; [Nilsson, Jakob; Yekezare, Mona; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England; [Minshull, Jeremy] DNA 2 0 Inc, Menlo Pk, CA 94025 USA		Pines, J (corresponding author), Wellcome CR UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jp103@cam.ac.uk		Pines, Jonathon/0000-0002-5227-6004; Nilsson, Jakob/0000-0003-4100-1125	Carlsberg Foundation; Danish Cancer Society; Yousef Jameel scholarship; Cancer Research UK [C29/A3211]	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Yousef Jameel scholarship(American University Cairo); Cancer Research UK(Cancer Research UK)	We thank Daisuke Izawa for pioneering APC3 and APC11 siRNA depletion, Paola Marco for help with the BubR1 constructs, Stephen Taylor, Gowei Fang and Andrea Musacchio for reagents, Athanassios Giannis for dimethylanastron, Mercedes Pardo and Lu Yu of the Mass Spectroscopy group at the Sanger Centre for mass spectroscopy, and Andrea Musacchio and members of our laboratory for helpful discussions. M.Y. is particularly grateful to Takahiro Matsusaka for help with microscopy and microinjection. J.N. was supported by fellowships from the Carlsberg Foundation and the Danish Cancer Society, M. Y. was supported by a Yousef Jameel scholarship. This work was supported by a Program Grant from Cancer Research UK to J.P. (C29/A3211).	Acquaviva C, 2004, NAT CELL BIOL, V6, P892, DOI 10.1038/ncb1167; BRITO DA, 2008, J CELL BIOL; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027	37	227	236	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1411	U74		10.1038/ncb1799	http://dx.doi.org/10.1038/ncb1799			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18997788	Green Accepted			2022-12-25	WOS:000261261800011
J	Vitaliano-Prunier, A; Menant, A; Hobeika, M; Geli, V; Gwizdek, C; Dargemont, C				Vitaliano-Prunier, Adeline; Menant, Alexandra; Hobeika, Maria; Geli, Vincent; Gwizdek, Carole; Dargemont, Catherine			Ubiquitylation of the COMPASS component Swd2 links H2B ubiquitylation to H3K4 trimethylation	NATURE CELL BIOLOGY			English	Article							HISTONE-3 LYSINE-4 METHYLATION; TRANSCRIPTION TERMINATION; MOLECULAR RECOGNITION; STRUCTURAL BASIS; PROTEIN WDR5; COMPLEX; UBIQUITINATION; RECRUITMENT; SET1; MONOUBIQUITINATION	Mono-ubiquitylation of histone H2B correlates with transcriptional activation and is required for di- and trimethylation at Lys 4 on the histone H3 tail (H3K4) by the SET1/COMPASS methyltransferase complex through a poorly characterized trans-tail pathway(1,2). Here we show that mono-ubiquitylation of histone H2B promotes ubiquitylation at Lys 68 and Lys 69 of Swd2, the essential component of SET1/COMPASS in Saccharomyces cerevisiae. We found that Rad6/Bre1 ubiquitylation enzymes responsible for H2B ubiquitylation also participate directly in Swd2 modification. Preventing Swd2 or H2B ubiquitylation did not affect Set1 stability, interaction of Swd2 with Set1 or the ability of Swd2 to interact with chromatin. However, we found that mutation of Lys 68 and Lys 69 of Swd2 markedly reduced trimethylation, and to a lesser extent dimethylation, of H3K4 at the 5'- end of transcribing genes without affecting monomethylation. This effect results from the ability of Swd2 ubiquitylation to control recruitment of Spp1, a COMPASS subunit necessary for trimethylation. Our results further indicate that Swd2 is a major H3-binding component of COMPASS. Swd2 thus represents a key factor that mediates crosstalk between H2B ubiquitylation and H3K4 trimethylation on chromatin.	[Vitaliano-Prunier, Adeline; Menant, Alexandra; Hobeika, Maria; Gwizdek, Carole; Dargemont, Catherine] Univ Paris 06, Univ Paris 07, Inst Jacques Monod, CNRS, F-75251 Paris 05, France; [Geli, Vincent] CNRS, Inst Biol Struct & Microbiol, UPR3081, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Gwizdek, C (corresponding author), Univ Paris 06, Univ Paris 07, Inst Jacques Monod, CNRS, 2 Pl Jussieu,Tour 43, F-75251 Paris 05, France.	gwizdek@ijm.jussieu.fr; dargemont@ijm.jussieu.fr			Agence Nationale pour la Recherche [BLAN06-1_ 134099]; Ligue contre le Cancer; Ministere de l'Enseignement Superieur et de la Recherche; Association de Recherche contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur et de la Recherche; Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	We would like to thank P. Nagy for antibodies, G. Divita for help with molecular modelling and V. Oreal for reagents. We are most grateful to S. Dokudovskaya and A. Morillon for very helpful discussions and critical reading of the manuscript. This study was funded by grants from the Agence Nationale pour la Recherche (grant BLAN06-1_ 134099 to CD) and the Ligue contre le Cancer (C. D. and V. G. laboratories are 'Equipes labellisees'). A. V. P. and M. H. are supported by the Ministere de l'Enseignement Superieur et de la Recherche and the Association de Recherche contre le Cancer respectively.	Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	32	76	76	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1365	U269		10.1038/ncb1796	http://dx.doi.org/10.1038/ncb1796			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849979				2022-12-25	WOS:000260586700020
J	Schloss, JA				Schloss, Jeffery A.			How to get genomes at one ten-thousandth the cost	NATURE BIOTECHNOLOGY			English	Letter							DNA; MOLECULES		NHGRI, US Natl Inst Hlth, Div Extramural Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schloss, JA (corresponding author), NHGRI, US Natl Inst Hlth, Div Extramural Res, Bethesda, MD 20892 USA.	jeff_schloss@nih.gov		Schloss, Jeffery/0000-0003-4646-3652				Ashcroft BA, 2008, SMALL, V4, P1468, DOI 10.1002/smll.200800233; Bashford G, 2008, OPT EXPRESS, V16, P3445, DOI 10.1364/OE.16.003445; Bayley H, 2006, CURR OPIN CHEM BIOL, V10, P628, DOI 10.1016/j.cbpa.2006.10.040; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Blazej RG, 2007, ANAL CHEM, V79, P4499, DOI 10.1021/ac070126f; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Foquet M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831366; Gershow M, 2007, NAT NANOTECHNOL, V2, P775, DOI 10.1038/nnano.2007.381; Korlach J, 2008, NUCLEOS NUCLEOT NUCL, V27, P1072, DOI 10.1080/15257770802260741; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Lizardi PM, 2008, NAT BIOTECHNOL, V26, P649, DOI 10.1038/nbt0608-649; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Williams JGK, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn531; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zwolak M, 2008, REV MOD PHYS, V80, P141, DOI 10.1103/RevModPhys.80.141	21	72	78	5	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1113	1115		10.1038/nbt1008-1113	http://dx.doi.org/10.1038/nbt1008-1113			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18846084				2022-12-25	WOS:000259926000025
J	Ukai-Tadenuma, M; Kasukawa, T; Ueda, HR				Ukai-Tadenuma, Maki; Kasukawa, Takeya; Ueda, Hiroki R.			Proof-by-synthesis of the transcriptional logic of mammalian circadian clocks	NATURE CELL BIOLOGY			English	Article							RECEPTOR REV-ERBA; GENE-EXPRESSION; MOUSE-LIVER; CKI-DELTA; COMPONENT; PROTEINS; MUTATION; PAR; CLONING; CRYPTOCHROMES	Mammalian circadian clocks consist of complex regulatory loops mediated through-at least-morning, daytime and night-time DNA elements. To prove the transcriptional logic of mammalian clocks, we developed an in cellulo mammalian cell-culture system that allowed us to design and implement artificial transcriptional circuits. Here we show that morning activation and night-time repression can yield the transcriptional output during the daytime, and similarly that daytime activation and morning repression can yield night-time transcriptional output. We also observed that the diverse transcriptional outputs of other phases can be generated through the expression of simple combinations of transcriptional activators and repressors. These results reveal design principles not only for understanding the continuous transcriptional outputs observed in vivo but also for the logical construction of artificial promoters working at novel phases. Logical synthesis of artificial circuits, with an identified structure and observed dynamics, provides an alternative strategy applicable to the investigation of complex biological systems.	[Ukai-Tadenuma, Maki; Ueda, Hiroki R.] RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kasukawa, Takeya; Ueda, Hiroki R.] RIKEN, Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN	Ueda, HR (corresponding author), RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Kasukawa, Takeya/N-5070-2015; Ueda, Hiroki R/C-5037-2014	Kasukawa, Takeya/0000-0001-5085-0802; Ueda, Hiroki R/0000-0001-8342-9176				Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Dunlap JC, 2007, COLD SH Q B, V72, P57; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Falvey E, 1996, BIOL CHEM, V377, P797; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kojima S, 2003, BIOCHEM BIOPH RES CO, V301, P1, DOI 10.1016/S0006-291X(02)02938-8; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Okano T, 2001, NEUROSCI LETT, V300, P111, DOI 10.1016/S0304-3940(01)01581-6; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber EL, 2001, J BIOL CHEM, V276, P45921, DOI 10.1074/jbc.M107726200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	81	81	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1154	1163		10.1038/ncb1775	http://dx.doi.org/10.1038/ncb1775			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18806789				2022-12-25	WOS:000259682900009
J	Budde, BS; Namavar, Y; Barth, PG; Poll-The, BT; Nurnberg, G; Becker, C; van Ruissen, F; Weterman, MAJ; Fluiter, K; Beek, ETT; Aronica, E; van der Knaap, MS; Hohne, W; Toliat, MR; Crow, YJ; Steinlin, M; Voit, T; Roelens, F; Brussel, W; Brockmann, K; Kyllerman, M; Boltshauser, E; Hammersen, G; Willemsen, M; Basel-Vanagaite, L; Krageloh-Mann, I; de Vries, LS; Sztriha, L; Muntoni, F; Ferrie, CD; Battini, R; Hennekam, RCM; Grillo, E; Beemer, FA; Stoets, LME; Wollnik, B; Nurnberg, P; Baas, F				Budde, Birgit S.; Namavar, Yasmin; Barth, Peter G.; Poll-The, Bwee Tien; Nuernberg, Gudrun; Becker, Christian; van Ruissen, Fred; Weterman, Marian A. J.; Fluiter, Kees; Beek, Erik T. te; Aronica, Eleonora; van der Knaap, Marjo S.; Hoehne, Wolfgang; Toliat, Mohammad Reza; Crow, Yanick J.; Steinlin, Maja; Voit, Thomas; Roelens, Filip; Brussel, Wim; Brockmann, Knut; Kyllerman, Marten; Boltshauser, Eugen; Hammersen, Gerhard; Willemsen, Michel; Basel-Vanagaite, Lina; Kraegeloh-Mann, Ingeborg; de Vries, Linda S.; Sztriha, Laszlo; Muntoni, Francesco; Ferrie, Colin D.; Battini, Roberta; Hennekam, Raoul C. M.; Grillo, Eugenio; Beemer, Frits A.; Stoets, Loes M. E.; Wollnik, Bernd; Nuernberg, Peter; Baas, Frank			tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; OLIVOPONTOCEREBELLAR HYPOPLASIA; FETAL-ONSET; PEDIGREES; SPECTRUM; DISEASE; TYPE-2; TOOL; FORM	Pontocerebellar hypoplasias (PCH) represent a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. In two subtypes, PCH2 and PCH4, we identified mutations in three of the four different subunits of the tRNA-splicing endonuclease complex. Our findings point to RNA processing as a new basic cellular impairment in neurological disorders.	[Namavar, Yasmin; van Ruissen, Fred; Weterman, Marian A. J.; Fluiter, Kees; Beek, Erik T. te; Baas, Frank] Univ Amsterdam, Dept Neurogenet, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Budde, Birgit S.; Nuernberg, Gudrun; Becker, Christian; Toliat, Mohammad Reza; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Budde, Birgit S.; Nuernberg, Gudrun; Becker, Christian; Toliat, Mohammad Reza; Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Namavar, Yasmin; Barth, Peter G.; Poll-The, Bwee Tien] Univ Amsterdam, Div Pediat Neurol, Emma Childrens Hosp, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] Univ Amsterdam, Dept Pathol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat & Child Neurol, NL-1081 HV Amsterdam, Netherlands; [Hoehne, Wolfgang] Charite Univ Med Berlin, Inst Biochem, D-10117 Berlin, Germany; [Crow, Yanick J.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Steinlin, Maja] Univ Hosp Bern, Dept Pediat Neurol, CH-3010 Bern, Switzerland; [Voit, Thomas] Grp Hosp Pitie Salpetriere, Inst Myol, F-75651 Paris 13, France; [Roelens, Filip] Heilig Hartziekenhuis, Dept Pediat, B-8800 Roeselare, Belgium; [Brussel, Wim] Rijnstate Hosp, Dept Pediat, NL-6815 AD Arnhem, Netherlands; [Brockmann, Knut] Univ Gottingen, Dept Paediat & Child Neurol, D-37075 Gottingen, Germany; [Kyllerman, Marten] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Paediat, S-41685 Gothenburg, Sweden; [Boltshauser, Eugen] Univ Childrens Hosp, CH-8032 Zurich, Switzerland; [Hammersen, Gerhard] CNOPFsche Kinderklin, D-90419 Nurnberg, Germany; [Willemsen, Michel] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Neurol, NL-6500 HB Nijmegen, Netherlands; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Raphael Recanati Genet Inst, Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel; [Kraegeloh-Mann, Ingeborg] Univ Tubingen, Dept Paediat Neurol & Dev Med, D-72076 Tubingen, Germany; [de Vries, Linda S.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Neonatol, NL-3584 AE Utrecht, Netherlands; [Sztriha, Laszlo] Univ Szeged, Dept Paediat, H-6726 Szeged, Hungary; [Muntoni, Francesco; Hennekam, Raoul C. M.] UCL, Great Ormond St Hosp Children, Inst Child Hlth, London WC1N 1EH, England; [Ferrie, Colin D.] Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Battini, Roberta] Univ Pisa, Stella Maris Sci Inst, Div Child Neurol & Psychiat, I-56018 Calambrone Pisa, Italy; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Grillo, Eugenio] Hosp Infantil Joana de Gusmao, Dept Neurol, BR-88025301 Florianopolis, SC, Brazil; [Beemer, Frits A.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 AE Utrecht, Netherlands; [Stoets, Loes M. E.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Wollnik, Bernd; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Wollnik, Bernd; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Wollnik, Bernd] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey	University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne; University of Cologne; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saint James's University Hospital; University of Leeds; University of Bern; University Hospital of Bern; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Rijnstate Hospital; University of Gottingen; Queen Silvia Children's Hospital; Sahlgrenska University Hospital; University Children's Hospital Zurich; Radboud University Nijmegen; Rabin Medical Center; Eberhard Karls University of Tubingen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Szeged University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Leeds General Infirmary; IRCCS Fondazione Stella Maris; University of Pisa; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Cologne; University of Cologne; University of Cologne; Istanbul University	Baas, F (corresponding author), Univ Amsterdam, Dept Neurogenet, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	f.baas@amc.uva.nl	de Vries, Linda S/AAB-6454-2021; Patterson, Marc/AAI-5056-2020; battini, roberta/P-9095-2017; Crow, Yanick J/N-6120-2014; Steinlin, Maja/G-5991-2010; Wollnik, Bernd/GRY-6062-2022; Fluiter, Kees/H-2828-2015; Patterson, Marc C./H-5331-2019; Baas, Frank/F-9574-2010; Willemsen, Michel A.A.P./H-8119-2014	battini, roberta/0000-0002-7889-1355; Crow, Yanick J/0000-0001-7211-7564; Wollnik, Bernd/0000-0003-2589-0364; Fluiter, Kees/0000-0003-0898-7260; Baas, Frank/0000-0003-3912-5428; Aronica, Eleonora/0000-0002-3542-3770; Grillo, Eugenio/0000-0002-1002-6613; Poll-The, Bwee Tien/0000-0002-8118-5419; Budde, Birgit/0000-0001-9385-4168; Namavar, Yasmin/0000-0002-0176-5959; van Ruissen, Fred/0000-0002-9458-7505; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157				ALBRECHT S, 1993, ACTA NEUROPATHOL, V85, P394, DOI 10.1007/BF00334450; Barth PG, 2007, ACTA NEUROPATHOL, V114, P373, DOI 10.1007/s00401-007-0263-0; BARTH PG, 1995, NEUROLOGY, V45, P311, DOI 10.1212/WNL.45.2.311; BARTH PG, 1993, BRAIN DEV-JPN, V15, P411, DOI 10.1016/0387-7604(93)90080-R; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; GOUTIERES F, 1977, J NEUROL NEUROSUR PS, V40, P370, DOI 10.1136/jnnp.40.4.370; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Muntoni F, 1999, NEUROPEDIATRICS, V30, P243, DOI 10.1055/s-2007-973498; Patel MS, 2006, AM J MED GENET A, V140A, P594, DOI 10.1002/ajmg.a.31095; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Rajab A, 2003, NEUROLOGY, V60, P1664, DOI 10.1212/01.WNL.0000068548.58498.41; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Sztriha L, 2005, AM J MED GENET A, V135A, P134, DOI 10.1002/ajmg.a.30701; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Trotta CR, 2006, NATURE, V441, P375, DOI 10.1038/nature04741; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112	19	162	168	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1113	1118		10.1038/ng.204	http://dx.doi.org/10.1038/ng.204			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711368				2022-12-25	WOS:000258761200026
J	Candeias, MM; Malbert-Colas, L; Powell, DJ; Daskalogianni, C; Maslon, MM; Naski, N; Bourougaa, K; Calvo, F; Fahraeus, R				Candeias, Marco M.; Malbert-Colas, Laurence; Powell, Darren J.; Daskalogianni, Chrysoula; Maslon, Magda M.; Naski, Nadia; Bourougaa, Karima; Calvo, Fabien; Fahraeus, Robin			p53 mrNA controls p53 activity by managing Mdm2 functions	NATURE CELL BIOLOGY			English	Article							PROTEIN INTERACTIONS; TRANSACTIVATION; TRANSLATION; MUTATIONS; STABILITY; APOPTOSIS; DOMAIN; PHOSPHORYLATION; EXPRESSION; COMPLEXES	The E3 ubiquitin ligase Mdm2 is a focal regulator of p53 tumour suppressor activity. It binds p53, promoting its polyubiquitination and degradation, and also controls p53 synthesis. However, it is not known how this dual function of Mdm2 on p53 synthesis and degradation is achieved. Here we show that the p53 mRNA region encoding the Mdm2-binding site interacts directly with the RING domain of Mdm2. This impairs the E3 ligase activity of Mdm2 and promotes p53 mRNA translation. We also show that introduction of cancer-derived single silent point-mutations in the p53 mRNA weakens its binding to Mdm2 and results in reduced p53 activity. These data are consistent with a mechanism by which changes in silent nucleotides can affect the function of the encoded protein, and indicate that Mdm2-mediated control of p53 synthesis and degradation has evolved in the p53 mRNA sequence and its encoded amino acids.	[Candeias, Marco M.; Malbert-Colas, Laurence; Powell, Darren J.; Daskalogianni, Chrysoula; Maslon, Magda M.; Naski, Nadia; Bourougaa, Karima; Calvo, Fabien; Fahraeus, Robin] Hop St Louis, Inst Genet Mol, INSERM, U716, F-75010 Paris, France; [Candeias, Marco M.; Malbert-Colas, Laurence; Powell, Darren J.; Daskalogianni, Chrysoula; Maslon, Magda M.; Naski, Nadia; Bourougaa, Karima; Calvo, Fabien; Fahraeus, Robin] Univ Paris, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fahraeus, R (corresponding author), Hop St Louis, Inst Genet Mol, INSERM, U716, 27 Rue Juliette Dodu, F-75010 Paris, France.	robinfahraeus@yahoo.co.uk	Maslon, Magdalena/AAC-4790-2022; Maslon, Magdalena/AAB-9609-2020; fahraeus, robin/K-8726-2014; Powell, Darren Jmaes/GOE-5236-2022	Powell, Darren Jmaes/0000-0001-9439-5880; Maslon, Magdalena/0000-0002-1050-1306; calvo, fabien/0000-0002-0298-7633; Candeias, Marco/0000-0002-5731-0179; daskalogianni, chrysoula/0000-0001-8177-3141; Bourougaa, Karima/0000-0003-0339-962X; , robin/0000-0003-0402-8492	AICR; AVENIR/INSERM; La Ligue Contre le Cancer; Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BD/16697/2004]	AICR; AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology)	This work was supported by AICR, AVENIR/INSERM and La Ligue Contre le Cancer. M.M.C. was supported by grant SFRH/BD/16697/2004 from the Fundacao para a Ciencia e a Tecnologia of Portugal. Bacterial purified hMdm2 was a gift from D. Xirodimas and we are thankful to Chris M. Brown and Nattanan Panjaworayan, Dunedin, New Zealand for providing the TriFC constructs. Anti-p53 and anti-Mdm2 antibodies were a gift from B. Vojtesek. Flow cytometry and immunofluorescence microscopy experiments were performed at the Imagery Department of the Institut Universitaire d'Hematologie-IFR105.	Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Cheng TH, 2007, MOL CELL BIOL, V27, P111, DOI 10.1128/MCB.00235-06; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Fahraeus R, 2005, NAT REV MOL CELL BIO, V6, P263, DOI 10.1038/nrm1590; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayes VM, 1999, DIAGN MOL PATHOL, V8, P2, DOI 10.1097/00019606-199903000-00002; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jaffray EG, 2006, METHODS, V38, P35, DOI 10.1016/j.ymeth.2005.07.020; Jin SK, 2001, J CELL SCI, V114, P4139; JUVEN T, 1993, ONCOGENE, V8, P3411; KANJILAL S, 1995, CANCER RES, V55, P3604; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Lima SMB, 2004, EUR J BIOCHEM, V271, P135, DOI 10.1046/j.1432-1033.2003.03911.x; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Perry ME, 2004, MOL CANCER RES, V2, P9; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	31	168	173	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1098	1105		10.1038/ncb1770	http://dx.doi.org/10.1038/ncb1770			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160491				2022-12-25	WOS:000258910400016
J	Chen, JR; Chang, BH; Allen, JE; Stiffler, MA; MacBeath, G				Chen, Jiunn R.; Chang, Bryan H.; Allen, John E.; Stiffler, Michael A.; MacBeath, Gavin			Predicting PDZ domain-peptide interactions from primary sequences	NATURE BIOTECHNOLOGY			English	Article							PROTEIN INTERACTIONS; WIDE PREDICTION; RECOGNITION; MOTIFS	PDZ domains constitute one of the largest families of interaction domains and function by binding the C termini of their target proteins(1,2). Using Bayesian estimation, we constructed a three-dimensional extension of a position-specific scoring matrix that predicts to which peptides a PDZ domain will bind, given the primary sequences of the PDZ domain and the peptides. The model, which was trained using interaction data from 82 PDZ domains and 93 peptides encoded in the mouse genome(3), successfully predicts interactions involving other mouse PDZ domains, as well as PDZ domains from Drosophila melanogaster and, to a lesser extent, PDZ domains from Caenorhabditis elegans. The model also predicts the differential effects of point mutations in peptide ligands on their PDZ domain-binding affinities. Overall, we show that our approach captures, in a single model, the binding selectivity of the PDZ domain family.	[Chang, Bryan H.; Allen, John E.; Stiffler, Michael A.; MacBeath, Gavin] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Chen, Jiunn R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	MacBeath, G (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	macbeath@chemistry.harvard.edu		MacBeath, Gavin/0000-0003-2585-6772; Allen, John/0000-0001-5005-5139	Arnold and Mabel Beckman Foundation; W.M. Keck Foundation; Camille and Henry Dreyfus Foundation; US National Institutes of Health [1 RO1 GM072872-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072872] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; W.M. Keck Foundation(W.M. Keck Foundation); Camille and Henry Dreyfus Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anna M. Lone for experimental contributions and Eugene I. Shakhnovich for helpful discussions. This work was supported by awards from the Arnold and Mabel Beckman Foundation, the W.M. Keck Foundation and the Camille and Henry Dreyfus Foundation, and by a grant from the US National Institutes of Health (1 RO1 GM072872-01).	Betel D, 2007, PLOS COMPUT BIOL, V3, P1783, DOI 10.1371/journal.pcbi.0030182; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Lu H, 2003, BIOPHYS J, V84, P1895, DOI 10.1016/S0006-3495(03)74997-2; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Russell S.J., 2016, ARTIF INTELL; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; SWETS JA, 1979, SCIENCE, V205, P753, DOI 10.1126/science.462188; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	17	114	141	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2008	26	9					1041	1045		10.1038/nbt.1489	http://dx.doi.org/10.1038/nbt.1489			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	346NG	18711339	Green Accepted			2022-12-25	WOS:000259074700028
J	Draper, SJ; Moore, AC; Goodman, AL; Long, CA; Holder, AA; Gilbert, SC; Hill, F; Hill, AVS				Draper, Simon J.; Moore, Anne C.; Goodman, Anna L.; Long, Carole A.; Holder, Anthony A.; Gilbert, Sarah C.; Hill, Fergal; Hill, Adrian V. S.			Effective induction of high-titer antibodies by viral vector vaccines	NATURE MEDICINE			English	Article							MEROZOITE SURFACE PROTEIN-1; C4B-BINDING PROTEIN; MALARIA VACCINE; PROTECTION; IMMUNITY; ANTIGEN; MICE; IMMUNOGENICITY; IMMUNIZATION; FRAGMENT	Protein-in-adjuvant vaccines have shown limited success against difficult diseases such as blood-stage malaria. Here we show that a recombinant adenovirus-poxvirus prime-boost immunization regime (known to induce strong T cell immunogenicity) can also induce very strong antigen-specific antibody responses, and we identify a simple complement-based adjuvant to further enhance immunogenicity. Antibodies induced against a blood-stage malaria antigen by this viral vector platform are highly effective against Plasmodium yoelii parasites in mice and against Plasmodium falciparum in vitro.	[Draper, Simon J.; Moore, Anne C.; Goodman, Anna L.; Gilbert, Sarah C.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England; [Long, Carole A.] NIAID, Lab Malaria & Vector Res, US NIH, Rockville, MD 20852 USA; [Holder, Anthony A.] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Hill, Fergal] Imaxio, F-69007 Lyon, France	University of Oxford; Jenner Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); MRC National Institute for Medical Research	Draper, SJ (corresponding author), Univ Oxford, Jenner Inst, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	simon.draper@ndm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019; Hill, Fergal/AAI-1329-2021; HILL, Adrian V>S>/C-1306-2008; Holder, Anthony A/A-7554-2013; Draper, Simon J/F-1758-2011	Gilbert, Sarah C./0000-0002-6823-9750; Holder, Anthony A/0000-0002-8490-6058; Draper, Simon J/0000-0002-9415-1357; Moore, Anne/0000-0003-3656-4230; Goodman, Anna/0000-0003-0643-9017	MRC [G0700735, MC_U117532067, G0600424] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001020] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI001020-02, Z01 AI001020-01] Funding Source: Medline; Medical Research Council [MC_U117532067, G0600424, G0700735] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ahlborg N, 2002, INFECT IMMUN, V70, P820, DOI 10.1128/IAI.70.2.820-825.2002; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; Bruna-Romera O, 2001, P NATL ACAD SCI USA, V98, P11491, DOI 10.1073/pnas.191380898; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Genton B, 2007, CURR OPIN INFECT DIS, V20, P467, DOI 10.1097/QCO.0b013e3282dd7a29; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; OGUN SA, 2008, INFECT IMMUN    0512; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Tian JH, 1996, J IMMUNOL, V157, P1176; Wipasa J, 2002, J IMMUNOL, V169, P944, DOI 10.4049/jimmunol.169.2.944	16	123	136	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2008	14	8					819	821		10.1038/nm.1850	http://dx.doi.org/10.1038/nm.1850			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18660818	Green Accepted, Bronze			2022-12-25	WOS:000258237500027
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Jonasson, JG; Sigurdsson, A; Bergthorsson, JT; He, HL; Blondal, T; Geller, F; Jakobsdottir, M; Magnusdottir, DN; Matthiasdottir, S; Stacey, SN; Skarphedinsson, OB; Helgadottir, H; Li, W; Nagy, R; Aguillo, E; Faure, E; Prats, E; Saez, B; Martinez, M; Eyjolfsson, GI; Bjornsdottir, US; Holm, H; Kristjansson, K; Frigge, ML; Kristvinsson, H; Gulcher, JR; Jonsson, T; Rafnar, T; Hjartarsson, H; Mayordomo, JI; de la Chapelle, A; Hrafnkelsson, J; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Jonasson, Jon G.; Sigurdsson, Asgeir; Bergthorsson, Jon T.; He, Huiling; Blondal, Thorarinn; Geller, Frank; Jakobsdottir, Margret; Magnusdottir, Droplaug N.; Matthiasdottir, Sigurborg; Stacey, Simon N.; Skarphedinsson, Oskar B.; Helgadottir, Hafdis; Li, Wei; Nagy, Rebecca; Aguillo, Esperanza; Faure, Eduardo; Prats, Enrique; Saez, Berta; Martinez, Mariano; Eyjolfsson, Gudmundur I.; Bjornsdottir, Unnur S.; Holm, Hilma; Kristjansson, Kristleifur; Frigge, Michael L.; Kristvinsson, Hoskuldur; Gulcher, Jeffrey R.; Jonsson, Thorvaldur; Rafnar, Thorunn; Hjartarsson, Hannes; Mayordomo, Jose I.; de la Chapelle, Albert; Hrafnkelsson, Jon; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; CLEFT-PALATE; CARCINOMA; RISK; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; NEOPLASIA; GENETICS; ICELAND	In order to search for sequence variants conferring risk of thyroid cancer we conducted a genome-wide association study in 192 and 37,196 Icelandic cases and controls, respectively, followed by a replication study in individuals of European descent. Here we show that two common variants, located on 9q22.33 and 14q13.3, are associated with the disease. Overall, the strongest association signals were observed for rs965513 on 9q22.33 ( OR = 1.75; P = 1.7 x 10(-27)) and rs944289 on 14q13.3 (OR = 1.37; P = 2.0 x 10(-9)). The gene nearest to the 9q22.33 locus is FOXE1 (TTF2) and NKX2-1 (TTF1) is among the genes located at the 14q13.3 locus. Both variants contribute to an increased risk of both papillary and follicular thyroid cancer. Approximately 3.7% of individuals are homozygous for both variants, and their estimated risk of thyroid cancer is 5.7-fold greater than that of noncarriers. In a study on a large sample set from the general population, both risk alleles are associated with low concentrations of thyroid stimulating hormone (TSH), and the 9q22.33 allele is associated with low concentration of thyroxin (T-4) and high concentration of triiodothyronine (T-3).	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Sigurdsson, Asgeir; Bergthorsson, Jon T.; Blondal, Thorarinn; Geller, Frank; Jakobsdottir, Margret; Magnusdottir, Droplaug N.; Matthiasdottir, Sigurborg; Stacey, Simon N.; Skarphedinsson, Oskar B.; Helgadottir, Hafdis; Holm, Hilma; Kristjansson, Kristleifur; Frigge, Michael L.; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.] Landspitali Univ Hosp Hringbraut, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.; Bjornsdottir, Unnur S.; Jonsson, Thorvaldur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.] Iceland Canc Registry, IS-105 Reykjavik, Iceland; [Bergthorsson, Jon T.; Li, Wei; Nagy, Rebecca; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Aguillo, Esperanza; Faure, Eduardo] Univ Hosp, Div Endocrinol, Zaragoza 50009, Spain; [Prats, Enrique] Univ Hosp, Div Nucl Med, Zaragoza 50009, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Hlth Sci Inst, Zaragoza 50009, Spain; [Martinez, Mariano] Univ Hosp, Div Surg, Zaragoza 50009, Spain; [Eyjolfsson, Gudmundur I.] Lab Mjodd, IS-109 Reykjavik, Iceland; [Holm, Hilma] Emory Univ, Sch Med, Dept Internal Med, Div Cardiol, Atlanta, GA 30322 USA; [Kristvinsson, Hoskuldur; Jonsson, Thorvaldur] Landspitali Univ Hosp Hringbraut, Dept Surg, IS-101 Reykjavik, Iceland; [Hjartarsson, Hannes] Landspitali Univ Hosp Fossvogi, H&N Surg Dept, ORL, IS-108 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; [Hrafnkelsson, Jon] Landspitali Univ Hosp Hringbraut, Dept Oncol, IS-101 Reykjavik, Iceland	University of Iceland; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Miguel Servet University Hospital; Miguel Servet University Hospital; Miguel Servet University Hospital; Emory University; Lozano Blesa University Clinical Hospital; University of Zaragoza	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	julius.gudmundsson@decode.is	Nagy, Rebecca Shrigley/E-4088-2011; Mayordomo, Jose/K-3453-2013; Stefansson, Kari/AAE-7187-2019; Pillay, Nischalan/F-9536-2012	Helgadottir, Hafdis/0000-0003-4352-152X; Bergthorsson, Jon Thor/0000-0002-0560-2639; Saez, Berta/0000-0003-0753-1165; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Geller, Frank/0000-0002-9238-3269; Jonasson, Jon G./0000-0002-2635-5032	US National Institutes of Health [CA16058, CA124570]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA124570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the study participants whose contribution made this work possible. This project was funded in part by the following contract numbers: US National Institutes of Health CA16058 and CA124570.	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dathan N, 2002, DEV DYNAM, V224, P450, DOI 10.1002/dvdy.10118; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; Delellis RA, 2006, J SURG ONCOL, V94, P662, DOI 10.1002/jso.20700; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Hrafnkelsson J, 2001, J MED GENET, V38, P189, DOI 10.1136/jmg.38.3.189; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Parlato R, 2004, DEV BIOL, V276, P464, DOI 10.1016/j.ydbio.2004.08.048; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sequeira MJ, 2001, THYROID, V11, P995, DOI 10.1089/105072501753271662; Zhang P, 2006, PATHOL INT, V56, P240, DOI 10.1111/j.1440-1827.2006.01959.x	27	299	314	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					460	464		10.1038/ng.339	http://dx.doi.org/10.1038/ng.339			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19198613	Green Accepted			2022-12-25	WOS:000264659000021
J	Henrichsen, CN; Vinckenbosch, N; Zollner, S; Chaignat, E; Pradervand, S; Schutz, F; Ruedi, M; Kaessmann, H; Reymond, A				Henrichsen, Charlotte N.; Vinckenbosch, Nicolas; Zoellner, Sebastian; Chaignat, Evelyne; Pradervand, Sylvain; Schuetz, Frederic; Ruedi, Manuel; Kaessmann, Henrik; Reymond, Alexandre			Segmental copy number variation shapes tissue transcriptomes	NATURE GENETICS			English	Article							INBRED MOUSE STRAINS; GENE-EXPRESSION; HUMAN GENOME; STRUCTURAL VARIATION; LABORATORY MOUSE; DISEASE; MAP; POLYMORPHISMS; ORGANIZATION; EVOLUTION	Copy number variation (CNV) is a key source of genetic diversity, but a comprehensive understanding of its phenotypic effect is only beginning to emerge. We have generated a CNV map in wild mice and classical inbred strains. Genome-wide expression data from six major organs show not only that expression of genes within CNVs tend to correlate with copy number changes, but also that CNVs influence the expression of genes in their vicinity, an effect that extends up to half a megabase. Genes within CNVs show lower expression and more specific spatial expression patterns than genes mapping elsewhere. Our analyses reveal differential constraint on copy number changes of genes expressed in different tissues. Dosage alterations of brain-expressed genes are less frequent than those of other genes and are buffered by tighter transcriptional regulation. Our study provides initial evidence that CNVs shape tissue transcriptomes on a global scale.	[Henrichsen, Charlotte N.; Vinckenbosch, Nicolas; Chaignat, Evelyne; Pradervand, Sylvain; Schuetz, Frederic; Kaessmann, Henrik; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Zoellner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Zoellner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Schuetz, Frederic] Swiss Inst Bioinformat, Lausanne, Switzerland; [Ruedi, Manuel] Nat Hist Museum, Dept Mammal & Ornithol, Geneva, Switzerland	University of Lausanne; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Swiss Institute of Bioinformatics	Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	henrik.kaessmann@unil.ch; alexandre.reymond@unil.ch	Hor, Charlotte/AAB-4850-2020; Hor, Charlotte/H-5908-2015; Kaessmann, Henrik/B-4989-2013; Kutalik, Zoltan/HHZ-5697-2022; Ruedi, Manuel/B-3320-2013	Hor, Charlotte/0000-0002-5361-2372; Hor, Charlotte/0000-0002-5361-2372; Kaessmann, Henrik/0000-0001-7563-839X; Kutalik, Zoltan/0000-0001-8285-7523; Ruedi, Manuel/0000-0003-3283-7764; Reymond, Alexandre/0000-0003-1030-8327; Schutz, Frederic/0000-0001-7048-7692	Jerome Lejeune Foundation; Desiree and Niels Yde Foundation; Novartis Foundation; Swiss National Science Foundation; European Commission anEUploidy Integrated Project [037627]; NIH [R01 GM073822]; European Commission [PKB140404]; EMBO Young Investigator Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073822] Funding Source: NIH RePORTER	Jerome Lejeune Foundation; Desiree and Niels Yde Foundation; Novartis Foundation(Novartis); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission anEUploidy Integrated Project(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Paillusson, O. Hagenbuchle and K. Harshman from the Lausanne DNA Array Facility for technical help; F. Bonhomme, P. Boursot, J. Gillieron, S. Maret, A. Orth and M. Tafti for reagents; and S. Deutsch and J. Goudet for suggestions. We are grateful to R. W. Williams for sharing expression data and to the Montpellier wild mice genetic repository and the Museum of Natural History of Geneva for mice and tissue samples. This work was supported by grants from the Jerome Lejeune Foundation, the Desiree and Niels Yde Foundation, the Novartis Foundation, the Swiss National Science Foundation and the European Commission anEUploidy Integrated Project (grant 037627) to A.R.; by grant NIH R01 GM073822 (PI J. Borevitz) to S. Z.; as well as grants from the European Commission (STREP, PKB140404), EMBO Young Investigator Program and Swiss National Science Foundation to H. K.	Adams DJ, 2005, NAT GENET, V37, P532, DOI 10.1038/ng1551; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Molina J, 2008, HUM MOL GENET, V17, P2486, DOI 10.1093/hmg/ddn148; Muncke N, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019141; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reymond A, 2007, CURR OPIN GENET DEV, V17, P381, DOI 10.1016/j.gde.2007.08.009; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	36	228	233	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					424	429		10.1038/ng.345	http://dx.doi.org/10.1038/ng.345			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19270705				2022-12-25	WOS:000264659000015
J	Manicassamy, S; Ravindran, R; Deng, JS; Oluoch, H; Denning, TL; Kasturi, SP; Rosenthal, KM; Evavold, BD; Pulendran, B				Manicassamy, Santhakumar; Ravindran, Rajesh; Deng, Jiusheng; Oluoch, Herold; Denning, Timothy L.; Kasturi, Sudhir Pai; Rosenthal, Kristen M.; Evavold, Brian D.; Pulendran, Bali			Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity	NATURE MEDICINE			English	Article							TRANS-RETINOIC ACID; ACTIVATED PROTEIN-KINASE; BETA-GLUCANS; TGF-BETA; C-FOS; DECTIN-1; DIFFERENTIATION; IMMUNITY; MACROPHAGES; GENERATION	Immune sensing of a microbe occurs via multiple receptors. How signals from different receptors are coordinated to yield a specific immune response is poorly understood. We show that two pathogen recognition receptors, Toll-like receptor 2 (TLR2) and dectin-1, recognizing the same microbial stimulus, stimulate distinct innate and adaptive responses. TLR2 signaling induced splenic dendritic cells (DCs) to express the retinoic acid metabolizing enzyme retinaldehyde dehydrogenase type 2 and interleukin-10 (IL-10) and to metabolize vitamin A and stimulate Foxp(3+) T regulatory cells (T-reg cells). Retinoic acid acted on DCs to induce suppressor of cytokine signaling-3 expression, which suppressed activation of p38 mitogen-activated protein kinase and proinflammatory cytokines. Consistent with this finding, TLR2 signaling induced Treg cells and suppressed IL-23 and T helper type 17 (T(H)17) and T(H)1-mediated autoimmune responses in vivo. In contrast, dectin-1 signaling mostly induced IL-23 and proinflammatory cytokines and augmented T(H)17 and T(H)1-mediated autoimmune responses in vivo. These data define a new mechanism for the systemic induction of retinoic acid and immune suppression against autoimmunity.	[Manicassamy, Santhakumar; Ravindran, Rajesh; Deng, Jiusheng; Oluoch, Herold; Denning, Timothy L.; Kasturi, Sudhir Pai; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Manicassamy, Santhakumar; Ravindran, Rajesh; Deng, Jiusheng; Oluoch, Herold; Denning, Timothy L.; Kasturi, Sudhir Pai; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Rosenthal, Kristen M.; Evavold, Brian D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Pulendran, B (corresponding author), Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu	Pulendran, Bali/AAW-9550-2021; Denning, Timothy/F-2271-2011	Pulendran, Bali/0000-0001-6517-4333; Evavold, Brian/0000-0002-3561-3494; Denning, Timothy/0000-0002-1072-7444	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R21AI056947, U54AI057157, R01AI056499, R01AI048638, R56AI048638, N01AI050025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000165-485850, P51 RR000165-477484, P51 RR000165-440250, P51 RR000165-440176, P51 RR000165-477423, P51 RR000165, P51 RR000165-436421, P51 RR000165-450176, P51 RR000165-450178, P51 RR000165-436422, P51 RR000165-440177, P51 RR000165-485851, P51 RR000165-436423, P51 RR000165-477422, P51 RR000165-450177, P51 RR000165-440178, P51 RR000165-460177, P51 RR000165-460295, P51 RR000165-457321, P51 RR000165-485900, P51 RR000165-460178, P51 RR000165-477421, P51 RR000165-460176] Funding Source: Medline; NIAID NIH HHS [R21 AI056947-01A1, R01 AI048638-06, U54 AI057157-06S10017, R01 AI056499-04, U19 AI057266-010002, U19 AI057266-05S10002, R01 AI048638-09A1, R01 AI048638-01, U19 AI057266, N01 AI050025, U54 AI057157, R01 AI048638-08, R56 AI048638, R01 AI056499-01, R21 AI056947, N01 AI050019, R01 AI048638-04, R01 AI056499-03, R01 AI048638-07, R01 AI048638, R56 AI048638-09, R01 AI048638-02, R01 AI056499, R01 AI048638-05A1, R01 AI048638-03, R01 AI056499-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK057665-03, R01 DK057665-09, R01 DK057665-10, R01 DK057665-04, R01 DK057665, R01 DK057665-02, R01 DK057665-08, R01 DK057665-07, R01 DK057665-05, R01 DK057665-01, R01 DK057665-06] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; DEIHE H, 1990, NATURE, V343, P177; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; DUESTER G, 1991, MOL CELL BIOL, V11, P1638, DOI 10.1128/MCB.11.3.1638; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geissmann F, 2003, J EXP MED, V198, P623, DOI 10.1084/jem.20030390; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saurer L, 2007, J IMMUNOL, V179, P3504, DOI 10.4049/jimmunol.179.6.3504; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tao YH, 2006, FEMS IMMUNOL MED MIC, V47, P444, DOI 10.1111/j.1574-695X.2006.00108.x; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zapata-Gonzalez F, 2007, J IMMUNOL, V178, P6130, DOI 10.4049/jimmunol.178.10.6130; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	51	240	249	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					401	409		10.1038/nm.1925	http://dx.doi.org/10.1038/nm.1925			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19252500	Green Accepted			2022-12-25	WOS:000264937200027
J	Malinin, NL; Zhang, L; Choi, J; Ciocea, A; Razorenova, O; Ma, YQ; Podrez, EA; Tosi, M; Lennon, DP; Caplan, AI; Shurin, SB; Plow, EF; Byzova, TV				Malinin, Nikolay L.; Zhang, Li; Choi, Jeongsuk; Ciocea, Alieta; Razorenova, Olga; Ma, Yan-Qing; Podrez, Eugene A.; Tosi, Michael; Lennon, Donald P.; Caplan, Arnold I.; Shurin, Susan B.; Plow, Edward F.; Byzova, Tatiana V.			A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans	NATURE MEDICINE			English	Article							CELL-MATRIX ADHESION; LAD-III; PLATELET-AGGREGATION; LOCALIZATION; GLYCOPROTEIN; DEFICIENCY; COMPONENT; MEMBRANE; UNC-112; GENE	Monogenic deficiency diseases provide unique opportunities to define the contributions of individual molecules to human physiology and to identify pathologies arising from their dysfunction. Here we describe a deficiency disease in two human siblings that presented with severe bleeding, frequent infections and osteopetrosis at an early age. These symptoms are consistent with but more severe than those reported for people with leukocyte adhesion deficiency III (LAD-III). Mechanistically, these symptoms arose from an inability to activate the integrins expressed on hematopoietic cells, including platelets and leukocytes. Immortalized lymphocyte cell lines isolated from the two individuals showed integrin activation defects. Several proteins previously implicated in integrin activation, including Ras-associated protein-1 (RAP1)(1) and calcium and diacylglycerol-regulated guanine nucleotide exchange factor-1 (CALDAG-GEF1)(2), were present and functional in these cell lines. The genetic basis for this disease was traced to a point mutation in the coding region of the KINDLIN3 (official gene symbol FERMT3) gene(3). When wild-type KINDLIN-3 was expressed in the immortalized lymphocytes, their integrins became responsive to activation signals. These results identify a genetic disease that severely compromises the health of the affected individuals and establish an essential role of KINDLIN-3 in integrin activation in humans. Furthermore, allogeneic bone marrow transplantation was shown to alleviate the symptoms of the disease.	[Malinin, Nikolay L.; Choi, Jeongsuk; Ciocea, Alieta; Razorenova, Olga; Ma, Yan-Qing; Podrez, Eugene A.; Plow, Edward F.; Byzova, Tatiana V.] Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [Zhang, Li] Univ Maryland, Ctr Vasc & Inflammatory Dis, Dept Physiol, Sch Med, Baltimore, MD 21201 USA; [Tosi, Michael] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Lennon, Donald P.; Caplan, Arnold I.] Case Western Reserve Univ, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA; [Shurin, Susan B.] NHLBI, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Byzova, TV (corresponding author), Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	byzovat@ccf.org	Malinin, Nikolay/Z-5308-2019; Razorenova, Olga V/A-6400-2014; Malinin, Nikolay/J-4271-2012	Malinin, Nikolay/0000-0002-2654-1783; Byzova, Tatiana/0000-0002-2615-875X; Caplan, Arnold/0000-0002-8677-6621	US National Institutes of Health [HL073311, HL071625]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077213, P01HL054710, R01HL061589, P01HL073311, R01HL071625] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Roswell Park Cancer Institute Proteomics Resources, Lerner Research Institute Proteomics and Imaging Cores (J. Drazba) and Stranad Fellows I. Byzov and R. Swaninger for help with the project, A. Graybiel (Massachusetts Institute of Technology) for providing antibodies to CALDAG-GEF1 and L. Parise (University of North Carolina) for providing the GST-RALGDS fusion cDNA construct. This study was supported by HL073311 and HL071625 US National Institutes of Health grants.	Alon R, 2003, TRENDS IMMUNOL, V24, P561, DOI 10.1016/j.it.2003.08.001; Alon R, 2003, BLOOD, V101, P4437, DOI 10.1182/blood-2002-11-3427; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kuijpers TW, 2007, BLOOD, V109, P3529, DOI 10.1182/blood-2006-05-021402; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; MOYLE M, 1994, J BIOL CHEM, V269, P10008; NEWMAN PJ, 1991, P NATL ACAD SCI USA, V88, P3160, DOI 10.1073/pnas.88.8.3160; Quinn MJ, 2003, ARTERIOSCL THROM VAS, V23, P945, DOI 10.1161/01.ATV.0000066686.46338.F1; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030	27	247	253	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					313	318		10.1038/nm.1917	http://dx.doi.org/10.1038/nm.1917			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19234460	Green Accepted			2022-12-25	WOS:000263914000032
J	Stanton, BZ; Peng, LF; Maloof, N; Nakai, K; Wang, X; Duffner, JL; Taveras, KM; Hyman, JM; Lee, SW; Koehler, AN; Chen, JK; Fox, JL; Mandinova, A; Schreiber, SL				Stanton, Benjamin Z.; Peng, Lee F.; Maloof, Nicole; Nakai, Kazuo; Wang, Xiang; Duffner, Jay L.; Taveras, Kennedy M.; Hyman, Joel M.; Lee, Sam W.; Koehler, Angela N.; Chen, James K.; Fox, Julia L.; Mandinova, Anna; Schreiber, Stuart L.			A small molecule that binds Hedgehog and blocks its signaling in human cells	NATURE CHEMICAL BIOLOGY			English	Article							PATHWAY; CYCLOPAMINE; MICROARRAYS; ACTIVATION; MUTATIONS; CANCER; MICE	Small-molecule inhibition of extracellular proteins that activate membrane receptors has proven to be extremely challenging. Diversity-oriented synthesis and small-molecule microarrays enabled the discovery of robotnikinin, a small molecule that binds the extracellular Sonic hedgehog (Shh) protein and blocks Shh signaling in cell lines, human primary keratinocytes and a synthetic model of human skin. Shh pathway activity is rescued by small-molecule agonists of Smoothened, which functions immediately downstream of the Shh receptor Patched.	[Stanton, Benjamin Z.; Peng, Lee F.; Maloof, Nicole; Wang, Xiang; Duffner, Jay L.; Taveras, Kennedy M.; Koehler, Angela N.; Schreiber, Stuart L.] Harvard Univ, Howard Hughes Med Inst, Broad Inst, Cambridge, MA 02142 USA; [Stanton, Benjamin Z.; Peng, Lee F.; Maloof, Nicole; Wang, Xiang; Duffner, Jay L.; Taveras, Kennedy M.; Koehler, Angela N.; Schreiber, Stuart L.] MIT, Cambridge, MA 02142 USA; [Stanton, Benjamin Z.; Peng, Lee F.; Nakai, Kazuo; Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Peng, Lee F.] Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Hyman, Joel M.; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, CCSR, Stanford, CA 94305 USA; [Lee, Sam W.; Mandinova, Anna] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Fox, Julia L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University	Peng, LF (corresponding author), Harvard Univ, Howard Hughes Med Inst, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	lpeng@partners.org; stuart_schreiber@harvard.edu	Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436; Stanton, Benjamin/0000-0002-2613-2955	NATIONAL CANCER INSTITUTE [P01CA080058, R01CA195534, R01CA149477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038627, R37GM038627] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA149477, N01 CO012400, N01CO12400, P01 CA080058, N01-CO-12400, R01 CA195534] Funding Source: Medline; NIGMS NIH HHS [R37 GM038627, R01 GM038627, GM-38627, R01 GM038627-17] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bradner JE, 2006, CHEM BIOL, V13, P493, DOI 10.1016/j.chembiol.2006.03.004; Burke MD, 2003, SCIENCE, V302, P613, DOI 10.1126/science.1089946; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tan DS, 2002, NAT BIOTECHNOL, V20, P561, DOI 10.1038/nbt0602-561; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Von Hoff DD, 2008, P 99 ANN M AM ASS CA; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Wong JC, 2004, CHEM BIOL, V11, P1279, DOI 10.1016/j.chembiol.2004.07.012; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040	24	239	250	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2009	5	3					154	156		10.1038/nchembio.142	http://dx.doi.org/10.1038/nchembio.142			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410DG	19151731	Green Accepted			2022-12-25	WOS:000263556100012
J	Barroca, V; Lassalle, B; Coureuil, M; Louis, JP; Le Page, F; Testart, J; Allemand, I; Riou, L; Fouchet, P				Barroca, Vilma; Lassalle, Bruno; Coureuil, Mathieu; Louis, Jean Paul; Le Page, Florence; Testart, Jacques; Allemand, Isabelle; Riou, Lydia; Fouchet, Pierre			Mouse differentiating spermatogonia can generate germinal stem cells in vivo	NATURE CELL BIOLOGY			English	Article							UNDIFFERENTIATED SPERMATOGONIA; GENETIC-ANALYSIS; SELF-RENEWAL; KIT-LIGAND; C-KIT; SPERMATOGENESIS; TESTIS; NICHE; PROLIFERATION; PLURIPOTENCY	In adults, stem cells are responsible for the maintenance of many actively renewing tissues, such as haematopoietic, skin, gut and germinal tissues. These stem cells can self-renew or be committed to becoming progenitors. Stem-cell commitment is thought to be irreversible but in male and female Drosophila melanogaster, it was shown recently that differentiating germ cells can revert to functional stem cells that can restore germinal lineage(1,2). Whether progenitors are also able to generate stem cells in mammals remains unknown. Here we show that purified mouse spermatogonial progenitors committed to differentiation can generate functional germinal stem cells that can repopulate germ-cell-depleted testes when transplanted into adult mice. We found that GDNF, a key regulator of the stem-cell niche, and FGF2 are able to reprogram in vitro spermatogonial progenitors for reverse differentiation. This study supports the emerging concept that the stem-cell identity is not restricted in adults to a definite pool of cells that self-renew, but that stemness could be acquired by differentiating progenitors after tissue injury and throughout life.	[Barroca, Vilma; Lassalle, Bruno; Coureuil, Mathieu; Le Page, Florence; Testart, Jacques; Allemand, Isabelle; Riou, Lydia; Fouchet, Pierre] CEA, Direct Sci Vivant, Inst Radiobiol Cellulaire & Mol,U566, Lab Gametogenese Apoptose & Genotoxicite,INSERM, F-92265 Fontenay Aux Roses, France; [Louis, Jean Paul] CNRS, UMR 6218, F-45071 Orleans, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Fouchet, P (corresponding author), CEA, Direct Sci Vivant, Inst Radiobiol Cellulaire & Mol,U566, Lab Gametogenese Apoptose & Genotoxicite,INSERM, F-92265 Fontenay Aux Roses, France.	pierre.fouchet@cea.fr	Coureuil, Mathieu/D-4793-2017	Coureuil, Mathieu/0000-0001-7655-9685; RIOU, Lydia/0000-0002-3878-7844; Fouchet, Pierre/0000-0003-0891-079X; allemand, isabelle/0000-0002-8861-7632	Electricite De France	Electricite De France	We thank P.H. Romeo for critical review of the manuscript and helpful comments. We thank M. Okabe for the generous gift of the EGFP transgenic mice; S. Leblay and V. Neuville for their technical assistance in the animal facilities, and T. Andrieu for assistance with Aria, LSR and LSRII. This work was supported in part by a grant from Electricite De France.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; AOI T, 2008, SCIENCE, V26, P101; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Bedell MA, 2004, J ANDROL, V25, P188; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Ohta H, 2000, DEVELOPMENT, V127, P2125; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Yeh JR, 2007, BIOL REPROD, V77, P897, DOI 10.1095/biolreprod.107.063057; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Zhang XF, 2003, BIOL REPROD, V69, P1872, DOI 10.1095/biolreprod.103.019273	33	128	135	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					190	U173		10.1038/ncb1826	http://dx.doi.org/10.1038/ncb1826			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098901				2022-12-25	WOS:000263285500017
J	Carrasquillo, MM; Zou, FG; Pankratz, VS; Wilcox, SL; Ma, L; Walker, LP; Younkin, SG; Younkin, CS; Younkin, LH; Bisceglio, GD; Ertekin-Taner, N; Crook, JE; Dickson, DW; Petersen, RC; Graff-Radford, NR; Younkin, SG				Carrasquillo, Minerva M.; Zou, Fanggeng; Pankratz, V. Shane; Wilcox, Samantha L.; Ma, Li; Walker, Louise P.; Younkin, Samuel G.; Younkin, Curtis S.; Younkin, Linda H.; Bisceglio, Gina D.; Ertekin-Taner, Nilufer; Crook, Julia E.; Dickson, Dennis W.; Petersen, Ronald C.; Graff-Radford, Neill R.; Younkin, Steven G.			Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease	NATURE GENETICS			English	Article							EXPRESSION; POPULATION; CANDIDATE; ALLELE; BRAIN	By analyzing late-onset Alzheimer's disease (LOAD) in a genome-wide association study (313,504 SNPs, three series, 844 cases and 1,255 controls) and evaluating the 25 SNPs with the most significant allelic association in four additional series (1,547 cases and 1,209 controls), we identified a SNP (rs5984894) on Xq21.3 in PCDH11X that is strongly associated with LOAD in individuals of European descent from the United States. Analysis of rs5984894 by multivariable logistic regression adjusted for sex gave global P values of 5.7 x 10(-5) in stage 1, 4.8 x 10(-6) in stage 2 and 3.9 x 10(-12) in the combined data. Odds ratios were 1.75 (95% CI 1.42-2.16) for female homozygotes (P = 2.0 x 10(-7)) and 1.26 (95% CI = 1.05-1.51) for female heterozygotes (P = 0.01) compared to female non-carriers. For male hemizygotes (P = 0.07) compared to male noncarriers, the odds ratio was 1.18 (95% CI = 0.99-1.41).	[Carrasquillo, Minerva M.; Zou, Fanggeng; Wilcox, Samantha L.; Ma, Li; Walker, Louise P.; Younkin, Samuel G.; Younkin, Curtis S.; Younkin, Linda H.; Bisceglio, Gina D.; Ertekin-Taner, Nilufer; Dickson, Dennis W.; Graff-Radford, Neill R.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Pankratz, V. Shane] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Ertekin-Taner, Nilufer; Petersen, Ronald C.; Graff-Radford, Neill R.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Crook, Julia E.] Mayo Clin, Coll Med, Biostat Unit, Rochester, MN 55905 USA; [Petersen, Ronald C.] Mayo Clin, Coll Med, Mayo Alzheimer Dis Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Younkin, SG (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	younkin.steven@mayo.edu		Younkin, Samuel/0000-0001-9424-656X; Dickson, Dennis W/0000-0001-7189-7917	US National Institutes of Health, NIA [R01 AG18023]; Mayo Alzheimer's Disease Research Center [P50 AG16574]; Mayo Alzheimer's Disease Patient Registry [U01 AG06576]; US National Institute on Aging [AG25711, AG17216, AG03949]; National Cell Repository for Alzheimer's Disease (NCRAD); National Institute on Aging (NIA); Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research;  [U24 AG21886]; NATIONAL INSTITUTE ON AGING [P50AG016574, F32AG020903, P50AG025711, R01AG018023, P01AG003949, P01AG017216, U01AG006786, U24AG021886] Funding Source: NIH RePORTER	US National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Alzheimer's Disease Research Center; Mayo Alzheimer's Disease Patient Registry; US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cell Repository for Alzheimer's Disease (NCRAD); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this research was provided by grants from the US National Institutes of Health, NIA R01 AG18023 (N.R.G.-R., Steven G. Younkin); Mayo Alzheimer's Disease Research Center, P50 AG16574 (R.C.P., D.W.D., N.R.G.-R., Steven G. Younkin); Mayo Alzheimer's Disease Patient Registry, U01 AG06576 (R. C. P.); and US National Institute on Aging, AG25711, AG17216, AG03949 (D. W. D.). Samples from the National Cell Repository for Alzheimer's Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by the National Institute on Aging (NIA), were used in this study. We thank contributors, including the Alzheimer's disease centers who collected samples used in this study, as well as subjects and their families, whose help and participation made this work possible. This project was also generously supported by the Robert and Clarice Smith Postdoctoral Fellowship (M. M. C.); Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (R. C. P., D. W. D., N.R.G.-R.; Steven G. Younkin) and by the Palumbo Professorship in Alzheimer's Disease Research (Steven G. Younkin).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanco P, 2000, MAMM GENOME, V11, P906, DOI 10.1007/s003350010177; Blanco-Arias P, 2004, MAMM GENOME, V15, P41, DOI 10.1007/s00335-003-3028-7; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Durand CM, 2006, AM J MED GENET B, V141B, P67, DOI 10.1002/ajmg.b.30229; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Lopes AM, 2006, HUM GENET, V119, P267, DOI 10.1007/s00439-006-0134-0; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Williams NA, 2006, AM J MED GENET B, V141B, P623, DOI 10.1002/ajmg.b.30357	15	225	237	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2009	41	2					192	198		10.1038/ng.305	http://dx.doi.org/10.1038/ng.305			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19136949	Green Accepted, Green Submitted			2022-12-25	WOS:000263091300019
J	Keinan, A; Mullikin, JC; Patterson, N; Reich, D				Keinan, Alon; Mullikin, James C.; Patterson, Nick; Reich, David			Accelerated genetic drift on chromosome X during the human dispersal out of Africa	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; Y-CHROMOSOME; PATTERNS; DIVERSITY; SELECTION; DNA; VARIABILITY; POPULATIONS; MITOCHONDRIAL; EVOLUTION	Comparisons of chromosome X and the autosomes can illuminate differences in the histories of males and females as well as shed light on the forces of natural selection. We compared the patterns of variation in these parts of the genome using two datasets that we assembled for this study that are both genomic in scale. Three independent analyses show that around the time of the dispersal of modern humans out of Africa, chromosome X experienced much more genetic drift than is expected from the pattern on the autosomes. This is not predicted by known episodes of demographic history, and we found no similar patterns associated with the dispersals into East Asia and Europe. We conclude that a sex-biased process that reduced the female effective population size, or an episode of natural selection unusually affecting chromosome X, was associated with the founding of non-African populations.	[Keinan, Alon; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Keinan, Alon; Patterson, Nick; Reich, David] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA 02142 USA; [Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Keinan, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	akeinan@genetics.med.harvard.edu; reich@genetics.med.harvard.edu		Keinan, Alon/0000-0002-9760-1122	US National Human Genome Research Institutes (NHGRI); US National Institutes of Health (NIH); Wellcome Career Development Award in the Biomedical Sciences; NIH [U01 HG004168]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, U01HG004168] Funding Source: NIH RePORTER	US National Human Genome Research Institutes (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Career Development Award in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Aquadro, O. Bar-Yosef, M. Bernstein, B. Charlesworth, A. Helgason, E. Lander, D. Lieberman, K. Lohmueller, S. Myers, S. Paabo, A. Price, S. Schaffner and C. Stringer for comments, and J. Neubauer and A. Waliszewska for genotyping SNPs discovered in two West African X chromosomes. The orangutan sequence reads were generated by the Washington University genome sequencing center (ftp.ncbi.nih.gov/pub/TraceDB/pongo_pygmaeus_abelii); we thank R. Wilson for permission to use these data. J. C. M. was supported by the Intramural Research Program of the US National Human Genome Research Institutes (NHGRI), N. P. by a K-01 career transition award from the US National Institutes of Health (NIH) and D. R. by a Burroughs Wellcome Career Development Award in the Biomedical Sciences. A. K., N. P. and D. R. were also supported by NIH grant U01 HG004168.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Betancourt AJ, 2004, GENETICS, V168, P2261, DOI 10.1534/genetics.104.030999; CABALLERO A, 1995, GENETICS, V139, P1007; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Storz JF, 2004, MOL BIOL EVOL, V21, P1800, DOI 10.1093/molbev/msh192; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wall JD, 2002, GENETICS, V162, P203	30	97	98	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2009	41	1					66	70		10.1038/ng.303	http://dx.doi.org/10.1038/ng.303			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19098910	Green Accepted			2022-12-25	WOS:000262085300017
J	Manent, JB; Wang, Y; Chang, Y; Paramasivam, M; LoTurco, JJ				Manent, Jean-Bernard; Wang, Yu; Chang, YoonJeung; Paramasivam, Murugan; LoTurco, Joseph J.			Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder	NATURE MEDICINE			English	Article							DOUBLE CORTEX SYNDROME; CORTICAL DEVELOPMENT; GENETIC MALFORMATIONS; LAMINAR HETEROTOPIA; CEREBRAL-CORTEX; RAT NEOCORTEX; EPILEPSY; DOUBLECORTIN; METHYLAZOXYMETHANOL; SUSCEPTIBILITY	Disorders of neuronal migration can lead to malformations of the cerebral neocortex that greatly increase the risk of seizures. It remains untested whether malformations caused by disorders in neuronal migration can be reduced by reactivating cellular migration and whether such repair can decrease seizure risk. Here we show, in a rat model of subcortical band heterotopia (SBH) generated by in utero RNA interference of the Dcx gene, that aberrantly positioned neurons can be stimulated to migrate by reexpressing Dcx after birth. Restarting migration in this way both reduces neocortical malformations and restores neuronal patterning. We further find that the capacity to reduce SBH continues into early postnatal development. Moreover, intervention after birth reduces the convulsant-induced seizure threshold to a level similar to that in malformation-free controls. These results suggest that disorders of neuronal migration may be eventually treatable by reengaging developmental programs both to reduce the size of cortical malformations and to reduce seizure risk.	[Manent, Jean-Bernard; Wang, Yu; Chang, YoonJeung; Paramasivam, Murugan; LoTurco, Joseph J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut	LoTurco, JJ (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, 75 N Eagleville Rd,U-3156, Storrs, CT 06269 USA.	joseph.loturco@uconn.edu	Manent, Jean-Bernard/A-2162-2015	Manent, Jean-Bernard/0000-0002-2436-8593; Chang, YoonJeung/0000-0001-9549-8208	US National Institutes of Health [MH056524, NS062416]; Jerome Lejeune foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056524, R29MH056524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062416] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jerome Lejeune foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CALNL-eGFP and CAG-ERT2CreERT2 were gifts from T. Matsuda and C. Cepko, Harvard Medical School. ImageJ software was from W. Rasband, US National Institutes of Health. NeuronJ 1.2 was from E. Meijering ( Erasmus University Medical Center Rotterdam). This work was supported by the US National Institutes of Health ( MH056524 and NS062416 to J. J. L.) and the Jerome Lejeune foundation ( research fellowship to J.-B.M.).	Andres M, 2005, CEREB CORTEX, V15, P194, DOI 10.1093/cercor/bhh122; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Baraban SC, 1996, EPILEPSY RES, V23, P189, DOI 10.1016/0920-1211(95)00094-1; Baraban SC, 1997, DEV BRAIN RES, V102, P189, DOI 10.1016/S0165-3806(97)00096-5; Baraban Scott C., 2001, Epilepsy Curr, V1, P6, DOI 10.1046/j.1535-7597.2001.00011.x; BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409; BARKOVICH AJ, 1989, RADIOLOGY, V171, P455, DOI 10.1148/radiology.171.2.2468173; Bernasconi A, 2001, EPILEPSIA, V42, P1124, DOI 10.1046/j.1528-1157.2001.39900.x; Cepeda C, 2005, DEV NEUROSCI-BASEL, V27, P59, DOI 10.1159/000084533; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chevassus-au-Louis N, 1999, EPILEPSIA, V40, P811, DOI 10.1111/j.1528-1157.1999.tb00786.x; Chevassus-Au-Louis N, 1998, J COMP NEUROL, V394, P520, DOI 10.1002/(SICI)1096-9861(19980518)394:4<520::AID-CNE9>3.0.CO;2-3; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Corbo JC, 2002, J NEUROSCI, V22, P7548; Crino PB, 2004, ADV EXP MED BIOL, V548, P175; D'Agostino MD, 2002, BRAIN, V125, P2507, DOI 10.1093/brain/awf248; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Guerrini R, 1999, Neurologia, V14 Suppl 3, P32; Guerrini R, 2001, AM J MED GENET, V106, P160, DOI 10.1002/ajmg.1569; Hablitz JJ, 1998, EPILEPSY RES, V32, P75, DOI 10.1016/S0920-1211(98)00041-2; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Jacobs KM, 1996, CEREB CORTEX, V6, P514, DOI 10.1093/cercor/6.3.514; Kalman M, 2001, INT J DEV NEUROSCI, V19, P101, DOI 10.1016/S0736-5748(00)00058-7; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Kuzniecky RI, 2001, BRAIN DEV-JPN, V23, P2, DOI 10.1016/S0387-7604(00)00195-9; Lee KS, 1997, J NEUROSCI, V17, P6236; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Luhmann HJ, 1996, EPILEPSY RES, V26, P67, DOI 10.1016/S0920-1211(96)00041-1; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548; Nosten-Bertrand M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002473; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PINARD JM, 1994, J NEUROL NEUROSUR PS, V57, P914, DOI 10.1136/jnnp.57.8.914; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; ROPER SN, 1995, EPILEPSY RES, V21, P205, DOI 10.1016/0920-1211(95)00027-8; Schwartzkroin PA, 2000, MENT RETARD DEV D R, V6, P268, DOI 10.1002/1098-2779(2000)6:4<268::AID-MRDD6>3.0.CO;2-B; Sheen Volney L, 2003, Curr Neurol Neurosci Rep, V3, P433, DOI 10.1007/s11910-003-0027-8; Sisodiya SM, 2004, LANCET NEUROL, V3, P29, DOI 10.1016/S1474-4422(03)00620-3; Sisodiya SM, 2000, BRAIN, V123, P1075, DOI 10.1093/brain/123.6.1075; STICHEL CC, 1991, J NEUROCYTOL, V20, P97, DOI 10.1007/BF01279614	46	111	113	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2009	15	1					84	90		10.1038/nm.1897	http://dx.doi.org/10.1038/nm.1897			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	394DF	19098909	Green Accepted			2022-12-25	WOS:000262425100022
J	Verweij, W; Spelt, C; Di Sansebastiano, GP; Vermeer, J; Reale, L; Ferranti, F; Koes, R; Quattrocchio, F				Verweij, Walter; Spelt, Cornelis; Di Sansebastiano, Gian-Pietro; Vermeer, Joop; Reale, Lara; Ferranti, Francesco; Koes, Ronald; Quattrocchio, Francesca			An H+ P-ATPase on the tonoplast determines vacuolar pH and flower colour	NATURE CELL BIOLOGY			English	Article							GFP-FUSION PROTEINS; PLASMA-MEMBRANE; SEED COAT; ARABIDOPSIS; PETUNIA; ACIDIFICATION; TRANSCRIPTION; ANTHOCYANIN1; EVOLUTION; PATHWAY	The regulation of pH in cellular compartments is crucial for intracellular trafficking of vesicles and proteins and the transport of small molecules, including hormones. In endomembrane compartments, pH is regulated by vacuolar H+-ATPase(1) (V-ATPase), which, in plants, act together with H+-pyrophosphatases(2) (PPase), whereas distinct P-type H+-ATPases in the cell membrane control the pH in the cytoplasm and energize the plasma membrane(3). Flower colour mutants have proved useful in identifying genes controlling the pH of vacuoles where anthocyanin pigments accumulate(4,5). Here we show that PH5 of petunia encodes a P-3A-ATPase proton pump that, unlike other P-type H+-ATPases, resides in the vacuolar membrane. Mutation of PH5 reduces vacuolar acidification in petals, resulting in a blue flower colour and abolishes the accumulation of proanthocyanindins (condensed tannins) in seeds. Expression of PH5 is directly activated by transcription regulators of the anthocyanin pathway, in conjunction with PH3 and PH4. Thus, flower coloration, a key-factor in plant reproduction, involves the coordinated activation of pigment synthesis and a specific pathway for vacuolar acidification.	[Verweij, Walter; Spelt, Cornelis; Koes, Ronald; Quattrocchio, Francesca] Vrije Univ Amsterdam, Inst Mol Cell Biol, Grad Sch Expt Plant Sci, NL-1081 HV Amsterdam, Netherlands; [Di Sansebastiano, Gian-Pietro] Univ Lecce, Lab Bot DiSTeBA, I-73100 Lecce, Italy; [Vermeer, Joop] Univ Amsterdam, Ctr Adv Microscopy, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; [Reale, Lara; Ferranti, Francesco] Univ Perugia, Dept Appl Biol, I-06121 Perugia, Italy	Vrije Universiteit Amsterdam; University of Salento; University of Amsterdam; University of Perugia	Quattrocchio, F (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Grad Sch Expt Plant Sci, Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	francesca.quattrocchio@falw.vu.nl	Koes, Ronald/AAB-1716-2021; Vermeer, Joop E.M./J-2232-2014; Di Sansebastiano, Gian Pietro/I-7193-2012; Quattrocchio, Francesca M./N-6658-2019	Koes, Ronald/0000-0003-3793-5072; Vermeer, Joop E.M./0000-0001-8876-5873; Di Sansebastiano, Gian Pietro/0000-0001-5388-0695; Quattrocchio, Francesca M./0000-0001-8040-4061; REALE, Lara/0000-0001-7570-3972; FERRANTI, Francesco/0000-0002-2548-3868	The Netherlands Organization of Scientific Research (NWO-ALW)	The Netherlands Organization of Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	We are grateful to. Inhwan Hwang (Pohang, Korea) and Katrin Czempinski (Golm, Germany) for AHA2-GFP and KCO1-GFP constructs, and to Dorus Gadella (University of Amsterdam, The Netherlands) for the use of confocal microscopy facilities. We thank Pieter Hoogeveen, Martina Meesters and Daisy Kloos for plant care. This work was supported by a grant from The Netherlands Organization of Scientific Research (NWO-ALW).	Ando T, 2005, ANN BOT-LONDON, V96, P887, DOI 10.1093/aob/mci241; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Baxter IR, 2005, P NATL ACAD SCI USA, V102, P2649, DOI 10.1073/pnas.0406377102; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Fluckiger R, 2003, J EXP BOT, V54, P1577, DOI 10.1093/jxb/erg160; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Gaxiola RA, 2002, PLANT PHYSIOL, V129, P967, DOI 10.1104/pp.020009; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim DH, 2001, PLANT CELL, V13, P287, DOI 10.1105/tpc.13.2.287; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Lefebvre B, 2005, PLANT MOL BIOL, V58, P775, DOI 10.1007/s11103-005-7875-3; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Tobena-Santamaria R, 2002, GENE DEV, V16, P753, DOI 10.1101/gad.219502; Vermeer JEM, 2004, J MICROSC-OXFORD, V214, P190, DOI 10.1111/j.0022-2720.2004.01318.x; Yoshida K, 2003, PLANT CELL PHYSIOL, V44, P262, DOI 10.1093/pcp/pcg033	30	141	156	10	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1456	1462		10.1038/ncb1805	http://dx.doi.org/10.1038/ncb1805			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18997787				2022-12-25	WOS:000261261800017
J	Gyrd-Hansen, M; Darding, M; Miasari, M; Santoro, MM; Zender, L; Xue, W; Tenev, T; da Fonseca, PCA; Zvelebil, M; Bujnicki, JM; Lowe, S; Silke, J; Meier, P				Gyrd-Hansen, Mads; Darding, Maurice; Miasari, Maria; Santoro, Massimo M.; Zender, Lars; Xue, Wen; Tenev, Tencho; da Fonseca, Paula C. A.; Zvelebil, Marketa; Bujnicki, Janusz M.; Lowe, Scott; Silke, John; Meier, Pascal			IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappa B as well as cell survival and oncogenesis	NATURE CELL BIOLOGY			English	Article							ALPHA-DEPENDENT APOPTOSIS; SIGNALING PATHWAY; LINKED INHIBITOR; STRUCTURAL BASIS; PROTEIN LIGASE; MALT LYMPHOMA; UBA DOMAIN; ACTIVATION; XIAP; BCL10	The covalent attachment of ubiquitin to target proteins influences various cellular processes, including DNA repair, NF-kappa B signalling and cell survival(1). The most common mode of regulation by ubiquitin-conjugation involves specialized ubiquitin-binding proteins that bind to ubiquitylated proteins and link them to downstream biochemical processes. Unravelling how the ubiquitin-message is recognized is essential because aberrant ubiquitin-mediated signalling contributes to tumour formation(2). Recent evidence indicates that inhibitor of apoptosis (IAP) proteins are frequently overexpressed in cancer and their expression level is implicated in contributing to tumorigenesis, chemoresistance, disease progression and poor patient-survival(3). Here, we have identified an evolutionarily conserved ubiquitin-associated (UBA) domain in IAPs, which enables them to bind to Lys 63-linked polyubiquitin. We found that the UBA domain is essential for the oncogenic potential of cIAP1, to maintain endothelial cell survival and to protect cells from TNF-alpha-induced apoptosis. Moreover, the UBA domain is required for XIAP and cIAP2-MALT1 to activate NF-kappa B. Our data suggest that the UBA domain of cIAP2-MALT1 stimulates NF-kappa B signalling by binding to polyubiquitylated NEMO. Significantly, 98% of all cIAP2-MALT1 fusion proteins retain the UBA domain, suggesting that ubiquitin-binding contributes to the oncogenic potential of cIAP2-MALT1 in MALT lymphoma. Our data identify IAPs as ubiquitin-binding proteins that contribute to ubiquitin-mediated cell survival, NF-kappa B signalling and oncogenesis.	[Gyrd-Hansen, Mads; Darding, Maurice; Tenev, Tencho; Zvelebil, Marketa; Meier, Pascal] Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England; [Miasari, Maria; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Santoro, Massimo M.] Univ Turin, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Santoro, Massimo M.] Univ Piemonte Orientale, Dept Environm & Life Sci, I-15100 Alessandria, Italy; [Zender, Lars; Xue, Wen; Lowe, Scott] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Xue, Wen] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Xue, Wen] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [da Fonseca, Paula C. A.] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Bujnicki, Janusz M.] Int Inst Mol & Cell Biol Warsaw, PL-02109 Warsaw, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ Poznan, PL-61614 Poznan, Poland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; La Trobe University; University of Turin; University of Eastern Piedmont Amedeo Avogadro; Cold Spring Harbor Laboratory; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University	Gyrd-Hansen, M (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloees Vej 5, DK-2200 Copenhagen, Denmark.	mads.gyrd@bric.dk; pmeier@icr.ac.uk	Silke, John/B-7622-2008	Silke, John/0000-0002-7611-5774; Meier, Pascal/0000-0003-2760-6523; Zvelebil, Marketa/0000-0001-8018-5591; da Fonseca, Paula/0000-0001-8656-5747; Tenev, Tencho/0000-0001-8762-1069; SANTORO, Massimo Mattia/0000-0003-4605-5085; Gyrd-Hansen, Mads/0000-0001-5641-5019	Danish Cancer Society; HFSP Career Developmental Award; Fondazione San Paolo and Regione Piemonte; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER	Danish Cancer Society(Danish Cancer Society); HFSP Career Developmental Award; Fondazione San Paolo and Regione Piemonte(Compagnia di San Paolo); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Xiaolu Yang, David Komander, David Barford, Thomas Farkas, Ivan Dikic and Marja Jaattela for reagents, discussions and invaluable technical support. We thank Irene Scarf for help with the cIAP1 zebrafish experiments, and Hyejin Cho and Beicong Ma for excellent technical assistance and help with the mouse tumour model. We thank Alan Ashworth and members of the Meier laboratory for critical reading of the manuscript and helpful discussions. We thank Vishva Dixit for sharing unpublished results. M. G.- H. is supported by a fellowship from the Danish Cancer Society. M. M. S. is supported by a HFSP Career Developmental Award, Fondazione San Paolo and Regione Piemonte.	Baens M, 2000, GENE CHROMOSOME CANC, V29, P281, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1036>3.0.CO;2-I; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; COOK WJ, 1992, J BIOL CHEM, V267, P15116; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Isaacson PG, 2005, J PATHOL, V205, P255, DOI 10.1002/path.1703; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2002, J CELL BIOL, V157, P115, DOI 10.1083/jcb.200108085; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Young SS, 1999, MAMM GENOME, V10, P44; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	41	186	189	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1309	U130		10.1038/ncb1789	http://dx.doi.org/10.1038/ncb1789			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931663	Green Accepted			2022-12-25	WOS:000260586700013
J	Naetar, N; Korbei, B; Kozlov, S; Kerenyi, MA; Dorner, D; Kral, R; Gotic, I; Fuchs, P; Cohen, TV; Bittner, R; Stewart, CL; Foisner, R				Naetar, Nana; Korbei, Barbara; Kozlov, Serguei; Kerenyi, Marc A.; Dorner, Daniela; Kral, Rosana; Gotic, Ivana; Fuchs, Peter; Cohen, Tatiana V.; Bittner, Reginald; Stewart, Colin L.; Foisner, Roland			Loss of nucleoplasmic LAP2 alpha-lamin A complexes causes erythroid and epidermal progenitor hyperproliferation	NATURE CELL BIOLOGY			English	Article							STEM-CELL DIFFERENTIATION; LAMIN-A; ERYTHROPOIESIS; RB; PROTEINS; MOUSE; GENE; PROLIFERATION; ASSOCIATION; EXPRESSION	Lamina-associated polypeptide (LAP) 2 alpha is a chromatin-associated protein that binds A-type lamins(1,2). Mutations in both LAP2 alpha and A-type lamins are linked to human diseases called laminopathies(3), but the molecular mechanisms are poorly understood. The A-type lamin-LAP2a complex interacts with and regulates retinoblastoma protein (pRb)(4,5), but the significance of this interaction in vivo is unknown. Here we address the function of the A-type lamin-LAP2a complex with the use of LAP2 alpha-deficient mice. We show that LAP2a loss causes relocalization of nucleoplasmic A-type lamins to the nuclear envelope and impairs pRb function. This causes inefficient cell-cycle arrest in dense fibroblast cultures and hyperproliferation of epidermal and erythroid progenitor cells in vivo, leading to tissue hyperplasia. Our results support a disease-relevant model(6) in which LAP2a defines A-type lamin localization in the nucleoplasm, which in turn affects pRb-mediated regulation of progenitor cell proliferation and differentiation in highly regenerative tissues.	[Naetar, Nana; Korbei, Barbara; Kerenyi, Marc A.; Dorner, Daniela; Kral, Rosana; Gotic, Ivana; Fuchs, Peter; Foisner, Roland] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Naetar, Nana; Korbei, Barbara; Kerenyi, Marc A.; Dorner, Daniela; Kral, Rosana; Gotic, Ivana; Fuchs, Peter; Foisner, Roland] Univ Vienna, A-1030 Vienna, Austria; [Kozlov, Serguei; Cohen, Tatiana V.; Stewart, Colin L.] NCI, Adv BioSci Labs, Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Kerenyi, Marc A.] Vienna Bioctr, Inst Mol Pathol, A-1030 Vienna, Austria; [Bittner, Reginald] Med Univ Vienna, Neuromuscular Res Ctr, Ctr Anat & Cell Biol, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna	Foisner, R (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	roland.foisner@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019	Naetar, Nana/0000-0002-8978-466X; Foisner, Roland/0000-0003-4734-4647; Fuchs, Peter/0000-0003-3933-7674; Kral, Rosana Maria/0000-0003-4775-4398; Korbei, Barbara/0000-0002-0439-0435; Gotic, Ivana/0000-0003-1111-871X	Austrian Science Research Fund [FWF P17871]; European Commission [LSHM-CT-2005-018690]; L'Oreal/UNESCO/OADW/BMWF	Austrian Science Research Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); L'Oreal/UNESCO/OADW/BMWF	We thank W. Muller for the Cre-deleter mouse strain, Larry Gerace for the genomic BAC clone, T. Jacks for triple knockout mouse embryonic fibroblasts, P. Luvalle for providing paws from lamin A/C-deficient mice, K. Biadasiewicz for expert technical assistance, and H. Beug and E. W. Mullner for helpful discussions. This study was supported by grants from the Austrian Science Research Fund (FWF P17871) and the EURO-Laminopathies research project of the European Commission (contract LSHM-CT-2005-018690) to R. F. and a postdoctoral fellowship from L'Oreal/UNESCO/OADW/BMWF to N. N.	Andra K, 1998, GENE DEV, V12, P3442, DOI 10.1101/gad.12.21.3442; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Constantinescu D, 2006, STEM CELLS, V24, P177, DOI 10.1634/stemcells.2004-0159; Dechat T, 2000, J CELL SCI, V113, P3473; Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Taylor MRG, 2005, HUM MUTAT, V26, P566, DOI 10.1002/humu.20250; Vlcek S, 1999, EMBO J, V18, P6370, DOI 10.1093/emboj/18.22.6370; Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103	33	119	120	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1341	U213		10.1038/ncb1793	http://dx.doi.org/10.1038/ncb1793			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849980				2022-12-25	WOS:000260586700017
J	Zhang, YP; Deng, MM				Zhang, Y. Philip; Deng, Michelle M.			Enforcing pharmaceutical and biotech patent rights in China	NATURE BIOTECHNOLOGY			English	Editorial Material								Companies with a significant intellectual property stake in China should put in place an effective protection and enforcement strategy against local and overseas competitors.	[Zhang, Y. Philip] Cooley Godward Kronish LLP, Boston, MA 02199 USA; [Deng, Michelle M.] Genzyme Corp, Cambridge, MA 02142 USA	Sanofi-Aventis; Genzyme Corporation	Zhang, YP (corresponding author), Cooley Godward Kronish LLP, 800 Boylston St,46th Floor, Boston, MA 02199 USA.	pzhang@cooley.com; michelle.deng@genzyme.com						Gong YD, 2005, SCIENCE, V309, P735, DOI 10.1126/science.309.5735.735; Guo J, 2006, SCIENCE, V314, P1232, DOI 10.1126/science.314.5803.1232; Hu Y., 2007, J MED MARKETING DEVI, V7, P295; Jia H, 2007, NAT BIOTECHNOL, V25, P1337, DOI 10.1038/nbt1207-1337; *WIPO, PAR CONV MADR AGR IN; 2008, CHEM ENG NEWS   0519	6	8	8	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2008	26	11					1235	1241		10.1038/nbt1108-1235	http://dx.doi.org/10.1038/nbt1108-1235			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	371LG	18997760				2022-12-25	WOS:000260832200015
J	Fu, Z; Malureanu, L; Huang, J; Wang, W; Li, H; Van Deursen, JM; Tindall, DJ; Chen, J				Fu, Zheng; Malureanu, Liviu; Huang, Jun; Wang, Wei; Li, Hao; Van Deursen, Jan M.; Tindall, Donald J.; Chen, Junjie			Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression	NATURE CELL BIOLOGY			English	Article							POLO-LIKE KINASE-1; SCF-BETA-TRCP; CELL-CYCLE; BOX DOMAIN; PLK1; CYTOKINESIS; PROTEIN; INHIBITOR; SUBSTRATE; DIVISION	Proper control of entry into and progression through mitosis is essential for normal cell proliferation and the maintenance of genome stability(1-4). The mammalian mitotic kinase Polo-like kinase 1 (Plk1) is involved in multiple stages of mitosis(5). Here we report that Forkhead Box M1 (FoxM1), a substrate of Plk1 (refs 6-8), controls a transcriptional programme that mediates Plk1-dependent regulation of cell-cycle progression. The carboxy-terminal domain of FoxM1 binds Plk1, and phosphorylation of two key residues in this domain by Cdk1 is essential for Plk1-FoxM1 interaction. Formation of the Plk1-FoxM1 complex allows for direct phosphorylation of FoxM1 by Plk1 at G2/M and the subsequent activation of FoxM1 activity, which is required for expression of key mitotic regulators, including Plk1 itself. Thus, Plk1-dependent regulation of FoxM1 activity provides a positive-feedback loop ensuring tight regulation of transcriptional networks essential for orderly mitotic progression.	[Huang, Jun; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Fu, Zheng; Tindall, Donald J.] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA; [Malureanu, Liviu; Van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA; [Fu, Zheng; Malureanu, Liviu; Van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wang, Wei; Li, Hao] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	Yale University; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of New Mexico	Chen, J (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	tindall.donald@mayo.edu; junjie.chen@yale.edu	li, hao/J-6585-2012; CHEN, JUNJIE/HHM-8428-2022		National Institutes of Health [NIH RO1 CA113381]; Mayo SPORE P50 [CA116201]; T.J. Martell Foundation; DOD; NATIONAL CANCER INSTITUTE [R01CA113381, P50CA116201, P50CA091956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo SPORE P50; T.J. Martell Foundation; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for extensive discussions with R. H. Medema and J. Laoukili and their input. We thank H. M. Thompson for editing the manuscript. Mass spectrometry analysis was performed by Taplin Biological Mass Spectrometry Facility at Harvard University. This work was supported in part by grants from the National Institutes of Health (NIH RO1 CA113381 to JC), Mayo SPORE P50 (CA116201 project no. 1 to J. C.) and the T.J. Martell Foundation (to D.J.T.). J.C. is a recipient of an Era of Hope Scholars award from DOD. Z.F. is a recipient of a Ruth L. Kirschstein NRSA individual Fellowship from NIH.	Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2	28	240	245	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1076	1082		10.1038/ncb1767	http://dx.doi.org/10.1038/ncb1767			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160488	Green Accepted			2022-12-25	WOS:000258910400013
J	Schneider, CK; Kalinke, U				Schneider, Christian K.; Kalinke, Ulrich			Toward biosimilar monoclonal antibodies	NATURE BIOTECHNOLOGY			English	Editorial Material							MASS-SPECTROMETRY		[Schneider, Christian K.] Paul Ehrlich Inst, Fed Agcy Sera & Vaccines, Div EU Cooperat Microbiol, D-63225 Langen, Germany; [Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-30625 Hannover, Germany; [Kalinke, Ulrich] Twincore Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany	Paul Ehrlich Institute; Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center for Infection Research		schci@pei.de; kalul@pei.de		Kalinke, Ulrich/0000-0003-0503-9564				Beck A, 2005, J CHROMATOGR B, V819, P203, DOI 10.1016/j.jchromb.2004.06.052; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; Clark M, 2000, IMMUNOL TODAY, V21, P397, DOI 10.1016/S0167-5699(00)01680-7; *EUR PHARM, 2008, MON EUR PHARM, V784; *EUR PHARM, 2008, MON EUR PHARM, V2031; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Harvey DJ, 2008, MASS SPECTROM REV, V27, P125, DOI 10.1002/mas.20157; Hu S, 2002, ANAL CHEM, V74, P2833, DOI 10.1021/ac0202379; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; The European Parliament and the Council of the European Union, 2004, OFF J EUR COMM L, VL311, P67	14	80	81	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2008	26	9					985	990		10.1038/nbt0908-985	http://dx.doi.org/10.1038/nbt0908-985			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	346NG	18779806				2022-12-25	WOS:000259074700017
J	Shan, G; Li, YJ; Zhang, JL; Li, WD; Szulwach, KE; Duan, RH; Faghihi, MA; Khalil, AM; Lu, LH; Paroo, Z; Chan, AWS; Shi, ZJ; Liu, QH; Wahlestedt, C; He, C; Jin, P				Shan, Ge; Li, Yujing; Zhang, Junliang; Li, Wendi; Szulwach, Keith E.; Duan, Ranhui; Faghihi, Mohammad A.; Khalil, Ahmad M.; Lu, Lianghua; Paroo, Zain; Chan, Anthony W. S.; Shi, Zhangjie; Liu, Qinghua; Wahlestedt, Claes; He, Chuan; Jin, Peng			A small molecule enhances RNA interference and promotes microRNA processing	NATURE BIOTECHNOLOGY			English	Article							MICROARRAY ANALYSIS; COMPLEX; MATURATION; PROTEIN; MICE	Small interfering RNAs (siRNAs) and microRNAs (miRNAs) are sequence-specific post-transcriptional regulators of gene expression. Although major components of the RNA interference (RNAi) pathway have been identified, regulatory mechanisms for this pathway remain largely unknown. Here we demonstrate that the RNAi pathway can be modulated intracellularly by small molecules. We have developed a cell-based assay to monitor the activity of the RNAi pathway and find that the small-molecule enoxacin (Penetrex) enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. We show that this RNAi-enhancing activity depends on the trans-activation-responsive region RNA-binding protein. Our results provide a proof-of-principle demonstration that small molecules can be used to modulate the activity of the RNAi pathway. RNAi enhancers may be useful in the development of research tools and therapeutics.	[Shan, Ge; Li, Yujing; Li, Wendi; Szulwach, Keith E.; Duan, Ranhui; Chan, Anthony W. S.; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Zhang, Junliang; Lu, Lianghua; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Faghihi, Mohammad A.; Khalil, Ahmad M.; Wahlestedt, Claes] Scripps Res Inst, Dept Mol & Integrat Neurosci, Jupiter, FL 33458 USA; [Paroo, Zain; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Shi, Zhangjie] Peking Univ, Coll Chem, Beijing 100871, Peoples R China	Emory University; University of Chicago; Scripps Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Peking University	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	pjin@genetics.emory.edu	Li, Yujing/AAJ-1411-2020; Li, yujing/GQA-4109-2022; Shi, Zhang-Jie/A-9756-2015; Jin, Peng/B-5977-2012; Faghihi, Mohammad Ali/AAD-7159-2020; Faghihi, Mohammad Ali/AAH-3139-2019; Shan, Ge/B-7323-2016; Wahlestedt, Claes/A-7039-2009; Zhang, Junliang/AAG-2137-2021	Li, Yujing/0000-0002-4363-2484; Jin, Peng/0000-0001-6137-6659; Faghihi, Mohammad Ali/0000-0002-8330-9067; Shan, Ge/0000-0002-3561-2088; Zhang, Junliang/0000-0002-4636-2846	NIMH NIH HHS [R01 MH076090, R01 MH076090-03, R56 MH076090, MH076090] Funding Source: Medline; NINDS NIH HHS [NS051630, R01 NS051630-03, R01 NS051630] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH076090, R01MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051630] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bhanot SK, 2001, CURR PHARM DESIGN, V7, P311, DOI 10.2174/1381612013398059; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Dykxhoorn DM, 2006, ANNU REV BIOMED ENG, V8, P377, DOI 10.1146/annurev.bioeng.8.061505.095848; Dykxhoorn DM, 2005, ANNU REV MED, V56, P401, DOI 10.1146/annurev.med.56.082103.104606; Eriksson E, 2003, J LEUKOCYTE BIOL, V74, P456, DOI 10.1189/jlb.0103048; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HOPPER DC, 2003, QUINOLONE ANTIMICROB; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pasquinelli AE, 2006, DEV CELL, V10, P419, DOI 10.1016/j.devcel.2006.03.005; Patel SS, 1996, DRUGS, V51, P137, DOI 10.2165/00003495-199651010-00009; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Schaltegger CA, 2002, PUBLIC CHOICE, V113, P1, DOI 10.1023/A:1020377207035; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	30	190	197	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2008	26	8					933	940		10.1038/nbt.1481	http://dx.doi.org/10.1038/nbt.1481			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	335WX	18641635	Green Accepted			2022-12-25	WOS:000258325500028
J	Eiseler, T; Doppler, H; Yan, IK; Kitatani, K; Mizuno, K; Storz, P				Eiseler, Tim; Doeppler, Heike; Yan, Irene K.; Kitatani, Kanae; Mizuno, Kensaku; Storz, Peter			Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; LEADING-EDGE; TYROSINE PHOSPHORYLATION; PHOSPHATASE SLINGSHOT; ARP2/3 COMPLEX; LIM-KINASE; ACTIVATION; MIGRATION; PATHWAY; TRANSPORT	Dynamic actin remodelling processes at the leading edge of migrating tumour cells are concerted events controlled by a fine-tuned temporal and spatial interplay of kinases and phosphatases. Actin severing is regulated by actin depolymerizing factor (ADF)/cofilin, which regulates stimulus-induced lamellipodia protrusion and directed cell motility. Cofilin is activated by dephosphorylation through phosphatases of the slingshot (SSH) family. SSH activity is strongly increased by its binding to filamentous actin (F-actin); however, other upstream regulators remain unknown. Here we show that in response to RhoA activation, protein kinase D1 (PKD1) phosphorylates the SSH enzyme SSH1L at a serine residue located in its actin-binding motif. This generates a 14-3-3-binding motif and blocks the localization of SSH1L to F-actin-rich structures in the lamellipodium by sequestering it in the cytoplasm. Consequently, expression of constitutively active PKD1 in invasive tumour cells enhanced the phosphorylation of cofilin and effectively blocked the formation of free actin-filament barbed ends and directed cell migration.	[Eiseler, Tim; Doeppler, Heike; Yan, Irene K.; Storz, Peter] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Kitatani, Kanae; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Mayo Clinic; Tohoku University	Storz, P (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu	Mizuno, Kensaku/G-8631-2015		Mayo Foundation; Mayo Comprehensive Cancer Center; Mayo Clinic Breast Cancer SPORE [CA116201-03DR4]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL CANCER INSTITUTE [P50CA116201] Funding Source: NIH RePORTER	Mayo Foundation; Mayo Comprehensive Cancer Center; Mayo Clinic Breast Cancer SPORE; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Lewis-Tuffin for help with the video microscopy, and R. Mooney (University of Rochester Medical Center, New York) for providing MTLn3 cells. This work was sponsored in part by funds from the Mayo Foundation and the Mayo Comprehensive Cancer Center, the Mayo Clinic Breast Cancer SPORE (CA116201-03DR4), a 'Friends for an Earlier Breast Cancer Test' Grant (all to P. S.) and by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. M.).	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jaggi M, 2005, CANCER RES, V65, P483; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; MIZUNO K, 1994, ONCOGENE, V9, P1605; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mullin MJ, 2006, J BIOL CHEM, V281, P25089, DOI 10.1074/jbc.M603591200; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	46	180	182	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					545	U64		10.1038/ncb1861	http://dx.doi.org/10.1038/ncb1861			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19329994	Green Accepted			2022-12-25	WOS:000265640000014
J	Kolasinska-Zwierz, P; Down, T; Latorre, I; Liu, T; Liu, XS; Ahringer, J				Kolasinska-Zwierz, Paulina; Down, Thomas; Latorre, Isabel; Liu, Tao; Liu, X. Shirley; Ahringer, Julie			Differential chromatin marking of introns and expressed exons by H3K36me3	NATURE GENETICS			English	Article							TRANSCRIPTION ELONGATION; METHYLATION STATES; HISTONE H3; SET2; RNA; METHYLTRANSFERASE; INTERFERENCE; RECRUITMENT; PATTERNS; MAPS	Variation in patterns of methylations of histone tails reflects and modulates chromatin structure and function(1). To provide a framework for the analysis of chromatin function in Caenorhabditis elegans, we generated a genome-wide map of histone H3 tail methylations. We find that C. elegans genes show distributions of histone modifications that are similar to those of other organisms, with H3K4me3 near transcription start sites, H3K36me3 in the body of genes and H3K9me3 enriched on silent genes. We also observe a novel pattern: exons are preferentially marked with H3K36me3 relative to introns. H3K36me3 exon marking is dependent on transcription and is found at lower levels in alternatively spliced exons, supporting a splicing-related marking mechanism. We further show that the difference in H3K36me3 marking between exons and introns is evolutionarily conserved in human and mouse. We propose that H3K36me3 exon marking in chromatin provides a dynamic link between transcription and splicing.	[Kolasinska-Zwierz, Paulina; Down, Thomas; Latorre, Isabel; Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Kolasinska-Zwierz, Paulina; Down, Thomas; Latorre, Isabel; Ahringer, Julie] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Cambridge; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Ahringer, J (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ja219@cam.ac.uk	Liu, Tao/AAO-6310-2021; Liu, Tao/G-3585-2010	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Latorre, Isabel/0000-0003-0638-1783; Ahringer, Julie/0000-0002-7074-4051; Liu, Tao/0000-0003-0446-9001	National Human Genome Research Institute [1-U01HG004270-01]; Wellcome Trust Senior Research Fellowship [054523]; Cambridge Newton Trust; Gates Foundation; Wellcome Trust Research Career Development Fellowship [083563]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust Senior Research Fellowship(Wellcome Trust); Cambridge Newton Trust(National Institute for Health Research (NIHR)); Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all the members of our modENCODE consortium for help and advice, and especially J. Lieb's laboratory for help with ChIP protocol development and S. Strome's laboratory for discussions about H3K36me3. We are very grateful to H. Holster for expert microarray processing at Roche. This work was supported by National Human Genome Research Institute modENCODE grant 1-U01HG004270-01, by a Wellcome Trust Senior Research Fellowship (054523) and Cambridge Newton Trust funding to J. A., by a Gates Foundation studentship to P. K.-Z. and by a Wellcome Trust Research Career Development Fellowship (083563) to T. D.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blumenthal Thomas, 2005, WormBook, P1, DOI 10.1895/wormbook.1.5.1; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cui M., 2007, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.139.1; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187	30	470	482	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					376	381		10.1038/ng.322	http://dx.doi.org/10.1038/ng.322			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19182803	Green Accepted			2022-12-25	WOS:000263640200022
J	Tokunaga, F; Sakata, S; Saeki, Y; Satomi, Y; Kirisako, T; Kamei, K; Nakagawa, T; Kato, M; Murata, S; Yamaoka, S; Yamamoto, M; Akira, S; Takao, T; Tanaka, K; Iwai, K				Tokunaga, Fuminori; Sakata, Shin-ichi; Saeki, Yasushi; Satomi, Yoshinori; Kirisako, Takayoshi; Kamei, Kiyoko; Nakagawa, Tomoko; Kato, Michiko; Murata, Shigeo; Yamaoka, Shoji; Yamamoto, Masahiro; Akira, Shizuo; Takao, Toshifumi; Tanaka, Keiji; Iwai, Kazuhiro			Involvement of linear polyubiquitylation of NEMO in NF-kappa B activation	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-CONJUGATING ENZYME; PROTEIN-KINASE-C; LIGASE COMPLEX; DEUBIQUITINATING ENZYMES; CANCER DEVELOPMENT; CHAIN; IDENTIFICATION; REQUIRES; BINDING; SITE	Nuclear factor-kappa B (NF-kappa B) is a key transcription factor in inflammatory, anti-apoptotic and immune processes. The ubiquitin pathway is crucial in regulating the NF-kappa B pathway. We have found that the LUBAC ligase complex, composed of the two RING finger proteins HOIL-1L and HOIP, conjugates a head-to-tail- linked linear polyubiquitin chain to substrates. Here, we demonstrate that LUBAC activates the canonical NF-kappa B pathway by binding to NEMO (NF-kappa B essential modulator, also called IKK gamma) and conjugates linear polyubiquitin chains onto specific Lys residues in the CC2-LZ domain of NEMO in a Ubc13-independent manner. Moreover, in HOIL-1 knockout mice and cells derived from these mice, NF-kappa B signalling induced by pro-inflammatory cytokines such as TNF-alpha and IL-1 beta was suppressed, resulting in enhanced TNF-alpha-induced apoptosis in hepatocytes of HOIL-1 knockout mice. These results indicate that LUBAC is involved in the physiological regulation of the canonical NF-kappa B activation pathway through linear polyubiquitylation of NEMO.	[Tokunaga, Fuminori; Sakata, Shin-ichi; Kamei, Kiyoko; Nakagawa, Tomoko; Iwai, Kazuhiro] Osaka Univ, Dept Biochem & Biophys, Grad Sch Med & Cell Biol, Suita, Osaka 5650871, Japan; [Tokunaga, Fuminori; Sakata, Shin-ichi; Kamei, Kiyoko; Nakagawa, Tomoko; Iwai, Kazuhiro] Osaka Univ, Metab Grp, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tokunaga, Fuminori; Sakata, Shin-ichi; Iwai, Kazuhiro] Japan Sci Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; [Tokunaga, Fuminori; Sakata, Shin-ichi; Kirisako, Takayoshi; Kamei, Kiyoko; Nakagawa, Tomoko; Kato, Michiko; Iwai, Kazuhiro] Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Abeno Ku, Osaka 5458585, Japan; [Saeki, Yasushi; Murata, Shigeo; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan; [Satomi, Yoshinori; Takao, Toshifumi] Osaka Univ, Inst Prot Res, Lab Prot Profiling & Funct Prote, Suita, Osaka 5650871, Japan; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Bunkyo Ku, Tokyo 1138519, Japan; [Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Lab Immune Regulat, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tokyo Metropolitan Institute of Medical Science; Osaka University; University of Tokyo; Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University	Iwai, K (corresponding author), Osaka Univ, Dept Biochem & Biophys, Grad Sch Med & Cell Biol, Suita, Osaka 5650871, Japan.	kiwai@cellbio.med.osaka-u.ac.jp	Murata, Shigeo/A-1426-2010; Saeki, Yasushi/AAR-8198-2021; IWAI, KAZUHIRO/GSN-7385-2022; Akira, Shizuo/C-3134-2009	Murata, Shigeo/0000-0002-3177-3503; Saeki, Yasushi/0000-0002-9202-5453; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951; Satomi, Yoshinori/0000-0002-8991-1040	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Health Sciences Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; Naito Foundation(Naito Memorial Foundation)	We would like to thank Nobuhito Goda and Natsuko Fujiki for instruction in mouse primary hepatocyte preparation; Ayumi Taya for supporting the LC and MS analyses; and Koichi Nakajima for reagents. This work was partly supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (F.T., T.T. and K.I.), the Japan Health Sciences Foundation (F.T.) and the Naito Foundation (F.T.).	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen F, 2006, CELL DEATH DIFFER, V13, P1835, DOI 10.1038/sj.cdd.4402014; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cong YS, 1997, J BIOL CHEM, V272, P16482, DOI 10.1074/jbc.272.26.16482; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DWORKINRASTL E, 1984, CELL, V39, P321, DOI 10.1016/0092-8674(84)90010-2; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; EINSPANIER R, 1987, BIOCHEM BIOPH RES CO, V147, P581, DOI 10.1016/0006-291X(87)90970-3; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Fernandez-de-Cossio J, 2000, ELECTROPHORESIS, V21, P1694, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1694::AID-ELPS1694>3.0.CO;2-W; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Nakamura M, 2006, BIOCHEM BIOPH RES CO, V351, P340, DOI 10.1016/j.bbrc.2006.09.163; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Saito N, 2003, J BIOL CHEM, V278, P46565, DOI 10.1074/jbc.M302549200; Sebban-Benin H, 2007, HUM MOL GENET, V16, P2805, DOI 10.1093/hmg/ddm237; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Thompson HGR, 2004, EXP CELL RES, V295, P448, DOI 10.1016/j.yexcr.2004.01.019; Tokunaga C, 1998, BIOCHEM BIOPH RES CO, V244, P353, DOI 10.1006/bbrc.1998.8270; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367	40	720	747	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					123	U40		10.1038/ncb1821	http://dx.doi.org/10.1038/ncb1821			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136968				2022-12-25	WOS:000263285500010
J	Kastrup, CJ; Boedicker, JQ; Pomerantsev, AP; Moayeri, M; Bian, Y; Pompano, RR; Kline, TR; Sylvestre, P; Shen, F; Leppla, SH; Tang, WJ; Ismagilov, RF				Kastrup, Christian J.; Boedicker, James Q.; Pomerantsev, Andrei P.; Moayeri, Mahtab; Bian, Yao; Pompano, Rebecca R.; Kline, Timothy R.; Sylvestre, Patricia; Shen, Feng; Leppla, Stephen H.; Tang, Wei-Jen; Ismagilov, Rustem F.			Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'	NATURE CHEMICAL BIOLOGY			English	Article							FACTOR PATHWAY INHIBITOR; BACILLUS-ANTHRACIS; TISSUE FACTOR; THRESHOLD RESPONSE; IMMUNE-RESPONSE; PATCH SIZE; FACTOR-X; ACTIVATION; FIBRINOLYSIS; INFECTION	Blood coagulation often accompanies bacterial infections and sepsis and is generally accepted as a consequence of immune responses. Though many bacterial species can directly activate individual coagulation factors, they have not been shown to directly initiate the coagulation cascade that precedes clot formation. Here we demonstrated, using microfluidics and surface patterning, that the spatial localization of bacteria substantially affects coagulation of human and mouse blood and plasma. Bacillus cereus and Bacillus anthracis, the anthrax-causing pathogen, directly initiated coagulation of blood in minutes when bacterial cells were clustered. Coagulation of human blood by B. anthracis required secreted zinc metalloprotease InhA1, which activated prothrombin and factor X directly (not via factor XII or tissue factor pathways). We refer to this mechanism as 'quorum acting' to distinguish it from quorum sensing-it does not require a change in gene expression, it can be rapid and it can be independent of bacterium-to-bacterium communication.	[Kastrup, Christian J.; Boedicker, James Q.; Pompano, Rebecca R.; Kline, Timothy R.; Ismagilov, Rustem F.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Kastrup, Christian J.; Boedicker, James Q.; Pompano, Rebecca R.; Kline, Timothy R.; Ismagilov, Rustem F.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Pomerantsev, Andrei P.; Moayeri, Mahtab; Leppla, Stephen H.] NIAID, Bacterial Toxins & Therapeut Sect, NIH, Bethesda, MD 20892 USA; [Bian, Yao; Tang, Wei-Jen] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; [Sylvestre, Patricia] Inst Pasteur, Unite Toxines & Pathogenie Bacteriennes, F-75724 Paris 15, France; [Sylvestre, Patricia] CNRS, Unite Rech Associee 2172, F-75724 Paris 15, France	University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Chicago; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ismagilov, RF (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	r-ismagilov@uchicago.edu	Shen, Feng/K-6298-2019; Pompano, Rebecca R./K-5353-2019	Shen, Feng/0000-0002-4709-330X; Pompano, Rebecca R./0000-0002-8644-9313; Tang, Wei-Jen/0000-0002-8267-8995; Moayeri, Mahtab/0000-0002-4448-8883	US National Institutes of Health [DP1OD003584]; US National Science Foundation [CHE-0349034]; US Office of Naval Research [N000140610630]; Camille Dreyfus Teacher-Scholar Awards Program; Cottrell Scholar of Research Corporation; NIH [GM 62548, GM 81539]; NIAID; The University of Chicago; University of Wisconsin; New York University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539, R01GM062548] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003584] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); US Office of Naval Research(Office of Naval Research); Camille Dreyfus Teacher-Scholar Awards Program; Cottrell Scholar of Research Corporation(Research Corporation for Science Advancement); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The University of Chicago(University of Chicago); University of Wisconsin; New York University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the US National Institutes of Health (NIH) Director's Pioneer Award (grant number DP1OD003584), the US National Science Foundation CAREER Award (grant number CHE-0349034), the US Office of Naval Research (grant number N000140610630), the Camille Dreyfus Teacher-Scholar Awards Program and the Cottrell Scholar of Research Corporation Awards Program to R. F. I., by NIH grants (GM 62548 and GM 81539) to W.- J. T., and by the Intramural Research Program of the NIAID. We thank J. Alverdy, B. Bishop, S. Crosson, C. Esmon, M. Mock, M. Runyon, J. Shapiro, U. Spitz, T. Van Ha, D. Wiebel and O. Zaborina for helpful discussions; O. Zaborina (The University of Chicago) for the gift of the EGPF plasmid for E. coli and for assisting in the transformation procedure; M. Mock (Institut Pasteur) for the gift of the mouse anti- InhA1 serum; L. Cheng and D. Crown for assisting in the animal studies; H. Herwald (Lund University) for the gift of the E. coli Ymel-1 strain; J. Handelsman (University of Wisconsin) for the gift of the B. cereus GFP strain; M. Blaser (New York University) for the gift of the B. anthracis DluxS strain; and J. Price for contributions in writing and editing this manuscript. We thank C. Tallant (Institut de Biologia Molecular de Barcelona) for assistance in construction of the protease gene knockout strains.	Akiyama N, 1997, INTERNAL MED, V36, P221, DOI 10.2169/internalmedicine.36.221; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Beltrami E, 2001, MATH BIOSCI, V172, P1, DOI 10.1016/S0025-5564(01)00064-5; Bugge TH, 2006, NAT GENET, V38, P137, DOI 10.1038/ng0206-137; Chung MC, 2008, J BIOL CHEM, V283, P9531, DOI 10.1074/jbc.M705871200; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Friedrich R, 2006, J BIOL CHEM, V281, P1188, DOI 10.1074/jbc.M507957200; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Heidtmann HH, 1998, THROMB RES, V92, P33, DOI 10.1016/S0049-3848(98)00110-8; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Imamura T, 1997, J BIOL CHEM, V272, P16062, DOI 10.1074/jbc.272.25.16062; Jesty J, 2005, PATHOPHYSIOL HAEMO T, V34, P71, DOI 10.1159/000089928; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Jones MB, 2003, INFECT IMMUN, V71, P3914, DOI 10.1128/IAI.71.7.3914-3919.2003; Kastrup CJ, 2007, BIOPHYS J, V93, P2969, DOI 10.1529/biophysj.107.109009; Kastrup CJ, 2006, P NATL ACAD SCI USA, V103, P15747, DOI 10.1073/pnas.0605560103; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Levi M, 2004, ANN MED, V36, P41, DOI 10.1080/07853890310017251; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Min DH, 2004, NAT BIOTECHNOL, V22, P717, DOI 10.1038/nbt973; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Narasaki R, 2005, J BIOL CHEM, V280, P14278, DOI 10.1074/jbc.M500241200; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Pawlinski R, 2003, BLOOD, V101, P3940, DOI 10.1182/blood-2002-07-2303; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Pompano RR, 2008, BIOPHYS J, V95, P1531, DOI 10.1529/biophysj.108.129486; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; Siegel AC, 2006, ANGEW CHEM INT EDIT, V45, P6877, DOI 10.1002/anie.200602273; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Tang H, 2007, AM J PATHOL, V171, P1066, DOI 10.2353/ajpath.2007.070104; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; WEAVER JC, 1988, BIO-TECHNOL, V6, P1084, DOI 10.1038/nbt0988-1084; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335	50	75	76	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2008	4	12					742	750		10.1038/nchembio.124	http://dx.doi.org/10.1038/nchembio.124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	373FH	19031531	Green Accepted			2022-12-25	WOS:000260955900010
J	Lawrence, S				Lawrence, Stacy			Biotech patents-business as usual?	NATURE BIOTECHNOLOGY			English	News Item																			0	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1326	1326		10.1038/nbt1208-1326	http://dx.doi.org/10.1038/nbt1208-1326			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19060861				2022-12-25	WOS:000261591300007
J	Lee, DJ; Modlin, RL				Lee, Delphine J.; Modlin, Robert L.			DNA transportation authority	NATURE MEDICINE			English	Editorial Material							ANTIMICROBIAL PEPTIDE; ATOPIC-DERMATITIS; RESPONSES; TLR2		[Lee, Delphine J.; Modlin, Robert L.] Univ Calif Los Angeles, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; [Modlin, Robert L.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, DJ (corresponding author), Univ Calif Los Angeles, Div Dermatol, Dept Med, 10833 Le Conte Ave,CHS 52-121, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073539, R37AI047868] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI073539-01A2, R37 AI047868, R01 AI073539, R37 AI047868-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Hata TR, 2008, J ALLERGY CLIN IMMUN, V122, P829, DOI 10.1016/j.jaci.2008.08.020; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Kuner N, 2003, HAUTARZT, V54, P274, DOI 10.1007/s00105-002-0470-5; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142	10	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2008	14	12					1319	1320		10.1038/nm1208-1319	http://dx.doi.org/10.1038/nm1208-1319			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19057557	Green Accepted			2022-12-25	WOS:000261393600015
J	Rauzi, M; Verant, P; Lecuit, T; Lenne, PF				Rauzi, Matteo; Verant, Pascale; Lecuit, Thomas; Lenne, Pierre-Francois			Nature and anisotropy of cortical forces orienting Drosophila tissue morphogenesis	NATURE CELL BIOLOGY			English	Article							DIFFERENTIAL ADHESION; CONVERGENT EXTENSION; CELL INTERCALATION; SURFACE MECHANICS; POTTS-MODEL; ELONGATION; HYPOTHESIS; PATTERNS; CADHERIN; RETINA	The morphogenesis of developing embryos and organs relies on the ability of cells to remodel their contacts with neighbouring cells. Using quantitative modelling and laser nano-dissection, we probed the mechanics of a morphogenetic process, the elongation of Drosophila melanogaster embryos, which results from polarized cell neighbour exchanges. We show that anisotropy of cortical tension at apical cell junctions is sufficient to drive tissue elongation. We estimated its value through comparisons between in silico and in vivo data using various tissue descriptors. Nano-dissection of the actomyosin network indicates that tension is anisotropically distributed and depends on myosin II accumulation. Junction relaxation after nano-dissection also suggests that cortical elastic forces are dominant in this process. Interestingly, fluctuations in vertex position ( points where three or more cells meet) facilitate neighbour exchanges. We delineate the contribution of subcellular tensile activity polarizing junction remodelling, and the permissive role of vertex fluctuations during tissue elongation.	[Rauzi, Matteo; Verant, Pascale; Lecuit, Thomas] Univ Aix Marseille 2, IBDML, CNRS, UMR 6216, Marseille 09, France; [Rauzi, Matteo; Verant, Pascale; Lenne, Pierre-Francois] Univ Aix Marseille 3, Inst Fresnel, CNRS, Ecole Cent Marseille,UMR 6133, F-13397 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, IBDML, CNRS, UMR 6216, Campus Luminy Case 907, Marseille 09, France.	lecuit@ibdm.univ-mrs.fr; lenne@fresnel.fr		Rauzi, Matteo/0000-0002-6313-0668; Lenne, Pierre-Francois/0000-0003-1066-7506	CNRS and an ANR-Blanc; Bourse Region Entreprise	CNRS and an ANR-Blanc(French National Research Agency (ANR)); Bourse Region Entreprise	We thank all the members of the Lenne and Lecuit labs for technical help in particular M. Cavey and C. Bertet. We thank C. Bertet for Fig. 1c. We are grateful for D. Kiehart H. Oda and C. Field for the gift of flies and antibodies. We thank everyone especially Loic Le Goff for fruitful discussions during the course of this project. K. Brakke is acknowledged for help with Surface Evolver F. Graner and A. Nicolas for insights and useful suggestions on the manuscript and J. Axelrod E. Munro O. Pourqui and members of the Lenne and Lecuit labs for critical reading of the manuscript. Supported by the CNRS and an ANR-Blanc grant to T. L. and P.-F.L.M. R. is supported by a Bourse Region Entreprise (Amplitude Systems) and P. V. is supported by a Postdoctoral Fellowship from ANR.	Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRAKKE K, 1990, EXP MATH, V1, P41; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey Matthieu, 2008, V420, P219, DOI 10.1007/978-1-59745-583-1_13; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Graner F, 2008, EUR PHYS J E, V25, P349, DOI 10.1140/epje/i2007-10298-8; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; MOMBACH JCM, 1995, PHYS REV LETT, V75, P2244, DOI 10.1103/PhysRevLett.75.2244; Oda H, 2001, J CELL SCI, V114, P493; Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0; Rasband W, IMAGEJ; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Zajac M, 2000, PHYS REV LETT, V85, P2022, DOI 10.1103/PhysRevLett.85.2022; Zajac M, 2003, J THEOR BIOL, V222, P247, DOI 10.1016/S0022-5193(03)00033-X; Zallen JA, 2004, J PHYS-CONDENS MAT, V16, pS5073, DOI 10.1088/0953-8984/16/44/005; [No title captured]	32	416	421	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1401	U57		10.1038/ncb1798	http://dx.doi.org/10.1038/ncb1798			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18978783				2022-12-25	WOS:000261261800010
J	Wai, T; Teoli, D; Shoubridge, EA				Wai, Timothy; Teoli, Daniella; Shoubridge, Eric A.			The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes	NATURE GENETICS			English	Article							BALBIANI BODY; RAPID SEGREGATION; MOUSE; CELLS; REDUCTION; MOLECULES; VARIANCES; SELECTION; GENOTYPES; EQUALITY	In mammals, mitochondrial DNA (mtDNA) sequence variants are observed to segregate rapidly between generations despite the high mtDNA copy number in the oocyte. This has led to the concept of a genetic bottleneck for the transmission of mtDNA(1-3), but the mechanism remains contentious. Several studies have suggested that the bottleneck occurs during embryonic development, as a result of a marked reduction in germline mtDNA copy number(4,5). Mitotic segregation of mtDNAs during preimplantation(5), or during the expansion of primordial germ cells (PGCs) before they colonize the gonad(4,5), is thought to account for the increase in genotypic variance observed among mature oocytes from heteroplasmic mothers. This view has, however, been challenged by studies suggesting that the bottleneck occurs without a reduction in germline mtDNA content(6). To resolve this controversy, we measured mtDNA heteroplasmy and copy number in single germ cells isolated from heteroplasmic mice. By directly tracking the evolution of mtDNA genotypic variance during oogenesis, we show that the genetic bottleneck occurs during postnatal folliculogenesis and not during embryonic oogenesis.	[Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	eric@ericpc.mni.mcgill.ca	Wai, Timothy/AAA-7226-2019	Wai, Timothy/0000-0002-6770-6222	Canadian Institutes of Health Research; US National Institutes of Health; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050794] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank L. Villeneuve for help with confocal microscopy; J. Mui for assistance with electron microscopy; T. Johns, F. Jones and D. Sabour for technical assistance; and J. Correa for statistical design. We are grateful for antibodies directed against TFAM (B. Kaufman, MNI), mt-SSB (M. Zeviani, Instituto Carlo Besta) and POLG (W. Copeland, US National Institutes of Health). The OCT4 Delta PE-EGFP mice were obtained from H. R. Scholer (University of Pennsylvania). This research was supported by the Canadian Institutes of Health Research and the US National Institutes of Health. E. A. S. is an International Scholar of the Howard Hughes Medical Institute.	Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Jansen R P, 2000, Hum Reprod, V15 Suppl 2, P112; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lim TS, 1996, COMPUT STAT DATA AN, V22, P287, DOI 10.1016/0167-9473(95)00054-2; MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PAN G, 2007, J NONPARAMETR STAT, V14, P459; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zhang YH, 2006, MOL GENET METAB, V89, P164, DOI 10.1016/j.ymgme.2006.03.014	30	314	321	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1484	1488		10.1038/ng.258	http://dx.doi.org/10.1038/ng.258			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19029901				2022-12-25	WOS:000261215900027
J	Abriata, LA; Banci, L; Bertini, I; Ciofi-Baffoni, S; Gkazonis, P; Spyroulias, GA; Vila, AJ; Wang, S				Abriata, Luciano A.; Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Gkazonis, Petros; Spyroulias, Georgios A.; Vila, Alejandro J.; Wang, Shenlin			Mechanism of Cu-A assembly	NATURE CHEMICAL BIOLOGY			English	Article							CYTOCHROME-C; HUMAN SCO1; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; METAL-BINDING; OXIDASE; PROTEIN; MITOCHONDRION; HOMOLOG; REDOX	Copper is essential for proper functioning of cytochrome c oxidases, and therefore for cellular respiration in eukaryotes and many bacteria. Here we show that a new periplasmic protein (PCuAC) selectively inserts Cu(I) ions into subunit II of Thermus thermophilus ba(3) oxidase to generate a native Cu-A site. The purported metallochaperone Sco1 is unable to deliver copper ions; instead, it works as a thiol-disulfide reductase to maintain the correct oxidation state of the CuA cysteine ligands.	[Abriata, Luciano A.; Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Gkazonis, Petros; Wang, Shenlin] Univ Florence, Magnet Resonance Ctr CERM, I-50019 Florence, Italy; [Abriata, Luciano A.; Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Gkazonis, Petros; Wang, Shenlin] Univ Florence, Dept Chem, I-50019 Florence, Italy; [Abriata, Luciano A.; Vila, Alejandro J.] Univ Nacl Rosario, Inst Mol & Cellular Biol Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Argentina; [Gkazonis, Petros; Spyroulias, Georgios A.] Univ Patras, Dept Pharm, GR-26504 Patras, Greece	University of Florence; University of Florence; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Patras	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Sci Campus, I-50019 Florence, Italy.	ivanobertini@cerm.unifi.it	wang, shenlin/B-6530-2016; Ciofi-Baffoni, Simone/AAH-9778-2021	wang, shenlin/0000-0002-0153-0578; Vila, Alejandro/0000-0002-7978-3233; Ciofi Baffoni, Simone/0000-0002-2376-3321; BANCI, LUCIA/0000-0003-0562-5774	European Commission [026145, LSHG-CT-2006-031220, MEST-CT-2004-504391]; NMR; Ente Cassa di Risparmio di Firenze; US National Institutes of Health [R01-GM068682]; Howard Hughes Medical Institute and Agencia Nacional de Promocion Cientifica y Tecnologica [PME2003-0026, PICT2002-01-11625]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068682] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); NMR; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute and Agencia Nacional de Promocion Cientifica y Tecnologica(Howard Hughes Medical Institute); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the European Commission (European Network of Research Infrastructures for Providing Access and Technological Advancements in Bio-NMR contract n degrees 026145, SPINE2-Complexes contract n degrees LSHG-CT-2006-031220 and Marie Curie host fellowships for early stage research training n degrees MEST-CT-2004-504391, NMR in Inorganic Structural Biology) and by a grant from Ente Cassa di Risparmio di Firenze. Work in Rosario (Argentina) was supported by the US National Institutes of Health (R01-GM068682), the Howard Hughes Medical Institute and Agencia Nacional de Promocion Cientifica y Tecnologica (PME2003-0026 and PICT2002-01-11625) grants to A. J. V. L. A. A. thanks Consejo Nacional de Investigaciones Cientificas y Tecnicas for a doctoral fellowship. We thank D. Winge (Departments of Medicine and Biochemistry, University of Utah Health Sciences Center, University of Utah) for kindly providing the expression plasmid for Tt Sco1.	Abajian C, 2006, J BIOL INORG CHEM, V11, P459, DOI 10.1007/s00775-006-0096-7; Andruzzi L, 2005, J AM CHEM SOC, V127, P16548, DOI 10.1021/ja0529539; Arnesano F, 2005, J PROTEOME RES, V4, P63, DOI 10.1021/pr049862f; Balatri E, 2003, STRUCTURE, V11, P1431, DOI 10.1016/j.str.2003.10.004; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2007, STRUCTURE, V15, P1132, DOI 10.1016/j.str.2007.07.011; Banci L, 2007, J PROTEOME RES, V6, P1568, DOI 10.1021/pr060538p; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2006, P NATL ACAD SCI USA, V103, P8595, DOI 10.1073/pnas.0601375103; Bertini I, 1996, J AM CHEM SOC, V118, P11658, DOI 10.1021/ja9621410; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Imriskova-Sosova I, 2005, BIOCHEMISTRY-US, V44, P16949, DOI 10.1021/bi051343i; Khalimonchulk E, 2008, BBA-MOL CELL RES, V1783, P618, DOI 10.1016/j.bbamcr.2007.10.016; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; Mattatall NR, 2000, J BIOL CHEM, V275, P28802, DOI 10.1074/jbc.M002741200; McEwan AG, 2002, FEBS LETT, V518, P10, DOI 10.1016/S0014-5793(02)02532-2; Ostermeier C, 1996, CURR OPIN STRUC BIOL, V6, P460, DOI 10.1016/S0959-440X(96)80110-2; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200; Ye QL, 2005, BIOCHEMISTRY-US, V44, P2934, DOI 10.1021/bi0480537	22	106	106	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2008	4	10					599	601		10.1038/nchembio.110	http://dx.doi.org/10.1038/nchembio.110			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	349ZV	18758441	Green Accepted			2022-12-25	WOS:000259323100009
J	Brown, HA				Brown, H. Alex			New mechanism for a classic folate inhibitor	NATURE CHEMICAL BIOLOGY			English	News Item								Metabolomics reveals new insights into the mechanism of an antimicrobial agent and folate metabolism.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Brown, HA (corresponding author), Vanderbilt Univ, Sch Med, 23rd Ave S & Pierce, Nashville, TN 37232 USA.	alex.brown@vanderbilt.edu						Ferguson LR, 2008, ANNU REV NUTR, V28, P313, DOI 10.1146/annurev.nutr.28.061807.155449; HARDMAN JG, 2001, PHARMACOL BASIS THER, P1176; Hess DC, 2006, PLOS BIOL, V4, P2012, DOI 10.1371/journal.pbio.0040351; Ivanova PT, 2001, P NATL ACAD SCI USA, V98, P7152, DOI 10.1073/pnas.131195098; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131	9	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2008	4	10					581	582		10.1038/nchembio1008-581	http://dx.doi.org/10.1038/nchembio1008-581			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	349ZV	18800042				2022-12-25	WOS:000259323100003
J	Einav, S; Gerber, D; Bryson, PD; Sklan, EH; Elazar, M; Maerkl, SJ; Glenn, JS; Quake, SR				Einav, Shirit; Gerber, Doron; Bryson, Paul D.; Sklan, Ella H.; Elazar, Menashe; Maerkl, Sebastian J.; Glenn, Jeffrey S.; Quake, Stephen R.			Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis	NATURE BIOTECHNOLOGY			English	Article							RNA-BINDING PROTEIN; AU-RICH RNA; VIRUS-RNA; REPLICATION COMPLEX; MEMBRANE ASSOCIATION; AMPHIPATHIC HELIX; CELL-CULTURE; IDENTIFICATION; NS4B; 2C	More effective therapies are urgently needed against hepatitis C virus (HCV), a major cause of viral hepatitis. We used in vitro protein expression and microfluidic affinity analysis to study RNA binding by the HCV transmembrane protein NS4B, which plays an essential role in HCV RNA replication. We show that HCV NS4B binds RNA and that this binding is specific for the 3' terminus of the negative strand of the viral genome with a dissociation constant (K-d) of similar to 3.4 nM. A high-throughput microfluidic screen of a compound library identified 18 compounds that substantially inhibited binding of RNA by NS4B. One of these compounds, clemizole hydrochloride, was found to inhibit HCV RNA replication in cell culture that was mediated by its suppression of NS4B's RNA binding, with little toxicity for the host cell. These results yield new insight into the HCV life cycle and provide a candidate compound for pharmaceutical development.	[Einav, Shirit; Bryson, Paul D.; Sklan, Ella H.; Elazar, Menashe; Glenn, Jeffrey S.] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Med, Stanford, CA 94305 USA; [Einav, Shirit] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA; [Gerber, Doron; Maerkl, Sebastian J.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gerber, Doron; Maerkl, Sebastian J.; Quake, Stephen R.] Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute	Glenn, JS (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Med, CCSR 3115A,269 Campus Dr, Stanford, CA 94305 USA.	jeffrey.glenn@stanford.edu; quake@stanford.edu	Maerkl, Sebastian J. J/C-5438-2008	Maerkl, Sebastian J. J/0000-0003-1917-5268	Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; National Institutes of Health (NIH) [RO1 DK066793]; NIH Director's Pioneer Award; Fulbright Foundation; American Liver Foundation Postdoctoral Fellowship Award; Stanford University SPARK Program;  [NIH 1RO1 HG002644-01A1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Foundation; American Liver Foundation Postdoctoral Fellowship Award; Stanford University SPARK Program(Stanford University); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (to J.S.G.)and National Institutes of Health (NIH) RO1 DK066793, an NIH Director's Pioneer Award (to S.R.Q.) and NIH 1RO1 HG002644-01A1. D.G. was supported in part by the Fulbright Foundation. S. E. is a recipient of an American Liver Foundation Postdoctoral Fellowship Award. We also wish to thank the Stanford University SPARK Program, High-Throughput Bioscience Center and the Microfluidic Foundry. The plasmid FL-J6/JFH-5'C19Rluc2AUbi that consists of the full- length HCV genome and expresses Renilla luciferase was a gift from Charles M. Rice, Rockefeller University.	Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; ECHEVERRI AC, 1995, VIROLOGY, V208, P540, DOI 10.1006/viro.1995.1185; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Einav S, 2004, J VIROL, V78, P11288, DOI 10.1128/JVI.78.20.11288-11295.2004; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; GLENN JS, 1992, SCIENCE, V256, P1331, DOI 10.1126/science.1598578; GLENN JS, 1990, J VIROL, V64, P3104, DOI 10.1128/JVI.64.6.3104-3107.1990; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Kang LF, 2008, DRUG DISCOV TODAY, V13, P1, DOI 10.1016/j.drudis.2007.10.003; Kusov YY, 1998, ARCH VIROL, V143, P931, DOI 10.1007/s007050050343; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Park-Lee S, 2003, J BIOL CHEM, V278, P39801, DOI 10.1074/jbc.M307105200; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; RICE CM, 1996, FIELDS VIROLOGY, P991; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Spangberg K, 2000, VIROLOGY, V274, P378, DOI 10.1006/viro.2000.0461; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wung CH, 1999, J GEN VIROL, V80, P1119, DOI 10.1099/0022-1317-80-5-1119	36	182	198	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2008	26	9					1019	1027		10.1038/nbt.1490	http://dx.doi.org/10.1038/nbt.1490			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	346NG	18758449	Green Accepted, Green Published			2022-12-25	WOS:000259074700025
J	Zhang, X; Jiang, G; Cai, Y; Monkley, SJ; Critchley, DR; Sheetz, MP				Zhang, Xian; Jiang, Guoying; Cai, Yunfei; Monkley, Susan J.; Critchley, David R.; Sheetz, Michael P.			Talin depletion reveals independence of initial cell spreading from integrin activation and traction	NATURE CELL BIOLOGY			English	Article							ADHESION; DOMAIN; CYTOSKELETON; MIGRATION; BINDING; FIBERS; TAILS; FORCE; SRC	Cell spreading, adhesion and remodelling of the extracellular matrix (ECM) involve bi-directional signalling and physical linkages between the ECM, integrins and the cell cytoskeleton(1-3). the actin-binding proteins talin1 and 2 link ligand-bound integrins to the actin cytoskeleton and increase the affinity of integrin for the ECM4-6. Here we report that depletion of talin2 in talin1-null (talin1(-/-)) cells did not affect the initiation of matrix-activated spreading or Src family kinase (sFK) activation, but abolished the ECM-integrin-cytoskeleton linkage and sustained cell spreading and adhesion. specifically, focal adhesion assembly, focal adhesion kinase (FAK) signalling and traction force generation on substrates were severely affected. the talin1 head domain restored beta 1 integrin activation but only full-length talin1 restored the ECM-cytoskeleton linkage and normal cytoskeleton organization. Our results demonstrate three biochemically distinct steps in fibronectin-activated cell spreading and adhesion: 1) fibronectin-integrin binding and initiation of spreading, 2) fast cell spreading and 3) focal adhesion formation and substrate traction. We suggest that talin is not required for initial cell spreading. However, talin provides the important mechanical linkage between ligand-bound integrins and the actin cytoskeleton required to catalyse focal adhesion-dependent pathways.	[Zhang, Xian; Jiang, Guoying; Cai, Yunfei; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Monkley, Susan J.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	Columbia University; University of Leicester	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	ms2001@columbia.edu		Monkley, Susan/0000-0001-9174-6278	National Institutes of Health [PN2 EY016586]; Wellcome Trust;  [GM-003267]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. De Camilli for talin2-specific antibody, N. Bate for various talin1 constructs and A.J. Woods for the talin1<SUP>ABS</SUP> construct. We thank N. Gauthier, T. Perez and O. Rossier for helpful discussions, and the continuing help from all members of the Sheetz laboratory. Work in the laboratory of M.P.S. was supported by the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY016586) and X.Z. was supported by GM-003267. Work in the D.R.C. laboratory was funded by the Wellcome Trust.	Bailly M, 1998, MICROSC RES TECHNIQ, V43, P433, DOI 10.1002/(SICI)1097-0029(19981201)43:5<433::AID-JEMT9>3.0.CO;2-2; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Burton K, 1999, MOL BIOL CELL, V10, P3745, DOI 10.1091/mbc.10.11.3745; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061	30	334	357	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1062	1068		10.1038/ncb1765	http://dx.doi.org/10.1038/ncb1765			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160486	Green Accepted			2022-12-25	WOS:000258910400011
J	Miyamoto, Y; Shi, D; Nakajima, M; Ozaki, K; Sudo, A; Kotani, A; Uchida, A; Tanaka, T; Fukui, N; Tsunoda, T; Takahashi, A; Nakamura, Y; Jiang, Q; Ikegawa, S				Miyamoto, Yoshinari; Shi, Dongquan; Nakajima, Masahiro; Ozaki, Kouichi; Sudo, Akihiro; Kotani, Akihiro; Uchida, Atsumasa; Tanaka, Toshihiro; Fukui, Naoshi; Tsunoda, Tatsuhiko; Takahashi, Atsushi; Nakamura, Yusuke; Jiang, Qing; Ikegawa, Shiro			Common variants in DVWA on chromosome 3p24.3 are associated with susceptibility to knee osteoarthritis	NATURE GENETICS			English	Article							ACID REPEAT POLYMORPHISM; POPULATION STRATIFICATION; SEQUENCE POLYMORPHISMS; HIP OSTEOARTHRITIS; GENE; IDENTIFICATION; PATHOGENESIS; JAPANESE; GENOME; CALM1	Susceptibility to osteoarthritis, the most common human arthritis, is known to be influenced by genetic factors(1,2). Through a genome-wide association study using B100,000 SNPs, we have identified a previously unknown gene on chromosome 3p24.3, DVWA, which is associated with susceptibility to knee osteoarthritis. Expressed specifically in cartilage, DVWA encodes a 276-amino-acid protein with two regions corresponding to the von Willebrand factor type A domain (VWA domain)3. Several DVWA SNPs are significantly associated with knee osteoarthritis in two independent Japanese case-control cohorts. This association was replicated in a Japanese population cohort and a Han Chinese case-control cohort (combined P = 7.3 x 10(-11)). DVWA protein binds to beta-tubulin, and the binding is influenced by two highly associated missense SNPs (rs11718863 and rs7639618) located in the VWA domain. The Tyr169-Cys260 isoform of DVWA, which is overrepresented in knee osteoarthritis, showed weaker interaction. Our findings reveal a new paradigm for study of osteoarthritis etiology and pathogenesis.	[Miyamoto, Yoshinari; Nakajima, Masahiro; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; [Shi, Dongquan; Jiang, Qing] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Jiangsu 210008, Peoples R China; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Tsurumi Ku, Kanagawa 2300045, Japan; [Sudo, Akihiro; Uchida, Atsumasa] Mie Univ, Dept Orthopaed Surg, Fac Med, Tsu, Mie 5148507, Japan; [Kotani, Akihiro] Kyorin Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1818611, Japan; [Fukui, Naoshi] Sagamihara Natl Hosp, Natl Hosp Org, Dept Pathomech, Clin Res Ctr Rheumatol & Allergy, Sagamihara, Kanagawa 2288522, Japan; [Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Ctr Genom Med, Tsurumi Ku, Kanagawa 2300045, Japan; [Takahashi, Atsushi] RIKEN, Ctr Genom Med, Lab Stat Anal, Minato Ku, Tokyo 1088639, Japan; [Nakamura, Yusuke] RIKEN, Ctr Genom Med, Lab Genotyping, Minato Ku, Tokyo 1088639, Japan	RIKEN; Nanjing University; RIKEN; Mie University; Kyorin University; RIKEN; RIKEN; RIKEN	Ikegawa, S (corresponding author), RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; shi, dongquan/AAE-9956-2020; Ikegawa, Shiro/N-6895-2015; shi, dongquan/ABH-3078-2021; Shi, Dongquan/ABG-6949-2021; Tanaka, Toshihiro/J-9310-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ikegawa, Shiro/0000-0003-0316-2147; shi, dongquan/0000-0002-4769-7816; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Capin-Gutierrez N, 2004, HISTOL HISTOPATHOL, V19, P1125, DOI 10.14670/HH-19.1125; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Farquharson C, 1999, BONE, V25, P405, DOI 10.1016/S8756-3282(99)00187-8; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gupta S, 2005, RHEUMATOLOGY, V44, P1531, DOI 10.1093/rheumatology/kei049; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Mabuchi Akihiko, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9286; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pollard B, 2006, CURR OPIN RHEUMATOL, V18, P531, DOI 10.1097/01.bor.0000240368.39713.e6; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Spector TD, 1996, BRIT MED J, V312, P940; SPECTOR TD, 2004, OSTEOARTHRITIS CAR S, VA, pS39; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	29	100	106	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					994	998		10.1038/ng.176	http://dx.doi.org/10.1038/ng.176			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622395				2022-12-25	WOS:000258026900016
J	Wollscheid, B; Bausch-Fluck, D; Henderson, C; O'Brien, R; Bibel, M; Schiess, R; Aebersold, R; Watts, JD				Wollscheid, Bernd; Bausch-Fluck, Damaris; Henderson, Christine; O'Brien, Robert; Bibel, Miriam; Schiess, Ralph; Aebersold, Ruedi; Watts, Julian D.			Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; CD MOLECULES; SIALIC-ACID; DIFFERENTIATION; EXPRESSION; HYDRAZIDE; NETWORKS	Although the classification of cell types often relies on the identification of cell surface proteins as differentiation markers, flow cytometry requires suitable antibodies and currently permits detection of only up to a dozen differentiation markers in a single measurement. We use multiplexed mass-spectrometric identification of several hundred N-linked glycosylation sites specifically from cell surface-exposed glycoproteins to phenotype cells without antibodies in an unbiased fashion and without a priori knowledge. We apply our cell surface-capturing (CSC) technology, which covalently labels extracellular glycan moieties on live cells, to the detection and relative quantitative comparison of the cell surface N-glycoproteomes of T and B cells, as well as to monitor changes in the abundance of cell surface N-glycoprotein markers during T-cell activation and the controlled differentiation of embryonic stem cells into the neural lineage. A snapshot view of the cell surface N-glycoproteins will enable detection of panels of N-glycoproteins as potential differentiation markers that are currently not accessible by other means.	[Wollscheid, Bernd; Bausch-Fluck, Damaris; Henderson, Christine; O'Brien, Robert; Aebersold, Ruedi; Watts, Julian D.] Inst Syst Biol, Seattle, WA USA; [Bibel, Miriam] Novartis Inst BioMed Res, Neurodegenerat Dept, Basel, Switzerland; [Schiess, Ralph; Aebersold, Ruedi] Univ Zurich, Inst Mol Syst Biol, ETHZ, Fac Nat Sci, CH-8006 Zurich, Switzerland; [Schiess, Ralph; Aebersold, Ruedi] Ctr Syst Physiol Metab Dis, Zurich, Switzerland; [Wollscheid, Bernd; Bausch-Fluck, Damaris] Univ Zurich, NCCR Neuro Ctr Prote, CH-8006 Zurich, Switzerland	Institute for Systems Biology (ISB); Novartis; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Wollscheid, B (corresponding author), Inst Syst Biol, Seattle, WA USA.	bernd.wollscheid@imsb.biol.ethz.ch	Wollscheid, Bernd/E-8909-2010	Wollscheid, Bernd/0000-0002-3923-1610	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH) [N01-HV-28179]; NIH [RO1-AI51344-01, N01-HV-28179-22]; National Center of Competence in Research (NCCR); DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051344] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been funded in part with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), under contract no. N01-HV-28179 (to R. A.), from NIH RO1-AI51344-01 (to J. D. W.), from NIH N01-HV-28179-22 (to B. W.) and from National Center of Competence in Research (NCCR) Neural Plasticity and Repair (to B. W.). Thanks to AnneClaude Gingras and Peter Zandstra for critical reading of the manuscript; to Andreas Hofmann and Thomas Bock for supplying information and graphics support; to Alexander Schmidt for LTQ-FT performance; and to Jimmy Eng, Andy Keller, Alexey Nesvizhskii, David Shteynberg, Luis Mendoza, Josh Tasman, James Eddes, Andreas Panagiotidis and Patrick Pedrioli for bioinformatic support.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ahram Mamoun, 2006, In Silico Biology, V6, P379; Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780; Arnott D, 2002, MOL CELL PROTEOMICS, V1, P148, DOI 10.1074/mcp.M100027-MCP200; Aumiller JJ, 2003, GLYCOBIOLOGY, V13, P497, DOI 10.1093/glycob/cwg051; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BAYER EA, 1988, ANAL BIOCHEM, V170, P271, DOI 10.1016/0003-2697(88)90631-8; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Elortza F, 2003, MOL CELL PROTEOMICS, V2, P1261, DOI 10.1074/mcp.M300079-MCP200; Evans EJ, 2003, IMMUNITY, V19, P213, DOI 10.1016/S1074-7613(03)00198-5; GAHMBERG CG, 1977, J BIOL CHEM, V252, P5888; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X; Josic D, 2007, PROTEOMICS, V7, P3010, DOI 10.1002/pmic.200700139; Kaji H, 2006, NAT PROTOC, V1, P3019, DOI 10.1038/nprot.2006.444; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lewandrowski U, 2006, MOL CELL PROTEOMICS, V5, P226, DOI 10.1074/mcp.M500324-MCP200; Macher BA, 2007, MOL BIOSYST, V3, P705, DOI 10.1039/b708581h; MARTIN D, 2008, Patent No. 0666610148; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicholson IC, 2005, J LEUKOCYTE BIOL, V77, P190, DOI 10.1189/jlb.0804450; North SJ, 2006, GLYCOCONJUGATE J, V23, P345, DOI 10.1007/s10719-006-6693-4; Nunomura K, 2005, MOL CELL PROTEOMICS, V4, P1968, DOI 10.1074/mcp.M500216-MCP200; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schiess R, 2009, MOL CELL PROTEOMICS, V8, P624, DOI 10.1074/mcp.M800172-MCP200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STEWART C, 2000, IMMUNOPHENOTYPING; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; VARKI A, 2002, ESSENTIALS GLYCOBIOL; Viswanathan K, 2003, BIOCHEMISTRY-US, V42, P15215, DOI 10.1021/bi034994s; von Heijne G, 2007, J INTERN MED, V261, P543, DOI 10.1111/j.1365-2796.2007.01792.x; Watarai H, 2005, PROTEOMICS, V5, P4001, DOI 10.1002/pmic.200401258; Wollscheid B, 2004, SUB CELL BIOCHEM, V37, P121; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang W, 2003, ELECTROPHORESIS, V24, P2855, DOI 10.1002/elps.200305569; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola; Zola H, 2007, J IMMUNOL METHODS, V319, P1, DOI 10.1016/j.jim.2006.11.001	50	396	694	2	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					378	386		10.1038/nbt.1532	http://dx.doi.org/10.1038/nbt.1532			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19349973	Green Accepted			2022-12-25	WOS:000264971800024
J	Goodman, C				Goodman, Catherine			Monell Chemical Senses Center	NATURE CHEMICAL BIOLOGY			English	Editorial Material													Goodman, Catherine/AAO-6148-2020	Goodman, Catherine/0000-0003-3415-8554					0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2009	5	1					2	2		10.1038/nchembio0109-2	http://dx.doi.org/10.1038/nchembio0109-2			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387EW	19088708	Bronze			2022-12-25	WOS:000261935500002
J	Valiante, N; De Gregorio, E; Rappuoli, R				Valiante, Nicholas; De Gregorio, Ennio; Rappuoli, Rino			Taking on Toll-like receptors	NATURE MEDICINE			English	Editorial Material							BACTERIAL-INFECTIONS; DEFICIENCY; ENCEPHALITIS		[Valiante, Nicholas; Rappuoli, Rino] Novartis Vaccines & Diagnost, Cambridge, MA 02139 USA; [De Gregorio, Ennio; Rappuoli, Rino] Novartis Vaccines & Diagnost, I-53100 Siena, Italy	Novartis; Novartis	Valiante, N (corresponding author), Novartis Vaccines & Diagnost, 45 Sidney St, Cambridge, MA 02139 USA.	rino.rappuoli@novartis.com	De Gregorio, Ennio/J-8073-2012					Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	7	4	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2008	14	12					1318	1319		10.1038/nm1208-1318	http://dx.doi.org/10.1038/nm1208-1318			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19057556				2022-12-25	WOS:000261393600014
J	Friese, MA; Jakobsen, KB; Friis, L; Etzensperger, R; Craner, MJ; McMahon, RM; Jensen, LT; Huygelen, V; Jones, EY; Bell, JI; Fugger, L				Friese, Manuel A.; Jakobsen, Karen B.; Friis, Lone; Etzensperger, Ruth; Craner, Matthew J.; McMahon, Roisin M.; Jensen, Lise T.; Huygelen, Veronique; Jones, E. Yvonne; Bell, John I.; Fugger, Lars			Opposing effects of HLA class I molecules in tuning autoreactive CD8(+) T cells in multiple sclerosis	NATURE MEDICINE			English	Article							GENETIC SUSCEPTIBILITY; DOUBLE-BLIND; PHASE-II; MHC; REGION; ANTIBODY; LINKAGE; DISEASE; ENCEPHALOMYELITIS; ASSOCIATION	The major known genetic risk factors in multiple sclerosis reside in the major histocompatibility complex (MHC) region. Although there is strong evidence implicating MHC class II alleles and CD4(+) T cells in multiple sclerosis pathogenesis, possible contributions from MHC class I genes and CD8(+) T cells are controversial. We have generated humanized mice expressing the multiple sclerosis-associated MHC class I alleles HLA-A*0301 (encoding human leukocyte antigen-A3 (HLA-A3)) and HLA-A*0201 (encoding HLA-A2) and a myelin-specific autoreactive T cell receptor (TCR) derived from a CD8(+) T cell clone from an individual with multiple sclerosis to study mechanisms of disease susceptibility. We demonstrate roles for HLA-A3-restricted CD8(+) T cells in induction of multiple sclerosis-like disease and for CD4(+) T cells in its progression, and we also define a possible mechanism for HLA-A*0201-mediated protection. To our knowledge, these data provide the first direct evidence incriminating MHC class I genes and CD8(+) T cells in the pathogenesis of human multiple sclerosis and reveal a network of MHC interactions that shape the risk of multiple sclerosis.	[Friese, Manuel A.; Jakobsen, Karen B.; Friis, Lone; Etzensperger, Ruth; McMahon, Roisin M.; Huygelen, Veronique; Bell, John I.; Fugger, Lars] Univ Oxford, Human Immunol Unit, MRC, Oxford OX3 9DS, England; [Craner, Matthew J.; Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Dept Clin Neurol, Oxford OX3 9DS, England; [Friese, Manuel A.] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Klin MS Forsch, D-20251 Hamburg, Germany; [Friese, Manuel A.] Univ Klinikum Hamburg Eppendorf, Inst Neuroimmunol, D-20251 Hamburg, Germany; [McMahon, Roisin M.; Jones, E. Yvonne] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [Jensen, Lise T.; Fugger, Lars] Aarhus Univ Hosp, Inst Clin, DK-8200 Aarhus N, Denmark; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oxford; Aarhus University; University of Oxford	Fugger, L (corresponding author), Univ Oxford, Human Immunol Unit, MRC, Headley Way, Oxford OX3 9DS, England.	lars.fugger@imm.ox.ac.uk	McMahon, Roisin/A-9823-2014; Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019	McMahon, Roisin/0000-0001-5437-0355; Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Friese, Manuel A./0000-0001-6380-2420	Deutsche Forschungsgemeinschaft [DFG FR1720/1-1]; Deutsche Forschungsgemeinschaft Emmy Noether Programme [FR1720/3-1]; Schweizerische MS Gesellschaft; Cancer Research UK Principal Research Fellow; MRC [G9900061, MC_U137884178, MC_U137881016] Funding Source: UKRI; Medical Research Council [MC_U137884178, MC_U137881016, G9900061] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Emmy Noether Programme(German Research Foundation (DFG)); Schweizerische MS Gesellschaft; Cancer Research UK Principal Research Fellow(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. von Boehmer (Dana-Farber Cancer Institute) for the BW58TCR-alpha beta<SUP>-</SUP> T cell hybridoma, A. McMichael (University of Oxford) for GAP.A3, W. E. Biddison (US National Institutes of Health) for providing DNA and RNA from the 2D1 T cell clone and N. Willcox and A. Vincent for critical reading of the manuscript. Work in the authors' laboratories is supported by the Danish (to L. Fugger) and UK (to L. Fugger and E. Y. J.) Medical Research Councils, the Karen Elise Jensen Foundation, the Lundbeck Foundation, the Danish Multiple Sclerosis Society, the European Union (European Commission Descartes Prize and FP6 Neuropromise, Mugen and ARDIS) and GB Holding (Viby) Aps (L. Fugger). M. A. F. was supported by the Deutsche Forschungsgemeinschaft (DFG FR1720/1-1) and a Medical Research Council UK Career Development Fellowship and is supported by the Deutsche Forschungsgemeinschaft Emmy Noether Programme (FR1720/3-1). R. E. is supported by the Schweizerische MS Gesellschaft and a Berrow Scholarship. E. Y. J. is a Cancer Research UK Principal Research Fellow.	Alam SM, 1998, J IMMUNOL, V160, P3883; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; BOOSS J, 1983, J NEUROL SCI, V62, P219, DOI 10.1016/0022-510X(83)90201-0; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Chao MJ, 2007, HUM MOL GENET, V16, P1951, DOI 10.1093/hmg/ddm142; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Govermant Joan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P239, DOI 10.2174/1568010053586264; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Honma K, 1997, J NEUROIMMUNOL, V73, P7, DOI 10.1016/S0165-5728(96)00161-0; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JERSILD C, 1973, LANCET, V2, P1221; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Koeleman BPC, 2000, ANN HUM GENET, V64, P207, DOI 10.1017/S0003480000008095; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Lassmann H, 2004, TRENDS IMMUNOL, V25, P132, DOI 10.1016/j.it.2004.01.007; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Najafian N, 2003, J CLIN INVEST, V112, P1037, DOI 10.1172/JCI200317935; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Sawcer S, 2005, AM J HUM GENET, V77, P454; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sim BC, 1998, CURR BIOL, V8, P701, DOI 10.1016/S0960-9822(98)70276-3; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Wallstrom E, 1998, EUR J IMMUNOL, V28, P3329, DOI 10.1002/(SICI)1521-4141(199810)28:10<3329::AID-IMMU3329>3.0.CO;2-B	50	143	149	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11					1227	1235		10.1038/nm.1881	http://dx.doi.org/10.1038/nm.1881			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18953350				2022-12-25	WOS:000260751200042
J	Jeong, Y; Leskow, FC; El-Jaick, K; Roessler, E; Muenke, M; Yocum, A; Dubourg, C; Li, X; Geng, X; Oliver, G; Epstein, DJ				Jeong, Yongsu; Leskow, Federico Coluccio; El-Jaick, Kenia; Roessler, Erich; Muenke, Maximilian; Yocum, Anastasia; Dubourg, Christele; Li, Xue; Geng, Xin; Oliver, Guillermo; Epstein, Douglas J.			Regulation of a remote Shh forebrain enhancer by the Six3 homeoprotein	NATURE GENETICS			English	Article							VENTRAL FOREBRAIN; EYE DEVELOPMENT; GENE; EXPRESSION; MUTATIONS; REPRESSION; MEMBERS; FAMILY; RISK; FACE	In humans, SHH haploinsufficiency results in holoprosencephaly (HPE), a defect in anterior midline formation(1,2). Despite the importance of maintaining SHH transcript levels above a critical threshold, we know little about the upstream regulators of SHH expression in the forebrain. Here we describe a rare nucleotide variant located 460 kb upstream of SHH in an individual with HPE that resulted in the loss of Shh brain enhancer-2 (SBE2) activity in the hypothalamus of transgenic mouse embryos. Using a DNA affinity-capture assay, we screened the SBE2 sequence for DNA-binding proteins and identified members of the Six3 and Six6 homeodomain family as candidate regulators of Shh transcription. Six3 showed reduced binding affinity for the mutant compared to the wild-type SBE2 sequence. Moreover, Six3 with HPE-causing alterations failed to bind and activate SBE2. These data suggest a direct link between Six3 and Shh regulation during normal forebrain development and in the pathogenesis of HPE.	[Jeong, Yongsu; Leskow, Federico Coluccio; Epstein, Douglas J.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [El-Jaick, Kenia; Roessler, Erich; Muenke, Maximilian] NHGRI, Med Genet Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Yocum, Anastasia] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Dubourg, Christele] Univ Rennes 1, CNRS, UMR 6061, F-35043 Rennes, France; [Li, Xue] Harvard Univ, Sch Med, Childrens Hosp, Dept Urol Surg, Boston, MA 02115 USA; [Geng, Xin; Oliver, Guillermo] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Harvard University; Boston Children's Hospital; Harvard Medical School; St Jude Children's Research Hospital	Epstein, DJ (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.	epsteind@mail.med.upenn.edu	Jeong, Yongsu/AAK-7397-2020; El-Jaick, Kenia/P-1303-2014	El-Jaick, Kenia/0000-0003-3316-9323; Jeong, Yongsu/0000-0002-0008-9928; Muenke, Maximilian/0000-0002-7719-6545	NINDS [R01 NS39421, R01 NS052386]; March of Dimes [1-FY05-112]; Pew Scholar Award in the Biomedical Sciences; Cancer Center [CA-21765]; American Lebanese Syrian Associated Charities (ALSAC); Division of Intramural Research; National Human Genome Research Institute; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000209, ZIAHG000175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039421, R01NS052386] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes(March of Dimes); Pew Scholar Award in the Biomedical Sciences; Cancer Center; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation in these studies. We also thank J. Richa and his staff at the University of Pennsylvania Transgenic and Mouse Chimeric Facility for their assistance in transgenic mouse production. We are grateful to V. Cheung, D. Kessler and T. Kadesch for their helpful comments on the manuscript. We are also grateful to K. Ewens and W. Ankener (R. Spielman laboratory) for the control human genotyping data and P. Bovolenta (Instituto Cajal, CSIC, Madrid, Spain) for kindly providing the human Six3 and Six6 expression constructs. This work was supported by NIH grants R01 NS39421 from NINDS (D.J.E.), R01 NS052386 (G.O.), March of Dimes grant # 1-FY05-112 (D.J.E.), a Pew Scholar Award in the Biomedical Sciences (D.J.E.), Cancer Center Support CA-21765 (G.O.), the American Lebanese Syrian Associated Charities (ALSAC) (G.O.) and the Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health (M.M.).	Carl M, 2002, DEVELOPMENT, V129, P4057; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Li X, 2002, SCIENCE, V297, P1180; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Park SS, 2005, ANAL BIOCHEM, V344, P152, DOI 10.1016/j.ab.2005.05.019; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Treier M, 2001, DEVELOPMENT, V128, P377; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	30	133	137	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1348	1353		10.1038/ng.230	http://dx.doi.org/10.1038/ng.230			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836447	Green Accepted			2022-12-25	WOS:000260501500029
J	Lee, M; Choi, Y; Burla, B; Kim, YY; Jeon, B; Maeshima, M; Yoo, JY; Martinoia, E; Lee, Y				Lee, Miyoung; Choi, Yongwook; Burla, Bo; Kim, Yu-Young; Jeon, Byeongwook; Maeshima, Masayoshi; Yoo, Joo-Yeon; Martinoia, Enrico; Lee, Youngsook			The ABC transporter AtABCB14 is a malate importer and modulates stomatal response to CO2	NATURE CELL BIOLOGY			English	Article							BINDING CASSETTE TRANSPORTER; GUARD-CELLS; PLASMA-MEMBRANE; ANION CHANNELS; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; DICARBOXYLATE TRANSPORTER; ABSCISIC-ACID; ATMRP5; HOMEOSTASIS	Carbon dioxide uptake and water vapour release in plants occur through stomata, which are formed by guard cells. These cells respond to light intensity, CO2 and water availability, and plant hormones(1,2). The predicted increase in the atmospheric concentration of CO2 is expected to have a profound effect on our ecosystem. However, many aspects of CO2-dependent stomatal movements are still not understood(3). Here we show that the ABC transporter AtABCB14 modulates stomatal closure on transition to elevated CO2. Stomatal closure induced by high CO2 levels was accelerated in plants lacking AtABCB14. Apoplastic malate has been suggested to be one of the factors mediating the stomatal response to CO2 (refs 4, 5) and indeed, exogenously applied malate induced a similar AtABCB14-dependent response as high CO2 levels. In isolated epidermal strips that contained only guard cells, malate-dependent stomatal closure was faster in plants lacking the AtABCB14 and slower in AtABCB14-overexpressing plants, than in wild-type plants, indicating that AtABCB14 catalyses the transport of malate from the apoplast into guard cells. Indeed, when AtABCB14 was heterologously expressed in Escherichia coli and HeLa cells, increases in malate transport activity were observed. We therefore suggest that AtABCB14 modulates stomatal movement by transporting malate from the apoplast into guard cells, thereby increasing their osmotic pressure.	[Lee, Miyoung; Burla, Bo; Kim, Yu-Young; Jeon, Byeongwook; Martinoia, Enrico; Lee, Youngsook] Pohang Univ Sci & Technol, Postech UZH Global Res Lab, Pohang 790784, South Korea; [Lee, Miyoung; Choi, Yongwook; Kim, Yu-Young; Jeon, Byeongwook; Yoo, Joo-Yeon; Martinoia, Enrico; Lee, Youngsook] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Burla, Bo; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bio Agr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Zurich; Nagoya University	Lee, Y (corresponding author), Pohang Univ Sci & Technol, Postech UZH Global Res Lab, Pohang 790784, South Korea.	ylee@postech.ac.kr	Martinoia, Enrico/AAH-8712-2021; Maeshima, Masayoshi/D-3073-2013; Burla, Bo/J-2850-2013; Lee, Youngsook/E-6578-2016	Maeshima, Masayoshi/0000-0002-1611-5481; Burla, Bo/0000-0002-5918-3249; Lee, Youngsook/0000-0002-5808-9613	Ministry of Science and Technology of Korea; Swiss National Foundation	Ministry of Science and Technology of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Swiss National Foundation(Swiss National Science Foundation (SNSF))	We thank N. Amrhein, Swiss Federal School of Technology for reading the manuscript, A. Vavasseur for helpful discussion on gas-exchange measurements and M. Schellenberg for making section images of AtABCB14:GUS. This project was supported by the Global Research Laboratory programme of the Ministry of Science and Technology of Korea. The work in the laboratory of E. M. was partially supported by the Swiss National Foundation.	Abel S, 1998, METH MOL B, V82, P209; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; HEDRICH R, 1994, PLANT J, V6, P741, DOI 10.1046/j.1365-313X.1994.6050741.x; HEDRICH R, 1993, EMBO J, V12, P897, DOI 10.1002/j.1460-2075.1993.tb05730.x; Hedrich R, 2001, PLANTA, V213, P594, DOI 10.1007/s004250100524; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Holland I. B., 2003, ABC PROTEINS BACTERI; HUNKE S, 1995, BIOCHEM BIOPH RES CO, V216, P589, DOI 10.1006/bbrc.1995.2663; Hurth MA, 2005, PLANT PHYSIOL, V137, P901, DOI 10.1104/pp.104.058453; Hwang JU, 1997, PLANT PHYSIOL, V115, P335, DOI 10.1104/pp.115.2.335; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Jeong JY, 2004, PLANT PHYSIOL, V134, P969, DOI 10.1104/pp.103.032102; KELLER BU, 1989, NATURE, V341, P450, DOI 10.1038/341450a0; Kimoto E, 2007, DRUG METAB PHARMACOK, V22, P307, DOI 10.2133/dmpk.22.307; Klein M, 2003, PLANT J, V33, P119, DOI 10.1046/j.1365-313X.2003.016012.x; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Raschke K, 2003, PLANTA, V217, P651, DOI 10.1007/s00425-003-1034-3; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SCHROEDER JI, 1995, PLANT MOL BIOL, V28, P353, DOI 10.1007/BF00020385; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; VANKIRK CA, 1978, PLANT PHYSIOL, V61, P474, DOI 10.1104/pp.61.3.474; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103	35	199	211	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1217	1223		10.1038/ncb1782	http://dx.doi.org/10.1038/ncb1782			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18776898	Green Accepted			2022-12-25	WOS:000259682900016
J	Kalyuzhnaya, MG; Lapidus, A; Ivanova, N; Copeland, AC; McHardy, AC; Szeto, E; Salamov, A; Grigoriev, IV; Suciu, D; Levine, SR; Markowitz, VM; Rigoutsos, I; Tringe, SG; Bruce, DC; Richardson, PM; Lidstrom, ME; Chistoserdova, L				Kalyuzhnaya, Marina G.; Lapidus, Alla; Ivanova, Natalia; Copeland, Alex C.; McHardy, Alice C.; Szeto, Ernest; Salamov, Asaf; Grigoriev, Igor V.; Suciu, Dominic; Levine, Samuel R.; Markowitz, Victor M.; Rigoutsos, Isidore; Tringe, Susannah G.; Bruce, David C.; Richardson, Paul M.; Lidstrom, Mary E.; Chistoserdova, Ludmila			High-resolution metagenomics targets specific functional types in complex microbial communities	NATURE BIOTECHNOLOGY			English	Article							METHANE OXIDATION; SP-NOV.; BACTERIUM; METABOLISM; GENOME; LAKE; POPULATIONS; SEQUENCE	Most microbes in the biosphere remain unculturable(1). Whole genome shotgun (WGS) sequencing of environmental DNA (metagenomics) can be used to study the genetic and metabolic properties of natural microbial communities(2-4). However, in communities of high complexity, metagenomics fails to link specific microbes to specific ecological functions. To overcome this limitation, we developed a method to target microbial subpopulations by labeling DNA through stable isotope probing ( SIP), followed by WGS sequencing. Metagenome analysis of microbes from Lake Washington in Seattle that oxidize single-carbon (C-1) compounds shows specific sequence enrichments in response to different C-1 substrates, revealing the ecological roles of individual phylotypes. We also demonstrate the utility of our approach by extracting a nearly complete genome of a novel methylotroph, Methylotenera mobilis, reconstructing its metabolism and conducting genome-wide analyses. This high-resolution, targeted metagenomics approach may be applicable to a wide variety of ecosystems.	[Levine, Samuel R.; Lidstrom, Mary E.; Chistoserdova, Ludmila] Univ Washington, Dept Chem Engn, Seattle, WA 98105 USA; [Kalyuzhnaya, Marina G.; Lidstrom, Mary E.] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA; [Lapidus, Alla; Ivanova, Natalia; Copeland, Alex C.; Salamov, Asaf; Grigoriev, Igor V.; Tringe, Susannah G.; Richardson, Paul M.] DOE Joint Genome Inst, Prod Genom Facil, Walnut Creek, CA 94596 USA; [McHardy, Alice C.; Rigoutsos, Isidore] IBM Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA; [Szeto, Ernest; Markowitz, Victor M.] Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA; [Suciu, Dominic] Combimatrix Corp, Mukilteo, WA 98275 USA; [Bruce, David C.] DOE Joint Genome Inst, Los Alamos Natl Lab, Los Alamos, NM 87545 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); International Business Machines (IBM); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Chistoserdova, L (corresponding author), Univ Washington, Dept Chem Engn, Benjamin Hall IRB,616 NE Northlake Pl, Seattle, WA 98105 USA.	milachis@u.washington.edu	Tringe, Susannah Green/T-9431-2019; McHardy, Alice C/K-9377-2018; McHardy, Alice/ABF-2322-2020; Chistoserdova, Ludmila/K-2364-2017; Lapidus, Alla L/I-4348-2013; Rigoutsos, Isidore/C-5381-2012	Tringe, Susannah Green/0000-0001-6479-8427; McHardy, Alice C/0000-0003-2370-3430; McHardy, Alice/0000-0003-2370-3430; Chistoserdova, Ludmila/0000-0002-5777-0263; Lapidus, Alla L/0000-0003-0427-8731; Rigoutsos, Isidore/0000-0003-1529-8631; Ivanova, Natalia/0000-0002-5802-9485; Grigoriev, Igor/0000-0002-3136-8903; Kalyuzhnaya, Marina/0000-0002-9058-7794	National Science Foundation [MCB-0604269]; US Department of Energy's Office of Science Biological and Environmental Research Program; University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]	National Science Foundation(National Science Foundation (NSF)); US Department of Energy's Office of Science Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This research was supported by the National Science Foundation as part of the Microbial Observatories program (MCB-0604269). This work was performed, in part, under the auspices of the US Department of Energy's Office of Science Biological and Environmental Research Program, and by the University of California, Lawrence Livermore National Laboratory under contract no. W-7405-Eng-48, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231 and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. The sequencing for the project was provided through the US Department of Energy Community Sequencing Program (http://www.jgi.doe.gov/CSP/index.html).	Auman AJ, 2000, APPL ENVIRON MICROB, V66, P5259, DOI 10.1128/AEM.66.12.5259-5266.2000; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; *COMM MET BOARD LI, 2007, NEW SCI MET REV SECR; Das A, 2007, PROTEINS, V67, P167, DOI 10.1002/prot.21094; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Ginzburg B, 1998, ENVIRON SCI TECHNOL, V32, P2130, DOI 10.1021/es9709076; Guenther A, 2002, CHEMOSPHERE, V49, P837, DOI 10.1016/S0045-6535(02)00384-3; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Islam T, 2008, P NATL ACAD SCI USA, V105, P300, DOI 10.1073/pnas.0704162105; Kalyuzhnaya MG, 2008, ISME J, V2, P696, DOI 10.1038/ismej.2008.32; Kalyuzhnaya MG, 2006, INT J SYST EVOL MICR, V56, P2819, DOI 10.1099/ijs.0.64191-0; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Krupovic M, 2006, J VIROL, V80, P9270, DOI 10.1128/JVI.00536-06; Lidstrom ME, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P618, DOI 10.1007/0-387-30742-7_20; Liu MS, 2004, J BACTERIOL, V186, P1503, DOI 10.1128/JB.186.5.1503-1517.2004; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; McDonald IR, 2008, APPL ENVIRON MICROB, V74, P1305, DOI 10.1128/AEM.02233-07; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Nercessian O, 2005, APPL ENVIRON MICROB, V71, P6885, DOI 10.1128/AEM.71.11.6885-6899.2005; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Pol A, 2007, NATURE, V450, P874, DOI 10.1038/nature06222; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sauer K, 1997, EUR J BIOCHEM, V249, P280, DOI 10.1111/j.1432-1033.1997.t01-1-00280.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P109, DOI 10.1099/ijs.0.63728-0	30	203	216	4	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2008	26	9					1029	1034		10.1038/nbt.1488	http://dx.doi.org/10.1038/nbt.1488			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	346NG	18711340				2022-12-25	WOS:000259074700026
J	Wanzel, M; Russ, AC; Kleine-Kohlbrecher, D; Colombo, E; Pelicci, PG; Eilers, M				Wanzel, Michael; Russ, Annika C.; Kleine-Kohlbrecher, Daniela; Colombo, Emanuela; Pelicci, Pier-Guiseppe; Eilers, Martin			A ribosomal protein L23-nucleophosmin circuit coordinates Miz1 function with cell growth	NATURE CELL BIOLOGY			English	Article							ARF TUMOR-SUPPRESSOR; RNA-POLYMERASE-I; NUCLEOPHOSMIN B23; DNA-DAMAGE; MYC TARGET; P53; TRANSCRIPTION; EXPRESSION; GENES; IDENTIFICATION	The Myc-associated zinc-finger protein, Miz1, is a negative regulator of cell proliferation and induces expression of the cell-cycle inhibitors p15(Ink4b) and p21(Cip1). Here we identify the ribosomal protein L23 as a negative regulator of Miz1-dependent transactivation. L23 exerts this function by retaining nucleophosmin, an essential co-activator of Miz1 required for Miz1-induced cell-cycle arrest, in the nucleolus. Mutant forms of nucleophosmin found in acute myeloid leukaemia fail to co-activate Miz1 and re-localize it to the cytosol. As L23 is encoded by a direct target gene of Myc, this regulatory circuit may provide a feedback mechanism that links translation of Myc target genes and cell growth to Miz1-dependent cell-cycle arrest.	[Wanzel, Michael; Russ, Annika C.; Eilers, Martin] Inst Mol Biol & Tumor Res IMT, D-35033 Marburg, Germany; [Kleine-Kohlbrecher, Daniela] Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Colombo, Emanuela; Pelicci, Pier-Guiseppe] Inst Europeo Oncol, Dept Expt Oncol, I-20141 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Eilers, M (corresponding author), Inst Mol Biol & Tumor Res IMT, Emil Mannkopff Str 2, D-35033 Marburg, Germany.	eilers@imt.uni-marburg.de	Pelicci, Pier Giuseppe/AAL-6572-2020; Colombo, Emanuela/AAO-8113-2020	Colombo, Emanuela/0000-0003-2079-7398; Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft; Research Group Chromatin-mediated Biological Decisions	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Group Chromatin-mediated Biological Decisions	This study was supported by grants from the Deutsche Forschungsgemeinschaft through the Transregio 17 (Ras-dependent Pathways in Human Tumorigenesis) and the Research Group Chromatin-mediated Biological Decisions. The authors thank Katrien Berns and Rene Bernards for help with retroviral cloning techniques and Bianca Jebavy and Doris Dobrin for excellent technical support.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; den Besten W, 2005, CELL CYCLE, V4, P1593; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guo QM, 2000, CANCER RES, V60, P5922; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; LIU QR, 1991, EUR J BIOCHEM, V200, P715, DOI 10.1111/j.1432-1033.1991.tb16236.x; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78	44	84	88	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1051	1061		10.1038/ncb1764	http://dx.doi.org/10.1038/ncb1764			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160485				2022-12-25	WOS:000258910400010
J	van Oijen, AM				van Oijen, Antoine M.			Cutting the forest to see a single tree?	NATURE CHEMICAL BIOLOGY			English	Editorial Material							HAND-OVER-HAND; PROTEIN H-NS; ENZYME MOLECULES; DNA-REPLICATION; DYNAMICS; ORGANIZATION; CHROMATIN	The development of single-molecule tools has significantly impacted the way we think about biochemical processes. Watching a single protein in action allows us to observe kinetic details and rare subpopulations that are hidden in ensemble-averaging techniques. I will discuss here the pros and cons of the single-molecule approach in studying ligand binding in macromolecular systems and how these techniques can be applied to characterize the behavior of large multicomponent biochemical systems.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	van Oijen, AM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,SGM204A, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077248] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077248-02, R01 GM077248] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Amit R, 2004, BIOPHYS J, V87, P1392, DOI 10.1529/biophysj.104.039503; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Benitez JJ, 2008, J AM CHEM SOC, V130, P2446, DOI 10.1021/ja7107867; Cisse I, 2007, P NATL ACAD SCI USA, V104, P12646, DOI 10.1073/pnas.0610673104; Cornish PV, 2007, ACS CHEM BIOL, V2, P53, DOI 10.1021/cb600342a; CORNISHBOWDEN A, 1987, J THEOR BIOL, V124, P1, DOI 10.1016/S0022-5193(87)80248-5; Dame RT, 2003, BIOPHYS J, V85, P4146, DOI 10.1016/S0006-3495(03)74826-7; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Edman L, 2000, P NATL ACAD SCI USA, V97, P8266, DOI 10.1073/pnas.130589397; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Flomenbom O, 2005, P NATL ACAD SCI USA, V102, P2368, DOI 10.1073/pnas.0409039102; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; QIAN H, 2008, BIOPHYS J       0425; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Rissin DM, 2008, J AM CHEM SOC, V130, P5349, DOI 10.1021/ja711414f; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; van Oijen AM, 2007, BIOPOLYMERS, V85, P144, DOI 10.1002/bip.20624; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	28	17	17	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2008	4	8					440	443		10.1038/nchembio0808-440	http://dx.doi.org/10.1038/nchembio0808-440			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329FO	18641617	Green Published			2022-12-25	WOS:000257852500003
J	Thomas, G; Jacobs, KB; Kraft, P; Yeager, M; Wacholder, S; Cox, DG; Hankinson, SE; Hutchinson, A; Wang, Z; Yu, K; Chatterjee, N; Garcia-Closas, M; Gonzalez-Bosquet, J; Prokunina-Olsson, L; Orr, N; Willett, WC; Colditz, GA; Ziegler, RG; Berg, CD; Buys, SS; McCarty, CA; Feigelson, HS; Calle, EE; Thun, MJ; Diver, R; Prentice, R; Jackson, R; Kooperberg, C; Chlebowski, R; Lissowska, J; Peplonska, B; Brinton, LA; Sigurdson, A; Doody, M; Bhatti, P; Alexander, BH; Buring, J; Lee, IM; Vatten, LJ; Hveem, K; Kumle, M; Hayes, RB; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, RN; Chanock, SJ; Hunter, DJ				Thomas, Gilles; Jacobs, Kevin B.; Kraft, Peter; Yeager, Meredith; Wacholder, Sholom; Cox, David G.; Hankinson, Susan E.; Hutchinson, Amy; Wang, Zhaoming; Yu, Kai; Chatterjee, Nilanjan; Garcia-Closas, Montserrat; Gonzalez-Bosquet, Jesus; Prokunina-Olsson, Ludmila; Orr, Nick; Willett, Walter C.; Colditz, Graham A.; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S.; McCarty, Catherine A.; Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, Ryan; Prentice, Ross; Jackson, Rebecca; Kooperberg, Charles; Chlebowski, Rowan; Lissowska, Jolanta; Peplonska, Beata; Brinton, Louise A.; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Alexander, Bruce H.; Buring, Julie; Lee, I-Min; Vatten, Lars J.; Hveem, Kristian; Kumle, Merethe; Hayes, Richard B.; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.			A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)	NATURE GENETICS			English	Article							SUSCEPTIBILITY GENE; CONFER SUSCEPTIBILITY; COMMON VARIANTS; MUTATIONS; BRCA2; LOCI	We conducted a three-stage genome-wide association study (GWAS) of breast cancer in 9,770 cases and 10,799 controls in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. In stage 1, we genotyped 528,173 SNPs in 1,145 cases of invasive breast cancer and 1,142 controls. In stage 2, we analyzed 24,909 top SNPs in 4,547 cases and 4,434 controls. In stage 3, we investigated 21 loci in 4,078 cases and 5,223 controls. Two new loci achieved genome-wide significance. A pericentromeric SNP on chromosome 1p11.2 (rs11249433; P = 6.74 x 10(-10) adjusted genotype test, 2 degrees of freedom) resides in a large linkage disequilibrium block neighboring NOTCH2 and FCGR1B; this signal was stronger for estrogen-receptor-positive tumors. A second SNP on chromosome 14q24.1 (rs999737; P = 1.74 x 10(-7)) localizes to RAD51L1, a gene in the homologous recombination DNA repair pathway. We also confirmed associations with loci on chromosomes 2q35, 5p12, 5q11.2, 8q24, 10q26 and 16q12.1.	[Thomas, Gilles; Jacobs, Kevin B.; Yeager, Meredith; Wacholder, Sholom; Hutchinson, Amy; Wang, Zhaoming; Yu, Kai; Chatterjee, Nilanjan; Garcia-Closas, Montserrat; Gonzalez-Bosquet, Jesus; Prokunina-Olsson, Ludmila; Ziegler, Regina G.; Brinton, Louise A.; Sigurdson, Alice; Doody, Michele; Bhatti, Parveen; Hayes, Richard B.; Tucker, Margaret; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD USA; [Jacobs, Kevin B.; Hutchinson, Amy; Wang, Zhaoming] NCI, SAIC Frederick Inc, Core Genotyping Facil, Adv Technol Program, Frederick, MD 21701 USA; [Kraft, Peter; Cox, David G.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Cox, David G.; Hankinson, Susan E.; Willett, Walter C.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Cox, David G.; Hankinson, Susan E.; Willett, Walter C.; Buring, Julie; Lee, I-Min; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Willett, Walter C.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Colditz, Graham A.] Washington Univ, Sch Med, St Louis, MO USA; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Buys, Saundra S.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Diver, Ryan] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Prentice, Ross; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Jackson, Rebecca] Ohio State Univ, Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Chlebowski, Rowan] Harbor Univ Calif Los Angeles, Med Ctr, Torrance, CA USA; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Peplonska, Beata] Nofer Inst Occupat Med, Lodz, Poland; [Alexander, Bruce H.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Buring, Julie; Lee, I-Min] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Vatten, Lars J.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Kumle, Merethe] Univ Tromso, Inst Community Med, Tromso, Norway; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Hunter, David J.] Broad Inst Harvard & MIT, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; American Cancer Society; Fred Hutchinson Cancer Center; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hunter, DJ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.	dhunter@hsph.harvard.edu	Hveem, Kristian/AFV-4683-2022; Colditz, Graham/A-3963-2009; Lee, I-Min/ABD-5409-2021; Yeager, Meredith/AAA-5322-2020; Cox, David G/A-2023-2009; Prokunina-Olsson, Ludmila/A-8240-2019; Tucker, Margaret A/B-4297-2015; Vatten, Lars/AAF-9380-2022; Lissowska, Jolanta/AAH-3252-2020; Peplonska, Beata/F-6004-2010; Brinton, Louise A/G-7486-2015; Diver, Ryan/AAG-3469-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Garcia-Closas, Montserrat/F-3871-2015; Wang, Zhaoming/R-5527-2018; Garcia-Closas, Montserrat/AAZ-6930-2021; Vatten, Lars/AFK-2073-2022; Peplonska, Beata/AAO-1265-2020; Cox, David/ABA-7454-2020	Colditz, Graham/0000-0002-7307-0291; Cox, David G/0000-0002-2152-9259; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Lissowska, Jolanta/0000-0003-2695-5799; Brinton, Louise A/0000-0003-3853-8562; Diver, Ryan/0000-0002-5418-9000; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Garcia-Closas, Montserrat/0000-0003-1033-2650; Wang, Zhaoming/0000-0001-7556-3869; Garcia-Closas, Montserrat/0000-0003-1033-2650; Peplonska, Beata/0000-0003-3915-2872; Bhatti, Parveen/0000-0003-1709-1781; Cox, David/0000-0003-2047-4687; Gonzalez Bosquet, Jesus/0000-0002-2079-4528; McCarty, Catherine/0000-0003-1089-0142; Hayes, Richard/0000-0002-0918-661X; Jacobs, Kevin/0000-0002-4657-6473	US National Institutes of Health [CA65725, CA87969, CA49449, CA67262, CA50385, 5UO1CA098233]; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; National Cancer Institute; NIH; DHHS;  [UO1 CA098710]; NATIONAL CANCER INSTITUTE [R01CA067262, U01CA098710, R01CA049449, U01CA049449, P01CA087969, U01CA067262, R01CA050385, U01CA098233, R01CA065725] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Nurses' Health Studies are supported by US National Institutes of Health grants CA65725, CA87969, CA49449, CA67262, CA50385 and 5UO1CA098233. We thank B. Egan, L. Egan, H. Judge Ellis, H. Ranu and P. Soule for assistance, and the participants in the Nurses' Health Studies. The WHI program is supported by contracts from the National Heart, Lung and Blood Institute, NIH. We thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. A full listing of WHI investigators can be found at http://www.whi.org. The ACS study is supported by UO1 CA098710. We thank C. Lichtman for data management and the participants on the CPS-II. The US Radiologic Technologists Study (USRT) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS. The PLCO study is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. We thank P. Prorok, Division of Cancer Prevention, National Cancer Institute, the Screening Center investigators and staff of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), and T. Sheehy and staff at SAIC- Frederick. We acknowledge the study participants for their contributions to making this study possible. We thank the radiologic technologists who participated in the study; J. Reid of the American Registry of Radiologic Technologists for continued support of the study; D. Kampa and A. Iwan of the University of Minnesota for study coordination and data collection; B. Kopp and staff at SAIC- Frederick for biospecimen processing; and L. Bowen of Information Management Systems for data management.	Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COLDITZ GA, 2006, CANC EPIDEMIOLOGY PR, P995; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Falush D, 2003, GENETICS, V164, P1567; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Pepe MS, 2008, JNCI-J NATL CANCER I, V100, P978, DOI 10.1093/jnci/djn215; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	27	435	450	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					579	584		10.1038/ng.353	http://dx.doi.org/10.1038/ng.353			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19330030	Green Accepted			2022-12-25	WOS:000265575600019
J	Gross, S; Gammon, ST; Moss, BL; Rauch, D; Harding, J; Heinecke, JW; Ratner, L; Piwnica-Worms, D				Gross, Shimon; Gammon, Seth T.; Moss, Britney L.; Rauch, Daniel; Harding, John; Heinecke, Jay W.; Ratner, Lee; Piwnica-Worms, David			Bioluminescence imaging of myeloperoxidase activity in vivo	NATURE MEDICINE			English	Article							LUMINOL-DEPENDENT CHEMILUMINESCENCE; HUMAN-NEUTROPHILS; CHEMI-LUMINESCENCE; MICE; ATHEROSCLEROSIS; DISEASE; OXIDASE; GRANULOCYTES; INFLAMMATION; MACROPHAGES	The myeloperoxidase (MPO) system of activated phagocytes is central to normal host defense mechanisms, and dysregulated MPO contributes to the pathogenesis of inflammatory disease states ranging from atherosclerosis to cancer. Here we show that upon systemic administration, the small molecule luminol enables noninvasive bioluminescence imaging (BLI) of MPO activity in vivo. Luminol-BLI allowed quantitative longitudinal monitoring of MPO activity in animal models of acute dermatitis, mixed allergic contact hypersensitivity, focal arthritis and spontaneous large granular lymphocytic tumors. Bioluminescence colocalized with histological sites of inflammation and was totally abolished in gene-deleted Mpo(-/-) mice, despite massive tissue infiltration of neutrophils and activated eosinophils, indicating that eosinophil peroxidase did not contribute to luminol-BLI in vivo. Thus, luminol-BLI provides a noninvasive, specific and highly sensitive optical readout of phagocyte-mediated MPO activity in vivo and may enable new diagnostic applications in a wide range of acute and chronic inflammatory conditions.	[Rauch, Daniel; Harding, John; Ratner, Lee] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA; [Gross, Shimon; Gammon, Seth T.; Moss, Britney L.; Piwnica-Worms, David] Washington Univ, Sch Med, Dept Med, Mallinckrodt Inst Radiol,Mol Imaging Ctr, St Louis, MO 63110 USA; [Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; Washington University (WUSTL)	Piwnica-Worms, D (corresponding author), Washington Univ, Sch Med, Dept Med, Mallinckrodt Inst Radiol,Mol Imaging Ctr, St Louis, MO 63110 USA.	piwnica-wormsd@mir.wustl.edu	Gammon, Seth/C-8778-2014	Gammon, Seth/0000-0001-8647-0975; Moss, Britney/0000-0002-1037-5717; Ratner, Lee/0000-0003-2744-7294	NATIONAL CANCER INSTITUTE [R01CA063417, P01CA100730, P50CA094056, R01CA105218] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NCI NIH HHS [CA105218, CA10073, P50 CA094056, P01 CA100730-07S10005, P50 CA094056-090003, P01 CA100730-01, P50 CA94056, R01 CA063417, R01 CA105218, CA63417, P01 CA100730, R01 CA063417-11] Funding Source: Medline; NHLBI NIH HHS [P01 HL030086, P01 HL030086.] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN RC, 1976, BIOCHEM BIOPH RES CO, V69, P245, DOI 10.1016/S0006-291X(76)80299-9; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Bednar MM, 1996, J LEUKOCYTE BIOL, V60, P619, DOI 10.1002/jlb.60.5.619; BENDER JG, 1986, INFLAMMATION, V10, P443, DOI 10.1007/BF00915828; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; BRESTEL EP, 1985, BIOCHEM BIOPH RES CO, V126, P482, DOI 10.1016/0006-291X(85)90631-X; CANTIN AM, 1987, J CLIN INVEST, V79, P1665, DOI 10.1172/JCI113005; Chen JW, 2006, RADIOLOGY, V240, P473, DOI 10.1148/radiol.2402050994; Chen Wei-Tsung, 2004, Mol Imaging, V3, P159, DOI 10.1162/1535350042380290; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; DECHATELET LR, 1982, J IMMUNOL, V129, P1589; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; FREIBURGHAUS J, 1991, J BIOLUM CHEMILUM, V6, P115, DOI 10.1002/bio.1170060209; FRETLAND DJ, 1995, INFLAMMATION, V19, P333, DOI 10.1007/BF01534391; Gerber CE, 1996, EUR J CLIN CHEM CLIN, V34, P901; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Gross S, 2005, METHOD ENZYMOL, V399, P512, DOI 10.1016/S0076-6879(05)99035-6; GROSS S, 2009, NAT PROTOC      0322, DOI DOI 10.1038/NPR0T.2009.73; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Hallett Maurice B, 2003, Methods Mol Biol, V225, P61; Haqqani AS, 1999, ANAL BIOCHEM, V273, P126, DOI 10.1006/abio.1999.4206; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; IRIE S, 1960, Curr Ther Res Clin Exp, V2, P107; Jancinova V, 2006, REDOX REP, V11, P110, DOI 10.1179/135100006X116592; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Komatsu J, 2006, INFLAMM RES, V55, P200, DOI 10.1007/s00011-006-0071-3; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; Malle E, 2003, KIDNEY INT, V64, P1956, DOI 10.1046/j.1523-1755.2003.00336.x; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; Pennathur S, 1999, J BIOL CHEM, V274, P34621, DOI 10.1074/jbc.274.49.34621; Querol M, 2006, ORG BIOMOL CHEM, V4, P1887, DOI 10.1039/b601540a; RAY MC, 1983, J IMMUNOL, V131, P1096; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Reynolds WF, 1997, BLOOD, V90, P2730, DOI 10.1182/blood.V90.7.2730.2730_2730_2737; Sanders JM, 2000, XENOBIOTICA, V30, P263, DOI 10.1080/004982500237659; Sans MQ, 2005, MOL IMAGING BIOL, V7, P403, DOI 10.1007/s11307-005-0020-5; Shepherd J, 2007, CHEM BIOL, V14, P1221, DOI 10.1016/j.chembiol.2007.10.005; SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903; STEVENS P, 1978, INFECT IMMUN, V22, P41, DOI 10.1128/IAI.22.1.41-51.1978	41	242	264	7	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					455	461		10.1038/nm.1886	http://dx.doi.org/10.1038/nm.1886			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19305414	Green Accepted			2022-12-25	WOS:000264937200034
J	Loane, DJ; Pocivavsek, A; Moussa, CEH; Thompson, R; Matsuoka, Y; Faden, AI; Rebeck, GW; Burns, MP				Loane, David J.; Pocivavsek, Ana; Moussa, Charbel E-H; Thompson, Rachel; Matsuoka, Yasuji; Faden, Alan I.; Rebeck, G. William; Burns, Mark P.			Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury	NATURE MEDICINE			English	Article							LONG-TERM ACCUMULATION; ALZHEIMERS-DISEASE; BETA-SECRETASE; HEAD TRAUMA; PRESENILIN-1; MOUSE; EXPRESSION; DEPOSITION; AXONS; INHIBITORS	Amyloid-beta (A beta) peptides, found in Alzheimer's disease brain, accumulate rapidly after traumatic brain injury (TBI) in both humans and animals. Here we show that blocking either beta- or gamma-secretase, enzymes required for production of A beta from amyloid precursor protein (APP), can ameliorate motor and cognitive deficits and reduce cell loss after experimental TBI in mice. Thus, APP secretases are promising targets for treatment of TBI.	[Loane, David J.; Pocivavsek, Ana; Moussa, Charbel E-H; Thompson, Rachel; Faden, Alan I.; Rebeck, G. William; Burns, Mark P.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Matsuoka, Yasuji] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	Georgetown University; Georgetown University	Burns, MP (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	mpb37@georgetown.edu	Loane, David/ABD-5177-2021; Rebeck, George William/J-2192-2012; Pocivavsek, Ana/AAW-8923-2020	Loane, David/0000-0003-0393-3503; Rebeck, George William/0000-0001-6276-248X; Burns, Mark P/0000-0003-4750-2000; Pocivavsek, Ana/0000-0002-3817-3201	National Institutes of Health [R03NS57635, R24HD050845]; Klingel Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD050845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS057635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingel Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank A. Pajoohesh-Ganji and P. Washington for technical assistance; S. Fricke and O. Rodriguez of the Small Animal Imaging Laboratory at Georgetown University; and P. Mathews (Nathan S. Kline Institute) for antibody C1/6.1. This work was funded by grant R03NS57635 (M. P. B.) and a pilot award from the National Capital Area Rehabilitation Research Network R24HD050845 (M. P. B.), both from the US National Institutes of Health, and by the Klingel Family Foundation (M. P. B.).	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cribbs DH, 1996, NEUROREPORT, V7, P1773, DOI 10.1097/00001756-199607290-00016; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; El Mouedden M, 2006, CURR PHARM DESIGN, V12, P671; Esposito L, 2004, J NEUROCHEM, V91, P1260, DOI 10.1111/j.1471-4159.2004.02816.x; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	29	189	217	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					377	379		10.1038/nm.1940	http://dx.doi.org/10.1038/nm.1940			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19287391	Green Accepted			2022-12-25	WOS:000264937200023
J	Kathiresan, S; Altschuler, D; Anand, S; Ardissino, D; Asselta, R; Ball, SG; Balmforth, AJ; Berger, K; Berglund, G; Bernardi, F; Bernardinelli, L; Berzuini, C; Braund, PS; Burnett, MS; Burtt, N; Cambien, F; Casari, G; Celli, P; Chen, Z; Corrocher, R; Daly, MJ; Deloukas, P; Devaney, J; Do, R; Duga, S; Elosua, R; Engert, JC; Epstein, SE; Erdmann, J; Ferrario, M; Fetiveau, R; Fischer, M; Friedlander, Y; Gabriel, SB; Galli, M; Gianniny, L; Girelli, D; Grosshennig, A; Guiducci, C; Hakonarson, HH; Hall, AS; Havulinna, AS; Hengstenberg, C; Hirschhorn, JN; Holm, H; Huge, A; Kent, KM; Konig, IR; Korn, JM; Li, M; Lieb, W; Lindsay, JM; Linsel-Nitschke, P; Lucas, G; MacRae, CA; Mannucci, PM; Marrugat, J; Martinelli, N; Marziliano, N; Matthai, W; McCarroll, SA; McKeown, PP; Meigs, JB; Melander, O; Merlini, PA; Mirel, D; Morgan, T; Musunuru, K; Nathan, DM; Nemesh, J; O'Donnell, CJ; Olivieri, O; Ouwehand, W; Parkin, M; Patterson, CC; Peltonen, L; Peyvandi, F; Piazza, A; Pichard, AD; Preuss, M; Purcell, S; Qasim, A; Rader, DJ; Ramos, R; Reilly, MP; Ribichini, F; Rossi, M; Sala, J; Salomaa, V; Samani, NJ; Satler, L; Scheffold, T; Scholz, M; Schreiber, S; Schunkert, H; Schwartz, SM; Siscovick, DS; Spertus, JA; Spreafico, M; Stark, K; Stefansson, K; Stoll, M; Subirana, I; Surti, A; Thompson, JR; Thorleifsson, G; Thorsteinsdottir, U; Tubaro, M; Voight, BF; Waksman, R; Wichmann, HE; Wilensky, R; Williams, G; Wright, BJ; Xie, C; Yee, J; Ziegler, A; Zonzin, P				Kathiresan, Sekar; Altschuler, David; Anand, Sonia; Ardissino, Diego; Asselta, Rosanna; Ball, Stephen G.; Balmforth, Anthony J.; Berger, Klaus; Berglund, Goran; Bernardi, Francesco; Bernardinelli, Luisa; Berzuini, Carlo; Braund, Peter S.; Burnett, Mary-Susan; Burtt, Noel; Cambien, Francois; Casari, Giorgio; Celli, Patrizia; Chen, Zhen; Corrocher, Roberto; Daly, Mark J.; Deloukas, Panos; Devaney, Joe; Do, Ron; Duga, Stefano; Elosua, Roberto; Engert, James C.; Epstein, Stephen E.; Erdmann, Jeanette; Ferrario, Maurizio; Fetiveau, Raffaela; Fischer, Marcus; Friedlander, Yechiel; Gabriel, Stacey B.; Galli, Michele; Gianniny, Lauren; Girelli, Domenico; Grosshennig, Anika; Guiducci, Candace; Hakonarson, Hakon H.; Hall, Alistair S.; Havulinna, Aki S.; Hengstenberg, Christian; Hirschhorn, Joel N.; Holm, Hilma; Huge, Andreas; Kent, Kenneth M.; Konig, Inke R.; Korn, Joshua M.; Li, Mingyao; Lieb, Wolfgang; Lindsay, Joseph M.; Linsel-Nitschke, Patrick; Lucas, Gavin; MacRae, Calum A.; Mannucci, Pier M.; Marrugat, Jaume; Martinelli, Nicola; Marziliano, Nicola; Matthai, William; McCarroll, Steven A.; McKeown, Pascal P.; Meigs, James B.; Melander, Olle; Merlini, Pier Angelica; Mirel, Daniel; Morgan, Thomas; Musunuru, Kiran; Nathan, David M.; Nemesh, James; O'Donnell, Christopher J.; Olivieri, Oliviero; Ouwehand, Willem; Parkin, Melissa; Patterson, Chris C.; Peltonen, Leena; Peyvandi, Flora; Piazza, Alberto; Pichard, Augusto D.; Preuss, Michael; Purcell, Shaun; Qasim, Atif; Rader, Daniel J.; Ramos, Rafael; Reilly, Muredach P.; Ribichini, Flavio; Rossi, Marco; Sala, Joan; Salomaa, Veikko; Samani, Nilesh J.; Satler, Lowell; Scheffold, Thomas; Scholz, Michael; Schreiber, Stefan; Schunkert, Heribert; Schwartz, Stephen M.; Siscovick, David S.; Spertus, John A.; Spreafico, Marta; Stark, Klaus; Stefansson, Kari; Stoll, Monika; Subirana, Isaac; Surti, Aarti; Thompson, John R.; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Tubaro, Marco; Voight, Benjamin F.; Waksman, Ron; Wichmann, H-Erich; Wilensky, Robert; Williams, Gordon; Wright, Benjamin J.; Xie, Changchun; Yee, Jean; Ziegler, Andreas; Zonzin, Pietro		Myocardial Infarction Genetics Consortium	Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; LDL-RECEPTOR GENE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; RISK; CHOLESTEROL; LOCI; PCSK9; HYPERCHOLESTEROLEMIA	We conducted a genome-wide association study testing single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) for association with early-onset myocardial infarction in 2,967 cases ad 3,075 controls. We carried out replication in an independent sample with an effective sample size of up to 19,492. SNPs at nine loci reached genome-wide significance: three are newly identified (21q22 near MRPS6-SLC5A3-KCNE2, 6p24 in PHACTR1 and 2q33 in WDR12) and six replicated prior observations(1-4) (9p21, 1p13 near CERSL2-PSRC1-SORT1, 10q11 near CXCL12, 1q41 in MIA3, 19p13 near LDLR and 1p32 near PCSK9). We tested 554 common copy number polymorphisms (> 1% allele frequency) and none met the pre-specified threshold for replication (P < 10(-3)). We identified 8,065 rare CNVs but did not detect a greater CNV burden in cases compared to controls, in genes compared to the genome as a whole, or at any individual locus. SNPs at nine loci were reproducibly associated with myocardial infarction, but tests of common and rare CNVs failed to identify additional associations with myocardial infarction risk.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Hum Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Gen Med Div, Boston, MA 02114 USA; Broad Inst MIT & Harvard, Prgm Med Populat Genet, Cambridge, MA 02142 USA; Harvard Med Sch, Dept Med, Boston, MA 02115 USA; Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; Univ Parma, Azienda Osped, I-43100 Parma, Italy; Univ Milan, Dept Intern Med & Med Specialities, Fdn Ist Ricov & Cura Carattere Sci, Osped Maggiore Mangiagalle & Regina Elena, I-20122 Milan, Italy; Univ Milan, Dept Biol Genet Med Sci, I-20133 Milan, Italy; McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Hamilton Hlth Sci, Dept Med, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Hamilton Hlth Sci, Dept Clin Epidemiol, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Hamilton Hlth Sci, Dept Biostatist, Hamilton, ON L8L 2X2, Canada; McGill Univ, Dept Med, Quebec City, PQ H3A 1A1, Canada; McGill Univ, Dept Human Genet, Quebec City, PQ H3A 1A1, Canada; Azienda Osped Niguarda Ca Granda, Div Cardiol, I-20162 Milan, Italy; Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Cardiovasc Endocrinol Sect, Boston, MA 02115 USA; Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; Univ Kiel, Inst Klin Molekularbiol, D-24105 Kiel, Germany; CIBER Epidemiol & Salud Publ, Barcelona 08003, Spain; Ctr Mathemat Sci, Stat Lab, Cambridge CB3 0WA, England; deCODE Genet Inc, IS-101 Reykjavik, Iceland; Framingham Heart Study &, Natl Heart Lung Blood Inst, Framingham, MA 01702 USA; Hebrew Univ Hadassah Sch Publ Hlth, Epidemiol, IL-91120 Jerusalem, Israel; Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Hosp Girona Josep Trueta, Cardiol, Coronar, Girona 17007, Spain; Inst Catala Salut, IDIAP Jordi Gol, Barcelona 08007, Spain; Inst Invest Biomed Girona, Girona 17007, Spain; Inst Municip Invest Med, Cardiovasc Epidemiol & Genet, Barcelona 08003, Spain; Ist Clin Humanitas, Fdn Ist Ricov & Cura Carrattere Sci, Div Cardiol, I-20089 Milan, Italy; Ludwig Maximilians Univ Munchen, Inst Med Inform Sci Biometr & Epidemiol, D-81377 Munich, Germany; Lund Univ, Univ Hosp Malmo, Dept Clin Sci Hypertens & Cardiovasc Dis, S-20502 Malmo, Sweden; Lund Univ, Univ Hosp Malmo, Dept Clin Sci, Int Med, S-20502 Malmo, Sweden; MRC, Biostat Unit, Cambridge, England; Mid America Heart Inst & Univ Missouri, Kansas City, MO 64111 USA; Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Helsinki 00300, Finland; Osped Livorno, Div Cardiol, I-57100 Livorno, Italy; Osped San Camillo, Div Cardiol, I-00151 Rome, Italy; Osped San Filippo Neri, Div Cardiol, I-00135 Rome, Italy; Policlin San Matteo, Fdn Ist Ricov & Cura Carrattere Sci, I-27100 Pavia, Italy; Queens Univ Belfast, Ctr Publ Hlth, Inst Clin Sci, Belfast BT12 6BJ, North Ireland; Ist Sci San Raffaele, Milan, Italy; San Raffaele Univ, Vita Salute, I-20132 Milan, Italy; Trium Anal Online GmbH, D-81677 Munich, Germany; Univ Cambridge, Dept Hematol, Cambridge CB2 2PT, England; Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy; Univ Helsinki, Inst Mol Med, Helsinki 00029, Finland; Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; Univ Leeds, LIGHT Res Inst, Fac Med & Hlth, Leeds LS1 3EX, England; Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, England; Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, England; Univ Lubeck, Med Klinik 2, D-23538 Lubeck, Germany; Univ Lubeck, Inst Med Biometr & Stat, D-23538 Lubeck, Germany; Univ Munster, Liebniz Inst Arterioscler Res, D-48149 Munster, Germany; Univ Munster, Inst Epidemiol & Social Med, D-48149 Munster, Germany; Univ Paris 06, INSERM UMR S 525, F-75634 Paris, France; Univ Pavia, Dept Appl Hlth Sci, I-27100 Pavia, Italy; Univ Pennsylvania, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; Univ Pennsylvania, Cardiovasc Inst, Philadelphia, PA 19104 USA; Univ Pennsylvania, Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Regensburg, Klin & Poliklin Innere Med 2, D-93042 Regensburg, Germany; Osped Rovigo, Div Cardiol, I-45100 Rovigo, Italy; Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; Univ Verona, Dept Clin & Expt Med, I-37134 Verona, Italy; Univ Verona, Osped Borgo Trento, Div Cardiol, I-37126 Verona, Italy; Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Witten Herdecke, Inst Heart & Circulat Res, D-44227 Dortmund, Germany; Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA; Washington Hosp Ctr, MedStar Res Inst, Cardiovasc Res Inst, Washington, DC 20010 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Parma; University Hospital of Parma; University of Milan; University of Milan; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McGill University; McGill University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Kiel; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Cambridge; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); IRCCS Humanitas Research Hospital; University of Munich; Lund University; Skane University Hospital; Lund University; Skane University Hospital; MRC Biostatistics Unit; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Finland National Institute for Health & Welfare; Azienda Ospedaliera San Camillo-Forlanini; San Filippo Neri Hospital; IRCCS Fondazione San Matteo; Queens University Belfast; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Cambridge; University of Ferrara; University of Helsinki; University of Iceland; University of Leeds; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester; University of Lubeck; University of Lubeck; University of Munster; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Pavia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Regensburg; ULSS 5 Polesana; Ospedale di Rovigo; University of Turin; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Witten Herdecke University; Vanderbilt University; MedStar Washington Hospital Center; Wellcome Trust Sanger Institute	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	skathiresan1@partners.org	Ramos, Rafel/D-9627-2016; Voight, Benjamin/F-1775-2011; Stark, Klaus/L-7367-2013; Stark, Klaus/D-3813-2009; bernardi, francesco/F-5443-2013; Meigs, James/P-3927-2019; Wang, Weili/D-1546-2011; Erdmann, Jeanette/P-7513-2014; Hall, Alistair/K-1953-2019; Cambien, Francois/AAP-9751-2020; Erdmann, Jeanette/A-4417-2009; Asselta, Rosanna/AAC-2367-2019; Bernardinelli, Luisa/AAL-5750-2021; Lieb, Wolfgang/AAC-7650-2022; Lucas, Gavin/D-4346-2012; König, Inke R/A-4544-2009; Duga, Stefano/F-8173-2014; Stefansson, Kari/AAE-7187-2019; Daly, Mark J/B-2453-2017; Chen, Zhen/M-3936-2017; Ribichini, Flavio/AAB-7767-2022; Nicola, Marziliano/ABF-9518-2021; Olivieri, Oliviero/A-9126-2008; Girelli, Domenico/B-1183-2008; Wichmann, Heinz Erich/AAA-5695-2022; Deloukas, Panos/B-2922-2013; Spertus, John/ABD-3075-2021; Morgan, Tom/C-3478-2012; Peyvandi, Flora/AAK-7437-2020; Ardissino, Diego/AAC-4041-2022; Hengstenberg, Christian/U-5485-2019; Ramos, Rafel/P-2083-2019; Casari, Giorgio/J-3070-2018; Martinelli, Nicola/J-5622-2016; Altshuler, David M/A-4476-2009; Berzuini, Carlo/AAA-7023-2019; Havulinna, Aki/AAM-4769-2021; Ziegler, Andreas/G-4246-2012; Spreafico, Marta/C-5945-2014	Ramos, Rafel/0000-0001-7970-5537; Stark, Klaus/0000-0002-7832-1942; Stark, Klaus/0000-0002-7832-1942; Meigs, James/0000-0002-2439-2657; Erdmann, Jeanette/0000-0002-4486-6231; Asselta, Rosanna/0000-0001-5351-0619; König, Inke R/0000-0003-0504-6465; Duga, Stefano/0000-0003-3457-1410; Daly, Mark J/0000-0002-0949-8752; Chen, Zhen/0000-0002-9946-1362; Olivieri, Oliviero/0000-0001-8209-9056; Girelli, Domenico/0000-0001-9684-1899; Deloukas, Panos/0000-0001-9251-070X; Peyvandi, Flora/0000-0001-7423-9864; Ramos, Rafel/0000-0001-7970-5537; Casari, Giorgio/0000-0002-0115-8980; Martinelli, Nicola/0000-0001-6465-5119; Altshuler, David M/0000-0002-7250-4107; Berzuini, Carlo/0000-0001-6056-0489; Preuss, Michael/0000-0001-5266-8465; Hall, Alistair/0000-0003-0306-7887; Reilly, Muredach/0000-0002-3035-9386; Ziegler, Andreas/0000-0002-8386-5397; Marrugat, Jaume/0000-0003-3320-554X; solinas, emilia/0000-0003-3532-1317; Melander, Olle/0000-0002-2581-484X; Lucas, Gavin/0000-0003-4166-9416; Spreafico, Marta/0000-0003-3378-5513; Engert, James/0000-0001-8411-4790; Voight, Benjamin/0000-0002-6205-9994; Piazza, Alberto/0000-0002-2355-4183; Ferrario, Marco M/0000-0003-2741-7124	Canada Graduate Scholarship Doctoral Award from the Canadian Institutes for Health Research; May Cohen Eli Lilly Endowed Chair in Womens Health Research, McMaster University; Michael G. DeGroote and Heart and Stroke Foundation of Ontario Chair in Population Health; Cardiovascular Institute of the University of Pennsylvania; UK Medical Research Council; European Union [LSHM-CT- 2006-037593]; Canadian Institutes for Health Research; German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft; Heart Trust Fund (Royal Victoria Hospital); Northern Ireland Chest, Heart and Stroke Association; Royal Victoria Hospital Research Fellowship; Northern Ireland Research and Development Office; Cariverona Foundation, Verona, Italy; Veneto Region; Italian Ministry of University and Research; MedStar Research Institute; GlaxoSmithKline; British Heart Foundation; Wellcome Trust; Finnish Foundation for Cardiovascular Research; Nordic Center of Excellence in Disease Genetics; Center of Excellence in Complex Disease Genetics of the Academy of Finland; Sigrid Juselius Foundation; National Center for Research Resources [U54 RR020278]; The Broad Institute Center for Genotyping and Analysis; Department of Medicine and Cardiovascular Research Center at Massachusetts General Hospital; Donovan Family Foundation; Fannie E. Rippel Foundation; Doris Duke Charitable Foundation Clinical Scientist Development Award; National Heart, Lung, and Blood Institute; AGAUR Generalitat de Catalunya; FIS de Catalunya; CIBER Epidemiologia y Salud Publica; Ministerio de Sanidad y Consumo Instituto de Salud Carlos III [Red HERACLES RD06/0009]; US National Institutes of Health [K24 DK080140, N01HD013107, P30ES007033, R01HL056931]; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0802320] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G0802320] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	Canada Graduate Scholarship Doctoral Award from the Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); May Cohen Eli Lilly Endowed Chair in Womens Health Research, McMaster University; Michael G. DeGroote and Heart and Stroke Foundation of Ontario Chair in Population Health; Cardiovascular Institute of the University of Pennsylvania; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heart Trust Fund (Royal Victoria Hospital); Northern Ireland Chest, Heart and Stroke Association; Royal Victoria Hospital Research Fellowship; Northern Ireland Research and Development Office; Cariverona Foundation, Verona, Italy(Fondazione Cariverona); Veneto Region(Regione Veneto); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); MedStar Research Institute; GlaxoSmithKline(GlaxoSmithKline); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Finnish Foundation for Cardiovascular Research; Nordic Center of Excellence in Disease Genetics; Center of Excellence in Complex Disease Genetics of the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); The Broad Institute Center for Genotyping and Analysis; Department of Medicine and Cardiovascular Research Center at Massachusetts General Hospital; Donovan Family Foundation; Fannie E. Rippel Foundation; Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGAUR Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); FIS de Catalunya; CIBER Epidemiologia y Salud Publica; Ministerio de Sanidad y Consumo Instituto de Salud Carlos III(Instituto de Salud Carlos III); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The HARPS study was supported by the grants (R01HL056931, P30ES007033) and a contract (N01HD013107) from US National Institutes of Health.; The REGICOR study was partially funded by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Red HERACLES RD06/0009), the CIBER Epidemiologia y Salud Publica, the FIS and AGAUR Generalitat de Catalunya.; Massachusetts General Hospital. The MIGen study was funded by the US National Institutes of Health (NIH) and National Heart, Lung, and Blood Institutes STAMPEED genomics research program through a grant to D.A. S.K. is supported by a Doris Duke Charitable Foundation Clinical Scientist Development Award, a charitable gift from the Fannie E. Rippel Foundation, the Donovan Family Foundation, a career development award from the NIH and the Department of Medicine and Cardiovascular Research Center at Massachusetts General Hospital. J.B.M. is supported by grant K24 DK080140 from the NIH.; Broad Institute. Genotyping was partially funded by The Broad Institute Center for Genotyping and Analysis, which is supported by grant U54 RR020278 from the National Center for Research Resources.; FINRISK. V.S. was supported by the Sigrid Juselius Foundation. L.P. was supported by the Center of Excellence in Complex Disease Genetics of the Academy of Finland, the Nordic Center of Excellence in Disease Genetics and the Finnish Foundation for Cardiovascular Research.; WTCCC Study. The study was funded by the Wellcome Trust. Recruitment of cases for the WTCCC Study was carried out by the British Heart Foundation (BHF) Family Heart Study Research Group and supported by the BHF and the UK Medical Research Council. N.J.S. and S.G.B. hold chairs funded by the BHF.; PennCATH/MedStar. Recruitment of the PennCATH cohort was supported by the Cardiovascular Institute of the University of Pennsylvania. Recruitment of the MedStar cohort was supported by a research grant from GlaxoSmithKline and from the MedStar Research Institute. Genotyping was done at the Center for Applied Genomics at the Childrens Hospital of Philadelphia and supported by GlaxoSmithKline through an Alternate Drug Discovery Initiative research alliance award (to M.P.R. and D.J.R.) with the University of Pennsylvania School of Medicine. D.J.R. was supported by a Doris Duke Charitable Foundation Distinguished Clinical Scientist Award.; Verona Heart Study. The study was supported by a grant from the Italian Ministry of University and Research and grants from the Veneto Region and the Cariverona Foundation, Verona, Italy; Mid-America Heart Institute. T.M. is supported by a career development grant from the NIH.; Irish Family Study. We thank the clinical staff members for their valuable contribution to the collection of families for this study. The research was supported by the Northern Ireland Research and Development Office, a Royal Victoria Hospital Research Fellowship, the Northern Ireland Chest, Heart and Stroke Association, and the Heart Trust Fund (Royal Victoria Hospital).; GerMIFS I and II. The German Study was supported by the Deutsche Forschungsgemeinschaft and the German Federal Ministry of Education and Research in the context of the German National Genome Research Network. Cardiogenics. Cardiogenics is an EU-funded integrated project (LSHM-CT- 2006-037593).; INTERHEART. S.A. holds the Michael G. DeGroote and Heart and Stroke Foundation of Ontario Chair in Population Health and the May Cohen Eli Lilly Endowed Chair in Womens Health Research, McMaster University. We acknowledge the contribution of S. Yusuf who initiated and, together with the Steering Committee, supervised the conduct of the INTERHEART study. We thank members of the Project Office, S. Rangarajan (study coordinator) and K. Hall (laboratory manager), for their assistance in coordinating the genetics component of the INTERHEART project. R.D. is a recipient of a Canada Graduate Scholarship Doctoral Award from the Canadian Institutes for Health Research.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; *CTR DIS CTRL PREV, 2004, MMWR-MORBID MORTAL W, V56, P113; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; KWON HM, 1992, J BIOL CHEM, V267, P6297; Linsel-Nitschke P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002986; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	847	867	2	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					334	341		10.1038/ng.327	http://dx.doi.org/10.1038/ng.327			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198609	Green Accepted			2022-12-25	WOS:000263640200023
J	Saenz, JB; Sun, WJ; Chang, JW; Li, JM; Bursulaya, B; Gray, NS; Haslam, DB				Saenz, Jose B.; Sun, William J.; Chang, Jae Won; Li, Jinmei; Bursulaya, Badry; Gray, Nathanael S.; Haslam, David B.			Golgicide A reveals essential roles for GBF1 in Golgi assembly and function	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; BREFELDIN-A; TRANS-GOLGI; ENDOPLASMIC-RETICULUM; MEMBRANE-TRANSPORT; TYROSYLPROTEIN SULFOTRANSFERASE; RETROGRADE TRANSPORT; PLASMA-MEMBRANE; PROTEIN COMPLEX; SEC7 DOMAINS	ADP ribosylation factor 1 (Arf1) plays a critical role in regulating secretory traffic and membrane transport within the Golgi of eukaryotic cells. Arf1 is activated by guanine nucleotide exchange factors (ArfGEFs), which confer spatial and temporal specificity to vesicular transport. We describe here the discovery and characterization of golgicide A, a potent, highly specific, reversible inhibitor of the cis-Golgi ArfGEF GBF1. Inhibition of GBF1 function resulted in rapid dissociation of COPI vesicle coat from Golgi membranes and subsequent disassembly of the Golgi and trans-Golgi network. Secretion of soluble and membrane-associated proteins was arrested at the endoplasmic reticulum-Golgi intermediate compartment, whereas endocytosis and recycling of transferrin were unaffected by GBF1 inhibition. Internalized shiga toxin was arrested within the endocytic compartment and was unable to reach the dispersed trans-Golgi network. Collectively, these results highlight the central role for GBF1 in coordinating bidirectional transport and maintaining structural integrity of the Golgi.	[Saenz, Jose B.; Sun, William J.; Li, Jinmei; Haslam, David B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Saenz, Jose B.; Sun, William J.; Li, Jinmei; Haslam, David B.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Chang, Jae Won; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chang, Jae Won; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Bursulaya, Badry] Genom Inst Novartis Res Fdn, San Diego, CA 92121 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Novartis	Haslam, DB (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave, St Louis, MO 63110 USA.	haslam@kids.wustl.edu	Chang, Jae Won/AAN-4139-2020; Haslam, David/G-3825-2012; Haslam, David/AAS-3175-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER; NIAID NIH HHS [F31 AI078716, U54 AI057160, U54 AI057160-05S10028] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; El Meskini R, 2001, ENDOCRINOLOGY, V142, P864, DOI 10.1210/endo.142.2.7929; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Ghosh P, 2004, EUR J CELL BIOL, V83, P257, DOI 10.1078/0171-9335-00374; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Holloway ZG, 2007, AM J PHYSIOL-CELL PH, V293, pC1753, DOI 10.1152/ajpcell.00253.2007; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; LIN WH, 1992, J BIOL CHEM, V267, P2876; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; NIEHRS C, 1990, EMBO J, V9, P35, DOI 10.1002/j.1460-2075.1990.tb08077.x; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Pacheco-Rodriguez G, 2002, METHOD ENZYMOL, V345, P397; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; Puri S, 2003, MOL BIOL CELL, V14, P5011, DOI 10.1091/mbc.E03-06-0437; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shmuel M, 2006, J BIOL CHEM, V281, P13300, DOI 10.1074/jbc.M513723200; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhao LY, 2005, J MED MICROBIOL, V54, P1023, DOI 10.1099/jmm.0.46143-0; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	50	150	154	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2009	5	3					157	165		10.1038/nchembio.144	http://dx.doi.org/10.1038/nchembio.144			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410DG	19182783	Green Accepted, Green Submitted			2022-12-25	WOS:000263556100013
J	Sun, J; Madan, R; Karp, CL; Braciale, TJ				Sun, Jie; Madan, Rajat; Karp, Christopher L.; Braciale, Thomas J.			Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10	NATURE MEDICINE			English	Article							DENDRITIC CELLS; CUTTING EDGE; LYMPH-NODES; INTERLEUKIN-10; RESPONSES; MACROPHAGES; ACTIVATION; INDUCTION; MEMORY	Activated antigen-specific T cells produce a variety of effector molecules for clearing infection but also contribute to inflammation and tissue injury. Here we report an anti-inflammatory property of antiviral CD8(+) and CD4(+) effector T cells (T-eff cells) in the infected periphery during acute virus infection. We find that, during acute influenza infection, interleukin-10 (IL-10) is produced in the infected lungs in large amounts-exclusively by infiltrating virus-specific Teff cells, with CD8(+) Teff cells contributing a larger fraction of the IL-10 produced. These Teff cells in the periphery simultaneously produce IL-10 and proinflammatory cytokines and express lineage markers characteristic of conventional T helper type 1 or T cytotoxic type 1 cells. Notably, blocking the action of the T-eff cell-derived IL-10 results in enhanced pulmonary inflammation and lethal injury. Our results show that antiviral Teff cells exert regulatory functions-that is, they fine-tune the extent of lung inflammation and injury associated with influenza infection by producing an anti-inflammatory cytokine. We discuss the potential implications of these findings for infection with highly pathogenic influenza viruses.	[Sun, Jie; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Madan, Rajat; Karp, Christopher L.] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA; [Madan, Rajat; Karp, Christopher L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Braciale, Thomas J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Virginia; University of Virginia	Braciale, TJ (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, 409 Lane Rd, Charlottesville, VA 22908 USA.	tjb2r@virginia.edu	Madan, Rajat/V-6168-2019	Madan, Rajat/0000-0002-9821-1257; Karp, Christopher/0000-0002-0832-2659	US National Institutes of Health [AI-15608, HL-33391, AI37293, AI057992]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057992, R37AI015608, R01AI015608, R01AI037293] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Hufford and T. Kim for critical comments and B. Small and S. Gill for excellent technical assistance. This work was supported by the US National Institutes of Health (grants AI-15608, HL-33391 and AI37293 to T.J.B. and AI057992 to C.L.K.).	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Doyle AG, 1999, J EXP MED, V190, P1081, DOI 10.1084/jem.190.8.1081; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jelley-Gibbs DM, 2007, J IMMUNOL, V178, P7563, DOI 10.4049/jimmunol.178.12.7563; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Noble A, 2006, BLOOD, V107, P4475, DOI 10.1182/blood-2005-10-3994; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; SARAWAR SR, 1994, J VIROL, V68, P3112, DOI 10.1128/JVI.68.5.3112-3119.1994; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun J, 2007, J IMMUNOL, V178, P1635, DOI 10.4049/jimmunol.178.3.1635; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Yoon H, 2007, J IMMUNOL, V179, P391, DOI 10.4049/jimmunol.179.1.391	37	441	459	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					277	284		10.1038/nm.1929	http://dx.doi.org/10.1038/nm.1929			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19234462	Green Accepted, Bronze			2022-12-25	WOS:000263914000027
J	Svensson, L; Howarth, K; McDowall, A; Patzak, I; Evans, R; Ussar, S; Moser, M; Metin, A; Fried, M; Tomlinson, I; Hogg, N				Svensson, Lena; Howarth, Kimberley; McDowall, Alison; Patzak, Irene; Evans, Rachel; Ussar, Siegfried; Moser, Markus; Metin, Ayse; Fried, Mike; Tomlinson, Ian; Hogg, Nancy			Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation	NATURE MEDICINE			English	Article							CALDAG-GEFI; PLATELET-AGGREGATION; BETA(2) INTEGRINS; GENETIC-ANALYSIS; EXCHANGE FACTOR; T-LYMPHOCYTES; CAIDAG-GEFI; LAD-III; PROTEIN; TALIN	Integrins are the major adhesion receptors of leukocytes and platelets. beta(1) and beta(2) integrin function on leukocytes is crucial for a successful immune response and the platelet integrin alpha(IIb)beta(3) initiates the process of blood clotting through binding fibrinogen(1-3). Integrins on circulating cells bind poorly to their ligands but become active after 'inside-out' signaling through other membrane receptors(4,5). Subjects with leukocyte adhesion deficiency-1 (LAD-I) do not express beta(2) integrins because of mutations in the gene specifying the beta(2) subunit, and they suffer recurrent bacterial infections(6,7). Mutations affecting aIIbb3 integrin cause the bleeding disorder termed Glanzmann's thrombasthenia(3). Subjects with LAD-III show symptoms of both LAD-I and Glanzmann's thrombasthenia. Their hematopoietically-derived cells express beta(1), beta(2) and beta(3) integrins, but defective inside-out signaling causes immune deficiency and bleeding problems(8). The LAD-III lesion has been attributed to a C -> A mutation in the gene encoding calcium and diacylglycerol guanine nucleotide exchange factor (CALDAGGEF1; official symbol RASGRP2) specifying the CALDAG-GEF1 protein(9), but we show that this change is not responsible for the LAD-III disorder. Instead, we identify mutations in the KINDLIN3 (official symbol FERMT3) gene specifying the KINDLIN-3 protein as the cause of LAD-III in Maltese and Turkish subjects. Two independent mutations result in decreased KINDLIN3 messenger RNA levels and loss of protein expression. Notably, transfection of the subjects' lymphocytes with KINDLIN3 complementary DNA but not CALDAGGEF1 cDNA reverses the LAD-III defect, restoring integrin-mediated adhesion and migration.	[Svensson, Lena; McDowall, Alison; Patzak, Irene; Evans, Rachel; Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London WC2A 3PX, England; [Howarth, Kimberley; Tomlinson, Ian] Canc Res UK London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; [Ussar, Siegfried; Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Metin, Ayse] SB Ankara Diskapi Childrens Hosp, Div Immunol, TR-06110 Ankara, Turkey; [Fried, Mike] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA	Cancer Research UK; Cancer Research UK; Max Planck Society; Ankara Children's Hematology Oncology Training & Research Hospital; University of California System; University of California San Francisco	Hogg, N (corresponding author), Canc Res UK London Res Inst, Leukocyte Adhes Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	nancy.hogg@cancer.org.uk	Evans, Rachel/GYU-7083-2022; Ussar, Siegfried/AAL-4331-2021; METIN, AYSE/AAS-2382-2020	Ussar, Siegfried/0000-0001-7575-0920; McDowall, Alison/0000-0003-2018-1462; Evans, Rachel/0000-0002-3723-2249; METIN, AYSE/0000-0002-0731-5799	Cancer Research UK [A3582] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Alon R, 2003, BLOOD, V101, P4437, DOI 10.1182/blood-2002-11-3427; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Etzioni A, 2004, CURR OPIN ALLERGY CL, V4, P485, DOI 10.1097/00130832-200412000-00003; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Harris ES, 2001, BLOOD, V97, P767, DOI 10.1182/blood.V97.3.767; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kellermann SA, 2002, IMMUNOL REV, V186, P172, DOI 10.1034/j.1600-065X.2002.18615.x; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kuijpers TW, 2007, BLOOD, V109, P3529, DOI 10.1182/blood-2006-05-021402; Kuijpers TW, 1997, J CLIN INVEST, V100, P1725, DOI 10.1172/JCI119697; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; McDowall A, 2003, J CLIN INVEST, V111, P51, DOI 10.1172/JCI200314076; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Springett GM, 2004, BIOESSAYS, V26, P730, DOI 10.1002/bies.20057; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Weinstein EJ, 2003, BBA-MOL BASIS DIS, V1637, P207, DOI 10.1016/S0925-4439(03)00035-8	36	285	290	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					306	312		10.1038/nm.1931	http://dx.doi.org/10.1038/nm.1931			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19234463	Green Accepted			2022-12-25	WOS:000263914000031
J	Jones, AR; Kramer, EM; Knox, K; Swarup, R; Bennett, MJ; Lazarus, CM; Leyser, HMO; Grierson, CS				Jones, Angharad R.; Kramer, Eric M.; Knox, Kirsten; Swarup, Ranjan; Bennett, Malcolm J.; Lazarus, Colin M.; Leyser, H. M. Ottoline; Grierson, Claire S.			Auxin transport through non-hair cells sustains root-hair development	NATURE CELL BIOLOGY			English	Article							LATERAL ROOT; ARABIDOPSIS; EFFLUX; PIN; TRAFFICKING; POLARITY; LOCALIZATION; INFORMATION; ELONGATION; EPIDERMIS	The plant hormone auxin controls root epidermal cell development in a concentration-dependent manner(1-3). Root hairs are produced on a subset of epidermal cells as they increase in distance from the root tip. Auxin is required for their initiation(4-7) and continued growth(8-11), but little is known about its distribution in this region of the root. Contrary to the expectation that hair cells might require active auxin influx to ensure auxin supply, we did not detect the auxin-influx transporter AUX1 in root-hair cells. A high level of AUX1 expression was detected in adjacent non-hair cell files. Non-hair cells were necessary to achieve wild-type root-hair length, although an auxin response was not required in these cells. Three-dimensional modelling of auxin flow in the root tip suggests that AUX1-dependent transport through non-hair cells maintains an auxin supply to developing hair cells as they increase in distance from the root tip, and sustains root-hair outgrowth. Experimental data support the hypothesis that instead of moving uniformly though the epidermal cell layer(3,12), auxin is mainly transported through canals that extend longitudinally into the tissue.	[Jones, Angharad R.; Lazarus, Colin M.; Grierson, Claire S.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Kramer, Eric M.] Bard Coll Simons Rock, Dept Phys, Massachusetts, MA 01230 USA; [Kramer, Eric M.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Knox, Kirsten; Leyser, H. M. Ottoline] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Knox, Kirsten] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Swarup, Ranjan; Bennett, Malcolm J.] Univ Nottingham, Sch Biosci, Plant Sci Div, Loughborough LE12 5RD, Leics, England	University of Bristol; University of Nottingham; University of York - UK; University of Edinburgh; University of Nottingham	Grierson, CS (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England.	Claire.Grierson@bristol.ac.uk	Leyser, Ottoline/AAC-5577-2019; Lazarus, Colin M/B-9474-2011; Bennett, Malcolm/G-4004-2010; Kramer, Eric M/B-9752-2008	Bennett, Malcolm/0000-0003-0475-390X; Leyser, Ottoline/0000-0003-2161-3829; Kramer, Eric/0000-0002-1424-2356; Knox, Kirsten/0000-0002-5487-1763; Jones, Angharad/0000-0001-7493-9625; swarup, Ranjan/0000-0002-6438-9188	BBSRC studentship; Lady Emily Smyth Agricultural Research Station; BBSRC Case Award; Centre for Plant Integrative Biology; Biotechnology and Biological Sciences Research Council [BB/C514958/1, BB/D019613/1] Funding Source: researchfish; BBSRC [BB/D019613/1] Funding Source: UKRI	BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lady Emily Smyth Agricultural Research Station; BBSRC Case Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre for Plant Integrative Biology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Schiefelbein for sharing material before publication, and Alan Champneys and Robert Payne for insightful discussions. A. R. J. was supported by a BBSRC studentship awarded to C. M. L. and C. S. G., and by the Lady Emily Smyth Agricultural Research Station; K. K. was supported by a BBSRC Case Award to H. M. O. L. and C. S. G.; M. B., R. S. and E. K. received support from the Centre for Plant Integrative Biology, which is a BBSRC/EPSRC Centre for Integrative Systems Biology.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; Berger F, 1998, CURR BIOL, V8, P421, DOI 10.1016/S0960-9822(98)70176-9; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Grierson CS, 1997, PLANT PHYSIOL, V115, P981, DOI 10.1104/pp.115.3.981; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; Kramer EM, 2007, J EXP BOT, V58, P3005, DOI 10.1093/jxb/erm155; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Kramer EM, 2006, PLANT PHYSIOL, V141, P1233, DOI 10.1104/pp.106.083790; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356	36	175	184	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					78	U156		10.1038/ncb1815	http://dx.doi.org/10.1038/ncb1815			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079245	Green Submitted, Green Accepted			2022-12-25	WOS:000262157000014
J	Limaye, N; Wouters, V; Uebelhoer, M; Tuominen, M; Wirkkala, R; Mulliken, JB; Eklund, L; Boon, LM; Vikkula, M				Limaye, Nisha; Wouters, Vinciane; Uebelhoer, Melanie; Tuominen, Marjut; Wirkkala, Riikka; Mulliken, John B.; Eklund, Lauri; Boon, Laurence M.; Vikkula, Miikka			Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations	NATURE GENETICS			English	Article							TYROSINE KINASES; VASCULAR DEVELOPMENT; ACTIVATION LOOP; TIE2 RECEPTOR; CELL-CELL; ANGIOGENESIS; EXPRESSION; CONTACTS; PROTEIN; EMBRYO	Germline substitutions in the endothelial cell tyrosine kinase receptor TIE2 (encoded by TEK) cause a rare, inherited form of venous anomaly known as a mucocutaneous venous malformation (VMCM; refs. 1-3 and V. W., N.L., M. U., A. Irrthum, L. M. B. et al., unpublished data). We identified a somatic 'second hit' causing loss of function of TIE2 in a resected VMCM and assessed whether such localized, tissue-specific events have a role in the etiology of sporadic venous malformations, which are far more common. We identified eight somatic TEK mutations in lesions from 28 of 57 individuals (49.1%) with sporadic venous malformations; the mutations were absent from the individuals' blood and control tissues. The somatic mutations included one causing a frequent L914F substitution and several double mutations in cis, all of which resulted in ligand-independent TIE2 hyperphosphorylation in vitro. When overexpressed in human umbilical vein endothelial cells, the L914F mutant was abnormally localized and responded to ligand, in contrast to wild-type TIE2 and the common, inherited R849W mutant, suggesting that the mutations have distinct effects. The presence of the same mutations in multifocal sporadic venous malformations in two individuals suggests a common origin for the abnormal endothelial cells at the distant sites. These data show that a sporadic disease may be explained by somatic changes in a gene causing rare, inherited forms and pinpoint TIE2 pathways as potential therapeutic targets for venous malformations.	[Limaye, Nisha; Wouters, Vinciane; Uebelhoer, Melanie; Boon, Laurence M.; Vikkula, Miikka] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium; [Tuominen, Marjut; Wirkkala, Riikka; Eklund, Lauri] Univ Oulu, Bioctr, Oulu Ctr Cell Matrix Res, FI-90014 Oulu, Finland; [Tuominen, Marjut; Wirkkala, Riikka; Eklund, Lauri] Univ Oulu, Dept Med Biochem & Mol Biol, FI-90014 Oulu, Finland; [Mulliken, John B.] Childrens Hosp, Dept Plast Surg, Boston, MA 02115 USA; [Mulliken, John B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Boon, Laurence M.] Univ Catholique Louvain, Clin Univ St Luc, Div Plast Surg, Ctr Vasc Anomalies, B-1200 Brussels, Belgium	Universite Catholique Louvain; University of Oulu; University of Oulu; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Vikkula, M (corresponding author), Univ Catholique Louvain, Duve Inst, Ave Hippocrate 74 5,Bp 75-39, B-1200 Brussels, Belgium.	miikka.vikkula@uclouvain.be	Boon, Laurence/HCI-3629-2022; Vikkula, Miikka/Q-1038-2018	Vikkula, Miikka/0000-0002-6236-338X	Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy [5/25, 6/05]; Belgian French Community Ministry [02/07/276, 7/12-005]; National Institutes of Health [P01 AR048564-01A1]; EU FW6 Integrated Project LYMPHANGIOGENOMICS [LSHG-CT2004-503573]; FNRS; UCL; Academy of Finland [116138]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy(Belgian Federal Science Policy Office); Belgian French Community Ministry; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU FW6 Integrated Project LYMPHANGIOGENOMICS(European Commission); FNRS(Fonds de la Recherche Scientifique - FNRS); UCL; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients for their invaluable contributions; A. Mendola, A. Van Egeren and J. Traskelin for expert technical assistance; C. Godfraind for immunohistochemistry; and L. Niculescu for secretarial help. These studies were partially supported by the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy (network 5/25 and 6/05), Concerted Research Actions (ARC) Conventions no. 02/07/276 and 7/12-005 of the Belgian French Community Ministry, National Institutes of Health program project P01 AR048564-01A1, EU FW6 Integrated Project LYMPHANGIOGENOMICS (LSHG-CT2004-503573), the Fonds national de la recherche scientifique (to M. V., a 'Maitre de recherches du FNRS'); a fellowship from Fonds pour la formation a la recherche dans l'industrie et dans l'agriculture (to V. W.), the Patrimoine UCL and the Academy of Finland (116138 to L. E. and M. T.).	Boon LM, 2004, ARCH DERMATOL, V140, P971, DOI 10.1001/archderm.140.8.971; BOON LM, 1994, HUM MOL GENET, V3, P1583, DOI 10.1093/hmg/3.9.1583; Calvert JT, 1999, HUM MOL GENET, V8, P1279, DOI 10.1093/hmg/8.7.1279; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Colmone A, 2008, TRANSL RES, V151, P1, DOI 10.1016/j.trsl.2007.09.003; DUMONT DJ, 1992, ONCOGENE, V7, P1471; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; Loughna S, 2001, MATRIX BIOL, V20, P319, DOI 10.1016/S0945-053X(01)00149-4; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Nobuhara Y, 2006, SURG TODAY, V36, P283, DOI 10.1007/s00595-005-3138-9; Partanen J, 1999, CURR TOP MICROBIOL, V237, P159; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; WOUTERS V, 2007, INBORN ERRORS DEV	27	262	272	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					118	124		10.1038/ng.272	http://dx.doi.org/10.1038/ng.272			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079259	Green Accepted			2022-12-25	WOS:000262085300026
J	Lefort, N; Feyeux, M; Bas, C; Feraud, O; Bennaceur-Griscelli, A; Tachdjian, G; Peschanski, M; Perrier, AL				Lefort, Nathalie; Feyeux, Maxime; Bas, Cecile; Feraud, Olivier; Bennaceur-Griscelli, Annelise; Tachdjian, Gerard; Peschanski, Marc; Perrier, Anselme L.			Human embryonic stem cells reveal recurrent genomic instability at 20q11.21	NATURE BIOTECHNOLOGY			English	Article							BREAST-CANCER; GENES; AMPLIFICATION; HYBRIDIZATION; MICROARRAY; REGIONS; LINES; 20Q; ARM	By analyzing five human embryonic stem (hES) cell lines over long-term culture, we identified a recurrent genomic instability in the human genome. An amplification of 2.5-4.6 Mb at 20q11.21, encompassing similar to 23 genes in common, was detected in four cell lines of different origins. This amplification, which has been associated with oncogenic transformation, may provide a selective advantage to hES cells in culture.	[Lefort, Nathalie; Feyeux, Maxime; Peschanski, Marc; Perrier, Anselme L.] Inst Stem Cell Therapy & Explorat Monogen Dis, AFM, INSERM, UEVE,I STEM,UMR 861, F-91030 Evry, France; [Bas, Cecile; Tachdjian, Gerard] Univ Paris 11, Hop Antoine Beclere, INSERM, Serv Biol & Genet Reprod,U782, Clamart, France; [Feraud, Olivier; Bennaceur-Griscelli, Annelise] Univ Paris 11, Hop Paul Brousse, INSERM, U602, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Perrier, AL (corresponding author), Inst Stem Cell Therapy & Explorat Monogen Dis, AFM, INSERM, UEVE,I STEM,UMR 861, 5 Rue Henri Desbrueres, F-91030 Evry, France.	aperrier@istem.genethon.fr	Perrier, Anselme L/B-2272-2019; Perrier, Anselme/E-3764-2010; Peschanski, Marc/N-5769-2017	Perrier, Anselme L/0000-0001-7915-1968; FERAUD, Olivier/0000-0002-5332-600X; bennaceur griscelli, annelise/0000-0002-3557-4499	Medicen Paris Region; EC; ANR	Medicen Paris Region; EC(European CommissionEuropean Commission Joint Research Centre); ANR(French National Research Agency (ANR))	This study has been supported in part by additional grants from Medicen Paris Region (IngeCELL), EC (FP6, STEM-HD) and ANR (HESCREEN). The authors thank K. Sermon (AZ-VUB, Brussels) for kindly providing VUB cell lines.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Guan XY, 1996, CANCER RES, V56, P3446; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; Josephson R, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-28; Koynova DK, 2007, MELANOMA RES, V17, P37, DOI 10.1097/CMR.0b013e3280141617; Loring JF, 2006, STEM CELLS, V24, P145, DOI 10.1634/stemcells.2005-0432; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Midorikawa Y, 2006, ONCOGENE, V25, P5581, DOI 10.1038/sj.onc.1209537; RITHIDECH K, 1995, P NATL ACAD SCI USA, V92, P1152, DOI 10.1073/pnas.92.4.1152; Rithidech KN, 1997, BLOOD CELL MOL DIS, V23, P99, DOI 10.1006/bcmd.1997.0126; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Tanner MM, 1996, CANCER RES, V56, P3441; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993	15	155	161	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1364	1366		10.1038/nbt.1509	http://dx.doi.org/10.1038/nbt.1509			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19029913				2022-12-25	WOS:000261591300021
J	Arimoto, K; Fukuda, H; Imajoh-Ohmi, S; Saito, H; Takekawa, M				Arimoto, Kyoko; Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu; Saito, Haruo; Takekawa, Mutsuhiro			Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways	NATURE CELL BIOLOGY			English	Article							KINASE KINASE; PROTEIN; ACTIVATION; MTK1/MEKK4; RACK1; P38; JNK; IDENTIFICATION; TRANSLATION; RECEPTOR	When confronted with environmental stress, cells either activate defence mechanisms to survive, or initiate apoptosis, depending on the type of stress. Certain types of stress, such as hypoxia, heatshock and arsenite (type 1 stress), induce cells to assemble cytoplasmic stress granules (SGs), a major adaptive defence mechanism. SGs are multimolecular aggregates of stalled translation pre-initiation complexes that prevent the accumulation of mis-folded proteins(1). Type 2 stress, which includes X-rays and genotoxic drugs, induce apoptosis through the stress-activated p38 and JNK MAPK (SAPK) pathways. A functional relationship between the SG and SAPK responses is unknown. Here, we report that SG formation negatively regulates the SAPK apoptotic response, and that the signalling scaffold protein RACK1 functions as a mediator between the two responses. RACK1 binds to the stress-responsive MTK1 MAPKKK and facilitates its activation by type 2 stress; however, under conditions of type 1 stress, RACK1 is sequestered into SGs. Thus, type 1 conditions suppress activation of the MTK1-SAPK pathway and apoptosis induced by type 2 stress. These findings may be relevant to the problem of hypoxia-induced resistance to cancer chemotherapy.	[Arimoto, Kyoko; Saito, Haruo; Takekawa, Mutsuhiro] Univ Tokyo, Inst Med Sci, Dept Mol Cell Signaling, Minato Ku, Tokyo 1088639, Japan; [Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Arimoto, Kyoko; Saito, Haruo; Takekawa, Mutsuhiro] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Saito, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Cell Signaling, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	saito@ims.u-tokyo.ac.jp; takekawa@ims.u-tokyo.ac.jp	Saito, Haruo/AAF-6113-2019	Saito, Haruo/0000-0001-7891-1689; Takekawa, Mutsuhiro/0000-0002-8027-3847	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by several grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M. T. and H. S.), and by a PRESTO programme from the Japan Science and Technology Agency (M. T.). We thank P. O'Grady for critical reading of the manuscript and T. Chano (Shiga University of Medical Science), S. Iwata (University of Tokyo), K. Matsumoto ( Nagoya University) and H. Ichijo (University of Tokyo) for plasmids.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kayali F, 2005, NEUROSCIENCE, V134, P1223, DOI 10.1016/j.neuroscience.2005.05.047; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; KIMBALL SR, 2002, AM J PHYSIOL-CELL PH, V284, P273; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	30	387	398	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1324	U167		10.1038/ncb1791	http://dx.doi.org/10.1038/ncb1791			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836437				2022-12-25	WOS:000260586700015
J	Capaldi, AP; Kaplan, T; Liu, Y; Habib, N; Regev, A; Friedman, N; O'Shea, EK				Capaldi, Andrew P.; Kaplan, Tommy; Liu, Ying; Habib, Naomi; Regev, Aviv; Friedman, Nir; O'Shea, Erin K.			Structure and function of a transcriptional network activated by the MAPK Hog1	NATURE GENETICS			English	Article							DEPENDENT OSMOTIC REGULATION; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; PROTEIN-KINASE; EXPRESSION PROFILES; REGULATORY NETWORK; GENE-EXPRESSION; REDUNDANT ROLES; STRESS; GENOME	Cells regulate gene expression using a complex network of signaling pathways, transcription factors and promoters. To gain insight into the structure and function of these networks, we analyzed gene expression in single- and multiple-mutant strains to build a quantitative model of the Hog1 MAPK-dependent osmotic stress response in budding yeast. Our model reveals that the Hog1 and general stress (Msn2/4) pathways interact, at both the signaling and promoter level, to integrate information and create a context-dependent response. This study lays out a path to identifying and characterizing the role of signal integration and processing in other gene regulatory networks.	[Capaldi, Andrew P.; Liu, Ying; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci Ctr, Ctr Syst Biol, Howard Hughes Med Inst,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Capaldi, Andrew P.; Liu, Ying; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci Ctr, Ctr Syst Biol,Northwest Labs, Howard Hughes Med Inst,Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kaplan, Tommy; Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Kaplan, Tommy; Habib, Naomi] Hebrew Univ Jerusalem, Fac Med, Dept Mol Genet & Biotechnol, IL-91120 Jerusalem, Israel; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02142 USA; [Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	O'Shea, EK (corresponding author), Harvard Univ, Fac Arts & Sci Ctr, Ctr Syst Biol, Howard Hughes Med Inst,Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Habib, Naomi/AAA-8937-2020; Kaplan, Tommy/T-2528-2017; Friedman, Nir/H-9692-2012	Kaplan, Tommy/0000-0002-1892-5461; Friedman, Nir/0000-0002-9678-3550	HHMI; Human Frontiers Science Program	HHMI(Howard Hughes Medical Institute); Human Frontiers Science Program(Human Frontier Science Program)	We thank D. Steger, D. Wykoff, A. Carroll and C. Hopkins from Agilent for advice regarding microarray, ChIP and other procedures; T. Lee and R. Young for sharing their tiling-array design and hybridization protocol before publication; H. Margalit and members of the O'Shea, Friedman and Regev laboratories for helpful discussions; and P. Grosu for help with Rosetta Resolver. We are also grateful to E. Lander, D. Pe'er, D. Koller, R. Losick, M. Brenner and B. Stern for reading the manuscript before publication. A. P. C. was a Howard Hughes Medical Institute (HHMI) Fellow of the Life Sciences Research Foundation and A. R. was supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. This work was supported by HHMI (E.K.O.) and a grant from the Human Frontiers Science Program (E.K.O., A.R. and N.F.).	Alon U, 2007, INTRO SYSTEMS BIOL D; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Durchschlag E, 2004, J BIOL CHEM, V279, P55425, DOI 10.1074/jbc.M407264200; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Erasmus DJ, 2003, FEMS YEAST RES, V3, P375, DOI 10.1016/S1567-1356(02)00203-9; Garreau H, 2000, MICROBIOL-UK, V146, P2113, DOI 10.1099/00221287-146-9-2113; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nevitt T, 2004, BIOCHEM J, V379, P367, DOI 10.1042/BJ20031127; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Robyr D, 2004, METHOD ENZYMOL, V376, P289; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; [No title captured]	35	166	174	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1300	1306		10.1038/ng.235	http://dx.doi.org/10.1038/ng.235			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18931682	Green Accepted			2022-12-25	WOS:000260501500021
J	Chechik, G; Oh, E; Rando, O; Weissman, J; Regev, A; Koller, D				Chechik, Gal; Oh, Eugene; Rando, Oliver; Weissman, Jonathan; Regev, Aviv; Koller, Daphne			Activity motifs reveal principles of timing in transcriptional control of the yeast metabolic network	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PROTEIN EXPRESSION; GLOBAL ANALYSIS; ARCHITECTURE; MODULARITY; EVOLUTION; SELECTION	Significant insight about biological networks arises from the study of network motifs-overly abundant network subgraphs(1,2)-but such wiring patterns do not specify when and how potential routes within a cellular network are used. To address this limitation, we introduce activity motifs, which capture patterns in the dynamic use of a network. Using this framework to analyze transcription in Saccharomyces cerevisiae metabolism, we find that cells use different timing activity motifs to optimize transcription timing in response to changing conditions: forward activation to produce metabolic compounds efficiently, backward shutoff to rapidly stop production of a detrimental product and synchronized activation for co-production of metabolites required for the same reaction. Measuring protein abundance over a time course reveals that mRNA timing motifs also occur at the protein level. Timing motifs significantly overlap with binding activity motifs, where genes in a linear chain have ordered binding affinity to a transcription factor, suggesting a mechanism for ordered transcription. Finely timed transcriptional regulation is therefore abundant in yeast metabolism, optimizing the organism's adaptation to new environmental conditions.	[Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02142 USA; [Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chechik, Gal; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Oh, Eugene; Weissman, Jonathan] Univ Calif San Francisco, Howard Hughes Med Fdn, San Francisco, CA 94143 USA; [Oh, Eugene; Weissman, Jonathan] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Rando, Oliver] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01655 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester	Regev, A (corresponding author), MIT, Dept Biol, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; koller@cs.stanford.edu		Oh, Eugene/0000-0003-1970-8423; Weissman, Jonathan/0000-0003-2445-670X; Chechik, Gal/0000-0001-9164-5303; Rando, Oliver/0000-0003-1516-9397	National Science Foundation [BDI-0345474]; Burroughs Wellcome Fund; NIGMS; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079205] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by the National Science Foundation under grant BDI-0345474. A.R. was supported by a Career award at the Scientific Interface from the Burroughs Wellcome Fund and by NIGMS. J.W. was supported by the Howard Hughes Medical Institute. The authors thank Trey Ideker, Dwight Kuo, Craig Mak and Eran Segal for assistance in early stages of this project, and Dana Pe'er and especially Eric Lander for useful discussions.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bilu Y, 2006, PLOS COMPUT BIOL, V2, P932, DOI 10.1371/journal.pcbi.0020106; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHECHIK G, J CELL BIOL IN PRESS; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goh KI, 2002, P NATL ACAD SCI USA, V99, P12583, DOI 10.1073/pnas.202301299; Grant Chris M, 2008, J Biol, V7, P1, DOI 10.1186/jbiol63; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kharchenko P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100023; Kitagawa E, 2005, BIOSCI BIOTECH BIOCH, V69, P2285, DOI 10.1271/bbb.69.2285; Lai LC, 2005, MOL CELL BIOL, V25, P4075, DOI 10.1128/MCB.25.10.4075-4091.2005; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Mercier G, 2005, NUCLEIC ACIDS RES, V33, P6635, DOI 10.1093/nar/gki959; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; O'Rourke SM, 2002, MOL CELL BIOL, V22, P4739, DOI 10.1128/MCB.22.13.4739-4749.2002; Ozier O, 2003, NAT BIOTECHNOL, V21, P490, DOI 10.1038/nbt0503-490; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; Raijman D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040007; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rossell S, 2006, P NATL ACAD SCI USA, V103, P2166, DOI 10.1073/pnas.0509831103; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tanay A, 2004, GENOME RES, V14, P829, DOI 10.1101/gr.2064404; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Zakrzewska A, 2005, EUKARYOT CELL, V4, P703, DOI 10.1128/EC.4.4.703-715.2005; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zhang Lan V, 2005, J Biol, V4, P6, DOI 10.1186/jbiol23	47	122	122	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2008	26	11					1251	1259		10.1038/nbt.1499	http://dx.doi.org/10.1038/nbt.1499			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	371LG	18953355	Green Accepted			2022-12-25	WOS:000260832200020
J	Wang, E; Wang, J; Zhu, XD; Hao, W; Wang, LY; Li, Q; Zhang, LX; He, W; Lu, BR; Lin, HX; Ma, H; Zhang, GQ; He, ZH				Wang, Ertao; Wang, Jianjun; Zhu, Xudong; Hao, Wei; Wang, Linyou; Li, Qun; Zhang, Lixia; He, Wei; Lu, Baorong; Lin, Hongxuan; Ma, Hong; Zhang, Guiquan; He, Zuhua			Control of rice grain-filling and yield by a gene with a potential signature of domestication	NATURE GENETICS			English	Article							CELL-WALL INVERTASE; QUANTITATIVE TRAIT LOCI; ENCODES; SELECTION; WEIGHT; PLANT; ENDOSPERM; GENOME; WIDTH; QTL	Grain-filling, an important trait that contributes greatly to grain weight, is regulated by quantitative trait loci and is associated with crop domestication syndrome(1-4). However, the genes and underlying molecular mechanisms controlling crop grain-filling remain elusive. Here we report the isolation and functional analysis of the rice GIF1 (GRAIN INCOMPLETE FILLING 1) gene that encodes a cell-wall invertase required for carbon partitioning during early grain-filling. The cultivated GIF1 gene shows a restricted expression pattern during grain-filling compared to the wild rice allele, probably a result of accumulated mutations in the gene's regulatory sequence through domestication. Fine mapping with introgression lines revealed that the wild rice GIF1 is responsible for grain weight reduction. Ectopic expression of the cultivated GIF1 gene with the 35S or rice Waxy promoter resulted in smaller grains, whereas overexpression of GIF1 driven by its native promoter increased grain production. These findings, together with the domestication signature that we identified by comparing nucleotide diversity of the GIF1 loci between cultivated and wild rice, strongly suggest that GIF1 is a potential domestication gene and that such a domestication-selected gene can be used for further crop improvement.	[Wang, Ertao; Hao, Wei; Li, Qun; Lin, Hongxuan; He, Zuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Wang, Ertao; Zhu, Xudong] China Natl Rice Res Inst, Hangzhou 31006, Zhejiang, Peoples R China; [Wang, Jianjun; Wang, Linyou; Zhang, Lixia] Zhenjiang Acad Agr Sci, Hangzhou 310021, Zhejiang, Peoples R China; [Lu, Baorong] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Ma, Hong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ma, Hong] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Zhang, Guiquan] S China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Jiangsu Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; South China Agricultural University	He, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	zhhe@sibs.ac.cn	WANG, TAO ER/GYV-0174-2022; cxzhou, cxzhou/AEO-7639-2022; Wang, Ertao/GYU-4506-2022; Lu, Bao-Rong/C-3130-2009; Lin, Hong-Xuan/AEQ-6607-2022; Ma, Hong/W-5251-2018	Wang, Ertao/0000-0002-5178-3530; Lu, Bao-Rong/0000-0002-0214-2390; Lin, Hong-Xuan/0000-0002-2818-023X; Ma, Hong/0000-0001-8717-4422; He, Zuhua/0000-0002-6098-7893	Ministry of Science and Technology of China [2007AA02Z162, 2006AA10A102, 2007AA10Z187]; National Natural Science Foundation of China [30721061, 30623006]; Reproductive Development Project of the Shanghai Institutes for Biological Sciences; Direct For Biological Sciences [1120417] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1026094] Funding Source: National Science Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Reproductive Development Project of the Shanghai Institutes for Biological Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J.Y. Li, T. Sang and J.M. Li for critical reading of the manuscript and helpful suggestions; B. Han for the rice BAC clone; Z.Y. Wang for the Waxy promoter; D. Luo for help with in situ hybridization; X.Y. Gao and X. S. Gao for assistance with scanning electron microscopy and confocal laser microscopy; X.M. Zhang, L.J. Zeng and S.H. Ye for rice growth; and H.Q. Zheng for assistance with sugar measurement. This work was supported by grants from the Ministry of Science and Technology of China (2007AA02Z162, 2006AA10A102 and 2007AA10Z187), grants from the National Natural Science Foundation of China (30721061 and 30623006) and the Reproductive Development Project of the Shanghai Institutes for Biological Sciences.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fridman E, 2004, SCIENCE, V305, P1786, DOI 10.1126/science.1101666; Hao Wei, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P354; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li JM, 2004, GENETICS, V168, P2187, DOI 10.1534/genetics.104.034165; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nagata K, 2001, PLANT PROD SCI, V4, P173, DOI 10.1626/pps.4.173; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	30	516	639	11	303	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1370	1374		10.1038/ng.220	http://dx.doi.org/10.1038/ng.220			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820698				2022-12-25	WOS:000260501500033
J	Wood, K				Wood, Kathryn			Outlook for longer-lasting islets	NATURE MEDICINE			English	Editorial Material							MEMORY T-CELLS; TRANSPLANTATION; HOMEOSTASIS; TOLERANCE		John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England	University of Oxford	Wood, K (corresponding author), John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Headley Way, Oxford OX3 9DU, England.	kathryn.wood@nds.ox.ac.uk						Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; Monti P, 2008, J CLIN INVEST, V118, P1806, DOI 10.1172/JCI35197; Pearson T, 2003, ANN NY ACAD SCI, V1005, P148, DOI 10.1196/annals.1288.016; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Trzonkowski P, 2006, TRANSPLANTATION, V82, P1342, DOI 10.1097/01.tp.0000239268.64408.84	9	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2008	14	11					1156	1157		10.1038/nm1108-1156	http://dx.doi.org/10.1038/nm1108-1156			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18989281				2022-12-25	WOS:000260751200016
J	Endo, A				Endo, Akira			A gift from nature: the birth of the statins	NATURE MEDICINE			English	Editorial Material							COENZYME-A REDUCTASE; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; HYPOCHOLESTEROLEMIC ACTIVITY; COMPETITIVE INHIBITOR; ML-236B; HYPERCHOLESTEROLEMIA; DISCOVERY		Biopharm Res Labs Inc, Tokyo 1810013, Japan		Endo, A (corresponding author), Biopharm Res Labs Inc, 3-41-3 501 Shimorenjaku, Tokyo 1810013, Japan.	aerdo@biopharm.co.jp						ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; ENDO A, 1992, J LIPID RES, V33, P1569; ENDO A, 1979, BIOCHIM BIOPHYS ACTA, V575, P266; MABUCHI H, 1981, NEW ENGL J MED, V305, P478, DOI 10.1056/NEJM198108273050902; Steinberg D, 2006, J LIPID RES, V47, P1339, DOI 10.1194/jlr.R600009-JLR200; TSUJITA Y, 1979, ATHEROSCLEROSIS, V32, P307, DOI 10.1016/0021-9150(79)90174-6; YAMAMOTO A, 1980, ATHEROSCLEROSIS, V35, P259, DOI 10.1016/0021-9150(80)90124-0	9	78	82	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1050	1052		10.1038/nm1008-1050	http://dx.doi.org/10.1038/nm1008-1050			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18841147				2022-12-25	WOS:000259892300034
J	Gutierrez, JA; Crowder, T; Rinaldo-Matthis, A; Ho, MC; Almo, SC; Schramm, VL				Gutierrez, Jemy A.; Crowder, Tamara; Rinaldo-Matthis, Agnes; Ho, Meng-Chiao; Almo, Steven C.; Schramm, Vern L.			Transition state analogs of 5 '-methylthioadenosine nucleosidase disrupt quorum sensing	NATURE CHEMICAL BIOLOGY			English	Article							CONTROLS BIOFILM FORMATION; VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; STREPTOCOCCUS-PNEUMONIAE; PATHOGENIC BACTERIA; PHOSPHORYLASE; INHIBITORS; AUTOINDUCER-2	5'-Methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) is a bacterial enzyme involved in S-adenosylmethionine related quorum sensing pathways that induce bacterial pathogenesis factors. Transition state analogs MT-DADMe-Immucillin-A, EtT-DADMe-Immucillin-A and BuT-DADMe-Immucillin-A are slow-onset, tight-binding inhibitors of Vibrio cholerae MTAN (VcMTAN), with equilibrium dissociation constants of 73, 70 and 208 pM, respectively. Structural analysis of VcMTAN with BuT-DADMe-Immucillin-A revealed interactions contributing to the high affinity. We found that in V. cholerae cells, these compounds are potent MTAN inhibitors with IC50 values of 27, 31 and 6 nM for MT-, EtT- and BuT-DADMe-Immucillin-A, respectively; the compounds disrupt autoinducer production in a dose-dependent manner without affecting growth. MT- and BuT-DADMe- Immucillin-A also inhibited autoinducer-2 production in enterohemorrhagic Escherichia coli O157:H7 with IC50 values of 600 and 125 nM, respectively. BuT-DADMe-Immucillin-A inhibition of autoinducer-2 production in both strains persisted for several generations and caused reduction in biofilm formation. These results support MTAN's role in quorum sensing and its potential as a target for bacterial anti-infective drug design.	[Gutierrez, Jemy A.; Crowder, Tamara; Rinaldo-Matthis, Agnes; Ho, Meng-Chiao; Almo, Steven C.; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Schramm, VL (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	vern@aecom.yu.edu	Ho, Meng-Chiao/H-2448-2015	Ho, Meng-Chiao/0000-0002-5424-4524	US National Institutes of Health [GM41916]; US Department of Energy; US National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041916, R37GM041916] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge R. H. Furneaux, G. B. Evans, D. H. Lenz, G. F. Painter and P. C. Tyler of Industrial Research Laboratory, Inc. for supplying the DADMe-Immucillins; M. G. Surette (University of Calgary) for providing V. harveyi strains BB120 and BB170; C. Bradbeer (University of Virginia) for the E. coli MTAN knockout; and the US National Institutes of Health grant GM41916 for funding. Data for this study were collected at beamline X29A of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources of the US National Institutes of Health.	Anand SK, 2003, INT J FOOD MICROBIOL, V85, P1, DOI 10.1016/S0168-1605(02)00482-8; Balakrishnan K, 2006, BLOOD, V108, P2392, DOI 10.1182/blood-2006-03-007468; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans GB, 2005, J MED CHEM, V48, P4679, DOI 10.1021/jm050269z; Evans GB, 2004, J MED CHEM, V47, P3275, DOI 10.1021/jm0306475; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Gutierrez JA, 2007, ACS CHEM BIOL, V2, P725, DOI 10.1021/cb700166z; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Harasawa H, 2002, LEUKEMIA, V16, P1799, DOI 10.1038/sj.leu.2402570; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; Joyce EA, 2004, INFECT IMMUN, V72, P2964, DOI 10.1128/IAI.72.5.2964-2975.2004; Lee JE, 2005, J BIOL CHEM, V280, P18274, DOI 10.1074/jbc.M414471200; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Robak T, 2006, CURR MED CHEM, V13, P3165, DOI 10.2174/092986706778742918; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; Singh V, 2005, BIOCHEMISTRY-US, V44, P11647, DOI 10.1021/bi050863a; Singh V, 2005, J BIOL CHEM, V280, P18265, DOI 10.1074/jbc.M414472200; Singh V, 2004, BIOCHEMISTRY-US, V43, P9, DOI 10.1021/bi0358420; Singh V, 2007, J AM CHEM SOC, V129, P13831, DOI 10.1021/ja0754204; Singh V, 2007, J AM CHEM SOC, V129, P2783, DOI 10.1021/ja065082r; Singh V, 2006, J AM CHEM SOC, V128, P14691, DOI 10.1021/ja065419p; Singh V, 2006, BIOCHEMISTRY-US, V45, P12929, DOI 10.1021/bi061184i; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Sperondio V, 2007, EXPERT REV ANTI-INFE, V5, P271, DOI 10.1586/14787210.5.2.271; Stroeher UH, 2003, INFECT IMMUN, V71, P3206, DOI 10.1128/IAI.71.6.3206-3212.2003; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Winzer K, 2002, INFECT IMMUN, V70, P2245, DOI 10.1128/IAI.70.4.2245-2248.2002; Winzer K, 2001, INT J MED MICROBIOL, V291, P131, DOI 10.1078/1438-4221-00110; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	49	128	137	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2009	5	4					251	257		10.1038/nchembio.153	http://dx.doi.org/10.1038/nchembio.153			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	422KH	19270684	Green Accepted			2022-12-25	WOS:000264426100014
J	Meynard, D; Kautz, L; Darnaud, V; Canonne-Hergaux, F; Coppin, H; Roth, MP				Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Canonne-Hergaux, Francois; Coppin, Helene; Roth, Marie-Paule			Lack of the bone morphogenetic protein BMP6 induces massive iron overload	NATURE GENETICS			English	Article							HEPCIDIN; EXPRESSION; HEMOCHROMATOSIS; FERROPORTIN; HEMOJUVELIN; MEMBRANE; MODEL; MICE; TFR2; HFE	Expression of hepcidin, a key regulator of intestinal iron absorption, can be induced in vitro by several bone morphogenetic proteins (BMPs), including BMP2, BMP4 and BMP9 (refs. 1,2). However, in contrast to BMP6, expression of other BMPs is not regulated at the mRNA level by iron in vivo(3), and their relevance to iron homeostasis is unclear. We show here that targeted disruption of Bmp6 in mice causes a rapid and massive accumulation of iron in the liver, the acinar cells of the exocrine pancreas, the heart and the renal convoluted tubules. Despite their severe iron overload, the livers of Bmp6-deficient mice have low levels of phosphorylated Smad1, Smad5 and Smad8, and these Smads are not significantly translocated to the nucleus. In addition, hepcidin synthesis is markedly reduced. This indicates that Bmp6 is critical for iron homeostasis and that it is functionally nonredundant with other members of the Bmp subfamily. Notably, Bmp6-deficient mice retain their capacity to induce hepcidin in response to inflammation. The iron burden in Bmp6 mutant mice is significantly greater than that in mice deficient in the gene associated with classical hemochromatosis (Hfe), suggesting that mutations in BMP6 might cause iron overload in humans with severe juvenile hemochromatosis for which the genetic basis has not yet been characterized.	[Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Coppin, Helene; Roth, Marie-Paule] INSERM, U563, F-31300 Toulouse, France; [Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Coppin, Helene; Roth, Marie-Paule] Univ Toulouse, UPS, Ctr Physiopathol Toulouse Purpan, F-31300 Toulouse, France; [Meynard, Delphine; Kautz, Leon; Darnaud, Valerie; Coppin, Helene; Roth, Marie-Paule] Inst Biomed, F-31300 Toulouse, France; [Canonne-Hergaux, Francois] CNRS, UPR 2301, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Roth, MP (corresponding author), INSERM, U563, F-31300 Toulouse, France.	marie.paule.roth@inserm.fr	Coppin, Hélène/G-4326-2013; CANONNE-HERGAUX, François/AAC-2073-2020; meynard, delphine/B-4236-2014; Canonne-Hergaux, Francois/L-5363-2016; Roth, Marie-Paule/Q-2866-2018	Coppin, Hélène/0000-0001-7911-6353; CANONNE-HERGAUX, François/0000-0002-0621-2157; meynard, delphine/0000-0002-9927-5535; Canonne-Hergaux, Francois/0000-0002-0621-2157; Roth, Marie-Paule/0000-0001-9691-4234; Kautz, Leon/0000-0002-2320-0457	Agence Nationale pour la Recherche (ANR); European Commission [LSHM-CT-2006-037296]; Fondation pour la Recherche Medicale	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The authors thank E. Robertson (Dunn School of Pathology, University of Oxford) for kindly providing the Bmp6-deficient mice, C. Rouanet for excellent technical assistance, J. Seumois and M. Calise (Service de Zootechnie, IFR30, Toulouse) for their help with the mouse breeding, and S. Allart (Cellular Imaging platform, IFR30), F. Capilla and T. Al Saati (Experimental Histopathology platform, IFR30) for skilled advice. This work was supported in part by grants from the Agence Nationale pour la Recherche (ANR, programme IRONGENES), the European Commission (LSHM-CT-2006-037296: EUROIRON1) and the Fondation pour la Recherche Medicale (to L. K.).	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Canonne-Hergaux F, 2001, BLOOD, V97, P1138, DOI 10.1182/blood.V97.4.1138; Cox TM, 2002, BLOOD CELL MOL DIS, V29, P411, DOI 10.1006/bcmd.2002.0580; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pipemo A, 2007, BLOOD, V110, P4096, DOI 10.1182/blood-2007-06-096503; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	26	448	474	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					478	481		10.1038/ng.320	http://dx.doi.org/10.1038/ng.320			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19252488				2022-12-25	WOS:000264659000024
J	Naylor, E; Arredouani, A; Vasudevan, SR; Lewis, AM; Parkesh, R; Mizote, A; Rosen, D; Thomas, JM; Izumi, M; Ganesan, A; Galione, A; Churchill, GC				Naylor, Edmund; Arredouani, Abdelilah; Vasudevan, Sridhar R.; Lewis, Alexander M.; Parkesh, Raman; Mizote, Akiko; Rosen, Daniel; Thomas, Justyn M.; Izumi, Minoru; Ganesan, A.; Galione, Antony; Churchill, Grant C.			Identification of a chemical probe for NAADP by virtual screening	NATURE CHEMICAL BIOLOGY			English	Article							CYCLIC ADP-RIBOSE; CA2+ RELEASE; ENDOPLASMIC-RETICULUM; PANCREATIC ACINAR; DRUG DISCOVERY; RECEPTOR; INACTIVATION; SELECTION; DOCKING; MODEL	Research into the biological role of the Ca2+-releasing second messenger NAADP (nicotinic acid adenine dinucleotide phosphate) has been hampered by a lack of chemical probes. To find new chemical probes for exploring NAADP signaling, we turned to virtual screening, which can evaluate millions of molecules rapidly and inexpensively. We used NAADP as the query ligand to screen the chemical library ZINC for compounds with similar three-dimensional shape and electrostatic properties. We tested the top-ranking hits in a sea urchin egg bioassay and found that one hit, Ned-19, blocks NAADP signaling at nanomolar concentrations. In intact cells, Ned-19 blocked NAADP signaling and fluorescently labeled NAADP receptors. Moreover, we show the utility of Ned-19 as a chemical probe by using it to demonstrate that NAADP is a key causal link between glucose sensing and Ca2+ increases in mouse pancreatic beta cells.	[Naylor, Edmund; Arredouani, Abdelilah; Vasudevan, Sridhar R.; Lewis, Alexander M.; Parkesh, Raman; Rosen, Daniel; Thomas, Justyn M.; Galione, Antony; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Mizote, Akiko; Izumi, Minoru] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Ganesan, A.] Univ Southampton, Sch Chem, Southampton, Hants, England	University of Oxford; Okayama University; University of Southampton	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Ganesan, A/F-6698-2011; Galione, Antony/E-5884-2011; arredouani, abdelilah/Q-9650-2019; Vasudevan, Sridhar/B-1841-2015	Vasudevan, Sridhar/0000-0003-0516-2984; arredouani, abdelilah/0000-0002-5060-916X; Ganesan, A/0000-0003-4862-7999; Galione, Antony/0000-0002-4132-7646	Biotechnology and Biological Sciences Research Council [BB/D012694/1]; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; BBSRC [BB/D012694/1, BB/G008523/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Our research was supported by a grant from the Biotechnology and Biological Sciences Research Council (grant number BB/D012694/1). We thank P. Hawkins (OpenEye Scientific Software) for advice with virtual screening, H.-C. Lee (University of Hong Kong) for providing ADP-ribosyl cyclase and C. Garnham (Oxford University) for help with the plate reader.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Arredouani A, 2002, AM J PHYSIOL-ENDOC M, V282, pE982, DOI 10.1152/ajpendo.00347.2001; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Billington RA, 2005, CELL CALCIUM, V37, P81, DOI 10.1016/j.ceca.2004.06.009; Billington RA, 2004, BRIT J PHARMACOL, V142, P1241, DOI 10.1038/sj.bjp.0705886; Billington RA, 2004, BIOCHEM J, V378, P275, DOI 10.1042/BJ20031284; Billington RA, 2007, CELL CALCIUM, V41, P505, DOI 10.1016/j.ceca.2006.10.002; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Bostrom J, 2007, BIOORGAN MED CHEM, V15, P4077, DOI 10.1016/j.bmc.2007.03.075; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Dowden J, 2006, CHEM BIOL, V13, P659, DOI 10.1016/j.chembiol.2006.05.005; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Galione A, 2004, BRIT J PHARMACOL, V142, P1203, DOI 10.1038/sj.bjp.0705888; Galione A, 2005, CELL CALCIUM, V38, P273, DOI 10.1016/j.ceca.2005.06.031; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; ISLAM MS, 1993, SCIENCE, V262, P584, DOI 10.1126/science.8211188; Jenkins JL, 2004, J MED CHEM, V47, P6144, DOI 10.1021/jm049654z; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Lee HC, 1998, BBA-GEN SUBJECTS, V1425, P263, DOI 10.1016/S0304-4165(98)00079-8; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, J BIOL CHEM, V272, P20378, DOI 10.1074/jbc.272.33.20378; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; MORGAN AJ, 2006, METHODS CALCIUM SIGN, P265; Nicholls A, 2004, J COMPUT AID MOL DES, V18, P451, DOI 10.1007/s10822-004-5202-8; Oprea TI, 2004, CURR OPIN CHEM BIOL, V8, P349, DOI 10.1016/j.cbpa.2004.06.008; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2004, BIOL CELL, V96, P19, DOI 10.1016/j.biolcel.2003.12.001; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	48	222	227	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2009	5	4					220	226		10.1038/nchembio.150	http://dx.doi.org/10.1038/nchembio.150			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	422KH	19234453	Green Accepted			2022-12-25	WOS:000264426100010
J	Chambers, SM; Fasano, CA; Papapetrou, EP; Tomishima, M; Sadelain, M; Studer, L				Chambers, Stuart M.; Fasano, Christopher A.; Papapetrou, Eirini P.; Tomishima, Mark; Sadelain, Michel; Studer, Lorenz			Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; SPEMANN ORGANIZER; DIFFERENTIATION; INDUCTION; SPECIFICATION; EXPRESSION; SURVIVAL; NEURONS; NOGGIN	Current neural induction protocols for human embryonic stem (hES) cells rely on embryoid body formation, stromal feeder co-culture or selective survival conditions. Each strategy has considerable drawbacks, such as poorly defined culture conditions, protracted differentiation and low yield. Here we report that the synergistic action of two inhibitors of SMAD signaling, Noggin and SB431542, is sufficient to induce rapid and complete neural conversion of > 80% of hES cells under adherent culture conditions. Temporal fate analysis reveals the appearance of a transient FGF5(+) epiblast-like stage followed by PAX6(+) neural cells competent to form rosettes. Initial cell density determines the ratio of central nervous system and neural crest progeny. Directed differentiation of human induced pluripotent stem (hiPS) cells into midbrain dopamine and spinal motoneurons confirms the robustness and general applicability of the induction protocol. Noggin/SB431542-based neural induction should facilitate the use of hES and hiPS cells in regenerative medicine and disease modeling and obviate the need for protocols based on stromal feeders or embryoid bodies.	[Chambers, Stuart M.; Fasano, Christopher A.; Tomishima, Mark; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Papapetrou, Eirini P.; Tomishima, Mark; Sadelain, Michel; Studer, Lorenz] Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA; [Sadelain, Michel] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chambers, SM (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	chambers@mskcc.org; studerl@mskcc.org	Pillay, Nischalan/F-9536-2012; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	Starr Foundation, NINDS [1R01NS052671]; Starr Stem Scholar fellowship (S.M.C.); New York Stem Cell Foundation fellowship (C.A.F.); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	Starr Foundation, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Starr Stem Scholar fellowship (S.M.C.); New York Stem Cell Foundation fellowship (C.A.F.); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to F. Vaccarino for providing Otx2 antibody and E. Lai for BF1 antibody. This work was supported in part by the Starr Foundation, NINDS grant 1R01NS052671, the Starr Stem Scholar fellowship (S.M.C.) and the a New York Stem Cell Foundation fellowship (C.A.F.).	Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tomishima MJ, 2007, STEM CELLS, V25, P39, DOI 10.1634/stemcells.2006-0173; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	24	2219	2376	13	442	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2009	27	3					275	280		10.1038/nbt.1529	http://dx.doi.org/10.1038/nbt.1529			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	416UJ	19252484	Green Accepted			2022-12-25	WOS:000264030700021
J	Harada, M; Murakami, H; Okawa, A; Okimoto, N; Hiraoka, S; Nakahara, T; Akasaka, R; Shiraishi, Y; Futatsugi, N; Mizutani-Koseki, Y; Kuroiwa, A; Shirouzu, M; Yokoyama, S; Taiji, M; Iseki, S; Ornitz, DM; Koseki, H				Harada, Masayo; Murakami, Hirotaka; Okawa, Akihiko; Okimoto, Noriaki; Hiraoka, Shuichi; Nakahara, Taka; Akasaka, Ryogo; Shiraishi, Yo-ichi; Futatsugi, Noriyuki; Mizutani-Koseki, Yoko; Kuroiwa, Atsushi; Shirouzu, Mikako; Yokoyama, Shigeyuki; Taiji, Makoto; Iseki, Sachiko; Ornitz, David M.; Koseki, Haruhiko			FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion	NATURE GENETICS			English	Article							FIBROBLAST-GROWTH-FACTOR; MOUSE CORONAL SUTURE; HEPARAN-SULFATE; CHONDROCYTE DIFFERENTIATION; EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; BONE-DEVELOPMENT; RECEPTOR; BINDING; OSTEOGENESIS	The spontaneous dominant mouse mutant, Elbow knee synostosis (Eks), shows elbow and knee joint synosotsis, and premature fusion of cranial sutures. Here we identify a missense mutation in the Fgf9 gene that is responsible for the Eks mutation. Through investigation of the pathogenic mechanisms of joint and suture synostosis in Eks mice, we identify a key molecular mechanism that regulates FGF9 signaling in developing tissues. We show that the Eks mutation prevents homodimerization of the FGF9 protein and that monomeric FGF9 binds to heparin with a lower affinity than dimeric FGF9. These biochemical defects result in increased diffusion of the altered FGF9 protein (FGF9(Eks)) through developing tissues, leading to ectopic FGF9 signaling and repression of joint and suture development. We propose a mechanism in which the range of FGF9 signaling in developing tissues is limited by its ability to homodimerize and its affinity for extracellular matrix heparan sulfate proteoglycans.	[Harada, Masayo; Hiraoka, Shuichi; Mizutani-Koseki, Yoko; Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunl, Tsurumi Ku, Kanagawa 2300045, Japan; [Harada, Masayo] Chiba Univ, Dept Immunol, Chuo Ku, Chiba 2608670, Japan; [Murakami, Hirotaka; Okawa, Akihiko] Chiba Univ, Grad Sch, Dept Orthopaed Surg, Chuo Ku, Chiba 2608670, Japan; [Okimoto, Noriaki; Futatsugi, Noriyuki; Taiji, Makoto] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Tsurumi Ku, Kanagawa 2300046, Japan; [Nakahara, Taka; Iseki, Sachiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Mol Craniofacial Embryol, Bunkyo Ku, Tokyo 1138549, Japan; [Akasaka, Ryogo; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Shiraishi, Yo-ichi; Kuroiwa, Atsushi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	RIKEN; Chiba University; Chiba University; RIKEN; Tokyo Medical & Dental University (TMDU); RIKEN; Nagoya University; University of Tokyo; Washington University (WUSTL)	Koseki, H (corresponding author), RIKEN, Res Ctr Allergy & Immunl, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	koseki@rcai.riken.jp	Okimoto, Noriaki/AAI-4656-2020; Taiji, Makoto/N-1077-2014; Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015; Harada, Masayo/AAA-2691-2022; Koseki, Haruhiko/I-3825-2014; Nakahara, Taka/AAM-4112-2020	Okimoto, Noriaki/0000-0002-2956-1317; Taiji, Makoto/0000-0002-5317-0500; Yokoyama, Shigeyuki/0000-0003-3133-7338; Koseki, Haruhiko/0000-0001-8424-5854; Nakahara, Taka/0000-0002-4637-1072; Harada, Masayo/0000-0001-8916-5618; Kuroiwa, Atsushi/0000-0001-7710-4041; Ornitz, David/0000-0003-1592-7629	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analysis; Ministry of Education, Culture, Sports, Science and Technology of Japan; US National Institutes of Health [HD049808]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049808] Funding Source: NIH RePORTER	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analysis; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported in part by the RIKEN Structural Genomics/ Proteomics Initiative (RSGI) and the National Project on Protein Structural and Functional Analysis, Ministry of Education, Culture, Sports, Science and Technology of Japan (S.Y.) and US National Institutes of Health grant HD049808 (D.M.O.).	CASE DA, 2004, AMBER, V8; Colvin JS, 1999, DEV DYNAM, V216, P72; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Hajihosseini MK, 2002, MECH DEVELOP, V113, P79, DOI 10.1016/S0925-4773(01)00656-6; Hecht HJ, 2001, ACTA CRYSTALLOGR D, V57, P378, DOI 10.1107/S0907444900020813; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Iseki S, 1997, DEVELOPMENT, V124, P3375; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Murakami H, 2002, MAMM GENOME, V13, P341, DOI 10.1007/s00335-001-2143-6; NALIN AM, 1995, DEV DYNAM, V203, P352, DOI 10.1002/aja.1002030307; NARUMI T, 2006, 55 TFLOPS SIMULATION, DOI DOI 10.1145/1188455.11885064; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Storm EE, 1996, DEVELOPMENT, V122, P3969; Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890; TSANG M, 2004, SCI STKE; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P1892, DOI 10.1073/pnas.96.5.1892; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang O, 2001, DEVELOPMENT, V128, P3867; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Yoshida T, 2005, J ANAT, V206, P437, DOI 10.1111/j.1469-7580.2005.00411.x	43	91	91	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					289	298		10.1038/ng.316	http://dx.doi.org/10.1038/ng.316			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19219044	Green Accepted			2022-12-25	WOS:000263640200009
J	Lemon, SM; Burton, DR; Abrignani, S; Bartenschlager, R				Lemon, Stanley M.; Burton, Dennis R.; Abrignani, Sergio; Bartenschlager, Ralf			Moving closer to a mouse model for hepatitis C	NATURE MEDICINE			English	Editorial Material							CELLS; REPLICATION; INFECTION		[Lemon, Stanley M.] Univ Texas Galveston, Med Branch, Inst Human Infect & Immun, Galveston, TX 77550 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Abrignani, Sergio] Natl Inst Mol Genet, Milan, Italy; [Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, D-6900 Heidelberg, Germany	University of Texas System; University of Texas Medical Branch Galveston; Scripps Research Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Ruprecht Karls University Heidelberg	Lemon, SM (corresponding author), Univ Texas Galveston, Med Branch, Inst Human Infect & Immun, Galveston, TX 77550 USA.		Bartenschlager, Ralf/L-2582-2015	Bartenschlager, Ralf/0000-0001-5601-9307				Barth H, 2008, J HEPATOL, V49, P134, DOI 10.1016/j.jhep.2008.03.012; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	5	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					251	251		10.1038/nm0309-251	http://dx.doi.org/10.1038/nm0309-251			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19265825				2022-12-25	WOS:000263914000022
J	Feng, B; Jiang, JM; Kraus, P; Ng, JH; Heng, JCD; Chan, YS; Yaw, LP; Zhang, WW; Loh, YH; Han, JY; Vega, VB; Cacheux-Rataboul, V; Lim, B; Lufkin, T; Ng, HH				Feng, Bo; Jiang, Jianming; Kraus, Petra; Ng, Jia-Hui; Heng, Jian-Chien Dominic; Chan, Yun-Shen; Yaw, Lai-Ping; Zhang, Weiwei; Loh, Yuin-Han; Han, Jianyong; Vega, Vinsensius B.; Cacheux-Rataboul, Valere; Lim, Bing; Lufkin, Thomas; Ng, Huck-Hui			Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb	NATURE CELL BIOLOGY			English	Article							SELF-RENEWAL; ERR-BETA; MOUSE; GENERATION; NETWORK; MYC; EXPRESSION; GENES	The dominant effect of transcription factors in imparting expanded potency is best exemplified by the reprogramming of fibroblasts to pluripotent cells using retrovirus-mediated transduction of defined transcription factors. In the murine system, Oct4, Sox2, c-Myc and KIf4 are sufficient to convert fibroblasts to induced pluripotent stem (iPS) cells that have many characteristics of embryonic stem (ES) cells. Here we show that the orphan nuclear receptor Esrrb functions in conjunction with Oct4 and Sox2 to mediate reprogramming of mouse embryonic fibroblasts (MEFs) to iPS cells. Esrrb-reprogrammed cells share similar expression and epigenetic signatures as ES cells. These cells are also pluripotent and can differentiate in vitro and in vivo into the three major embryonic cell lineages. Furthermore, these cells contribute to mouse chimaeras and are germline transmissible. In ES cells, Esrrb targets many genes involved in self-renewal and pluripotency. This suggests that Esrrb may mediate reprogramming through the upregulation of ES-cell-specific genes. Our findings also indicate that it is possible to reprogram MEFs without exogenous KIf transcription factors and link a nuclear receptor to somatic cell reprogramming.	[Feng, Bo; Jiang, Jianming; Ng, Jia-Hui; Heng, Jian-Chien Dominic; Chan, Yun-Shen; Yaw, Lai-Ping; Zhang, Weiwei; Loh, Yuin-Han; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Jiang, Jianming; Heng, Jian-Chien Dominic; Chan, Yun-Shen; Zhang, Weiwei; Loh, Yuin-Han; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Harvard University; Harvard Medical School	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, 60 Biopolis St,02-01 Genome Bldg, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Lufkin, Thomas/AAG-7476-2019; Loh, Yuin-Han/E-1096-2014; Ng, Huck Hui/A-1135-2009; Feng, Bo/D-7831-2014; Lufkin, Thomas/B-5352-2011; Kraus, Petra/I-5849-2014; jiang, jianming/B-3421-2012; Chan, Yun-Shen/GWC-4616-2022	Lufkin, Thomas/0000-0002-7902-4771; Loh, Yuin-Han/0000-0002-4715-6454; Feng, Bo/0000-0002-4018-3257; Lufkin, Thomas/0000-0002-7902-4771; Kraus, Petra/0000-0002-6716-5550; jiang, jianming/0000-0003-3251-2716; 	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); Singapore Stem Cell Consortium; Singapore Millennium Foundation; NUS	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; Singapore Millennium Foundation(Singapore Millennium Foundation); NUS(National University of Singapore)	We are grateful to the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR) and Singapore Stem Cell Consortium for funding. J.J is supported by the Singapore Millennium Foundation graduate scholarship and the NUS graduate scholarship. Y.L. and J.N. are supported by the A*STAR graduate scholarship. J.H and Y.C are supported by the NUS graduate school scholarship. We are grateful to Kuee-Theng Kuay for technical support. We thank Andrew Hutchins, Tara Huber and Edwin Cheung for critical comments on the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2007, NAT CELL BIOL, V9, P871, DOI 10.1038/ncb0807-871; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	32	348	426	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					197	U193		10.1038/ncb1827	http://dx.doi.org/10.1038/ncb1827			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136965				2022-12-25	WOS:000263285500018
J	Silverberg, MS; Cho, JH; Rioux, JD; McGovern, DPB; Wu, J; Annese, V; Achkar, JP; Goyette, P; Scott, R; Xu, W; Barmada, MM; Klei, L; Daly, MJ; Abraham, C; Bayless, TM; Bossa, F; Griffiths, AM; Ippoliti, AF; Lahaie, RG; Latiano, A; Pare, P; Proctor, DD; Regueiro, MD; Steinhart, AH; Targan, SR; Schumm, LP; Kistner, EO; Lee, AT; Gregersen, PK; Rotter, JI; Brant, SR; Taylor, KD; Roeder, K; Duerr, RH				Silverberg, Mark S.; Cho, Judy H.; Rioux, John D.; McGovern, Dermot P. B.; Wu, Jing; Annese, Vito; Achkar, Jean-Paul; Goyette, Philippe; Scott, Regan; Xu, Wei; Barmada, M. Michael; Klei, Lambertus; Daly, Mark J.; Abraham, Clara; Bayless, Theodore M.; Bossa, Fabrizio; Griffiths, Anne M.; Ippoliti, Andrew F.; Lahaie, Raymond G.; Latiano, Anna; Pare, Pierre; Proctor, Deborah D.; Regueiro, Miguel D.; Steinhart, A. Hillary; Targan, Stephan R.; Schumm, L. Philip; Kistner, Emily O.; Lee, Annette T.; Gregersen, Peter K.; Rotter, Jerome I.; Brant, Steven R.; Taylor, Kent D.; Roeder, Kathryn; Duerr, Richard H.			Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; GENE; EXPRESSION; MULTIPLE; PATHOGENESIS; REPLICATION; CONTRIBUTE	Ulcerative colitis is a chronic inflammatory disease of the colon that presents as diarrhea and gastrointestinal bleeding. We performed a genome-wide association study using DNA samples from 1,052 individuals with ulcerative colitis and preexisting data from 2,571 controls, all of European ancestry. In an analysis that controlled for gender and population structure, ulcerative colitis loci attaining genome-wide significance and subsequent replication in two independent populations were identified on chromosomes 1p36 (rs6426833, combined P = 5.1 x 10(-13), combined odds ratio OR = 0.73) and 12q15 (rs1558744, combined P = 2.5 x 10(-12), combined OR = 1.35). In addition, combined genome-wide significant evidence for association was found in a region spanning BTNL2 to HLA-DQB1 on chromosome 6p21 (rs2395185, combined P = 1.0 x 10(-16), combined OR = 0.66) and at the IL23R locus on chromosome 1p31 (rs11209026, combined P = 1.3 x 10(-8), combined OR = 0.56; rs10889677, combined P = 1.3 x 10(-8), combined OR = 1.29).	[Silverberg, Mark S.; Steinhart, A. Hillary] Univ Toronto, Mt Sinai Hosp, Inflammatory Bowel Dis Grp, Toronto, ON M5G 1X5, Canada; [Cho, Judy H.; Proctor, Deborah D.] Yale Univ, Sect Digest Dis, Dept Med, New Haven, CT 06520 USA; [Cho, Judy H.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Rioux, John D.; Goyette, Philippe; Abraham, Clara] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.; Goyette, Philippe] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [McGovern, Dermot P. B.; Ippoliti, Andrew F.; Targan, Stephan R.; Rotter, Jerome I.; Taylor, Kent D.] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; [Wu, Jing; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Annese, Vito; Bossa, Fabrizio; Latiano, Anna] IRCCS CSS Hosp, I-71013 San Giovanni Rotondo, FG, Italy; [Achkar, Jean-Paul] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44195 USA; [Scott, Regan; Regueiro, Miguel D.; Duerr, Richard H.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Sch Med,UPMC PUH, Pittsburgh, PA 15213 USA; [Xu, Wei] Univ Toronto, Princess Margaret Hosp, Dept Publ Hlth Sci, Toronto, ON M5G 2M9, Canada; [Barmada, M. Michael; Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Klei, Lambertus] Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; [Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Bayless, Theodore M.; Brant, Steven R.] Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Infammatory Bowel Dis, Baltimore, MD 21287 USA; [Griffiths, Anne M.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Lahaie, Raymond G.] Univ Montreal, Dept Med, Montreal, PQ H2X 3J4, Canada; [Lahaie, Raymond G.] CHUM, Hop St Luc, Montreal, PQ H2X 3J4, Canada; [Pare, Pierre; Rotter, Jerome I.] Univ Laval, Dept Med, Div Gastroenterol, Quebec City, PQ G1K 7P4, Canada; [Pare, Pierre] CHAUQ Hop St Sacrement, Ste Foy, PQ G1S 4L8, Canada; [Schumm, L. Philip; Kistner, Emily O.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Lee, Annette T.; Gregersen, Peter K.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Taylor, Kent D.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Brant, Steven R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21231 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Yale University; Yale University; Universite de Montreal; Universite de Montreal; Cedars Sinai Medical Center; Carnegie Mellon University; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; Universite de Montreal; Laval University; Laval University; University of Chicago; Northwell Health; Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Duerr, RH (corresponding author), Univ Toronto, Mt Sinai Hosp, Inflammatory Bowel Dis Grp, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	duerr@pitt.edu	Bossa, Fabrizio/B-3078-2017; Daly, Mark J/B-2453-2017; Duerr, Richard H/B-4188-2009; Silverberg, Mark/B-4183-2008; Rotter, Jerome/AAY-6598-2021; Annese, Vito/AGW-4200-2022; Palmieri, Orazio/J-7697-2012; Latiano, Anna/R-1965-2016; Rioux, John D/A-9599-2015	Bossa, Fabrizio/0000-0002-4518-9949; Daly, Mark J/0000-0002-0949-8752; Duerr, Richard H/0000-0001-6586-3905; Annese, Vito/0000-0002-0082-892X; Palmieri, Orazio/0000-0002-0019-7929; Latiano, Anna/0000-0003-3719-2061; Rioux, John D/0000-0001-7560-8326; Barmada, M Michael/0000-0002-3604-6460; Roeder, Kathryn/0000-0002-8869-6254; Schumm, Phil/0000-0002-3050-2429	NIDDK IBD Genetics Consortium [DK062431, DK062422, DK062420, DK062432, DK062423, DK062413, DK062429]; Atran Foundation; Board of Governor's Chair in Medical Genetics at Cedars-Sinai Medical Center; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation; Crohn's and Colitis Foundation of America; Crohn's and Colitis Foundation of Canada; Feintech Chair in Immunobiology; Gale and Graham Wright Research Chair in Digestive Diseases; Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center; US National Institutes of Health [RR00052, DK077905, DK068112, DK072373, RR024139, DK076025, DK064869, MH057881, DK046763, RR00425]; Rainin IBD Genetics Research Fund; W. Buford Lewis family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, M01RR000425, M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062423, U01DK062429, U01DK062432, R01DK076025, P01DK046763, U01DK062431, R01DK064869, K23DK068112, R01DK072373, R01DK077905, U01DK062422, P30DK063491, U01DK062413, U01DK062420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057881, R37MH057881] Funding Source: NIH RePORTER	NIDDK IBD Genetics Consortium; Atran Foundation; Board of Governor's Chair in Medical Genetics at Cedars-Sinai Medical Center; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; Crohn's and Colitis Foundation of Canada; Feintech Chair in Immunobiology; Gale and Graham Wright Research Chair in Digestive Diseases; Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rainin IBD Genetics Research Fund; W. Buford Lewis family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to L. Wu Datta, J. Fultz and J. Stempak for coordinating study subject recruitment, to A. Andriulli and O. Palmieri for providing clinical data and to J. Lian, A. Liew and H. Khalili for technical support. The NIDDK IBD Genetics Consortium is funded by the following grants: DK062431 (S. R. B.), DK062422 (J. H. C.), DK062420 (R. H. D.), DK062432 (J. D. R.), DK062423 (M. S. S.), DK062413 (K. D. T.) and DK062429 (J. H. C.). The authors would also like to acknowledge additional support from the Atran Foundation (S. R. B.), Board of Governor's Chair in Medical Genetics at Cedars-Sinai Medical Center (J. I. R.), Bohmfalk Funds for Medical Research (J. H. C.), Burroughs Wellcome Medical Foundation (J. H. C.), Crohn's and Colitis Foundation of America (C. A., T. M. B., S. R. B., J. H. C., R. H. D., J. D. R.), Crohn's and Colitis Foundation of Canada (M. S. S.), Feintech Chair in Immunobiology (S. R. T.), Gale and Graham Wright Research Chair in Digestive Diseases (M. S. S.), Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center (T. M. B., S. R. B.), US National Institutes of Health grants RR00052 (S. R. B.), DK077905 (C. A.), DK068112 (J.-P. A.), DK072373 (J. H. C.), RR024139 H. C.), DK076025 (R. H. D.), DK064869 (J. D. R.), MH057881 (K. R.), DK046763 (J. I. R., S. R. T., K. D. T.) and RR00425 (K. D. T.), the Rainin IBD Genetics Research Fund (J.-P. A.) and the W. Buford Lewis family (S. R. B.).	Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Murakami M, 2002, BIOCHEM BIOPH RES CO, V292, P689, DOI 10.1006/bbrc.2002.6716; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	28	302	313	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					216	220		10.1038/ng.275	http://dx.doi.org/10.1038/ng.275			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19122664	Green Accepted, Green Submitted			2022-12-25	WOS:000263091300023
J	Rentmeister, A; Arnold, FH; Fasan, R				Rentmeister, Andrea; Arnold, Frances H.; Fasan, Rudi			Chemo-enzymatic fluorination of unactivated organic compounds	NATURE CHEMICAL BIOLOGY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYTOCHROME P450BM-3; MONOOXYGENASE; METABOLISM; MOLECULES; CHEMISTRY	Fluorination has gained an increasingly important role in drug discovery and development. Here we describe a versatile strategy that combines cytochrome P450-catalyzed oxygenation with deoxofluorination to achieve mono- and polyfluorination of nonreactive sites in a variety of organic scaffolds. This procedure was applied for the rapid identification of fluorinated drug derivatives with enhanced membrane permeability.	[Rentmeister, Andrea; Arnold, Frances H.; Fasan, Rudi] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Fasan, R (corresponding author), Univ Rochester, Dept Chem, Hutchison Hall,RC Box 270216, Rochester, NY 14627 USA.	fasan@chem.rochester.edu	Fasan, Rudi/D-1765-2011; Rentmeister, Andrea/E-7981-2010	Fasan, Rudi/0000-0003-4636-9578; Arnold, Frances H./0000-0002-4027-364X; Rentmeister, Andrea/0000-0002-3107-4147	US National Institutes of Health [GM068664]; US Department of Agriculture [2006-35505-16660]; Jacobs Institute (Caltech); Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068664] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); Jacobs Institute (Caltech); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Shahgholi for assistance with the LC-MS and HRMS analyses. This work was supported by US National Institutes of Health grant GM068664 and US Department of Agriculture grant 2006-35505-16660 to F. H. A. and by the Jacobs Institute (Caltech). A. R. acknowledges the Deutsche Forschungsgemeinschaft for financial support.	Bobbio C, 2006, ORG BIOMOL CHEM, V4, P2065, DOI 10.1039/b603163c; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fujisawa H, 2005, CHEM PHARM BULL, V53, P524, DOI 10.1248/cpb.53.524; GUNTER H, 2004, J FLUORINE CHEM, V125, P875; Hamman MA, 1997, BIOCHEM PHARMACOL, V54, P33, DOI 10.1016/S0006-2952(97)00143-3; Iacazio G, 2005, TETRAHEDRON-ASYMMETR, V16, P3633, DOI 10.1016/j.tetasy.2005.09.015; Kirsch P., 2004, MODERN FLUOROORGANIC; Landwehr M, 2006, J AM CHEM SOC, V128, P6058, DOI 10.1021/ja061261x; Leuchtenberger S, 2006, CURR PHARM DESIGN, V12, P4337, DOI 10.2174/138161206778793029; Ma JA, 2004, CHEM REV, V104, P6119, DOI 10.1021/cr030143e; Mikolajczyk M, 1999, PURE APPL CHEM, V71, P473, DOI 10.1351/pac199971030473; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Singh RP, 2002, SYNTHESIS-STUTTGART, P2561; Warman AJ, 2005, BIOCHEM SOC T, V33, P747, DOI 10.1042/BST0330747; Wong TS, 2004, BIOTECHNOL BIOENG, V85, P351, DOI 10.1002/bit.10896	19	104	108	5	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2009	5	1					26	28		10.1038/nchembio.128	http://dx.doi.org/10.1038/nchembio.128			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387EW	19011638	Green Accepted			2022-12-25	WOS:000261935500010
J	Bell, JC; Kirn, D				Bell, John C.; Kirn, David			MicroRNAs fine-tune oncolytic viruses	NATURE BIOTECHNOLOGY			English	Editorial Material							TRANSGENE EXPRESSION; ENDOGENOUS MICRORNA; MESSENGER-RNA; MECHANISMS; PROGRESS; CANCER; TISSUE		[Bell, John C.] Ottawa Hlth Res Inst, Ottawa, ON K1G 0K8, Canada; [Kirn, David] Jennerex Inc, San Francisco, CA 94105 USA	University of Ottawa; Ottawa Hospital Research Institute	Bell, JC (corresponding author), Ottawa Hlth Res Inst, Ottawa, ON K1G 0K8, Canada.	jbell@ohri.ca; dkirn@jennerex.com						Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Berry LJ, 2008, PROSTATE, V68, P577, DOI 10.1002/pros.20741; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Dekel B, 2002, ACTA PAEDIATR, V91, P357, DOI 10.1080/08035250252834067; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kong W, 2009, J CELL PHYSIOL, V218, P22, DOI 10.1002/jcp.21577; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	17	16	17	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1346	1348		10.1038/nbt1208-1346	http://dx.doi.org/10.1038/nbt1208-1346			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19060871				2022-12-25	WOS:000261591300017
J	Strauss, JF; De Paolo, LV				Strauss, Jerome F., III; De Paolo, Louis V.			Funding for the reproductive sciences in the US	NATURE MEDICINE			English	Editorial Material							ANIMAL REPRODUCTION; AGRICULTURE; TECHNOLOGY; PRIORITIES; BIOLOGY		[Strauss, Jerome F., III] Virginia Commonwealth Univ, Sch Med, Richmond, VA 23298 USA; [De Paolo, Louis V.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA	Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Sch Med, 1101 E Marshall St, Richmond, VA 23298 USA.	jfstrauss@vcu.edu						Behrman RE, 2007, PRETERM BIRTH CAUSES; Clarke Adele, 1998, DISCIPLINING REPRODU; HARRISON PJ, 1996, CONTRACEPTIVE RES AN; Ireland JJ, 2008, J ANIM SCI, V86, P2797, DOI 10.2527/jas.2008-1088; Longo LD, 2008, AM J OBSTET GYNECOL, V198, P489, DOI 10.1016/j.ajog.2008.02.032; Makinson C, 1999, INT J GYNECOL OBSTET, V67, pS101, DOI 10.1016/S0020-7292(99)00153-8; Mirando MA, 2007, J ANIM SCI, V85, pE11, DOI 10.2527/jas.2006-506; Mirando MA, 2006, BIOL REPROD, V74, P459, DOI 10.1095/biolreprod.105.048686; NASS S, 2004, NEW FRONTIERS CONTRA; Pion GA, 2006, BIOL REPROD, V74, P230, DOI 10.1095/biolreprod.105.045427; Population Reference Bureau, 2008, WORLD POP DAT SHEET; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Strauss JF, 2007, FERTIL STERIL, V87, P717, DOI 10.1016/j.fertnstert.2006.11.003; Strauss JF, 2004, NATURE, V432, P43, DOI 10.1038/432043a; Townsend J, 1992, STRENGTHENING RES AC	15	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2008	14	11					1214	1217		10.1038/nm1108-1214	http://dx.doi.org/10.1038/nm1108-1214			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	370GR	18989308				2022-12-25	WOS:000260751200039
J	Xing, HY; Vanderford, NL; Sarge, KD				Xing, Hongyan; Vanderford, Nathan L.; Sarge, Kevin D.			The TBP-PP2A mitotic complex bookmarks genes by preventing condensin action	NATURE CELL BIOLOGY			English	Article							CHROMOSOME CONDENSATION; TRANSCRIPTION FACTOR; IN-VIVO; PROTEIN; CHROMATIN; TBP; LOCALIZATION; ASSOCIATION; INHIBITION; ACTIVATION	To maintain phenotypes of cell lineages, cells must 'remember' which genes were active before mitosis entry and transmit this information to their daughter cells so that expression patterns can be faithfully re-established in G1. This phenomenon is called gene bookmarking. However, during mitosis transcription ceases, most sequence-specific proteins dissociate from DNA and the chromatin is tightly compacted, making it difficult to understand how gene activity 'memory' is maintained through this stage of the cell cycle(1,2). A feature of gene bookmarking is that in mitotic cells, the promoters of formerly active genes lack compaction, but how compaction of these regions is inhibited is unknown(3,4). Here we show that during mitosis, TATA-binding protein (TBP), which remains bound to DNA during mitosis, recruits PP2A. TBP also interacts with condensin to allow efficient dephosphorylation and inactivation of condensin near these promoters to inhibit their compaction. Further, ChIP-on-chip data show that TBP is bound to many chromosomal sites during mitosis, and is higher in transcribed regions but low in regions containing pseudogenes and genes whose expression is tissue-restricted. These results suggest that TBP is involved not only in gene transcription during interphase but also in preserving the memory of gene activity through mitosis to daughter cells.	[Xing, Hongyan; Vanderford, Nathan L.; Sarge, Kevin D.] Univ Kentucky, Dept Mol & Cellular Biochem, Chandler Med Ctr, Lexington, KY 40536 USA	University of Kentucky	Sarge, KD (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Chandler Med Ctr, Lexington, KY 40536 USA.	kdsarge@uky.edu			NIH [GM61053, GM64606]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061053, R01GM064606] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to Sui Huang and Arnold Berk for their generous gifts of GFP-TBP and GST-TBP plasmids, respectively, and to lab members for insightful discussions. This research was supported by NIH grants to K. D. S. (GM61053 and GM64606).	Allegrucci C, 2004, LANCET, V364, P206, DOI 10.1016/S0140-6736(04)16636-1; Armstrong L, 2006, STEM CELLS, V24, P805, DOI 10.1634/stemcells.2005-0350; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Fairley JA, 2003, EMBO J, V22, P5841, DOI 10.1093/emboj/cdg544; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gulledge BM, 2002, CURR MED CHEM, V9, P1991, DOI 10.2174/0929867023368845; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; LARSEN A, 1982, CELL, V29, P609, DOI 10.1016/0092-8674(82)90177-5; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Schubart DB, 1996, NUCLEIC ACIDS RES, V24, P1913, DOI 10.1093/nar/24.10.1913; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006	28	73	75	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1318	U150		10.1038/ncb1790	http://dx.doi.org/10.1038/ncb1790			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931662	Green Accepted			2022-12-25	WOS:000260586700014
J	Adair-Kirk, TL; Atkinson, JJ; Senior, RM				Adair-Kirk, Tracy L.; Atkinson, Jeffrey J.; Senior, Robert M.			Smoke particulates stress lung cells	NATURE MEDICINE			English	Editorial Material							NALP3 INFLAMMASOME; CIGARETTE-SMOKING; PROTEIN RESPONSE; GENE-EXPRESSION; ACTIVATION; SILICA		[Adair-Kirk, Tracy L.; Atkinson, Jeffrey J.; Senior, Robert M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Senior, Robert M.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Adair-Kirk, TL (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8052, St Louis, MO 63110 USA.	tkirk@im.wustl.edu		Atkinson, Jeffrey/0000-0001-9125-7968				Adair-Kirk TL, 2008, AM J RESP CELL MOL, V39, P400, DOI 10.1165/rcmb.2007-0295OC; BERNARD AM, 1994, ENVIRON RES, V66, P96, DOI 10.1006/enrs.1994.1047; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chen JP, 2007, CANCER EPIDEM BIOMAR, V16, P577, DOI 10.1158/1055-9965.EPI-06-0923; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jung EJ, 2007, PROTEOMICS, V7, P3906, DOI 10.1002/pmic.200700377; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC	12	16	17	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1024	1025		10.1038/nm1008-1024	http://dx.doi.org/10.1038/nm1008-1024			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18841140				2022-12-25	WOS:000259892300028
J	Altarejos, JY; Goebel, N; Conkright, MD; Inotiel, H; Xie, JX; Arias, CM; Sawchenko, PE; Montminy, M				Altarejos, Judith Y.; Goebel, Naomi; Conkright, Michael D.; Inotiel, Hiroshi; Xie, Jianxin; Arias, Carlos M.; Sawchenko, Paul E.; Montminy, Marc			The Creb1 coactivator Crtc1 is required for energy balance and fertility	NATURE MEDICINE			English	Article							CORTICOTROPIN-RELEASING FACTOR; HYPOTHALAMIC CART; HORMONE NEURONS; GENE PROMOTER; POMC NEURONS; LEPTIN; ACTIVATION; TRANSCRIPTION; KISSPEPTIN; TORC2	The adipocyte-derived hormone leptin maintains energy balance by acting on hypothalamic leptin receptors (Leprs) that act on the signal transducer and activator of transcription 3 (Stat3)(1-4). Although disruption of Lepr-Stat3 signaling promotes obesity in mice, other features of Lepr function, such as fertility, seem normal, pointing to the involvement of additional regulators. Here we show that the cyclic AMP responsive element-binding protein-1 (Creb1)-regulated transcription coactivator-1 (Crtc1) is required for energy balance and reproduction-Crtc1(-/-) mice are hyperphagic, obese and infertile. Hypothalamic Crtc1 was phosphorylated and inactive in leptin-deficient ob/ob mice, while leptin administration increased amounts of dephosphorylated nuclear Crtc1. Dephosphorylated Crtc1 stimulated expression of the Cartpt and Kiss1 genes, which encode hypothalamic neuropeptides that mediate leptin's effects on satiety and fertility(5-7). Crtc1 overexpression in hypothalamic cells increased Cartpt and Kiss1 gene expression, whereas Crtc1 depletion decreased it. Indeed, leptin enhanced Crtc1 activity over the Cartpt and Kiss1 promoters in cells overexpressing Lepr, and these effects were disrupted by expression of a dominant-negative Creb1 polypeptide. As leptin administration increased recruitment of hypothalamic Crtc1 to Cartpt and Kissl promoters, our results indicate that the Creb1-Crtc1 pathway mediates the central effects of hormones and nutrients on energy balance and fertility.	[Altarejos, Judith Y.; Goebel, Naomi; Inotiel, Hiroshi; Montminy, Marc] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Conkright, Michael D.] Scripps Res Inst, Jupiter, FL 33458 USA; [Xie, Jianxin] Cell Signaling Technol, Danvers, MA 01923 USA; [Arias, Carlos M.; Sawchenko, Paul E.] Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute; Salk Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu		Inoue, Hiroshi/0000-0002-7724-6637	US National Institutes of Health [DK049777]; Foundation for Medical Research and the Keickhefer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049777] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Medical Research and the Keickhefer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Myers (University of Michigan School of Medicine) for leptin receptor expression plasmid, P. Mellon (University of California at San Diego) for mouse GTI-7 hypothalamic cells and M. Kuhar (Emory University School of Medicine) for Cartpt-luciferase reporter. This work was supported by the US National Institutes of Health (DK049777) the Foundation for Medical Research and the Keickhefer Foundation.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Barrett P, 2002, OBES RES, V10, P1291, DOI 10.1038/oby.2002.175; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dominguez G, 2002, J NEUROCHEM, V80, P885, DOI 10.1046/j.0022-3042.2002.00775.x; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lakatos A, 2002, MOL BRAIN RES, V104, P81, DOI 10.1016/S0169-328X(02)00321-2; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; LIPOSITS Z, 1991, ENDOCRINOLOGY, V129, P1575, DOI 10.1210/endo-129-3-1575; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; SAWCHENKO PE, 1984, J NEUROSCI, V4, P1118; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Smith JT, 2006, J NEUROENDOCRINOL, V18, P298, DOI 10.1111/j.1365-2826.2006.01417.x; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	37	155	164	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1112	1117		10.1038/nm.1866	http://dx.doi.org/10.1038/nm.1866			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18758446	Green Accepted			2022-12-25	WOS:000259892300042
J	Unoki, H; Takahashi, A; Kawaguchi, T; Hara, K; Horikoshi, M; Andersen, G; Ng, DPK; Holmkvist, J; Borch-Johnsen, K; Jorgensen, T; Sandbaek, A; Lauritzen, T; Hansen, T; Nurbaya, S; Tsunoda, T; Kubo, M; Babazono, T; Hirose, H; Hayashi, M; Iwamoto, Y; Kashiwagi, A; Kaku, K; Kawamori, R; Tai, ES; Pedersen, O; Kamatani, N; Kadowaki, T; Kikkawa, R; Nakamura, Y; Maeda, S				Unoki, Hiroyuki; Takahashi, Atsushi; Kawaguchi, Takahisa; Hara, Kazuo; Horikoshi, Momoko; Andersen, Gitte; Ng, Daniel P. K.; Holmkvist, Johan; Borch-Johnsen, Knut; Jorgensen, Torben; Sandbaek, Annelli; Lauritzen, Torsten; Hansen, Torben; Nurbaya, Siti; Tsunoda, Tatsuhiko; Kubo, Michiaki; Babazono, Tetsuya; Hirose, Hiroshi; Hayashi, Matsuhiko; Iwamoto, Yasuhiko; Kashiwagi, Atsunori; Kaku, Kohei; Kawamori, Ryuzo; Tai, E. Shyong; Pedersen, Oluf; Kamatani, Naoyuki; Kadowaki, Takashi; Kikkawa, Ryuichi; Nakamura, Yusuke; Maeda, Shiro			SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TARGETED DISRUPTION; RISK LOCI; INTERVENTION; REPLICATION; JERVELL; VARIANT	We conducted a genome-wide association study using 207,097 SNP markers in Japanese individuals with type 2 diabetes and unrelated controls, and identified KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1) to be a strong candidate for conferring susceptibility to type 2 diabetes. We detected consistent association of a SNP in KCNQ1 (rs2283228) with the disease in several independent case-control studies (additive model P = 3.1 x 10(-12); OR = 1.26, 95% CI = 1.18-1.34). Several other SNPs in the same linkage disequilibrium (LD) block were strongly associated with type 2 diabetes (additive model: rs2237895, P = 7.3 x 10(-9); OR = 1.32, 95% CI = 1.20-1.45, rs2237897, P = 6.8 x 10(-13); OR = 1.41, 95% CI = 1.29-1.55). The association of these SNPs with type 2 diabetes was replicated in samples from Singaporean (additive model: rs2237895, P = 8.5 x 10(-3); OR = 1.14, rs2237897, P = 2.4 x 10(-4); OR = 1.22) and Danish populations (additive model: rs2237895, P = 3.7 x 10(-11); OR = 1.24, rs2237897, P = 1.2 x 10(-4); OR = 1.36).	[Unoki, Hiroyuki; Maeda, Shiro] RIKEN, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Kawaguchi, Takahisa; Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Ctr Gen Med, Yokohama, Kanagawa 2300045, Japan; [Hara, Kazuo; Horikoshi, Momoko; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1138655, Japan; [Andersen, Gitte; Holmkvist, Johan; Borch-Johnsen, Knut; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; [Ng, Daniel P. K.; Nurbaya, Siti] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Community Occupat & Family Med, Singapore 117597, Singapore; [Borch-Johnsen, Knut; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Borch-Johnsen, Knut] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, DK-8000 Aarhus, Denmark; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Babazono, Tetsuya; Iwamoto, Yasuhiko] Tokyo Womens Med Univ, Ctr Diabet, Tokyo 1628666, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo 1608582, Japan; [Hayashi, Matsuhiko] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan; [Kashiwagi, Atsunori; Kikkawa, Ryuichi] Shiga Univ Med Sci, Dept Med, Shiga 5202192, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Div Endocrinol & Metab, Okayama 7010192, Japan; [Kawamori, Ryuzo] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 1138421, Japan; [Tai, E. Shyong] Singapore Gen Hosp, Dept Endocrinol, Singapore 169608, Singapore; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan	RIKEN; RIKEN; RIKEN; University of Tokyo; Steno Diabetes Center; National University of Singapore; University of Copenhagen; Aarhus University; Aarhus University; RIKEN; Tokyo Women's Medical University; Keio University; Keio University; Shiga University of Medical Science; Kawasaki Medical School; Juntendo University; Singapore General Hospital; University of Tokyo	Maeda, S (corresponding author), RIKEN, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan.	smaeda@src.riken.jp	Kashiwagi, Atsunori/H-8712-2019; Kubo, Michiaki/N-7947-2015; Horikoshi, Momoko/AAF-9034-2019; Tsunoda, Tatsuhiko/K-2061-2014; Unoki-Kubota, Hiroyuki/H-7268-2019; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Tai, E Shyong/J-9831-2013; Jørgensen, Torben/Z-1335-2018; Hirose, Hiroshi/F-8556-2014; Hayashi, Matsuhiko/J-4748-2013	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Unoki-Kubota, Hiroyuki/0000-0003-4827-8805; Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Tai, E Shyong/0000-0003-2929-8966; Jorgensen, Torben/0000-0001-9453-2830	Ministry of Education, Culture, Sports, Science and Technology Japan; Lundbeck Foundation Centre of Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LUCAMP); European Union [LSHM-CT-2004-512013]; Danish Medical Research Council; National Medical Research Council [NMRC/1115/2007]	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Lundbeck Foundation Centre of Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LUCAMP); European Union(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all participating doctors and staff from collaborating institutes for providing DNA samples. We also thank the technical staff of the Laboratory for Endocrinology and Metabolism at the Center for Genomic Medicine for providing technical assistance. This work was partly supported by a grant from the Leading Project of Ministry of Education, Culture, Sports, Science and Technology Japan. The Danish study was supported by Lundbeck Foundation Centre of Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LUCAMP), the European Union (EUGENE2, grant no. LSHM-CT-2004-512013) and the Danish Medical Research Council. Funding for Singapore arm of the study was supported by the National Medical Research Council (NMRC/1115/2007). We thank the staff of National Healthcare Group Polyclinics and National University of Singapore for their contributions towards the establishment of the Singapore Diabetes Cohort Study.	Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	25	537	565	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1098	1102		10.1038/ng.208	http://dx.doi.org/10.1038/ng.208			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711366				2022-12-25	WOS:000258761200023
J	Bochkis, IM; Rubins, NE; White, P; Furth, EE; Friedman, JR; Kaestner, KH				Bochkis, Irina M.; Rubins, Nir E.; White, Peter; Furth, Emma E.; Friedman, Joshua R.; Kaestner, Klaus H.			Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress	NATURE MEDICINE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; NUCLEAR FACTOR 3-BETA; FARNESOID-X-RECEPTOR; P-GLYCOPROTEIN; TRANSCRIPTION FACTORS; DEFINITIVE ENDODERM; FEEDBACK-REGULATION; KNOCKOUT MICE; LIVER-DISEASE; CHOLESTASIS	Production of bile by the liver is crucial for the absorption of lipophilic nutrients. Dysregulation of bile acid homeostasis can lead to cholestatic liver disease and endoplasmic reticulum ( ER) stress. We show by global location analysis ('ChIP-on-chip') and cell type-specific gene ablation that the winged helix transcription factor Foxa2 is required for normal bile acid homeostasis. As suggested by the location analysis, deletion of Foxa2 in hepatocytes in mice using the Cre-lox system leads to decreased transcription of genes encoding bile acid transporters on both the basolateral and canalicular membranes, resulting in intrahepatic cholestasis. Foxa2-deficient mice are strikingly sensitive to a diet containing cholic acid, which results in toxic accumulation of hepatic bile salts, ER stress and liver injury. In addition, we show that expression of FOXA2 is markedly decreased in liver samples from individuals with different cholestatic syndromes, suggesting that reduced FOXA2 abundance could exacerbate the injury.	[Bochkis, Irina M.; Rubins, Nir E.; White, Peter; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Bochkis, Irina M.; Rubins, Nir E.; White, Peter; Kaestner, Klaus H.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Furth, Emma E.] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Friedman, Joshua R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu	White, Peter/E-4301-2011; Friedman, Joshua/Q-9367-2019; Bochkis, Irina/AAR-8865-2020	White, Peter/0000-0002-5218-5903; Friedman, Joshua/0000-0001-9382-8429; Bochkis, Irina/0000-0001-8073-8408	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, U01DK056947, R24DK056947, P01DK049210] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG000046, T32-HG000046] Funding Source: Medline; NIDDK NIH HHS [P30 DK019525, P30DK19525, P01 DK049210, DK-056947, DK-049210, R24 DK056947, U01 DK056947] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANG SL, 1993, DEVELOPMENT, V119, P1301; BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; Bernstein H, 1999, TOXICOL LETT, V108, P37, DOI 10.1016/S0378-4274(99)00113-7; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Bombail V, 2004, DRUG METAB DISPOS, V32, P525, DOI 10.1124/dmd.32.5.525; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Coffinier C, 2002, DEVELOPMENT, V129, P1829; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Eloranta JJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P397, DOI 10.1016/j.abb.2004.09.019; FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667; Fischer S, 1996, CLIN CHIM ACTA, V251, P173, DOI 10.1016/0009-8981(96)06305-X; Geier A, 2005, J HEPATOL, V43, P1021, DOI 10.1016/j.jhep.2005.05.031; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Oswald M, 2001, LIVER, V21, P247, DOI 10.1034/j.1600-0676.2001.021004247.x; Pauli-Magnus C, 2004, HEPATOLOGY, V39, P779, DOI 10.1002/hep.20159; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Rubins NE, 2005, MOL CELL BIOL, V25, P7069, DOI 10.1128/MCB.25.16.7069-7077.2005; Ruiz ML, 2007, DRUG METAB DISPOS, V35, P2060, DOI 10.1124/dmd.107.016519; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Suzuki K, 2006, MOL CELL ENDOCRINOL, V250, P184, DOI 10.1016/j.mce.2005.12.043; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vendemiale G, 2002, J HEPATOL, V37, P601, DOI 10.1016/S0168-8278(02)00234-9; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang RX, 2003, HEPATOLOGY, V38, P1489, DOI 10.1016/j.hep.2003.09.037; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zollner G, 2002, AM J PHYSIOL-GASTR L, V282, pG184, DOI 10.1152/ajpgi.00215.2001; Zollner G, 2005, AM J PHYSIOL-GASTR L, V289, pG798, DOI 10.1152/ajpgi.00319.2004; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s	54	130	131	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2008	14	8					828	836		10.1038/nm.1853	http://dx.doi.org/10.1038/nm.1853			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	334QY	18660816	Green Accepted			2022-12-25	WOS:000258237500029
J	Birnbaum, S; Ludwig, KU; Reutter, H; Herms, S; Steffens, M; Rubini, M; Baluardo, C; Ferrian, M; de Assis, NA; Alblas, MA; Barth, S; Freudenberg, J; Lauster, C; Schmidt, G; Scheer, M; Braumann, B; Berge, SJ; Reich, RH; Schiefke, F; Hemprich, A; Potzsch, S; Steegers-Theunissen, RP; Potzsch, B; Moebus, S; Horsthemke, B; Kramer, FJ; Wienker, TF; Mossey, PA; Propping, P; Cichon, S; Hoffmann, P; Knapp, M; Nothen, MM; Mangold, E				Birnbaum, Stefanie; Ludwig, Kerstin U.; Reutter, Heiko; Herms, Stefan; Steffens, Michael; Rubini, Michele; Baluardo, Carlotta; Ferrian, Melissa; de Assis, Nilma Almeida; Alblas, Margrieta A.; Barth, Sandra; Freudenberg, Jan; Lauster, Carola; Schmidt, Guel; Scheer, Martin; Braumann, Bert; Berge, Stefaan J.; Reich, Rudolf H.; Schiefke, Franziska; Hemprich, Alexander; Poetzsch, Simone; Steegers-Theunissen, Regine P.; Poetzsch, Bernd; Moebus, Susanne; Horsthemke, Bernhard; Kramer, Franz-Josef; Wienker, Thomas F.; Mossey, Peter A.; Propping, Peter; Cichon, Sven; Hoffmann, Per; Knapp, Michael; Noethen, Markus M.; Mangold, Elisabeth			Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; EXPRESSION; RISK; IRF6; METAANALYSIS; DISEASE; DESIGN; CANCER; SCAN	We conducted a genome-wide association study involving 224 cases and 383 controls of Central European origin to identify susceptibility loci for nonsyndromic cleft lip with or without cleft palate (NSCL/P). A 640-kb region at chromosome 8q24.21 was found to contain multiple markers with highly significant evidence for association with the cleft phenotype, including three markers that reached genome-wide significance. The 640-kb cleft-associated region was saturated with 146 SNP markers and then analyzed in our entire NSCL/P sample of 462 unrelated cases and 954 controls. In the entire sample, the most significant SNP (rs987525) had a P value of 3.34 x 10(-24). The odds ratio was 2.57 (95% CI = 2.02-3.26) for the heterozygous genotype and 6.05 (95% CI = 3.88-9.43) for the homozygous genotype. The calculated population attributable risk for this marker is 0.41, suggesting that this study has identified a major susceptibility locus for NSCL/P.	[Birnbaum, Stefanie; Reutter, Heiko; de Assis, Nilma Almeida; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.; Mangold, Elisabeth] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Birnbaum, Stefanie; Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany; [Ludwig, Kerstin U.; Herms, Stefan; Alblas, Margrieta A.; Barth, Sandra; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Steffens, Michael; Wienker, Thomas F.; Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Rubini, Michele; Baluardo, Carlotta; Ferrian, Melissa] Univ Ferrara, Dept Expt & Diagnost Med, Med Genet Unit, I-44100 Ferrara, Italy; [Freudenberg, Jan] Northshore LIJ Univ Hosp, Feinstein Inst Med Res, Ctr Genom & Human Genet, New York, NY USA; [Lauster, Carola; Schmidt, Guel] Humboldt Univ, Dept Cleft Lip & Cleft Palate Surg, Berlin, Germany; [Scheer, Martin] Univ Cologne, Dept Oral & Maxillofacial Surg, Cologne, Germany; [Braumann, Bert] Univ Cologne, Dept Orthodont, Cologne, Germany; [Berge, Stefaan J.] Radboud Univ Nijmegen, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Reich, Rudolf H.] Univ Bonn, Dept Oral & Maxillofacial Plast Surg, D-5300 Bonn, Germany; [Schiefke, Franziska; Hemprich, Alexander] Univ Leipzig, Dept Oral & Maxillofacial Surg, Leipzig, Germany; [Poetzsch, Simone] Univ Magdeburg, D-39106 Magdeburg, Germany; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Rotterdam, Netherlands; [Poetzsch, Bernd] Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Duisburg, Germany; [Horsthemke, Bernhard] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Duisburg, Germany; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Orthodont Unit, Dundee, Scotland	University of Bonn; University of Gottingen; University of Bonn; University of Bonn; University of Ferrara; Northwell Health; Humboldt University of Berlin; University of Cologne; University of Cologne; Radboud University Nijmegen; University of Bonn; Leipzig University; Otto von Guericke University; University of Bonn; University of Duisburg Essen; University of Duisburg Essen; University of Dundee	Mangold, E (corresponding author), Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany.	e.mangold@uni-bonn.de	Cichon, Sven/H-8803-2013; Hoffmann, Per/A-5149-2010; Bergé, S.J./H-8011-2014; Herms, Stefan/J-1949-2014; Rubini, Michele/AFF-8477-2022; Ludwig, Kerstin/H-7828-2019; Nöthen, Markus/B-2027-2009; Cichon, Sven/B-9618-2014; Berge, Stefaan/AAP-3708-2020	Cichon, Sven/0000-0002-9475-086X; Hoffmann, Per/0000-0002-6573-983X; Herms, Stefan/0000-0002-2786-8200; Rubini, Michele/0000-0003-1448-9516; Ludwig, Kerstin/0000-0002-8541-2519; Nöthen, Markus/0000-0002-8770-2464; Cichon, Sven/0000-0002-9475-086X; Ferrian, Melissa/0000-0002-3746-4576; Mossey, Peter/0000-0002-9914-6901; Steffens, Michael/0000-0002-6445-8593; Moebus, Susanne/0000-0002-0072-5410	Deutsche Forschungsgemeinschaft [MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1]; Heinz Nixdorf Foundation, Germany; European Comission FP5 [QLG1-CT-2000-01019]; University of Ferrara; CNPq/Brazil	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinz Nixdorf Foundation, Germany; European Comission FP5; University of Ferrara; CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank the subjects and their families for their participation in the study as well as the German support group for people with cleft lip and/or palate (Deutsche Selbsthilfevereinigung fur Lippen-Gaumen-Fehlbildungen e. V.). We acknowledge M. Saffar, H. Koch, C. Opitz, M. Krimmel, K. Gundlach, K. Lohrer and B. Blaumeiser for their kind support in contacting subjects. The EUROCRAN project included contributions from R. Brusati, G. Garattini, E. Calzolari, M. Accordi and A. Franchella (Italy), W. C. Shaw, P. Nelson and P. Houston (UK), S. de Weerd and I. Krapels (Netherlands), V. Kozelj and B. Peterlin (Slovenia), Y. Anastassov (Bulgaria), S. Hanstein (Estonia), A. Czeizel (Hungary), I. Klimova (Slovak Republic) and J. Little (Canada). We also thank S. Raeder, S. Uhlhaas, N. Kluck, A. Flosdorff and M. Arbustini for their laboratory work; H. Henschke and A. Diaz Lacava for their database management; and S. Boehringer for discussions. The study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and individual grants MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1). The Heinz Nixdorf Recall cohort was established with the generous support of the Heinz Nixdorf Foundation, Germany (Chairman: Dr. jur. G. Schmidt). The EUROCRAN study was supported by the European Comission FP5 (contract no. QLG1-CT-2000-01019) and the ITALCLEFT study by a FAR-2008 grant from the University of Ferrara. N.A. is supported by the CNPq/Brazil.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker T, 2004, AM J HUM GENET, V75, P561, DOI 10.1086/424390; Cann HM, 2002, SCIENCE, V296, P261; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Hirano T, 2008, MUTAT RES-FUND MOL M, V640, P97, DOI 10.1016/j.mrfmmm.2007.12.008; Jackson MR, 2002, ANN HUM GENET, V66, P307, DOI 10.1017/S0003480002001203; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Mossey P., 2002, CLEFT LIP PALATE, P127; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; RISCH N, 1996, SCIENCE, V273, P1517; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466	29	332	349	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					473	477		10.1038/ng.333	http://dx.doi.org/10.1038/ng.333			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19270707				2022-12-25	WOS:000264659000023
J	Bellinger, AM; Reiken, S; Carlson, C; Mongillo, M; Liu, XP; Rothman, L; Matecki, S; Lacampagne, A; Marks, AR				Bellinger, Andrew M.; Reiken, Steven; Carlson, Christian; Mongillo, Marco; Liu, Xiaoping; Rothman, Lisa; Matecki, Stefan; Lacampagne, Alain; Marks, Andrew R.			Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MDX MOUSE; S-NITROSYLATION; DEFECTIVE REGULATION; HEART-FAILURE; PHOSPHORYLATION; PROTEIN; FIBERS	Duchenne muscular dystrophy is characterized by progressive muscle weakness and early death resulting from dystrophin deficiency. Loss of dystrophin results in disruption of a large dystrophin glycoprotein complex, leading to pathological calcium (Ca2+)-dependent signals that damage muscle cells(1-5). We have identified a structural and functional defect in the ryanodine receptor (RyR1), a sarcoplasmic reticulum Ca2+ release channel, in the mdx mouse model of muscular dystrophy that contributes to altered Ca2+ homeostasis in dystrophic muscles. RyR1 isolated from mdx skeletal muscle showed an age-dependent increase in S-nitrosylation coincident with dystrophic changes in the muscle. RyR1 S-nitrosylation depleted the channel complex of FKBP12 (also known as calstabin-1, for calcium channel stabilizing binding protein), resulting in 'leaky' channels. Preventing calstabin-1 depletion from RyR1 with S107, a compound that binds the RyR1 channel and enhances the binding affinity of calstabin-1 to the nitrosylated channel, inhibited sarcoplasmic reticulum Ca2+ leak, reduced biochemical and histological evidence of muscle damage, improved muscle function and increased exercise performance in mdx mice. On the basis of these findings, we propose that sarcoplasmic reticulum Ca2+ leak via RyR1 due to S-nitrosylation of the channel and calstabin-1 depletion contributes to muscle weakness in muscular dystrophy, and that preventing the RyR1-mediated sarcoplasmic reticulum Ca2+ leak may provide a new therapeutic approach.	[Bellinger, Andrew M.; Reiken, Steven; Carlson, Christian; Mongillo, Marco; Liu, Xiaoping; Rothman, Lisa; Marks, Andrew R.] Columbia Univ, Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Bellinger, Andrew M.; Reiken, Steven; Carlson, Christian; Mongillo, Marco; Liu, Xiaoping; Rothman, Lisa; Marks, Andrew R.] Columbia Univ, Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Med, New York, NY 10032 USA; [Matecki, Stefan] INSERM, ERI 25, F-34295 Montpellier, France; [Matecki, Stefan; Lacampagne, Alain] Univ Montpellier 1, Unite Format & Rech Med, F-34295 Montpellier, France; [Lacampagne, Alain] INSERM, U 637, F-34295 Montpellier, France	Columbia University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Marks, AR (corresponding author), Columbia Univ, Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	arm42@columbia.edu	Lacampagne, Alain/S-3719-2016	Lacampagne, Alain/0000-0003-0264-1787	Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056180] Funding Source: NIH RePORTER	Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant from the Leducq Foundation. We thank J. Shan for assistance with analyses of histologic sections and J. Fauconnier for help with voluntary exercise measurements in mice.	Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Aracena P, 2003, J BIOL CHEM, V278, P42927, DOI 10.1074/jbc.M306969200; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BRADLEY WG, 1978, NEUROLOGY, V28, P670, DOI 10.1212/WNL.28.7.670; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; GLESBY MJ, 1988, MUSCLE NERVE, V11, P852, DOI 10.1002/mus.880110809; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vilquin JT, 1998, MUSCLE NERVE, V21, P567, DOI 10.1002/(SICI)1097-4598(199805)21:5<567::AID-MUS2>3.0.CO;2-6; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200	42	359	369	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					325	330		10.1038/nm.1916	http://dx.doi.org/10.1038/nm.1916			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19198614	Green Accepted			2022-12-25	WOS:000263914000034
J	Patel, BK; Gavin-Smyth, J; Liebman, SW				Patel, Basant K.; Gavin-Smyth, Jackie; Liebman, Susan W.			The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; INVERTASE SYNTHESIS; NUCLEAR-FUSION; SWI-SNF; GENE; PIN+; MUTATIONS; MECHANISM; TOXICITY; REGION	Although many proteins can misfold into a self-seeding amyloid-like conformation(1), only six are known to be infectious, that is prions. The prions [PSI+], [PIN+], [URE3], [SWI+] and [HET-s] cause distinct heritable physiological changes in fungi(2-4), whereas PrPSc causes infectious encephalopathies in mammals(5). It is unknown whether 'protein-only' inheritance is limited to these exceptional cases or whether it represents a widespread mechanism of epigenetic control. Towards this goal, we now describe a new prion formed by the Cyc8 (Ssn6) protein of Saccharomyces cerevisiae. Analogously to other yeast prions, transient overproduction of a glutamine-rich region of Cyc8 induced a heritable dominant cyc8-phenotype that is transmitted cytoplasmically and is dependent on the chaperone Hsp104 and the continued presence of the Cyc8 protein. The evolutionarily conserved Cyc8-Tup1 global transcriptional repressor complex(6) forms one of the largest gene regulatory circuits, controlling the expression of more than 7% of yeast genes(7). Our finding that Cyc8 can propagate as a prion, together with a recent report that Swi1 of the Swi-Snf global transcriptional regulatory complex also has a prion form(4), shows that prionization can lead to mass activation or repression of yeast genes and is suggestive of a link between the epigenetic phenomena of chromatin remodelling and prion formation.	[Patel, Basant K.; Gavin-Smyth, Jackie; Liebman, Susan W.] Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liebman, SW (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, 900 S Ashland Ave, Chicago, IL 60607 USA.	suel@uic.edu	Patel, basant/Y-8732-2019	Patel, basant/0000-0001-9465-4803	NIH [GM-56350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056350] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Sherman and R. Zitomer for yeast strains; R. Trumbly, H. Ronne, Y. Chernoff, S. Lindquist, M. Duennwald, M. D. Rose, S. Ruby, H. van Vuuren, I. Derkatch and M. Carlson for plasmids; and S. Y. R. Dent for anti- cyc8 and anti- Tup1 antibodies. We also thank K. Kirkland, V. Mathur, J. Hong and O. Appelebe for help with experiments; A. O'Dell for helpful suggestions; and S.- K. Park, A. Manogaran and N. Vishveshwara for commenting on the manuscript. This work was supported by NIH grant GM-56350 to S. W. L. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of NIH.	ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2003, YEAST, V20, P625, DOI 10.1002/yea.985; CARLSON M, 1984, GENETICS, V107, P19; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; Fleming AB, 2001, EMBO J, V20, P5219, DOI 10.1093/emboj/20.18.5219; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; MELNICK L, 1993, J MOL BIOL, V233, P372, DOI 10.1006/jmbi.1993.1518; MIKI BLA, 1982, J BACTERIOL, V150, P878, DOI 10.1128/JB.150.2.878-889.1982; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; ROTHSTEIN RJ, 1980, GENETICS, V94, P871; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; Sherman F., 1986, METHODS YEAST GENETI; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TRUMBLY RJ, 1988, GENE, V73, P97, DOI 10.1016/0378-1119(88)90316-2; TRUMBLY RJ, 1986, J BACTERIOL, V166, P1123, DOI 10.1128/jb.166.3.1123-1127.1986; TUITE MF, 1981, GENETICS, V98, P691; VALLEN EA, 1992, J CELL BIOL, V117, P1277, DOI 10.1083/jcb.117.6.1277; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner Reed B., 2004, VVolume 41, P305; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	37	191	195	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					344	U255		10.1038/ncb1843	http://dx.doi.org/10.1038/ncb1843			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19219034	Green Accepted			2022-12-25	WOS:000263777900019
J	Fusaro, VA; Mani, DR; Mesirov, JP; Carr, SA				Fusaro, Vincent A.; Mani, D. R.; Mesirov, Jill P.; Carr, Steven A.			Prediction of high-responding peptides for targeted protein assays by mass spectrometry	NATURE BIOTECHNOLOGY			English	Article							PROTEOTYPIC PEPTIDES; RANDOM FOREST; PROTEOMICS; DISCOVERY; PLASMA; QUANTIFICATION; CLASSIFICATION; SENSITIVITY; PERFORMANCE; SELECTION	Protein biomarker discovery produces lengthy lists of candidates that must subsequently be verified in blood or other accessible biofluids. Use of targeted mass spectrometry (MS) to verify disease- or therapy-related changes in protein levels requires the selection of peptides that are quantifiable surrogates for proteins of interest. Peptides that produce the highest ion-current response (high-responding peptides) are likely to provide the best detection sensitivity. Identification of the most effective signature peptides, particularly in the absence of experimental data, remains a major resource constraint in developing targeted MS-based assays. Here we describe a computational method that uses protein physicochemical properties to select high-responding peptides and demonstrate its utility in identifying signature peptides in plasma, a complex proteome with a wide range of protein concentrations. Our method, which employs a Random Forest classifier, facilitates the development of targeted MS-based assays for biomarker verification or any application where protein levels need to be measured.	[Fusaro, Vincent A.; Mani, D. R.; Mesirov, Jill P.; Carr, Steven A.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Fusaro, Vincent A.; Mani, D. R.; Mesirov, Jill P.; Carr, Steven A.] Harvard Univ, Cambridge, MA 02142 USA; [Fusaro, Vincent A.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston University	Carr, SA (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	mesirov@broad.mit.edu; scarr@broad.mit.edu	Mesirov, Jill/AGF-7626-2022; Carr, Steven A./AAH-8366-2019	Mani, D. R./0000-0003-3914-133X	National Institutes of Health [1U24 CA126476, R01 CA126219]; NCI's Clinical Proteomic Technologies Assessment in Cancer Program; National Heart, Lung, and Blood Institute [U01-HL081341]; Women's Cancer Research Fund; National Science Foundation; NIGMS; NATIONAL CANCER INSTITUTE [R01CA126219, U24CA126476] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI's Clinical Proteomic Technologies Assessment in Cancer Program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Women's Cancer Research Fund; National Science Foundation(National Science Foundation (NSF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Cancer Institute (NCI) Clinical Proteomic Technology Assessment in Cancer Program (NCI-CPTAC, http://proteomics.cancer.gov/programs/CPTAC/) for providing samples of yeast lysate and raw MS data generated by the CPTAC centers. We thank Rushdy Ahmad, Kathy Do, Amy Ham, Emily Rudomin, and Shao-En Ong for MS data generation, and Hasmik Keshishian and Terri Addona for generating the lists of validated MRM peptides. We also thank Shao-En Ong, Jacob Jaffe, Karl Clauser, Eric Kuhn, Pablo Tamayo, and Nick Patterson for helpful discussions. We would like to thank the reviewers for their insightful comments. This work was supported in part by grants to S. A. C. from the National Institutes of Health Grants 1U24 CA126476 as part of the NCI's Clinical Proteomic Technologies Assessment in Cancer Program, the National Heart, Lung, and Blood Institute, U01-HL081341 and The Women's Cancer Research Fund; to J.P.M. from the National Science Foundation and NIGMS the National Institutes of Health (NIGMS and NCI); to D. R. M. from the National Institutes of Health grant R01 CA126219, as part of NCI's Clinical Proteomic Technologies for Cancer Program.	Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Bishop C. M., 1995, NEURAL NETWORKS PATT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cech NB, 2000, ANAL CHEM, V72, P2717, DOI 10.1021/ac9914869; Cech NB, 2001, MASS SPECTROM REV, V20, P362, DOI 10.1002/mas.10008; Chen C., 2004, 666 U CAL BERK STAT, V110, P24; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; COWAN R, 1990, Peptide Research, V3, P75; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Enot DP, 2006, P NATL ACAD SCI USA, V103, P14865, DOI 10.1073/pnas.0605152103; Fawcett T., 2004, ROC GRAPHS NOTES PRA; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Jaffe JD, 2008, MOL CELL PROTEOMICS, V7, P1952, DOI 10.1074/mcp.M800218-MCP200; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Klimek J, 2008, J PROTEOME RES, V7, P96, DOI 10.1021/pr070244j; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sanders WS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S23; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Tang HX, 2006, BIOINFORMATICS, V22, pE481, DOI 10.1093/bioinformatics/btl237; Thomson R, 2003, BIOINFORMATICS, V19, P1741, DOI 10.1093/bioinformatics/btg237; UHLEN M, 2008, J MOL RECOGNIT; Wang HX, 2005, J PROTEOME RES, V4, P2397, DOI 10.1021/pr050160f; Webb-Robertson BJM, 2008, BIOINFORMATICS, V24, P1503, DOI 10.1093/bioinformatics/btn218; Whiteaker JR, 2007, J PROTEOME RES, V6, P3962, DOI 10.1021/pr070202v; Yen CY, 2006, ANAL CHEM, V78, P1071, DOI 10.1021/ac051127f; Zhang ZQ, 2004, ANAL CHEM, V76, P3908, DOI 10.1021/ac049951b; Zolg JW, 2004, MOL CELL PROTEOMICS, V3, P345, DOI 10.1074/mcp.M400007-MCP200	38	228	251	2	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2009	27	2					190	198		10.1038/nbt.1524	http://dx.doi.org/10.1038/nbt.1524			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	405FT	19169245	Green Accepted			2022-12-25	WOS:000263209000026
J	Aulchenko, YS; Ripatti, S; Lindqvist, I; Boomsma, D; Heid, IM; Pramstaller, PP; Penninx, BWJH; Janssens, ACJW; Wilson, JF; Spector, T; Martin, NG; Pedersen, NL; Kyvik, KO; Kaprio, J; Hofman, A; Freimer, NB; Jarvelin, MR; Gyllensten, U; Campbell, H; Rudan, I; Johansson, A; Marroni, F; Hayward, C; Vitart, V; Jonasson, I; Pattaro, C; Wright, A; Hastie, N; Pichler, I; Hicks, AA; Falchi, M; Willemsen, G; Hottenga, JJ; de Geus, EJC; Montgomery, GW; Whitfield, J; Magnusson, P; Saharinen, J; Perola, M; Silander, K; Isaacs, A; Sijbrands, EJG; Uitterlinden, AG; Witteman, JCM; Oostra, BA; Elliott, P; Ruokonen, A; Sabatti, C; Gieger, C; Meitinger, T; Kronenberg, F; Doring, A; Wichmann, HE; Smit, JH; McCarthy, MI; van Duijn, CM; Peltonen, L				Aulchenko, Yurii S.; Ripatti, Samuli; Lindqvist, Ida; Boomsma, Dorret; Heid, Iris M.; Pramstaller, Peter P.; Penninx, Brenda W. J. H.; Janssens, A. Cecile J. W.; Wilson, James F.; Spector, Tim; Martin, Nicholas G.; Pedersen, Nancy L.; Kyvik, Kirsten Ohm; Kaprio, Jaakko; Hofman, Albert; Freimer, Nelson B.; Jarvelin, Marjo-Riitta; Gyllensten, Ulf; Campbell, Harry; Rudan, Igor; Johansson, Asa; Marroni, Fabio; Hayward, Caroline; Vitart, Veronique; Jonasson, Inger; Pattaro, Cristian; Wright, Alan; Hastie, Nick; Pichler, Irene; Hicks, Andrew A.; Falchi, Mario; Willemsen, Gonneke; Hottenga, Jouke-Jan; de Geus, Eco J. C.; Montgomery, Grant W.; Whitfield, John; Magnusson, Patrik; Saharinen, Juha; Perola, Markus; Silander, Kaisa; Isaacs, Aaron; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.; Oostra, Ben A.; Elliott, Paul; Ruokonen, Aimo; Sabatti, Chiara; Gieger, Christian; Meitinger, Thomas; Kronenberg, Florian; Doering, Angela; Wichmann, H-Erich; Smit, Johannes H.; McCarthy, Mark I.; van Duijn, Cornelia M.; Peltonen, Leena		Engage Consortium	Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; PLASMA; POLYMORPHISMS; OBJECTIVES; SPECTRUM; DESIGN; KORA	Recent genome-wide association (GWA) studies of lipids have been conducted in samples ascertained for other phenotypes, particularly diabetes. Here we report the first GWA analysis of loci affecting total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides sampled randomly from 16 population-based cohorts and genotyped using mainly the Illumina HumanHap300-Duo platform. Our study included a total of 17,797-22,562 persons, aged 18-104 years and from geographic regions spanning from the Nordic countries to Southern Europe. We established 22 loci associated with serum lipid levels at a genome-wide significance level (P < 5 x 10(-8)), including 16 loci that were identified by previous GWA studies. The six newly identified loci in our cohort samples are ABCG5 (TC, P = 1.5 x 10(-11); LDL, P = 2.6 x 10(-10)), TMEM57 (TC, P = 5.4 x 10(-10)), CTCF-PRMT8 region (HDL, P = 8.3 x 10(-16)), DNAH11 (LDL, P = 6.1 x 10(-9)), FADS3-FADS2 (TC, P = 1.5 x 10(-10); LDL, P = 4.4 x 10(-13)) and MADD-FOLH1 region (HDL, P = 6 x 10(-11)). For three loci, effect sizes differed significantly by sex. Genetic risk scores based on lipid loci explain up to 4.8% of variation in lipids and were also associated with increased intima media thickness (P = 0.001) and coronary heart disease incidence (P = 0.04). The genetic risk score improves the screening of high-risk groups of dyslipidemia over classical risk factors.	[Ripatti, Samuli; Lindqvist, Ida; Perola, Markus; Silander, Kaisa; Peltonen, Leena] Natl Publ Hlth Inst, Biomedicum, Helsinki 00251, Finland; [Aulchenko, Yurii S.; Janssens, A. Cecile J. W.; Hofman, Albert; Isaacs, Aaron; Sijbrands, Eric J. G.; Witteman, Jacqueline C. M.] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; [Ripatti, Samuli; Lindqvist, Ida; Perola, Markus; Silander, Kaisa; Peltonen, Leena] Inst Mol Med, FIMM, Helsinki 00251, Finland; [Boomsma, Dorret; Willemsen, Gonneke; Hottenga, Jouke-Jan; de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Heid, Iris M.; Gieger, Christian; Doering, Angela; Wichmann, H-Erich] Helmholtz Ctr Munich, Inst Epidemiol, D-85764 Neuherberg, Germany; [Heid, Iris M.; Wichmann, H-Erich] Univ Munich, IBE, Chair Epidemiol, D-81377 Munich, Germany; [Pramstaller, Peter P.; Marroni, Fabio; Pattaro, Cristian; Pichler, Irene; Hicks, Andrew A.] EURAC Res, Inst Med Genet, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Penninx, Brenda W. J. H.; Smit, Johannes H.] Vrije Univ Amsterdam Med Ctr, Inst Neurosci, EMGO Inst, Dept Psychiat, Amsterdam, Netherlands; [Wilson, James F.; Campbell, Harry; Rudan, Igor] Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Wilson, James F.; Hayward, Caroline; Wright, Alan; Hastie, Nick] MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Spector, Tim; Falchi, Mario] Kings Coll London, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England; [Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John] PO Royal Brisbane Hosp, Queensland Inst Med Res, Genet Epidemiol Unit, Brisbane, Qld 4029, Australia; [Pedersen, Nancy L.; Magnusson, Patrik] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Publ Hlth, Inst Reg Hlth Res, DK-5000 Odense, Denmark; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Publ Hlth, Danish Twin Registry, DK-5000 Odense, Denmark; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Fac Med, FIN-00014 Helsinki, Finland; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, FIN-00300 Helsinki, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Ctr Neurobehav Genet,Jane & Terry Semel Inst Neur, Los Angeles, CA 90095 USA; [Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; [Gyllensten, Ulf; Johansson, Asa; Jonasson, Inger] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Rudan, Igor] Univ Split Med Sch, Croatian Ctr Global Hlth, Split 21000, Croatia; [Rudan, Igor] Univ Hosp Sestre Milosrdnice, Inst Clin Med Res, Zagreb 10000, Croatia; [Falchi, Mario] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Sijbrands, Eric J. G.; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Oostra, Ben A.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Ruokonen, Aimo] Univ Hosp Oulu, Dept Biochem, Oulu 90220, Finland; [Sabatti, Chiara] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Meitinger, Thomas] Helmholtz Ctr Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Peltonen, Leena] MIT, Broad Inst, Cambridge, MA 02142 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst Wellcome Trust Genom C, Cambridge CB10 1SA, England	Finland National Institute for Health & Welfare; University of Helsinki; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; European Academy of Bozen-Bolzano; Krankenhaus Bozen; University of Lubeck; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Edinburgh; University of Edinburgh; University of London; King's College London; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Karolinska Institutet; University of Southern Denmark; University of Southern Denmark; University of Helsinki; Finland National Institute for Health & Welfare; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Imperial College London; University of Oulu; Uppsala University; University of Split; Imperial College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Medical University of Innsbruck; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Biomedicum, POB 104, Helsinki 00251, Finland.	leena@sanger.ac.uk	Rudan, Igor/I-1467-2012; Spector, Tim D/F-6533-2012; Wichmann, Heinz Erich/AAA-5695-2022; Marroni, Fabio/R-1819-2017; Sijbrands, Eric/A-1065-2009; Kyvik, Kirsten O/K-5680-2016; Kronenberg, Florian/B-1736-2008; Ripatti, Samuli/H-9446-2014; Kaprio, Jaakko/A-1820-2008; Wilson, James F/A-5704-2009; de Geus, Eco J.C./M-9318-2015; Hayward, Caroline/M-8818-2016; Falchi, Mario/F-5956-2013; Hicks, Andrew Anthony/E-9518-2017; Boomsma, Dorret I/AAX-4470-2020; Johansson, Åsa/G-5270-2011; Pramstaller, Peter P/C-2357-2008; Montgomery, Grant W/B-7148-2008; Aulchenko, Yurii/M-8270-2013; Johansson, Åsa/AAG-6799-2021; Campbell, Harry/E-2959-2010; Meitinger, Thomas/O-1318-2015; Penninx, Brenda WJH/S-7627-2017; Magnusson, Patrik KE/C-4458-2017; McCarthy, Mark/M-3763-2015	Rudan, Igor/0000-0001-6993-6884; Marroni, Fabio/0000-0002-1556-5907; Sijbrands, Eric/0000-0001-8857-7389; Kyvik, Kirsten O/0000-0003-2981-0245; Kronenberg, Florian/0000-0003-2229-1120; Ripatti, Samuli/0000-0002-0504-1202; Kaprio, Jaakko/0000-0002-3716-2455; Wilson, James F/0000-0001-5751-9178; de Geus, Eco J.C./0000-0001-6022-2666; Hayward, Caroline/0000-0002-9405-9550; Hicks, Andrew Anthony/0000-0001-6320-0411; Johansson, Åsa/0000-0002-2915-4498; Montgomery, Grant W/0000-0002-4140-8139; Aulchenko, Yurii/0000-0002-7899-1575; Johansson, Åsa/0000-0002-2915-4498; Campbell, Harry/0000-0002-6169-6262; Penninx, Brenda WJH/0000-0001-7779-9672; Magnusson, Patrik KE/0000-0002-7315-7899; Pichler, Irene/0000-0001-8251-0757; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Whitfield, John/0000-0002-1103-0876; Elliott, Paul/0000-0002-7511-5684; Falchi, Mario/0000-0002-5646-1004; Martin, Nicholas/0000-0003-4069-8020; Meitinger, Thomas/0000-0002-8838-8403; Janssens, A Cecile/0000-0002-6153-4976; Willemsen, Gonneke/0000-0003-3755-0236; Surakka, Ida/0000-0002-6669-5541; Gieger, Christian/0000-0001-6986-9554; Van Duijn, Cornelia/0000-0002-2374-9204; Vitart, Veronique/0000-0002-4991-3797; McCarthy, Mark/0000-0002-4393-0510	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561128] Funding Source: Medline; NHLBI NIH HHS [5R01HL087679-02, R01 HL087679] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; MRC [MC_U127561128] Funding Source: UKRI	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; ENDO A, 1992, J LIPID RES, V33, P1569; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedlander Y, 1997, AM J HUM GENET, V60, P1502, DOI 10.1086/515462; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Howard BV, 2003, ENDOCRIN METAB CLIN, V32, P855, DOI 10.1016/S0889-8529(03)00073-2; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2008, CURR OPIN LIPIDOL, V19, P122, DOI 10.1097/MOL.0b013e3282f70296; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Law S W, 1986, Adv Exp Med Biol, V201, P151; MILLER NE, 1975, LANCET, V1, P1033, DOI 10.1016/S0140-6736(75)91977-7; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Peltonen L, 2003, TWIN RES, V6, P354, DOI 10.1375/twin.6.5.354; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Rudan I, 1999, COLLEGIUM ANTROPOL, V23, P531; Rudkowska I, 2008, NUTR REV, V66, P343, DOI 10.1111/j.1753-4887.2008.00042.x; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SING CF, 1985, AM J HUM GENET, V37, P268; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wilson JD., HARRISONS PRINCIPLES, V1994, P472	41	687	701	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					47	55		10.1038/ng.269	http://dx.doi.org/10.1038/ng.269			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19060911	Green Published, Green Accepted			2022-12-25	WOS:000262085300015
J	Long, JZ; Li, WW; Booker, L; Burston, JJ; Kinsey, SG; Schlosburg, JE; Pavon, FJ; Serrano, AM; Selley, DE; Parsons, LH; Lichtman, AH; Cravatt, BF				Long, Jonathan Z.; Li, Weiwei; Booker, Lamont; Burston, James J.; Kinsey, Steven G.; Schlosburg, Joel E.; Pavon, Francisco J.; Serrano, Antonia M.; Selley, Dana E.; Parsons, Loren H.; Lichtman, Aron H.; Cravatt, Benjamin F.			Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects	NATURE CHEMICAL BIOLOGY			English	Article							ACID AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID SYSTEM; REVERSIBLE INHIBITORS; ANANDAMIDE; ENZYME; MICE; 2-ARACHIDONYLGLYCEROL; IDENTIFICATION; DEGRADATION	2-Arachidonoylglycerol (2-AG) and anandamide are endocannabinoids that activate the cannabinoid receptors CB1 and CB2. Endocannabinoid signaling is terminated by enzymatic hydrolysis, a process that for anandamide is mediated by fatty acid amide hydrolase ( FAAH), and for 2-AG is thought to involve monoacylglycerol lipase (MAGL). FAAH inhibitors produce a select subset of the behavioral effects observed with CB1 agonists, which suggests a functional segregation of endocannabinoid signaling pathways in vivo. Testing this hypothesis, however, requires specific tools to independently block anandamide and 2-AG metabolism. Here, we report a potent and selective inhibitor of MAGL called JZL184 that, upon administration to mice, raises brain 2-AG by eight-fold without altering anandamide. JZL184-treated mice exhibited a broad array of CB1-dependent behavioral effects, including analgesia, hypothermia and hypomotility. These data indicate that 2-AG endogenously modulates several behavioral processes classically associated with the pharmacology of cannabinoids and point to overlapping and unique functions for 2-AG and anandamide in vivo.	[Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Pavon, Francisco J.; Serrano, Antonia M.; Parsons, Loren H.] Scripps Res Inst, Comm Neurobiol Addict, La Jolla, CA 92037 USA; [Booker, Lamont; Burston, James J.; Kinsey, Steven G.; Schlosburg, Joel E.; Selley, Dana E.; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Virginia Commonwealth University	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu	Pavón Morón, Francisco Javier/AAG-9721-2020; LI, WEWEI/F-8657-2010	Pavón Morón, Francisco Javier/0000-0002-5256-8904; Serrano, Antonia/0000-0002-8017-9754; Long, Jonathan/0000-0003-2631-7463	US National Institutes of Health [DA017259, DA025285, DA007027, DA005274, AA014619, DA024194, AA06420]; Helen L. Dorris Institute Child and Adolescent Neuro-Psychiatric Disorder Institute; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA006420, R01AA014619, P50AA006420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007027, P20DA024194, R01DA015683, P50DA005274, R01DA025285, P01DA017259, R01DA003672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen L. Dorris Institute Child and Adolescent Neuro-Psychiatric Disorder Institute; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Cravatt lab for helpful discussion and critical reading of the manuscript. This work was supported by the US National Institutes of Health (DA017259, DA025285, DA007027, DA005274 AA014619, DA024194 and AA06420), the Helen L. Dorris Institute Child and Adolescent Neuro-Psychiatric Disorder Institute and the Skaggs Institute for Chemical Biology.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Bequet F, 2007, EUR J NEUROSCI, V26, P3458, DOI 10.1111/j.1460-9568.2007.05900.x; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Burston JJ, 2008, J PHARMACOL EXP THER, V327, P546, DOI 10.1124/jpet.108.141382; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Chen JK, 2008, J BIOL CHEM, V283, P24514, DOI 10.1074/jbc.M709873200; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Holt S, 2005, BRIT J PHARMACOL, V146, P467, DOI 10.1038/sj.bjp.0706348; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Karlsson M, 2001, GENE, V272, P11, DOI 10.1016/S0378-1119(01)00559-5; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; King AR, 2007, CHEM BIOL, V14, P1357, DOI 10.1016/j.chembiol.2007.10.017; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Saario SM, 2005, CHEM BIOL, V12, P649, DOI 10.1016/j.chembiol.2005.04.013; Siegel G.J., 1994, BASIC NEUROCHEMISTRY; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Vandevoorde S, 2007, BRIT J PHARMACOL, V150, P186, DOI 10.1038/sj.bjp.0706971; Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9; Zhang D, 2007, NEUROPHARMACOLOGY, V52, P1095, DOI 10.1016/j.neuropharm.2006.11.009	43	711	760	0	59	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2009	5	1					37	44		10.1038/nchembio.129	http://dx.doi.org/10.1038/nchembio.129			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387EW	19029917	Green Accepted			2022-12-25	WOS:000261935500012
J	Dunlop, MJ; Cox, RS; Levine, JH; Murray, RM; Elowitz, MB				Dunlop, Mary J.; Cox, Robert Sidney, III; Levine, Joseph H.; Murray, Richard M.; Elowitz, Michael B.			Regulatory activity revealed by dynamic correlations in gene expression noise	NATURE GENETICS			English	Article							INCOHERENT FEEDFORWARD LOOP; ESCHERICHIA-COLI; PATHWAY; CONSEQUENCES; CONSTRUCTION; NETWORK; LAMBDA; SYSTEM; TIME	Gene regulatory interactions are context dependent, active in some cellular states but not in others. Stochastic fluctuations, or 'noise', in gene expression propagate through active, but not inactive, regulatory links(1,2). Thus, correlations in gene expression noise could provide a noninvasive means to probe the activity states of regulatory links. However, global, 'extrinsic', noise sources generate correlations even without direct regulatory links. Here we show that single-cell time-lapse microscopy, by revealing time lags due to regulation, can discriminate between active regulatory connections and extrinsic noise. We demonstrate this principle mathematically, using stochastic modeling, and experimentally, using simple synthetic gene circuits. We then use this approach to analyze dynamic noise correlations in the galactose metabolism genes of Escherichia coli. We find that the CRP-GalS-GalE feed-forward loop is inactive in standard conditions but can become active in a GalR mutant. These results show how noise can help analyze the context dependence of regulatory interactions in endogenous gene circuits.	[Cox, Robert Sidney, III; Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dunlop, Mary J.; Levine, Joseph H.; Murray, Richard M.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Elowitz, MB (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd,M-C 114-96, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Murray, Richard/J-2518-2015	Murray, Richard/0000-0002-5785-7481	US Army Research Office [DAAD19-03-D-0004]; Department of Energy Computational Science Graduate Fellowship; US National Institutes of Health [R01GM079771, P50 GM068763]; National Science Foundation [0644463]; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM079771] Funding Source: NIH RePORTER	US Army Research Office; Department of Energy Computational Science Graduate Fellowship(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Fontes, F. Tan, L. Cai, E. Franco, and all members of the Elowitz and Murray groups for their feedback and suggestions. H. Garcia provided advice on the chromosomal integration and gene knockout experiments. We thank J. Garcia-Ojalvo, U. Alon, R. Kishony, N. Rosenfeld and B. Shraiman for discussions. M. J. D. and R. M. M. are supported by the Institute for Collaborative Biotechnologies through grant DAAD19-03-D-0004 from the US Army Research Office. M. J. D. was additionally supported by a Department of Energy Computational Science Graduate Fellowship. This research was supported by US National Institutes of Health grants R01GM079771, P50 GM068763, National Science Foundation CAREER Award 0644463 and the Packard Foundation.	Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; Arkin A, 1998, GENETICS, V149, P1633; ARKIN A, 1995, J PHYS CHEM-US, V99, P970, DOI 10.1021/j100003a020; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Cox CD, 2008, P NATL ACAD SCI USA, V105, P10809, DOI 10.1073/pnas.0804829105; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gillespie DT, 1996, PHYS REV E, V54, P2084, DOI 10.1103/PhysRevE.54.2084; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Semsey S, 2007, MOL MICROBIOL, V65, P465, DOI 10.1111/j.1365-2958.2007.05798.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tsang J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100064; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	30	156	157	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1493	1498		10.1038/ng.281	http://dx.doi.org/10.1038/ng.281			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19029898	Green Accepted			2022-12-25	WOS:000261215900029
J	Nasr, R; Guillemin, MC; Ferhi, O; Soilihi, H; Peres, L; Berthier, C; Rousselot, P; Robledo-Sarmiento, M; Lallemand-Breitenbach, V; Gourmel, B; Vitoux, D; Pandolfi, PP; Rochette-Egly, C; Zhu, J; The, H				Nasr, Rihab; Guillemin, Marie-Claude; Ferhi, Omar; Soilihi, Hassan; Peres, Laurent; Berthier, Caroline; Rousselot, Philippe; Robledo-Sarmiento, Macarena; Lallemand-Breitenbach, Valerie; Gourmel, Bernard; Vitoux, Dominique; Pandolfi, Pier Paolo; Rochette-Egly, Cecile; Zhu, Jun; de The, Hugues			Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation	NATURE MEDICINE			English	Article							TRANS-RETINOIC ACID; ARSENIC-TRIOXIDE; MYELOID-LEUKEMIA; STEM-CELLS; CROSS-TALK; ALPHA; PROTEIN; RXR; DIFFERENTIATION; APOPTOSIS	Retinoic acid and arsenic trioxide target the protein stability and transcriptional repression activity of the fusion oncoprotein PML-RARA, resulting in regression of acute promyelocytic leukemia (APL). Phenotypically, retinoic acid induces differentiation of APL cells. Here we show that retinoic acid also triggers growth arrest of leukemia-initiating cells (LICs) ex vivo and their clearance in PML-RARA mouse APL in vivo. Retinoic acid treatment of mouse APLs expressing the fusion protein PLZF-RARA triggers full differentiation, but not LIC loss or disease remission, establishing that differentiation and LIC loss can be uncoupled. Although retinoic acid and arsenic synergize to clear LICs through cooperative PML-RARA degradation, this combination does not enhance differentiation. A cyclic AMP (cAMP)-dependent phosphorylation site in PML-RARA is crucial for retinoic acid-induced PML-RARA degradation and LIC clearance. Moreover, activation of cAMP signaling enhances LIC loss by retinoic acid, identifying cAMP as another potential APL therapy. Thus, whereas transcriptional activation of PML-RARA is likely to control differentiation, its catabolism triggers LIC eradication and long-term remission of mouse APL. Therapy-triggered degradation of oncoproteins could be a general strategy to eradicate cancer stem cells.	[Rousselot, Philippe] Univ Paris 05, UFR Med, F-78157 Le Chesnay, France; [Nasr, Rihab; Guillemin, Marie-Claude; Ferhi, Omar; Soilihi, Hassan; Peres, Laurent; Berthier, Caroline; Robledo-Sarmiento, Macarena; Lallemand-Breitenbach, Valerie; Gourmel, Bernard; Vitoux, Dominique; Zhu, Jun; de The, Hugues] Univ Paris 07, CNRS, Hop St Louis,UMR 7151, Serv Biochim,Equipe Labellisee Ligue Natl Ctr Can, F-75475 Paris, France; [Rousselot, Philippe] Hop Mignot, F-78157 Le Chesnay, France; [Pandolfi, Pier Paolo] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Rochette-Egly, Cecile] Inst Genet & Biol Mol & Cellulaire, Dept Funct Genom, F-67400 Illkirch Graffenstaden, France; [Zhu, Jun; de The, Hugues] Rui Jin Hosp, Shanghai Inst Hematol, CNRS, Lab Associe MPC, Shanghai 200025, Peoples R China	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier de Versailles; Harvard University; Beth Israel Deaconess Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	The, H (corresponding author), Univ Paris 07, CNRS, Hop St Louis,UMR 7151, Serv Biochim,Equipe Labellisee Ligue Natl Ctr Can, 1 Av C Vellefaux, F-75475 Paris, France.	dethe@univ-paris-diderot.fr	Nasr, Rihab/AAF-1606-2020	Nasr, Rihab/0000-0003-1166-4999; Lallemand, Valerie/0000-0001-9852-204X	Lady Tata Foundation (London); ARECA; EPITRON [LSHC-CT-2005-518417]; INCa/Canceropole	Lady Tata Foundation (London); ARECA; EPITRON; INCa/Canceropole(Institut National du Cancer (INCA) France)	R.N. was supported by the Lady Tata Foundation (London). This work was supported by the ARECA, EPITRON (an integrated project funded by the European Union under the sixth framework program (LSHC-CT-2005-518417)) and INCa/Canceropole programs. We thank J. Godet and the Comite des Yvelines de la Ligue contre le Cancer for their continuous support of this project; M. Pla and the animal housing facility; C. Leboeuf, L. Legres and A. Janin for facilitation of the pathological analysis of the mice; M. Kawatika, M. Giovanini and F. Riaucoux for the derivation of MRP8-PML-RARAS873A transgenic mice; P. Chambon for the antibody to RARA; S. Kogan for the APLs and the MSCV-luciferase vector; B. Arnulf for bortezomib; H. Tenor (Altana/Nycomed) for piclamilast; O. Hermine and F. Valensi for help with the t(11;17) human data; the Treilles and IPSEN foundations for providing the setting where this work was first presented and developed; and A. Saib, J.C. Gluckman and F. Sigaux for critical reading of the manuscript.	Altucci L, 2005, CANCER RES, V65, P8754, DOI 10.1158/0008-5472.CAN-04-3569; Chen GQ, 1996, LEUKEMIA, V10, P825; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Gaillard E, 2006, P NATL ACAD SCI USA, V103, P9548, DOI 10.1073/pnas.0509717103; Guillemin MC, 2002, J EXP MED, V196, P1373, DOI 10.1084/jem.20021129; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Koken MHM, 1999, ONCOGENE, V18, P1113, DOI 10.1038/sj.onc.1202414; Lallemand-Breitenbach V, 2005, NAT REV CANCER, V5, P821, DOI 10.1038/nrc1719; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Mann KK, 2005, J CLIN INVEST, V115, P2924, DOI 10.1172/JCI23628; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MUINDI J, 1992, BLOOD, V79, P299; Nervi C, 1998, BLOOD, V92, P2244; Parrella E, 2004, J BIOL CHEM, V279, P42026, DOI 10.1074/jbc.M406530200; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Quignon F, 1997, BBA-REV CANCER, V1333, pM53, DOI 10.1016/S0304-419X(97)00025-5; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; RUCHAUD S, 1994, P NATL ACAD SCI USA, V91, P8428, DOI 10.1073/pnas.91.18.8428; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Tsimberidou AM, 2006, LEUKEMIA LYMPHOMA, V47, P1062, DOI 10.1080/10428190500463932; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; VOM BE, 1996, EMBO J, V15, P110; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Westervelt P, 2002, P NATL ACAD SCI USA, V99, P9468, DOI 10.1073/pnas.132657799; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102; Zheng XM, 2007, HAEMATOLOGICA, V92, P323, DOI 10.3324/haematol.10541; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978; Zhu J, 2001, ONCOGENE, V20, P7257, DOI 10.1038/sj.onc.1204852; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	50	265	282	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1333	1342		10.1038/nm.1891	http://dx.doi.org/10.1038/nm.1891			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19029980				2022-12-25	WOS:000261393600017
J	Ostrand-Rosenberg, S				Ostrand-Rosenberg, Suzanne			Cancer and complement	NATURE BIOTECHNOLOGY			English	Editorial Material							SUPPRESSOR-CELLS; TUMOR PROGRESSION; ACCUMULATION; INFLAMMATION; EXPANSION; PROTEINS		Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Ostrand-Rosenberg, S (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	srosenbe@umbc.edu			NCI NIH HHS [R01 CA084232, R01 CA115880-03, R01 CA115880-02, R01 CA115880, R01 CA084232-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084232, R01CA115880] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gorter A, 1999, IMMUNOL TODAY, V20, P576, DOI 10.1016/S0167-5699(99)01537-6; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	12	38	42	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1348	1349		10.1038/nbt1208-1348	http://dx.doi.org/10.1038/nbt1208-1348			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19060872	Green Accepted			2022-12-25	WOS:000261591300018
J	Richards, JB; Yuan, X; Geller, F; Waterworth, D; Bataille, V; Glass, D; Song, K; Waeber, G; Vollenweider, P; Aben, KKH; Kiemeney, LA; Walters, B; Soranzo, N; Thorsteinsdottir, U; Kong, A; Rafnar, T; Deloukas, P; Sulem, P; Stefansson, H; Stefansson, K; Spector, TD; Mooser, V				Richards, J. Brent; Yuan, Xin; Geller, Frank; Waterworth, Dawn; Bataille, Veronique; Glass, Daniel; Song, Kijoung; Waeber, Gerard; Vollenweider, Peter; Aben, Katja K. H.; Kiemeney, Lambertus A.; Walters, Bragi; Soranzo, Nicole; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Deloukas, Panos; Sulem, Patrick; Stefansson, Hreinn; Stefansson, Kari; Spector, Tim D.; Mooser, Vincent			Male-pattern baldness susceptibility locus at 20p11	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; HAIR FOLLICLE; ALOPECIA; POLYMORPHISM; ASSOCIATION; RISK	We conducted a genome-wide association study for androgenic alopecia in 1,125 men and identified a newly associated locus at chromosome 20p11.22, confirmed in three independent cohorts (n = 1,650; OR = 1.60, P = 1.1 x 10(-14) for rs1160312). The one man in seven who harbors risk alleles at both 20p11.22 and AR (encoding the androgen receptor) has a sevenfold-increased odds of androgenic alopecia (OR = 7.12, P = 3.7 x 10(-15)).	[Richards, J. Brent; Bataille, Veronique; Glass, Daniel; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Richards, J. Brent] McGill Univ, Fac Med, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Yuan, Xin; Waterworth, Dawn; Song, Kijoung; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet, King Of Prussia, PA 19406 USA; [Geller, Frank; Walters, Bragi; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Sulem, Patrick; Stefansson, Hreinn; Stefansson, Kari] DeCode Genet, IS-101 Reykjavik, Iceland; [Waeber, Gerard; Vollenweider, Peter] CHUV Univ Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Aben, Katja K. H.] Radboud Univ Nijmegen, Med Ctr, Comprehens Canc Ctr IKO, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 GA Nijmegen, Netherlands; [Soranzo, Nicole; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of London; King's College London; McGill University; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Wellcome Trust Sanger Institute	Spector, TD (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.	tim.spector@kcl.ac.uk	Aben, Katja KH/G-9686-2016; Kiemeney, Lambertus A./D-3357-2009; Richards, J Brent/AAF-4225-2019; Walters, G. Bragi/L-4215-2013; Deloukas, Panos/B-2922-2013; Colaus, PsyColaus/K-6607-2013; Stefansson, Kari/AAE-7187-2019	Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Richards, J Brent/0000-0002-3746-9086; Walters, G. Bragi/0000-0002-5415-6487; Deloukas, Panos/0000-0001-9251-070X; Stefansson, Hreinn/0000-0002-9331-6666; Waeber, Gerard/0000-0003-4193-788X; Kong, Augustine/0000-0001-8193-5438; Soranzo, Nicole/0000-0003-1095-3852; Geller, Frank/0000-0002-9238-3269	GlaxoSmithKline; deCODE Genetics; Wellcome Trust; NIHR Biomedical Research Centre; Chronic Disease Research Foundation; Canadian Institutes of Health Research; EU [018827]	GlaxoSmithKline(GlaxoSmithKline); deCODE Genetics; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Chronic Disease Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EU(European Commission)	We wish to acknowledge the cooperation and dedication of the study participants and the personnel at the recruitment centers and core facilities. We would like to acknowledge the genotyping contributions of D. Smyth and J. Todd. This study was funded in part by GlaxoSmithKline; deCODE Genetics; the Wellcome Trust; NIHR Biomedical Research Centre (grant to Guys' and St. Thomas' Hospitals and King's College London); the Chronic Disease Research Foundation; the Canadian Institutes of Health Research (J. B. R.) and the Sixth Framework Program of the EU contract number 018827 (Polygene).	CASH TF, 1993, J AM ACAD DERMATOL, V29, P568, DOI 10.1016/0190-9622(93)70223-G; Domashenko A, 2000, NAT BIOTECHNOL, V18, P420, DOI 10.1038/74480; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; LI LN, 1995, NAT MED, V1, P705, DOI 10.1038/nm0795-705; Littman AJ, 2005, ANN EPIDEMIOL, V15, P771, DOI 10.1016/j.annepidem.2005.02.013; Lo JC, 2006, J CLIN ENDOCR METAB, V91, P1357, DOI 10.1210/jc.2005-2430; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Olsen E.A., 1994, DISORDERS HAIR GROWT, P257; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1	14	82	84	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1282	1284		10.1038/ng.255	http://dx.doi.org/10.1038/ng.255			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849991	Green Accepted, Green Published			2022-12-25	WOS:000260501500017
J	Baulcombe, D				Baulcombe, David			Of maize and men, or peas and people: case histories to justify plants and other model systems	NATURE MEDICINE			English	Editorial Material							DOUBLE-STRANDED-RNA; TRANSGENIC PLANTS; GENE-EXPRESSION; HOMOLOGOUS GENES; INTERFERING RNA; TOBACCO PLANTS; ANTISENSE RNA; MOSAIC-VIRUS; C-ELEGANS; SUPPRESSION		Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Baulcombe, D (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	dcb40@cam.ac.uk		Baulcombe, David/0000-0003-0780-6878	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABEL PP, 1986, SCIENCE, V232, P738, DOI 10.1126/science.3457472; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Comfort NC, 2001, TRENDS BIOCHEM SCI, V26, P454, DOI 10.1016/S0968-0004(01)01898-9; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FISCHHOFF DA, 1987, BIO-TECHNOL, V5, P807, DOI 10.1038/nbt0887-807; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Hooke R, 1664, MICROGRAPHIA; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; LONGSTAFF M, 1993, EMBO J, V12, P379, DOI 10.1002/j.1460-2075.1993.tb05669.x; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Matzke MA, 2004, PLOS BIOL, V2, P582, DOI 10.1371/journal.pbio.0020133; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Potrykus I, 2001, PLANT PHYSIOL, V125, P1157, DOI 10.1104/pp.125.3.1157; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; SMITH CJS, 1990, MOL GEN GENET, V224, P477, DOI 10.1007/BF00262443; SMITH CJS, 1988, NATURE, V334, P724, DOI 10.1038/334724a0; van Kammen A, 1999, ARCH VIROL, P1; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; VANDUN CMP, 1987, VIROLOGY, V159, P299, DOI 10.1016/0042-6822(87)90467-3; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zamore PD, 2006, CELL, V127, P1083, DOI 10.1016/j.cell.2006.12.001; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	53	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2008	14	10					1046	1049		10.1038/nm1008-1046	http://dx.doi.org/10.1038/nm1008-1046			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	358BU	18841146				2022-12-25	WOS:000259892300033
J	Cooper, GM; Zerr, T; Kidd, JM; Eichler, EE; Nickerson, DA				Cooper, Gregory M.; Zerr, Troy; Kidd, Jeffrey M.; Eichler, Evan E.; Nickerson, Deborah A.			Systematic assessment of copy number variant detection via genome-wide SNP genotyping	NATURE GENETICS			English	Article							HIDDEN-MARKOV MODEL; STRUCTURAL VARIATION; SEGMENTAL DUPLICATIONS; ASSOCIATION; MAP; POLYMORPHISMS; DISORDERS; DISEASES; GENES	SNP genotyping has emerged as a technology to incorporate copy number variants (CNVs) into genetic analyses of human traits. However, the extent to which SNP platforms accurately capture CNVs remains unclear. Using independent, sequence-based CNV maps, we find that commonly used SNP platforms have limited or no probe coverage for a large fraction of CNVs. Despite this, in 9 samples we inferred 368 CNVs using Illumina SNP genotyping data and experimentally validated over two-thirds of these. We also developed a method (SNP-Conditional Mixture Modeling, SCIMM) to robustly genotype deletions using as few as two SNP probes. We find that HapMap SNPs are strongly correlated with 82% of common deletions, but the newest SNP platforms effectively tag about 50%. We conclude that currently available genome-wide SNP assays can capture CNVs accurately, but improvements in array designs, particularly in duplicated sequences, are necessary to facilitate more comprehensive analyses of genomic variation.	[Cooper, Gregory M.; Zerr, Troy; Kidd, Jeffrey M.; Eichler, Evan E.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Cooper, GM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	coopergm@u.washington.edu	Cooper, Gregory/D-6914-2011	Cooper, Gregory/0000-0001-5509-9923; Kidd, Jeffrey/0000-0002-9631-1465	Merck, Jane Coffin Childs Memorial Fund Postdoctoral Fellowship; National Human Genome Research Institute (NHGRI) [T32 HG00035]; National Science Foundation; National Heart, Lung, and Blood Institute Programs [HL066682]; NHGRI [HG004120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, P01HG004120] Funding Source: NIH RePORTER	Merck, Jane Coffin Childs Memorial Fund Postdoctoral Fellowship(Merck & Company); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); National Heart, Lung, and Blood Institute Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Peiffer and colleagues at Illumina for sharing Human 1M and HumanHap 550K genotyping data. We apologize to all colleagues whose work we could not cite because of space constraints. G. M. C. is supported by a Merck, Jane Coffin Childs Memorial Fund Postdoctoral Fellowship. T. Z. acknowledges support from the National Human Genome Research Institute (NHGRI) Interdisciplinary Training in Genomic Sciences grant T32 HG00035. J. M. K. is supported by a National Science Foundation graduate fellowship. This work was supported by the National Heart, Lung, and Blood Institute Programs for Genomic Applications grant HL066682 to D. A. N. and NHGRI grant HG004120 to E. E. E. E. E. E. is an investigator of the Howard Hughes Medical Institute.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	30	162	171	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1199	1203		10.1038/ng.236	http://dx.doi.org/10.1038/ng.236			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776910	Green Accepted			2022-12-25	WOS:000259651000019
J	Herrgard, MJ; Swainston, N; Dobson, P; Dunn, WB; Arga, KY; Arvas, M; Bluthgen, N; Borger, S; Costenoble, R; Heinemann, M; Hucka, M; Le Novere, N; Li, P; Liebermeister, W; Mo, ML; Oliveira, AP; Petranovic, D; Pettifer, S; Simeonidis, E; Smallbone, K; Spasic, I; Weichart, D; Brent, R; Broomhead, DS; Westerhoff, HV; Kirdar, B; Penttila, M; Klipp, E; Palsson, BO; Sauer, U; Oliver, SG; Mendes, P; Nielsen, J; Kell, DB				Herrgard, Markus J.; Swainston, Neil; Dobson, Paul; Dunn, Warwick B.; Arga, K. Yalcin; Arvas, Mikko; Bluethgen, Nils; Borger, Simon; Costenoble, Roeland; Heinemann, Matthias; Hucka, Michael; Le Novere, Nicolas; Li, Peter; Liebermeister, Wolfram; Mo, Monica L.; Oliveira, Ana Paula; Petranovic, Dina; Pettifer, Stephen; Simeonidis, Evangelos; Smallbone, Kieran; Spasic, Irena; Weichart, Dieter; Brent, Roger; Broomhead, David S.; Westerhoff, Hans V.; Kirdar, Betuel; Penttila, Merja; Klipp, Edda; Palsson, Bernhard O.; Sauer, Uwe; Oliver, Stephen G.; Mendes, Pedro; Nielsen, Jens; Kell, Douglas B.			A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; FUNCTIONAL GENOMICS; GLOBAL ANALYSIS; MODELS; INFORMATION; EXPRESSION; DATABASE; TECHNOLOGIES; ANNOTATION; VALIDATION	Genomic data allow the large-scale manual or semi-automated assembly of metabolic network reconstructions, which provide highly curated organism-specific knowledge bases. Although several genome-scale network reconstructions describe Saccharomyces cerevisiae metabolism, they differ in scope and content, and use different terminologies to describe the same chemical entities. This makes comparisons between them difficult and underscores the desirability of a consolidated metabolic network that collects and formalizes the 'community knowledge' of yeast metabolism. We describe how we have produced a consensus metabolic network reconstruction for S. cerevisiae. In drafting it, we placed special emphasis on referencing molecules to persistent databases or using database-independent forms, such as SMILES or InChI strings, as this permits their chemical structure to be represented unambiguously and in a manner that permits automated reasoning. The reconstruction is readily available via a publicly accessible database and in the Systems Biology Markup Language (http://www.comp-sys-bio.org/yeastnet). It can be maintained as a resource that serves as a common denominator for studying the systems biology of yeast. Similar strategies should benefit communities studying genome-scale metabolic networks of other organisms.	[Swainston, Neil; Dobson, Paul; Dunn, Warwick B.; Bluethgen, Nils; Li, Peter; Pettifer, Stephen; Simeonidis, Evangelos; Smallbone, Kieran; Spasic, Irena; Weichart, Dieter; Westerhoff, Hans V.; Oliver, Stephen G.; Mendes, Pedro; Kell, Douglas B.] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Herrgard, Markus J.; Mo, Monica L.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Swainston, Neil; Li, Peter; Spasic, Irena; Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester M13 9PL, Lancs, England; [Dobson, Paul; Dunn, Warwick B.; Weichart, Dieter; Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester M13 9PL, England; [Arga, K. Yalcin; Kirdar, Betuel] Bogazici Univ, Dept Chem Engn, TR-34342 Bebek, Turkey; [Arvas, Mikko; Penttila, Merja] VTT Biotechnol Espoo, FIN-02044 Espoo, Finland; [Bluethgen, Nils; Simeonidis, Evangelos; Westerhoff, Hans V.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M13 9PL, Lancs, England; [Borger, Simon; Liebermeister, Wolfram; Klipp, Edda] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Costenoble, Roeland; Heinemann, Matthias; Sauer, Uwe] ETH, Inst Mol Systembiol, CH-8093 Zurich, Switzerland; [Hucka, Michael] CALTECH, Control & Dynam Syst, Pasadena, CA 91125 USA; [Le Novere, Nicolas] EMBL EBI, Cambridge CB10 1SD, England; [Oliveira, Ana Paula; Petranovic, Dina; Nielsen, Jens] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Smallbone, Kieran; Broomhead, David S.] Univ Manchester, Sch Math, Manchester M13 9PL, England; [Brent, Roger] Inst Mol Sci, Berkeley, CA 94704 USA; [Westerhoff, Hans V.] Vrije Univ Amsterdam, Dept Mol & Cell Physiol, NL-1081 HV Amsterdam, Netherlands; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Mendes, Pedro] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden	University of Manchester; University of California System; University of California San Diego; University of Manchester; University of Manchester; Bogazici University; VTT Technical Research Center Finland; University of Manchester; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology; European Molecular Biology Laboratory (EMBL); Technical University of Denmark; University of Manchester; The Molecular Sciences Institute; Vrije Universiteit Amsterdam; University of Cambridge; Virginia Polytechnic Institute & State University; Chalmers University of Technology	Kell, DB (corresponding author), Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester Interdisciplinary Bioctr, 131 Princess st, Manchester M1 7DN, Lancs, England.	dbk@manchester.ac.uk	Arvas, Mikko/A-4757-2011; Kell, Douglas/E-8318-2011; Le Novère, Nicolas/F-9973-2010; Broomhead, David S/C-6836-2009; Sauer, Uwe/Y-3556-2019; Hucka, Michael/B-1896-2012; Arga, Kazim Yalcin/Z-3711-2019; Westerhoff, Hans V/I-5762-2012; Arvas, Mikko/AAA-7438-2021; Liebermeister, Wolfram/AAC-7326-2020; Kirdar, Betul/ABI-7250-2020; Heinemann, Matthias/B-9421-2008; Penttilä, Merja E/A-4710-2013; Bluthgen, Nils/A-1711-2011; Oliveira, Ana Paula/B-8366-2009; Oliver, Stephen/AAQ-5992-2021; Dunn, Warwick/CAJ-1648-2022; Spasic, Irena/D-2259-2010; Nielsen, Jens/Q-1347-2017	Arvas, Mikko/0000-0002-6902-8488; Kell, Douglas/0000-0001-5838-7963; Le Novère, Nicolas/0000-0002-6309-7327; Hucka, Michael/0000-0001-9105-5960; Arga, Kazim Yalcin/0000-0002-6036-1348; Westerhoff, Hans V/0000-0002-0443-6114; Arvas, Mikko/0000-0002-6902-8488; Liebermeister, Wolfram/0000-0002-2568-2381; Heinemann, Matthias/0000-0002-5512-9077; Bluthgen, Nils/0000-0002-0171-7447; Oliveira, Ana Paula/0000-0003-3787-9138; Oliver, Stephen/0000-0003-3410-6439; Dunn, Warwick/0000-0001-6924-0027; Pettifer, Steve/0000-0002-1809-5621; Li, Peter/0000-0001-9602-9550; Palsson, Bernhard/0000-0003-2357-6785; Petranovic, Dina/0000-0001-8724-3942; Mendes, Pedro/0000-0001-6507-9168; Smallbone, Kieran/0000-0003-2815-7045; Nielsen, Jens/0000-0002-9955-6003; Penttila, Merja/0000-0002-6929-1032; Simeonidis, Vangelis/0000-0001-6153-4493	UK Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); National Institutes of Health [NIH R01 GM071808]; Yeast Systems Biology Network [LSHG-CT-2005-018942]; BBSRC [BB/E016065/1, BB/F010516/1, BB/E006248/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E006248/1, BB/C008219/1, BB/F010516/1, BB/E016065/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071808, R01GM097479] Funding Source: NIH RePORTER	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yeast Systems Biology Network; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Manchester groups thank the UK Biotechnology and Biological Sciences Research Council (BBSRC) and the Engineering and Physical Sciences Research Council (EPSRC) for financial support including for the Manchester Centre for Integrative Systems Biology (http://www.mcisb.org/). The UCSD participants thank the National Institutes of Health for financial support (NIH R01 GM071808). We thank Diane Kelly, Sarah Keating and Norman Paton for many useful discussions. The Jamboree was held under the auspices and with the sponsorship of the Yeast Systems Biology Network (EC Contract: LSHG-CT-2005-018942).	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Ananiadou S, 2006, TRENDS BIOTECHNOL, V24, P571, DOI 10.1016/j.tibtech.2006.10.002; Arakawa K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-168; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Brooksbank C, 2005, NUCLEIC ACIDS RES, V33, pD46, DOI 10.1093/nar/gki026; Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Coles SJ, 2005, ORG BIOMOL CHEM, V3, P1832, DOI 10.1039/b502828k; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Forster Jochen, 2003, OMICS A Journal of Integrative Biology, V7, P193, DOI 10.1089/153623103322246584; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goble C, 2004, COMP FUNCT GENOM, V5, P623, DOI 10.1002/cfg.442; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kell DB, 2006, FEBS J, V273, P873, DOI 10.1111/j.1742-4658.2006.05136.x; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; Li P, 2008, BIOINFORMATICS, V24, P287, DOI 10.1093/bioinformatics/btm578; Li XJ, 2003, METABOLIC PROFILING: ITS ROLE IN BIOMARKER DISCOVERY AND GENE FUNCTION ANALYSIS, P293; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Oliver S, 1996, TRENDS GENET, V12, P241, DOI 10.1016/0168-9525(96)30053-X; Palsson B, 2004, NAT BIOTECHNOL, V22, P1218, DOI 10.1038/nbt1004-1218; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spasic I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S5; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Suter B, 2006, BIOTECHNIQUES, V40, P625, DOI 10.2144/000112151; Tapscott Don, 2007, WIKINOMICS MASS COLL; Vallabhajosyula RR, 2006, BIOINFORMATICS, V22, P346, DOI 10.1093/bioinformatics/bti800; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Whelan KE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-97; Williams AJ, 2008, DRUG DISCOV TODAY, V13, P495, DOI 10.1016/j.drudis.2008.03.017; Williams AJ, 2008, DRUG DISCOV TODAY, V13, P502, DOI 10.1016/j.drudis.2008.03.015; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Yen KY, 2003, YEAST, V20, P1255, DOI 10.1002/yea.1037; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	61	408	423	1	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1155	1160		10.1038/nbt1492	http://dx.doi.org/10.1038/nbt1492			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18846089	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000259926000030
J	Lasserre, R; Guo, XJ; Conchonaud, F; Hamon, Y; Hawchar, O; Bernard, AM; Soudja, SM; Lenne, PF; Rigneault, H; Olive, D; Bismuth, G; Nunes, JA; Payrastre, B; Marguet, D; He, HT				Lasserre, Remi; Guo, Xiao-Jun; Conchonaud, Fabien; Hamon, Yannick; Hawchar, Omar; Bernard, Anne-Marie; Soudja, Saidi M'Homa; Lenne, Pierre-Francois; Rigneault, Herve; Olive, Daniel; Bismuth, Georges; Nunes, Jacques A.; Payrastre, Bernard; Marguet, Didier; He, Hai-Tao			Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation	NATURE CHEMICAL BIOLOGY			English	Article							LIPID RAFTS; PROTEIN-KINASE; LIVING CELLS; SIGNAL-TRANSDUCTION; T-LYMPHOCYTES; LIVE CELLS; CHOLESTEROL; DOMAINS; ORGANIZATION; MICRODOMAINS	Membrane rafts are thought to be sphingolipid- and cholesterol-dependent lateral assemblies involved in diverse cellular functions. Their biological roles and even their existence, however, remain controversial. Using an original fluorescence correlation spectroscopy strategy that recently enabled us to identify nanoscale membrane organizations in live cells, we report here that highly dynamic nanodomains exist in both the outer and inner leaflets of the plasma membrane. Through specific inhibition of biosynthesis, we show that sphingolipids and cholesterol are essential and act in concert for formation of nanodomains, thus corroborating their raft nature. Moreover, we find that nanodomains play a crucial role in triggering the phosphatidylinositol-3kinase/Akt signaling pathway, by facilitating Akt recruitment and activation upon phosphatidylinositol-3,4,5-triphosphate accumulation in the plasma membrane. Thus, through direct monitoring and controlled alterations of rafts in living cells, we demonstrate that rafts are critically involved in the activation of a signaling axis that is essential for cell physiology.	[Lasserre, Remi; Guo, Xiao-Jun; Conchonaud, Fabien; Hamon, Yannick; Hawchar, Omar; Bernard, Anne-Marie; Soudja, Saidi M'Homa; Payrastre, Bernard; Marguet, Didier; He, Hai-Tao] INSERM, Ctr Physiopathol Toulouse Purpan, Dept Oncogenese Signalisat & Innovat Therapeut, U563, F-31300 Toulouse, France; [Lasserre, Remi; Guo, Xiao-Jun; Conchonaud, Fabien; Hamon, Yannick; Hawchar, Omar; Bernard, Anne-Marie; Soudja, Saidi M'Homa; Marguet, Didier; He, Hai-Tao] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; INSERM, UMR 631, F-13288 Marseille 09, France; [Lasserre, Remi; Conchonaud, Fabien; Hamon, Yannick; Hawchar, Omar; Bernard, Anne-Marie; Soudja, Saidi M'Homa; Marguet, Didier; He, Hai-Tao] CNRS, UMR 6102, F-13288 Marseille 09, France; [Guo, Xiao-Jun] Univ Paul Cezanne, Lab Interact Mol & Syst Membranaires, CNRS, UMR 6231, F-13331 Marseille 20, France; [Lenne, Pierre-Francois; Rigneault, Herve] Univ Paul Cezanne, Inst Fresnel, F-13397 Marseille 20, France; [Lenne, Pierre-Francois; Rigneault, Herve] CNRS, UMR 6133, F-13397 Marseille 20, France; [Olive, Daniel; Nunes, Jacques A.] INSERM, Ctr Rech Cancerol Marseille, UMR 891, F-13009 Marseille, France; [Olive, Daniel; Nunes, Jacques A.] Inst J Paoli I Calmettes, F-13273 Marseille 09, France; [Olive, Daniel; Nunes, Jacques A.] Univ Aix Marseille 2, F-13007 Marseille, France; [Bismuth, Georges] INSERM, U567, F-75014 Paris, France; [Bismuth, Georges] Univ Paris 05, CNRS, UMR 8104, F-75014 Paris, France; [Payrastre, Bernard] Univ Toulouse 3, F-31400 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Payrastre, B (corresponding author), INSERM, Ctr Physiopathol Toulouse Purpan, Dept Oncogenese Signalisat & Innovat Therapeut, U563, Pl Docteur Baylac, F-31300 Toulouse, France.	bernard.payrastre@toulouse.inserm.fr; he@ciml.univ-mrs.fr	HAMON, Yannick/S-3118-2019; Marguet, Didier/AGO-5421-2022; HE, Hai-Tao/O-6551-2016; NUNES, Jacques A/F-4952-2013; Lasserre, Rémi/N-5646-2016; RIGNEAULT, Hervé/L-6303-2017; Marguet, Didier/B-9946-2008; HAMON, Yannick YH/N-5372-2016; Guo, Xiao-Jun/M-9454-2016	HAMON, Yannick/0000-0002-7636-2310; Marguet, Didier/0000-0003-3198-5095; HE, Hai-Tao/0000-0002-6594-290X; NUNES, Jacques A/0000-0003-4865-0400; Lasserre, Rémi/0000-0002-6996-0179; RIGNEAULT, Hervé/0000-0001-6007-0631; HAMON, Yannick YH/0000-0002-7636-2310; , Bernard/0000-0002-8693-0190; Lenne, Pierre-Francois/0000-0003-1066-7506				Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Epand RM, 2004, BIOCHEM J, V379, P527, DOI 10.1042/BJ20040204; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jones KA, 2004, EXP CELL RES, V295, P512, DOI 10.1016/j.yexcr.2004.01.022; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Magee AI, 2005, J CELL SCI, V118, P3141, DOI 10.1242/jcs.02442; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Wenger J, 2007, BIOPHYS J, V92, P913, DOI 10.1529/biophysj.106.096586; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhuang LY, 2002, CANCER RES, V62, P2227	50	224	228	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2008	4	9					538	547		10.1038/nchembio.103	http://dx.doi.org/10.1038/nchembio.103			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	339SN	18641634				2022-12-25	WOS:000258597700012
J	Mills, AE; Tereskerz, P				Mills, Ann E.; Tereskerz, Patti			DNA-based patents: an empirical analysis	NATURE BIOTECHNOLOGY			English	Editorial Material									[Mills, Ann E.; Tereskerz, Patti] Univ Virginia, Ctr Biomed Eth, Charlottesville, VA 22908 USA	University of Virginia	Mills, AE (corresponding author), Univ Virginia, Ctr Biomed Eth, Box 800758, Charlottesville, VA 22908 USA.	amh2r@virginia.edu						Azher AI, 2004, U PA J INT ECON LAW, V25, P383; *BIOT IND ORG, BIOT IND ORG POS PAT; *COMM INF PROP RIG, 2004, PAT SYST 21 CENT; Committee on intellectual property rights in genomic and protein research and innovation, 2006, REAP BEN GEN PROT RE; Federal Trade Commission, 2003, PROM INN PROP BAL CO; HEATH E, 2008, 33 AAAS RED DEV; LANJOUW JO, 2003, PATENTS KNOWLEDGE BA, P145; OBAMA B, B OBAMA CONNECTING E; 2007, NAT BIOTECHNOL, V25, P1187	9	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2008	26	9					993	996		10.1038/nbt0908-993	http://dx.doi.org/10.1038/nbt0908-993			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	346NG	18779808				2022-12-25	WOS:000259074700018
J	Simpson, KJ; Selfors, LM; Bui, J; Reynolds, A; Leake, D; Khvorova, A; Brugge, JS				Simpson, Kaylene J.; Selfors, Laura M.; Bui, James; Reynolds, Angela; Leake, Devin; Khvorova, Anastasia; Brugge, Joan S.			Identification of genes that regulate epithelial cell migration using an siRNA screening approach	NATURE CELL BIOLOGY			English	Article							RNA INTERFERENCE; MOVEMENT; CARCINOMA; ADHESION; GTPASES; TARGET; ROLES; POLARIZATION; SUPPRESSORS; ONCOGENESIS	To provide a systematic analysis of genes that regulate epithelial cell migration, we performed a high throughput wound healing screen with MCF-10A breast epithelial cells, using siRNAs targeting 1,081 human genes encoding phosphatases, kinases and proteins predicted to influence cell migration and adhesion. The primary screen identified three categories of hits: those that accelerate, those that inhibit and those that impair migration with associated effects on cell proliferation or metabolism. Extensive validation of all the hits yielded 66 high confidence genes that, when downregulated, either accelerated or impaired migration; 42 of these high confidence genes have not been previously associated with motility or adhesion. Time-lapse video microscopy revealed a broad spectrum of phenotypic changes involving alterations in the extent and nature of disruption of cell-cell adhesion, directionality of motility, cell polarity and shape, and protrusion dynamics. Informatics analysis highlighted three major signalling nodes, beta-catenin, beta-integrin and actin, and a large proportion of the genes that accelerated migration impaired cell-cell adhesion.	[Simpson, Kaylene J.; Selfors, Laura M.; Bui, James; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Reynolds, Angela; Leake, Devin; Khvorova, Anastasia] Dharmacon, Thermo Fisher Sci, Lafayette, CO 80026 USA	Harvard University; Harvard Medical School; Thermo Fisher Scientific	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu		Simpson, Kaylene/0000-0001-9136-1781; SELFORS, LAURA/0000-0002-1317-7353	DOD [W81XWH-04-1-0360]; Cell Migration Consortium; NIH/NIGMS [GM064346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Cell Migration Consortium; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank Stewart Rudnicki and Caroline Shamu (Institute for Chemical and Cell Biology) for screening assistance; Jim Horn (Department of Cell Biology) for manufacturing the wound healing pin; William Pearson for conceptualizing and generating the interactive website hosted by the Cell Migration Consortium; Sabina Winograd-Katz and Benjamin Geiger (Weizmann Institute) for collaborative creation of the MAR custom siRNA library; Rick Horwitz, Alan Hall, Gaudenz Danuser and Ghassan Mouneimne for stimulating and helpful discussions and critical reading of the manuscript and Lara Petrak (Nikon Imaging Centre) for assistance with time-lapse microscopy. We are also grateful to William Hahn, David Root and The RNAi Consortium for providing shRNA vectors. Funding was from the DOD W81XWH-04-1-0360 (K.J.S.) and the Cell Migration Consortium, supported by a grant from the NIH/NIGMS GM064346 (J.S.B.). A.R., D.L. and A.K. are employees of Thermo Fisher Scientific, which supported this work in part by supplying a subset of the siRNA reagents.	Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rupp PA, 2007, DEV BIOL, V311, P159, DOI 10.1016/j.ydbio.2007.08.027; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104	34	316	318	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1027	1038		10.1038/ncb1762	http://dx.doi.org/10.1038/ncb1762			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160483				2022-12-25	WOS:000258910400008
J	Wang, XW; Zuo, XM; Kucejova, B; Chen, XJ				Wang, Xiaowen; Zuo, Xiaoming; Kucejova, Blanka; Chen, Xin Jie			Reduced cytosolic protein synthesis suppresses mitochondrial degeneration	NATURE CELL BIOLOGY			English	Article							REPLICATIVE LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; ADP/ATP CARRIER; YEAST; EXTENDS; MUTATIONS; EXTENSION; GENES; RESPIRATION	Mitochondrial function degenerates with ageing and in ageing-related neuromuscular degenerative diseases, causing physiological decline of the cell(1). Factors that can delay the degenerative process are actively sought after. Here, we show that reduced cytosolic protein synthesis is a robust cellular strategy that suppresses ageing-related mitochondrial degeneration. We modelled autosomal dominant progressive external ophthalmoplegia (adPEO), an adult- or later-onset degenerative disease, by introducing the A128P mutation into the adenine nucleotide translocase Aac2p of Saccharomyces cerevisiae. The aac2(A128P) allele dominantly induces ageing-dependent mitochondrial degeneration and phenotypically tractable degenerative cell death, independently of its ADP/ATP exchange activity. Mitochondrial degeneration was suppressed by lifespan-extending nutritional interventions and by eight longevity mutations, which are all known to reduce cytosolic protein synthesis. These longevity interventions also independently suppressed ageing-related mitochondrial degeneration in the pro-ageing prohibitin mutants. The aac2(A128P) mutant has reduced mitochondrial membrane potential (Delta psi(m)) and is synthetically lethal to low Delta psi(m) conditions, including the loss of prohibitin. Mitochondrial degeneration was accelerated by defects in protein turnover on the inner membrane and was suppressed by cycloheximide, a specific inhibitor of cytosolic ribosomes. Reduced cytosolic protein synthesis suppressed membrane depolarization and defects in mitochondrial gene expression in aac2(A128P) cells. Our finding thus establishes a link between protein homeostasis (proteostasis), cellular bioenergetics and mitochondrial maintenance during ageing.	[Wang, Xiaowen; Chen, Xin Jie] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Wang, Xiaowen; Zuo, Xiaoming; Kucejova, Blanka; Chen, Xin Jie] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, XJ (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	chenx@upstate.edu		Kucejova, Blanka/0000-0002-5058-330X	National Institutes of Health [AG023731]; American Heart Association [0435047N]; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Schmitt and M. Kucej for critical reading of the manuscript, and L. Sabova and C. Koehler for providing the anti-Aac2 antibody. This work was supported by grants from National Institutes of Health (AG023731) and the American Heart Association (0435047N).	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Lai CY, 2002, GENETICS, V162, P73; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Meskauskas A, 2003, MOL CELL BIOL, V23, P1602, DOI 10.1128/MCB.23.5.1602-1613.2003; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; PEARCE DA, 1995, J BIOL CHEM, V270, P20879, DOI 10.1074/jbc.270.36.20879; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379; Tavernarakis N, 2008, TRENDS CELL BIOL, V18, P228, DOI 10.1016/j.tcb.2008.02.004; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	35	66	67	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1090	1097		10.1038/ncb1769	http://dx.doi.org/10.1038/ncb1769			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160490	Green Accepted			2022-12-25	WOS:000258910400015
J	Abad, P; Gouzy, J; Aury, JM; Castagnone-Sereno, P; Danchin, EGJ; Deleury, E; Perfus-Barbeoch, L; Anthouard, V; Artiguenave, F; Blok, VC; Caillaud, MC; Coutinho, PM; Dasilva, C; De Luca, F; Deau, F; Esquibet, M; Flutre, T; Goldstone, JV; Hamamouch, N; Hewezi, T; Jaillon, O; Jubin, C; Leonetti, P; Magliano, M; Maier, TR; Markov, GV; McVeigh, P; Pesole, G; Poulain, J; Robinson-Rechavi, M; Sallet, E; Segurens, B; Steinbach, D; Tytgat, T; Ugarte, E; van Ghelder, C; Veronico, P; Baum, TJ; Blaxter, M; Bleve-Zacheo, T; Davis, EL; Ewbank, JJ; Favery, B; Grenier, E; Henrissat, B; Jones, JT; Laudet, V; Maule, AG; Quesneville, H; Rosso, MN; Schiex, T; Smant, G; Weissenbach, J; Wincker, P				Abad, Pierre; Gouzy, Jerome; Aury, Jean-Marc; Castagnone-Sereno, Philippe; Danchin, Etienne G. J.; Deleury, Emeline; Perfus-Barbeoch, Laetitia; Anthouard, Veronique; Artiguenave, Francois; Blok, Vivian C.; Caillaud, Marie-Cecile; Coutinho, Pedro M.; Dasilva, Corinne; De Luca, Francesca; Deau, Florence; Esquibet, Magali; Flutre, Timothe; Goldstone, Jared V.; Hamamouch, Noureddine; Hewezi, Tarek; Jaillon, Olivier; Jubin, Claire; Leonetti, Paola; Magliano, Marc; Maier, Tom R.; Markov, Gabriel V.; McVeigh, Paul; Pesole, Graziano; Poulain, Julie; Robinson-Rechavi, Marc; Sallet, Erika; Segurens, Beatrice; Steinbach, Delphine; Tytgat, Tom; Ugarte, Edgardo; van Ghelder, Cyril; Veronico, Pasqua; Baum, Thomas J.; Blaxter, Mark; Bleve-Zacheo, Teresa; Davis, Eric L.; Ewbank, Jonathan J.; Favery, Bruno; Grenier, Eric; Henrissat, Bernard; Jones, John T.; Laudet, Vincent; Maule, Aaron G.; Quesneville, Hadi; Rosso, Marie-Noelle; Schiex, Thomas; Smant, Geert; Weissenbach, Jean; Wincker, Patrick			Genome sequence of the metazoan plant-parasitic nematode Meloidogyne incognita	NATURE BIOTECHNOLOGY			English	Article							ROOT-KNOT NEMATODES; CAENORHABDITIS-ELEGANS; GENES; PROTEIN; CLONING; IDENTIFICATION; EXPRESSION; PREDICTION; RESISTANCE; EVOLUTION	Plant-parasitic nematodes are major agricultural pests worldwide and novel approaches to control them are sorely needed. We report the draft genome sequence of the root-knot nematode Meloidogyne incognita, a biotrophic parasite of many crops, including tomato, cotton and coffee. Most of the assembled sequence of this asexually reproducing nematode, totaling 86 Mb, exists in pairs of homologous but divergent segments. This suggests that ancient allelic regions in M. incognita are evolving toward effective haploidy, permitting new mechanisms of adaptation. The number and diversity of plant cell wall-degrading enzymes in M. incognita is unprecedented in any animal for which a genome sequence is available, and may derive from multiple horizontal gene transfers from bacterial sources. Our results provide insights into the adaptations required by metazoans to successfully parasitize immunocompetent plants, and open the way for discovering new antiparasitic strategies.	[Abad, Pierre; Castagnone-Sereno, Philippe; Danchin, Etienne G. J.; Deleury, Emeline; Perfus-Barbeoch, Laetitia; Caillaud, Marie-Cecile; Deau, Florence; Magliano, Marc; van Ghelder, Cyril; Favery, Bruno; Rosso, Marie-Noelle] INRA, UMR 1301, F-06903 Sophia Antipolis, France; [Abad, Pierre; Castagnone-Sereno, Philippe; Danchin, Etienne G. J.; Deleury, Emeline; Perfus-Barbeoch, Laetitia; Caillaud, Marie-Cecile; Deau, Florence; Magliano, Marc; van Ghelder, Cyril; Favery, Bruno; Rosso, Marie-Noelle] CNRS, UMR 6243, F-06903 Sophia Antipolis, France; [Abad, Pierre; Castagnone-Sereno, Philippe; Danchin, Etienne G. J.; Deleury, Emeline; Perfus-Barbeoch, Laetitia; Caillaud, Marie-Cecile; Deau, Florence; van Ghelder, Cyril; Favery, Bruno; Rosso, Marie-Noelle] UNSA, UMR 1301, F-06903 Sophia Antipolis, France; [Gouzy, Jerome] INRA, CNRS, Lab Interact Plantes Microorganismes, F-31320 Castanet Tolosan, France; [Aury, Jean-Marc; Anthouard, Veronique; Artiguenave, Francois; Dasilva, Corinne; Jaillon, Olivier; Jubin, Claire; Poulain, Julie; Segurens, Beatrice; Ugarte, Edgardo; Weissenbach, Jean; Wincker, Patrick] Genoscope CEA, F-91057 Evry, France; [Aury, Jean-Marc; Anthouard, Veronique; Dasilva, Corinne; Jaillon, Olivier; Jubin, Claire; Poulain, Julie; Segurens, Beatrice; Ugarte, Edgardo; Weissenbach, Jean; Wincker, Patrick] Univ Evry, F-91057 Evry, France; [Blok, Vivian C.; Jones, John T.] Scottish Crop Res Inst, Plant Pathol Programme, Dundee DD2 5DA, Scotland; [Coutinho, Pedro M.; Henrissat, Bernard] CNRS, UMR 6098, F-13288 Marseille, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France; [De Luca, Francesca; Leonetti, Paola; Veronico, Pasqua; Bleve-Zacheo, Teresa] CNR, Ist Protez Piante, I-70126 Bari, Italy; [Esquibet, Magali; Grenier, Eric] Univ Rennes 1, INRA, UMR1099, BiO3P, F-35653 Le Rheu, France; [Flutre, Timothe; Steinbach, Delphine; Quesneville, Hadi] INRA, URGI, UR1164, F-91034 Evry, France; [Goldstone, Jared V.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Hamamouch, Noureddine; Davis, Eric L.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27607 USA; [Hewezi, Tarek; Maier, Tom R.; Baum, Thomas J.] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA; [Markov, Gabriel V.; Laudet, Vincent] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, Mol Zool Team,CNRS,INRA,Inst Federatif Biosci Ger, F-69364 Lyon 07, France; [Markov, Gabriel V.] Museum Natl Hist Nat, USM Evolut Regulat Endoriniennes 501, F-75005 Paris, France; [McVeigh, Paul; Maule, Aaron G.] Queens Univ Belfast, Sch Biol Sci, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland; [Pesole, Graziano] Univ Bari, Dipartmento Biochim & Biol Mol E Quagliariello, I-70126 Bari, Italy; [Pesole, Graziano] CNR, Ist Tecnol Biomed, I-70126 Bari, Italy; [Robinson-Rechavi, Marc] Univ Lausanne, UNIL Sorge, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Robinson-Rechavi, Marc] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Sallet, Erika] GIS Toulouse Genopole, Plateforme Bioinformat Genopole Toulouse Midi Pyr, F-31320 Castanet Tolosan, France; [Sallet, Erika; Schiex, Thomas] INRA, Unite Biometrie & Intelligence Artificielle UR875, F-31320 Castanet Tolosan, France; [Tytgat, Tom; Smant, Geert] Wageningen Univ, Nematol Lab, NL-6709 PD Wageningen, Netherlands; [Blaxter, Mark] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Ewbank, Jonathan J.] Univ Mediterranee, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; [Aury, Jean-Marc; Anthouard, Veronique; Artiguenave, Francois; Dasilva, Corinne; Jaillon, Olivier; Jubin, Claire; Poulain, Julie; Segurens, Beatrice; Ugarte, Edgardo; Weissenbach, Jean; Wincker, Patrick] CNRS, UMR 8030, F-91057 Evry, France	INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; James Hutton Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consiglio Nazionale delle Ricerche (CNR); INRAE; Universite de Rennes; INRAE; Woods Hole Oceanographic Institution; University of North Carolina; North Carolina State University; Iowa State University; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Museum National d'Histoire Naturelle (MNHN); Queens University Belfast; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Lausanne; Swiss Institute of Bioinformatics; INRAE; Wageningen University & Research; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Abad, P (corresponding author), INRA, UMR 1301, 400 Route Chappes, F-06903 Sophia Antipolis, France.	pierre.abad@sophia.inra.fr	Pesole, Graziano/E-9051-2014; De Luca, Francesca/AAX-5759-2020; Gouzy, Jerome/AAH-4977-2020; Pesole, Graziano/C-1408-2009; Tytgat, Tom/C-7777-2011; Pesole, Graziano/K-5283-2019; McVeigh, Paul/AAV-7138-2020; Hamamouch, Noureddine/AAY-7473-2020; de luca, francesca/C-1518-2015; Quesneville, Hadi/AAG-1048-2020; Henrissat, Bernard/J-2475-2012; Robinson-Rechavi, Marc/E-9727-2011; Blaxter, Mark L/B-4113-2010; Favery, Bruno/B-9062-2008; Danchin, Etienne GJ/X-6969-2019; Danchin, Etienne G.J./A-6648-2008; Blaxter, Mark/O-2535-2019; Leonetti, Paola/AAX-1987-2020; Aury, Jean-Marc/N-1621-2019; Coutinho, Pedro M/C-4473-2008; Caillaud, Marie-Cecile/G-9320-2018; Markov, Gabriel V./Y-5043-2019; Grenier, Eric/Q-7349-2016; Grenier, Eric/AAR-8124-2020; perfus-barbeoch, laetitia/AAO-7897-2020; Ewbank, Jonathan J/G-4948-2010; Jaillon, Olivier/GRY-6287-2022	Pesole, Graziano/0000-0003-3663-0859; Gouzy, Jerome/0000-0001-5695-4557; Pesole, Graziano/0000-0003-3663-0859; McVeigh, Paul/0000-0003-1850-9692; Quesneville, Hadi/0000-0003-3001-4908; Henrissat, Bernard/0000-0002-3434-8588; Robinson-Rechavi, Marc/0000-0002-3437-3329; Blaxter, Mark L/0000-0003-2861-949X; Favery, Bruno/0000-0003-3323-1852; Danchin, Etienne GJ/0000-0003-4146-5608; Danchin, Etienne G.J./0000-0003-4146-5608; Aury, Jean-Marc/0000-0003-1718-3010; Caillaud, Marie-Cecile/0000-0002-0348-7024; Markov, Gabriel V./0000-0002-8566-7482; Grenier, Eric/0000-0002-2260-1101; Grenier, Eric/0000-0002-2260-1101; Ewbank, Jonathan J/0000-0002-1257-6862; Steinbach, Delphine/0000-0001-7144-7908; LEONETTI, PAOLA/0000-0003-2636-3419; VERONICO, PASQUA/0000-0003-2704-7936; Poulain, Julie/0000-0002-8744-3116; Flutre, Timothee/0000-0003-4489-4782; Sallet, Erika/0000-0003-4637-473X; De Luca, Francesca/0000-0002-6646-8066; Van Ghelder, Cyril/0000-0001-5109-2249; Jones, John/0000-0003-2074-0551; Goldstone, Jared/0000-0002-9618-4961; Maule, Aaron/0000-0003-0862-2667				Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Birky CW, 2004, P NATL ACAD SCI USA, V101, P2651, DOI 10.1073/pnas.0308453101; Blaxter ML, 2003, ADV PARASIT, V54, P101, DOI 10.1016/S0065-308X(03)54003-9; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caillaud MC, 2008, PLANT CELL, V20, P423, DOI 10.1105/tpc.107.057422; Caillaud MC, 2008, J PLANT PHYSIOL, V165, P104, DOI 10.1016/j.jplph.2007.05.007; Castagnone-Sereno P, 2006, HEREDITY, V96, P282, DOI 10.1038/sj.hdy.6800794; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; Degroeve S, 2005, BIOINFORMATICS, V21, P1332, DOI 10.1093/bioinformatics/bti166; Ewbank Jonathan J, 2006, WormBook, P1; Foissac S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-25; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Lambert KN, 1999, MOL PLANT MICROBE IN, V12, P328, DOI 10.1094/MPMI.1999.12.4.328; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; MARKS NJ, 2008, NEUROPEPTIDE SYSTEMS; Menzel R, 2001, ARCH BIOCHEM BIOPHYS, V395, P158, DOI 10.1006/abbi.2001.2568; PAPADOPOULOU J, 1982, J NEMATOL, V14, P549; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; PIOTTE C, 1994, GENE, V138, P175, DOI 10.1016/0378-1119(94)90803-6; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Robertson Hugh M, 2006, WormBook, P1; Robinson-Rechavi M, 2005, J MOL EVOL, V60, P577, DOI 10.1007/s00239-004-0175-8; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Triantaphyllou A.C., 1985, ADV TREATISE MELOIDO, VI, P113; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Wei YD, 2006, COMP BIOCHEM PHYS B, V145, P220, DOI 10.1016/j.cbpb.2006.07.007; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DBM, 2004, P NATL ACAD SCI USA, V101, P1622, DOI 10.1073/pnas.2136686100; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Zarkower D, 2006, WORMBOOK, V1, P1, DOI DOI 10.1895/WORMBOOK.1.84.1; Zawadzki JL, 2006, TRENDS PARASITOL, V22, P495, DOI 10.1016/j.pt.2006.08.015	45	768	861	13	234	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2008	26	8					909	915		10.1038/nbt.1482	http://dx.doi.org/10.1038/nbt.1482			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	335WX	18660804	Green Published, hybrid			2022-12-25	WOS:000258325500025
J	Piomelli, D				Piomelli, Daniele			The element of surprise	NATURE MEDICINE			English	Editorial Material							CANNABINOID-1 RECEPTOR BLOCKER; CARDIOMETABOLIC RISK-FACTORS; OVERWEIGHT PATIENTS; RIMONABANT; WEIGHT		[Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Piomelli, Daniele] Italian Inst Technol, Unit Drug Discovery & Dev, I-161631 Genoa, Italy	University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	piomelli@uci.edu						Bortolato M, 2007, BIOL PSYCHIAT, V62, P1103, DOI 10.1016/j.biopsych.2006.12.001; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Garnier JP, 2008, HARVARD BUS REV, V86, P68; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Meltzer HY, 2004, AM J PSYCHIAT, V161, P975, DOI 10.1176/appi.ajp.161.6.975; MOREAU J, 1945, HACHICH ALIENATION M; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; VANGAAL L, 2008, EUR HEART J     0415	15	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2008	14	7					720	721		10.1038/nm0708-720	http://dx.doi.org/10.1038/nm0708-720			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	323NL	18607371	Green Submitted			2022-12-25	WOS:000257452700017
J	Fonseca, S; Chini, A; Hamberg, M; Adie, B; Porzel, A; Kramell, R; Miersch, O; Wasternack, C; Solano, R				Fonseca, Sandra; Chini, Andrea; Hamberg, Mats; Adie, Bruce; Porzel, Andrea; Kramell, Robert; Miersch, Otto; Wasternack, Claus; Solano, Roberto			(+)-7-iso-Jasmonoyl-L-isoleucine is the endogenous bioactive jasmonate	NATURE CHEMICAL BIOLOGY			English	Article							ALLENE OXIDE CYCLASE; METHYL JASMONATE; PHYTOTOXIN CORONATINE; 12-OXO-PHYTODIENOIC ACID; GENE-EXPRESSION; PLANT BIOLOGY; ARABIDOPSIS; DEFENSE; COI1; ISOLEUCINE	Hormone-triggered activation of the jasmonate signaling pathway in Arabidopsis thaliana requires SCFCOI1-mediated proteasome degradation of JAZ repressors. (-)-JA-L-Ile is the proposed bioactive hormone, and SCFCOI1 is its likely receptor. We found that the biological activity of (-)-JA-L-Ile is unexpectedly low compared to coronatine and the synthetic isomer (+)-JA-L-Ile, which suggests that the stereochemical orientation of the cyclopentanone-ring side chains greatly affects receptor binding. Detailed GC-MS and HPLC analyses showed that the (-)-JA-L-Ile preparations currently used in ligand binding studies contain small amounts of the C7 epimer (+)-7-iso-JA-L-Ile. Purification of each of these molecules demonstrated that pure (-)-JA-L-Ile is inactive and that the active hormone is (+)-7-iso-JA-L-Ile, which is also structurally more similar to coronatine. In addition, we show that pH changes promote conversion of (+)-7-iso-JA-L-Ile to the inactive (-)-JA-L-Ile form, thus providing a simple mechanism that can regulate hormone activity through epimerization.	[Fonseca, Sandra; Chini, Andrea; Adie, Bruce; Solano, Roberto] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid, Spain; [Hamberg, Mats] Karolinska Inst, Div Physiol Chem II, Dept Med Biochem & Biophys, Stockholm, Sweden; [Porzel, Andrea] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Germany; [Kramell, Robert; Miersch, Otto; Wasternack, Claus] Leibniz Inst Plant Biochem, Dept Nat Prod Biotechnol, Halle, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Karolinska Institutet; Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie	Solano, R (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ Autonoma, Madrid, Spain.	rsolano@cnb.csic.es	Fonseca, Sandra/AAB-3639-2019; Porzel, Andrea/B-1423-2014; Solano, Roberto/O-5908-2017; Chini, Andrea/D-1336-2009	Fonseca, Sandra/0000-0002-2021-4482; Porzel, Andrea/0000-0002-8148-6895; Solano, Roberto/0000-0001-5459-2417; Chini, Andrea/0000-0001-5841-0254; Hamberg, Mats/0000-0002-8910-7810				Bartel Bonnie, 1997, Annu Rev Plant Physiol Plant Mol Biol, V48, P51, DOI 10.1146/annurev.arplant.48.1.51; Blechert S, 1999, PLANTA, V207, P470, DOI 10.1007/s004250050506; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; CHINI A, PLANT J IN PRESS; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Farmer EE, 2007, NATURE, V448, P659, DOI 10.1038/448659a; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Holbrook L, 1997, PLANT PHYSIOL, V114, P419, DOI 10.1104/pp.114.2.419; HOPKE J, 1994, FEBS LETT, V352, P146, DOI 10.1016/0014-5793(94)00948-1; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KRAMELL R, 1988, TETRAHEDRON, V44, P5791, DOI 10.1016/S0040-4020(01)81437-X; Kramell R, 1997, CHROMATOGRAPHIA, V45, P104, DOI 10.1007/BF02505545; KRAMELL R, 1995, J PLANT GROWTH REGUL, V14, P29, DOI 10.1007/BF00212643; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; MIERSCH O, 1986, J PLANT GROWTH REGUL, V5, P91, DOI 10.1007/BF02025960; Miersch O, 1999, PHYTOCHEMISTRY, V50, P353, DOI 10.1016/S0031-9422(98)00597-4; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Ogawa N, 2008, TETRAHEDRON LETT, V49, P7124, DOI 10.1016/j.tetlet.2008.09.144; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Romano P, 2004, PLANT PHYSIOL, V134, P1241, DOI 10.1104/pp.103.900108; Schulze B, 2006, ANAL BIOCHEM, V348, P269, DOI 10.1016/j.ab.2005.10.021; SEMBDNER G, 1994, PLANT MOL BIOL, V26, P1459, DOI 10.1007/BF00016485; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stenzel I, 2003, PLANT J, V33, P577, DOI 10.1046/j.1365-313X.2003.01647.x; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; VICK BA, 1979, LIPIDS, V14, P734, DOI 10.1007/BF02533899; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708	51	631	658	5	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2009	5	5					344	350		10.1038/nchembio.161	http://dx.doi.org/10.1038/nchembio.161			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	436PT	19349968				2022-12-25	WOS:000265427000016
J	Cao, L; Lin, EJD; Cahill, MC; Wang, CS; Liu, XL; During, MJ				Cao, Lei; Lin, En-Ju D.; Cahill, Michael C.; Wang, Chuansong; Liu, Xianglan; During, Matthew J.			Molecular therapy of obesity and diabetes by a physiological autoregulatory approach	NATURE MEDICINE			English	Article							NEUROTROPHIC FACTOR; GENE-EXPRESSION; ENERGY-EXPENDITURE; NONHUMAN-PRIMATES; AAV VECTORS; PPAR-GAMMA; BRAIN; MICE; BDNF; PROTEIN	Hypothalamic brain-derived neurotrophic factor (BDNF) is a key element in the regulation of energy balance. Here we investigated the therapeutic efficacy of BDNF by gene transfer in mouse models of obesity and diabetes. Gene transfer of BDNF led to marked weight loss and alleviation of obesity-associated insulin resistance. To facilitate clinical translation and ensure that BDNF protein expression was appropriately decreased as weight loss progressed, thus preventing cachexia, we developed a molecular autoregulatory system involving a single recombinant adeno-associated virus vector harboring two expression cassettes, one constitutively driving BDNF and the other driving a specific microRNA targeting BDNF. The microRNA element was controlled by a promoter (that controlling the Agrp gene encoding agouti-related peptide) responsive to BDNF-induced physiological changes. Hence, as body weight decreased and agouti-related protein is induced, microRNA expression was activated, inhibiting transgene expression. In contrast to the progressive weight loss associated with a nonregulated approach, this microRNA-approach led to a sustainable plateau of body weight after notable weight loss was achieved. This strategy mimics the body's endogenous physiological feedback mechanisms, thereby resetting the hypothalamic set point to reverse obesity and metabolic syndrome.	[During, Matthew J.] Ohio State Univ, Canc Genet & Neurosci Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	During, MJ (corresponding author), Ohio State Univ, Canc Genet & Neurosci Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	during.1@osu.edu	Cao, Lei/H-3185-2019; During, Matthew/AAC-1388-2020; Cao, Lei/E-2841-2011	Cao, Lei/0000-0003-0322-4985	NCI NIH HHS [P30 CA016058] Funding Source: Medline; NINDS NIH HHS [R01 NS044576, NS44576] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044576] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bertile F, 2003, BIOCHEM BIOPH RES CO, V303, P1106, DOI 10.1016/S0006-291X(03)00481-9; Brown AM, 2001, GENE, V277, P231, DOI 10.1016/S0378-1119(01)00705-3; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Jiang L, 2004, GENE THER, V11, P1057, DOI 10.1038/sj.gt.3302245; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Le Bec C, 2006, GENE THER, V13, P805, DOI 10.1038/sj.gt.3302724; Lebherz C, 2005, HUM GENE THER, V16, P178, DOI 10.1089/hum.2005.16.178; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McMillan DC, 2006, BRIT MED J, V333, P1109, DOI 10.1136/bmj.39042.565035.BE1; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nakagawa T, 2003, INT J OBESITY, V27, P557, DOI 10.1038/sj.ijo.0802265; Nakagawa T, 2002, DIABETES-METAB RES, V18, P185, DOI 10.1002/dmrr.290; Nguyen M, 2007, MOL THER, V15, P912, DOI 10.1038/mt.sj.6300079; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Stieger K, 2006, MOL THER, V13, P967, DOI 10.1016/j.ymthe.2005.12.001; Takahashi N, 2004, J HEPATOL, V41, P391, DOI 10.1016/j.jhep.2004.05.006; TOWNSEND KL, 2008, ENDOCRINE, V33; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Wisse BE, 2003, NAT NEUROSCI, V6, P655, DOI 10.1038/nn0703-655; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Ye XH, 1999, SCIENCE, V283, P88, DOI 10.1126/science.283.5398.88; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	40	83	86	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					447	454		10.1038/nm.1933	http://dx.doi.org/10.1038/nm.1933			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19270710	Green Accepted			2022-12-25	WOS:000264937200033
J	Hogan, BM; Bos, FL; Bussmann, J; Witte, M; Chi, NC; Duckers, HJ; Schulte-Merker, S				Hogan, Benjamin M.; Bos, Frank L.; Bussmann, Jeroen; Witte, Merlijn; Chi, Neil C.; Duckers, Henricus J.; Schulte-Merker, Stefan			ccbe1 is required for embryonic lymphangiogenesis and venous sprouting	NATURE GENETICS			English	Article							ENDOTHELIAL-GROWTH-FACTOR; LYMPHATIC-SYSTEM; ZEBRAFISH; RECEPTOR; PROX1; MICE	Lymphatic vessels have important roles in fluid homeostasis, fat absorption, inflammation and cancer metastasis and develop in a dynamic process (called lymphangiogenesis) involving budding, migration and proliferation of lymphangioblasts. Using a genetic screen in zebrafish we identify ccbe1 (collagen and calcium-binding EGF domain-1) as indispensible for embryonic lymphangiogenesis. Ccbe1 acts at the same stage of development as Vegfc and is required for lymphangioblast budding and angiogenic sprouting from venous endothelium.	[Hogan, Benjamin M.; Bos, Frank L.; Bussmann, Jeroen; Witte, Merlijn; Schulte-Merker, Stefan] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Hogan, Benjamin M.; Bos, Frank L.; Bussmann, Jeroen; Witte, Merlijn; Schulte-Merker, Stefan] Univ Med Ctr, Utrecht, Netherlands; [Bos, Frank L.; Duckers, Henricus J.] Erasmus Univ, Med Ctr, Thoraxctr, Rotterdam, Netherlands; [Chi, Neil C.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schulte-Merker, S (corresponding author), KNAW, Hubrecht Inst, Utrecht, Netherlands.	s.schulte@niob.knaw.nl	Hogan, Benjamin M/J-1807-2014; Bussmann, Jeroen/D-8106-2011; Hogan, Benjamin/AAD-7410-2022	Hogan, Benjamin M/0000-0002-0651-7065; Bussmann, Jeroen/0000-0003-2814-3305; Hogan, Benjamin/0000-0002-0651-7065	NHLBI, GSK Research & Education Foundation Cardiovascular Awards [K08]; NWO VIDI	NHLBI, GSK Research & Education Foundation Cardiovascular Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NWO VIDI(Netherlands Organization for Scientific Research (NWO))	M. H. was supported by an EMBO long term fellowship and an NH&MRC CJ Martin Fellowship and J. B. by the Stichting Vrienden van het Hubrecht. N. C. C. is supported by K08 grants from the NHLBI, GSK Research & Education Foundation Cardiovascular Awards, and Fellow to Faculty AHA postdoctoral awards. N. C. C. also thanks D. Stainier for support. H. J. D. received an NWO VIDI grant. The authors thank the Hubrecht Screen Team, J. Korving for sectioning, R. Korswagen, A. MacInnes, K. Smith and H. Clevers for critical reading of the manuscript.	Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	14	320	331	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					396	398		10.1038/ng.321	http://dx.doi.org/10.1038/ng.321			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287381				2022-12-25	WOS:000264659000011
J	Olcaydu, D; Harutyunyan, A; Jager, R; Berg, T; Gisslinger, B; Pabinger, I; Gisslinger, H; Kralovics, R				Olcaydu, Damla; Harutyunyan, Ashot; Jaeger, Roland; Berg, Tiina; Gisslinger, Bettina; Pabinger, Ingrid; Gisslinger, Heinz; Kralovics, Robert			A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms	NATURE GENETICS			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ACTIVATING MUTATION; MYELOID METAPLASIA; GENETIC-VARIATION; DISORDERS; MYELOFIBROSIS; HETEROGENEITY; CANCER; TUMORS	Genome-wide association studies have identified a number of new disease susceptibility loci that represent haplotypes defined by numerous SNPs. SNPs within a disease-associated haplotype are thought to influence either the expression of genes or the sequence of the proteins they encode. In a series of investigations of the JAK2 gene in myeloproliferative neoplasms, we uncovered a new property of haplotypes that can explain their disease association. We observed a nonrandom distribution of the somatic JAK2(V617F) oncogenic mutation between two parental alleles of the JAK2 gene. We identified a haplotype that preferentially acquires JAK2(V617F) and confers susceptibility to myeloproliferative neoplasms. One interpretation of our results is that a certain combination of SNPs may render haplotypes differentially susceptible to somatic mutagenesis. Thus, disease susceptibility loci may harbor somatic mutations that have a role in disease pathogenesis.	[Olcaydu, Damla; Harutyunyan, Ashot; Jaeger, Roland; Berg, Tiina; Kralovics, Robert] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Gisslinger, Bettina; Pabinger, Ingrid; Gisslinger, Heinz; Kralovics, Robert] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Blood Coagulat, Vienna, Austria	Austrian Academy of Sciences; Medical University of Vienna	Kralovics, R (corresponding author), Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria.	robert.kralovics@cemm.oeaw.ac.at	Harutyunyan, Ashot S/M-3528-2014	Harutyunyan, Ashot S/0000-0002-9050-9315; Jager, Roland/0000-0003-4530-1344; Kralovics, Robert/0000-0002-6997-8539	Austrian Academy of Sciences; Austrian Science Fund [P20033-B11]; Medical University of Vienna	Austrian Academy of Sciences; Austrian Science Fund(Austrian Science Fund (FWF)); Medical University of Vienna	The study was supported by funding from the Austrian Academy of Sciences, Austrian Science Fund (FWF, P20033-B11) and the Initiative for Cancer Research of the Medical University of Vienna. We thank C. Ay and N. Bachhofner for help with sample collection and T. Burkard for advice on statistical analysis. We thank H. Pickersgill for help with the manuscript.	Agaiwy A, 2008, AM J SURG PATHOL, V32, P1553, DOI 10.1097/PAS.0b013e31817587ea; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Laghi L, 2001, BRIT J CANCER, V84, P196, DOI 10.1054/bjoc.2000.1560; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LEVI S, 1991, CANCER RES, V51, P3497; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li S, 2008, BLOOD, V111, P3863, DOI 10.1182/blood-2007-09-111971; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Mechanic LE, 2007, CANCER EPIDEM BIOMAR, V16, P214, DOI 10.1158/1055-9965.EPI-06-0790; Moskaluk CA, 1997, CANCER RES, V57, P2140; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; SOZZI G, 1995, CANCER RES, V55, P135	22	272	280	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					450	454		10.1038/ng.341	http://dx.doi.org/10.1038/ng.341			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287385				2022-12-25	WOS:000264659000019
J	Arora, P; Goyal, A; Natarajan, VT; Rajakumara, E; Verma, P; Gupta, R; Yousuf, M; Trivedi, OA; Mohanty, D; Tyagi, A; Sankaranarayanan, R; Gokhale, RS				Arora, Pooja; Goyal, Aneesh; Natarajan, Vivek T.; Rajakumara, Eerappa; Verma, Priyanka; Gupta, Radhika; Yousuf, Malikmohamed; Trivedi, Omita A.; Mohanty, Debasisa; Tyagi, Anil; Sankaranarayanan, Rajan; Gokhale, Rajesh S.			Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; ACYL-AMP LIGASE; CELL-WALL CORE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SIDEROPHORE BIOSYNTHESIS; ADENYLATION DOMAINS; DRUG DISCOVERY; COENZYME-A; COA	The recent discovery of fatty acyl-AMP ligases (FAALs) in Mycobacterium tuberculosis (Mtb) provided a new perspective of fatty acid activation. These proteins convert fatty acids to the corresponding adenylates, which are intermediates of acyl-CoA-synthesizing fatty acyl-CoA ligases (FACLs). Presently, it is not evident how obligate pathogens such as Mtb have evolved such new themes of functional versatility and whether the activation of fatty acids to acyladenylates could indeed be a general mechanism. Here, based on elucidation of the first structure of an FAAL protein and by generating loss-of-function and gain-of-function mutants that interconvert FAAL and FACL activities, we demonstrate that an insertion motif dictates formation of acyladenylate. Because FAALs in Mtb are crucial nodes in the biosynthetic network of virulent lipids, inhibitors directed against these proteins provide a unique multipronged approach to simultaneously disrupting several pathways.	[Arora, Pooja; Natarajan, Vivek T.; Verma, Priyanka; Trivedi, Omita A.; Mohanty, Debasisa; Gokhale, Rajesh S.] Natl Inst Immunol, New Delhi 110067, India; [Goyal, Aneesh; Rajakumara, Eerappa; Yousuf, Malikmohamed; Sankaranarayanan, Rajan] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Gupta, Radhika; Tyagi, Anil] Univ Delhi, Dept Biochem, New Delhi 110021, India; [Gokhale, Rajesh S.] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Delhi; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Gokhale, RS (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sankar@ccmb.res.in; rsg@nii.res.in	Sankaranarayanan, Rajan/AAI-9295-2020; Mohanty, Debasisa/A-1428-2009	Gupta, Radhika/0000-0002-0445-0194; arora, pooja/0000-0002-4037-7406; Rajan, Sankaranarayanan/0000-0003-4524-9953; MOHANTY, DEBASISA/0000-0002-3374-0588; Eerappa, Rajakumara/0000-0002-9341-0070	Howard Hughes Medical Institute Funding Source: Medline; Wellcome Trust [070010] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)		Arora P, 2005, J AM CHEM SOC, V127, P9388, DOI 10.1021/ja052991s; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; CASTROPICHEL J, 1989, ARCH PHARM, V322, P11, DOI 10.1002/ardp.19893220104; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Goyal A, 2006, ACTA CRYSTALLOGR F, V62, P350, DOI 10.1107/S1744309106005938; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hansen DB, 2007, J AM CHEM SOC, V129, P6366, DOI 10.1021/ja070890j; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linne U, 2007, FEBS LETT, V581, P905, DOI 10.1016/j.febslet.2007.01.066; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; WHO, 2008, GLOBAL TUBERCULOSIS	50	88	96	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2009	5	3					166	173		10.1038/nchembio.143	http://dx.doi.org/10.1038/nchembio.143			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410DG	19182784	Green Accepted			2022-12-25	WOS:000263556100014
J	Schmelz, S; Kadi, N; McMahon, SA; Song, LJ; Oves-Costales, D; Oke, M; Liu, HT; Johnson, KA; Carter, LG; Botting, CH; White, MF; Challis, GL; Naismith, JH				Schmelz, Stefan; Kadi, Nadia; McMahon, Stephen A.; Song, Lijiang; Oves-Costales, Daniel; Oke, Muse; Liu, Huanting; Johnson, Kenneth A.; Carter, Lester G.; Botting, Catherine H.; White, Malcolm F.; Challis, Gregory L.; Naismith, James H.			AcsD catalyzes enantioselective citrate desymmetrization in siderophore biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; CRYSTAL-STRUCTURE; BACILLUS-ANTHRACIS; PETROBACTIN BIOSYNTHESIS; ERWINIA-CHRYSANTHEMI; STRUCTURAL BASIS; PROTEIN-KINASE; ACTIVE-SITE; COENZYME-A; MODEL	Bacterial pathogens need to scavenge iron from their host for growth and proliferation during infection. They have evolved several strategies to do this, one being the biosynthesis and excretion of small, high-affinity iron chelators known as siderophores. The biosynthesis of siderophores is an important area of study, not only for potential therapeutic intervention but also to illuminate new enzyme chemistries. Two general pathways for siderophore biosynthesis exist: the well-characterized nonribosomal peptide synthetase (NRPS)-dependent pathway and the NRPS-independent siderophore (NIS) pathway, which relies on a different family of sparsely investigated synthetases. Here we report structural and biochemical studies of AcsD from Pectobacterium (formerly Erwinia) chrysanthemi, an NIS synthetase involved in achromobactin biosynthesis. The structures of ATP and citrate complexes provide a mechanistic rationale for stereospecific formation of an enzyme-bound (3R)-citryladenylate, which reacts with L-serine to form a likely achromobactin precursor. AcsD is a unique acyladenylate-forming enzyme with a new fold and chemical catalysis strategy.	[Kadi, Nadia; Song, Lijiang; Oves-Costales, Daniel; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Schmelz, Stefan; McMahon, Stephen A.; Oke, Muse; Liu, Huanting; Johnson, Kenneth A.; Carter, Lester G.; Botting, Catherine H.; White, Malcolm F.; Naismith, James H.] Univ St Andrews, Scottish Struct Prote Facil, St Andrews KY16 9ST, Fife, Scotland; [Schmelz, Stefan; McMahon, Stephen A.; Oke, Muse; Liu, Huanting; Johnson, Kenneth A.; Carter, Lester G.; Botting, Catherine H.; White, Malcolm F.; Naismith, James H.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	University of Warwick; University of St Andrews; University of St Andrews	Challis, GL (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	g.l.challis@warwick.ac.uk; naismith@st-and.ac.uk	Oves-Costales, Daniel/I-1543-2015; White, Malcolm F/A-6055-2010; Naismith, James Henderson/AAB-8614-2020; Carter, Lester/G-6561-2014; Naismith, James Henderson/H-3408-2012	Oves-Costales, Daniel/0000-0001-9986-4623; White, Malcolm F/0000-0003-1543-9342; Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Oke, Muse/0000-0002-0169-752X; Challis, Gregory/0000-0001-5976-3545	Biotechnology and Biological Sciences Research Council [BB/S/B14450, BBS/B/14426, BB/F013760/1, BBS/B/14450] Funding Source: Medline; Medical Research Council [G0500367] Funding Source: Medline; BBSRC [BB/F013760/1] Funding Source: UKRI; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Challis GL, 2004, CURR OPIN STRUC BIOL, V14, P748, DOI 10.1016/j.sbi.2004.10.005; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; FULDA M, 1994, MOL GEN GENET, V242, P241, DOI 10.1007/BF00280412; Ginder ND, 2006, J BIOL CHEM, V281, P20680, DOI 10.1074/jbc.M602109200; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Kadi N, 2008, CHEM COMMUN, P5119, DOI 10.1039/b813029a; Kadi N, 2008, J AM CHEM SOC, V130, P10458, DOI 10.1021/ja8027263; Kadi N, 2007, NAT CHEM BIOL, V3, P652, DOI 10.1038/nchembio.2007.23; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lautru S, 2004, MICROBIOL-SGM, V150, P1629, DOI 10.1099/mic.0.26837-0; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; LIU CF, 1994, J AM CHEM SOC, V116, P4149, DOI 10.1021/ja00089a001; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McMahon SA, 2008, ACTA CRYSTALLOGR F, V64, P1052, DOI 10.1107/S1744309108032132; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Munzinger M, 2000, Z NATURFORSCH C, V55, P328; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oves-Costales D, 2008, CHEM COMMUN, P4034, DOI 10.1039/b809353a; Oves-Costales D, 2007, J AM CHEM SOC, V129, P8416, DOI 10.1021/ja072391o; Pfleger BF, 2007, BIOCHEMISTRY-US, V46, P4147, DOI 10.1021/bi6023995; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Steinbacher S, 1999, EMBO J, V18, P2923, DOI 10.1093/emboj/18.11.2923; Taylor SS, 1999, PHARMACOL THERAPEUT, V82, P133, DOI 10.1016/S0163-7258(99)00007-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thoden JB, 2002, J BIOL CHEM, V277, P23898, DOI 10.1074/jbc.M202251200; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WU MX, 1993, ANAL BIOCHEM, V211, P320, DOI 10.1006/abio.1993.1276	43	55	59	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2009	5	3					174	182		10.1038/nchembio.145	http://dx.doi.org/10.1038/nchembio.145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410DG	19182782	Green Accepted			2022-12-25	WOS:000263556100015
J	Rathore, AS; Winkle, H				Rathore, Anurag S.; Winkle, Helen			Quality by design for biopharmaceuticals	NATURE BIOTECHNOLOGY			English	Article							PROCESS ANALYTICAL TECHNOLOGY; MULTIVARIATE DATA-ANALYSIS; PAT; RECOMMENDATIONS; OPTIMIZATION; PRODUCT; ASSAYS; SPACE		[Rathore, Anurag S.] Proc Dev, Thousand Oaks, CA 91320 USA; [Winkle, Helen] Off Pharmaceut, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Rathore, AS (corresponding author), Proc Dev, M-S 30-2-A,1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	asrathore@yahoo.com	Rathore, Anurag S/ABG-9493-2020	Rathore, Anurag S/0000-0002-5913-4244				Barrett YC, 2007, J PHARMACEUT BIOMED, V44, P938, DOI 10.1016/j.jpba.2007.03.030; Cook S, 2007, BIOPHARM INT, V20, P28; FDA, 2004, PAT GUID IND FRAM IN; Gnoth S, 2007, J BIOTECHNOL, V132, P180, DOI 10.1016/j.jbiotec.2007.03.020; Gupta S, 2007, J IMMUNOL METHODS, V321, P1, DOI 10.1016/j.jim.2006.12.004; Harms J, 2008, BIOTECHNOL PROGR, V24, P655, DOI 10.1021/bp070338y; Johnson R, 2007, BIOPHARM INT, V20, P130; Kirdar AO, 2008, BIOTECHNOL PROGR, V24, P720, DOI 10.1021/bp0704384; Kirdar AO, 2007, BIOTECHNOL PROGR, V23, P61, DOI 10.1021/bp060377u; Klakamp SL, 2007, ANAL CHEM, V79, P8176, DOI 10.1021/ac071364d; Kozlowski S, 2006, ADV DRUG DELIVER REV, V58, P707, DOI 10.1016/j.addr.2006.05.002; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Munson J, 2006, CURR PHARM ANAL, V2, P405, DOI 10.2174/157341206778699582; Nail SL, 2008, BIOPHARM INT, V21, P44; Rathore AS, 2008, BIOTECHNOL BIOENG, V100, P306, DOI 10.1002/bit.21759; Rathore AS, 2007, BIOPHARM INT, V20, P36; Rathore AS, 2006, BIOPHARM INT, V19, P48; Seely JE, 2005, BIOTECHNOL & BIOPROC, V29, P31; Seely RJ, 2005, BIOTECHNOL & BIOPROC, V29, P13; Stein KE, 1997, TRENDS BIOTECHNOL, V15, P88, DOI 10.1016/S0167-7799(96)10075-5; *US FDA, 1996, FDA GUID CONC DEM CO; US Food and Drug Administration, 1999, REV GUID IND PROV RE; US Food and Drug Administration, 2006, GUID IND Q10 QUAL SY; US Food and Drug Administration, 2006, GUID IND Q8 PHARM DE; US Food and Drug Administration. Department of Health and Human Services, 2002, PHARM CGMPS 21 CENT; US-FDA, 2006, GUID IND Q9 QUAL RIS; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Yu LX, 2004, ADV DRUG DELIVER REV, V56, P349, DOI 10.1016/j.addr.2003.10.012	28	533	552	6	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2009	27	1					26	34		10.1038/nbt0109-26	http://dx.doi.org/10.1038/nbt0109-26			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	394TP	19131992				2022-12-25	WOS:000262471200018
J	Stein, U; Walther, W; Arlt, F; Schwabe, H; Smith, J; Fichtner, I; Birchmeier, W; Schlag, PM				Stein, Ulrike; Walther, Wolfgang; Arlt, Franziska; Schwabe, Holger; Smith, Janice; Fichtner, Iduna; Birchmeier, Walter; Schlag, Peter M.			MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis	NATURE MEDICINE			English	Article							HEPATOCYTE GROWTH-FACTOR; SMALL INTERFERING RNA; C-MET; COLORECTAL-CANCER; INVASIVE GROWTH; FACTOR RECEPTOR; EPITHELIAL-CELLS; TRANSGENIC MICE; IN-VIVO; EXPRESSION	We identified a previously undescribed gene associated with colon cancer by genome-wide expression analysis in primary and metastatic carcinomas: metastasis-associated in colon cancer-1, MACC1. MACC1 expression in tumor specimens is an independent prognostic indicator of metastasis formation and metastasis- free survival. We show that the gene encoding the hepatocyte growth factor (HGF) receptor, MET, is a transcriptional target of MACC1. MACC1 promotes proliferation, invasion and HGF-induced scattering of colon cancer cells in cell culture and tumor growth and metastasis in mouse models. These phenotypes are lost in cells expressing MACC1 mutants lacking the SH3 domain or the proline-rich motif. For clinical practice, MACC1 will be useful for the identification of poor prognosis subjects with colorectal cancer and is a promising new target for intervention in metastasis formation.	[Stein, Ulrike; Walther, Wolfgang; Arlt, Franziska; Smith, Janice; Fichtner, Iduna; Birchmeier, Walter] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Stein, Ulrike; Walther, Wolfgang; Arlt, Franziska; Schwabe, Holger; Schlag, Peter M.] Charite, Robert Rossle Canc Hosp, Dept Surg & Surg Oncol, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stein, U (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	ustein@mdc-berlin.de		Walther, Wolfgang/0000-0003-2360-1370; Stein, Ulrike/0000-0001-7006-282X	Wilhelm-Sander Foundation, Germany	Wilhelm-Sander Foundation, Germany	This work was supported by a grant from the Wilhelm-Sander Foundation, Germany.	BEAHRS OH, 1992, CANCER, V70, P1393, DOI 10.1002/1097-0142(19920901)70:3+<1393::AID-CNCR2820701530>3.0.CO;2-P; Becker M, 2002, BRIT J CANCER, V87, P1328, DOI 10.1038/sj.bjc.6600573; BELLUSCI S, 1994, ONCOGENE, V9, P1091; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Birchmeier W, 1997, CIBA F SYMP, V212, P230; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Boon EMJ, 2002, CANCER RES, V62, P5126; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Cardoso J, 2007, BBA-REV CANCER, V1775, P103, DOI 10.1016/j.bbcan.2006.08.004; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Dunlevy JR, 1999, GENOMICS, V62, P519, DOI 10.1006/geno.1999.5994; Fazekas K, 2001, CLIN EXP METASTAS, V18, P639, DOI 10.1023/A:1013136303880; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fujita S, 1997, JPN J CLIN ONCOL, V27, P378, DOI 10.1093/jjco/27.6.378; Giles RH, 2006, ONCOGENE, V25, P3065, DOI 10.1038/sj.onc.1209330; Horiguchi N, 2002, ONCOGENE, V21, P1791, DOI 10.1038/sj.onc.1205248; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liang HY, 2004, INT J ONCOL, V24, P1057; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Liu YH, 1998, GENE, V215, P159, DOI 10.1016/S0378-1119(98)00264-9; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; MILLER RG, 1998, SURVIVAL ANAL, pCH6; Moshitch-Moshkovitz S, 2006, NEOPLASIA, V8, P353, DOI 10.1593/neo.05634; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; RONG S, 1994, P NATL ACAD SCI USA, V91, P4731, DOI 10.1073/pnas.91.11.4731; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Stein Ulrike, 2007, V176, P61; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Stella MC, 2005, MOL CELL BIOL, V25, P3982, DOI 10.1128/MCB.25.10.3982-3996.2005; STOKER M, 1985, J CELL SCI, V77, P209; Takayama T, 2006, J GASTROENTEROL, V41, P185, DOI 10.1007/s00535-006-1801-6; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; WORKMAN P, 1989, CANCER METAST REV, V8, P82; Zhang SZ, 2005, MOL CANCER THER, V4, P1577, DOI 10.1158/1535-7163.MCT-05-0106	50	393	448	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2009	15	1					59	67		10.1038/nm.1889	http://dx.doi.org/10.1038/nm.1889			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	394DF	19098908				2022-12-25	WOS:000262425100019
J	Adams, JU				Adams, Jill U.			Hypertension's shot in the arm	NATURE BIOTECHNOLOGY			English	News Item								Two small companies developing therapeutic vaccines against hypertension are blazing a trail for immune treatments that address diseases of lifestyle with massive markets. But doubts linger over the safety of eliciting an immune response to normal body constituents. Jill U. Adams investigates.										Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; MICHEL JB, 1990, CIRCULATION, V81, P1899, DOI 10.1161/01.CIR.81.6.1899; MUNGER MA, 2007, MEDGENMED, V19, P58; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; 2008, NAT REV DRUG DISCOV, V7, P794	6	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1327	1329		10.1038/nbt1208-1327	http://dx.doi.org/10.1038/nbt1208-1327			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19060862				2022-12-25	WOS:000261591300008
J	Kao, KC; Sherlock, G				Kao, Katy C.; Sherlock, Gavin			Molecular characterization of clonal interference during adaptive evolution in asexual populations of Saccharomyces cerevisiae	NATURE GENETICS			English	Article							BENEFICIAL MUTATIONS; ESCHERICHIA-COLI; SELECTION; FITNESS; FREQUENCY	The classical model of adaptive evolution in an asexual population postulates that each adaptive clone is derived from the one preceding it(1). However, experimental evidence has suggested more complex dynamics(2-5), with theory predicting the fixation probability of a beneficial mutation as dependent on the mutation rate, population size and the mutation's selection coefficient(6). Clonal interference has been demonstrated in viruses(7) and bacteria(8) but not in a eukaryote, and a detailed molecular characterization is lacking. Here we use three different fluorescent markers to visualize the dynamics of asexually evolving yeast populations. For each adaptive clone within one of our evolving populations, we identified the underlying mutations, monitored their population frequencies and used microarrays to characterize changes in the transcriptome. These results represent the most detailed molecular characterization of experimental evolution to date and provide direct experimental evidence supporting both the clonal interference and the multiple mutation models.	[Sherlock, Gavin] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kao, Katy C.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Stanford University; Texas A&M University System; Texas A&M University College Station	Sherlock, G (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	sherlock@genome.stanford.edu	Sherlock, Gavin J/E-9110-2012; Sherlock, Gavin J/B-1831-2009	Sherlock, Gavin/0000-0002-1692-4983; Kao, Katy/0000-0002-1184-276X	US National Institutes of Health [R01 HG003328, F32 GM079113]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079113] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01 HG003328 (G. S.) and F32 GM079113 (K. C. K.). We thank J. Ying for help with sample handling, E. Tanner for carrying out some of the gene expression microarray experiments, H. Tang for discussions on experimental design, J. Horecka for help with RT-PCR and F. Rosenzweig, B. Dunn and A. Sidow for comments on the manuscript.	ADAMS J, 1986, P NATL ACAD SCI USA, V83, P7124, DOI 10.1073/pnas.83.18.7124; ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Blanc VM, 2003, GENETICS, V165, P975; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gerrish P, 2001, NATURE, V413, P299, DOI 10.1038/35095046; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HELLING RB, 1987, GENETICS, V116, P349; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Kim Y, 2005, GENETICS, V171, P1377, DOI 10.1534/genetics.105.045252; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Notley-McRobb L, 2000, GENETICS, V156, P1493; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; NOVICK A, 1950, P NATL ACAD SCI USA, V36, P708, DOI 10.1073/pnas.36.12.708; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Segre AV, 2006, PLOS BIOL, V4, P1372, DOI 10.1371/journal.pbio.0040256; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128	30	205	208	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1499	1504		10.1038/ng.280	http://dx.doi.org/10.1038/ng.280			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19029899	Green Accepted			2022-12-25	WOS:000261215900030
J	Pan, Q; Shai, O; Lee, LJ; Frey, J; Blencowe, BJ				Pan, Qun; Shai, Ofer; Lee, Leo J.; Frey, J.; Blencowe, Benjamin J.			Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing	NATURE GENETICS			English	Article							GENOME; MOUSE	We carried out the first analysis of alternative splicing complexity in human tissues using mRNA-Seq data. New splice junctions were detected in similar to 20% of multiexon genes, many of which are tissue specific. By combining mRNA-Seq and EST-cDNA sequence data, we estimate that transcripts from similar to 95% of multiexon genes undergo alternative splicing and that there are similar to 100,000 intermediate- to high-abundance alternative splicing events in major human tissues. From a comparison with quantitative alternative splicing microarray profiling data, we also show that mRNA-Seq data provide reliable measurements for exon inclusion levels.	[Pan, Qun; Shai, Ofer; Lee, Leo J.; Frey, J.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Shai, Ofer; Lee, Leo J.; Frey, J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto; University of Toronto	Blencowe, BJ (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca			Canadian Institutes of Health Research; Genome Canada through the Ontario Genomics Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	We thank S. Luo, I. Khrebtukova and G. Schroth of Illumina Inc. for providing some of the mRNA-Seq datasets used in this analysis. We also thank M. Brudno, Y. Barash, J. Calarco and S. Ahmad for helpful suggestions and comments on the manuscript. B.J.B and B.J.F. acknowledge support from the Canadian Institutes of Health Research and from Genome Canada through the Ontario Genomics Institute.	Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Calarco JA, 2007, ADV EXP MED BIOL, V623, P64, DOI 10.1007/978-0-387-77374-2_5; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Sorek R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-273; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	15	2401	2533	6	248	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1413	1415		10.1038/ng.259	http://dx.doi.org/10.1038/ng.259			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978789				2022-12-25	WOS:000261215900017
J	Yu, XW; Ng, CP; Habacher, H; Roy, S				Yu, Xianwen; Ng, Chee Peng; Habacher, Hermann; Roy, Sudipto			Foxj1 transcription factors are master regulators of the motile ciliogenic program	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; AIRWAY EPITHELIAL-CELLS; PROTEIN-KINASE-A; ZEBRAFISH EMBRYO; HEDGEHOG ACTIVITY; KUPFFERS VESICLE; SONIC-HEDGEHOG; FACTOR HFH-4; NEURAL-TUBE; FACTOR RFX3	Motile cilia induce fluid movement through their rhythmic beating activity. In mammals, the transcription factor Foxj1 has been implicated in motile cilia formation. Here we show that a zebrafish Foxj1 homolog, foxj1a, is a target of Hedgehog signaling in the floor plate. Loss of Foxj1a compromises the assembly of motile cilia that decorate floor plate cells. Besides the floor plate, foxj1a is expressed in Kupffer's vesicle and pronephric ducts, where it also promotes ciliary differentiation. We show that Foxj1a activates a constellation of genes essential for motile cilia formation and function, and that its activity is sufficient for ectopic development of cilia that resemble motile cilia. We also document that a paralogous gene, foxj1b, is expressed in the otic vesicle and seems to regulate motile cilia formation in this tissue. Our findings identify a dedicated master regulatory role for Foxj1 in the transcriptional program that controls the production of motile cilia.	[Yu, Xianwen; Ng, Chee Peng; Habacher, Hermann; Roy, Sudipto] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Roy, Sudipto] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Roy, S (corresponding author), Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, 61 Biopolis Dr, Singapore 138673, Singapore.	sudipto@imcb.a-star.edu.sg	Yu, Xianwen/Q-2646-2019		Institute of Molecular and Cell Biology; Agency for Science, Technology and Research of Singapore	Institute of Molecular and Cell Biology; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	We wish to thank J. Briscoe for discussion, M. Ma for the plasmid containing zebrafish cetn2 cDNA, C. X. Goh for technical assistance, S. Choksi for advice on ChIP and S. Choksi and other members of our laboratory for their comments on the manuscript. This work was funded by the Institute of Molecular and Cell Biology and the Agency for Science, Technology and Research of Singapore. S. R. is an adjunct faculty member in the Department of Biological Sciences, National University of Singapore.	Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; AMOS WB, 1985, CELL MOTIL CYTOSKEL, V5, P239, DOI 10.1002/cm.970050306; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Chen WB, 2001, DEVELOPMENT, V128, P2385; Choi VM, 2006, GENE EXPR PATTERNS, V6, P443, DOI 10.1016/j.modgep.2005.11.007; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Ikeda T, 2005, FEBS LETT, V579, P819, DOI 10.1016/j.febslet.2004.12.070; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Majumdar A, 2000, DEVELOPMENT, V127, P2089; Odenthal J, 2000, DEV BIOL, V219, P350, DOI 10.1006/dbio.1999.9589; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Pelletier GJ, 1998, AM J PHYSIOL-LUNG C, V274, pL351, DOI 10.1152/ajplung.1998.274.3.L351; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Xu J, 2006, GENETICS, V174, P735, DOI 10.1534/genetics.106.061523; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	44	275	282	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1445	1453		10.1038/ng.263	http://dx.doi.org/10.1038/ng.263			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19011630				2022-12-25	WOS:000261215900021
J	Kiemeney, LA; Thorlacius, S; Sulem, P; Geller, F; Aben, KKH; Stacey, SN; Gudmundsson, J; Jakobsdottir, M; Bergthorsson, JT; Sigurdsson, A; Blondal, T; Witjes, JA; Vermeulen, SH; Hulsbergen-van de Kaa, CA; Swinkels, DW; Ploeg, M; Cornel, EB; Vergunst, H; Thorgeirsson, TE; Gudbjartsson, D; Gudjonsson, SA; Thorleifsson, G; Kristinsson, KT; Mouy, M; Snorradottir, S; Placidi, D; Campagna, M; Arici, C; Koppova, K; Gurzau, E; Rudnai, P; Kellen, E; Polidoro, S; Guarrera, S; Sacerdote, C; Sanchez, M; Saez, B; Valdivia, G; Ryk, C; De Verdier, P; Lindblom, A; Golka, K; Bishop, DT; Knowles, MA; Nikulasson, S; Petursdottir, V; Jonsson, E; Geirsson, G; Kristjansson, B; Mayordomo, JI; Steineck, G; Porru, S; Buntinx, F; Zeegers, MP; Fletcher, T; Kumar, R; Matullo, G; Vineis, P; Kiltie, AE; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Rafnar, T; Stefansson, K				Kiemeney, Lambertus A.; Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Aben, Katja K. H.; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Witjes, J. Alfred; Vermeulen, Sita H.; Hulsbergen-van de Kaa, Christina A.; Swinkels, Dorine W.; Ploeg, Martine; Cornel, Erik B.; Vergunst, Henk; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Koppova, Kvetoslava; Gurzau, Eugene; Rudnai, Peter; Kellen, Eliane; Polidoro, Silvia; Guarrera, Simonetta; Sacerdote, Carlotta; Sanchez, Manuel; Saez, Berta; Valdivia, Gabriel; Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika; Golka, Klaus; Bishop, D. Timothy; Knowles, Margaret A.; Nikulasson, Sigfus; Petursdottir, Vigdis; Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin; Mayordomo, Jose I.; Steineck, Gunnar; Porru, Stefano; Buntinx, Frank; Zeegers, Maurice P.; Fletcher, Tony; Kumar, Rajiv; Matullo, Giuseppe; Vineis, Paolo; Kiltie, Anne E.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari			Sequence variant on 8q24 confers susceptibility to urinary bladder cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; UROTHELIAL CELL-CARCINOMA; PROSTATE-CANCER; LUNG-CANCER; NICOTINE DEPENDENCE; GENE-EXPRESSION; P63 EXPRESSION; BREAST-CANCER; RISK; DISEASE	We conducted a genome-wide SNP association study on 1,803 urinary bladder cancer (UBC) cases and 34,336 controls from Iceland and The Netherlands and follow up studies in seven additional case-control groups (2,165 cases and 3,800 controls). The strongest association was observed with allele T of rs9642880 on chromosome 8q24, 30 kb upstream of MYC (allele-specific odds ratio (OR) = 1.22; P = 9.34 x 10(-12)). Approximately 20% of individuals of European ancestry are homozygous for rs9642880[T], and their estimated risk of developing UBC is 1.49 times that of noncarriers. No association was observed between UBC and the four 8q24 variants previously associated with prostate, colorectal and breast cancers, nor did rs9642880 associate with any of these three cancers. A weaker signal, but nonetheless of genome-wide significance, was captured by rs710521[A] located near TP63 on chromosome 3q28 (allele-specific OR = 1.19; P = 1.15 x 10(-7)).	[Kiemeney, Lambertus A.; Aben, Katja K. H.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred; Ploeg, Martine] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K. H.] Ctr Comprehens Canc E, NL-6501 BG Nijmegen, Netherlands; [Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari] DeCode Genet, IS-101 Reykjavik, Iceland; [Hulsbergen-van de Kaa, Christina A.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [Cornel, Erik B.] Streekziekenhuis Midden Twente, Dept Urol, NL-7550 AM Hengelo, Netherlands; [Vergunst, Henk] Canisius Wilhelmina Ziekenhuis, Dept Urol, NL-6500 GS Nijmegen, Netherlands; [Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Porru, Stefano] Univ Brescia, Dept Expt & Appl Med, Sect Occupat Med & Ind Hyg, I-25125 Brescia, Italy; [Koppova, Kvetoslava] State Hlth Inst, SK-97556 Banska Bystrica, Slovakia; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca 400166, Romania; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Kellen, Eliane; Buntinx, Frank] Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium; [Kellen, Eliane] Catholic Univ Louvain, Ctr Canc Prevent LUCK, B-3000 Louvain, Belgium; [Polidoro, Silvia; Matullo, Giuseppe; Vineis, Paolo] ISI Fdn, Turin, Italy; [Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, I-10123 Turin, Italy; Ctr Canc Epidemiol & Prevent CPO Piemonte, I-10123 Turin, Italy; [Sanchez, Manuel] Univ Hosp, Div Urol, Zaragoza 50009, Spain; [Valdivia, Gabriel] Univ Zaragoza, Sch Med, Dept Urol, E-50009 Zaragoza, Spain; [Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Golka, Klaus] Univ Dortmund, Inst Occupat Physiol, Dortmund, Germany; [Bishop, D. Timothy] St James Univ Hosp, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England; [Knowles, Margaret A.; Kiltie, Anne E.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Leeds LS9 7TF, W Yorkshire, England; [Nikulasson, Sigfus; Petursdottir, Vigdis] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin] Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Mayordomo, Jose I.] Hlth Sci Inst, Nanotechnol Inst Aragon, Zaragoza 50009, Spain; [Steineck, Gunnar] Karolinska Hosp, Dept Oncol & Pathol, S-17176 Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden; [Buntinx, Frank] Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Zeegers, Maurice P.] Univ Birmingham, Dept Publ Hlth & Epidemiol, Unit Genet Epidemiol, Birmingham B15 2TT, W Midlands, England; [Zeegers, Maurice P.] Nutr & Toxicol Res Inst, Dept Complex Genet, NL-6200 MD Maastricht, Netherlands; [Fletcher, Tony] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; University of Brescia; Universite Catholique Louvain; Universite Catholique Louvain; University of Turin; University of Turin; Miguel Servet University Hospital; University of Zaragoza; Karolinska Institutet; Dortmund University of Technology; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Landspitali National University Hospital; Landspitali National University Hospital; Miguel Servet University Hospital; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Maastricht University; University of Birmingham; Maastricht University; University of London; London School of Hygiene & Tropical Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; University of Iceland	Stefansson, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands.	b.kiemeney@ebh.umcn.nl; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Steineck, Gunnar/W-1515-2019; Campagna, Marcello/L-1011-2016; Aben, Katja KH/G-9686-2016; Placidi, Donatella/A-6965-2011; Matullo, Giuseppe/K-6383-2016; Guarrera, Simonetta/AAB-8482-2022; de Kaa, Christina A Hulsbergen-van/L-4399-2015; Kiemeney, Lambertus A./D-3357-2009; Mayordomo, Jose/K-3453-2013; Polidoro, Silvia/GYJ-3517-2022; Witjes, Fred/N-9665-2013; Buntinx, Frank/E-4950-2011; Swinkels, Dorine W./H-8098-2014; Vermeulen, Sita H./L-4716-2015; Kumar, Rajiv/H-6431-2019; Arici, Cecilia/AAO-7689-2020; Fletcher, Tony/D-2394-2011	Steineck, Gunnar/0000-0002-0787-3969; Campagna, Marcello/0000-0002-5277-8477; Aben, Katja KH/0000-0002-0214-2147; Placidi, Donatella/0000-0003-1606-5397; Matullo, Giuseppe/0000-0003-0674-7757; Kiemeney, Lambertus A./0000-0002-2368-1326; Swinkels, Dorine W./0000-0002-1040-9446; Vermeulen, Sita H./0000-0003-4913-8601; Kumar, Rajiv/0000-0002-6093-0395; Arici, Cecilia/0000-0003-1493-590X; Saez, Berta/0000-0003-0753-1165; Knowles, Margaret/0000-0002-9363-8657; Gudbjartsson, Daniel/0000-0002-5222-9857; Zeegers, Maurice/0000-0002-2387-083X; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Polidoro, Silvia/0000-0003-2968-0575; Kiltie, Anne/0000-0001-7208-2912; Bishop, Tim/0000-0002-8752-8785; Fletcher, Tony/0000-0003-3385-200X; Geller, Frank/0000-0002-9238-3269; Ryk, Charlotta/0000-0002-7881-7614; Kong, Augustine/0000-0001-8193-5438; Sacerdote, Carlotta/0000-0002-8008-5096; Gurzau, Eugen/0000-0002-8688-6118; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Bergthorsson, Jon Thor/0000-0002-0560-2639	European Commission [LSHC-CT-2005-018827, LSHM-CT-2004-005166]; National Institute of Health [R01-DA017932]; Radboud University Nijmegen Medical Centre; Cancer Research UK; Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility),; European Union [513943]; compagnia di San Paolo; Italian Association for Cancer Research, Italy; Piedmont Region Progetti di Ricerca Sanitaria Finalizzata; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radboud University Nijmegen Medical Centre; Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility),; European Union(European Commission); compagnia di San Paolo(Compagnia di San Paolo); Italian Association for Cancer Research, Italy(Fondazione AIRC per la ricerca sul cancro); Piedmont Region Progetti di Ricerca Sanitaria Finalizzata; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the individuals that participated in the study and whose contribution made this work possible. We also thank the nurses at Noatun (deCODE's participant recruitment center) and the personnel at the deCODE core facilities. We acknowledge the Icelandic Cancer Registry for assistance in the ascertainment of the Icelandic UBC cases. Collection of samples and data in Iceland and The Netherlands was funded in part by the European Commission (POLYGENE: LSHC-CT-2005-018827 and GENADDICT: LSHM-CT-2004-005166), the National Institute of Health (R01-DA017932) and a research investment grant of the Radboud University Nijmegen Medical Centre. The Leeds Bladder Cancer Study was funded by Cancer Research UK and Yorkshire Cancer Research. Torino Bladder Cancer Case Control Study was supported by a grant to ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: "Food Quality and Safety'' (Contract No 513943); by a grant of the compagnia di San Paolo, the Italian Association for Cancer Research, Italy and the Piedmont Region Progetti di Ricerca Sanitaria Finalizzata.	Aben KKH, 2006, EUR J CANCER, V42, P1428, DOI 10.1016/j.ejca.2005.07.039; Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; DEPINHO RA, 1991, ADV CANCER RES, V57, P1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Koga F, 2003, CLIN CANCER RES, V9, P5501; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; *NAT CANC I DIV CA, 2007, SURV EP END RES PROG; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	30	323	334	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1307	1312		10.1038/ng.229	http://dx.doi.org/10.1038/ng.229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18794855	Green Accepted			2022-12-25	WOS:000260501500022
J	Stacey, SN; Gudbjartsson, DF; Sulem, P; Bergthorsson, JT; Kumar, R; Thorleifsson, G; Sigurdsson, A; Jakobsdottir, M; Sigurgeirsson, B; Benediktsdottir, KR; Thorisdottir, K; Ragnarsson, R; Scherer, D; Rudnai, P; Gurzau, E; Koppova, K; Hoiom, V; Botella-Estrada, R; Soriano, V; Juberias, P; Grasa, M; Carapeto, FJ; Tabuenca, P; Gilaberte, Y; Gudmundsson, J; Thorlacius, S; Helgason, A; Thorlacius, T; Jonasdottir, A; Blondal, T; Gudjonsson, SA; Jonsson, GF; Saemundsdottir, J; Kristjansson, K; Bjornsdottir, G; Sveinsdottir, SG; Mouy, M; Geller, F; Nagore, E; Mayordomo, JI; Hansson, J; Rafnar, T; Kong, A; Olafsson, JH; Thorsteinsdottir, U; Stefansson, K				Stacey, Simon N.; Gudbjartsson, Daniel F.; Sulem, Patrick; Bergthorsson, Jon T.; Kumar, Rajiv; Thorleifsson, Gudmar; Sigurdsson, Asgeir; Jakobsdottir, Margret; Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Scherer, Dominique; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Hoiom, Veronica; Botella-Estrada, Rafael; Soriano, Virtudes; Juberias, Pablo; Grasa, Matilde; Carapeto, Francisco J.; Tabuenca, Pilar; Gilaberte, Yolanda; Gudmundsson, Julius; Thorlacius, Steinunn; Helgason, Agnar; Thorlacius, Theodora; Jonasdottir, Aslaug; Blondal, Thorarinn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjroern F.; Saemundsdottir, Jona; Kristjansson, Kristleifur; Bjornsdottir, Gyda; Sveinsdottir, Steinunn G.; Mouy, Magali; Geller, Frank; Nagore, Eduardo; Mayordomo, Jose I.; Hansson, Johan; Rafnar, Thorunn; Kong, Augustine; Olafsson, Jon H.; Thorsteinsdottir, Unnur; Stefansson, Kari			Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits	NATURE GENETICS			English	Article							SKIN-CANCER; PEPTIDYLARGININE DEIMINASE; GENETIC-DETERMINANTS; HUMAN HOMOLOG; RISK-FACTORS; CITRULLINATION; EPIDEMIOLOGY; MEMBER; FAMILY	To search for new sequence variants that confer risk of cutaneous basal cell carcinoma (BCC), we conducted a genome-wide SNP association study of 930 Icelanders with BCC and 33,117 controls. After analyzing 304,083 SNPs, we observed signals from loci at 1p36 and 1q42, and replicated these associations in additional sample sets from Iceland and Eastern Europe. Overall, the most significant signals were from rs7538876 on 1p36 (OR = 1.28, P = 4.4 x 10(-12)) and rs801114 on 1q42 (OR = 1.28, P = 5.9 x. 10(-12)). The 1p36 locus contains the candidate genes PADI4, PADI6, RCC2 and ARHGEF10L, and the gene nearest to the 1q42 locus is the ras-homolog RHOU. Neither locus was associated with fair pigmentation traits that are known risk factors for BCC, and no risk was observed for melanoma. Approximately 1.6% of individuals of European ancestry are homozygous for both variants, and their estimated risk of BCC is 2.68 times that of noncarriers.	[Stacey, Simon N.; Gudbjartsson, Daniel F.; Sulem, Patrick; Bergthorsson, Jon T.; Thorleifsson, Gudmar; Sigurdsson, Asgeir; Jakobsdottir, Margret; Gudmundsson, Julius; Thorlacius, Steinunn; Helgason, Agnar; Thorlacius, Theodora; Jonasdottir, Aslaug; Blondal, Thorarinn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjroern F.; Saemundsdottir, Jona; Kristjansson, Kristleifur; Bjornsdottir, Gyda; Mouy, Magali; Geller, Frank; Rafnar, Thorunn; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] Decode Genet, IS-101 Reykjavik, Iceland; [Kumar, Rajiv; Scherer, Dominique] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, SK-97556 Banska Bystrica, Slovakia; [Hoiom, Veronica; Hansson, Johan] Karolinska Univ Hosp Solna, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Botella-Estrada, Rafael; Soriano, Virtudes; Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia 46009, Spain; [Juberias, Pablo; Grasa, Matilde; Carapeto, Francisco J.] Univ Hosp, Div Dermatol, Zaragoza 50009, Spain; [Tabuenca, Pilar] Hlth Sci Inst, Zaragoza 50009, Spain; [Gilaberte, Yolanda] San Jorge Gen Hosp, Div Dermatol, Huesca 22004, Spain; [Sveinsdottir, Steinunn G.] Clin Res Ctr, IS-110 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland	Helmholtz Association; German Cancer Research Center (DKFZ); Landspitali National University Hospital; Landspitali National University Hospital; Karolinska Institutet; Karolinska University Hospital; Instituto Valenciano De Oncologia; Miguel Servet University Hospital; Hospital Universidad San Jorge; Miguel Servet University Hospital; Landspitali National University Hospital	Thorsteinsdottir, U (corresponding author), Decode Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kari.stefansson@decode.is	Gilaberte, Yolanda/K-6416-2019; Höiom, Veronica/F-4153-2012; Mayordomo, Jose/K-3453-2013; Stefansson, Kari/AAE-7187-2019; Kumar, Rajiv/H-6431-2019; Helgason, Agnar/K-1522-2015; Sigurgeirsson, Bárður/B-6130-2011; Sigurgeirsson, Bardur/AAP-7755-2020; Nagore, Eduardo/Z-2126-2019	Kumar, Rajiv/0000-0002-6093-0395; Nagore, Eduardo/0000-0003-3433-8707; Sigurgeirsson, Bardur/0000-0002-9733-9742; Geller, Frank/0000-0002-9238-3269; Gilaberte, Yolanda/0000-0001-8034-3617; Helgason, Agnar/0000-0002-8545-3767; Gurzau, Eugen/0000-0002-8688-6118; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Bjornsdottir, Gyda/0000-0002-8100-0306; Bergthorsson, Jon Thor/0000-0002-0560-2639				Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Esposito G, 2007, MOL CELL ENDOCRINOL, V273, P25, DOI 10.1016/j.mce.2007.05.005; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Han JL, 2006, INT J CANCER, V119, P1976, DOI 10.1002/ijc.22074; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lear JT, 2005, CLIN EXP DERMATOL, V30, P49, DOI 10.1111/j.1365-2230.2004.01669.x; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; O'Driscoll L, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-74; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x; Scherer D, 2008, INT J CANCER, V122, P1787, DOI 10.1002/ijc.23257; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Suzuki A, 2007, ANN NY ACAD SCI, V1108, P323, DOI 10.1196/annals.1422.034; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Winkler S, 2005, BIOCHEM BIOPH RES CO, V335, P1280, DOI 10.1016/j.bbrc.2005.08.025; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xu LY, 2006, INT J DERMATOL, V45, P1275, DOI 10.1111/j.1365-4632.2006.02999.x; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192	28	96	104	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1313	1318		10.1038/ng.234	http://dx.doi.org/10.1038/ng.234			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849993				2022-12-25	WOS:000260501500023
J	Patterson, EE; Minor, KM; Tchernatynskaia, AV; Taylor, SM; Shelton, GD; Ekenstedt, KJ; Mickelson, JR				Patterson, Edward E.; Minor, Katie M.; Tchernatynskaia, Anna V.; Taylor, Susan M.; Shelton, G. Diane; Ekenstedt, Kari J.; Mickelson, James R.			A canine DNM1 mutation is highly associated with the syndrome of exercise-induced collapse	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; CENTRONUCLEAR MYOPATHY; LINKAGE ANALYSIS; GENOME; GENE; TEMPERATURE; DYNAMIN; DOGS; IDENTIFICATION; POPULATION	Labrador retrievers are the most common dog breed in the world, with over 200,000 new kennel club registrations per year. The syndrome of exercise-induced collapse (EIC) in this breed is manifested by muscle weakness, incoordination and life-threatening collapse after intense exercise. Using a genome-wide microsatellite marker scan for linkage in pedigrees, we mapped the EIC locus to canine chromosome 9. We then used SNP association and haplotype analysis to fine map the locus, and identified a mutation in the dynamin 1 gene (DNM1) that causes an R256L substitution in a highly conserved region of the protein. This first documented mammalian DNM1 mutation is present at a high frequency in the breed and is a compelling candidate causal mutation for EIC, as the dynamin 1 protein has an essential role in neurotransmission and synaptic vesicle endocytosis.	[Patterson, Edward E.; Tchernatynskaia, Anna V.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Minor, Katie M.; Mickelson, James R.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Taylor, Susan M.] Univ Saskatchewan, Western Coll Vet Med, Dept Small Anim Clin Sci, Saskatoon, SK S7N 5B4, Canada; [Shelton, G. Diane] Univ Calif San Diego, Dept Pathol, Comparat Neuromuscular Lab, La Jolla, CA 92093 USA; [Ekenstedt, Kari J.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Saskatchewan; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities	Patterson, EE (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.	patte037@umn.edu	Fiumefreddo, Andrea/T-2977-2019	Mickelson, James/0000-0001-6951-0234; Minor, Katie/0000-0002-5472-5088				Breen M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-65; Chen XH, 2008, NEUROGENETICS, V9, P41, DOI 10.1007/s10048-007-0112-2; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Echaniz-Laguna A, 2007, NEUROMUSCULAR DISORD, V17, P955, DOI 10.1016/j.nmd.2007.06.467; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Grant D, 1998, GENETICS, V149, P1019; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Guyon R, 2003, P NATL ACAD SCI USA, V100, P5296, DOI 10.1073/pnas.0831002100; Hungs M, 2001, GENOME RES, V11, P531, DOI 10.1101/gr.GR-1610R; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Lohi H, 2005, SCIENCE, V307, P81, DOI 10.1126/science.1102832; Matwichuk CL, 1999, AM J VET RES, V60, P88; Noakes PG, 1999, J COMP NEUROL, V410, P531; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pennisi E, 2007, SCIENCE, V317, P1668, DOI 10.1126/science.317.5845.1668; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; TAYLOR SM, 2007, BLACKWELLS 5 MINUTE, P458; TAYLOR SM, J AM ANIM H IN PRESS; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	28	45	46	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1235	1239		10.1038/ng.224	http://dx.doi.org/10.1038/ng.224			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18806795				2022-12-25	WOS:000259651000025
J	Yamanaka, M				Yamanaka, Miles			A nail in the coffin for DNA sequence patents?	NATURE BIOTECHNOLOGY			English	Editorial Material							CLONING		[Yamanaka, Miles] Berliner & Associates, Los Angeles, CA 90013 USA; [Yamanaka, Miles] Fulbright & Jaworski, Los Angeles, CA 90071 USA		Yamanaka, M (corresponding author), Berliner & Associates, 555 W 5th St,31st Floor, Los Angeles, CA 90013 USA.	myamanaka@berliner-ip.com						Kubin MZ, 1999, EUR J IMMUNOL, V29, P3466, DOI 10.1002/(SICI)1521-4141(199911)29:11<3466::AID-IMMU3466>3.0.CO;2-9; MATHEW PA, 1993, J IMMUNOL, V151, P5328; Sambrook J., 2002, MOL CLONING LAB MANU; Teitelbaum R, 2007, NAT BIOTECHNOL, V25, P1105, DOI 10.1038/nbt1007-1105; 2007, FED REG, V72, P57526; 1997, Patent No. 5688690	6	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2008	26	10					1085	1086		10.1038/nbt1008-1085	http://dx.doi.org/10.1038/nbt1008-1085			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	358NY	18846072				2022-12-25	WOS:000259926000015
J	Ulker, B; Li, Y; Rosso, MG; Logemann, E; Somssich, IE; Weisshaar, B				Uelker, Bekir; Li, Yong; Rosso, Mario G.; Logemann, Elke; Somssich, Imre E.; Weisshaar, Bernd			T-DNA-mediated transfer of Agrobacterium tumefaciens chromosomal DNA into plants	NATURE BIOTECHNOLOGY			English	Article							ARABIDOPSIS-THALIANA; REVERSE GENETICS; GENOME; SEQUENCES; C58	Besides the well-documented integration of DNA flanked by the transfer DNA borders, occasional insertion of fragments from the tumor-inducing plasmid into plant genomes has also been reported during Agrobacterium tumefaciens-mediated transformation. We demonstrate that large (up to similar to 18 kb) gene-bearing fragments of Agrobacterium chromosomal DNA (AchrDNA) can be integrated into Arabidopsis thaliana genomic DNA during transformation. One in every 250 transgenic plants may carry AchrDNA fragments. This has implications for horizontal gene transfer and indicates a need for greater scrutiny of transgenic plants for undesired bacterial DNA.	[Li, Yong; Rosso, Mario G.; Weisshaar, Bernd] Univ Bielefeld, Inst Genome Res & Syst Biol, D-33594 Bielefeld, Germany; [Weisshaar, Bernd] Max Planck Inst Plant Breeding Res, Dept Mol Plant Genet, D-50829 Cologne, Germany; [Uelker, Bekir; Logemann, Elke; Somssich, Imre E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany	University of Bielefeld; Max Planck Society; Max Planck Society	Ulker, B (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Sci Site,South Rd, Durham DH1 3LE, England.	dr.bulker@gmail.com; bernd.weisshaar@uni-bielefeld.de	Somssich, Imre/GLT-3738-2022; Li, Yong/A-6283-2011; Weisshaar, Bernd/B-3859-2014	Somssich, Imre/0000-0003-3066-5794; Weisshaar, Bernd/0000-0002-7635-3473; Li, Yong/0000-0003-2651-8791	Max-Planck Society; EU; BMBF	Max-Planck Society(Max Planck SocietyFoundation CELLEX); EU(European Commission); BMBF(Federal Ministry of Education & Research (BMBF))	We thank the students Pino Cagna and Alexander Boes for initial inverse PCR experiments leading to the discovery of the Agrobacterium chromosomal DNA in the transgenic locus named PM (PaperMaker) in a WRKY40 promoter:: GUS line generated by Hikaru Seki, Prisca Viehoever for technical assistance and Csaba Koncz and Steven Spiker for suggestions and critical reading of the manuscript. This work was supported in part by the Max-Planck Society, the EU-funded REGIA project and the BMBF-funded GABI-Kat project.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MIRANDA A, 1992, J BACTERIOL, V174, P2288, DOI 10.1128/JB.174.7.2288-2297.1992; PORTER RD, 2002, MODERN MICROBIAL GEN, P463; Rommens CM, 2005, PLANT PHYSIOL, V139, P1338, DOI 10.1104/pp.105.068692; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Smith N, 1998, TRENDS PLANT SCI, V3, P85, DOI 10.1016/S1360-1385(98)01206-0; TIMMERMAN B, 1988, J MOL BIOL, V203, P373, DOI 10.1016/0022-2836(88)90005-8; Ulker B, 2002, TRANSGENIC RES, V11, P311, DOI 10.1023/A:1015614220200; VANHAAREN MJJ, 1989, PLANT MOL BIOL, V13, P523, DOI 10.1007/BF00027312; WHITE FF, 1983, NATURE, V301, P348, DOI 10.1038/301348a0; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804	17	49	53	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2008	26	9					1015	1017		10.1038/nbt.1491	http://dx.doi.org/10.1038/nbt.1491			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	346NG	18758448	Green Published			2022-12-25	WOS:000259074700024
J	Liu, L; Cottrell, JW; Scott, LG; Fedor, MJ				Liu, Lu; Cottrell, Joseph W.; Scott, Lincoln G.; Fedor, Martha J.			Direct measurement of the ionization state of an essential guanine in the hairpin ribozyme	NATURE CHEMICAL BIOLOGY			English	Article							ION-BINDING-PROPERTIES; ACID-BASE CATALYSIS; ACTIVE-SITE; TRANSITION-STATE; METAL-IONS; RNA; MECHANISM; WATER; STABILIZATION; DYNAMICS	Active site guanines are critical for self-cleavage reactions of several ribozymes, but their precise functions in catalysis are unclear. To learn whether protonated or deprotonated forms of guanine predominate in the active site, microscopic pK(a) values were determined for ionization of 8-azaguanosine substituted for G8 in the active site of a fully functional hairpin ribozyme in order to determine microscopic pK(a) values for 8-azaguanine deprotonation from the pH dependence of fluorescence. Microscopic pK(a) values above 9 for deprotonation of 8-azaguanine in the active site were about 3 units higher than apparent pK(a) values determined from the pH dependence of self-cleavage kinetics. Thus, the increase in activity with increasing pH does not correlate with deprotonation of G8, and most of G8 is protonated at neutral pH. These results do not exclude a role in proton transfer, but a simple interpretation is that G8 functions in the protonated form, perhaps by donating hydrogen bonds.	[Liu, Lu; Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Dept Physiol Chem, Dept Mol Biol, La Jolla, CA 92037 USA; [Liu, Lu; Cottrell, Joseph W.; Fedor, Martha J.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Scott, Lincoln G.] Cassia LLC, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute	Fedor, MJ (corresponding author), Scripps Res Inst, Dept Physiol Chem, Dept Mol Biol, La Jolla, CA 92037 USA.	mfedor@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046422, R55GM046422] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM046422, R01 GM046422, R01 GM046422-16, R01 GM046422-17] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON P, 1994, NUCLEIC ACIDS RES, V22, P1096, DOI 10.1093/nar/22.6.1096; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Da Costa CP, 2007, J AM CHEM SOC, V129, P3426, DOI 10.1021/ja067699e; Da Costa CP, 2003, INORG CHEM, V42, P3475, DOI 10.1021/ic020672l; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; Fedor MJ, 1999, BIOCHEMISTRY-US, V38, P11040, DOI 10.1021/bi991069q; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Gong B, 2007, J AM CHEM SOC, V129, P13335, DOI 10.1021/Ja0743893; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Jencks W. P., 1969, CATALYSIS CHEM ENZYM, P163; Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868; JOSEPH S, 1993, GENE DEV, V7, P130, DOI 10.1101/gad.7.1.130; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Knobloch B, 2006, ORG BIOMOL CHEM, V4, P1085, DOI 10.1039/b517904a; Kuzmin YI, 2005, J MOL BIOL, V349, P989, DOI 10.1016/j.jmb.2005.04.005; Kuzmin YI, 2004, J MOL BIOL, V340, P233, DOI 10.1016/j.jmb.2004.04.067; Lebruska LL, 2002, CHEM BIOL, V9, P465, DOI 10.1016/S1074-5521(02)00130-8; Luptak A, 2001, J AM CHEM SOC, V123, P8447, DOI 10.1021/ja016091x; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nakano S, 2001, BIOCHEMISTRY-US, V40, P12022, DOI 10.1021/bi011253n; Nam K, 2008, RNA, V14, P1501, DOI 10.1261/rna.863108; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; Nesbitt SM, 1999, J MOL BIOL, V286, P1009, DOI 10.1006/jmbi.1999.2543; Park H, 2006, J CHEM THEORY COMPUT, V2, P858, DOI 10.1021/ct0503015; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; PUGLISI JD, 1990, BIOCHEMISTRY-US, V29, P4215, DOI 10.1021/bi00469a026; Ravindranathan S, 2000, BIOCHEMISTRY-US, V39, P16026, DOI 10.1021/bi001976r; Rhodes MM, 2006, P NATL ACAD SCI USA, V103, P13380, DOI 10.1073/pnas.0605090103; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Salter J, 2006, BIOCHEMISTRY-US, V45, P686, DOI 10.1021/bi051887k; Sigel H, 2005, CHEM SOC REV, V34, P875, DOI 10.1039/b505986k; Torelli AT, 2007, RNA, V13, P1052, DOI 10.1261/rna.510807; VANTOL H, 1990, NUCLEIC ACIDS RES, V18, P1971, DOI 10.1093/nar/18.8.1971; Virta P, 2005, ORG BIOMOL CHEM, V3, P2924, DOI 10.1039/b505508c; Walter NG, 2007, MOL CELL, V28, P923, DOI 10.1016/j.molcel.2007.12.001; Wierzchowski J, 1996, BBA-GEN SUBJECTS, V1290, P9, DOI 10.1016/0304-4165(95)00181-6; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	46	53	53	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2009	5	5					351	357		10.1038/nchembio.156	http://dx.doi.org/10.1038/nchembio.156			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	436PT	19330013	Green Accepted			2022-12-25	WOS:000265427000017
J	Kajiro, M; Hirota, R; Nakajima, Y; Kawanowa, K; So-Ma, K; Ito, I; Yamaguchi, Y; Ohie, S; Kobayashi, Y; Seino, Y; Kawano, M; Kawabe, Y; Takei, H; Hayashi, S; Kurosumi, M; Murayama, A; Kimura, K; Yanagisawa, J				Kajiro, Masashi; Hirota, Ryuichi; Nakajima, Yuka; Kawanowa, Kaori; So-ma, Kae; Ito, Ichiaki; Yamaguchi, Yuri; Ohie, Sho-hei; Kobayashi, Yasuhito; Seino, Yuko; Kawano, Miwako; Kawabe, Yoh-ichi; Takei, Hiroyuki; Hayashi, Shin-ichi; Kurosumi, Masafumi; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn			The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEAT-SHOCK PROTEINS; MEDIATED DEGRADATION; ESTROGEN-RECEPTOR; PROTEASOMAL DEGRADATION; SIGNALING PATHWAY; COACTIVATOR; CHAPERONE; BREAST; CANCER	CHIP is a U-box-type ubiquitin ligase that induces ubiquitylation and degradation of its substrates, which include several oncogenic proteins(1-12). The relationship between CHIP and tumour progression, however, has not been elucidated. Here, we show that CHIP suppresses tumour progression in human breast cancer by inhibiting oncogenic pathways. CHIP levels were negatively correlated with the malignancy of human breast tumour tissues. In a nude mouse xenograft model, tumour growth and metastasis were significantly inhibited by CHIP expression. In contrast, knockdown of CHIP (shCHIP) in breast cancer cells resulted in rapid tumour growth and metastastic phenotypes in mice. In cell-based experiments, anchorage-independent growth and invasiveness of shCHIP cells was significantly elevated due to increased expression of Bcl2, Akt1, Smad and Twist. Proteomic analysis identified the transcriptional co-activator SRC-3 (refs13-19) as a direct target for ubiquitylation and degradation by CHIP. Knocking down SRC-3 in shCHIP cells reduced the expression of Smad and Twist, and suppressed tumour metastasis in vivo. Conversely, SRC-3 co-expression prevented CHIP-induced suppression of metastasis formation. These observations demonstrate that CHIP inhibits anchorage-independent cell growth and metastatic potential by degrading oncogenic proteins including SRC-3.	[Kajiro, Masashi; Hirota, Ryuichi; Nakajima, Yuka; So-ma, Kae; Ito, Ichiaki; Ohie, Sho-hei; Kawano, Miwako; Kawabe, Yoh-ichi; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kawanowa, Kaori; Kobayashi, Yasuhito; Takei, Hiroyuki; Kurosumi, Masafumi] Saitama Canc Ctr, Dept Pathol, Ina, Saitama 3620806, Japan; [Yamaguchi, Yuri; Seino, Yuko] Saitama Canc Ctr, Res Inst Clin Oncol, Ina, Saitama 3620806, Japan; [Hayashi, Shin-ichi] Tohoku Univ, Sch Med, Course Hlth Sci, Dept Med Technol,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Murayama, Akiko; Yanagisawa, Junn] Univ Tsukuba, TARA, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; Tohoku University; University of Tsukuba	Yanagisawa, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	junny@agbi.tsukuba.ac.jp	Hirota, Ryuichi/Q-3138-2016	Hirota, Ryuichi/0000-0003-3959-5892	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a nuclear system to decipher operation code (DECODE) and Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Hudelist G, 2003, BREAST CANCER RES TR, V78, P193, DOI 10.1023/A:1022930710850; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	30	127	131	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					312	U190		10.1038/ncb1839	http://dx.doi.org/10.1038/ncb1839			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198599				2022-12-25	WOS:000263777900015
J	Gerzanich, V; Woo, SK; Vennekens, R; Tsymbalyuk, O; Ivanova, S; Ivanov, A; Geng, ZH; Chen, Z; Nilius, B; Flockerzi, V; Freichel, M; Simard, JM				Gerzanich, Volodymyr; Woo, S. Kyoon; Vennekens, Rudi; Tsymbalyuk, Orest; Ivanova, Svetlana; Ivanov, Alexander; Geng, Zhihua; Chen, Zheng; Nilius, Bernd; Flockerzi, Veit; Freichel, Marc; Simard, J. Marc			De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury	NATURE MEDICINE			English	Article							ANOXIC NEURONAL DEATH; CATION CHANNEL TRPM4; ENDOTHELIAL PERMEABILITY; VASCULAR MECHANISMS; CELL-ACTIVATION; ISCHEMIC-STROKE; MOUSE STRAINS; TRAUMA; RATS; HEMOGLOBIN	The role of transient receptor potential M4 (Trpm4), an unusual member of the Trp family of ion channels, is poorly understood. Using rodent models of spinal cord injury, we studied involvement of Trpm4 in the progressive expansion of secondary hemorrhage associated with capillary fragmentation, the most destructive mechanism of secondary injury in the central nervous system. Trpm4 mRNA and protein were abundantly upregulated in capillaries preceding their fragmentation and formation of petechial hemorrhages. Trpm4 expression in vitro rendered COS-7 cells highly susceptible to oncotic swelling and oncotic death following ATP depletion. After spinal cord injury, in vivo gene suppression in rats treated with Trpm4 antisense or in Trpm4(-/-) mice preserved capillary structural integrity, eliminated secondary hemorrhage, yielded a threefold to fivefold reduction in lesion volume and produced a substantial improvement in neurological function. To our knowledge, this is the first example of a Trp channel that must undergo de novo expression for manifestation of central nervous system pathology.	[Gerzanich, Volodymyr; Woo, S. Kyoon; Tsymbalyuk, Orest; Ivanova, Svetlana; Ivanov, Alexander; Geng, Zhihua; Chen, Zheng; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Vennekens, Rudi; Nilius, Bernd] Katholieke Univ Leuven, Dept Mol Celbiol, Div Physiol, Lab Channel Res, B-3000 Louvain, Belgium; [Flockerzi, Veit; Freichel, Marc] Univ Saarland, D-66421 Homburg, Germany; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; KU Leuven; Saarland University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu	Vennekens, Rudi/AAQ-1664-2020	Vennekens, Rudi/0000-0002-2564-5150	US National Heart, Lung, and Blood Institute [HL082517]; US National Institute of Neurological Disorders and Stroke [NS048260, NS061934]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048260, R01NS061934] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to J. M. S. from the US National Heart, Lung, and Blood Institute ( HL082517), the US National Institute of Neurological Disorders and Stroke ( NS048260), the US Department of Veterans Affairs and the Christopher and Dana Reeve Foundation; to V. G. from the US National Institute of Neurological Disorders and Stroke ( NS061934); and to M. F. and V. F. from the Deutsche Forschungsgemeinschaft. R. V. is supported by the FWO Vlaanderen. The mTrpm4-GFP plasmid was kindly provided by E. R. Liman ( University of Southern California).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; BALENTINE JD, 1978, LAB INVEST, V39, P236; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Colak A, 2003, J NEUROSURG, V98, P275, DOI 10.3171/spi.2003.98.3.0275; GRIFFITHS IR, 1978, ACTA NEUROPATHOL, V41, P33, DOI 10.1007/BF00689554; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Guth L, 1999, ANN NY ACAD SCI, V890, P366, DOI 10.1111/j.1749-6632.1999.tb08017.x; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1007/BF03206569; Hayes KC, 1997, J NEUROTRAUM, V14, P235, DOI 10.1089/neu.1997.14.235; IIZUKA H, 1987, J NEUROSURG, V66, P595, DOI 10.3171/jns.1987.66.4.0595; Kawata Kazuhiro, 1993, Neurological Surgery, V21, P45; KHAN M, 1985, CAN J NEUROL SCI, V12, P259, DOI 10.1017/S0317167100047120; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OSTERHOLM JL, 1984, NEUROSURGERY, V15, P373, DOI 10.1227/00006123-198409000-00013; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2007, BBA-MOL BASIS DIS, V1772, P947, DOI 10.1016/j.bbadis.2007.03.004; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R., 2007, V179, P269; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhao QY, 1998, ANTISENSE NUCLEIC A, V8, P451, DOI 10.1089/oli.1.1998.8.451	44	152	156	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2009	15	2					185	191		10.1038/nm.1899	http://dx.doi.org/10.1038/nm.1899			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	403ZB	19169264	Green Published, Green Accepted			2022-12-25	WOS:000263119400021
J	Luo, KT; Yuan, J; Chen, JJ; Lou, ZK				Luo, Kuntian; Yuan, Jian; Chen, Junjie; Lou, Zhenkun			Topoisomerase II alpha controls the decatenation checkpoint	NATURE CELL BIOLOGY			English	Article							CASEIN KINASE-II; DNA STRAND BREAKS; MAMMALIAN-CELLS; CYCLE CHECKPOINT; G(2) CHECKPOINT; BINDING DOMAIN; IN-VITRO; DAMAGE; PHOSPHORYLATION; INHIBITION	Topoisomerase II (Topo II) is required to separate intertwined sister chromatids before chromosome segregation can occur in mitosis(1). However, it remains to be resolved whether Topo II has any role in checkpoint control. Here we report that when phosphorylated, Ser 1524 of Topo II alpha acts as a binding site for the BRCT domain of MDC1 (mediator of DNA damage checkpoint protein-1), thereby recruiting MDC1 to chromatin. Although Topo II alpha-MDC1 interaction is not required for checkpoint activation induced by DNA damage, it is required for activation of the decatenation checkpoint. Mutation of Ser 1524 results in a defective decatenation checkpoint. These results reveal an important role of Topo II in checkpoint activation and in the maintenance of genomic stability.	[Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Luo, Kuntian; Yuan, Jian; Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA	Yale University; Mayo Clinic	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	Junjie.Chen@yale.edu; Lou.Zhenkun@mayo.edu	Yuan, Jian/B-1310-2012	Yuan, Jian/0000-0002-2801-8849	National Institutes of Health (NIH); Richard Schulze Family Foundation; Susan G. Komen Breast Cancer Foundation; NIH [CA130996]; Department of Defense,; Mayo Clinic Breast SPORE; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Schulze Family Foundation; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense,(United States Department of Defense); Mayo Clinic Breast SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants to J.C. from the National Institutes of Health (NIH). Z.L. was supported by grants from the Richard Schulze Family Foundation, Susan G. Komen Breast Cancer Foundation and NIH (CA130996). J.C. is a recipient of an Era of Hope Scholars award from the Department of Defense, and a member of the Mayo Clinic Breast SPORE program.	ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; Andrews CA, 2006, GENE DEV, V20, P1162, DOI 10.1101/gad.1367206; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; CLARKE DJ, 1993, J CELL SCI, V105, P563; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Doherty SC, 2003, J NATL CANCER I, V95, P1859, DOI 10.1093/jnci/djg120; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Franchitto A, 2003, CANCER RES, V63, P3289; Gimenez-Abian JF, 2000, CHROMOSOMA, V109, P235, DOI 10.1007/s004120000065; Hajji N, 2003, MUTAT RES-FUND MOL M, V530, P35, DOI 10.1016/S0027-5107(03)00135-0; HOLM C, 1994, CELL, V77, P955, DOI 10.1016/0092-8674(94)90433-2; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Kimura K, 1996, J BIOL CHEM, V271, P10990, DOI 10.1074/jbc.271.18.10990; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Park I, 2006, EXP CELL RES, V312, P1996, DOI 10.1016/j.yexcr.2006.02.029; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Redwood C, 1998, J BIOL CHEM, V273, P3635, DOI 10.1074/jbc.273.6.3635; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Wessel I, 1999, CANCER RES, V59, P3442; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	30	75	78	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					204	U196		10.1038/ncb1828	http://dx.doi.org/10.1038/ncb1828			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098900	Green Accepted			2022-12-25	WOS:000263285500019
J	Mason, MG; Shepherd, M; Nicholls, P; Dobbin, PS; Dodsworth, KS; Poole, RK; Cooper, CE				Mason, Maria G.; Shepherd, Mark; Nicholls, Peter; Dobbin, Paul S.; Dodsworth, Kathryn S.; Poole, Robert K.; Cooper, Chris E.			Cytochrome bd confers nitric oxide resistance to Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							RESPIRATORY-CHAIN; TERMINAL OXIDASES; C-OXIDASE; OXYGEN; BINDING; FLAVOHEMOGLOBIN; DISSOCIATION; INHIBITION; REDUCTASE; HEME	The aerobic respiratory chain of Escherichia coli has two terminal quinol oxidases: cytochrome bo and cytochrome bd. Cytochrome bd was thought to function solely to facilitate micro-aerobic respiration. However, it has recently been shown to be overexpressed under conditions of nitric oxide (NO) stress; we show here that cytochrome bd is crucial for protecting E. coli cells from NO-induced growth inhibition by virtue of its fast NO dissociation rate.	[Mason, Maria G.; Nicholls, Peter; Dobbin, Paul S.; Cooper, Chris E.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Shepherd, Mark; Dodsworth, Kathryn S.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Firth Court, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Essex; University of Sheffield	Mason, MG (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	mgmaso@essex.ac.uk	Cooper, Chris/AAK-9729-2020	Cooper, Chris/0000-0003-0381-3990; Shepherd, Mark/0000-0002-7472-2300	Wellcome Trust [069769]; Biotechnology and Biological Sciences Research Council [BB/D017858/1]; BBSRC [BB/D017858/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Wellcome Trust (069769) and the Biotechnology and Biological Sciences Research Council (BB/D017858/1) for financial support.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; BLACKMORE RS, 1991, J BIOL CHEM, V266, P19245; Borisov VB, 2004, FEBS LETT, V576, P201, DOI 10.1016/j.febslet.2004.09.013; Borisov VB, 2007, BIOCHEM BIOPH RES CO, V355, P97, DOI 10.1016/j.bbrc.2007.01.118; CALHOUN MW, 1993, J BACTERIOL, V175, P3020, DOI 10.1128/JB.175.10.3020-3025.1993; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Cooper CE, 2003, BBA-BIOENERGETICS, V1607, P27, DOI 10.1016/j.bbabio.2003.08.003; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; GENNIS RB, 1996, RESPIRATION, V1, P217; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; JUNEMANN S, 1995, J BIOL CHEM, V270, P16213, DOI 10.1074/jbc.270.27.16213; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; RICE CW, 1978, J BACTERIOL, V134, P115, DOI 10.1128/JB.134.1.115-124.1978; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; ROTHERY RA, 1989, BIOCHEM J, V261, P437, DOI 10.1042/bj2610437; Sarti P, 2000, BIOCHEM BIOPH RES CO, V274, P183, DOI 10.1006/bbrc.2000.3117; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Verkhovsky MI, 1996, NATURE, V380, P268, DOI 10.1038/380268a0; Yu H, 1997, FEBS LETT, V409, P161, DOI 10.1016/S0014-5793(97)00494-8	25	126	131	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2009	5	2					94	96		10.1038/nchembio.135	http://dx.doi.org/10.1038/nchembio.135			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	403OA	19109594				2022-12-25	WOS:000263090700012
J	Pohl, C; Jentsch, S				Pohl, Christian; Jentsch, Stefan			Midbody ring disposal by autophagy is a post-abscission event of cytokinesis	NATURE CELL BIOLOGY			English	Article							PROTEIN-DEGRADATION; CENTRAL SPINDLE; MACROAUTOPHAGY; TUMORIGENESIS; MITOCHONDRIA; INHIBITION; MECHANISMS; INDUCTION; DEATH; BCL-2	At the end of cytokinesis, the dividing cells are connected by an intercellular bridge, containing the midbody along with a single, densely ubiquitylated, circular structure called the midbody ring (Mr)(1-3). recent studies revealed that the Mr serves as a target site for membrane delivery and as a physical barrier between the prospective daughter cells(2,3). the Mr materializes in telophase, localizes to the intercellular bridge during cytokinesis, and moves asymmetrically into one cell after abscission(2,3). Daughter cells rarely accumulate MRs of previous divisions(2,3), but how these large structures finally disappear remains unknown. Here, we show that MRs are discarded by autophagy, which involves their sequestration into autophagosomes and delivery to lysosomes for degradation. Notably, autophagy factors, such as the ubiquitin adaptor p62 (refs 4, 5) and the ubiquitin-related protein Atg8 (ref. 6), associate with the Mr during abscission, suggesting that autophagy is coupled to cytokinesis. Moreover, MRs accumulate in cells of patients with lysosomal storage disorders, indicating that defective Mr disposal is characteristic of these diseases. thus our findings suggest that autophagy has a broader role than previously assumed, and that cell renovation by clearing from superfluous large macromolecular assemblies, such as MRs, is an important autophagic function.	[Pohl, Christian; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Pohl, Christian/D-4700-2011		Max Planck Society; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	Max Planck Society(Max Planck Society); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	We thank Masaaki Komatsu and Keiji Tanaka for providing Atg7 knockout MEFs and controls, the Bryan Tsou laboratory and Tim Ammon for technical support and help, and Alex Buchberger for comments on the manuscript. S. J. is supported by the Max Planck Society, Center for Integrated Protein Science Munich, and RUBICON EU Network of Excellence.	Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hein LK, 2004, J MOL BIOL, V338, P453, DOI 10.1016/j.jmb.2004.03.012; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mach L, 2002, BIOL CHEM, V383, P751, DOI 10.1515/BC.2002.078; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Mukai A, 2008, J CELL SCI, V121, P1325, DOI 10.1242/jcs.027417; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681	27	145	150	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					65	U122		10.1038/ncb1813	http://dx.doi.org/10.1038/ncb1813			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079246				2022-12-25	WOS:000262157000012
J	Tooley, AJ; Gilden, J; Jacobelli, J; Beemiller, P; Trimble, WS; Kinoshita, M; Krummel, MF				Tooley, Aaron J.; Gilden, Julia; Jacobelli, Jordan; Beemiller, Peter; Trimble, William S.; Kinoshita, Makoto; Krummel, Matthew F.			Amoeboid T lymphocytes require the septin cytoskeleton for cortical integrity and persistent motility	NATURE CELL BIOLOGY			English	Article							MAMMALIAN SEPTINS; GENE FAMILY; FILAMENT FORMATION; CELL MOTILITY; ACTIN; YEAST; COMPARTMENTALIZATION; POLARIZATION; MICROTUBULES; EXPRESSION	The systems that refine actomyosin forces during motility remain poorly understood. Septins assemble on the T-cell cortex and are enriched at the mid-zone in filaments. Septin knockdown causes membrane blebbing, excess leading-edge protrusions and lengthening of the trailing-edge uropod. The associated loss of rigidity permits motility, but cells become uncoordinated and poorly persistent. This also relieves a previously unrecognized restriction to migration through small pores. Pharmacologically rigidifying cells counteracts this effect, and relieving cytoskeletal rigidity synergizes with septin depletion. These data suggest that septins tune actomyosin forces during motility and probably regulate lymphocyte trafficking in confined tissues.	[Tooley, Aaron J.; Gilden, Julia; Jacobelli, Jordan; Beemiller, Peter; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Kinoshita, Makoto] Kyoto Univ, Grad Sch Med, HMRO, Biochem & Cell Biol Unit,Sakyo Ku, Kyoto 6068501, Japan	University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Kyoto University	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu		KINOSHITA, MAKOTO/0000-0002-7592-2400; Beemiller, Peter/0000-0002-2736-3405	NIH [R21-AI062899]; Sandler family fund; National Science Foundation; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116, R21AI062899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler family fund; National Science Foundation(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Weiss and M. T. McManus for insight and critical discussions, ShuWei Jiang and Cliff McArthur for expert technical assistance with cell sorting and Christine Lin and Ed Shimazu for computer support. We also thank Cynthia Voong for critical reading of the manuscript and members of the Krummel lab for thoughtful discussions. This work was supported by the NIH(R21-AI062899), the Sandler family fund, the National Science Foundation and the Leukemia and Lymphoma Society.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Field CM, 2005, DEVELOPMENT, V132, P2849, DOI 10.1242/dev.01843; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Montagna C, 2003, CANCER RES, V63, P2179; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; NOTTENBURG C, 1990, GENE, V95, P279, DOI 10.1016/0378-1119(90)90372-X; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ratner S, 1997, J IMMUNOL, V159, P1063; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Russell SEH, 2005, BRIT J CANCER, V93, P499, DOI 10.1038/sj.bjc.6602753; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Sorensen AB, 2000, J VIROL, V74, P2161, DOI 10.1128/JVI.74.5.2161-2168.2000; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tooley AJ, 2005, SEMIN IMMUNOL, V17, P65, DOI 10.1016/j.smim.2004.09.006; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350	38	125	128	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					17	U37		10.1038/ncb1808	http://dx.doi.org/10.1038/ncb1808			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19043408	Green Accepted			2022-12-25	WOS:000262157000007
J	Aulchenko, YS; Hoppenbrouwers, IA; Ramagopalan, SV; Broer, L; Jafari, N; Hillert, J; Link, J; Lundstrom, W; Greiner, E; Sadovnick, AD; Goossens, D; Van Broeckhoven, C; Del-Favero, J; Ebers, GC; Oostra, BA; van Duijn, CM; Hintzen, RQ				Aulchenko, Yurii S.; Hoppenbrouwers, Ilse A.; Ramagopalan, Sreeram V.; Broer, Linda; Jafari, Naghmeh; Hillert, Jan; Link, Jenny; Lundstrom, Wangko; Greiner, Eva; Sadovnick, A. Dessa; Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen; Ebers, George C.; Oostra, Ben A.; van Duijn, Cornelia M.; Hintzen, Rogier Q.			Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; RISK; DYSFUNCTION; MUTATION	The few loci associated with multiple sclerosis (MS) are all related to immune function. We report a GWA study identifying a new locus replicated in 2,679 cases and 3,125 controls. An rs10492972[C] variant located in the KIF1B gene was associated with MS with an odds ratio of 1.35 (P = 2.5 x 10(-10)). KIF1B is a neuronally expressed gene plausibly implicated in the irreversible axonal loss characterizing MS in the long term.	[Hoppenbrouwers, Ilse A.; Broer, Linda; Jafari, Naghmeh; Hintzen, Rogier Q.] Erasmus MC, MS Ctr ErasMS, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Aulchenko, Yurii S.; Broer, Linda; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol & Biostat & Clin Genet, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [Ramagopalan, Sreeram V.; Ebers, George C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 9DU, England; [Ramagopalan, Sreeram V.; Ebers, George C.] Univ Oxford, Dept Clin Neurol, Oxford OX3 9DU, England; [Hillert, Jan; Link, Jenny; Lundstrom, Wangko; Greiner, Eva] Karolinska Inst, Dept Neurol, SE-14186 Stockholm, Sweden; [Sadovnick, A. Dessa] Univ British Columbia, Dept Med Genet, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] VIB, Dept Mol Genet, Appl Mol Genom Grp, B-2610 Antwerp, Belgium; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] Univ Antwerp, B-2610 Antwerp, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Karolinska Institutet; University of British Columbia; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); University of Antwerp	Hintzen, RQ (corresponding author), Erasmus MC, MS Ctr ErasMS, Dept Neurol, NL-3000 CA Rotterdam, Netherlands.	rhintzen@xs4all.nl	Van Broeckhoven, Christine/M-7853-2019; Aulchenko, Yurii/M-8270-2013; Van Broeckhoven, Christine/G-8362-2017; Link, Jenny/J-1629-2012	Van Broeckhoven, Christine/0000-0003-0183-7665; Aulchenko, Yurii/0000-0002-7899-1575; Van Broeckhoven, Christine/0000-0003-0183-7665; Goossens, Dirk/0000-0002-2080-7464; Link, Jenny/0000-0002-6134-9404; Ebers, George/0000-0003-4771-4177; Del Favero, jurgen/0000-0002-7427-7489; Van Duijn, Cornelia/0000-0002-2374-9204; Broer, Linda/0000-0003-0011-123X	MS Research Netherlands; Erasmus University Trust Fund; Netherlands Organisation for Scientific Research; Erasmus MC; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; Centre for Medical Systems Biology (CMSB); Bibbi and Nils Jensen Foundation; Swedish Research Council; EU [LSHM-CT-2005-018637]	MS Research Netherlands(Netherlands Government); Erasmus University Trust Fund; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Erasmus MC; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; Centre for Medical Systems Biology (CMSB); Bibbi and Nils Jensen Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission)	This study was supported by grants from MS Research Netherlands (R. Q. H. and C. M. v. D.), the Erasmus University Trust Fund, The Netherlands Organisation for Scientific Research (ZON-MW, R.Q.H.), the Erasmus MC and the Multiple Sclerosis Society of Canada Scientific Research Foundation and the Multiple Sclerosis Society of the United Kingdom (S.V.R., G.C.E.). The GRIP study is supported by Centre for Medical Systems Biology (CMSB). The Stockholm part of the study was supported by the Bibbi and Nils Jensen Foundation, by the Swedish Research Council and by the EU project no. LSHM-CT-2005-018637, NeuroproMiSe. We are grateful to all participants and their relatives; general practitioners and neurologists for their contributions; P. Veraart for her help in genealogy; D. Lont and the personnel of the VIB Genetic Service Facility for genotyping; and P. Snijders for his help in data collection.	Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Hoppenbrouwers IA, 2007, MULT SCLER, V13, P17, DOI 10.1177/1352458506071216; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Waxman SG, 2008, ANN NEUROL, V63, P411, DOI 10.1002/ana.21361; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	15	138	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1402	1403		10.1038/ng.251	http://dx.doi.org/10.1038/ng.251			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997785				2022-12-25	WOS:000261215900013
J	Melzer, S; Lens, F; Gennen, J; Vanneste, S; Rohde, A; Beeckman, T				Melzer, Siegbert; Lens, Frederic; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom			Flowering-time genes modulate meristem determinacy and growth form in Arabidopsis thaliana	NATURE GENETICS			English	Article							FLORAL INDUCTION; FT; ACTIVATION; TRANSITION; EXPRESSION; MORPHOLOGY; FRUITFULL; EVOLUTION; PATHWAYS; SIGNALS	Plants have evolved annual and perennial life forms as alternative strategies to adapt reproduction and survival to environmental constraints. In isolated situations, such as islands, woody perennials have evolved repeatedly from annual ancestors(1). Although the molecular basis of the rapid evolution of insular woodiness is unknown, the molecular difference between perennials and annuals might be rather small, and a change between these life strategies might not require major genetic innovations(2,3). Developmental regulators can strongly affect evolutionary variation(4) and genes involved in meristem transitions are good candidates for a switch in growth habit. We found that the MADS box proteins SUPPRESSOR OF OVEREXPRESSION OF CONSTANS 1 ( SOC1) and FRUITFULL (FUL) not only control flowering time, but also affect determinacy of all meristems. In addition, downregulation of both proteins established phenotypes common to the lifestyle of perennial plants, suggesting their involvement in the prevention of secondary growth and longevity in annual life forms.	[Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Lens, Frederic] Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Plant Syst, B-3001 Louvain, Belgium; [Lens, Frederic] Nat Herbarium Netherlands, Leiden Univ Branch, NL-2300 RA Leiden, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; Leiden University; Leiden University - Excl LUMC	Melzer, S (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	siegbert.melzer@psb.ugent.be	Rohde, Antje/AFO-6894-2022; Lens, Frederic/B-8482-2011; Vanneste, Steffen/K-8353-2013; Beeckman, Tom/ABA-1164-2020; Beeckman, Tom/ABI-1703-2020	Lens, Frederic/0000-0002-5001-0149; Vanneste, Steffen/0000-0002-9948-9672; Beeckman, Tom/0000-0001-8656-2060; Rohde, Antje/0000-0002-1574-1843; Melzer, Siegbert/0000-0003-4008-4782	Technology in Flanders; Research Foundation-Flanders (FWO)	Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders (FWO)(FWO)	We appreciate the continuous support of K. Apel, D. Inze and E. Smets. We thank J. Chandler and M. De Cock for critical reading of the manuscript. S. V. is indebted to the Institute for the Promotion of Innovation through Science and Technology in Flanders for a predoctoral fellowship. F. L. and A. R. are postdoctoral fellows of the Research Foundation-Flanders (FWO). Seeds of 35S:FT plants were provided by P. Wigge (John Innes Centre), seeds of the soc1-1 allele were provided by G. Coupland (Max Planck Institute for Plant Breeding Research) and seeds of soc1-2 in Col and Ler backgrounds by I. Lee (University of Seoul).	Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cronk QCB, 2001, NAT REV GENET, V2, P607, DOI 10.1038/35084556; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Poduska B, 2003, GENETICS, V163, P1457; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Sibout R, 2008, CURR BIOL, V18, P458, DOI 10.1016/j.cub.2008.02.070; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Thomas H, 2000, J EXP BOT, V51, P1781, DOI 10.1093/jexbot/51.352.1781; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	28	290	320	7	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1489	1492		10.1038/ng.253	http://dx.doi.org/10.1038/ng.253			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997783	Green Published, Green Submitted			2022-12-25	WOS:000261215900028
J	Varela-Rohena, A; Molloy, PE; Dunn, SM; Li, Y; Suhoski, MM; Carroll, RG; Milicic, A; Mahon, T; Sutton, DH; Laugel, B; Moysey, R; Cameron, BJ; Vuidepot, A; Purbhoo, MA; Cole, DK; Phillips, RE; June, CH; Jakobsen, BK; Sewell, AK; Riley, JL				Varela-Rohena, Angel; Molloy, Peter E.; Dunn, Steven M.; Li, Yi; Suhoski, Megan M.; Carroll, Richard G.; Milicic, Anita; Mahon, Tara; Sutton, Deborah H.; Laugel, Bruno; Moysey, Ruth; Cameron, Brian J.; Vuidepot, Annelise; Purbhoo, Marco A.; Cole, David K.; Phillips, Rodney E.; June, Carl H.; Jakobsen, Bent K.; Sewell, Andrew K.; Riley, James L.			Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LYMPHOCYTE RESPONSES; INFECTION; EPITOPE; TYPE-1; GAG; IMMUNODOMINANT; EVOLUTION; REVERSION; MUTATION	HIV's considerable capacity to vary its HLA-I-restricted peptide antigens allows it to escape from host cytotoxic T lymphocytes (CTLs). Nevertheless, therapeutics able to target HLA-I-associated antigens, with specificity for the spectrum of preferred CTL escape mutants, could prove effective. Here we use phage display to isolate and enhance a T-cell antigen receptor (TCR) originating from a CTL line derived from an infected person and specific for the immunodominant HLA-A*02-restricted, HIVgag-specific peptide SLYNTVATL (SL9). High-affinity (K-D < 400 pM) TCRs were produced that bound with a half-life in excess of 2.5 h, retained specificity, targeted HIV-infected cells and recognized all common escape variants of this epitope. CD8 T cells transduced with this supraphysiologic TCR produced a greater range of soluble factors and more interleukin-2 than those transduced with natural SL9-specific TCR, and they effectively controlled wild-type and mutant strains of HIV at effector-to-target ratios that could be achieved by T-cell therapy.	[Jakobsen, Bent K.] Adaptimmune Ltd, Abingdon OX14 4RX, Oxon, England; [Varela-Rohena, Angel; Suhoski, Megan M.; Carroll, Richard G.; June, Carl H.; Riley, James L.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Varela-Rohena, Angel; Suhoski, Megan M.; Carroll, Richard G.; June, Carl H.; Riley, James L.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Molloy, Peter E.; Dunn, Steven M.; Li, Yi; Mahon, Tara; Sutton, Deborah H.; Moysey, Ruth; Cameron, Brian J.; Vuidepot, Annelise; Purbhoo, Marco A.] Immunocore Ltd, Abingdon OX14 4RX, Oxon, England; [Milicic, Anita; Laugel, Bruno; Phillips, Rodney E.; Sewell, Andrew K.] Univ Oxford, Oxford OX1 3SY, England; [Cole, David K.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Oxford; Cardiff University	Jakobsen, BK (corresponding author), Adaptimmune Ltd, 57C Milton Pk, Abingdon OX14 4RX, Oxon, England.	bent.jakobsen@adaptimmune.com; rileyj@exchange.upenn.edu	Cole, David/C-8387-2012; Milicic, Anita/B-7693-2011; Sewell, Andrew/GPT-4220-2022	Milicic, Anita/0000-0002-7984-1317; Sewell, Andrew/0000-0003-3194-3135; Cole, David/0000-0003-0028-9396; Riley, James/0000-0002-1057-576X; June, Carl/0000-0003-0241-3557; Molloy, Peter/0000-0002-0238-4744	Wellcome Trust Senior Fellow; Cardiff University; US National Institutes of Health [R21 AI060477, R01 CA105216, PO1 AI066290]; NATIONAL CANCER INSTITUTE [R01CA105216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060477, U19AI082628, U19AI066290] Funding Source: NIH RePORTER	Wellcome Trust Senior Fellow(Wellcome Trust); Cardiff University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to R. Ashfield, B. Classon and R. Vonderheide for their help in initiating collaborations. We thank P. Goulder, A. Leslie and T. Scriba for encouragement, critical reading of the manuscript and helpful suggestions. A. Bennett designed the TCR expression constructs. M. Milone confirmed the SL9 sequence of 92BR-017, 92BR-018 and 92BR-028. A. K. S. was a Wellcome Trust Senior Fellow and is funded by Cardiff University. This work was also supported in part by US National Institutes of Health grants R21 AI060477, R01 CA105216 and PO1 AI066290. The authors would like to dedicate this study to the memory of our colleague and friend Jonathan Michael Boulter, who contributed immensely in the field of soluble T cell receptors.	Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Darden JM, 2000, CYTOMETRY, V40, P141, DOI 10.1002/(SICI)1097-0320(20000601)40:2<141::AID-CYTO8>3.3.CO;2-6; Edwards CTT, 2005, J VIROL, V79, P9363, DOI 10.1128/JVI.79.14.9363-9366.2005; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; Holler PD, 2001, J EXP MED, V194, P1043, DOI 10.1084/jem.194.8.1043; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Kan-Mitchell J, 2006, J IMMUNOL, V176, P6690, DOI 10.4049/jimmunol.176.11.6690; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Martinez-Hackert E, 2006, J BIOL CHEM, V281, P20205, DOI 10.1074/jbc.M601934200; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Molloy PE, 2005, CURR OPIN PHARMACOL, V5, P438, DOI 10.1016/j.coph.2005.02.004; Morikawa Y, 1998, J VIROL, V72, P7659, DOI 10.1128/JVI.72.9.7659-7663.1998; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1998, J MOL MED-JMM, V76, P699, DOI 10.1007/s001090050270; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Sewell AK, 1997, EUR J IMMUNOL, V27, P2323, DOI 10.1002/eji.1830270929; Sewell AK, 2000, STEM CELLS, V18, P230, DOI 10.1634/stemcells.18-4-230; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Whelan JA, 1999, J IMMUNOL, V163, P4342; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	30	196	248	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1390	1395		10.1038/nm.1779	http://dx.doi.org/10.1038/nm.1779			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	18997777	Green Accepted			2022-12-25	WOS:000261393600026
J	Butelli, E; Titta, L; Giorgio, M; Mock, HP; Matros, A; Peterek, S; Schijlen, EGWM; Hall, RD; Bovy, AG; Luo, J; Martin, C				Butelli, Eugenio; Titta, Lucilla; Giorgio, Marco; Mock, Hans-Peter; Matros, Andrea; Peterek, Silke; Schijlen, Elio G. W. M.; Hall, Robert D.; Bovy, Arnaud G.; Luo, Jie; Martin, Cathie			Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors	NATURE BIOTECHNOLOGY			English	Article							ANTIOXIDANT CAPACITY; PIGMENTATION; GENE; CYANIDIN; BIOSYNTHESIS; ISCHEMIA; HEART; P53	Dietary consumption of anthocyanins, a class of pigments produced by higher plants, has been associated with protection against a broad range of human diseases. However, anthocyanin levels in the most commonly eaten fruits and vegetables may be inadequate to confer optimal benefits. When we expressed two transcription factors from snapdragon in tomato, the fruit of the plants accumulated anthocyanins at levels substantially higher than previously reported for efforts to engineer anthocyanin accumulation in tomato and at concentrations comparable to the anthocyanin levels found in blackberries and blueberries. Expression of the two transgenes enhanced the hydrophilic antioxidant capacity of tomato fruit threefold and resulted in fruit with intense purple coloration in both peel and flesh. In a pilot test, cancer-susceptible Trp53(-/-) mice fed a diet supplemented with the high-anthocyanin tomatoes showed a significant extension of life span.	[Butelli, Eugenio; Luo, Jie; Martin, Cathie] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Titta, Lucilla; Giorgio, Marco] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Mock, Hans-Peter; Matros, Andrea; Peterek, Silke] Leibniz Inst Plant Genet & Crop Plant Res, D-06466 Gatersleben, Germany; [Schijlen, Elio G. W. M.; Bovy, Arnaud G.] Plant Res Int, Business Unit Biosci, NL-6700 AA Wageningen, Netherlands; [Hall, Robert D.] Ctr BioSyst Genom, NL-6700 AB Wageningen, Netherlands	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; IRCCS European Institute of Oncology (IEO); Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Centre for BioSystems Genomics	Martin, C (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	cathie.martin@bbsrc.ac.uk	Titta, Lucilla/AAQ-4928-2020; HALL, ROBERT D/B-8707-2015; Giorgio, Marco/I-9425-2012; Mock, Hans-Peter/C-8202-2019	HALL, ROBERT D/0000-0002-5786-768X; Giorgio, Marco/0000-0002-5842-6042; Mock, Hans-Peter/0000-0002-3983-3099; Matros, Andrea/0000-0002-4399-6149; Bovy, Arnaud/0000-0003-2643-7377	EU FP5 PROFOOD [QLK1-CT-2001-01080]; EU FP6 FLORA [FOOD-CT-01730]; Biological and Biotechnological Science Research Council (BBSRC)	EU FP5 PROFOOD(European Commission); EU FP6 FLORA(European Commission); Biological and Biotechnological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Andrew Davis for photography and David Hopwood for comments on the manuscript. This work was supported by the EU FP5 PROFOOD project (QLK1-CT-2001-01080) awarded to A.G.B., R.D.H., H.-P.M. and C.M.; by the EU FP6 FLORA project (FOOD-CT-01730) awarded to H.-P.M., R.D.H., M. G. and C. M.; by the Centre for Biosystems Genomics as part of the Netherlands Genomic Initiative which supports A.G.B. and R.D.H.; and by the core strategic grant of the Biological and Biotechnological Science Research Council (BBSRC) to JIC, which supports C.M.	BATE NJ, 1994, P NATL ACAD SCI USA, V91, P7608, DOI 10.1073/pnas.91.16.7608; Bovy A, 2002, PLANT CELL, V14, P2509, DOI 10.1105/tpc.004218; Broun P, 2001, P NATL ACAD SCI USA, V98, P8925, DOI 10.1073/pnas.171310598; Chun OK, 2003, J AGR FOOD CHEM, V51, P8067, DOI 10.1021/jf034740d; Davuluri GR, 2005, NAT BIOTECHNOL, V23, P890, DOI 10.1038/nbt1108; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DOONER HK, 1983, MOL GEN GENET, V67, P345; GOODRICH J, 1992, CELL, V68, P955, DOI 10.1016/0092-8674(92)90038-E; Hou DX, 2004, J BIOMED BIOTECHNOL, P321, DOI 10.1155/S1110724304403040; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Joseph JA, 1999, J NEUROSCI, V19, P8114; Kneissl ML, 1996, PLANT PHYSIOL, V112, P537, DOI 10.1104/pp.112.2.537; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Martin C, 1996, CURR OPIN BIOTECH, V7, P130, DOI 10.1016/S0958-1669(96)80002-4; MARTIN PJ, 1991, JOINING SCI, V1, P49; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; Meiers S, 2001, J AGR FOOD CHEM, V49, P958, DOI 10.1021/jf0009100; MOONEY M, 1995, PLANT J, V7, P333, DOI 10.1046/j.1365-313X.1995.7020333.x; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; Prior RL, 2003, AM J CLIN NUTR, V78, p570S, DOI 10.1093/ajcn/78.3.570S; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sapir M, 2008, J HERED, V99, P292, DOI 10.1093/jhered/esm128; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778; Shin WH, 2006, LIFE SCI, V79, P130, DOI 10.1016/j.lfs.2005.12.033; Toufektsian MC, 2008, J NUTR, V138, P747, DOI 10.1093/jn/138.4.747; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Tsuda T, 2008, J AGR FOOD CHEM, V56, P642, DOI 10.1021/jf073113b; Wightman JD, 2004, ACS SYM SER, V871, P123; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Yeum KJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P97, DOI 10.1016/j.abb.2004.03.006	34	802	860	16	438	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2008	26	11					1301	1308		10.1038/nbt.1506	http://dx.doi.org/10.1038/nbt.1506			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	371LG	18953354				2022-12-25	WOS:000260832200026
J	Sun, J; Zheng, SL; Wiklund, F; Isaacs, SD; Purcell, LD; Gao, Z; Hsu, FC; Kim, ST; Liu, W; Zhu, Y; Stattin, P; Adami, HO; Wiley, KE; Dimitrov, L; Sun, J; Li, T; Turner, AR; Adams, TS; Adolfsson, J; Johansson, JE; Lowey, J; Trock, BJ; Partin, AW; Walsh, PC; Trent, JM; Duggan, D; Carpten, J; Chang, BL; Gronberg, H; Isaacs, WB; Xu, JF				Sun, Jielin; Zheng, Siqun Lilly; Wiklund, Fredrik; Isaacs, Sarah D.; Purcell, Lina D.; Gao, Zhengrong; Hsu, Fang-Chi; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Stattin, Paer; Adami, Hans-Olov; Wiley, Kathleen E.; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Adolfsson, Jan; Johansson, Jan-Erik; Lowey, James; Trock, Bruce J.; Partin, Alan W.; Walsh, Patrick C.; Trent, Jeffrey M.; Duggan, David; Carpten, John; Chang, Bao-Li; Gronberg, Henrik; Isaacs, William B.; Xu, Jianfeng			Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; 8Q24; AMERICANS	We carried out a fine-mapping study in the HNF1B gene at 17q12 in two study populations and identified a second locus associated with prostate cancer risk, similar to 26 kb centromeric to the first known locus (rs4430796); these loci are separated by a recombination hot spot. We confirmed the association with a SNP in the second locus (rs11649743) in five additional populations, with P = 1.7 x 10(-9) for an allelic test of the seven studies combined. The association at each SNP remained significant after adjustment for the other SNP.	[Wiklund, Fredrik; Adami, Hans-Olov; Gronberg, Henrik] Karolinska Inst, CLINTEC, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Sun, Jielin; Zheng, Siqun Lilly; Purcell, Lina D.; Gao, Zhengrong; Hsu, Fang-Chi; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC 27157 USA; [Sun, Jielin; Zheng, Siqun Lilly; Purcell, Lina D.; Gao, Zhengrong; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Isaacs, Sarah D.; Wiley, Kathleen E.; Trock, Bruce J.; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA; [Hsu, Fang-Chi] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Stattin, Paer] Umea Univ Hosp, Dept Surg & Perioperat Sci, SE-90787 Umea, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Adolfsson, Jan] Karolinska Inst, CLINTEC, Ctr Oncol, SE-17177 Stockholm, Sweden; [Johansson, Jan-Erik] Orebro Univ Hosp, Dept Urol, SE-70182 Orebro, Sweden; [Lowey, James; Trent, Jeffrey M.; Duggan, David; Carpten, John] Translat Genom Res Inst, Phoenix, AZ 85004 USA	Karolinska Institutet; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Orebro University; Translational Genomics Research Institute	Gronberg, H (corresponding author), Karolinska Inst, CLINTEC, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	henrik.gronberg@ki.se; wisaacs@jhmi.edu	LI, TAO/AAL-5932-2020; Kim, Seong-Tae/E-4474-2017	LI, TAO/0000-0001-7343-9688; Kim, Seong-Tae/0000-0001-7436-1405; Adolfsson, Jan/0000-0003-2992-1869	National Cancer Institute [CA106523, CA95052, CA112517, CA58236, CA86323]; Department of Defense [PC051264]; Swedish Cancer Society (Cancerfonden); Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA112517, R01CA095052, U01CA086323, P50CA058236, R01CA106523] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the study subjects who participated in this study. We also thank the Regional Cancer Registries and the CAPS-steering committee, including E. Varenhorst. We acknowledge the support of W. T. Gerrard, M. Duhon, Jennifer and John Chalsty and D. Koch. We also thank the National Cancer Institute Cancer Genetic Markers of Susceptibility Initiative (CGEMS) for making the data available publicly. We take full responsibility for the study design, data collection, analysis and interpretation of the data, the decision to submit the manuscript for publication, and the writing of the manuscript. The study is supported by National Cancer Institute (CA106523, CA106523 and CA95052 to J.X., CA112517, CA58236 to W.B.I., CA86323 to A.W.P., Department of Defense grant PC051264 to J. X.), as well as support from Swedish Cancer Society (Cancerfonden) and Swedish Research Council to H. G.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Sun JL, 2008, PROSTATE, V68, P691, DOI 10.1002/pros.20754; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	15	134	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1153	1155		10.1038/ng.214	http://dx.doi.org/10.1038/ng.214			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758462	Green Accepted			2022-12-25	WOS:000259651000011
J	Jiang, HL; Wu, JR; Zhang, LH; Liang, WP; Gao, FX; Du, CP; Feng, XL; Chen, YJ				Jiang, Hualiang; Wu, Jiarui; Zhang, Lihe; Liang, Wenping; Gao, Feixue; Du, Canping; Feng, Xuelian; Chen, Yongjun			Chemical biology in China takes on signal transduction	NATURE CHEMICAL BIOLOGY			English	Editorial Material							ACUTE PROMYELOCYTIC LEUKEMIA; CONFORMATIONAL TRANSITION; ACTIVATION; EXPRESSION; RECEPTORS; MEDICINE; SURVIVAL; PEPTIDE; CELLS; DRUG	Funding support for chemical biology is essential for its growth around the world. A new funding initiative from the National Natural Science Foundation of China provides a model of a targeted funding program in the area of signal transduction.	[Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Wu, Jiarui] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zhang, Lihe] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China; [Liang, Wenping; Gao, Feixue; Du, Canping; Feng, Xuelian; Chen, Yongjun] Natl Nat Sci Fdn China, Beijing 100085, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Peking University; National Natural Science Foundation of China (NSFC)	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.	hljiang@mail.schcnc.ac.cn; chenyj@mail.nsfc.gov.cn						Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Chen GQ, 1996, BLOOD, V88, P1052; Chen YH, 2006, J MED CHEM, V49, P1613, DOI 10.1021/jm050896o; Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; Jiang HL, 2003, CURR MED CHEM, V10, P2231, DOI 10.2174/0929867033456747; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Krencik R, 2006, CURR OPIN CHEM BIOL, V10, P592, DOI 10.1016/j.cbpa.2006.10.002; Li Y, 2003, CURR MED CHEM, V10, P2197, DOI 10.2174/0929867033456710; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liu DX, 2006, BIOCHEMISTRY-US, V45, P10963, DOI 10.1021/bi060955f; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; NIN Y, 2006, NAT MED, V12, P1390; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; 2006, SCI TIMES, V5, P29	25	2	4	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2008	4	9					515	518		10.1038/nchembio0908-515	http://dx.doi.org/10.1038/nchembio0908-515			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	339SN	18711374				2022-12-25	WOS:000258597700003
J	Yasuda, K; Miyake, K; Horikawa, Y; Hara, K; Osawa, H; Furuta, H; Hirota, Y; Mori, H; Jonsson, A; Sato, Y; Yamagata, K; Hinokio, Y; Wang, HY; Tanahashi, T; Nakamura, N; Oka, Y; Iwasaki, N; Iwamoto, Y; Yamada, Y; Seino, Y; Maegawa, H; Kashiwagi, A; Takeda, J; Maeda, E; Shin, HD; Cho, YM; Park, KS; Lee, HK; Ng, MCY; Ma, RCW; So, WY; Chan, JCN; Lyssenko, V; Tuomi, T; Nilsson, P; Groop, L; Kamatani, N; Sekine, A; Nakamura, Y; Yamamoto, K; Yoshida, T; Tokunaga, K; Itakura, M; Makino, H; Nanjo, K; Kadowaki, T; Kasuga, M				Yasuda, Kazuki; Miyake, Kazuaki; Horikawa, Yukio; Hara, Kazuo; Osawa, Haruhiko; Furuta, Hiroto; Hirota, Yushi; Mori, Hiroyuki; Jonsson, Anna; Sato, Yoshifumi; Yamagata, Kazuya; Hinokio, Yoshinori; Wang, He-Yao; Tanahashi, Toshihito; Nakamura, Naoto; Oka, Yoshitomo; Iwasaki, Naoko; Iwamoto, Yasuhiko; Yamada, Yuichiro; Seino, Yutaka; Maegawa, Hiroshi; Kashiwagi, Atsunori; Takeda, Jun; Maeda, Eiichi; Shin, Hyoung Doo; Cho, Young Min; Park, Kyong Soo; Lee, Hong Kyu; Ng, Maggie C. Y.; Ma, Ronald C. W.; So, Wing-Yee; Chan, Juliana C. N.; Lyssenko, Valeriya; Tuomi, Tiinamaija; Nilsson, Peter; Groop, Leif; Kamatani, Naoyuki; Sekine, Akihiro; Nakamura, Yusuke; Yamamoto, Ken; Yoshida, Teruhiko; Tokunaga, Katsushi; Itakura, Mitsuo; Makino, Hideichi; Nanjo, Kishio; Kadowaki, Takashi; Kasuga, Masato			Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POTASSIUM CHANNEL GENE; CARDIAC-ARRHYTHMIAS; RISK LOCI; JAPANESE; KVLQT1; REPLICATION; MUTATIONS; GLUCOSE; JERVELL	We carried out a multistage genome-wide association study of type 2 diabetes mellitus in Japanese individuals, with a total of 1,612 cases and 1,424 controls and 100,000 SNPs. The most significant association was obtained with SNPs in KCNQ1, and dense mapping within the gene revealed that rs2237892 in intron 15 showed the lowest P value (6.7 x 10(-13), odds ratio (OR) = 1.49). The association of KCNQ1 with type 2 diabetes was replicated in populations of Korean, Chinese and European ancestry as well as in two independent Japanese populations, and meta-analysis with a total of 19,930 individuals (9,569 cases and 10,361 controls) yielded a P value of 1.7 x 10(-42) (OR = 1.40; 95% CI = 1.34-1.47) for rs2237892. Among control subjects, the risk allele of this polymorphism was associated with impairment of insulin secretion according to the homeostasis model assessment of beta-cell function or the corrected insulin response. Our data thus implicate KCNQ1 as a diabetes susceptibility gene in groups of different ancestries.	[Miyake, Kazuaki; Hirota, Yushi; Mori, Hiroyuki; Kasuga, Masato] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan; [Yasuda, Kazuki; Wang, He-Yao] Int Med Ctr Japan, Res Inst, Dept Metab Disorder, Tokyo 1628655, Japan; [Horikawa, Yukio; Takeda, Jun] Gifu Univ, Sch Med, Dept Endocrinol & Diabet, Div Mol & Struct, Gifu 5011194, Japan; [Hara, Kazuo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1138655, Japan; [Osawa, Haruhiko; Makino, Hideichi] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Ehime 7910295, Japan; [Furuta, Hiroto; Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama 6418509, Japan; [Jonsson, Anna; Lyssenko, Valeriya; Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Sato, Yoshifumi; Yamagata, Kazuya] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka 5650871, Japan; [Hinokio, Yoshinori; Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 9808574, Japan; [Tanahashi, Toshihito; Itakura, Mitsuo] Univ Tokushima, Inst Genome Res, Div Genet Informat, Tokushima 7708503, Japan; [Nakamura, Naoto] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto 6028566, Japan; [Iwasaki, Naoko; Iwamoto, Yasuhiko] Tokyo Womens Med Univ, Dept Med, Ctr Diabet, Tokyo 1628666, Japan; [Yamada, Yuichiro; Seino, Yutaka] Kyoto Univ, Sch Med, Dept Diabet & Clin Nutr, Kyoto 6068501, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Div Endocrinol & Metab, Shiga 5202192, Japan; [Maeda, Eiichi] Kobe Univ, Grad Sch Med, Clin Genome Informat Ctr, Kobe, Hyogo 6500017, Japan; [Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul 110834, South Korea; [Cho, Young Min; Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Ng, Maggie C. Y.; Ma, Ronald C. W.; So, Wing-Yee; Chan, Juliana C. N.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Tuomi, Tiinamaija; Groop, Leif] Helsinki Univ Hosp, Dept Med, FIN-00300 Helsinki, Finland; [Tuomi, Tiinamaija] Folkhaelsan Res Ctr, FIN-00014 Helsinki, Finland; [Nilsson, Peter] Lund Univ, Malmo Univ Hosp, Med Res Unit, Dept Clin Sci, S-20502 Malmo, Sweden; [Kamatani, Naoyuki] Tokyo Womens Med Univ, Dept Adv Biomed Engn & Sci, Div Gen Med, Tokyo 1628666, Japan; [Sekine, Akihiro] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Yokohama, Kanagawa 2300045, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 8128582, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan	Kobe University; National Center for Global Health & Medicine - Japan; Gifu University; University of Tokyo; Ehime University; Wakayama Medical University; Lund University; Skane University Hospital; Osaka University; Tohoku University; Tokushima University; Kyoto Prefectural University of Medicine; Tokyo Women's Medical University; Kyoto University; Shiga University of Medical Science; Kobe University; SNP Genetics; Seoul National University (SNU); Chinese University of Hong Kong; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Lund University; Skane University Hospital; Tokyo Women's Medical University; RIKEN; Kyushu University; National Cancer Center - Japan; University of Tokyo	Kasuga, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan.	kasuga@med.kobe-u.ac.jp	Sato, Yoshifumi/GYQ-7230-2022; Chan, Juliana/B-7918-2016; Ma, Ronald/C-2788-2009; Kashiwagi, Atsunori/H-8712-2019; Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012	Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X; Park, Kyong Soo/0000-0003-3597-342X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tuomi, Tiinamaija/0000-0002-8306-6202; Jonsson, Anna/0000-0003-1252-8673; Tanahashi, Toshihito/0000-0002-9308-210X; Maegawa, Hiroshi/0000-0002-4611-8149; Sato, Yoshifumi/0000-0003-0697-1476	Pharmaceuticals and Medical Devices Agency (PMDA) of Japan; National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour, and Welfare of Japan; New Energy and Industrial Technology Development Organization (NEDO); Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER, Tokushima, Japan); Hong Kong Research Grants Committee Central Allocation Scheme [1/04C]; Ministry of Health and Welfare of the Republic of Korea [00-PJ3-PG6-GN07-001]; Swedish Research Council; Sigrid Juselius Foundation; Folkhaelsan Research Foundation; European Foundation for the Study of Diabetes; Swedish Diabetes Research Foundation	Pharmaceuticals and Medical Devices Agency (PMDA) of Japan; National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER, Tokushima, Japan); Hong Kong Research Grants Committee Central Allocation Scheme(Hong Kong Research Grants Council); Ministry of Health and Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkhaelsan Research Foundation; European Foundation for the Study of Diabetes; Swedish Diabetes Research Foundation	We thank all the participants in the project; S. Sugano and S. Tsuji for support and helpful discussion throughout the project; H. Sakamoto, K. Yoshimura and N. Nishida for genotyping and quality control of the data; M. Yamaoka-Sageshima, K. Nagase, D. Suzuki and A. Berglund for technical assistance; and staff of Mitsui Knowledge Industry Inc. (Tokyo) for help with bioinformatics. This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan; a grant from the National Institute of Biomedical Innovation (NIBIO) of Japan; grants from the Ministry of Health, Labour, and Welfare of Japan; a Grant-in-Aid for Scientific Research on Priority Areas (C), "Medical Genome Science (Millennium Genome Project),'' "Applied Genomics'' and "Comprehensive Genomics'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and a grant from New Energy and Industrial Technology Development Organization (NEDO). The replication 2 study was supported by a grant from Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER, Tokushima, Japan). The Hong Kong diabetes case-control study was supported by the Hong Kong Research Grants Committee Central Allocation Scheme 1/04C. The Korean case-control study was supported by a grant from the Korea Health 21 R&D Project of the Ministry of Health and Welfare of the Republic of Korea (00-PJ3-PG6-GN07-001 to K. S. P.). The replication 5 study and Botnia prospective study were supported by Swedish Research Council (Linne grant), Sigrid Juselius Foundation, Folkhaelsan Research Foundation, European Foundation for the Study of Diabetes and Swedish Diabetes Research Foundation.	Bannai M, 2004, ANAL BIOCHEM, V327, P215, DOI 10.1016/j.ab.2004.01.012; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; HORIKAWA Y, 2002, J CLIN ENDO IN PRESS; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; Nawata H, 2004, J HUM GENET, V49, P629, DOI 10.1007/s10038-004-0199-3; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Sato Y, 2004, J HUM GENET, V49, P669, DOI 10.1007/s10038-004-0205-9; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	566	593	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1092	1097		10.1038/ng.207	http://dx.doi.org/10.1038/ng.207			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711367				2022-12-25	WOS:000258761200022
J	Hoon, S; Smith, AM; Wallace, IM; Suresh, S; Miranda, M; Fung, E; Proctor, M; Shokat, KM; Zhang, C; Davis, RW; Giaever, G; StOnge, RP; Nislow, C				Hoon, Shawn; Smith, Andrew M.; Wallace, Iain M.; Suresh, Sundari; Miranda, Molly; Fung, Eula; Proctor, Michael; Shokat, Kevan M.; Zhang, Chao; Davis, Ronald W.; Giaever, Guri; StOnge, Robert P.; Nislow, Corey			An integrated platform of genomic assays reveals small-molecule bioactivities	NATURE CHEMICAL BIOLOGY			English	Article							TYPE-1 PROTEIN PHOSPHATASE; ANTI-TUMOR ACTIVITY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; OKADAIC ACID; YEAST; KINASE; OVEREXPRESSION; INHIBITOR; DISCOVERY	Bioactive compounds are widely used to modulate protein function and can serve as important leads for drug development. Identifying the in vivo targets of these compounds remains a challenge. Using yeast, we integrated three genome-wide gene-dosage assays to measure the effect of small molecules in vivo. A single TAG microarray was used to resolve the fitness of strains derived from pools of (i) homozygous deletion mutants, (ii) heterozygous deletion mutants and (iii) genomic library transformants. We demonstrated, with eight diverse reference compounds, that integration of these three chemogenomic profiles improves the sensitivity and specificity of small-molecule target identification. We further dissected the mechanism of action of two protein phosphatase inhibitors and in the process developed a framework for the rational design of multidrug combinations to sensitize cells with specific genotypes more effectively. Finally, we applied this platform to 188 novel synthetic chemical compounds and identified both potential targets and structure-activity relationships.	[Hoon, Shawn; Suresh, Sundari; Miranda, Molly; Fung, Eula; Proctor, Michael; Davis, Ronald W.; StOnge, Robert P.] Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Hoon, Shawn; Davis, Ronald W.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Smith, Andrew M.; Giaever, Guri; Nislow, Corey] Univ Toronto, Kings Coll Circle 1, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wallace, Iain M.] Univ Toronto, Dept Med Res, Toronto, ON M5S 3E1, Canada; [Smith, Andrew M.; Giaever, Guri; Nislow, Corey] Univ Toronto, Donnelly Ctr Cellular & Biomed Res, Toronto, ON M5S 3E1, Canada; [Shokat, Kevan M.; Zhang, Chao] Univ Calif San Francisco, Dept Mol Pharmacol, San Francisco, CA 94158 USA; [Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada	Stanford University; Stanford University; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California San Francisco; University of Toronto	StOnge, RP (corresponding author), Stanford Genome Technol Ctr, 855 Calif Ave, Palo Alto, CA 94304 USA.	bstonge@stanford.edu; corey.nislow@utoronto.ca	Giaever, Guri/D-3930-2009; Hoon, Shawn/Q-2472-2016; Smith, Andrew/C-1253-2009; Wallace, Iain/B-9464-2009	Hoon, Shawn/0000-0002-3892-3332; Nislow, Corey/0000-0002-4016-8874; Wallace, Iain/0000-0002-9491-7025				Andrews PD, 2000, J CELL SCI, V113, P507; Arnaud MB, 2007, NUCLEIC ACIDS RES, V35, pD452, DOI 10.1093/nar/gkl899; BAGULEY BC, 1981, EUR J CANCER, V17, P671, DOI 10.1016/0014-2964(81)90271-1; Baker SH, 1997, GENETICS, V145, P615; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Breitling R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-181; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brenner C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-240; Butcher RA, 2006, NAT CHEM BIOL, V2, P103, DOI 10.1038/nchembio762; DENNY WA, 1982, J MED CHEM, V25, P276, DOI 10.1021/jm00345a015; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; Kontoyiannis DP, 1999, ANTIMICROB AGENTS CH, V43, P2798, DOI 10.1128/AAC.43.11.2798; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kung C, 2005, P NATL ACAD SCI USA, V102, P3587, DOI 10.1073/pnas.0407170102; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lan CY, 2002, P NATL ACAD SCI USA, V99, P14907, DOI 10.1073/pnas.232566499; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Li XM, 2004, CHEM BIOL, V11, P1423, DOI 10.1016/j.chembiol.2004.08.014; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; MYERS CE, 1975, P NATL ACAD SCI USA, V72, P3683, DOI 10.1073/pnas.72.9.3683; NELSON EM, 1984, P NATL ACAD SCI-BIOL, V81, P1361, DOI 10.1073/pnas.81.5.1361; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Walsh EP, 2002, BIOCHEMISTRY-US, V41, P2409, DOI 10.1021/bi015815e; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	50	143	149	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2008	4	8					498	506		10.1038/nchembio.100	http://dx.doi.org/10.1038/nchembio.100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329FO	18622389				2022-12-25	WOS:000257852500016
J	Canton, B; Labno, A; Endy, D				Canton, Barry; Labno, Anna; Endy, Drew			Refinement and standardization of synthetic biological parts and devices	NATURE BIOTECHNOLOGY			English	Article							DIRECTED EVOLUTION; BACTERIAL BIOLUMINESCENCE; GENE; LUXR; COMMUNICATION; AUTOINDUCER; LACTONES; CIRCUIT	The ability to quickly and reliably engineer many-component systems from libraries of standard interchangeable parts is one hallmark of modern technologies. Whether the apparent complexity of living systems will permit biological engineers to develop similar capabilities is a pressing research question. We propose to adapt existing frameworks for describing engineered devices to biological objects in order to (i) direct the refinement and use of biological 'parts' and 'devices', (ii) support research on enabling reliable composition of standard biological parts and (iii) facilitate the development of abstraction hierarchies that simplify biological engineering. We use the resulting framework to describe one engineered biological device, a genetically encoded cell-cell communication receiver named BBa_F2620. The description of the receiver is summarized via a 'datasheet' similar to those widely used in engineering. The process of refinement and characterization leading to the BBa_F2620 datasheet may serve as a starting template for producing many standardized genetically encoded objects.	[Canton, Barry; Endy, Drew] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Labno, Anna] MIT, Dept Biol, Cambridge, MA 02139 USA; [Labno, Anna] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Endy, D (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave,68-580, Cambridge, MA 02139 USA.	endy@mit.edu		Endy, Drew/0000-0001-6952-8098				Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Andersen JB, 2001, APPL ENVIRON MICROB, V67, P575, DOI 10.1128/AEM.67.2.575-585.2001; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; BOETTCHER KJ, 1995, J BACTERIOL, V177, P1053, DOI 10.1128/jb.177.4.1053-1058.1995; BRINDLEY K, 1988, SENSORS TRANSDUCERS; Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; De Silva W.C., 2007, SENSORS ACTUATORS CO; Dyson F., 2005, TECHNOL REV; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; FRENCH C, 2007, BMC SYST BIOL S1, V1, pS11; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Haseltine EL, 2007, ANNU REV BIOPH BIOM, V36, P1, DOI 10.1146/annurev.biophys.36.040306.132600; Knight T., 2003, STRUCTURE, V1, P11, DOI 10.21236/ADA457791; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; NEALSON KH, 1977, ARCH MICROBIOL, V112, P73, DOI 10.1007/BF00446657; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; *REG STAND BIOL PA, BBAF2620; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100185; Rucker R., 1988, WETWARE; Schaefer AL, 1996, J BACTERIOL, V178, P2897, DOI 10.1128/jb.178.10.2897-2901.1996; SELLERS W, 1864, J FRANKLIN I, V47, P344; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; *TEX INSTR, 1988, TTL LOG STAND TTL SC; WARD A, 1990, COMPUTATION STRUCTUR; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; [No title captured]	35	519	555	0	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2008	26	7					787	793		10.1038/nbt1413	http://dx.doi.org/10.1038/nbt1413			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	324BC	18612302				2022-12-25	WOS:000257491600023
J	Zhang, YN; Appleton, BA; Wiesmann, C; Lau, T; Costa, M; Hannoush, RN; Sidhu, SS				Zhang, Yingnan; Appleton, Brent A.; Wiesmann, Christian; Lau, Ted; Costa, Mike; Hannoush, Rami N.; Sidhu, Sachdev S.			Inhibition of Wnt signaling by Dishevelled PDZ peptides	NATURE CHEMICAL BIOLOGY			English	Article							BETA-CATENIN; TRANSCRIPTIONAL ACTIVITY; DOMAIN; SPECIFICITY; PATHWAY; OVEREXPRESSION; ANTAGONIST; ACTIVATION; PROTEINS; CANCER	Dishevelled proteins are key regulators of Wnt signaling pathways that have been implicated in the progression of human cancers. We found that the binding cleft of the Dishevelled PDZ domain is more flexible than those of canonical PDZ domains and enables recognition of both C-terminal and internal peptides. These peptide ligands inhibit Wnt/beta-catenin signaling in cells, showing that Dishevelled PDZ domains are potential targets for small-molecule cancer therapeutics.	[Zhang, Yingnan; Appleton, Brent A.; Wiesmann, Christian; Hannoush, Rami N.; Sidhu, Sachdev S.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Lau, Ted; Costa, Mike] Genentech Inc, Dept Canc Targets & Pathways, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	hannoush.rami@gene.com; sachdev.sidhu@utoronto.ca		Wiesmann, Christian/0000-0002-4092-9880; Appleton, Brent/0000-0003-1136-5649				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Mahindroo N, 2008, BIOORG MED CHEM LETT, V18, P946, DOI 10.1016/j.bmcl.2007.12.039; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Weitzel HE, 2004, DEVELOPMENT, V131, P2947, DOI 10.1242/dev.01152; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1	19	122	129	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2009	5	4					217	219		10.1038/nchembio.152	http://dx.doi.org/10.1038/nchembio.152			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	422KH	19252499				2022-12-25	WOS:000264426100009
J	Hansen, SG; Vieville, C; Whizin, N; Coyne-Johnson, L; Siess, DC; Drummond, DD; Legasse, AW; Axthelm, MK; Oswald, K; Trubey, CM; Piatak, M; Lifson, JD; Nelson, JA; Jarvis, MA; Picker, LJ				Hansen, Scott G.; Vieville, Cassandra; Whizin, Nathan; Coyne-Johnson, Lia; Siess, Don C.; Drummond, Derek D.; Legasse, Alfred W.; Axthelm, Michael K.; Oswald, Kelli; Trubey, Charles M.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.			Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge	NATURE MEDICINE			English	Article							CYTOMEGALOVIRUS-SPECIFIC CD4(+); SIV; CMV; INDUCTION; VACCINES; MODEL; AIDS; IMMUNIZATION; REPLICATION; LYMPHOCYTES	The rapid onset of massive, systemic viral replication during primary HIV or simian immunodeficiency virus (SIV) infection and the immune evasion capabilities of these viruses pose fundamental problems for vaccines that depend upon initial viral replication to stimulate effector T cell expansion and differentiation(1-5). We hypothesized that vaccines designed to maintain differentiated effector memory T cell (T-EM cell) responses(5,6) at viral entry sites might improve efficacy by impairing viral replication at its earliest stage(2), and we have therefore developed SIV protein-encoding vectors based on rhesus cytomegalovirus (RhCMV), the prototypical inducer of life-long TEM cell responses(7-9). RhCMV vectors expressing SIV Gag, Rev-Tat-Nef and Env persistently infected rhesus macaques, regardless of preexisting RhCMV immunity, and primed and maintained robust, SIV-specific CD4(+) and CD8(+) TEM cell responses (characterized by coordinate tumor necrosis factor, interferon-c and macrophage inflammatory protein-1 beta expression, cytotoxic degranulation and accumulation at extralymphoid sites) in the absence of neutralizing antibodies. Compared to control rhesus macaques, these vaccinated rhesus macaques showed increased resistance to acquisition of progressive SIVmac239 infection upon repeated limiting-dose intrarectal challenge, including four macaques who controlled rectal mucosal infection without progressive systemic dissemination. These data suggest a new paradigm for AIDS vaccine development-vaccines capable of generating and maintaining HIV-specific TEM cells might decrease the incidence of HIV acquisition after sexual exposure.	[Hansen, Scott G.; Vieville, Cassandra; Whizin, Nathan; Coyne-Johnson, Lia; Siess, Don C.; Drummond, Derek D.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Mol Microbiol, Beaverton, OR 97006 USA; [Hansen, Scott G.; Vieville, Cassandra; Whizin, Nathan; Coyne-Johnson, Lia; Siess, Don C.; Drummond, Derek D.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Immunol, Beaverton, OR 97006 USA; [Hansen, Scott G.; Vieville, Cassandra; Whizin, Nathan; Coyne-Johnson, Lia; Siess, Don C.; Drummond, Derek D.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Pathol, Beaverton, OR 97006 USA; [Hansen, Scott G.; Vieville, Cassandra; Whizin, Nathan; Coyne-Johnson, Lia; Siess, Don C.; Drummond, Derek D.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Oswald, Kelli; Trubey, Charles M.; Piatak, Michael, Jr.; Lifson, Jeffrey D.] Sci Applicat Int Corp, AIDS & Canc Virus Program, Natl Canc Inst Frederick, Frederick, MD 21702 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Mol Microbiol, 505 NW 185th Ave, Beaverton, OR 97006 USA.	pickerl@ohsu.edu		Jarvis, Michael A/0000-0002-0124-4061	US National Institute of Allergy and Infectious Diseases; International AIDS Vaccine Initiative; Bill & Melinda Gates Foundation; AIDS Vaccine Discovery; US National Center for Research Resources; US National Cancer Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021640, R01AI060392] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); AIDS Vaccine Discovery; US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institute of Allergy and Infectious Diseases, the International AIDS Vaccine Initiative, the Bill & Melinda Gates Foundation-supported Collaboration for AIDS Vaccine Discovery, the US National Center for Research Resources and the US National Cancer Institute. We thank J. Edgar, A. Keech, J. Ford, J. Cook, M. Rohankhedkar, T. Ha, A. Sylwester and J. Dewane for technical assistance; P. Barry (University of California-Davis) for the RhCMV bacterial artificial chromosome, G. Pavlakis (National Cancer Institute) for the SIV Gag and Env constructs, G. Franchini (National Cancer Institute) for the SIV Retanef construct, R. Seder (Vaccine Research Center, National Institutes of Health) for the Gag protein immunogens, C. Miller (University of California-Davis) for the pathogenic SIVmac239 challenge stock, K. Reimann and Centocor for the cM-T807 antibody, M. Mori and J. O'Malley for statistical assistance and K. Frueh and S. Wong for helpful discussion and advice.	Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; CHACKERIAN B, 1995, VIROLOGY, V213, P386, DOI 10.1006/viro.1995.0011; Chan KS, 2007, J IMMUNOL METHODS, V325, P20, DOI 10.1016/j.jim.2007.05.011; Chang WLW, 2003, J VIROL, V77, P5073, DOI 10.1128/JVI.77.9.5073-5083.2003; Cline AN, 2005, J MED PRIMATOL, V34, P303; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Grossman Z, 2008, CURR OPIN HIV AIDS, V3, P380, DOI 10.1097/COH.0b013e3282fbaae6; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kern F, 1999, EUR J IMMUNOL, V29, P2908, DOI 10.1002/(SICI)1521-4141(199909)29:09<2908::AID-IMMU2908>3.0.CO;2-8; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Letvin NL, 2007, J VIROL, V81, P12368, DOI 10.1128/JVI.00822-07; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Lu XS, 1998, AIDS, V12, P1, DOI 10.1097/00002030-199801000-00001; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Passs RF, 2001, FIELDS VIROLOGY, P2675; Petravic J, 2008, J VIROL, V82, P11589, DOI 10.1128/JVI.01596-08; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Pipeling MR, 2008, J IMMUNOL, V181, P546, DOI 10.4049/jimmunol.181.1.546; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Powers C, 2008, MED MICROBIOL IMMUN, V197, P109, DOI 10.1007/s00430-007-0073-y; Price DA, 2008, J IMMUNOL, V180, P269, DOI 10.4049/jimmunol.180.1.269; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rue CA, 2004, J VIROL, V78, P12529, DOI 10.1128/JVI.78.22.12529-12536.2004; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker DH, 2004, SER COMPUTERS OPER R, V4, P535; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	40	549	573	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2009	15	3					293	299		10.1038/nm.1935	http://dx.doi.org/10.1038/nm.1935			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	415DH	19219024	Green Accepted, Green Submitted			2022-12-25	WOS:000263914000029
J	Hayashi, MT; Takahashi, TS; Nakagawa, T; Nakayama, J; Masukata, H				Hayashi, Makoto T.; Takahashi, Tatsuro S.; Nakagawa, Takuro; Nakayama, Jun-ichi; Masukata, Hisao			The heterochromatin protein Swi6/HP1 activates replication origins at the pericentromeric region and silent mating-type locus	NATURE CELL BIOLOGY			English	Article							FISSION YEAST; CHROMODOMAIN PROTEIN; EPIGENETIC CONTROL; DNA-REPLICATION; ESTABLISHMENT; CENTROMERES; POLYMERASE; GENOME; RNAI	Heterochromatin is a structurally compacted region of chromosomes in which transcription and recombination are inactivated(1,2). DNA replication is temporally regulated in heterochromatin, but the molecular mechanism for regulation has not been elucidated. Among heterochromatin loci in Schizosaccharomyces pombe, the pericentromeric region and the silent mating-type (mat) locus replicate in early S phase, whereas the sub-telomeric region does not(3-5), suggesting complex mechanisms for regulation of replication in heterochromatic regions. Here, we show that Swi6, an S. pombe counterpart of heterochromatin protein 1 (HP1), is required for early replication of the pericentromeric region and the mat locus. Origin-loading of Sld3, which depends on Dfp1/Dbf4-dependent kinase Cdc7 (DDK), is stimulated by Swi6. An HP1-binding motif within Dfp1 is required for interaction with Swi6 in vitro and for early replication of the pericentromeric region and mat locus. Tethering of Dfp1 to the pericentromeric region and mat locus in swi6-deficient cells restores early replication of these loci. Our results show that a heterochromatic protein positively regulates initiation of replication in silenced chromatin by interacting with an essential kinase.	[Hayashi, Makoto T.; Takahashi, Tatsuro S.; Nakagawa, Takuro; Masukata, Hisao] Osaka Univ, Grad Sch Sci, Osaka 5600043, Japan; [Nakayama, Jun-ichi] RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Kobe, Hyogo 6500047, Japan	Osaka University; RIKEN	Masukata, H (corresponding author), Osaka Univ, Grad Sch Sci, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	masukata@bio.sci.osaka-u.ac.jp	Nakagawa, Takuro/A-1367-2017; Hayashi, Makoto/K-7155-2019; Takahashi, Tatsuro/AAD-9936-2020; Takahashi, Tatsuro/F-4669-2016; Nakayama, Jun-ichi/C-6003-2011	Nakagawa, Takuro/0000-0003-3455-8224; Hayashi, Makoto/0000-0001-6360-7131; Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Nakayama, Jun-ichi/0000-0002-5597-8239	JSPS Fellows; Ministry of Education, Science, Technology, Sports and Culture, Japan	JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Hiroyuki Araki for critical reading and Yoshinori Watanabe for providing CFP- chromodomain constructs. M. T. H. is a Research Fellow of the Japan Society for the Promotion of Science. This study was supported by a Grant- in- Aid for JSPS Fellows to M. T. H., and in part by a Grant- in- Aid to H. M. and to J. N. from the Ministry of Education, Science, Technology, Sports and Culture, Japan.	Ahmed S, 2001, J BIOL CHEM, V276, P47814, DOI 10.1074/jbc.M109186200; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; KLAR AJS, 1991, GENETICS, V129, P1033; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; OLSSON T, 1993, NUCLEIC ACIDS RES, V21, P855; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; SMITH JG, 1995, MOL CELL BIOL, V15, P5165; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yamada Y, 2004, MOL BIOL CELL, V15, P3740, DOI 10.1091/mbc.E04-04-0292	24	115	116	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					357	U284		10.1038/ncb1845	http://dx.doi.org/10.1038/ncb1845			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182789				2022-12-25	WOS:000263777900021
J	Irizarry, RA; Ladd-Acosta, C; Wen, B; Wu, ZJ; Montano, C; Onyango, P; Cui, HM; Gabo, K; Rongione, M; Webster, M; Ji, H; Potash, JB; Sabunciyan, S; Feinberg, AP				Irizarry, Rafael A.; Ladd-Acosta, Christine; Wen, Bo; Wu, Zhijin; Montano, Carolina; Onyango, Patrick; Cui, Hengmi; Gabo, Kevin; Rongione, Michael; Webster, Maree; Ji, Hong; Potash, James B.; Sabunciyan, Sarven; Feinberg, Andrew P.			The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores	NATURE GENETICS			English	Article							FALSE DISCOVERY RATE; GENE-EXPRESSION; DNA METHYLATION; BREAST-CANCER; GENOME; NORMALIZATION; PROMOTERS; FREQUENT	For the past 25 years, it has been known that alterations in DNA methylation (DNAm) occur in cancer, including hypomethylation of oncogenes and hypermethylation of tumor suppressor genes. However, most studies of cancer methylation have assumed that functionally important DNAm will occur in promoters, and that most DNAm changes in cancer occur in CpG islands. Here we show that most methylation alterations in colon cancer occur not in promoters, and also not in CpG islands, but in sequences up to 2 kb distant, which we term 'CpG island shores'. CpG island shore methylation was strongly related to gene expression, and it was highly conserved in mouse, discriminating tissue types regardless of species of origin. There was a notable overlap (45-65%) of the locations of colon cancer-related methylation changes with those that distinguished normal tissues, with hypermethylation enriched closer to the associated CpG islands, and hypomethylation enriched further from the associated CpG island and resembling that of noncolon normal tissues. Thus, methylation changes in cancer are at sites that vary normally in tissue differentiation, consistent with the epigenetic progenitor model of cancer, which proposes that epigenetic alterations affecting tissue-specific differentiation are the predominant mechanism by which epigenetic changes cause cancer.	[Irizarry, Rafael A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Irizarry, Rafael A.; Ladd-Acosta, Christine; Wen, Bo; Montano, Carolina; Onyango, Patrick; Cui, Hengmi; Gabo, Kevin; Rongione, Michael; Ji, Hong; Potash, James B.; Sabunciyan, Sarven; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Inst Basic Biomed Sci, Baltimore, MD 21205 USA; [Ladd-Acosta, Christine; Wen, Bo; Montano, Carolina; Onyango, Patrick; Cui, Hengmi; Gabo, Kevin; Rongione, Michael; Ji, Hong; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wu, Zhijin] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; [Webster, Maree] Uniformed Serv Univ Hlth Sci, Stanley Lab Brain Res, Bethesda, MD 20892 USA; [Potash, James B.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Sabunciyan, Sarven] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Brown University; Uniformed Services University of the Health Sciences - USA; Johns Hopkins University; Johns Hopkins University	Irizarry, RA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	rafa@jhu.edu; afeinberg@jhu.edu	wu, zhijin/J-2282-2014; Feinberg, Andrew/AAY-7666-2020; jia, xu/A-8386-2016; wu, zhijin/J-4995-2016; Wen, Bo/P-5332-2019	wu, zhijin/0000-0002-9596-9134; Wen, Bo/0000-0003-0394-7366; Ji, Hong/0000-0002-9558-0620; Feinberg, Andrew/0000-0002-8364-1991; Sabunciyan, Sarven/0000-0002-7231-0820; Montano, Carolina/0000-0002-2772-2025	US National Institutes of Health [P50HG003233, R37CA54358, 5R01RR021967]; NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR021967] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Volgelstein (Johns Hopkins University School of Medicine) for providing colon tumors and matched normal mucosa samples. Postmortem brain, liver and spleen tissue was donated by The Stanley Medical Research Institute collection courtesy of M. B. Knable, E. F. Torrey and R. H. Yolken, whom we also thank for making available gene expression data for the brain and the liver tissue. We thank B. Carvalho for help with statistical software and C. Crainiceanu for advice with statistical methods. This work was supported by US National Institutes of Health grants P50HG003233 (A. P. F.), R37CA54358 (A. P. F.) and 5R01RR021967 (R. A. I.).	Antequera F, 1999, CURR BIOL, V9, pR661, DOI 10.1016/S0960-9822(99)80418-7; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornsson HT, 2008, GENOME RES, V18, P771, DOI 10.1101/gr.073254.107; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cantor AB, 2008, J EXP MED, V205, P611, DOI 10.1084/jem.20070544; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pedersen IS, 1999, CANCER RES, V59, P5449; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Segditsas S, 2008, HUM MOL GENET, V17, P3864, DOI 10.1093/hmg/ddn286; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	34	1557	1618	1	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					178	186		10.1038/ng.298	http://dx.doi.org/10.1038/ng.298			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19151715	Green Accepted, Green Submitted			2022-12-25	WOS:000263091300017
J	Ziel, JW; Hagedorn, EJ; Audhya, A; Sherwood, DR				Ziel, Joshua W.; Hagedorn, Elliott J.; Audhya, Anjon; Sherwood, David R.			UNC-6 (netrin) orients the invasive membrane of the anchor cell in C-elegans	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; AXON GUIDANCE; EXPRESSION; ANGIOGENESIS; MATRIX; CANCER; PROTOONCOGENE; MORPHOGENESIS; ATTRACTION; MIGRATIONS	Despite their profound importance in the development of cancer, the extracellular cues that target cell invasion through basement membrane barriers remain poorly understood(1). A central obstacle has been the difficulty of studying the interactions between invading cells and basement membranes in vivo(2,3). Using the genetically and visually tractable model of Caenorhabditis elegans anchor cell (AC) invasion, we show that UNC-6 (netrin) signalling, a pathway not previously implicated in controlling cell invasion in vivo, is a key regulator of this process. site of action studies reveal that before invasion, localized UNC-6 secretion directs its receptor, UNC-40, to the plasma membrane of the AC, in contact with the basement membrane. there, UNC-40 polarizes a specialized invasive membrane domain through the enrichment of actin regulators, F-actin and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). Cell ablation experiments indicate that UNC-6 promotes the formation of invasive protrusions from the AC that break down the basement membrane in response to a subsequent vulval cue. together, these results characterize an invasive membrane domain in vivo, and reveal a role for UNC-6 (netrin) in polarizing this domain towards its basement membrane target.	[Ziel, Joshua W.; Hagedorn, Elliott J.; Sherwood, David R.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Audhya, Anjon] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Sherwood, David R.] Duke Univ, Mol Canc Biol Program, Durham, NC 27708 USA	Duke University; University of Wisconsin System; University of Wisconsin Madison; Duke University	Sherwood, DR (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	david.sherwood@duke.edu	Sherwood, David/ABG-4265-2020	Sherwood, David/0000-0002-4448-6917	Basil O'Connor Award; Pew Scholars Award; NIH [GM079320]; NATIONAL CANCER INSTITUTE [K01CA098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079320] Funding Source: NIH RePORTER	Basil O'Connor Award(March of Dimes); Pew Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Bargmann for the GFP::unc-34 and unc-40::GFP vectors, the hs>unc-6::HA integrated strain, and advice; W. Wadsworth for the Lam-1::GFP vector; E. Lundquist for the GFP::ced-10 vector; Y. Goshima for Venus:: unc-6 strains; D. Kiehart for the moeADB::GFP vector; the Caenorhabditis Genetics Center for providing strains; and N. Sherwood, Z. Wang, G. Lopez, G. Miley and D. Matus for comments on the manuscript. This work was supported by a Basil O'Connor Award, Pew Scholars Award, and NIH Grant GM079320 to D.R.S.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Asakura T, 2007, DEV BIOL, V304, P800, DOI 10.1016/j.ydbio.2007.01.028; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hwang BJ, 2007, DEVELOPMENT, V134, P669, DOI 10.1242/dev.02769; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kao G, 2006, DEV BIOL, V290, P211, DOI 10.1016/j.ydbio.2005.11.026; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Machesky L, 2008, EMBO REP, V9, P139, DOI 10.1038/sj.embor.7401162; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rimann I, 2007, DEV BIOL, V308, P187, DOI 10.1016/j.ydbio.2007.05.023; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Sharma-Kishore R, 1999, DEVELOPMENT, V126, P691; Sherwood DR, 2005, CELL, V121, P951, DOI 10.1016/j.cell.2005.03.031; Sherwood DR, 2003, DEV CELL, V5, P21, DOI 10.1016/S1534-5807(03)00168-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704	29	98	195	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					183	U161		10.1038/ncb1825	http://dx.doi.org/10.1038/ncb1825			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098902	Green Accepted			2022-12-25	WOS:000263285500016
J	Kathiresan, S; Willer, CJ; Peloso, GM; Demissie, S; Musunuru, K; Schadt, EE; Kaplan, L; Bennett, D; Li, Y; Tanaka, T; Voight, BF; Bonnycastle, LL; Jackson, AU; Crawford, G; Surti, A; Guiducci, C; Burtt, NP; Parish, S; Clarke, R; Zelenika, D; Kubalanza, KA; Morken, MA; Scott, LJ; Stringham, HM; Galan, P; Swift, AJ; Kuusisto, J; Bergman, RN; Sundvall, J; Laakso, M; Ferrucci, L; Scheet, P; Sanna, S; Uda, M; Yang, Q; Lunetta, KL; Dupuis, J; de Bakker, PIW; O'Donnell, CJ; Chambers, JC; Kooner, JS; Hercberg, S; Meneton, P; Lakatta, EG; Scuteri, A; Schlessinger, D; Tuomilehto, J; Collins, FS; Groop, L; Altshuler, D; Collins, R; Lathrop, GM; Melander, O; Salomaa, V; Peltonen, L; Orho-Melander, M; Ordovas, JM; Boehnke, M; Abecasis, GR; Mohlke, KL; Cupples, LA				Kathiresan, Sekar; Willer, Cristen J.; Peloso, Gina M.; Demissie, Serkalem; Musunuru, Kiran; Schadt, Eric E.; Kaplan, Lee; Bennett, Derrick; Li, Yun; Tanaka, Toshiko; Voight, Benjamin F.; Bonnycastle, Lori L.; Jackson, Anne U.; Crawford, Gabriel; Surti, Aarti; Guiducci, Candace; Burtt, Noel P.; Parish, Sarah; Clarke, Robert; Zelenika, Diana; Kubalanza, Kari A.; Morken, Mario A.; Scott, Laura J.; Stringham, Heather M.; Galan, Pilar; Swift, Amy J.; Kuusisto, Johanna; Bergman, Richard N.; Sundvall, Jouko; Laakso, Markku; Ferrucci, Luigi; Scheet, Paul; Sanna, Serena; Uda, Manuela; Yang, Qiong; Lunetta, Kathryn L.; Dupuis, Josee; de Bakker, Paul I. W.; O'Donnell, Christopher J.; Chambers, John C.; Kooner, Jaspal S.; Hercberg, Serge; Meneton, Pierre; Lakatta, Edward G.; Scuteri, Angelo; Schlessinger, David; Tuomilehto, Jaakko; Collins, Francis S.; Groop, Leif; Altshuler, David; Collins, Rory; Lathrop, G. Mark; Melander, Olle; Salomaa, Veikko; Peltonen, Leena; Orho-Melander, Marju; Ordovas, Jose M.; Boehnke, Michael; Abecasis, Goncalo R.; Mohlke, Karen L.; Cupples, L. Adrienne			Common variants at 30 loci contribute to polygenic dyslipidemia	NATURE GENETICS			English	Article							HIGH-DENSITY-LIPOPROTEIN; GENOME-WIDE ASSOCIATION; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; PHOSPHOLIPID TRANSFER PROTEIN; CORONARY-HEART-DISEASE; GENE-EXPRESSION; PLASMA-LIPIDS; CHOLESTEROL; RECEPTOR; PCSK9	Blood low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglyceride levels are risk factors for cardiovascular disease. To dissect the polygenic basis of these traits, we conducted genome-wide association screens in 19,840 individuals and replication in up to 20,623 individuals. We identified 30 distinct loci associated with lipoprotein concentrations (each with P < 5 x 10(-8)), including 11 loci that reached genome-wide significance for the first time. The 11 newly defined loci include common variants associated with LDL cholesterol near ABCG8, MAFB, HNF1A and TIMD4; with HDL cholesterol near ANGPTL4, FADS1-FADS2-FADS3, HNF4A, LCAT, PLTP and TTC39B; and with triglycerides near AMAC1L2, FADS1-FADS2-FADS3 and PLTP. The proportion of individuals exceeding clinical cut points for high LDL cholesterol, low HDL cholesterol and high triglycerides varied according to an allelic dosage score (P < 10(-15) for each trend). These results suggest that the cumulative effect of multiple common variants contributes to polygenic dyslipidemia.	[Kathiresan, Sekar; Musunuru, Kiran] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar; Musunuru, Kiran] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar; Musunuru, Kiran; Voight, Benjamin F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar; Voight, Benjamin F.; Crawford, Gabriel; Surti, Aarti; Guiducci, Candace; Burtt, Noel P.; Altshuler, David; Peltonen, Leena] Harvard & Massachusetts Inst, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kathiresan, Sekar; Peloso, Gina M.; Demissie, Serkalem; Yang, Qiong; Lunetta, Kathryn L.; Dupuis, Josee; O'Donnell, Christopher J.; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Kathiresan, Sekar; Peloso, Gina M.; Demissie, Serkalem; Yang, Qiong; Lunetta, Kathryn L.; Dupuis, Josee; O'Donnell, Christopher J.; Cupples, L. Adrienne] Boston Univ, Framingham, MA 01702 USA; [Kathiresan, Sekar; Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Willer, Cristen J.; Li, Yun; Jackson, Anne U.; Scott, Laura J.; Stringham, Heather M.; Scheet, Paul; Peltonen, Leena; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Bonnycastle, Lori L.; Kubalanza, Kari A.; Morken, Mario A.; Swift, Amy J.; Collins, Francis S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Schadt, Eric E.] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Kaplan, Lee] Massachusetts Gen Hosp, Weight Ctr, Boston, MA 02114 USA; [Bennett, Derrick; Parish, Sarah; Clarke, Robert; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, NIH, Baltimore, MD 21225 USA; [Voight, Benjamin F.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kubalanza, Kari A.; Morken, Mario A.; Swift, Amy J.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Zelenika, Diana; Lathrop, G. Mark] Inst Genom Commissariat Energie Atom, Ctr Natl Genotypage, F-91057 Evry, France; [Galan, Pilar; Hercberg, Serge] Paris 13 SMBH, CNAM, INRA, INSERM,U557,U1125, Bobigny, France; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Sundvall, Jouko; Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland; [Sanna, Serena; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, I-08045 Cagliari, Italy; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [O'Donnell, Christopher J.] Natl Lung & Blood Inst, NIH, Framingham, MA 01702 USA; [Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Hammersmith Hosp, London W12 0NN, England; [Meneton, Pierre] Ctr Rech Cordeliers, INSERM, U872, F-75270 Paris 06, France; [Lakatta, Edward G.] NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Scuteri, Angelo] Ist Nazl Ricovero & Cura Anziani, Unita Operat Geriatria, I-00189 Rome, Italy; [Schlessinger, David] NIA, Genet Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Groop, Leif; Orho-Melander, Marju] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Groop, Leif] Helsinki Univ Hosp, Dept Med, Helsinki 00029, Finland; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, S-20502 Malmo, Sweden; [Peltonen, Leena] Univ Helsinki, Inst Mol Med, Helsinki 00029, Finland; [Salomaa, Veikko] Natl Publ Hlth Inst, Chron Dis Epidemiol Unit, Dept Hlth Promot & Chron Dis Prevent, SF-00300 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Nutr & Genom Lab, Boston, MA 02111 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Boston University; Merck & Company; Harvard University; Massachusetts General Hospital; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); CEA; UDICE-French Research Universities; Universite Paris Saclay; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; University of Eastern Finland; University of Southern California; Finland National Institute for Health & Welfare; Consiglio Nazionale delle Ricerche (CNR); Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Imperial College London; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Lund University; Skane University Hospital; University of Helsinki; Helsinki University Central Hospital; Harvard University; Harvard Medical School; Lund University; Skane University Hospital; University of Helsinki; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; Tufts University; United States Department of Agriculture (USDA); University of North Carolina; University of North Carolina Chapel Hill	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	skathiresan@partners.org; goncalo@umich.edu; mohlke@med.unc.edu; adrienne@bu.edu	de Bakker, Paul IW/B-8730-2009; sanna, serena/H-3009-2019; Bennett, Derrick/AFL-9254-2022; , Bennett/O-7998-2019; Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Abecasis, Goncalo R/B-7840-2010; Meneton, Pierre/T-1216-2019; Bennett, Derrick/AAH-1220-2022; Altshuler, David M/A-4476-2009; Yang, Qiong/G-5438-2014; Lakatta, Edward G/AAL-1447-2020; Voight, Benjamin/F-1775-2011; Uda, Manuela/AAC-2645-2019; Ordovas, Jose/B-8727-2013	de Bakker, Paul IW/0000-0001-7735-7858; sanna, serena/0000-0002-3768-1749; Bennett, Derrick/0000-0002-9170-8447; Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Bennett, Derrick/0000-0002-9170-8447; Altshuler, David M/0000-0002-7250-4107; Uda, Manuela/0000-0002-4890-6456; Lunetta, Kathryn/0000-0002-9268-810X; Voight, Benjamin/0000-0002-6205-9994; Demissie, Serkalem/0000-0002-8009-0987; Dupuis, Josee/0000-0003-2871-3603; Cupples, L. Adrienne/0000-0003-0273-7965; SCUTERI, ANGELO/0000-0003-4784-5441; Willer, Cristen/0000-0001-5645-4966; Lakatta, Edward/0000-0002-4772-0035; Ordovas, Jose/0000-0002-7581-5680; Melander, Olle/0000-0002-2581-484X; Abecasis, Goncalo/0000-0003-1509-1825; Bergman, Richard/0000-0003-1539-4471	MRC [MC_U137686857] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083102, U01HL084729, R01HL054776] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403, Z01HG000024, R01HG002651, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193, P30DK040561, R01DK029867, R56DK062370, R01DK062370, R01DK075030, U01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, ZIAAG000799] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Cancer Research UK Funding Source: Medline; Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [MC_U137686857] Funding Source: Medline; NHGRI NIH HHS [R01 HG002651, HG02651, N01HG65403] Funding Source: Medline; NHLBI NIH HHS [HL084729, N01-HC-25195, N01HC25195, HL-54776, K23 HL083102-03, R01 HL054776, U01 HL084729, K23 HL083102] Funding Source: Medline; NIDDK NIH HHS [U01 DK062370, R01 DK075030, P30 DK040561, P30 DK040561-13, R01 DK029867, R01 DK062370, DK072193, R01 DK072193, R56 DK062370, DK062370] Funding Source: Medline; PHS HHS [53-K06-5-10] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); Department of Health		AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Ek J, 2005, J CLIN ENDOCR METAB, V90, P3054, DOI 10.1210/jc.2004-2159; FUNKE H, 1991, P NATL ACAD SCI USA, V88, P4855, DOI 10.1073/pnas.88.11.4855; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hegele RA, 2000, ARTERIOSCL THROM VAS, V20, P217, DOI 10.1161/01.ATV.20.1.217; HUNT D, 1992, LANCET, V339, P753; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiang XC, 1996, J CLIN INVEST, V98, P2373, DOI 10.1172/JCI119050; Kajinami K, 2004, J LIPID RES, V45, P653, DOI 10.1194/jlr.M300278-JLR200; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Petersen HH, 2004, FEBS LETT, V565, P23, DOI 10.1016/j.febslet.2004.03.069; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Spirin V, 2007, AM J HUM GENET, V81, P1298, DOI 10.1086/522497; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; TOOMEY RE, 1966, J BIOL CHEM, V241, P1159; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	50	1050	1069	1	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					56	65		10.1038/ng.291	http://dx.doi.org/10.1038/ng.291			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19060906	Green Submitted, Green Accepted			2022-12-25	WOS:000262085300016
J	Liu, XJ; Gingrich, JR; Vargas-Caballero, M; Dong, YN; Sengar, A; Beggs, S; Wang, SH; Ding, HK; Frankland, PW; Salter, MW				Liu, Xue Jun; Gingrich, Jeffrey R.; Vargas-Caballero, Mariana; Dong, Yi Na; Sengar, Ameet; Beggs, Simon; Wang, Szu-Han; Ding, Hoi Ki; Frankland, Paul W.; Salter, Michael W.			Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex	NATURE MEDICINE			English	Article							PAW FORMALIN TEST; TYROSINE PHOSPHORYLATION; SYNAPTIC-TRANSMISSION; NR2B SUBUNIT; PROTEIN; KINASE; MECHANISMS; TRANSDUCTION; POTENTIATION; MAINTENANCE	Chronic pain hypersensitivity depends on N-methyl-D-aspartate receptors (NMDARs). However, clinical use of NMDAR blockers is limited by side effects resulting from suppression of the physiological functions of these receptors. Here we report a means to suppress pain hypersensitivity without blocking NMDARs, but rather by inhibiting the binding of a key enhancer of NMDAR function, the protein tyrosine kinase Src. We show that a peptide consisting of amino acids 40-49 of Src fused to the protein transduction domain of the HIV Tat protein (Src40-49Tat) prevented pain behaviors induced by intraplantar formalin and reversed pain hypersensitivity produced by intraplantar injection of complete Freund's adjuvant or by peripheral nerve injury. Src40-49Tat had no effect on basal sensory thresholds, acute nociceptive responses or cardiovascular, respiratory, locomotor or cognitive functions. Thus, through targeting of Src-mediated enhancement of NMDARs, inflammatory and neuropathic pain are suppressed without the deleterious consequences of directly blocking NMDARs, an approach that may be of broad relevance to managing chronic pain.	[Liu, Xue Jun; Gingrich, Jeffrey R.; Vargas-Caballero, Mariana; Dong, Yi Na; Sengar, Ameet; Beggs, Simon; Wang, Szu-Han; Ding, Hoi Ki; Frankland, Paul W.; Salter, Michael W.] Univ Toronto, Program Neurosci & Mental Hlth, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Liu, Xue Jun; Gingrich, Jeffrey R.; Vargas-Caballero, Mariana; Dong, Yi Na; Sengar, Ameet; Beggs, Simon; Wang, Szu-Han; Ding, Hoi Ki; Frankland, Paul W.; Salter, Michael W.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Liu, Xue Jun; Dong, Yi Na; Beggs, Simon; Salter, Michael W.] Univ Toronto, Univ Toronto Ctr Study Pain, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Salter, MW (corresponding author), Univ Toronto, Program Neurosci & Mental Hlth, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.	Mike.salter@utoronto.ca	Sengar, Ameet/E-6940-2011; Beggs, Simon/AAI-4438-2021; Wang, Szu-Han/AAR-1137-2021	Sengar, Ameet/0000-0002-6328-1108; Beggs, Simon/0000-0002-1582-8391; Vargas-Caballero, Mariana/0000-0003-2326-4001; Wang, Szu-Han/0000-0003-0500-0352	Canadian Institutes of Health Research [MT-12682]; Neuroscience Canada Brain Repair Program; Ontario Neurotrauma Foundation through the Brain Repair Program; Krembil Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Neuroscience Canada Brain Repair Program; Ontario Neurotrauma Foundation through the Brain Repair Program; Krembil Foundation	This work is supported by grants from the Canadian Institutes of Health Research (CIHR; grant number MT-12682), the Neuroscience Canada Brain Repair Program and its partner the Ontario Neurotrauma Foundation through the Brain Repair Program, and the Krembil Foundation (all to M. W. S.). M. W. S. is an International Research Scholar of the Howard Hughes Medical Institute and holds a Canada Research Chair (Tier I) in Neuroplasticity and Pain. X.J.L. is a CIHR & Ronald Melzack Pain Research Award recipient and a fellow of the Canadian Arthritis Network, as well as of the Pain: Molecules to Community Strategic Training Initiative in Health Research of CIHR. M.V.-C. is an International Fellow of the Wellcome Trust UK. Src knockout mice were obtained as gift from B. F. Boyce, University of Rochester Medical Center. We thank S. Singhroy and D. Wong for technical support and T. Trang and J. Hicks for helpful comments on the manuscript.	Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; Bast T, 2003, HIPPOCAMPUS, V13, P657, DOI 10.1002/hipo.10115; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Brown DG, 2006, CURR TOP MED CHEM, V6, P749, DOI 10.2174/156802606777057571; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Dingledine R, 1999, PHARMACOL REV, V51, P7; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101; GINGRICH JR, 2004, THESIS U TORONTO; Guo W, 2002, J NEUROSCI, V22, P6208; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Katsura H, 2006, J NEUROSCI, V26, P8680, DOI 10.1523/JNEUROSCI.1771-06.2006; Liu ST, 2001, ASIAN PAC J ALLERGY, V19, P29; Liu XJ, 2000, EUR J PHARMACOL, V408, P143, DOI 10.1016/S0014-2999(00)00742-1; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; ROSENBLUM K, 1995, P NATL ACAD SCI USA, V92, P1157, DOI 10.1073/pnas.92.4.1157; Saade NE, 2006, PAIN, V126, P280, DOI 10.1016/j.pain.2006.07.010; SALTER MW, 1994, J NEUROSCI, V14, P1563, DOI 10.1523/JNEUROSCI.14-03-01563.1994; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sawynok Jana, 2004, Reviews in Analgesia, V7, P145; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Smith Paul F, 2003, Curr Opin Investig Drugs, V4, P826; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; WHEELERACETO H, 1991, PSYCHOPHARMACOLOGY, V104, P35, DOI 10.1007/BF02244551; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xu JD, 2008, J BIOL CHEM, V283, P17503, DOI 10.1074/jbc.M800917200; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	45	156	165	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2008	14	12					1325	1332		10.1038/nm.1883	http://dx.doi.org/10.1038/nm.1883			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	379JX	19011637	Green Accepted			2022-12-25	WOS:000261393600016
J	Sun, XG; Rogoff, HA; Li, CJ				Sun, Xiangao; Rogoff, Harry A.; Li, Chiang J.			Asymmetric RNA duplexes mediate RNA interference in mammalian cells	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRANDED-RNA; SIRNA DUPLEXES; MESSENGER-RNA; GUIDE STRAND; POTENT RNAI; TARGET; SPECIFICITY; DISSECTION; ACTIVATION; ARGONAUTE2	RNA interference (RNAi) has become an indispensable technology for biomedical research and has demonstrated the potential to become a new class of therapeutic(1-3). Current RNAi technology in mammalian cells relies on short interfering RNA (siRNA) consisting of symmetrical duplexes of 19-21 base pairs (bp) with 3' overhangs(4,5). Here we report that asymmetric RNA duplexes with 3' and 5' antisense overhangs silence mammalian genes effectively. An asymmetric interfering RNA (aiRNA) of 15 bp was incorporated into the RNA-induced silencing complex (RISC) and mediated sequence-specific cleavage of the target mRNA between base 10 and 11 relative to the 5' end of the antisense strand. The gene silencing mediated by aiRNA was efficacious, durable and correlated with reduced off-target silencing by the sense strand. These results establish aiRNA as a scaffold structure for designing RNA duplexes to induce RNAi in mammalian cells.	[Sun, Xiangao; Rogoff, Harry A.; Li, Chiang J.] Boston Biomed Inc, Dept Therapeut Biol, Norwood, MA 02062 USA; [Li, Chiang J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol,Skip Ackerman Ctr Mol Therapeut, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Li, CJ (corresponding author), Boston Biomed Inc, Dept Therapeut Biol, 333 Providence Highway, Norwood, MA 02062 USA.	cli@bostonbiomedical.com						Bolcato-Bellemin AL, 2007, P NATL ACAD SCI USA, V104, P16050, DOI 10.1073/pnas.0707831104; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chu CY, 2008, RNA, V14, P1714, DOI 10.1261/rna.1161908; Clark PR, 2008, NUCLEIC ACIDS RES, V36, P1081, DOI 10.1093/nar/gkm630; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Hohjoh H, 2004, FEBS LETT, V557, P193, DOI 10.1016/S0014-5793(03)01492-3; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Sano M, 2008, NUCLEIC ACIDS RES, V36, P5812, DOI 10.1093/nar/gkn584; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P2136, DOI 10.1093/nar/gkn042; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	29	97	145	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2008	26	12					1379	1382		10.1038/nbt.1512	http://dx.doi.org/10.1038/nbt.1512			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	382FR	19029911				2022-12-25	WOS:000261591300024
J	Aggarwal, S				Aggarwal, Saurabh			What's fueling the biotech engine-2007	NATURE BIOTECHNOLOGY			English	Editorial Material								Despite losses in revenue from erythropoietins, historically the highest earner of all biologics, more than 100 biotech drugs continued their upward trend in sales begun in 2006, with antibodies and insulin analogs fueling growth at double-digit rates.				saurabhaggarwal@gmail.com						Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kuter DJ, 2008, EUR J HAEMATOL, V80, P9, DOI 10.1111/j.1600-0609.2007.00999.x; Lanthier M, 2008, NAT REV DRUG DISCOV, V7, P733, DOI 10.1038/nrd2636; LONG D, 2008, US PHARM MARKET TREN; Mack GS, 2007, NAT BIOTECHNOL, V25, P1331, DOI 10.1038/nbt1207-1331; Ratner Mark, 2008, Nat Biotechnol, V26, P485, DOI 10.1038/nbt0508-485b; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Schneider CK, 2008, NAT BIOTECHNOL, V26, P985, DOI 10.1038/nbt0908-985; Steinbrook R, 2007, NEW ENGL J MED, V356, P2448, DOI 10.1056/NEJMp078100	11	39	41	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2008	26	11					1227	1233		10.1038/nbt1108-1227	http://dx.doi.org/10.1038/nbt1108-1227			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	371LG	18997759				2022-12-25	WOS:000260832200014
J	Ahmed, ZM; Masmoudi, S; Kalay, E; Belyantseva, IA; Mosrati, MA; Collin, RWJ; Riazuddin, S; Hmani-Aifa, M; Venselaar, H; Kawar, MN; Tlili, A; van der Zwaag, B; Khan, SY; Ayadi, L; Riazuddin, SA; Morell, RJ; Griffith, AJ; Charfedine, I; Caylan, R; Oostrik, J; Karaguzel, A; Ghorbel, A; Riazuddin, S; Friedman, TB; Ayadi, H; Kremer, H				Ahmed, Zubair M.; Masmoudi, Saber; Kalay, Ersan; Belyantseva, Inna A.; Mosrati, Mohamed Ali; Collin, Rob W. J.; Riazuddin, Saima; Hmani-Aifa, Mounira; Venselaar, Hanka; Kawar, Mayya N.; Tlili, Abdelaziz; van der Zwaag, Bert; Khan, Shahid Y.; Ayadi, Leila; Riazuddin, S. Amer; Morell, Robert J.; Griffith, Andrew J.; Charfedine, Ilhem; Caylan, Refik; Oostrik, Jaap; Karaguzel, Ahmet; Ghorbel, Abdelmonem; Riazuddin, Sheikh; Friedman, Thomas B.; Ayadi, Hammadi; Kremer, Hannie			Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans	NATURE GENETICS			English	Article							CATECHOL-O-METHYLTRANSFERASE; OUTER HAIR-CELLS; HEARING IMPAIRMENT; CORTICAL LATTICE; LOCUS DFNB63; GENOME-WIDE; EAR; TRANSCRIPTION; LOCALIZATION; METHYLATION	Many proteins necessary for sound transduction have been identified through positional cloning of genes that cause deafness(1-3). We report here that mutations of LRTOMT are associated with profound nonsyndromic hearing loss at the DFNB63 locus on human chromosome 11q13.3-q13.4. LRTOMT has two alternative reading frames and encodes two different proteins, LRTOMT1 and LRTOMT2, detected by protein blot analyses. LRTOMT2 is a putative methyltransferase. During evolution, new transcripts can arise through partial or complete coalescence of genes(4). We provide evidence that in the primate lineage LRTOMT evolved from the fusion of two neighboring ancestral genes, which exist as separate genes (Lrrc51 and Tomt) in rodents.	[Kalay, Ersan; Collin, Rob W. J.; Oostrik, Jaap; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Kalay, Ersan; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Ahmed, Zubair M.; Belyantseva, Inna A.; Riazuddin, Saima; Kawar, Mayya N.; Morell, Robert J.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, Rockville, MD 20850 USA; [Masmoudi, Saber; Mosrati, Mohamed Ali; Hmani-Aifa, Mounira; Tlili, Abdelaziz; Ayadi, Leila; Ayadi, Hammadi] Ctr Biotechnol, Unite Cibles Diagnost & Therapie, Sfax 3018, Tunisia; [Kalay, Ersan; Karaguzel, Ahmet] Karadeniz Tech Univ, Fac Med, Dept Med Biol, TR-61080 Trabzon, Turkey; [Venselaar, Hanka] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; [van der Zwaag, Bert] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, NL-3584 CG Utrecht, Netherlands; [Khan, Shahid Y.; Riazuddin, S. Amer; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, Rockville, MD 20850 USA; [Charfedine, Ilhem; Ghorbel, Abdelmonem] CHU Habib Bourguiba Sfax, Serv ORL, Sfax 3029, Tunisia; [Caylan, Refik] Karadeniz Tech Univ, Fac Med, Dept Otorhinolaryngol, TR-61080 Trabzon, Turkey; [Kremer, Hannie] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Kremer, Hannie] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Centre de Biotechnologie de Borj Cedria; Centre de Biotechnologie de Sfax; Universite de Sfax; Karadeniz Technical University; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Universite de Sfax; Hopital Habib Bourguiba; Karadeniz Technical University; Radboud University Nijmegen; Radboud University Nijmegen	Kremer, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands.	friedman@nidcd.nih.gov; directeur.general@cbs.rnrt.tn; H.Kremer@antrg.umcn.nl	Tlili, Abdelaziz/AAE-8699-2020; Kalay, Ersan/AAL-2906-2021; Oostrik, Jaap/A-1703-2016; Venselaar, Hanka/D-2009-2016; Kremer, Hannie/F-5126-2010; SHEIKH, RIAZUDDIN/L-2406-2015; Morell, Robert James/Q-2042-2019; Collin, Rob/N-3575-2014; Masmoudi, Saber/W-1478-2019; Mosrati, Mohamed Ali/D-9625-2019	Kalay, Ersan/0000-0002-1467-2268; Venselaar, Hanka/0000-0001-9824-6559; Kremer, Hannie/0000-0002-0841-8693; Mosrati, Mohamed Ali/0000-0001-9663-9885; Saber, Masmoudi/0000-0002-1076-5256; Tlili, Abdelaziz/0000-0002-8039-3013; Morell, Robert/0000-0003-1537-7356	NIDCD/NIH [ZO1DC00035-06, ZO1DC000060, ZO1DC000064]; European Commission FP6 Integrated Project EUROHEAR [LSHG-CT-20054-512063:2]; Heinsius Houbolt Foundation; Karadeniz Technical University Research Fund [2002.114.001.3, 2006.114.001.1]; Le Ministere de l'Enseignement Superieur; de la Recherche Scientifique et de la Technologie, Tunisia; Higher Education Commission and the Ministry of Science and Technology in Islamabad, Pakistan; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039, ZIADC000060] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); European Commission FP6 Integrated Project EUROHEAR(European CommissionEuropean Commission Joint Research Centre); Heinsius Houbolt Foundation; Karadeniz Technical University Research Fund; Le Ministere de l'Enseignement Superieur; de la Recherche Scientifique et de la Technologie, Tunisia; Higher Education Commission and the Ministry of Science and Technology in Islamabad, Pakistan; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the families for their participation in this study, which was supported by NIDCD/NIH (intramural research fund ZO1DC00035-06 and ZO1DC00035-06 to T.B.F., ZO1DC000060 and ZO1DC000064 to A.J.G.), funds from the European Commission FP6 Integrated Project EUROHEAR (contract number LSHG-CT-20054-512063:2), the Heinsius Houbolt Foundation and the Karadeniz Technical University Research Fund (contract numbers 2002.114.001.3 and 2006.114.001.1). In Tunisia work was also funded by Le Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Technologie, Tunisia. In Pakistan the Higher Education Commission and the Ministry of Science and Technology in Islamabad, Pakistan supported this project. We thank B. Ploplis, M. Ansari, A. Lagziel, E. Boger, S. Kitajiri, E. van Wijk, T. Peters and H. Spierenburg for their technical help and G. Vriend, F. Cremers, H. Brunner and C. Cremers for discussion. We also thank J. Bird, D. Drayna, M. Meisler and S. Sullivan for advice and comments in preparing the manuscript. We thank the Southwest National Primate Research Center, San Antonio, Texas for providing brain tissue samples from chimpanzee and baboon, and the Duke Lemur Center, Durham, North Carolina for brain tissue samples from a lemur.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Frolenkov GI, 1998, MOL BIOL CELL, V9, P1961, DOI 10.1091/mbc.9.8.1961; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Grant L, 2007, PFLUG ARCH EUR J PHY, V454, P793, DOI 10.1007/s00424-007-0253-z; Gregory-Evans CY, 2007, HUM MOL GENET, V16, P2482, DOI 10.1093/hmg/ddm204; HOLLEY MC, 1990, J CELL SCI, V96, P283; HOLLEY MC, 1992, J CELL SCI, V102, P569; Kalay E, 2007, J MOL MED, V85, P397, DOI 10.1007/s00109-006-0136-3; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Khan SY, 2007, HUM GENET, V120, P789, DOI 10.1007/s00439-006-0275-1; Lautala P, 2001, MOL PHARMACOL, V59, P393, DOI 10.1124/mol.59.2.393; Liang H, 2006, GENOME RES, V16, P190, DOI 10.1101/gr.4246506; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; NISHIDA Y, 1993, HEARING RES, V65, P274, DOI 10.1016/0378-5955(93)90220-U; Parra MK, 2008, EMBO J, V27, P122, DOI 10.1038/sj.emboj.7601957; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; QUELLE DE, 1995, CELL, V83, P993; Tekin M, 2007, AM J HUM GENET, V80, P338, DOI 10.1086/510920; Tlili A, 2007, ANN HUM GENET, V71, P271, DOI 10.1111/j.1469-1809.2006.00337.x; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	30	49	62	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1335	1340		10.1038/ng.245	http://dx.doi.org/10.1038/ng.245			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18953341	Green Accepted			2022-12-25	WOS:000260501500027
J	Choi, CK; Vicente-Manzanares, M; Zareno, J; Whitmore, LA; Mogilner, A; Horwitz, AR				Choi, Colin K.; Vicente-Manzanares, Miguel; Zareno, Jessica; Whitmore, Leanna A.; Mogilner, Alex; Horwitz, Alan Rick			Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESIONS; MIGRATING CELLS; ARP2/3 COMPLEX; STRESS FIBERS; REGULATES ADHESION; MATRIX ADHESIONS; F-ACTIN; PROTRUSION; PAXILLIN; DYNAMICS	Using two-colour imaging and high resolution TIRF microscopy, we investigated the assembly and maturation of nascent adhesions in migrating cells. We show that nascent adhesions assemble and are stable within the lamellipodium. The assembly is independent of myosin II but its rate is proportional to the protrusion rate and requires actin polymerization. At the lamellipodium back, the nascent adhesions either disassemble or mature through growth and elongation. Maturation occurs along an alpha-actinin-actin template that elongates centripetally from nascent adhesions. alpha-Actinin mediates the formation of the template and organization of adhesions associated with actin filaments, suggesting that actin crosslinking has a major role in this process. Adhesion maturation also requires myosin II. Rescue of a myosin IIA knockdown with an actin-bound but motor-inhibited mutant of myosin IIA shows that the actin crosslinking function of myosin II mediates initial adhesion maturation. From these studies, we have developed a model for adhesion assembly that clarifies the relative contributions of myosin II and actin polymerization and organization.	[Choi, Colin K.; Vicente-Manzanares, Miguel; Zareno, Jessica; Whitmore, Leanna A.; Horwitz, Alan Rick] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Choi, Colin K.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95618 USA; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95618 USA	University of Virginia; University of Virginia; University of California System; University of California Davis; University of California System; University of California Davis	Vicente-Manzanares, M (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA.	mvicente@virginia.edu	Vicente-Manzanares, Miguel/H-1010-2018; Bustelo, Xose R./A-9526-2010; Mogilner, Alex/A-3135-2008	Vicente-Manzanares, Miguel/0000-0001-5943-3220; Bustelo, Xose R./0000-0001-9398-6072; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023244, R37GM023244, U54GM064346] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM023244-33, R37 GM023244, GM23244, U54 GM064346-08, U54 GM064346, R01 GM023244] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Eto M, 2007, J BIOL CHEM, V282, P17806, DOI 10.1074/jbc.M700944200; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Ma XF, 2004, MOL BIOL CELL, V15, P2568, DOI 10.1091/mbc.E03-11-0836; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Schafer DA, 1998, J CELL BIOL, V143, P1919, DOI 10.1083/jcb.143.7.1919; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Triplett JW, 2006, AM J PHYSIOL-CELL PH, V291, pC909, DOI 10.1152/ajpcell.00113.2006; VASILIEV JM, 1984, BIOCHIM BIOPHYS ACTA, V780, P21, DOI 10.1016/0304-419X(84)90006-4; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Xu XXS, 2001, DEV BIOL, V232, P255, DOI 10.1006/dbio.2000.0132; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	49	543	546	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1039	U36		10.1038/ncb1763	http://dx.doi.org/10.1038/ncb1763			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160484	Green Accepted			2022-12-25	WOS:000258910400009
J	Myers, S; Freeman, C; Auton, A; Donnelly, P; McVean, G				Myers, Simon; Freeman, Colin; Auton, Adam; Donnelly, Peter; McVean, Gil			A common sequence motif associated with recombination hot spots and genome instability in humans	NATURE GENETICS			English	Article							MEIOTIC RECOMBINATION; GERMLINE MUTATION; ALLELE DIVERSITY; MINISATELLITE; HOTSPOT; COMPLEX; CROSSOVERS; REARRANGEMENTS; MICRODELETION; GENERATION	In humans, most meiotic crossover events are clustered into short regions of the genome known as recombination hot spots. We have previously identified DNA motifs that are enriched in hot spots, particularly the 7-mer CCTCCCT. Here we use the increased hot-spot resolution afforded by the Phase 2 HapMap and novel search methods to identify an extended family of motifs based around the degenerate 13-mer CCNCCNTNNCCNC, which is critical in recruiting crossover events to at least 40% of all human hot spots and which operates on diverse genetic backgrounds in both sexes. Furthermore, these motifs are found in hypervariable minisatellites and are clustered in the breakpoint regions of both disease-causing nonallelic homologous recombination hot spots and common mitochondrial deletion hot spots, implicating the motif as a driver of genome instability.	[Myers, Simon] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Myers, Simon; Freeman, Colin; Auton, Adam; Donnelly, Peter; McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Auton, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Cornell University; University of Oxford; Wellcome Centre for Human Genetics	Myers, S (corresponding author), Massachusetts Inst Technol & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	myers@stats.ox.ac.uk	Myers, Simon R/A-6792-2015; Auton, Adam J/B-1159-2009	Myers, Simon R/0000-0002-2585-9626; Donnelly, Peter/0000-0001-9495-3408	Engineering and Physical Sciences Research Council (EPSRC); Wolfson Foundation; EU; Wellcome Trust	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wolfson Foundation; EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank J. Lupski for help with compiling information on NAHR hot spots and G. Coop for discussion. We thank the Engineering and Physical Sciences Research Council (EPSRC), the Wolfson Foundation, the EU and the Wellcome Trust for financial support.	Andreassen R, 1998, HUM MOL GENET, V7, P2113, DOI 10.1093/hmg/7.13.2113; Baudat F, 2007, PLOS GENET, V3, P1029, DOI 10.1371/journal.pgen.0030100; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Berg I, 2003, AM J HUM GENET, V72, P1436, DOI 10.1086/375629; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Buard J, 2000, AM J HUM GENET, V67, P333, DOI 10.1086/303015; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Lopes J, 2006, MOL CELL BIOL, V26, P6675, DOI 10.1128/MCB.00649-06; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; May CA, 1996, HUM MOL GENET, V5, P1823, DOI 10.1093/hmg/5.11.1823; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Tamaki K, 1999, HUM MOL GENET, V8, P879, DOI 10.1093/hmg/8.5.879; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950	30	324	328	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1124	1129		10.1038/ng.213	http://dx.doi.org/10.1038/ng.213			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165926				2022-12-25	WOS:000258761200028
J	Meixner, A; Zenz, R; Schonthaler, HB; Kenner, L; Scheuch, H; Penninger, JM; Wagner, EF				Meixner, Arabella; Zenz, Rainer; Schonthaler, Helia B.; Kenner, Lukas; Scheuch, Harald; Penninger, Josef M.; Wagner, Erwin F.			Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation	NATURE CELL BIOLOGY			English	Article							COLONY-STIMULATING FACTOR; MICE LACKING JUNB; SKIN-DISEASE; C-JUN; EXPRESSION; GRANULOCYTE; PHASE; DIFFERENTIATION; PROLIFERATION; KERATINOCYTES	Mice that lack JunB in epidermal cells are born with normal skin; however, keratinocytes hyperproliferate in vitro and on TPA treatment in vivo. Loss of JunB expression in the epidermis of adult mice affects the skin, the proliferation of haematopoietic cells and bone formation. G-CSF is a direct transcriptional target of JunB and mutant epidermis releases large amounts of G-CSF that reach high systemic levels and cause skin ulcerations, myeloproliferative disease and low bone mass. The absence of G-CSF significantly improves hyperkeratosis and prevents the development of myeloproliferative disease, but does not affect bone loss. This study describes a mechanism by which the absence of JunB in epithelial cells causes multi-organ disease, suggesting that the epidermis can act as an endocrine-like organ.	[Meixner, Arabella; Zenz, Rainer; Schonthaler, Helia B.; Kenner, Lukas; Scheuch, Harald; Wagner, Erwin F.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Meixner, Arabella; Penninger, Josef M.] Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Zenz, Rainer; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res LBI CR, A-1090 Vienna, Austria; [Kenner, Lukas] Med Univ Vienna, Inst Clin Pathol, A-1090 Vienna, Austria; [Schonthaler, Helia B.; Wagner, Erwin F.] CNIO, Canc Cell Biol Programme, E-28029 Madrid, Spain	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Ludwig Boltzmann Institute; Medical University of Vienna; Centro Nacional de Investigaciones Oncologicas (CNIO)	Wagner, EF (corresponding author), Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	ewagner@cnio.es	Schönthaler, Helia/AAG-4767-2021; Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Wagner, Erwin F/0000-0001-7872-0196; Kenner, Lukas/0000-0003-2184-1338				Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Borregaard N, 2005, J LEUKOCYTE BIOL, V77, P439, DOI 10.1189/jlb.0704381; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Hess J, 2003, J CELL SCI, V116, P4587, DOI 10.1242/jcs.00772; Kawada A, 1997, ARCH DERMATOL RES, V289, P600, DOI 10.1007/s004030050246; Kawakami T, 2004, ARCH DERMATOL, V140, P570, DOI 10.1001/archderm.140.5.570; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kokai Y, 2002, BONE, V30, P880, DOI 10.1016/S8756-3282(02)00733-0; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LEE MY, 1991, BLOOD, V77, P2135; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Licht AH, 2006, J CELL BIOL, V175, P981, DOI 10.1083/jcb.200605149; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu DL, 2004, LEUKEMIA RES, V28, pS61, DOI 10.1016/S0145-2126(03)00247-1; Mueller MM, 1999, INT J CANCER, V83, P780, DOI 10.1002/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.3.CO;2-3; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	33	42	43	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					1003	1011		10.1038/ncb1761	http://dx.doi.org/10.1038/ncb1761			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641637				2022-12-25	WOS:000258147100019
